PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Akeju, O; Kim, SE; Vazquez, R; Rhee, J; Pavone, KJ; Hobbs, LE; Purdon, PL; Brown, EN				Akeju, Oluwaseun; Kim, Seong-Eun; Vazquez, Rafael; Rhee, James; Pavone, Kara J.; Hobbs, Lauren E.; Purdon, Patrick L.; Brown, Emery N.			Spatiotemporal Dynamics of Dexmedetomidine-Induced Electroencephalogram Oscillations	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; CRITICALLY-ILL PATIENTS; HYPNOTIC RESPONSE; AGONIST DEXMEDETOMIDINE; POSTOPERATIVE DELIRIUM; SYSTEMIC INFLAMMATION; GENERAL-ANESTHESIA; COHERENCE ANALYSIS; ELDERLY-PATIENTS; LOCUS-COERULEUS	An improved understanding of the neural correlates of altered arousal states is fundamental for precise brain state targeting in clinical settings. More specifically, electroencephalogram recordings are now increasingly being used to relate drug-specific oscillatory dynamics to clinically desired altered arousal states. Dexmedetomidine is an anesthetic adjunct typically administered in operating rooms and intensive care units to produce and maintain a sedative brain state. However, a high-density electroencephalogram characterization of the neural correlates of the dexmedetomidine-induced altered arousal state has not been previously accomplished. Therefore, we administered dexmedetomidine (1mcg/kg bolus over 10 minutes, followed by 0.7mcg/kg/hr over 50 minutes) and recorded high-density electroencephalogram signals in healthy volunteers, 18-36 years old (n = 8). We analyzed the data with multitaper spectral and global coherence methods. We found that dexmedetomidine was associated with increased slow-delta oscillations across the entire scalp, increased theta oscillations in occipital regions, increased spindle oscillations in frontal regions, and decreased beta oscillations across the entire scalp. The theta and spindle oscillations were globally coherent. During recovery from this state, these electroencephalogram signatures reverted towards baseline signatures. We report that dexmedetomidineinduced electroencephalogram signatures more closely approximate the human sleep onset process than previously appreciated. We suggest that these signatures may be targeted by real time visualization of the electroencephalogram or spectrogram in clinical settings. Additionally, these signatures may aid the development of control systems for principled neurophysiological based brain-state targeting.	[Akeju, Oluwaseun; Vazquez, Rafael; Rhee, James; Pavone, Kara J.; Hobbs, Lauren E.; Purdon, Patrick L.; Brown, Emery N.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Kim, Seong-Eun; Brown, Emery N.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Akeju, O (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA.	oluwaseun.akeju@mgh.harvard.edu	Akeju, Oluwaseun/R-7846-2019; GARCÍA, RAFAEL VÁZQUEZ/J-8595-2018; Rhee, James/V-9973-2019	Akeju, Oluwaseun/0000-0002-6740-1250; GARCÍA, RAFAEL VÁZQUEZ/0000-0001-8876-474X; PAVONE, KARA/0000-0003-3425-8651	National Institutes of Health (Bethesda, MD) [R01 AG053582, TR01 GM104948]; Foundation of Anesthesia Education and Research, Rochester, Minnesota; Massachusetts General Hospital Faculty Development Award, Boston, MA; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts	National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation of Anesthesia Education and Research, Rochester, Minnesota; Massachusetts General Hospital Faculty Development Award, Boston, MA; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts	This work was supported by the National Institutes of Health (Bethesda, MD) R01 AG053582 (to OA) and TR01 GM104948 (to ENB); Foundation of Anesthesia Education and Research, Rochester, Minnesota (to OA); Massachusetts General Hospital Faculty Development Award, Boston, MA (to OA); and by the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts.	Akeju O, 2014, ELIFE, V3, DOI 10.7554/eLife.04499; Akeju O, 2014, ANESTHESIOLOGY, V121, P978, DOI 10.1097/ALN.0000000000000419; Alexopoulou C, 2014, ANESTHESIOLOGY, V121, P801, DOI 10.1097/ALN.0000000000000361; Asimakopoulos G, 1999, PERFUSION-UK, V14, P269, DOI 10.1177/026765919901400406; Babadi B, 2014, IEEE T BIO-MED ENG, V61, P1555, DOI 10.1109/TBME.2014.2311996; Bjornsson GL, 2007, SCAND J IMMUNOL, V65, P99, DOI 10.1111/j.1365-3083.2006.01872.x; Bryclon L, 2008, BIOL PSYCHIAT, V63, P1022, DOI 10.1016/j.biopsych.2007.12.007; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Capri M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00173; CHIU TH, 1995, EUR J PHARMACOL, V285, P261, DOI 10.1016/0014-2999(95)00417-J; Cimenser A, 2011, P NATL ACAD SCI USA, V108, P8832, DOI 10.1073/pnas.1017041108; CORREASALES C, 1992, ANESTHESIOLOGY, V76, P948, DOI 10.1097/00000542-199206000-00013; Culley DJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00107; De Gennaro L, 2007, NEUROIMAGE, V36, P1277, DOI 10.1016/j.neuroimage.2007.04.013; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Finelli LA, 2001, NEUROPSYCHOPHARMACOL, V25, pS57, DOI 10.1016/S0893-133X(01)00320-7; Garrity AG, 2015, SLEEP, V38, P73, DOI 10.5665/sleep.4328; Huotari AM, 2004, BRIT J ANAESTH, V92, P18, DOI 10.1093/bja/aeh022; Huupponen E, 2008, ACTA ANAESTH SCAND, V52, P289, DOI 10.1111/j.1399-6576.2007.01537.x; Ingiosi AM, 2013, CURR OPIN NEUROBIOL, V23, P806, DOI 10.1016/j.conb.2013.02.003; Jacobs J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0304; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; JORM CM, 1993, BRIT J ANAESTH, V71, P447, DOI 10.1093/bja/71.3.447; Keck M, 2009, WIEN MED WOCHENSCHR, V159, P327, DOI 10.1007/s10354-009-0651-2; KRAGSBJERG P, 1995, EUR J SURG, V161, P17; Krzyszton CP, 2008, AM J PHYSIOL-REG I, V295, pR1109, DOI 10.1152/ajpregu.90302.2008; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Li B, 2015, SCI REP-UK, V5, DOI 10.1038/srep12342; Liu P, 2013, CHINESE MED J-PEKING, V126, P3621, DOI 10.3760/cma.j.issn.0366-6999.20130211; Marx N, 1997, J AM COLL CARDIOL, V30, P165, DOI 10.1016/S0735-1097(97)00116-2; Marzano C, 2013, SLEEP MED, V14, P1112, DOI 10.1016/j.sleep.2013.05.021; Mizobe T, 1996, J CLIN INVEST, V98, P1076, DOI 10.1172/JCI118887; NACIFCOELHO C, 1994, ANESTHESIOLOGY, V81, P1527, DOI 10.1097/00000542-199412000-00029; Nelson LE, 2003, ANESTHESIOLOGY, V98, P428, DOI 10.1097/00000542-200302000-00024; OKEEFE ST, 1994, BRIT J ANAESTH, V73, P673, DOI 10.1093/bja/73.5.673; Oto J, 2012, INTENS CARE MED, V38, P1982, DOI 10.1007/s00134-012-2685-y; Ozgoren Murat, 2010, Open Neuroimag J, V4, P121, DOI 10.2174/1874440001004010121; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Purdon PL, 2015, ANESTHESIOLOGY, V123, P937, DOI 10.1097/ALN.0000000000000841; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; Reade MC, 2016, JAMA-J AM MED ASSOC, V315, P1460, DOI 10.1001/jama.2016.2707; Reade MC, 2009, CRIT CARE, V13, DOI 10.1186/cc7890; Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445; Richwine AF, 2009, BRAIN BEHAV IMMUN, V23, P794, DOI 10.1016/j.bbi.2009.02.020; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Shawcross DL, 2010, HEPATOLOGY, V51, P1062, DOI 10.1002/hep.23367; Shimaoka M, 2008, EUR J ANAESTH, V25, P146, DOI 10.1017/S0265021507003389; Siami S, 2008, CRIT CARE CLIN, V24, P67, DOI 10.1016/j.ccc.2007.10.001; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Stinghen AEM, 2009, NEPHRON CLIN PRACT, V111, pC117, DOI 10.1159/000191205; Sun Y, 2007, TRANSL RES, V150, P197, DOI 10.1016/j.trsl.2007.06.003; Vacas S, 2013, BRIT MED BULL, V106, P161, DOI 10.1093/bmb/ldt006; van Munster BC, 2008, J AM GERIATR SOC, V56, P1704, DOI 10.1111/j.1532-5415.2008.01851.x; Weichhart T, 2008, EUR J CLIN INVEST, V38, P29, DOI 10.1111/j.1365-2362.2008.02006.x; Wolter S, 2006, CLIN NEUROPHYSIOL, V117, P157, DOI 10.1016/j.clinph.2005.08.031; Wright KP, 1995, SLEEP, V18, P880, DOI 10.1093/sleep/18.10.880	58	49	51	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163431	10.1371/journal.pone.0163431	http://dx.doi.org/10.1371/journal.pone.0163431			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711165	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600025
J	Kumar, D; Broor, S; Rajala, MS				Kumar, Deepshikha; Broor, Shobha; Rajala, Maitreyi S.			Interaction of Host Nucleolin with Influenza A Virus Nucleoprotein in the Early Phase of Infection Limits the Late Viral Gene Expression	PLOS ONE			English	Article							PROTEIN; IDENTIFICATION; REPLICATION; POLYMERASE; NS1; LOCALIZATION; HELICASE; NUCLEUS; COMPLEX; PLAYS	Influenza A virus nucleoprotein, is a multifunctional RNA-binding protein, encoded by segment-5 of the negative sense RNA genome. It serves as a key connector between the virus and the host during virus replication. It continuously shuttles between the cytoplasm and the nucleus interacting with various host cellular factors. In the current study, host proteins interacting with nucleoprotein of Influenza A virus of H1N1 2009 pandemic strain were identified by co-immunoprecipitation studies followed by MALDI-TOF/MS analysis. Here we report the host nucleolin, a major RNA-binding protein of the nucleolus as a novel interacting partner to influenza A virus nucleoprotein. We thus, explored the implications of this interaction in virus life cycle and our studies have shown that these two proteins interact early during infection in the cytoplasm of infected cells. Depletion of nucleolin in A549 cells by siRNA targeting endogenous nucleolin followed by influenza A virus infection, disrupted its interaction with viral nucleoprotein, resulting in increased expression of gene transcripts encoding late viral proteins; matrix (M1) and hemagglutinin (HA) in infected cells. On the contrary, over expression of nucleolin in cells transiently transfected with pEGFP-NCL construct followed by virus infection significantly reduced the late viral gene transcripts, and consequently the viral titer. Altered expression of late viral genes and titers following manipulation of host cellular nucleolin, proposes the functional importance of its interaction with nucleoprotein during influenza A virus infection.	[Kumar, Deepshikha; Rajala, Maitreyi S.] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi, India; [Broor, Shobha] Shree Guru Gobind Singh Tricentenary Univ, Dept Microbiol, Fac Med & Hlth Sci, Gurgaon, Haryana, India	Jawaharlal Nehru University, New Delhi	Rajala, MS (corresponding author), Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi, India.	msrajala@mail.jnu.ac.in	Broor, Shobha/AAX-4163-2021	Broor, Shobha/0000-0001-9679-4180	Indian Council of Medical Research [VIR/15/2011-ECD-I]; Indian Council of Medical Research, New Delhi, India [VIR/15/2011-ECD-I]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research (www.icmr.nic.in), No. VIR/15/2011-ECD-I to MSR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Indian Council of Medical Research (No. No. VIR/15/2011-ECD-I), New Delhi, India. We acknowledge the facilities (Mass spectrometry and Laser Confocal Microscope) and the technical staff of Advanced Instrumentation Research Facility at JNU, New Delhi.	Abdoli A, 2013, CELL J, V15, P130; Bacharach E, 2000, J VIROL, V74, P11027, DOI 10.1128/JVI.74.23.11027-11039.2000; Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Bose S, 2004, J VIROL, V78, P8146, DOI 10.1128/JVI.78.15.8146-8158.2004; BOURBON H, 1983, FEBS LETT, V155, P218, DOI 10.1016/0014-5793(82)80606-6; Chan CM, 2016, VIROLOGY, V494, P78, DOI 10.1016/j.virol.2016.04.008; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; COMPANS RW, 1969, VIROLOGY, V39, P499, DOI 10.1016/0042-6822(69)90098-1; Daniely Y, 2000, J CELL BIOL, V149, P799, DOI 10.1083/jcb.149.4.799; de Araujo Mariana Eca Guimaraes, 2007, Methods Mol Biol, V357, P73; Digard P, 1999, J VIROL, V73, P2222, DOI 10.1128/JVI.73.3.2222-2231.1999; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Flint S.J., 2020, PRINCIPLES VIROLOGY, V2; Generous A, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0228-6; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Hamamoto I, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.00589892, DOI 10.1371/JOURNAL.PONE.00589892]; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hirano M, 2003, J BIOL CHEM, V278, P5109, DOI 10.1074/jbc.M207629200; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Hovanessian AG, 2000, CELL SURFACE EXPRESS, V328, P312; Huang WH, 2001, J BIOL CHEM, V276, P25166, DOI 10.1074/jbc.M010087200; Hutchinson EC, 2012, VACCINE, V30, P7353, DOI 10.1016/j.vaccine.2012.04.085; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losfeld ME, 2011, FEBS J, V278, P2552, DOI 10.1111/j.1742-4658.2011.08180.x; Manz B, 2013, J VIROL, V87, P7200, DOI 10.1128/JVI.00980-13; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Melen K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-167; Muramoto Y, 2013, J VIROL, V87, P2455, DOI 10.1128/JVI.02656-12; Murayama R, 2007, BIOCHEM BIOPH RES CO, V362, P880, DOI 10.1016/j.bbrc.2007.08.091; Naito T, 2007, P NATL ACAD SCI USA, V104, P18235, DOI 10.1073/pnas.0705856104; Oksayan S, 2015, J VIROL, V89, P1939, DOI 10.1128/JVI.03320-14; Olson MOJ, 2000, TRENDS CELL BIOL, V10, P189, DOI 10.1016/S0962-8924(00)01738-4; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; ProkudinaKantorovich EN, 1996, VIROLOGY, V223, P51, DOI 10.1006/viro.1996.0454; RAO SVV, 1982, J BIOL CHEM, V257, P5035; Selman M, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.38; SHAPIRO GI, 1988, J VIROL, V62, P2285, DOI 10.1128/JVI.62.7.2285-2290.1988; Sharma S, 2014, FEBS J, V281, P2899, DOI 10.1111/febs.12828; Shih SR, 1998, VIRUS GENES, V17, P179, DOI 10.1023/A:1008024909222; Shimakami T, 2006, J VIROL, V80, P3332, DOI 10.1128/JVI.80.7.3332-3340.2006; SHU LL, 1993, J VIROL, V67, P2723, DOI 10.1128/JVI.67.5.2723-2729.1993; SKORKO R, 1991, VIROLOGY, V180, P668, DOI 10.1016/0042-6822(91)90080-U; STOYKOVA AS, 1985, J NEUROCHEM, V45, P1667, DOI 10.1111/j.1471-4159.1985.tb10521.x; Strang BL, 2010, J VIROL, V84, P1771, DOI 10.1128/JVI.01510-09; Tafforeau L, 2011, J VIROL, V85, P13010, DOI 10.1128/JVI.02651-10; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Wise HM, 2011, NUCLEIC ACIDS RES, V39, P7775, DOI 10.1093/nar/gkr487; Wisskirchen C, 2011, J VIROL, V85, P8646, DOI 10.1128/JVI.02559-10	54	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164146	10.1371/journal.pone.0164146	http://dx.doi.org/10.1371/journal.pone.0164146			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711134	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600087
J	Vassilev, B; Louhimo, R; Ikonen, E; Hautaniemi, S				Vassilev, Boris; Louhimo, Riku; Ikonen, Elina; Hautaniemi, Sampsa			Language-Agnostic Reproducible Data Analysis Using Literate Programming	PLOS ONE			English	Article							BREAST-CANCER; EXPRESSION ANALYSES; TARGET INTERACTIONS; LAPTM4B; INTEGRATION; PREDICTOR; MICRORNAS; RESOURCE; GENES; CELLS	A modern biomedical research project can easily contain hundreds of analysis steps and lack of reproducibility of the analyses has been recognized as a severe issue. While thorough documentation enables reproducibility, the number of analysis programs used can be so large that in reality reproducibility cannot be easily achieved. Literate programming is an approach to present computer programs to human readers. The code is rearranged to follow the logic of the program, and to explain that logic in a natural language. The code executed by the computer is extracted from the literate source code. As such, literate programming is an ideal formalism for systematizing analysis steps in biomedical research. We have developed the reproducible computing tool Lir (literate, reproducible computing) that allows a tool-agnostic approach to biomedical data analysis. We demonstrate the utility of Lir by applying it to a case study. Our aim was to investigate the role of endosomal trafficking regulators to the progression of breast cancer. In this analysis, a variety of tools were combined to interpret the available data: a relational database, standard command-line tools, and a statistical computing environment. The analysis revealed that the lipid transport related genes LAPTM4B and NDRG1 are coamplified in breast cancer patients, and identified genes potentially cooperating with LAPTM4B in breast cancer progression. Our case study demonstrates that with Lir, an array of tools can be combined in the same data analysis to improve efficiency, reproducibility, and ease of understanding. Lir is an open-source software available at github. com/borisvassilev/lir.	[Vassilev, Boris; Ikonen, Elina] Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland; [Louhimo, Riku; Hautaniemi, Sampsa] Univ Helsinki, Genome Scale Biol, Res Programs Unit, Helsinki, Finland; [Ikonen, Elina] Minerva Fdn, Inst Med Res, Helsinki, Finland	University of Helsinki; University of Helsinki	Vassilev, B (corresponding author), Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland.	boris.vassilev@heisinki.fi	Hautaniemi, Sampsa/A-3122-2009; Hautaniemi, Sampsa/CAG-0362-2022; Vassilev, Boris/F-6065-2019	Hautaniemi, Sampsa/0000-0002-7749-2694; Hautaniemi, Sampsa/0000-0002-7749-2694; Vassilev, Boris/0000-0003-3727-4331; Ikonen, Elina/0000-0001-8382-1135	Finnish Society of Science and Letters; Biomedicum Helsinki Foundation; Paulon Saatio; K. Albin Johanssons Stiftelse; Ida Montinin Saatio; Academy of Finland [282192]; Biocentrum Helsinki	Finnish Society of Science and Letters; Biomedicum Helsinki Foundation; Paulon Saatio; K. Albin Johanssons Stiftelse; Ida Montinin Saatio; Academy of Finland(Academy of Finland); Biocentrum Helsinki	BV received personal grants by the Finnish Society of Science and Letters (http://www.scientiarum.fi/eng/); the Biomedicum Helsinki Foundation (http://www.biomedicum.com/index.php?page=112& The Paulon Saatio (http://www.paulo.fi/); the K. Albin Johanssons Stiftelse (http://www.foundationweb.net/johansson/); and the Ida Montinin Saatio (www.idamontininsaatio.fi/). RL received no specific funding for this work. El received grant 282192 by the Academy of Finland (www.aka.fi). SH received funding by Biocentrum Helsinki (http://www.helsinki.fi/biocentrum/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; [Anonymous], [No title captured]; Baggerly K, 2010, NATURE, V467, P401, DOI 10.1038/467401b; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blom T, 2015, NAT CHEM BIOL, V11, P799, DOI [10.1038/NCHEMBIO.1889, 10.1038/nchembio.1889]; Bornigen D, 2015, PEERJ, V3, DOI 10.7717/peerj.791; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Chan HJ, 2015, ONCOTARGET, V6, P25815, DOI 10.18632/oncotarget.4441; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Fang BA, 2014, BBA-REV CANCER, V1845, P1, DOI 10.1016/j.bbcan.2013.11.002; He XH, 2016, ONCOGENE; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Kitchin JR, 2015, ACS CATAL, V5, P3894, DOI 10.1021/acscatal.5b00538; KNUTH DE, 1984, COMPUT J, V27, P97, DOI 10.1093/comjnl/27.2.97; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Leisch F, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P575; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Luo EC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05908; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Noble WS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000424; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ovaska K, 2010, GENOME MED, V2, DOI 10.1186/gm186; Parris TZ, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.8; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Pietiainen V, 2013, J CELL SCI, V126, P3961, DOI 10.1242/jcs.128132; Prechelt L, 2000, COMPUTER, V33, P23, DOI 10.1109/2.876288; R Core Team, 2014, R A LANGUAGE AND ENV; RAMSEY N, 1994, IEEE SOFTWARE, V11, P97, DOI 10.1109/52.311070; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Shade A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002303; Shen H, 2014, NATURE, V515, P151, DOI 10.1038/515151a; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Song JK, 2007, PROTEIN SCI, V16, P807, DOI 10.1110/ps.072752407; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Terry M, 2000, MODELING SURVIVAL DA; Vassilev B, 2015, AM J PATHOL, V185, P987, DOI 10.1016/j.ajpath.2014.12.018; Wielemaker J, 2012, THEOR PRACT LOG PROG, V12, P67, DOI 10.1017/S1471068411000494; Wilson G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001745; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xie Y., 2014, IMPLEMENTING REPRODU, V1, P1; Zhang HT, 2015, ONCOTARGET, V6, P6092, DOI 10.18632/oncotarget.3341	48	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164023	10.1371/journal.pone.0164023	http://dx.doi.org/10.1371/journal.pone.0164023			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711123	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600064
J	Bajaj, NS; Kalra, R; Patel, N; Hashim, T; Godara, H; Ather, S; Arora, G; Pasala, T; Whitfield, TT; McGiffin, DC; Ahmed, MI; Lloyd, SG; Limdi, NA; Arora, P				Bajaj, Navkaranbir S.; Kalra, Rajat; Patel, Nirav; Hashim, Taimoor; Godara, Hemant; Ather, Sameer; Arora, Garima; Pasala, Tilak; Whitfield, Thomas T.; McGiffin, David C.; Ahmed, Mustafa I.; Lloyd, Steven G.; Limdi, Nita A.; Arora, Pankaj			Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials	PLOS ONE			English	Article							ORAL ANTICOAGULANTS; APPENDAGE CLOSURE; WARFARIN; EFFICACY; MORTALITY; SAFETY; INTERVENTIONS; COMBINATION; QUALITY; DEVICE	Background Multiple novel oral anticoagulants and left atrial appendage closure devices (WATCHMAN) have been tested against dose-adjusted vitamin K antagonists in randomized controlled trials for stroke prophylaxis in non-valvular atrial fibrillation. No direct comparisons of these strategies are available from randomized controlled trials. We conducted the current analyses by combining efficacy and safety characteristics of all FDA approved stroke prophylaxis treatment strategies for patients with non-valvular atrial fibrillation. Materials and Methods We searched SCOPUS from 1945 till October 2015 for randomized controlled trials comparing these strategies and reporting efficacy and safety outcomes. Six randomized controlled trials were identified and included in the final analyses and review. We followed PRISMA guidelines for network meta-analyses while reporting the current analyses. We collected data on ischemic stroke, major bleeding, and the composite primary safety end-point as defined by various randomized controlled trials. Network meta-analyses were conducted using consistency and inconsistency models for efficacy and safety outcomes. Surface under the cumulative ranking curve were then utilized to cluster rank these treatments for safety and efficacy. Results Six randomized controlled trials with 59,627 patients comparing six treatment strategies were eligible for the analyses. All prophylaxis strategies had comparable rates of ischemic stroke. Apixaban was associated with the least number of primary safety endpoint events as compared with all other treatments. In the cluster analyses assessing safety and efficacy, apixaban, edoxaban and dabigatran ranked best followed by vitamin K antagonists and rivaroxaban, whereas the WATCHMAN left atrial appendage closure device ranked last. Conclusions Dose-adjusted vitamin K antagonists, novel oral anticoagulants, and the WATCHMAN left atrial appendage closure devices are equally efficacious for ischemic stroke prevention but these treatments have different safety profiles. More randomized controlled trials are needed to directly compare these strategies.	[Bajaj, Navkaranbir S.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Bajaj, Navkaranbir S.] Harvard Med Sch, Boston, MA 02115 USA; [Bajaj, Navkaranbir S.; Patel, Nirav; Hashim, Taimoor; Godara, Hemant; Ather, Sameer; Arora, Garima; Whitfield, Thomas T.; Lloyd, Steven G.; Arora, Pankaj] Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA; [Kalra, Rajat] Univ Minnesota, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA; [Kalra, Rajat] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Pasala, Tilak] Univ Utah, Sch Med, Div Cardiovasc Med, Salt Lake City, UT 84132 USA; [McGiffin, David C.] Alfred Hosp, Dept Surg, Div Cardiac Surg, Melbourne, Vic, Australia; [McGiffin, David C.] Monash Univ, Melbourne, Vic, Australia; [Ahmed, Mustafa I.] Baptist Princeton, Div Cardiol, Birmingham, AL USA; [Limdi, Nita A.] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL 35294 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; Florey Institute of Neuroscience & Mental Health; Monash University; University of Alabama System; University of Alabama Birmingham	Bajaj, NS (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.; Bajaj, NS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Bajaj, NS; Arora, P (corresponding author), Univ Alabama Birmingham, Div Cardiovasc Dis, Birmingham, AL 35294 USA.	nbajaj@uabmc.edu; parora@uabmc.edu	Arora, Pankaj/F-3437-2011; Kalra, Rajat/AAX-2945-2021; bajaj, Navkaranbir/AAM-1706-2020	Arora, Pankaj/0000-0003-2420-3550; Kalra, Rajat/0000-0002-8982-0595; bajaj, Navkaranbir/0000-0002-4605-0797	Walter B. Frommeyer Junior Fellowship in Investigative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL133373, R01HL092173] Funding Source: NIH RePORTER	Walter B. Frommeyer Junior Fellowship in Investigative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the Walter B. Frommeyer, Junior Fellowship in Investigative Medicine that was awarded to PA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj NS, 2014, AM J CARDIOL, V114, P909, DOI 10.1016/j.amjcard.2014.05.045; Bajaj NS, 2014, JACC-CARDIOVASC INTE, V7, P296, DOI 10.1016/j.jcin.2013.11.010; Cameron C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004301; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Koifman E, 2016, INT J CARDIOL, V205, P17, DOI 10.1016/j.ijcard.2015.11.181; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lip GYH, 2012, J AM COLL CARDIOL, V60, P738, DOI 10.1016/j.jacc.2012.03.019; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Marcucci M, 2014, AM J MED, V127, P979, DOI 10.1016/j.amjmed.2014.05.003; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Reddy VY, 2014, JAMA-J AM MED ASSOC, V312, P1988, DOI 10.1001/jama.2014.15192; Romesburg, 1985, CLUSTER ANAL RES; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; White IR, 2011, STATA J, V11, P255, DOI 10.1177/1536867X1101100206	31	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163608	10.1371/journal.pone.0163608	http://dx.doi.org/10.1371/journal.pone.0163608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706224	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697200049
J	Pereira, JL; Mendes, A; Crispim, SP; Marchioni, DM; Fisberg, RM				Pereira, Jaqueline Lopes; Mendes, Aline; Crispim, Sandra Patricia; Marchioni, Dirce Maria; Fisberg, Regina Mara			Association of Overweight with Food Portion Size among Adults of Sao Paulo - Brazil	PLOS ONE			English	Article							ENERGY-INTAKE; OBESITY EPIDEMIC; WEIGHT; WOMEN; QUESTIONNAIRE; CONSUMPTION; DENSITY; RISK; DIET; MEN	Background Although studies show that portion size affects energy intake, few have demonstrated a link between portion size and weight status, especially in free-living populations. The objective of the present study was to assess the relationship between food portion sizes and overweight in a representative population of adults of Sao Paulo, Brazil. Methods Cross-sectional population-based study with 1005 adults from Sao Paulo, Brazil. Dietary data were obtained from two 24-hour recalls. Reported foods were classified into groups and energy contribution, prevalence of consumers and portion sizes were calculated. Individuals were classified according to BMI in with and without overweight. Logistic regression models were used to evaluate the association between food portion sizes and being overweight. Results The most consumed food groups were: beans, breads/rolls, coffee/tea, milk, rice, and sugar. Rice, red meat, breads/rolls, and white meat were the groups with the highest percentage of contribution to total energy intake. Butter/margarine, toasts/biscuits, sugar, and cakes were the groups with the highest energy density. After adjustment for confounding variables, overweight was associated with larger portions of pizza (OR = 1.052; p = 0.048), red meat (OR = 1.025; p = 0.043), rice (OR = 1.033; p<0.001), salted snacks (OR = 1.078; p = 0.022), and soft drinks (OR = 1.016; p = 0.007). Conclusions Larger portions of few food groups with different energy densities were associated with being overweight, suggesting that overweight may be related to the consumption of larger portion sizes of a series of food groups, not a food group alone. Additionally, we highlight the importance of considering underreporting as a confounding factor in these associations.	[Mendes, Aline; Marchioni, Dirce Maria; Fisberg, Regina Mara] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil; [Crispim, Sandra Patricia] Univ Fed Parana, Dept Nutr, Curitiba, Parana, Brazil	Universidade de Sao Paulo; Universidade Federal do Parana	Fisberg, RM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, Brazil.	rfisberg@usp.br	Marchioni, Dirce M/C-6053-2012; Crispim, Sandra P./G-9983-2011; Fisberg, Regina M/C-4069-2012; Pereira, Jaqueline/P-7261-2019; Fisberg, Regina Mara/Q-6494-2019; Marchioni, Dirce/ABH-7023-2020	Marchioni, Dirce M/0000-0002-6810-5779; Crispim, Sandra P./0000-0002-2257-9899; Fisberg, Regina M/0000-0002-4490-9035; Pereira, Jaqueline/0000-0002-0009-1040; Fisberg, Regina Mara/0000-0002-4490-9035; Marchioni, Dirce/0000-0002-6810-5779	Health Department of the City of Sao Paulo (SMS-SP); Sao Paulo Research Foundation (FAPESP) [2009/15831-0, 2012/08431-8]; National Council for Scientific and Technological Development (CNPq) [503128/2010-4]	Health Department of the City of Sao Paulo (SMS-SP); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financed by the Health Department of the City of Sao Paulo (SMS-SP); Sao Paulo Research Foundation (FAPESP process #2009/15831-0, process #2012/08431-8 (JLP)); and National Council for Scientific and Technological Development (CNPq process #503128/2010-4).	Albar SA, 2014, BRIT J NUTR, V112, P841, DOI 10.1017/S0007114514001548; Azagba S, 2012, J PRIM CARE COMMUNIT, V3, P210, DOI 10.1177/2150131911434206; BAENINGER Rosana, 2012, FASES FACES MIGRACAO; Blake CE, 2015, APPETITE, V88, P17, DOI 10.1016/j.appet.2014.11.005; Bliss RM, 2004, AGR RES, V52, P10; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Carvalho Aline Martins de, 2014, Rev. bras. epidemiol., V17, P735, DOI 10.1590/1809-4503201400030013; Castro Michelle Alessandra de, 2009, Rev. Saúde Pública, V43, P991, DOI 10.1590/S0034-89102009005000084; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Duffey KJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001050; Fisberg R.M., 2002, MANUAL RECEITAS MEDI; Fisberg RM, 2002, NUTR CLIN ADULTO, P47; Fisher JO, 2015, APPETITE, V88, P1, DOI 10.1016/j.appet.2014.11.025; Harttig U, 2011, EUR J CLIN NUTR, V65, pS87, DOI 10.1038/ejcn.2011.92; He K, 2004, INT J OBESITY, V28, P1569, DOI 10.1038/sj.ijo.0802795; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Institute of Medicine of the National Academies, 2002, DIET REF INT EN CARB; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2010, IND IBGE PESQ ORC FA; Kelly MT, 2009, BRIT J NUTR, V101, P1413, DOI 10.1017/S0007114508060777; Kral TV, 2004, PHYSIOL BEHAV, V82, P131, DOI 10.1016/j.physbeh.2004.04.063; Lafay L, 2000, INT J OBESITY, V24, P1500, DOI 10.1038/sj.ijo.0801392; Ledikwe JH, 2005, J NUTR, V135, P905, DOI 10.1093/jn/135.4.905; Lioret S, 2009, EUR J CLIN NUTR, V63, P382, DOI 10.1038/sj.ejcn.1602958; Lissner L, 2002, PUBLIC HEALTH NUTR, V5, P889, DOI 10.1079/PHN2002388; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; Matthiessen J, 2003, PUBLIC HEALTH NUTR, V6, P65, DOI 10.1079/PHN2002361; Maurer J, 2006, NUTR REV, V64, P53, DOI 10.1111/j.1753-4887.2006.tb00188.x; Mendez MA, 2011, AM J EPIDEMIOL, V173, P448, DOI 10.1093/aje/kwq380; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Nielsen Samara Joy, 2003, JAMA (Journal of the American Medical Association), V289, P450, DOI 10.1001/jama.289.4.450; Organization WH, 1998, WELLB MEAS PRIM HLTH; Pinheiro A.B.V., 2008, TABELA AVALIACAO CON; Raper N, 2004, J FOOD COMPOS ANAL, V17, P545, DOI 10.1016/j.jfca.2004.02.013; Rolls BJ, 2014, INT J OBESITY, V38, pS1, DOI 10.1038/ijo.2014.82; Rolls BJ, 2007, OBESITY, V15, P1535, DOI 10.1038/oby.2007.182; Rolls BJ, 2004, APPETITE, V42, P63, DOI 10.1016/S0195-6663(03)00117-X; Rolls BJ, 2002, AM J CLIN NUTR, V76, P1207, DOI 10.1093/ajcn/76.6.1207; Sichieri Rosely, 2003, Cad. Saúde Pública, V19, pS47, DOI 10.1590/S0102-311X2003000700006; Smiciklas-Wright H, 2003, J AM DIET ASSOC, V103, P41, DOI 10.1053/jada.2003.50000; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Steenhuis IHM, 2010, PUBLIC HEALTH NUTR, V13, P852, DOI 10.1017/S1368980009992011; Tontisirin K., 2003, FOOD ENERGY METHODS; Vergnaud AC, 2010, AM J CLIN NUTR, V92, P398, DOI 10.3945/ajcn.2009.28713; Verly E, 2012, J ACAD NUTR DIET, V112, P1015, DOI 10.1016/j.jand.2012.03.028; Vernarelli JA, 2015, EUR J NUTR, V54, P59, DOI 10.1007/s00394-014-0685-0; Wansink B, 2007, J AM DIET ASSOC, V107, P1103, DOI 10.1016/j.jada.2007.05.019; *WHO, 2003, TECH REP SERV, V916, pR1; Wright SM, 2012, ABDOM IMAGING, V37, P730, DOI 10.1007/s00261-012-9862-x; Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246	50	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164127	10.1371/journal.pone.0164127	http://dx.doi.org/10.1371/journal.pone.0164127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706222	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200087
J	Zhou, ZY; Jin, Q; Yu, L; Wu, LQ; He, B				Zhou, Zhaoye; Jin, Qi; Yu, Long; Wu, Liqun; He, Bin			Noninvasive Imaging of Human Atrial Activation during Atrial Flutter and Normal Rhythm from Body Surface Potential Maps	PLOS ONE			English	Article							VENTRICULAR ELECTRICAL ACTIVATION; EQUIVALENT CURRENT-DENSITY; CARDIAC ACTIVATION; EPICARDIAL POTENTIALS; EXCITATION MODEL; INVERSE SOLUTION; SWINE MODEL; HEART-MODEL; ELECTROPHYSIOLOGY; RECONSTRUCTION	Background Knowledge of atrial electrophysiological properties is crucial for clinical intervention of atrial arrhythmias and the investigation of the underlying mechanism. This study aims to evaluate the feasibility of a novel noninvasive cardiac electrical imaging technique in imaging bi-atrial activation sequences from body surface potential maps (BSPMs). Methods The study includes 7 subjects, with 3 atrial flutter patients, and 4 healthy subjects with normal atrial activations. The subject-specific heart-torso geometries were obtained from MRI/ CT images. The equivalent current densities were reconstructed from 208-channel BSPMs by solving the inverse problem using individual heart-torso geometry models. The activation times were estimated from the time instant corresponding to the highest peak in the time course of the equivalent current densities. To evaluate the performance, a total of 32 cycles of atrial flutter were analyzed. The imaged activation maps obtained from single beats were compared with the average maps and the activation maps measured from CARTO, by using correlation coefficient (CC) and relative error (RE). Results The cardiac electrical imaging technique is capable of imaging both focal and reentrant activations. The imaged activation maps for normal atrial activations are consistent with findings from isolated human hearts. Activation maps for isthmus-dependent counterclockwise reentry were reconstructed on three patients with typical atrial flutter. The method was capable of imaging macro counterclockwise reentrant loop in the right atrium and showed inter-atria electrical conduction through coronary sinus. The imaged activation sequences obtained from single beats showed good correlation with both the average activation maps (CC = 0.91 +/- 0.03, RE = 0.29 +/- 0.05) and the clinical endocardial findings using CARTO (CC = 0.70 +/- 0.04, RE = 0.42 +/- 0.05). Conclusions The noninvasive cardiac electrical imaging technique is able to reconstruct complex atrial reentrant activations and focal activation patterns in good consistency with clinical electrophysiological mapping. It offers the potential to assist in radio-frequency ablation of atrial arrhythmia and help defining the underlying arrhythmic mechanism.	[Zhou, Zhaoye; Yu, Long; He, Bin] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Jin, Qi; Wu, Liqun] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Cardiol, Shanghai, Peoples R China; [He, Bin] Univ Minnesota, Inst Engn Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities	He, B (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.; He, B (corresponding author), Univ Minnesota, Inst Engn Med, Minneapolis, MN 55455 USA.	binhe@umn.edu			NIH [R01HL080093, RO1HL080093]; NSF [CBET-0756331]; Chinese "111 Project" [B08020]; Institute of Engineering in Medicine from University of Minnesota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080093] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Chinese "111 Project"; Institute of Engineering in Medicine from University of Minnesota; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH R01HL080093 and NSF CBET-0756331, the Chinese "111 Project" (B08020), and a grant from the Institute of Engineering in Medicine from the University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by NIH RO1HL080093 and NSF CBET-0756331, the Chinese "111 Project" (B08020), and a grant from the Institute of Engineering in Medicine from the University of Minnesota.	Arevalo HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11437; Armoundas AA, 2003, ANN BIOMED ENG, V31, P564, DOI 10.1114/1.1567281; BARR RC, 1977, IEEE T BIO-MED ENG, V24, P1, DOI 10.1109/TBME.1977.326201; Cakulev I, 2013, CIRC-ARRHYTHMIA ELEC, V6, P68, DOI 10.1161/CIRCEP.112.975813; Compumedics, 2008, CURRY USER GUIDE; CUPPEN JJM, 1984, IEEE T BIO-MED ENG, V31, P652, DOI 10.1109/TBME.1984.325315; DURRER D, 1970, CIRCULATION, V41, P899, DOI 10.1161/01.CIR.41.6.899; Greensite F, 1998, IEEE T BIO-MED ENG, V45, P98, DOI 10.1109/10.650360; GULRAJANI RM, 1984, IEEE T BIO-MED ENG, V31, P903, DOI 10.1109/TBME.1984.325257; Han CZ, 2015, AM J PHYSIOL-HEART C, V308, pH108, DOI 10.1152/ajpheart.00196.2014; Han CZ, 2013, HEART RHYTHM, V10, P1509, DOI 10.1016/j.hrthm.2013.06.010; Han CZ, 2012, AM J PHYSIOL-HEART C, V302, pH244, DOI 10.1152/ajpheart.00618.2011; Han CZ, 2011, HEART RHYTHM, V8, P1266, DOI 10.1016/j.hrthm.2011.03.014; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; He B, 2003, IEEE T BIO-MED ENG, V50, P1190, DOI 10.1109/TBME.2003.817637; He B, 2002, PHYS MED BIOL, V47, P4063, DOI 10.1088/0031-9155/47/22/310; He B, 2001, IEEE T INF TECHNOL B, V5, P181, DOI 10.1109/4233.945288; He B, 2010, CARDIAC ELECTROPHYSIOLOGY METHODS AND MODELS, P357, DOI 10.1007/978-1-4419-6658-2_18; Henriquez CS, 2014, IEEE T BIO-MED ENG, V61, P1457, DOI 10.1109/TBME.2014.2310515; Huiskamp G, 1997, IEEE T BIO-MED ENG, V44, P433, DOI 10.1109/10.581930; Jamison C, 2011, IEEE T BIO-MED ENG, V58, P876, DOI 10.1109/TBME.2010.2093525; Lai DK, 2010, IEEE T INF TECHNOL B, V14, P1318, DOI 10.1109/TITB.2010.2051448; Li GL, 2001, IEEE T BIO-MED ENG, V48, P660, DOI 10.1109/10.923784; Liu C, 2008, J CARDIOVASC ELECTR, V19, P535, DOI 10.1111/j.1540-8167.2007.01066.x; Liu ZM, 2006, IEEE T MED IMAGING, V25, P1307, DOI 10.1109/TMI.2006.882140; Modre R, 2003, J CARDIOVASC ELECTR, V14, P712, DOI 10.1046/j.1540-8167.2003.02558.x; Ng J, 2014, IEEE T BIO-MED ENG, V61, P273, DOI 10.1109/TBME.2013.2290003; Nielsen BF, 2007, MATH BIOSCI, V210, P523, DOI 10.1016/j.mbs.2007.06.003; Ohyu S, 2002, IEEE T BIO-MED ENG, V49, P509, DOI 10.1109/TBME.2002.1001964; Oster HS, 1997, CIRCULATION, V96, P1012; Pascual-Marqui R, 1995, COMMUNICATION, P16; Perlman O, 2014, IEEE T BIO-MED ENG, V61, P1034, DOI 10.1109/TBME.2013.2292930; Prakosa A, 2014, IEEE T BIO-MED ENG, V61, P235, DOI 10.1109/TBME.2013.2281619; Pullan AJ, 2001, ANN BIOMED ENG, V29, P817, DOI 10.1114/1.1408921; Rahimi A, 2015, IEEE T BIO-MED ENG, V62, P1563, DOI 10.1109/TBME.2015.2395387; Ramanathan C, 2006, P NATL ACAD SCI USA, V103, P6309, DOI 10.1073/pnas.0601533103; Ramanathan C, 2004, NAT MED, V10, P422, DOI 10.1038/nm1011; Revishvili AS, 2015, EUROPACE, V17, P1282, DOI 10.1093/europace/euu339; Roten L, 2012, J CARDIOVASC ELECTR, V23, P553, DOI 10.1111/j.1540-8167.2011.02250.x; Seger M, 2006, COMPUT CARDIOL, V2006, P601; Shah AJ, 2013, J AM COLL CARDIOL, V62, P889, DOI 10.1016/j.jacc.2013.03.082; Skipa O, 2002, INT J BIOELECTROMAGN, V4, P17; Tilg B, 2003, MED IMAGE ANAL, V7, P391, DOI 10.1016/S1361-8415(03)00013-6; Tilg B, 2002, IEEE T MED IMAGING, V21, P1031, DOI 10.1109/TMI.2002.804438; Tilg B, 2001, FUNCTIONAL IMAGING M, P148; Wang DF, 2013, J COMPUT PHYS, V250, P403, DOI 10.1016/j.jcp.2013.05.027; WANG JZ, 1992, IEEE T BIO-MED ENG, V39, P665, DOI 10.1109/10.142641; Wang LW, 2010, IEEE T BIO-MED ENG, V57, P296, DOI 10.1109/TBME.2009.2024531; Wang Y, 2007, HEART RHYTHM, V4, P1565, DOI 10.1016/j.hrthm.2007.08.019; Wang Y, 2007, HEART RHYTHM, V4, P1081, DOI 10.1016/j.hrthm.2007.04.014; Yu L, 2015, IEEE T MED IMAGING, V34, P2309, DOI 10.1109/TMI.2015.2429134; Zhang X, 2005, AM J PHYSIOL-HEART C, V289, pH2724, DOI 10.1152/ajpheart.00639.2005; Zhou ZY, 2015, IEEE T BIO-MED ENG, V62, P468, DOI 10.1109/TBME.2014.2358618	53	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163445	10.1371/journal.pone.0163445	http://dx.doi.org/10.1371/journal.pone.0163445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706179	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200045
J	Faber, BW; Hellwig, S; Houard, S; Havelange, N; Drossard, J; Mertens, H; Croon, A; Kastilan, R; Byrne, R; van der Werff, N; van der Eijk, M; Thomas, AW; Kooken, CHM; Remarque, EJ				Faber, Bart W.; Hellwig, Stephan; Houard, Sophie; Havelange, Nicolas; Drossard, Jurgen; Mertens, Hubert; Croon, Alexander; Kastilan, Robin; Byrne, Richard; van der Werff, Nicole; van der Eijk, Marjolein; Thomas, Alan W.; Kooken, Clemens H. M.; Remarque, Edmond J.			Production, Quality Control, Stability and Pharmacotoxicity of a Malaria Vaccine Comprising Three Highly Similar PfAMA1 Protein Molecules to Overcome Antigenic Variation	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; HIGH-LEVEL EXPRESSION; OVINE INTERFERON-TAU; PICHIA-PASTORIS; ERYTHROCYTE INVASION; CANDIDATE; FERMENTATION; IMMUNIZATION; TRIAL; AMA1	Plasmodium falciparum apical membrane antigen 1 (PfAMA1) is a leading asexual blood stage vaccine candidate for malaria. In preparation for clinical trials, three Diversity Covering (DiCo) PfAMA1 ectodomain proteins, designed to overcome the intrinsic polymorphism that is present in PfAMA1, were produced under Good Manufacturing Practice (GMP) in Pichia pastoris. Using identical methodology, the 3 strains were cultivated in 70-L scale fed-batch fermentations and PfAMA1-DiCos were purified by two chromatography steps, an ultrafiltration/diafiltration procedure and size exclusion chromatography, resulting in highly pure (>95%) PfAMA1-DiCo1, PfAMA1 DiCo2 and PfAMA1 DiCo3, with final yields of 1.8, 1.9 and 1.3 gram, respectively. N-terminal determinations showed that approximately 50% of each of the proteins lost 12 residues from their N-terminus, in accordance with SDS-PAGE (2 main bands) and MS-data. Under reducing conditions a site of limited proteolytic cleavage within a disulphide bonded region became evident. The three proteins quantitatively bound to the mAb 4G2 that recognizes a conformational epitope, suggesting proper folding of the proteins. The lyophilized Drug Product (1: 1: 1 mixture of PfAMA1-DiCo1, DiCo2, DiCo3) fulfilled all pre-set release criteria (appearance, dissolution rate, identity, purity, protein content, moisture content, sub-visible particles, immuno-potency (after reconstitution with adjuvant), abnormal toxicity, sterility and endotoxin), was stable in accelerated and real-time stability studies at -20 degrees C for over 24 months. When formulated with adjuvants selected for clinical phase I evaluation, the Drug Product did not show adverse effect in a repeated-dose toxicity study in rabbits. The Drug Product has entered a phase Ia/Ib clinical trial.	[Faber, Bart W.; van der Werff, Nicole; van der Eijk, Marjolein; Thomas, Alan W.; Kooken, Clemens H. M.; Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Hellwig, Stephan; Drossard, Jurgen; Mertens, Hubert; Croon, Alexander; Kastilan, Robin] Fraunhofer IME, Aachen, Germany; [Houard, Sophie; Havelange, Nicolas] Univ Klinikum Heidelberg, European Vaccine Initiat, Heidelberg, Germany; [Byrne, Richard] Nova Labs Ltd, Martin House, Leicester, Leics, England	Ruprecht Karls University Heidelberg	Faber, BW (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	Faber@bprc.nl	Remarque, Ed/AAE-8643-2020	Kocken, Clemens/0000-0002-4784-1734; Faber, Bart/0000-0001-6808-1204	European (Malaria) Vaccine Initiative; DGIS Netherlands; BPRC; Bill and Melinda Gates Foundation [42387]	European (Malaria) Vaccine Initiative; DGIS Netherlands; BPRC; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work received financial support from the European (Malaria) Vaccine Initiative, DGIS Netherlands and BPRC. We thank Odile Leroy for support and Henk van Westbroek and Francisca van Hassel for support in preparing the figures. We are grateful to Anna Marie Beckmann and Randy Howard from The Infectious Disease Research Institute (IDRI) for providing the GLA-SE adjuvant under Bill and Melinda Gates Foundation grant 42387 to Steven G Reed.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Belew M, 2008, SEP SCI TECHNOL, V43, P3134, DOI 10.1080/01496390802221857; Brunel L, 2004, J BIOTECHNOL, V111, P41, DOI 10.1016/j.jbiotec.2004.03.007; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; Damasceno LM, 2012, APPL MICROBIOL BIOT, V93, P31, DOI 10.1007/s00253-011-3654-z; Damasceno LM, 2004, PROTEIN EXPRES PURIF, V37, P18, DOI 10.1016/j.pep.2004.03.019; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; DIGAN ME, 1989, BIO-TECHNOL, V7, P160, DOI 10.1038/nbt0289-160; DOE J, 1999, EUROPEAN PHARMACOPOE; EDMAN P, 1956, ACTA CHEM SCAND, V10, P761, DOI 10.3891/acta.chem.scand.10-0761; Faber BW, 2013, INFECT IMMUN, V81, P1479, DOI 10.1128/IAI.01267-12; Faber BW, 2008, VACCINE, V26, P6143, DOI 10.1016/j.vaccine.2008.08.055; Fricke J, 2013, BIOTECHNOL J, V8, P738, DOI 10.1002/biot.201200190; Fricke J, 2011, BIOTECHNOL J, V6, P437, DOI 10.1002/biot.201000385; Hamid MMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020547; Hellwig S, 1999, BIOTECHNOL APPL BIOC, V30, P267; Huang CJ, 2011, APPL MICROBIOL BIOT, V90, P235, DOI 10.1007/s00253-011-3118-5; Jahic M, 2003, J BIOTECHNOL, V102, P45, DOI 10.1016/S0168-1656(03)00003-8; Jahic M, 2003, MICROB CELL FACT, V2, DOI 10.1186/1475-2859-2-6; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Martens S, 2011, ENG LIFE SCI, V11, P429, DOI 10.1002/elsc.201000163; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Payne RO, 2016, J INFECT DIS, V213, P1743, DOI 10.1093/infdis/jiw039; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sigoillot M, 2012, APPL MICROBIOL BIOT, V96, P1253, DOI 10.1007/s00253-012-3897-3; Sinha J, 2005, BIOTECHNOL BIOENG, V89, P102, DOI 10.1002/bit.20318; Sinha J, 2003, BIOTECHNOL PROGR, V19, P794, DOI 10.1021/bp025744q; Sinha J, 2007, J BIOTECHNOL, V127, P462, DOI 10.1016/j.jbiotec.2006.07.022; Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325; Spring M, 2013, VACCINE, V31, P4975, DOI 10.1016/j.vaccine.2013.08.007; Srinivasan P, 2014, P NATL ACAD SCI USA, V111, P10311, DOI 10.1073/pnas.1409928111; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Toikkanen JH, 2007, J BIOTECHNOL, V130, P161, DOI 10.1016/j.jbiotec.2007.03.004; Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002755; Whittaker MM, 2002, J BIOL INORG CHEM, V7, P136, DOI 10.1007/s007750100281; WHO, 2013, WORLD MALARIA REPORT 2013, P1	46	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164053	10.1371/journal.pone.0164053	http://dx.doi.org/10.1371/journal.pone.0164053			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695087	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100081
J	Korshoej, AR; Saturnino, GB; Rasmussen, LK; von Oettingen, G; Sorensen, JCH; Thielscher, A				Korshoej, Anders Rosendal; Saturnino, Guilherme Bicalho; Rasmussen, Line Kirkegaard; von Oettingen, Gorm; Sorensen, Jens Christian Hedemann; Thielscher, Axel			Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study	PLOS ONE			English	Article							PHYSICIANS CHOICE CHEMOTHERAPY; RANDOMIZED PHASE-III; ADJUVANT TEMOZOLOMIDE; DIELECTRIC-PROPERTIES; BRAIN; CONDUCTIVITY; NOVOTTF-100A; TISSUE; RADIOTHERAPY; CONCOMITANT	Objective The present work proposes a new clinical approach to TTFields therapy of glioblastoma. The approach combines targeted surgical skull removal (craniectomy) with TTFields therapy to enhance the induced electrical field in the underlying tumor tissue. Using computer simulations, we explore the potential of the intervention to improve the clinical efficacy of TTFields therapy of brain cancer. Methods We used finite element analysis to calculate the electrical field distribution in realistic head models based on MRI data from two patients: One with left cortical/subcortical glioblastoma and one with deeply seated right thalamic anaplastic astrocytoma. Field strength was assessed in the tumor regions before and after virtual removal of bone areas of varying shape and size (10 to 100 mm) immediately above the tumor. Field strength was evaluated before and after tumor resection to assess realistic clinical scenarios. Results For the superficial tumor, removal of a standard craniotomy bone flap increased the electrical field strength by 60-70% in the tumor. The percentage of tissue in expected growth arrest or regression was increased from negligible values to 30-50%. The observed effects were highly focal and targeted at the regions of pathology underlying the craniectomy. No significant changes were observed in surrounding healthy tissues. Median field strengths in tumor tissue increased with increasing craniectomy diameter up to 50-70 mm. Multiple smaller burr holes were more efficient than single craniectomies of equivalent area. Craniectomy caused no significant field enhancement in the deeply seated tumor, but rather a focal enhancement in the brain tissue underlying the skull defect. Conclusions Our results provide theoretical evidence that small and clinically feasible craniectomies may provide significant enhancement of TTFields intensity in cerebral hemispheric tumors without severely compromising brain protection or causing unacceptable heating in healthy tissues. A clinical trial is being planned to validate safety and efficacy.	[Korshoej, Anders Rosendal; Rasmussen, Line Kirkegaard; von Oettingen, Gorm; Sorensen, Jens Christian Hedemann] Aarhus Univ Hosp, Dept Neurosurg, Aarhus, Denmark; [Saturnino, Guilherme Bicalho; Thielscher, Axel] Univ Copenhagen, Danish Res Ctr Magnet Resonance, Hvidovre Hosp, Hvidovre, Denmark; [Saturnino, Guilherme Bicalho; Thielscher, Axel] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Thielscher, Axel] Tech Univ Denmark, Biomed Engn, DTU Elektro, Lyngby, Denmark	Aarhus University; University of Copenhagen; Max Planck Society; Technical University of Denmark	Korshoej, AR (corresponding author), Aarhus Univ Hosp, Dept Neurosurg, Aarhus, Denmark.	andekors@rm.dk		Bicalho Saturnino, Guilherme/0000-0002-3466-8725; Thielscher, Axel/0000-0002-4752-5854	Eva og Henry Frarkels Mindefond; Danish Council for Independent Research, Medical Sciences, Lundbeckfonden [R118-A11308, R59 A5399]; NovoNordiskfonden [11413]; Brazilian Ministry of Science and Technology; Lundbeck Foundation [R118-2012-11308] Funding Source: researchfish	Eva og Henry Frarkels Mindefond; Danish Council for Independent Research, Medical Sciences, Lundbeckfonden; NovoNordiskfonden(Novo Nordisk Foundation); Brazilian Ministry of Science and Technology; Lundbeck Foundation(Lundbeckfonden)	This work was supported by Eva og Henry Frarkels Mindefond (PI: Anders R. Korshoej), The Danish Council for Independent Research, Medical Sciences, Lundbeckfonden (PI: Axel Thielscher; Grant Nr. R118-A11308 and PI: Hartwig Siebner; Grant Nr. R59 A5399, Grant of Excellence "ContAct"), an Interdisciplinary Synergy Grant "Basics" sponsored by NovoNordiskfonden (recipients: Hartwig Siebner, Axel Thielscher & Lars K. Hansen, Grant Nr. 11413) and a Science Without Borders Scholarship from the Brazilian Ministry of Science and Technology (Recipient: Guilherme B. Saturnino). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SEMINARS ONCOLOGY, DOI [10.1053/j.seminoncol.2014.09.009, DOI 10.1053/J.SEMINONCOL.2014.09.009]; [Anonymous], 2011, P 19 SCI M INT SOC M; [Anonymous], 2015, ASCO ANN M P; [Anonymous], 2014, SEMINARS ONCOLOGY, DOI [10.1053/j.seminoncol.2014.09.010, DOI 10.1053/J.SEMINONCOL.2014.09.010]; [Anonymous], 2013, SEMINARS ONCOLOGY, DOI [10.1053/j.seminoncol.2013.10.002, DOI 10.1053/J.SEMINONCOL.2013.10.002]; [Anonymous], 2011, P ISMRM; Becker KP, 2012, CANCER J, V18, P12, DOI 10.1097/PPO.0b013e318244d7eb; Datta A, 2010, NEUROIMAGE, V52, P1268, DOI 10.1016/j.neuroimage.2010.04.252; Drabycz S, 2010, NEUROIMAGE, V49, P1398, DOI 10.1016/j.neuroimage.2009.09.049; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Go K G, 1972, Acta Neurochir (Wien), V27, P113, DOI 10.1007/BF01401876; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Korshoej AR, 2015, PHYS BIOL MED UNPUB; Korshoej AR, 2015, J NEUROONC UNPUB OCT; Latikka J, 2001, PHYS MED BIOL, V46, P1611, DOI 10.1088/0031-9155/46/6/302; Lok E, 2015, CANCER MED-US, V4, P1697, DOI 10.1002/cam4.519; LU Y, 1992, INT J HYPERTHER, V8, P755, DOI 10.3109/02656739209005023; Mannas JP, 2014, J CLIN NEUROSCI, V21, P121, DOI 10.1016/j.jocn.2013.03.039; Miranda PC, 2014, PHYS MED BIOL, V59, P4137, DOI 10.1088/0031-9155/59/15/4137; Mrugala MM, 2013, DISCOV MED, V15, P221; Muftuler LT, 2006, TECHNOL CANCER RES T, V5, P381; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Opitz A, 2011, NEUROIMAGE, V58, P849, DOI 10.1016/j.neuroimage.2011.06.069; PELOSO R, 1984, IEEE T BIO-MED ENG, V31, P725, DOI 10.1109/TBME.1984.325399; Rullmann M, 2009, NEUROIMAGE, V44, P399, DOI 10.1016/j.neuroimage.2008.09.009; Rulseh AM, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-220; Saturnino GB, 2015, NEUROIMAGE, V120, P25, DOI 10.1016/j.neuroimage.2015.06.067; Stupp R, 2014, ANN ONCOL, V25, P93, DOI 10.1093/annonc/mdu050; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2015, JAMA-J AM MED ASSOC, V314, P2535, DOI 10.1001/jama.2015.16669; Stupp R, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou265.40; Stupp R, 2012, EUR J CANCER, V48, P2192, DOI 10.1016/j.ejca.2012.04.011; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Thielscher A, 2015, IEEE ENG MED BIO, P222, DOI 10.1109/EMBC.2015.7318340; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Turner SG, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-162; Wagner TA, 2004, IEEE T BIO-MED ENG, V51, P1586, DOI 10.1109/TBME.2004.827925; Weathers Shiao-Pei, 2014, F1000Prime Rep, V6, P46, DOI 10.12703/P6-46; Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7; Wenger C, ALTERNATING ELECT FI; Wenger C, 2015, IEEE ENG MED BIO, P6892, DOI 10.1109/EMBC.2015.7319977; Wenger C, 2015, PHYS MED BIOL, V60, P7339, DOI 10.1088/0031-9155/60/18/7339; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479; Wong ET, 2014, CANCER MED-US, V3, P592, DOI 10.1002/cam4.210; Wong ET, 2014, NEUROONCOLOGY S5, V16, pv74; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	47	18	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164051	10.1371/journal.pone.0164051	http://dx.doi.org/10.1371/journal.pone.0164051			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695068	Green Submitted, Green Published, gold			2022-12-27	WOS:000385553100080
J	Elsey, H; Manandah, S; Sah, D; Khanal, S; MacGuire, F; King, R; Wallace, H; Baral, SC				Elsey, Helen; Manandah, Shraddha; Sah, Dilip; Khanal, Sudeepa; MacGuire, Frances; King, Rebecca; Wallace, Hilary; Baral, Sushil Chandra			Public Health Risks in Urban Slums: Findings of the Qualitative 'Healthy Kitchens Healthy Cities' Study in Kathmandu, Nepal	PLOS ONE			English	Article								Background Communities in urban slums face multiple risks to their health. These are shaped by intermediary and structural determinants. Gaining a clear understanding of these determinants is a prerequisite for developing interventions to reduce the health consequences of urban poverty. With 828 million people living in slum conditions, the need to find ways to reduce risks to health has never been greater. In many low income settings, the kitchen is the epicentre of activities and behaviours which either undermine or enhance health. Methods We used qualitative methods of semi-structured interviews, observation and participatory workshops in two slum areas in Kathmandu, Nepal to gain women's perspectives on the health risks they faced in and around their kitchens. Twenty one women were interviewed and four participatory workshops with a total of 69 women were held. The women took photographs of their kitchens to trigger discussions. Findings The main health conditions identified by the women were respiratory disease, gastrointestinal disease and burn injuries. Women clearly understood intermediary (psychosocial, material and behavioural) determinants to these health conditions such as poor ventilation, cooking on open fires, over-crowding, lack of adequate child supervision. Women articulated the stress they experienced and clearly linked this to health conditions such as heart disease and uptake of smoking. They were also able to identify protective factors, particularly social capital. Subsequent analysis highlighted how female headed-households and those with disabilities had to contend with greater risks to health. Conclusions Women living in slums are very aware of the intermediary determinants-material, behavioural and psychosocial, that increase their vulnerability to ill health. They are also able to identify protective factors, particularly social capital. It is only by understanding the determinants at all levels, not just the behavioural, that we will be able to identify appropriate interventions.	[Elsey, Helen; MacGuire, Frances; King, Rebecca] Univ Leeds, NCIHD, Charles Thackrah Bldg, Leeds, W Yorkshire, England; [Manandah, Shraddha; Sah, Dilip; Khanal, Sudeepa; Baral, Sushil Chandra] Hlth Res & Social Dev Forum HERD, Kathmandu, Nepal; [Wallace, Hilary] Univ Western Australia, Burn Injury Res Unit, Perth, WA, Australia	University of Leeds; University of Western Australia	Elsey, H (corresponding author), Univ Leeds, NCIHD, Charles Thackrah Bldg, Leeds, W Yorkshire, England.	h.elsey@leeds.ac.uk	Elsey, Helen/AAZ-1121-2020	Elsey, Helen/0000-0003-4724-0581; Wallace, Hilary/0000-0002-8370-7647	World Universities Network	World Universities Network	This work was supported by the World Universities Network (http:/www.wun.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonge O, 2014, ARCH DIS CHILD, V99, P62, DOI 10.1136/archdischild-2013-304177; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; Bennett L, 2006, CASTE ETHNIC REGIONA; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Care, 2008, HLTH PROBL URB POOR; Chambers R., 1997, WHOSE REALITY COUNTS, DOI [10.3362/9781780440453, DOI 10.3362/9781780440453]; Collier J., 1986, VISUAL ANTHR PHOTOGR; Elsey H, 2016, J URBAN HEALTH, V93, P526, DOI 10.1007/s11524-016-0046-9; Golshan A, 2013, J PUBLIC HEALTH-UK, V35, P384, DOI 10.1093/pubmed/fds102; Keller C, 2008, QUAL HEALTH RES, V18, P428, DOI 10.1177/1049732307313615; Kumar S., 2002, METHODS COMMUNITY PA; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Muzzini E., 2013, URBAN GROWTH SPATIAL, DOI [10.1596/978-0-8213-9659-9, DOI 10.1596/978-0-8213-9659-9]; NEST , 2010, PHYS MAPP SQUATT SET; Ompad DC, 2007, J URBAN HEALTH, V84, pI42, DOI 10.1007/s11524-007-9168-4; Organization WH, 2009, GLOB HLTH RISKS MORT; Pink Sarah, 2001, DOING VISUAL ANTHR; Prosser Jon., 1998, IMAGE BASED RES SOUR; Rehfuess EA, 2014, ENVIRON HEALTH PERSP, V122, P120, DOI 10.1289/ehp.1306639; Ritchie J, 1993, ANAL QUALITATIVE DAT, P173, DOI DOI 10.1016/J.JPSYCHORES.2008.12.001; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8; Solar O, 2007, CONCEPTUAL FRAMEWORK; Subbaraman R, 2014, SOC SCI MED, V119, P155, DOI 10.1016/j.socscimed.2014.08.021; UNDP/GoN, 2014, NEP HUM DEV REP GEOG; Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3; Vlahov D, 2011, J URBAN HEALTH, V88, P793, DOI 10.1007/s11524-011-9613-2; WHO UNHabitat, 2013, HIDD CIT UNM OV HLTH	27	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2016	11	9							e0163798	10.1371/journal.pone.0163798	http://dx.doi.org/10.1371/journal.pone.0163798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CV	27685999	gold, Green Published			2022-12-27	WOS:000384328500116
J	Bruchmann, M; Korsukewitz, C; Kramer, J; Wiendl, H; Meuth, SG				Bruchmann, Maximilian; Korsukewitz, Catharina; Kraemer, Julia; Wiendl, Heinz; Meuth, Sven G.			Dichoptic Metacontrast Masking Functions to Infer Transmission Delay in Optic Neuritis	PLOS ONE			English	Article							VISUAL-EVOKED-POTENTIALS; MULTIPLE-SCLEROSIS; RETROBULBAR NEURITIS; BACKWARD-MASKING; BRIGHTNESS; PERCEPTION; VISIBILITY; REVERSAL; STIMULUS; ACCESS	Optic neuritis (ON) has detrimental effects on the transmission of neuronal signals generated at the earliest stages of visual information processing. The amount, as well as the speed of transmitted visual signals is impaired. Measurements of visual evoked potentials (VEP) are often implemented in clinical routine. However, the specificity of VEPs is limited because multiple cortical areas are involved in the generation of P1 potentials, including feedback signals from higher cortical areas. Here, we show that dichoptic metacontrast masking can be used to estimate the temporal delay caused by ON. A group of 15 patients with unilateral ON, nine of which had sufficient visual acuity and volunteered to participate, and a group of healthy control subjects (N = 8) were presented with flashes of gray disks to one eye and flashes of gray annuli to the corresponding retinal location of the other eye. By asking subjects to report the subjective visibility of the target (i.e. the disk) while varying the stimulus onset asynchrony (SOA) between disk and annulus, we obtained typical U-shaped masking functions. From these functions we inferred the critical SOA(max) at which the mask (i.e. the annulus) optimally suppressed the visibility of the target. ON-associated transmission delay was estimated by comparing the SOA(max) between conditions in which the disk had been presented to the affected and the mask to the other eye, and vice versa. SOA(max) differed on average by 28 ms, suggesting a reduction in transmission speed in the affected eye. Compared to previously reported methods assessing perceptual consequences of altered neuronal transmission speed the presented method is more accurate as it is not limited by the observers' ability to judge subtle variations in perceived synchrony.	[Bruchmann, Maximilian] Univ Munster, Inst Med Psychol & Syst Neurosci, Munster, Germany; [Bruchmann, Maximilian] Univ Munster, Inst Biomagnetism & Biosignal Anal, Munster, Germany; [Korsukewitz, Catharina; Kraemer, Julia; Wiendl, Heinz; Meuth, Sven G.] Univ Munster, Dept Neurol, Munster, Germany	University of Munster; University of Munster; University of Munster	Bruchmann, M (corresponding author), Univ Munster, Inst Med Psychol & Syst Neurosci, Munster, Germany.; Bruchmann, M (corresponding author), Univ Munster, Inst Biomagnetism & Biosignal Anal, Munster, Germany.	Maximilian.Bruchmann@uni-muenster.de	Wiendl, Heinz/AAX-6041-2021; Meuth, Sven G/HHM-8941-2022	Meuth, Sven G/0000-0003-2571-3501; Wiendl, Heinz/0000-0003-4310-3432	Deutsche Forschungsgemeinschaft [BR 3832/1-2]; German Research Foundation (DFG) [BR3832/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG))	MB received funding from the Deutsche Forschungsgemeinschaft (www.dfg.de), grant number BR 3832/1-2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the German Research Foundation (DFG), BR3832/1-2.	ALPERN M, 1953, J OPT SOC AM, V43, P648, DOI 10.1364/JOSA.43.000648; Bachmann T, 2005, PERCEPTION, V34, P139, DOI 10.1068/p5344b; Bachmann T, 2004, VISION RES, V44, P241, DOI 10.1016/j.visres.2003.10.012; Bachmann T, 1997, CONSCIOUS COGN, V6, P491, DOI 10.1006/ccog.1997.0320; Bachmann T, 2009, SPATIAL VISION, V22, P127, DOI 10.1163/156856809787465645; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breitmeyer B., 2006, VISUAL MASKING; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; BREITMEYER BG, 1976, PSYCHOL REV, V83, P1, DOI 10.1037/0033-295X.83.1.1; Breitmeyer BG, 2006, VISION RES, V46, P2645, DOI 10.1016/j.visres.2005.10.020; Bruchmann M, 2010, J VISION, V10, DOI 10.1167/10.6.12; DALEY ML, 1979, ARCH NEUROL-CHICAGO, V36, P292, DOI 10.1001/archneur.1979.00500410070010; Di Russo F, 2005, NEUROIMAGE, V24, P874, DOI 10.1016/j.neuroimage.2004.09.029; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; HALLIDAY AM, 1972, LANCET, V1, P982; HERON JR, 1974, BRAIN, V97, P69, DOI 10.1093/brain/97.1.69; JONES SJ, 1993, J NEUROL, V240, P489, DOI 10.1007/BF00874118; Kirt T, 2013, CONSCIOUS COGN, V22, P330, DOI 10.1016/j.concog.2012.07.007; Kleiner M, 2007, WHATS NEW PSYCHTOOLB, P14; KOLERS PA, 1960, AM J PSYCHOL, V73, P2, DOI 10.2307/1419113; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; MARX MS, 1984, DOC OPHTHALMOL, V56, P243, DOI 10.1007/BF00159076; Meuth SG, 2011, MULT SCLER J, V17, P198, DOI 10.1177/1352458510386998; Parsons MP, 1957, AMA ARCH NEUROL PSYC, V77, P134, DOI [10.1001/archneurpsyc.1957.02330320032004, DOI 10.1001/ARCHNEURPSYC.1957.02330320032004]; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; QUIGLEY HA, 1977, INVEST OPHTH VIS SCI, V16, P841; REGAN D, 1976, BRAIN, V99, P43, DOI 10.1093/brain/99.1.43; Reuter F, 2007, NEUROPSYCHOLOGIA, V45, P2683, DOI 10.1016/j.neuropsychologia.2007.04.010; Reuter F, 2009, NEUROIMAGE, V44, P590, DOI 10.1016/j.neuroimage.2008.08.024; Ro T, 2003, CURR BIOL, V13, P1038, DOI 10.1016/S0960-9822(03)00337-3; SCHILLER PH, 1968, PERCEPT PSYCHOPHYS, V3, P237, DOI 10.3758/BF03212735; Stigler R, 1926, HDB BIOL ARBEITSMETH, P949; Stromeyer CF, 2003, VISION RES, V43, P285, DOI 10.1016/S0042-6989(02)00412-1; Toosy AT, 2014, LANCET NEUROL, V13, P83, DOI 10.1016/S1474-4422(13)70259-X; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575	40	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163375	10.1371/journal.pone.0163375	http://dx.doi.org/10.1371/journal.pone.0163375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711139	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600022
J	Fujikawa, S; Ando, S; Shimodera, S; Koike, S; Usami, S; Toriyama, R; Kanata, S; Sasaki, T; Kasai, K; Okazaki, Y; Nishida, A				Fujikawa, Shinya; Ando, Shuntaro; Shimodera, Shinji; Koike, Shinsuke; Usami, Satoshi; Toriyama, Rie; Kanata, Sho; Sasaki, Tsukasa; Kasai, Kiyoto; Okazaki, Yuji; Nishida, Atsushi			The Association of Current Violence from Adult Family Members with Adolescent Bullying Involvement and Suicidal Feelings	PLOS ONE			English	Article							PSYCHOTIC-LIKE EXPERIENCES; ENVIRONMENTAL-INFLUENCES; MENTAL-HEALTH; SCHOOL; RISK; VICTIMIZATION; CHILDHOOD; BEHAVIORS; METAANALYSIS; POPULATION	Although several studies have reported that child physical abuse increased the risk for bullying involvement, the effect of current violence from adult family members (CVA) on bullying involvement and suicidal feelings among adolescents has not been sufficiently examined. This study investigated the association of CVA with adolescent bullying involvement and the interaction effect of CVA and bullying involvement on suicidal feelings. This cross-sectional study used data from a school-based survey with a general population of adolescents (grades 7 to 12). Data were collected using a self-report questionnaire completed by 17,530 students. Logistic regression analyses were performed to explore the association of CVA with adolescent bullying involvement and suicidal feelings. The overall response rate was 90.2%. The odds of students being characterized as bullies, victims, and bully-victims were higher among adolescents with CVA than without CVA (odds ratios (OR) = 2.9, 95% confidence interval (CI), [2.3-3.7], 4.6 [3.6-5.8], and 5.8 [4.4-7.6], respectively). Both CVA (OR = 3.4 [95% CI 2.7-4.3]) and bullying (bullies, victims, and bully-victims; OR = 2.0 [95% CI 1.6-2.6], 4.0 [3.1-5.1], 4.1 [3.0-5.6], respectively), were associated with increased odds of current suicidal feelings after adjusting for confounding factors. Furthermore, positive additive effects of CVA and all three types of bullying involvement on suicidal feelings were found. For example, bully-victims with CVA had about 19-fold higher odds of suicidal feelings compared with uninvolved adolescents without CVA. This study, although correlational, suggested that CVA avoidance might prevent bullying involvement and suicidal feelings in adolescents.	[Fujikawa, Shinya; Ando, Shuntaro; Toriyama, Rie; Kanata, Sho; Kasai, Kiyoto] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Ando, Shuntaro; Nishida, Atsushi] Tokyo Metropolitan Inst Med Sci, Dept Psychiat & Behav Sci, Tokyo, Japan; [Shimodera, Shinji] Kochi Univ, Kochi Med Sch, Dept Neuropsychiat, Kochi, Japan; [Koike, Shinsuke] Univ Tokyo, Inst Divers & Adaptat Human Mind UTIDAHM, Tokyo, Japan; [Koike, Shinsuke] Univ Tokyo, Grad Sch Art & Sci, Ctr Evolutionary Cognit Sci, Tokyo, Japan; [Usami, Satoshi] Univ Tsukuba, Div Psychol, Fac Human Sci, Ibaraki, Japan; [Kanata, Sho] Teikyo Univ, Sch Med, Dept Psychiat, Tokyo, Japan; [Sasaki, Tsukasa] Univ Tokyo, Dept Phys & Hlth Educ, Grad Sch Educ, Tokyo, Japan; [Sasaki, Tsukasa] Univ Tokyo, Div Counseling & Support, Tokyo, Japan; [Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Tokyo, Japan	University of Tokyo; Tokyo Metropolitan Institute of Medical Science; Kochi University; University of Tokyo; University of Tokyo; University of Tsukuba; Teikyo University; University of Tokyo; University of Tokyo	Fujikawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan.	fujikawa-s@umin.ac.jp	Andoh, Akira/AAB-9303-2022; Kasai, Kiyoto/GSJ-1237-2022; Koike, Shinsuke/AIC-4690-2022; Kanata, Sho/AAY-7770-2021	Kasai, Kiyoto/0000-0002-4443-4535; 	Ministry of Health, Labour and Welfare of Japan [H19-kokoro-ippan-012]; Ministry of Education, Culture, Sports, Science and Technology of Japan [23118001, 23118002, 23118004]; Research Group for Schizophrenia in Japan; JSPS KAKENHI [JP 16H01689, 16H06395, 16H06398, 16H06399, 16K21720]; Grants-in-Aid for Scientific Research [16H06399, 16K21720] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Group for Schizophrenia in Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant from the Ministry of Health, Labour and Welfare of Japan #H19-kokoro-ippan-012 Atsushi Nishida, a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan 23118001, 23118002, & 23118004; Adolescent Mind & Self-Regulation Kiyoto Kasai, a Grant-in-aid from the Research Group for Schizophrenia in Japan (Award for Research Excellence 2011 to A. N.) Atsushi Nishida, JSPS KAKENHI Grant Number JP 16H01689, 16H06395, 16H06398, 16H06399, and 16K21720 Kiyoto Kasai	Ando S, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-30; [Anonymous], 2010, POP CENS JAP; Arseneault L, 2010, PSYCHOL MED, V40, P717, DOI 10.1017/S0033291709991383; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Bond L, 2001, BRIT MED J, V323, P480, DOI 10.1136/bmj.323.7311.480; Bowes L, 2009, J AM ACAD CHILD PSY, V48, P545, DOI 10.1097/CHI.0b013e31819cb017; Copeland WE, 2013, JAMA PSYCHIAT, V70, P419, DOI 10.1001/jamapsychiatry.2013.504; Craig W, 2009, INT J PUBLIC HEALTH, V54, P216, DOI 10.1007/s00038-009-5413-9; Herba CM, 2008, J CHILD PSYCHOL PSYC, V49, P867, DOI 10.1111/j.1469-7610.2008.01900.x; Hinduja S, 2010, ARCH SUICIDE RES, V14, P206, DOI 10.1080/13811118.2010.494133; Jacobson KC, 2002, DEV PSYCHOPATHOL, V14, P395, DOI 10.1017/S0954579402002110; Juvonen J, 2008, J SCHOOL HEALTH, V78, P496, DOI 10.1111/j.1746-1561.2008.00335.x; Kaltiala-Heino R, 1999, BRIT MED J, V319, P348, DOI 10.1136/bmj.319.7206.348; Klomek AB, 2011, SUICIDE LIFE-THREAT, V41, P501, DOI 10.1111/j.1943-278X.2011.00046.x; Klomek AB, 2010, CAN J PSYCHIAT, V55, P282, DOI 10.1177/070674371005500503; Klomek AB, 2009, J AM ACAD CHILD PSY, V48, P254, DOI 10.1097/CHI.0b013e318196b91f; Lereya ST, 2013, CHILD ABUSE NEGLECT, V37, P1091, DOI 10.1016/j.chiabu.2013.03.001; McKenna M., 2011, Morbidity and Mortality Weekly Report, V60, P465; McMurran M, 2002, AGGRESSIVE BEHAV, V28, P439, DOI 10.1002/ab.80017; Nansel TR, 2001, JAMA-J AM MED ASSOC, V285, P2094, DOI 10.1001/jama.285.16.2094; Nishida A, 2010, ACTA PSYCHIAT SCAND, V121, P301, DOI 10.1111/j.1600-0447.2009.01439.x; Nishida A, 2014, SCHIZOPHR RES, V159, P257, DOI 10.1016/j.schres.2014.09.030; Olweus D, 2010, AM J ORTHOPSYCHIAT, V80, P124, DOI 10.1111/j.1939-0025.2010.01015.x; PAYKEL ES, 1974, BRIT J PSYCHIAT, V124, P460, DOI 10.1192/bjp.124.5.460; Reijntjes A, 2010, CHILD ABUSE NEGLECT, V34, P244, DOI 10.1016/j.chiabu.2009.07.009; Rhee SH, 2002, PSYCHOL BULL, V128, P490, DOI 10.1037//0033-2909.128.3.490; Schiamberg L, 2016, ADOLESCENT PARENT CO; Schwartz D, 2000, DEV PSYCHOL, V36, P646, DOI 10.1037//0012-1649.36.5.646; Shetgiri R, 2013, CHILD PSYCHIAT HUM D, V44, P89, DOI 10.1007/s10578-012-0312-3; Silverman AB, 1996, CHILD ABUSE NEGLECT, V20, P709, DOI 10.1016/0145-2134(96)00059-2; Smokowski PR, 2005, CHILD SCH, V27, P101, DOI 10.1093/cs/27.2.101; Solberg ME, 2003, AGGRESSIVE BEHAV, V29, P239, DOI 10.1002/ab.10047; Spriggs AL, 2007, J ADOLESCENT HEALTH, V41, P283, DOI 10.1016/j.jadohealth.2007.04.009; Takizawa R, 2014, AM J PSYCHIAT, V171, P777, DOI 10.1176/appi.ajp.2014.13101401; Tochigi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045736; Ttofi MM, 2011, J AGGRESS CONFL PEAC, V3, P63, DOI 10.1108/17596591111132873; Vreeman RC, 2007, ARCH PEDIAT ADOL MED, V161, P78, DOI 10.1001/archpedi.161.1.78; Winsper C, 2012, J AM ACAD CHILD PSY, V51, P271, DOI 10.1016/j.jaac.2012.01.001	38	7	7	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163707	10.1371/journal.pone.0163707	http://dx.doi.org/10.1371/journal.pone.0163707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711150	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600035
J	Hosono, K; Isonaka, R; Kawakami, T; Narumiya, S; Majima, M				Hosono, Kanako; Isonaka, Risa; Kawakami, Tadashi; Narumiya, Shuh; Majima, Masataka			Signaling of Prostaglandin E Receptors, EP3 and EP4 Facilitates Wound Healing and Lymphangiogenesis with Enhanced Recruitment of M2 Macrophages in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INFLAMMATORY-BOWEL-DISEASE; C-TERMINAL TAIL; LYMPHATIC VESSELS; TUMOR-GROWTH; ANGIOGENESIS; SUBTYPE; EXPRESSION; MOUSE; CLONING	Lymphangiogenesis plays an important role in homeostasis, metabolism, and immunity, and also occurs during wound-healing. Here, we examined the roles of prostaglandin E-2 (PGE(2)) receptor (EP) signaling in enhancement of lymphangiogenesis in wound healing processes. The hole-punch was made in the ears of male C57BL/6 mice using a metal ear punch. Healing process and lymphangiogenesis together with macrophage recruitment were analyzed in EP knockout mice. Lymphangiogenesis was up-regulated in the granulation tissues at the margins of punched-hole wounds in mouse ears, and this increase was accompanied by increased expression levels of COX-2 and microsomal prostaglandin E synthase-1. Administration of celecoxib, a COX-2 inhibitor, suppressed lymphangiogenesis in the granulation tissues and reduced the induction of the pro-lymphangiogenic factors, vascular endothelial growth factor (VEGF)-C and VEGF-D. Topical applications of selective EP receptor agonists enhanced the expressions of lymphatic vessel endothelial hyaluronan receptor-1 and VEGF receptor-3. The wound-healing processes and recruitment of CD11b-positive macrophages, which produced VEGF-C and VEGF-D, were suppressed under COX-2 inhibition. Mice lacking either EP3 or EP4 exhibited reduced wound-healing, lymphangiogenesis and recruitment of M2 macrophages, compared with wild type mice. Proliferation of cultured human lymphatic endothelial cells was not detected under PGE2 stimulation. Lymphangiogenesis and recruitment of M2 macrophages that produced VEGF-C/D were suppressed in mice treated with a COX-2 inhibitor or lacking either EP3 or EP4 during wound healing. COX-2 and EP3/EP4 signaling may be novel targets to control lymphangiogenesis in vivo.	[Hosono, Kanako; Majima, Masataka] Kitasato Univ, Grad Sch Med Sci, Dept Mol Pharmacol, Sagamihara, Kanagawa, Japan; [Hosono, Kanako; Majima, Masataka] Kitasato Univ, Sch Med, Dept Pharmacol, Sagamihara, Kanagawa, Japan; [Hosono, Kanako; Isonaka, Risa; Kawakami, Tadashi] Kitasato Univ, Sch Med, Dept Physiol, Sagamihara, Kanagawa, Japan; [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan	Kitasato University; Kitasato University; Kitasato University; Kyoto University	Majima, M (corresponding author), Kitasato Univ, Grad Sch Med Sci, Dept Mol Pharmacol, Sagamihara, Kanagawa, Japan.; Majima, M (corresponding author), Kitasato Univ, Sch Med, Dept Pharmacol, Sagamihara, Kanagawa, Japan.	mmajima@med.kitasato-u.ac.jp	Majima, Masataka/ABH-3063-2021		Ministry of Education, Culture, Sports, Science and Technology (MEXT) [15K08241, 25860192, 15K15056, 26293055, 24659119, 23116102]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the grants from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), #15K08241, #25860192, #15K15056, #26293055, #24659119, #23116102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Ae T, 2010, AM J PHYSIOL-GASTR L, V299, pG1139, DOI 10.1152/ajpgi.00013.2010; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Amano H, 2003, J EXP MED, V197, P221, DOI 10.1084/jem.20021408; Baldwin ME, 2001, J BIOL CHEM, V276, P19166, DOI 10.1074/jbc.M100097200; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Binger KJ, 2015, J CLIN INVEST, V125, P4223, DOI 10.1172/JCI80919; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Bryer MD, 2001, ANNU REV PHYSIOL, V63, P579, DOI 10.1146/annurev.physiol.63.1.579; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; FUNK CD, 1993, J BIOL CHEM, V268, P26767; Guo RL, 2009, ARTHRITIS RHEUM-US, V60, P2666, DOI 10.1002/art.24764; Hatae N, 2002, J BIOCHEM, V131, P781, DOI 10.1093/oxfordjournals.jbchem.a003165; Hirai S, 2013, ANDROLOGY-US, V1, P147, DOI 10.1111/j.2047-2927.2012.00015.x; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; HONDA A, 1993, J BIOL CHEM, V268, P7759; IRIE A, 1993, EUR J BIOCHEM, V217, P313, DOI 10.1111/j.1432-1033.1993.tb18248.x; Ji RC, 2012, CELL MOL LIFE SCI, V69, P897, DOI 10.1007/s00018-011-0848-6; Jurisic G, 2013, INFLAMM BOWEL DIS, V19, P1983, DOI 10.1097/MIB.0b013e31829292f7; Kaiserling E, 2003, LYMPHOLOGY, V36, P52; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kashiwagi S, 2011, LAB INVEST, V91, P1314, DOI 10.1038/labinvest.2011.84; Katoh H, 2010, AM J PATHOL, V176, P1469, DOI 10.2353/ajpath.2010.090607; Katori M, 2000, INFLAMM RES, V49, P367, DOI 10.1007/s000110050605; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kim H, 2012, TRENDS IMMUNOL, V33, P350, DOI 10.1016/j.it.2012.03.006; Kubo H, 2010, BIOMED PHARMACOTHER, V64, P101, DOI 10.1016/j.biopha.2009.04.039; Kurashige C, 2014, FASEB J, V28, P1237, DOI 10.1096/fj.13-238998; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Majima M, 2000, BRIT J PHARMACOL, V130, P641, DOI 10.1038/sj.bjp.0703327; Majima M, 2003, TRENDS PHARMACOL SCI, V24, P524, DOI 10.1016/j.tips.2003.08.005; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Mumprecht V, 2009, J CELL MOL MED, V13, P1405, DOI 10.1111/j.1582-4934.2009.00834.x; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Oike Y, 2003, P NATL ACAD SCI USA, V100, P9494, DOI 10.1073/pnas.1531901100; Paavonen K, 2000, AM J PATHOL, V156, P1499, DOI 10.1016/S0002-9440(10)65021-3; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Schledzewski K, 2006, J PATHOL, V209, P67, DOI 10.1002/path.1942; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; SUGIMOTO Y, 1992, J BIOL CHEM, V267, P6463; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; WATABE A, 1993, J BIOL CHEM, V268, P20175; Witmer AN, 2001, J PATHOL, V195, P490, DOI 10.1002/path.969; WOODWARD DF, 1995, BIOCHEM PHARMACOL, V50, P1731, DOI 10.1016/0006-2952(95)02035-7; Yao LC, 2014, ADV ANAT EMBRYOL CEL, V214, P41, DOI 10.1007/978-3-7091-1646-3_4; Yin N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028023; Zhang MZ, 2015, J CLIN INVEST, V125, P4281, DOI 10.1172/JCI81550; Zheng M, 2014, BIOMED RES-TOKYO, V35, P37, DOI 10.2220/biomedres.35.37	53	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0162532	10.1371/journal.pone.0162532	http://dx.doi.org/10.1371/journal.pone.0162532			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711210	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600007
J	Rueda-Martinez, C; Fernandez, MC; Soto-Navarrete, MT; Jimenez-Navarro, M; Duran, AC; Fernandez, B				Rueda-Martinez, Carmen; Carmen Fernandez, M.; Teresa Soto-Navarrete, Maria; Jimenez-Navarro, Manuel; Carmen Duran, Ana; Fernandez, Borja			Identification of Reference Genes for Quantitative Real Time PCR Assays in Aortic Tissue of Syrian Hamsters with Bicuspid Aortic Valve	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; VALVULAR HEART-DISEASE; EXPRESSION; ANEURYSMS; MODEL; QUANTIFICATION; NORMALIZATION; EFFICIENCY; DILATATION; SELECTION	Bicuspid aortic valve (BAV) is the most frequent congenital cardiac malformation in humans, and appears frequently associated with dilatation of the ascending aorta. This association is likely the result of a common aetiology. Currently, a Syrian hamster strain with a relatively high (similar to 40%) incidence of BAV constitutes the only spontaneous animal model of BAV disease. The characterization of molecular alterations in the aorta of hamsters with BAV may serve to identify pathophysiological mechanisms and molecular markers of disease in humans. In this report, we evaluate the expression of ten candidate reference genes in aortic tissue of hamsters in order to identify housekeeping genes for normalization using quantitative real time PCR (RT-qPCR) assays. A total of 51 adult (180- 240 days old) and 56 old (300-440 days old) animals were used. They belonged to a control strain of hamsters with normal, tricuspid aortic valve (TAV; n = 30), or to the affected strain of hamsters with TAV (n = 45) or BAV (n = 32). The expression stability of the candidate reference genes was determined by RT-qPCR using three statistical algorithms, GeNorm, NormFinder and Bestkeeper. The expression analyses showed that the most stable reference genes for the three algorithms employed were Cdkn1 beta, G3pdh and Polr2a. We propose the use of Cdkn1 beta, or both Cdkn1 beta and G3pdh as reference genes for mRNA expression analyses in Syrian hamster aorta.	[Rueda-Martinez, Carmen; Jimenez-Navarro, Manuel] Univ Malaga, RIC, Hosp Univ Virgen Victoria, UGC Corazon, Malaga, Spain; [Carmen Fernandez, M.; Teresa Soto-Navarrete, Maria; Carmen Duran, Ana; Fernandez, Borja] Univ Malaga, Fac Ciencias, Dept Biol Anim, Malaga, Spain; [Jimenez-Navarro, Manuel] Univ Malaga, Fac Med, Dept Med, Malaga, Spain; [Jimenez-Navarro, Manuel; Carmen Duran, Ana; Fernandez, Borja] Inst Invest Biomed Malaga IBIMA, Malaga, Spain	Hospital Virgen de la Victoria; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga	Fernandez, B (corresponding author), Univ Malaga, Fac Ciencias, Dept Biol Anim, Malaga, Spain.; Fernandez, B (corresponding author), Inst Invest Biomed Malaga IBIMA, Malaga, Spain.	borjafe@uma.es	/AAG-9282-2020; jimenez-navarro, manuel/AAJ-3236-2020; Corujo, Francisco Borja Fernández/AAG-8258-2020; Soto-Navarrete, Maria Teresa/AAG-7163-2020	Corujo, Francisco Borja Fernández/0000-0001-9179-910X; Jimenez Navarro, Manuel Francisco/0000-0002-6759-0514; Rueda Martinez, Carmen/0000-0002-3278-8475; Fernandez, M. Carmen/0000-0002-9051-8668	Junta de Andalucia (Sevilla, Spain) [P10-6068/2010, PI-0689/2010]; Red de Investigacion Cardiovascular (RIC; RETICs) (Madrid, Spain)	Junta de Andalucia (Sevilla, Spain)(Junta de Andalucia); Red de Investigacion Cardiovascular (RIC; RETICs) (Madrid, Spain)	This work was supported by Grants P10-6068/2010 and PI-0689/2010 from Junta de Andalucia (Sevilla, Spain); and Red de Investigacion Cardiovascular (RIC; RETICs) (Madrid, Spain).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basso C, 2004, AM J CARDIOL, V93, P661, DOI 10.1016/j.amjcard.2003.11.031; Bechtel JFM, 2003, J HEART VALVE DIS, V12, P54; Boon RA, 2011, CIRC RES, V109, P1115, DOI 10.1161/CIRCRESAHA.111.255737; Brattelid T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-22; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Butany J, 2009, CARDIOVASC PATHOL, V18, P11, DOI 10.1016/j.carpath.2007.12.004; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067360; Cotrufo M, 2005, J THORAC CARDIOV SUR, V130, P504, DOI 10.1016/j.jtcvs.2005.01.016; Della Corte A, 2008, J THORAC CARDIOV SUR, V135, P8, DOI 10.1016/j.jtcvs.2007.09.009; EDWARDS JE, 1961, CIRCULATION, V23, P485, DOI 10.1161/01.CIR.23.4.485; Espitia CM, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-31; Fedak PWM, 2008, EUR HEART J, V29, P432, DOI 10.1093/eurheartj/ehm609; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Fernandez B, 2014, REV ESP CARDIOL, V67, P712; Fernandez B, 2009, J AM COLL CARDIOL, V54, P2312, DOI 10.1016/j.jacc.2009.07.044; Fernandez MC, 2000, LAB ANIM-UK, V34, P145, DOI 10.1258/002367700780457545; Folkersen L, 2011, MOL MED, V17, P1365, DOI 10.2119/molmed.2011.00286; Gomez D, 2011, CARDIOVASC RES, V89, P446, DOI 10.1093/cvr/cvq291; Grewal N, 2014, NETH HEART J, V22, P363, DOI 10.1007/s12471-014-0576-2; Henn D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054132; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jackson V, 2012, J THORAC CARDIOV SUR, V144, P459, DOI 10.1016/j.jtcvs.2011.08.043; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; LaHaye S, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0487-2; LeMaire SA, 2011, NAT REV CARDIOL, V8, P103, DOI 10.1038/nrcardio.2010.187; Lincoln J, 2014, CIRC J, V78, P1801, DOI 10.1253/circj.CJ-14-0510; Losenno KL, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/145202; Maleki S, 2013, J MOL MED, V91, P129, DOI 10.1007/s00109-012-0942-8; Noutsias M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-3; Paloschi V, 2011, ARTERIOSCL THROM VAS, V31, P691, DOI 10.1161/ATVBAHA.110.218461; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfister Christina, 2011, BMC Res Notes, V4, P275, DOI 10.1186/1756-0500-4-275; Phillippi JA, 2010, ANN THORAC SURG, V90, P1893, DOI 10.1016/j.athoracsur.2010.07.069; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Prakash SK, 2014, J AM COLL CARDIOL, V64, P832, DOI 10.1016/j.jacc.2014.04.073; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rueda-Martinez C, 2017, EUR J CARDIO-THORAC, V51, P104, DOI 10.1093/ejcts/ezw277; Rueda-Martinez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097449; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Sans-Coma V, 2012, J ANAT, V220, P92, DOI 10.1111/j.1469-7580.2011.01440.x; SansComa V, 1996, ANAT RECORD, V244, P490, DOI 10.1002/(SICI)1097-0185(199604)244:4<490::AID-AR7>3.0.CO;2-Z; Sciacca S, 2013, HEART VESSELS, V28, P268, DOI 10.1007/s00380-012-0238-5; Siu SC, 2010, J AM COLL CARDIOL, V55, P2789, DOI 10.1016/j.jacc.2009.12.068; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma S, 2014, NEW ENGL J MED, V370, P1920, DOI 10.1056/NEJMra1207059; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yperman J, 2004, J HEART VALVE DIS, V13, P848; Zivcec M, 2011, J IMMUNOL METHODS, V368, P24, DOI 10.1016/j.jim.2011.02.004; Zyzynska-Granica B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051547	55	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164070	10.1371/journal.pone.0164070	http://dx.doi.org/10.1371/journal.pone.0164070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711171	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600073
J	Asaolu, IO; Gunn, JK; Center, KE; Koss, MP; Iwelunmor, JI; Ehiri, JE				Asaolu, Ibitola O.; Gunn, Jayleen K.; Center, Katherine E.; Koss, Mary P.; Iwelunmor, Juliet I.; Ehiri, John E.			Predictors of HIV Testing among Youth in Sub-Saharan Africa: A Cross-Sectional Study	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; STI/HIV COINFECTIONS; TRANSMISSION; PREVALENCE; ADOLESCENTS; LINKAGE; WOMEN; CARE; MEN	Introduction In spite of a high prevalence of HIV infection among adolescents and young adults in sub-Saharan Africa, uptake of HIV testing and counseling among youth in the region remains sub-optimal. The objective of this study was to assess factors that influence uptake of HIV testing and counseling among youth aged 15-24 years in sub-Saharan Africa. Methods This study used the Demographic and Health Survey (DHS) data from countries that represent four geographic regions of sub-Saharan Africa: Congo (Brazzaville), representing central Africa (DHS 2011-2012); Mozambique, representing southern Africa (DHS 2011); Nigeria, representing western Africa (DHS 2013); and Uganda, representing eastern Africa (DHS 2011). Analyses were restricted to 23,367 male and female respondents aged 15-24 years with complete data on the variables of interest. Chi-square tests and logistic regression models were used to assess predictors of HIV testing. Statistical significance was set at p<0.01. Results The analysis revealed that a majority of the respondents were female (78.1%) and aged 20-24-years (60.7%). Only a limited proportion of respondents (36.5%) had ever tested for HIV and even fewer (25.7%) demonstrated comprehensive knowledge of HIV/AIDS. There was a significant association between HIV testing and respondents' gender, age, age at sexual debut, and comprehensive knowledge of HIV in the pooled sample. Older youth (adjusted OR (aOR) = 2.19; 99% CI = 1.99-2.40) and those with comprehensive knowledge of HIV (aOR = 1.98; 1.76-2.22) had significantly higher odds of ever being tested for HIV than younger respondents and those with limited HIV/AIDS knowledge respectively. Furthermore, men had lower odds of HIV testing than women (aOR = 0.32; 0.28-0.37). Conclusions Reaching youth in sub-Saharan Africa for HIV testing continues to be a challenge. Public health programs that seek to increase HIV counseling and testing among youth should pay particular attention to efforts that target high-risk subpopulations of youth. The results further suggest that these initiatives would be strengthened by including strategies to increase HIV comprehensive knowledge.	[Asaolu, Ibitola O.; Koss, Mary P.; Ehiri, John E.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Hlth Promot Sci, 1295 N Martin Ave, Tucson, AZ 85724 USA; [Gunn, Jayleen K.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Epidemiol & Biostat, 1295 N Martin Ave, Tucson, AZ 85724 USA; [Center, Katherine E.] Univ Arizona, Dept Obstet & Gynecol, 1501 N Campbell Ave, Tucson, AZ 85724 USA; [Iwelunmor, Juliet I.] Univ Illinois, Dept Kinesiol & Community Hlth, 1206 S 4th St, Champaign, IL 61820 USA	University of Arizona; University of Arizona; University of Arizona; University of Illinois System; University of Illinois Urbana-Champaign	Ehiri, JE (corresponding author), Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Hlth Promot Sci, 1295 N Martin Ave, Tucson, AZ 85724 USA.	jehiri@email.arizona.edu						Alene GD, 2004, AIDS CARE, V16, P57, DOI 10.1080/09540120310001633976; Anderson KG, 2007, INT FAM PLAN PERSPEC, V33, P98, DOI 10.1363/3309807; [Anonymous], 2010, NATL HIV AIDS STRATE; Breakwell G M, 1996, J Health Psychol, V1, P79, DOI 10.1177/135910539600100107; Centers for Disease Control Prevention, 2011, ANN EMERG MED, V58, P67, DOI [10.1016/j.annemergmed.2011.04.006, DOI 10.1016/J.ANNEMERGMED.2011.04.006]; Ezeanolue EE, 2015, LANCET GLOB HEALTH, V3, pE692, DOI 10.1016/S2214-109X(15)00195-3; Fox K., 2013, HIV ADOLESCENTS GUID; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Green EC, 2006, AIDS BEHAV, V10, P335, DOI 10.1007/s10461-006-9073-y; Gunn JKL, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20605; ICF International, 2012, SAMPL HOUS LIST MAN; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Kehinde AO, 2005, J R SOC PROMO HEALTH, V125, P186, DOI 10.1177/146642400512500413; Khan, 2008, DHS COMP REPORTS, V19; Kyaddondo D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-966; Lapsley DK, BIANN M SOC RES CHIL, V8; Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x; Mhlongo S, 2010, SEX TRANSM DIS, V37, P566, DOI 10.1097/OLQ.0b013e3181d877b7; Mugo N, 2011, SEX TRANSM DIS, V38, P1059, DOI 10.1097/OLQ.0b013e31822e60b6; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Oginni A, 2014, AIDS RES HUM RETROV, V30, pA113, DOI 10.1089/aid.2014.5216.abstract; Omoigberale AI, 2007, NIGER J CLIN PRACT, V9, P11; Pharr JR, 2016, JAIDS-J ACQ IMM DEF, V72, pS154, DOI 10.1097/QAI.0000000000001051; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Sam-Agudu NA, 2016, PEDIATR RES, V79, P838, DOI 10.1038/pr.2016.28; Sanga Z, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1771-9; Sekandi JN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-730; The Republic of Uganda, 2015, HIV AIDS UG COUNTR P; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; UNAIDS, 2015, UNAIDS GAP REP 2014; UNICEF, 2012, PROGR CHILDR REP CAR; United Republic of Tanzania, 2007, NAT AIDS CONTR PROGR; who, AD HLTH RISKS SOL; WHO, 2015, CONSOLIDATED GUIDELI; Wilson CM, 2010, JAIDS-J ACQ IMM DEF, V54, pS5, DOI 10.1097/QAI.0b013e3181e243a1	36	72	73	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164052	10.1371/journal.pone.0164052	http://dx.doi.org/10.1371/journal.pone.0164052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706252	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200080
J	Gonzalez, EB; Knutsen, H; Jorde, PE				Gonzalez, Enrique Blanco; Knutsen, Halvor; Jorde, Per Erik			Habitat Discontinuities Separate Genetically Divergent Populations of a Rocky Shore Marine Fish	PLOS ONE			English	Article							FALSE DISCOVERY RATE; SEASCAPE GENETICS; PHYLOGEOGRAPHIC BREAKS; CORKWING WRASSE; CLIMATE-CHANGE; DIFFERENTIATION; CONNECTIVITY; ADAPTATION; DISPERSAL; DIVERSITY	Habitat fragmentation has been suggested to be responsible for major genetic differentiations in a range of marine organisms. In this study, we combined genetic data and environmental information to unravel the relative role of geography and habitat heterogeneity on patterns of genetic population structure of corkwing wrasse (Symphodus melops), a rocky shore species at the northern limit of its distribution range in Scandinavia. Our results revealed a major genetic break separating populations inhabiting the western and southern coasts of Norway. This genetic break coincides with the longest stretch of sand in the whole study area, suggesting habitat fragmentation as a major driver of genetic differentiation of this obligate rocky shore benthic fish in Scandinavia. The complex fjords systems extending along the western coast of Norway appeared responsible for further regional genetic structuring. Our findings indicate that habitat discontinuities may lead to significant genetic fragmentation over short geographical distances, even for marine species with a pelagic larval phase, as for this rocky shore fish.	[Gonzalez, Enrique Blanco; Knutsen, Halvor] Univ Agder, Ctr Coastal Res, N-4604 Kristiansand, Norway; [Knutsen, Halvor] IMR, N-4817 His, Norway; [Knutsen, Halvor; Jorde, Per Erik] Univ Oslo, CEES, Dept Biosci, POB 1066 Blindern, N-0316 Oslo, Norway	University of Agder; Institute of Marine Research - Norway; University of Oslo	Gonzalez, EB (corresponding author), Univ Agder, Ctr Coastal Res, N-4604 Kristiansand, Norway.	enrique.blanco@uia.no	Gonzalez, Enrique Blanco/O-7721-2019; Knutsen, Halvor/A-4261-2009	Gonzalez, Enrique Blanco/0000-0002-2631-2331; Knutsen, Halvor/0000-0002-7627-7634; Jorde, Per Erik/0000-0001-5515-7257	MarinERA program of the European Science Foundation [189570]; Havkyst program of the Norwegian Research Council [234328/MO]; EU Interreg (Kattegat-Skagerrak-Oresund) project [MarGen]	MarinERA program of the European Science Foundation; Havkyst program of the Norwegian Research Council; EU Interreg (Kattegat-Skagerrak-Oresund) project	This work was funded under the MarinERA program of the European Science Foundation (project # 189570, "Marine phylogenetic structuring during climate change: the signature of leading and rear edge of range shifting population"; http://biocongroup.eu/MarinEra/Welcome.html) and the Havkyst program of the Norwegian Research Council (project #234328/MO "Adaptation or plasticity as response to large scale translocations and harvesting over a climatic gradient in the marine ecosystem?"; https://corkwingadapt.wordpress.com/). HK and PEJ were also funded by the EU Interreg (Kattegat-Skagerrak-Oresund) project #"MarGen", http://interreg.no/prosjektbank/margen/.	Araki H., 2010, AQUACULTURE S1, V308, P52, DOI DOI 10.1016/j.aquaculture.2010.05.036; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; Barcelo C, 2016, GLOBAL CHANGE BIOL, V22, P1155, DOI 10.1111/gcb.13047; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Belkhir K, 2004, 5000 CNRS UMR LAB GE; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardi G, 2000, EVOLUTION, V54, P226, DOI 10.1111/j.0014-3820.2000.tb00023.x; Blanco Gonzalez E, 2011, ANAL GENETIC VARIATI, P217; Bradbury IR, 2008, MOL ECOL, V17, P1438, DOI 10.1111/j.1365-294X.2008.03694.x; Corner GD, PHYS GEOGRAPHY FENNO, P203; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Darwall WRY, 2002, J FISH BIOL SB, V41, P111; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Espeland SH, 2010, KUNNSKAPSSTATUS LEPP; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Gonzalez EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125743; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P2222, DOI 10.1093/bioinformatics/btn419; Halvorsen KT, 2016, ICES J MAR SCI, V73, P2586, DOI 10.1093/icesjms/fsw135; Hansen Michael Moller, 2007, J Biol, V6, P6, DOI 10.1186/jbiol59; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Hellberg ME, 2002, B MAR SCI, V70, P273; Hickey AJR, 2009, MOL ECOL, V18, P680, DOI 10.1111/j.1365-294X.2008.04052.x; Irwin DE, 2002, EVOLUTION, V56, P2383; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johannesson K, 2006, MOL ECOL, V15, P2013, DOI 10.1111/j.1365-294X.2006.02919.x; Jolly MT, 2005, HEREDITY, V94, P23, DOI 10.1038/sj.hdy.6800543; Jorde PE, 2007, MAR ECOL PROG SER, V343, P229, DOI 10.3354/meps06922; Kawecki TJ, 2008, ANNU REV ECOL EVOL S, V39, P321, DOI 10.1146/annurev.ecolsys.38.091206.095622; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Knutsen H, 2015, ICES J MAR SCI, V72, P863, DOI 10.1093/icesjms/fsu204; Knutsen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067492; Knutsen H, 2009, CONSERV GENET RESOUR, V1, P433, DOI 10.1007/s12686-009-9100-1; Knutsen H, 2009, MOL ECOL, V18, P3151, DOI 10.1111/j.1365-294X.2009.04253.x; Kuo CH, 2005, GENETICA, V124, P179, DOI 10.1007/s10709-005-2095-y; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Merila J, 2014, EVOL APPL, V7, P1, DOI 10.1111/eva.12137; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Olsen JL, 2013, MAR ECOL PROG SER, V486, P121, DOI 10.3354/meps10373; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pritchard JK, 2000, GENETICS, V155, P945; QGIS Development Team, 2009, QUANT GIS GEOGR INF; Quignard J.-P., 1986, P919; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raventos N, 2001, MAR BIOL, V138, P1115; Riginos C, 2001, MOL ECOL, V10, P1439, DOI 10.1046/j.1365-294X.2001.01294.x; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; Robalo JI, 2012, ECOL EVOL, V2, P153, DOI 10.1002/ece3.77; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Satre R., 2007, NORWEGIAN COASTAL CU; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Sivasundar A, 2010, MAR BIOL, V157, P1433, DOI 10.1007/s00227-010-1419-3; Skiftesvik AB, 2014, MAR BIOL RES, V10, P289, DOI 10.1080/17451000.2013.810760; Sodeland M, 2016, GENOME BIOL EVOL, V8, P1012, DOI 10.1093/gbe/evw057; Takezaki N., 2000, POPTREE POPULATION T; Teske PR, 2011, S AFR J SCI, V107, P43, DOI 10.4102/sajs.v107i5/6.514; Toms JA, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0330; Uglem I, 2002, ENVIRON BIOL FISH, V63, P17, DOI 10.1023/A:1013886112191; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Von der Heyden S., 2013, FRONTIERS BIOGEOGRAP, V5, P29, DOI [10.21425/f5fbg13391, DOI 10.21425/F55113391, DOI 10.21425/F5FBG13391]; Wang IJ, 2013, EVOLUTION, V67, P3403, DOI 10.1111/evo.12134; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1943, GENETICS, V28, P114	73	45	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163052	10.1371/journal.pone.0163052	http://dx.doi.org/10.1371/journal.pone.0163052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706178	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200032
J	Liu, Y; Cao, F; Xiong, H; Shen, YB; Wang, M				Liu, Yang; Cao, Fei; Xiong, Hui; Shen, Yanbing; Wang, Min			Application of 2,4-Dinitrophenylhydrazine (DNPH) in High-ThroughputScreening for Microorganism Mutants Accumulating 9 alpha-Hydroxyandrost-4-ene-3,17-dione (9 alpha-OHAD)	PLOS ONE			English	Article							RHODOCOCCUS-ERYTHROPOLIS; 3-KETOSTEROID DELTA(1)-DEHYDROGENASE; MYCOBACTERIUM-NEOAURUM; CELLS; FORMALDEHYDE; ALDEHYDES; STEROLS; GENE	To develop a quick method for the preliminarily screening of mutant strains that can accumulate 9 alpha-hydroxyandrost-4-ene-3,17-dione (9 alpha-OH-AD), a high-throughput screening method was presented by applying the principle that 2,4-dinitrophenylhydrazine (DNPH) can react with ketones to produce precipitation. The optimal color assay conditions were the substrate androst-4-ene-3,17-dione (AD) concentration at 2.0 g/L, the ratio of AD to DNPH solution at 1: 4, and the sulfuric acid and ethanol solution percentages in DNPH solution at 2% and 35%, respectively. This method was used to preliminarily screen the mutants of Rhodococcus rhodochrous DSM43269, from which the three ones obtained could produce more 9 alpha-OH-AD. This DNPH color assay method not only broadens screening methods and increases screening efficiency in microbial mutation breeding but also establishes a good foundation for obtaining strains for industrial application.	[Liu, Yang; Cao, Fei; Xiong, Hui; Shen, Yanbing; Wang, Min] Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ, Key Lab Ind Fermentat Microbiol, Tianjin, Peoples R China	Tianjin University Science & Technology	Wang, M (corresponding author), Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ, Key Lab Ind Fermentat Microbiol, Tianjin, Peoples R China.	minw@tust.edu.cn			National Natural Science Foundation of China [21276196]; The National Natural Science Foundation of China [21406167]; Key Project of Chinese Ministry of Education [213004A]; Student's Platform for Innovation and Entrepreneurship Training Program [201510057059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China); Student's Platform for Innovation and Entrepreneurship Training Program	Support was provided by: the National Natural Science Foundation of China (21276196, http://www.nsfc.gov.cn/): MW; the National Natural Science Foundation of China (21406167, http://www.nsfc.gov.cn/): YS; the Key Project of Chinese Ministry of Education (213004A, http://www.moe.gov.cn/): MW; the Student's Platform for Innovation and Entrepreneurship Training Program (201510057059, http://www.tjmec.gov.cn/): YS. All of these funders had important roles in the study design, experiments performed and preparation of the manuscript.	Andryushina VA, 2011, APPL BIOCHEM MICRO+, V47, P270, DOI 10.1134/S0003683811030021; Angelova B, 2005, ENZYME MICROB TECH, V37, P718, DOI 10.1016/j.enzmictec.2005.04.014; Carpova-Rodina NV, 2011, APPL BIOCHEM MICRO+, V47, P386, DOI 10.1134/S0003683811040041; de las Heras LF, 2012, J STEROID BIOCHEM, V132, P271, DOI 10.1016/j.jsbmb.2012.06.005; Kang HK, 1997, ARCH PHARM RES, V20, P519, DOI 10.1007/BF02975204; Kim YU, 2007, ARCH PHARM, V340, P209, DOI 10.1002/ardp.200600175; LIPARI F, 1982, J CHROMATOGR, V247, P297, DOI 10.1016/S0021-9673(00)85953-1; Liu C, 2015, J ZHEJIANG UNIV-SC B, V16, P286, DOI 10.1631/jzus.B1400274; Medvedev VS, 2012, PHARM CHEM J+, V46, P573, DOI 10.1007/s11094-012-0849-2; Sandner F, 2001, INT J HYG ENVIR HEAL, V203, P275, DOI 10.1078/S1438-4639(04)70038-3; Sukhodolskaya GV, 2007, APPL MICROBIOL BIOT, V74, P867, DOI 10.1007/s00253-006-0728-4; van der Geize R, 2002, MICROBIOL-SGM, V148, P3285, DOI 10.1099/00221287-148-10-3285; van der Geize R, 2001, FEMS MICROBIOL LETT, V205, P197, DOI 10.1016/S0378-1097(01)00464-5; Yao K, 2013, METAB ENG, V15, P75, DOI 10.1016/j.ymben.2012.10.005; Zhang QY, 2015, ANN MICROBIOL, V65, P1961, DOI 10.1007/s13213-015-1034-0	15	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163836	10.1371/journal.pone.0163836	http://dx.doi.org/10.1371/journal.pone.0163836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706217	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697200063
J	Meddeb, M; Carpentier, W; Cagnard, N; Nadaud, S; Grillon, A; Barthel, C; De Martino, SJ; Jaulhac, B; Boulanger, N; Schramm, F				Meddeb, Mariam; Carpentier, Wassila; Cagnard, Nicolas; Nadaud, Sophie; Grillon, Antoine; Barthel, Cathy; De Martino, Sylvie Josiane; Jaulhac, Benoit; Boulanger, Nathalie; Schramm, Frederic			Homogeneous Inflammatory Gene Profiles Induced in Human Dermal Fibroblasts in Response to the Three Main Species of Borrelia burgdorferi sensu lato	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; ERYTHEMA MIGRANS; ENDOTHELIAL-CELLS; I IFN; DIVERSITY; ACTIVATION; EXPRESSION; CHEMOKINES; BISSETTII; AUSTRIA	In Lyme borreliosis, the skin is the key site for bacterial inoculation by the infected tick and for cutaneous manifestations. We previously showed that different strains of Borrelia burgdorferi sensu stricto isolated from tick and from different clinical stages of the Lyme borreliosis (erythema migrans, and acrodermatitis chronica atrophicans) elicited a very similar transcriptional response in normal human dermal fibroblasts. In this study, using whole transcriptome microarray chips, we aimed to compare the transcriptional response of normal human dermal fibroblasts stimulated by 3 Borrelia burgdorferi sensu lato strains belonging to 3 main pathogenic species (B. afzelii, B. garinii and B. burgdorferi sensu stricto) in order to determine whether "species-related" inflammatory pathways could be identified. The three Borrelia strains tested exhibited similar transcriptional profiles, and no species-specific fingerprint of transcriptional changes in fibroblasts was observed. Conversely, a common core of chemokines/cytokines (CCL2, CXCL1, CXCL2, CXCL6, CXCL10, IL-6, IL-8) and interferon-related genes was stimulated by all the 3 strains. Dermal fibroblasts appear to play a key role in the cutaneous infection with Borrelia, inducing a homogeneous inflammatory response, whichever Borrelia species was involved.	[Meddeb, Mariam; Grillon, Antoine; Barthel, Cathy; De Martino, Sylvie Josiane; Jaulhac, Benoit; Boulanger, Nathalie; Schramm, Frederic] Univ Strasbourg, FMTS, Lyme Borreliosis Grp, Early Bacterial Virulence EA7290, Strasbourg, France; [Carpentier, Wassila] Univ Paris 06, Fac Med, Plateforme Postgenom P3S, Paris, France; [Cagnard, Nicolas] Univ Paris 05, INSERM, CNRS,UMS 3633,US24, Plateforme Bioinformat,Struct Federat Rech Necker, Paris, France; [Nadaud, Sophie] Univ Paris 06, INSERM, UMR 1166, Paris, France; [De Martino, Sylvie Josiane; Jaulhac, Benoit; Boulanger, Nathalie] Univ Hosp, French Natl Reference Ctr Borrelia, Strasbourg, France; [Schramm, Frederic] Univ Strasbourg, Fac Med, EA 7490, Inst Bacteriol, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schramm, F (corresponding author), Univ Strasbourg, FMTS, Lyme Borreliosis Grp, Early Bacterial Virulence EA7290, Strasbourg, France.; Schramm, F (corresponding author), Univ Strasbourg, Fac Med, EA 7490, Inst Bacteriol, Strasbourg, France.	fredericschramm@unistra.fr	Boulanger, Nathalie/ABF-1353-2020; Nadaud, Sophie/GXV-0505-2022; Nadaud, Sophie/A-7063-2013; Schramm, Frédéric/M-8166-2015; Schramm, Frédéric/R-9953-2019; Cagnard, Nicolas/K-2754-2014	Nadaud, Sophie/0000-0002-1452-6009; Schramm, Frédéric/0000-0002-6889-515X; Schramm, Frédéric/0000-0002-6889-515X; Cagnard, Nicolas/0000-0002-9051-1896				Abdullah Z, 2014, EMBO J, V33, P2283, DOI 10.15252/embj.201489055; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Antonara S, 2010, INFECT IMMUN, V78, P4723, DOI 10.1128/IAI.00464-10; Baranton Guy, 2009, V37, P1, DOI 10.1159/000213066; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brisson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022926; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Carlsson SA, 2003, SCAND J INFECT DIS, V35, P31, DOI 10.1080/0036554021000026978; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Diza E, 2004, EMERG INFECT DIS, V10, P1692, DOI 10.3201/eid1009.030439; Dunham-Ems SM, 2009, J CLIN INVEST, V119, P3652, DOI 10.1172/JCI39401; Ebnet K, 1997, J IMMUNOL, V158, P3285; Filgueira L, 1996, J IMMUNOL, V157, P2998; Jones KL, 2008, CLIN INFECT DIS, V46, P85, DOI 10.1086/524022; Kern A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133195; KLEMPNER MS, 1993, J INFECT DIS, V167, P1074, DOI 10.1093/infdis/167.5.1074; Krupna-Gaylord MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100174; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P1110, DOI 10.1001/jama.2013.278331; Lochhead RB, 2012, J IMMUNOL, V189, P2488, DOI 10.4049/jimmunol.1201095; Logar M, 2004, INFECTION, V32, P15, DOI 10.1007/s15010-004-3042-z; Maraspin V, 2006, EMERG INFECT DIS, V12, P1177, DOI 10.3201/eid1207.060077; Marchal C, 2011, INFECT IMMUN, V79, P774, DOI 10.1128/IAI.00482-10; Marchal CMP, 2009, J INVEST DERMATOL, V129, P2515, DOI 10.1038/jid.2009.73; Markowicz M, 2015, EMERG INFECT DIS, V21, P1052, DOI 10.3201/eid2106.141516; Miller JC, 2010, INFECT IMMUN, V78, P3144, DOI 10.1128/IAI.01070-09; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Mullegger RR, 2007, INFECT IMMUN, V75, P4621, DOI 10.1128/IAI.00263-07; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Piesman J, 2001, J CLIN MICROBIOL, V39, P4145, DOI 10.1128/JCM.39.11.4145-4148.2001; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rego ROM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101009; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Rizzoli A, 2011, EUROSURVEILLANCE, V16, P2; Rudenko N, 2009, FEMS MICROBIOL LETT, V292, P274, DOI 10.1111/j.1574-6968.2009.01498.x; Rudenko N, 2008, J CLIN MICROBIOL, V46, P3540, DOI 10.1128/JCM.01032-08; Schramm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040046; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Stewart PE, 2005, PLASMID, V53, P1, DOI 10.1016/j.plasmid.2004.10.006; Strle F, 2011, VECTOR-BORNE ZOONOT, V11, P1253, DOI 10.1089/vbz.2010.0230; Suhonen J, 2003, SCAND J IMMUNOL, V58, P67, DOI 10.1046/j.1365-3083.2003.01284.x; Talkington J, 1999, INFECT IMMUN, V67, P1107, DOI 10.1128/IAI.67.3.1107-1115.1999; Wu J, 2011, INFECT IMMUN, V79, P1338, DOI 10.1128/IAI.01188-10	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164117	10.1371/journal.pone.0164117	http://dx.doi.org/10.1371/journal.pone.0164117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706261	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200085
J	Petrovan, SO; Schmidt, BR				Petrovan, Silviu O.; Schmidt, Benedikt R.			Volunteer Conservation Action Data Reveals Large-Scale and Long-Term Negative Population Trends of a Widespread Amphibian, the Common Toad (Bufo bufo)	PLOS ONE			English	Article							CITIZEN SCIENCE; DECLINES; ABUNDANCE; LANDSCAPE; MORTALITY; VIABILITY; COLLAPSE; INVASION; ECOLOGY; MODELS	Rare and threatened species are the most frequent focus of conservation science and action. With the ongoing shift from single-species conservation towards the preservation of ecosystem services, there is a greater need to understand abundance trends of common species because declines in common species can disproportionately impact ecosystems function. We used volunteer-collected data in two European countries, the United Kingdom (UK) and Switzerland, since the 1970s to assess national and regional trends for one of Europe's most abundant amphibian species, the common toad (Bufo bufo). Millions of toads were moved by volunteers across roads during this period in an effort to protect them from road traffic. For Switzerland, we additionally estimated trends for the common frog (Rana temporaria), a similarly widespread and common amphibian species. We used state-space models to account for variability in detection and effort and included only populations with at least 5 years of data; 153 populations for the UK and 141 for Switzerland. Common toads declined continuously in each decade in both countries since the 1980s. Given the declines, this common species almost qualifies for International Union for the Conservation of Nature (IUCN) red-listing over this period despite volunteer conservation efforts. Reasons for the declines and wider impacts remain unknown. By contrast, common frog populations were stable or increasing in Switzerland, although there was evidence of declines after 2003. "Toads on Roads" schemes are vital citizen conservation action projects, and the data from such projects can be used for large scale trend estimations of widespread amphibians. We highlight the need for increased research into the status of common amphibian species in addition to conservation efforts focusing on rare and threatened species.	[Petrovan, Silviu O.] Froglife, 1 Loxley, Peterborough PE45BW, Cambs, England; [Petrovan, Silviu O.] Univ Hull, Ctr Environm & Marine Sci, Scarborough Campus,Filey Rd, Scarborough YO11 3AZ, England; [Schmidt, Benedikt R.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Schmidt, Benedikt R.] KARCH, Passage Maximilien De Meuron 6, CH-2000 Neuchatel, Switzerland	University of Hull; University of Zurich	Schmidt, BR (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Schmidt, BR (corresponding author), KARCH, Passage Maximilien De Meuron 6, CH-2000 Neuchatel, Switzerland.	benedikt.schmidt@ieu.uzh.ch	Petrovan, Silviu/ADM-9976-2022; Schmidt, Benedikt R./B-8491-2008; Petrovan, Silviu/AAZ-9299-2021	Petrovan, Silviu/0000-0002-3984-2403; Schmidt, Benedikt R./0000-0002-4023-1001; Petrovan, Silviu/0000-0002-3984-2403	Esmee Fairbairn Foundation [14-0534]; WWF-UK; Department of Transport	Esmee Fairbairn Foundation; WWF-UK; Department of Transport	SP is supported by a grant from Esmee Fairbairn Foundation to Froglife (grant ref nr 14-0534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Volunteer conservation action is generally not financially supported. Sometimes volunteers are supported by local authorities (e.g. supply of materials, help with setting up drift fences).; This analysis would not be possible without the thousands of dedicated volunteers who have tirelessly given their time for toad patrols, data collection and submission over the last 30 or more years. In the UK, Froglife was supported by a range of NGOs including WWF-UK and government bodies, including the Department of Transport. County and local Amphibian and Reptile Groups (ARGs) as well as some Wildlife Trusts have supported these efforts over the years. We are grateful to Tom Langton for developing and promoting Toads on Roads in the UK since its inception as a national project in 1984. Chris Monk, John Heaser and others have greatly contributed as regional patrol coordinators. Natural England has supported Froglife on amphibian road research. In Switzerland, the Swiss Federal Office of the Environment supports KARCH, the Swiss Amphibian and Reptile Conservation Program, which allowed collection and maintenance of all the Swiss data. SP is supported by a grant from Esmee Fairbairn Foundation. We thank Richard Chandler and Marc Kery for help with help with the statistical analysis of the data and Silvia Zumbach and three anonymous reviewers for comments on the manuscript.	Agasyan A, 2009, IUCN RED LIST THREAT, V2009; [Anonymous], 2014, R LANG ENV STAT COMP; Bonardi A, 2011, BIOL CONSERV, V144, P2328, DOI 10.1016/j.biocon.2011.06.011; Buckley J, 2014, ANIM CONSERV, V17, P27, DOI 10.1111/acv.12052; Carrier JA, 2003, BIOL CONSERV, V111, P395, DOI 10.1016/S0006-3207(02)00308-7; Cooke Arnold, 2011, Nature in Cambridgeshire, V53, P45; COOKE AS, 1972, J ZOOL, V167, P161; Cosentino BJ, 2014, BIOL CONSERV, V180, P31, DOI 10.1016/j.biocon.2014.09.027; Cruickshank SS, 2016, CONSERV BIOL, V30, P1112, DOI 10.1111/cobi.12688; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; Departmentfor Transport, 2014, VEH LIC STAT 2013 ST; Di Minin E, 2011, ECOGRAPHY, V34, P162, DOI 10.1111/j.1600-0587.2010.06263.x; Dixon PM, 2005, ECOLOGY, V86, P1751, DOI 10.1890/04-1343; Doddington BJ, 2013, ECOLOGY, V94, P1795, DOI 10.1890/12-1270.1; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gaston KJ, 2011, BIOSCIENCE, V61, P354, DOI 10.1525/bio.2011.61.5.4; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Grant EHC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25625; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Hartel T, 2009, NORTH-WEST J ZOOL, V5, P130; Hels T, 2002, ECOGRAPHY, V25, P730, DOI 10.1034/j.1600-0587.2002.250609.x; Hels T, 2001, BIOL CONSERV, V99, P331, DOI 10.1016/S0006-3207(00)00215-9; Hocking DJ, 2014, HERPETOL CONSERV BIO, V9, P1; Hocking DJ, 2013, BIOL CONSERV, V167, P194, DOI 10.1016/j.biocon.2013.08.006; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hostetler JA, 2015, ECOLOGY, V96, P1713, DOI 10.1890/14-1487.1; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; Kamp J, 2015, CONSERV BIOL, V29, P1684, DOI 10.1111/cobi.12537; Kellner K., JAGSUI WRAPPER RJAGS; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; Kuzmin S, 2009, IUCN RED LIST THREAT, V2009; Lampo M, 1998, ECOL APPL, V8, P388, DOI 10.2307/2641079; Langton T.E.S., 1989, P TOAD TUNN C RENDSB; Langton TES, 2015, WILDL MANAGE CONSERV, P7; Lawson B, 2015, ECOHEALTH, V12, P693, DOI 10.1007/s10393-015-1054-z; Lindenmayer DB, 2011, BIOL CONSERV, V144, P1663, DOI 10.1016/j.biocon.2011.02.022; Mace GM, 2014, SCIENCE, V345, P1558, DOI 10.1126/science.1254704; Marsh DM, 2001, BIOL CONSERV, V101, P327, DOI 10.1016/S0006-3207(01)00076-3; Mazerolle MJ, 2014, WETL ECOL MANAG, V22, P325, DOI 10.1007/s11273-013-9332-4; Meisterhans K, 1970, AMPHIBIEN IHRE LEBEN; Meyer AH, 1998, P ROY SOC B-BIOL SCI, V265, P523, DOI 10.1098/rspb.1998.0326; Muller P., 1968, Naturforsch Ges Schaffhausen (2), VNo. 3, P1; OECD Road Traffic Vehicles and Networks, 2013, ROAD TRAFF VEH NETW; Plummer M., 2003, P 3 INT WORKSH DISTR, P125, DOI DOI 10.1038/S41598-018-29599-W; Price SJ, 2014, CURR BIOL, V24, P2586, DOI 10.1016/j.cub.2014.09.028; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; Redford KH, 2013, ORYX, V47, P157, DOI 10.1017/S0030605313000331; Schmidt Benedikt R., 2008, P157; Schmidt BR, 2008, J NAT CONSERV, V16, P157, DOI 10.1016/j.jnc.2008.05.001; Schmidt BR, 2003, CR BIOL, V326, pS119, DOI 10.1016/S1631-0691(03)00048-9; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tobler U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034667; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; VANGELDER JJ, 1973, OECOLOGIA, V13, P93, DOI 10.1007/BF00379622; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; Zylstra ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125670	59	60	66	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0161943	10.1371/journal.pone.0161943	http://dx.doi.org/10.1371/journal.pone.0161943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706154	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000385697200004
J	Bardoscia, M; Caccioli, F; Perotti, JI; Vivaldo, G; Caldarelli, G				Bardoscia, Marco; Caccioli, Fabio; Perotti, Juan Ignacio; Vivaldo, Gianna; Caldarelli, Guido			Distress Propagation in Complex Networks: The Case of Non-Linear DebtRank	PLOS ONE			English	Article							SYSTEMIC RISK; INTERBANK MARKET; CONTAGION; DIFFUSION; EXPOSURES; CASCADES; MODEL	We consider a dynamical model of distress propagation on complex networks, which we apply to the study of financial contagion in networks of banks connected to each other by direct exposures. The model that we consider is an extension of the DebtRank algorithm, recently introduced in the literature. The mechanics of distress propagation is very simple: When a bank suffers a loss, distress propagates to its creditors, who in turn suffer losses, and so on. The original DebtRank assumes that losses are propagated linearly between connected banks. Here we relax this assumption and introduce a one-parameter family of non-linear propagation functions. As a case study, we apply this algorithm to a data-set of 183 European banks, and we study how the stability of the system depends on the non-linearity parameter under different stress-test scenarios. We find that the system is characterized by a transition between a regime where small shocks can be amplified and a regime where shocks do not propagate, and that the overall stability of the system increases between 2008 and 2013.	[Bardoscia, Marco] Univ Zurich, Dept Banking & Finance, Zurich, Switzerland; [Bardoscia, Marco; Caldarelli, Guido] London Inst Math Sci, London, England; [Caccioli, Fabio] UCL, Dept Comp Sci, London, England; [Caccioli, Fabio] London Sch Econ & Polit Sci, System Risk Ctr, London, England; [Perotti, Juan Ignacio; Vivaldo, Gianna; Caldarelli, Guido] IMT Inst Adv Studies, Lucca, Italy; [Caldarelli, Guido] CNR ISC Inst Complex Syst, Rome, Italy	University of Zurich; University of London; University College London; University of London; London School Economics & Political Science; IMT School for Advanced Studies Lucca; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Bardoscia, M (corresponding author), Univ Zurich, Dept Banking & Finance, Zurich, Switzerland.; Bardoscia, M (corresponding author), London Inst Math Sci, London, England.	mb@lims.ac.uk	Caldarelli, Guido/AAB-8206-2022; Vivaldo, Gianna/HIK-2195-2022; Caldarelli, Guido/A-5274-2010	Vivaldo, Gianna/0000-0003-4935-5710; Perotti, Juan Ignacio/0000-0001-7424-9552; Caldarelli, Guido/0000-0001-9377-3616	Economic and Social Research Council [ES/K002309/1] Funding Source: researchfish; ESRC [ES/K002309/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; ALLEN LJS, 1994, MATH BIOSCI, V124, P83, DOI 10.1016/0025-5564(94)90025-6; Barabasi AL, 2012, NAT PHYS, V8, P14, DOI 10.1038/nphys2188; Bardoscia M, 2016, PATHWAYS INSTABILITY; Bardoscia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130406; Bardoscia M, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/08/P08017; Barrat A., 2008, DYNAMICAL PROCESSES, DOI [10.1017/CBO9780511791383, DOI 10.1017/CBO9780511791383]; Battiston S, 2015, LEVERAGING NETWORK S; Battiston S, 2016, J ALTERN INVEST, V18, P68, DOI 10.3905/jai.2016.18.4.068; Battiston S, 2016, UNDERST COMPLEX SYST, P195, DOI 10.1007/978-3-319-23947-7_12; Battiston S, 2012, J ECON DYN CONTROL, V36, P1121, DOI 10.1016/j.jedc.2012.04.001; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Caccioli F, 2015, J ECON DYN CONTROL, V51, P50, DOI 10.1016/j.jedc.2014.09.041; Caccioli F, 2014, J BANK FINANC, V46, P233, DOI 10.1016/j.jbankfin.2014.05.021; Caccioli F, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525912500580; Caldarelli G., 2007, SCALE FREE NETWORKS, DOI [DOI 10.1093/ACPROF:OSO/9780199211517.001.0001, 10.1093/acprof:oso/9780199211517.001.0001]; Cimini G, 2015, SCI REP-UK, V5, DOI 10.1038/srep15758; Cimini G, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.040802; De Masi G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066112; Di Iasio G, 2013, CAPITAL CONTAGION FI; Ehrhardt G, 2006, INT J GAME THEORY, V34, P383, DOI 10.1007/s00182-006-0025-6; Elliott M, 2014, FINANCIAL NETWORKS C; Furfine CH, 2003, J MONEY CREDIT BANK, V35, P111, DOI 10.1353/mcb.2003.0004; Gai P, 2010, P ROY SOC A-MATH PHY, V466, P2401, DOI 10.1098/rspa.2009.0410; Guo W, 2015, TOPOLOGY OVERLAPPING; Heise S, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-20740-0; Huang XQ, 2013, SCI REP-UK, V3, DOI 10.1038/srep01219; Iori G, 2006, J ECON BEHAV ORGAN, V61, P525, DOI 10.1016/j.jebo.2004.07.018; Kubelec Chris, 2010, 384 BANK ENGL; Lee KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018443; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Markose S, 2012, J ECON BEHAV ORGAN, V83, P627, DOI 10.1016/j.jebo.2012.05.016; Markose Sheri M, 2012, SYSTEMIC RISK GLOBAL; Memmel C, 2013, J FINANC STABIL, V9, P46, DOI 10.1016/j.jfs.2013.01.001; Motter AE, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016116; Musmeci N, 2013, J STAT PHYS, V151, P720, DOI 10.1007/s10955-013-0720-1; Nekovee M, 2007, PHYSICA A, V374, P457, DOI 10.1016/j.physa.2006.07.017; Nier E, 2007, J ECON DYN CONTROL, V31, P2033, DOI 10.1016/j.jedc.2007.01.014; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Roukny T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02759; Sandoval L, 2014, ENTROPY-SWITZ, V16, P4443, DOI 10.3390/e16084443; Santos E.B., 2010, SSRN, DOI DOI 10.1017/CBO9781139151184.018; Scholtes I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6024; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Tan JPL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31762; Thurner S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01888; Tran HAQ, 2015, NEW MATH NAT COMPUT, V11, P151, DOI 10.1142/S1793005715400037; Upper C, 2004, EUR ECON REV, V48, P827, DOI 10.1016/j.euroecorev.2003.12.009; Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2334-11-37, 10.1186/1471-2458-11-575]; Vitali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025995; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	51	32	34	8	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163825	10.1371/journal.pone.0163825	http://dx.doi.org/10.1371/journal.pone.0163825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701457	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000385696900022
J	Cooper, GE; Pounce, ZC; Wallington, JC; Bastidas-Legarda, LY; Nicholas, B; Chidomere, C; Robinson, EC; Martin, K; Tocheva, AS; Christodoulides, M; Djukanovic, R; Wilkinson, TMA; Staples, KJ				Cooper, Grace E.; Pounce, Zoe C.; Wallington, Joshua C.; Bastidas-Legarda, Leidy Y.; Nicholas, Ben; Chidomere, Chiamaka; Robinson, Emily C.; Martin, Kirstin; Tocheva, Anna S.; Christodoulides, Myron; Djukanovic, Ratko; Wilkinson, Tom M. A.; Staples, Karl J.			Viral Inhibition of Bacterial Phagocytosis by Human Macrophages: Redundant Role of CD36	PLOS ONE			English	Article							INFLUENZA-VIRUS; IFN-BETA; RECEPTOR; INTERFERON; CELLS; RECOGNITION; NEUTROPHILS; IMPAIRMENT; ACTIVATION; EXPRESSION	Macrophages are essential to maintaining lung homoeostasis and recent work has demonstrated that influenza-infected lung macrophages downregulate their expression of the scavenger receptor CD36. This receptor has also been shown to be involved in phagocytosis of Streptococcus pneumoniae, a primary agent associated with pneumonia secondary to viral infection. The aim of this study was to investigate the role of CD36 in the effects of viral infection on macrophage phagocytic function. Human monocyte-derived macrophages (MDM) were exposed to H3N2 X31 influenza virus, M37 respiratory syncytial virus (RSV) or UV-irradiated virus. No infection of MDM was seen upon exposure to UV-irradiated virus but incubation with live X31 or M37 resulted in significant levels of viral detection by flow cytometry or RT-PCR respectively. Infection resulted in significantly diminished uptake of S. pneumoniae by MDM and significantly decreased expression of CD36 at both the cell surface and mRNA level. Concurrently, there was a significant increase in IFN beta gene expression in response to infection and we observed a significant decrease in bacterial phagocytosis (p = 0.031) and CD36 gene expression (p = 0.031) by MDM cultured for 24 h in 50IU/ml IFN beta. Knockdown of CD36 by siRNA resulted in decreased phagocytosis, but this was mimicked by transfection reagent alone. When MDM were incubated with CD36 blocking antibodies no effect on phagocytic ability was observed. These data indicate that autologous IFN beta production by virally-infected cells can inhibit bacterial phagocytosis, but that decreased CD36 expression by these cells does not play a major role in this functional deficiency.	[Cooper, Grace E.; Pounce, Zoe C.; Wallington, Joshua C.; Bastidas-Legarda, Leidy Y.; Nicholas, Ben; Chidomere, Chiamaka; Robinson, Emily C.; Martin, Kirstin; Tocheva, Anna S.; Christodoulides, Myron; Djukanovic, Ratko; Wilkinson, Tom M. A.; Staples, Karl J.] Univ Southampton, Southampton Gen Hosp, Clin & Expt Sci, Fac Med,Sir Henry Wellcome Labs, Tremona Rd, Southampton SO16 6YD, Hants, England; [Djukanovic, Ratko; Wilkinson, Tom M. A.] Southampton Gen Hosp, Southampton NIHR Resp Biomed Res Unit, Tremona Rd, Southampton SO16 6YD, Hants, England	University of Southampton; University of Southampton	Staples, KJ (corresponding author), Univ Southampton, Southampton Gen Hosp, Clin & Expt Sci, Fac Med,Sir Henry Wellcome Labs, Tremona Rd, Southampton SO16 6YD, Hants, England.	k.staples@southampton.ac.uk	Christodoulides, Myron/C-6699-2011	Christodoulides, Myron/0000-0002-9663-4731; Pounce, Zoe/0000-0002-1874-6842; Nicholas, Benjamin/0000-0003-1467-9643; Staples, Karl/0000-0003-3844-6457; Djukanovic, Ratko/0000-0001-6039-5612; Wilkinson, Tom/0000-0003-1771-3851; Cooper, Grace/0000-0002-4125-6278	Medical Research Council [1585540, 1560673] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10085] Funding Source: researchfish; Asthma UK [08/026] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK		Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Cardone M, 2014, J LEUKOCYTE BIOL, V95, P161, DOI 10.1189/jlb.0313168; Chan A, 2003, GLIA, V43, P231, DOI 10.1002/glia.10258; Djukanovic R, 2014, AM J RESP CRIT CARE, V190, P145, DOI 10.1164/rccm.201312-2235OC; Do TTH, 2011, MICROBIOL IMMUNOL, V55, P751, DOI 10.1111/j.1348-0421.2011.00383.x; GUINEA R, 1995, J VIROL, V69, P2306, DOI 10.1128/JVI.69.4.2306-2312.1995; Hoeve MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029443; JAKAB GJ, 1982, AM REV RESPIR DIS, V126, P778; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Liang ZK, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-72; Ludewick HP, 2011, J GEN VIROL, V92, P1662, DOI 10.1099/vir.0.030825-0; Martin-Fuentes P, 2007, J IMMUNOL, V179, P3242, DOI 10.4049/jimmunol.179.5.3242; McClellan K, 2001, DRUGS, V61, P263, DOI 10.2165/00003495-200161020-00011; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762; Nicholas B, 2015, J IMMUNOL, V194, P6144, DOI 10.4049/jimmunol.1402283; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; REN Y, 1995, J EXP MED, V181, P1857, DOI 10.1084/jem.181.5.1857; RODGERS BC, 1982, INFECT IMMUN, V36, P1154, DOI 10.1128/IAI.36.3.1154-1159.1982; RODGERS BC, 1982, J MED VIROL, V9, P177, DOI 10.1002/jmv.1890090304; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Sharif O, 2013, J IMMUNOL, V190, P5640, DOI 10.4049/jimmunol.1202270; Sheng ZM, 2011, P NATL ACAD SCI USA, V108, P16416, DOI 10.1073/pnas.1111179108; SIBILLE Y, 1990, AM REV RESPIR DIS, V141, P471, DOI 10.1164/ajrccm/141.2.471; Staples KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121527; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Taylor AE, 2010, EUR RESPIR J, V35, P1039, DOI 10.1183/09031936.00036709; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; Wang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029879; WARSHAUER D, 1977, AM REV RESPIR DIS, V115, P269; Weigert A, 2009, BIOL CHEM, V390, P379, DOI 10.1515/BC.2009.048; Wright AKA, 2009, J LEUKOCYTE BIOL, V86, P479, DOI 10.1189/jlb.1108699	35	9	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163889	10.1371/journal.pone.0163889	http://dx.doi.org/10.1371/journal.pone.0163889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701435	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000385696900027
J	Foratori, GA; de Andrade, FJP; Mosquim, V; Peres, MDS; Ceneviva, R; Chaim, EA; Peres, SHDS				Foratori Junior, Gerson Aparecido; Pires de Andrade, Francisco Juliherme; Mosquim, Victor; Sales Peres, Matheus de Carvalho; Ceneviva, Reginaldo; Chaim, Elinton Adami; de Carvalho Sales Peres, Silvia Helena			Presence of Serum Ferritin before and after Bariatric Surgery: Analysis in Dentate and Edentulous Patients	PLOS ONE			English	Article							Y GASTRIC BYPASS; WEIGHT-LOSS; INSULIN-RESISTANCE; IRON-DEFICIENCY; MORBID-OBESITY; LONG-TERM; ANEMIA; RISK; DISEASE; PERIODONTITIS	Society has changed its own lifestyle, specially its eating habits and physical activities, leading to excessive weight and a sedentary behavior, which has contributed to obesity increase. Bariatric surgery is the most effective treatment to obesity, allowing weight loss and its maintenance. However, it has been related high levels of iron deficiency after surgery. A person's nutritional status might be affected by total or partial tooth loss. The aim of this longitudinal prospective cohort study was to evaluate the levels of serum ferritin before and after bariatric surgery and to identify if there is a relation with tooth loss. The sample was composed of 50 patients selected and assisted at Amaral Carvalho Hospital, located in Jau A city, Brazil. The use and necessity of prosthesis, dental absence or presence, and serum ferritin dosage were evaluated. Student's t test, Univariate analysis, Chi-square and Odds Ratio were adopted (p<0.05). There was no significant difference regarding the serum ferritin levels between dentate and edentulous patients prior to surgery (p = 0.436). After surgery, the serum ferritin levels were higher in edentulous patients (prosthesis users) when compared to the pre-surgical levels, and the post-surgical levels presented significant difference regarding the dentate patients (p = 0.024). It can be concluded that rehabilitated patients in postoperative period showed better levels of serum ferritin after surgical intervention.	[Foratori Junior, Gerson Aparecido; Pires de Andrade, Francisco Juliherme; Mosquim, Victor; de Carvalho Sales Peres, Silvia Helena] Univ Sao Paulo, Bauru Sch Dent, Dept Pediat Dent Orthodont & Publ Hlth, Sao Paulo, Brazil; [Sales Peres, Matheus de Carvalho] Univ State Sao Paulo, Botucatu Sch Med, Dept Gen Surg, Sao Paulo, Brazil; [Ceneviva, Reginaldo] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Surg & Anat, Sao Paulo, Brazil; [Chaim, Elinton Adami] Univ Estadual Campinas, Fac Med Sci Campinas, Dept Surg, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	Peres, SHDS (corresponding author), Univ Sao Paulo, Bauru Sch Dent, Dept Pediat Dent Orthodont & Publ Hlth, Sao Paulo, Brazil.	shcperes@usp.br	Mosquim, Victor/U-8419-2019; Chaim, Elinton A/C-7518-2019; Sales-Peres, SILVIA/C-2714-2012; Foratori-Junior, Gerson Aparecido/P-5143-2019	Mosquim, Victor/0000-0003-0442-5690; Chaim, Elinton A/0000-0003-4627-0631; Sales-Peres, SILVIA/0000-0003-3811-7899; Foratori-Junior, Gerson Aparecido/0000-0003-4760-8948; Chaim, Elinton/0000-0001-9370-9518	CNPq; FAPESP [2012/10994-0, 2015/05749-5]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by CNPq and FAPESP (Proc. 2012/10994-0 and 2015/05749-5).	Aasheim ET, 2009, AM J CLIN NUTR, V90, P15, DOI 10.3945/ajcn.2009.27583; Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; AKEEL R, 1992, SWED DENT J, V16, P191; Albert TE, 2003, J ORAL REHABIL, V30, P720, DOI 10.1046/j.1365-2842.2003.01155.x; Allen F, 2002, CLIN ORAL IMPLAN RES, V13, P320, DOI 10.1034/j.1600-0501.2002.130313.x; ANDERSON D J, 1956, J Dent Res, V35, P664, DOI 10.1177/00220345560350050201; [Anonymous], 2008, AM J CLIN NUTR, V87, P362; Arasaki CH, 2005, OBES SURG, V15, P1408, DOI 10.1381/096089205774859209; Aron-Wisnewsky J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149588; Atlantis E, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3868; Baceviciene M, 2009, MEDICINA-LITHUANIA, V45, P565, DOI 10.3390/medicina45070075; Bal B, 2010, NAT REV GASTRO HEPAT, V7, P320, DOI 10.1038/nrgastro.2010.60; Balsa JA, 2008, J ENDOCRINOL INVEST, V31, P845, DOI 10.1007/BF03346429; Balsiger BM, 2000, MAYO CLIN PROC, V75, P673; Barugahara E. I., 2013, African Journal of Food, Agriculture, Nutrition and Development, V13, P7679; Bavaresco M, 2010, OBES SURG, V20, P716, DOI 10.1007/s11695-008-9721-6; Beard J, 2001, J NUTR, V131, p563S, DOI 10.1093/jn/131.2.563S; Benevides Márcio Luiz, 2006, Rev. Bras. Anestesiol., V56, P408, DOI 10.1590/S0034-70942006000400009; Blackburn GL, 2009, OBESITY, V17, P842, DOI 10.1038/oby.2008.578; BRASIL, 2012, SB BRASIL 2010 PESQU; Brasil. Ministerio da Saude, 2014, VIG FAT RISC PROT DO, V37; Buchwald H, 2004, OBES SURG, V14, P1157, DOI 10.1381/0960892042387057; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Bundy Donald, 2005, Food and Nutrition Bulletin, V26, pS186; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Censo, 2010, IBGE CENS 2010; Chang CY, 2010, OBES SURG, V20, P1121, DOI 10.1007/s11695-008-9513-z; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; CHAUNCEY HH, 1984, INT DENT J, V34, P98; CHONGSHAN S, 1990, J ORAL REHABIL, V17, P611, DOI 10.1111/j.1365-2842.1990.tb01432.x; Colquitt JL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub4; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; Corti MC, 1997, ANN EPIDEMIOL, V7, P62, DOI 10.1016/S1047-2797(96)00112-3; Cummings David E., 2004, Journal of Clinical Endocrinology & Metabolism, V89, P2608, DOI 10.1210/jc.2004-0433; Sales-Peres SHD, 2015, J CLIN PERIODONTOL, V42, P530, DOI 10.1111/jcpe.12410; de Moura-Grec PG, 2014, CIENC SAUDE COLETIVA, V19, P1763, DOI 10.1590/1413-81232014196.13482013; de Moura-Grec PG, 2014, INT DENT J, V64, P144, DOI 10.1111/idj.12090; De Prisco C, 2005, AM J MED SCI, V329, P57, DOI 10.1097/00000441-200502000-00001; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Djokic D, 2010, HIPPOKRATIA, V14, P252; EDGERTON VR, 1979, BRIT MED J, V2, P1546, DOI 10.1136/bmj.2.6204.1546; Elder KA, 2007, GASTROENTEROLOGY, V132, P2253, DOI 10.1053/j.gastro.2007.03.057; Ettinger JEMTM, 2007, OBES SURG, V17, P525, DOI 10.1007/s11695-007-9091-5; Fernandez-Real JM, 1998, DIABETES CARE, V21, P62, DOI 10.2337/diacare.21.1.62; FINCH CA, 1986, WESTERN J MED, V145, P657; Flancbaum L, 2006, J GASTROINTEST SURG, V10, P1033, DOI 10.1016/j.gassur.2006.03.004; Fleet JC, 2008, J NUTR, V138, P1114, DOI 10.1093/jn/138.6.1114; Gasteyger C, 2008, AM J CLIN NUTR, V87, P1128, DOI 10.1093/ajcn/87.5.1128; Genco RJ, 2005, J PERIODONTOL, V76, P2075, DOI 10.1902/jop.2005.76.11-S.2075; Gesquiere I, 2014, OBES SURG, V24, P56, DOI 10.1007/s11695-013-1042-8; GEY KF, 1993, BRIT MED BULL, V49, P679, DOI 10.1093/oxfordjournals.bmb.a072640; Haap M, 2003, ANN INTERN MED, V139, P869, DOI 10.7326/0003-4819-139-10-200311180-00029; Haffajee AD, 2009, J CLIN PERIODONTOL, V36, P89, DOI 10.1111/j.1600-051X.2008.01356.x; Hague Anne L, 2008, J Dent Hyg, V82, P22; Harris AA, 2010, J MIDWIFERY WOM HEAL, V55, P529, DOI 10.1016/j.jmwh.2010.06.018; Heling I, 2006, OBES SURG, V16, P1131, DOI 10.1381/096089206778392211; HOWELL AH, 1950, J DENT RES, V29, P133, DOI 10.1177/00220345500290020401; International Nutritional Anemia Consultative Group (INACG), 1985, MEAS IR STAT; Isaksson Helen, 2013, Swed Dent J Suppl, P1; Kassebaum NJ, 2014, J DENT RES, V93, P20, DOI 10.1177/0022034514537828; Kolotkin R L, 2001, Obes Rev, V2, P219, DOI 10.1046/j.1467-789X.2001.00040.x; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Koukounari A, 2008, INT J PARASITOL, V38, P1663, DOI 10.1016/j.ijpara.2008.05.013; Levine R, 2012, BRIT DENT J, V213, P453, DOI 10.1038/sj.bdj.2012.1009; Lopez-Jimenez F, 2011, REV ESP CARDIOL, V64, P140, DOI 10.1016/j.recesp.2010.10.010; Love AL, 2008, AM J HEMATOL, V83, P403, DOI 10.1002/ajh.21106; Madan AK, 2006, OBES SURG, V16, P603, DOI 10.1381/096089206776945057; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Malinowski SS, 2006, AM J MED SCI, V331, P219, DOI 10.1097/00000441-200604000-00009; Marinella MA, 2008, SOUTH MED J, V101, P1024, DOI 10.1097/SMJ.0b013e31817cf7b7; Marsicano Juliane A, 2012, Eur J Dent, V6, P191; Mathus-Vliegen EMH, 2007, INT DENT J, V57, P249; Mattes RD, 1997, J AM DIET ASSOC, V97, P406, DOI 10.1016/S0002-8223(97)00101-6; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Mesfin F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123615; MICHAEL CG, 1990, J PROSTHET DENT, V63, P549, DOI 10.1016/0022-3913(90)90074-M; Moize V, 2011, OBES SURG, V21, P1382, DOI 10.1007/s11695-011-0360-y; Moura-Grec PG, 2012, ABCD-ARQ BRAS CIR DI, V25, P173, DOI 10.1590/S0102-67202012000300008; Mulugeta A, 2010, FASEB J, V24; National Center for Health Statistics, 2015, HLTH US 2015 SPEC FE, P107; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oliveira Verenice Martins de, 2004, Arch. Clin. Psychiatry (São Paulo), V31, P199; Pataro AL, 2012, J PERIODONTOL, V83, P257, DOI 10.1902/jop.2011.100782; Prema A., 2011, INT J NUTR PHARM NEU, V1, P184, DOI [10.4103/2231-0738.84212, DOI 10.4103/2231-0738.84212]; Prinz JF, 2000, J ORAL REHABIL, V27, P765, DOI 10.1046/j.1365-2842.2000.00577.x; Reginster JY, 2005, CURR MED RES OPIN, V21, P579, DOI 10.1185/030079905X41435; Reji P, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.198; Saini R, 2010, ANN CARD ANAESTH, V13, P159, DOI 10.4103/0971-9784.62936; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Sarwer DB, 2011, SURG OBES RELAT DIS, V7, P644, DOI 10.1016/j.soard.2011.06.016; Sato H, 2003, J ORAL REHABIL, V30, P68, DOI 10.1046/j.1365-2842.2003.01049.x; Shinogle JA, 2005, OBES RES, V13, P2202, DOI 10.1038/oby.2005.273; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; SMITH CD, 1993, ANN SURG, V218, P91, DOI 10.1097/00000658-199307000-00014; Tatala S R, 2008, Tanzan J Health Res, V10, P189; Trevisan M, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.030; Tsakos G, 2010, J DENT RES, V89, P462, DOI 10.1177/0022034510363247; Tsiftsis DDA, 2009, OBES SURG, V19, P1497, DOI 10.1007/s11695-009-9938-z; Tucker ON, 2007, MED CLIN N AM, V91, P499, DOI 10.1016/j.mcna.2007.01.006; Valderas JP, 2009, OBES SURG, V19, P1132, DOI 10.1007/s11695-009-9890-y; Vandenbroucke JP, 2007, LANCET, V4, P297; Vargas-Ruiz AG, 2008, OBES SURG, V18, P288, DOI 10.1007/s11695-007-9310-0; von Drygalski A, 2009, NUTR CLIN PRACT, V24, P217, DOI 10.1177/0884533609332174; Wang Angela, 2009, Am J Orthop (Belle Mead NJ), V38, P77; Weng TC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006964; WIDMARK G, 1995, J ORAL REHABIL, V22, P589, DOI 10.1111/j.1365-2842.1995.tb01054.x; Williams SE, 2008, CLEV CLIN J MED, V75, P333, DOI 10.3949/ccjm.75.5.333; Yamashita JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129687; Zacharski LR, 2000, AM HEART J, V140, P98, DOI 10.1067/mhj.2000.106646	110	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164084	10.1371/journal.pone.0164084	http://dx.doi.org/10.1371/journal.pone.0164084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695053	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100087
J	Haley, BJ; Kim, SW; Pettengill, J; Luo, Y; Karns, JS; Van Kessel, JAS				Haley, Bradd J.; Kim, Seon Woo; Pettengill, James; Luo, Yan; Karns, Jeffrey S.; Van Kessel, Jo Ann S.			Genomic and Evolutionary Analysis of Two Salmonella enterica Serovar Kentucky Sequence Types Isolated from Bovine and Poultry Sources in North America	PLOS ONE			English	Article							SIALIC-ACID; ANTIMICROBIAL RESISTANCE; POPULATION-STRUCTURE; EFFECTOR PROTEINS; HEMOLYSIN-III; PREVALENCE; VIRULENCE; SEROTYPES; EPIDEMIC; FARM	Salmonella enterica subsp. enterica serovar Kentucky is frequently isolated from healthy poultry and dairy cows and is occasionally isolated from people with clinical disease. A genomic analysis of 119 isolates collected in the United States from dairy cows, ground beef, poultry and poultry products, and human clinical cases was conducted. Results of the analysis demonstrated that the majority of poultry and bovine-associated S. Kentucky were sequence type (ST) 152. Several bovine-associated (n = 3) and food product isolates (n = 3) collected from the United States and the majority of human clinical isolates were ST198, a sequence type that is frequently isolated from poultry and occasionally from human clinical cases in Northern Africa, Europe and Southeast Asia. A phylogenetic analysis indicated that both STs are more closely related to other Salmonella serovars than they are to each other. Additionally, there was strong evidence of an evolutionary divergence between the poultry-associated and bovine-associated ST152 isolates that was due to polymorphisms in four core genome genes. The ST198 isolates recovered from dairy farms in the United States were phylogenetically distinct from those collected from human clinical cases with 66 core genome SNPs differentiating the two groups, but more isolates are needed to determine the significance of this distinction. Identification of S. Kentucky ST198 from dairy animals in the United States suggests that the presence of this pathogen should be monitored in food-producing animals.	[Haley, Bradd J.; Kim, Seon Woo; Karns, Jeffrey S.; Van Kessel, Jo Ann S.] ARS, Environm Microbial & Food Safety Lab, Beltsville Area Res Ctr, USDA, Beltsville, MD 20705 USA; [Pettengill, James; Luo, Yan] US FDA, Off Analyt & Outreach, Ctr Food Safety & Appl Nutr, College Pk, MD USA	United States Department of Agriculture (USDA); US Food & Drug Administration (FDA)	Van Kessel, JAS (corresponding author), ARS, Environm Microbial & Food Safety Lab, Beltsville Area Res Ctr, USDA, Beltsville, MD 20705 USA.	joann.vankessel@ars.usda.gov	Haley, Bradd/AAB-9164-2020	Haley, Bradd/0000-0001-7996-1143	internal USDA/ARS research funding	internal USDA/ARS research funding	This project was supported by internal USDA/ARS research funding.; We gratefully acknowledge Jakeitha Sonnier for laboratory assistance. This project was supported by internal USDA/ARS research funding. The mention of a trade name, proprietary product, or specific equipment does not constitute guarantee or warranty by the USDA and does not imply approval to the exclusion of other products that might be suitable.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Albert MJ, 2014, J CLIN MICROBIOL, V52, P4090, DOI 10.1128/JCM.01775-14; Almagro-Moreno S, 2010, GUT MICROBES, V1, P45, DOI 10.4161/gmic.1.1.10386; Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09; Baida GE, 1996, BBA-BIOMEMBRANES, V1284, P122, DOI 10.1016/S0005-2736(96)00168-X; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Baucheron S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00213; Blau DM, 2005, J FOOD PROTECT, V68, P696, DOI 10.4315/0362-028X-68.4.696; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyd DA, 2008, ANTIMICROB AGENTS CH, V52, P340, DOI 10.1128/AAC.00902-07; Callaway TR, 2014, FOODBORNE PATHOG DIS, V11, P791, DOI 10.1089/fpd.2014.1800; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carlson JC, 2015, VET MICROBIOL, V179, P109, DOI 10.1016/j.vetmic.2015.03.015; Centers for Disease Control and Prevention, 2011, SALM ANN SUMM TABL 2; Chaudhuri RR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003456; Chen YC, 2004, CURR MICROBIOL, V49, P175, DOI 10.1007/s00284-004-4288-5; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Daniels MJ, 2003, EPIDEMIOL INFECT, V130, P561, DOI 10.1017/S0950268803008483; Deng XY, 2014, EMERG INFECT DIS, V20, P1481, DOI 10.3201/eid2009.131095; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Edrington TS, 2004, LETT APPL MICROBIOL, V38, P366, DOI 10.1111/j.1472-765X.2004.01495.x; Foley SL, 2011, APPL ENVIRON MICROB, V77, P4273, DOI 10.1128/AEM.00598-11; Fricke WF, 2009, APPL ENVIRON MICROB, V75, P5963, DOI 10.1128/AEM.00786-09; Gal-Mor O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000036; Haley BJ, 2015, EPIDEMIOL INFECT, V143, P682, DOI 10.1017/S0950268814001289; Hamidian M, 2015, J ANTIMICROB CHEMOTH, V70, P305, DOI 10.1093/jac/dku331; Hensel M, 1998, MOL MICROBIOL, V30, P163, DOI 10.1046/j.1365-2958.1998.01047.x; Herrera-Leon S, 2007, RES MICROBIOL, V158, P122, DOI 10.1016/j.resmic.2006.09.009; Johnson TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015524; Karns JS, 2015, J FOOD PROTECT, V78, P1182, DOI 10.4315/0362-028X.JFP-14-475; Katz LS, 2013, MBIO, V4, DOI 10.1128/mBio.00398-13; Kingsley RA, 2002, MOL MICROBIOL, V43, P895, DOI 10.1046/j.1365-2958.2002.02805.x; Kingsley RA, 2000, INFECT IMMUN, V68, P2720, DOI 10.1128/IAI.68.5.2720-2727.2000; Kroger C, 2009, J BACTERIOL, V191, P545, DOI 10.1128/JB.01253-08; Ladely SR, 2016, FOODBORNE PATHOG DIS, V13, P309, DOI 10.1089/fpd.2015.2102; Latasa C, 2005, MOL MICROBIOL, V58, P1322, DOI 10.1111/j.1365-2958.2005.04907.x; Le Hello S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00395; Le Hello S, 2013, LANCET INFECT DIS, V13, P672, DOI 10.1016/S1473-3099(13)70124-5; Le Hello S, 2012, ANTIMICROB AGENTS CH, V56, P5096, DOI 10.1128/AAC.00732-12; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Levings RS, 2005, J BACTERIOL, V187, P4401, DOI 10.1128/JB.187.13.4401-4409.2005; Li X, 2007, POULTRY SCI, V86, P591, DOI 10.1093/ps/86.3.591; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Parveen S, 2007, J FOOD PROTECT, V70, P2466, DOI 10.4315/0362-028X-70.11.2466; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Santos FBO, 2007, J FOOD PROTECT, V70, P1328, DOI 10.4315/0362-028X-70.6.1328; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Timme RE, 2013, GENOME BIOL EVOL, V5, P2109, DOI 10.1093/gbe/evt159; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Van Kessel JAS, 2013, FOODBORNE PATHOG DIS, V10, P448, DOI 10.1089/fpd.2012.1380; Van Kessel JAS, 2012, FOODBORNE PATHOG DIS, V9, P319, DOI 10.1089/fpd.2011.1054; Van Kessel JAS, 2011, J FOOD PROTECT, V74, P759, DOI 10.4315/0362-028X.JFP-10-423; Wells SJ, 2001, J FOOD PROTECT, V64, P3, DOI 10.4315/0362-028X-64.1.3; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002	62	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0161225	10.1371/journal.pone.0161225	http://dx.doi.org/10.1371/journal.pone.0161225			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695032	gold, Green Submitted, Green Published			2022-12-27	WOS:000385553100008
J	Hamann, M; Biggs, R; Reyers, B				Hamann, Maike; Biggs, Reinette; Reyers, Belinda			An Exploration of Human Well-Being Bundles as Identifiers of Ecosystem Service Use Patterns	PLOS ONE			English	Article							LIFE SATISFACTION; UNEMPLOYMENT; POVERTY; NEED; LIVELIHOODS; HOUSEHOLDS; LINKAGES; SECURITY	We take a social-ecological systems perspective to investigate the linkages between ecosystem services and human well-being in South Africa. A recent paper identified different types of social-ecological systems in the country, based on distinct bundles of ecosystem service use. These system types were found to represent increasingly weak direct feed-backs between nature and people, from rural "green-loop" communities to urban "red-loop" societies. Here we construct human well-being bundles and explore whether the well-being bundles can be used to identify the same social-ecological system types that were identified using bundles of ecosystem service use. Based on national census data, we found three distinct well-being bundle types that are mainly characterized by differences in income, unemployment and property ownership. The distribution of these well-being bundles approximates the distribution of ecosystem service use bundles to a substantial degree: High levels of income and education generally coincided with areas characterised by low levels of direct ecosystem service use (or red-loop systems), while the majority of low well-being areas coincided with medium and high levels of direct ecosystem service use (or transition and green-loop systems). However, our results indicate that transformations from green-loop to red-loop systems do not always entail an immediate improvement in well-being, which we suggest may be due to a time lag between changes in the different system components. Using human well-being bundles as an indicator of social-ecological dynamics may be useful in other contexts since it is based on socio-economic data commonly collected by governments, and provides important insights into the connections between ecosystem services and human well-being at policy-relevant sub-national scales.	[Hamann, Maike; Biggs, Reinette; Reyers, Belinda] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Hamann, Maike; Biggs, Reinette] Univ Stellenbosch, Ctr Complex Syst Transit, Stellenbosch, South Africa; [Reyers, Belinda] CSIR, Nat Resources & Environm, Stellenbosch, South Africa	Stockholm University; Stellenbosch University; Council for Scientific & Industrial Research (CSIR) - South Africa	Hamann, M (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.; Hamann, M (corresponding author), Univ Stellenbosch, Ctr Complex Syst Transit, Stellenbosch, South Africa.	maike.hamann@su.se	Reyers, Belinda/AAF-6225-2019; Biggs, Reinette/A-5155-2010	Reyers, Belinda/0000-0002-2194-8656; Biggs, Reinette/0000-0003-0300-4149; Hamann, Maike/0000-0003-2906-4043	Swedish International Development Cooperation Agency (Sida); Swedish Research Council (VR); Branco Weiss Society in Science Fellowship; DST/NRF South African Research Chairs Initiative [93097]; WISER project by the Ecosystem Services for Poverty Alleviation program (ESPA) [NE/L001322/1]; Department for International Development (DFID); Economic and Social Research Council (ESRC); Natural Environment Research Council (NERC); NERC [NE/L001284/1] Funding Source: UKRI; Natural Environment Research Council [NE/L001284/1] Funding Source: researchfish	Swedish International Development Cooperation Agency (Sida); Swedish Research Council (VR)(Swedish Research Council); Branco Weiss Society in Science Fellowship; DST/NRF South African Research Chairs Initiative(Department of Science & Technology (India)); WISER project by the Ecosystem Services for Poverty Alleviation program (ESPA); Department for International Development (DFID); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a grant from the Swedish International Development Cooperation Agency (Sida) and the Swedish Research Council (VR). RB is supported by a Branco Weiss Society in Science Fellowship and the DST/NRF South African Research Chairs Initiative (Grant No 93097). BR received support from the WISER project (NE/L001322/1) funded by the Ecosystem Services for Poverty Alleviation program (ESPA). ESPA receives its funding from the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire S, 2002, WORLD DEV, V30, P181, DOI 10.1016/S0305-750X(01)00109-7; Angelsen A, 2014, WORLD DEV, V64, pS12, DOI 10.1016/j.worlddev.2014.03.006; Baiphethi MN, 2009, AGREKON, V48, P459, DOI 10.1080/03031853.2009.9523836; Bank World, 1993, HOUS EN MARK WORK; Bennett EM, 2015, CURR OPIN ENV SUST, V14, P76, DOI 10.1016/j.cosust.2015.03.007; Bennett Thomas W., 2004, CUSTOMARY LAW S AFRI; BLAAUW D., 2013, J EC FINANCIAL SERVI, V6, P179, DOI DOI 10.4102/jef.v6i1.283; Booysen F, 2002, SOC INDIC RES, V59, P115, DOI 10.1023/A:1016275505152; Borg I, 2010, MODERN MULTIDIMENSIO; Bostic RW, 2008, HOMEOWNERSHIP AM DRE; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Collinson M., 2006, MIGRATION CHANGING S; Cousins B., 2005, WILL FORMALISING PRO, V18, P1; Cox D., 1990, World Bank Research Observer, V5, P205, DOI 10.1093/wbro/5.2.205; Croissant Y., 2013, PACKAGE MLOGIT MULTI; Cumming GS, 2014, NATURE, V515, P50, DOI 10.1038/nature13945; Cummins R.A., 2000, J HAPPINESS STUDIES, V1, P133, DOI DOI 10.1023/A:1010079728426; Daw T, 2011, ENVIRON CONSERV, V38, P370, DOI 10.1017/S0376892911000506; Daw TM, 2015, P NATL ACAD SCI USA, V112, P6949, DOI 10.1073/pnas.1414900112; Dawson N, 2015, ECOL ECON, V117, P62, DOI 10.1016/j.ecolecon.2015.06.018; De Soto H., 2000, MYSTERY CAPITAL; DFID, 2002, REPORT COMMITTEE EXP; DIENER E, 1995, J PERS SOC PSYCHOL, V69, P851, DOI 10.1037/0022-3514.69.5.851; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Diener E, 2009, SOC INDIC RES SER, V37, P201, DOI 10.1007/978-90-481-2350-6_9; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; Earth Future, 2015, FUT EARTH RES GLOB S; Ebrahim A, 2013, DEV SO AFR, V30, P168, DOI 10.1080/0376835X.2013.797227; Edmark K, 2005, SCAND J ECON, V107, P353, DOI 10.1111/j.1467-9442.2005.00412.x; ESRI, 2011, ARCGIS DESKT REL 10; Fernandes Edesio, 2002, INFLUENCE SOTOS MYST, P5; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Glaeser EL, 2007, J ECON GROWTH, V12, P77, DOI 10.1007/s10887-007-9015-1; HAGEN-ZANKER J, 2011, S AFRICAS CASH SOCIA; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Hamann M, 2015, GLOBAL ENVIRON CHANG, V34, P218, DOI 10.1016/j.gloenvcha.2015.07.008; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hulse K, 2012, WHAT ARE BENEFITS RI; Jensen RT, 2004, J PUBLIC ECON, V88, P89, DOI 10.1016/S0047-2727(02)00085-3; Kahneman D, 2006, J ECON PERSPECT, V20, P3, DOI 10.1257/089533006776526030; Klugman J, 2011, J ECON INEQUAL, V9, P249, DOI 10.1007/s10888-011-9178-z; Kumar Pushpam, 2010, EC ECOSYSTEMS BIODIV, DOI DOI 10.1017/S1355770X11000088; Leibbrandt M., 2010, WORKING PAPER NO 101, DOI [10.1787/5kmms0t7p1ms-en, DOI 10.1787/5KMMS0T7P1MS-EN]; Lemanski C, 2011, INT J URBAN REGIONAL, V35, P57, DOI 10.1111/j.1468-2427.2010.00945.x; MA, 2005, EC HUM WELL BEING SY; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Masemola M, 2012, 429 UNISA BUR MARK R; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Naude A, 2007, GEOSPATIAL ANAL PLAT; Nelson EJ, 2013, FRONT ECOL ENVIRON, V11, P483, DOI 10.1890/120312; Pereira E, 2005, ECOL SOC, V10; Phillips J, 2012, SOC SCI RES, V41, P681, DOI 10.1016/j.ssresearch.2012.01.001; Posel D, 2001, SOC DYNAMICS, V27, P165; POTTS D, 1990, J S AFR STUD, V16, P677, DOI 10.1080/03057079008708256; R Development Core Team, 2012, R LANG ENV STAT COMP; Raphael S, 2001, J LAW ECON, V44, P259, DOI 10.1086/320275; Raudsepp-Hearne C, 2010, BIOSCIENCE, V60, P576, DOI 10.1525/bio.2010.60.8.4; Reyers B, 2013, FRONT ECOL ENVIRON, V11, P268, DOI 10.1890/120144; Rigg J, 2006, WORLD DEV, V34, P180, DOI 10.1016/j.worlddev.2005.07.015; Selomane O, 2015, ECOL ECON, V118, P140, DOI 10.1016/j.ecolecon.2015.07.024; Shackleton C. M., 2001, Development Southern Africa, V18, P581, DOI 10.1080/03768350120097441; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sirgy MJ, 2006, SOC INDIC RES, V76, P343, DOI 10.1007/s11205-005-2877-8; Smit W, 1998, ENVIRON URBAN, V10, P77, DOI 10.1177/095624789801000119; Stats S.A., 2012, FIND STAT; Stats S.A., 2013, MIDYEAR POPULATION E; Stats SA, 2008, COMMUNITY SURVEY 200; Summers JK, 2012, AMBIO, V41, P327, DOI 10.1007/s13280-012-0256-7; TIGGEMANN M, 1984, J OCCUP PSYCHOL, V57, P33, DOI 10.1111/j.2044-8325.1984.tb00145.x; UNDP, 1990, HUM DEV REP 1990, DOI [10.1016/j.ecolecon.2015.06.018, DOI 10.1016/J.ECOLECON.2015.06.018]; Van Gelder JL, 2009, INT J URBAN REGIONAL, V33, P126, DOI 10.1111/j.1468-2427.2009.00833.x; Vemuri AW, 2006, ECOL ECON, V58, P119, DOI 10.1016/j.ecolecon.2005.02.008; Walker BH, 2012, ECOL SOC, V17, DOI 10.5751/ES-05063-170330; Wei T., 2013, CORRPLOT VISUALIZATI; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; WRI, 2005, MILLENNIUM DEV GOALS; Wright G, 2009, S AFRICAN INDEX MULT	79	30	32	5	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163476	10.1371/journal.pone.0163476	http://dx.doi.org/10.1371/journal.pone.0163476			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695120	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100034
J	Ji, XY; Wang, JX; Liu, B; Zheng, ZQ; Fu, SY; Tarekegn, GM; Bai, X; Bai, YS; Li, H; Zhang, WG				Ji, Xiao-yang; Wang, Jian-xun; Liu, Bin; Zheng, Zhu-qing; Fu, Shao-yin; Tarekegn, Getinet Mekuriaw; Bai, Xue; Bai, Yong-sheng; Li, Heng; Zhang, Wen-guang			Comparative Transcriptome Analysis Reveals that a Ubiquitin-Mediated Proteolysis Pathway Is Important for Primary and Secondary Hair Follicle Development in Cashmere Goats	PLOS ONE			English	Article							KAPPA-B; ECTODERMAL DYSPLASIA; GENE; GROWTH; MORPHOGENESIS; DEGRADATION; EXPRESSION; EXON	Background The fleece of cashmere goats contains two distinct populations of fibers, a short and fine non-medullated insulating cashmere fiber and a long and coarse medullated guard hair. The former is produced by secondary follicles (SFs) and the later by primary follicles (PFs). Evidence suggests that the induction of PFs and SFs may require different signaling pathways. The regulation of BMP2/4 signaling by noggin and Edar signaling via Downless genes are essential for the induction of SFs and PFs, respectively. However, these differently expressed genes of the signaling pathway cannot directly distinguish between the PFs and SFs. Results In this study, we selected RNA samples from 11 PFs and 7 SFs that included 145,525 exons. The pathway analysis of 4512 differentially expressed exons revealed that the most statistically significant metabolic pathway was related to the ubiquitin-mediated proteolysis pathway (UMPP) (P<3.32x 10(-7)). In addition, the 51 exons of the UMPP that were differentially expressed between the different types of hair follicle (HFs) were compared by cluster analysis. This resulted in the PFs and SFs being divided into two classes. The expression level of two selected exons was analyzed by qRT-PCR, and the results indicated that the expression patterns were consistent with the deep sequencing results obtained by RNASeq. Conclusions Based on the comparative transcriptome analysis of 18 HFs from cashmere goats, a large number of differentially expressed exons were identified using a high-throughput sequencing approach. This study suggests that UMPP activation is a prominent signaling pathway for distinguishing the PFs and SFs of cashmere goats. It is also a meaningful contribution to the theoretical basis of the biological study of the HFs of cashmere goats and other mammals.	[Ji, Xiao-yang; Liu, Bin; Zheng, Zhu-qing; Bai, Xue; Zhang, Wen-guang] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot 010018, Peoples R China; [Ji, Xiao-yang; Liu, Bin; Zheng, Zhu-qing; Fu, Shao-yin; Bai, Xue; Zhang, Wen-guang] Inst ATCG, Nei Mongol Bioinformat, Hohhot 010020, Peoples R China; [Zhang, Wen-guang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Wang, Jian-xun] Anim Sci Acad XinJiang Uygur Autonomous Reg, Anim Res Inst, Urumqi 830001, Peoples R China; [Fu, Shao-yin] Inner Mongolia Acad Agr & Anim Husb Sci, Hohhot 010031, Peoples R China; [Bai, Yong-sheng] Indiana State Univ, Dept Biol, Ctr Genom Advocacy, Terre Haute, IN 47809 USA; [Tarekegn, Getinet Mekuriaw] Univ Addis Ababa, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Tarekegn, Getinet Mekuriaw] Bahir Dar Univ, Biotechnol Res Inst, Dept Anim Prod & Technol, Addis Ababa, Ethiopia; [Li, Heng] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot 010018, Peoples R China	Inner Mongolia Agricultural University; Chinese Academy of Sciences; Kunming Institute of Zoology; Indiana State University; Addis Ababa University; Bahir Dar University; Inner Mongolia Agricultural University	Zhang, WG (corresponding author), Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot 010018, Peoples R China.; Zhang, WG (corresponding author), Inst ATCG, Nei Mongol Bioinformat, Hohhot 010020, Peoples R China.; Zhang, WG (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China.; Bai, YS (corresponding author), Indiana State Univ, Dept Biol, Ctr Genom Advocacy, Terre Haute, IN 47809 USA.; Li, H (corresponding author), Inner Mongolia Agr Univ, Coll Life Sci, Hohhot 010018, Peoples R China.	Yongsheng.Bai@indstate.edu; wyxbio@163.com; atcgnmbi@aliyun.com	Tarekegn, Getinet/AAO-1857-2021		National Natural Science Foundation of China [31560622, 31260538, 30960246]; Nei Mongol Major Special Science and Technology Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nei Mongol Major Special Science and Technology Project	This work was supported by the National Natural Science Foundation of China (Grant No. 31560622, No. 31260538 and 30960246) and by the Nei Mongol Major Special Science and Technology Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (Grant No. 31560622, No. 31260538 and 30960246) and by the Nei Mongol Major Special Science and Technology Project.	Botchkarev VA, 2002, J INVEST DERMATOL, V118, P3, DOI 10.1046/j.1523-1747.2002.01645.x; Botchkarev VA, 2005, J INVEST DERM SYMP P, V10, P247, DOI 10.1111/j.1087-0024.2005.10129.x; Ciechanover A, 2000, BIOESSAYS, V22, P442, DOI 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0.CO;2-Q; Dennis AP, 2005, J STEROID BIOCHEM, V93, P139, DOI 10.1016/j.jsbmb.2004.12.015; Dhananjayan SC, 2005, ESSAYS BIOCHEM, V41, P69, DOI 10.1042/EB0410069; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Frey BJ, 2005, NAT GENET, V37, P991, DOI 10.1038/ng1630; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Guo J, 2010, ACCOUNTS CHEM RES, V43, P551, DOI 10.1021/ar900255c; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntzicker EG, 2008, J INVEST DERMATOL, V128, P1081, DOI 10.1038/sj.jid.5700957; IBRAHEEM M, 1994, J ANAT, V185, P135; Imamura T, 2013, J BIOCHEM, V154, P481, DOI 10.1093/jb/mvt097; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Lyon M., 1989, GENETIC VARIANTS STR; McCall MN, 2012, BIOINFORMATICS, V28, P3153, DOI 10.1093/bioinformatics/bts588; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Najafpanah MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083041; NIXON AJ, 1991, J ZOOL, V224, P589, DOI 10.1111/j.1469-7998.1991.tb03787.x; Oro AE, 1998, CELL, V95, P575, DOI 10.1016/S0092-8674(00)81624-4; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Shimizu H, 2004, J INVEST DERMATOL, V122, P239, DOI 10.1046/j.0022-202X.2004.22224.x; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Su R, 2009, CAN J ANIM SCI, V89, P457, DOI 10.4141/CJAS08130; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vielkind U, 1996, ACTA ANAT, V157, P183; Yu H, 2006, AM J PATHOL, V168, P1879, DOI 10.2353/ajpath.2006.051170; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686; Zhang XF, 2013, EMBO J, V32, P996, DOI 10.1038/emboj.2013.38; Zhang XF, 2013, CELL RES, V23, P366, DOI 10.1038/cr.2013.21; Zhang Y, 2007, SCI AGR SINICA, V5, P020; Zhu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076282	45	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0156124	10.1371/journal.pone.0156124	http://dx.doi.org/10.1371/journal.pone.0156124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695037	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100003
J	Paul, M; Xiao, R; Gao, JB; Bossomaier, T				Paul, Manoranjan; Xiao, Rui; Gao, Junbin; Bossomaier, Terry			Reflectance Prediction Modelling for Residual-Based Hyperspectral Image Coding	PLOS ONE			English	Article							COMPRESSION; EFFICIENT	A Hyperspectral (HS) image provides observational powers beyond human vision capability but represents more than 100 times the data compared to a traditional image. To transmit and store the huge volume of an HS image, we argue that a fundamental shift is required from the existing "original pixel intensity"-based coding approaches using traditional image coders (e.g., JPEG2000) to the "residual"-based approaches using a video coder for better compression performance. A modified video coder is required to exploit spatial-spectral redundancy using pixel-level reflectance modelling due to the different characteristics of HS images in their spectral and shape domain of panchromatic imagery compared to traditional videos. In this paper a novel coding framework using Reflectance Prediction Modelling (RPM) in the latest video coding standard High Efficiency Video Coding (HEVC) for HS images is proposed. An HS image presents a wealth of data where every pixel is considered a vector for different spectral bands. By quantitative comparison and analysis of pixel vector distribution along spectral bands, we conclude that modelling can predict the distribution and correlation of the pixel vectors for different bands. To exploit distribution of the known pixel vector, we estimate a predicted current spectral band from the previous bands using Gaussian mixture-based modelling. The predicted band is used as the additional reference band together with the immediate previous band when we apply the HEVC. Every spectral band of an HS image is treated like it is an individual frame of a video. In this paper, we compare the proposed method with mainstream encoders. The experimental results are fully justified by three types of HS dataset with different wavelength ranges. The proposed method outperforms the existing mainstream HS encoders in terms of rate-distortion performance of HS image compression.	[Paul, Manoranjan; Xiao, Rui; Bossomaier, Terry] Charles Sturt Univ, Sch Comp & Math, Res Unit CM3, Bathurst, NSW 2795, Australia; [Gao, Junbin] Univ Sydney, Sch Business, Discipline Business Analyt, Sydney, NSW 2006, Australia	Charles Sturt University; University of Sydney	Paul, M (corresponding author), Charles Sturt Univ, Sch Comp & Math, Res Unit CM3, Bathurst, NSW 2795, Australia.	mpaul@csu.edu.au	Paul, Manoranjan/AAD-4047-2021; Gao, Junbin/C-6566-2008; Gao, Junbin/A-1766-2009	Gao, Junbin/0000-0001-9803-0256; Paul, Manoranjan/0000-0001-6870-5056	Charles Sturt University PhD scholarship, Faculty of Business, Charles Sturt University compact funding; Charles Sturt University RIBG grant	Charles Sturt University PhD scholarship, Faculty of Business, Charles Sturt University compact funding; Charles Sturt University RIBG grant	This work was funded by a Charles Sturt University PhD scholarship, Faculty of Business, Charles Sturt University compact funding, and Charles Sturt University RIBG grant.	Abrardo A, 2010, IEEE T GEOSCI REMOTE, V48, P1892, DOI 10.1109/TGRS.2009.2033470; [Anonymous], 2014, RES J APPL SCI ENG T; [Anonymous], [No title captured]; Blanes I, 2010, IEEE T GEOSCI REMOTE, V48, P2854, DOI 10.1109/TGRS.2010.2042063; Chen Z, 2014, 2014 5TH IEEE INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING AND SERVICE SCIENCE (ICSESS), P1177, DOI 10.1109/ICSESS.2014.6933776; Cheng Kai-Jen, 2014, J COMPUTER COMMUNICA, V2, P31; Dalal S, 2014, INT J COMPUTER SCI M, V3, P512; Du Q, 2007, IEEE GEOSCI REMOTE S, V4, P201, DOI 10.1109/LGRS.2006.888109; Du Q, 2012, INT GEOSCI REMOTE SE, P1357, DOI 10.1109/IGARSS.2012.6351284; Foster DH, 2006, J OPT SOC AM A, V23, P2359, DOI 10.1364/JOSAA.23.002359; Gao FY, 2014, PROC SPIE, V9273, DOI 10.1117/12.2070610; George R, 2014, INT C EL COMM SYST I, P1; Hanhart P, 2013, P 7 INT WORKSH VID P; Haque M, 2008, INT C PATT RECOG, P1001; Huber-Lerner M, 2014, IEEE J-STARS, V7, P2246, DOI 10.1109/JSTARS.2014.2320754; Ibarria L, 2007, IEEE DATA COMPR CONF, P163; Karami A., 2012, 2012 11th International Conference on Information Sciences, Signal Processing and their Applications (ISSPA), P809, DOI 10.1109/ISSPA.2012.6310664; Lei Chen, 2011, 2011 International Conference on Multimedia and Signal Processing (CMSP), P193, DOI 10.1109/CMSP.2011.46; Magli E, 2004, IEEE GEOSCI REMOTE S, V1, P21, DOI 10.1109/LGRS.2003.822312; Miguel AC, 2006, HYPERSPECTRAL DATA COMPRESSION, P197, DOI 10.1007/0-387-28600-4_8; Motta B, 2006, HYPERSPECTRAL DATA C; Nian YJ, 2015, J VIS COMMUN IMAGE R, V28, P113, DOI 10.1016/j.jvcir.2014.06.008; Pan XZ, 2012, IEEE GEOSCI REMOTE S, V9, P224, DOI 10.1109/LGRS.2011.2165271; Paul M, 2016, NEUROCOMPUTING, V175, P544, DOI 10.1016/j.neucom.2015.10.094; Paul M, 2014, IEEE T CIRC SYST VID, V24, P1729, DOI 10.1109/TCSVT.2014.2302555; Paul M, 2011, IEEE T CIRC SYST VID, V21, P1242, DOI 10.1109/TCSVT.2011.2138750; Paul M, 2010, IEEE T IMAGE PROCESS, V19, P691, DOI 10.1109/TIP.2009.2033406; Pearlman WA, 2004, IEEE T CIRC SYST VID, V14, P1219, DOI 10.1109/TCSVT.2004.835150; Penna B, 2007, IEEE T GEOSCI REMOTE, V45, P1408, DOI 10.1109/TGRS.2007.894565; Plaza A, 2011, REMOTE SENS ENVIRON, V113, pS110; Podder P, 2015, P 40 IEEE INT C AC S; Qiao T, 2014, INT J REMOTE SENS, V35, P7316, DOI 10.1080/01431161.2014.968682; Raja S. P., 2011, ACEEE INT J INFORM T, V01, P23; Rasti B, 2012, INT GEOSCI REMOTE SE, P1349, DOI 10.1109/IGARSS.2012.6351286; Santos L, 2012, IEEE J-STARS, V5, P451, DOI 10.1109/JSTARS.2011.2173906; Sullivan GJ, 2013, IEEE J-STSP, V7, P1001, DOI 10.1109/JSTSP.2013.2283657; Suruliandi A, 2015, INT J WAVELETS MULTI, V13, DOI 10.1142/S0219691315500125; Tang Yi, 2012, Optics and Precision Engineering, V20, P668, DOI 10.3788/OPE.20122003.0668; Tang YY, 2015, IEEE T GEOSCI REMOTE, V53, P2467, DOI 10.1109/TGRS.2014.2360672; Wang L, 2009, IEEE GEOSCI REMOTE S, V6, P587, DOI 10.1109/LGRS.2009.2021674; Wu XL, 2000, IEEE T IMAGE PROCESS, V9, P994, DOI 10.1109/83.846242; Xiangbing Kong, 2010, Proceedings of the 2010 3rd International Congress on Image and Signal Processing (CISP 2010), P2269, DOI 10.1109/CISP.2010.5647885; Xiao R, 2015, LECT NOTES COMPUT SC, V8935, P167; Zhu W, 2011, IEEE GEOSCI REMOTE S, V8, P416, DOI 10.1109/LGRS.2010.2081661	44	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0161212	10.1371/journal.pone.0161212	http://dx.doi.org/10.1371/journal.pone.0161212			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695102	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100007
J	Rosario, R; Filis, P; Tessyman, V; Kinnell, H; Childs, AJ; Gray, NK; Anderson, RA				Rosario, Roseanne; Filis, Panagiotis; Tessyman, Victoria; Kinnell, Hazel; Childs, Andrew J.; Gray, Nicola K.; Anderson, Richard A.			FMRP Associates with Cytoplasmic Granules at the Onset of Meiosis in the Human Oocyte	PLOS ONE			English	Article							FRAGILE-X PREMUTATION; PRIMARY OVARIAN INSUFFICIENCY; GERM-CELL PROLIFERATION; PROCESSING BODIES; STRESS GRANULES; RNA GRANULES; P BODIES; PCR DATA; EXPRESSION; PROTEIN	Germ cell development and primordial follicle formation during fetal life is critical in establishing the pool of oocytes that subsequently determines the reproductive lifespan of women. Fragile X-associated primary ovarian insufficiency (FXPOI) is caused by inheritance of the FMR1 premutation allele and approximately 20% of women with the premutation allele develop ovarian dysfunction and premature ovarian insufficiency. However, the underlying disease mechanism remains obscure, and a potential role of FMRP in human ovarian development has not been explored. We have characterised the expression of FMR1 and FMRP in the human fetal ovary at the time of germ cell entry into meiosis through to primordial follicle formation. FMRP expression is exclusively in germ cells in the human fetal ovary. Increased FMRP expression in germ cells coincides with the loss of pluripotency-associated protein expression, and entry into meiosis is associated with FMRP granulation. In addition, we have uncovered FMRP association with components of P-bodies and stress granules, suggesting it may have a role in mRNA metabolism at the time of onset of meiosis. Therefore, this data support the hypothesis that FMRP plays a role regulating mRNAs during pivotal maturational processes in fetal germ cells, and ovarian dysfunction resulting from FMR1 premutation may have its origins during these stages of oocyte development.	[Rosario, Roseanne; Filis, Panagiotis; Tessyman, Victoria; Kinnell, Hazel; Childs, Andrew J.; Gray, Nicola K.; Anderson, Richard A.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Filis, Panagiotis] Univ Aberdeen, Inst Med Sci, Med Sci &Nutr, Foresterhill Campus,Foresterhill, Aberdeen AB25 2ZD, Scotland; [Childs, Andrew J.] Royal Vet Coll, Dept Comparat Biomed Sci, London NW1 0TU, England	University of Edinburgh; University of Aberdeen; University of London; University of London Royal Veterinary College	Anderson, RA (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	richard.anderson@ed.ac.uk		Tessyman, Victoria/0000-0001-7755-814X; gray, nicola/0000-0002-0413-1767; Filis, Panagiotis/0000-0002-4121-9354	United Kingdom Medical Research Council [WBS: U.1276.00.002.00001.01]; Medical Research Council [G1100357, MC_U127692697, G117/564] Funding Source: researchfish; MRC [G117/564, G1100357, MC_U127692697] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the United Kingdom Medical Research Council (WBS: U.1276.00.002.00001.01 to RAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Mora MI, 2015, GENE, V571, P52, DOI 10.1016/j.gene.2015.06.039; Anderson RA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-136; Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; BACHNER D, 1993, HUM MOL GENET, V2, P2043, DOI 10.1093/hmg/2.12.2043; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; Bibi G, 2010, FERTIL STERIL, V94, P869, DOI 10.1016/j.fertnstert.2009.04.047; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Childs AJ, 2012, STEM CELLS DEV, V21, P2343, DOI 10.1089/scd.2011.0730; Childs AJ, 2012, METHODS MOL BIOL, V825, P199, DOI 10.1007/978-1-61779-436-0_15; Clarke Hugh J, 2012, Results Probl Cell Differ, V55, P1, DOI 10.1007/978-3-642-30406-4_1; Damell JC, 2011, CELL, V146, P247, DOI DOI 10.1016/J.CELL.2011.06.013; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Fulton N, 2005, J CLIN ENDOCR METAB, V90, P4664, DOI 10.1210/jc.2005-0219; Hagerman RJ, 2002, CURR OPIN GENET DEV, V12, P278, DOI 10.1016/S0959-437X(02)00299-X; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; Hoffman GE, 2012, J HISTOCHEM CYTOCHEM, V60, P439, DOI 10.1369/0022155412441002; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kobayashi S, 1996, NATURE, V380, P708, DOI 10.1038/380708a0; Koprunner M, 2001, GENE DEV, V15, P2877; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Lu CL, 2012, HUM MOL GENET, V21, P5039, DOI 10.1093/hmg/dds348; Nguyen-Chi M, 2011, REPRODUCTION, V142, P803, DOI 10.1530/REP-11-0257; Mailick MR, 2014, AM J MED GENET B, V165, P705, DOI 10.1002/ajmg.b.32277; Oh B, 2000, DEVELOPMENT, V127, P3795; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rife M, 2004, AM J MED GENET A, V124A, P129, DOI 10.1002/ajmg.a.20342; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schuettler J, 2011, HUM REPROD, V26, P1241, DOI 10.1093/humrep/der018; Sengupta MS, 2012, IUBMB LIFE, V64, P586, DOI 10.1002/iub.1039; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Sherman SL, 2000, AM J MED GENET, V97, P189, DOI 10.1002/1096-8628(200023)97:3<189::AID-AJMG1036>3.0.CO;2-J; Sherman SL, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-26; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Subramaniam K, 1999, DEVELOPMENT, V126, P4861; Tanaka SS, 2000, GENE DEV, V14, P841; Tassone F, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-22; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Webber L, 2016, HUM REPROD, V31, P926, DOI 10.1093/humrep/dew027	51	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163987	10.1371/journal.pone.0163987	http://dx.doi.org/10.1371/journal.pone.0163987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695106	Green Published, Green Accepted, gold			2022-12-27	WOS:000385553100072
J	Shou, D; Dong, Y; Wang, NN; Li, HY; Zhang, Y; Zhu, Y				Shou, Dan; Dong, Yu; Wang, Nani; Li, Hongyu; Zhang, Yang; Zhu, Yan			Simultaneous Quantification of Antioxidant Compounds in Phellinus igniarius Using Ultra Performance Liquid Chromatography-Photodiode Array Detection-Electrospray Ionization Tandem Mass Spectrometry	PLOS ONE			English	Article							COUNTER-CURRENT CHROMATOGRAPHY; MEDICINAL MUSHROOMS; POLYPHENOLS; HPLC; EXTRACT; BAUMII; PURIFICATION; METABOLITES; SEPARATION; LINTEUS	Natural antioxidants are widely used in the life sciences. Phellinus igniarius is a historically used natural antioxidant containing a variety of active compounds. Phenols, particularly Inoscavin A and Hypholomine B, are found in the high concentrations. Better quantitative methods are needed to perform quality control in order to support further research of this mushroom. An ultra-performance liquid chromatography method coupled to photodiodearray detection and an electrospray ionization tandem mass spectrometry method (UPLC-PAD-MS) was developed to simultaneously quantify Inoscavin A and Hypholomine B levels in the medicinal fungus Phellinus igniarius. The two compounds were quantified using UPLC-PAD and UPLC-MS. The methods were accurate (mean accuracy for spiked matrix ranged from 101.5% to 105.8%), sensitive (limit of detection ranged from 0.28 to 1.14 mg L-1) and precise (the relative standard deviations ranged from 0.13 to 2.8%). Inoscavin A and Hypholomine B were purified using high-speed counter-current chromatography (HSCCC), structural evaluated to meet the request of standard substances. UPLC separation was performed on a reversed-phase C18 column using gradient elution with acetonitrile and 0.1% formic acid over 10 min. The developed method was successfully applied to determine Inoscavin A and Hypholomine B in twelve Phellinus igniarius samples of different origins and the results showed that it was suitable for the analysis of these active components in Phellinus igniarius samples.	[Shou, Dan; Zhu, Yan] Zhejiang Univ, Dept Chem, Tianmushan Rd 148, Hangzhou 310028, Zhejiang, Peoples R China; [Shou, Dan; Dong, Yu; Wang, Nani; Li, Hongyu; Zhang, Yang] Zhejiang Acad Tradit Chinese Med, Dept Med, Tianmushan Rd 132, Hangzhou 310007, Zhejiang, Peoples R China	Zhejiang University	Shou, D; Zhu, Y (corresponding author), Zhejiang Univ, Dept Chem, Tianmushan Rd 148, Hangzhou 310028, Zhejiang, Peoples R China.; Shou, D (corresponding author), Zhejiang Acad Tradit Chinese Med, Dept Med, Tianmushan Rd 132, Hangzhou 310007, Zhejiang, Peoples R China.	shoudanok@163.com; zhuyan@zju.edu.cn			National Natural Science Foundation of China [81603349]; Zhejiang Provincial Natural Science Foundation [LQ15H280008]; Science and Technology Plan of Zhejiang Province [2016ZB008, 2016C33097]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Science and Technology Plan of Zhejiang Province	This study was financially supported by National Natural Science Foundation of China (Grant No. 81603349), Zhejiang Provincial Natural Science Foundation (Grant No. LQ15H280008), Science and Technology Plan of Zhejiang Province (No. 2016ZB008, 2016C33097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajith TA, 2007, J CLIN BIOCHEM NUTR, V40, P157, DOI 10.3164/jcbn.40.157; Alwis KU, 2012, ANAL CHIM ACTA, V750, P152, DOI 10.1016/j.aca.2012.04.009; Bai XL, 2010, J SEP SCI, V33, P3751, DOI 10.1002/jssc.201000430; Choi DY, 2012, BRAIN RES BULL, V87, P144, DOI 10.1016/j.brainresbull.2011.11.014; Cui X, 2011, J CHROMATOGR A, V1218, P8718, DOI 10.1016/j.chroma.2011.10.014; Dai XP, 2013, FOOD CHEM, V139, P563, DOI 10.1016/j.foodchem.2013.02.006; Dong Y, 2015, J SEP SCI, V38, P1137, DOI 10.1002/jssc.201401293; Han QB, 2008, J SEP SCI, V31, P1189, DOI 10.1002/jssc.200700582; Kim JP, 1999, TETRAHEDRON LETT, V40, P6643, DOI 10.1016/S0040-4039(99)01406-9; Kojima K, 2008, J NAT MED, V62, P441, DOI 10.1007/s11418-008-0260-1; Krzyzanowska J, 2011, J AOAC INT, V94, P43; Lee IK, 2007, BIOORGAN MED CHEM, V15, P3309, DOI 10.1016/j.bmc.2007.03.039; Lee IK, 2010, BIOORG MED CHEM LETT, V20, P5459, DOI 10.1016/j.bmcl.2010.07.093; Lee S, 2013, J MICROBIOL, V51, P676, DOI 10.1007/s12275-013-3384-2; Lee YS, 2010, NAT PROD COMMUN, V5, P1927; Liu D, 2012, J SEP SCI, V35, P2146, DOI 10.1002/jssc.201200283; Pelillo M, 2004, FOOD CHEM, V87, P465, DOI 10.1016/j.foodchem.2003.12.034; Sha C, 2012, ANAL CHIM ACTA, V724, P127, DOI [10.1016/j.aca.2012.02.051, DOI 10.1016/J.ACA.2012.02.051]; Shon MY, 2003, FOOD CHEM, V82, P593, DOI 10.1016/S0308-8146(03)00015-3; Shou D, 2014, J CHROMATOGR SCI, V52, P501, DOI 10.1093/chromsci/bmt069; Song TY, 2008, J ETHNOPHARMACOL, V115, P50, DOI 10.1016/j.jep.2007.09.001; Wu CS, 2011, BIOORG MED CHEM LETT, V21, P3261, DOI 10.1016/j.bmcl.2011.04.025; Ying XX, 2012, NAT PROD RES, V26, P585, DOI 10.1080/14786419.2010.543903; Yue HL, 2013, J CHROMATOGR B, V936, P57, DOI 10.1016/j.jchromb.2013.08.007; Zhang J, 2011, J SEP SCI, V35, P128, DOI [10.1002/jssc.201100695, DOI 10.1002/JSSC.201100695]	25	11	11	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163797	10.1371/journal.pone.0163797	http://dx.doi.org/10.1371/journal.pone.0163797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689891	gold, Green Published, Green Submitted			2022-12-27	WOS:000384329200028
J	Marx, FG; Fordyce, RE				Marx, Felix G.; Fordyce, R. Ewan			A Link No Longer Missing: New Evidence for the Cetotheriid Affinities of Caperea	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; CETACEA MYSTICETI; BALEEN WHALE; NEW-ZEALAND; PLIOCENE; GENUS; MORPHOLOGY; OLIGOCENE; ANATOMY; FOSSIL	The origins of the enigmatic pygmy right whale Caperea marginata, the only living member of its subfamily (Neobalaeninae), are an outstanding mystery of cetacean evolution. Its strikingly disparate morphology sets Caperea apart from all other whales, and has turned it into a wildcard taxon that holds the key to understanding modern baleen whale diversity. Morphological cladistics generally ally this species with right whales, whereas molecular analyses consistently cluster it with rorquals and grey whales (Balaenopteroidea). A recent study potentially resolved this conflict by proposing that Caperea belongs with the otherwise extinct Cetotheriidae, but has been strongly criticised on morphological grounds. Evidence from the neobalaenine fossil record could potentially give direct insights into morphological transitions, but is currently limited to just a single species: the Late Miocene Miocaperea pulchra, from Peru. We show that Miocaperea has a highly unusual morphology of the auditory region, resulting from a-presumably feeding-related-strengthening of the articulation of the hyoid apparatus with the skull. This distinctive arrangement is otherwise only found in the extinct Cetotheriidae, which makes Miocaperea a 'missing link" that demonstrates the origin of pygmy right whales from cetotheriids, and confirms the latter's resurrection from the dead.	[Marx, Felix G.] Monash Univ, Sch Biol Sci, 25 Rainforest Walk, Clayton, Vic 3800, Australia; [Marx, Felix G.] Museum Victoria, Geosci, Melbourne, Vic, Australia; [Marx, Felix G.] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Brussels, Belgium; [Fordyce, R. Ewan] Univ Otago, Dept Geol, Dunedin, New Zealand; [Fordyce, R. Ewan] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20560 USA; [Fordyce, R. Ewan] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA	Monash University; Museum Victoria; Royal Belgian Institute of Natural Sciences; University of Otago; Smithsonian Institution; Smithsonian National Museum of Natural History; Smithsonian Institution; Smithsonian National Museum of Natural History	Marx, FG (corresponding author), Monash Univ, Sch Biol Sci, 25 Rainforest Walk, Clayton, Vic 3800, Australia.; Marx, FG (corresponding author), Museum Victoria, Geosci, Melbourne, Vic, Australia.; Marx, FG (corresponding author), Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Brussels, Belgium.	felix.marx@monash.edu	Marx, Felix Georg/AAI-3480-2021	Marx, Felix Georg/0000-0002-1029-4001	European Commission [656010]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research was supported by a European Commission Horizon 2020 Marie Sklodowska-Curie Global Postdoctoral fellowship to FGM (grant ID 656010).	[Anonymous], 1885, INTRO OSTEOLOGY MAMM; Beauregard H, 1894, J ANAT PHYSL, V30, P366; Bischoff N, 2012, VISUAL NEUROSCI, V29, P95, DOI 10.1017/S0952523812000107; Bisconti M, 2005, PALAEONTOLOGY, V48, P793, DOI 10.1111/j.1475-4983.2005.00488.x; Bisconti M, 2015, J SYST PALAEONTOL, V13, P377, DOI 10.1080/14772019.2014.890136; Bisconti M, 2012, ZOOL J LINN SOC-LOND, V166, P876, DOI 10.1111/j.1096-3642.2012.00862.x; Boessenecker RW, 2015, ZOOL J LINN SOC-LOND, V175, P607, DOI 10.1111/zoj.12297; Boessenecker RW, 2015, PEERJ, V3, DOI 10.7717/peerj.1129; Bouetel V, 2006, GEODIVERSITAS, V28, P319; CABRERA A., 1926, REV MUSEO LA PLATA, V29, P363; COPE ED, 1896, P AM PHILOS SOC, V35, P139; Ekdale EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021311; El Adli JJ, 2014, ZOOL J LINN SOC-LOND, V170, P400, DOI 10.1111/zoj.12108; Fordyce RE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2645; Fraser F. C., 1960, B BRIT MUS NAT HIST, V7, P3; Gol'din P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135500; GoL'Din P, 2014, ACTA PALAEONTOL POL, V59, P795, DOI 10.4202/app.2012.0107; Kellogg R., 1968, B US NATL MUSEUM, V247, P103; Kemper CM, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P939; Maddison WP, 2011, MESQUITE MODULAR SYS; Marx FG, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150476; Marx FG, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140434; Marx FG, 2013, NATURWISSENSCHAFTEN, V100, P257, DOI 10.1007/s00114-013-1012-y; Marx FG, 2016, PEERJ, V4, DOI 10.7717/peerj.1572; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Meredith RW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003432; Miller M.A., 2010, P GAT COMP ENV WORKS; RAY GC, 1974, MAR FISH REV, V36, P31; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Steeman ME, 2007, ZOOL J LINN SOC-LOND, V150, P875, DOI 10.1111/j.1096-3642.2007.00313.x; True FW, 1904, SMITHSONIAN CONTRIBU, V33, P1, DOI DOI 10.5962/BHL.TITLE.25586; Tsai CH, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0875	33	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164059	10.1371/journal.pone.0164059	http://dx.doi.org/10.1371/journal.pone.0164059			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711216	Green Published, gold			2022-12-27	WOS:000385697600071
J	Murgia, A; Veronesi, E; Candini, O; Caselli, A; D'souza, N; Rasini, V; Giorgini, A; Catani, F; Iughetti, L; Dominici, M; Burns, JS				Murgia, Alba; Veronesi, Elena; Candini, Olivia; Caselli, Anna; D'souza, Naomi; Rasini, Valeria; Giorgini, Andrea; Catani, Fabio; Iughetti, Lorenzo; Dominici, Massimo; Burns, Jorge S.			Potency Biomarker Signature Genes from Multiparametric Osteogenesis Assays: Will cGMP Human Bone Marrow Mesenchymal Stromal Cells Make Bone?	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; HUMAN PLATELET LYSATE; STEM-CELLS; IN-VITRO; TGF-BETA; OSTEOBLAST DIFFERENTIATION; FORMING CAPACITY; MORPHOGENETIC PROTEIN-2; EXTRACELLULAR-MATRIX; INTERFERON-GAMMA	In skeletal regeneration approaches using human bone marrow derived mesenchymal stromal cells (hBM-MSC), functional evaluation before implantation has traditionally used biomarkers identified using fetal bovine serum-based osteogenic induction media and time courses of at least two weeks. However, emerging pre-clinical evidence indicates donor-dependent discrepancies between these ex vivo measurements and the ability to form bone, calling for improved tests. Therefore, we adopted a multiparametric approach aiming to generate an osteogenic potency assay with improved correlation. hBM-MSC populations from six donors, each expanded under clinical-grade (cGMP) conditions, showed heterogeneity for ex vivo growth response, mineralization and bone-forming ability in a murine xenograft assay. A subset of literature-based biomarker genes was reproducibly upregulated to a significant extent across all populations as cells responded to two different osteogenic induction media. These 12 biomarkers were also measurable in a one-week assay, befitting clinical cell expansion time frames and cGMP growth conditions. They were selected for further challenge using a combinatorial approach aimed at determining ex vivo and in vivo consistency. We identified five globally relevant osteogenic signature genes, notably TGF-beta 1 pathway interactors; ALPL, COL1A2, DCN, ELN and RUNX2. Used in agglomerative cluster analysis, they correctly grouped the bone-forming cell populations as distinct. Although donor #6 cells were correlation slope outliers, they contrastingly formed bone without showing ex vivo mineralization. Mathematical expression level normalization of the most discrepantly upregulated signature gene COL1A2, sufficed to cluster donor #6 with the bone-forming classification. Moreover, attenuating factors causing genuine COL1A2 gene down-regulation, restored ex vivo mineralization. This suggested that the signature gene had an osteogenically influential role; nonetheless no single biomarker was fully deterministic whereas all five signature genes together led to accurate cluster analysis. We show proof of principle for an osteogenic potency assay providing early characterization of primary cGMP-hBM-MSC cultures according to their donor-specific bone-forming potential.	[Murgia, Alba; Veronesi, Elena; Candini, Olivia; D'souza, Naomi; Rasini, Valeria; Iughetti, Lorenzo; Dominici, Massimo; Burns, Jorge S.] Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Modena, Italy; [Veronesi, Elena; Dominici, Massimo; Burns, Jorge S.] TPM, Sci & Technol Pk Med, Modena, Italy; [Caselli, Anna] Osped Pediat Giovanni XXIII, CVBF Consorzio Valutaz Biol & Farmacol, Bari, Italy; [Giorgini, Andrea; Catani, Fabio] Univ Hosp Modena & Reggio Emilia, Dept Orthoped Surg, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital	Dominici, M; Burns, JS (corresponding author), Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Modena, Italy.; Dominici, M; Burns, JS (corresponding author), TPM, Sci & Technol Pk Med, Modena, Italy.	massimo.dominici@unimore.it; jorge.burns@unimore.it	Dominici, Massimo/K-8014-2016; Burns, Jorge S./J-3395-2012; Burns, Jorge/AAF-5291-2019; Iughetti, Lorenzo/I-4602-2014; Catani, Fabio/B-3642-2017	Burns, Jorge S./0000-0002-8602-1536; Iughetti, Lorenzo/0000-0003-0370-7872; Catani, Fabio/0000-0002-1078-7666; Candini, Olivia/0000-0002-5749-9100; Veronesi, Elena/0000-0001-6262-1388; Dominici, Massimo/0000-0002-4007-1503	European Commission through REBORNE project [241879]	European Commission through REBORNE project	This work was supported in parts by the European Commission Seventh Framework Programme (FP7/2007-2013) (grant no. 241879), through the REBORNE project.	Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059; Achille V, 2011, J CELL BIOCHEM, V112, P1817, DOI 10.1002/jcb.23100; Acil Y, 2014, J CRANIO MAXILL SURG, V42, P2002, DOI 10.1016/j.jcms.2014.09.006; Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Aldahmash A, 2011, STEM CELL REV REP, V7, P860, DOI 10.1007/s12015-011-9274-2; Alm JJ, 2012, TISSUE ENG PART C-ME, V18, P658, DOI [10.1089/ten.tec.2011.0675, 10.1089/ten.TEC.2011.0675]; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97; Bernardo ME, 2011, BEST PRACT RES CL HA, V24, P73, DOI 10.1016/j.beha.2010.11.002; Bhumiratana S, 2012, STEM CELL TRANSL MED, V1, P64, DOI 10.5966/sctm.2011-0020; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; Burns JS, 2010, TISSUE ENG PT A, V16, P2331, DOI [10.1089/ten.tea.2009.0735, 10.1089/ten.TEA.2009.0735]; Cruz ACC, 2012, J APPL ORAL SCI, V20, P628, DOI 10.1590/S1678-77572012000600007; Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082; Chappuis V, 2012, BONE, V51, P800, DOI 10.1016/j.bone.2012.07.017; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen Jiani, 2005, Journal of Medical and Dental Sciences, V52, P27; Chevallier N, 2010, BIOMATERIALS, V31, P270, DOI 10.1016/j.biomaterials.2009.09.043; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Cordonnier T, 2014, J TISSUE ENG REGEN M, V8, P364, DOI 10.1002/term.1529; Couchourel D, 2009, ARTHRITIS RHEUM-US, V60, P1438, DOI 10.1002/art.24489; Crane JL, 2014, J CLIN INVEST, V124, P466, DOI 10.1172/JCI70050; De Bari C, 2008, ARTHRITIS RHEUM, V58, P240, DOI 10.1002/art.23143; DelMonaco M, 1997, J INVEST DERMATOL, V108, P938, DOI 10.1111/1523-1747.ep12295241; Dennis JE, 1998, BIOMATERIALS, V19, P1323, DOI 10.1016/S0142-9612(97)00170-1; Duque G, 2011, J BONE MINER RES, V26, P1472, DOI 10.1002/jbmr.350; Edwards JR, 2010, J BONE MINER RES, V25, P2419, DOI 10.1002/jbmr.139; Fekete N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043255; Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420; Fiorentini E, 2011, INT J ARTIF ORGANS, V34, P998, DOI 10.5301/ijao.5000001; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gomez-Barrena E, 2015, BONE, V70, P93, DOI 10.1016/j.bone.2014.07.033; Gothard D, 2013, CELL TISSUE RES, V352, P237, DOI 10.1007/s00441-013-1564-3; Grafel I, 2014, NAT MED, V20, P670, DOI 10.1038/nm.3544; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hee CK, 2011, CYTOTHERAPY, V13, P528, DOI 10.3109/14653249.2010.542454; Higashi K, 2003, J BIOL CHEM, V278, P43470, DOI 10.1074/jbc.M302339200; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Isaksson H, 2008, J THEOR BIOL, V255, P26, DOI 10.1016/j.jtbi.2008.07.037; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Janicki P, 2011, EUR CELLS MATER, V21, P488, DOI 10.22203/eCM.v021a37; Jansen BJH, 2010, STEM CELLS DEV, V19, P481, DOI 10.1089/scd.2009.0288; Jaquiery C, 2005, ANN SURG, V242, P859, DOI 10.1097/01.sla.0000189572.02554.2c; Jorgensen NR, 2004, STEROIDS, V69, P219, DOI 10.1016/j.steroids.2003.12.005; Jung S, 2012, BIOTECHNOL APPL BIOC, V59, P106, DOI 10.1002/bab.1006; Karsenty G, 1995, Int Rev Immunol, V12, P177, DOI 10.3109/08830189509056711; Khanna-Jain R, 2010, GROWTH FACTORS, V28, P437, DOI 10.3109/08977194.2010.495719; Kisiel M, 2012, J CONTROL RELEASE, V162, P646, DOI 10.1016/j.jconrel.2012.08.004; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Larsen KH, 2010, J BONE MINER RES, V25, P796, DOI 10.1359/jbmr.091018; Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.3.CO;2-5; Lian J B, 1995, Iowa Orthop J, V15, P118; Linsley C, 2013, TISSUE ENG PT A, V19, P1416, DOI [10.1089/ten.tea.2012.0523, 10.1089/ten.TEA.2012.0523]; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Madras N, 2002, STEM CELLS, V20, P230, DOI 10.1634/stemcells.20-3-230; Manferdini C, 2011, J CELL PHYSIOL, V226, P2675, DOI 10.1002/jcp.22618; Mankani MH, 2004, RADIOLOGY, V230, P369, DOI 10.1148/radiol.2302011529; Mathews S, 2012, DIFFERENTIATION, V84, P185, DOI 10.1016/j.diff.2012.05.001; Matsuoka F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055082; Mendes SC, 2004, J MATER SCI-MATER M, V15, P1123, DOI 10.1023/B:JMSM.0000046394.53153.21; Mentink A, 2013, BIOMATERIALS, V34, P4592, DOI 10.1016/j.biomaterials.2013.03.001; Mizuno D, 2010, GROWTH FACTORS, V28, P34, DOI 10.3109/08977190903326362; Mochida Y, 2009, MATRIX BIOL, V28, P44, DOI 10.1016/j.matbio.2008.11.003; Mostafa NZ, 2012, CONNECT TISSUE RES, V53, P117, DOI 10.3109/03008207.2011.611601; Narisawa S, 2013, J BONE MINER RES, V28, P1587, DOI 10.1002/jbmr.1901; Niikura N, 2012, CANCER SCI, V103, P1508, DOI 10.1111/j.1349-7006.2012.02319.x; O'Regan AW, 2000, J LEUKOCYTE BIOL, V68, P495; Phinney DG, 2012, J CELL BIOCHEM, V113, P2806, DOI 10.1002/jcb.24166; Pietila M, 2010, TISSUE ENG PART C-ME, V16, P435, DOI 10.1089/ten.tec.2009.0247; Prins HJ, 2014, STEM CELL RES, V12, P428, DOI 10.1016/j.scr.2013.12.001; Prins HJ, 2009, TISSUE ENG PT A, V15, P3741, DOI [10.1089/ten.tea.2008.0666, 10.1089/ten.TEA.2008.0666]; PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110; Quarto N, 2012, STEM CELLS, V30, P2709, DOI 10.1002/stem.1250; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Quivy V, 2004, CLONING STEM CELLS, V6, P140, DOI 10.1089/1536230041372454; Ramirez F, 2006, MATRIX BIOL, V25, P365, DOI 10.1016/j.matbio.2006.05.002; Razzouk Sleiman, 2012, N Y State Dent J, V78, P37; Rich CB, 1999, J BIOL CHEM, V274, P33433, DOI 10.1074/jbc.274.47.33433; Russell KC, 2011, BIOTECHNOL BIOENG, V108, P2716, DOI 10.1002/bit.23193; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Schrezenmeier H, 2010, VOX SANG, V99, P1, DOI 10.1111/j.1423-0410.2009.01295.x; Seiler C, 2014, J TISSUE ENG REGEN M, V8, P737, DOI 10.1002/term.1575; Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197; Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587; Sibiya SJ, 2013, J BIOMED MATER RES A, V101, P641, DOI 10.1002/jbm.a.34365; Simionescu A, 2007, AM J PATHOL, V171, P116, DOI 10.2353/ajpath.2007.060930; Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592; STEIN GS, 1989, CONNECT TISSUE RES, V20, P3, DOI 10.3109/03008208909049996; Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120; Sudo K, 2007, STEM CELLS, V25, P1610, DOI 10.1634/stemcells.2006-0504; Tachi K, 2011, TISSUE ENG PT A, V17, P597, DOI [10.1089/ten.tea.2010.0094, 10.1089/ten.TEA.2010.0094]; Tohma Y, 2012, J TISSUE ENG REGEN M, V6, P96, DOI 10.1002/term.401; TURNER RT, 1991, AM J PHYSIOL, V261, pE348, DOI 10.1152/ajpendo.1991.261.3.E348; Veronesi E, 2014, TISSUE ENG PART C-ME, V20, P239, DOI [10.1089/ten.tec.2013.0250, 10.1089/ten.TEC.2013.0250]; Volk SW, 2014, CALCIFIED TISSUE INT, V94, P621, DOI 10.1007/s00223-014-9843-x; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang HY, 2012, CYTOTHERAPY, V14, P423, DOI 10.3109/14653249.2011.652735; Wegman F, 2013, TISSUE ENG PT A, V19, P2686, DOI [10.1089/ten.tea.2012.0569, 10.1089/ten.TEA.2012.0569]; Xia WJ, 2011, CELL BIOL INT, V35, P639, DOI 10.1042/CBI20100361; Yamagiwa H, 2001, J BONE MINER METAB, V19, P20, DOI 10.1007/s007740170056; Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.tea.2010.0555, 10.1089/ten.TEA.2010.0555]; Zhang ZL, 2012, J BONE MINER METAB, V30, P69, DOI 10.1007/s00774-011-0284-6; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054645	105	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163629	10.1371/journal.pone.0163629	http://dx.doi.org/10.1371/journal.pone.0163629			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711115	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600032
J	Paul, K; Padalhin, AR; Linh, NTB; Kim, B; Sarkar, SK; Lee, BT				Paul, Kallyanashis; Padalhin, Andrew R.; Nguyen Thuy Ba Linh; Kim, Boram; Sarkar, Swapan Kumar; Lee, Byong Taek			A Study of BMP-2-Loaded Bipotential Electrolytic Complex around a Biphasic Calcium Phosphate-Derived (BCP) Scaffold for Repair of Large Segmental Bone Defect	PLOS ONE			English	Article							TGF-BETA; BMP-2; DIFFERENTIATION; DELIVERY	A bipotential polyelectrolyte complex with biphasic calcium phosphate (BCP) powder dispersion provides an excellent option for protein adsorption and cell attachment and can facilitate enhanced bone regeneration. Application of the bipotential polyelectrolyte complex embedded in a spongy scaffold for faster healing of large segmental bone defects (LSBD) can be a promising endeavor in tissue engineering application. In the present study, a hollow scaffold suitable for segmental long bone replacement was fabricated by the sponge replica method applying the microwave sintering process. The fabricated scaffold was coated with calcium alginate at the shell surface, and genipin-crosslinked chitosan with biphasic calcium phosphate (BCP) dispersion was loaded at the central hollow core. The chitosan core was subsequently loaded with BMP-2. The electrolytic complex was characterized using SEM, porosity measurement, FTIR spectroscopy and BMP-2 release for 30 days. In vitro studies such as MTT, live/dead, cell proliferation and cell differentiation were performed. The scaffold was implanted into a 12 mm critical size defect of a rabbit radius. The efficacy of this complex is evaluated through an in vivo study, one and two month post implantation. BV/TV ratio for BMP-2 loaded sample was (42 +/- 1.76) higher compared with hollow BCP scaffold (32 +/- 0.225).	[Paul, Kallyanashis; Padalhin, Andrew R.; Kim, Boram; Lee, Byong Taek] Soonchunhyang Univ, Coll Med, Dept Regenerat Med, 366-1 Ssangyong Dong, Cheonan 330090, South Korea; [Nguyen Thuy Ba Linh; Sarkar, Swapan Kumar; Lee, Byong Taek] Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, 366-1 Ssangyong Dong, Cheonan 330090, South Korea	Soonchunhyang University; Soonchunhyang University	Lee, BT (corresponding author), Soonchunhyang Univ, Coll Med, Dept Regenerat Med, 366-1 Ssangyong Dong, Cheonan 330090, South Korea.; Lee, BT (corresponding author), Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, 366-1 Ssangyong Dong, Cheonan 330090, South Korea.	lbt@sch.ac.kr	Padalhin, Andrew/ABF-4523-2021	Padalhin, Andrew/0000-0002-3869-5720; Paul, Kallyanashis/0000-0002-0953-3263; Lee, Byong-Taek/0000-0001-9072-0033; Nguyen, Linh/0000-0002-8532-8296	Soonchunhyang University [20150000]; basic science research program through national research foundation of Republic of Korea (NRF) - ministry of education [2015R1A6A1A03032522]; Soonchunhyang University	Soonchunhyang University; basic science research program through national research foundation of Republic of Korea (NRF) - ministry of education; Soonchunhyang University	This work was supported by Mid-career Research Program through Soonchunhyang University Research Fund only (No. 20150000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by basic science research program through the national research foundation of Republic of Korea (NRF) funded by the ministry of education (2015R1A6A1A03032522) and was partially supported by Soonchunhyang University research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to thank Dr. Hae Il Jung and Mr. Shin-Woo Kim for their contributions to the in vivo operation.	Almodovar J, 2010, BIOMACROMOLECULES, V11, P2629, DOI 10.1021/bm1005799; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Bi LX, 2014, MAT SCI ENG C-MATER, V42, P816, DOI 10.1016/j.msec.2014.06.022; BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165; CARTER DR, 1984, CALCIFIED TISSUE INT, V36, pS19, DOI 10.1007/BF02406129; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Cheng LJ, 2012, APPL SURF SCI, V262, P188, DOI 10.1016/j.apsusc.2012.04.122; Cipitria A, 2012, J BONE MINER RES, V27, P1275, DOI 10.1002/jbmr.1589; Detzel CJ, 2011, TISSUE ENG PART B-RE, V17, P101, DOI [10.1089/ten.teb.2010.0548, 10.1089/ten.TEB.2010.0548]; Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168; Farzadi A, 2011, CERAM INT, V37, P65, DOI 10.1016/j.ceramint.2010.08.021; Feng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049955; Henrionnet C, 2010, BIO-MED MATER ENG, V20, P175, DOI 10.3233/BME-2010-0629; Hesse E, 2010, BONE, V46, P1457, DOI 10.1016/j.bone.2010.02.011; Jillavenkatesa A, 1998, SPECTROSC LETT, V31, P1619, DOI 10.1080/00387019808007439; Jin HH, 2012, INT J BIOL MACROMOL, V51, P1079, DOI 10.1016/j.ijbiomac.2012.08.027; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Kim A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051813; Kim M, 2011, J EUR CERAM SOC, V31, P1541, DOI 10.1016/j.jeurceramsoc.2011.03.019; Kim S, 2012, ACTA BIOMATER, V8, P1768, DOI 10.1016/j.actbio.2012.01.009; Lee YT, 2007, MATER CHEM PHYS, V104, P249, DOI 10.1016/j.matchemphys.2007.02.009; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Lu ZF, 2015, NANOMED-NANOTECHNOL, V11, P219, DOI 10.1016/j.nano.2014.09.008; Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Nath SD, 2015, CARBOHYD POLYM, V115, P160, DOI 10.1016/j.carbpol.2014.08.077; Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018; Ohta S, 2006, INT J CANCER, V119, P2236, DOI 10.1002/ijc.22127; Paderni Stefania, 2009, Chir Organi Mov, V93, P89, DOI 10.1007/s12306-009-0028-0; Rahman CV, 2014, J TISSUE ENG REGEN M, V8, P59, DOI 10.1002/term.1497; Rhim JW, 2004, LEBENSM-WISS TECHNOL, V37, P323, DOI 10.1016/j.lwt.2003.09.008; SANDBERG MM, 1993, CLIN ORTHOP RELAT R, P292; Scharenberg MA, 2014, J CELL SCI, V127, P1079, DOI 10.1242/jcs.142075; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; Shen BJ, 2009, TISSUE ENG PT A, V15, P1311, DOI 10.1089/ten.tea.2008.0132; Son SR, 2014, J BIOMATER APPL; Nguyen TBL, 2014, TISSUE ENG PT A, V20, P1993, DOI [10.1089/ten.tea.2013.0352, 10.1089/ten.TEA.2013.0352]; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Umoh JU, 2009, PHYS MED BIOL, V54, P2147, DOI 10.1088/0031-9155/54/7/020; van der Linden Jacqueline C, 2006, Drug Discov Today Technol, V3, P213, DOI 10.1016/j.ddtec.2006.06.006; Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003	41	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163708	10.1371/journal.pone.0163708	http://dx.doi.org/10.1371/journal.pone.0163708			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711142	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600036
J	Auty, H; Cleaveland, S; Malele, I; Masoy, J; Lembo, T; Bessell, P; Torr, S; Picozzi, K; Welburn, SC				Auty, Harriet; Cleaveland, Sarah; Malele, Imna; Masoy, Joseph; Lembo, Tiziana; Bessell, Paul; Torr, Stephen; Picozzi, Kim; Welburn, Susan C.			Quantifying Heterogeneity in Host-Vector Contact: Tsetse (Glossina swynnertoni and G. pallidipes) Host Choice in Serengeti National Park, Tanzania	PLOS ONE			English	Article							WEST-NILE-VIRUS; TRYPANOSOMA-BRUCEI; LUANGWA VALLEY; FLIES DIPTERA; SLEEPING-SICKNESS; RESPONSES; IDENTIFICATION; TRANSMISSION; RHODESIENSE; PREFERENCES	Background Identifying hosts of blood-feeding insect vectors is crucial in understanding their role in disease transmission. Rhodesian human African trypanosomiasis (rHAT), also known as acute sleeping sickness is caused by Trypanosoma brucei rhodesiense and transmitted by tsetse flies. The disease is commonly associated with wilderness areas of east and southern Africa. Such areas hold a diverse range of species which form communities of hosts for disease maintenance. The relative importance of different wildlife hosts remains unclear. This study quantified tsetse feeding preferences in a wilderness area of great host species richness, Serengeti National Park, Tanzania, assessing tsetse feeding and host density contemporaneously. Methods Glossina swynnertoni and G. pallidipes were collected from six study sites. Bloodmeal sources were identified through matching Cytochrome B sequences amplified from bloodmeals from recently fed flies to published sequences. Densities of large mammal species in each site were quantified, and feeding indices calculated to assess the relative selection or avoidance of each host species by tsetse. Results The host species most commonly identified in G. swynnertoni bloodmeals, warthog (94/220), buffalo (48/220) and giraffe (46/220), were found at relatively low densities (3-11/km(2)) and fed on up to 15 times more frequently than expected by their relative density. Wildebeest, zebra, impala and Thomson's gazelle, found at the highest densities, were never identified in bloodmeals. Commonly identified hosts for G. pallidipes were buffalo (26/46), giraffe (9/46) and elephant (5/46). Conclusions This study is the first to quantify tsetse host range by molecular analysis of tsetse diet with simultaneous assessment of host density in a wilderness area. Although G. swynnertoni and G. pallidipes can feed on a range of species, they are highly selective. Many host species are rarely fed on, despite being present in areas where tsetse are abundant. These feeding patterns, along with the ability of key host species to maintain and transmit T. b. rhodesiense, drive the epidemiology of rHAT in wilderness areas.	[Auty, Harriet] SRUC, Epidemiol Res Unit, Inverness, Scotland; [Auty, Harriet; Picozzi, Kim; Welburn, Susan C.] Univ Edinburgh, Edinburgh Med Sch, Sch Biomed Sci, Div Pathway & Infect Med,Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Cleaveland, Sarah; Lembo, Tiziana] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland; [Malele, Imna] TTRI, Tanga, Tanzania; [Masoy, Joseph] Tanzania Wildlife Res Inst, Serengeti Biodivers Project, Arusha, Tanzania; [Bessell, Paul] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Torr, Stephen] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England; [Torr, Stephen] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England	University of Edinburgh; University of Glasgow; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; Liverpool School of Tropical Medicine; University of Warwick	Auty, H (corresponding author), SRUC, Epidemiol Res Unit, Inverness, Scotland.; Auty, H; Welburn, SC (corresponding author), Univ Edinburgh, Edinburgh Med Sch, Sch Biomed Sci, Div Pathway & Infect Med,Ctr Infect Dis, Edinburgh, Midlothian, Scotland.	harriet.auty@sruc.ac.uk; Sue.Welburn@ed.ac.uk	; Torr, Stephen/N-7161-2016	Auty, Harriet/0000-0002-6181-3780; Torr, Stephen/0000-0001-9550-4030; Malele, Imna/0000-0002-9343-7150	DFID RNRRS Animal Health Programme; University of Edinburgh	DFID RNRRS Animal Health Programme; University of Edinburgh	The authors are grateful for support from DFID RNRRS Animal Health Programme (SCW, KP, SC, HA). HA was a beneficiary of an MRC studentship, awarded by University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-68; Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Ali Oshaghi M, 2006, EXP PARASITOL, V112, P232, DOI 10.1016/j.exppara.2005.11.008; Anderson NE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001211; Auty H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001828; Auty HK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001501; AWAN MAQ, 1979, ACTA TROP, V36, P343; Baker JR, 1968, S ZOOLOGICAL SOC LON, V24, P147; Buckland S.T., 2001, pi; Calvo JH, 2012, B ENTOMOL RES, V102, P692, DOI 10.1017/S0007485312000284; Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535; Clausen PH, 1998, MED VET ENTOMOL, V12, P169, DOI 10.1046/j.1365-2915.1998.00097.x; DILLMANN JSS, 1979, ACTA TROP, V36, P349; Fairbairn H., 1948, Tropical Diseases Bulletin London, V45, P1; GEIGY R, 1971, Acta Tropica, V28, P211; GEIGY R, 1973, Acta Tropica, V30, P12; Geigy R, 1973, ACTA TROP, V30, P50; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; GIBSON G, 1992, PHYSIOL ENTOMOL, V17, P141, DOI 10.1111/j.1365-3032.1992.tb01191.x; GLASGOW JP, 1958, J ANIM ECOL, V27, P59, DOI 10.2307/2174; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; HARGROVE JW, 1995, B ENTOMOL RES, V85, P215, DOI 10.1017/S0007485300034295; HARGROVE JW, 1990, B ENTOMOL RES, V80, P397, DOI 10.1017/S0007485300050653; HARGROVE JW, 1978, B ENTOMOL RES, V68, P607, DOI 10.1017/S0007485300009573; HARGROVE JW, 1995, MED VET ENTOMOL, V9, P109, DOI 10.1111/j.1365-2915.1995.tb00166.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hassan HK, 2003, AM J TROP MED HYG, V69, P641, DOI 10.4269/ajtmh.2003.69.641; HEISCH RB, 1958, BRIT MED J, V2, P1203, DOI 10.1136/bmj.2.5106.1203; IRVIN AD, 1973, VET REC, V93, P200, DOI 10.1136/vr.93.7.200; Jelinek T, 2002, EMERG INFECT DIS, V8, P634, DOI 10.3201/eid0806.010432; Kaare Magai T, 2007, Travel Med Infect Dis, V5, P117, DOI 10.1016/j.tmaid.2006.01.014; Kanga EM, 2011, ORYX, V45, P20, DOI 10.1017/S0030605310000931; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kubi C, 2006, MED VET ENTOMOL, V20, P388, DOI 10.1111/j.1365-2915.2006.00644.x; LAMPREY HF, 1962, J ANIM ECOL, V31, P151, DOI 10.2307/2336; Lardeux F, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-8; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Mduma SAR, 2008, SERENGETI; Meier R, 2016, CLADISTICS, V32, P100, DOI 10.1111/cla.12115; MOLOO S K, 1971, Acta Tropica, V28, P189; Muturi CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017284; Ogutu JO, 2006, J ZOOL, V269, P149, DOI 10.1111/j.1469-7998.2006.00055.x; Ripamonti D, 2002, CLIN INFECT DIS, V34, pE18, DOI 10.1086/338157; ROBSON J, 1972, B WORLD HEALTH ORGAN, V46, P765; ROGERS D, 1973, Acta Tropica, V30, P24; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Simpson JE, 2012, P ROY SOC B-BIOL SCI, V279, P925, DOI 10.1098/rspb.2011.1282; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Sinclair A.R.E., 1979, SERENGETI DYNAMICS E; STAAK C, 1986, TROP MED PARASITOL, V37, P59; Tanzania Wildlife Research Institute, 2010, AER CENS SER EC WET; Thomas L., 2009, DISTANCE 6 0 RELEASE; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torr SJ, 1997, B ENTOMOL RES, V87, P299, DOI 10.1017/S0007485300037251; TORR SJ, 1994, B ENTOMOL RES, V84, P411, DOI 10.1017/S0007485300032545; VALE GA, 1977, B ENTOMOL RES, V67, P635, DOI 10.1017/S0007485300007008; VALE GA, 1974, B ENTOMOL RES, V64, P545, DOI 10.1017/S0007485300035860; VANDERPLANK FL, 1947, ANN TROP MED PARASIT, V41, P365, DOI 10.1080/00034983.1947.11685339; WAAGE J K, 1981, Journal of the Entomological Society of Southern Africa, V44, P351; WEITZ B, 1963, B WORLD HEALTH ORGAN, V28, P711; Welburn SC, 2005, CONSERVATION AND DEVELOPMENT INTERVENTIONS AT THE WILDLIFE/LIVESTOCK INTERFACE, P55; Welburn SC, 2001, LANCET, V358, P2017, DOI 10.1016/S0140-6736(01)07096-9; Welburn S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000347	64	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0161291	10.1371/journal.pone.0161291	http://dx.doi.org/10.1371/journal.pone.0161291			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706167	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000385697200003
J	Blas, J; Abaurrea, T; D'Amico, M; Barcellona, F; Revilla, E; Roman, J; Carrete, M				Blas, Julio; Abaurrea, Teresa; D'Amico, Marcello; Barcellona, Francesca; Revilla, Eloy; Roman, Jacinto; Carrete, Martina			Management-Related Traffic as a Stressor Eliciting Parental Care in a Roadside-Nesting Bird: The European Bee-Eater Merops apiaster	PLOS ONE			English	Article							HUMAN DISTURBANCE; RESPONSES; NETWORKS; BEHAVIOR; IMPACT; COSTS	Traffic is often acknowledged as a threat to biodiversity, but its effects have been mostly studied on roads subjected to high traffic intensity. The impact of lower traffic intensity such as those affecting protected areas is generally neglected, but conservation-oriented activities entailing motorized traffic could paradoxically transform suitable habitats into ecological traps. Here we questioned whether roadside-nesting bee-eaters Merops apiaster perceived low traffic intensity as a stressor eliciting risk-avoidance behaviors (alarm calls and flock flushes) and reducing parental care. Comparisons were established within Donana National Park (Spain), between birds exposed to either negligible traffic (ca. 0-10 vehicles per day) or low traffic intensity (ca. 10-90 vehicles per day) associated to management and research activities. The frequencies of alarm calls and flock flushes were greater in areas of higher traffic intensity, which resulted in direct mortality at moderate vehicle speeds (<= 40 km/h). Parental feeding rates paralleled changes in traffic intensity, but contrary to our predictions. Indeed, feeding rates were highest in traffic-exposed nests, during working days and traffic rush-hours. Traffic-avoidance responses were systematic and likely involved costs (energy expenditure and mortality), but vehicle transit positively influenced the reproductive performance of bee-eaters through an increase of nestling feeding rates. Because the expected outcome of traffic on individual performance can be opposed when responses are monitored during mating (i.e. negative effect by increase of alarm calls and flock flushes) or nestling-feeding period (i.e. at least short-term positive effect by increase of nestling feeding rates), caution should be taken before inferring fitness consequences only from isolated behaviors or specific life history stages.	[Blas, Julio; Abaurrea, Teresa; D'Amico, Marcello; Barcellona, Francesca; Revilla, Eloy; Roman, Jacinto; Carrete, Martina] Estn Biol Donana CSIC, Dept Conservat Biol, Seville 41092, Spain; [Carrete, Martina] Pablo Olavide Univ, Dept Phys Chem & Nat Syst, Ctra Utrera Km 1, Seville 41013, Spain; [Abaurrea, Teresa] Univ St Andrews, Sch Psychol & Neurosci, St Andrews KY16 9JP, Fife, Scotland; [D'Amico, Marcello] Univ Porto, CIBIO InBIO, REN Biodivers Chair, P-1349017 Lisbon, Portugal; [D'Amico, Marcello] Univ Lisbon, CEABN InBIO, P-1349017 Lisbon, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidad Pablo de Olavide; University of St Andrews; Universidade do Porto; Universidade de Lisboa	D'Amico, M (corresponding author), Estn Biol Donana CSIC, Dept Conservat Biol, Seville 41092, Spain.; D'Amico, M (corresponding author), Univ Porto, CIBIO InBIO, REN Biodivers Chair, P-1349017 Lisbon, Portugal.; D'Amico, M (corresponding author), Univ Lisbon, CEABN InBIO, P-1349017 Lisbon, Portugal.	damico@ebd.csic.es	Revilla, Eloy/B-5100-2008; Abaurrea, Teresa/AAJ-6839-2021; Blas, Julio/A-2487-2012; Carrete, Martina/D-2618-2017; D'Amico, Marcello/B-5322-2016; Carrete, Martina/A-6376-2009	Revilla, Eloy/0000-0001-5534-5581; Abaurrea, Teresa/0000-0003-4304-9819; Blas, Julio/0000-0003-0589-3322; D'Amico, Marcello/0000-0002-0573-9184; Carrete, Martina/0000-0002-0491-2950	Ramon y Cajal; JAE-PRE fellowship (Consejo Superior de Investigaciones Cientificas CSIC - Ministerio de Economia y Competitividad MINECO); Ministerio de Economia y Competitividad MINECO - Feder funds [CGL2012-32544]; Organismo Autonomo Parques Nacionales OAPN - Ministerio de Agricultura, Alimentacion y Medio Ambiente MAGRAMA [511/2012]	Ramon y Cajal(Spanish Government); JAE-PRE fellowship (Consejo Superior de Investigaciones Cientificas CSIC - Ministerio de Economia y Competitividad MINECO); Ministerio de Economia y Competitividad MINECO - Feder funds; Organismo Autonomo Parques Nacionales OAPN - Ministerio de Agricultura, Alimentacion y Medio Ambiente MAGRAMA	J.B. and M.G. were supported by Ramon y Cajal contracts and M.D. by a JAE-PRE fellowship (Consejo Superior de Investigaciones Cientificas CSIC - Ministerio de Economia y Competitividad MINECO). We acknowledge grants CGL2012-32544 (Ministerio de Economia y Competitividad MINECO - Feder funds) and 511/2012 (Organismo Autonomo Parques Nacionales OAPN - Ministerio de Agricultura, Alimentacion y Medio Ambiente MAGRAMA).	Alvarez F., 1974, Donana Acta vert, V1, P61; Ardia DR, 2007, CAN J ZOOL, V85, P847, DOI 10.1139/Z07-070; Barton K., 2012, MUMIN MULTIMODEL INF; Baudains TP, 2007, ANIM CONSERV, V10, P400, DOI 10.1111/j.1469-1795.2007.00126.x; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Bennett VJ, 2013, LANDSCAPE ECOL, V28, P979, DOI 10.1007/s10980-013-9874-0; Bergstrom CT, 2001, ANIM BEHAV, V61, P535, DOI 10.1006/anbe.2000.1636; Blumstein DT, 2004, CONSERV BIOL, V18, P1175, DOI 10.1111/j.1523-1739.2004.00587.x; Bolker B., 2012, GETTING STARTED GLMM; BOSWALL J, 1970, Bulletin of the British Ornithologists' Club, V90, P92; Bryant DM, 1988, FUNCT ECOL, V2, P23, DOI 10.2307/2389456; Burnham KP, 2002, MODEL SELECTION MULT, DOI [10.1007/978-1-4757-2917-73, DOI 10.1007/978-1-4757-2917-73]; Cardoni DA, 2008, BIOL CONSERV, V141, P797, DOI 10.1016/j.biocon.2007.12.024; Casas-Criville A, 2005, J ARID ENVIRON, V60, P227, DOI 10.1016/j.jaridenv.2004.03.012; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cramp S., 1985, HDB BIRDS EUROPE MID, VIV; D'Amico M, 2015, BIOL CONSERV, V191, P234, DOI 10.1016/j.biocon.2015.06.010; D'Amico M, 2016, J APPL ECOL, V53, P181, DOI 10.1111/1365-2664.12572; D'Amico Marcello, 2013, Oecologia Australis, V17, P86; DEAN WRJ, 1981, OSTRICH, V52, P135, DOI 10.1080/00306525.1981.9633599; Fajardo Inigo, 1998, Alauda, V66, P49; FERNANDEZJURICIC E, 2003, CONDOR, V105, P316; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Garcia-Novo F, 2006, WATER BIOSPHERE; Gill JA, 1996, J APPL ECOL, V33, P786, DOI 10.2307/2404948; Gonzalez-Gallina A, 2013, BIODIVERS CONSERV, V22, P325, DOI 10.1007/s10531-012-0396-x; Grimwood I., 1964, B BRIT ORNITHOL CLUB, V84, P105; GUTZWILLER KJ, 1994, AUK, V111, P28, DOI 10.2307/4088502; Hanna D, 2011, J EXP BIOL, V214, P3549, DOI 10.1242/jeb.060194; JILKA A, 1980, Egretta, V23, P8; KALAS JA, 1995, AM NAT, V146, P59, DOI 10.1086/285787; Kuitunen MT, 2003, ENVIRON MANAGE, V31, P79, DOI 10.1007/s00267-002-2694-7; McGowan CP, 2006, WILSON J ORNITHOL, V118, P485, DOI 10.1676/05-084.1; Morgan GM, 2010, AUK, V127, P581, DOI 10.1525/auk.2010.09033; Mortensen DA, 2009, INVAS PLANT SCI MANA, V2, P191, DOI 10.1614/IPSM-08-125.1; R Core Team, 2013, R LANG ENV STAT COMP; Rees EC, 2005, BIOL CONSERV, V121, P369, DOI 10.1016/j.biocon.2004.05.009; Roman J, 2010, EVALUACION EFECTOS T; Santos SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025383; Strasser EH, 2013, J APPL ECOL, V50, P912, DOI 10.1111/1365-2664.12103; Teixeira Fernanda Z., 2013, Oecologia Australis, V17, P36; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Valera F, 1758, ENCICLOPEDIA VIRTUAL; VALVERDE J. A., 1958, BRIT BIRDS, V51, P1; Williams R, 2006, BIOL CONSERV, V133, P301, DOI 10.1016/j.biocon.2006.06.010; Yamac E, 2012, EKOLOJI, V21, P1, DOI 10.5053/ekoloji.2012.831; [No title captured]	47	1	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164371	10.1371/journal.pone.0164371	http://dx.doi.org/10.1371/journal.pone.0164371			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706229	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200102
J	Ma, LH; Trinh, T; Ren, YF; Dirksen, RT; Liu, XX				Ma, Lihua; Thu Trinh; Ren, Yanfang; Dirksen, Robert T.; Liu, Xiuxin			Neuronal NTPDase3 Mediates Extracellular ATP Degradation in Trigeminal Nociceptive Pathway	PLOS ONE			English	Article							NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE-3; MEDULLARY DORSAL-HORN; CENTRAL SENSITIZATION; PURINERGIC RECEPTORS; PAIN; ECTONUCLEOTIDASES; NUCLEOTIDES; PHOSPHATASE; EXPRESSION; ADENOSINE	ATP induces pain via activation of purinergic receptors in nociceptive sensory nerves. ATP signaling is terminated by ATP hydrolysis mediated by cell surface-localized ecto-nucleotidases. Using enzymatic histochemical staining, we show that ecto-ATPase activity is present in mouse trigeminal nerves. Using immunofluorescence staining, we found that ecto-NTPDase3 is expressed in trigeminal nociceptive neurons and their projections to the brainstem. In addition, ecto-ATPase activity and ecto-NTPDase3 are also detected in the nociceptive outermost layer of the trigeminal subnucleus caudalis. Furthermore, we demonstrate that incubation with anti-NTPDase3 serum reduces extracellular ATP degradation in the nociceptive lamina of both the trigeminal subnucleus caudalis and the spinal cord dorsal horn. These results are consistent with neuronal NTPDase3 activity modulating pain signal transduction and transmission by affecting extracellular ATP hydrolysis within the trigeminal nociceptive pathway. Thus, disruption of trigeminal neuronal NTPDase3 expression and localization to presynaptic terminals during chronic inflammation, local constriction and injury may contribute to the pathogenesis of orofacial neuropathic pain.	[Ma, Lihua; Thu Trinh; Ren, Yanfang; Liu, Xiuxin] Univ Rochester, Sch Med & Dent, Eastman Inst Oral Hlth, Dept Dent, Rochester, NY 14611 USA; [Ma, Lihua] Zhengzhou Univ, Sch Stomatol, Dept Dent, Zhengzhou, Peoples R China; [Dirksen, Robert T.; Liu, Xiuxin] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14611 USA	University of Rochester; Zhengzhou University; University of Rochester	Liu, XX (corresponding author), Univ Rochester, Sch Med & Dent, Eastman Inst Oral Hlth, Dept Dent, Rochester, NY 14611 USA.; Liu, XX (corresponding author), Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14611 USA.	xiuxin_liu@urmc.rochester.edu	Ren, Yan-Fang/N-9369-2019	Ren, Yan-Fang/0000-0001-6428-2252	University of Rochester Clinical and Translational Science Award from National Center for Advancing Translational Sciences of the National Institutes of Health [KL2 TR000095]; National Institutes of Health [AR059646]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059646] Funding Source: NIH RePORTER	University of Rochester Clinical and Translational Science Award from National Center for Advancing Translational Sciences of the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by a University of Rochester Clinical and Translational Science Award from the National Center for Advancing Translational Sciences of the National Institutes of Health (KL2 TR000095 to X.L.) and a research grant from the National Institutes of Health (AR059646 to R.T.D.) The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambalavanar R, 2005, PAIN, V117, P280, DOI 10.1016/j.pain.2005.06.029; Aoyama R, 2011, PAIN, V152, P2085, DOI 10.1016/j.pain.2011.05.014; Bae JY, 2015, J COMP NEUROL, V523, P126, DOI 10.1002/cne.23672; Belcher SM, 2006, NEUROSCIENCE, V137, P1331, DOI 10.1016/j.neuroscience.2005.08.086; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Cardoso AM, 2015, AUTON NEUROSCI-BASIC, V191, P25, DOI 10.1016/j.autneu.2015.04.014; Cherkas PS, 2012, NEUROSCI LETT, V526, P160, DOI 10.1016/j.neulet.2012.08.007; Donnelly-Roberts D, 2008, J PHARMACOL EXP THER, V324, P409, DOI 10.1124/jpet.106.105890; Fabbretti E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00236; Fausther M, 2012, AM J PHYSIOL-GASTR L, V302, pG447, DOI [10.1152/ajpgi.00165.2011., 10.1152/ajpgi.00165.2011]; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Hamilton Sara G, 2002, Pain Pract, V2, P289, DOI 10.1046/j.1533-2500.2002.02041.x; Hamilton SG, 2000, J AUTONOM NERV SYST, V81, P187, DOI 10.1016/S0165-1838(00)00137-5; Itoh K, 2011, NEUROSCIENCE, V192, P721, DOI 10.1016/j.neuroscience.2011.06.083; Jarvis MF, 2010, TRENDS NEUROSCI, V33, P48, DOI 10.1016/j.tins.2009.10.003; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Kukulski F, 2011, ADV PHARMACOL, V61, P263, DOI 10.1016/B978-0-12-385526-8.00009-6; Langer D, 2007, NEUROSCIENCE, V150, P863, DOI 10.1016/j.neuroscience.2007.07.064; Li N, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-21; Liu X, 2015, J DENT RES, V94, P1259, DOI 10.1177/0022034515592858; Liu X, 2012, J DENT RES, V91, P261, DOI 10.1177/0022034511431582; Martin-Satue M, 2009, HISTOCHEM CELL BIOL, V131, P615, DOI 10.1007/s00418-008-0551-3; McCoy Eric, 2014, F1000Res, V3, P163, DOI 10.12688/f1000research.4563.2; Pankratov Y, 2006, PFLUG ARCH EUR J PHY, V452, P589, DOI 10.1007/s00424-006-0061-x; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Sowa NA, 2010, J NEUROSCI, V30, P10282, DOI 10.1523/JNEUROSCI.2162-10.2010; Street SE, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-80; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Vongtau HO, 2011, NEUROSCIENCE, V193, P387, DOI 10.1016/j.neuroscience.2011.07.044; Wink MR, 2006, NEUROSCIENCE, V138, P421, DOI 10.1016/j.neuroscience.2005.11.039; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Zimmermann H, 1996, J AUTON PHARMACOL, V16, P397, DOI 10.1111/j.1474-8673.1996.tb00062.x	35	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164028	10.1371/journal.pone.0164028	http://dx.doi.org/10.1371/journal.pone.0164028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706204	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200075
J	Mittnik, A; Wang, CC; Svoboda, J; Krause, J				Mittnik, Alissa; Wang, Chuan-Chao; Svoboda, Jiri; Krause, Johannes			A Molecular Approach to the Sexing of the Triple Burial at the Upper Paleolithic Site of Dolni Vestonice	PLOS ONE			English	Article							ANCIENT DNA	In the past decades ancient DNA research has brought numerous insights to archaeological research where traditional approaches were limited. The determination of sex in human skeletal remains is often challenging for physical anthropologists when dealing with incomplete, juvenile or pathological specimens. Molecular approaches allow sexing on the basis of sex-specific markers or by calculating the ratio of DNA derived from different chromosomes. Here we propose a novel approach that relies on the ratio of X chromosome-derived shotgun sequencing data to the autosomal coverage, thus establishing the probability of an XX or XY karyotype. Applying this approach to the individuals of the Upper Paleolithic triple burial of Dolni Vestonice reveals that all three skeletons, including the individual DV 15, whose sex has long been debated due to a pathological condition, were male.	[Mittnik, Alissa; Krause, Johannes] Max Planck Inst Sci Human Hist, D-07745 Jena, Germany; [Mittnik, Alissa; Wang, Chuan-Chao; Krause, Johannes] Univ Tubingen, Inst Archeol Sci, D-72070 Tubingen, Germany; [Wang, Chuan-Chao] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Svoboda, Jiri] Masaryk Univ, Fac Sci, Dept Anthropol, CS-61137 Brno, Czech Republic; [Svoboda, Jiri] Acad Sci Czech Republ, Inst Archaeol, Dolni Vestonice 69129, Czech Republic	Eberhard Karls University of Tubingen; Harvard University; Harvard Medical School; Masaryk University Brno; Czech Academy of Sciences; Institute of Archaeology of the Czech Academy of Sciences - Brno	Mittnik, A (corresponding author), Max Planck Inst Sci Human Hist, D-07745 Jena, Germany.; Mittnik, A (corresponding author), Univ Tubingen, Inst Archeol Sci, D-72070 Tubingen, Germany.	mittnik@shh.mpg.de	Svoboda, Jiří/H-4621-2014; Krause, Johannes/AFP-2642-2022; Wang, Chuan-Chao/B-2975-2011; Wang, Chuan-Chao/AGY-2940-2022	Svoboda, Jiří/0000-0003-4256-9708; Krause, Johannes/0000-0001-9144-3920; Wang, Chuan-Chao/0000-0001-9628-0307; Wang, Chuan-Chao/0000-0003-4630-5232	Deutsche Forschungsgemeinschaft [KR 4015/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by the Deutsche Forschungsgemeinschaft (KR 4015/1-1 to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Alt KW, 1997, AM J PHYS ANTHROPOL, V102, P123, DOI 10.1002/(SICI)1096-8644(199701)102:1<123::AID-AJPA10>3.0.CO;2-2; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aughton DJ, 2003, AM J MED GENET A, V116A, P255, DOI 10.1002/ajmg.a.10852; Bruzek J, 2006, EARLY MODERN HUMAN E, P46; Cerny Milan, 1992, Sbornik Narodniho Muzea v Praze Rada B Prirodni Vedy, V48, P130; Daskalaki E, 2011, J ARCHAEOL SCI, V38, P1326, DOI 10.1016/j.jas.2011.01.009; Formicola V, 2001, AM J PHYS ANTHROPOL, V115, P372, DOI 10.1002/ajpa.1093; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Gibbon V, 2009, FORENSIC SCI INT-GEN, V3, P74, DOI 10.1016/j.fsigen.2008.10.007; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Green RE, 2009, EMBO J, V28, P2494, DOI 10.1038/emboj.2009.222; HUMMEL S, 1991, NATURWISSENSCHAFTEN, V78, P266, DOI 10.1007/BF01134353; Jelinek J., 1992, AVENTURE HUMAINE 500, V56, P207; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; KLIMA B, 1987, J HUM EVOL, V16, P831, DOI 10.1016/0047-2484(87)90027-3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Milunsky JM, 2003, AM J MED GENET A, V116A, P249, DOI 10.1002/ajmg.a.10849; Novotny V., 1992, SBORNIK NARODNIHO B, V48, P152; Peltzer A, EAGER EFFIC IN PRESS, P700, DOI [10.1073/pnas.1519905112, DOI 10.1073/PNAS.1519905112]; Quincey D, 2013, SCI JUSTICE, V53, P253, DOI 10.1016/j.scijus.2013.04.003; Rivollat M, 2014, INT J PALEOPATHOL, V7, P8, DOI 10.1016/j.ijpp.2014.05.004; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Sawyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034131; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Sladek V., 2000, SKELETAL CATALOGUE O; Svoboda JA, 2006, EARLY MODERN HUMANS AT THE MORAVIAN GATE: THE MLADEC CAVES AND THEIR REMAINS, P27, DOI 10.1007/978-3-211-49294-9_3; Vlcek E, 1991, MAMMUTJAGER DOLNI VE, P22	34	52	53	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163019	10.1371/journal.pone.0163019	http://dx.doi.org/10.1371/journal.pone.0163019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706187	gold, Green Submitted, Green Published			2022-12-27	WOS:000385697200030
J	Poynard, T; Pham, T; Perazzo, H; Munteanu, M; Luckina, E; Elaribi, D; Ngo, Y; Bonyhay, L; Seurat, N; Legroux, M; Ngo, A; Deckmyn, O; Thabut, D; Ratziu, V; Lucidarme, O				Poynard, Thierry; Tam Pham; Perazzo, Hugo; Munteanu, Mona; Luckina, Elena; Elaribi, Djamel; Ngo, Yen; Bonyhay, Luminita; Seurat, Noemie; Legroux, Muriel; An Ngo; Deckmyn, Olivier; Thabut, Dominique; Ratziu, Vlad; Lucidarme, Olivier		FIBROFRANCE-HECAM	Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; LIVER STIFFNESS MEASUREMENT; DIAGNOSTIC PERFORMANCE; SAMPLING VARIABILITY; 7 CATEGORIES; FIBROTEST; BIOPSY	Background and Aims Real-time shear wave elastography (2D-SWE) is a two-dimensional transient elastography and a competitor as a biomarker of liver fibrosis in comparison with the standard reference transient elastography by Mprobe (TE-M). The aims were to compare several criteria of applicability, and to assess inflammation and steatosis impact on elasticity values, two unmet needs. Methods We took FibroTest as the fibrosis reference and ActiTest and SteatoTest as quantitative estimates of inflammation and steatosis. After standardization of estimates, analyses used curve fitting, quantitative Lin concordance coefficient [LCC], and multivariate logistic regression. Results A total of 2,251 consecutive patients were included. We validated the predetermined 0.2 kPa cut-off as a too low minimal elasticity value identifying not-reliable 2D-SWE results (LCC with FibroTest = 0.0281[-0.119; 0.175]. Other criteria, elasticity CV, body mass index and depth of measures were not sufficiently discriminant. The applicability of 2D-SWE (95% CI) 89.6%(88.2-90.8), was significantly higher than that of TE, 85.6%(84.0-87.0; P<0.0001). In patients with non-advanced fibrosis (METAVIR F0F1F2), elasticity values estimated by 2D-SWE was less impacted by inflammation and steatosis than elasticity value estimated by TE-M: LCC (95% CI) 0.039 (0.021; 0.058) vs 0.090 (0.068; 0.112; P<0.01) and 0.105 (0.068; 0.141) vs 0.192 (0.153; 0.230; P<0.01) respectively. The three analyses methods gave similar results. Conclusions Elasticity results including very low minimal signal in the region of interest should be considered not reliable. 2D-SWE had a higher applicability than TE, the reference elastography, with less impact of inflammation and steatosis especially in patients with non-advanced fibrosis, as presumed by blood tests.	[Poynard, Thierry; Tam Pham; Perazzo, Hugo; Luckina, Elena; Elaribi, Djamel; Bonyhay, Luminita; Seurat, Noemie; Legroux, Muriel; Thabut, Dominique; Ratziu, Vlad] APHP UPMC Liver Ctr, Hepatogastroenterol, Paris, France; [Poynard, Thierry] INSERM, UMR S938, Paris, France; [Munteanu, Mona; Ngo, Yen; An Ngo; Deckmyn, Olivier] BioPredictive, Hepatol Res Unit, Paris, France; [Lucidarme, Olivier] APHP UPMC Liver Ctr, Radiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite	Poynard, T (corresponding author), APHP UPMC Liver Ctr, Hepatogastroenterol, Paris, France.; Poynard, T (corresponding author), INSERM, UMR S938, Paris, France.	thierry@poynard.com	Poynard, Thierry/C-1355-2010; Lucidarme, Olivier/CAF-8228-2022	Poynard, Thierry/0000-0002-3726-7230; Lucidarme, Olivier/0000-0003-0893-3764; Deckmyn, Olivier/0000-0002-1589-9368; Perazzo, Hugo/0000-0003-0931-6418; Ratziu, Vlad/0000-0002-6865-3791; Munteanu, Mona/0000-0003-4517-2757	HECAM; "Association Pour la Recherche sur les Maladies Virales et Hepatiques"(ARMHV)	HECAM; "Association Pour la Recherche sur les Maladies Virales et Hepatiques"(ARMHV)	This work was funded in part by HECAM (HEpatocellular CArcinoma Multi-technological consortium grant number and "Association Pour la Recherche sur les Maladies Virales et Hepatiques"(ARMHV). MM, OD, AN and YN are BioPredictive employees. BioPredictive did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries.	[Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Castera L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425; Chung JH, 2013, CLIN MOL HEPATOL, V19, P156, DOI 10.3350/cmh.2013.19.2.156; de Ledinghen V, 2016, J GASTROEN HEPATOL, V31, P848, DOI 10.1111/jgh.13219; de Ledinghen V, 2012, J HEPATOL, V56, P833, DOI 10.1016/j.jhep.2011.10.017; Elkrief L, 2015, RADIOLOGY, V275, P589, DOI 10.1148/radiol.14141210; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Friedrich-Rust M, 2016, NAT REV GASTRO HEPAT, V13, P402, DOI 10.1038/nrgastro.2016.86; Hintze J, 2003, NCSS 2013 LCC; Houot M, 2016, ALIMENT PHARM THER, V43, P16, DOI 10.1111/apt.13446; Macaluso FS, 2014, J HEPATOL, V61, P523, DOI 10.1016/j.jhep.2014.04.045; Muller M, 2009, ULTRASOUND MED BIOL, V35, P219, DOI 10.1016/j.ultrasmedbio.2008.08.018; Munteanu M, 2016, ALIMENT PHARM THER, V44, P877, DOI 10.1111/apt.13770; Pellot-Barakat C, 2015, ULTRASOUND MED BIOL, V41, P936, DOI 10.1016/j.ultrasmedbio.2014.11.010; Poynard T, 2010, GASTROEN CLIN BIOL, V34, P388, DOI 10.1016/j.gcb.2010.05.001; Poynard T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-010017; Poynard Thierry, 2005, Comp Hepatol, V4, P10; Poynard T, 2014, J HEPATOL, V61, P994, DOI 10.1016/j.jhep.2014.06.027; Poynard T, 2014, J HEPATOL, V60, P706, DOI 10.1016/j.jhep.2013.11.016; Poynard T, 2013, J HEPATOL, V58, P928, DOI 10.1016/j.jhep.2012.12.021; Poynard T, 2012, J HEPATOL, V57, P541, DOI 10.1016/j.jhep.2012.04.025; Poynard T, 2012, J HEPATOL, V56, P541, DOI 10.1016/j.jhep.2011.08.007; Poynard T, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-39; Poynard T, 2011, J HEPATOL, V54, P227, DOI 10.1016/j.jhep.2010.06.038; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Schuetz GM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6717; Sporea I, 2013, MED ULTRASON, V15, P268; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	30	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163276	10.1371/journal.pone.0163276	http://dx.doi.org/10.1371/journal.pone.0163276			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706177	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200037
J	Shen, W; Le, S; Li, Y; Hu, FQ				Shen, Wei; Le, Shuai; Li, Yan; Hu, Fuquan			SeqKit: A Cross-Platform and Ultrafast Toolkit for FASTA/Q File Manipulation	PLOS ONE			English	Article							FORMAT	FASTA and FASTQ are basic and ubiquitous formats for storing nucleotide and protein sequences. Common manipulations of FASTA/Q file include converting, searching, filtering, deduplication, splitting, shuffling, and sampling. Existing tools only implement some of these manipulations, and not particularly efficiently, and some are only available for certain operating systems. Furthermore, the complicated installation process of required packages and running environments can render these programs less user friendly. This paper describes a cross-platform ultrafast comprehensive toolkit for FASTA/Q processing. SeqKit provides executable binary files for all major operating systems, including Windows, Linux, and Mac OSX, and can be directly used without any dependencies or pre-configurations. SeqKit demonstrates competitive performance in execution time and memory usage compared to similar tools. The efficiency and usability of SeqKit enable researchers to rapidly accomplish common FASTA/Q file manipulations. SeqKit is open source and available on Githubathttps://github.com/shenwei356/seqkit.	[Shen, Wei; Le, Shuai; Hu, Fuquan] Third Mil Med Univ, Coll Basic Med Sci, Dept Microbiol, 30 Gaotanyan St, Chongqing, Peoples R China; [Li, Yan] Third Mil Med Univ, Southwest Hosp, Med Res Ctr, 29 Gaotanyan St, Chongqing, Peoples R China	Army Medical University; Army Medical University	Hu, FQ (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Microbiol, 30 Gaotanyan St, Chongqing, Peoples R China.; Li, Y (corresponding author), Third Mil Med Univ, Southwest Hosp, Med Res Ctr, 29 Gaotanyan St, Chongqing, Peoples R China.	liyan.com@gmail.com; hufuquan2009@aliyun.com	Shen, Wei/AFL-4859-2022	Shen, Wei/0000-0002-8099-8258; Li, Yan/0000-0002-2091-7313; Le, Shuai/0000-0003-3748-5454	National Natural Science Foundation of China [81373133, 31570173]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant No. 81373133 to YL and No. 31570173 to FH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Hester J., COLLECTION SCRIPTS D; Kortschak RD, 2015, BIOGO SIMPLE HIGH PE; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Shen W, 2016, SCI REP-UK, V6, DOI 10.1038/srep30425; SHIRLEY MD, 2015, PEERJ PREPRINTS, V3, pE1196, DOI DOI 10.7717/PEERJ.1196	8	542	547	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163962	10.1371/journal.pone.0163962	http://dx.doi.org/10.1371/journal.pone.0163962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706213	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200071
J	Bener, AB; Caglayan, B; Henry, AD; Pralat, P				Bener, Ayse Baser; Caglayan, Bora; Henry, Adam Douglas; Pralat, Pawel			Empirical Models of Social Learning in a Large, Evolving Network	PLOS ONE			English	Article							BIASED ASSIMILATION; ATTITUDE POLARIZATION; EMERGENCE; DIFFUSION; SEGREGATION; STRATEGIES; CHALLENGE; SELECTION; DYNAMICS; INSIGHTS	This paper advances theories of social learning through an empirical examination of how social networks change over time. Social networks are important for learning because they constrain individuals' access to information about the behaviors and cognitions of other people. Using data on a large social network of mobile device users over a one-month time period, we test three hypotheses: 1) attraction homophily causes individuals to form ties on the basis of attribute similarity, 2) aversion homophily causes individuals to delete existing ties on the basis of attribute dissimilarity, and 3) social influence causes individuals to adopt the attributes of others they share direct ties with. Statistical models offer varied degrees of support for all three hypotheses and show that these mechanisms are more complex than assumed in prior work. Although homophily is normally thought of as a process of attraction, people also avoid relationships with others who are different. These mechanisms have distinct effects on network structure. While social influence does help explain behavior, people tend to follow global trends more than they follow their friends.	[Bener, Ayse Baser; Caglayan, Bora] Ryerson Univ, Data Sci Lab, Toronto, ON, Canada; [Henry, Adam Douglas] Univ Arizona, Sch Govt & Publ Policy, Tucson, AZ 85721 USA; [Pralat, Pawel] Ryerson Univ, Dept Math, Toronto, ON, Canada	Toronto Metropolitan University; University of Arizona; Toronto Metropolitan University	Henry, AD (corresponding author), Univ Arizona, Sch Govt & Publ Policy, Tucson, AZ 85721 USA.	adhenry@mail.arizona.edu	Basar, Ayse/ABF-9265-2020	Basar, Ayse/0000-0003-4934-8326				Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Aiello W, 2008, INTERNET MATH, V5, P175, DOI 10.1080/15427951.2008.10129305; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berry F.S., 2007, THEORIES POLICY PROC, P223; Bidwell D, 2013, NAT CLIM CHANGE, V3, P610, DOI 10.1038/nclimate1931; Blondel VD, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0046-0; Boardman JD, 2012, P NATL ACAD SCI USA, V109, P17377, DOI 10.1073/pnas.1208975109; Bollinger B, 2012, MARKET SCI, V31, P900, DOI 10.1287/mksc.1120.0727; Boucher V, 2015, INT ECON REV, V56, P235, DOI 10.1111/iere.12101; Bramoulle Y, 2012, J ECON THEORY, V147, P1754, DOI 10.1016/j.jet.2012.05.007; Burt RS, 2000, RES ORGAN BEHAV, V22, P345, DOI 10.1016/S0191-3085(00)22009-1; Calabrese F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020814; Gonzalez-Avella JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020207; Carpenter DP, 2004, J POLIT, V66, P224, DOI 10.1046/j.1468-2508.2004.00149.x; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; Currarini S, 2010, P NATL ACAD SCI USA, V107, P4857, DOI 10.1073/pnas.0911793107; Currarini S, 2009, ECONOMETRICA, V77, P1003, DOI 10.3982/ECTA7528; D'Souza RM, 2007, P NATL ACAD SCI USA, V104, P6112, DOI 10.1073/pnas.0606779104; Dandekar P, 2013, P NATL ACAD SCI USA, V110, P5791, DOI 10.1073/pnas.1217220110; DEGROOT MH, 1974, J AM STAT ASSOC, V69, P118, DOI 10.2307/2285509; Dietz T, 2009, INTRO SOCIAL STAT LO; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Easley D, 2010, NETWORKS CROWDS MARK; Feiock RC, 2013, POLICY STUD J, V41, P397, DOI 10.1111/psj.12023; Feldman MW, 1996, ANTHROPOL SCI, V104, P209, DOI 10.1537/ase.104.209; Ferrara E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142390; Friedkin N. E., 2011, SOCIAL INFLUENCE NET, DOI [10.1017/CBO9780511976735, DOI 10.1017/CBO9780511976735]; Friedkin NE, 2001, SOC NETWORKS, V23, P167, DOI 10.1016/S0378-8733(01)00036-3; Friedkin NE, 1997, SOC NETWORKS, V19, P209, DOI 10.1016/S0378-8733(96)00298-5; Gerber ER, 2013, AM J POLIT SCI, V57, P598, DOI 10.1111/ajps.12011; Gerlak AK, 2011, J PUBL ADM RES THEOR, V21, P619, DOI 10.1093/jopart/muq089; Gillespie BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128900; Girard Y, 2015, J ECON BEHAV ORGAN, V115, P197, DOI 10.1016/j.jebo.2014.12.005; Henry AD, 2013, INTERNET MATH, V9, P33, DOI 10.1080/15427951.2012.678157; Henry AD, 2016, NETW SCI, V4, P81, DOI 10.1017/nws.2016.1; Henry AD, 2014, ANNU REV ENV RESOUR, V39, P583, DOI 10.1146/annurev-environ-101813-013246; Henry AD, 2014, J COMP POLICY ANAL, V16, P299, DOI 10.1080/13876988.2014.941200; Henry AD, 2011, POLICY STUD J, V39, P361, DOI 10.1111/j.1541-0072.2011.00413.x; Henry AD, 2011, P NATL ACAD SCI USA, V108, P8605, DOI 10.1073/pnas.1014486108; Henry AD, 2009, HUM ECOL REV, V16, P131; Ingold K, 2014, GLOBAL ENVIRON CHANG, V24, P88, DOI 10.1016/j.gloenvcha.2013.11.021; INNES JM, 1978, J SOC PSYCHOL, V106, P261, DOI 10.1080/00224545.1978.9924177; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Ji L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121105; Jones JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052168; KANDEL DB, 1978, AM J SOCIOL, V84, P427, DOI 10.1086/226792; Kendal RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006541; Kleinbaum AM, 2013, ORGAN SCI, V24, P1316, DOI 10.1287/orsc.1120.0804; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Kossinets G, 2009, AM J SOCIOL, V115, P405, DOI 10.1086/599247; Krackhardt D, 1999, RES SOC ORG, V16, P183; Lazer D, 2001, J MATH SOCIOL, V25, P69, DOI 10.1080/0022250X.2001.9990245; Leach WD, 2005, AM POLIT SCI REV, V99, P491, DOI 10.1017/S000305540505183X; Liu H, 2007, J COMPUT-MEDIAT COMM, V13, P252, DOI 10.1111/j.1083-6101.2007.00395.x; LORD CG, 1979, J PERS SOC PSYCHOL, V37, P2098, DOI 10.1037/0022-3514.37.11.2098; Mas M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000959; MARSDEN PV, 1993, SOCIOL METHOD RES, V22, P127, DOI 10.1177/0049124193022001006; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mesoudi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007252; Munro GD, 1997, PERS SOC PSYCHOL B, V23, P636, DOI 10.1177/0146167297236007; O'Neill HM, 1998, ACAD MANAGE REV, V23, P98, DOI 10.2307/259101; Olsson A, 2007, NAT NEUROSCI, V10, P1095, DOI 10.1038/nn1968; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Parson E. A., 2005, BARRIERS BRIDGES REN, P428; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Sabatier P. A., 1993, POLICY CHANGE LEARNI; Sandberg J, 2012, SOC NETWORKS, V34, P264, DOI 10.1016/j.socnet.2012.01.001; Saramaki J, 2014, P NATL ACAD SCI USA, V111, P942, DOI 10.1073/pnas.1308540110; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Snijders TAB, 2006, SOCIOL METHODOL, V36, P99, DOI 10.1111/j.1467-9531.2006.00176.x; Stehle J, 2013, SOC NETWORKS, V35, P604, DOI 10.1016/j.socnet.2013.08.003; Weible CM, 2005, POLICY STUD J, V33, P181, DOI 10.1111/j.1541-0072.2005.00101.x; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	77	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0160307	10.1371/journal.pone.0160307	http://dx.doi.org/10.1371/journal.pone.0160307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701430	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900001
J	Yamada, H; Yaguchi, H; Tomatsu, S; Takei, T; Oya, T; Seki, K				Yamada, Hiroshi; Yaguchi, Hiroaki; Tomatsu, Saeka; Takei, Tomohiko; Oya, Tomomichi; Seki, Kazuhiko			Representation of Afferent Signals from Forearm Muscle and Cutaneous Nerves in the Primary Somatosensory Cortex of the Macaque Monkey	PLOS ONE			English	Article							LOW-THRESHOLD MUSCLE; PRIMARY MOTOR CORTEX; PYRAMIDAL CELL STRUCTURE; CORTICAL AREA 3A; CEREBRAL-CORTEX; HUMAN HAND; PROPRIOCEPTIVE REPRESENTATION; INTRACELLULAR INJECTION; CINGULATE GYRUS; SENSORY INPUTS	Proprioception is one's overall sense of the relative positions and movements of the various parts of one's body. The primary somatosensory cortex (SI) is involved in generating the proprioception by receiving peripheral sensory inputs from both cutaneous and muscle afferents. In particular, area 3a receives input from muscle afferents and areas 3b and 1 from cutaneous afferents. However, segregation of two sensory inputs to these cortical areas has not been evaluated quantitatively because of methodological difficulties in distinguishing the incoming signals. To overcome this, we applied electrical stimulation separately to two forearm nerves innervating muscle (deep radial nerve) and skin (superficial radial nerve), and examined the spatiotemporal distribution of sensory evoked potentials (SEPs) in SI of anaesthetized macaques. The SEPs arising from the deep radial nerve were observed exclusively at the bottom of central sulcus (CS), which was identified as area 3a using histological reconstruction. In contrast, SEPs evoked by stimulation of the superficial radial nerve were observed in the superficial part of SI, identified as areas 3b and 1. In addition to these earlier, larger potentials, we also found small and slightly delayed SEPs evoked by cutaneous nerve stimulation in area 3a. Coexistence of the SEPs from both deep and superficial radial nerves suggests that area 3a could integrate muscle and cutaneous signals to shape proprioception.	[Yamada, Hiroshi; Yaguchi, Hiroaki; Tomatsu, Saeka; Takei, Tomohiko; Oya, Tomomichi; Seki, Kazuhiko] Natl Ctr Neurol & Psychiat, Dept Neurophysiol, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan; [Yamada, Hiroshi] Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki 3058577, Japan; [Yamada, Hiroshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; [Seki, Kazuhiko] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	National Center for Neurology & Psychiatry - Japan; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST)	Seki, K (corresponding author), Natl Ctr Neurol & Psychiat, Dept Neurophysiol, Natl Inst Neurosci, Kodaira, Tokyo 1878502, Japan.; Seki, K (corresponding author), Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan.	seki@ncnp.go.jp	Takei, Tomohiko/F-1384-2010; Yamada, Hiroshi/V-7433-2018	Takei, Tomohiko/0000-0002-6429-5798; hu song, cai hua/0000-0001-6542-980X; Yamada, Hiroshi/0000-0001-8155-8847; Seki, Kazuhiko/0000-0002-4262-9590	Grants-in-Aid for Scientific Research [26250013] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ASANUMA H, 1982, J NEUROPHYSIOL, V48, P1048, DOI 10.1152/jn.1982.48.4.1048; AVENDANO C, 1992, J COMP NEUROL, V321, P373, DOI 10.1002/cne.903210306; BURKE D, 1988, J PHYSIOL-LONDON, V402, P347, DOI 10.1113/jphysiol.1988.sp017208; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; CAMPBELL JN, 1979, J NEUROPHYSIOL, V42, P1669, DOI 10.1152/jn.1979.42.6.1669; Collins DF, 1996, J PHYSIOL-LONDON, V496, P857, DOI 10.1113/jphysiol.1996.sp021733; Collins DF, 2000, J PHYSIOL-LONDON, V529, P505, DOI 10.1111/j.1469-7793.2000.00505.x; EDIN BB, 1995, J PHYSIOL-LONDON, V487, P243, DOI 10.1113/jphysiol.1995.sp020875; EDIN BB, 1992, J NEUROPHYSIOL, V67, P1105, DOI 10.1152/jn.1992.67.5.1105; Edin BB, 2001, J PHYSIOL-LONDON, V531, P289, DOI 10.1111/j.1469-7793.2001.0289j.x; EDIN BB, 1991, J NEUROPHYSIOL, V65, P657, DOI 10.1152/jn.1991.65.3.657; Elston GN, 2005, EXP BRAIN RES, V167, P315, DOI 10.1007/s00221-005-0043-9; Elston GN, 2005, NEUROSCI LETT, V387, P130, DOI 10.1016/j.neulet.2005.06.010; FRIEDMAN DP, 1981, J NEUROPHYSIOL, V45, P59, DOI 10.1152/jn.1981.45.1.59; GANDEVIA SC, 1985, BRAIN, V108, P965, DOI 10.1093/brain/108.4.965; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; GOODWN GM, 1972, J PHYSIOL-LONDON, V221, pP8; GORDON J, 1995, J NEUROPHYSIOL, V73, P347, DOI 10.1152/jn.1995.73.1.347; HEATH CJ, 1976, J PHYSIOL-LONDON, V257, P199, DOI 10.1113/jphysiol.1976.sp011364; HUERTA MF, 1990, BRAIN RES, V537, P367, DOI 10.1016/0006-8993(90)90388-R; Huffman KJ, 2001, CEREB CORTEX, V11, P849, DOI 10.1093/cercor/11.9.849; HULLIGER M, 1979, J PHYSIOL-LONDON, V291, P233, DOI 10.1113/jphysiol.1979.sp012809; JONES EG, 1980, BRAIN RES REV, V2, P1, DOI 10.1016/0165-0173(80)90002-8; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; JONES EG, 1979, J COMP NEUROL, V183, P833, DOI 10.1002/cne.901830410; Jorntell H, 2014, NEURON, V83, P1444, DOI 10.1016/j.neuron.2014.07.038; KAAS JH, 1983, PHYSIOL REV, V63, P206, DOI 10.1152/physrev.1983.63.1.206; KANG R, 1985, EXP BRAIN RES, V57, P271; Kim SS, 2015, NEURON, V86, P555, DOI 10.1016/j.neuron.2015.03.020; LUCIER GE, 1975, J PHYSIOL-LONDON, V251, P833, DOI 10.1113/jphysiol.1975.sp011125; MACGILLIS M, 1983, BRAIN RES, V276, P329, DOI 10.1016/0006-8993(83)90741-2; Moscatelli A, 2016, CURR BIOL, V26, P1159, DOI 10.1016/j.cub.2016.02.052; Mountcastle V. B., 2005, SENSORY HAND NEURAL; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; OSCARSSON O, 1966, J PHYSIOL-LONDON, V182, P164, DOI 10.1113/jphysiol.1966.sp007816; PHILLIPS CG, 1971, J PHYSIOL-LONDON, V217, P419, DOI 10.1113/jphysiol.1971.sp009579; PONS TP, 1992, J NEUROPHYSIOL, V68, P518, DOI 10.1152/jn.1992.68.2.518; Pruszynski JA, 2014, NAT NEUROSCI, V17, P1404, DOI 10.1038/nn.3804; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; SANES JN, 1984, P NATL ACAD SCI-BIOL, V81, P979, DOI 10.1073/pnas.81.3.979; Seki K, 2012, J NEUROSCI, V32, P890, DOI 10.1523/JNEUROSCI.4958-11.2012; TANJI J, 1975, BRAIN RES, V88, P549, DOI 10.1016/0006-8993(75)90669-1; TANJI J, 1976, BRAIN RES, V115, P328, DOI 10.1016/0006-8993(76)90518-7; van den Broeke EN, 2016, J PHYSIOL-LONDON, V594, P6767, DOI 10.1113/JP272599; Wang XL, 2007, NAT NEUROSCI, V10, P640, DOI 10.1038/nn1878; Weerakkody NS, 2007, J PHYSIOL-LONDON, V581, P971, DOI 10.1113/jphysiol.2006.126854; WISE SP, 1981, J NEUROPHYSIOL, V45, P482, DOI 10.1152/jn.1981.45.3.482; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; Xu YX, 2011, J NEUROPHYSIOL, V106, P71, DOI 10.1152/jn.00668.2010; YUMIYA H, 1974, BRAIN RES, V78, P169, DOI 10.1016/0006-8993(74)90544-7; ZARZECKI P, 1978, EXP BRAIN RES, V33, P269; ZARZECKI P, 1982, EXP BRAIN RES, V48, P28; Zhang MS, 2008, PROG BRAIN RES, V171, P37, DOI 10.1016/S0079-6123(08)00606-7	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163948	10.1371/journal.pone.0163948	http://dx.doi.org/10.1371/journal.pone.0163948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701434	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900037
J	Banai, B; Perin, V				Banai, Benjamin; Perin, Visnja			Type of High School Predicts Academic Performance at University Better than Individual Differences	PLOS ONE			English	Article							TYPICAL INTELLECTUAL ENGAGEMENT; PERSONALITY-TRAITS; COGNITIVE-ABILITY; GENERAL KNOWLEDGE; COLLEGE-STUDENTS; HIGHER-EDUCATION; INTELLIGENCE; ACHIEVEMENT; SUCCESS; METAANALYSIS	Psychological correlates of academic performance have always been of high relevance to psychological research. The relation between psychometric intelligence and academic performance is one of the most consistent and well-established findings in psychology. It is hypothesized that intelligence puts a limit on what an individual can learn or achieve. Moreover, a growing body of literature indicates a relationship between personality traits and academic performance. This relationship helps us to better understand how an individual will learn or achieve their goals. The aim of this study is to further investigate the relationship between psychological correlates of academic performance by exploring the potentially moderating role of prior education. The participants in this study differed in the type of high school they attended. They went either to gymnasium, a general education type of high school that prepares students specifically for university studies, or to vocational school, which prepares students both for the labour market and for further studies. In this study, we used archival data of psychological testing during career guidance in the final year of high school, and information about the university graduation of those who received guidance. The psychological measures included intelligence, personality and general knowledge. The results show that gymnasium students had greater chances of performing well at university, and that this relationship exceeds the contribution of intelligence and personality traits to university graduation. Moreover, psychological measures did not interact with type of high school, which indicates that students from different school types do not profit from certain individual characteristics.	[Perin, Visnja] Zadar Reg Off, Croatian Employment Serv, Zadar, Croatia		Perin, V (corresponding author), Zadar Reg Off, Croatian Employment Serv, Zadar, Croatia.	benjamin.banai@gmail.com		Perin, Visnja/0000-0001-7583-6169				Ackerman PL, 1997, PSYCHOL BULL, V121, P219, DOI 10.1037/0033-2909.121.2.219; Aluja-Fabregat A, 1998, PERS INDIV DIFFER, V25, P973, DOI 10.1016/S0191-8869(98)00122-6; [Anonymous], 1985, PERSONALITY INDIVIDU, DOI 13877; Binet A., 1916, DEV INTELLIGENCE CHI; Binet Alfred., 1903, ETUDE EXPT INTELLIGE; Brebner J, 1995, INT HDB PERSONALITY, P321; Brody N., 2000, HDB INTELLIGENCE, P16; Busato VV, 1999, PERS INDIV DIFFER, V26, P129; Busato VV, 2000, PERS INDIV DIFFER, V29, P1057, DOI 10.1016/S0191-8869(99)00253-6; Caprara GV, 2011, BRIT J EDUC PSYCHOL, V81, P78, DOI 10.1348/2044-8279.002004; Carr A, 2016, HDB INTELLECTUAL DIS, P3; Ceci SJ, 1997, AM PSYCHOL, V52, P1051, DOI 10.1037/0003-066X.52.10.1051; Chamorro-Premuzic T, 2002, SOC BEHAV PERSONAL, V30, P807, DOI 10.2224/sbp.2002.30.8.807; Chamorro-Premuzic T, 2003, J RES PERS, V37, P319, DOI 10.1016/S0092-6566(02)00578-0; Chamorro-Premuzic T, 2003, EUR J PERSONALITY, V17, P237, DOI 10.1002/per.473; Chamorro-Premuzic T., 2014, PERSONALITY INTELLEC; Chamorro-Premuzic T, 2006, PERS INDIV DIFFER, V41, P419, DOI 10.1016/j.paid.2005.11.036; Clark E., 1990, ED RES PERSPECTIVES, V17, P47, DOI [10.1080/13596749700200012, DOI 10.1080/13596749700200012]; Cohen J., 2003, APPL MULTIPLE REGRES; Collis JM, 2012, INTELLIGENCE PERSONA; Conard MA, 2006, J RES PERS, V40, P339, DOI 10.1016/j.jrp.2004.10.003; Conrad N., 2012, INT J SCHOLARSHIP TE, V6, P8, DOI [DOI 10.20429/IJS0T1.2012.060108, 10.20429/ijsotl.2012.060108, DOI 10.20429/IJSOTL.2012.060108]; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; DeFruyt F, 1996, EUR J PERSONALITY, V10, P405, DOI 10.1002/(SICI)1099-0984(199612)10:5<405::AID-PER255>3.0.CO;2-M; DeRaad B, 1996, EUR J PERSONALITY, V10, P303, DOI 10.1002/(SICI)1099-0984(199612)10:5<303::AID-PER262>3.0.CO;2-2; Di Fabio A, 2007, PERS INDIV DIFFER, V43, P2095, DOI 10.1016/j.paid.2007.06.025; Dvorak BJ, 1947, J APPL PSYCHOL, V31, P372, DOI 10.1037/h0063266; Education Audiovisual and Culture Executive Agency, 2012, EUR HIGH ED AR 2012; ELSHOUT JJ, 1992, J EDUC RES, V85, P134, DOI 10.1080/00220671.1992.9944429; European Commission, 2010, REINVENTING ACCOUNTI; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Eysenck HJ, 1993, PRIRUONIK EYSENCKOV; Farsides T, 2003, PERS INDIV DIFFER, V34, P1225, DOI 10.1016/S0191-8869(02)00111-3; FURNHAM A, 1995, PERS INDIV DIFFER, V19, P197, DOI 10.1016/0191-8869(95)00026-3; Furnham A, 2005, J APPL SOC PSYCHOL, V35, P1968, DOI 10.1111/j.1559-1816.2005.tb02205.x; Furnham A, 2009, BRIT J EDUC PSYCHOL, V79, P769, DOI 10.1348/978185409X412147; Furnham A, 2009, LEARN INDIVID DIFFER, V19, P28, DOI 10.1016/j.lindif.2008.02.001; Gagne F, 2002, INTELLIGENCE, V30, P71, DOI 10.1016/S0160-2896(01)00068-X; GERDES H, 1994, J COUNS DEV, V72, P281, DOI 10.1002/j.1556-6676.1994.tb00935.x; Glover S, 2004, PSYCHON B REV, V11, P791, DOI 10.3758/BF03196706; GOFF M, 1992, J EDUC PSYCHOL, V84, P537, DOI 10.1037/0022-0663.84.4.537; Gottfredson LS, 1997, INTELLIGENCE, V24, P13, DOI 10.1016/S0160-2896(97)90011-8; Gottfried AW, 2006, J EDUC GIFTED, V29, P430, DOI 10.4219/jeg-2006-244; Gregorie J., 2014, INT HDB CAREER GUIDA, P565; Hagerty MR, 2001, SOC INDIC RES, V55, P1, DOI 10.1023/A:1010811312332; Heaven PCL, 2002, PERS INDIV DIFFER, V32, P453, DOI 10.1016/S0191-8869(01)00041-1; Hostfee WKB, 2001, INTELLIGENCE PERSONA, P43; Jensen A.R., 1980, BIAS MENTAL TESTING; Jensen A.R., 1998, G FACTOR SCI MENTAL; JONES SH, 1995, PERS INDIV DIFFER, V19, P225, DOI 10.1016/0191-8869(95)00033-3; Kappe R, 2012, EUR J PSYCHOL EDUC, V27, P605, DOI 10.1007/s10212-011-0099-9; Kaufman SB, 2012, INTELLIGENCE, V40, P123, DOI 10.1016/j.intell.2012.01.009; Kline R.B., 2011, PRINCIPLES PRACTICE; Kuncel NR, 2014, INTELLIGENCE, V46, P203, DOI 10.1016/j.intell.2014.06.003; Leeson P, 2008, PERS INDIV DIFFER, V45, P630, DOI 10.1016/j.paid.2008.07.006; Letica J, 2014, VET EUROPE COUNTRY R; Lohmar B., 2014, ED SYSTEM FEDERAL RE; Luciano M, 2006, PERS INDIV DIFFER, V40, P1189, DOI 10.1016/j.paid.2005.10.013; Lynn R, 2002, BRIT J PSYCHOL, V93, P545, DOI 10.1348/000712602761381394; Maltby J., 2010, PERSONALITY INDIVIDU; Mayer R.E., 2011, CAMBRIDGE HDB INTELL, P738, DOI [10.1017/CBO9780511977244.037, DOI 10.1017/CBO9780511977244.037]; Moutafi J, 2006, PERS INDIV DIFFER, V40, P587, DOI 10.1016/j.paid.2005.08.004; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; Nisbett RE, 2012, AM PSYCHOL, V67, P130, DOI 10.1037/a0026699; O'Connor MC, 2007, PERS INDIV DIFFER, V43, P971, DOI 10.1016/j.paid.2007.03.017; Oishi S, 2007, PERSPECT PSYCHOL SCI, V2, P346, DOI 10.1111/j.1745-6916.2007.00048.x; Petrides KV, 2005, BRIT J EDUC PSYCHOL, V75, P239, DOI 10.1348/000709904X24735; Pind J, 2003, PERS INDIV DIFFER, V34, P375, DOI 10.1016/S0191-8869(02)00058-2; Plant EA, 2005, CONTEMP EDUC PSYCHOL, V30, P96, DOI 10.1016/j.cedpsych.2004.06.001; Poropat AE, 2011, BRIT J EDUC PSYCHOL, V81, P41, DOI 10.1348/000709910X497671; Poropat AE, 2009, PSYCHOL BULL, V135, P322, DOI 10.1037/a0014996; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; Rikoon SH, 2016, J RES PERS, V61, P22, DOI 10.1016/j.jrp.2016.01.002; Robbins SB, 2004, PSYCHOL BULL, V130, P261, DOI 10.1037/0033-2909.130.2.261; Rohde TE, 2007, INTELLIGENCE, V35, P83, DOI 10.1016/j.intell.2006.05.004; Rolfhus EL, 1996, J EDUC PSYCHOL, V88, P174, DOI 10.1037/0022-0663.88.1.174; Ryan AM, 2014, ANNU REV PSYCHOL, V65, P693, DOI 10.1146/annurev-psych-010213-115134; Sanchez MM, 2001, SOC BEHAV PERSONAL, V29, P299, DOI 10.2224/sbp.2001.29.3.299; Schneider W, 2014, LEARN INDIVID DIFFER, V32, P156, DOI 10.1016/j.lindif.2014.02.001; Slobodskaya HR, 2005, PERS INDIV DIFFER, V39, P167, DOI 10.1016/j.paid.2004.12.013; Sobota I., 1998, CONTEMP PSYCHOL, V1, P31; Spengler M, 2013, J RES PERS, V47, P613, DOI 10.1016/j.jrp.2013.05.008; Sternberg R.J., 2000, HDB INTELLIGENCE, P581, DOI [DOI 10.1017/CBO9780511807947.027, 10.1017/CBO9780511807947.027]; Sternberg RJ, 1998, ANNU REV PSYCHOL, V49, P479, DOI 10.1146/annurev.psych.49.1.479; Sternberg RJ, 1997, AM PSYCHOL, V52, P1030, DOI 10.1037/0003-066X.52.10.1030; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Tarbuk D., 1977, PRIRUCNIK ZAPSIHOLOG; TINTO V, 1975, REV EDUC RES, V45, P89, DOI 10.2307/1170024; Tinto V, 1997, J HIGH EDUC, V68, P599, DOI 10.2307/2959965; Tinto V., 1982, REV EDUC RES, V53, P687; Vermetten YJ, 2001, CONTEMP EDUC PSYCHOL, V26, P149, DOI 10.1006/ceps.1999.1042; Zarevski P, 1991, TEST OPCE INFORM UCE; Zarevski P, 2005, HORIZONS PSYCHOL, V14, P9	93	1	1	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163996	10.1371/journal.pone.0163996	http://dx.doi.org/10.1371/journal.pone.0163996			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695073	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100074
J	Das, A; Srinivasan, M; Ghosh, TS; Mande, SS				Das, Anubhav; Srinivasan, Meenakshi; Ghosh, Tarini Shankar; Mande, Sharmila S.			Xenobiotic Metabolism and Gut Microbiomes	PLOS ONE			English	Article							METAGENOMIC ANALYSIS; INTESTINAL BACTERIA; FLORA; DRUG; ENZYMES; MICROFLORA; SEQUENCE; RATS; ATHEROSCLEROSIS; BIOACTIVATION	Humans are exposed to numerous xenobiotics, a majority of which are in the form of pharmaceuticals. Apart from human enzymes, recent studies have indicated the role of the gut bacterial community (microbiome) in metabolizing xenobiotics. However, little is known about the contribution of the plethora of gut microbiome in xenobiotic metabolism. The present study reports the results of analyses on xenobiotic metabolizing enzymes in various human gut microbiomes. A total of 397 available gut metagenomes from individuals of varying age groups from 8 nationalities were analyzed. Based on the diversities and abundances of the xenobiotic metabolizing enzymes, various bacterial taxa were classified into three groups, namely, least versatile, intermediately versatile and highly versatile xenobiotic metabolizers. Most interestingly, specific relationships were observed between the overall drug consumption profile and the abundance and diversity of the xenobiotic metabolizing repertoire in various geographies. The obtained differential abundance patterns of xenobiotic metabolizing enzymes and bacterial genera harboring them, suggest their links to pharmacokinetic variations among individuals. Additional analyses of a few well studied classes of drug modifying enzymes (DMEs) also indicate geographic as well as age specific trends.	[Das, Anubhav; Ghosh, Tarini Shankar; Mande, Sharmila S.] Tata Consultancy Serv Ltd, TCS Res, Pune, Maharashtra, India; [Srinivasan, Meenakshi] Manipal Univ, Manipal Coll Pharmaceut Sci, Manipal, Karnataka, India	Tata Sons; Tata Consultancy Services Limited (TCS); Manipal Academy of Higher Education (MAHE)	Mande, SS (corresponding author), Tata Consultancy Serv Ltd, TCS Res, Pune, Maharashtra, India.	sharmila.mande@tcs.com	Ghosh, Tarini/AAW-5456-2020	Ghosh, Tarini/0000-0001-9570-0365				Al-Asmakh M, 2012, GUT MICROBES, V3, P366, DOI 10.4161/gmic.21287; Alomar MJ, 2014, SAUDI PHARM J, V22, P83, DOI 10.1016/j.jsps.2013.02.003; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bhattacharya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142038; Bowey E, 2003, FOOD CHEM TOXICOL, V41, P631, DOI 10.1016/S0278-6915(02)00324-1; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; DRASAR BS, 1972, BIOCHEM J, V129, P881, DOI 10.1042/bj1290881; Forslund K, 2013, GENOME RES, V23, P1163, DOI 10.1101/gr.155465.113; Ghosh TS, 2011, BIOINFORMATION, V6, P91, DOI 10.6026/97320630006091; Ghosh TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095547; Ghosh TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083823; Ghosh TS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S14; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goodman L.S., 2011, GOODMAN GILMANS PHAR, V13th ed.; Grilo NM, 2014, TOXICOL LETT, V224, P416, DOI 10.1016/j.toxlet.2013.10.036; Grundmann O., 2010, J DRUG METAB TOXICOL, V1, P104, DOI DOI 10.4172/2157-7609.1000104; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hu YF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3151; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Ishizuka T, 2010, J BIOL CHEM, V285, P11892, DOI 10.1074/jbc.M109.072629; JAKOBY WB, 1990, J BIOL CHEM, V265, P20715; Jancova P, 2010, BIOMED PAP, V154, P103, DOI 10.5507/bp.2010.017; Jung Lee Woo, 2015, Gastroenterol Hepatol (N Y), V11, P24; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; KOCH RL, 1980, BIOCHEM PHARMACOL, V29, P3281, DOI 10.1016/0006-2952(80)90304-4; KOCH RL, 1979, BIOCHEM PHARMACOL, V28, P3611, DOI 10.1016/0006-2952(79)90407-6; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Laine JE, 2009, XENOBIOTICA, V39, P11, DOI [10.1080/00498250802512830, 10.1080/00498250802512830 ]; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lhoste EF, 2003, FOOD CHEM TOXICOL, V41, P695, DOI 10.1016/S0278-6915(03)00010-3; Li H, 2013, NATURE, V94, P1; Ma Q, 2011, PHARMACOL REV, V63, P437, DOI 10.1124/pr.110.003533; MATHAN VI, 1989, GUT, V30, P971, DOI 10.1136/gut.30.7.971; Nash DB, 2012, AM HEALTH DRUG BENEF, V5, P423; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Peabody MA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0788-5; Penner N., 2012, ADME ENABLING TECHNO, V1st ed., P545; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rafii F, 2007, COMPARATIVE MED, V57, P282; ROWLAND IR, 1988, TOXICOL PATHOL, V16, P147, DOI 10.1177/019262338801600207; Saad R, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-16; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Sen Gupta S, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-7; Shah RR, 2007, PHARMACOGENOMICS ADM, P180; SHU YZ, 1991, XENOBIOTICA, V21, P737, DOI 10.3109/00498259109039513; Smith HF, 2013, CR PALEVOL, V12, P339, DOI 10.1016/j.crpv.2012.12.001; Smyth RMD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024061; Springael D, 2004, TRENDS MICROBIOL, V12, P53, DOI 10.1016/j.tim.2003.12.010; STRONG HA, 1987, XENOBIOTICA, V17, P685, DOI 10.3109/00498258709043976; Suicide, 2012, HLTH GLANC EUR 2012, P28; Tamames J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-85; Tedjo DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126685; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; VANDERMEER JR, 1992, MICROBIOL REV, V56, P677, DOI 10.1128/MMBR.56.4.677-694.1992; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; WRIGHTON SA, 1992, CRIT REV TOXICOL, V22, P1, DOI 10.3109/10408449209145319; Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	70	31	33	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163099	10.1371/journal.pone.0163099	http://dx.doi.org/10.1371/journal.pone.0163099			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695034	Green Submitted, Green Published, gold			2022-12-27	WOS:000385553100024
J	Gutierrez, D; Hidalgo-Cantabrana, C; Rodriguez, A; Garcia, P; Ruas-Madiedo, P				Gutierrez, Diana; Hidalgo-Cantabrana, Claudio; Rodriguez, Ana; Garcia, Pilar; Ruas-Madiedo, Patricia			Monitoring in Real Time the Formation and Removal of Biofilms from Clinical Related Pathogens Using an Impedance-Based Technology	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS; PSEUDOMONAS-AERUGINOSA; MICROBIAL BIOFILMS; FOOD-INDUSTRY; IN-VITRO; AUREUS; GROWTH; ANTIBIOTICS; INFECTIONS; CARIES	Bacteria found in diverse ecosystems grow in a community of aggregated cells that favors their survival and colonization. Different extracellular polymeric substances are used to entrap this multispecies community forming a biofilm, which can be associated to biotic and abiotic surfaces. This widespread and successful way of bacterial life, however, can lead to negative effects for human activity since many pathogen and spoiling bacteria form biofilms which are not easy to eradicate. Therefore, the search for novel anti-biofilm bio-active molecules is a very active research area for which simple, reliable, and fast screening methods are demanded. In this work we have successfully validated an impedance-based method, initially developed for the study of adherent eukaryotic cells, to monitor the formation of single-species biofilms of three model bacteria in real time. The xCelligence real time cell analyzer (RTCA) equipment uses specific microtiter E-plates coated with gold-microelectrodes that detect the attachment of adherent cells, thus modifying the impedance signal. In the current study, this technology allowed the distinction between biofilm-producers and non-producers of Staphylococcus aureus and Staphylococcus epidermidis, as well as the formation of Streptococcus mutans biofilms only when sucrose was present in the culture medium. Besides, different impedance values permitted discrimination among the biofilm-producing strains tested regardless of the nature of the polymeric biofilm matrix. Finally, we have continuously monitored the inhibition of staphylococcal biofilm formation by the bacteriophage phi-IPLA7 and the bacteriophage-encoded endolysin LysH5, as well as the removal of a preformed biofilm by this last antimicrobial treatment. Results observed with the impedance-based method showed high correlation with those obtained with standard approaches, such as crystal violet staining and bacteria enumeration, as well as with those obtained upon other abiotic surfaces (polystyrene and stainless steel). Therefore, this RTCA technology opens new opportunities in the biofilm research arena and its application could be further explored for other bacterial genera as well as for different bio-active molecules.	[Gutierrez, Diana; Hidalgo-Cantabrana, Claudio; Rodriguez, Ana; Garcia, Pilar; Ruas-Madiedo, Patricia] IPLA CSIC, Villaviciosa, Asturias, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA)	Ruas-Madiedo, P (corresponding author), IPLA CSIC, Villaviciosa, Asturias, Spain.	ruas-madiedo@ipla.csic.es	Suárez, Pilar García/H-2544-2012; Hidalgo-Cantabrana, Claudio/AAA-9952-2019; Rodriguez, Ana/H-4846-2012; Rodríguez, Ana/GQR-0554-2022; Gutiérrez, Diana/E-8712-2017; Rodriguez, Ana/GLQ-7829-2022; Garcia, Pilar/AAP-3768-2020; Ruas-Madiedo, Patricia/H-2502-2012	Suárez, Pilar García/0000-0003-1213-8165; Rodriguez, Ana/0000-0002-1577-9905; Gutiérrez, Diana/0000-0002-0473-1447; Rodriguez, Ana/0000-0002-1577-9905; Garcia, Pilar/0000-0003-1213-8165; Ruas-Madiedo, Patricia/0000-0001-6158-9320	FEDER European Union from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economia y Competitividad MINECO) [AGL2015-64901-R, AGL2015-65673-R]; Program of Science, Technology and Innovation, Principado de Asturias [EQUIP11, GRUPIN14-139]; MINECO	FEDER European Union from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economia y Competitividad MINECO); Program of Science, Technology and Innovation, Principado de Asturias; MINECO(Spanish Government)	This work was financed by the FEDER European Union funds through the projects AGL2015-64901-R and AGL2015-65673-R from the Spanish Ministry of Economy and Competitiveness (Ministerio de Economia y Competitividad MINECO) and through the grants EQUIP11 and GRUPIN14-139 (Program of Science, Technology and Innovation, Principado de Asturias). DG and CH-C hold FPI-scholarships of MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Cihalova K, 2015, INT J MOL SCI, V16, P24656, DOI 10.3390/ijms161024656; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Meira QGD, 2012, FOOD CONTROL, V25, P469, DOI 10.1016/j.foodcont.2011.11.030; Delgado S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-82; Dheilly A, 2008, APPL MICROBIOL BIOT, V79, P157, DOI 10.1007/s00253-008-1404-7; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Donlan RM, 2009, TRENDS MICROBIOL, V17, P66, DOI 10.1016/j.tim.2008.11.002; Estrada-Leypon O, 2015, BIOELECTROCHEMISTRY, V105, P56, DOI 10.1016/j.bioelechem.2015.05.006; Fenton Mark, 2013, Int J Microbiol, V2013, P625341, DOI 10.1155/2013/625341; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fu WL, 2010, ANTIMICROB AGENTS CH, V54, P397, DOI 10.1128/AAC.00669-09; Gula G, 2012, SENSOR ACTUAT B-CHEM, V175, P34, DOI 10.1016/j.snb.2011.11.044; Gutierrez D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107307; Gutierrez D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-228; Gutierrez D, 2010, CURR MICROBIOL, V61, P601, DOI 10.1007/s00284-010-9659-5; Hall-Stoodley L, 2012, FEMS IMMUNOL MED MIC, V65, P127, DOI 10.1111/j.1574-695X.2012.00968.x; Hidalgo-Cantabrana C, 2014, J FUNCT FOODS, V6, P348, DOI 10.1016/j.jff.2013.11.001; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; Junka AF, 2012, POL J MICROBIOL, V61, P191, DOI 10.33073/pjm-2012-024; Kelly D, 2012, LETT APPL MICROBIOL, V54, P286, DOI 10.1111/j.1472-765X.2012.03205.x; Knezevic P, 2011, J APPL MICROBIOL, V111, P245, DOI 10.1111/j.1365-2672.2011.05043.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kropec A, 2005, INFECT IMMUN, V73, P6868, DOI 10.1128/IAI.73.10.6868-6876.2005; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Mashima I, 2015, J BACTERIOL, V197, P2104, DOI 10.1128/JB.02512-14; Meng XP, 2011, APPL ENVIRON MICROB, V77, P8272, DOI 10.1128/AEM.05151-11; Navarro G, 2014, ANTIMICROB AGENTS CH, V58, P1092, DOI 10.1128/AAC.01781-13; Obeso JM, 2008, INT J FOOD MICROBIOL, V128, P212, DOI 10.1016/j.ijfoodmicro.2008.08.010; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Ramirez MDF, 2015, INT J FOOD MICROBIOL, V207, P23, DOI 10.1016/j.ijfoodmicro.2015.04.030; Rodriguez-Rubio L, 2016, CRIT REV BIOTECHNOL, V36, P542, DOI 10.3109/07388551.2014.993587; Romling U, 2014, J INTERN MED, V276, P98, DOI 10.1111/joim.12242; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; SHIRO H, 1994, J INFECT DIS, V169, P1042, DOI 10.1093/infdis/169.5.1042; Simon-Soro A, 2015, TRENDS MICROBIOL, V23, P76, DOI 10.1016/j.tim.2014.10.010; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Soderling EM, 2008, CURR MICROBIOL, V56, P382, DOI 10.1007/s00284-007-9076-6; Solano C, 2014, CURR OPIN MICROBIOL, V18, P96, DOI 10.1016/j.mib.2014.02.008; Teschler JK, 2015, NAT REV MICROBIOL, V13, P255, DOI 10.1038/nrmicro3433; Tremblay YDN, 2015, APPL ENVIRON MICROB, V81, P2827, DOI 10.1128/AEM.04208-14; Valdes L, 2015, J MICROBIOL METH, V119, P66, DOI 10.1016/j.mimet.2015.09.022; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Wang Y, 2015, ANN MICROBIOL, V65, P1159, DOI 10.1007/s13213-014-0883-2; Whitehead KA, 2015, CURR OPIN FOOD SCI, V2, P84, DOI 10.1016/j.cofs.2015.02.003; Zhao W, 2014, NUTRIENTS, V6, P3572, DOI 10.3390/nu6093572	54	57	58	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163966	10.1371/journal.pone.0163966	http://dx.doi.org/10.1371/journal.pone.0163966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695058	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100070
J	Horiguchi, K; Yako, H; Yoshida, S; Fujiwara, K; Tsukada, T; Kanno, N; Ueharu, H; Nishihara, H; Kato, T; Yashiro, T; Kato, Y				Horiguchi, Kotaro; Yako, Hideji; Yoshida, Saishu; Fujiwara, Ken; Tsukada, Takehiro; Kanno, Naoko; Ueharu, Hiroki; Nishihara, Hiroto; Kato, Takako; Yashiro, Takashi; Kato, Yukio			S100 beta-Positive Cells of Mesenchymal Origin Reside in the Anterior Lobe of the Embryonic Pituitary Gland	PLOS ONE			English	Article							FOLLICULO-STELLATE CELLS; EARLY NEURAL PRIMORDIUM; QUAIL CHICK CHIMERAS; STEM/PROGENITOR CELLS; STEM-CELLS; RAT PITUITARY; S100 PROTEINS; BRAIN ASTROCYTES; PROGENITOR CELLS; GENE-EXPRESSION	The anterior and intermediate lobes of the pituitary gland develop through invagination of the oral ectoderm and as they are endocrine tissues, they participate in the maintenance of vital functions via the synthesis and secretion of numerous hormones. We recently observed that several extrapituitary cells invade the anterior lobe of the developing pituitary gland. This raised the question of the origin(s) of these S100 beta-positive cells, which are not classic endocrine cells but instead comprise a heterogeneous cell population with plural roles, especially as stem/progenitor cells. To better understand the roles of these S100 beta-positive cells, we performed immunohistochemical analysis using several markers in S100 beta/GFP-TG rats, which express GFP in S100 beta-expressing cells under control of the S100 beta promoter. GFP-positive cells were present as mesenchymal cells surrounding the developing pituitary gland and at Atwell's recess but were not present in the anterior lobe on embryonic day 15.5. These cells were negative for SOX2, a pituitary stem/progenitor marker, and PRRX1, a mesenchyme and pituitary stem/progenitor marker. However, three days later, GFP-positive and PRRX1-positive (but SOX2-negative) cells were observed in the parenchyma of the anterior lobe. Furthermore, some GFP-positive cells were positive for vimentin, p75, isolectin B4, DESMIN, and Ki67. These data suggest that S100 beta-positive cells of extrapituitary origin invade the anterior lobe, undergoing proliferation and diverse transformation during pituitary organogenesis.	[Horiguchi, Kotaro] Kyorin Univ, Dept Hlth Sci, Lab Anat & Cell Biol, Mitaka, Tokyo, Japan; [Horiguchi, Kotaro; Yoshida, Saishu; Kato, Takako; Kato, Yukio] Meiji Univ, Inst Endocrinol, Kawasaki, Kanagawa, Japan; [Yako, Hideji; Yoshida, Saishu; Kanno, Naoko; Ueharu, Hiroki; Nishihara, Hiroto; Kato, Yukio] Meiji Univ, Grad Sch Agr, Div Life Sci, Kawasaki, Kanagawa, Japan; [Fujiwara, Ken; Tsukada, Takehiro; Yashiro, Takashi] Jichi Med Univ, Sch Med, Dept Anat, Div Histol & Cell Biol, Shimotsuke, Tochigi, Japan	Kyorin University; Meiji University; Meiji University; Jichi Medical University	Kato, Y (corresponding author), Meiji Univ, Inst Endocrinol, Kawasaki, Kanagawa, Japan.; Kato, Y (corresponding author), Meiji Univ, Grad Sch Agr, Div Life Sci, Kawasaki, Kanagawa, Japan.	yukato@meiji.ac.jp		Yako, Hideji/0000-0003-2632-8488	Grants-in-Aid for Scientific Research [16K08475] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Allaerts W, 2005, EUR J ENDOCRINOL, V153, P1, DOI 10.1530/eje.1.01949; Allaerts W, 1996, J NEUROENDOCRINOL, V8, P17, DOI 10.1111/j.1365-2826.1996.tb00682.x; Andoniadou CL, 2013, CELL STEM CELL, V13, P433, DOI 10.1016/j.stem.2013.07.004; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; BORSON S, 1994, NEUROENDOCRINOLOGY, V59, P466, DOI 10.1159/000126693; Boyd NL, 2007, EXP BIOL MED, V232, P833; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; COULY GF, 1985, DEV BIOL, V110, P422, DOI 10.1016/0012-1606(85)90101-0; COULY GF, 1987, DEV BIOL, V120, P198, DOI 10.1016/0012-1606(87)90118-7; DAIKOKU S, 1981, ARCH HISTOL JAPON, V44, P103, DOI 10.1679/aohc1950.44.103; Davis SW, 2010, MOL CELL ENDOCRINOL, V323, P4, DOI 10.1016/j.mce.2009.12.012; Davis SW, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0118-9; DEJONG R, 1993, DEV BIOL, V157, P133, DOI 10.1006/dbio.1993.1118; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Fauquier T, 2001, P NATL ACAD SCI USA, V98, P8891, DOI 10.1073/pnas.151339598; Gleiberman AS, 1999, DEV BIOL, V213, P340, DOI 10.1006/dbio.1999.9386; Hauser S, 2012, STEM CELLS DEV, V21, P742, DOI 10.1089/scd.2011.0419; Higuchi M, 2015, CELL TISSUE RES, V361, P557, DOI 10.1007/s00441-015-2128-5; Higuchi M, 2014, CELL TISSUE RES, V357, P767, DOI 10.1007/s00441-014-1890-0; Higuchi M, 2013, CELL TISSUE RES, V353, P27, DOI 10.1007/s00441-013-1632-8; HOFLER H, 1984, VIRCHOWS ARCH A, V404, P359, DOI 10.1007/BF00695220; Horiguchi K, 2014, CELL TISSUE RES, V358, P515, DOI 10.1007/s00441-014-1958-x; Horiguchi K, 2014, CELL TISSUE RES, V357, P757, DOI 10.1007/s00441-014-1864-2; Horiguchi K, 2014, CELL TISSUE RES, V357, P301, DOI 10.1007/s00441-014-1817-9; Hunziker E, 2000, BIOCHEM BIOPH RES CO, V271, P116, DOI 10.1006/bbrc.2000.2611; Inoue K, 1999, ARCH HISTOL CYTOL, V62, P205, DOI 10.1679/aohc.62.205; INOUE K, 1987, ARCH HISTOL CYTOL, V50, P567, DOI 10.1679/aohc.50.567; Itakura E, 2007, ENDOCRINOLOGY, V148, P1518, DOI 10.1210/en.2006-1390; Korsching E, 2005, J PATHOL, V206, P451, DOI 10.1002/path.1797; Kouki T, 2001, DEVELOPMENT, V128, P959; Krylyshkina O, 2005, ENDOCRINOLOGY, V146, P2376, DOI 10.1210/en.2004-1209; Kurz H, 2008, HISTOCHEM CELL BIOL, V130, P1027, DOI 10.1007/s00418-008-0478-8; LEUSSINK B, 1995, MECH DEVELOP, V52, P51, DOI 10.1016/0925-4773(95)00389-I; Liu HX, 2012, DEV BIOL, V368, P294, DOI 10.1016/j.ydbio.2012.05.028; Mogi C, 2004, EXP CELL RES, V292, P288, DOI 10.1016/j.yexcr.2003.09.018; Motohashi T, 2014, DEV DYNAM, V243, P368, DOI 10.1002/dvdy.24072; NAKAJIMA T, 1980, BRAIN RES, V191, P523, DOI 10.1016/0006-8993(80)91300-1; Osuna M, 2012, J ENDOCRINOL, V213, P231, DOI 10.1530/JOE-12-0043; Qiao B, 2012, BIOL CELL, V104, P476, DOI 10.1111/boc.201100077; RINEHART JF, 1953, J HISTOCHEM CYTOCHEM, V1, P93, DOI 10.1177/1.2.93; ROSS AH, 1984, P NATL ACAD SCI-BIOL, V81, P6681, DOI 10.1073/pnas.81.21.6681; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Shih CC, 2001, BLOOD, V98, P2412, DOI 10.1182/blood.V98.8.2412; Shimozaki K, 2013, J NEUROSCI, V33, P4066, DOI 10.1523/JNEUROSCI.4586-12.2013; SOJI T, 1989, ANAT RECORD, V224, P523, DOI 10.1002/ar.1092240410; Susa T, 2012, J NEUROENDOCRINOL, V24, P1201, DOI 10.1111/j.1365-2826.2012.02336.x; TACHIBANA O, 1988, ACTA NEUROPATHOL, V76, P458, DOI 10.1007/BF00686384; Trost A, 2013, INVEST OPHTH VIS SCI, V54, P7910, DOI 10.1167/iovs.13-12946; Vankelecom H, 2007, SEMIN CELL DEV BIOL, V18, P559, DOI 10.1016/j.semcdb.2007.04.006; Vankelecom H, 2012, CURR STEM CELL RES T, V7, P36, DOI 10.2174/157488812798483467; Widera D, 2011, STEM CELLS DEV, V20, P2053, DOI 10.1089/scd.2010.0525; Woodhoo A, 2004, MOL CELL NEUROSCI, V25, P30, DOI 10.1016/j.mcn.2003.09.006; Yako H, 2013, CELL TISSUE RES, V354, P837, DOI 10.1007/s00441-013-1717-4; Yoshida S, 2013, J NEUROENDOCRINOL, V25, P779, DOI 10.1111/jne.12077; Yoshida S, 2011, J NEUROENDOCRINOL, V23, P933, DOI 10.1111/j.1365-2826.2011.02198.x; Zhu XY, 2004, CURR OPIN GENET DEV, V14, P567, DOI 10.1016/j.gde.2004.08.006	58	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163981	10.1371/journal.pone.0163981	http://dx.doi.org/10.1371/journal.pone.0163981			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695124	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100071
J	Latsko, MS; Gilman, TL; Matt, LM; Nylocks, KM; Coifman, KG; Jasnow, AM				Latsko, Maeson S.; Gilman, T. Lee; Matt, Lindsey M.; Nylocks, K. Maria; Coifman, Karin G.; Jasnow, Aaron M.			A Novel Interaction between Tryptophan Hydroxylase 2 (TPH2) Gene Polymorphism (rs4570625) and BDNF Val(66)Met Predicts a High-Risk Emotional Phenotype in Healthy Subjects	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NEUROTROPHIC FACTOR; SEROTONIN TRANSPORTER; VAL66MET POLYMORPHISM; PROMOTER REGION; HUMAN-MEMORY; ANXIETY; DEPRESSION; ALLELE; STROOP	Poor inhibitory processing of negative emotional content is central to many psychiatric disorders, including depression and anxiety. Moreover, increasing evidence suggests that core aspects of emotion-inhibitory processing are largely inherited and as such may represent a key intermediate or risk-related phenotype for common affective diseases (e.g., unipolar depressive, anxiety disorders). The current study employed a candidate-gene approach in order to most effectively examine this complex behavioral phenotype. We examined the novel interaction between BDNF (Val(66)Met) and TPH2 (rs4570625) polymorphisms and their influence on behavioral inhibition of negative emotion in two independent investigations of healthy adults. BDNF Met carriers consistently report greater symptoms of affective disease and display corresponding behavioral rigidity, while TPH2 T carriers display poor inhibitory processing. These genotypes are traditionally perceived as 'risk' genotypes when compared to their respective major Val and G homozygous genotypes, but evidence is mixed. Recent studies in humans and mutant mouse models suggest biological epistasis between BDNF and genes involved in serotonin regulation. Moreover, polymorphisms in the TPH2 gene may have greater influence on serotonergic function than other more commonly studied polymorphisms (e.g., 5-HTTLPR). We observed consistent evidence across two different emotion-inhibition paradigms, one with high internal validity (Study 1, n = 119) and one with high ecological validity (Study 2, n = 115) that the combination of Val/Val and G/G genotypes was clearly associated with impaired inhibition of negative emotional content. This was followed by individuals carrying the BDNF-Met allele (including Met/Val and Met/Met) when combined with the TPH2-T allele (including T/G and T/T combinations). The consistency of these results across tasks and studies suggests that these two groups may be particularly vulnerable to the most common psychiatric disorders and should be targets for future clinical investigation.	[Latsko, Maeson S.; Gilman, T. Lee; Matt, Lindsey M.; Nylocks, K. Maria; Coifman, Karin G.; Jasnow, Aaron M.] Kent State Univ, Dept Psychol Sci, Kent, OH 44242 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem	Jasnow, AM (corresponding author), Kent State Univ, Dept Psychol Sci, Kent, OH 44242 USA.	ajasnow@kent.edu	Coifman, Karin/AAR-5286-2021; Gilman, T. Lee/P-4041-2014	Coifman, Karin/0000-0002-2372-0081; Gilman, T. Lee/0000-0001-8398-0195	Institute for Clinical and Translational Research, Kent State University; Applied Psychology Center, Department of Psychological Sciences	Institute for Clinical and Translational Research, Kent State University; Applied Psychology Center, Department of Psychological Sciences	The research described in this manuscript was funded, in part, by the Institute for Clinical and Translational Research, Kent State University; and The Applied Psychology Center, Department of Psychological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfimova MV, 2012, B EXP BIOL MED+, V152, P606, DOI 10.1007/s10517-012-1587-x; Anchordoquy HC, 2003, BEHAV GENET, V33, P73, DOI 10.1023/A:1021007701808; ANDERSON MC, 1995, PSYCHOL REV, V102, P68, DOI 10.1037/0033-295X.102.1.68; Anttila S, 2007, J NEURAL TRANSM, V114, P1065, DOI 10.1007/s00702-007-0705-9; Bargh John A., 2007, HDB EMOTION REGULATI, P429, DOI DOI 10.1037/A0017745; Barlow DH, 2014, CLIN PSYCHOL SCI, V2, P344, DOI 10.1177/2167702613505532; Beevers CG, 2011, J ABNORM PSYCHOL, V120, P187, DOI 10.1037/a0022125; Bosker FJ, 2011, MOL PSYCHIATR, V16, P516, DOI 10.1038/mp.2010.38; Bremner JD, 2004, BIOL PSYCHIAT, V55, P612, DOI 10.1016/j.biopsych.2003.10.001; Brown SM, 2005, MOL PSYCHIATR, V10, P884, DOI 10.1038/sj.mp.4001716; Bueller JA, 2006, BIOL PSYCHIAT, V59, P812, DOI 10.1016/j.biopsych.2005.09.022; Canli T, 2005, J NEURAL TRANSM, V112, P1479, DOI 10.1007/s00702-005-0391-4; Canli T, 2009, NEUROSCIENCE, V164, P43, DOI 10.1016/j.neuroscience.2009.06.049; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; Chen GL, 2008, HUM GENET, V122, P645, DOI 10.1007/s00439-007-0443-y; Cohen JE, 2013, HUM BRAIN MAPP, V34, P1344, DOI 10.1002/hbm.21516; Coifman KG, 2010, J ABNORM PSYCHOL, V119, P479, DOI 10.1037/a0020113; Cuellar AK, 2005, CLIN PSYCHOL REV, V25, P307, DOI 10.1016/j.cpr.2004.12.002; Daws LC, 2011, PHARMACOL THERAPEUT, V131, P61, DOI 10.1016/j.pharmthera.2011.03.013; Diminich ED, 2014, J ABNORM PSYCHOL, V123, P350, DOI 10.1037/a0036398; Dougherty LR, 2010, BIOL PSYCHOL, V83, P93, DOI 10.1016/j.biopsycho.2009.10.009; Drago A, 2009, INT J ENV RES PUB HE, V6, P1980, DOI 10.3390/ijerph6071980; EATON MJ, 1995, DEV BIOL, V170, P169, DOI 10.1006/dbio.1995.1205; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; EMDE RN, 1992, CHILD DEV, V63, P1437, DOI 10.1111/j.1467-8624.1992.tb01706.x; Fernandez SP, 2012, NEUROPHARMACOLOGY, V62, P144, DOI 10.1016/j.neuropharm.2011.08.049; Fisher AJ, 2013, BIOL PSYCHOL, V93, P65, DOI 10.1016/j.biopsycho.2013.01.012; Foland-Ross LC, 2013, PSYCHOL SCI, V24, P334, DOI 10.1177/0956797612457380; Freund N, 2013, NEUROSCIENCE, V249, P88, DOI 10.1016/j.neuroscience.2013.06.066; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Frings C, 2010, Q J EXP PSYCHOL, V63, P42, DOI 10.1080/17470210903156594; Gajewski PD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.010; Galter D, 2000, J NEUROSCI RES, V61, P295, DOI 10.1002/1097-4547(20000801)61:3<295::AID-JNR7>3.0.CO;2-4; Galvin C, 2015, NEUROPSYCHOPHARMACOL, V40, P2269, DOI 10.1038/npp.2015.76; Gao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036721; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Gilman T.L., 2015, PSYCHOL NEUROSCIENCE, V8, P397, DOI [10.1037/pne0000017, DOI 10.1037/PNE0000017, 10.1037/pne0000017.]; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gross JJ, 2013, EMOTION, V13, P359, DOI 10.1037/a0032135; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gutknecht L, 2007, INT J NEUROPSYCHOPH, V10, P309, DOI 10.1017/S1461145706007437; Gutknecht L, 2009, EUR NEUROPSYCHOPHARM, V19, P266, DOI 10.1016/j.euroneuro.2008.12.005; Gyekis JP, 2013, AM J MED GENET B, V162B, P61, DOI 10.1002/ajmg.b.32122; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Harvey M, 2004, MOL PSYCHIATR, V9, P980, DOI 10.1038/sj.mp.4001557; Havranek M, 2015, NEUROPSYCHOPHARMACOL; Hayden EP, 2010, PSYCHOL SCI, V21, P1678, DOI 10.1177/0956797610385357; Henningsson S, 2009, BIOL PSYCHIAT, V66, P477, DOI 10.1016/j.biopsych.2009.04.009; Herrmann MJ, 2007, CEREB CORTEX, V17, P1160, DOI 10.1093/cercor/bhl026; Hofmann W, 2009, J EXP SOC PSYCHOL, V45, P431, DOI 10.1016/j.jesp.2008.09.013; Huennerkopf R, 2007, NEUROPSYCHOPHARMACOL, V32, P2552, DOI 10.1038/sj.npp.1301383; Janes AC, 2010, BIOL PSYCHIAT, V67, P722, DOI 10.1016/j.biopsych.2009.12.034; Jansson M, 2007, BEHAV RES THER, V45, P511, DOI 10.1016/j.brat.2006.04.003; Johnson DC, 2015, DEV COGN NEUROS-NETH, V11, P42, DOI 10.1016/j.dcn.2014.07.006; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Kepser LJ, 2015, BEHAV BRAIN RES, V277, P3, DOI 10.1016/j.bbr.2014.05.022; Kronenberg G, 2015, EUROPEAN ARCH PSYCHI, P1; Lan MJ, 2014, NEUROIMAGE, V94, P33, DOI 10.1016/j.neuroimage.2014.02.027; LeDoux J, 2012, EMOT REV, V4, P375, DOI 10.1177/1754073912445822; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lehto K, 2015, PROG NEURO-PSYCHOPH, V57, P31, DOI 10.1016/j.pnpbp.2014.10.005; Leonardo ED, 2008, NEUROPSYCHOPHARMACOL, V33, P134, DOI 10.1038/sj.npp.1301569; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; Lewis CM, 2010, AM J PSYCHIAT, V167, P949, DOI 10.1176/appi.ajp.2010.09091380; Li M, 2016, GENET EPIDEMIOL, V40, P341, DOI 10.1002/gepi.21970; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Mamounas LA, 1995, J NEUROSCI, V15, P7929; Mandell D, 2014, J ABNORM PSYCHOL, V123, P35, DOI 10.1037/a0035834; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; McLaughlin KA, 2011, BEHAV RES THER, V49, P186, DOI 10.1016/j.brat.2010.12.006; McRae K, 2012, SOC COGN AFFECT NEUR, V7, P253, DOI 10.1093/scan/nsq103; Mennin DS, 2013, CLIN PSYCHOL-SCI PR, V20, P258, DOI 10.1111/cpsp.12038; Migliarini S, 2013, MOL PSYCHIATR, V18, P1106, DOI 10.1038/mp.2012.128; Mossner R, 2006, INT J NEUROPSYCHOPH, V9, P437, DOI 10.1017/S1461145705005997; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Murphy DL, 2003, GENES BRAIN BEHAV, V2, P350, DOI 10.1046/j.1601-1848.2003.00049.x; Naumenko VS, 2012, NEUROSCIENCE, V214, P59, DOI 10.1016/j.neuroscience.2012.04.031; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Osinsky R, 2009, BEHAV BRAIN RES, V198, P404, DOI 10.1016/j.bbr.2008.11.022; Payer DE, 2012, EMOTION, V12, P229, DOI 10.1037/a0027421; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Pezawas L, 2008, MOL PSYCHIATR, V13, P709, DOI 10.1038/mp.2008.32; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ren-Patterson RF, 2006, CELL MOL NEUROBIOL, V26, P755, DOI 10.1007/s10571-006-9048-6; Ren-Patterson RF, 2005, J NEUROSCI RES, V79, P756, DOI 10.1002/jnr.20410; Reuter M, 2007, INT J NEUROPSYCHOPH, V10, P401, DOI 10.1017/S1461145706007073; Reuter M, 2007, J COGNITIVE NEUROSCI, V19, P401, DOI 10.1162/jocn.2007.19.3.401; Rotberg B, 2013, J CHILD ADOL PSYCHOP, V23, P117, DOI 10.1089/cap.2012.0020; Rottenberg J, 2005, J ABNORM PSYCHOL, V114, P627, DOI 10.1037/0021-843X.114.4.627; Rottenberg J, 2002, EMOTION, V2, P135, DOI 10.1037//1528-3542.2.2.135; Scheuch K, 2007, BIOL PSYCHIAT, V62, P1288, DOI 10.1016/j.biopsych.2007.01.015; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Siuciak JA, 1996, BRAIN RES, V710, P11, DOI 10.1016/0006-8993(95)01289-3; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Soussignan R, 2009, INFANT BEHAV DEV, V32, P1, DOI 10.1016/j.infbeh.2008.09.002; Strobel A, 2007, J COGNITIVE NEUROSCI, V19, P1923, DOI 10.1162/jocn.2007.19.12.1923; Tukey JW, 1977, EXPLORATORY DATA ANA; UDENFRIEND S, 1956, J BIOL CHEM, V219, P335; Veenstra-VanderWeele J, 2012, P NATL ACAD SCI USA, V109, P5469, DOI 10.1073/pnas.1112345109; Waider J, 2011, PSYCHONEUROENDOCRINO, V36, P393, DOI 10.1016/j.psyneuen.2010.12.012; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Whitmer AJ, 2012, J ABNORM PSYCHOL, V121, P570, DOI 10.1037/a0027474; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525	114	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162585	10.1371/journal.pone.0162585	http://dx.doi.org/10.1371/journal.pone.0162585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695066	gold, Green Published			2022-12-27	WOS:000385553100015
J	Xiong, XC; Jin, C; Chen, HL; Luo, L				Xiong, Xuechen; Jin, Chao; Chen, Haile; Luo, Li			Using the Fusion Proximal Area Method and Gravity Method to Identify Areas with Physician Shortages	PLOS ONE			English	Article							PRIMARY-HEALTH-CARE; SPATIAL ACCESSIBILITY; ACCESS; JOBS	Objectives This paper presents a geographic information system (GIS)-based proximal area method and gravity method for identifying areas with physician shortages. The innovation of this paper is that it uses the appropriate methods to discover each type of health resource and then integrates all these methods to assess spatial access to health resources using population distribution data. In this way, spatial access to health resources for an entire city can be visualized in one neat package, which can help health policy makers quickly comprehend realistic distributions of health resources at a macro level. Methods First, classify health resources according to the trade areas of the patients they serve. Second, apply an appropriate method to each different type of health resource to measure spatial access to those resources. Third, integrate all types of access using population distribution data. Results In case study of Shanghai with the fusion method, areas with physician shortages are located primarily in suburban districts, especially in district junction areas. The result suggests that the government of Shanghai should pay more attention to these areas by investing in new or relocating existing health resources. Conclusion The fusion method is demonstrated to be more accurate and practicable than using a single method to assess spatial access to health resources.	[Xiong, Xuechen; Jin, Chao; Chen, Haile; Luo, Li] Fudan Univ, Sch Publ Hlth, Collaborat Innovat Ctr Hlth Risks Governance, Shanghai 200433, Peoples R China	Fudan University	Luo, L (corresponding author), Fudan Univ, Sch Publ Hlth, Collaborat Innovat Ctr Hlth Risks Governance, Shanghai 200433, Peoples R China.	liluo@fudan.edu.cn			National Natural Science Foundation of China [71473045]; Key Projects of Philosophy and Social Sciences Research, Ministry of Education, China [15JZD029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects of Philosophy and Social Sciences Research, Ministry of Education, China(Ministry of Education, China)	Funding for this research was provided by the National Natural Science Foundation of China (No. 71473045) and the Key Projects of Philosophy and Social Sciences Research, Ministry of Education, China (No. 15JZD029).	[Anonymous], 1978, INT C PRIM HLTH CAR, V9, P6; Christaller W., 1966, CENTRAL PALCES SO GE; Crooks VA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-230; Dewulf B, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-122; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; HSIAO WCL, 1995, SOC SCI MED, V41, P1047, DOI 10.1016/0277-9536(94)00421-O; Hu RS, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-35; Huff D., 2000, BUS GEOGR, V8, P12; Immergluck D, 1998, URBAN STUD, V35, P7, DOI 10.1080/0042098985041; Jin C, 2015, INT J EQUITY HEALTH, V8, P1; Luo W, 2004, HEALTH PLACE, V10, P1, DOI 10.1016/S1353-8292(02)00067-9; Luo W, 2003, ENVIRON PLANN B, V30, P865, DOI 10.1068/b29120; Luo W, 2012, HEALTH PLACE, V18, P789, DOI 10.1016/j.healthplace.2012.04.002; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; Munoz UH, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-40; Nykiforuk CIJ, 2011, HEALTH PROMOT PRACT, V12, P63, DOI 10.1177/1524839909334624; Ranga V, 2014, GEOSPATIAL HEALTH, V8, P545, DOI 10.4081/gh.2014.44; Shanghai Health and Population and Family Planning Commission, SHANGH REG HLTH PLAN; Song PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070227; Wang F., 2015, QUANTITATIVE METHODS, V2nd ed., DOI DOI 10.1080/2325548X.2015.1050769; Wang FH, 2005, HEALTH PLACE, V11, P131, DOI 10.1016/j.healthplace.2004.02.003; Wang FH, 2002, ANN ASSOC AM GEOGR, V92, P435, DOI 10.1111/1467-8306.00298	22	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163504	10.1371/journal.pone.0163504	http://dx.doi.org/10.1371/journal.pone.0163504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695105	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100039
J	Cheng, HC; Guo, CY; Chen, YJ; Chen, MJ; Ko, YC; Huang, N; Liu, CJL				Cheng, Hui-Chen; Guo, Chao-Yu; Chen, Yu-Jing; Chen, Mei-Ju; Ko, Yu-Chieh; Huang, Nicole; Liu, Catherine Jui-ling			Patient-Reported Vision-Related Quality-of-Life Differences between Primary Angle-Closure Glaucoma and Primary Open-Angle Glaucoma	PLOS ONE			English	Article							VISUAL-FIELD LOSS; SALISBURY EYE EVALUATION; INTRAOCULAR-PRESSURE; PHYSICAL-ACTIVITY; HEALTH; QUESTIONNAIRE; DISABILITY; IMPACT; PHACOEMULSIFICATION; ACCELEROMETER	Purpose To investigate the different impacts on patient-reported vision-related quality of life (pVRQOL) outcomes in patients with primary angle-closure glaucoma(PACG) and primary open-angle glaucoma(POAG). Methods Prospective cross-sectional study. PACG and POAG patients who had a best-corrected visual acuity(BCVA) in the better eye equal to or better than 20/60, intraocular pressure controlled at or below 25 mmHg and reliable visual field test were invited to participate. The control group included patients with BCVA in the better eye equal to or better than 20/60 and who did not have major eye disease. A validated Taiwanese version of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25(T)) was performed to assess pVRQOL. The association between each domain of NEI VFQ-25(T) among 3 groups was determined using multivariable linear regression analysis. Results A total of 106 PACG, 186 POAG, and 95 controls were enrolled. In multivariable regression analysis of all three groups(PACG/POAG/controls), compared to POAG, PACG showed a weakly positive association with social functioning (R-2 = 0.13, beta = 0.22, P = 0.04). PACG showed no significantly negative impact on pVRQOL compared to controls. Taking only glaucoma patients into consideration, PACG patients had a higher score on social functioning compared to POAG (R-2 = 0.16, beta = 0.27, P = 0.01). The results of other domains of NEI VFQ-25(T) between the two groups did not differ significantly(p > 0.05). Conclusions In patients with controlled disease, the impact of PACG and POAG on most domains of NEI VFQ-25(T) were similar, except for better social functioning in PACG compared to POAG.	[Cheng, Hui-Chen; Chen, Mei-Ju; Ko, Yu-Chieh; Liu, Catherine Jui-ling] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Cheng, Hui-Chen; Chen, Mei-Ju; Ko, Yu-Chieh; Liu, Catherine Jui-ling] Natl Yang Ming Univ, Sch Med, Dept Ophthalmol, Taipei, Taiwan; [Guo, Chao-Yu] Natl Yang Ming Univ, Inst Publ Hlth, Dept Publ Hlth, Taipei, Taiwan; [Chen, Yu-Jing] Natl Yang Ming Univ, Inst Publ Hlth, Div Biostat, Taipei, Taiwan; [Huang, Nicole] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Liu, CJL (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Liu, CJL (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Ophthalmol, Taipei, Taiwan.	jlliu@vghtpe.gov.tw		Huang, Nicole/0000-0002-6629-1176; Guo, Chao-Yu/0000-0002-9066-9933				Alsagoff Z, 2000, OPHTHALMOLOGY, V107, P2300, DOI 10.1016/S0161-6420(00)00385-7; Arora KS, 2013, OPHTHALMOLOGY, V120, P2476, DOI 10.1016/j.ophtha.2013.07.020; Asaoka R, 2011, INVEST OPHTH VIS SCI, V52, P7007, DOI 10.1167/iovs.11-7643; Brown SM, 2005, J CATARACT REFR SURG, V31, P687, DOI 10.1016/j.jcrs.2004.09.036; Chan EW, 2015, OPHTHALMOLOGY, V122, P494, DOI 10.1016/j.ophtha.2014.09.030; Chen PP, 2015, OPHTHALMOLOGY, V122, P1294, DOI 10.1016/j.ophtha.2015.03.021; Cheng HC, 2015, JAMA OPHTHALMOL, V133, P269, DOI 10.1001/jamaophthalmol.2014.4908; Cheng JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103222; Freeman EE, 2008, OPHTHALMOLOGY, V115, P233, DOI 10.1016/j.ophtha.2007.04.050; Friedman DS, 2006, OPHTHALMOLOGY, V113, P1087, DOI 10.1016/j.ophtha.2006.02.016; Gallicchio L, 2007, QUAL LIFE RES, V16, P777, DOI 10.1007/s11136-006-9162-4; Gutierrez P, 1997, ARCH OPHTHALMOL-CHIC, V115, P777, DOI 10.1001/archopht.1997.01100150779014; Hochberg C, 2012, INVEST OPHTH VIS SCI, V53, P3201, DOI 10.1167/iovs.12-9469; Jampel HD, 2002, INVEST OPHTH VIS SCI, V43, P1059; Janz NK, 2007, OPHTHALMOLOGY, V114, P2213, DOI 10.1016/j.ophtha.2007.02.014; Ko YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149698; Kong XM, 2015, J GLAUCOMA, V24, pe57, DOI 10.1097/IJG.0000000000000025; Lin JC, 2010, J EVAL CLIN PRACT, V16, P619, DOI 10.1111/j.1365-2753.2009.01253.x; Liu CJL, 2006, ARCH OPHTHALMOL-CHIC, V124, P1390, DOI 10.1001/archopht.124.10.1390; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; McKean-Cowdin R, 2008, OPHTHALMOLOGY, V115, P941, DOI 10.1016/j.ophtha.2007.08.037; McKean-Cowdin R, 2007, AM J OPHTHALMOL, V143, P1013, DOI 10.1016/j.ajo.2007.02.022; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; Onakoya AO, 2012, J GLAUCOMA, V21, P287, DOI 10.1097/IJG.0b013e31820d7cfd; Park HK, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0331-4; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Ramulu PY, 2013, INVEST OPHTH VIS SCI, V54, P666, DOI 10.1167/iovs.12-10618; Ramulu PY, 2012, OPHTHALMOLOGY, V119, P1159, DOI 10.1016/j.ophtha.2012.01.013; Ramulu PY, 2009, OPHTHALMOLOGY, V116, P1846, DOI 10.1016/j.ophtha.2009.03.033; Ramulu PY, 2009, ARCH OPHTHALMOL-CHIC, V127, P82, DOI 10.1001/archophthalmol.2008.523; Ringsdorf L, 2006, J GLAUCOMA, V15, P414, DOI 10.1097/01.ijg.0000212252.72207.c2; Skalicky S, 2008, J GLAUCOMA, V17, P546, DOI 10.1097/IJG.0b013e318163bdd1; Solomon KD, 2009, OPHTHALMOLOGY, V116, P691, DOI 10.1016/j.ophtha.2008.12.037; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Turano KA, 2004, OPTOMETRY VISION SCI, V81, P298, DOI 10.1097/01.opx.0000134903.13651.8e; van Landingham SW, 2012, OPHTHALMOLOGY, V119, P2486, DOI 10.1016/j.ophtha.2012.06.034; Varma R, 2006, OPHTHALMOLOGY, V113, P1846, DOI 10.1016/j.ophtha.2006.04.028; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang BS, 2013, J GLAUCOMA, V22, P330, DOI 10.1097/IJG.0b013e3182408593; Wilson MR, 1998, OPHTHALMOLOGY, V105, P2112, DOI 10.1016/S0161-6420(98)91135-6; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P963, DOI 10.1136/bjo.86.9.963	43	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163123	10.1371/journal.pone.0163123	http://dx.doi.org/10.1371/journal.pone.0163123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690232	Green Submitted, gold, Green Published			2022-12-27	WOS:000384329200012
J	Fu, JY; Lv, HP; Chen, F				Fu, Jianyu; Lv, Haipeng; Chen, Feng			Diversity and Variation of Bacterial Community Revealed by MiSeq Sequencing in Chinese Dark Teas	PLOS ONE			English	Article							PU-ERH TEA; CHEMICAL-CONSTITUENTS; FERMENTATION; DYNAMICS; CONSUMPTION	Chinese dark teas (CDTs) are now among the popular tea beverages worldwide due to their unique health benefits. Because the production of CDTs involves fermentation that is characterized by the effect of microbes, microorganisms are believed to play critical roles in the determination of the chemical characteristics of CDTs. Some dominant fungi have been identified from CDTs. In contrast, little, if anything, is known about the composition of bacterial community in CDTs. This study was set to investigate the diversity and variation of bacterial community in four major types of CDTs from China. First, the composition of the bacterial community of CDTs was determined using MiSeq sequencing. From the four typical CDTs, a total of 238 genera that belong to 128 families of bacteria were detected, including most of the families of beneficial bacteria known to be associated with fermented food. While different types of CDTs had generally distinct bacterial structures, the two types of brick teas produced from adjacent regions displayed strong similarity in bacterial composition, suggesting that the producing environment and processing condition perhaps together influence bacterial succession in CDTs. The global characterization of bacterial communities in CDTs is an essential first step for us to understand their function in fermentation and their potential impact on human health. Such knowledge will be important guidance for improving the production of CDTs with higher quality and elevated health benefits.	[Fu, Jianyu; Lv, Haipeng] Chinese Acad Agr Sci, Tea Res Inst, Minist Agr, Key Lab Tea Plants Biol & Resources Utilizat, Hangzhou 310008, Zhejiang, Peoples R China; [Fu, Jianyu] Chinese Acad Agr Sci, Grad Sch, Beijing 100081, Peoples R China; [Chen, Feng] Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Fu, JY (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Minist Agr, Key Lab Tea Plants Biol & Resources Utilizat, Hangzhou 310008, Zhejiang, Peoples R China.; Fu, JY (corresponding author), Chinese Acad Agr Sci, Grad Sch, Beijing 100081, Peoples R China.	mybatigoal@mail.tricaas.com	Lv, Haipeng/ABB-4552-2021	Lv, Haipeng/0000-0002-4644-4323	National Natural Science Foundation of China [31470693, 31100503]; Science and Technology Innovation Program of CAAS; Public Technology Application Research of Zhejiang Province [2013C32086]; Natural Science Foundation of Zhejiang Province [Y3080150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Program of CAAS; Public Technology Application Research of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (31470693, 31100503), the Science and Technology Innovation Program of CAAS, the Public Technology Application Research of Zhejiang Province (2013C32086) and the Natural Science Foundation of Zhejiang Province (Y3080150).	Abe M, 2008, INT J FOOD MICROBIOL, V124, P199, DOI 10.1016/j.ijfoodmicro.2008.03.008; Amato KR, 2013, ISME J, V7, P1344, DOI 10.1038/ismej.2013.16; [Anonymous], J TEA SCI; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Bourdichon F, 2012, INT J FOOD MICROBIOL, V154, P87, DOI 10.1016/j.ijfoodmicro.2011.12.030; Chakravorty S, 2016, INT J FOOD MICROBIOL, V220, P63, DOI 10.1016/j.ijfoodmicro.2015.12.015; Einother SJ, 2013, AM J CLIN NUTR, V98, p1700S, DOI 10.3945/ajcn.113.058248; Gong JS, 2016, INT FOOD SCI ENG KNO, V11, P175, DOI 10.1007/978-1-4899-7671-0_15; Hu J.C, 1957, TEA, V2, P20; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Hursel R, 2013, AM J CLIN NUTR, V98, p1682S, DOI 10.3945/ajcn.113.058396; Leong KH, 2014, CURR MICROBIOL, V68, P440, DOI 10.1007/s00284-013-0495-2; Lv HP, 2013, FOOD RES INT, V53, P608, DOI 10.1016/j.foodres.2013.02.043; Lv SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116428; Michelsen CF, 2014, POLAR BIOL, V37, P61, DOI 10.1007/s00300-013-1410-9; Mo HZ, 2008, TRENDS FOOD SCI TECH, V19, P124, DOI 10.1016/j.tifs.2007.10.001; Nam YD, 2012, INT J FOOD MICROBIOL, V155, P36, DOI 10.1016/j.ijfoodmicro.2012.01.013; Schoustra SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063948; Silva CF, 2008, FOOD MICROBIOL, V25, P951, DOI 10.1016/j.fm.2008.07.003; Tong XL, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-98; Vilela DM, 2010, FOOD MICROBIOL, V27, P1128, DOI 10.1016/j.fm.2010.07.024; Wang QP, 2015, J FOOD SCI, V80, pM809, DOI 10.1111/1750-3841.12831; [文杰宇 Wen Jieyu], 2010, [食品科学, Food Science], V31, P329; Wu QJ, 2014, J AGR FOOD CHEM, V62, P9336, DOI 10.1021/jf5025483; Xu AQ, 2011, INT J FOOD MICROBIOL, V146, P14, DOI 10.1016/j.ijfoodmicro.2011.01.024; Yang CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08476; Zhang L, 2013, FOOD RES INT, V53, P600, DOI 10.1016/j.foodres.2013.01.016; Zhang XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125732; Zhao M, 2013, WORLD J MICROB BIOT, V29, P1877, DOI 10.1007/s11274-013-1351-z; Zheng WJ, 2015, PHYTOCHEM REV, V14, P499, DOI 10.1007/s11101-015-9402-8; Zhou HongJie, 2004, Journal of Tea Science, V24, P212	31	20	26	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0162719	10.1371/journal.pone.0162719	http://dx.doi.org/10.1371/journal.pone.0162719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690376	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200006
J	Roncone, A; Hoffmann, M; Pattacini, U; Fadiga, L; Metta, G				Roncone, Alessandro; Hoffmann, Matej; Pattacini, Ugo; Fadiga, Luciano; Metta, Giorgio			Peripersonal Space and Margin of Safety around the Body: Learning Visuo-Tactile Associations in a Humanoid Robot with Artificial Skin	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; POSTERIOR PARIETAL; MACAQUE MONKEY; CORTEX; REPRESENTATION; INTEGRATION; LOCATION; SCHEMA; MOTION; MOTOR	This paper investigates a biologically motivated model of peripersonal space through its implementation on a humanoid robot. Guided by the present understanding of the neurophysiology of the fronto-parietal system, we developed a computational model inspired by the receptive fields of polymodal neurons identified, for example, in brain areas F4 and VIP. The experiments on the iCub humanoid robot show that the peripersonal space representation i) can be learned efficiently and in real-time via a simple interaction with the robot, ii) can lead to the generation of behaviors like avoidance and reaching, and iii) can contribute to the understanding the biological principle of motor equivalence. More specifically, with respect to i) the present model contributes to hypothesizing a learning mechanisms for peripersonal space. In relation to point ii) we show how a relatively simple controller can exploit the learned receptive fields to generate either avoidance or reaching of an incoming stimulus and for iii) we show how the robot can select arbitrary body parts as the controlled endpoint of an avoidance or reaching movement.	[Roncone, Alessandro; Hoffmann, Matej; Pattacini, Ugo; Metta, Giorgio] Ist Italiano Tecnol, ICub Facil, Genoa, Italy; [Roncone, Alessandro] Yale Univ, Dept Comp Sci, Social Robot Lab, POB 2158, New Haven, CT 06520 USA; [Fadiga, Luciano] Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Genoa, Italy; [Fadiga, Luciano] Univ Ferrara, Sect Human Physiol, Ferrara, Italy	Istituto Italiano di Tecnologia - IIT; Yale University; Istituto Italiano di Tecnologia - IIT; University of Ferrara	Hoffmann, M (corresponding author), Ist Italiano Tecnol, ICub Facil, Genoa, Italy.	matej.hoffmann@iit.it	Fadiga, Luciano/AAC-7404-2022; Pattacini, Ugo/J-4652-2014; Hoffmann, Matej/E-2710-2017	Pattacini, Ugo/0000-0001-8754-1632; Hoffmann, Matej/0000-0001-8137-3412; Roncone, Alessandro/0000-0001-7385-1875; fadiga, luciano/0000-0001-5691-5080	European Community [FP7-ICT-270273]; Swiss National Science Foundation [PBZHP2-147259]; Marie Curie Intra European Fellowship (iCub Body Schema) within European Community [625727]; European Community project POETICON++ [FP7-ICT-2011-7]; MIUR-PRIN [2010MEFNF7_003]; European Community WYSIWYD [FP7-ICT-612139]	European Community(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Intra European Fellowship (iCub Body Schema) within European Community; European Community project POETICON++; MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); European Community WYSIWYD	AR was supported by 7th European Community Framework Programme (http://cordis.europa.eu) Xperience (FP7-ICT-270273). MH was supported by the Swiss National Science Foundation (www.snf.ch) Prospective Researcher Fellowship PBZHP2-147259 and by a Marie Curie Intra European Fellowship (iCub Body Schema 625727) within the 7th European Community Framework Programme. LF was supported by the 7th European Community Framework Programme project POETICON++ (FP7-ICT-2011-7) and by the MIUR-PRIN (http://prin.miur.it/) 2010MEFNF7_003 grant. UP and GM were supported by the 7th European Community Framework Programme project WYSIWYD (FP7-ICT-612139).	Albu-Schaffer A, 2008, IEEE ROBOT AUTOM MAG, V15, P20, DOI 10.1109/MRA.2008.927979; Antonelli Marco, 2012, From Animals to Animats 12. Proceedings of the 12th International Conference on Simulation of Adaptive Behavior, SAB 2012, P167, DOI 10.1007/978-3-642-33093-3_17; Antonelli M, 2014, IEEE T AUTON MENT DE, V6, P259, DOI 10.1109/TAMD.2014.2332875; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; BERKINBLIT MB, 1986, BEHAV BRAIN SCI, V9, P585, DOI 10.1017/S0140525X00051268; Bradski G., 2000, DOBBS J SOFTWARE TOO; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Ciliberto C, 2011, IEEE INT C INT ROBOT, P4154, DOI 10.1109/IROS.2011.6048661; Clery J, 2015, NEUROPSYCHOLOGIA, V70, P313, DOI 10.1016/j.neuropsychologia.2014.10.022; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; Corbetta D, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00576; Courty N, 2008, LECT NOTES COMPUT SC, V5098, P1, DOI 10.1007/978-3-540-70517-8_1; Dahiya R. S., 2013, ROBOTIC TACTILE SENS, DOI [10.1007/978-94-007-0579-1, DOI 10.1007/978-94-007-0579-1]; De Luca A, 2012, P IEEE RAS-EMBS INT, P288, DOI 10.1109/BioRob.2012.6290917; Del Prete A, 2011, IEEE INT C INT ROBOT, P3694, DOI 10.1109/IROS.2011.6048537; Fanello SR, 2014, HUM ROB HUM 14 IEEE; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fuke S, 2009, IEEE T AUTON MENT DE, V1, P131, DOI 10.1109/TAMD.2009.2031013; FUKSON OI, 1980, SCIENCE, V209, P1261, DOI 10.1126/science.7403886; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P2621, DOI 10.1016/j.neuropsychologia.2005.09.011; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Graziano MSA, 2000, EXP BRAIN RES, V135, P259, DOI 10.1007/s002210000518; Harrar V, 2010, EXP BRAIN RES, V203, P615, DOI 10.1007/s00221-010-2252-0; Heed T, 2015, TRENDS COGN SCI, V19, P251, DOI 10.1016/j.tics.2015.03.001; Hikita M, 2009, 7 INT C DEV LEARN IC; Hoffmann M, 2010, IEEE T AUTON MENT DE, V2, P304, DOI 10.1109/TAMD.2010.2086454; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Hulse M, 2010, IEEE T AUTON MENT DE, V2, P355, DOI 10.1109/TAMD.2010.2081667; Iriki A, 1996, NEUROREPORT, V7, P2325; Jain A, 2013, INT J ROBOT RES, V32, P458, DOI 10.1177/0278364912471865; KHATIB O, 1986, INT J ROBOT RES, V5, P90, DOI 10.1177/027836498600500106; MacKay-Lyons M, 2002, PHYS THER, V82, P69, DOI 10.1093/ptj/82.1.69; Magosso E, 2010, NEURAL COMPUT, V22, P190, DOI 10.1162/neco.2009.01-08-694; Maiolino P, 2013, IEEE SENS J, V13, P3910, DOI 10.1109/JSEN.2013.2258149; Metta G, 2010, NEURAL NETWORKS, V23, P1125, DOI 10.1016/j.neunet.2010.08.010; Mittendorfer Philipp, 2011, 2011 11th IEEE-RAS International Conference on Humanoid Robots (Humanoids 2011), P59, DOI 10.1109/Humanoids.2011.6100819; Mueller S, 2014, NEUROPSYCHOLOGIA, V62, P184, DOI 10.1016/j.neuropsychologia.2014.07.025; Parmiggiani A, 2012, INT J HUM ROBOT, V9, DOI 10.1142/S0219843612500272; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Pattacini U, 2010, P IEEE RSJ INT C INT; Pattacini U., 2011, THESIS; Piaget J., 1954, CONSTRUCTION REALITY, DOI [10.1007/s10071-014-0788-2, DOI 10.1007/S10071-014-0788-2]; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; Rizzolatti G, 2002, CURR OPIN NEUROBIOL, V12, P149, DOI 10.1016/S0959-4388(02)00308-2; Rochat P, 1998, EXP BRAIN RES, V123, P102, DOI 10.1007/s002210050550; Roncone A, 2016, SUPPORTING MAT SOURC; Roncone A, 2016, ROBOTICS: SCIENCE AND SYSTEMS XII; Roncone A, 2015, IEEE INT C INT ROBOT, P3366, DOI 10.1109/IROS.2015.7353846; Roncone A, 2014, IEEE INT CONF ROBOT, P2305, DOI 10.1109/ICRA.2014.6907178; Schaafsma SJ, 1996, J NEUROPHYSIOL, V76, P4056; Sclafani V, 2015, NEUROPSYCHOLOGIA, V70, P429, DOI 10.1016/j.neuropsychologia.2014.12.002; Shimizu T, 2012, NEURAL NETWORKS, V32, P109, DOI 10.1016/j.neunet.2012.02.011; Thomas BL, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01526; Tikhanoff V, 2013, HUM ROB HUM 13 IEEE; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363	60	32	32	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163713	10.1371/journal.pone.0163713	http://dx.doi.org/10.1371/journal.pone.0163713			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711136	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600037
J	Sammour, I; Somashekar, S; Huang, J; Batlahally, S; Breton, M; Valasaki, K; Khan, A; Wu, S; Young, KC				Sammour, Ibrahim; Somashekar, Santhosh; Huang, Jian; Batlahally, Sunil; Breton, Matthew; Valasaki, Krystalenia; Khan, Aisha; Wu, Shu; Young, Karen C.			The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury	PLOS ONE			English	Article							INDUCED PULMONARY-HYPERTENSION; BRONCHOPULMONARY DYSPLASIA; STROMAL CELLS; PRETERM INFANTS; DISEASE; THERAPY; MICE; SEX; RATS; ALVEOLARIZATION	Background Mesenchymal stem cells (MSC) improve alveolar and vascular structures in experimental models of bronchopulmonary dysplasia (BPD). Female MSC secrete more anti-inflammatory and pro-angiogenic factors as compared to male MSC. Whether the therapeutic efficacy of MSC in attenuating lung injury in an experimental model of BPD is influenced by the sex of the donor MSC or recipient is unknown. Here we tested the hypothesis that female MSC would have greater lung regenerative properties than male MSC in experimental BPD and this benefit would be more evident in males. Objective To determine whether intra-tracheal (IT) administration of female MSC to neonatal rats with experimental BPD has more beneficial reparative effects as compared to IT male MSC. Methods Newborn Sprague-Dawley rats exposed to normoxia (RA) or hyperoxia (85% O2) from postnatal day (P) 2-P21 were randomly assigned to receive male or female IT bone marrow (BM)-derived green fluorescent protein (GFP(+)) MSC (1 x 10(6) cells/ 50 mu l), or Placebo on P7. Pulmonary hypertension (PH), vascular remodeling, alveolarization, and angiogenesis were assessed at P21. PH was determined by measuring right ventricular systolic pressure (RVSP) and pulmonary vascular remodeling was evaluated by quantifying the percentage of muscularized peripheral pulmonary vessels. Alveolarization was evaluated by measuring mean linear intercept (MLI) and radial alveolar count (RAC). Angiogenesis was determined by measuring vascular density. Data are expressed as mean +/- SD, and analyzed by ANOVA. Results There were no significant differences in the RA groups. Exposure to hyperoxia resulted in a decrease in vascular density and RAC, with a significant increase in MLI, RVSP, and the percentage of partially and fully muscularized pulmonary arterioles. Administration of both male and female MSC significantly improved vascular density, alveolarization, RVSP, percent of muscularized vessels and alveolarization. Interestingly, the improvement in PH and vascular remodeling was more robust in the hyperoxic rodents who received MSC from female donors. In keeping with our hypothesis, male animals receiving female MSC, had a greater improvement in vascular remodeling. This was accompanied by a more significant decrease in lung pro-inflammatory markers and a larger increase in anti-inflammatory and pro-angiogenic markers in male rodents that received female MSC. There were no significant differences in MSC engraftment among groups. Conclusions Female BM-derived MSC have greater therapeutic efficacy than male MSC in reducing neonatal hyperoxia-induced lung inflammation and vascular remodeling. Furthermore, the beneficial effects of female MSC were more pronounced in male animals. Together, these findings suggest that female MSC maybe the most potent BM-derived MSC population for lung repair in severe BPD complicated by PH.	[Sammour, Ibrahim; Somashekar, Santhosh; Huang, Jian; Batlahally, Sunil; Wu, Shu; Young, Karen C.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA; [Sammour, Ibrahim; Somashekar, Santhosh; Huang, Jian; Wu, Shu; Young, Karen C.] Univ Miami, Miller Sch Med, Batchelor Childrens Res Inst, Miami, FL 33136 USA; [Breton, Matthew; Valasaki, Krystalenia; Khan, Aisha; Young, Karen C.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Young, KC (corresponding author), Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA.; Young, KC (corresponding author), Univ Miami, Miller Sch Med, Batchelor Childrens Res Inst, Miami, FL 33136 USA.; Young, KC (corresponding author), Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA.	Kyoung3@med.miami.edu	Sammour, Ibrahim/ABB-6915-2020		Batchelor Research Foundation	Batchelor Research Foundation	This study was supported by the Batchelor Research Foundation (KY) and Project Newborn (KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed LA, 2014, EUR J PHARMACOL, V740, P379, DOI 10.1016/j.ejphar.2014.07.026; Bhandari A, 2011, CLIN PULM MED, V18, P137, DOI [DOI 10.1097/CPM.0B013E318218A071, 10.1097/CPM.0b013e318218a071]; Bhandari A, 2013, SEMIN PERINATOL, V37, P132, DOI 10.1053/j.semperi.2013.01.010; Burchfield JS, 2008, CIRC RES, V103, P203, DOI 10.1161/CIRCRESAHA.108.178475; Cabral RM, 2011, MICROSC RES TECHNIQ, V74, P957, DOI 10.1002/jemt.20981; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Carey MA, 2007, AM J PHYSIOL-LUNG C, V293, pL272, DOI 10.1152/ajplung.00174.2007; Chang YS, 2014, J PEDIATR-US, V164, P966, DOI 10.1016/j.jpeds.2013.12.011; Chang YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052419; Chen SY, 2011, AM J PHYSIOL-LUNG C, V300, pL330, DOI 10.1152/ajplung.00270.2010; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Crisostomo PR, 2007, SURGERY, V142, P215, DOI 10.1016/j.surg.2007.04.013; Crisostomo PR, 2007, J MOL CELL CARDIOL, V42, P142, DOI 10.1016/j.yjmcc.2006.09.016; Deasy BM, 2007, J CELL BIOL, V177, P73, DOI 10.1083/jcb.200612094; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Erwin GS, 2009, J SURG RES, V152, P319, DOI 10.1016/j.jss.2008.02.006; Farstad T, 2011, ACTA PAEDIATR, V100, P53, DOI 10.1111/j.1651-2227.2010.01959.x; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Hansmann Georg, 2012, Pulm Circ, V2, P170, DOI 10.4103/2045-8932.97603; Heathman TRJ, 2016, BIOCHEM ENG J, V108, P14, DOI 10.1016/j.bej.2015.06.018; Henderson-Smart DJ, 2006, ARCH DIS CHILD-FETAL, V91, pF40, DOI 10.1136/adc.2005.072264; Huang CK, 2014, STEM CELLS, V32, P2299, DOI 10.1002/stem.1722; Ireys HT, 1997, PEDIATRICS, V100, P197, DOI 10.1542/peds.100.2.197; Jain D, 2014, BIRTH DEFECTS RES A, V100, P134, DOI 10.1002/bdra.23229; Jiang XP, 2015, CYTOTHERAPY, V17, P560, DOI 10.1016/j.jcyt.2015.02.011; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kakkera DK, 2005, BIOL NEONATE, V87, P82, DOI 10.1159/000081504; Kotecha S, 1996, PEDIATR RES, V40, P250, DOI 10.1203/00006450-199608000-00010; Latini G, 2013, EARLY HUM DEV, V89, pS69, DOI 10.1016/S0378-3782(13)70020-3; Lee JW, 2009, EXPERT OPIN BIOL TH, V9, P1259, DOI 10.1517/14712590903213651; Li HD, 2015, EXP PHYSIOL, V100, P331, DOI 10.1113/expphysiol.2014.083337; Li JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15286; Lingappan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101581; Lingappan K, 2013, TOXICOL APPL PHARM, V272, P281, DOI 10.1016/j.taap.2013.06.007; LIPKE DW, 1993, AM J RESP CELL MOL, V9, P418, DOI 10.1165/ajrcmb/9.4.418; Maniscalco WM, 2002, AM J PHYSIOL-LUNG C, V282, pL811, DOI 10.1152/ajplung.00325.2001; Manukyan MC, 2011, AM J PHYSIOL-REG I, V300, pR1506, DOI 10.1152/ajpregu.00518.2010; Melief SM, 2013, HAEMATOLOGICA, V98, P888, DOI 10.3324/haematol.2012.078055; Murtaza B, 2009, JCPSP-J COLL PHYSICI, V19, P609, DOI 10.2009/JCPSP.609613; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Ragerdi Kashani Iraj, 2012, Acta Med Iran, V50, P789; Ramachandran S, 2015, CELL TRANSPLANT, V24, P85, DOI 10.3727/096368913X667736; Siegel G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-146; Sutsko RR, 2013, PEDIATR RES, V73, P46, DOI 10.1038/pr.2012.152; Tan RB, 2013, CARDIOVASC RES, V100, P19, DOI 10.1093/cvr/cvt165; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Watkins RH, 1999, AM J PHYSIOL-LUNG C, V276, pL858, DOI 10.1152/ajplung.1999.276.5.L858; Weiss Daniel J, 2013, Ann Am Thorac Soc, V10, pS25, DOI 10.1513/AnnalsATS.201304-089AW; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Young KC, 2009, CIRC RES, V104, P1293, DOI 10.1161/CIRCRESAHA.109.197533; Zhang B, 2014, STEM CELLS DEV, V23, P1233, DOI 10.1089/scd.2013.0479	53	48	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164269	10.1371/journal.pone.0164269	http://dx.doi.org/10.1371/journal.pone.0164269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711256	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600109
J	Trinh, TT; Yatich, N; Ngomoa, R; McGrath, CJ; Richardson, BA; Sakr, SR; Langat, A; John-Stewart, GC; Chung, MH				Trinh, T. Tony; Yatich, Nelly; Ngomoa, Richard; McGrath, Christine J.; Richardson, Barbra A.; Sakr, Samah R.; Langat, Agnes; John-Stewart, Grace C.; Chung, Michael H.			Partner Disclosure and Early CD4 Response among HIV-Infected Adults Initiating Antiretroviral Treatment in Nairobi Kenya	PLOS ONE			English	Article							SEROSTATUS DISCLOSURE; SOCIAL SUPPORT; POSITIVE MEN; THERAPY; PREVENTION; WOMEN; TRANSMISSION; ADHERENCE; TANZANIA; BARRIERS	Background Disclosure of HIV serostatus can have significant benefits for people living with HIV/AIDS. However, there is limited data on whether partner disclosure influences ART treatment response. Methods We conducted a retrospective cohort study of newly diagnosed, ART-naive HIV-infected adults (>18 years) who enrolled at the Coptic Hope Center in Nairobi, Kenya between January 1st 2009 and July 1st 2011 and initiated ART within 3 months. Analysis was restricted to adults who reported to have either disclosed or not disclosed their HIV status to their partner. Analysis of CD4 response at 6 and 12 months post-ART was stratified by age group. Results Among 615 adults newly initiating ART with partner disclosure data and 12 month follow-up, mean age was 38 years and 52% were male; 76% reported that they had disclosed their HIV-status to their partner. Those who disclosed were significantly younger and more likely to be married/cohabitating than non-disclosers. At baseline, median CD4 counts were similar between disclosure groups. Among younger adults (<38 years) those who disclosed had higher CD4 recovery than those who did not at 6 months post-ART (mean difference = 31, 95% CI 3 to 58 p = 0.03) but not at 12 months (mean difference = 17, 95% CI -19 to 52, p = 0.4). Among older adults (>= 38years) there was no observed difference in CD4 recovery at 6 or 12 months between disclosure groups. Conclusion Among younger adults, disclosure of HIV status to partners may be associated with CD4 recovery following ART.	[Trinh, T. Tony; John-Stewart, Grace C.; Chung, Michael H.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Trinh, T. Tony; John-Stewart, Grace C.; Chung, Michael H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Trinh, T. Tony; John-Stewart, Grace C.; Chung, Michael H.] Univ Washington, Dept Med, Seattle, WA USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [John-Stewart, Grace C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Yatich, Nelly; Ngomoa, Richard; Sakr, Samah R.] Copt Hosp, Nairobi, Kenya; [McGrath, Christine J.] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Langat, Agnes] US Ctr Dis Control & Prevent, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Medical Branch Galveston	Trinh, TT (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Trinh, TT (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.; Trinh, TT (corresponding author), Univ Washington, Dept Med, Seattle, WA USA.	ttonytrinh@gmail.com	John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019	John-Stewart, Grace/0000-0002-4301-1573	NIH/NIAID [5T32AI7044-38]; NIH/NRSA [T32AI007140]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH/NIAID Grant 5T32AI7044-38 (TTT) and NIH/NRSA T32AI007140 (CJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, GEND DIM HIV STAT DI; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Bachanas P, 2013, AIDS PATIENT CARE ST, V27, P425, DOI 10.1089/apc.2012.0388; Birbeck GL, 2009, AM J TROP MED HYG, V80, P669, DOI 10.4269/ajtmh.2009.80.669; Brooks RA, 2011, AIDS CARE, V23, P1136, DOI 10.1080/09540121.2011.554528; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1062; Chemaitelly H, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18765; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; Crepaz N, 2003, AIDS CARE, V15, P379, DOI 10.1080/0954012031000105432; Dima AL, 2014, SOC SCI MED, V108, P166, DOI 10.1016/j.socscimed.2014.02.045; Emlet CA, 2006, AIDS PATIENT CARE ST, V20, P350, DOI 10.1089/apc.2006.20.350; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Halperin J, 2013, AIDS PATIENT CARE ST, V27, P375, DOI 10.1089/apc.2013.0037; Kalichman SC, 2003, J BEHAV MED, V26, P315, DOI 10.1023/A:1024252926930; Larkins S, 2005, AIDS CARE, V17, P521, DOI 10.1080/09540120512331314321; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Panel of Antiretroviral Guidelines for Adults and Adolescents, GUIDELINES USE ANTIR; Przybyla SM, 2013, AIDS CARE, V25, P566, DOI 10.1080/09540121.2012.722601; Sendo EG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-765; Shacham E, 2012, AIDS PATIENT CARE ST, V26, P29, DOI 10.1089/apc.2011.0183; Skogmar S, 2006, AIDS CARE, V18, P725, DOI 10.1080/09540120500307248; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Tsai AC, 2013, ANN BEHAV MED, V46, P285, DOI 10.1007/s12160-013-9514-6; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y; Waddell EN, 2006, AIDS BEHAV, V10, P263, DOI 10.1007/s10461-005-9042-x	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163594	10.1371/journal.pone.0163594	http://dx.doi.org/10.1371/journal.pone.0163594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711164	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600031
J	Hoffman, S; Exner, TM; Lince-Deroche, N; Leu, CS; Phillip, JL; Kelvin, EA; Gandhi, AD; Levin, B; Singh, D; Mantell, JE; Blanchard, K; Ramjee, G				Hoffman, Susie; Exner, Theresa M.; Lince-Deroche, Naomi; Leu, Cheng-Shiun; Phillip, Jessica L.; Kelvin, Elizabeth A.; Gandhi, Anisha D.; Levin, Bruce; Singh, Dinesh; Mantell, Joanne E.; Blanchard, Kelly; Ramjee, Gita			Immediate Blood Draw for CD4+Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ART INITIATION; RETENTION; DIAGNOSIS; SCALE; SITES	Background Timely linkage to care by newly-diagnosed HIV+ individuals remains a significant challenge to achieving UNAIDS 90-90-90 goals. Current World Health Organization (WHO) guidelines recommend initiating anti-retroviral treatment (ART) regardless of CD4+ count, with priority given to those with CD4+ <350 cells/mu l. We evaluated the impact of not having a day-of-diagnosis CD4+ count blood draw, as recommended by South African guidelines, on time to linkage, using data from a prospective cohort study. Methods Individuals (N = 2773) were interviewed prior to HIV counseling and testing at three public sector primary care clinics in the greater Durban area; 785 were newly-diagnosed and eligible for the cohort study; 459 (58.5%) joined and were followed for eight months with three structured assessments. Linkage to care, defined as returning to clinic for CD4+ count results, and day-of-diagnosis blood draw were self-reported. Results Overall, 72.5% did not have a day-of-diagnosis CD4+ count blood draw, and 19.2% of these never returned. Compared with a day-of-diagnosis blood draw, the adjusted hazard ratio of linkage (AHR(linkage)) associated with not having day-of-diagnosis blood draw was 0.66 (95% CI: 0.51, 0.85). By 4 months, 54.8% of those without day-of-diagnosis blood draw vs. 75.2% with one were linked to care (chi-squared p = 0.004). Of those who deferred blood draw, 48.3% cited clinic-related and 51.7% cited personal reasons. AHRlinkage was 0.60 (95% CI: 0.44, 0.82) for clinic-related and 0.53 (95% CI: 0.38, 0.75) for personal reasons relative to having day-of-diagnosis blood draw. Conclusions Newly-diagnosed HIV+ individuals who did not undergo CD4+ count blood draw on the day they were diagnosed-regardless of the reason for deferring-had delayed linkage to care relative to those with same-day blood draw. To enhance prompt linkage to care even when test and treat protocols are implemented, all diagnostic testing required before ART initiation should be performed on the same day as HIV testing/diagnosis. This may require modifying clinic procedures to enable overnight blood storage if same-day draws cannot be performed, and providing additional counseling to encourage newly-diagnosed individuals to complete day-of-diagnosis testing. Tracking HIV+ individuals via clinic registries should commence immediately from diagnosis to reduce these early losses to care.	[Hoffman, Susie; Exner, Theresa M.; Leu, Cheng-Shiun; Gandhi, Anisha D.; Levin, Bruce; Mantell, Joanne E.] Columbia Univ, New York State Psychiat Inst, HIV Ctr Clin & Behav Studies, New York, NY 10027 USA; [Hoffman, Susie] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Lince-Deroche, Naomi] Ibis Reprod Hlth, Johannesburg, South Africa; [Leu, Cheng-Shiun; Levin, Bruce] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Phillip, Jessica L.; Singh, Dinesh; Ramjee, Gita] South African Med Res Council, HIV Prevent Res Unit, Durban, South Africa; [Kelvin, Elizabeth A.] CUNY, Grad Sch Publ Hlth & Hlth Policy, Epidemiol & Biostat Program, New York, NY 10021 USA; [Blanchard, Kelly] Ibis Reprod Hlth, Cambridge, MA USA; [Lince-Deroche, Naomi] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hlth Econ & Epidemiol Res Off,Dept Internal Med, Johannesburg, South Africa; [Phillip, Jessica L.] Hlth Syst Trust, Midrand, South Africa	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; South African Medical Research Council; City University of New York (CUNY) System; University of Witwatersrand	Hoffman, S (corresponding author), Columbia Univ, New York State Psychiat Inst, HIV Ctr Clin & Behav Studies, New York, NY 10027 USA.; Hoffman, S (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	sh51@cumc.columbia.edu		Lince-Deroche, Naomi/0000-0003-3689-4205; Kelvin, Elizabeth/0000-0002-0566-8697	National Institute of Mental Health [R01 MH83561, R01 MH083561-03S1, T32 MH19139]; Columbia University [P30-MH43520]; South African Medical Research Council HIV Prevention Research Unit (MRC HPRU); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083561, P30MH043520, T32MH019139] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Columbia University; South African Medical Research Council HIV Prevention Research Unit (MRC HPRU); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institute of Mental Health (R01 MH83561 and R01 MH083561-03S1; Principal Investigator: Susie Hoffman, DrPH), and by a center grant from the National Institute of Mental Health to the HIV Center for Clinical and Behavioral Studies at NY State Psychiatric Institute and Columbia University [P30-MH43520; Principal Investigators: Anke A. Ehrhardt (1987-2013)/Robert H. Remien, Ph.D. (2013-2018)]. Dr. Gandhi was supported by a training grant from the National Institute of Mental Health (T32 MH19139, Behavioral Sciences Research in HIV Infection; Principal Investigator: Theo Sandfort, Ph.D.). Additional support was provided by the South African Medical Research Council HIV Prevention Research Unit (MRC HPRU). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIMH or the MRC HPRU.	Bekker LG, 2014, ANTIVIR THER, V19, P105, DOI 10.3851/IMP2905; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Drain PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055305; Fishbein M, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P3; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hoffman S, 2014, AIDS, V28, P2429, DOI 10.1097/QAD.0000000000000427; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kalichman SC, 2005, AIDS BEHAV, V9, P135, DOI 10.1007/s10461-005-3895-x; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Lahuerta M, 2013, J HEALTH CARE POOR U, V24, P359, DOI 10.1353/hpu.2013.0014; Larson BA, 2012, JAIDS-J ACQ IMM DEF, V61, pE13, DOI 10.1097/QAI.0b013e31825eec60; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; MacPherson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044794; National Department of Health Republic of South Africa, 2010, CLIN GUID MAN HIV AI; National Department of Health Republic of South Africa, 2015, NAT CONS GUID PREV M; Patten GEM, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18518; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Shisana O, 2014, S AFRICAN NATL HIV P; Skhosana M, 2016, S AFR J HIV MED, V17, DOI 10.4102/sajhivmed.v17i1.444; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; UNAIDS, 2014, 90 90 90 AMB TREATM; World Health Organization, 2015, GUID START ANT THER	25	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162085	10.1371/journal.pone.0162085	http://dx.doi.org/10.1371/journal.pone.0162085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706150	Green Published, gold			2022-12-27	WOS:000385697200007
J	Huh, S; Kim, SY; Cho, HM				Huh, Sun; Kim, Soo Young; Cho, Hye-Min			Characteristics of Retractions from Korean Medical Journals in the KoreaMed Database: A Bibliometric Analysis	PLOS ONE			English	Article							MISCONDUCT	Background Flawed or misleading articles may be retracted because of either honest scientific errors or scientific misconduct. This study explored the characteristics of retractions in medical journals published in Korea through the KoreaMed database. Methods We retrieved retraction articles indexed in the KoreaMed database from January 1990 to January 2016. Three authors each reviewed the details of the retractions including the reason for retraction, adherence to retraction guidelines, and appropriateness of retraction. Points of disagreement were reconciled by discussion among the three. Results Out of 217,839 articles in KoreaMed published from 1990 to January 2016, the publication type of 111 articles was retraction (0.051%). Of the 111 articles (addressing the retraction of 114 papers), 58.8% were issued by the authors, 17.5% were jointly issued (author, editor, and publisher), 15.8% came from editors, and 4.4% were dispatched by institutions; in 5.3% of the instances, the issuer was unstated. The reasons for retraction included duplicate publication (57.0%), plagiarism (8.8%), scientific error (4.4%), author dispute (3.5%), and other (5.3%); the reasons were unstated or unclear in 20.2%. The degree of adherence to COPE's retraction guidelines varied (79.8%-100%), and some retractions were inappropriate by COPE standards. These were categorized as follows: retraction of the first published article in the case of duplicate publication (69.2%), authorship dispute (15.4%), errata (7.7%), and other (7.7%). Conclusion The major reason for retraction in Korean medical journals is duplicate publication. Some retractions resulted from overreaction by the editors. Therefore, editors of Korean medical journals should take careful note of the COPE retraction guidelines and should undergo training on appropriate retraction practices.	[Huh, Sun] Hallym Univ, Coll Med, Dept Parasitol, Chunchon, South Korea; [Kim, Soo Young] Hallym Univ, Gangdong Sacred Heart Hosp, Coll Med, Dept Family Med, Seoul, South Korea; [Cho, Hye-Min] Infolumi Co, Songnam, South Korea	Hallym University; Hallym University	Kim, SY (corresponding author), Hallym Univ, Gangdong Sacred Heart Hosp, Coll Med, Dept Family Med, Seoul, South Korea.	hallymfm@gmail.com	Kim, Soo Young/GLR-4223-2022; Cho, Hye-Min/D-9097-2019; Huh, Sun/A-3068-2011	Cho, Hye-Min/0000-0002-1672-0200; Huh, Sun/0000-0002-8559-8640	Hallym University Research Fund [HRF-G-2015-4]	Hallym University Research Fund	This research was supported by the Hallym University (http://www.hallym.ac.kr) Research Fund (HRF-G-2015-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HM Cho is employed by a commercial company: Infolumi Co, Inforumi. The company did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries. The specific roles of these authors are articulated in the 'author contributions' section.	Budd JM, 1998, JAMA-J AM MED ASSOC, V280, P296, DOI 10.1001/jama.280.3.296; Choi J, 2016, SCI ED, V3, P26, DOI 10.6087/kcse.59; COPE (Committee on Publication Ethics), 2009, RETR GUID; Fang FC, 2012, P NATL ACAD SCI USA, V109, P17028, DOI 10.1073/pnas.1212247109; Furman JL, 2012, RES POLICY, V41, P276, DOI 10.1016/j.respol.2011.11.001; Kim SY, 2014, J KOREAN MED SCI, V29, P172, DOI 10.3346/jkms.2014.29.2.172; Lammey R, 2014, SCI ED, V1, P13, DOI [10.6087/kcse.2014.1.84, 10.6087/kcse.2014.1.13, 10.6087/kcse.2014.1.76]; Nath SB, 2006, MED J AUSTRALIA, V185, P152, DOI 10.5694/j.1326-5377.2006.tb00504.x; Steen RG, 2011, J MED ETHICS, V37, P249, DOI 10.1136/jme.2010.040923; US National Library of Medicine, 2015, FACT SHEET ERR RETR; Wager E, 2015, SCI ED, V2, P32, DOI 10.6087/kcse.34; Wager E, 2011, J MED ETHICS, V37, P567, DOI 10.1136/jme.2010.040964	12	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163588	10.1371/journal.pone.0163588	http://dx.doi.org/10.1371/journal.pone.0163588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706245	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697200048
J	Patel, NM; Moore, JD; Blackwell, HE; Amador-Noguez, D				Patel, Nishaben M.; Moore, Joseph D.; Blackwell, Helen E.; Amador-Noguez, Daniel			Identification of Unanticipatedand Novel N-Acyl L-Homoserine Lactones (AHLs) Using a Sensitive Non-Targeted LC-MS/MS Method	PLOS ONE			English	Article							QUORUM-SENSING SIGNAL; PSEUDOMONAS-AERUGINOSA; ACYLHOMOSERINE LACTONES; BIOFILM FORMATION; EXOPOLYSACCHARIDE PRODUCTION; YERSINIA-PSEUDOTUBERCULOSIS; MOLECULES; SYSTEM; VIRULENCE; GROWTH	N-acyl L-homoserine lactones (AHLs) constitute a predominant class of quorum-sensing signaling molecules used by Gram-negative bacteria. Here, we report a sensitive and non-targeted HPLC-MS/MS method based on parallel reaction monitoring (PRM) to identify and quantitate known, unanticipated, and novel AHLs in microbial samples. Using a hybrid quadrupole-high resolution mass analyzer, this method integrates MS scans and all-ion fragmentation MS/MS scans to allow simultaneous detection of AHL parent-ion masses and generation of full mass spectra at high resolution and high mass accuracy in a single chromatographic run. We applied this method to screen for AHL production in a variety of Gram-negative bacteria (i.e. B. cepacia, E. tarda, E. carotovora, E. herbicola, P. stewartii, P. aeruginosa, P. aureofaciens, and R. sphaeroides) and discovered that nearly all of them produce a larger set of AHLs than previously reported. Furthermore, we identified production of an uncommon AHL (i.e. 3-oxo-C7-HL) in E. carotovora and P. stewartii, whose production has only been previously observed within the genera Serratia and Yersinia. Finally, we used our method to quantitate AHL degradation in B. cepacia, E. carotovora, E. herbicola, P. stewartii, P. aeruginosa, P. aureofaciens, the non-AHL producer E. coli, and the Gram-positive bacterium B. subtilis. We found that AHL degradation ability varies widely across these microbes, of which B. subtilis and E. carotovora are the best degraders, and observed that there is a general trend for AHLs containing long acyl chains (>= 10 carbons) to be degraded at faster rates than AHLs with short acyl chains (<= 6 carbons).	[Patel, Nishaben M.; Amador-Noguez, Daniel] Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA; [Patel, Nishaben M.] Univ Wisconsin, Sci Bacteriol Program, Madison, WI 53706 USA; [Moore, Joseph D.; Blackwell, Helen E.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Amador-Noguez, D (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	amadornoguez@wisc.edu		Patel, Nishaben/0000-0003-4724-5710	NSF [CHE-1213526]; Burroughs Welcome Fund; UW-Madison NIH Biotechnology Training Program [5 T32 GM008349]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Burroughs Welcome Fund(Burroughs Wellcome Fund); UW-Madison NIH Biotechnology Training Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	H.E.B. acknowledges the NSF (CHE-1213526) and the Burroughs Welcome Fund for support of this work in her laboratory. J.D.M was supported in part by the UW-Madison NIH Biotechnology Training Program (5 T32 GM008349).	Barnard AML, 2007, PHILOS T R SOC B, V362, P1165, DOI 10.1098/rstb.2007.2042; Burton EO, 2005, APPL ENVIRON MICROB, V71, P4906, DOI 10.1128/AEM.71.8.4906-4909.2005; Charlesworth J, 2015, J MICROBIOL METH, V118, P164, DOI 10.1016/j.mimet.2015.09.012; Chen F, 2013, INT J MOL SCI, V14, P17477, DOI 10.3390/ijms140917477; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Czajkowski R, 2009, ACTA BIOCHIM POL, V56, P1; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; Dong YH, 2005, J MICROBIOL, V43, P101; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Fetzner S, 2015, J BIOTECHNOL, V201, P2, DOI 10.1016/j.jbiotec.2014.09.001; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Galloway WRJD, 2011, CHEM REV, V111, P28, DOI 10.1021/cr100109t; Geske GD, 2007, J AM CHEM SOC, V129, P13613, DOI 10.1021/ja074135h; Gould TA, 2006, J BACTERIOL, V188, P773, DOI 10.1128/JB.188.2.773-783.2006; Grandclement C, 2016, FEMS MICROBIOL REV, V40, P86, DOI 10.1093/femsre/fuv038; Han Y, 2010, J APPL MICROBIOL, V108, P139, DOI 10.1111/j.1365-2672.2009.04405.x; Hong KW, 2012, SENSORS-BASEL, V12, P4661, DOI 10.3390/s120404661; Horng YT, 2002, MOL MICROBIOL, V45, P1655, DOI 10.1046/j.1365-2958.2002.03117.x; Huang JJ, 2003, APPL ENVIRON MICROB, V69, P5941, DOI 10.1128/AEM.69.10.5941-5949.2003; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Lindemann A, 2011, P NATL ACAD SCI USA, V108, P16765, DOI 10.1073/pnas.1114125108; Lithgow JK, 2000, MOL MICROBIOL, V37, P81, DOI 10.1046/j.1365-2958.2000.01960.x; Liu M, 2007, J APPL MICROBIOL, V103, P2174, DOI 10.1111/j.1365-2672.2007.03488.x; Liu X, 2010, WORLD J MICROB BIOT, V26, P1465, DOI 10.1007/s11274-010-0321-y; Liu XG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-26; Maddula VSRK, 2006, MICROB ECOL, V52, P289, DOI 10.1007/s00248-006-9064-6; Marketon MM, 2003, J BACTERIOL, V185, P325, DOI 10.1128/JB.185.1.325-331.2003; MCKENNEY D, 1995, J BACTERIOL, V177, P6989, DOI 10.1128/jb.177.23.6989-6992.1995; Medina-Martinez MS, 2007, APPL ENVIRON MICROB, V73, P2329, DOI 10.1128/AEM.01993-06; Minogue TD, 2002, MOL MICROBIOL, V44, P1625, DOI 10.1046/j.1365-2958.2002.02987.x; Moore JD, 2015, J AM CHEM SOC, V137, P14626, DOI 10.1021/jacs.5b06728; Morin D, 2003, J CHROMATOGR A, V1002, P79, DOI 10.1016/S0021-9673(03)00730-1; Morohoshi T, 2004, J BIOSCI BIOENG, V98, P274, DOI 10.1016/S1389-1723(04)00281-6; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; Ortori CA, 2007, ANAL BIOANAL CHEM, V387, P497, DOI 10.1007/s00216-006-0710-0; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; Palmer AG, 2014, ACS CHEM BIOL, V9, P1834, DOI 10.1021/cb500191a; Pana J, 2008, MICROBIOL RES, V163, P711, DOI 10.1016/j.micres.2007.12.002; Penalver CGN, 2006, FEBS LETT, V580, P561, DOI 10.1016/j.febslet.2005.12.062; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; Purohit AA, 2013, J APPL MICROBIOL, V115, P835, DOI 10.1111/jam.12264; Puskas A, 1997, J BACTERIOL, V179, P7530, DOI 10.1128/jb.179.23.7530-7537.1997; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Schu DJ, 2009, J BACTERIOL, V191, P7402, DOI 10.1128/JB.00994-09; Sio CF, 2006, INFECT IMMUN, V74, P1673, DOI 10.1128/IAI.74.3.1673-1682.2006; SISTROM WR, 1960, J GEN MICROBIOL, V22, P778, DOI 10.1099/00221287-22-3-778; Steidle A, 2002, APPL ENVIRON MICROB, V68, P6371, DOI 10.1128/AEM.68.12.6371-6382.2002; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Uroz S, 2008, FEMS MICROBIOL ECOL, V65, P271, DOI 10.1111/j.1574-6941.2008.00477.x; Venturi V, 2004, RES MICROBIOL, V155, P238, DOI 10.1016/j.resmic.2004.01.006; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; VONBODMAN SB, 1995, J BACTERIOL, V177, P5000, DOI 10.1128/JB.177.17.5000-5008.1995; Wahjudi M, 2011, MICROBIOL-SGM, V157, P2042, DOI 10.1099/mic.0.043935-0; Wang LH, 2004, J BIOL CHEM, V279, P13645, DOI 10.1074/jbc.M311194200; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Welsh MA, 2016, FEMS MICROBIOL REV, V40, P774, DOI 10.1093/femsre/fuw009; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Wisniewski-Dye F, 2002, J BACTERIOL, V184, P1597, DOI 10.1128/JB.184.6.1597-1606.2002; Wisniewski-Dye F, 2002, ANTON LEEUW INT J G, V81, P397, DOI 10.1023/A:1020501104051; Wood DW, 1997, J BACTERIOL, V179, P7663, DOI 10.1128/jb.179.24.7663-7670.1997; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang Z, 2011, APPL ENVIRON MICROB, V67, P4305, DOI [10.1128/AEM.67.9.4305, DOI 10.1128/AEM.67.9.4305]; Zhang ZG, 2001, APPL ENVIRON MICROB, V67, P4305, DOI 10.1128/AEM.67.9.4305-4315.2001; Zhu J, 1998, J BACTERIOL, V180, P5398, DOI 10.1128/JB.180.20.5398-5405.1998	72	39	40	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163469	10.1371/journal.pone.0163469	http://dx.doi.org/10.1371/journal.pone.0163469			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706219	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697200046
J	Wilson, C; Perkin, OJ; McGuigan, MP; Stokes, KA				Wilson, Cassie; Perkin, Oliver J.; McGuigan, Miranda P.; Stokes, Keith A.			The Effect of Age on Technique Variability and Outcome Variability during a Leg Press	PLOS ONE			English	Article							RELATIVE PHASE; MUSCLE POWER; ADULTS; COORDINATION; STRENGTH; HEALTHY	The aim of this study was to determine the effect of aging on power generation and joint coordination during a leg press, in order to increase understanding of how functional movements are affected during the aging process. 44 older and 24 younger adults performed eight sub-maximal power repetitions on a seated leg press dynamometer. Peak power and velocity (at 40% maximum resistance) were measured along with the coordination (coupling angle) of the lower limb joints using the vector coding technique. The younger adults produced significantly greater peak power than the older adults (mean +/- SD; 762W +/- 245 vs 361W +/- 162, p < 0.01) and at higher peak velocities (mean +/- SD; 1.37 m/s +/- 0.05 vs 1.00 m/s +/- 0.06, p < 0.01). The older adults produced less consistent values of peak power than younger adults, evidenced by a higher coefficient of variation (mean +/- SD; 7.6% +/- 5.2 vs 5.0% +/- 3.0, p < 0.01), however, there was significantly less variability in the coupling angles displayed by the older adults compared to the younger adults (mean +/- SD; 2.0 degrees +/- 1.1 vs 3.5 degrees +/- 2.7, p < 0.01 (ankle-knee); 1.7 degrees +/- 0.6 vs 4.1 degrees +/- 3.0, p < 0.01 (knee-hip)). The results of this study demonstrate that older adults display higher outcome variability but lower variability in technique (coordination). The more rigid movement strategies displayed by the older adults potentially reflects an increased risk of overuse injury due to repetitive demands on the same structures, or the reduced ability to respond to unexpected situations due to a lack of flexibility in joint control.	[Wilson, Cassie; Perkin, Oliver J.; McGuigan, Miranda P.; Stokes, Keith A.] Univ Bath, Dept Hlth, Bath, Avon, England; [Perkin, Oliver J.; Stokes, Keith A.] Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Bath, Avon, England	University of Bath	Wilson, C (corresponding author), Univ Bath, Dept Hlth, Bath, Avon, England.	c.wilson3@bath.ac.uk	; Stokes, Keith/C-2605-2009	Perkin, Oliver/0000-0001-8921-8708; Stokes, Keith/0000-0002-5049-2838				ARUTYUNYAN GA, 1969, BIOPHYS-USSR, V14, P1162; Bartletti R, 2007, SPORT BIOMECH, V6, P224, DOI 10.1080/14763140701322994; Batschelet E, 1981, CIRCULAR STAT BIOL; Bemben MG, 1999, J STRENGTH COND RES, V13, P330; BROOKS SV, 1994, MED SCI SPORT EXER, V26, P432; BROOKS SV, 1991, J GERONTOL, V46, pB28, DOI 10.1093/geronj/46.1.B28; BURGESSLIMERICK R, 1993, J BIOMECH, V26, P91, DOI 10.1016/0021-9290(93)90617-N; Christou EA, 2011, EXERC SPORT SCI REV, V39, P77, DOI 10.1097/JES.0b013e31820b85ab; Cofre LE, 2010, IFMBE PROC, V31, P301, DOI 10.1007/978-3-642-14515-5_78; Cohen J.E., 1988, STAT POWER ANAL BEHA; Fejer R, 2012, CHIROPR MAN THER, V20, DOI 10.1186/2045-709X-20-31; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haguenauer M, 2005, J APPL BIOMECH, V21, P236, DOI 10.1123/jab.21.3.236; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Hein T, 2012, HUM MOVEMENT SCI, V31, P683, DOI 10.1016/j.humov.2011.07.008; Hsu WL, 2014, EUR J APPL PHYSIOL, V114, P261, DOI 10.1007/s00421-013-2768-7; Laidlaw DH, 2000, MUSCLE NERVE, V23, P600, DOI 10.1002/(SICI)1097-4598(200004)23:4<600::AID-MUS20>3.3.CO;2-4; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; MAYHEW JL, 1990, EUR J APPL PHYSIOL, V60, P133, DOI 10.1007/BF00846033; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Michel-Pellegrino V, 2008, J AGING PHYS ACTIV, V16, P171, DOI 10.1123/japa.16.2.171; MORASSO P, 1981, EXP BRAIN RES, V42, P223; MORGAN M, 1994, J GERONTOL, V49, pM133, DOI 10.1093/geronj/49.3.M133; O'Connor KM, 2009, MED SCI SPORT EXER, V41, P867, DOI 10.1249/MSS.0b013e31818f8743; Reid KF, 2014, EUR J APPL PHYSIOL, V114, P29, DOI 10.1007/s00421-013-2728-2; Reid KF, 2012, EXERC SPORT SCI REV, V40, P4, DOI 10.1097/JES.0b013e31823b5f13; Schmorrow D, 2009, FDN AUGMENTED COGNIT; Seidler-Dobrin R D, 1998, Motor Control, V2, P314; Sleimen-Malkoun R, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-145; SPARROW WA, 1987, J MOTOR BEHAV, V19, P115, DOI 10.1080/00222895.1987.10735403; Tucker MG, 2008, HUM MOVEMENT SCI, V27, P728, DOI 10.1016/j.humov.2008.03.002; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; Wheat JS, 2006, MOVEMENT SYSTEM VARI, P153; Wilson C, 2008, SPORT BIOMECH, V7, P2, DOI 10.1080/14763140701682983	35	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163764	10.1371/journal.pone.0163764	http://dx.doi.org/10.1371/journal.pone.0163764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701431	Green Published, Green Submitted, gold			2022-12-27	WOS:000385696900019
J	Gil, B; Hwang, EJ; Lee, S; Jang, J; Choi, HS; Jung, SL; Ahn, KJ; Kim, BS				Gil, Bomi; Hwang, Eo-Jin; Lee, Song; Jang, Jinhee; Choi, Hyun Seok; Jung, So-Lyung; Ahn, Kook-Jin; Kim, Bum-soo			Detection of Leptomeningeal Metastasis by Contrast-Enhanced 3D T1-SPACE: Comparison with 2D FLAIR and Contrast-Enhanced 2D T1-Weighted Images	PLOS ONE			English	Article							BRAIN METASTASIS; MR; ECHO; EXPERIENCE; DIAGNOSIS; TUMORS	Introduction To compare the diagnostic accuracy of contrast-enhanced 3D(dimensional) T1-weighted sampling perfection with application-optimized contrasts by using different flip angle evolutions (T1-SPACE), 2D fluid attenuated inversion recovery (FLAIR) images and 2D contrast-enhanced T1-weighted image in detection of leptomeningeal metastasis except for invasive procedures such as a CSF tapping. Materials and Methods Three groups of patients were included retrospectively for 9 months (from 2013-04-01 to 2013-12-31). Group 1 patients with positive malignant cells in CSF cytology (n = 22); group 2, stroke patients with steno-occlusion in ICA or MCA (n = 16); and group 3, patients with negative results on MRI, whose symptom were dizziness or headache (n = 25). A total of 63 sets of MR images are separately collected and randomly arranged: (1) CE 3D T1SPACE; (2) 2D FLAIR; and (3) CE T1-GRE using a 3-Tesla MR system. A faculty neuroradiologist with 8-year-experience and another 2nd grade trainee in radiology reviewed each MR image-blinded by the results of CSF cytology and coded their observations as positives or negatives of leptomeningeal metastasis. The CSF cytology result was considered as a gold standard. Sensitivity and specificity of each MR images were calculated. Diagnostic accuracy was compared using a McNemar's test. A Cohen's kappa analysis was performed to assess inter-observer agreements. Results Diagnostic accuracy was not different between 3D T1-SPACE and CSF cytology by both raters. However, the accuracy test of 2D FLAIR and 2D contrast-enhanced T1-weighted GRE was inconsistent by the two raters. The Kappa statistic results were 0.657 (3D T1-SPACE), 0.420 (2D FLAIR), and 0.160 (2D contrast-enhanced T1-weighted GRE). The 3D T1-SPACE images showed the highest inter-observer agreements between the raters. Conclusions Compared to 2D FLAIR and 2D contrast-enhanced T1-weighted GRE, contrast-enhanced 3D T1 SPACE showed a better detection rate of leptomeningeal metastasis.	[Gil, Bomi; Hwang, Eo-Jin; Lee, Song; Jang, Jinhee; Choi, Hyun Seok; Jung, So-Lyung; Ahn, Kook-Jin; Kim, Bum-soo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Choi, HS (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea.	hschoi@catholic.ac.kr		Kim, Bum-soo/0000-0002-3870-6813; Choi, Hyun Seok/0000-0003-4999-8513				BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; CHAMBERLAIN MC, 1990, NEUROLOGY, V40, P435, DOI 10.1212/WNL.40.3_Part_1.435; Chou M S, 1994, Gaoxiong Yi Xue Ke Xue Za Zhi, V10, P186; DAVIS PC, 1987, RADIOLOGY, V163, P449, DOI 10.1148/radiology.163.2.3562825; FREILICH RJ, 1995, ANN NEUROL, V38, P51, DOI 10.1002/ana.410380111; Kaal EC, 2005, LANCET NEUROL, V4, P289, DOI 10.1016/S1474-4422(05)70072-7; Kato Y, 2009, AM J NEURORADIOL, V30, P923, DOI 10.3174/ajnr.A1506; Kim ES, 2010, AM J NEURORADIOL, V31, P1055, DOI 10.3174/ajnr.A2010; Kitajima M, 2012, AM J NEURORADIOL, V33, P922, DOI 10.3174/ajnr.A2874; Komada Tomohiro, 2008, Magn Reson Med Sci, V7, P13, DOI 10.2463/mrms.7.13; MUGLER JP, 1993, JMRI-J MAGN RESON IM, V3, P761, DOI 10.1002/jmri.1880030512; Naganawa S, 2015, MAGN RESON MED SCI, V14, P203, DOI [10.2463/mrms.mp.2015-0065, 10.2463/mrms.2014-0112]; Pakdaman MN, 2016, AM J NEURORADIOL, V37, P1903, DOI 10.3174/ajnr.A4822; ROGERS LR, 1992, NEUROLOGY, V42, P1239, DOI 10.1212/WNL.42.6.1239; Singh SK, 2000, RADIOLOGY, V217, P50, DOI 10.1148/radiology.217.1.r00oc3550; Singh SK, 2002, AM J NEURORADIOL, V23, P817; SZE G, 1989, AM J ROENTGENOL, V153, P1039, DOI 10.2214/ajr.153.5.1039; WASSERSTROM WR, 1982, CANCER, V49, P759, DOI 10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7; WENZ F, 1994, MAGN RESON IMAGING, V12, P553, DOI 10.1016/0730-725X(94)92449-X; Yang S, 2013, INVEST RADIOL, V48, P113, DOI 10.1097/RLI.0b013e318277f078	20	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163081	10.1371/journal.pone.0163081	http://dx.doi.org/10.1371/journal.pone.0163081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695096	gold, Green Submitted, Green Published			2022-12-27	WOS:000385553100023
J	Nyberg, T; Myrberg, IH; Omerov, P; Steineck, G; Nyberg, U				Nyberg, Tommy; Myrberg, Ida Hed; Omerov, Pernilla; Steineck, Gunnar; Nyberg, Ullakarin			Depression among Parents Two to Six Years Following the Loss of a Child by Suicide: A Novel Prediction Model	PLOS ONE			English	Article							PSYCHIATRIC-ILLNESS; BEREAVED PARENTS; TRAUMATIC GRIEF; RISK-FACTOR; DEATH; SEVERITY; DURATION; SUDDEN; HEALTH; IMPACT	Background Parents who lose a child by suicide have elevated risks of depression. No clinical prediction tools exist to identify which suicide-bereaved parents will be particularly vulnerable; we aimed to create a prediction model for long-term depression for this purpose. Method During 2009 and 2010 we collected data using a nationwide study-specific questionnaire among parents in Sweden who had lost a child aged 15-30 by suicide in years 2004-2007. Current depression was assessed with the Patient Health Questionnaire (PHQ-9) and a single question on antidepressant use. We considered 26 potential predictors assumed clinically assessable at the time of loss, including socio-economics, relationship status, history of psychological stress and morbidity, and suicide-related circumstances. We developed a novel prediction model using logistic regression with all subsets selection and stratified cross-validation. The model was assessed for classification performance and calibration, overall and stratified by time since loss. Results In total 666/915 (73%) participated. The model showed acceptable classification performance (adjusted area under the curve [AUC] = 0.720, 95% confidence interval [CI] 0.673-0.766), but performed classification best for those at shortest time since loss. Agreement between model-predicted and observed risks was fair, but with a tendency for underestimation and overestimation for individuals with shortest and longest time since loss, respectively. The identified predictors include female sex (odds ratio [OR] = 1.84); sick-leave (OR = 2.81) or unemployment (OR = 1.64); psychological premorbidity debuting during the last 10 years, before loss (OR = 3.64), or more than 10 years ago (OR = 4.96); suicide in biological relatives (OR = 1.54); with non-legal guardianship during the child's upbringing (OR = 0.48); and non-biological parenthood (OR = 0.22) found as protective. Conclusions Our prediction model shows promising internal validity, but should be externally validated before application. Psychological premorbidity seems to be a prominent predictor of long-term depression among suicide-bereaved parents, and thus important for healthcare providers to assess.	[Nyberg, Tommy; Steineck, Gunnar] Karolinska Inst, Div Clin Canc Epidemiol, Dept Oncol Pathol, Stockholm, Sweden; [Myrberg, Ida Hed] Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Omerov, Pernilla] Ersta Skondal Univ Coll, Dept Hlth Care Sci, Stockholm, Sweden; [Steineck, Gunnar] Univ Gothenburg, Sahlgrenska Acad, Div Clin Canc Epidemiol, Dept Oncol,Inst Clin Sci, Gothenburg, Sweden; [Nyberg, Ullakarin] Karolinska Inst, Stockholm Ctr Psychiat Res & Educ, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Karolinska Institutet	Nyberg, T (corresponding author), Karolinska Inst, Div Clin Canc Epidemiol, Dept Oncol Pathol, Stockholm, Sweden.	tommy.nyberg@ki.se	Steineck, Gunnar/W-1515-2019; Nyberg, Tommy/AGG-2330-2022; Omerov, Pernilla/Y-8340-2019; Omerov, Pernilla/N-5127-2017	Steineck, Gunnar/0000-0002-0787-3969; Nyberg, Tommy/0000-0002-9436-0626; Omerov, Pernilla/0000-0003-1835-1960; Omerov, Pernilla/0000-0003-1835-1960; Hed Myrberg, Ida/0000-0002-8297-2238	Swedish Council for Working Life and Social Research (FAS) [2006-1099]; ALF Grants, County Council of Stockholm [20110338]	Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); ALF Grants, County Council of Stockholm	The study was supported by The Swedish Council for Working Life and Social Research (FAS) (grant 2006-1099, http://www.forte.se/, grant recipient: UN), and ALF Grants, County Council of Stockholm (grant 20110338, www.forskningsstod.sll.se, grant recipient: UN). The funders had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	Agerbo E, 2005, J EPIDEMIOL COMMUN H, V59, P407, DOI 10.1136/jech.2004.024950; Bolton JM, 2013, JAMA PSYCHIAT, V70, P158, DOI 10.1001/jamapsychiatry.2013.275; Brent D, 2009, AM J PSYCHIAT, V166, P786, DOI 10.1176/appi.ajp.2009.08081244; BREWIN CR, 1993, PSYCHOL BULL, V113, P82, DOI 10.1037/0033-2909.113.1.82; Brown GW, 2008, J AFFECT DISORDERS, V111, P1, DOI 10.1016/j.jad.2008.04.009; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Cvinar JG, 2005, PERSPECT PSYCHIATR C, V41, P14, DOI 10.1111/j.0031-5990.2005.00004.x; de Groot M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5519; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dyregrov K, 2003, DEATH STUD, V27, P143, DOI 10.1080/07481180302892; Feigelman W, 2008, OMEGA-J DEATH DYING, V58, P251, DOI 10.2190/OM.58.4.a; Forte Amanda L, 2004, BMC Palliat Care, V3, P3, DOI 10.1186/1472-684X-3-3; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Halfin A, 2007, AM J MANAG CARE, V13, pS92; Harrell FE, 2001, REGRESSION MODELING; Hjern A, 2002, LANCET, V360, P443, DOI 10.1016/S0140-6736(02)09674-5; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Kessing LV, 2003, PSYCHOL MED, V33, P1177, DOI 10.1017/S0033291703007852; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Kreicbergs U, 2004, PSYCHOL MED, V34, P1431, DOI 10.1017/S0033291704002740; Kristensen P, 2012, PSYCHIATRY, V75, P76, DOI 10.1521/psyc.2012.75.1.76; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Ljung T, 2014, PSYCHOL MED, V44, P1879, DOI 10.1017/S0033291713002572; MANSFIELD ER, 1982, AM STAT, V36, P158, DOI 10.2307/2683167; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Meij LWD, 2005, J CONSULT CLIN PSYCH, V73, P617, DOI 10.1037/0022-006X.73.4.617; Melhem NM, 2004, AM J PSYCHIAT, V161, P1411, DOI 10.1176/appi.ajp.161.8.1411; Nomograms Banks J., 1985, ENCY STAT SCI, V6; Omerov P, 2014, PSYCHOL MED, V44, P3409, DOI 10.1017/S0033291713001670; Omerov P, 2017, SUICIDE LIFE-THREAT, V47, P38, DOI 10.1111/sltb.12260; Omerov P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101799; Omerov P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003108; Omerov P, 2013, CRISIS, V34, P200, DOI 10.1027/0227-5910/a000175; Petrie Keith J, 2013, JRSM Short Rep, V4, p2042533313493271, DOI 10.1177/2042533313493271; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Prigerson HG, 1997, AM J PSYCHIAT, V154, P616, DOI 10.1176/ajp.154.5.616; Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797; Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Stroebe MS, 2006, SOC SCI MED, V63, P2440, DOI 10.1016/j.socscimed.2006.06.012; Tidemalm D, 2011, PSYCHOL MED, V41, P2527, DOI 10.1017/S0033291711000833; von Borczyskowski A, 2011, PSYCHOL MED, V41, P749, DOI 10.1017/S0033291710001315; Wakefield JC, 2011, ACTA PSYCHIAT SCAND, V124, P487, DOI 10.1111/j.1600-0447.2011.01768.x; Wang M, 2014, OCCUP ENVIRON MED, V71, P12, DOI 10.1136/oemed-2013-101462; Windish DM, 2007, JAMA-J AM MED ASSOC, V298, P1010, DOI 10.1001/jama.298.9.1010	48	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164091	10.1371/journal.pone.0164091	http://dx.doi.org/10.1371/journal.pone.0164091			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695063	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100089
J	Pruyne, D				Pruyne, David			Revisiting the Phylogeny of the Animal Formins: Two New Subtypes, Relationships with Multiple Wing Hairs Proteins, and a Lost Human Formin	PLOS ONE			English	Article							F-ACTIN; DOMAIN; ACTIVATION; MUTATIONS; ALIGNMENT; WORMBASE; POSITION; DISEASE; SEARCH; GENES	Formins are a widespread family of eukaryotic cytoskeleton-organizing proteins. Many species encode multiple formin isoforms, and for animals, much of this reflects the presence of multiple conserved subtypes. Earlier phylogenetic analyses identified seven major formin subtypes in animals (DAAM, DIAPH, FHOD, FMN, FMNL, INF, and GRID2IP/delphilin), but left a handful of formins, particularly from nematodes, unassigned. In this new analysis drawing from genomic data from a wider range of taxa, nine formin subtypes are identified that encompass all the animal formins analyzed here. Included in this analysis are Multiple Wing Hairs proteins (MWH), which bear homology to formin N-terminal domains. Originally identified in Drosophila melanogaster and other arthropods, MWH-related proteins are also identified here in some nematodes (including Caenorhabditis elegans), and are shown to be related to a novel MWH-related formin (MWHF) subtype. One surprising result of this work is the discovery that a family of pleckstrin homology domain-containing formins (PHCFs) is represented in many vertebrates, but is strikingly absent from placental mammals. Consistent with a relatively recent loss of this formin, the human genome retains fragments of a defunct homologous formin gene.	[Pruyne, David] SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Pruyne, D (corresponding author), SUNY Upstate Med Univ, Dept Cell & Dev Biol, Syracuse, NY 13210 USA.	pruyned@upstate.edu			National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health [R01AR064760]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064760] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	DP was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, http://www.niams.nih.gov/, through grant number R01AR064760. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amin NM, 2007, DEVELOPMENT, V134, P19, DOI 10.1242/dev.02709; Arimura T, 2013, CIRC J, V77, P2990, DOI 10.1253/circj.CJ-13-0255; Bohnert KA, 2013, BIOCHEM SOC T, V41, P1750, DOI 10.1042/BST20130208; Bor B, 2012, MOL BIOL CELL, V23, P3801, DOI 10.1091/mbc.E12-04-0288; Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Brown Elizabeth J, 2010, Nat Genet, V42, P72, DOI 10.1038/ng.505; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chalkia D, 2008, MOL BIOL EVOL, V25, P2717, DOI 10.1093/molbev/msn215; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; Ercan-Sencicek AG, 2015, EUR J HUM GENET, V23, P165, DOI 10.1038/ejhg.2014.82; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Grunt M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-115; Halanych KM, 2015, J EXP BIOL, V218, P592, DOI 10.1242/jeb.111872; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heimsath Ernest G Jr, 2012, J Biol Chem, V287, P3087, DOI 10.1074/jbc.M111.312207; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Howe KL, 2016, NUCLEIC ACIDS RES, V44, pD774, DOI 10.1093/nar/gkv1217; Johnston RJ, 2006, DEVELOPMENT, V133, P3317, DOI 10.1242/dev.02494; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Law R, 2014, AM J HUM GENET, V95, P721, DOI 10.1016/j.ajhg.2014.10.016; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lei MM, 2012, J CELL BIOL, V198, P87, DOI 10.1083/jcb.201202053; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Lu QH, 2015, DEVELOPMENT, V142, P2478, DOI 10.1242/dev.122119; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Nei M., 2000, MOL EVOLUTION PHYLOG; Nosenko T, 2013, MOL PHYLOGENET EVOL, V67, P223, DOI 10.1016/j.ympev.2013.01.010; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Rivero F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-28; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shaye DD, 2015, DEV CELL, V32, P743, DOI 10.1016/j.devcel.2015.01.009; Strutt D, 2008, DEVELOPMENT, V135, P3103, DOI 10.1242/dev.025205; Swan KA, 1998, J CELL SCI, V111, P2017; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka H, 2004, DEV BIOL, V274, P413, DOI 10.1016/j.ydbio.2004.07.035; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaillant DC, 2008, J BIOL CHEM, V283, P33750, DOI 10.1074/jbc.M803156200; Vizcarra CL, 2014, J BIOL CHEM, V289, P30602, DOI 10.1074/jbc.M114.588368; Watanabe S, 2008, MOL BIOL CELL, V19, P2328, DOI 10.1091/mbc.E07-10-1086; Wooten EC, 2013, CIRC-CARDIOVASC GENE, V6, P10, DOI 10.1161/CIRCGENETICS.112.965277; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Yan J, 2008, GENETICS, V180, P219, DOI 10.1534/genetics.108.091314; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	54	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164067	10.1371/journal.pone.0164067	http://dx.doi.org/10.1371/journal.pone.0164067			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695129	Green Submitted, gold, Green Published			2022-12-27	WOS:000385553100084
J	Stavridi, F; Kalogeras, KT; Pliarchopoulou, K; Wirtz, RM; Alexopoulou, Z; Zagouri, F; Veltrup, E; Timotheadou, E; Gogas, H; Koutras, A; Lazaridis, G; Christodoulou, C; Pentheroudakis, G; Laskarakis, A; Arapantoni-Dadioti, P; Batistatou, A; Sotiropoulou, M; Aravantinos, G; Papakostas, P; Kosmidis, P; Pectasides, D; Fountzilas, G				Stavridi, Flora; Kalogeras, Konstantine T.; Pliarchopoulou, Kyriaki; Wirtz, Ralph M.; Alexopoulou, Zoi; Zagouri, Flora; Veltrup, Elke; Timotheadou, Eleni; Gogas, Helen; Koutras, Angelos; Lazaridis, Georgios; Christodoulou, Christos; Pentheroudakis, George; Laskarakis, Apostolos; Arapantoni-Dadioti, Petroula; Batistatou, Anna; Sotiropoulou, Maria; Aravantinos, Gerasimos; Papakostas, Pavlos; Kosmidis, Paris; Pectasides, Dimitrios; Fountzilas, George			Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study	PLOS ONE			English	Article							DENSE SEQUENTIAL CHEMOTHERAPY; MESSENGER-RNA EXPRESSION; RANDOMIZED PHASE-III; DISTANT RECURRENCE; ADJUVANT ONLINE; RHO-GTPASES; PAM50 RISK; TISSUE MICROARRAYS; PACLITAXEL; SURVIVAL	Background-Aim Early breast cancer is a heterogeneous disease, and, therefore, prognostic tools have been developed to evaluate the risk for distant recurrence. In the present study, we sought to develop a risk for recurrence score (RRS) based on mRNA expression of three proliferation markers in high-risk early breast cancer patients and evaluate its ability to predict risk for relapse and death. In addition the Adjuvant! Online score (AOS) was also determined for each patient, providing a 10-year estimate of relapse and mortality risk. We then evaluated whether RRS or AOS might possibly improve the prognostic information of the clinical treatment score (CTS), a model derived from clinicopathological variables. Methods A total of 1,681 patients, enrolled in two prospective phase III trials, were treated with anthracycline-based adjuvant chemotherapy. Sufficient RNA was extracted from 875 samples followed by multiplex quantitative reverse transcription-polymerase chain reaction for assessing RACGAP1, TOP2A and Ki67 mRNA expression. The CTS, slightly modified to fit our cohort, integrated the prognostic information from age, nodal status, tumor size, histological grade and treatment. Patients were also classified to breast cancer subtypes defined by immunohistochemistry. Likelihood ratio (LR) tests and concordance indices were used to estimate the relative increase in the amount of information provided when either RRS or AOS is added to CTS. Results The optimal RRS, in terms of disease-free survival (DFS) and overall survival (OS), was based on the co-expression of two of the three evaluated genes (RACGAP1 and TOP2A). CTS was prognostic for DFS (p<0.001), while CTS, AOS and RRS were all prognostic for OS (p<0.001, p<0.001 and p = 0.036, respectively). The use of AOS in addition to CTS added prognostic information regarding DFS (LR-Delta chi(2) 8.7, p = 0.003), however the use of RRS in addition to CTS did not. For estimating OS, the use of either AOS or RRS in addition to CTS added significant prognostic information. Specifically, the use of both CTS and AOS had significantly better prognostic value vs. CTS alone (LR-Delta chi(2) 20.8, p<0.001), as well as the use of CTS and RRS vs. CTS alone (LR-Delta chi(2) 4.8, p = 0.028). Additionally, more patients were scored as high-risk by AOS than CTS. According to immunohistochemical subtypes, prognosis was improved in the Luminal A (LR-Delta chi(2) 7.2, p = 0.007) and Luminal B (LR-Delta chi(2) 8.3, p = 0.004) subtypes, in HER2-negative patients (LR-Delta chi(2) 23.4, p<0.001) and in patients with >3 positive nodes (LR-Delta chi(2) 23.9, p<0.001) when AOS was added to CTS. Conclusions The current study has shown a clear benefit in predicting overall survival of high-risk early breast cancer patients when combining CTS with either AOS or RRS. The combination of CTS and AOS adds significant prognostic information compared to CTS alone for DFS, while the combination of CTS with either AOS or RRS has better prognostic value than CTS alone for OS. These findings could possibly add on the information needed for the best risk prediction strategy in high-risk early breast cancer patients in a rather simple and inexpensive way, especially in Luminal A and B subtypes, HER2-negative patients and those with >3 positive nodes.	[Stavridi, Flora] Hygeia Hosp, Dept Med Oncol 3, Athens, Greece; [Kalogeras, Konstantine T.; Fountzilas, George] Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Mol Oncol Lab, Thessaloniki, Greece; [Kalogeras, Konstantine T.] Data Off, Translat Res Sect, Hellen Cooperat Oncol Grp, Athens, Greece; [Pliarchopoulou, Kyriaki; Pectasides, Dimitrios] Hippokrateion Hosp, Dept Internal Med 2, Oncol Sect, Athens, Greece; [Wirtz, Ralph M.; Veltrup, Elke] STRATIFYER Mol Pathol GmbH, Cologne, Germany; [Alexopoulou, Zoi] Hlth Data Specialists Ltd, Dept Biostat, Athens, Greece; [Zagouri, Flora] Natl & Kapodistrian Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece; [Timotheadou, Eleni; Lazaridis, Georgios] Aristotle Univ Thessaloniki, Dept Med Oncol, Papageorgiou Hosp, Sch Hlth Sci,Fac Med, Thessaloniki, Greece; [Gogas, Helen] Natl & Kapodistrian Univ Athens, Sch Med, Laiko Gen Hosp, Dept Med 1, Athens, Greece; [Koutras, Angelos] Univ Patras, Sch Med, Univ Hosp, Div Oncol,Dept Med, Patras, Greece; [Christodoulou, Christos] Metropolitan Hosp, Dept Med Oncol 2, Piraeus, Greece; [Pentheroudakis, George] Ioannina Univ Hosp, Dept Med Oncol, Ioannina, Greece; [Laskarakis, Apostolos] Metropolitan Hosp, Dept Med Oncol 1, Piraeus, Greece; [Arapantoni-Dadioti, Petroula] Micromed Labs, Dept Pathol, Athens, Greece; [Batistatou, Anna] Ioannina Univ Hosp, Dept Pathol, Ioannina, Greece; [Sotiropoulou, Maria] Alexandra Hosp, Dept Pathol, Athens, Greece; [Aravantinos, Gerasimos] Agii Anargiri Canc Hosp, Dept Med Oncol 2, Athens, Greece; [Papakostas, Pavlos] Hippokrateion Hosp, Oncol Unit, Athens, Greece; [Kosmidis, Paris] Hygeia Hosp, Dept Med Oncol 2, Athens, Greece; [Fountzilas, George] Aristotle Univ Thessaloniki, Thessaloniki, Greece	Hygeia Hospital; Aristotle University of Thessaloniki; Hellenic Cooperative Oncology Group; Hippokration General Hospital; Stratifyer Molecular Pathology GmbH; Alexandra Hospital; Athens Medical School; National & Kapodistrian University of Athens; Aristotle University of Thessaloniki; Papageorgiou Hospital; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; University of Patras; University Hospital Ioannina; University Hospital Ioannina; Alexandra Hospital; Hippokration General Hospital; Hygeia Hospital; Aristotle University of Thessaloniki	Fountzilas, G (corresponding author), Aristotle Univ Thessaloniki, Hellen Fdn Canc Res, Mol Oncol Lab, Thessaloniki, Greece.; Fountzilas, G (corresponding author), Aristotle Univ Thessaloniki, Thessaloniki, Greece.	fountzil@auth.gr	Zagouri, Flora/AAD-7986-2019; Fountzilas, George/ABF-2139-2020; TIMOTHEADOU, ELENI/AAM-6301-2020	Aravantinos, Gerasimos/0000-0002-2106-1713; Fountzilas, George/0000-0001-8045-2186	internal Hellenic Cooperative Oncology Group (HeCOG) translational research grant (HE TRANS_BR); Health Data Specialists Ltd	internal Hellenic Cooperative Oncology Group (HeCOG) translational research grant (HE TRANS_BR); Health Data Specialists Ltd	This study was supported by an internal Hellenic Cooperative Oncology Group (HeCOG) translational research grant (HE TRANS_BR). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Health Data Specialists Ltd provided support in the form of salaries for author Zoi Alexopoulou but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Health Data Specialists Ltd did not provide financial support in any other form.	Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Arpino G, 2013, BREAST, V22, P109, DOI 10.1016/j.breast.2013.01.016; Bartlett JMS, 2010, LANCET ONCOL, V11, P266, DOI 10.1016/S1470-2045(10)70006-1; Baum M, 2002, LANCET, V359, P2131; Bhoo-Pathy N, 2012, EUR J CANCER, V48, P982, DOI 10.1016/j.ejca.2012.01.034; Campbell HE, 2009, BRIT J CANCER, V101, P1074, DOI 10.1038/sj.bjc.6605283; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Fountzilas G, 2008, ANN ONCOL, V19, P853, DOI [10.1093/annonc/mdm539, 10.1093/annonc/mdm464]; Fountzilas G, 2005, ANN ONCOL, V16, P1762, DOI 10.1093/annonc/mdi366; Fountzilas G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-163; Fountzilas G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-212; Fountzilas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037946; Fountzilas G, 2011, ANTICANCER RES, V31, P3007; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Gnant M, 2014, ANN ONCOL, V25, P339, DOI 10.1093/annonc/mdt494; Gogas H, 2012, BREAST CANCER RES TR, V132, P609, DOI 10.1007/s10549-011-1913-4; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hearne BJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005576; Jankowitz RC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3038; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Loprinzi CL, 2001, J CLIN ONCOL, V19, P972, DOI 10.1200/JCO.2001.19.4.972; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mook S, 2009, LANCET ONCOL, V10, P1070, DOI 10.1016/S1470-2045(09)70254-2; Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178; Pentheroudakis G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124612; Pentheroudakis G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070634; Pliarchopoulou K, 2013, CANCER CHEMOTH PHARM, V71, P245, DOI 10.1007/s00280-012-2002-z; Press MF, 2011, J CLIN ONCOL, V29, P859, DOI 10.1200/JCO.2009.27.5644; Psyrri A, 2012, ANN ONCOL, V23, P1422, DOI 10.1093/annonc/mdr527; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Razis E, 2011, BREAST CANCER RES TR, V128, P447, DOI 10.1007/s10549-011-1572-5; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Sauter G, 2009, J CLIN ONCOL, V27, P1323, DOI 10.1200/JCO.2007.14.8197; Sestak I, 2015, J CLIN ONCOL, V33, P916, DOI 10.1200/JCO.2014.55.6894; Sinn P, 2013, GEBURTSH FRAUENHEILK, V73, P932, DOI 10.1055/s-0033-1350831; Skacel M, 2002, APPL IMMUNOHISTO M M, V10, P1, DOI 10.1097/00022744-200203000-00001; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Toss A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0560-9; van Kleef JJ, 2015, SAN ANT BREAST CANC; Vanden Bempt I, 2008, J CLIN ONCOL, V26, P4869, DOI 10.1200/JCO.2007.13.4296; Welsh CF, 2004, BREAST CANCER RES TR, V84, P33, DOI 10.1023/B:BREA.0000018425.31633.07; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Zhao X, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-211	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164013	10.1371/journal.pone.0164013	http://dx.doi.org/10.1371/journal.pone.0164013			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695115	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100075
J	Wang, J; Kalhor, N; Hu, JH; Wang, BC; Chu, HL; Zhang, BC; Gum, YP; Wu, Y				Wang, Jun; Kalhor, Neda; Hu, Jianhua; Wang, Baocheng; Chu, Huili; Zhang, Bicheng; Gum, Yaping; Wu, Yun			Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NEUTROPHIL/LYMPHOCYTE RATIO; PROGNOSTIC-FACTOR; PREOPERATIVE NEUTROPHIL; CLINICAL-SIGNIFICANCE; PERIPHERAL-BLOOD; INFLAMMATION; PREDICTOR; RESECTION; PLATELET	Background Neutrophil-to-lymphocyte ratio (NLR) has been shown to be a prognostic indicator in several types of cancer. We aimed to investigate the association between NLR and survival in surgery-treated non-small cell lung cancer (NSCLC) patients. Study Design This large retrospective study included 1,245 patients who underwent initial surgery for stage I-III NSCLC at The University of Texas MD Anderson Cancer Center between December 2002 and November 2010. We analyzed the relationship of NLR with clinicopathological variables, local recurrence-free survival (LRFS), distant recurrence-free survival (DRFS), recurrence-free survival (RFS), overall survival (OS), and disease-specific survival (DSS) in patients with high or low NLR using Kaplan-Meier method. Hazard ratios (HRs) with 95% confidence intervals (CIs) were used to assess the prognostic strength of NLR. Results There was a statistically significant association between the pretreatment NLR and histology type (P = 0.003) and tumor grade (P = 0.028). At a median follow-up time of 50.6 months, high NLR was associated with reduced DRFS (P = 0.011), OS (P < 0.0001) and DSS (P = 0.004); it was not associated with LRFS and RFS. Multivariable Cox analysis further revealed that NLR (P = 0.027), pathologic stage (P < 0.0001) and lymphovascular invasion (P < 0.0001) were strong independent predictors for DRFS. NLR was also an independent marker predicting poor OS (P = 0.002) and DSS (P = 0.017). Conclusion The pretreatment NLR can serve as a biomarker to predict distant recurrence and death in stage I-III NSCLC patients. Combination of NLR and pathologic stage can better predict the OS and DSS in stage I-II NSCLC patients.	[Wang, Jun; Wang, Baocheng; Chu, Huili; Gum, Yaping] Gen Hosp, Dept Oncol, Jinan Command Peoples Liberat Army, Jinan, Peoples R China; [Wang, Jun; Kalhor, Neda; Wu, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hu, Jianhua] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Zhang, Bicheng] Wuhan Gen Hosp, Dept Oncol, Guangzhou Command Peoples Liberat Army, Wuhan, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wu, Y (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	yunwu@mdanderson.org	Wang, Jun/AAZ-2098-2020		National Nature Science Foundation of China [81272619, 81572875]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Nature Science Foundation of China (grants 81272619 and 81572875 to JW).	ALBERTI W, 1995, BRIT MED J, V311, P899; Alifano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106914; Azab B, 2012, ANN SURG ONCOL, V19, P217, DOI 10.1245/s10434-011-1814-0; Botta C, 2013, CANCER BIOL THER, V14, P469, DOI 10.4161/cbt.24425; Bremnes RM, 2011, J THORAC ONCOL, V6, P824, DOI 10.1097/JTO.0b013e3182037b76; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Cannon NA, 2015, J THORAC ONCOL, V10, P280, DOI 10.1097/JTO.0000000000000399; Cedres S, 2012, CLIN TRANSL ONCOL, V14, P864, DOI 10.1007/s12094-012-0872-5; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fang HY, 2013, LARYNGOSCOPE, V123, P2690, DOI 10.1002/lary.24105; Fridlender ZG, 2012, CARCINOGENESIS, V33, P949, DOI 10.1093/carcin/bgs123; Go SI, 2014, LUNG CANCER, V84, P79, DOI 10.1016/j.lungcan.2014.01.014; Gratchev A, 2006, IMMUNOBIOLOGY, V211, P473, DOI 10.1016/j.imbio.2006.05.017; Han YJ, 2011, INT J BIOL MARKER, V26, P209, DOI 10.5301/JBM.2011.8872; Jafri SH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-158; Kacan T, 2014, ASIAN PAC J CANCER P, V15, P2089, DOI 10.7314/APJCP.2014.15.5.2089; Kameyama K, 2002, J THORAC CARDIOV SUR, V124, P503, DOI 10.1067/mtc.2002.123810; Kaneko M, 2012, ONCOLOGY-BASEL, V82, P261, DOI 10.1159/000337228; Kang MH, 2014, BRIT J CANCER, V111, P452, DOI 10.1038/bjc.2014.317; Kemal Y, 2014, ASIAN PAC J CANCER P, V15, P2651, DOI 10.7314/APJCP.2014.15.6.2651; Leung EYL, 2012, J THORAC ONCOL, V7, P655, DOI 10.1097/JTO.0b013e318244ffe1; Lin GN, 2017, ASIA-PAC J CLIN ONCO, V13, pE189, DOI 10.1111/ajco.12273; MacDonald Neil, 2007, J Support Oncol, V5, P157; Mascaux C, 2006, BRIT J CANCER, V95, P139, DOI 10.1038/sj.bjc.6603226; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Miyazaki T, 2015, EUR J CARDIO-THORAC, V47, pE140, DOI 10.1093/ejcts/ezu514; Nakayama Y, 2014, SURG TODAY, V44, P2146, DOI 10.1007/s00595-014-0917-1; O'Callaghan DS, 2010, J THORAC ONCOL, V5, P2024, DOI 10.1097/JTO.0b013e3181f387e4; PETRIE HT, 1985, J IMMUNOL, V134, P230; Pichler M, 2013, BRIT J CANCER, V108, P901, DOI 10.1038/bjc.2013.28; Pinato DJ, 2014, BRIT J CANCER, V110, P1930, DOI 10.1038/bjc.2014.145; Pinato DJ, 2012, J THORAC ONCOL, V7, P587, DOI 10.1097/JTO.0b013e31823f45c1; Richards CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041883; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; SHAU H, 1988, J IMMUNOL, V141, P4395; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sonpavde G, 2014, CLIN GENITOURIN CANC, V12, P317, DOI 10.1016/j.clgc.2014.03.005; Srimuninnimit Vichien, 2012, J Med Assoc Thai, V95 Suppl 2, pS199; Stotz M, 2014, BRIT J CANCER, V110, P435, DOI 10.1038/bjc.2013.785; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Szkandera J, 2013, BRIT J CANCER, V108, P1677, DOI 10.1038/bjc.2013.135; Takahashi Y, 2015, ANN SURG ONCOL, V22, pS1324, DOI 10.1245/s10434-015-4735-5; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Tibaldi C, 2008, J CANCER RES CLIN, V134, P1143, DOI 10.1007/s00432-008-0378-2; Tomita M, 2011, ANTICANCER RES, V31, P2995; Troppan K, 2014, BRIT J CANCER, V110, P369, DOI 10.1038/bjc.2013.763; Unal D, 2013, ASIAN PAC J CANCER P, V14, P5237, DOI 10.7314/APJCP.2013.14.9.5237; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052704; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028844; Williams KA, 2014, GYNECOL ONCOL, V132, P542, DOI 10.1016/j.ygyno.2014.01.026; Zhang H, 2015, AM J SURG, V210, P526, DOI 10.1016/j.amjsurg.2015.03.022; Zhang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126496	53	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163397	10.1371/journal.pone.0163397	http://dx.doi.org/10.1371/journal.pone.0163397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695079	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100032
J	Yuan, L; Uttal, D; Franconeri, S				Yuan, Lei; Uttal, David; Franconeri, Steven			Are Categorical Spatial Relations Encoded by Shifting Visual Attention between Objects?	PLOS ONE			English	Article							PERCEPTION; LANGUAGE; FEATURES; APPREHENSION; ASYMMETRIES; SEMANTICS; STIMULUS; NUMBERS; BINDING; SEARCH	Perceiving not just values, but relations between values, is critical to human cognition. We tested the predictions of a proposed mechanism for processing categorical spatial relations between two objects D the shift account of relation processing D which states that relations such as 'above' or 'below' are extracted by shifting visual attention upward or downward in space. If so, then shifts of attention should improve the representation of spatial relations, compared to a control condition of identity memory. Participants viewed a pair of briefly flashed objects and were then tested on either the relative spatial relation or identity of one of those objects. Using eye tracking to reveal participants' voluntary shifts of attention over time, we found that when initial fixation was on neither object, relational memory showed an absolute advantage for the object following an attention shift, while identity memory showed no advantage for either object. This result is consistent with the shift account of relation processing. When initial fixation began on one of the objects, identity memory strongly benefited this fixated object, while relational memory only showed a relative benefit for objects following an attention shift. This result is also consistent, although not as uniquely, with the shift account of relation processing. Taken together, we suggest that the attention shift account provides a mechanistic explanation for the overall results. This account can potentially serve as the common mechanism underlying both linguistic and perceptual representations of spatial relations.	[Yuan, Lei; Uttal, David; Franconeri, Steven] Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA; [Yuan, Lei] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Northwestern University; Indiana University System; Indiana University Bloomington	Yuan, L (corresponding author), Northwestern Univ, Dept Psychol, Evanston, IL 60208 USA.; Yuan, L (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA.	leiyuan@indiana.edu	Yuan, Lei/P-8759-2019	Yuan, Lei/0000-0003-1280-2599	Institute of Education Sciences; U.S. Department of Education [R305A120531]; National Science Foundation [SBE-1041707]	Institute of Education Sciences(US Department of EducationInstitute of Education Sciences (IES)); U.S. Department of Education(US Department of Education); National Science Foundation(National Science Foundation (NSF))	The research reported here was supported by the Institute of Education Sciences (https://ies.ed.gov), U.S. Department of Education, through Grant R305A120531 to Steven Franconeri, and by National Science Foundation (http://www.nst.gov) Grant SBE-1041707 to David Uttal through the Spatial Intelligence and Learning Center (SILC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACREDOLO LP, 1978, DEV PSYCHOL, V14, P224, DOI 10.1037/0012-1649.14.3.224; [Anonymous], 1994, ELEMENTS GRAPH DESIG; Biederman I, 2007, J VISION VISION SCI, P1030; Boroditsky L, 2011, COGNITION, V118, P123, DOI 10.1016/j.cognition.2010.09.010; Borst G, 2010, NEUROPSYCHOLOGIA, V48, P2769, DOI 10.1016/j.neuropsychologia.2010.04.027; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burigo M, 2016, Q J EXP PSYCHOL, V69, P2319, DOI 10.1080/17470218.2015.1124894; CarlsonRadvansky LA, 1997, J MEM LANG, V37, P411, DOI 10.1006/jmla.1997.2519; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; CHASE WG, 1971, BRIT J PSYCHOL, V62, P311, DOI 10.1111/j.2044-8295.1971.tb02042.x; CLARK HH, 1974, MEM COGNITION, V2, P101, DOI 10.3758/BF03197499; CLARK HH, 1972, COGNITIVE PSYCHOL, V3, P472, DOI 10.1016/0010-0285(72)90019-9; Danckert JA, 2003, BRADFORD BOOKS, P29; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dickinson CA, 2009, ATTEN PERCEPT PSYCHO, V71, P1251, DOI 10.3758/APP.71.6.1251; Dolscheid S, 2013, PSYCHOL SCI, V24, P613, DOI 10.1177/0956797612457374; Duffy S, 2005, J COGN DEV, V6, P51, DOI 10.1207/s15327647jcd0601_4; Franconeri S.L., 2013, OXFORD HDB COGNITIVE, P147, DOI [10.1093/oxfordhb/9780195376746.013.0010, DOI 10.1093/OXFORDHB/9780195376746.013.0010]; Franconeri SL, 2012, COGNITION, V122, P210, DOI 10.1016/j.cognition.2011.11.002; Gentner D, 2011, WIRES COGN SCI, V2, P266, DOI 10.1002/wcs.105; Gentner D, 2010, COGNITIVE SCI, V34, P752, DOI 10.1111/j.1551-6709.2010.01114.x; Gleitman LR, 2007, J MEM LANG, V57, P544, DOI 10.1016/j.jml.2007.01.007; Gleitman LR, 1996, COGNITION, V58, P321, DOI 10.1016/0010-0277(95)00686-9; Haun DBM, 2006, P NATL ACAD SCI USA, V103, P17568, DOI 10.1073/pnas.0607999103; HAYWARD WG, 1995, COGNITION, V55, P39, DOI 10.1016/0010-0277(94)00643-Y; Hayward WG, 2003, TRENDS COGN SCI, V7, P425, DOI 10.1016/j.tics.2003.08.004; Hayworth K, 2009, EXPLICIT ENCODING SP; Hayworth K, 2008, J VISION VISION SCI, P35, DOI [10.1167/8.6.35WNL.44.4.703, DOI 10.1167/8.6.35WNL.44.4.703]; Hegarty M, 2011, TOP COGN SCI, V3, P446, DOI 10.1111/j.1756-8765.2011.01150.x; Hegarty M, 2009, LEARN INDIVID DIFFER, V19, P61, DOI 10.1016/j.lindif.2008.04.006; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Holcombe AO, 2011, CURR BIOL, V21, P1135, DOI 10.1016/j.cub.2011.05.031; Hummel JE, 2003, PSYCHOL REV, V110, P220, DOI 10.1037/0033-295X.110.2.220; HUMMEL JE, 1992, PSYCHOL REV, V99, P480, DOI 10.1037/0033-295X.99.3.480; Hummel JE, 2000, COGNITIVE DYNAMICS, P157; Hyun JS, 2009, VIS COGN, V17, P10, DOI 10.1080/13506280802113894; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; JEERAKATHIL TJ, 1994, NEUROLOGY, V44, P703, DOI 10.1212/WNL.44.4.703; JUST MA, 1975, BRIT J PSYCHOL, V66, P427, DOI 10.1111/j.2044-8295.1975.tb01478.x; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kraft A, 2011, HUM BRAIN MAPP, V32, P1036, DOI 10.1002/hbm.21087; Laeng B, 2011, COGNITIVE SCI, V35, P297, DOI 10.1111/j.1551-6709.2010.01139.x; LANDAU B, 1993, BEHAV BRAIN SCI, V16, P255, DOI 10.1017/S0140525X00029927; Landy D, 2007, J EXP PSYCHOL LEARN, V33, P720, DOI 10.1037/0278-7393.33.4.720; Levelt W.J.M., 1984, LIMITS PERCEPTION, P323; Livins KA, 2015, P 37 ANN M COGN SCI; LOGAN GD, 1994, J EXP PSYCHOL HUMAN, V20, P1015, DOI 10.1037/0096-1523.20.5.1015; LOGAN GD, 1995, COGNITIVE PSYCHOL, V28, P103, DOI 10.1006/cogp.1995.1004; Luck SJ, 1998, P NATL ACAD SCI USA, V95, P825, DOI 10.1073/pnas.95.3.825; Matthews WJ, 2014, J EXP PSYCHOL GEN, V143, P510, DOI 10.1037/a0034143; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Miller GA., 1976, LANGUAGE PERCEPTION; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; PALMER J, 1994, VISION RES, V34, P1703, DOI 10.1016/0042-6989(94)90128-7; PELI E, 1990, J OPT SOC AM A, V7, P2032, DOI 10.1364/JOSAA.7.002032; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Proctor RW, 2006, PSYCHOL BULL, V132, P416, DOI 10.1037/0033-2909.132.3.416; PYLYSHYN Z, 1989, COGNITION, V32, P65, DOI 10.1016/0010-0277(89)90014-0; Roth JC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00464; Ruotolo F, 2011, Q J EXP PSYCHOL, V64, P1138, DOI 10.1080/17470218.2010.539700; Schubert TW, 2005, J PERS SOC PSYCHOL, V89, P1, DOI 10.1037/0022-3514.89.1.1; SEYMOUR PHK, 1974, J EXP PSYCHOL, V102, P447, DOI 10.1037/h0035865; Shah P, 1999, J EDUC PSYCHOL, V91, P690, DOI 10.1037/0022-0663.91.4.690; Shaki S, 2008, COGNITION, V108, P590, DOI 10.1016/j.cognition.2008.04.001; Stieff M, 2005, MODEL MODEL SCI EDUC, V1, P93, DOI 10.1007/1-4020-3613-2_7; Talmy L., 1983, SPATIAL ORIENTATION, V225, P282, DOI [DOI 10.1007/978-1-4615-9325-6_11, 10.1007/978-1-4615-9325-6_11]; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Tarr MJ, 1998, COGNITION, V67, P1, DOI 10.1016/S0010-0277(98)00026-2; Taylor HA, 1996, J MEM LANG, V35, P371, DOI 10.1006/jmla.1996.0021; Tomlin R. S., 1997, LANGUAGE CONCEPTUALI, P162, DOI DOI 10.1017/CBO9781139086677.007; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; van der Ham IJM, 2014, NEUROSCI BIOBEHAV R, V45, P142, DOI 10.1016/j.neubiorev.2014.05.006; Wolfe JM, 1997, VISION RES, V37, P25, DOI 10.1016/S0042-6989(96)00111-3; Wolfe JM, 1998, PERCEPT PSYCHOPHYS, V60, P140, DOI 10.3758/BF03211924; Wolfe JM, 1998, PSYCHOL SCI, V9, P33, DOI 10.1111/1467-9280.00006; Woodman GF, 2003, J EXP PSYCHOL HUMAN, V29, P121, DOI 10.1037/0096-1523.29.1.121; Xu YQ, 2015, PSYCHOL SCI, V26, P1241, DOI 10.1177/0956797615585002; Zacks J, 1999, MEM COGNITION, V27, P1073, DOI 10.3758/BF03201236	80	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163141	10.1371/journal.pone.0163141	http://dx.doi.org/10.1371/journal.pone.0163141			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695104	gold, Green Published			2022-12-27	WOS:000385553100025
J	Zee, BM; Dibona, AB; Alekseyenko, AA; French, CA; Kuroda, MI				Zee, Barry M.; Dibona, Amy B.; Alekseyenko, Artyom A.; French, Christopher A.; Kuroda, Mitzi I.			The Oncoprotein BRD4-NUT Generates Aberrant Histone Modification Patterns	PLOS ONE			English	Article							NUT MIDLINE CARCINOMA; TRANSCRIPTION; ACETYLATION; CHROMATIN; ACTIVATION; CANCER; DIFFERENTIATION; EXPRESSION; COMPLEXES; PROTEINS	Defects in chromatin proteins frequently manifest in diseases. A striking case of a chromatin-centric disease is NUT-midline carcinoma (NMC), which is characterized by expression of NUT as a fusion partner most frequently with BRD4. ChIP-sequencing studies from NMC patients revealed that BRD4-NUT (B4N) covers large genomic regions and elevates transcription within these domains. To investigate how B4N modulates chromatin, we performed affinity purification of B4N when ectopically expressed in 293-TREx cells and quantified the associated histone posttranslational modifications (PTM) using proteomics. We observed significant enrichment of acetylation particularly on H3 K18 and of combinatorial patterns such as H3 K27 acetylation paired with K36 methylation. We postulate that B4N complexes override the preexisting histone code with new PTM patterns that reflect aberrant transcription and that epigenetically modulate the nucleosome environment toward the NMC state.	[Zee, Barry M.; Alekseyenko, Artyom A.; Kuroda, Mitzi I.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Zee, Barry M.; Alekseyenko, Artyom A.; Kuroda, Mitzi I.] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Dibona, Amy B.; French, Christopher A.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Kuroda, MI (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Kuroda, MI (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.	mkuroda@genetics.med.harvard.edu		Zee, Barry/0000-0002-3123-8375	National Institute of General Medical Sciences [R01 GM101958]; Jane Coffin Childs Memorial Fund for Medical Research Fellowship [61-1571]; National Institutes of Health [2 T32 HL 7627-31]; National Cancer Institute [5R01CA124633-10]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101958] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Jane Coffin Childs Memorial Fund for Medical Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institute of General Medical Sciences grant R01 GM101958 to MIK, a Jane Coffin Childs Memorial Fund for Medical Research Fellowship 61-1571 to BMZ, a National Institutes of Health grant 2 T32 HL 7627-31 to ABD, and a National Cancer Institute grant 5R01CA124633-10 to CAF.	Alekseyenko AA, 2015, GENE DEV, V29, P1507, DOI 10.1101/gad.267583.115; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Beesley AH, 2014, BRIT J CANCER, V110, P1189, DOI 10.1038/bjc.2014.54; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Brookes E, 2014, ANNU REV GENET, V48, P237, DOI 10.1146/annurev-genet-120213-092518; Evertts AG, 2013, J BIOL CHEM, V288, P12142, DOI 10.1074/jbc.M112.428318; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2014, CANCER DISCOV, V4, P928, DOI 10.1158/2159-8290.CD-14-0014; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; Gilan O, 2016, NAT STRUCT MOL BIOL, V23, P673, DOI 10.1038/nsmb.3249; Hayashi-Takanaka Y, 2015, CHROMOSOME RES, V23, P753, DOI 10.1007/s10577-015-9486-4; Henry RA, 2013, BIOCHEMISTRY-US, V52, P5746, DOI 10.1021/bi400684q; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; LeRoy G, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-20; McManus KJ, 2003, MOL CELL BIOL, V23, P7611, DOI 10.1128/MCB.23.21.7611-7627.2003; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Schwartz BE, 2011, CANCER RES, V71, P2686, DOI 10.1158/0008-5472.CAN-10-3513; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Suzuki S, 2015, PATHOL RES PRACT, V211, P404, DOI 10.1016/j.prp.2014.10.013; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Thompson-Wicking K, 2013, ONCOGENE, V32, P4664, DOI 10.1038/onc.2012.487; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Wang RR, 2015, J BIOL CHEM, V290, P2744, DOI 10.1074/jbc.M114.600759; Wang RR, 2014, CANCER RES, V74, P3332, DOI 10.1158/0008-5472.CAN-13-2658; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zee BM, 2016, P NATL ACAD SCI USA, V113, P1784, DOI 10.1073/pnas.1522750113	29	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163820	10.1371/journal.pone.0163820	http://dx.doi.org/10.1371/journal.pone.0163820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27698495	Green Submitted, Green Published, gold			2022-12-27	WOS:000385553100056
J	Raboisson, D; Barbier, M; Maigne, E				Raboisson, Didier; Barbier, Maxime; Maigne, Elise			How Metabolic Diseases Impact the Use of Antimicrobials: A Formal Demonstration in the Field of Veterinary Medicine	PLOS ONE			English	Article							DAIRY-COWS; ANTIBIOTIC-RESISTANCE; SUBCLINICAL KETOSIS; POTENTIAL IMPACT; MILK-PRODUCTION; CATTLE; HEALTH; HYPERKETONEMIA; ASSOCIATION; PERFORMANCE	Decreasing the use of antimicrobials has become a primary objective for both human and veterinary medicine in many countries. Medical prevention and good nutrition are seen as key parameters for reducing antimicrobial use. However, little consideration has been given to how metabolic diseases may influence the use of antimicrobials in humans and animals through limiting the prevalence and severity of infectious diseases. To quantify this relationship using the example of a common metabolic disease in dairy cows (subclinical ketosis, SCK), we constructed a stochastic model reporting the total quantity of curative antimicrobials for a given population with the prevalence of cows at risk for SCK. We considered the prevalence of SCK, the relative risk of the disease in cases of SCK compared to no SCK and the use of antimicrobials to treat SCK-induced infectious diseases. Reducing the percentage of cows at risk for SCK from 80% to 10% was associated with an average decrease in the use of antimicrobials of 11% (prevalence of SCK from 34% to 17%, respectively) or 25% (prevalence of SCK from 68% to 22%, respectively), depending on the relative risk to contract SCK if risk was present. For a large percentage of the cows at risk for SCK, using a preventive bolus of monensin reduced the use of curative antimicrobials to the same level that was observed when the percentage of cows at risk for SCK was low. The present work suggests similar approaches for obesity and diabetes.	[Raboisson, Didier; Barbier, Maxime] Univ Toulouse, IHAP, INRA, ENVT, Toulouse, France; [Maigne, Elise] INRA, ODR, Toulouse, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; INRAE	Raboisson, D (corresponding author), Univ Toulouse, IHAP, INRA, ENVT, Toulouse, France.	d.raboisson@envt.fr	Raboisson, Didier/AAL-4025-2020	Raboisson, Didier/0000-0003-1630-6218	Elanco France	Elanco France	The work was funded by Elanco France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affair MoE, 2014, RED STIB FOOD PROD A; Barnett ML, 2014, JAMA-J AM MED ASSOC, V311, P2020, DOI 10.1001/jama.2013.286141; Berge AC, 2014, J DAIRY SCI, V97, P2145, DOI 10.3168/jds.2013-7163; Chevance A, 2014, SUIVI VENTES MED VET; Duffield TF, 2009, J DAIRY SCI, V92, P571, DOI 10.3168/jds.2008-1507; Duffield TF, 1998, J DAIRY SCI, V81, P2866, DOI 10.3168/jds.S0022-0302(98)75846-1; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Finch RG, 2004, NAT REV MICROBIOL, V2, P989, DOI 10.1038/nrmicro1049; Finch RG, 2004, CLIN MICROBIOL INFEC, V10, P1, DOI 10.1111/j.1470-9465.2004.00861.x; Finch RG, 2004, LANCET INFECT DIS, V4, P44, DOI 10.1016/S1473-3099(03)00860-0; Foster KR, 2006, PLOS MED, V3, P177, DOI 10.1371/journal.pmed.0030029; Galyean ML, 1999, J ANIM SCI, V77, P1120; Kesselheim AS, 2010, HEALTH AFFAIR, V29, P1689, DOI 10.1377/hlthaff.2009.0439; Lhermie G., 2015, EC RURALE, V348, P3, DOI [10.4000/economierurale.4671, DOI 10.4000/ECONOMIERURALE.4671, DOI 10.4000/EC0N0MIERURALE.4671]; Mcart JAA, 2013, J DAIRY SCI, V96, P198, DOI 10.3168/jds.2012-5681; Ospina PA, 2010, J DAIRY SCI, V93, P3595, DOI 10.3168/jds.2010-3074; Philippe P, 2012, PREVALENCE CETOSE SU, P137; Raboisson D, 2015, PREV VET MED, V122, P417, DOI 10.1016/j.prevetmed.2015.07.010; Raboisson D, 2014, J DAIRY SCI, V97, P7547, DOI 10.3168/jds.2014-8237; Russell JB, 2003, FEMS MICROBIOL REV, V27, P65, DOI 10.1016/S0168-6445(03)00019-6; Simjee S, 2012, J ANTIMICROB CHEMOTH, V67, P2388, DOI 10.1093/jac/dks236; Vanholder T, 2015, J DAIRY SCI, V98, P880, DOI 10.3168/jds.2014-8362; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03	23	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164200	10.1371/journal.pone.0164200	http://dx.doi.org/10.1371/journal.pone.0164200			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716805	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100032
J	Choi, HG; Choi, S; Back, YW; Park, HS; Bae, HS; Choi, CH; Kim, HJ				Choi, Han-Gyu; Choi, Seunga; Back, Yong Woo; Park, Hye-Soo; Bae, Hyun Shik; Choi, Chul Hee; Kim, Hwa-Jung			Mycobacterium tuberculosis Rv2882c Protein Induces Activation of Macrophages through TLR4 and Exhibits Vaccine Potential	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSE; TUMOR-NECROSIS-FACTOR; DENDRITIC CELLS; PROINFLAMMATORY CYTOKINES; INTERFERON-GAMMA; INFECTION; LIPOPROTEIN; MICE; MATURATION	Macrophages constitute the first line of defense against Mycobacterium tuberculosis and are critical in linking innate and adaptive immunity. Therefore, the identification and characterization of mycobacterial proteins that modulate macrophage function are essential for understanding tuberculosis pathogenesis. In this study, we identified the novel macrophage- activating protein, Rv2882c, from M. tuberculosis culture filtrate proteins. Recombinant Rv2882c protein activated macrophages to secrete pro-inflammatory cytokines and express co-stimulatory and major histocompatibility complex molecules via Toll-like receptor 4, myeloid differentiation primary response protein 88, and Toll/IL-1 receptor-domaincontaining adaptor inducing IFN-beta. Mitogen-activated protein kinases and NF-kappa B signaling pathways were involved in Rv2882c-induced macrophage activation. Further, Rv2882c-treated macrophages induced expansion of the effector/memory T cell population and Th1 immune responses. In addition, boosting Bacillus Calmette-Guerin vaccination with Rv2882c improved protective efficacy against M. tuberculosis in our model system. These results suggest that Rv2882c is an antigen that could be used for tuberculosis vaccine development.	[Choi, Han-Gyu; Choi, Seunga; Back, Yong Woo; Park, Hye-Soo; Bae, Hyun Shik; Choi, Chul Hee; Kim, Hwa-Jung] Chungnam Natl Univ, Coll Med, Dept Microbiol & Med Sci, Daejeon 301747, South Korea	Chungnam National University	Kim, HJ (corresponding author), Chungnam Natl Univ, Coll Med, Dept Microbiol & Med Sci, Daejeon 301747, South Korea.	hjukim@cnu.ac.kr		Kim, Hwa-Jung/0000-0002-1127-0909; Choi, Chul Hee/0000-0003-2373-048X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2013R1A2A1A03069903]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A1A03069903).	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Andersen P, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018523; Bansal K, 2010, J BIOL CHEM, V285, P36511, DOI 10.1074/jbc.M110.158055; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Bhatt K, 2007, J CLIN IMMUNOL, V27, P347, DOI 10.1007/s10875-007-9084-0; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Branger J, 2004, INT IMMUNOL, V16, P509, DOI 10.1093/intimm/dxh052; Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200; Byun EH, 2012, FASEB J, V26, P2695, DOI 10.1096/fj.11-199588; Byun EH, 2012, J MOL MED, V90, P285, DOI 10.1007/s00109-011-0819-2; Chen K, 2013, ANNU REV IMMUNOL, V31, P605, DOI 10.1146/annurev-immunol-032712-100019; Chen ST, 2012, J IMMUNOL, V188, P668, DOI 10.4049/jimmunol.1102177; Choi HG, 2015, EUR J IMMUNOL, V45, P1957, DOI 10.1002/eji.201445329; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; de Souza GA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002527; Deng WY, 2014, CELL PHYSIOL BIOCHEM, V33, P273, DOI 10.1159/000356668; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fremond CM, 2007, J IMMUNOL, V179, P1178, DOI 10.4049/jimmunol.179.2.1178; Fremond CMC, 2003, MICROBES INFECT, V5, P1070, DOI 10.1016/j.micinf.2003.06.001; Gehring AJ, 2003, INFECT IMMUN, V71, P4487, DOI 10.1128/IAI.71.8.4487-4497.2003; Gehring AJ, 2004, J IMMUNOL, V173, P2660, DOI 10.4049/jimmunol.173.4.2660; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Guirado E, 2013, SEMIN IMMUNOPATHOL, V35, P563, DOI 10.1007/s00281-013-0388-2; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Jung SB, 2006, INFECT IMMUN, V74, P2686, DOI 10.1128/IAI.74.5.2686-2696.2006; Kim KH, 2011, IMMUNE NETW, V11, P123, DOI DOI 10.4110/IN.2011.11.2.123; Kim K, 2012, IMMUNOLOGY, V136, P231, DOI 10.1111/j.1365-2567.2012.03575.x; Lata M, 2015, J PROTEOMICS, V127, P114, DOI 10.1016/j.jprot.2015.07.031; Li AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011066; Lim JH, 2004, FEMS MICROBIOL LETT, V232, P51, DOI 10.1016/S0378-1097(04)00018-7; Maggioli MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122571; Majumder N, 2008, SCAND J IMMUNOL, V67, P329, DOI 10.1111/j.1365-3083.2008.02070.x; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910; Pecora ND, 2006, J IMMUNOL, V177, P422, DOI 10.4049/jimmunol.177.1.422; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; ROSENTHA.AS, 1973, J EXP MED, V138, P1194, DOI 10.1084/jem.138.5.1194; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x; Shin AR, 2008, CLIN VACCINE IMMUNOL, V15, P1788, DOI 10.1128/CVI.00231-08; Shin DM, 2010, CELL MICROBIOL, V12, P1648, DOI 10.1111/j.1462-5822.2010.01497.x; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Vashishtha VM, 2009, INDIAN PEDIATR, V46, P401; Wang X, 2015, 3RD INTERNATIONAL CONFERENCE ON ADVANCED COMPOSITE MATERIALS AND MANUFACTURING ENGINEERING (CMME 2015), P10; Weir RE, 2004, INFECT IMMUN, V72, P1807, DOI 10.1128/IAI.72.3.1807-1811.2004; Xu Y, 2015, J MOL MED, V93, P645, DOI 10.1007/s00109-014-1243-1; Zygmunt BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018032	56	16	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164458	10.1371/journal.pone.0164458	http://dx.doi.org/10.1371/journal.pone.0164458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711141	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600128
J	Neufeld, C; Kramer, SE; Lapinskaya, N; Heffner, CC; Malko, A; Lau, EF				Neufeld, Chris; Kramer, Stephanie E.; Lapinskaya, Natalia; Heffner, Christopher C.; Malko, Anton; Lau, Ellen F.			The Electrophysiology of Basic Phrase Building	PLOS ONE			English	Article							ANTERIOR TEMPORAL-LOBE; SUPERIOR PARIETAL CORTEX; TIME-COURSE; LANGUAGE PRODUCTION; BRAIN POTENTIALS; CORTICAL REPRESENTATION; SEMANTIC CONTEXT; WORD; COMPREHENSION; N400	A defining trait of linguistic competence is the ability to combine elements into increasingly complex structures to denote, and to comprehend, a potentially infinite number of meanings. Recent magnetoencephalography (MEG) work has investigated these processes by comparing the response to nouns in combinatorial (blue car) and non-combinatorial (rnsh car) contexts. In the current study we extended this paradigm using electroencephalography (EEG) to dissociate the role of semantic content from phonological well-formedness (yerl car). We used event-related potential (ERP) recordings in order to better relate the observed neurophysiological correlates of basic combinatorial operations to prior ERP work on comprehension. We found that nouns in combinatorial contexts (blue car) elicited a greater centro-parietal negativity between 180-400ms, independent of the phonological well-formedness of the context word. We discuss the potential relationship between this 'combinatorial' effect and classic N400 effects. We also report preliminary evidence for an early anterior negative deflection immediately preceding the critical noun in combinatorial contexts, which we tentatively interpret as an electrophysiological reflex of syntactic structure initialization.	[Neufeld, Chris; Lapinskaya, Natalia; Heffner, Christopher C.; Malko, Anton; Lau, Ellen F.] Univ Maryland, Dept Linguist, College Pk, MD 20742 USA; [Kramer, Stephanie E.] Georgetown Univ, Dept Linguist, Washington, DC USA; [Heffner, Christopher C.; Lau, Ellen F.] Univ Maryland, Program Neurosci & Cognit Sci, College Pk, MD 20742 USA; [Heffner, Christopher C.] Univ Maryland, Dept Hearing & Speech Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; Georgetown University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Neufeld, C (corresponding author), Univ Maryland, Dept Linguist, College Pk, MD 20742 USA.	neufeldc@umd.edu			Natural Sciences and Engineering Research Council of Canada [D3-443975-2013]; National Science Foundation, NSF Graduate Research Fellowship; Bagget Fellowship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation, NSF Graduate Research Fellowship(National Science Foundation (NSF)); Bagget Fellowship	This work was supported by Natural Sciences and Engineering Research Council of Canada, PGS D3-443975-2013, http:/www.nserc-crsng.gc.ca/index_eng.asp, CN; National Science Foundation, NSF Graduate Research Fellowship (no grant number), hyttps:/www.nsfgrfp.org/, CCH; and Bagget Fellowship (no grant number), http://ling.umd.edu/baggett/#fellowship, NL. The funders had no role in study design, data collection andanalysis, decision to publish, or preparation of the manuscript.	Baggio G, 2011, LANG COGNITIVE PROC, V26, P1338, DOI 10.1080/01690965.2010.542671; Baggio G, 2010, J COGNITIVE NEUROSCI, V22, P2131, DOI 10.1162/jocn.2009.21303; Bai C, 2008, NEUROREPORT, V19, P695, DOI 10.1097/WNR.0b013e3282fc1eb7; BARSALOU LW, 1982, MEM COGNITION, V10, P82, DOI 10.3758/BF03197629; Bartke S, 2005, J NEUROLINGUIST, V18, P29, DOI 10.1016/j.jneuroling.2004.10.001; Bemis DK, 2013, CEREB CORTEX, V23, P1859, DOI 10.1093/cercor/bhs170; Bemis DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073949; Bemis Douglas K, 2012, Front Psychol, V3, P583, DOI 10.3389/fpsyg.2012.00583; Bemis DK, 2011, J NEUROSCI, V31, P2801, DOI 10.1523/JNEUROSCI.5003-10.2011; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Blanco-Elorrieta E, 2016, NEUROIMAGE, V124, P194, DOI 10.1016/j.neuroimage.2015.08.049; Brennan J, 2012, NEUROIMAGE, V60, P1139, DOI 10.1016/j.neuroimage.2012.01.030; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; Coch D, 2010, BRAIN RES, V1329, P159, DOI 10.1016/j.brainres.2010.02.084; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Davies M., 2008, CORPUS CONT AM ENGLI; Dikker S, 2013, BRAIN LANG, V127, P55, DOI 10.1016/j.bandl.2012.08.004; Federmeier KD, 1999, J MEM LANG, V41, P469, DOI 10.1006/jmla.1999.2660; Fedorenko E, 2010, J NEUROPHYSIOL, V104, P1177, DOI 10.1152/jn.00032.2010; FRAZIER L, 1978, COGNITION, V6, P291, DOI 10.1016/0010-0277(78)90002-1; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Graves WW, 2010, NEUROIMAGE, V53, P638, DOI 10.1016/j.neuroimage.2010.06.055; Hagoort P, 2008, PHILOS T R SOC B, V363, P1055, DOI 10.1098/rstb.2007.2159; Hale J, 2003, J PSYCHOLINGUIST RES, V32, P101, DOI 10.1023/A:1022492123056; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Humphries C, 2007, NEUROIMAGE, V36, P924, DOI 10.1016/j.neuroimage.2007.03.059; Janssen U, 2006, J NEUROLINGUIST, V19, P466, DOI 10.1016/j.jneuroling.2006.04.002; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Kuperberg GR, 2010, J COGNITIVE NEUROSCI, V22, P2685, DOI 10.1162/jocn.2009.21333; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1984, NATURE, V307, P161, DOI 10.1038/307161a0; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau EF, DIRECT COMP N4 UNPUB; Lau E, 2006, BRAIN LANG, V98, P74, DOI 10.1016/j.bandl.2006.02.003; Lau EF, 2016, CEREB CORTEX, V26, P1377, DOI 10.1093/cercor/bhu219; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; NOBRE AC, 1995, J NEUROSCI, V15, P1090; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Pallier C, 2011, P NATL ACAD SCI USA, V108, P2522, DOI 10.1073/pnas.1018711108; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; Price AR, 2015, J NEUROSCI, V35, P3276, DOI 10.1523/JNEUROSCI.3446-14.2015; Pylkkanen L, 2007, J COGNITIVE NEUROSCI, V19, P1905, DOI 10.1162/jocn.2007.19.11.1905; Pylkkanen L, 2014, COGNITION, V133, P371, DOI 10.1016/j.cognition.2014.07.001; Pylkkanen L, 2009, LANG COGNITIVE PROC, V24, P1313, DOI 10.1080/01690960903120176; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; RUGG MD, 1985, PSYCHOPHYSIOLOGY, V22, P642, DOI 10.1111/j.1469-8986.1985.tb01661.x; Staub A, 2006, J EXP PSYCHOL LEARN, V32, P425, DOI 10.1037/0278-7393.32.2.425; Steinhauer K, 2001, J PSYCHOLINGUIST RES, V30, P267, DOI 10.1023/A:1010443001646; Stowe LA, 1998, NEUROREPORT, V9, P2995, DOI 10.1097/00001756-199809140-00014; Tse CY, 2007, P NATL ACAD SCI USA, V104, P17157, DOI 10.1073/pnas.0707901104; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; Vandenberghe R, 2002, J COGNITIVE NEUROSCI, V14, P550, DOI 10.1162/08989290260045800; VANPETTEN C, 1991, MEM COGNITION, V19, P95, DOI 10.3758/BF03198500; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Westerlund M, 2014, NEUROPSYCHOLOGIA, V57, P59, DOI 10.1016/j.neuropsychologia.2014.03.001; Wilson SM, 2014, J COGNITIVE NEUROSCI, V26, P970, DOI 10.1162/jocn_a_00550; Yoshida M, 2013, LANG COGNITIVE PROC, V28, P272, DOI 10.1080/01690965.2011.622905; Zhang LM, 2015, NEUROIMAGE, V111, P228, DOI 10.1016/j.neuroimage.2015.02.028; Ziegler JC, 1997, J COGNITIVE NEUROSCI, V9, P758, DOI 10.1162/jocn.1997.9.6.758	68	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0158446	10.1371/journal.pone.0158446	http://dx.doi.org/10.1371/journal.pone.0158446			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711111	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600001
J	Nomoto, H; Miyoshi, H; Furumoto, T; Oba, K; Tsutsui, H; Inoue, A; Atsumi, T; Manda, N; Kurihara, Y; Aoki, S				Nomoto, Hiroshi; Miyoshi, Hideaki; Furumoto, Tomoo; Oba, Koji; Tsutsui, Hiroyuki; Inoue, Atsushi; Atsumi, Tatsuya; Manda, Naoki; Kurihara, Yoshio; Aoki, Shin		SAIS Study Grp	A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1)	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; FLOW-MEDIATED VASODILATION; TYPE-2 DIABETES-MELLITUS; CARDIOVASCULAR OUTCOMES; DIPEPTIDYL PEPTIDASE-4; BRACHIAL-ARTERY; OXIDATIVE STRESS; RECEPTOR AGONIST; DPP-4 INHIBITOR; DYSFUNCTION	Objectives The DPP-4 inhibitors are incretin-related drugs that improve hyperglycemia in a glucose-dependent manner and have been reported to exert favorable effects on atherosclerosis. However, it has not been fully elucidated whether DPP-4 inhibitors are able to improve endothelial function in patients with type 2 diabetes. Therefore, we investigated the efficacy of sitagliptin, a DPP-4 inhibitor, on endothelial function and glycemic metabolism compared with that of the sulfonylurea glimepiride. Materials and Methods In this multicenter, prospective, randomized parallel-group comparison study, 103 outpatients with type 2 diabetes (aged 59.9 +/- 9.9 years with HbA1c levels of 7.5 +/- 0.4%) with dietary cure only and/or current metformin treatment were enrolled and randomly assigned to receive sitagliptin or glimepiride therapy once daily for 26 weeks. Flow-mediated dilation (FMD), a comprehensive panel of hemodynamic parameters (Task Force 1 Monitor), and serum metabolic markers were assessed before and after the treatment. Results During the study period, no statistically significant change in %FMD was seen in both groups (sitagliptin, 5.6 to 5.6%; glimepiride, 5.6 to 6.0%). Secretory units of islets in transplantation, TNF-alpha, adiponectin and biological antioxidant potential significantly improved in the sitagliptin group, and superoxide dismutase also tended to improve in the sitagliptin group, while improvements in HbA1c levels were similar between groups. Cardiac index, blood pressure and most other metabolic parameters were not different. Conclusions Regardless of glycemic improvement, early sitagliptin therapy did not affect endothelial function but may provide favorable effects on beta-cell function and on inflammatory and oxidative stress in patients with type 2 diabetes without advanced atherosclerosis.	[Nomoto, Hiroshi; Miyoshi, Hideaki; Atsumi, Tatsuya] Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan; [Furumoto, Tomoo] NTT East Japan Sapporo Hosp, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Furumoto, Tomoo; Tsutsui, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Oba, Koji] Univ Tokyo, Grad Sch Med, Sch Publ Hlth, Dept Biostat, Tokyo, Japan; [Oba, Koji] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan; [Inoue, Atsushi] Hokkaido Hosp, Japan Community Healthcare & Org, Sapporo, Hokkaido, Japan; [Manda, Naoki] Manda Mem Hosp, Sapporo, Hokkaido, Japan; [Kurihara, Yoshio] Kurihara Clin, Sapporo, Hokkaido, Japan; [Aoki, Shin] Aoki Clin, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; University of Tokyo; University of Tokyo	Miyoshi, H (corresponding author), Hokkaido Univ, Grad Sch Med, Div Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido, Japan.	hmiyoshi@med.hokudai.ac.jp	OBA, Koji/I-3980-2019; Nomoto, Hiroshi/AGJ-2652-2022	OBA, Koji/0000-0001-5468-8988; Nomoto, Hiroshi/0000-0003-0713-221X; Yamamoto, Kohei/0000-0002-6227-7617	Japan Waksman Foundation of Japan; Hokkaido Diabetes Clinical Research Organization including Aoki Clinic; Kurihara Clinic; Manda Memorial Hospital; Hokkaido University Hospital; NTT East Japan Sapporo Hospital; Yuri Ono Clinic; Clark Hospital	Japan Waksman Foundation of Japan; Hokkaido Diabetes Clinical Research Organization including Aoki Clinic; Kurihara Clinic; Manda Memorial Hospital; Hokkaido University Hospital; NTT East Japan Sapporo Hospital; Yuri Ono Clinic; Clark Hospital	This work was financially supported by grants from the Japan Waksman Foundation of Japan, and Hokkaido Diabetes Clinical Research Organization including Aoki Clinic, Kurihara Clinic, Manda Memorial Hospital, Hokkaido University Hospital, NTT East Japan Sapporo Hospital, Yuri Ono Clinic, and Clark Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2004, AM J CARDIOL, V93, P947, DOI 10.1016/j.amjcard.2003.12.032; Anuradha R, 2014, DNA CELL BIOL, V33, P743, DOI 10.1089/dna.2014.2352; Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Ayaori M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003277; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Benjamin EJ, 2004, CIRCULATION, V109, P613, DOI 10.1161/01.CIR.0000112565.60887.1E; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Calles-Escandon J, 2001, ENDOCR REV, V22, P36, DOI 10.1210/er.22.1.36; Cesarone MR, 1999, INT ANGIOL, V18, P127; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Ervinna N, 2013, ENDOCRINOLOGY, V154, P1260, DOI 10.1210/en.2012-1855; Furumoto T, 2004, AM J CARDIOL, V93, P997, DOI 10.1016/j.amjcard.2003.12.053; Gaspari T, 2011, DIABETES VASC DIS RE, V8, P117, DOI 10.1177/1479164111404257; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Henderson A, 1997, INT J CARDIOL, V62, pS43, DOI 10.1016/S0167-5273(97)00212-X; Henry RMA, 2004, ATHEROSCLEROSIS, V174, P49, DOI 10.1016/j.atherosclerosis.2004.01.002; Hermann C, 2000, ARTERIOSCL THROM VAS, V20, P402, DOI 10.1161/01.ATV.20.2.402; Hibuse T, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-96; Hollenberg SM, 2009, CRIT CARE, V13, DOI 10.1186/cc7706; Ishibashi Y, 2011, HORM METAB RES, V43, P731, DOI 10.1055/s-0031-1284383; Iwata M, 2012, AM J CARDIOVASC DIS, V2, P111; Kim SJ, 2008, DIABETES, V57, P1331, DOI 10.2337/db07-1639; Kim YG, 2013, DIABETOLOGIA, V56, P696, DOI 10.1007/s00125-012-2827-3; Kimura K, 2005, CEREBROVASC DIS, V19, P171, DOI 10.1159/000083252; Kubota Y, 2012, J KOREAN MED SCI, V27, P1364, DOI 10.3346/jkms.2012.27.11.1364; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090217; Liu HB, 2008, J ENDOCRINOL, V196, P57, DOI 10.1677/JOE-07-0387; Mita T, 2016, DIABETES CARE, V39, P455, DOI 10.2337/dc15-2145; Mu J, 2006, DIABETES, V55, P1695, DOI 10.2337/db05-1602; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Nomoto H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135854; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Okamoto T, 2013, CLIN PHYSIOL FUNCT I, V33, P455, DOI 10.1111/cpf.12052; Papathanassiou K, 2009, ATHEROSCLEROSIS, V205, P221, DOI 10.1016/j.atherosclerosis.2008.11.027; Pyke C, 2014, ENDOCRINOLOGY, V155, P1280, DOI 10.1210/en.2013-1934; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sawada T, 2014, CIRC J, V78, P248, DOI 10.1253/circj.CJ-13-0918; Shah P, 2013, J CLIN ENDOCR METAB, V98, pE1163, DOI 10.1210/jc.2013-1029; Spieker LE, 2002, CIRCULATION, V105, P2817, DOI 10.1161/01.CIR.0000021598.15895.34; Takagi H, 2012, INT J CARDIOL, V158, P285, DOI 10.1016/j.ijcard.2012.04.054; Tomiyama H, 2012, INT HEART J, V53, P170, DOI 10.1536/ihj.53.170; Udell JA, 2015, DIABETES CARE, V38, P696, DOI 10.2337/dc14-1850; van Poppel PCM, 2011, DIABETES CARE, V34, P2072, DOI 10.2337/dc10-2421; Wang XM, 2014, MED SCI MONITOR, V20, P1792, DOI 10.12659/MSM.892299; Wascher TC, 2005, EUR J CLIN INVEST, V35, P551, DOI 10.1111/j.1365-2362.2005.01550.x; White WB, 2011, AM HEART J, V162, P620, DOI 10.1016/j.ahj.2011.08.004	50	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164255	10.1371/journal.pone.0164255	http://dx.doi.org/10.1371/journal.pone.0164255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711199	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600106
J	Price, MN; Wetmore, KM; Deutschbauer, AM; Arkin, AP				Price, Morgan N.; Wetmore, Kelly M.; Deutschbauer, Adam M.; Arkin, Adam P.			A Comparison of the Costs and Benefits of Bacterial Gene Expression	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; IN-VIVO; FLUX ANALYSIS; GROWTH; EVOLUTION; YEAST; POPULATIONS; GLUTATHIONE; METABOLISM; MECHANISMS	To study how a bacterium allocates its resources, we compared the costs and benefits of most (86%) of the proteins in Escherichia coli K-12 during growth in minimal glucose medium. The cost or investment in each protein was estimated from ribosomal profiling data, and the benefit of each protein was measured by assaying a library of transposon mutants. We found that proteins that are important for fitness are usually highly expressed, and 95% of these proteins are expressed at above 13 parts per million (ppm). Conversely, proteins that do not measurably benefit the host (with a benefit of less than 5% per generation) tend to be weakly expressed, with a median expression of 13 ppm. In aggregate, genes with no detectable benefit account for 31% of protein production, or about 22% if we correct for genetic redundancy. Although some of the apparently unnecessary expression could have subtle benefits in minimal glucose medium, the majority of the burden is due to genes that are important in other conditions. We propose that at least 13% of the cell's protein is "on standby" in case conditions change.	[Price, Morgan N.; Wetmore, Kelly M.; Deutschbauer, Adam M.; Arkin, Adam P.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Price, MN (corresponding author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol, Berkeley, CA 94720 USA.	morgannprice@yahoo.com; aparkin@lbl.gov	Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; , ENIGMA/0000-0002-0894-2831; Price, Morgan/0000-0002-4251-0362	U.S. Department of Energy, Office of Science, Office of Biological & Environmental Research [DE-AC02-05CH11231]	U.S. Department of Energy, Office of Science, Office of Biological & Environmental Research(United States Department of Energy (DOE))	This material by ENIGMA Ecosystems and Networks Integrated with Genes and Molecular Assemblies (http://enigma.lbl.gov), a Scientific Focus Area Program at Lawrence Berkeley National Laboratory, is based upon work supported by the U.S. Department of Energy, Office of Science, Office of Biological & Environmental Research under contract number DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Boulineau S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061686; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Deutschbauer A, 2014, J BACTERIOL, V196, P3643, DOI 10.1128/JB.01836-14; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Fischer E, 2005, NAT GENET, V37, P636, DOI 10.1038/ng1555; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Goelzer A, 2015, METAB ENG, V32, P232, DOI 10.1016/j.ymben.2015.10.003; Good BH, 2014, GENETICS, V198, P1183, DOI 10.1534/genetics.114.170233; Grenier F, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01038-14; HAFNER EW, 1979, J BIOL CHEM, V254, P2419; Ho WC, 2014, MOL BIOL EVOL, V31, P1568, DOI 10.1093/molbev/msu131; Hottes AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003617; Hui S, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145697; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Kato JI, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100174; Kayser A, 2005, MICROBIOL-SGM, V151, P693, DOI 10.1099/mic.0.27481-0; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; LaCroix RA, 2015, APPL ENVIRON MICROB, V81, P17, DOI 10.1128/AEM.02246-14; LAWRENCE J, 1974, J BACTERIOL, V118, P41, DOI 10.1128/JB.118.1.41-45.1974; Leiby N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001789; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Malinverni JC, 2009, P NATL ACAD SCI USA, V106, P8009, DOI 10.1073/pnas.0903229106; Nakahigashi K, 2002, P NATL ACAD SCI USA, V99, P1473, DOI 10.1073/pnas.032488499; O'Brien EJ, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004998; OWENS RA, 1986, J BACTERIOL, V168, P109, DOI 10.1128/jb.168.1.109-114.1986; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Price MN, 2016, GENOME BIOL EVOL, V8, P1917, DOI 10.1093/gbe/evw126; Price MN, 2015, MBIO, V6, DOI 10.1128/mBio.01302-15; Price MN, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.16; Qian WF, 2012, CELL REP, V2, P1399, DOI 10.1016/j.celrep.2012.09.017; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Shachrai I, 2010, MOL CELL, V38, P758, DOI 10.1016/j.molcel.2010.04.015; Smith AM, 2009, GENOME RES, V19, P1836, DOI 10.1101/gr.093955.109; Suzuki H, 2005, J BACTERIOL, V187, P5861, DOI 10.1128/JB.187.17.5861-5867.2005; Tomala K, 2013, GENOME BIOL EVOL, V5, P2051, DOI 10.1093/gbe/evt154; Tsui HCT, 1996, J BACTERIOL, V178, P5719, DOI 10.1128/jb.178.19.5719-5731.1996; Venturelli OS, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002042; Waegeman H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-70; Wagner A, 2003, J THEOR BIOL, V225, P45, DOI 10.1016/S0022-5193(03)00219-4; Wang J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002041; Weisse AY, 2015, P NATL ACAD SCI USA, V112, pE1038, DOI 10.1073/pnas.1416533112; Wetmore KM, 2015, MBIO, V6, DOI 10.1128/mBio.00306-15; XIE QW, 1993, GENE, V126, P115, DOI 10.1016/0378-1119(93)90598-W	53	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164314	10.1371/journal.pone.0164314	http://dx.doi.org/10.1371/journal.pone.0164314			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711251	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600116
J	Santos, UP; Garcia, MLSB; Braga, ALF; Pereira, LAA; Lin, CA; de Andre, PA; de Andre, CDS; Singer, JD; Saldiva, PHN				Santos, Ubiratan Paula; Siqueira Bueno Garcia, Maria Lucia; Ferreira Braga, Alfesio Luis; Amador Pereira, Luiz Alberto; Lin, Chin An; de Andre, Paulo Afonso; Saldiva de Andre, Carmen Diva; Singer, Julio da Motta; Nascimento Saldiva, Paulo Hilario			Association between Traffic Air Pollution and Reduced Forced Vital Capacity: A Study Using Personal Monitors for Outdoor Workers	PLOS ONE			English	Article							LONG-TERM EXPOSURE; LUNG-FUNCTION; PARTICULATE MATTER; PULMONARY-FUNCTION; DISEASE; PARTICLES; CHILDREN; DECLINE; HUMANS; COHORT	Background The effects of outdoor air pollution on lung function in adults are still controversial. Objective Evaluate the effects of exposure to different levels of traffic-generated PM2.5 on workers' lung functions in Sao Paulo, Brazil. Methods To cover a wide range of exposures, 101 non-smoking workers from three occupations (taxi drivers, traffic controllers, and forest rangers) were selected for the study. After clinical evaluation, the participants were scheduled to attend four consecutive weekly visits in which they received a 24-hour personal PM2.5 sampler and had lung function tests measured on the following day. The association between the spirometric variables and the averaged PM2.5 levels was assessed using robust regression models adjusted for age, waist circumference, time at the job, daily work hours, diabetes or hypertension and former smoking habits. Results Relative to workers in the lowest exposed group (all measures <25 mu g/m(3)), those with the highest level of exposure (all measures >39.6 mu g/m(3)) showed a reduction of predicted FVC (-12.2%; CI 95%: [-20.0% to -4.4%]), a marginal reduction of predicted FEV1 (-9.1%; CI 95%: [-19.1% to 0.9%]) and an increase of predicted FEF25-75%/FVC (14.9%; CI 95%: [2.9% to 26.8%]) without changes of FEV1/FVC. Conclusions Exposure to vehicular traffic air pollution is associated with a small but significant reduction of FVC without a reduction of FEV1/FVC.	[Santos, Ubiratan Paula] Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Heart Inst InCor, Sao Paulo, Brazil; [Siqueira Bueno Garcia, Maria Lucia] Univ Sao Paulo, Fac Med, Lab Expt Therapeut, Sao Paulo, Brazil; [Ferreira Braga, Alfesio Luis; Amador Pereira, Luiz Alberto; Lin, Chin An] Univ Sao Paulo, Fac Med, Lab Expt Air Pollut, Environm Epidemiol Study Grp, Sao Paulo, Brazil; [Ferreira Braga, Alfesio Luis; Amador Pereira, Luiz Alberto] Univ Catolica Santos, Collect Hlth Postgrad Program, Environm Exposure & Risk Assessment Grp, Santos, Brazil; [Lin, Chin An] Univ Sao Paulo, Fac Med, Dept Internal Med, Sao Paulo, Brazil; [de Andre, Paulo Afonso; Saldiva de Andre, Carmen Diva; Nascimento Saldiva, Paulo Hilario] Univ Sao Paulo, Fac Med, Dept Pathol, Lab Expt Air Pollut, BR-05508 Sao Paulo, Brazil; [Saldiva de Andre, Carmen Diva; Singer, Julio da Motta] Univ Sao Paulo, Inst Math & Stat, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Catolica de Santos; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Santos, UP (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Pulm Div,Heart Inst InCor, Sao Paulo, Brazil.	pneubiratan@incor.usp.br	Singer, Julio M/C-1232-2013; Braga, Alfésio L. F./G-6920-2012; Pereira, Luiz AA/D-8167-2016; Saldiva, Paulo HN/D-7385-2012; Santos, Ubiratan/H-7862-2012	Singer, Julio M/0000-0001-6515-9643; Braga, Alfésio L. F./0000-0003-3254-3029; Saldiva, Paulo HN/0000-0003-2005-8253; Santos, Ubiratan/0000-0003-4919-884X	Brazilian National Council of Technological and Scientific Development (MCTI-CNPq) [18/2006, 308613/211-2]	Brazilian National Council of Technological and Scientific Development (MCTI-CNPq)	This work was supported by Brazilian National Council of Technological and Scientific Development (MCTI-CNPq, Edital 18/2006, CNPq, grant 308613/211-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey DE, 1998, AM J RESP CRIT CARE, V158, P289, DOI 10.1164/ajrccm.158.1.9710101; Adam M, 2015, EUR RESPIR J, V45, P38, DOI 10.1183/09031936.00130014; Andersen ZJ, 2011, AM J RESP CRIT CARE, V183, P455, DOI 10.1164/rccm.201006-0937OC; Berger KI, 2013, CHEST, V144, P249, DOI 10.1378/chest.12-1411; Boogaard H, 2013, EPIDEMIOLOGY, V24, P753, DOI 10.1097/EDE.0b013e31829e1639; Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237; BRUNEKREEF B, 2005, RES REP HLTH EFF I, V127, P1; Calderon-Garciduenas L, 2006, ENVIRON HEALTH PERSP, V114, P1432, DOI 10.1289/ehp.8377; de Miranda RM, 2012, AIR QUAL ATMOS HLTH, V5, P63, DOI 10.1007/s11869-010-0124-1; Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625; Forbes LJL, 2009, THORAX, V64, P657, DOI 10.1136/thx.2008.109389; Gotschi T, 2008, EPIDEMIOLOGY, V19, P690, DOI 10.1097/EDE.0b013e318181650f; Johannson KA, 2015, CHEST, V147, P1161, DOI 10.1378/chest.14-1299; Kalappanavar NK, 2012, INT J OCCUP ENV MED, V3, P68; Kan HD, 2007, THORAX, V62, P873, DOI 10.1136/thx.2006.073015; Kjaergaard SK, 2004, J APPL PHYSIOL, V96, P1651, DOI 10.1152/japplphysiol.00507.2003; Mauad T, 2008, AM J RESP CRIT CARE, V178, P721, DOI 10.1164/rccm.200803-436OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miller MR, 2005, EUR RESPIR J, V26, P153, DOI 10.1183/09031936.05.00034505; Morse D, 2014, ANNU REV PHYSIOL, V76, P493, DOI 10.1146/annurev-physiol-021113-170411; Pal Pravati, 2010, Indian J Physiol Pharmacol, V54, P329; Patil P., 2013, NATL J PHYSL PHARM P, V3, P162, DOI DOI 10.5455/NJPPP.2013.3.220420131; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008; Pinkerton KE, 2000, ENVIRON HEALTH PERSP, V108, P1063, DOI 10.2307/3434960; Rice MB, 2015, AM J RESP CRIT CARE, V191, P656, DOI 10.1164/rccm.201410-1875OC; Romieu Isabelle, 2012, Res Rep Health Eff Inst, P5; Saieg MA, 2011, INHAL TOXICOL, V23, P459, DOI 10.3109/08958378.2011.582895; Sava F, 2012, CLIN CHEST MED, V33, P759, DOI 10.1016/j.ccm.2012.07.003; Schikowski T, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-152; Schikowski T, 2014, EUR RESPIR J, V43, P250, DOI 10.1183/09031936.00100112; Scovronik N., 2015, REDUCING GLOBAL HLTH; Sonnappa S, 2015, AM J RESP CRIT CARE, V191, P79, DOI 10.1164/rccm.201406-1049OC; Souza MB, 1998, CHEST, V113, P1312, DOI 10.1378/chest.113.5.1312; Strak M, 2012, ENVIRON HEALTH PERSP, V120, P1183, DOI 10.1289/ehp.1104389; Vassallo R, 2012, CLIN CHEST MED, V33, P165, DOI 10.1016/j.ccm.2011.11.004; WATT M, 1995, OCCUP ENVIRON MED, V52, P790, DOI 10.1136/oem.52.12.790	37	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163225	10.1371/journal.pone.0163225	http://dx.doi.org/10.1371/journal.pone.0163225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711222	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600018
J	Yang, LL; Chen, JJ; Hu, WM; Yang, TS; Zhang, YJ; Yukiyoshi, T; Zhou, YY; Wang, Y				Yang, Lulu; Chen, Jianjun; Hu, Weiming; Yang, Tianshun; Zhang, Yanjun; Yukiyoshi, Tamura; Zhou, Yanyang; Wang, Ying			Population Genetic Structure of Glycyrrhiza inflata B. (Fabaceae) Is Shaped by Habitat Fragmentation, Water Resources and Biological Characteristics	PLOS ONE			English	Article							EST-SSR MARKERS; CORE COLLECTION; CONSERVATION GENETICS; DIVERSITY; CONSEQUENCES; SOFTWARE; DESERT; WILD; INFERENCE; TRAITS	Background Habitat fragmentation, water resources and biological characteristics are important factors that shape the genetic structure and geographical distribution of desert plants. Analysis of the relationships between these factors and population genetic variation should help to determine the evolutionary potential and conservation strategies for genetic resources for desert plant populations. As a traditional Chinese herb, Glycyrrhiza inflata B. (Fabaceae) is restricted to the fragmented desert habitat in China and has undergone a dramatic decline due to long-term over-excavation. Determining the genetic structure of the G. inflata population and identifying a core collection could help with the development of strategies to conserve this species. Results We investigated the genetic variation of 25 G. inflata populations based on microsatellite markers. A high level of population genetic divergence (F-ST = 0.257), population bottlenecks, reduced gene flow and moderate genetic variation (H-E = 0.383) were detected. The genetic distances between the populations significantly correlated with the geographical distances, and this suggests that habitat fragmentation has driven a special genetic structure of G. inflata in China through isolation by distance. STRUCTURE analysis showed that G. inflata populations were structured into three clusters and that the populations belonged to multiple water systems, which suggests that water resources were related to the genetic structure of G. inflata. In addition, the biological characteristics of the perennial species G. inflata, such as its long-lived seeds, asexual reproduction, and oasis ecology, may be related to its resistance to habitat fragmentation. A core collection of G. inflata, that included 57 accessions was further identified, which captured the main allelic diversity of G. inflata. Conclusions Recent habitat fragmentation has accelerated genetic divergence. The population genetic structure of G. inflata has been shaped by habitat fragmentation, water resources and biological characteristics. This genetic information and core collection will facilitate the conservation of wild germplasm and breeding of this Chinese medicinal plant.	[Yang, Lulu; Chen, Jianjun; Hu, Weiming; Yang, Tianshun; Zhang, Yanjun] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China; [Yang, Lulu; Hu, Weiming] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Ying] Chinese Acad Sci, Key Lab South China Agr Plant Mol Anal & Genet Im, Prov Key Lab Appl Bot, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Yukiyoshi, Tamura; Zhou, Yanyang] Maruzen Pharmaceut Co LTD, Tokyo, Japan	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS	Wang, Y (corresponding author), Chinese Acad Sci, Key Lab South China Agr Plant Mol Anal & Genet Im, Prov Key Lab Appl Bot, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	yingwang@scib.ac.cn		Yang, Lulu/0000-0002-0365-4179; Hu, Weiming/0000-0002-0151-886X	Talent Introduction Project of the South China Botanical Garden; STS Project of the Chinese Academy of Sciences [KFJ-EW-STS-118]; Licorice International Cooperation Project; Maruzen Pharmaceuticals Co., LTD. [Y051011001]	Talent Introduction Project of the South China Botanical Garden; STS Project of the Chinese Academy of Sciences; Licorice International Cooperation Project; Maruzen Pharmaceuticals Co., LTD.	This research was partially supported by the Talent Introduction Project of the South China Botanical Garden, STS Project of the Chinese Academy of Sciences (KFJ-EW-STS-118), and the Licorice International Cooperation Project with Maruzen Pharmaceuticals Co., LTD. (Y051011001). Maruzen Pharmaceuticals Co., LTD. provided support in the form of salaries for authors [TY, YZ] and played a role in the design and the statistical analysis of this study, but did not have any additional role in the decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Ashfaq UA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-112; Bataillon TM, 1996, GENETICS, V144, P409; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Bruelheide H, 2003, PHYTOCOENOLOGIA, V33, P801, DOI 10.1127/0340-269X/2003/0033-0801; Bruelheide H, 2010, APPL VEG SCI, V13, P56, DOI 10.1111/j.1654-109X.2009.01050.x; Chabane K, 2005, GENET RESOUR CROP EV, V52, P903, DOI 10.1007/s10722-003-6112-7; Chen FJ, 2009, BIOCHEM SYST ECOL, V37, P613, DOI 10.1016/j.bse.2009.08.004; Chen S., 2006, FLORA CHINA; Cho JJ, 2014, INT J ONCOL, V45, P667, DOI 10.3892/ijo.2014.2461; Cubry P, 2014, PLANT BREEDING, V133, P419, DOI 10.1111/pbr.12158; de Lafontaine G, 2013, MOL ECOL, V22, P4397, DOI 10.1111/mec.12403; Diamond J., 1989, P37; Doyle J. J., 1987, PHYTOCHEM B, P11; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Escribano P, 2008, ANN APPL BIOL, V153, P25, DOI 10.1111/j.1744-7348.2008.00232.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; [樊自立 Fan Zili], 2013, [自然资源学报, Journal of Natural Resources], V28, P713; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Franco J, 2006, CROP SCI, V46, P854, DOI 10.2135/cropsci2005.07-0201; Frankel O.H., 1984, GENETICS NEW FRONTIE, VIV, P1; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Gao X, 2011, PHARM CLIN CHIN MAT, V27, P79; Ge XJ, 2005, ANN BOT-LONDON, V95, P843, DOI 10.1093/aob/mci089; Ge XJ, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-1; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Grenier C, 2001, CROP SCI, V41, P241, DOI 10.2135/cropsci2001.411241x; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; Hamrick J. L., 1996, P281; Hamsiya A, 2013, JOURNAL ARID LAND RE, V27, P40; Hayashi H, 2009, PLANT BIOTECHNOL-NAR, V26, P101, DOI 10.5511/plantbiotechnology.26.101; Hedrick PW, 2004, FOREST ECOL MANAG, V197, P3, DOI 10.1016/j.foreco.2004.05.002; Heinken T, 2013, PERSPECT PLANT ECOL, V15, P205, DOI 10.1016/j.ppees.2013.05.003; Hu J, 2011, BIOL PLANTARUM, V55, P577, DOI 10.1007/s10535-011-0129-0; Jacquemyn H, 2012, J ECOL, V100, P76, DOI 10.1111/j.1365-2745.2011.01919.x; Jia XP, 2007, GENET RESOUR CROP EV, V54, P233, DOI 10.1007/s10722-006-9139-8; Kang M, 2008, CONSERV GENET, V9, P191, DOI 10.1007/s10592-007-9324-0; Kingman JFC, 2000, GENETICS, V156, P1461; Krichen L, 2012, HEREDITAS, V149, P163, DOI 10.1111/j.1601-5223.2012.02245.x; Larsen HO, 2007, BIODIVERS CONSERV, V16, P1679, DOI 10.1007/s10531-006-9039-4; Le Cunff L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-31; Li XH, 2010, CHINESE J EXPT TRADI, V5; [李学斌 Li Xuebin], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P718; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu ZG, 2012, BIOCHEM SYST ECOL, V45, P86, DOI 10.1016/j.bse.2012.07.017; Ma Chunying, 2011, Front Agric China, V5, P400, DOI 10.1007/s11703-011-1121-3; Ma JZ, 2000, J LANZHOU U NATURAL, P88; Ma SM, 2012, CONSERV GENET, V13, P1531, DOI 10.1007/s10592-012-0397-z; MANTEL N, 1967, CANCER RES, V27, P209; Marita JM, 2000, GENET RESOUR CROP EV, V47, P515, DOI 10.1023/A:1008784610962; National Pharmacopoeia Committee, 2010, CHINESE PHARMACOPOEI; Nei M., 1987, MOL EVOLUTIONARY GEN; NEVO E, 1989, J ARID ENVIRON, V17, P241, DOI 10.1016/S0140-1963(18)30911-X; Okpul T, 2004, GENET RESOUR CROP EV, V51, P671, DOI 10.1023/B:GRES.0000024656.41571.09; Ortiz R, 1998, THEOR APPL GENET, V96, P475, DOI 10.1007/s001220050764; Park HY, 2004, ARCH PHARM RES, V27, P57, DOI 10.1007/BF02980047; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2001, GENETIC ANAL EXCEL G; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Potts SM, 2012, PLANT MOL BIOL REP, V30, P827, DOI 10.1007/s11105-011-0399-x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RITLAND K, 1990, EVOLUTION, V44, P1230, DOI [10.2307/2409284, 10.1111/j.1558-5646.1990.tb05227.x]; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Simko I, 2009, J HERED, V100, P256, DOI 10.1093/jhered/esn072; Sun QM, 2012, SCI HORTIC-AMSTERDAM, V146, P29, DOI 10.1016/j.scienta.2012.08.012; Taba S, 1998, CROP SCI, V38, P1378, DOI 10.2135/cropsci1998.0011183X003800050037x; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Villinski JR, 2014, J NAT PROD, V77, P521, DOI 10.1021/np400788r; Wang J, 2011, ANN FOREST SCI, V68, P1143, DOI 10.1007/s13595-011-0119-6; Wang KH, 2006, J ETHNOPHARMACOL, V106, P353, DOI 10.1016/j.jep.2006.01.010; Wang MX, 2008, HEREDITY, V101, P527, DOI 10.1038/hdy.2008.61; Wang R, 2011, MOL ECOL, V20, P4421, DOI 10.1111/j.1365-294X.2011.05293.x; [王玉庆 Wang Yuqing], 2004, [中国生态农业学报, Chinese journal of eco-agriculture], V12, P194; Wang YZ, 2011, SCI HORTIC-AMSTERDAM, V128, P311, DOI 10.1016/j.scienta.2011.01.025; Wilson GA, 2003, GENETICS, V163, P1177; Yan J, 2009, ANN BOT-LONDON, V103, P825, DOI 10.1093/aob/mcp006; Yan S, 1999, ACTA MICROPALAEONTOL, V17, P165; Yang X.P., 2001, EARTH SCI FRONTIERS, V8, P83; Yang XP, 2002, QUATERN INT, V97-8, P155, DOI 10.1016/S1040-6182(02)00061-7; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zhang JT, 2011, BOT STUD, V52, P493; Zhang QY, 2009, J CHROMATOGR A, V1216, P1954, DOI 10.1016/j.chroma.2008.07.072; Zhang XM, 2001, SUSTAINABLE LAND USE IN DESERTS, P350; Zhao Y, 2013, MOL ECOL, V22, P5531, DOI 10.1111/mec.12517	98	8	8	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164129	10.1371/journal.pone.0164129	http://dx.doi.org/10.1371/journal.pone.0164129			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711241	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600082
J	Bandeira, KLN; Simbras, FM; Machado, EB; Campos, DD; Oliveira, GR; Kellner, AWA				Bandeira, Kamila L. N.; Simbras, Felipe Medeiros; Machado, Elaine Batista; Campos, Diogenes de Almeida; Oliveira, Gustavo R.; Kellner, Alexander W. A.			A New Giant Titanosauria (Dinosauria: Sauropoda) from the Late Cretaceous Bauru Group, Brazil	PLOS ONE			English	Article							VERTEBRAL PNEUMATICITY; SP-NOV.; PATAGONIA; NEUQUEN; GEN.; NOMENCLATURE; EVOLUTION; SPECIMEN; BASIN	Titanosaurian dinosaurs include some of the largest land-living animals that ever existed, and most were discovered in Cretaceous deposits of Argentina. Here we describe the first Brazilian gigantic titanosaur, Austroposeidon magnificus gen. et sp. nov., from the Late Cretaceous Presidente Prudente Formation (Bauru Group, Parana A Basin), Sao Paulo State, southeast Brazil. The size of this animal is estimated around 25 meters. It consists of a partial vertebral column composed by the last two cervical and the first dorsal vertebrae, all fairly complete and incomplete portions of at least one sacral and seven dorsal elements. The new species displays four autapomorphies: robust and tall centropostzygapophyseal laminae (cpol) in the last cervical vertebrae; last cervical vertebra bearing the posterior centrodiapophyseal lamina (pcdl) bifurcated; first dorsal vertebra with the anterior and posterior centrodiapophyseal laminae (acdl/pcdl) curved ventrolaterally, and the diapophysis reaching the dorsal margin of the centrum; posterior dorsal vertebra bearing forked spinoprezygapophyseal laminae (sprl). The phylogenetic analysis presented here reveals that Austroposeidon magnificus is the sister group of the Lognkosauria. CT scans reveal some new osteological internal features in the cervical vertebrae such as the intercalation of dense growth rings with camellae, reported for the first time in sauropods. The new taxon further shows that giant titanosaurs were also present in Brazil during the Late Cretaceous and provides new information about the evolution and internal osteological structures in the vertebrae of the Titanosauria clade.	[Bandeira, Kamila L. N.; Machado, Elaine Batista; Kellner, Alexander W. A.] Univ Fed Rio de Janeiro, Museu Nacl, Dept Geol & Paleontol, Lab Sistemat & Tafon Vertebrados Fosseis, Quinta Boa Vista S-N, BR-20940040 Rio De Janeiro, RJ, Brazil; [Simbras, Felipe Medeiros] Petr Brasileiro SA PETROBRAS, Ave Republ Chile 330,17 Andar, Rio De Janeiro, RJ, Brazil; [Machado, Elaine Batista] Univ Estacio Sa, Rua Andre Rocha 838, BR-22710560 Rio De Janeiro, RJ, Brazil; [Campos, Diogenes de Almeida] CPRM, Museu Ciencias Terra, Av Pasteur 404, BR-22290240 Rio De Janeiro, RJ, Brazil; [Oliveira, Gustavo R.] Univ Fed Rural Pernambuco, Dept Biol, Rua Dom Manuel de Medeiros S-N, BR-52171900 Recife, PE, Brazil	Universidade Federal do Rio de Janeiro; Petrobras; Universidade Estacio de Sa; Universidade Federal Rural de Pernambuco (UFRPE)	Bandeira, KLN; Kellner, AWA (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Geol & Paleontol, Lab Sistemat & Tafon Vertebrados Fosseis, Quinta Boa Vista S-N, BR-20940040 Rio De Janeiro, RJ, Brazil.	kamilabandeira@yahoo.com.br; kellner@mn.ufrj.br	Kellner, Alexander W/H-1023-2015; Kellner, Alexander/ABE-9591-2020; Oliveira, Gustavo R/F-7432-2012	Kellner, Alexander W/0000-0001-7174-9447; Kellner, Alexander/0000-0001-7174-9447; Oliveira, Gustavo R/0000-0002-9871-1235; L.N. Bandeira, Kamila/0000-0002-2744-8126	Fundacao de Desenvolvimento Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/102.327/2010]; Fundacao de Desenvolvimento Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/ 202.893/2015]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304780/2013-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Desenvolvimento Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Fundacao de Desenvolvimento Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding for this project was provided by the Fundacao de Desenvolvimento Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (E-26/102.327/2010 and FAPERJ #E-26/ 202.893/2015 to AWAK) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq #304780/2013-8 to AWAK). KLNB also is grateful to the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the scholarship of her master degree studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apesteguia S, 2004, NATURWISSENSCHAFTEN, V91, P493, DOI 10.1007/s00114-004-0560-6; Bittencourt JS, 2011, AN ACAD BRAS CIENC, V83, P23, DOI 10.1590/S0001-37652011000100003; BONAPARTE JF, 1979, SCIENCE, V205, P1377, DOI 10.1126/science.205.4413.1377; Bonaparte JF, 2006, CRETACEOUS RES, V27, P364, DOI 10.1016/j.cretres.2005.07.004; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; Borsuk-Biatynicka M., 1977, Palaeontologia Polonica, V37, P5; CALVO J O, 1991, Ameghiniana, V28, P303; Calvo JO, 2003, REV GEOL CHILE, V30, P333; Calvo JO, 2007, AN ACAD BRAS CIENC, V79, P529, DOI 10.1590/S0001-37652007000300013; Calvo Jorge O., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P485; Campos DA, 1978, CARTA GEOLOGICA BRAS, P46; Cerda IA, 2012, NATURWISSENSCHAFTEN, V99, P83, DOI 10.1007/s00114-011-0869-x; Coria RA, 2013, ZOOTAXA, V3683, P357, DOI 10.11646/zootaxa.3683.4.2; D'Emic MD, 2012, ZOOL J LINN SOC-LOND, V166, P624, DOI 10.1111/j.1096-3642.2012.00853.x; De Almeida Campos Diogenes, 2005, Arquivos do Museu Nacional Rio de Janeiro, V63, P565; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; de Azevedo RPF, 2013, CRETACEOUS RES, V40, P131, DOI 10.1016/j.cretres.2012.06.004; Fernandes LA, 2007, SEDIMENT GEOL, V199, P51, DOI 10.1016/j.sedgeo.2005.12.030; Filippi LS, 2011, GEOL ACTA, V9, P1, DOI 10.1344/105.000001648; Filippi LS, 2011, ACTA PALAEONTOL POL, V56, P505, DOI 10.4202/app.2010.0019; Fowler DW, 2011, ACTA PALAEONTOL POL, V56, P685, DOI 10.4202/app.2010.0105; Gallina PA, 2011, AN ACAD BRAS CIENC, V83, P235, DOI 10.1590/S0001-37652011005000001; Garcia G, 2010, B SOC GEOL FR, V181, P269, DOI 10.2113/gssgfbull.181.3.269; Gilmore C. W., 1922, Smithsonian Miscellaneous Collections, V72, P1; Goloboff P.A., 2008, TNT TREE ANAL USING; Gomani EM, 2005, PALAEONTOL ELECTRON, V8; GONZALEZ RIGA B, 2005, AMEGHINIANA, V42, P535; Riga BJG, 2014, AMEGHINIANA, V51, P3, DOI 10.5710/AMEGH.26.12.1013.1889; Gorscak E, 2014, J VERTEBR PALEONTOL, V34, P1133, DOI 10.1080/02724634.2014.845568; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Huene F. V., 1933, PALEONT INDICA, V21, P1; JACOBS LL, 1993, PALAEONTOLOGY, V36, P523; Jain SL, 1997, J VERTEBR PALEONTOL, V17, P114, DOI 10.1080/02724634.1997.10010958; Kellner AWA, 2015, AN ACAD BRAS CIENC, V87, P669, DOI 10.1590/0001-3765201520150307; Kellner Alexander W.A., 1999, National Science Museum Monographs, V15, P111; Kellner AWA, 2007, B MUSEU NAC, V74, P1; Lacovara KJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06196; Lautenschlager S, 2014, PALAEONTOL Z, V88, P111, DOI 10.1007/s12542-013-0184-2; Le Loeuff J., 1993, REV PALENBIOLOGIE, P107; Lehman TM, 2002, J PALEONTOL, V76, P156, DOI 10.1666/0022-3360(2002)076<0156:AJSOTS>2.0.CO;2; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; Li LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085979; Lu JC, 2008, ACTA GEOL SIN-ENGL, V82, P225; Lydekker R., 1893, ANALES MUSEO LA PLAT, V2, P1; Machado EB, 2013, ZOOTAXA, V3701, P301, DOI 10.11646/zootaxa.3701.3.1; Mannion PD, 2012, J VERTEBR PALEONTOL, V32, P614, DOI 10.1080/02724634.2012.660898; McIntosh J.S., 1990, P345; Nava WR, 2011, AN ACAD BRAS CIENC, V83, P291, DOI 10.1590/S0001-37652011000100017; Novas Fernando E., 2005, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V7, P37; OLIVEIRA GR, 2007, ARQ MUS NAC RIO J, V65, P113; Powell J.E., 1992, DINOSAURIOS ENTORNO, P165; Powell J. E., 2003, RECORDS QUEEN VICTOR, V111; Powell J.E., 1990, ACT 5 C ARG PAL BIOE, V1, P123, DOI DOI 10.1016/J.GEOBIOS.2005.06.001; Powell JE, 1987, C BRAS PAL RIO DE JA, V10, P155; Remes K, 2007, PALAEONTOLOGY, V50, P653, DOI 10.1111/j.1475-4983.2007.00652.x; Riga BJG, 2003, AMEGHINIANA, V40, P155; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Sales MAF, 2014, AN ACAD BRAS CIENC, V86, P127, DOI 10.1590/0001-37652013100412; Salgado L, 2005, J VERTEBR PALEONTOL, V25, P623, DOI 10.1671/0272-4634(2005)025[0623:ANSONA]2.0.CO;2; Salgado L, 2008, PALAEONTOLOGY, V51, P881, DOI 10.1111/j.1475-4983.2008.00781.x; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Santucci RM, 2011, ZOOTAXA, P1; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; Smith JB, 2001, SCIENCE, V292, P1704, DOI 10.1126/science.1060561; Upchurch P, 2005, NAT SCI MUS MONO, V26, P1; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; WEDEL MJ, 2004, P 19 INT C ZOOL BEIJ, P443; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA., 2012, CONTRIB MUS PALEONTO, V32, P91; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P471, DOI 10.1671/0272-4634(2006)26[471:ATDSAF]2.0.CO;2; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; You HL, 2009, P ROY SOC B-BIOL SCI, V276, P4077, DOI 10.1098/rspb.2009.1278; Zaher H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016663; Zaher H, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3512[1:ROTCMO]2.0.CO;2	76	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163373	10.1371/journal.pone.0163373	http://dx.doi.org/10.1371/journal.pone.0163373			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706250	gold, Green Published			2022-12-27	WOS:000385697200042
J	Roelfsema, C; Thurstan, R; Beger, M; Dudgeon, C; Loder, J; Kovacs, E; Gallo, M; Flower, J; Cabrera, KLG; Ortiz, J; Lea, A; Kleine, D				Roelfsema, Chris; Thurstan, Ruth; Beger, Maria; Dudgeon, Christine; Loder, Jennifer; Kovacs, Eva; Gallo, Michele; Flower, Jason; Cabrera, K-le Gomez; Ortiz, Juan; Lea, Alexandra; Kleine, Diana			A Citizen Science Approach: A Detailed Ecological Assessment of Subtropical Reefs at Point Lookout, Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; MARINE; SHARK; COAST	Subtropical reefs provide an important habitat for flora and fauna, and proper monitoring is required for conservation. Monitoring these exposed and submerged reefs is challenging and available resources are limited. Citizen science is increasing in momentum, as an applied research tool and in the variety of monitoring approaches adopted. This paper aims to demonstrate an ecological assessment and mapping approach that incorporates both top-down (volunteer marine scientists) and bottom-up (divers/community) engagement aspects of citizen science, applied at a subtropical reef at Point Lookout, Southeast Queensland, Australia. Marine scientists trained fifty citizen scientists in survey techniques that included mapping of habitat features, recording of substrate, fish and invertebrate composition, and quantifying impacts (e.g., occurrence of substrate damage, presence of litter). In 2014 these volunteers conducted four seasonal surveys along semi-permanent transects, at five sites, across three reefs. The project presented is a model on how citizen science can be conducted in a marine environment through collaboration of volunteer researchers, non-researchers and local marine authorities. Significant differences in coral and algal cover were observed among the three sites, while fluctuations in algal cover were also observed seasonally. Differences in fish assemblages were apparent among sites and seasons, with subtropical fish groups observed more commonly in colder seasons. The least physical damage occurred in the most exposed sites (Flat Rock) within the highly protected marine park zones. The broad range of data collected through this top-down/bottom-up approach to citizen science exemplifies the projects' value and application for identifying ecosystem trends or patterns. The results of the project support natural resource and marine park management, providing a valuable contribution to existing scientific knowledge and the conservation of local reefs.	[Roelfsema, Chris; Thurstan, Ruth; Beger, Maria; Dudgeon, Christine; Loder, Jennifer; Kovacs, Eva; Gallo, Michele; Flower, Jason; Cabrera, K-le Gomez; Ortiz, Juan; Lea, Alexandra; Kleine, Diana] Univ Queensland, Univ Queensland Underwater Club UniDive, St Lucia, Qld, Australia; [Roelfsema, Chris; Kovacs, Eva] Univ Queensland, Sch Geog Planning & Environm Management, Remote Sensing Res Ctr, St Lucia, Qld, Australia; [Thurstan, Ruth] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Thurstan, Ruth] Deakin Univ, Ctr Integrat Ecol, Warrnambool, Vic, Australia; [Beger, Maria; Flower, Jason; Ortiz, Juan] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Dudgeon, Christine] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Loder, Jennifer; Lea, Alexandra] Reef Check Fdn Ltd Australia, Reef Check Australia, Brisbane, Qld, Australia; [Cabrera, K-le Gomez] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia; [Cabrera, K-le Gomez] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Kleine, Diana] Univ Queensland, Queensland Brain Inst, CoralWatch, St Lucia, Qld, Australia	University of Queensland; University of Queensland; Deakin University; Deakin University; University of Queensland; University of Queensland; University of Queensland; University of Queensland; University of Queensland	Roelfsema, C (corresponding author), Univ Queensland, Univ Queensland Underwater Club UniDive, St Lucia, Qld, Australia.; Roelfsema, C (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Remote Sensing Res Ctr, St Lucia, Qld, Australia.		Roelfsema, Chris/AAV-1277-2020; Ortiz Cuellar, Juan carlos/GQZ-3899-2022; Beger, Maria/F-9049-2013; Kovacs, Eva/U-3526-2019; Beger, Maria/ABC-5975-2022; Flower, Jason/W-7656-2019; Dudgeon, Christine/A-1633-2017; Thurstan, Ruth/K-5551-2014	Roelfsema, Chris/0000-0003-0182-1356; Beger, Maria/0000-0003-1363-3571; Kovacs, Eva/0000-0002-7228-4028; Beger, Maria/0000-0003-1363-3571; Flower, Jason/0000-0002-6731-8182; Dudgeon, Christine/0000-0001-5059-7886; Thurstan, Ruth/0000-0002-8045-1631	Redland City Council; Sibelco community grants; Sibelco Australia Mineral Sands; Transit Systems / Stradbroke Ferries; Point Lookout SCUBA Charter; Manta Lodge SCUBA Centre; Reef Check Australia; CoralWatch and Remote Sensing Research Centre	Redland City Council; Sibelco community grants; Sibelco Australia Mineral Sands; Transit Systems / Stradbroke Ferries; Point Lookout SCUBA Charter; Manta Lodge SCUBA Centre; Reef Check Australia; CoralWatch and Remote Sensing Research Centre	Funded by Redland City Council and Sibelco community grants.; The project could not have succeeded without the support of the Redland City Council; Sibelco Australia Mineral Sands; Transit Systems / Stradbroke Ferries; Point Lookout SCUBA Charter; Manta Lodge SCUBA Centre; Reef Check Australia; CoralWatch and Remote Sensing Research Centre. Academic consultation was provided by the University of Queensland: Dr. Ian Tibbets, Prof. S. Phinn, Dr. C. Kilpatrick; Kevin Townsend, and Adin Hewat. Last but not least the UniDive and its members for providing volunteers for the project and those who collected data together with the authors: Aaron Aeberli, Trevor Barrenger, Liette Boisvert, Ryan Booker, Gavin Bott, Roxanne Borruat, Sarah Buckley, Peran Bray, Dunia Brunner, Jenni Calcraft, Olivier Cheneval, Robert Cook, Donna Easton, Stefano Freguia, Blair Jedras, Karen Johnson, Beth Kita, Julie Klint, Justin Mariner, Bruce McLean, Melanie Oey, Dee Passenger, Josh Passenger, Michael Pheasant, Lachlan Pollard, Lee Raby, James Sadler, Douglas Stetner, and Mark Stenhouse.	[Anonymous], 2014, CHANGE MARINE COMMUN; Bansemer CS, 2011, MAR FRESHWATER RES, V62, P596, DOI 10.1071/MF10152; Beeden RJ, 2014, ENVIRON MONIT ASSESS, V186, P8527, DOI 10.1007/s10661-014-4022-0; Beger M., 2011, ECOLOGICAL MANAGEMEN, V12, pe7, DOI DOI 10.1111/J.1442-8903.2011.00573.X; Beger M, 2014, DIVERS DISTRIB, V20, P245, DOI 10.1111/ddi.12140; Bonter DN, 2012, FRONT ECOL ENVIRON, V10, P305, DOI 10.1890/110273; Branchini S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131812; Branchini S, 2015, BIODIVERS CONSERV, V24, P319, DOI 10.1007/s10531-014-0810-7; Breckwoldt A, 2012, CURR OPIN ENV SUST, V4, P331, DOI 10.1016/j.cosust.2012.05.008; Burke L, 2012, REEFS RISK REVISITED; Cigliano JA, 2015, OCEAN COAST MANAGE, V115, P77, DOI 10.1016/j.ocecoaman.2015.06.012; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Darwall WRT, 1996, BIOL CONSERV, V78, P223, DOI 10.1016/0006-3207(95)00147-6; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Dickinson JL, ANN REV ECOLOGY EVOL, V41, P149; Dudgeon CL, 2013, ANIM BEHAV, V85, P471, DOI 10.1016/j.anbehav.2012.12.013; Feary DA, 2014, FISH FISH, V15, P593, DOI 10.1111/faf.12036; Fellegara I, 2008, MEM QUEENSL MUS, V54, P14; Ford S., 2003, SURVEYING HABITATS C; Foster-Smith J, 2003, BIOL CONSERV, V113, P199, DOI 10.1016/S0006-3207(02)00373-7; Goffredo S, 2010, ECOL APPL, V20, P2170, DOI 10.1890/09-1546.1; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Harborne AR, 2011, MAR ECOL PROG SER, V437, P201, DOI 10.3354/meps09280; Harriott VJ, 1999, MAR FRESHWATER RES, V50, P299, DOI 10.1071/MF98042; Hill JJ, 2004, METHODS ECOLOGICAL M; Hodgson G., 2000, INTEGRATED COASTAL Z, V1, P169; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hunter J, 2013, CONCURR COMP-PRACT E, V25, P454, DOI 10.1002/cpe.2923; Kovacs E, 2015, ECOLOGICAL ASSESSMEN; Lauer M, 2008, OCEAN COAST MANAGE, V51, P495, DOI 10.1016/j.ocecoaman.2008.04.006; Loder J, 2009, REEF CHECK AUSTR S E; Marshall NJ, 2012, FRONT ECOL ENVIRON, V10, P332, DOI 10.1890/110266; Maynou F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021818; McMahon K, 2002, 1 QUEENSL U DIV UN; Nichols T, 2004, ARCTIC, V57, P68; Noad MJ, 2008, 1 INT WHAL COMM SCI, P1; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pheasant M, 2015, CLUB UOQU; R Core Team, 2021, R LANGUAGE ENV STAT; Roelfsema C, 2014, HDL10013EPIC45045D00; Roelfsema C, 2008, P SPIE INT SOC OPTIC; Roelfsema C, 2010, J APPL REMOTE SENS, V4, DOI 10.1117/1.3430107; Siebeck UE, 2006, CORAL REEFS, V25, P453, DOI 10.1007/s00338-006-0123-8; Smith SDA, 2008, MAR POLLUT BULL, V56, P525, DOI 10.1016/j.marpolbul.2007.11.016; Sommer B, 2014, ECOLOGY, V95, P1000, DOI 10.1890/13-1445.1; Teleki KA, 2012, AQUAT CONSERV, V22, P1, DOI 10.1002/aqc.2219; Thiel M, 2014, OCEANOGR MAR BIOL, V52, P257; Thurstan R, 2014, SURVEY METHODS MANUA; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010	51	20	21	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163407	10.1371/journal.pone.0163407	http://dx.doi.org/10.1371/journal.pone.0163407			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706182	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200043
J	Teh, BK; Cheong, SA				Teh, Boon Kin; Cheong, Siew Ann			The Asian Correction Can Be Quantitatively Forecasted Using a Statistical Model of Fusion-Fission Processes	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; FINANCIAL-MARKETS; TIME-SERIES; FLUCTUATIONS; EARTHQUAKES; DYNAMICS; RETURNS; CRASHES	The Global Financial Crisis of 2007-2008 wiped out US$37 trillions across global financial markets, this value is equivalent to the combined GDPs of the United States and the European Union in 2014. The defining moment of this crisis was the failure of Lehman Brothers, which precipitated the October 2008 crash and the Asian Correction (March 2009). Had the Federal Reserve seen these crashes coming, they might have bailed out Lehman Brothers, and prevented the crashes altogether. In this paper, we show that some of these market crashes (like the Asian Correction) can be predicted, if we assume that a large number of adaptive traders employing competing trading strategies. As the number of adherents for some strategies grow, others decline in the constantly changing strategy space. When a strategy group grows into a giant component, trader actions become increasingly correlated and this is reflected in the stock price. The fragmentation of this giant component will leads to a market crash. In this paper, we also derived the mean-field market crash forecast equation based on a model of fusions and fissions in the trading strategy space. By fitting the continuous returns of 20 stocks traded in Singapore Exchange to the market crash forecast equation, we obtain crash predictions ranging from end October 2008 to mid-February 2009, with early warning four to six months prior to the crashes.	[Teh, Boon Kin; Cheong, Siew Ann] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, 21 Nanyang Link, Singapore 637371, Singapore; [Teh, Boon Kin; Cheong, Siew Ann] Nanyang Technol Univ, Complex Inst, Block 2 Innovat Ctr,Level 2 Unit 245, Singapore 637723, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Teh, BK (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, 21 Nanyang Link, Singapore 637371, Singapore.; Teh, BK (corresponding author), Nanyang Technol Univ, Complex Inst, Block 2 Innovat Ctr,Level 2 Unit 245, Singapore 637723, Singapore.	S130005@e.ntu.edu.sg	Cheong, Siew Ann/B-6991-2011	Cheong, Siew Ann/0000-0002-8589-6699				AKGIRAY V, 1989, J BUS, V62, P55, DOI 10.1086/296451; Bartolozzi M, 2005, PHYSICA A, V350, P451, DOI 10.1016/j.physa.2004.11.061; BOLLERSLEV T, 1992, J ECONOMETRICS, V52, P5, DOI 10.1016/0304-4076(92)90064-X; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Carr P, 2003, MATH FINANC, V13, P345, DOI 10.1111/1467-9965.00020; Chakrabarti BK, 2008, PRAMANA-J PHYS, V71, P203, DOI 10.1007/s12043-008-0154-5; Cheong SA, 2014, SCI REP-UK, V4, DOI 10.1038/srep03624; Chiang TC, 2007, J INT MONEY FINANC, V26, P1206, DOI 10.1016/j.jimonfin.2007.06.005; CHRISTIE AA, 1982, J FINANC ECON, V10, P407, DOI 10.1016/0304-405X(82)90018-6; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; da Cruz JP, 2012, PHYSICA A, V391, P1445, DOI 10.1016/j.physa.2011.11.012; Feng L, 2012, P NATL ACAD SCI USA, V109, P8388, DOI 10.1073/pnas.1205013109; HAMILTON JD, 1994, J ECONOMETRICS, V64, P307, DOI 10.1016/0304-4076(94)90067-1; Johansen A, 1999, INT J MOD PHYS C, V10, P563, DOI 10.1142/S0129183199000437; Johansen A, 2002, SOCIAL SCI RES NETWO; Johnson N, 2011, SCIENCE, V333, P81, DOI 10.1126/science.1205068; Johnson NF, 2011, AIP ADV, V1, DOI 10.1063/1.3563072; Lee SS, 2008, REV FINANC STUD, V21, P2535, DOI 10.1093/rfs/hhm056; Lillo F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.016119; Liu Henry C. K., 2010, CRISIS WEALTH DESTRU; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; PALMER RG, 1994, PHYSICA D, V75, P264, DOI 10.1016/0167-2789(94)90287-9; Preis T, 2011, P NATL ACAD SCI USA, V108, P7674, DOI 10.1073/pnas.1019484108; Quax R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01898; Saleur H, 1996, J GEOPHYS RES-SOL EA, V101, P17661, DOI 10.1029/96JB00876; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; SCHEINKMAN JA, 1994, AM ECON REV, V84, P417; SCHWERT GW, 1989, CARN ROCH CONF SERIE, V31, P83, DOI 10.1016/0167-2231(89)90006-7; Sornette D., 2001, Quantitative Finance, V1, P452, DOI 10.1088/1469-7688/1/4/305; Sornette D, 2002, P NATL ACAD SCI USA, V99, P2522, DOI 10.1073/pnas.022581999; Teh BK, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60456-y; Teh BK, 2015, PHYSICA A, V424, P225, DOI 10.1016/j.physa.2015.01.024; Zhao ZY, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056107	34	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163842	10.1371/journal.pone.0163842	http://dx.doi.org/10.1371/journal.pone.0163842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706198	gold, Green Submitted, Green Published			2022-12-27	WOS:000385697200064
J	Chang, YT; Huang, MY; Yeh, YS; Huang, CW; Tsai, HL; Cheng, TL; Wang, JY				Chang, Yu -Tang; Huang, Ming-Yii; Yeh, Yung-Sung; Huang, Ching-Wen; Tsai, Hsiang-Lin; Cheng, Tian-Lu; Wang, Jaw-Yuan			A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; MULTIPLE MOLECULAR MARKERS; MEMBRANE-ARRAY METHOD; PERIPHERAL-BLOOD; COLON-CANCER; CURATIVE RESECTION; MESSENGER-RNA; CARCINOMA; ONCOGENE; DISEASE	Background Circulating biomarkers can predict clinical outcomes in colorectal cancer patients. The aim of the study was to evaluate the feasibility of our multigene biomarker chip for detecting circulating tumor cells for postoperative surveillance of stage I-III colorectal cancer patients. Materials and Methods In total, 298 stage I-III colorectal cancer patients were analyzed after curative resection between June 2010 and October 2014. During each follow-up, a postoperative surveillance strategy, including ESMO Guidelines Working Group recommendations and the biochip, was used. Results After a 28.4-month median follow-up, 48 (16.1%) patients had postoperative relapse. Univariate analysis revealed that the postoperative relapse risk factors were rectal tumor, perineural invasion, elevated preoperative and postoperative serum carcinoembryonic antigen levels, and positive biochip results (all P < 0.05). Multivariate analyses revealed that postoperative relapse correlated significantly with elevated postoperative serum carcinoembryonic antigen levels (odds ratio = 4.136, P = 0.008) and positive biochip results (odds ratio = 66.878, P < 0.001). However, the sensitivity (P = 0.003), specificity (P = 0.003), positive (P = 0.002) and negative (P = 0.006) predictive values, and accuracy (P < 0.001) of the biochip for predicting postoperative relapse were significantly higher than those of elevated postoperative serum carcinoembryonic antigen levels. Moreover, the median lead time between positive biochip result and postoperative relapse detection was significantly earlier than that between elevated postoperative serum carcinoembryonic antigen level and postoperative relapse detection (10.7 vs. 2.8 months, P < 0.001). Furthermore, positive biochip results correlated strongly with lower disease-free survival and overall survival of colorectal cancer patients (both P < 0.001). Conclusion Compared with conventional serum carcinoembryonic antigen detection, our multigene chip aided more accurate and earlier prediction of postoperative relapse during stage I-III colorectal cancer patient surveillance. In clinical practice, this biochip may facilitate early postoperative relapse diagnosis in colorectal cancer patients.	[Chang, Yu -Tang; Yeh, Yung-Sung; Huang, Ching-Wen; Tsai, Hsiang-Lin; Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Gastroenterol & Gen Surg, Kaohsiung, Taiwan; [Chang, Yu -Tang; Yeh, Yung-Sung; Wang, Jaw-Yuan] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Chang, Yu -Tang; Tsai, Hsiang-Lin; Wang, Jaw-Yuan] Kaohsiung Med Univ, Dept Surg, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chang, Yu -Tang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Pediat Surg, Dept Surg, Kaohsiung, Taiwan; [Huang, Ming-Yii] Kaohsiung Med Univ Hosp, Dept Radiat Oncol, Ctr Canc, Kaohsiung, Taiwan; [Huang, Ming-Yii] Kaohsiung Med Univ, Dept Radiat Oncol, Coll Med, Fac Med, Kaohsiung, Taiwan; [Huang, Ming-Yii; Wang, Jaw-Yuan] Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan; [Huang, Ching-Wen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Trauma & Crit Care, Dept Surg, Kaohsiung, Taiwan; [Yeh, Yung-Sung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Huang, Ching-Wen; Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Colorectal Surg, Dept Surg, Kaohsiung, Taiwan; [Huang, Ching-Wen; Tsai, Hsiang-Lin; Wang, Jaw-Yuan] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Tsai, Hsiang-Lin] Kaohsiung Med Univ Hosp, Div Gen Surg Med, Dept Surg, Kaohsiung, Taiwan; [Cheng, Tian-Lu] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Wang, JY (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Gastroenterol & Gen Surg, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Dept Surg, Coll Med, Fac Med, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Colorectal Surg, Dept Surg, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.; Wang, JY (corresponding author), Kaohsiung Med Univ, Res Ctr Environm Med, Kaohsiung, Taiwan.	cy614112@ms14.hinet.net	Jaw-Yuan, Wang/AFS-8845-2022; Huang, Ming-Yii/AAS-8132-2021	Jaw-Yuan, Wang/0000-0002-7705-2621; Cheng, Tian-Lu/0000-0002-7263-2766				Chen YF, 2005, CANCER LETT, V229, P115, DOI 10.1016/j.canlet.2004.12.026; De Salvo L, 1997, EUR J SURG ONCOL, V23, P522, DOI 10.1016/S0748-7983(97)93045-6; Desch CE, 2005, J CLIN ONCOL, V23, P8512, DOI 10.1200/JCO.2005.04.0063; Edge SB, 2010, AJCC CANC STAGING MA; GOLD P, 1965, J EXP MED, V122, P467, DOI 10.1084/jem.122.3.467; Graham RA, 1998, ANN SURG, V228, P59, DOI 10.1097/00000658-199807000-00009; HINE KR, 1984, BRIT J CANCER, V49, P689, DOI 10.1038/bjc.1984.109; Hsiung SK, 2009, FOOYIN J HLTH SCI, V1, P72, DOI DOI 10.1016/S1877-8607(10); Hsiung SK, 2011, BIOMEDICAL ENGINEERING, TRENDS, RESEARCH AND TECHNOLOGIES, P151; Huang MY, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-147; Labianca R, 2010, ANN ONCOL, V21, pv70, DOI 10.1093/annonc/mdq168; Lu CY, 2013, BRIT J CANCER, V108, P791, DOI 10.1038/bjc.2012.595; MARTIN EW, 1980, J SURG RES, V28, P389, DOI 10.1016/0022-4804(80)90100-6; MCCALL JL, 1994, DIS COLON RECTUM, V37, P875, DOI 10.1007/BF02052591; MINTON JP, 1985, CANCER, V55, P1284, DOI 10.1002/1097-0142(19850315)55:6<1284::AID-CNCR2820550622>3.0.CO;2-B; MOERTEL CG, 1993, JAMA-J AM MED ASSOC, V270, P943, DOI 10.1001/jama.270.8.943; ROCKLIN MS, 1991, DIS COLON RECTUM, V34, P794, DOI 10.1007/BF02051073; Scheer Adena, 2009, Clin Colon Rectal Surg, V22, P242, DOI 10.1055/s-0029-1242464; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; SLENTZ K, 1994, AM SURGEON, V60, P528; Tsao DA, 2010, LUNG CANCER, V68, P51, DOI 10.1016/j.lungcan.2009.05.023; Uen YH, 2007, ANN SURG, V246, P1040, DOI 10.1097/SLA.0b013e318142d918; WANEBO HJ, 1989, SURG GYNECOL OBSTET, V169, P479; Wang JY, 2007, CLIN CANCER RES, V13, P2406, DOI 10.1158/1078-0432.CCR-06-2054; Wang JY, 2006, WORLD J SURG, V30, P1007, DOI 10.1007/s00268-005-0485-z; Wang JY, 2006, INT J MOL MED, V17, P737; Wang JY, 2005, ONCOL REP, V14, P65; Weitz J, 1998, CLIN CANCER RES, V4, P343; Wharton RQ, 1999, CLIN CANCER RES, V5, P4158; Wiratkapun S, 2001, DIS COLON RECTUM, V44, P231, DOI 10.1007/BF02234298; Wong IHN, 2001, CANCER LETT, V162, P65, DOI 10.1016/S0304-3835(00)00630-3; Yang MJ, 2010, ANN SURG ONCOL, V17, P624, DOI 10.1245/s10434-009-0831-8; Yeh CS, 2006, INT J ONCOL, V28, P411	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163264	10.1371/journal.pone.0163264	http://dx.doi.org/10.1371/journal.pone.0163264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701415	Green Submitted, gold, Green Published			2022-12-27	WOS:000385696900005
J	Sanaie, A; Mergenthaler, C; Nasrat, A; Seddiq, MK; Mahmoodi, SD; Stevens, RH; Creswell, J				Sanaie, A.; Mergenthaler, C.; Nasrat, A.; Seddiq, M. K.; Mahmoodi, S. D.; Stevens, R. H.; Creswell, J.			An Evaluation of Passive and Active Approaches to Improve Tuberculosis Notifications in Afghanistan	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; CASE-FINDING STRATEGIES; PULMONARY TUBERCULOSIS; RANDOMIZED TRIAL; HEALTH-CARE; IMPACT; METAANALYSIS; DIAGNOSIS; BURDEN; INTERVENTIONS	Background In Afghanistan, improving TB case detection remains challenging. In 2014, only half of the estimated incident TB cases were notified, and notifications have decreased since peaking in 2007. Active case finding has been increasingly considered to improve TB case notifications. While access to health services has improved in Afghanistan, it remains poor and many people seeking health services won't receive proper care. Methods From October 2011 through December 2012 we conducted three separate case finding strategies in six provinces of Afghanistan and measured impact on TB case notification. Systematically screening cough among attendees at 47 health facilities, active household contact investigation of smear-positive index TB patients, and active screening at 15 camps for internally displaced people were conducted. We collected both intervention yield and official quarterly notification data. Additional TB notifications were calculated by comparing numbers of cases notified during the intervention with those notified before the intervention, then adjusting for secular trends in notification. Results We screened 2,022,127 people for TB symptoms during the intervention, tested 59,838 with smear microscopy and detected 5,046 people with smear-positive TB. Most cases (81.7%, 4,125) were identified in health facilities while nearly 20% were found through active case finding. A 56% increase in smear-positive TB notifications was observed between the baseline and intervention periods among the 47 health facilities, where cases detected by all three strategies were notified. Discussion While most people with TB are likely to be identified through health facility screening, there are many people who remain without a proper diagnosis if outreach is not attempted. This is especially true in places like Afghanistan where access to general services is poor. Targeted active case finding can improve the number of people who are detected and treated for TB and can push towards the targets of the Stop TB Global Plan and End TB Strategy.	[Sanaie, A.] AntiTB Assoc Afghanistan, Kabul, Afghanistan; [Mergenthaler, C.; Creswell, J.] Stop TB Partnership, Geneva, Switzerland; [Nasrat, A.] ACREOD, Kabul, Afghanistan; [Seddiq, M. K.; Mahmoodi, S. D.] Natl TB Program, Kabul, Afghanistan; [Stevens, R. H.] Mott McDonald, London, England		Mergenthaler, C (corresponding author), Stop TB Partnership, Geneva, Switzerland.	christinamergenthaler@gmail.com		Creswell, Jacob/0000-0002-4885-940X				Afghanistan's National Tuberculosis Control Program, 2006, AFGH NAT TUB CONTR P; Ahmadzai H, 2008, INT J TUBERC LUNG D, V12, P180; [Anonymous], 2009, PLOS ONE, V4, pe5443, DOI [10.1371/journal.pone.0005443, DOI 10.1371/JOURNAL.PONE.0005443]; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Bates M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040774; Blok L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119822; Blok L, 2014, INT HEALTH, V6, P181, DOI 10.1093/inthealth/ihu055; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P608, DOI 10.5588/ijtld.12.0506; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Creswell J, 2015, INT J TUBERC LUNG D, V19, P545, DOI 10.5588/ijtld.14.0775; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; Dieleman M., 2006, IMPROVING HLTH WORKE; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Durovni B, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001766; Dye C, 2003, TUBERCULOSIS, V83, P35, DOI 10.1016/S1472-9792(02)00056-2; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Hinderaker SG, 2011, INT J TUBERC LUNG D, V15, P71; Internal Displacement Monitoring Centre (IDMC), 2014, GLOB OV 2014 PEOPL I; John S, 2015, INT J TUBERC LUNG D, V19, P463, DOI 10.5588/ijtld.14.0679; Joshi B, 2015, PUBLIC HEALTH ACTION, V5, P93, DOI 10.5588/pha.15.0004; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Mauch V, 2010, HEALTH POLICY, V96, P118, DOI 10.1016/j.healthpol.2010.01.003; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Muyoyeta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093757; Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534; Reilley B, 2004, AM J PUBLIC HEALTH, V94, P1686, DOI 10.2105/AJPH.94.10.1686; Sabawoon W, 2012, MYCOBAC DIS, V2, P115, DOI [10.4172/2161-1068.1000115, DOI 10.4172/2161-1068.1000115]; Shah SA, 2013, INT J TUBERC LUNG D, V17, P1569, DOI 10.5588/ijtld.13.0169; Somashekar N, 2014, INT J TUBERC LUNG D, V18, P1243, DOI 10.5588/ijtld.14.0141; Stop TB Partnership, 2015, PAR SHIFT GLOB PLAN; The Global Fund, 2014, GLOB FUND COUNTR ALL; The Global Fund, GLOB FUND STRAT FRAM; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Uplekar M, 2013, INT J TUBERC LUNG D, V17, P1248, DOI 10.5588/ijtld.13.0199; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; USAID, 2014, AFGH HLTH SECT FACTS; Van Rie A, 2014, INT J TUBERC LUNG D, V18, P377, DOI 10.5588/ijtld.13.0924; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yanjindulam P, 2012, INT J TUBERC LUNG D, V16, P327, DOI 10.5588/ijtld.11.0251; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	46	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163813	10.1371/journal.pone.0163813	http://dx.doi.org/10.1371/journal.pone.0163813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701446	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900021
J	Steiber, N				Steiber, Nadia			Strong or Weak Handgrip? Normative Reference Values for the German Population across the Life Course Stratified by Sex, Age, and Body Height	PLOS ONE			English	Article							GRIP STRENGTH; JAMAR DYNAMOMETER; PROGNOSTIC VALUE; MUSCLE STRENGTH; HEALTHY-ADULTS; METAANALYSIS; SARCOPENIA; GENDER; COHORT; OLDER	Handgrip strength is an important biomarker of healthy ageing and a powerful predictor of future morbidity and mortality both in younger and older populations. Therefore, the measurement of handgrip strength is increasingly used as a simple but efficient screening tool for health vulnerability. This study presents normative reference values for handgrip strength in Germany for use in research and clinical practice. It is the first study to provide normative data across the life course that is stratified by sex, age, and body height. The study used a nationally representative sample of test participants ages 17-90. It was based on pooled data from five waves of the German Socio-Economic Panel (2006-2014) and involved a total of 11,790 persons living in Germany (providing 25,285 observations). Handgrip strength was measured with a Smedley dynamometer. Results showed that peak mean values of handgrip strength are reached in men's and women's 30s and 40s after which handgrip strength declines in linear fashion with age. Following published recommendations, the study used a cut-off at 2 SD below the sex-specific peak mean value across the life course to define a 'weak grip'. Less than 10% of women and men aged 65-69 were classified as weak according to this definition, shares increasing to about half of the population aged 80-90. Based on survival analysis that linked handgrip strength to a relevant outcome, however, a 'critically weak grip' that warrants further examination was estimated to commence already at 1 SD below the group-specific mean value.	[Steiber, Nadia] IIASA, Wittgenstein Ctr Demog & Global Human Capital IIA, VID OAW, WU, Laxenburg, Austria; [Steiber, Nadia] Univ Vienna, Dept Econ Sociol, Vienna, Austria	International Institute for Applied Systems Analysis (IIASA); University of Vienna	Steiber, N (corresponding author), IIASA, Wittgenstein Ctr Demog & Global Human Capital IIA, VID OAW, WU, Laxenburg, Austria.; Steiber, N (corresponding author), Univ Vienna, Dept Econ Sociol, Vienna, Austria.	steiber@iiasa.ac.at		Steiber, Nadia/0000-0002-9425-8840				Ambrasat J, 2011, 54 DIW BERL GERM I E; Andersen-Ranberg K, 2009, EUR J AGEING, V6, P227, DOI 10.1007/s10433-009-0128-6; Aoyagi K, 2001, BMC Geriatr, V1, P3, DOI 10.1186/1471-2318-1-3; Bohannon RW, 2015, CURR OPIN CLIN NUTR, V18, P465, DOI 10.1097/MCO.0000000000000202; Bohannon RW, 2006, PHYSIOTHERAPY, V92, P11, DOI 10.1016/j.physio.2005.05.003; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dodds R, 2013, AGE AGEING, V42, P794, DOI 10.1093/ageing/aft124; Dodds RM, 2016, AGE AGEING, V45, P209, DOI 10.1093/ageing/afv192; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Eibich P, 2014, REG SCI URBAN ECON, V49, P305, DOI 10.1016/j.regsciurbeco.2014.06.005; Frederiksen H, 2006, ANN EPIDEMIOL, V16, P554, DOI 10.1016/j.annepidem.2005.10.006; Gunther CM, 2008, J HAND SURG-AM, V33A, P558, DOI 10.1016/j.jhsa.2008.01.008; Haidar SG, 2004, J HAND SURG-BRIT EUR, V29B, P82, DOI 10.1016/j.jhsb.2003.09.012; Hanten W P, 1999, J Hand Ther, V12, P193; Horder H, 2015, AGE AGEING, V44, P817, DOI 10.1093/ageing/afv084; Kamide N, 2015, ENVIRON HEALTH PREV, V20, P441, DOI 10.1007/s12199-015-0485-z; Kenny RA, 2013, J AM GERIATR SOC, V61, pS279, DOI [10.1111/jgs.12195, 10.1111/jgs.12200]; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Ling CHY, 2010, CAN MED ASSOC J, V182, P429, DOI 10.1503/cmaj.091278; Luna-Heredia E, 2005, CLIN NUTR, V24, P250, DOI 10.1016/j.clnu.2004.10.007; Martin-Ruiz C, 2014, P NUTR SOC, V73, P422, DOI 10.1017/S0029665114000147; Massy-Westropp Nicola M, 2011, BMC Res Notes, V4, P127, DOI 10.1186/1756-0500-4-127; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Nilsen T, 2012, SCAND J OCCUP THER, V19, P288, DOI 10.3109/11038128.2011.553687; Peters MJH, 2011, J PERIPHER NERV SYST, V16, P47, DOI 10.1111/j.1529-8027.2011.00318.x; Peterson MD, 2015, AM J PREV MED, V49, P935, DOI 10.1016/j.amepre.2015.05.013; Rantanen T, 1999, JAMA-J AM MED ASSOC, V281, P558, DOI 10.1001/jama.281.6.558; Rantanen T, 2012, AGE, V34, P563, DOI 10.1007/s11357-011-9256-y; Rijk JM, 2016, GERIATR GERONTOL INT, V16, P5, DOI 10.1111/ggi.12508; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Schlussel MM, 2008, CLIN NUTR, V27, P601, DOI 10.1016/j.clnu.2008.04.004; Seino S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099487; Smith JJ, 2014, SPORTS MED, V44, P1209, DOI 10.1007/s40279-014-0196-4; Spruit MA, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.06.013; Steiber N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136583; Werle S, 2009, J HAND SURG-EUR VOL, V34E, P76, DOI 10.1177/1753193408096763; Wu SW, 2009, APPL ERGON, V40, P811, DOI 10.1016/j.apergo.2008.08.006; Yorke AM, 2015, J GERIATR PHYS THER, V38, P115, DOI 10.1519/JPT.0000000000000037; Yoshimura N, 2011, J ORTHOP SCI, V16, P768, DOI 10.1007/s00776-011-0160-1	42	69	70	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163917	10.1371/journal.pone.0163917	http://dx.doi.org/10.1371/journal.pone.0163917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701433	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000385696900032
J	Ward, PR; Miller, E; Pearce, AR; Meyer, SB				Ward, Paul R.; Miller, Emma; Pearce, Alex R.; Meyer, Samantha B.			Predictors and Extent of Institutional Trust in Government, Banks, the Media and Religious Organisations: Evidence from Cross-Sectional Surveys in Six Asia-Pacific Countries	PLOS ONE			English	Article							GENETICALLY-MODIFIED FOODS; UNITED-STATES; HEALTH-CARE; CONSTRUCTION; PERCEPTIONS	Background Building or maintaining institutional trust is of central importance in democratic societies since negative experiences (potentially leading to mistrust) with government or other institutions may have a much more profound effect than positive experiences (potentially maintaining trust). Healthy democracy relies on more than simply trusting the national government of the time, and is mediated through other symbols of institutional power, such as the legal system, banks, the media and religious organisations. This paper focuses on institutional trust-the level and predictors of trust in some of the major institutions in society, namely politics, the media, banks, the legal system and religious organisations. We present analyses from a consolidated dataset containing data from six countries in the Asia Pacific region-ustralia, Hong Kong, Japan, South Korea, Taiwan and Thailand. Methods Cross-sectional surveys were undertaken in each country in 2009-10, with an overall sample of 6331. Analyses of differences in overall levels of institutional trust between countries were undertaken using Chi square analyses. Multivariate binomial logistic regression analysis was undertaken to identify socio-demographic predictors of trust in each country. Results Religious institutions, banks and the judicial system had the highest overall trust across all countries (70%, 70% and 67% respectively), followed by newspapers and TV (59% and 58%) and then political leaders (43%). The range of levels of higher trust between countries differed from 43% for banks (range 49% in Australia to 92% in Thailand) to 59% for newspapers (28% in Australia to 87% in Japan). Across all countries, except for Australia, trust in political leaders had the lowest scores, particularly in Japan and South Korea (25% in both countries). In Thailand, people expressed the most trust in religious organisations (94%), banks (92%) and in their judicial/legal system (89%). In Hong Kong, people expressed the highest level of trust in their judicial/legal system (89%), followed by religious organisations (75%) and banks (77%). Australian respondents reported the least amount of trust in TV/media (24%) and press/newspapers (28%). South Korea put the least trust in their political leaders (25%), their legal system (43%) and religious organisations (45%). The key predictors of lower trust in institutions across all countries were males, people under 44 years and people unsatisfied with the health and standard of living. Conclusion We interpreted our data using Fukuyama's theory of 'high/low trust' societies. The levels of institutional trust in each society did not conform to our hypothesis, with Thailand exhibiting the highest trust (predicted to be medium level), Hong Kong and Japan exhibiting medium trust (predicted to be low and high respectively) and Australia and South Korea exhibiting low trust (predicted to be high and medium respectively). Taiwan was the only country where the actual and predicted trust was the same, namely low trust. Given the fact that these predictors crossed national boundaries and institutional types, further research and policy should focus specifically on improving trust within these groups in order that they can be empowered to play a more central role in democratic vitality.	[Ward, Paul R.; Miller, Emma] Flinders Univ S Australia, Discipline Publ Hlth, Adelaide, SA, Australia; [Pearce, Alex R.] Univ Waterloo, Dept Knowledge Integrat, Waterloo, ON, Canada; [Meyer, Samantha B.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada	Flinders University South Australia; University of Waterloo; University of Waterloo	Ward, PR (corresponding author), Flinders Univ S Australia, Discipline Publ Hlth, Adelaide, SA, Australia.	paul.ward@flinders.edu.au	Miller, Emma R/G-9615-2018; Miller, Emma/GXW-3128-2022	Miller, Emma R/0000-0002-6373-5720; Ward, Paul/0000-0002-5559-9714				Barbalet J, 2009, THEOR SOC, V38, P367, DOI 10.1007/s11186-009-9087-3; Bauer M. W., 2015, ATOMS BYTES GENES PU; Bornstein B.H., 2016, INTERDISCIPLINARY PE, P157, DOI [DOI 10.1007/978-3-319-22261-5_9, 10.1007/978-3-319-22261-5_9, DOI 10.1007/978-3-319-22261-5]; Bowling A, 2009, RES METHODS HLTH; Braithwaite Valerie, 1998, TRUST GOVERNANCE; Brewer PR, 2004, AM J POLIT SCI, V48, P93, DOI 10.1111/j.0092-5853.2004.00058.x; Brown PR, 2015, CURR SOCIOL, V63, P729, DOI 10.1177/0011392115590091; Brown PR, 2009, HEALTH RISK SOC, V11, P391, DOI 10.1080/13698570903180455; Bureekul T, 2013, INT J SOCIAL QUALITY, V2; Chen F-1, 2013, INT J SOCIAL QUALITY, V2; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Freitag M, 2003, COMP POLIT STUD, V36, P936, DOI 10.1177/0010414003256116; Frewer LJ, 2003, RISK ANAL, V23, P1117, DOI 10.1111/j.0272-4332.2003.00385.x; Frewer LJ, 1998, RISK ANAL, V18, P95, DOI 10.1111/j.1539-6924.1998.tb00919.x; Frewer LJ, 2002, RISK ANAL, V22, P701, DOI 10.1111/0272-4332.00062; Fukuyama F., 1996, TRUST SOCIAL VIRTUES; Fukuyama F, 2010, J DEMOCR, V21, P33; Giddens A., 1994, REFLEXIVE MODERNISAT; Giddens Anthony, 1990, CONSEQUENCES MODERNI; Glaser, 1981, SIMULACRA SIMULATION; Good David, 1988, TRUST MAKING BREAKIN, P38; Govier T., 1998, DILEMMAS OF TRUST; Grimmelikhuijsen S, 2013, PUBLIC ADMIN REV, V73, P575, DOI 10.1111/puar.12047; Hardin R., 1998, TRUST GOVERNANCE; Hardin Russell, 2006, TRUST; Henderson J, 2014, HEALTH RISK SOC, V16, P615, DOI 10.1080/13698575.2014.966806; Hmielowski JD, 2014, PUBLIC UNDERST SCI, V23, P866, DOI 10.1177/0963662513480091; Hooghe M, 2017, EUR POLIT SCI REV, V9, P161, DOI 10.1017/S1755773915000314; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu K, 2013, INT J SOCIAL QUALITY, V2; Hudson J, 2006, KYKLOS, V59, P43, DOI 10.1111/j.1467-6435.2006.00319.x; Job J, 2005, AUST REV PUBLIC AFF, V6, P1; Kampen J.K., 2006, PUBLIC PERFORMANCE M, V29, P387, DOI [DOI 10.1080/15309576.2006.11051881, https://doi.org/10.1080/15309576.2006.11051881]; Kehr F, 2015, INFORM SYST J, V25, P607, DOI 10.1111/isj.12062; Khodyakov D, 2007, SOCIOLOGY, V41, P115, DOI 10.1177/0038038507072285; Kuwabaaa K, 2007, SOC PSYCHOL QUART, V70, P461, DOI 10.1177/019027250707000412; Levi M, 1998, TRUST TAND GOVERNANC; Luhmann N., 2000, TRUST MAKING BREAKIN; Luhmann N, 1988, TRUST MAKING BREAKIN, P94; LUHMANN Niklas, 1979, TRUST POWER; Meyer S, 2008, HEALTH SOCIOL REV, V17, P177, DOI 10.5172/hesr.451.17.2.177; Meyer SB, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-238; Meyer SB, 2013, AUST HEALTH REV, V37, P11, DOI 10.1071/AH11073; Mishler W, 2001, COMP POLIT STUD, V34, P30, DOI 10.1177/0010414001034001002; Misztal Barbara A, 1996, TRUST MODERN SOC; Mollering G, 2001, SOCIOLOGY, V35, P403, DOI 10.1177/S0038038501000190; Munoz J, 2011, EUR UNION POLIT, V12, P551, DOI 10.1177/1465116511419250; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Park SM, 2012, AM REV PUBLIC ADM, V42, P562, DOI 10.1177/0275074011410417; Peel Mark, 1998, TRUST GOVERNANCE; Putnam RD., 2000, BOWLING ALONE COLLAP; SABEL CF, 1993, HUM RELAT, V46, P1133, DOI 10.1177/001872679304600907; Schafer MS, 2009, SCI COMMUN, V30, P475, DOI 10.1177/1075547008326943; Sheppard BH, 1998, ACAD MANAGE REV, V23, P422, DOI 10.2307/259287; Simmel G., 2004, PHILOS MONEY; Sonderskov K, 2015, POLITICAL BEHAV, P1; Sztompka P., 1999, TRUST SOCIOLOGICAL T; Tokuda Y, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-4; Tsfati Y, 2005, HARV INT J PRESS/POL, V10, P28, DOI 10.1177/1081180X05280776; Tsfati Y, 2014, COMMUN RES, V41, P760, DOI 10.1177/0093650213485972; Vajirakachorn S, 2013, INT J SOCIAL QUALITY, V2; van der Schee E, 2007, HEALTH POLICY, V81, P56, DOI 10.1016/j.healthpol.2006.04.004; Wang C-H, SOCIAL SCI IN PRESS; Wang FX, 2005, ASIAN J SOC PSYCHOL, V8, P199, DOI 10.1111/j.1467-839x.2005.00167.x; Ward P, 2006, HEALTH, V10, P283, DOI 10.1177/1363459306064481; Ward PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095555; Ward PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083000; Ward PR, 2012, J SOCIOL, V48, P23, DOI 10.1177/1440783311407947; Ward PR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-630; Warren M, 2004, DEMOCRACY TRUST; Xiao CY, 2015, ENVIRON BEHAV, V47, P17, DOI 10.1177/0013916513491571; YAMAGISHI T, 1994, MOTIV EMOTION, V18, P129, DOI 10.1007/BF02249397	72	21	21	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164096	10.1371/journal.pone.0164096	http://dx.doi.org/10.1371/journal.pone.0164096			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701439	Green Published, gold			2022-12-27	WOS:000385696900043
J	Liu, JM; Wang, BY; Tai, C; Wu, L; Zhao, H; Guan, JD; Chen, LY				Liu, Jianmin; Wang, Baoyu; Tai, Chao; Wu, Li; Zhao, Han; Guan, Jiadong; Chen, Linyong			An Effective Method to Detect Volatile Intermediates Generated in the Bioconversion of Coal to Methane by Gas Chromatography-Mass Spectrometry after In-Situ Extraction Using Headspace Solid-Phase Micro-Extraction under Strict Anaerobic Conditions	PLOS ONE			English	Article							FATTY-ACIDS; MICROEXTRACTION; SPME; METHANOGENESIS; DEGRADATION; BIOGEOCHEMISTRY; HYDROCARBONS; METABOLOMICS; STIMULATION; BIOANALYSIS	Bioconversion of coal to methane has gained increased attention in recent decades because of its economic and environmental advantages. However, the mechanism of this process is difficult to study in depth, partly because of difficulties associated with the analysis of intermediates generated in coal bioconversion. In this investigation, we report on an effective method to analyze volatile intermediates generated in the bioconversion of coal under strict anaerobic conditions. We conduct in-situ extraction of intermediates using headspace solid-phase micro-extraction followed by detection by gas chromatography-mass spectrometry. Bioconversion simulation equipment was modified and combined with a solid-phase micro-extraction device. In-situ extraction could be achieved by using the combined units, to avoid a breakdown in anaerobic conditions and to maintain the experiment continuity. More than 30 intermediates were identified qualitatively in the conversion process, and the variation in trends of some typical intermediates has been discussed. Volatile organic acids (C2-C7) were chosen for a quantitative study of the intermediates because of their importance during coal bioconversion to methane. Fiber coating, extraction time, and solution acidity were optimized in the solid-phase micro-extraction procedure. The pressure was enhanced during the bioconversion process to investigate the influence of headspace pressure on analyte extraction. The detection limits of the method ranged from 0.0006 to 0.02 mmol/L for the volatile organic acids and the relative standard deviations were between 4.6% and 11.5%. The volatile organic acids (C2-C7) generated in the bioconversion process were 0.01-1.15 mmol/L with a recovery range from 80% to 105%. The developed method is useful for further in-depth research on the bioconversion of coal to methane.	[Liu, Jianmin; Tai, Chao; Wu, Li] Henan Polytech Univ, Inst Resources & Environm, Jiaozuo, Peoples R China; [Liu, Jianmin; Wang, Baoyu; Tai, Chao; Zhao, Han; Guan, Jiadong; Chen, Linyong] Natl Key Lab Coal & Coal Bed Methane Simultaneous, Jincheng, Peoples R China	Henan Polytechnic University	Tai, C (corresponding author), Henan Polytech Univ, Inst Resources & Environm, Jiaozuo, Peoples R China.; Tai, C (corresponding author), Natl Key Lab Coal & Coal Bed Methane Simultaneous, Jincheng, Peoples R China.	taichao@126.com			Coal-bed Methane Collaborative Fund of Shanxi [2013012016, 2012012013]; National Natural Science Foundation of China [41202113]; Foundation and Frontier Project of Henan [122300410241]; Program for Innovative Research Team (in Science and Technology) in University of Henan Province [16IRTSTHN014]	Coal-bed Methane Collaborative Fund of Shanxi; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation and Frontier Project of Henan; Program for Innovative Research Team (in Science and Technology) in University of Henan Province	This study was supported jointly by Coal-bed Methane Collaborative Fund of Shanxi (2013012016, 2012012013), the National Natural Science Foundation of China (41202113), Foundation and Frontier Project of Henan (122300410241), and Program for Innovative Research Team (in Science and Technology) in University of Henan Province (16IRTSTHN014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalos M, 2000, J CHROMATOGR A, V873, P107, DOI 10.1016/S0021-9673(99)01263-7; Abu Laban N, 2010, ENVIRON MICROBIOL, V12, P2783, DOI 10.1111/j.1462-2920.2010.02248.x; Ahmad S, 2013, BIOANALYSIS, V5, P2897, DOI 10.4155/bio.13.260; Beckmann S, 2011, APPL ENVIRON MICROB, V77, P3749, DOI 10.1128/AEM.02818-10; Beller HR, 2008, ENVIRON SCI TECHNOL, V42, P6065, DOI 10.1021/es8009666; Bessonneau V, 2015, ANAL CHIM ACTA, V856, P35, DOI 10.1016/j.aca.2014.11.029; Birjandi AP, 2014, ANAL CHEM, V86, P12022, DOI 10.1021/ac502627w; Bojko B, 2014, TRAC-TREND ANAL CHEM, V61, P168, DOI 10.1016/j.trac.2014.07.005; Bojko B, 2014, BIOANALYSIS, V6, P1227, DOI 10.4155/bio.14.91; Boll M., 2010, HDB HYDROCARBON LIPI, P1011, DOI DOI 10.1007/978-3-540-77587-4_71; Fakoussa RM, 1999, APPL MICROBIOL BIOT, V52, P25, DOI 10.1007/s002530051483; Fallgren PH, 2013, INT J COAL GEOL, V115, P92, DOI 10.1016/j.coal.2013.01.014; Ferry JG, 2011, CURR OPIN BIOTECH, V22, P351, DOI 10.1016/j.copbio.2011.04.011; Furmann A, 2013, CHEM GEOL, V339, P226, DOI 10.1016/j.chemgeo.2012.08.010; Gieg LM, 2010, ENVIRON MICROBIOL, V12, P3074, DOI 10.1111/j.1462-2920.2010.02282.x; Gieg LM, 2002, ENVIRON SCI TECHNOL, V36, P3755, DOI 10.1021/es0205333; Haider R, 2013, FUEL, V104, P717, DOI 10.1016/j.fuel.2012.05.015; Holker U, 2002, J IND MICROBIOL BIOT, V28, P207, DOI 10.1038/sj/jim/7000232; Hossain SMZ, 2013, ANAL CHIM ACTA, V776, P41, DOI 10.1016/j.aca.2013.03.018; Hosseini SE, 2013, RENEW SUST ENERG REV, V19, P454, DOI 10.1016/j.rser.2012.11.008; Huang ZX, 2013, FUEL, V111, P813, DOI 10.1016/j.fuel.2013.03.079; Jones EJP, 2013, INT J COAL GEOL, V115, P54, DOI 10.1016/j.coal.2013.03.011; Jones EJP, 2010, APPL ENVIRON MICROB, V76, P7013, DOI 10.1128/AEM.00728-10; Li DM, 2008, INT J COAL GEOL, V76, P14, DOI 10.1016/j.coal.2008.04.007; McIntosh J, 2008, INT J COAL GEOL, V76, P111, DOI 10.1016/j.coal.2008.03.004; Mesle M, 2013, RES MICROBIOL, V164, P959, DOI 10.1016/j.resmic.2013.07.004; Midgley DJ, 2010, INT J COAL GEOL, V82, P232, DOI 10.1016/j.coal.2010.01.009; Mushtaq F, 2014, RENEW SUST ENERG REV, V39, P555, DOI 10.1016/j.rser.2014.07.073; Noventa S, 2015, ANAL CHIM ACTA, V858, P66, DOI 10.1016/j.aca.2014.11.028; Orem WH, 2010, ORG GEOCHEM, V41, P997, DOI 10.1016/j.orggeochem.2010.03.005; PAN L, 1995, ANAL CHEM, V67, P4396, DOI 10.1021/ac00119a031; Parisi VA, 2009, MICROB BIOTECHNOL, V2, P202, DOI 10.1111/j.1751-7915.2009.00077.x; Singh AL, 2012, ENERG EXPLOR EXPLOIT, V30, P837, DOI 10.1260/0144-5987.30.5.837; Stephen A, 2014, RSC ADV, V4, P22779, DOI 10.1039/c4ra01628a; Strapoc D, 2011, ANNU REV EARTH PL SC, V39, P617, DOI 10.1146/annurev-earth-040610-133343; Tchapda AH, 2014, ENERGIES, V7, P1098, DOI 10.3390/en7031098; Wawrik B, 2012, FEMS MICROBIOL ECOL, V81, P26, DOI 10.1111/j.1574-6941.2011.01272.x; Yo SP, 1999, CHEMOSPHERE, V38, P823, DOI 10.1016/S0045-6535(98)00223-9	38	3	3	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163949	10.1371/journal.pone.0163949	http://dx.doi.org/10.1371/journal.pone.0163949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695055	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100068
J	Nieto, JA; Yamin, MA; Goldberg, ID; Narayan, P				Nieto, Jake A.; Yamin, Michael A.; Goldberg, Itzhak D.; Narayan, Prakash			An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal Recessive Polycystic Kidney Disease-The Nieto-Narayan Formula	PLOS ONE			English	Article							EXPERIENCE	Autosomal recessive polycystic kidney disease (ARPKD) is associated with progressive enlargement of the kidneys fuelled by the formation and expansion of fluid-filled cysts. The disease is congenital and children that do not succumb to it during the neonatal period will, by age 10 years, more often than not, require nephrectomy+renal replacement therapy for management of both pain and renal insufficiency. Since increasing cystic index (CI; percent of kidney occupied by cysts) drives both renal expansion and organ dysfunction, management of these patients, including decisions such as elective nephrectomy and prioritization on the transplant waitlist, could clearly benefit from serial determination of CI. So also, clinical trials in ARPKD evaluating the efficacy of novel drug candidates could benefit from serial determination of CI. Although ultrasound is currently the imaging modality of choice for diagnosis of ARPKD, its utilization for assessing disease progression is highly limited. Magnetic resonance imaging or computed tomography, although more reliable for determination of CI, are expensive, time-consuming and somewhat impractical in the pediatric population. Using a well-established mammalian model of ARPKD, we undertook a big datalike analysis of minimally-or non-invasive blood and urine biomarkers of renal injury/dysfunction to derive a family of equations for estimating CI. We then applied a signal averaging protocol to distill these equations to a single empirical formula for calculation of CI. Such a formula will eventually find use in identifying and monitoring patients at high risk for progressing to end-stage renal disease and aid in the conduct of clinical trials.	[Nieto, Jake A.; Yamin, Michael A.; Goldberg, Itzhak D.; Narayan, Prakash] Angion Biomed Corp, Dept Preclin Res, Uniondale, NY USA		Narayan, P (corresponding author), Angion Biomed Corp, Dept Preclin Res, Uniondale, NY USA.	pnarayan@angion.com		Narayan, Prakash/0000-0002-7007-0245				Chapman AB, 2011, SEMIN NEPHROL, V31, P237, DOI 10.1016/j.semnephrol.2011.05.003; Guay-Woodford LM, 2003, PEDIATRICS, V111, P1072, DOI 10.1542/peds.111.5.1072; Gunay-Aygun M, 2010, CLIN J AM SOC NEPHRO, V5, P972, DOI 10.2215/CJN.07141009; Hartung EA, 2014, PEDIATRICS, V134, pE833, DOI 10.1542/peds.2013-3646; Higashihara E, 2011, CLIN J AM SOC NEPHRO, V6, P2499, DOI 10.2215/CJN.03530411; Huang B, 2015, RECENT PATENTS BIOMA, V5, P35, DOI [10.2174/2210309005666150317225711, DOI 10.2174/2210309005666150317225711]; Kistler AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053016; Lager DJ, 2001, KIDNEY INT, V59, P126, DOI 10.1046/j.1523-1755.2001.00473.x; Petzold K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123555; Wen JW, 2014, PEDIATR TRANSPLANT, V18, P726, DOI 10.1111/petr.12330	10	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163063	10.1371/journal.pone.0163063	http://dx.doi.org/10.1371/journal.pone.0163063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695033	gold, Green Submitted, Green Published			2022-12-27	WOS:000385553100022
J	Ritter, A; Anton, G; Weber, T				Ritter, Andre; Anton, Gisela; Weber, Thomas			Simultaneous Maximum-Likelihood Reconstruction of Absorption Coefficient, Refractive Index and Dark-Field Scattering Coefficient in X-Ray Talbot-Lau Tomography	PLOS ONE			English	Article							ITERATIVE RECONSTRUCTION; CONTRAST; INTERFEROMETRY	A maximum-likelihood reconstruction technique for X-ray Talbot-Lau tomography is presented. This technique allows the iterative simultaneous reconstruction of discrete distributions of absorption coefficient, refractive index and a dark-field scattering coefficient. This technique avoids prior phase retrieval in the tomographic projection images and thus in principle allows reconstruction from tomographic data with less than three phase steps per projection. A numerical phantom is defined which is used to evaluate convergence of the technique with regard to photon statistics and with regard to the number of projection angles and phase steps used. It is shown that the use of a random phase sampling pattern allows the reconstruction even for the extreme case of only one single phase step per projection. The technique is successfully applied to measured tomographic data of a mouse. In future, this reconstruction technique might also be used to implement enhanced imaging models for X-ray Talbot-Lau tomography. These enhancements might be suited to correct for example beam hardening and dispersion artifacts and improve overall image quality of X-ray Talbot-Lau tomography.	[Ritter, Andre; Anton, Gisela; Weber, Thomas] Univ Erlangen Nurnberg, ECAP, Erwin Rommel Str 1, D-91052 Erlangen, Germany	University of Erlangen Nuremberg	Ritter, A (corresponding author), Univ Erlangen Nurnberg, ECAP, Erwin Rommel Str 1, D-91052 Erlangen, Germany.	andre.ritter@fau.de	Anton, Gisela/C-4840-2013; Weber, Thomas E/G-5590-2014	Anton, Gisela/0000-0003-2039-4724; Weber, Thomas E/0000-0003-1294-0908	Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg; IMPRS-PL; German Research Council (DFG) [AN 257/20-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg; IMPRS-PL; German Research Council (DFG)(German Research Foundation (DFG))	We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg within the funding program Open Access Publishing. AR thanks IMPRS-PL for scholarship. GA thanks the German Research Council (DFG grant AN 257/20-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow J, 1999, STAT GUIDE USE STAT; Bayer FL, 2014, P NATL ACAD SCI USA, V111, P12699, DOI 10.1073/pnas.1321080111; Bunk O, 2009, PHYS MED BIOL, V54, P2747, DOI [10.1088/0031-9155/54/9/010, DOI 10.1088/0031-9155/54/9/010]; David C, 2002, APPL PHYS LETT, V81, P3287, DOI 10.1063/1.1516611; Diemoz C, 2011, OPT EX, V9, P1691, DOI [10.1364/OE.19.001691, DOI 10.1364/OE.19.001691]; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; Fu J, 2013, Z MED PHYS, V23, P186, DOI 10.1016/j.zemedi.2012.11.002; Gaass T, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/48001; Herzen J, 2009, OPT EXPRESS, V17, P10010, DOI 10.1364/OE.17.010010; Kohler T, 2011, MED PHYS, V38, P4542, DOI 10.1118/1.3608906; Li XL, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-73; Michel T, 2013, PHYS MED BIOL, V58, P2713, DOI 10.1088/0031-9155/58/8/2713; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Momose A, 2006, JPN J APPL PHYS 1, V45, P5254, DOI 10.1143/JJAP.45.5254; Nilchian M, 2013, OPT EXPRESS, V21, P5511, DOI 10.1364/OE.21.005511; Nocedaland S J, 1999, NUMERICAL OPTIMIZATI; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Reznikova E, 2008, MICROSYST TECHNOL, V14, P1683, DOI 10.1007/s00542-007-0507-x; Ritter A, 2013, ARXIV13077912; Ritter A, 2014, OPT EXPRESS, V22, P23276, DOI 10.1364/OE.22.023276; SIDDON RL, 1985, MED PHYS, V12, P252, DOI 10.1118/1.595715; Van Rossum G., 2011, PYTHON LANGUAGE REFE; Weber T., 2012, ARXIV12125031; Yaroshenko A, 2013, RADIOLOGY, V269, P426, DOI 10.1148/radiol.13122413; Yashiro W, 2010, OPT EXPRESS, V18, P16890, DOI 10.1364/OE.18.016890; Zanette I, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3559849; Zhang K, 2011, ANAL BIOANAL CHEM, V401, P837, DOI 10.1007/s00216-011-5080-6	28	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163016	10.1371/journal.pone.0163016	http://dx.doi.org/10.1371/journal.pone.0163016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695126	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100019
J	Western, M; Tomaszewski, W				Western, Mark; Tomaszewski, Wojtek			Subjective Wellbeing, Objective Wellbeing and Inequality in Australia	PLOS ONE			English	Article							QUALITY-OF-LIFE; SATISFACTION; HEALTH; HAPPINESS	In recent years policy makers and social scientists have devoted considerable attention to wellbeing, a concept that refers to people's capacity to live healthy, creative and fulfilling lives. Two conceptual approaches dominate wellbeing research. The objective approach examines the objective components of a good life. The subjective approach examines people's subjective evaluations of their lives. In the objective approach how subjective wellbeing relates to objective wellbeing is not a relevant research question. The subjective approach does investigate how objective wellbeing relates to subjective wellbeing, but has focused primarily on one objective wellbeing indicator, income, rather than the comprehensive indicator set implied by the objective approach. This paper attempts to contribute by examining relationships between a comprehensive set of objective wellbeing measures and subjective wellbeing, and by linking wellbeing research to inequality research by also investigating how subjective and objective wellbeing relate to class, gender, age and ethnicity. We use three waves of a representative state-level household panel study from Queensland, Australia, undertaken from 2008 to 2010, to investigate how objective measures of wellbeing are socially distributed by gender, class, age, and ethnicity. We also examine relationships between objective wellbeing and overall life satisfaction, providing one of the first longitudinal analyses linking objective wellbeing with subjective evaluations. Objective aspects of wellbeing are unequally distributed by gender, age, class and ethnicity and are strongly associated with life satisfaction. Moreover, associations between gender, ethnicity, class and life satisfaction persist after controlling for objective wellbeing, suggesting that mechanisms in addition to objective wellbeing link structural dimensions of inequality to life satisfaction.	[Western, Mark] Univ Queensland, Social Sci Res Inst, Brisbane, Qld, Australia; Univ Queensland, ARC Ctr Excellence Children & Families Life Cours, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Western, M (corresponding author), Univ Queensland, Social Sci Res Inst, Brisbane, Qld, Australia.	m.western@uq.edu.au	Western, Mark C/C-4757-2008; Tomaszewski, Wojtek/M-7379-2013	Western, Mark C/0000-0001-5399-6911; Tomaszewski, Wojtek/0000-0003-4144-8613	Australian Research Council [LP0775040]; Queensland Public Sector Union; Australian Research Council Centre of Excellence for Children and Families over the Life Course [CE140100027]	Australian Research Council(Australian Research Council); Queensland Public Sector Union; Australian Research Council Centre of Excellence for Children and Families over the Life Course(Australian Research Council)	The dataset used in this paper was funded by the Australian Research Council under LP0775040 'The development and application of a conceptual and statistical framework for the measurement of non-market factors affecting social inequality and social wellbeing' and by the Queensland Public Sector Union. During the manuscript preparation the authors were supported by the Australian Research Council Centre of Excellence for Children and Families over the Life Course (grant number CE140100027). Neither the Australian Research Council nor the Queensland Public Sector Union were involved in decision-making about the research and publication process.	Allison P.D., 2009, FIXED EFFECTS REGRES, DOI DOI 10.4135/9781412993869; [Anonymous], 1999, DEV FREEDOM; [Anonymous], 2010, CONTEXTUAL FACTORS I; Arthaud-Day ML, 2005, SOC INDIC RES, V74, P511, DOI 10.1007/s11205-004-6397-8; Australian Bureau of Statistics, 2006, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics, 2009, HOUS INC INC DISTR; Australian Bureau of Statistics, 2010, DEM STAT JUN 2010; Baxter J, 1998, SOCIOLOGY, V32, P101, DOI 10.1177/0038038598032001007; Behkouche Y., 2015, GLOBAL GENDER GAP RE; Bellani L, 2011, SOC INDIC RES, V104, P67, DOI 10.1007/s11205-010-9718-0; Blanchflower DG, 2008, SOC SCI MED, V66, P1733, DOI 10.1016/j.socscimed.2008.01.030; Blau FrancineD., 2006, DECLINING SIGNIFICAN; Bohnke P, 2008, 2008201 WZB SP; Bu┬hnke P., 2005, 1 EUROPEAN QUALITY L; Burstrom B, 2001, J EPIDEMIOL COMMUN H, V55, P836, DOI 10.1136/jech.55.11.836; Charles M., 2004, OCCUPATIONAL GHETTOS; CHISWICK BR, 1995, J LABOR ECON, V13, P246, DOI 10.1086/298374; Clark A.E., 1997, LABOUR ECON, V4, P341, DOI DOI 10.1016/S0927-5371(97)00010-9; Cummins RA, 2003, SOC INDIC RES, V64, P159, DOI 10.1023/A:1024704320683; CUMMINS RA, 1995, SOC INDIC RES, V35, P179, DOI 10.1007/BF01079026; Cummins RA., 2002, J HAPPINESS STUD, V3, P37, DOI [10.1023/A:1015678915305, DOI 10.1023/A:1015678915305, 10.1023/a:1015678915305]; D'Acci L, 2011, SOC INDIC RES, V104, P47, DOI 10.1007/s11205-010-9717-1; Diener E, 1997, SOC INDIC RES, V40, P189, DOI 10.1023/A:1006859511756; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E., 2010, INT DIFFERENCES WELL, DOI 10.1093/acprof:oso/9780199732739.001.0001; Diener E., 2010, INT DIFFERENCES WELL, P3, DOI [10.1093/acprof:oso/9780199732739.003.0001, DOI 10.1093/ACPROF:OSO/9780199732739.003.0001]; Dockery AM, 2010, SOC INDIC RES, V99, P315, DOI 10.1007/s11205-010-9582-y; Ferrer-i-Carbonell A, 2004, ECON J, V114, P641, DOI 10.1111/j.1468-0297.2004.00235.x; Goldthorpe JH, 2007, SOCIOLOGY, DOI [10.1017/CBO9780511557880.004, DOI 10.1017/CBO9780511557880.004]; Gordon D., 2000, POVERTY SOCIAL EXCLU; Grusky David B., 2006, POVERTY INEQUALITY, P47; Head B., 2008, PUBLIC POLICY, V3, P101, DOI DOI 10.1128/MCB.00567-07; Headey B, 2010, SOC INDIC RES, V97, P7, DOI 10.1007/s11205-009-9559-x; Helliwell JF, 2003, ECON MODEL, V20, P331, DOI 10.1016/S0264-9993(02)00057-3; Hewitt B, 2006, J SOCIOL, V42, P61, DOI 10.1177/1440783306061353; Inglehart R., 2018, CULTURE SHIFT ADV IN; Islam A, 2014, IMMIGRANT NATIVE WAG; Kahneman D., 1999, WELL BEING FDN HEDON; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Lucas RE, 2003, J PERS SOC PSYCHOL, V84, P527, DOI 10.1037/0022-3514.84.3.527; Lucas RE, 2004, PSYCHOL SCI, V15, P8, DOI 10.1111/j.0963-7214.2004.01501002.x; Marcum CS., 2011, WR904 RAND, DOI [10.2139/ssrn.1978949, DOI 10.2139/SSRN.1978949]; Massey D.S., 2007, CATEGORICALLY UNEQUA; Mayer KU, 2009, ANNU REV SOCIOL, V35, P413, DOI 10.1146/annurev.soc.34.040507.134619; MUNDLAK Y, 1978, ECONOMETRICA, V46, P69, DOI 10.2307/1913646; Neckerman K, 2004, SOCIAL INEQUALITY; Nussbaum M.C., 2000, WOMEN HUMAN DEV CAPA; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pennay D, 2009, PROFILING MOBILE PH; Perales Francisco, 2013, MUNDLAK STAT MOD EST; Ridgeway CL, 2014, AM SOCIOL REV, V79, P1, DOI 10.1177/0003122413515997; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; SEN A, 1976, ECONOMETRICA, V44, P219, DOI 10.2307/1912718; Sen A, 1992, INEQUALITY RE EXAMIN; Sen A., 1973, EC INEQUALITY, DOI [10.1093/0198281935.001.0001, DOI 10.1093/0198281935.001.0001]; Spurrier NJ, 2003, AUST NZ J PUBL HEAL, V27, P27, DOI 10.1111/j.1467-842X.2003.tb00376.x; Stiglitz J, 2009, REPORT COMMISSON MEA; Swiss Re, 2015, AS PAC 2015 MORT PRO; Temkin Larry S., 1993, INEQUALITY; Tilly C, 1998, DURABLE INEQUALITY; Tomaszewski W, 2014, SOC INDIC RES, V118, P181, DOI 10.1007/s11205-013-0420-x; United Nations Development Program, 2011, SUST EQ BETT FUT ALL; Wright EO., 2000, CLASS COUNTS COMP ST, DOI [10.1017/CBO9780511488917, DOI 10.1017/CBO9780511488917]; Wright EO, 2009, NEW LEFT REV, P101; ZUCCHELLI E, 2010, AUSTR J LABOUR EC, V0013	66	63	63	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163345	10.1371/journal.pone.0163345	http://dx.doi.org/10.1371/journal.pone.0163345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695042	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100031
J	Al-Garawi, A; Carey, VJ; Chhabra, D; Mirzakhani, H; Morrow, J; Lasky-Su, J; Qiu, WL; Laranjo, N; Litonjua, AA; Weiss, ST				Al-Garawi, Amal; Carey, Vincent J.; Chhabra, Divya; Mirzakhani, Hooman; Morrow, Jarrett; Lasky-Su, Jessica; Qiu, Weiliang; Laranjo, Nancy; Litonjua, Augusto A.; Weiss, Scott T.			The Role of Vitamin D in the Transcriptional Program of Human Pregnancy	PLOS ONE			English	Article							CONTROLLED-TRIAL; FETAL-GROWTH; ASTHMA; CHILDREN; ATOPY; SUPPLEMENTATION; EXPRESSION; WHEEZE; GENES; RISK	Background Patterns of gene expression of human pregnancy are poorly understood. In a trial of vitamin D supplementation in pregnant women, peripheral blood transcriptomes were measured longitudinally on 30 women and used to characterize gene co-expression networks. Objective Studies suggest that increased maternal Vitamin D levels may reduce the risk of asthma in early life, yet the underlying mechanisms have not been examined. In this study, we used a network-based approach to examine changes in gene expression profiles during the course of normal pregnancy and evaluated their association with maternal Vitamin D levels. Design The VDAART study is a randomized clinical trial of vitamin D supplementation in pregnancy for reduction of pediatric asthma risk. The trial enrolled 881 women at 10-18 weeks of gestation. Longitudinal gene expression measures were obtained on thirty pregnant women, using RNA isolated from peripheral blood samples obtained in the first and third trimesters. Differentially expressed genes were identified using significance of analysis of microarrays (SAM), and clustered using a weighted gene co-expression network analysis (WGCNA). Gene-set enrichment was performed to identify major biological pathways. Results Comparison of transcriptional profiles between first and third trimesters of pregnancy identified 5839 significantly differentially expressed genes (FDR<0.05). Weighted gene coexpression network analysis clustered these transcripts into 14 co-expression modules of which two showed significant correlation with maternal vitamin D levels. Pathway analysis of these two modules revealed genes enriched in immune defense pathways and extracellular matrix reorganization as well as genes enriched in notch signaling and transcription factor networks. Conclusion Our data show that gene expression profiles of healthy pregnant women change during the course of pregnancy and suggest that maternal Vitamin D levels influence transcriptional profiles. These alterations of the maternal transcriptome may contribute to fetal immune imprinting and reduce allergic sensitization in early life.	[Al-Garawi, Amal; Carey, Vincent J.; Chhabra, Divya; Mirzakhani, Hooman; Morrow, Jarrett; Lasky-Su, Jessica; Qiu, Weiliang; Laranjo, Nancy; Litonjua, Augusto A.; Weiss, Scott T.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Weiss, ST (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	soott.weiss@channing.harvard.edu		Morrow, Jarrett/0000-0002-5670-5865; Mirzakhani, Hooman/0000-0002-2290-4436	National Heart, Lung, and Blood Institute [U01HL091528]; National Research Service Award [T32-HL007427]; National Centers for Advancing Translational Sciences (NCATS) [U54TR001012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091075, R01HL091528] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers for Advancing Translational Sciences (NCATS); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	VDAART was supported by U01HL091528 from the National Heart, Lung, and Blood Institute; and National Research Service Award T32-HL007427. Additional support was provided by U54TR001012 from the National Centers for Advancing Translational Sciences (NCATS) for participant visits at Boston Medical Center. NHLBI monitored the conduct of the trial and selected the membership of the Data and Safety Monitoring Board (DSMB). All communication between the investigators and the DSMB coursed through the staff of the NHLBI. All manuscripts, including this current one, during the course of the trial are presented to the DSMB for approval prior to submission for peer review. NHLBI had no role in the design and the conduct of the study, in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript, other than what pertained to the DSMB.	Artaza JN, 2009, J ENDOCRINOL, V200, P207, DOI 10.1677/JOE-08-0241; BARKER DJP, 1986, J EPIDEMIOL COMMUN H, V40, P37, DOI 10.1136/jech.40.1.37; Besnard V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026682; Bird AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017843; Brannon PM, 2012, P NUTR SOC, V71, P205, DOI 10.1017/S0029665111003399; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Carlson M., ILLUMINA HUMAN ILLUM, P2909, DOI 10.4049/jimmunol.173.5.2909; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chatzi L, 2008, THORAX, V63, P507, DOI 10.1136/thx.2007.081745; Chen YC, 2003, MOL CELL BIOL, V23, P4066, DOI 10.1128/MCB.23.12.4066-4082.2003; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Dhawan P, 2005, MOL CELL BIOL, V25, P472, DOI 10.1128/MCB.25.1.472-487.2005; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Dunstan JA, 2003, J ALLERGY CLIN IMMUN, V112, P1178, DOI 10.1016/j.jaci.2003.09.009; Fall CHD, 2003, J NUTR, V133, p1747S, DOI 10.1093/jn/133.5.1747S; Holick MF, 2006, MAYO CLIN PROC, V81, P353, DOI 10.4065/81.3.353; Hollams EM, 2012, CURR OPIN ALLERGY CL, V12, P228, DOI 10.1097/ACI.0b013e3283534a32; Jiang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046736; Kho AT, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-47; Kho AT, 2010, AM J RESP CRIT CARE, V181, P54, DOI 10.1164/rccm.200907-1063OC; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Litonjua AA, 2014, CONTEMP CLIN TRIALS, V38, P37, DOI 10.1016/j.cct.2014.02.006; Liu NQ, 2012, ARCH BIOCHEM BIOPHYS, V523, P37, DOI 10.1016/j.abb.2011.11.018; Miller RL, 2008, J CLIN INVEST, V118, P3265, DOI 10.1172/JCI37171; Montefort S, 2012, PEDIAT ALLERG IMM-UK, V23, P472, DOI 10.1111/j.1399-3038.2012.01276.x; Murthi P, 2014, PLACENTA, V35, pS46, DOI 10.1016/j.placenta.2013.11.006; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Peters JL, 2013, CURR OPIN ALLERGY CL, V13, P187, DOI 10.1097/ACI.0b013e32835e82d3; Rodriguez-Cruz M, 2011, BBA-MOL CELL BIOL L, V1811, P284, DOI 10.1016/j.bbalip.2011.01.007; Schwender H., IDENTIFYING DIFFEREN; Shek LP, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/730568; Shin JS, 2010, PLACENTA, V31, P1027, DOI 10.1016/j.placenta.2010.08.015; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang T, 2004, J NEURAL ENG, V1, DOI 10.1088/1741-2560/1/1/001; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Wendell SG, 2014, J ALLERGY CLIN IMMUN, V133, P1255, DOI 10.1016/j.jaci.2013.12.1087; Xu CR, 2009, J IMMUNOL, V182, P1362, DOI 10.4049/jimmunol.182.3.1362; Xu Y, 2012, J ENG FIBER FABR, V7, P7; Yang YW, 2008, J ALLERGY CLIN IMMUN, V121, P1393, DOI 10.1016/j.jaci.2008.02.031; Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388	42	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163832	10.1371/journal.pone.0163832	http://dx.doi.org/10.1371/journal.pone.0163832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711190	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600043
J	Baker, JK; Long, SM; Hassell, KL; Pettigrove, VJ; Gagnon, MM				Baker, Jarrad K.; Long, Sara M.; Hassell, Kathryn L.; Pettigrove, Vincent J.; Gagnon, Marthe M.			Health Status of Sand Flathead (Platycephalus bassensis), Inhabiting an Industrialisedand Urbanised Embayment, Port Phillip Bay, Victoria as Measured by Biomarkers of Exposure and Effects	PLOS ONE			English	Article							FIXED-WAVELENGTH FLUORESCENCE; SOLE PAROPHRYS-VETULUS; EROD ACTIVITY; AROMATIC-HYDROCARBONS; CONTAMINANT EXPOSURE; OXIDATIVE STRESS; HEPATIC-LESIONS; CHINOOK SALMON; PUGET-SOUND; FISH BILE	Port Phillip Bay, Australia, is a large semi-closed bay with over four million people living in its catchment basin. The Bay receives waters from the Yarra River which drains the city of Melbourne, as well as receiving the discharges of sewage treatment plants and petrochemical and agricultural chemicals. A 1999 study demonstrated that fish inhabiting Port Phillip Bay showed signs of effects related to pollutant exposure despite pollution management practices having been implemented for over a decade. To assess the current health status of the fish inhabiting the Bay, a follow up survey was conducted in 2015. A suite of biomarkers of exposure and effects were measured to determine the health status of Port Phillip Bay sand flathead (Platycephalus bassensis), namely ethoxyresorufin-O-deethylase (EROD) activity, polycyclic aromatic hydrocarbons (PAH) biliary metabolites, carboxylesterase activity (CbE) and DNA damage (8-oxo-dG). The reduction in EROD activity in the present study suggests a decline in the presence of EROD activity-inducing chemicals within the Bay since the 1990s. Fish collected in the most industrialised/urbanised sites did not display higher PAH metabolite levels than those in less developed areas of the Bay. Ratios of PAH biliary metabolite types were used to indicate PAH contaminant origin. Ratios indicated fish collected at Corio Bay and Hobsons Bay were subjected to increased low molecular weight hydrocarbons of petrogenic origin, likely attributed to the close proximity of these sites to oil refineries, compared to PAH biliary metabolites in fish from Geelong Arm and Mordialloc. Quantification of DNA damage indicated a localised effect of exposure to pollutants, with a 10-fold higher DNA damage level in fish sampled from the industrial site of Corio Bay relative to the less developed site of Sorrento. Overall, integration of biomarkers by multivariate analysis indicated that the health of fish collected in industrialised areas was compromised, with biologically significant biomarkers of effects (LSI, CF and DNA damage) discriminating between individuals collected in industrialised areas from observations made in fish collected in less developed areas of the Bay.	[Baker, Jarrad K.; Gagnon, Marthe M.] Curtin Univ, Dept Environm & Agr, Bentley, WA 6102, Australia; [Long, Sara M.] Univ Melbourne, CAPIM, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Hassell, Kathryn L.; Pettigrove, Vincent J.] Univ Melbourne, CAPIM, Parkville, Vic 3010, Australia	Curtin University; University of Melbourne; University of Melbourne	Gagnon, MM (corresponding author), Curtin Univ, Dept Environm & Agr, Bentley, WA 6102, Australia.	M.Gagnon@curtin.edu.au	Hassell, Kathryn/AAB-4980-2021; GAGNON, Marthe Monique/P-6078-2014; Hassell, Kathryn/F-3590-2016	GAGNON, Marthe Monique/0000-0002-3190-5094; Hassell, Kathryn/0000-0001-6077-775X; Baker, Jarrad/0000-0002-7622-3070; LONG, SARA/0000-0001-5323-8846				Aas E, 1998, MAR ENVIRON RES, V46, P225, DOI 10.1016/S0141-1136(97)00034-2; Abdel-Shafy Hussein I., 2016, Egyptian Journal of Petroleum, V25, P107, DOI 10.1016/j.ejpe.2015.03.011; Almeida C, 2011, J ENVIRON MONITOR, V13, P2559, DOI 10.1039/c1em10190k; [Anonymous], 1998, THESIS; [Anonymous], [No title captured]; Australian Animal Welfare Strategy, IK JIM HUM KILL FISH; Beyer J, 2010, ENVIRON TOXICOL PHAR, V30, P224, DOI 10.1016/j.etap.2010.08.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COLLIER TK, 1991, ARCH ENVIRON CON TOX, V20, P462, DOI 10.1007/BF01065834; Collier TK, 1993, ENV SCI, V2, P161; Fisher TC, 2000, ENVIRON TOXICOL CHEM, V19, P1749, DOI [10.1897/1551-5028(2000)019&lt;1749:AOMATD&gt;2.3.CO;2, 10.1002/etc.5620190707]; Gagnon MM, 2016, ARCH ENVIRON CON TOX, V70, P192, DOI 10.1007/s00244-015-0258-0; Gagnon MM, 2016, MAR POLLUT BULL, V109, P661, DOI 10.1016/j.marpolbul.2016.05.003; Gagnon MM, 2002, MAR POLLUT BULL, V44, P230, DOI 10.1016/S0025-326X(01)00245-4; Harris G., 1996, PORT PHILLIP BAY ENV; HELLOU J, 1995, INT J ENVIRON AN CH, V60, P101, DOI 10.1080/03067319508042868; HOLDWAY DA, 1994, MAR POLLUT BULL, V28, P683, DOI 10.1016/0025-326X(94)90304-2; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kasai H., MUTATION RES REV MUT; Kienzler A, 2013, AQUAT TOXICOL, V134, P47, DOI 10.1016/j.aquatox.2013.03.005; KRAHN MM, 1986, ARCH ENVIRON CON TOX, V15, P61, DOI 10.1007/BF01055249; KRAHN MM, 1992, ENVIRON SCI TECHNOL, V26, P116, DOI 10.1021/es00025a012; Li SN, 1997, J TOXICOL ENV HEALTH, V51, P149, DOI 10.1080/00984109708984018; Liang P, 2007, PEST MANAG SCI, V63, P365, DOI 10.1002/ps.1346; Lin ELC, 1996, ECOTOX ENVIRON SAFE, V35, P16, DOI 10.1006/eesa.1996.0077; Mangal D, 2009, CHEM RES TOXICOL, V22, P788, DOI 10.1021/tx800343c; Nagel F, 2012, ARCH ENVIRON CON TOX, V62, P254, DOI 10.1007/s00244-011-9693-8; National Center for Biotechnology Information, 2016, PUBCHEM COMP DAT; Navas JM, 2000, MAR ENVIRON RES, V50, P157, DOI 10.1016/S0141-1136(00)00083-0; Patino R, 2015, GEN COMP ENDOCR, V219, P112, DOI 10.1016/j.ygcen.2014.12.013; Robb DHF, 2000, VET REC, V147, P298, DOI 10.1136/vr.147.11.298; Sampson J., 2014, ESTUARIES AUSTR 2050, P49; Smith BJ, 2000, ENVIRON TOXICOL, V15, P1; Snedecor G.W., 1989, AMES IOWA STATE U PR; STEIN JE, 1995, ENVIRON TOXICOL CHEM, V14, P1019, DOI [10.1897/1552-8618(1995)14[1019:CEABEI]2.0.CO;2, 10.1002/etc.5620140613]; Torreiro-Melo AGAG, 2015, CHEMOSPHERE, V132, P17, DOI 10.1016/j.chemosphere.2014.12.079; Trevigen Inc, 2011, HT 8 OX DG ELISA KIL; TUVIKENE A, 1995, ANN ZOOL FENN, V32, P295; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; VANVELD PA, 1992, CARCINOGENESIS, V13, P505, DOI 10.1093/carcin/13.3.505; Victoria EPA, 2009, VICT EPA PUBL; Wheelock CE, 2005, AQUAT TOXICOL, V74, P172, DOI 10.1016/j.aquatox.2005.05.009; Wheelock CE, 2008, REV ENVIRON CONTAM T, V195, P117, DOI 10.1007/978-0-387-77030-7_5; Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239; Zar JH, 1999, BIOSTATISTICAL ANAL	47	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164257	10.1371/journal.pone.0164257	http://dx.doi.org/10.1371/journal.pone.0164257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711198	Green Published, gold			2022-12-27	WOS:000385697600107
J	Jakubkova, M; Dzugasova, V; Truban, D; Abelovska, L; Bhatia-Kissova, I; Valachovic, M; Klobucnikova, V; Zeiselova, L; Griac, P; Nosek, J; Tomaska, L				Jakubkova, Michaela; Dzugasova, Vladimira; Truban, Dominika; Abelovska, Lenka; Bhatia-Kissova, Ingrid; Valachovic, Martin; Klobucnikova, Vlasta; Zeiselova, Lucia; Griac, Peter; Nosek, Jozef; Tomaska, Lubomir			Identification of Yeast Mutants Exhibiting Altered Sensitivity to Valinomycin and Nigericin Demonstrate Pleiotropic Effects of Ionophores on Cellular Processes	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; MITOCHONDRIAL INNER MEMBRANE; FATTY-ACID ELONGATION; STEROL C-14 REDUCTASE; VACUOLAR MEMBRANE; PROTEIN-SYNTHESIS; K+/H+ EXCHANGE; INTACT-CELLS; LIFE-SPAN; GENE	Ionophores such as valinomycin and nigericin are potent tools for studying the impact of ion perturbance on cellular functions. To obtain a broader picture about molecular components involved in mediating the effects of these drugs on yeast cells under respiratory growth conditions, we performed a screening of the haploid deletion mutant library covering the Saccharomyces cerevisiae nonessential genes. We identified nearly 130 genes whose absence leads either to resistance or to hypersensitivity to valinomycin and/or nigericin. The processes affected by their protein products range from mitochondrial functions through ribosome biogenesis and telomere maintenance to vacuolar biogenesis and stress response. Comparison of the results with independent screenings performed by our and other laboratories demonstrates that although mitochondria might represent the main target for both ionophores, cellular response to the drugs is very complex and involves an intricate network of proteins connecting mitochondria, vacuoles, and other membrane compartments.	[Jakubkova, Michaela; Truban, Dominika; Abelovska, Lenka; Bhatia-Kissova, Ingrid; Nosek, Jozef] Comenius Univ, Fac Nat Sci, Dept Biochem, Ilkovicova 6, Bratislava 84215, Slovakia; [Dzugasova, Vladimira; Abelovska, Lenka; Zeiselova, Lucia; Tomaska, Lubomir] Comenius Univ, Dept Genet, Fac Nat Sci, Ilkovicova 6, Bratislava 84215, Slovakia; [Valachovic, Martin; Klobucnikova, Vlasta; Griac, Peter] Slovak Acad Sci, Dept Biochem Biomembranes, Inst Anim Biochem & Genet, Moyzesova 61, Ivanka Pri Dunaji 90028, Slovakia	Comenius University Bratislava; Comenius University Bratislava; Slovak Academy of Sciences	Nosek, J (corresponding author), Comenius Univ, Fac Nat Sci, Dept Biochem, Ilkovicova 6, Bratislava 84215, Slovakia.; Tomaska, L (corresponding author), Comenius Univ, Dept Genet, Fac Nat Sci, Ilkovicova 6, Bratislava 84215, Slovakia.	nosek@fns.uniba.sk; tomaska@fns.uniba.sk	, Peter/ABA-9227-2020; Valachovic, Martin/O-5962-2017; Fricova, Dominika/L-9216-2015; Bhatia, Ingrid/H-7016-2016; Nosek, Jozef/A-7581-2008; Tomaska, Lubomir/I-3071-2014	, Peter/0000-0003-3538-0405; Valachovic, Martin/0000-0001-7096-9325; Fricova, Dominika/0000-0002-6417-0370; Nosek, Jozef/0000-0002-1020-5451; Tomaska, Lubomir/0000-0003-4886-1910	Slovak Grant Agency VEGA [1/0311/12, 1/0052/16, 1/0333/15, 2/0111/15, 2/0185/14]; Slovak Grant Agency APVV [APVV-0035-11, APVV-15-0022, APVV-14-0253]; Howard Hughes Medical Institute [55005622]	Slovak Grant Agency VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Slovak Grant Agency APVV(Slovak Research and Development Agency); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by grants from the Slovak Grant Agencies VEGA (1/0311/12 and 1/0052/16 (L.T.), 1/0333/15 (J.N.), 2/0111/15 (P.G.), 2/0185/14 (M.V.)) and APVV (APVV-0035-11 and APVV-15-0022 (L.T.), APVV-14-0253 (J.N.)), and Howard Hughes Medical Institute (55005622 (J. N.)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2001, J BIOL CHEM, V276, P26923, DOI 10.1074/jbc.M102179200; Abelovska L, 2011, GEN PHYSIOL BIOPHYS, V30, pS13, DOI 10.4149/gpb_2011_SI1_13; Addinall SG, 2008, GENETICS, V180, P2251, DOI 10.1534/genetics.108.092577; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Batova M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-153; Bhuiyan MSA, 2007, LIPIDS, V42, P69, DOI 10.1007/s11745-006-1001-4; BREITBART H, 1975, MOL BIOL REP, V2, P167, DOI 10.1007/BF00357548; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; BROWN GC, 1986, BIOCHEM J, V234, P75, DOI 10.1042/bj2340075; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; CHOW JM, 1990, APPL ENVIRON MICROB, V56, P1588, DOI 10.1128/AEM.56.6.1588-1593.1990; Chung JH, 2003, J BIOL CHEM, V278, P28872, DOI 10.1074/jbc.M300943200; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Davies BSJ, 2005, MOL CELL BIOL, V25, P7375, DOI 10.1128/MCB.25.16.7375-7385.2005; Dimmer KS, 2005, J CELL BIOL, V168, P103, DOI 10.1083/jcb.200410030; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dorr T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000760; Eisenkolb M, 2002, MOL BIOL CELL, V13, P4414, DOI 10.1091/mbc.E02-02-0116; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Fricova D, 2006, THESIS; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Froschauer E, 2005, BBA-BIOMEMBRANES, V1711, P41, DOI 10.1016/j.bbamem.2005.02.018; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P1, DOI 10.1016/S0005-2728(03)00109-9; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gregan J, 2001, MOL GEN GENET, V264, P773, DOI 10.1007/s004380000366; Gustavsson M, 2008, MOL GENET GENOMICS, V280, P233, DOI 10.1007/s00438-008-0359-9; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hersh MN, 2004, RES MICROBIOL, V155, P352, DOI 10.1016/j.resmic.2004.01.020; HERZBERG M, 1980, MOL BIOL REP, V6, P163, DOI 10.1007/BF00775411; Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jungwirth H, 2008, FEBS LETT, V582, P2882, DOI 10.1016/j.febslet.2008.07.023; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; Kolisek M, 2003, EMBO J, V22, P1235, DOI 10.1093/emboj/cdg122; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; KOVAC L, 1982, BIOCHIM BIOPHYS ACTA, V721, P349, DOI 10.1016/0167-4889(82)90089-1; KOVAC L, 1982, BIOCHIM BIOPHYS ACTA, V721, P341, DOI 10.1016/0167-4889(82)90088-X; Kovac L, 1983, MITOCHONDRIA, P65; KRULWICH TA, 1990, MICROBIOL REV, V54, P52, DOI 10.1128/MMBR.54.1.52-65.1990; Kucejova B, 2005, GENETICS, V171, P517, DOI 10.1534/genetics.105.046540; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Lees ND, 2004, TOP CURR GENET, V6, P213; Lehner KR, 2007, GENETICS, V177, P1951, DOI 10.1534/genetics.107.079368; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Lockshon D, 2007, GENETICS, V175, P77, DOI 10.1534/genetics.106.064428; LORENZ RT, 1992, DNA CELL BIOL, V11, P685, DOI 10.1089/dna.1992.11.685; MARCIREAU C, 1990, ANTIMICROB AGENTS CH, V34, P989, DOI 10.1128/AAC.34.6.989; MOREHEAD MC, 1992, APPL ENVIRON MICROB, V58, P1617, DOI 10.1128/AEM.58.5.1617-1623.1992; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; NICHOLLS DG, 2001, BIOENERGETICS, V3, P17; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Petrezselyova S, 2008, MITOCHONDRION, V8, P117, DOI 10.1016/j.mito.2007.10.003; Pircher A, 2014, MOL CELL, V54, P147, DOI 10.1016/j.molcel.2014.02.024; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Ruggles KV, 2014, J BIOL CHEM, V289, P4417, DOI 10.1074/jbc.M113.515197; Safiulina D, 2006, J CELL PHYSIOL, V206, P347, DOI 10.1002/jcp.20476; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Shachar R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.13; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shimazu M, 2005, J BIOL CHEM, V280, P4851, DOI 10.1074/jbc.M412617200; Silve S, 1996, MOL CELL BIOL, V16, P2719; SMITH SJ, 1993, YEAST, V9, P1177, DOI 10.1002/yea.320091104; Stephan J, 2013, AGING CELL, V12, P574, DOI 10.1111/acel.12077; Sturley SL, 2000, BBA-MOL CELL BIOL L, V1529, P155, DOI 10.1016/S1388-1981(00)00145-1; Teng X, 2013, MOL CELL, V52, P485, DOI 10.1016/j.molcel.2013.09.026; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Valachovic M, 2006, GENETICS, V173, P1893, DOI 10.1534/genetics.105.053025; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wilcox LJ, 2002, J BIOL CHEM, V277, P32466, DOI 10.1074/jbc.M204707200; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zeviani Massimo, 2003, Curr Neurol Neurosci Rep, V3, P423, DOI 10.1007/s11910-003-0026-9	83	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164175	10.1371/journal.pone.0164175	http://dx.doi.org/10.1371/journal.pone.0164175			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711131	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600092
J	Thompson, M; Heath, SL; Sweeton, B; Williams, K; Cunningham, P; Keele, BF; Sen, S; Palmer, BE; Chomont, N; Xu, YX; Basu, R; Hellerstein, MS; Kwa, S; Robinson, HL				Thompson, Melanie; Heath, Sonya L.; Sweeton, Bentley; Williams, Kathy; Cunningham, Pamela; Keele, Brandon F.; Sen, Sharon; Palmer, Brent E.; Chomont, Nicolas; Xu, Yongxian; Basu, Rahul; Hellerstein, Michael S.; Kwa, Suefen; Robinson, Harriet L.			DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus	PLOS ONE			English	Article							T-CELL EXHAUSTION; PLACEBO-CONTROLLED TRIAL; HIV TYPE-1; INFLUENZA VACCINATION; DISEASE PROGRESSION; INFECTION; REPLICATION; EXPRESSION; IMMUNOGENICITY; VACCINES	GV-TH-01, a Phase 1 open-label trial of a DNA prime D Modified Vaccinia Ankara (MVA) boost vaccine (GOVX-B11), was undertaken in HIV infected participants on antiretroviral treatment (ART) to evaluate safety and vaccine-elicited T cell responses, and explore the ability of elicited CD8+ T cells to control viral rebound during analytical treatment interruption (TI). Nine men who began antiretroviral therapy (ART) within 18 months of seroconversion and had sustained plasma HIV-1 RNA <50 copies/mL for at least 6 months were enrolled. Median age was 38 years, median pre-ART HIV-1 RNA was 140,000 copies/ml and mean baseline CD4 count was 755/mu l. Two DNA, followed by 2 MVA, inoculations were given 8 weeks apart. Eight subjects completed all vaccinations and TI. Clinical and laboratory adverse events were generally mild, with no serious or grade 4 events. Only reactogenicity events were considered related to study drug. No treatment emergent viral resistance was seen. The vaccinations did not reduce viral reservoirs and virus re-emerged in all participants during TI, with a median time to re-emergence of 4 weeks. Eight of 9 participants had CD8+ T cells that could be stimulated by vaccine-matched Gag peptides prior to vaccination. Vaccinations boosted these responses as well as eliciting previously undetected CD8+ responses. Elicited T cells did not display signs of exhaustion. During TI, temporal patterns of viral re-emergence and Gag-specific CD8+ T cell expansion suggested that vaccine-specific CD8+ T cells had been stimulated by re-emergent virus in only 2 of 8 participants. In these 2, transient decreases in viremia were associated with Gag selection in known CD8+ T cell epitopes. We hypothesize that escape mutations, already archived in the viral reservoir, plus a poor ability of CD8+ T cells to traffic to and control virus at sites of re-emergence, limited the therapeutic efficacy of the DNA/MVA vaccine.	[Thompson, Melanie; Sweeton, Bentley; Williams, Kathy] AIDS Res Consortium Atlanta, Atlanta, GA 30312 USA; [Heath, Sonya L.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Cunningham, Pamela] Univ Alabama Birmingham, Alabama Vaccine Res Clin, Birmingham, AL USA; [Keele, Brandon F.] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Leidos Biomed Res Inc, Frederick, MD USA; [Sen, Sharon; Palmer, Brent E.] Univ Colorado, Anschutz Med Campus, Aurora, CO USA; [Chomont, Nicolas] CHUM, Ctr Rech, Montreal, PQ, Canada; [Chomont, Nicolas] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Xu, Yongxian] Emory Univ, Sch Med, Dept Med, Hope Clin,Emory Vaccine Ctr,Div Infect Dis, Atlanta, GA USA; [Basu, Rahul; Hellerstein, Michael S.; Kwa, Suefen; Robinson, Harriet L.] GeoVax Inc, Atlanta, GA USA; [Kwa, Suefen] ViiV Healthcare, Res Triangle Pk, NC USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Colorado System; University of Colorado Anschutz Medical Campus; Universite de Montreal; Universite de Montreal; Emory University; GlaxoSmithKline	Thompson, M (corresponding author), AIDS Res Consortium Atlanta, Atlanta, GA 30312 USA.	drmt@mindspring.com	Chomont, Nicolas/ABG-2545-2020	Chomont, Nicolas/0000-0001-9747-5018; Robinson, Harriet/0000-0001-6380-3458	GeoVax, Inc.; National Cancer Institute [HHSN261200800001E]	GeoVax, Inc.; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	GeoVax, Inc. provided support in the form of employee salaries for YX, RB, MSH, SK, and HLR. Funding for BFK was provided by the National Cancer Institute: HHSN261200800001E. Funding for MT and SLH was provided by GeoVax, Inc.	Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Autran B, 2008, AIDS, V22, P1313, DOI 10.1097/QAD.0b013e3282fdce94; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Casazza JP, 2013, J INFECT DIS, V207, P1829, DOI 10.1093/infdis/jit098; Connick E, 2007, J IMMUNOL, V178, P6975, DOI 10.4049/jimmunol.178.11.6975; D'Souza M, 2007, J IMMUNOL, V179, P1979, DOI 10.4049/jimmunol.179.3.1979; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Gomez CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141456; Folkvord JM, 2005, AIDS RES HUM RETROV, V21, P363, DOI 10.1089/aid.2005.21.363; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682; Garde D, 2015, ARGOS TANKS ITS HIV; Goepfert PA, 2014, J INFECT DIS, V210, P99, DOI 10.1093/infdis/jiu003; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Greenough TC, 2008, VACCINE, V26, P6883, DOI 10.1016/j.vaccine.2008.09.084; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Gunthard HF, 2000, J INFECT DIS, V181, P522, DOI 10.1086/315260; Haas DW, 2009, J INFECT DIS, V199, P872, DOI 10.1086/597125; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Jacobson JM, 2006, J INFECT DIS, V194, P623, DOI 10.1086/506364; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Kassu A, 2010, J IMMUNOL, V185, P3007, DOI 10.4049/jimmunol.1000156; Kassu A, 2009, CLIN IMMUNOL, V132, P234, DOI 10.1016/j.clim.2009.03.531; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; KOUP RA, 1994, J EXP MED, V180, P779, DOI 10.1084/jem.180.3.779; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Markowitz M, 2002, J INFECT DIS, V186, P634, DOI 10.1086/342559; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Palmer BE, 2005, J IMMUNOL, V175, P8415, DOI 10.4049/jimmunol.175.12.8415; Palmer BE, 2008, J IMMUNOL, V180, P2704, DOI 10.4049/jimmunol.180.4.2704; Panel on Antiretroviral Guidelines for Adults and Adolescents DHHS, 2019, GUIDELINES USE ANTIR; Procopio FA, 2015, EBIOMEDICINE, V2, P874, DOI 10.1016/j.ebiom.2015.06.019; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Scheller C, 2004, J BIOL CHEM, V279, P21897, DOI 10.1074/jbc.M311609200; Schooley RT, 2010, J INFECT DIS, V202, P705, DOI 10.1086/655468; Smith JM, 2004, AIDS RES HUM RETROV, V20, P1335, DOI 10.1089/aid.2004.20.1335; Smith JM, 2004, AIDS RES HUM RETROV, V20, P654, DOI 10.1089/0889222041217419; STAPRANS SI, 1995, J EXP MED, V182, P1727, DOI 10.1084/jem.182.6.1727; Stohr W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078287; Suschak JJ, 2016, J IMMUNOL, V196, P310, DOI 10.4049/jimmunol.1501836; Tasker SA, 1998, VACCINE, V16, P1039, DOI 10.1016/S0264-410X(97)00275-2; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Tubiana R, 2005, VACCINE, V23, P4292, DOI 10.1016/j.vaccine.2005.04.013; UNAIDS, 2015, AIDS CHANG EV MDG6 1; Vandergeeten C, 2014, J VIROL, V88, P12385, DOI 10.1128/JVI.00609-14; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Winckelmann AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062074; World Health Organization, 2015, GUID START ANT THER; Wyatt LS, 2008, VIROLOGY, V372, P260, DOI 10.1016/j.virol.2007.10.033; Wyatt LS, 2004, AIDS RES HUM RETROV, V20, P645, DOI 10.1089/0889222041217428	60	18	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163164	10.1371/journal.pone.0163164	http://dx.doi.org/10.1371/journal.pone.0163164			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711228	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600015
J	Ajioka, H; Kihara, H; Odaira, C; Kobayashi, T; Kondo, H				Ajioka, Hitoshi; Kihara, Hidemichi; Odaira, Chikayuki; Kobayashi, Takuya; Kondo, Hisatomo			Examination of the Position Accuracy of Implant Abutments Reproduced by Intra-Oral Optical Impression	PLOS ONE			English	Article							DIGITAL IMPRESSIONS; RESTORATIONS; SCANNER; FABRICATION; TECHNOLOGY; PRECISION; 10-YEAR; MODELS	An impression technique called optical impression using intraoral scanner has attracted attention in digital dentistry. This study aimed to evaluate the accuracy of the optical impression, comparing a virtual model reproduced by an intraoral scanner to a working cast made by conventional silicone impression technique. Two implants were placed on a master model. Working casts made of plaster were fabricated from the master model by silicone impression. The distance between the ball abutments and the angulation between the healing abutments of 5 mm and 7 mm height at master model were measured using Computer Numerical Control Coordinate Measuring Machine (CNCCMM) as control. Working casts were then measured using CNCCMM, and virtual models via stereo lithography data of master model were measured by a three-dimensional analyzing software. The distance between ball abutments of the master model was 9634.9 +/- 1.2 mu m. The mean values of trueness of the Lava COS and working casts were 64.5 mu m and 22.5 mu m, respectively, greater than that of control. The mean of precision values of the Lava COS and working casts were 15.6 mu m and 13.5 mu m, respectively. In the case of a 5-mm-height healing abutment, mean angulation error of the Lava COS was greater than that of the working cast, resulting in significant differences in trueness and precision. However, in the case of a 7-mm-height abutment, mean angulation errors of the Lava COS and the working cast were not significantly different in trueness and precision. Therefore, distance errors of the optical impression were slightly greater than those of conventional impression. Moreover, the trueness and precision of angulation error could be improved in the optical impression using longer healing abutments. In the near future, the development of information technology could enable improvement in the accuracy of the optical impression with intraoral scanners.	[Ajioka, Hitoshi; Kihara, Hidemichi; Odaira, Chikayuki; Kobayashi, Takuya; Kondo, Hisatomo] Iwate Med Univ, Sch Dent, Dept Prosthodont & Oral Implantol, Morioka, Iwate, Japan	Iwate Medical University	Kihara, H (corresponding author), Iwate Med Univ, Sch Dent, Dept Prosthodont & Oral Implantol, Morioka, Iwate, Japan.	hkihara@iwate-med.ac.jp	Kondo, Hisatomo/AAA-9939-2021					Andriessen FS, 2014, J PROSTHET DENT, V111, P186, DOI 10.1016/j.prosdent.2013.07.010; Souza ROA, 2012, J PROSTHODONT, V21, P94, DOI 10.1111/j.1532-849X.2011.00793.x; Assuncao Wirley Goncalves, 2004, Implant Dent, V13, P358; Beuer F, 2008, BRIT DENT J, V204, P505, DOI 10.1038/sj.bdj.2008.350; Bosch G, 2014, J PROSTHET DENT, V112, P1425, DOI 10.1016/j.prosdent.2014.05.012; Cardelli P, 2011, J DENT, DOI [10.1016/j.jdent.2011.10.005, DOI 10.1016/J.JDENT.2011.10.005]; Carr A B, 1991, Int J Oral Maxillofac Implants, V6, P448; Cuperus AMR, 2012, AM J ORTHOD DENTOFAC, V142, P308, DOI 10.1016/j.ajodo.2012.03.031; Ender A, 2011, Int J Comput Dent, V14, P11; Ender A, 2013, J PROSTHET DENT, V109, P121, DOI 10.1016/S0022-3913(13)60028-1; Fasbinder Dennis J, 2010, Compend Contin Educ Dent, V31 Spec No 4, P2; Grossmann Y, 2006, J PROSTHET DENT, V95, P258, DOI 10.1016/j.prosdent.2005.12.013; Henkel Gary L, 2007, Compend Contin Educ Dent, V28, P422; JOHNSON GH, 1985, J PROSTHET DENT, V53, P484, DOI 10.1016/0022-3913(85)90630-4; Kattadiyil MT, 2014, J PROSTHET DENT, V112, P444, DOI 10.1016/j.prosdent.2014.03.022; Lee H, 2008, J PROSTHET DENT, V100, P285, DOI 10.1016/S0022-3913(08)60208-5; Lee SJ, 2013, CLIN ORAL IMPLAN RES, V24, P111, DOI 10.1111/j.1600-0501.2012.02430.x; Li RWK, 2014, J PROSTHODONT RES, V58, P208, DOI 10.1016/j.jpor.2014.07.003; Mehl A, 2012, Int J Comput Dent, V15, P109; MILLSTEIN PL, 1992, J ORAL REHABIL, V19, P239, DOI 10.1111/j.1365-2842.1992.tb01098.x; Miyazaki T, 2013, J PROSTHODONT RES, V57, P236, DOI 10.1016/j.jpor.2013.09.001; Moermann WH, 2006, J AM DENT ASSOC, V137, p7S; Nayyar N, 2013, J PROSTHET DENT, V109, P210, DOI 10.1016/S0022-3913(13)00073-5; Nedelcu RG, 2014, J PROSTHET DENT, V112, P1461, DOI 10.1016/j.prosdent.2014.05.027; Odaira C, 2011, J PROSTHODONT RES, V55, P199, DOI 10.1016/j.jpor.2010.12.005; Patzelt SBM, 2014, CLIN ORAL INVEST, V18, P1687, DOI 10.1007/s00784-013-1132-y; Posselt A, 2003, Int J Comput Dent, V6, P231; Pradies G, 2014, J AM DENT ASSOC, V145, P338, DOI 10.14219/jada.2013.45; Rangel FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059130; Sjogren G, 2004, INT J PROSTHODONT, V17, P241; Svanborg P, 2014, INT J DENT, V2014, DOI 10.1155/2014/534382; Syrek A, 2010, J DENT, V38, P553, DOI 10.1016/j.jdent.2010.03.015; Takuma Y, 2013, J ESTHET DENT, V26, P1; Vafiadis Dean C, 2007, Pract Proced Aesthet Dent, V19, P443; van der Meer WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043312; Welander M, 2008, CLIN ORAL IMPLAN RES, V19, P635, DOI 10.1111/j.1600-0501.2008.01543.x; Zimmer S, 2008, OPER DENT, V33, P484, DOI 10.2341/07-142	37	37	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164048	10.1371/journal.pone.0164048	http://dx.doi.org/10.1371/journal.pone.0164048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706225	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697200079
J	Arnold, WK; Savage, CR; Brissette, CA; Seshu, J; Livny, J; Stevenson, B				Arnold, William K.; Savage, Christina R.; Brissette, Catherine A.; Seshu, Janakiram; Livny, Jonathan; Stevenson, Brian			RNA-Seq of Borrelia burgdorferi in Multiple Phases of Growth Reveals Insights into the Dynamics of Gene Expression, Transcriptome Architecture, and Noncoding RNAs	PLOS ONE			English	Article							LYME-DISEASE SPIROCHETE; DIFFERENTIAL EXPRESSION; RESPONSE REGULATOR; SURFACE-PROTEINS; PLASMID CONTENT; INFECTION; RPOS; SEQUENCE; GENOME; OSPC	Borrelia burgdorferi, the agent of Lyme disease, differentially expresses numerous genes and proteins as it cycles between mammalian hosts and tick vectors. Insights on regulatory mechanisms have been provided by earlier studies that examined B. burgdorferi gene expression patterns during cultivation. However, prior studies examined bacteria at only a single time point of cultivation, providing only a snapshot of what is likely a dynamic transcriptional program driving B. burgdorferi adaptations to changes during culture growth phases. To address that concern, we performed RNA sequencing (RNA-Seq) analysis of B. burgdorferi cultures at early-exponential, mid-exponential, and early-stationary phases of growth. We found that expression of nearly 18% of annotated B. burgdorferi genes changed significantly during culture maturation. Moreover, genome-wide mapping of the B. burgdorferi transcriptome in different growth phases enabled insight on transcript boundaries, operon structures, and identified numerous putative non-coding RNAs. These RNA-Seq data are discussed and presented as a resource for the community of researchers seeking to better understand B. burgdorferi biology and pathogenesis.	[Arnold, William K.; Savage, Christina R.; Stevenson, Brian] Univ Kentucky, Sch Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Brissette, Catherine A.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58201 USA; [Seshu, Janakiram] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Livny, Jonathan] Broad Inst MIT & Harvard, Cambridge, MA USA	University of Kentucky; University of North Dakota Grand Forks; University of Texas System; University of Texas at San Antonio (UTSA); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Stevenson, B (corresponding author), Univ Kentucky, Sch Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA.	brian.stevenson@uky.edu		Brissette, Catherine/0000-0003-0792-1403; Arnold, Will/0000-0003-2447-3489	National Institutes of Health [R03-AI113648, R21-AI120602]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI113648, R21AI120602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R03-AI113648 to B. Stevenson, J. Seshu, and J. Livny, and R21-AI120602 to B. Stevenson.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bono JL, 1998, MICROBIOL-UK, V144, P1033, DOI 10.1099/00221287-144-4-1033; Bugrysheva JV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118063; Bugrysheva JV, 2005, INFECT IMMUN, V73, P4972, DOI 10.1128/IAI.73.8.4972-4981.2005; Bunikis I, 2011, J MICROBIOL METH, V86, P243, DOI 10.1016/j.mimet.2011.05.004; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Bykowski T, 2006, J BACTERIOL, V188, P4879, DOI 10.1128/JB.00229-06; Caimano MJ, 2015, INFECT IMMUN, V83, P3043, DOI 10.1128/IAI.00315-15; Caimano MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004004; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Cloud JL, 1997, GENE, V194, P137, DOI 10.1016/S0378-1119(97)00196-0; Dobrikova EY, 2001, MOL MICROBIOL, V39, P370, DOI 10.1046/j.1365-2958.2001.02220.x; Drecktrah D, 2015, PLOS PATHOG, V11, DOI [10.1371/journal.ppat.1005160, 10.1371/journal.ppat.1005242]; Eggers CH, 2001, SPIROCHETES: MOLECULAR AND CELLULAR BIOLOGY, P35; Elias AF, 2000, J BACTERIOL, V182, P2909, DOI 10.1128/JB.182.10.2909-2918.2000; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Elvekrog MM, 2015, CURR OPIN CHEM BIOL, V29, P79, DOI 10.1016/j.cbpa.2015.09.016; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gaultney RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075643; Gautam A, 2009, FEMS MICROBIOL LETT, V293, P278, DOI 10.1111/j.1574-6968.2009.01542.x; Gilmore RD, 2001, MICROBES INFECT, V3, P799, DOI 10.1016/S1286-4579(01)01435-6; He M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002133; Huang WM, 2004, J BACTERIOL, V186, P4134, DOI 10.1128/JB.186.13.4134-4141.2004; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2006, MICROBIOL-SGM, V152, P2599, DOI 10.1099/mic.0.28996-0; Indest KJ, 1997, INFECT IMMUN, V65, P1165, DOI 10.1128/IAI.65.4.1165-1171.1997; Iqbal H, 2016, MOL MICROBIOL, V102, P757, DOI 10.1111/mmi.13492; Iyer R, 2016, MICROARRAYS, V5; Iyer R, 2015, MOL MICROBIOL, V95, P509, DOI 10.1111/mmi.12882; Jacobs GH, 2009, NUCLEIC ACIDS RES, V37, pD72, DOI 10.1093/nar/gkn763; Jutras BL, 2013, J BACTERIOL, V195, P4915, DOI 10.1128/JB.00819-13; Jutras BL, 2013, J BIOL CHEM, V288, P26220, DOI 10.1074/jbc.M113.491357; Jutras BL, 2013, J BACTERIOL, V195, P757, DOI 10.1128/JB.01956-12; Jutras BL, 2012, J BACTERIOL, V194, P3395, DOI 10.1128/JB.00252-12; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Li H, 2009, BIOINFORMATICS, V25, DOI 10.1093/bioinformatics/btp324; Livny J, 2014, NUCLEIC ACIDS RES, V42, P12212, DOI 10.1093/nar/gku891; Livny Jonathan, 2012, Methods Mol Biol, V905, P3, DOI 10.1007/978-1-61779-949-5_1; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Lybecker MC, 2010, MOL MICROBIOL, V78, P622, DOI 10.1111/j.1365-2958.2010.07374.x; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; MARCONI RT, 1993, J BACTERIOL, V175, P926, DOI 10.1128/JB.175.4.926-932.1993; Miller CL, 2013, MOL MICROBIOL, V88, P105, DOI 10.1111/mmi.12171; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Miller Jennifer C, 2005, Curr Protoc Microbiol, VChapter 1D, DOI 10.1002/9780471729259.mc01d03s00; Morrison TB, 1999, J CLIN MICROBIOL, V37, P987, DOI 10.1128/JCM.37.4.987-992.1999; Narasimhan S, 2002, J BACTERIOL, V184, P3122, DOI 10.1128/JB.184.11.3122-3125.2002; Nichols TL, 2000, FEMS MICROBIOL LETT, V183, P37, DOI 10.1111/j.1574-6968.2000.tb08930.x; Ojaimi C, 2005, INFECT IMMUN, V73, P6791, DOI 10.1128/IAI.73.10.6791-6802.2005; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Oliva G, 2015, FEMS MICROBIOL REV, V39, P331, DOI 10.1093/femsre/fuv022; Ostberg Y, 2004, J BACTERIOL, V186, P8472, DOI 10.1128/JB.186.24.8472-8477.2004; Pang YLJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku945; Papenfort K, 2015, FEMS MICROBIOL REV, V39, P362, DOI 10.1093/femsre/fuv016; Pappas CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002102; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramamoorthy R, 2005, J BACTERIOL, V187, P2592, DOI 10.1128/JB.187.8.2592-2600.2005; Ramamoorthy R, 1998, INFECT IMMUN, V66, P5119, DOI 10.1128/IAI.66.11.5119-5124.1998; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Rhodes RG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-108; Rogers EA, 2009, MOL MICROBIOL, V71, P1551, DOI 10.1111/j.1365-2958.2009.06621.x; Salman-Dilgimen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022168; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Savage CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125440; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Shishkin AA, 2015, NAT METHODS, V12, P323, DOI [10.1038/NMETH.3313, 10.1038/nmeth.3313]; Smith AH, 2007, J BACTERIOL, V189, P2139, DOI 10.1128/JB.01653-06; Stevenson B, 2001, SPIROCHETES: MOLECULAR AND CELLULAR BIOLOGY, P87; STEVENSON B, 1995, INFECT IMMUN, V63, P4535, DOI 10.1128/IAI.63.11.4535-4539.1995; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Wang YJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1555-8; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14; Zhang HM, 2005, J BACTERIOL, V187, P7985, DOI 10.1128/JB.187.23.7985-7995.2005; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0; Zuckert Wolfram R, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c01s4	88	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164165	10.1371/journal.pone.0164165	http://dx.doi.org/10.1371/journal.pone.0164165			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706236	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200092
J	Reuter, L; Ritala, A; Linder, M; Joensuu, J				Reuter, Lauri; Ritala, Anneli; Linder, Markus; Joensuu, Jussi			Novel Hydrophobin Fusion Tags for Plant-Produced Fusion Proteins	PLOS ONE			English	Article							TRICHODERMA-REESEI; RECOMBINANT PROTEINS; NICOTIANA-BENTHAMIANA; 2-PHASE SYSTEMS; BODY FORMATION; PURIFICATION; HFBI; EXPRESSION; CELLS	Hydrophobin fusion technology has been applied in the expression of several recombinant proteins in plants. Until now, the technology has relied exclusively on the Trichoderma reesei hydrophobin HFBI. We screened eight novel hydrophobin tags, T. reesei HFBII, HFBIII, HFBIV, HFBV, HFBVI and Fusarium verticillioides derived HYD3, HYD4 and HYD5, for production of fusion proteins in plants and purification by two-phase separation. To study the properties of the hydrophobins, we used N-terminal and C-terminal GFP as a fusion partner. Transient expression of the hydrophobin fusions in Nicotiana benthamiana revealed large variability in accumulation levels, which was also reflected in formation of protein bodies. In two-phase separations, only HFBII and HFBIV were able to concentrate GFP into the surfactant phase from a plant extract. The separation efficiency of both tags was comparable to HFBI. When the accumulation was tested side by side, HFBII-GFP gave a better yield than HFBI-GFP, while the yield of HFBIV-GFP remained lower. Thus we present here two alternatives for HFBI as functional fusion tags for plant-based protein production and first step purification.	[Reuter, Lauri; Ritala, Anneli; Linder, Markus; Joensuu, Jussi] VTT Tech Res Ctr Finland Ltd, Espoo, Finland; [Linder, Markus] Aalto Univ, Dept Biotechnol & Chem Technol, Espoo, Finland	VTT Technical Research Center Finland; Aalto University	Reuter, L (corresponding author), VTT Tech Res Ctr Finland Ltd, Espoo, Finland.	lauri.reuter@vtt.fi	Linder, Markus B/E-5879-2011; Linder, Markus/N-8043-2019	Linder, Markus B/0000-0002-7271-6441; Linder, Markus/0000-0002-7271-6441	Academy of Finland [252442]; Centres of Excellence Programme HYBER; Eurostars grant Hydropro [5320]; VTT Technical Research Centre of Finland Ltd.	Academy of Finland(Academy of Finland); Centres of Excellence Programme HYBER; Eurostars grant Hydropro; VTT Technical Research Centre of Finland Ltd.	We have received funding from Academy of Finland Grant number 252442 (AR LR JJ) and Centres of Excellence Programme HYBER (JJ ML) (http://www.aka.fi/) and Eurostars grant Hydropro 5320 (JJ) (www.eurostars-eureka.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors are, or have been, employed by VTT Technical research Centre of Finland. VTT Technical Research Centre of Finland Ltd., provided support in the form of salaries for authors [LR, AR, ML, JJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P419, DOI 10.1111/j.1467-7652.2011.00596.x; Cox AR, 2009, FOOD HYDROCOLLOID, V23, P366, DOI 10.1016/j.foodhyd.2008.03.001; Espino-Rammer L, 2013, APPL ENVIRON MICROB, V79, P4230, DOI 10.1128/AEM.01132-13; Fuchs U, 2004, FUNGAL GENET BIOL, V41, P852, DOI 10.1016/j.fgb.2004.04.004; Gutierrez SP, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-40; Phan HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099347; Jacquet N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115944; Joensuu JJ, 2012, METHODS MOL BIOL, V824, P527, DOI 10.1007/978-1-61779-433-9_28; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; Kisko K, 2007, J APPL CRYSTALLOGR, V40, pS355, DOI 10.1107/S0021889807001331; Lahtinen T, 2008, PROTEIN EXPRES PURIF, V59, P18, DOI 10.1016/j.pep.2007.12.014; Lienemann M, 2013, APPL ENVIRON MICROB, V79, P5533, DOI 10.1128/AEM.01493-13; Linder M, 2002, PROTEIN SCI, V11, P2257, DOI 10.1110/ps.0207902; Linder M, 2001, BIOMACROMOLECULES, V2, P511, DOI 10.1021/bm0001493; Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004; Linder MB, 2004, BIOCHEMISTRY-US, V43, P11873, DOI 10.1021/bi0488202; Miletic S, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01221; NakariSetala T, 1996, EUR J BIOCHEM, V235, P248, DOI 10.1111/j.1432-1033.1996.00248.x; NakariSetala T, 1997, EUR J BIOCHEM, V248, P415, DOI 10.1111/j.1432-1033.1997.00415.x; Pereira EO, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-59; Reuter LJ, 2014, PLANT BIOTECHNOL J, V12, P402, DOI 10.1111/pbi.12147; Saberianfar R, 2015, PLANT BIOTECHNOL J, V13, P927, DOI 10.1111/pbi.12329; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003; Valo HK, 2010, ACS NANO, V4, P1750, DOI 10.1021/nn9017558; Varjonen S, 2011, SOFT MATTER, V7, P2402, DOI 10.1039/c0sm01114b	26	12	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164032	10.1371/journal.pone.0164032	http://dx.doi.org/10.1371/journal.pone.0164032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706254	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697200076
J	Hayano, T; Matsui, H; Nakaoka, H; Ohtake, N; Hosomichi, K; Suzuki, K; Inoue, I				Hayano, Takahide; Matsui, Hiroshi; Nakaoka, Hirofumi; Ohtake, Nobuaki; Hosomichi, Kazuyoshi; Suzuki, Kazuhiro; Inoue, Ituro			Germline Variants of Prostate Cancer in Japanese Families	PLOS ONE			English	Article							SMALL-CELL CARCINOMA; SUSCEPTIBILITY LOCI; SOMATIC MUTATIONS; BRCA2 MUTATIONS; BREAST-CANCER; DISCOVERY; GENOME; GENES; FRAMEWORK; HOXB13	Prostate cancer (PC) is the second most common cancer in men. Family history is the major risk factor for PC. Only two susceptibility genes were identified in PC, BRCA2 and HOXB13. A comprehensive search of germline variants for patients with PC has not been reported in Japanese families. In this study, we conducted exome sequencing followed by Sanger sequencing to explore responsible germline variants in 140 Japanese patients with PC from 66 families. In addition to known susceptibility genes, BRCA2 and HOXB13, we identified TRRAP variants in a mutually exclusive manner in seven large PC families (three or four patients per family). We also found shared variants of BRCA2, HOXB13, and TRRAP from 59 additional small PC families (two patients per family). We identified two deleterious HOXB13 variants (F127C and G132E). Further exploration of the shared variants in rest of the families revealed deleterious variants of the so-called cancer genes (ATP1A1, BRIP1, FANCA, FGFR3, FLT3, HOXD11, MUTYH, PDGFRA, SMARCA4, and TCF3). The germline variant profile provides a new insight to clarify the genetic etiology and heterogeneity of PC among Japanese men.	[Hayano, Takahide; Nakaoka, Hirofumi; Inoue, Ituro] Natl Inst Genet, Div Human Genet, Mishima, Shizuoka, Japan; [Matsui, Hiroshi; Ohtake, Nobuaki; Suzuki, Kazuhiro] Gunma Univ, Grad Sch Med, Dept Urol, Maebashi, Gunma, Japan; [Hosomichi, Kazuyoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Bioinformat & Genom, Kanazawa, Ishikawa 9201192, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Gunma University; Kanazawa University	Inoue, I (corresponding author), Natl Inst Genet, Div Human Genet, Mishima, Shizuoka, Japan.	itinoue@nig.ac.jp	Hosomichi, Kazuyoshi/K-9477-2015	Hosomichi, Kazuyoshi/0000-0003-2712-1825; Nakaoka, Hirofumi/0000-0002-8454-1159				Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Bourdeaut F, 2013, AM J MED GENET A, V161A, P382, DOI 10.1002/ajmg.a.35719; Cavanagh H, 2015, HERED CANCER CLIN PR, V13, DOI 10.1186/s13053-015-0038-x; Choi DH, 2004, J CLIN ONCOL, V22, P1638, DOI 10.1200/JCO.2004.04.179; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Ellingson MS, 2015, BREAST CANCER RES TR, V153, P435, DOI 10.1007/s10549-015-3545-6; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fu W, 2015, NATURE, V493, P216; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; GLEASON DF, 1992, HUM PATHOL, V23, P273, DOI 10.1016/0046-8177(92)90108-F; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Higasa K, 2016, J HUM GENET, V61, P547, DOI 10.1038/jhg.2016.12; Hirotsu Y, 2015, MOL GENET GENOM MED, V3, P121, DOI 10.1002/mgg3.120; Hjelmborg JB, 2014, CANCER EPIDEM BIOMAR, V23, P2303, DOI 10.1158/1055-9965.EPI-13-0568; Hoffmann TJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004930; Hu N, 2004, ONCOGENE, V23, P852, DOI 10.1038/sj.onc.1207150; Katanoda K, 2015, JPN J CLIN ONCOL, V45, P390, DOI 10.1093/jjco/hyv002; Kicinski M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027130; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Leongamornlert D, 2014, BRIT J CANCER, V110, P1663, DOI 10.1038/bjc.2014.30; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin XL, 2013, PROSTATE, V73, P169, DOI 10.1002/pros.22552; Maia S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132728; Marugame T, 2006, JPN J CLIN ONCOL, V36, P399, DOI 10.1093/jjco/hyl049; Matsui H, 2004, J HUM GENET, V49, P9, DOI 10.1007/s10038-003-0099-y; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moorman AV, 2016, HAEMATOLOGICA, V101, P407, DOI 10.3324/haematol.2015.141101; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018; Postow MA, 2012, CLIN SARCOMA RES, V2, DOI 10.1186/2045-3329-2-16; Ramos P, 2014, NAT GENET, V46, P427, DOI 10.1038/ng.2928; Raval SH, 2016, VET WORLD, V9, P80, DOI 10.14202/vetworld.2016.80-90; Robinson PN, 2014, GENOME RES, V24, P340, DOI 10.1101/gr.160325.113; Shyr C, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0064-y; Smedley D, 2015, NAT PROTOC, V10, P2004, DOI 10.1038/nprot.2015.124; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Taketani T, 2002, CANCER RES, V62, P33; Tan A, 2015, BIOINFORMATICS, V31, P2202, DOI 10.1093/bioinformatics/btv112; Wang J, 2016, J BREAST CANCER, V19, P61, DOI 10.4048/jbc.2016.19.1.61; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Witkowski L, 2014, NAT GENET, V46, P438, DOI 10.1038/ng.2931; Yamaguchi-Kabata Yumi, 2015, Hum Genome Var, V2, P15050, DOI 10.1038/hgv.2015.50	50	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164233	10.1371/journal.pone.0164233	http://dx.doi.org/10.1371/journal.pone.0164233			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701467	Green Submitted, gold, Green Published			2022-12-27	WOS:000385696900052
J	Jain, CV; Jessmon, P; Kilburn, BA; Jodar, M; Sendler, E; Krawetz, SA; Armant, DR				Jain, Chandni V.; Jessmon, Philip; Kilburn, Brian A.; Jodar, Meritxell; Sendler, Edward; Krawetz, Stephen A.; Armant, D. Randall			Regulation of HBEGF by Micro-RNA for Survival of Developing Human Trophoblast Cells	PLOS ONE			English	Article							GROWTH-FACTOR; PROTEIN-SYNTHESIS; POSTTRANSCRIPTIONAL REGULATION; MESSENGER-RNA; GENE-EXPRESSION; BINDING; PREECLAMPSIA; PHOSPHORYLATION; TRANSLATION; BIOGENESIS	Introduction The growth factor HBEGF is upregulated post-transcriptionally in the low O-2 environment of the human placenta during the first 10 weeks of pregnancy. We have examined the possible roles of HBEGF turnover and micro-RNA (miRNA) in its regulation by O-2 in human first trimester trophoblast. Methods HTR-8/SVneo trophoblast cells were cultured at 2% or 20% O-2. The cells were transfected with a dual luciferase reporter construct (psiCHECK-2) containing no insert (control), the HBEGF 3' untranslated region (3' UTR), or sub-regions of the 3' UTR, as well as with siRNA for DGCR8. RNA was extracted from trophoblast cells cultured at 2% O-2 for 0-4 h for next-generation sequencing. HBEGF was quantified by ELISA. HBEGF, DGCR8, and beta-actin were examined by western blotting. Results Protein turnover studies, using 10 mu g/ml cyclohexamide, 1 mu g/ml lactocystin, or 100 mu g/ml MG132, demonstrated faster HBEGF degradation at 20% O-2 than 2% O-2, mediated by the proteasome. However, proteasome inhibition failed to initiate HBEGF accumulation at 20% O-2. Reporter assays, comparing to empty vector, demonstrated that the intact HBEGF 3' UTR inhibited expression (0.26), while fragments containing only its flanking regions increased reporter activity (3.15; 3.43). No differential expression of miRNAs was found in trophoblast cells cultured at 2% and 20% O-2. Nevertheless, HBEGF upregulation at 2% O-2 was blocked when the miRNA-processing protein DGCR8 was silenced, suggesting a role for miRNA. Conclusion Our findings suggest involvement of flanking regions of the 3'UTR in activating HBEGF protein synthesis in response to 2% O-2, possibly through a miRNA-mediated mechanism.	[Jain, Chandni V.; Jessmon, Philip] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Jain, Chandni V.; Kilburn, Brian A.; Jodar, Meritxell; Sendler, Edward; Krawetz, Stephen A.; Armant, D. Randall] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Jessmon, Philip; Armant, D. Randall] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Jodar, Meritxell; Sendler, Edward; Krawetz, Stephen A.] Wayne State Univ, Sch Med, Dept Ctr Mol Med & Genet, Detroit, MI USA; [Armant, D. Randall] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, US Dept HHS, Bethesda, MD 20892 USA	Wayne State University; Wayne State University; Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Armant, DR (corresponding author), Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA.; Armant, DR (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.; Armant, DR (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Reprod & Adult Endocrinol, NIH, US Dept HHS, Bethesda, MD 20892 USA.	d.armant@wayne.edu	krawetz, stephen/GQQ-3308-2022; Jodar, Meritxell/F-1961-2016	Jodar, Meritxell/0000-0002-3272-0163	NICHD NIH HHS [R21 HD071408] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Adams BD, 2009, ENDOCRINOLOGY, V150, P14, DOI 10.1210/en.2008-0984; Allaire AD, 2000, OBSTET GYNECOL, V96, P271, DOI 10.1016/S0029-7844(00)00895-4; Armant DR, 2015, PLACENTA, V36, P270, DOI 10.1016/j.placenta.2014.12.006; Armant DR, 2006, DEVELOPMENT, V133, P751, DOI 10.1242/dev.02237; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baudouin-Legros M, 2005, AM J PHYSIOL-CELL PH, V289, pC1240, DOI 10.1152/ajpcell.00595.2004; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chao A, 2010, CANCER LETT, V291, P99, DOI 10.1016/j.canlet.2009.10.005; De Baets G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002090; DiFederico E, 1999, AM J PATHOL, V155, P293, DOI 10.1016/S0002-9440(10)65123-1; Donker RB, 2007, MOL HUM REPROD, V13, P273, DOI 10.1093/molehr/gam006; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gsponer J, 2012, CELL REP, V2, P1425, DOI 10.1016/j.celrep.2012.09.036; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hentze MW, 2013, EMBO J, V32, P923, DOI 10.1038/emboj.2013.53; Horman SR, 2013, MOL CELL, V50, P356, DOI 10.1016/j.molcel.2013.03.015; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Iwasaki S, 2010, MOL CELL, V39, P292, DOI 10.1016/j.molcel.2010.05.015; Jessmon P, 2010, BIOL REPROD, V82, P921, DOI 10.1095/biolreprod.109.082305; Jessmon P, 2009, MOL REPROD DEV, V76, P1116, DOI 10.1002/mrd.21066; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kilburn BA, 2000, BIOL REPROD, V62, P739, DOI 10.1095/biolreprod62.3.739; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Koritzinsky M, 2005, RADIOTHER ONCOL, V76, P177, DOI 10.1016/j.radonc.2005.06.036; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Leach RE, 1999, J CLIN ENDOCR METAB, V84, P3355, DOI 10.1210/jc.84.9.3355; Leach RE, 2004, DEV BIOL, V266, P223, DOI 10.1016/j.ydbio.2003.09.026; Leach RE, 2002, LANCET, V360, P1215, DOI 10.1016/S0140-6736(02)11283-9; Leach RE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.009; Legewie S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.29; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mouillet JF, 2011, BIRTH DEFECTS RES A, V91, P737, DOI 10.1002/bdra.20782; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pang ALY, 2009, BIOL REPROD, V81, P302, DOI 10.1095/biolreprod.108.073221; Pang RTK, 2010, CARCINOGENESIS, V31, P1037, DOI 10.1093/carcin/bgq066; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phelps ED, 2006, AM J PHYSIOL-CELL PH, V290, pC352, DOI 10.1152/ajpcell.00050.2005; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Shiohama A, 2003, BIOCHEM BIOPH RES CO, V304, P184, DOI 10.1016/S0006-291X(03)00554-0; Soyensen BS, 2006, EXP CELL RES, V312, P3651, DOI 10.1016/j.yexcr.2006.08.007; Spruce T, 2010, DEV CELL, V19, P207, DOI 10.1016/j.devcel.2010.07.014; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Yoo HJ, 1997, DEV GENET, V21, P102, DOI 10.1002/(SICI)1520-6408(1997)21:1<102::AID-DVG12>3.0.CO;2-C; Yukawa K, 1999, MOL BRAIN RES, V69, P124, DOI 10.1016/S0169-328X(99)00086-8; Zhao W, 2008, J BIOL CHEM, V283, P1778, DOI 10.1074/jbc.M707573200; Zhu XM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.002	70	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163913	10.1371/journal.pone.0163913	http://dx.doi.org/10.1371/journal.pone.0163913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701455	Green Submitted, gold, Green Published			2022-12-27	WOS:000385696900031
J	Lee, HJ; Kim, SJ				Lee, Haeng Jin; Kim, Seong-Joon			Factors Associated with Visual Fatigue from Curved Monitor Use: A Prospective Study of Healthy Subjects	PLOS ONE			English	Article							TRANSIENT MYOPIA; 3D DISPLAYS; DRY EYE; ASTHENOPIA; ACCOMMODATION; PUPILLARY; SYMPTOMS; NEARWORK	Purpose To investigate the factors associated with visual fatigue using monitors with various radii of curvature. Methods Twenty normal healthy adults (8 men, 12 women; mean age, 26.2 +/- 2.5 years) prospectively watched five types of monitors including flat, 4000R, 3000R, 2000R, and 1000R curved monitors for 30 min. An experienced examiner measured the ophthalmological factors including near point of accommodation (NPA), near point of convergence (NPC), refraction, parameters during pupil response at light and saccadic movement just before and after the visual tasks. The questionnaires about subjective ocular symptoms were also investigated just before and after the visual tasks. Results The NPA increased after the visual tasks with a flat monitor compared with the curved monitors, with the 1000R curved monitor showing the smallest change (p = 0.020). The NPC increased for every monitor after the visual tasks; the largest increase occurred with the flat monitor (p = 0.001). There was no difference in refractive error, pupil response, or saccadic movement in the comparison of before and after the visual tasks. Among the nine factors in the questionnaire, the score of "eyepain" was significantly higher for the flat monitor versus the 1000R curved monitor after the visual tasks (p = 0.034). Conclusions We identified NPA, NPC, and eye pain as factors associated with visual fatigue. Also, the curvature of the monitor was related to the visual fatigue.	[Lee, Haeng Jin; Kim, Seong-Joon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Kim, Seong-Joon] Seoul Natl Univ Hosp, Clin Res Inst, Seoul Artificial Eye Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, SJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.; Kim, SJ (corresponding author), Seoul Natl Univ Hosp, Clin Res Inst, Seoul Artificial Eye Ctr, Seoul, South Korea.	ophjun@snu.ac.kr						Butzon Steve P, 2002, Optometry, V73, P221; Byron Jones MGK, 2003, DESIGN ANAL CROSS OV; Ciuffreda KJ, 2008, OPHTHAL PHYSL OPT, V28, P103, DOI 10.1111/j.1475-1313.2008.00550.x; CIUFFREDA KJ, 1995, OPTOMETRY VISION SCI, V72, P506, DOI 10.1097/00006324-199507000-00011; DAIN SJ, 1988, AM J OPTOM PHYS OPT, V65, P162; EHRLICH DL, 1987, OPHTHAL PHYSL OPT, V7, P353, DOI 10.1111/j.1475-1313.1987.tb00760.x; GUR S, 1994, OCCUP MED-OXFORD, V44, P201, DOI 10.1093/occmed/44.4.201; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; HIKICHI T, 1995, GRAEF ARCH CLIN EXP, V233, P555, DOI 10.1007/BF00404705; Iwasaki T, 2002, OPHTHAL PHYSL OPT, V22, P113, DOI 10.1046/j.1475-1313.2002.00014.x; IWASAKI T, 1988, ERGONOMICS, V31, P1743, DOI 10.1080/00140138808966825; Matsuda T, 2008, JPN J OPHTHALMOL, V52, P79, DOI 10.1007/s10384-007-0515-5; Salibello C, 1995, J Am Optom Assoc, V66, P479; Scheiman M, 1996, J Am Optom Assoc, V67, P531; Schlote T, 2004, GRAEF ARCH CLIN EXP, V242, P306, DOI 10.1007/s00417-003-0845-z; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; Shimmura S, 1999, CORNEA, V18, P408, DOI 10.1097/00003226-199907000-00003; Thomson WD, 1998, OPHTHAL PHYSL OPT, V18, P111, DOI 10.1016/S0275-5408(97)00067-7; TODA I, 1993, ACTA OPHTHALMOL, V71, P347, DOI 10.1111/j.1755-3768.1993.tb07146.x; Wee SW, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-29; Wee SW, 2012, BRIT J OPHTHALMOL, V96, P1391, DOI 10.1136/bjophthalmol-2012-301690	21	6	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164022	10.1371/journal.pone.0164022	http://dx.doi.org/10.1371/journal.pone.0164022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701441	Green Published, Green Submitted, gold			2022-12-27	WOS:000385696900039
J	Sasson, I				Sasson, Isaac			Diverging Trends in Cause-Specific Mortality and Life Years Lost by Educational Attainment: Evidence from United States Vital Statistics Data, 1990-2010	PLOS ONE			English	Article							US ADULT MORTALITY; SOCIOECONOMIC-STATUS; RECORD LINKAGE; AGE; EXPECTANCY; COHORT; DEATH; DIFFERENTIALS; ASSOCIATION; GRADIENTS	Background Life expectancy at birth in the United States will likely surpass 80 years in the coming decade. Yet recent studies suggest that longevity gains are unevenly shared across age and socioeconomic groups. First, mortality in midlife has risen among non-Hispanic whites. Second, low-educated whites have suffered stalls (men) or declines (women) in adult life expectancy, which is significantly lower than among their college-educated counterparts. Estimating the number of life years lost or gained by age and cause of death, broken down by educational attainment, is crucial in identifying vulnerable populations. Methods and Findings Using U.S. vital statistics data from 1990 to 2010, this study decomposes the change in life expectancy at age 25 by age and cause of death across educational attainment groups, broken down by race and gender. The findings reveal that mortality in midlife increased for white women (and to a lesser extent men) with 12 or fewer years of schooling, accounting for most of the stalls or declines in adult life expectancy observed in those groups. Among blacks, mortality declined in nearly all age and educational attainment groups. Although an educational gradient was found across multiple causes of death, between 60 and 80 percent of the gap in adult life expectancy was explained by cardiovascular diseases, smoking-related diseases, and external causes of death. Furthermore, the number of life years lost to smoking-related, external, and other causes of death increased among low-and high school-educated whites, explaining recent stalls or declines in longevity. Conclusions Large segments of the American population D particularly low- and high school-educated whites under age 55 D are diverging from their college-educated counterparts and losing additional years of life to smoking-related diseases and external causes of death. If this trend continues, old-age mortality may also increase for these birth cohorts in the coming decades.	[Sasson, Isaac] Tel Aviv Univ, Dept Sociol & Anthropol, IL-6997801 Tel Aviv, Israel	Tel Aviv University	Sasson, I (corresponding author), Tel Aviv Univ, Dept Sociol & Anthropol, IL-6997801 Tel Aviv, Israel.	isasson@tauex.tau.ac.il	Sasson, Isaac/AAU-6704-2021	Sasson, Isaac/0000-0001-7033-9497				Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Alperovitch A, 2009, EUR J EPIDEMIOL, V24, P669, DOI 10.1007/s10654-009-9383-2; Andersen PK, 2013, DEMOGR RES, V29, P1127, DOI 10.4054/DemRes.2013.29.41; Arias E, 2010, AM J PUBLIC HEALTH, V100, pS171, DOI 10.2105/AJPH.2008.135863; ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Backlund E, 1999, SOC SCI MED, V49, P1373, DOI 10.1016/S0277-9536(99)00209-9; Behrman JR, 2011, DEMOGRAPHY, V48, P1347, DOI 10.1007/s13524-011-0052-1; Bell FC, 2005, ACTUARIAL STUDY 120; Bound J, 2015, HEALTH AFFAIR, V34, P2167, DOI 10.1377/hlthaff.2015.0481; Brown DC, 2012, DEMOGRAPHY, V49, P819, DOI 10.1007/s13524-012-0104-1; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Disease Control and Prevention, VIT STAT DAT AV ONL; Cutler David M, 2010, J Health Econ, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Dowd JB, 2009, INT J EPIDEMIOL, V38, P1297, DOI 10.1093/ije/dyp277; Dupre ME, 2009, AM J EPIDEMIOL, V170, P546, DOI 10.1093/aje/kwp194; Edwards RD, 2005, POPUL DEV REV, V31, P645, DOI 10.1111/j.1728-4457.2005.00092.x; Everett BG, 2013, POPUL RES POLICY REV, V32, P893, DOI 10.1007/s11113-013-9299-0; Fenelon A, 2013, SOC SCI MED, V82, P1, DOI 10.1016/j.socscimed.2012.12.028; Gelman A, 2016, P NATL ACAD SCI USA, V113, pE816, DOI 10.1073/pnas.1523465113; Hayward MD, 2015, SOC SCI MED, V127, P8, DOI 10.1016/j.socscimed.2014.11.024; Hayward MD, 2004, DEMOGRAPHY, V41, P87, DOI 10.1353/dem.2004.0005; Hendi AS, 2015, INT J EPIDEMIOL, V44, P946, DOI 10.1093/ije/dyv062; Hill ME, 2000, DEMOGRAPHY, V37, P175, DOI 10.2307/2648119; Ho JY, 2015, J HEALTH SOC BEHAV, V56, P307, DOI 10.1177/0022146515592731; Hou F, 2008, CAN J SOCIOL, V33, P337; Hummer Robert A, 2013, Popul Bull, V68, P1; Hummer RA, 2011, INT HANDB POPUL, V2, P241, DOI 10.1007/978-90-481-9996-9_12; Keyfitz N, 2005, APPL MATH DEMOGRAPHY, DOI [10.1007/978-1-4757-1879-9, DOI 10.1007/978-1-4757-1879-9]; Lariscy JT, 2011, J AGING HEALTH, V23, P1263, DOI 10.1177/0898264311421369; Lleras-Muney A, 2005, REV ECON STUD, V72, P189, DOI 10.1111/0034-6527.00329; Ma JW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046096, 10.1371/journal.pone.0041560]; Masters RK, 2012, AM SOCIOL REV, V77, P548, DOI 10.1177/0003122412451019; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Miech R, 2011, AM SOCIOL REV, V76, P913, DOI 10.1177/0003122411411276; Montez JK, 2016, HEALTH AFFAIR, V35, P550, DOI 10.1377/hlthaff.2016.0132; Montez JK, 2013, AM J PUBLIC HEALTH, V103, P473, DOI 10.2105/AJPH.2012.301128; Montez JK, 2012, DEMOGRAPHY, V49, P315, DOI 10.1007/s13524-011-0082-8; Montez JK, 2011, RES AGING, V33, P145, DOI 10.1177/0164027510392388; Murphy SL, 2013, NATL VITAL STAT REP, P61; Olshansky SJ, 2012, HEALTH AFFAIR, V31, P1803, DOI 10.1377/hlthaff.2011.0746; Pampel FC, 2009, SOC PROBL, V56, P526, DOI 10.1525/sp.2009.56.3.526; Preston SH, 2006, DEMOGRAPHY, V43, P631, DOI 10.1353/dem.2006.0037; PRESTON SH, 1995, J AGING HEALTH, V7, P476, DOI 10.1177/089826439500700402; Preston SH, 2000, DEMOGRAPHY MEASURING, DOI [10.2307/1535065, DOI 10.2307/1535065]; Rogers RG, 2013, SOC SCI RES, V42, P465, DOI 10.1016/j.ssresearch.2012.09.003; Rostron Brian L, 2010, Vital Health Stat 2, P1; Ruggles S., 2010, INTEGRATED PUBLIC US, DOI DOI 10.18128/D010.V6.0; Sasson I, 2016, DEMOGRAPHY, V53, P269, DOI 10.1007/s13524-015-0453-7; Shkolnikov VM, 2007, SOC SCI MED, V64, P1392, DOI 10.1016/j.socscimed.2006.11.014; Sirin SR, 2005, REV EDUC RES, V75, P417, DOI 10.3102/00346543075003417; Sorlie PD, 1996, EPIDEMIOLOGY, V7, P437, DOI 10.1097/00001648-199607000-00017; Tinetti ME, 2012, J AM GERIATR SOC, V60, P1448, DOI 10.1111/j.1532-5415.2012.04077.x; World Health Organization, 2004, INT STAT CLASS DIS R; Yang Y, 2008, DEMOGRAPHY, V45, P387, DOI 10.1353/dem.0.0000	54	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163412	10.1371/journal.pone.0163412	http://dx.doi.org/10.1371/journal.pone.0163412			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701419	Green Submitted, Green Published, gold			2022-12-27	WOS:000385696900006
J	Suriyanarayanan, T; Periasamy, S; Lin, MH; Ishihama, Y; Swarup, S				Suriyanarayanan, Tanujaa; Periasamy, Saravanan; Lin, Miao-Hsia; Ishihama, Yasushi; Swarup, Sanjay			Flagellin FliC Phosphorylation Affects Type 2 Protease Secretion and Biofilm Dispersal in Pseudomonas aeruginosa PAO1	PLOS ONE			English	Article							III SECRETION; SER/THR/TYR PHOSPHOPROTEOME; SYSTEMS; GENE; PILI; ATTACHMENT; EXPRESSION; RESISTANCE; PEPTIDES; PROTEINS	Protein phosphorylation has a major role in controlling the life-cycle and infection stages of bacteria. Proteome-wide occurrence of S/T/Y phosphorylation has been reported for many prokaryotic systems. Previously, we reported the phosphoproteome of Pseudomonas aeruginosa and Pseudomonas putida. In this study, we show the role of S/T phosphorylation of one motility protein, FliC, in regulating multiple surface-associated phenomena of P. aeruginosa PAO1. This is the first report of occurrence of phosphorylation in the flagellar protein, flagellin FliC in its highly conserved N-terminal NDO domain across several Gram negative bacteria. This phosphorylation is likely a well-regulated phenomenon as it is growth phase dependent in planktonic cells. The absence of phosphorylation in the conserved T27 and S28 residues of FliC, interestingly, did not affect swimming motility, but affected the secretome of type 2 secretion system (T2SS) and biofilm formation of PAO1. FliC phosphomutants had increased levels and activities of type 2 secretome proteins. The secretion efficiency of T2SS machinery is associated with flagellin phosphorylation. FliC phosphomutants also formed reduced biofilms at 24 h under static conditions and had delayed biofilm dispersal under dynamic flow conditions, respectively. The levels of type 2 secretome and biofilm formation under static conditions had an inverse correlation. Hence, increase in type 2 secretome levels was accompanied by reduced biofilm formation in the FliC phosphomutants. As T2SS is involved in nutrient acquisition and biofilm dispersal during survival and spread of P. aeruginosa, we propose that FliC phosphorylation has a role in ecological adaptation of this opportunistic environmental pathogen. Altogether, we found a system of phosphorylation that affects key surface related processes such as proteases secretion by T2SS, biofilm formation and dispersal.	[Suriyanarayanan, Tanujaa; Swarup, Sanjay] Natl Univ Singapore, Metabolites Biol Lab, Dept Biol Sci, Singapore, Singapore; [Suriyanarayanan, Tanujaa] Natl Univ Singapore, Microbiol Lab, Fac Dent, Singapore, Singapore; [Swarup, Sanjay] Natl Univ Singapore, NERI, Singapore, Singapore; [Periasamy, Saravanan; Swarup, Sanjay] Nanyang Technol Univ, SCELSE, Singapore, Singapore; [Swarup, Sanjay] Natl Univ Singapore, Synthet Biol Clin & Technol Innovat SynCTI, Ctr Life Sci, Singapore, Singapore; [Periasamy, Saravanan] Rajalakshmi Engn Coll, Madras, Tamil Nadu, India; [Lin, Miao-Hsia; Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Bioanal, Kyoto, Japan	National University of Singapore; National University of Singapore; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Rajalakshmi Engineering College; Kyoto University	Swarup, S (corresponding author), Natl Univ Singapore, Metabolites Biol Lab, Dept Biol Sci, Singapore, Singapore.; Swarup, S (corresponding author), Natl Univ Singapore, NERI, Singapore, Singapore.; Swarup, S (corresponding author), Nanyang Technol Univ, SCELSE, Singapore, Singapore.; Swarup, S (corresponding author), Natl Univ Singapore, Synthet Biol Clin & Technol Innovat SynCTI, Ctr Life Sci, Singapore, Singapore.	sanjay@nus.edu.sg	Ishihama, Yasushi/B-3101-2016; Swarup, Sanjay/I-1592-2012; periasamy, saravanan/AAF-2860-2020	Ishihama, Yasushi/0000-0001-7714-203X; Swarup, Sanjay/0000-0001-6391-0624; 	Mechanobiology Institute (MBI), National University of Singapore, Singapore [R714-010-006-271]	Mechanobiology Institute (MBI), National University of Singapore, Singapore(National University of Singapore)	This work was supported by grant number R714-010-006-271 from Mechanobiology Institute (MBI), National University of Singapore, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beatson SA, 2006, TRENDS MICROBIOL, V14, P151, DOI 10.1016/j.tim.2006.02.008; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7; Crawford RW, 2010, J BACTERIOL, V192, P2981, DOI 10.1128/JB.01620-09; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Deutscher J, 2005, J MOL MICROB BIOTECH, V9, P125, DOI 10.1159/000089641; FLETCHER EL, 1993, CURR EYE RES, V12, P1067, DOI 10.3109/02713689309033504; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Ha UH, 2004, MOL MICROBIOL, V54, P307, DOI 10.1111/j.1365-2958.2004.04282.x; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; Jarrell KF, 2011, FEMS MICROBIOL LETT, V319, P44, DOI 10.1111/j.1574-6968.2011.02264.x; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Komoriya K, 1999, MOL MICROBIOL, V34, P767, DOI 10.1046/j.1365-2958.1999.01639.x; Kuang ZZ, 2011, MOL MICROBIOL, V79, P1220, DOI 10.1111/j.1365-2958.2010.07516.x; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Kyono Y, 2008, J PROTEOME RES, V7, P4585, DOI 10.1021/pr800305y; Lee KWK, 2014, ISME J, V8, P894, DOI 10.1038/ismej.2013.194; Lemon KP, 2015, CURR TOP MICROBIOL I, V322, P1, DOI [10.1007/978-3-540-75418-3, DOI 10.1007/978-3-540-75418-3_1]; Levine A, 2006, PROTEOMICS, V6, P2157, DOI 10.1002/pmic.200500352; Lin MH, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa3117; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Macek B, 2011, PROTEOMICS, V11, P3002, DOI 10.1002/pmic.201100012; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; MORIHARA K, 1965, J BIOL CHEM, V240, P3295; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Ravichandran A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123805; Ravichandran A, 2009, PROTEOMICS, V9, P2764, DOI 10.1002/pmic.200800655; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Robert V, 2005, FEMS MICROBIOL LETT, V252, P43, DOI 10.1016/j.femsle.2005.08.029; Robert V, 2005, RES MICROBIOL, V156, P880, DOI 10.1016/j.resmic.2005.04.002; Saier MH, 2006, J MEMBRANE BIOL, V214, P75, DOI 10.1007/s00232-006-0049-7; Senf F, 2008, MICROBIOL-SGM, V154, P3025, DOI 10.1099/mic.0.2008/018069-0; Soscia C, 2007, J BACTERIOL, V189, P3124, DOI 10.1128/JB.01677-06; Soufi B, 2008, PROTEOMICS, V8, P3486, DOI 10.1002/pmic.200800069; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Sternberg Claus, 2006, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b02s00; Sun XS, 2010, J PROTEOME RES, V9, P275, DOI 10.1021/pr900612v; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Van Houdt R, 2005, RES MICROBIOL, V156, P626, DOI 10.1016/j.resmic.2005.02.005; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830	54	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164155	10.1371/journal.pone.0164155	http://dx.doi.org/10.1371/journal.pone.0164155			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701473	gold, Green Published, Green Submitted			2022-12-27	WOS:000385696900046
J	Nunes, IKD; de Souza, ET; Cardozo, SVS; Carvalho, VD; Romeiro, NC; Silva, PMRE; Martins, MA; Barreiro, EJ; Lima, LM				da Costa Nunes, Isabelle Karine; de Souza, Everton Tenorio; Cardozo, Suzana Vanessa S.; Carvalho, Vinicius de Frias; Romeiro, Nelilma Correia; Rodrigues e Silva, Patricia Machado; Martins, Marco Aurelio; Barreiro, Eliezer J.; Lima, Lidia Moreira			Synthesis, Pharmacological Profile and Docking Studies of New Sulfonamides Designed as Phosphodiesterase-4 Inhibitors	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SWISS-MODEL WORKSPACE; PDE4 INHIBITORS; AIRWAY INFLAMMATION; DRUG DISCOVERY; ASTHMA; EOSINOPHILS; POTENT; SELECTIVITY; STRATEGY	Prior investigations showed that increased levels of cyclic AMP down-regulate lung inflammatory changes, stimulating the interest in phosphodiesterase (PDE) 4 as therapeutic target. Here, we described the synthesis, pharmacological profile and docking properties of a novel sulfonamide series (5 and 6a-k) designed as PDE4 inhibitors. Compounds were screened for their selectivity against the four isoforms of human PDE4 using an IMAP fluorescence polarized protocol. The effect on allergen-or LPS-induced lung inflammation and airway hyperreactivity (AHR) was studied in A/J mice, while the xylazine/ketamine-induced anesthesia test was employed as a behavioral correlate of emesis in rodents. As compared to rolipram, the most promising screened compound, 6a (LASSBio-448) presented a better inhibitory index concerning PDE4D/PDE4A or PDE4D/PDE4B. Accordingly, docking analyses of the putative interactions of LASSBio-448 revealed similar poses in the active site of PDE4A and PDE4C, but slight unlike orientations in PDE4B and PDE4D. LASSBio-448 (100 mg/kg, oral), 1 h before provocation, inhibited allergen-induced eosinophil accumulation in BAL fluid and lung tissue samples. Under an interventional approach, LASSBio-448 reversed ongoing lung eosinophilic infiltration, mucus exacerbation, peribronchiolar fibrosis and AHR by allergen provocation, in a mechanism clearly associated with blockade of pro-inflammatory mediators such as IL-4, IL-5, IL-13 and eotaxin-2. LASSBio-448 (2.5 and 10 mg/kg) also prevented inflammation and AHR induced by LPS. Finally, the sulfonamide derivative was shown to be less pro-emetic than rolipram and cilomilast in the assay employed. These findings suggest that LASSBio-448 is a new PDE4 inhibitor with marked potential to prevent and reverse pivotal pathological features of diseases characterized by lung inflammation, such as asthma.	[da Costa Nunes, Isabelle Karine; Carvalho, Vinicius de Frias; Romeiro, Nelilma Correia; Rodrigues e Silva, Patricia Machado; Martins, Marco Aurelio; Barreiro, Eliezer J.; Lima, Lidia Moreira] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Farmacos & Medicamento, Lab Avaliacao & Sintese Subst Bioat LASSBio, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [da Costa Nunes, Isabelle Karine; de Souza, Everton Tenorio; Cardozo, Suzana Vanessa S.; Rodrigues e Silva, Patricia Machado; Martins, Marco Aurelio; Barreiro, Eliezer J.; Lima, Lidia Moreira] Univ Fed Rio de Janeiro, Programa Posgrad Farmacol & Quim Med, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [de Souza, Everton Tenorio; Cardozo, Suzana Vanessa S.; Carvalho, Vinicius de Frias; Rodrigues e Silva, Patricia Machado; Martins, Marco Aurelio] Inst Oswaldo Cruz Fiocruz, Lab Inflamacao, Rio De Janeiro, Brazil; [Romeiro, Nelilma Correia] Univ Fed Rio de Janeiro, Nucl Pesquisas Ecol & Desenvolvimento Social Maca, Macae, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Martins, MA; Lima, LM (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Farmacos & Medicamento, Lab Avaliacao & Sintese Subst Bioat LASSBio, Inst Ciencias Biomed, Rio De Janeiro, Brazil.; Martins, MA; Lima, LM (corresponding author), Univ Fed Rio de Janeiro, Programa Posgrad Farmacol & Quim Med, Inst Ciencias Biomed, Rio De Janeiro, Brazil.; Martins, MA (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Inflamacao, Rio De Janeiro, Brazil.	mam2856@gmail.com; lidia@lassbio.icb.ufrj.br	Lima, Lidia M/D-9587-2015; Carvalho, Vinicius F/M-4762-2016; Barreiro, Eliezer J/B-1131-2011; SILVA, PATRICIA MACHADO RODRIGUES E/AAS-4906-2020	Lima, Lidia M/0000-0002-8625-6351; Barreiro, Eliezer J/0000-0003-1759-0038; 	CNPq; FAPERJ; FAPEAL; CAPES; INCT-INOFAR [573.564/2008-6, E-26/170.020/2008]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPEAL(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT-INOFAR	This work was supported by CNPq, FAPERJ, FAPEAL, CAPES, and INCT-INOFAR (573.564/2008-6 and E-26/170.020/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARCO A, 1973, SYNTHESIS-STUTTGART, P316; Bateman ED, 2006, ANN ALLERG ASTHMA IM, V96, P679, DOI 10.1016/S1081-1206(10)61065-4; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Card GL, 2005, NAT BIOTECHNOL, V23, P201, DOI 10.1038/nbt1059; Cheng R.K.Y., 2009, Crystal structure of human PDE4a with 4-(3-butoxy-4-methoxyphenyl)methyl-2- imidazolidone, DOI [10.2210/pdb3i8v/pdb, DOI 10.2210/PDB3I8V/PDB]; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Chung KF, 2012, CURR OPIN PULM MED, V18, P35, DOI 10.1097/MCP.0b013e32834d09a5; Coelho LP, 2008, J PHARMACOL EXP THER, V327, P206, DOI 10.1124/jpet.108.138032; Nunes IKC, 2014, CURR TOP MED CHEM, V14, P1388, DOI 10.2174/1568026614666140506123718; DeNinno MP, 2012, BIOORG MED CHEM LETT, V22, P6794, DOI 10.1016/j.bmcl.2012.09.028; Ferreira TPT, 2013, J IMMUNOL, V191, P5220, DOI 10.4049/jimmunol.1203551; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Gewald R, 2013, BIOORG MED CHEM LETT, V23, P4308, DOI 10.1016/j.bmcl.2013.05.099; Giembycz MA, 2001, EXPERT OPIN INV DRUG, V10, P1361, DOI 10.1517/13543784.10.7.1361; Hirano S, 1996, AM J PHYSIOL-LUNG C, V270, pL836, DOI 10.1152/ajplung.1996.270.5.L836; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; Kobayashi M, 2011, INT IMMUNOPHARMACOL, V11, P732, DOI 10.1016/j.intimp.2011.01.023; Kodimuthali A, 2008, J MED CHEM, V51, P5471, DOI 10.1021/jm800582j; Lima L M, 1999, Pharm Acta Helv, V73, P281, DOI 10.1016/S0031-6865(99)00004-7; Lima LMA, 2005, CURR MED CHEM, V12, P23, DOI 10.2174/0929867053363540; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Montana JG, 1998, BIOORG MED CHEM LETT, V8, P2635, DOI 10.1016/S0960-894X(98)00491-0; Moretto N, 2015, J PHARMACOL EXP THER, V352, P559, DOI 10.1124/jpet.114.220541; Nag SS, 2003, J ALLERGY CLIN IMMUN, V111, P558, DOI 10.1067/mai.2003.131; Nials AT, 2011, J PHARMACOL EXP THER, V337, P137, DOI 10.1124/jpet.110.173641; Niu MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082360; O'Byrne PM, 2013, CAN RESPIR J, V20, P23, DOI 10.1155/2013/183948; Olsen PC, 2011, CLIN EXP ALLERGY, V41, P250, DOI 10.1111/j.1365-2222.2010.03580.x; Olsen PC, 2012, EUR J PHARMACOL, V680, P102, DOI 10.1016/j.ejphar.2012.01.040; Page CP, 2014, INT ARCH ALLERGY IMM, V165, P152, DOI 10.1159/000368800; Patel M, 2015, CHRON RESP DIS, V12, P165, DOI 10.1177/1479972315573529; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Reddel HK, 2015, EUR RESPIR J, V46, P622, DOI 10.1183/13993003.00853-2015; Robichaud A, 2002, J CLIN INVEST, V110, P1045, DOI 10.1172/JCI200215506; Robichaud A, 2002, BRIT J PHARMACOL, V135, P113, DOI 10.1038/sj.bjp.0704457; Robichaud A, 2001, NEUROPHARMACOLOGY, V40, P262, DOI 10.1016/S0028-3908(00)00142-8; Saglani S, 2015, EUR RESPIR J, V46, P1796, DOI 10.1183/13993003.01196-2014; Serra MF, 2016, ANESTHESIOLOGY, V124, P109, DOI 10.1097/ALN.0000000000000919; Serra MF, 2012, ANESTHESIOLOGY, V117, P580, DOI 10.1097/ALN.0b013e31826687d5; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; STRATH M, 1985, J IMMUNOL METHODS, V83, P209, DOI 10.1016/0022-1759(85)90242-X; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Villetti G, 2015, J PHARMACOL EXP THER, V352, P568, DOI 10.1124/jpet.114.220558; Walsh ER, 2010, DISCOV MED, V9, P357; Wang HC, 2007, BIOCHEM J, V408, P193, DOI 10.1042/BJ20070970; Wills-Karp M, 2004, SCIENCE, V305, P1726, DOI 10.1126/science.1104134	51	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162895	10.1371/journal.pone.0162895	http://dx.doi.org/10.1371/journal.pone.0162895			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695125	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100017
J	Gerdle, B; Ernberg, M; Mannerkorpi, K; Larsson, B; Kosek, E; Christidis, N; Ghafouri, B				Gerdle, Bjorn; Ernberg, Malin; Mannerkorpi, Kaisa; Larsson, Britt; Kosek, Eva; Christidis, Nikolaos; Ghafouri, Bijar			Increased Interstitial Concentrations of Glutamate and Pyruvate in Vastus Lateralis of Women with Fibromyalgia Syndrome Are Normalized after an Exercise Intervention - A Case-Control Study	PLOS ONE			English	Article							MUSCLE BLOOD-FLOW; CHRONIC WIDESPREAD PAIN; TRAPEZIUS MUSCLE; SKELETAL-MUSCLE; NITRIC-OXIDE; LACTATE CONCENTRATIONS; MASSETER MUSCLE; REGIONAL PAIN; MICRODIALYSIS; METABOLISM	Background Fibromyalgia syndrome (FMS) is associated with central alterations, but controversies exist regarding the presence and role of peripheral factors. Microdialysis (MD) can be used in vivo to study muscle alterations in FMS. Furthermore for chronic pain conditions such as FMS, the mechanisms for the positive effects of exercise are unclear. This study investigates the interstitial concentrations of algesics and metabolites in the vastus lateralis muscle of 29 women with FMS and 28 healthy women before and after an exercise intervention. Methods All the participants went through a clinical examination and completed a questionnaire. In addition, their pressure pain thresholds (PPTs) in their upper and lower extremities were determined. For both groups, MD was conducted in the vastus lateralis muscle before and after a 15-week exercise intervention of mainly resistance training of the lower limbs. Muscle blood flow and interstitial muscle concentrations of lactate, pyruvate, glutamate, glucose, and glycerol were determined. Results FMS was associated with significantly increased interstitial concentrations of glutamate, pyruvate, and lactate. After the exercise intervention, the FMS group exhibited significant decreases in pain intensity and in mean interstitial concentrations of glutamate, pyruvate, and glucose. The decrease in pain intensity in FMS correlated significantly with the decreases in pyruvate and glucose. In addition, the FMS group increased their strength and endurance. Conclusion This study supports the suggestion that peripheral metabolic and algesic muscle alterations are present in FMS patients and that these alterations contribute to pain. After an exercise intervention, alterations normalized, pain intensity decreased (but not abolished), and strength and endurance improved, all findings that suggest the effects of exercise are partially peripheral.	[Gerdle, Bjorn; Larsson, Britt; Ghafouri, Bijar] Linkoping Univ, Pain & Rehabil Ctr, Linkoping, Sweden; [Gerdle, Bjorn; Larsson, Britt; Ghafouri, Bijar] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Ernberg, Malin; Christidis, Nikolaos] Karolinska Inst, Dept Dent Med, Sect Orofacial Pain & Jaw Funct, Stockholm, Sweden; [Ernberg, Malin; Christidis, Nikolaos] SCON, Stockholm, Sweden; [Mannerkorpi, Kaisa] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Sect Physiotherapy, Gothenburg, Sweden; [Mannerkorpi, Kaisa] Univ Gothenburg, Sahlgrenska Acad, Ctr Person Ctr Care GPCC, Gothenburg, Sweden; [Kosek, Eva] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Kosek, Eva] Karolinska Inst, Osher Ctr Integrat Med, Stockholm, Sweden	Linkoping University; Linkoping University; Karolinska Institutet; University of Gothenburg; University of Gothenburg; Karolinska Institutet; Karolinska Institutet	Gerdle, B (corresponding author), Linkoping Univ, Pain & Rehabil Ctr, Linkoping, Sweden.; Gerdle, B (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden.	bjorn.gerdle@liu.se	Ernberg, Malin/AAR-5588-2020; Christidis, Nikolaos/AAB-7471-2020	Christidis, Nikolaos/0000-0002-8199-7863; Kosek, Eva/0000-0003-0488-8177; Mannerkorpi, Kaisa/0000-0003-4997-9523	Swedish Rheumatism Association; Swedish Research Council; Health and Medical Care Executive Board of Vastra Gotaland Region; ALF-LUA at Sahlgrenska University Hospital and Linkbping University Hospital, Linkbping University, Gothenburg Centre for Person Centred Care (GPCC); AFA Insurance	Swedish Rheumatism Association; Swedish Research Council(Swedish Research CouncilEuropean Commission); Health and Medical Care Executive Board of Vastra Gotaland Region; ALF-LUA at Sahlgrenska University Hospital and Linkbping University Hospital, Linkbping University, Gothenburg Centre for Person Centred Care (GPCC); AFA Insurance	This work was funded by the Swedish Rheumatism Association, the Swedish Research Council, the Health and Medical Care Executive Board of Vastra Gotaland Region, ALF-LUA at Sahlgrenska University Hospital and Linkbping University Hospital, Linkbping University, Gothenburg Centre for Person Centred Care (GPCC) and AFA Insurance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AH, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0379-y; Alfredson H, 2001, J ORTHOPAED RES, V19, P881, DOI 10.1016/S0736-0266(01)00016-X; Allen M, 2011, PEDIATR CRIT CARE ME, V12, pS43, DOI 10.1097/PCC.0b013e3182211aed; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Bazzichi L, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-36; Benarroch EE, 2011, NEUROLOGY, V77, P1568, DOI 10.1212/WNL.0b013e318233b3e4; BENGTSSON A, 1986, SCAND J RHEUMATOL, V15, P1; Bengtsson A, 2002, RHEUMATOLOGY, V41, P721, DOI 10.1093/rheumatology/41.7.721; Bennett RM, 1999, MAYO CLIN PROC, V74, P385, DOI 10.4065/74.4.385; Birdsong WT, 2010, NEURON, V68, P739, DOI 10.1016/j.neuron.2010.09.029; Birklein F, 2000, NEUROLOGY, V55, P1213, DOI 10.1212/WNL.55.8.1213; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bradley Laurence A, 2009, Am J Med, V122, pS22, DOI 10.1016/j.amjmed.2009.09.008; Brodin E, 2008, SCAND J UROL NEPHROL, V42, P293, DOI 10.1080/00365590701797556; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Busch A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003786.pub2; Busch AJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010884; Cairns BE, 2008, J MUSCULOSKELET PAIN, V16, P85, DOI 10.1080/10582450801960388; Chalaye P, 2012, CLIN J PAIN, V28, P519, DOI 10.1097/AJP.0b013e31823ae69e; Coggeshall RE, 1998, J COMP NEUROL, V391, P78; Cury Y, 2011, NITRIC OXIDE-BIOL CH, V25, P243, DOI 10.1016/j.niox.2011.06.004; Das UN, 2006, NUTRITION, V22, P965, DOI 10.1016/j.nut.2006.05.009; Cruz RSD, 2012, SCI WORLD J, DOI 10.1100/2012/420984; de Paoli FV, 2010, J PHYSIOL-LONDON, V588, P4785, DOI 10.1113/jphysiol.2010.196568; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Draoui N, 2011, DIS MODEL MECH, V4, P727, DOI 10.1242/dmm.007724; Eisenhut M, 2011, PFLUG ARCH EUR J PHY, V461, P401, DOI 10.1007/s00424-010-0917-y; Elert J, 2001, J RHEUMATOL, V28, P1361; Elvin A, 2006, EUR J PAIN, V10, P137, DOI 10.1016/j.ejpain.2005.02.001; Eriksson L., 2006, MULTI MEGAVARIATE DA, V2nd, DOI DOI 10.1016/j.arabjc.2013.10.006; Ernberg M, 1999, LIFE SCI, V65, P313, DOI 10.1016/S0024-3205(99)00250-7; Ernberg M, 2013, EUR J PAIN, V17, P539, DOI 10.1002/j.1532-2149.2012.00216.x; Falla D, 2010, J ELECTROMYOGR KINES, V20, P457, DOI 10.1016/j.jelekin.2009.07.002; Fan WG, 2012, NITRIC OXIDE-BIOL CH, V26, P32, DOI 10.1016/j.niox.2011.11.003; Fink MP, 2007, J INTERN MED, V261, P349, DOI 10.1111/j.1365-2796.2007.01789.x; Gerdle B, 2013, EUR J PAIN, V17, P1205, DOI 10.1002/j.1532-2149.2013.00284.x; Gerdle B, 2012, POTENTIAL MUSCLE BIO; Gerdle B, 2014, J PAIN RES, V7, P313, DOI 10.2147/JPR.S59144; Gerdle B, 2014, CLIN J PAIN, V30, P409, DOI 10.1097/AJP.0b013e31829e9d2a; Gerdle B, 2010, J REHABIL MED, V42, P679, DOI 10.2340/16501977-0581; Gerdle B, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-42; Ghafouri N, 2014, PAIN MED, V15, P1379, DOI 10.1111/pme.12486; Ghafouri N, 2013, PAIN, V154, P1649, DOI 10.1016/j.pain.2013.05.002; Gjedsted J, 2011, ACTA PHYSIOL, V202, P641, DOI 10.1111/j.1748-1716.2011.02316.x; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Hannibal KE, 2014, PHYS THER, V94, P1816, DOI 10.2522/ptj.20130597; Hassett AL, 2011, BEST PRACT RES CL RH, V25, P299, DOI 10.1016/j.berh.2011.01.005; Herren-Gerber R, 2004, PAIN MED, V5, P366, DOI 10.1111/j.1526-4637.2004.04055.x; HICKNER RC, 1994, CLIN SCI, V86, P15, DOI 10.1042/cs0860015; Hurley BF, 2011, SPORTS MED, V41, P289, DOI 10.2165/11585920-000000000-00000; Immke D C, 2001, ScientificWorldJournal, V1, P510; Jansen JJ, 2012, METABOLOMICS, V8, P422, DOI 10.1007/s11306-011-0316-1; Jensen KB, 2012, NEUROSCI LETT, V520, P156, DOI 10.1016/j.neulet.2012.03.010; Jensen KB, 2009, PAIN, V144, P95, DOI 10.1016/j.pain.2009.03.018; Kallenborn-Gerhardt W, 2012, NOXIOUS SIGNALING PA; Kao KK, 2010, BIOCHEM PHARMACOL, V80, P151, DOI 10.1016/j.bcp.2010.03.007; Karlsson L, 2015, EUR J PAIN, V19, P1075, DOI 10.1002/ejp.630; Kim TJ, 2007, J PAIN, V8, P59, DOI 10.1016/j.jpain.2006.06.003; Kosek E, 1996, PAIN, V64, P415, DOI 10.1016/0304-3959(95)00112-3; Kristensen J, 2012, BRIT J SPORT MED, V46, P719, DOI 10.1136/bjsm.2010.079376; Kulshreshtha P, 2013, CLIN PHYSIOL FUNCT I, V33, P83, DOI 10.1111/cpf.12000; Lam David K, 2005, Pain Res Manag, V10, P145; Lannersten L, 2010, PAIN, V151, P77, DOI 10.1016/j.pain.2010.06.021; Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349; Lanza IR, 2010, PFLUG ARCH EUR J PHY, V459, P277, DOI 10.1007/s00424-009-0724-5; Lanza IR, 2009, AM J CLIN NUTR, V89, p467S, DOI 10.3945/ajcn.2008.26717D; Larsson A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0679-1; Lee Y, 2005, MOL CELLS, V20, P315; Leggin B G, 1996, J Shoulder Elbow Surg, V5, P18, DOI 10.1016/S1058-2746(96)80026-7; Louca S, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-89; LUND N, 1986, SCAND J RHEUMATOL, V15, P165, DOI 10.3109/03009748609102084; Mannerkorpi K, 1999, ARTHRIT CARE RES, V12, P193, DOI 10.1002/1529-0131(199906)12:3<193::AID-ART6>3.0.CO;2-N; Mannerkorpi K, 2009, J REHABIL MED, V41, P751, DOI 10.2340/16501977-0409; Mantyselka P, 2008, RHEUMATOLOGY, V47, P1235, DOI 10.1093/rheumatology/ken220; Mantyselka P, 2008, PAIN, V137, P34, DOI 10.1016/j.pain.2007.08.007; McIver KL, 2006, PAIN, V120, P161, DOI 10.1016/j.pain.2005.10.032; Miller KE, 2011, PHARMACOL THERAPEUT, V130, P283, DOI 10.1016/j.pharmthera.2011.01.005; NORREGAARD J, 1994, J NEUROL NEUROSUR PS, V57, P1106, DOI 10.1136/jnnp.57.9.1106; Oaklander AL, 2013, PAIN, V154, P2310, DOI 10.1016/j.pain.2013.06.001; Olausson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052560; Ortega E, 2009, EXERC IMMUNOL REV, V15, P42; Palstam A, 2014, J REHABIL MED, V46, P773, DOI 10.2340/16501977-1843; Park JH, 1998, ARTHRITIS RHEUM, V41, P406, DOI 10.1002/1529-0131(199803)41:3<406::AID-ART5>3.3.CO;2-C; Peolsson M, 2007, J REHABIL MED, V39, P260, DOI 10.2340/16501977-0052; Petersel DL, 2011, J NEUROSCI RES, V89, P29, DOI 10.1002/jnr.22512; Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961; Pohjanen E, 2007, J PROTEOME RES, V6, P2113, DOI 10.1021/pr070007g; Pollak KA, 2014, EXP PHYSIOL, V99, P368, DOI 10.1113/expphysiol.2013.075812; Ren G, 2009, EUR SPINE J, V18, P1604, DOI 10.1007/s00586-009-1021-x; Robergs RA, 2004, AM J PHYSIOL-REG I, V287, pR502, DOI 10.1152/ajpregu.00114.2004; Sandberg M, 2004, EUR J PAIN, V8, P163, DOI 10.1016/S1090-3801(03)00090-9; Schaible HG, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3305; Schaufelberger M, 1997, EUR HEART J, V18, P971; SCHELLER D, 1991, J NEUROSCI METH, V40, P31, DOI 10.1016/0165-0270(91)90114-F; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Schneider GM, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-29; Serra J, 2014, ANN NEUROL, V75, P196, DOI 10.1002/ana.24065; Shang Y, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4079; Sjogaard G, 2010, EUR J APPL PHYSIOL, V108, P657, DOI 10.1007/s00421-009-1268-2; Sjors A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-230; Smith HS, 2011, PAIN PHYSICIAN, V14, pE217; Stallknecht B, 1999, J APPL PHYSIOL, V86, P1054, DOI 10.1152/jappl.1999.86.3.1054; Staud R, 2008, J MUSCULOSKELET PAIN, V16, P67, DOI 10.1080/10582450801960339; Staud R, 2011, BEST PRACT RES CL RH, V25, P155, DOI 10.1016/j.berh.2010.01.010; Staud R, 2010, J PAIN, V11, P1376, DOI 10.1016/j.jpain.2010.03.011; Staud R, 2009, PAIN, V145, P96, DOI 10.1016/j.pain.2009.05.020; Steiger F, 2012, EUR SPINE J, V21, P575, DOI 10.1007/s00586-011-2045-6; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; Tegeder I, 2002, INFLAMM RES, V51, P393, DOI 10.1007/PL00000320; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Valkeinen H, 2006, ARTHRITIS RHEUM, V54, P1334, DOI 10.1002/art.21751; van Hall G, 2010, ACTA PHYSIOL, V199, P499, DOI 10.1111/j.1748-1716.2010.02122.x; Waelgaard L, 2006, SCAND J IMMUNOL, V64, P345, DOI 10.1111/j.1365-3083.2006.01826.x; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zhang YJ, 2013, PAIN MED, V14, P1291, DOI 10.1111/pme.12158; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	116	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162010	10.1371/journal.pone.0162010	http://dx.doi.org/10.1371/journal.pone.0162010			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695113	Green Submitted, gold, Green Published			2022-12-27	WOS:000385553100010
J	Jerczynski, O; Lacroix-Pepin, N; Boilard, E; Calvo, E; Bernet, A; Fortier, MA; Bjorkgren, I; Sipila, P; Belleannee, C				Jerczynski, Olivia; Lacroix-Pepin, Nicolas; Boilard, Eric; Calvo, Ezequiel; Bernet, Agathe; Fortier, Michel A.; Bjorkgren, Ida; Sipila, Petra; Belleannee, Clemence			Role of Dicer1-DependentFactors in the Paracrine Regulation of Epididymal Gene Expression	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; INTERCELLULAR COMMUNICATION; MICRORNA BIOGENESIS; SPERM; PROSTASOMES; SED1/MFG-E8; SPERMATOZOA; POPULATION; SECRETION; MEMBRANE	Dicer1 is an endoribonuclease involved in the biogenesis of functional molecules such as microRNAs (miRNAs) and endogenous small interfering RNAs (endo-siRNAs). These small non-coding RNAs are important regulators of post-transcriptional gene expression and participate in the control of male fertility. With the knowledge that 1) Dicer1-dependent factors are required for proper sperm maturation in the epididymis, and that 2) miRNAs are potent mediators of intercellular communication in most biological systems, we investigated the role of Dicer1-dependent factors produced by the proximal epididymis (initial segment/caput)-including miRNAs-on the regulation of epididymal gene expression in the distal epididymis regions (i.e. corpus and cauda). To this end, we performed comparative microarray and ANOVA analyses on control vs. Defb41(iCre/wt); Dicer1(fl/fl) mice in which functional Dicer1 is absent from the principal cells of the proximal epididymis. We identified 35 and 33 transcripts that displayed significant expression level changes in the corpus and cauda regions (Fold change > 2 or < -2; p < 0.002), respectively. Among these transcripts, Zn-alpha 2-glycoprotein (Azgp1) encodes for a sperm equatorial protein whose expression in the epididymis of Dicer1 cKO mice is significantly increased compared to controls. In addition, 154 miRNAs, including miR-210, miR-672, miR-191 and miR-204, showed significantly impaired biogenesis in the absence of Dicer1 from the principal cells of the proximal epididymis (Fold change > 2 or < -2; p < 0.01). These miRNAs are secreted via extracellular vesicles (EVs) derived from the DC2 epididymal principal cell line, and their expression correlates with target transcripts involved in distinct biological pathways, as evidenced by in silico analysis. Albeit correlative and based on in silico approach, our study proposes that Dicer1-dependent factors trigger-directly or not-significant genes expression changes in distinct regions of this organ. The paracrine control of functions important to post-testicular sperm maturation by Dicer1-dependent factors may open new avenues for the identification of molecular targets important to male fertility control.	[Jerczynski, Olivia; Lacroix-Pepin, Nicolas; Bernet, Agathe; Fortier, Michel A.; Belleannee, Clemence] Univ Laval, Dept Obstet Gynecol & Reprod, CHU Quebec Res Ctr CHUL, Quebec City, PQ, Canada; [Boilard, Eric] Univ Laval, Dept Immun & Infect Dis, CHU Quebec Res Ctr CHUL, Quebec City, PQ, Canada; [Calvo, Ezequiel] CHU Quebec Res Ctr CHUL, Endocrinol Unit, Quebec City, PQ, Canada; [Bjorkgren, Ida] Univ Turku, Inst Biomed, Dept Physiol, Turku, Finland; [Sipila, Petra] Univ Turku, Turku Ctr Dis Modeling, Turku, Finland; [Bjorkgren, Ida] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA USA	Laval University; Laval University; Laval University; University of Turku; University of Turku; University of California System; University of California Berkeley	Belleannee, C (corresponding author), Univ Laval, Dept Obstet Gynecol & Reprod, CHU Quebec Res Ctr CHUL, Quebec City, PQ, Canada.	Clemence.Belleannee@crchudequebec.ulaval.ca	Sipilä, Petra/GYE-3323-2022	Sipila, Petra/0000-0001-8187-7143; Bjorkgren, Ida/0000-0001-6678-2672	NSERC [CG109194, CG81470]; Centre de Recherche en Developpement et Sante Inter-generationnelle (CRDSI) scholarship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre de Recherche en Developpement et Sante Inter-generationnelle (CRDSI) scholarship	This work was supported by NSERC discovery grants CG109194 (to C.B) and CG81470 (to MAF). OJ is recipient of a Centre de Recherche en Developpement et Sante Inter-generationnelle (CRDSI) scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2002, J ANDROL, V23, P854; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belleannee C, 2013, BIOL REPROD, DOI [10.1095/bioireprod.113.110486, DOI 10.1095/BIOIREPROD.113.110486]; Belleannee C, 2013, HUM REPROD, V28, P1455, DOI 10.1093/humrep/det088; Belleannee C, 2012, CELL TISSUE RES, V349, P717, DOI 10.1007/s00441-012-1381-0; Belleannee C, 2010, AM J PHYSIOL-CELL PH, V298, pC817, DOI 10.1152/ajpcell.00460.2009; Bjorkgren I, 2015, FASEB J, V29, P433, DOI 10.1096/fj.14-259382; Bjorkgren I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038457; Boon RA, 2013, ARTERIOSCL THROM VAS, V33, P186, DOI 10.1161/ATVBAHA.112.300139; Borisenko GG, 2004, CELL DEATH DIFFER, V11, P943, DOI 10.1038/sj.cdd.4401421; Caballero J, 2012, J CELL PHYSIOL, V227, P3876, DOI 10.1002/jcp.24099; Caballero JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065364; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Cloutier N, 2013, EMBO MOL MED, V5, P235, DOI 10.1002/emmm.201201846; Comazzetto S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004597; Cooper TG, 1996, ANDROLOGIA, V28, P57; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; D'Amours O, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100990; Ding ZD, 2007, MOL REPROD DEV, V74, P1124, DOI 10.1002/mrd.20624; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Girouard J, 2011, INT J ANDROL, V34, pE475, DOI 10.1111/j.1365-2605.2011.01203.x; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hermo L, 2002, MOL REPROD DEV, V63, P394, DOI 10.1002/mrd.90023; Hoog JL, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28680; Hubert A, 2015, JAIDS-J ACQ IMM DEF, V70, P219, DOI 10.1097/QAI.0000000000000756; Jerczynski O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163876; Juang BT, 2013, CELL, V154, P1010, DOI 10.1016/j.cell.2013.08.006; Kaur Gurvinder, 2012, Spermatogenesis, V2, P1; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Krapf D, 2012, DEV BIOL, V369, P43, DOI 10.1016/j.ydbio.2012.06.017; Liu X, 2012, CELL CYCLE, V11, P2495, DOI 10.4161/cc.20898; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Mello CC, 2007, ANGEW CHEM INT EDIT, V46, P6985, DOI 10.1002/anie.200701713; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Nixon B, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132209; Nixon B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135605; Orgebin-Crist M. C., 1969, Biology of Reproduction Suppl, VNo.1, P155, DOI 10.1095/biolreprod1.Supplement_1.155; Osteikoetxea X, 2015, ORG BIOMOL CHEM, V13, P9775, DOI 10.1039/c5ob01451d; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajesh A, 2015, J REPROD IMMUNOL, V110, P117, DOI 10.1016/j.jri.2015.02.009; Raymond A, 2009, J CELL BIOCHEM, V106, P957, DOI 10.1002/jcb.22076; Raymond AS, 2010, MOL REPROD DEV, V77, P550, DOI 10.1002/mrd.21189; Rejraji H, 2006, BIOL REPROD, V74, P1104, DOI 10.1095/biolreprod.105.049304; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; Ronquist G, 2012, J INTERN MED, V271, P400, DOI 10.1111/j.1365-2796.2011.02487.x; Ronquist GK, 2012, PROSTATE, V72, P1736, DOI 10.1002/pros.22526; Rousseau M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116812; Ruan YC, 2012, J PHYSIOL-LONDON, V590, P4209, DOI 10.1113/jphysiol.2012.230581; Rybak-Wolf A, 2014, CELL, V159, P1153, DOI 10.1016/j.cell.2014.10.040; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Shelke GV, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24783; Shrimal S, 2013, J CELL SCI, V126, P5513, DOI 10.1242/jcs.139584; Shur BD, 2004, CURR OPIN CELL BIOL, V16, P477, DOI 10.1016/j.ceb.2004.07.005; Sullivan R, 2015, ASIAN J ANDROL, V17, P726, DOI 10.4103/1008-682X.155255; Sullivan R, 2013, REPRODUCTION, V146, pR21, DOI 10.1530/REP-13-0058; Suryawanshi AR, 2012, J ANDROL, V33, P963, DOI 10.2164/jandrol.111.014753; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Turunen HT, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-128; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Varkonyi-Gasic E, 2010, METHODS MOL BIOL, V631, P109, DOI 10.1007/978-1-60761-646-7_10; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu JW, 2014, P NATL ACAD SCI USA, V111, pE2851, DOI 10.1073/pnas.1407777111; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yuan SQ, 2016, DEVELOPMENT, V143, P635, DOI 10.1242/dev.131755; Zimmermann C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107023	71	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163876	10.1371/journal.pone.0163876	http://dx.doi.org/10.1371/journal.pone.0163876			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695046	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100060
J	Magalhaes, A; Matias, I; Palmela, I; Brito, MA; Dias, S				Magalhaes, Ana; Matias, Ines; Palmela, Ines; Brito, Maria Alexandra; Dias, Sergio			LDL-Cholesterol Increases the Transcytosis of Molecules through Endothelial Monolayers	PLOS ONE			English	Article							VASCULAR-PERMEABILITY; ALZHEIMERS-DISEASE; BARRIER FUNCTION; METASTASIS; KINASE; ATHEROSCLEROSIS; DYSFUNCTION; ACTIVATION; INTEGRITY; PATHWAYS	Cholesterol has been identified as a causative factor in numerous pathologies including atherosclerosis and cancer. One of the frequent effects of elevated cholesterol levels in humans is the compromise of endothelial function due to activation of pro-inflammatory signalling pathways. While the mechanisms involved in endothelial activation by cholesterol during an inflammatory response are well established, less is known about the mechanisms by which cholesterol may affect endothelial barrier function, which were the subject of the present study. Here we show that low density lipoprotein (LDL) increases the permeability of endothelial monolayers to high molecular weight dextrans in an LDL receptor and cholesterol-dependent manner. The increased permeability seen upon LDL treatment was not caused by disruption of cell-to-cell junctions as determined by a normal localization of VE-Cadherin and ZO-1 proteins, and no major alterations in transendothelial electrical resistance or permeability to fluorescein. We show instead that LDL increases the level of high molecular weight transcytosis and that this occurs in an LDL receptor, cholesterol and caveolae-dependent way. Our findings contribute to our understanding of the systemic pathological effects of elevated cholesterol and the transport of cargo through endothelial monolayers.	[Magalhaes, Ana; Matias, Ines; Dias, Sergio] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal; [Palmela, Ines; Brito, Maria Alexandra] Univ Lisbon, Fac Med, Res Inst Med, Lisbon, Portugal; [Brito, Maria Alexandra] Univ Lisbon, Fac Farm, Dept Biochem & Human Biol, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Dias, S (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.	sergiodias@fm.ul.pt	brito, maria/M-8278-2013; iMed.ULisboa, NeuronGliaBiol/B-5403-2014; brito, maria/HDO-2541-2022; Dias, Sergio/L-1250-2014	brito, maria/0000-0002-8493-4649; Dias, Sergio/0000-0002-7603-4616; Magalhaes, Ana/0000-0001-9929-3218	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Government; FCT [SFRH/BPD/73691/2010, SFRH/BD/61646/2009]	Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Government; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was supported by Fundacao para a Ciencia e Tecnologia (FCT) of the Portuguese Government A. Magalhaes and Ines Palmela were recipients of FCT fellowships (SFRH/BPD/73691/2010 and SFRH/BD/61646/2009, respectivelly). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; dos Santos CR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-132; dos Santos CR, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-16; Essler M, 1999, J BIOL CHEM, V274, P30361, DOI 10.1074/jbc.274.43.30361; Garcia-Roman J, 2013, CANCER LETT, V335, P259, DOI 10.1016/j.canlet.2013.03.005; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Han JY, 2013, BLOOD, V122, P4140, DOI 10.1182/blood-2013-03-491423; Jiang X., 2012, INT J ALZHEIMERS DIS, V2012, P109324, DOI DOI 10.1155/2012/109324; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; LIAO LX, 1995, ARTERIOSCL THROM VAS, V15, P2305, DOI 10.1161/01.ATV.15.12.2305; Monaghan-Benson E, 2011, METHODS MOL BIOL, V763, P281, DOI 10.1007/978-1-61779-191-8_19; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Notarnicola M, 2005, ONCOLOGY-BASEL, V68, P371, DOI 10.1159/000086977; Orr AW, 2007, J CELL BIOL, V176, P719, DOI 10.1083/jcb.200609008; Rangaswamy S, 1997, CIRC RES, V80, P37, DOI 10.1161/01.RES.80.1.37; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Stancu CS, 2012, CELL TISSUE RES, V349, P433, DOI 10.1007/s00441-012-1437-1; Veszelka S, 2007, NEUROCHEM INT, V50, P219, DOI 10.1016/j.neuint.2006.08.006; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Zhu Y, 2000, ARTERIOSCL THROM VAS, V20, P2465, DOI 10.1161/01.ATV.20.11.2465; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	27	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163988	10.1371/journal.pone.0163988	http://dx.doi.org/10.1371/journal.pone.0163988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695052	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100073
J	Vaganay, A				Vaganay, Arnaud			Outcome Reporting Bias in Government Sponsored Policy Evaluations: A Qualitative Content Analysis of 13 Studies	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; PUBLISHED PRIMARY OUTCOMES; CLINICAL-TRIALS; EMPIRICAL-EVIDENCE; SUBGROUP ANALYSES; RESEARCH ETHICS; SPIN; PUBLICATION; GUIDELINES; PREVALENCE	The reporting of evaluation outcomes can be a point of contention between evaluators and policy-makers when a given reform fails to fulfil its promises. Whereas evaluators are required to report outcomes in full, policy-makers have a vested interest in framing these outcomes in a positive light-especially when they previously expressed a commitment to the reform. The current evidence base is limited to a survey of policy evaluators, a study on reporting bias in education research and several studies investigating the influence of industry sponsorship on the reporting of clinical trials. The objective of this study was twofold. Firstly, it aimed to assess the risk of outcome reporting bias (ORB or 'spin') in pilot evaluation reports, using seven indicators developed by clinicians. Secondly, it sought to examine how the government's commitment to a given reform may affect the level of ORB found in the corresponding evaluation report. To answer these questions, 13 evaluation reports were content-analysed, all of which found a non-significant effect of the intervention on its stated primary outcome. These reports were systematically selected from a dataset of 233 pilot and experimental evaluations spanning three policy areas and 13 years of government-commissioned research in the UK. The results show that the risk of ORB is real. Indeed, all studies reviewed here resorted to at least one of the presentational strategies associated with a risk of spin. This study also found a small, negative association between the seniority of the reform's champion and the risk of ORB in the evaluation of that reform. The publication of protocols and the use of reporting guidelines are recommended.	[Vaganay, Arnaud] London Sch Econ & Polit Sci, London, England	University of London; London School Economics & Political Science	Vaganay, A (corresponding author), London Sch Econ & Polit Sci, London, England.	Arnaud.vaganay@gmail.com		Vaganay, Arnaud/0000-0001-5584-9050				Angell M., 2004, TRUTH DRUG CO THEY D; Begum R, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0042-8; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Bewley H, 2007, 435 DEP WORK PENS; Biehal N, 2012, 194 DEP ED; Bielby G, 2010, 206 DEP CHILDR SCH F; Bivand P, 2006, 337 DEP WORK PENS; Bland JM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-264; Boa I, 2010, REPORT NO 82; Bordage G, 2001, ACAD MED, V76, P889, DOI 10.1097/00001888-200109000-00010; Boult C, 2002, J AM GERIATR SOC, V50, pS143; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Boutron I, 2014, J CLIN ONCOL, V32, P4120, DOI 10.1200/JCO.2014.56.7503; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Catala-Lopez F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069462; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Copas J, 2014, BIOSTATISTICS, V15, P370, DOI 10.1093/biostatistics/kxt046; Dal-Re R, 2015, EUR J CLIN INVEST, V45, P895, DOI 10.1111/eci.12484; Dayem TA, 2014, PUBLIC ADMIN, V92, P224, DOI 10.1111/padm.12055; de Winter JCF, 2015, PEERJ, V3, DOI 10.7717/peerj.733; Dorsett R, 2011, 768 DEP WORK PENS; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; Dwan K, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-52; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; ERNST E, 1992, ANN INTERN MED, V116, P958, DOI 10.7326/0003-4819-116-11-958_2; Fisher R, 2010, 108A DEP ED; Fletcher J, 2007, BRIT MED J, V335, P96, DOI 10.1136/bmj.39265.596262.AD; Fletcher RH, 2007, MED LAW, V26, P511; Goldacre B., 2012, BAD PHARMA HOW MEDIC; Gottfredson D.C., 2002, EVIDENCE BASED CRIME, P13, DOI DOI 10.4324/9780203166697_CHAPTER_2; Hahn S, 2002, J EVAL CLIN PRACT, V8, P353, DOI 10.1046/j.1365-2753.2002.00314.x; Hannink G, 2013, ANN SURG, V257, P818, DOI 10.1097/SLA.0b013e3182864fa3; Henig JR, 2009, SPIN CYCLE RES USED; Hergovich A, 2010, CURR PSYCHOL, V29, P188, DOI 10.1007/s12144-010-9087-5; Hewitt C, 2008, BMJ-BRIT MED J, V336, P23, DOI 10.1136/bmj.39379.359560.AD; Hood C, 2011, BLAME GAME: SPIN, BUREAUCRACY, AND SELF-PRESERVATION IN GOVERNMENT, P1; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huan LN, 2014, J CLIN PHARM THER, V39, P501, DOI 10.1111/jcpt.12172; Ioannidis JPA, 2014, TRENDS COGN SCI, V18, P235, DOI 10.1016/j.tics.2014.02.010; Kaptchuk TJ, 2003, BRIT MED J, V326, P1453, DOI 10.1136/bmj.326.7404.1453; Kent Weaver R., 1986, J PUBLIC POLICY, V6, P371, DOI [DOI 10.1017/S0143814X00004219, 10.1017/S0143814X00004219]; Kirby S, 2003, 183 DEP WORK PENS; KOEHLER JJ, 1993, ORGAN BEHAV HUM DEC, V56, P28, DOI 10.1006/obhd.1993.1044; Lakens D, 2015, Q J EXP PSYCHOL, V68, P829, DOI 10.1080/17470218.2014.982664; Latronico N, 2013, INTENS CARE MED, V39, P1386, DOI 10.1007/s00134-013-2947-3; Lazarus C, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0079-x; Lee CJ, 2011, HYPATIA, V26, P352, DOI 10.1111/j.1527-2001.2011.01178.x; Lexchin Joel, 2012, Int J Risk Saf Med, V24, P233, DOI 10.3233/JRS-2012-0574; Marco CA, 2000, ACAD EMERG MED, V7, P691, DOI 10.1111/j.1553-2712.2000.tb02049.x; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Matthews GA, 2011, J CLIN EPIDEMIOL, V64, P1317, DOI 10.1016/j.jclinepi.2011.03.013; McCracken K, 2012, 2012 HOM OFF; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; McKercher B., 2007, J HOSP TOUR MANAG, V31, P455, DOI [10.1177/1096348007302355, DOI 10.1177/1096348007302355]; Middlemas J, 2006, 382 DEP WORK PENS; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moher D, 2011, J CLIN EPIDEMIOL, V64, P718, DOI 10.1016/j.jclinepi.2010.09.013; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nankervis H, 2012, J INVEST DERMATOL, V132, P2727, DOI 10.1038/jid.2012.231; OXMAN AD, 1992, ANN INTERN MED, V116, P78, DOI 10.7326/0003-4819-116-1-78; Page MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000035.pub2; Pearson M, 2012, J EPIDEMIOL COMMUN H, V66, P286, DOI 10.1136/jech.2010.122465; Pierson David J, 2004, Respir Care, V49, P1246; Pigott TD, 2013, EDUC RESEARCHER, V42, P424, DOI 10.3102/0013189X13507104; Pirracchio R, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-29; Purdon S, 2006, 342 DEP WORK PENS; Reid EK, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0070-y; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Roest AM, 2015, JAMA PSYCHIAT, V72, P500, DOI 10.1001/jamapsychiatry.2015.15; Schulz KF, 2005, LANCET, V365, P1657, DOI 10.1016/S0140-6736(05)66516-6; Shapland J, 2008, 1008 MIN JUST; Shattell MM, 2010, J NURS SCHOLARSHIP, V42, P58, DOI 10.1111/j.1547-5069.2009.01331.x; Smith R, 2009, 134 DEP CHILDR SCH F; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; Su CX, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0545-5; SUN X, 2010, BMJ-BRIT MED J, V340, DOI DOI 10.1136/BMJ.C117; Tannock IF, 1996, J NATL CANCER I, V88, P206, DOI 10.1093/jnci/88.3-4.206; The Magenta Book, 2011, MAGENTA BOOK GUIDANC; Urwin P, 2010, 710 MIN JUST; Vaganay A., 2014, THESIS; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang MTM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101533; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wang SS, 2010, BJU INT, V105, P162, DOI 10.1111/j.1464-410X.2009.09053.x; Williamson PR, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-9; Wing DA, 2010, J WOMENS HEALTH, V19, P1919, DOI 10.1089/jwh.2009.1904; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308	90	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163702	10.1371/journal.pone.0163702	http://dx.doi.org/10.1371/journal.pone.0163702			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DX4CZ	27690131	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000384329200020
J	An, DR; Im, HN; Jang, JY; Kim, HS; Kim, J; Yoon, HJ; Hesek, D; Lee, M; Mobashery, S; Kim, SJ; Suh, SW				An, Doo Ri; Im, Ha Na; Jang, Jun Young; Kim, Hyoun Sook; Kim, Jieun; Yoon, Hye Jin; Hesek, Dusan; Lee, Mijoon; Mobashery, Shahriar; Kim, Soon-Jong; Suh, Se Won			Structural Basis of the Heterodimer Formation between Cell Shape-Determining Proteins Csd1 and Csd2 from Helicobacter pylori	PLOS ONE			English	Article							PEPTIDOGLYCAN STRUCTURE; HELICAL SHAPE; LYTM-DOMAIN; COLONIZATION; MOTILITY; GROWTH; CAMPYLOBACTER; ARCHITECTURE; HYDROLASES; COMPONENTS	Colonization of the human gastric mucosa by Helicobacter pylori requires its high motility, which depends on the helical cell shape. In H. pylori, several genes (csd1, csd2, csd3/hdpA, ccmA, csd4, csd5, and csd6) play key roles in determining the cell shape by alteration of cross-linking or by trimming of peptidoglycan stem peptides. H. pylori Csd1, Csd2, and Csd3/HdpA are M23B metallopeptidase family members and may act as D,D-endopeptidases to cleave the D-Ala(4)-mDAP(3) peptide bond of cross-linked dimer muropeptides. Csd3 functions also as the D, D-carboxypeptidase to cleave the D-Ala(4)-D-Ala(5) bond of the muramyl pentapeptide. To provide a basis for understanding molecular functions of Csd1 and Csd2, we have carried out their structural characterizations. We have discovered that (i) Csd2 exists in monomer-dimer equilibrium and (ii) Csd1 and Csd2 form a heterodimer. We have determined crystal structures of the Csd2(121-308) homodimer and the heterodimer between Csd1(125-312) and Csd2(121-308). Overall structures of Csd1(125-312) and Csd2(121-308) monomers are similar to each other, consisting of a helical domain and a LytM domain. The helical domains of both Csd1 and Csd2 play a key role in the formation of homodimers or heterodimers. The Csd1 LytM domain contains a catalytic site with a Zn2+ ion, which is coordinated by three conserved ligands and two water molecules, whereas the Csd2 LytM domain has incomplete metal ligands and no metal ion is bound. Structural knowledge of these proteins sheds light on the events that regulate the cell wall in H. pylori.	[An, Doo Ri; Im, Ha Na; Suh, Se Won] Seoul Natl Univ, Dept Biophys & Chem Biol, Coll Nat Sci, Seoul, South Korea; [Jang, Jun Young; Kim, Jieun; Yoon, Hye Jin; Suh, Se Won] Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea; [Kim, Hyoun Sook] Natl Canc Ctr, Biomol Funct Res Branch, Div Precis Med & Canc Informat, Res Inst, Gyeonggi, South Korea; [Hesek, Dusan; Lee, Mijoon; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Kim, Soon-Jong] Mokpo Natl Univ, Dept Chem, Chungnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); University of Notre Dame; Mokpo National University	Suh, SW (corresponding author), Seoul Natl Univ, Dept Biophys & Chem Biol, Coll Nat Sci, Seoul, South Korea.; Suh, SW (corresponding author), Seoul Natl Univ, Dept Chem, Coll Nat Sci, Seoul, South Korea.	sewonsuh@snu.ac.kr	Lee, Mijoon/AFK-1543-2022	Lee, Mijoon/0000-0001-7432-0427	Korea Ministry of Science, ICT and Future Planning, National Research Foundation (NRF) of Korea [2013R1A2A1A05067303]; Innovative Drug Research Center for Metabolic and Inflammatory Disease; Korea Ministry of Education, the NRF of Korea [2015R1D1A4A01020265, 2014R1A1A3A04050250]; National Institutes of Health [AI090348, GM61629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061629] Funding Source: NIH RePORTER	Korea Ministry of Science, ICT and Future Planning, National Research Foundation (NRF) of Korea; Innovative Drug Research Center for Metabolic and Inflammatory Disease; Korea Ministry of Education, the NRF of Korea; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Korea Ministry of Science, ICT and Future Planning, National Research Foundation (NRF) of Korea (2013R1A2A1A05067303), and Innovative Drug Research Center for Metabolic and Inflammatory Disease to SWS. HSK and HJY were supported by the Korea Ministry of Education, the NRF of Korea (2015R1D1A4A01020265 and 2014R1A1A3A04050250, respectively). The work in the US was supported by grant from the National Institutes of Health (AI090348 and GM61629).	Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; An DR, 2015, ACTA CRYSTALLOGR D, V71, P675, DOI 10.1107/S1399004715000152; BERG HC, 1979, NATURE, V278, P349, DOI 10.1038/278349a0; Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chan ACK, 2015, J BIOL CHEM, V290, P3622, DOI 10.1074/jbc.M114.624734; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Costa K, 1999, J BACTERIOL, V181, P3710, DOI 10.1128/JB.181.12.3710-3715.1999; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franceschi F, 2015, HELICOBACTER, V20, P40, DOI 10.1111/hel.12256; Goley ED, 2010, MOL MICROBIOL, V77, P56, DOI 10.1111/j.1365-2958.2010.07222.x; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grabowska M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14833; Green, 2015, PRACTICAL HDB MICROB, P221, DOI [10.1201/b17871-17, DOI 10.1201/B17871-17]; HAZELL SL, 1986, J INFECT DIS, V153, P658, DOI 10.1093/infdis/153.4.658; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Kim HS, 2015, J BIOL CHEM, V290, P25103, DOI 10.1074/jbc.M115.658781; Kim HS, 2014, ACTA CRYSTALLOGR D, V70, P2800, DOI 10.1107/S1399004714018732; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee M, 2013, J AM CHEM SOC, V135, P3311, DOI 10.1021/ja309036q; Lee TK, 2013, CURR OPIN MICROBIOL, V16, P760, DOI 10.1016/j.mib.2013.08.005; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Levdikov VM, 2012, P NATL ACAD SCI USA, V109, P5441, DOI 10.1073/pnas.1120087109; Liu YJ, 2016, ACS CHEM BIOL, V11, P981, DOI 10.1021/acschembio.5b01039; Malfertheiner P, 2012, CURR OPIN GASTROEN, V28, P608, DOI 10.1097/MOG.0b013e32835918a7; Meisner J, 2012, P NATL ACAD SCI USA, V109, P5446, DOI 10.1073/pnas.1120113109; Meisner J, 2011, J BACTERIOL, V193, P591, DOI 10.1128/JB.01270-10; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Moll A, 2010, MOL MICROBIOL, V77, P90, DOI [10.1111/j.1365-2958.2010.07244.x, DOI 10.1111/J.1365-2958.2010.07244.X]; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters NT, 2013, MOL MICROBIOL, V89, P690, DOI 10.1111/mmi.12304; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Poggio S, 2010, MOL MICROBIOL, V77, P74, DOI 10.1111/j.1365-2958.2010.07223.x; READ RJ, 1988, J APPL CRYSTALLOGR, V21, P490, DOI 10.1107/S002188988800562X; Roesler BM, 2014, CLIN MED INSIGHTS-GA, V7, P9, DOI 10.4137/CGast.S13760; Sabala I, 2014, FEBS J, V281, P4112, DOI 10.1111/febs.12929; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh SK, 2012, MOL MICROBIOL, V86, P1036, DOI 10.1111/mmi.12058; Spencer J, 2010, J MOL BIOL, V396, P908, DOI 10.1016/j.jmb.2009.12.021; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Uehara T, 2009, J BACTERIOL, V191, P5094, DOI 10.1128/JB.00505-09; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Heijenoort J, 2011, MICROBIOL MOL BIOL R, V75, P636, DOI 10.1128/MMBR.00022-11; Vasa S, 2015, P NATL ACAD SCI USA, V112, pE127, DOI 10.1073/pnas.1418450112; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2012, MOL MICROBIOL, V86, P1031, DOI 10.1111/mmi.12059; WEIDEL W, 1964, ADV ENZYMOL REL S BI, V26, P193; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P4122, DOI [10.1111/febs.12929, DOI 10.1111/FEBS.12929]; Worku ML, 1999, MICROBIOL-SGM, V145, P2803, DOI 10.1099/00221287-145-10-2803; Wyckoff TJ, 2012, TRENDS MICROBIOL, V20, P540, DOI 10.1016/j.tim.2012.08.003	62	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164243	10.1371/journal.pone.0164243	http://dx.doi.org/10.1371/journal.pone.0164243			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711177	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600104
J	de Medeiros, AKA; Speeckaert, R; Desmet, E; Van Gele, M; De Schepper, S; Lambert, J				de Medeiros, Ana Karina Alves; Speeckaert, Reinhart; Desmet, Eline; Van Gele, Mireille; De Schepper, Sofie; Lambert, Jo			JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases	PLOS ONE			English	Article							KINASE INHIBITOR TOFACITINIB; SIGNAL-TRANSDUCTION; THERAPEUTIC TARGET; ATOPIC-DERMATITIS; LICHEN-PLANUS; PSORIASIS; EXPRESSION; STAT3; KERATINOCYTES; PATHWAY	The recent interest and elucidation of the JAK/STAT signaling pathway created new targets for the treatment of inflammatory skin diseases (ISDs). JAK inhibitors in oral and topical formulations have shown beneficial results in psoriasis and alopecia areata. Patients suffering from other ISDs might also benefit from JAK inhibition. Given the development of specific JAK inhibitors, the expression patterns of JAKs in different ISDs needs to be clarified. We aimed to analyze the expression of JAK/STAT family members in a set of prevalent ISDs: psoriasis, lichen planus (LP), cutaneous lupus erythematosus (CLE), atopic dermatitis (AD), pyoderma gangrenosum (PG) and alopecia areata (AA) versus healthy controls for (p) JAK1, (p) JAK2, (p) JAK3, (p) TYK2, pSTAT1, pSTAT2 and pSTAT3. The epidermis carried in all ISDs, except for CLE, a strong JAK3 signature. The dermal infiltrate showed a more diverse expression pattern. JAK1, JAK2 and JAK3 were significantly overexpressed in PG and AD suggesting the need for pan-JAK inhibitors. In contrast, psoriasis and LP showed only JAK1 and JAK3 upregulation, while AA and CLE were characterized by a single dermal JAK signal (pJAK3 and pJAK1, respectively). This indicates that the latter diseases may benefit from more targeted JAK inhibitors. Our in vitro keratinocyte psoriasis model displayed reversal of the psoriatic JAK profile following tofacitinib treatment. This direct interaction with keratinocytes may decrease the need for deep skin penetration of topical JAK inhibitors in order to exert its effects on dermal immune cells. In conclusion, these results point to the important contribution of the JAK/STAT pathway in several ISDs. Considering the epidermal JAK3 expression levels, great interest should go to the investigation of topical JAK3 inhibitors as therapeutic option of ISDs.	[de Medeiros, Ana Karina Alves; Speeckaert, Reinhart; De Schepper, Sofie; Lambert, Jo] Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium; [de Medeiros, Ana Karina Alves; Speeckaert, Reinhart; Desmet, Eline; Van Gele, Mireille; Lambert, Jo] Univ Ghent, Dept Dermatol, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University	de Medeiros, AKA (corresponding author), Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium.; de Medeiros, AKA (corresponding author), Univ Ghent, Dept Dermatol, Ghent, Belgium.	Ana.AlvesdeMedeiros@uzgent.be	Jo, Lambert LW/AAG-4880-2021; Jo, Lambert LW/ABD-3264-2021; Lauschner, Flavia H/P-2457-2018		TGO ("transformationeel geneeskundig onderzoek") (IWT, Belgium) [120829]	TGO ("transformationeel geneeskundig onderzoek") (IWT, Belgium)	This research was funded by a TGO ("transformationeel geneeskundig onderzoek") grant (number 120829, IWT, Belgium).	Andres RM, 2013, EXP DERMATOL, V22, P323, DOI 10.1111/exd.12128; Bachelez H, 2015, LANCET, V386, P552, DOI 10.1016/S0140-6736(14)62113-9; Bao Lei, 2013, JAKSTAT, V2, pe24137, DOI 10.4161/jkst.24137; Bao L, 2012, MOL IMMUNOL, V50, P91, DOI 10.1016/j.molimm.2011.12.008; Bracke S, 2013, ARCH DERMATOL RES, V305, P501, DOI 10.1007/s00403-013-1379-9; Camporeale A, 2012, FRONT BIOSCI-LANDMRK, V17, P2306, DOI 10.2741/4054; Chang BY, 2009, J IMMUNOL, V183, P2183, DOI 10.4049/jimmunol.0804063; Chen L, 2004, CLIN EXP IMMUNOL, V138, P375, DOI 10.1111/j.1365-2249.2004.02649.x; Craiglow BG, 2014, J INVEST DERMATOL, V134, P2988, DOI 10.1038/jid.2014.260; Dawson M a, 2013, EUROPE PMC FUNDERS G, V461, P819; Di TT, 2016, INT IMMUNOPHARMACOL, V32, P32, DOI 10.1016/j.intimp.2015.12.035; Fujii Y, 2013, PHARMACOLOGY, V91, P207, DOI 10.1159/000347184; Gambichler T, 2012, EUR J DERMATOL, V22, P319, DOI 10.1684/ejd.2012.1725; Gamero AM, 2010, CANCER PREV RES, V3, P495, DOI 10.1158/1940-6207.CAPR-09-0105; Ghoreschi K, 2014, EXP DERMATOL, V23, P7, DOI 10.1111/exd.12265; Guttman-Yassky E., 2011, ALLERGY CLIN IMMUNOL, V127, P1420, DOI DOI 10.1016/J.JACI.2011.01.054; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Ishizaki M, 2014, INT IMMUNOL, V26, P257, DOI 10.1093/intimm/dxt062; Levy LL, 2015, J AM ACAD DERMATOL, V73, P395, DOI 10.1016/j.jaad.2015.06.045; Li Jie, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P109, DOI 10.3969/j.issn.1672-7347.2011.02.003; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Palanivel JA, 2014, CLIN EXP DERMATOL, V39, P513, DOI 10.1111/ced.12273; Payeras MR, 2013, ARCH ORAL BIOL, V58, P1057, DOI 10.1016/j.archoralbio.2013.04.004; Ports WC, 2013, BRIT J DERMATOL, V169, P137, DOI 10.1111/bjd.12266; Punwani N, 2012, J AM ACAD DERMATOL, V67, P658, DOI 10.1016/j.jaad.2011.12.018; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Shaker O, 2012, BRIT J DERMATOL, V166, P1367, DOI 10.1111/j.1365-2133.2011.10793.x; Shi XW, 2011, J INVEST DERMATOL, V131, P2401, DOI 10.1038/jid.2011.222; Subramaniam SV, 1999, BIOCHEM BIOPH RES CO, V262, P14, DOI 10.1006/bbrc.1999.1156; Terlou A, 2012, J INVEST DERMATOL, V132, P658, DOI 10.1038/jid.2011.369; van de Kerkhof PCM, 2015, DERMATOL CLIN, V33, P73, DOI 10.1016/j.det.2014.09.006; Villarino AV, 2015, J IMMUNOL, V194, P21, DOI 10.4049/jimmunol.1401867; Wery-Zennaro S, 1999, FEBS LETT, V464, P91, DOI 10.1016/S0014-5793(99)01680-4; Wohlmann A, 2010, BIOL CHEM, V391, P181, DOI [10.1515/BC.2010.029, 10.1515/bc.2010.029]; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645; Zouein FA, 2011, GROWTH FACTORS, V29, P245, DOI 10.3109/08977194.2011.614949	39	93	100	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164080	10.1371/journal.pone.0164080	http://dx.doi.org/10.1371/journal.pone.0164080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711196	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600074
J	Kowalska, JD; Shepherd, L; Ankiersztejn-Bartczak, M; Cybula, A; Czeszko-Paprocka, H; Firlag-Burkacka, E; Mocroft, A; Horban, A				Kowalska, Justyna D.; Shepherd, Leah; Ankiersztejn-Bartczak, Magdalena; Cybula, Aneta; Czeszko-Paprocka, Hanna; Firlag-Burkacka, Ewa; Mocroft, Amanda; Horban, Andrzej			Poor Linkage to Care Despite Significant Improvement in Access to Early cART in Central Poland - Data from Test and Keep in Care (TAK) Project	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV DIAGNOSIS; INFECTION; PEOPLE; EUROPE	Background The main objective of the TAK project is investigating barriers in accessing HIV care after HIV-diagnosis at the CBVCTs of central Poland. Here we describe factors associated with and changes over time in linkage to care and access to cART. Method Data collected in 2010-2013 in CBVCTs were linked with HIV clinics records using unique identifiers. Individuals were followed from the day of CBVCTs visit until first clinical visit or 4/06/2014. Cox-proportional hazard models were used to identify factors associated with being linked to care and starting cART. Results In total 232 persons were diagnosed HIV-positive and 144 (62.1% 95% CI: 55.5-68.3) persons were linked to care. There was no change over time in linkage to care (p = 0.48), while time to starting cART decreased (p = 0.02). Multivariate factors associated with a lower rate of linkage to care were hetero/bisexual sexual orientation, lower education, not having an HIV-positive partner and not using condoms in a stable relationship. Multivariate factors associated with starting cART were lower education, recent year of linked to care, and first HIV RNA and CD4 cell count. Conclusions Benefits of linkage to care, measured by access to early treatment, steadily improved in recent years. However at least 1 in 3 persons aware of their HIV status in central Poland remained outside professional healthcare. Persons at higher risk of remaining outside care, thus target population for future interventions, are bi/heterosexuals and those with lower levels of education.	[Kowalska, Justyna D.; Czeszko-Paprocka, Hanna; Firlag-Burkacka, Ewa; Horban, Andrzej] Hosp Infect Dis, HIV Out Patient Clin, Warsaw, Poland; [Kowalska, Justyna D.; Horban, Andrzej] Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland; [Shepherd, Leah; Mocroft, Amanda] UCL, Dept Infect & Populat Hlth, London, England; [Ankiersztejn-Bartczak, Magdalena] FES, Warsaw, Poland; [Cybula, Aneta] Med Univ Warsaw, Dept Infect & Trop Dis & Hepatol, Warsaw, Poland	Medical University of Warsaw; University of London; University College London; Medical University of Warsaw	Kowalska, JD (corresponding author), Hosp Infect Dis, HIV Out Patient Clin, Warsaw, Poland.; Kowalska, JD (corresponding author), Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland.	jdkowalska@gmail.com	Cybula, Aneta/U-4130-2018	Cybula, Aneta/0000-0001-8071-7455	Research Development Foundation in Hospital for Infectious Diseases; Abbvie Poland; Gilead Sciences Poland	Research Development Foundation in Hospital for Infectious Diseases; Abbvie Poland(AbbVie); Gilead Sciences Poland(Gilead Sciences)	The TAK project received unrestricted research grants from Research Development Foundation in Hospital for Infectious Diseases, Abbvie Poland and Gilead Sciences Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.r The TAK project received unrestricted research grants from Research Development Foundation in Hospital for Infectious Diseases, Abbvie Poland and Gilead Sciences Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The authors of this paper declare no conflict of interest.	Ankiersztejn-Bartczak M, 2015, HIV MED, V16, P88, DOI 10.1111/hiv.12175; [Anonymous], HIV TEST INCR UPT EF; Antinori A, 2010, ANTIVIR THER, V15, P1, DOI 10.3851/IMP1521; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Bednarczyk M, 2004, N J MED S, V101, P52; Bednarczyk Marlene, 2004, N J Med, V101, P45; BHIVA, 2013, STAND CAR PEOPL LIV; Carvalho C, 2013, HIV MED, V14, P15, DOI 10.1111/hiv.12058; Casado JL, 2016, HIV MED, V17, P46, DOI 10.1111/hiv.12280; Chkhartishvili N, 2015, HIV MED, V16, P62, DOI 10.1111/hiv.12172; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Delpech V, 2013, HIV MED, V14, P19, DOI 10.1111/hiv.12070; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; European Centre for Disease Prevention and Control, 2011, HIV AIDS SURV EUR 20; Helleberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072257; Krentz HB, 2008, HIV MED, V9, P721, DOI 10.1111/j.1468-1293.2008.00613.x; Lange JMA, 2011, CLIN INFECT DIS, V52, P801, DOI 10.1093/cid/ciq254; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Oliva J, 2014, ENFERM INFEC MICR CL, V32, P170, DOI 10.1016/j.eimc.2013.09.007; Raben D, 2013, HIV MED, V14, P1, DOI 10.1111/hiv.12062; Raymond A, 2014, J INT AIDS SOC, V17, P13, DOI 10.7448/IAS.17.4.19507; Reyes-Uruena J, 2017, INT J STD AIDS, V28, P28, DOI 10.1177/0956462415623402; Rosinska M, 2013, AIDS RES HUM RETROV, V29, P805, DOI [10.1089/aid.2012.0314, 10.1089/AID.2012.0314]; WHO HIV/AIDS Programme, 2011, RET HIV PROGR DEF CH; World Health Organization, 2015, CONS STRAT INF GUID	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0162739	10.1371/journal.pone.0162739	http://dx.doi.org/10.1371/journal.pone.0162739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711159	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600009
J	Shen, XB; Wang, RF; Yu, N; Shi, YJ; Li, HG; Xiong, CL; Li, Y; Wells, EM; Zhou, YZ				Shen, Xubo; Wang, Ruifeng; Yu, Na; Shi, Yongjun; Li, Honggang; Xiong, Chengliang; Li, Yan; Wells, Ellen M.; Zhou, Yuanzhong			Reference Ranges and Association of Age and Lifestyle Characteristics with Testosterone, Sex Hormone Binding Globulin, and Luteinizing Hormone among 1166 Western Chinese Men	PLOS ONE			English	Article							LATE-ONSET HYPOGONADISM; ANDROGEN DEFICIENCY; OLDER MEN; BIOAVAILABLE TESTOSTERONE; SERUM TESTOSTERONE; RISK-FACTORS; PREVALENCE; COMMUNITY; SYMPTOMS; RHYTHMS	Decreased total testosterone (TT) is the recommended metric to identify age-related hypogonadism. However, average TT and the extent to which it varies by age, can vary substantially among different populations. Population-specific reference ranges are needed to understand normal versus abnormal TT levels. Therefore, the goal for this study was to describe androgen concentrations and their correlates among Western Chinese men. We completed a population-based, cross-sectional study including 227 young adults (YA) (20-39 years) and 939 older adults (OA) (40-89 years). We measured TT, sex-hormone binding globulin (SHBG), luteinizing hormone (LH), testosterone secreting index (TSI), and calculated free testosterone (cFT). Reference ranges for this population were determined using average YA concentrations. Multivariable regression models were used to predict hormone concentrations adjusting for age, waist-to-height ratio (WHR), marital status, education, occupation, smoking, alcohol, blood glucose, and blood pressure. Among OA, 3.8% had low TT, 15.2% had low cFT, 26.3% had low TSI, 21.6% had high SHBG, and 6.1% had high LH. Average cFT was significantly lower in OA (0.30 nmol/L; standard deviation (SD): 0.09) versus YA (0.37; SD: 0.11) but TT was not different in OA (16.82 nmol/L; SD: 4.80) versus YA (16.88; SD: 5.29). In adjusted models increasing age was significantly associated with increased SHBG or LH, and decreased cFT or TSI; however, TT was not significantly associated with age (beta = 0.02 nmol/L; 95% confidence interval (CI): -0.01, 0.04). Higher WHR was associated with significantly decreased TT, SHBG, TSI, and LH. The only variable significantly related to cFT was age (beta = -0.0033; 95% CI: -0.0037, -0.0028); suggesting that cFT measurements would not be confounded by other lifestyle factors. In conclusion, cFT, but not TT, varies with age in this population, suggesting cFT may be a better potential marker for age-related androgen deficiency than TT among Western Chinese men.	[Shen, Xubo; Yu, Na; Shi, Yongjun; Li, Yan; Zhou, Yuanzhong] Zunyi Med Univ, Sch Publ Hlth, Zunyi, Peoples R China; [Wang, Ruifeng] Huichuan Dist Ctr Dis Control & Prevent, Zunyi, Peoples R China; [Li, Honggang; Xiong, Chengliang] Huazhong Univ Sci & Technol, Inst Family Planning, Tongji Med Coll, Wuhan, Peoples R China; [Wells, Ellen M.] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA	Zunyi Medical University; Huazhong University of Science & Technology; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhou, YZ (corresponding author), Zunyi Med Univ, Sch Publ Hlth, Zunyi, Peoples R China.; Wells, EM (corresponding author), Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA.	wells54@purdue.edu; zhouyuanzhong@163.com		Wells, Ellen/0000-0002-7293-1395	Chinese "12th Five-Year Plan" Supporting Science and Technology Project [2012BAI32B03]; Central Special Talent Construction Funds of China [Qiancaijiao 2015-134]	Chinese "12th Five-Year Plan" Supporting Science and Technology Project; Central Special Talent Construction Funds of China	The Chinese "12th Five-Year Plan" Supporting Science and Technology Project (No. 2012BAI32B03) and Central Special Talent Construction Funds of China for Zunyi Medical University (Qiancaijiao 2015-134) sponsored this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anawalt BD, 2012, J UROLOGY, V187, P1369, DOI 10.1016/j.juro.2011.11.095; Antonio L, 2016, J CLIN ENDOCR METAB, V101, P2647, DOI 10.1210/jc.2015-4106; Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Ashwell M, 1996, BRIT MED J, V313, P559; BAKER HWG, 1975, J STEROID BIOCHEM, V6, P793, DOI 10.1016/0022-4731(75)90069-2; Bassil N, 2011, MED CLIN N AM, V95, P507, DOI 10.1016/j.mcna.2011.03.001; Bhasin S, 2011, J CLIN ENDOCR METAB, V96, P2430, DOI 10.1210/jc.2010-3012; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Buvat J, 2013, J SEX MED, V10, P245, DOI 10.1111/j.1743-6109.2012.02783.x; Camacho EM, 2013, EUR J ENDOCRINOL, V168, P445, DOI 10.1530/EJE-12-0890; Cao J, 2012, AGING MALE, V15, P85, DOI 10.3109/13685538.2012.666585; Cooper LA, 2015, CLIN ENDOCRINOL, V83, P828, DOI 10.1111/cen.12768; Corona G, 2013, BEST PRACT RES CL EN, V27, P557, DOI 10.1016/j.beem.2013.05.002; Corona G, 2011, J ENDOCRINOL INVEST, V34, P557, DOI 10.3275/7806; Deutschbein T, 2015, HORM METAB RES, V47, P846, DOI 10.1055/s-0034-1395569; Diver MJ, 2003, CLIN ENDOCRINOL, V58, P710, DOI 10.1046/j.1365-2265.2003.01772.x; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Friedrich N, 2008, J ANDROL, V29, P610, DOI 10.2164/jandrol.108.005561; Fukai S, 2010, GERIATR GERONTOL INT, V10, P32, DOI 10.1111/j.1447-0594.2009.00552.x; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; Hammond GL, 2012, CURR OPIN ENDOCRINOL, V19, P183, DOI 10.1097/MED.0b013e328353732f; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Iwamoto T, 2009, INT J UROL, V16, P168, DOI 10.1111/j.1442-2042.2008.02203.x; Jensen TK, 2014, HUM REPROD, V29, P1801, DOI 10.1093/humrep/deu118; Jones TH, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b352; Kacker R, 2013, AGING MALE, V16, P164, DOI 10.3109/13685538.2013.835800; Kelsey TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109346; Li J-Y, 2005, Aging Male, V8, P203, DOI 10.1080/13685530500356010; Liu PY, 2007, J CLIN ENDOCR METAB, V92, P3599, DOI 10.1210/jc.2007-0862; Liu ZS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0107-z; Liu ZY, 2016, ASIAN J ANDROL, V18, P747, DOI 10.4103/1008-682X.160883; Lunenfeld B, 2005, Aging Male, V8, P59; Midzak AS, 2009, MOL CELL ENDOCRINOL, V299, P23, DOI 10.1016/j.mce.2008.07.016; Moon DG, 2014, J SEX MED, V11, P583, DOI 10.1111/jsm.12393; MULLIGAN T, 1995, J CLIN ENDOCR METAB, V80, P3025, DOI 10.1210/jc.80.10.3025; Namiki M, 2008, INT J UROL, V15, P377, DOI 10.1111/j.1442-2042.2008.02010.x; Nieschlag E, 2005, EUR UROL, V48, P1, DOI 10.1016/j.eururo.2005.04.027; Orwoll E, 2006, J CLIN ENDOCR METAB, V91, P1336, DOI 10.1210/jc.2005-1830; Pye SR, 2014, J CLIN ENDOCR METAB, V99, P1357, DOI 10.1210/jc.2013-2052; Qin X, 2012, CLIN LAB, V58, P281; Ramasamy R, 2015, UROLOGY, V86, P287, DOI 10.1016/j.urology.2015.05.007; Saad F, 2012, CURR DIABETES REV, V8, P131, DOI 10.2174/157339912799424573; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Shi ZM, 2013, J CLIN ENDOCR METAB, V98, P3289, DOI 10.1210/jc.2012-3842; Svartberg J, 2003, EUR J ENDOCRINOL, V149, P145, DOI 10.1530/eje.0.1490145; Tajar A, 2012, J CLIN ENDOCR METAB, V97, P1508, DOI 10.1210/jc.2011-2513; VELDHUIS JD, 1990, J CLIN ENDOCR METAB, V71, P1616, DOI 10.1210/jcem-71-6-1616; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601; Wang C, 2009, INT J IMPOT RES, V21, P1, DOI 10.1038/ijir.2008.41; Wu FCW, 2008, J CLIN ENDOCR METAB, V93, P2737, DOI 10.1210/jc.2007-1972; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101	53	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164116	10.1371/journal.pone.0164116	http://dx.doi.org/10.1371/journal.pone.0164116			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711240	Green Published, gold			2022-12-27	WOS:000385697600080
J	Blankley, S; Graham, CM; Turner, J; Berry, MPR; Bloom, CI; Xu, ZH; Pascual, V; Banchereau, J; Chaussabel, D; Breen, R; Santis, G; Blankenship, DM; Lipman, M; O'Garra, A				Blankley, Simon; Graham, Christine M.; Turner, Jacob; Berry, Matthew P. R.; Bloom, Chloe I.; Xu, Zhaohui; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien; Breen, Ronan; Santis, George; Blankenship, Derek M.; Lipman, Marc; O'Garra, Anne			The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis	PLOS ONE			English	Article							BLOOD; EXPRESSION; DIAGNOSIS; PATTERNS; CELLS; RISK	Background Mycobacterium tuberculosis infection is a leading cause of infectious death worldwide. Gene-expression microarray studies profiling the blood transcriptional response of tuberculosis (TB) patients have been undertaken in order to better understand the host immune response as well as to identify potential biomarkers of disease. To date most of these studies have focused on pulmonary TB patients with gene-expression profiles of extra-pulmonary TB patients yet to be compared to those of patients with pulmonary TB or sarcoidosis. Methods A novel cohort of patients with extra-pulmonary TB and sarcoidosis was recruited and the transcriptional response of these patients compared to those with pulmonary TB using a variety of transcriptomic approaches including testing a previously defined 380 gene meta-signature of active TB. Results The 380 meta-signature broadly differentiated active TB from healthy controls in this new dataset consisting of pulmonary and extra-pulmonary TB. The top 15 genes from this meta-signature had a lower sensitivity for differentiating extra-pulmonary TB from healthy controls as compared to pulmonary TB. We found the blood transcriptional responses in pulmonary and extra-pulmonary TB to be heterogeneous and to reflect the extent of symptoms of disease. Conclusions The transcriptional signature in extra-pulmonary TB demonstrated heterogeneity of gene expression reflective of symptom status, while the signature of pulmonary TB was distinct, based on a higher proportion of symptomatic individuals. These findings are of importance for the rational design and implementation of mRNA based TB diagnostics.	[Blankley, Simon; Graham, Christine M.; Berry, Matthew P. R.; Bloom, Chloe I.; O'Garra, Anne] Francis Crick Inst, Mill Hill Lab, Lab Immunoregulat & Infect, London, England; [Turner, Jacob; Blankenship, Derek M.] Baylor Scott & White, Baylor Res Inst, Dallas, TX USA; [Berry, Matthew P. R.] St Marys Hosp, Imperial Coll Healthcare NHS Trust, Dept Resp Med, London, England; [Xu, Zhaohui; Pascual, Virginia] INSERM, ANRS Ctr Human Vaccines, Baylor Inst Immunol Res, Dallas, TX USA; [Banchereau, Jacques] Jackson Lab Genom Med, 10 Discovery Dr, Farmington, CT 06032 USA; [Chaussabel, Damien] Sidra Med & Res Ctr, Doha, Qatar; [Breen, Ronan; Santis, George] Kings Coll London, Dept Resp Med, London, England; [Santis, George] Kings Coll London, Div Asthma Allergy & Lung Biol, London, England; [Lipman, Marc] Royal Free London NHS Fdn Trust, Dept Resp Med, London, England; [Lipman, Marc] UCL, Div Med, London, England; [O'Garra, Anne] Imperial Coll, NHLI, Dept Med, London, England	Francis Crick Institute; Baylor Health Care System; Baylor Scott & White Health; Baylor University Medical Center; Imperial College London; Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Jackson Laboratory; Sidra Medical & Research Center; University of London; King's College London; University of London; King's College London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; Imperial College London	O'Garra, A (corresponding author), Francis Crick Inst, Mill Hill Lab, Lab Immunoregulat & Infect, London, England.; O'Garra, A (corresponding author), Imperial Coll, NHLI, Dept Med, London, England.	anne.ogarra@crick.ac.uk	Chaussabel, Damien/AAX-1909-2020; Pascual, Virginia/ABD-3099-2020; Bloom, Chloe/ABC-1693-2020	Bloom, Chloe/0000-0003-1285-7602; Blankley, Simon/0000-0001-9602-9075; Graham, Christine/0000-0001-9329-6231; Xu, Zhaohui/0000-0003-0645-1737; O'Garra, Anne/0000-0001-9845-6134; Chaussabel, Damien/0000-0002-6131-7242; Lipman, Marc/0000-0001-7501-4448	Francis Crick Institute; Cancer Research UK [FC001126]; U.K. Medical Research Council [FC001126]; Wellcome Trust [FC001126]; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID [MR/J010723/1]; Department of Health via the National Institutes of Health Research comprehensive Biomedical Research Centre; King's College London; SILA; Medical Research Council [MR/J010723/1, 1105853, 1365570, MC_U117565642] Funding Source: researchfish; The Francis Crick Institute [10127, 10126] Funding Source: researchfish; MRC [MC_U117565642, MR/J010723/1] Funding Source: UKRI	Francis Crick Institute; Cancer Research UK(Cancer Research UK); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health via the National Institutes of Health Research comprehensive Biomedical Research Centre; King's College London; SILA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AOG and this work is supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001126), the U.K. Medical Research Council (FC001126) and the Wellcome Trust (FC001126). SB was jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement (MR/J010723/1). GS was supported in part by the Department of Health via the National Institutes of Health Research comprehensive Biomedical Research Centre award to Guy's and St Thomas' National Health Service Foundation Trust in partnership with King's College London. This study received financial support from SILA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Blankley S, 2016, EUR RESPIR J, V47, P1873, DOI 10.1183/13993003.02121-2015; Blankley S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0427; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; Breen RAM, 2008, INT J TUBERC LUNG D, V12, P44; Cai Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092340; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Gonzalez OY, 2003, INT J TUBERC LUNG D, V7, P1178; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kaforou M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001538; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054961; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Kruijshaar ME, 2009, THORAX, V64, P1090, DOI 10.1136/thx.2009.118133; Lesho E, 2011, TUBERCULOSIS, V91, P390, DOI 10.1016/j.tube.2011.07.002; Lu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024290; Maertzdorf J, 2012, P NATL ACAD SCI USA, V109, P7853, DOI 10.1073/pnas.1121072109; Maertzdorf Jeroen, 2011, PLoS One, V6, pe26938, DOI 10.1371/journal.pone.0026938; Milman N, 1990, Sarcoidosis, V7, P113; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Ottenhoff THM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045839; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Public Health England, 2014, TUB UK 2014 REP; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Solovic I, 2013, EURO SURVEILLANCE B, V18; Sweeney TE, 2016, LANCET RESP MED, V4, P213, DOI 10.1016/S2213-2600(16)00048-5; Theron G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05658; Veenstra H, 2006, CLIN EXP IMMUNOL, V145, P252, DOI 10.1111/j.1365-2249.2006.03144.x; World Health Organization, 2014, GLOBAL TUBERCULOSIS; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644	35	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162220	10.1371/journal.pone.0162220	http://dx.doi.org/10.1371/journal.pone.0162220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706152	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200008
J	Chaverri, G; Garin, I; Alberdi, A; Jimenez, L; Castillo-Salazar, C; Aihartza, J				Chaverri, Gloriana; Garin, Inazio; Alberdi, Antton; Jimenez, Lide; Castillo-Salazar, Cristian; Aihartza, Joxerra			Unveiling the Hidden Bat Diversity of a Neotropical Montane Forest	PLOS ONE			English	Article							SPECIES-RICHNESS; EVOLUTIONARY HISTORY; ELEVATIONAL GRADIENT; CRYPTIC DIVERSITY; COMMUNITY STRUCTURE; CONTINENTAL-SCALE; FRUIT BATS; DNA; PATTERNS; CHIROPTERA	Mountain environments, characterized by high levels of endemism, are at risk of experiencing significant biodiversity loss due to current trends in global warming. While many acknowledge their importance and vulnerability, these ecosystems still remain poorly studied, particularly for taxa that are difficult to sample such as bats. Aiming to estimate the amount of cryptic diversity among bats of a Neotropical montane cloud forest in Talamanca Range-south-east Central America-, we performed a 15-night sampling campaign, which resulted in 90 captured bats belonging to 8 species. We sequenced their mitochondrial cytochrome c oxidase subunit I (COI) and screened their inter-and intraspecific genetic variation. Phylogenetic relations with conspecifics and closely related species from other geographic regions were established using Maximum Likelihood and Bayesian inference methods, as well as median-joining haplotype networks. Mitochondrial lineages highly divergent from hitherto characterized populations (> 9% COI dissimilarity) were found in Myotis oxyotus and Hylonycteris underwoodi. Sturnira burtonlimi and M. keaysi also showed distinct mitochondrial structure with sibling species and/or populations. These results suggest that mountains in the region hold a high degree of endemicity potential that has previously been ignored in bats. They also warn of the high extinction risk montane bats may be facing due to climatic change, particularly in isolated mountain systems like Talamanca Range.	[Chaverri, Gloriana] Univ Costa Rica, Golfito, Costa Rica; [Garin, Inazio; Alberdi, Antton; Jimenez, Lide; Aihartza, Joxerra] Univ Basque Country UPV EHU, Dept Zool & Anim Cell Biol, Leioa, The Basque Coun, Spain; [Alberdi, Antton] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark; [Castillo-Salazar, Cristian] Univ Nacl Costa Rica, Heredia, Costa Rica	Universidad Costa Rica; University of Basque Country; University of Copenhagen; Universidad Nacional Costa Rica	Chaverri, G (corresponding author), Univ Costa Rica, Golfito, Costa Rica.	gloriana.chaverri@ucr.ac.cr	Aihartza, Joxerra/GSO-2446-2022; Chaverri, Gloriana/J-4798-2012; Garin, Inazio/B-8115-2009; Aihartza, Joxerra/Z-3061-2019; Alberdi, Antton/M-2423-2017	Chaverri, Gloriana/0000-0002-1155-432X; Aihartza, Joxerra/0000-0003-0882-8964; Alberdi, Antton/0000-0002-2875-6446	Government of the Basque Country [IT754-13]	Government of the Basque Country	This project was supported by the Government of the Basque Country (project IT754-13) to JA and IG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029097; Alberdi A, 2015, J BIOGEOGR, V42, P1689, DOI 10.1111/jbi.12535; Alberdi A, 2013, ACTA CHIROPTEROL, V15, P451, DOI 10.3161/150811013X679071; Avise JC, 1999, P NATL ACAD SCI USA, V96, P992, DOI 10.1073/pnas.96.3.992; Bagley JC, 2014, BIOL REV, V89, P767, DOI 10.1111/brv.12076; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Barquez R, 2008, IUCN RED LIST THREAT; Barrera-Guzman AO, 2012, MOL PHYLOGENET EVOL, V62, P907, DOI 10.1016/j.ympev.2011.11.020; Blake JG, 2000, AUK, V117, P663, DOI 10.1642/0004-8038(2000)117[0663:DOBAAE]2.0.CO;2; Bogdanowicz W, 2015, ZOOL J LINN SOC-LOND, V174, P635, DOI 10.1111/zoj.12248; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Bowie RCK, 2009, IBIS, V151, P709, DOI 10.1111/j.1474-919X.2009.00954.x; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; Buzan EV, 2008, FOLIA ZOOL, V57, P274; Cadena C. D., 2011, P ROYAL SOC B, V279, P194, DOI DOI 10.1098/RSPB.2011.0720; Carothers JH, 1996, REV CHIL HIST NAT, V69, P301; Carranza S, 2005, ZOOL J LINN SOC-LOND, V145, P555, DOI 10.1111/j.1096-3642.2005.00197.x; Carvalho WD, 2013, MAMMALIA, V77, P341, DOI 10.1515/mammalia-2012-0012; Cerny T, 2015, APPL VEG SCI, V18, P5, DOI 10.1111/avsc.12124; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Clare EL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-26; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delciellos Ana Claudia, 2012, Check List, V8, P675; Feeley KJ, 2013, GLOBAL CHANGE BIOL, V19, P3472, DOI 10.1111/gcb.12300; Flaquer C, 2007, J MAMMAL, V88, P526, DOI 10.1644/06-MAMM-A-135R1.1; Flores-Saldaña Mónica Gabriela, 2008, Mastozool. neotrop., V15, P309; Garcia-Paris M, 2000, P NATL ACAD SCI USA, V97, P1640, DOI 10.1073/pnas.97.4.1640; Garcia-Rodriguez A, 2012, DIVERS DISTRIB, V18, P204, DOI 10.1111/j.1472-4642.2011.00862.x; GRAHAM GL, 1983, J MAMMAL, V64, P559, DOI 10.2307/1380511; GRAHAM GL, 1990, J BIOGEOGR, V17, P657, DOI 10.2307/2845147; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harvey CA, 2006, BIODIVERS CONSERV, V15, P555, DOI 10.1007/s10531-005-2088-2; Hassanin A, 2015, CR BIOL, V338, P197, DOI 10.1016/j.crvi.2014.12.003; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hernandez-Meza Beatriz, 2005, Mammalian Species, P1; Holdridge L. R., 1967, Life zone ecology.; Holzhaider J, 2001, MAMM BIOL, V66, P144; Hsieh TC, 2013, ECOL MONOGR; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Ibanez C, 2006, ACTA CHIROPTEROL, V8, P277, DOI 10.3161/1733-5329(2006)8[277:TICTCD]2.0.CO;2; Ivanova Natalia V, 2012, Methods Mol Biol, V858, P153, DOI 10.1007/978-1-61779-591-6_8; Jones Jr JK, 1974, HYLONYCTERIS UNDERWO, P1; JUSTE J, 1995, J TROP ECOL, V11, P141; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Kalko EKV, 1998, ZOOL-ANAL COMPLEX SY, V101, P281; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koopman K.F., 1978, American Museum Novitates, P1; Koopman K.F., 1983, P412; Larsen RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046578; LaVal R.K., 1973, Science Bull nat Hist Mus Los Ang Cty, V15, P1; LaVal RK, 2002, MARCIELAGOS COSTA RI; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lopez-Vinyallonga S, 2015, MOL PHYLOGENET EVOL, V92, P243, DOI 10.1016/j.ympev.2015.06.018; Loyola RD, 2008, DIVERS DISTRIB, V14, P949, DOI 10.1111/j.1472-4642.2008.00508.x; Magige FJ, 2013, AFR J ECOL, V51, P618, DOI 10.1111/aje.12075; Mantilla H, 2008, ANOURA CULTRATA HAND; Mantilla-Meluk H, 2014, ZOOTAXA, V3793, P60, DOI 10.11646/zootaxa.3793.1.2; Mayer F, 2001, P ROY SOC B-BIOL SCI, V268, P1825, DOI 10.1098/rspb.2001.1744; Mayer F, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-4; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2009, ECOL LETT, V12, P550, DOI 10.1111/j.1461-0248.2009.01308.x; MCNAB BK, 1969, COMP BIOCHEM PHYSIOL, V31, P227, DOI 10.1016/0010-406X(69)91651-X; Menendez R, 2014, GLOBAL ECOL BIOGEOGR, V23, P646, DOI 10.1111/geb.12142; Merckx VSFT, 2015, NATURE, V524, P347, DOI 10.1038/nature14949; Meyer CFJ, 2011, J APPL ECOL, V48, P777, DOI 10.1111/j.1365-2664.2011.01976.x; Moras Ligiane M, 2013, Mastozool. neotrop., V20, P269; Moratelli R, 2011, MAMM BIOL, V76, P592, DOI 10.1016/j.mambio.2011.01.003; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Morueta-Holme N, 2015, P NATL ACAD SCI USA, V112, P12741, DOI 10.1073/pnas.1509938112; Munoz Arango J., 1990, Studies on Neotropical Fauna and Environment, V25, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Navarro L. D., 1995, REV MEXICANA MASTOZO, V1, P9, DOI DOI 10.22201/IE.20074484E.1995.1.1.156; Nesi N, 2011, CR BIOL, V334, P544, DOI 10.1016/j.crvi.2011.05.003; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Patterson BD, 1996, J ZOOL, V240, P637, DOI 10.1111/j.1469-7998.1996.tb05313.x; Patterson BD, 1998, J BIOGEOGR, V25, P593, DOI 10.1046/j.1365-2699.1998.2530593.x; Pauls SU, 2006, MOL ECOL, V15, P2153, DOI 10.1111/j.1365-294X.2006.02916.x; Pech-Canche Juan M., 2010, Therya, V1, P221, DOI 10.12933/therya-10-17; Pech-Canche JM, 2011, REV MEX BIODIVERS, V82, P896; Pierson ED, 2006, DISTRIBUTION STATUS; Puechmaille SJ, 2007, ACTA CHIROPTEROL, V9, P269, DOI 10.3161/1733-5329(2007)9[269:GDFBD]2.0.CO;2; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rakotoarivelo AR, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0510-2; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Razgour O, 2015, MOL ECOL, V24, P5267, DOI 10.1111/mec.13379; RODRIGUEZ-HERRERA B, 1999, OCCASIONAL PAPERS CO, V5, P1; Rodriguez-Posada ME, 2010, CALDASIA, V32, P205; Ronquist F., 2011, MAN MRBAYES, P1; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Simmons Nancy B., 1998, Bulletin of the American Museum of Natural History, V237, P1; Soto Solis A, 2010, PRINC EC PARQ INT AM; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Stocker TF, 2013, CLIMATE CHANGE 2013, DOI [10.1017/CBO9781107415324, DOI 10.1017/CBO9781107415324]; Taylor DJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-336; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Thomas O., 1903, Annals of Natural History, V(7), P286; Timm Robert M., 1999, Brenesia, V52, P1; TUTTLE M D, 1970, University of Kansas Science Bulletin, V49, P45; Vargas Espinoza Aideé, 2008, Mastozool. neotrop., V15, P297; Velazco PM, 2014, ZOOKEYS, P42, DOI 10.3897/zookeys.402.7228; Velazco PM, 2013, MOL PHYLOGENET EVOL, V68, P683, DOI 10.1016/j.ympev.2013.04.016; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	116	13	15	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162712	10.1371/journal.pone.0162712	http://dx.doi.org/10.1371/journal.pone.0162712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706168	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200020
J	Cheng, CW; Liu, FC; Lin, JR; Tsai, YF; Chen, HP; Yu, HP				Cheng, Chih-Wen; Liu, Fu-Chao; Lin, Jr-Rung; Tsai, Yung-Fong; Chen, Hsiu-Pin; Yu, Huang-Ping			The Impact of Hospital/Surgeon Volume on Acute Renal Failure and Mortality in Liver Transplantation: A Nationwide Cohort Study	PLOS ONE			English	Article							CANCER SURGERY; OUTCOME RELATIONSHIP; LEARNING-CURVE; HOSPITALS; SURVIVAL; CASELOAD	The aim of this study was to assess whether the case volume of surgeons and hospitals affects the rates of postoperative complications and survival after liver transplantation. This population-based retrospective cohort study included 2938 recipients of liver transplantation performed between 1998 and 2012, enrolled from the Taiwan National Health Insurance Research Database. They were divided into two groups, according to the cumulative case volume of their operating surgeons and the case volume of their hospitals. The duration of intensive care unit stay and post-transplantation hospitalization, postoperative complications, and mortality were analyzed. The results showed that, in the low and high case volume surgeons groups, respectively, acute renal failure occurred at the rate of 14.11% and 5.86% (p<0.0001), and the overall mortality rates were 19.61% and 12.44% (p<0.0001). In the low and high case volume hospital groups, respectively, acute renal failure occurred in 11% and 7.11% of the recipients (p = 0.0004), and the overall mortality was 18.44% and 12.86% (p<0.0001). These findings suggest that liver transplantation recipients operated on higher case volume surgeons or in higher case volume hospitals have a lower rate of acute renal failure and mortality.	[Cheng, Chih-Wen; Liu, Fu-Chao; Tsai, Yung-Fong; Chen, Hsiu-Pin; Yu, Huang-Ping] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan 333, Taiwan; [Cheng, Chih-Wen; Liu, Fu-Chao; Tsai, Yung-Fong; Chen, Hsiu-Pin; Yu, Huang-Ping] Chang Gung Univ, Coll Med, Taoyuan 333, Taiwan; [Lin, Jr-Rung] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan 333, Taiwan; [Lin, Jr-Rung] Chang Gung Univ, Grad Inst Clin Med, Taoyuan 333, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University	Yu, HP (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan 333, Taiwan.; Yu, HP (corresponding author), Chang Gung Univ, Coll Med, Taoyuan 333, Taiwan.	yuhp2001@adm.cgmh.org.tw	Liu, Fu-Chao/AAB-3780-2021	Liu, F-C/0000-0003-1712-4053; Lin, Jr-Rung/0000-0002-8522-6601	Chang Gung Memorial Hospital [CORPG3E0131]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was partially supported by grants from the Chang Gung Memorial Hospital (CORPG3E0131) to Huang-Ping Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015; Albornoz CR, 2013, PLAST RECONSTR SURG, V132, p192E, DOI 10.1097/PRS.0b013e31829586c1; Alsfasser G, 2016, BRIT J SURG, V103, P136, DOI 10.1002/bjs.9958; Archampong D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005391.pub3; Billingsley KG, 2007, ARCH SURG-CHICAGO, V142, P23, DOI 10.1001/archsurg.142.1.23; Chang CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086444; Chen HP, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002320; Donkervoort SC, 2014, DIGEST DIS SCI, V59, P39, DOI 10.1007/s10620-013-2885-5; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; Fox AN, 2012, CLIN LIVER DIS, V16, P435, DOI 10.1016/j.cld.2012.03.014; Hata T, 2016, ANN SURG, V263, P664, DOI 10.1097/SLA.0000000000001437; Hayanga JA, 2016, AM J SURG, V211, P671, DOI 10.1016/j.amjsurg.2015.12.010; Li C, 2012, DIGEST LIVER DIS, V44, P597, DOI 10.1016/j.dld.2012.01.016; Marin-Gomez LM, 2014, TRANSPL P, V46, P3092, DOI 10.1016/j.transproceed.2014.09.176; Michihata N, 2016, PEDIATR INT, V58, P1171, DOI 10.1111/ped.13008; Nathan H, 2009, J AM COLL SURGEONS, V208, P528, DOI 10.1016/j.jamcollsurg.2009.01.007; Osada H, 2007, GEN THORAC CARDIOVAS, V55, P360, DOI 10.1007/s11748-007-0114-x; Paul JC, 2015, SPINE J, V15, P1963, DOI 10.1016/j.spinee.2015.04.028; Renzulli P, 2006, SURGERY, V139, P296, DOI 10.1016/j.surg.2005.08.023; Schreiber RA, 2010, J PEDIATR GASTR NUTR, V51, P61, DOI 10.1097/MPG.0b013e3181d67e5e; Sioris T, 2008, LUNG CANCER, V59, P119, DOI 10.1016/j.lungcan.2007.07.020; Wald R, 2015, KIDNEY INT, V88, P897, DOI 10.1038/ki.2015.184; Weng SF, 2014, INT J MED SCI, V11, P918, DOI 10.7150/ijms.8850; Yalavarthy Rajesh, 2007, Hemodial Int, V11 Suppl 3, pS7, DOI 10.1111/j.1542-4758.2007.00223.x	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162992	10.1371/journal.pone.0162992	http://dx.doi.org/10.1371/journal.pone.0162992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706183	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200028
J	Kim, H; Gerber, LC; Chiu, D; Lee, SA; Cira, NJ; Xia, SY; Riedel-Kruse, IH				Kim, Honesty; Gerber, Lukas Cyrill; Chiu, Daniel; Lee, Seung Ah; Cira, Nate J.; Xia, Sherwin Yuyang; Riedel-Kruse, Ingmar H.			LudusScope: Accessible Interactive Smartphone Microscopy for Life-Science Education	PLOS ONE			English	Article							GAMES	For centuries, observational microscopy has greatly facilitated biology education, but we still cannot easily and playfully interact with the microscopic world we see. We therefore developed the LudusScope, an accessible, interactive do-it-yourself smartphone microscopy platform that promotes exploratory stimulation and observation of microscopic organisms, in a design that combines the educational modalities of build, play, and inquire. The LudusScope's touchscreen and joystick allow the selection and stimulation of phototactic microorganisms such as Euglena gracilis with light. Organismal behavior is tracked and displayed in real time, enabling open and structured game play as well as scientific inquiry via quantitative experimentation. Furthermore, we used the Scratch programming language to incorporate biophysical modeling. This platform is designed as an accessible, low-cost educational kit for easy construction and expansion. User testing with both teachers and students demonstrates the educational potential of the LudusScope, and we anticipate additional synergy with the maker movement. Transforming observational microscopy into an interactive experience will make microbiology more tangible to society, and effectively support the interdisciplinary learning required by the Next Generation Science Standards.	[Kim, Honesty; Gerber, Lukas Cyrill; Chiu, Daniel; Lee, Seung Ah; Cira, Nate J.; Xia, Sherwin Yuyang; Riedel-Kruse, Ingmar H.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University	Riedel-Kruse, IH (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	ingmar@stanford.edu		Riedel-Kruse, Ingmar/0000-0002-6068-5561	NSF Cyberlearning Grant [1324753]; NIH SBIR Grant [1R43OD021978-01]; Stanford Graduate Fellowship; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R43OD021978] Funding Source: NIH RePORTER	NSF Cyberlearning Grant; NIH SBIR Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an NSF Cyberlearning Grant (#1324753), an NIH SBIR Grant (1R43OD021978-01), and the Stanford Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAAS-Benchmarks for Science Literacy. AAAS, AAAS BENCHM SCI LIT; Bonner S.F., 1977, ED ANCIENT ROME ELDE; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Cira NJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002110; Clark DB, 2013, DIGITAL GAMES LEARNI, P1; Cybulski JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098781; DIEHN B, 1973, SCIENCE, V181, P1009, DOI 10.1126/science.181.4104.1009; Doerr H. M., 1996, International Journal of Computers for Mathematical Learning, V1, P201, DOI 10.1007/BF00571080; Freeman S, 2014, P NATL ACAD SCI USA, V111, P8410, DOI 10.1073/pnas.1319030111; Gerber LC, 2016, P DIGRA FDG; Gerber LC, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4935593; Godsk M., 2013, P WORLD C E LEARN CO; Habgood MPJ, 2011, J LEARN SCI, V20, P169, DOI 10.1080/10508406.2010.508029; Harvey H, 2014, HASTINGS CENT REP, V44, P38, DOI 10.1002/hast.386; Holmes NG, 2015, P NATL ACAD SCI USA, V112, P11199, DOI 10.1073/pnas.1505329112; Hossain Z, 2015, BIOPHYS J, V108, p334A, DOI 10.1016/j.bpj.2014.11.1820; Lascarides V. C., 2000, HIST EARLY CHILDHOOD; Lee SA, P 9 INT C TANG EMB E, P273; Lee S, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP 2015), P938, DOI 10.1145/2750858.2804272; LEPPER MR, 1989, AM PSYCHOL, V44, P170, DOI 10.1037/0003-066X.44.2.170; Littleford RA, 1960, AM BIOL TEACH, P22; Martinez-Garza M, 2013, STUD SCI EDUC, V49, P170, DOI 10.1080/03057267.2013.839372; National Research Council, 2011, LEARNING SCI COMPUTE; National Research Council [NRC], 2013, NEXT GENERATION SCIE, DOI [10.17226/18290, DOI 10.17226/18290]; Ozcan A, 2014, LAB CHIP, V14, P3187, DOI 10.1039/c4lc00010b; Papert S., 1980, MINDSTORMS CHILDREN; Quinn  Helen, 2012, FRAMEWORK K 12 SCI E; Resnick M, 2000, J LEARN SCI, V9, P7, DOI 10.1207/s15327809jls0901_3; Resnick M., 2005, PROCEEDING 2005 C IN, P117, DOI [DOI 10.1145/1109540.1109556, 10.1145/1109540.1109556]; Resnick M, 2009, COMMUN ACM, V52, P60, DOI 10.1145/1592761.1592779; Riedel-Kruse IH, 2011, LAB CHIP, V11, P14, DOI 10.1039/c01c00399a; Salen Tekinbas K, 2003, RULES PLAY GAME DESI; Smith G, 2012, P 43 ACM TECHN S COM, P87; Sung K, 2009, COMMUN ACM, V52, P74, DOI 10.1145/1610252.1610273; Switz NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095330; Tinker R., 2000, HIST PROBEWARE; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Benitti FBV, 2012, COMPUT EDUC, V58, P978, DOI 10.1016/j.compedu.2011.10.006; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Zimmerman C, 2000, DEV REV, V20, P99, DOI 10.1006/drev.1999.0497	40	36	36	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162602	10.1371/journal.pone.0162602	http://dx.doi.org/10.1371/journal.pone.0162602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706189	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200014
J	Natusch, DJD; Lyons, JA; Brown, G; Shine, R				Natusch, Daniel J. D.; Lyons, Jessica A.; Brown, Gregory; Shine, Richard			Communally Nesting Migratory Birds Create Ecological Hot-Spots in Tropical Australia	PLOS ONE			English	Article							SNAKES; BEHAVIOR; DEFENSE; ISLAND	Large numbers of metallic starlings (Aplonis metallica) migrate annually from New Guinea to the rainforests of tropical Australia, where they nest communally in single emergent trees (up to 1,000 birds). These aggregations create dense and species-rich faunal "hot-spots", attracting a diverse assemblage of local consumers that utilise this seasonal resource. The starlings nested primarily in poison-dart trees (Antiaris toxicaria) near the rainforest-woodland boundary. Surveys underneath these colonies revealed that bird-derived nutrients massively increased densities of soil invertebrates and mammals (primarily wild pigs) beneath trees, year-round. Flying invertebrates, nocturnal birds, reptiles, and amphibians congregated beneath the trees when starlings were nesting (the wet-season). Diurnal birds (primarily cockatoos and bush turkeys) aggregated beneath the trees during the dry-season to utilise residual nutrients when the starlings were not nesting. The abundance of several taxa was considerably higher (to > 1000-fold) under colony trees than under nearby trees. The system strikingly resembles utilisation of bird nesting colonies by predators in other parts of the world but this spectacular system has never been described, emphasizing the continuing need for detailed natural-history studies in tropical Australia.	[Natusch, Daniel J. D.; Brown, Gregory; Shine, Richard] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Natusch, Daniel J. D.; Lyons, Jessica A.] Resource Evaluat & Dev, Bamaga, Qld, Australia	University of Sydney	Natusch, DJD (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.; Natusch, DJD (corresponding author), Resource Evaluat & Dev, Bamaga, Qld, Australia.	d_natusch_14@hotmail.com	Brown, Gregory P./F-9897-2011	Brown, Gregory P./0000-0002-2924-9040; Lyons, Jessica A./0000-0002-7579-447X	Australian Research Council; Holsworth Wildlife Research Trust; Skyrail Rainforest Foundation	Australian Research Council(Australian Research Council); Holsworth Wildlife Research Trust; Skyrail Rainforest Foundation	Funding was provided by the Australian Research Council, the Holsworth Wildlife Research Trust, and the Skyrail Rainforest Foundation. The funders had no role in the design of this study.	Ainley DG, 2005, ANTARCT SCI, V17, P335, DOI 10.1017/S0954102005002750; Banfield E, 1917, EMU, V17, P212, DOI [10.1071/MU917212, DOI 10.1071/MU917212]; Ben-David M, 2004, OECOLOGIA, V138, P465, DOI 10.1007/s00442-003-1442-x; Bonnet X, 1999, BEHAV ECOL SOCIOBIOL, V46, P267, DOI 10.1007/s002650050619; Bonnet X, 2002, AUSTRAL ECOL, V27, P442, DOI 10.1046/j.1442-9993.2002.01198.x; Boveng PL, 1998, ECOLOGY, V79, P2863, DOI 10.2307/176522; Bureau of Meteorology, 2015, MONTHL CLIM STAT; Coulson John C., 2002, P87; Covas R., 2002, THESIS PERCY FITZPAT; DUFFY DC, 1983, ECOLOGY, V64, P110, DOI 10.2307/1937334; Feare C., 2010, STARLINGS AND MYNAS; GILBERT MA, 1987, AUST J EXP AGR, V27, P863, DOI 10.1071/EA9870863; Grant CC, 2006, BIOL CONSERV, V130, P426, DOI 10.1016/j.biocon.2006.01.004; Hunter MD, 1992, EFFECTS RESOURCE DIS; Kennedy A.S., 2014, ANIMALS SERENGETI NG; Kimanzi JK, 2015, ORYX, V49, P295, DOI 10.1017/S0030605313000689; Klaus G., 1998, Mammalia, V62, P481; Letnic M, 2015, J APPL ECOL, V52, P341, DOI 10.1111/1365-2664.12390; Long DJ, 1996, GREAT WHITE SHARKS B; Magarry A., 1987, North Queensland Naturalist, P7; McIntyre NE, 1999, LANDSCAPE ECOL, V14, P437, DOI 10.1023/A:1008074407036; Natusch DJD, 2014, J HERPETOL, V48, P317, DOI 10.1670/12-207; Neldner V.J., 1995, VEGETATION CAPE YORK; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; ROBINSON SK, 1985, AUK, V102, P506, DOI 10.1093/auk/102.3.506; Sattler P., 1999, CONSERVATION QUEENSL; Shine R, 2004, BIOL CONSERV, V120, P201, DOI 10.1016/j.biocon.2004.02.014; Thiollay JM, 1998, IBIS, V140, P382, DOI 10.1111/j.1474-919X.1998.tb04599.x; Tingley R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025979; Zuur Alain F., 2009, P1	30	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162651	10.1371/journal.pone.0162651	http://dx.doi.org/10.1371/journal.pone.0162651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706197	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697200018
J	Swanson, CJ; Sommese, RF; Petersen, KJ; Ritt, M; Karslake, J; Thomas, DD; Sivaramakrishnan, S				Swanson, Carter J.; Sommese, Ruth F.; Petersen, Karl J.; Ritt, Michael; Karslake, Joshua; Thomas, David D.; Sivaramakrishnan, Sivaraj			Calcium Stimulates Self-Assembly of Protein Kinase C alpha In Vitro	PLOS ONE			English	Article							SUPRAMOLECULAR CHEMISTRY; HOMO-FRET; PKC-ALPHA; DOMAIN; ACTIVATION; CA2+; ORGANIZATION; MICROSCOPY; MEMBRANES; COMPLEX	Protein kinase C alpha (PKC alpha) is a nodal regulator in several intracellular signaling networks. PKC alpha is composed of modular domains that interact with each other to dynamically regulate spatial-temporal function. We find that PKC alpha specifically, rapidly and reversibly self-assembles in the presence of calcium in vitro. This phenomenon is dependent on, and can be modulated by an intramolecular interaction between the C1a and C2 protein domains of PKC alpha. Next, we monitor self-assembly of PKC-mCitrine fusion proteins using time-resolved and steady-state homoFRET. HomoFRET between full-length PKC alpha molecules is observed when in solution with both calcium and liposomes containing either diacylglycerol (DAG) or phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2). Surprisingly, the C2 domain is sufficient to cluster on liposomes containing PI(4,5)P-2, indicating the C1a domain is not required for self-assembly in this context. We conclude that three distinct clustered states of PKC alpha can be formed depending on what combination of cofactors are bound, but Ca2+ is minimally required and sufficient for clustering.	[Swanson, Carter J.; Karslake, Joshua] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA; [Sommese, Ruth F.; Ritt, Michael; Sivaramakrishnan, Sivaraj] Univ Minnesota Twin Cities, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Petersen, Karl J.; Thomas, David D.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sivaramakrishnan, S (corresponding author), Univ Minnesota Twin Cities, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	sivaraj@umn.edu		Thomas, David D./0000-0002-8822-2040	NIH Small Business Technology Transfer grant [R42 DA037622]; American Heart Association Scientist Development Grant [13SDG14270009]; NIH [1DP2 CA186752-01, 1-R01-GM-105646-01-A1, T32 AR007612]; NATIONAL CANCER INSTITUTE [DP2CA186752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612, R01AR032961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R42DA037622] Funding Source: NIH RePORTER	NIH Small Business Technology Transfer grant; American Heart Association Scientist Development Grant(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The reported time-resolved fluorescence measurements were performed in the Biophysical Technology Center, University of Minnesota, with support from an NIH Small Business Technology Transfer grant (R42 DA037622). This study was supported by the American Heart Association Scientist Development Grant (13SDG14270009) & the NIH (1DP2 CA186752-01 & 1-R01-GM-105646-01-A1) to S.S. K.J.P. was supported by an NIH training grant (T32 AR007612). R.F.S. is a Life Sciences Research Foundation postdoctoral fellow.	Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chinthalapudi K, 2014, J CELL BIOL, V207, P643, DOI 10.1083/jcb.201404128; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Egea-Jimenez AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095973; Egea-Jimenez AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069041; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Evans JH, 2006, MOL BIOL CELL, V17, P56, DOI 10.1091/mbc.e05-06-0499; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Ghosh S, 2012, METHOD ENZYMOL, V505, P291, DOI 10.1016/B978-0-12-388448-0.00024-3; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Huang SM, 1999, BIOCHEMISTRY-US, V38, P12020, DOI 10.1021/bi990594m; Kang CH, 2013, MOL CELLS, V35, P381, DOI 10.1007/s10059-013-2185-0; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lehn JM, 2002, P NATL ACAD SCI USA, V99, P4763, DOI 10.1073/pnas.072065599; LEHN JM, 1985, SCIENCE, V227, P849, DOI 10.1126/science.227.4689.849; Maasch C, 2000, FASEB J, V14, P1653, DOI 10.1096/fj.14.11.1653; Medkova M, 1998, J BIOL CHEM, V273, P17544, DOI 10.1074/jbc.273.28.17544; Muretta JM, 2013, P NATL ACAD SCI USA, V110, P7211, DOI 10.1073/pnas.1222257110; Muretta JM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3480647; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Petersen KJ, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4900727; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Ramakrishnan NA, 2014, J BIOL CHEM, V289, P8750, DOI 10.1074/jbc.M113.480533; Reither G, 2006, J CELL BIOL, V174, P521, DOI 10.1083/jcb.200604033; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sando JJ, 1998, J BIOL CHEM, V273, P34022, DOI 10.1074/jbc.273.51.34022; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Slater SJ, 2002, J BIOL CHEM, V277, P15277, DOI 10.1074/jbc.M112207200; Stahelin RV, 2005, J BIOL CHEM, V280, P36452, DOI 10.1074/jbc.M506224200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; Swanson CJ, 2014, J BIOL CHEM, V289, P17812, DOI 10.1074/jbc.M113.534750; Wang YH, 2012, J AM CHEM SOC, V134, P3387, DOI 10.1021/ja208640t; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Xu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027884; Yang L, 1996, BIOCHEMISTRY-US, V35, P13966, DOI 10.1021/bi9610008; Ziemba BP, 2016, BIOPHYS J, V110, P1811, DOI 10.1016/j.bpj.2016.03.001	43	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162331	10.1371/journal.pone.0162331	http://dx.doi.org/10.1371/journal.pone.0162331			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706148	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697200009
J	Young, AE; Choi, Y				Young, Amanda E.; Choi, YoonSun			Work-Related Factors Considered by Sickness-Absent Employees When Estimating Timeframes for Returning to Work	PLOS ONE			English	Article							LOW-BACK-PAIN; QUALITATIVE DESCRIPTION; RECOVERY EXPECTATIONS; OCCUPATIONAL INJURY; WORKPLACE INJURY; PREDICTORS; OUTCOMES; PATIENT; REHABILITATION; INTERVENTIONS	Introduction Work-related factors have been found to be influential in shaping a number of return-to-work outcomes including return-to-work expectations. Based on the idea that work-related factors have the potential for modification through workplace-based initiatives, this study involved a detailed examination of work-related factors referenced by workers as being taken into consideration when estimating timeframes for returning to work. Methods Focus groups were conducted with 30 employees, currently off work (<= 3 months) due to a musculoskeletal condition. During the focus groups, participants wrote and spoke about the factors that they considered when forming their expectations for returning to work. Data were subjected to thematic content analysis. Results Discussions revealed that participants' considerations tended to differ depending on whether or not they had a job to return to. Those with jobs (n = 23) referenced specific influences such as working relationships, accommodations, physical and practical limitations, as well as concerns about their ability to do their job. Those without a job to return to (n = 7) talked about the ways they would go about finding work, and how long they thought this would take. Both groups mentioned the influence of wanting to find the "right" job, retraining and being limited due to the need for income. Conclusion Findings indicate that employees reference numerous work-related factors when estimating their timeframes for returning to work, and that many of these have been previously identified as relating to other return-to-work outcomes. Findings suggest the potential to improve return-to-work expectation through addressing work-related influences, and helping people work through the tasks they need to complete in order to move forward in the return-to-work process.	[Young, Amanda E.; Choi, YoonSun] Liberty Mutual Res Inst Safety, Ctr Disabil Res, Hopkinton, MA 01748 USA	Liberty Mutual Research Institute for Safety	Young, AE (corresponding author), Liberty Mutual Res Inst Safety, Ctr Disabil Res, Hopkinton, MA 01748 USA.	amandae.young@libertymutual.com	Normandeau, Amanda/HHN-8881-2022; Young, Amanda Ellen/HDN-1629-2022	Young, Amanda Ellen/0000-0002-7288-3469				Boot CRL, 2014, INT ARCH OCC ENV HEA, V87, P871, DOI 10.1007/s00420-014-0928-7; Bultmann U, 2009, J OCCUP REHABIL, V19, P81, DOI 10.1007/s10926-009-9162-7; Denzin N.K., 2013, LANDSCAPE QUALITATIV; Durand M-J, 2013, HDB WORK DISABILITY, P229, DOI [10.1007/978-3-319-08825-9_5, DOI 10.1007/978-3-319-08825-9_5]; Ebrahim S, 2015, J OCCUP REHABIL, V25, P240, DOI 10.1007/s10926-014-9535-4; Ekberg K, 2015, J OCCUP REHABIL, V25, P627, DOI 10.1007/s10926-015-9570-9; Fadyl J, 2008, J OCCUP REHABIL, V18, P362, DOI 10.1007/s10926-008-9153-0; Hepburn CG, 2010, J OCCUP HEALTH PSYCH, V15, P409, DOI 10.1037/a0021001; Iles RA, 2012, J REHABIL MED, V44, P781, DOI 10.2340/16501977-1019; Iles RA, 2009, J OCCUP REHABIL, V19, P25, DOI 10.1007/s10926-008-9161-0; Johnston V, 2015, J OCCUP REHABIL, V25, P3, DOI 10.1007/s10926-014-9511-z; Katz JN, 2005, AM J IND MED, V47, P120, DOI 10.1002/ajim.20127; Levvic C, 2014, BMJ OPEN, V4, DOI [10.1136/bmjopen-2013-004321, DOI 10.1136/BMJOPEN-2013-004321]; Marnetoft S.-U., 2015, HDB VOCATIONAL REHAB, P73, DOI [10.1007/978-3-319-08825-9_5, DOI 10.1007/978-3-319-08825-9_5]; Murphy GC, 2006, INT J DISABILITY MAN, V1, P125; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Nevala N, 2015, J OCCUP REHABIL, V25, P432, DOI 10.1007/s10926-014-9548-z; OLIVER RL, 1987, J ECON PSYCHOL, V8, P469, DOI 10.1016/0167-4870(87)90037-7; Peerdeman KJ, 2016, PAIN, V157, P1179, DOI 10.1097/j.pain.0000000000000540; Quaigrain R, 2014, 30 ARCOM ANN C; Rushworth N., 2008, BRAIN INJURY A UNPUB; Sampere M, 2012, J OCCUP REHABIL, V22, P15, DOI 10.1007/s10926-011-9313-5; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Seing I, 2015, DISABIL REHABIL, V37, P1760, DOI 10.3109/09638288.2014.978509; Shaw WS, 2013, J OCCUP ENVIRON MED, V55, P885, DOI 10.1097/JOM.0b013e318289ee6c; Shaw WS, 2009, J OCCUP REHABIL, V19, P64, DOI 10.1007/s10926-008-9159-7; Steenstra IA, 2015, J OCCUP REHABIL, V25, P267, DOI 10.1007/s10926-014-9534-5; Stergiou-Kita M, 2014, J BURN CARE RES, V35, P498, DOI 10.1097/BCR.0000000000000041; Stochkendahl MJ, 2015, J OCCUP REHABIL, V25, P752, DOI 10.1007/s10926-015-9583-4; Street TD, 2015, WORK, V51, P373, DOI 10.3233/WOR-141980; Sullivan MJL, 2008, J OCCUP REHABIL, V18, P249, DOI 10.1007/s10926-008-9140-5; Sullivan MJL, 2005, J OCCUP REHABIL, V15, P475, DOI 10.1007/s10926-005-8029-9; Young AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143330; Young AE, 2015, DISABIL REHABIL, V37, P1808, DOI 10.3109/09638288.2014.979299; Young AE, 2014, DISABIL REHABIL, V36, P914, DOI 10.3109/09638288.2013.824033; Young AE, 2010, SCAND J WORK ENV HEA, V36, P473, DOI 10.5271/sjweh.2986	37	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163674	10.1371/journal.pone.0163674	http://dx.doi.org/10.1371/journal.pone.0163674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706194	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200052
J	de Araujo, MA; Marques, TEBS; Octacilio-Silva, S; de Arroxelas-Silva, CL; Pereira, MGAG; Peixoto-Santos, JE; Kandratavicius, L; Leite, JP; Garcia-Cairasco, N; Castro, OW; Duzzioni, M; Passos, GA; Paco-Larson, ML; Gitai, DLG				de Araujo, Mykaella Andrade; Batista Sales Marques, Thalita Ewellyn; Octacilio-Silva, Shirley; de Arroxelas-Silva, Carmem Lucia; Alves Goulart Pereira, Marina Gabriella; Peixoto-Santos, Jose Eduardo; Kandratavicius, Ludmyla; Leite, Joao Pereira; Garcia-Cairasco, Norberto; Castro, Olagide Wagner; Duzzioni, Marcelo; Passos, Geraldo Aleixo; Paco-Larson, Maria Luisa; Goes Gitai, Daniel Leite			Identification of microRNAs with Dysregulated Expression in Status Epilepticus Induced Epileptogenesis	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; PI3K/AKT/MTOR SIGNALING PATHWAY; RAT MODEL; NEURONAL EXCITABILITY; GENE-EXPRESSION; MOUSE MODELS; SEIZURE; HIPPOCAMPUS; PROFILES; BRAIN	The involvement of miRNA in mesial temporal lobe epilepsy (MTLE) pathogenesis has increasingly become a focus of epigenetic studies. Despite advances, the number of known miRNAs with a consistent expression response during epileptogenesis is still small. Addressing this situation requires additional miRNA profiling studies coupled to detailed individual expression analyses. Here, we perform a miRNA microarray analysis of the hippocampus of Wistar rats 24 hours after intra-hippocampal pilocarpine-induced Status Epilepticus (H-PILO SE). We identified 73 miRNAs that undergo significant changes, of which 36 were up-regulated and 37 were down-regulated. To validate, we selected 5 of these (10a-5p, 128a-3p, 196b-5p, 352 and 324-3p) for RT-qPCR analysis. Our results confirmed that miR-352 and 196b-5p levels were significantly higher and miR-128a-3p levels were significantly lower in the hippocampus of H-PILO SE rats. We also evaluated whether the 3 miRNAs show a dysregulated hippocampal expression at three time periods (0h, 24h and chronic phase) after systemic pilocarpine-induced status epilepticus (S-PILO SE). We demonstrate that miR-128a-3p transcripts are significantly reduced at all time points compared to the naive group. Moreover, miR-196b-5p was significantly higher only at 24h post-SE, while miR-352 transcripts were significantly up-regulated after 24h and in chronic phase (epileptic) rats. Finally, when we compared hippocampi of epileptic and non-epileptic humans, we observed that transcript levels of miRNAs show similar trends to the animal models. In summary, we successfully identified two novel dysregulated miRNAs (196b-5p and 352) and confirmed miR-128a-3p downregulation in SE-induced epileptogenesis. Further functional assays are required to understand the role of these miRNAs in MTLE pathogenesis.	[de Araujo, Mykaella Andrade; Batista Sales Marques, Thalita Ewellyn; de Arroxelas-Silva, Carmem Lucia; Goes Gitai, Daniel Leite] Univ Fed Alagoas, Dept Cellular & Mol Biol, Inst Biol Sci & Hlth, Maceio, Alagoas, Brazil; [Octacilio-Silva, Shirley] Univ Fed Sergipe, Dept Morphol, Hlth & Biol Sci Ctr, Aracaju, Sergipe, Brazil; [Alves Goulart Pereira, Marina Gabriella] Univ Fed Alfenas, Inst Biol Sci, Dept Biochem, Alfenas, MG, Brazil; [Peixoto-Santos, Jose Eduardo; Kandratavicius, Ludmyla; Leite, Joao Pereira] Univ Sao Paulo, Ribeirao Preto Sch Med, Div Neurol, Dept Neurosci & Behav Sci, Sao Paulo, Brazil; [Garcia-Cairasco, Norberto] Univ Sao Paulo, Dept Physiol, Ribeirao Preto Med Sch, Sao Paulo, Brazil; [Castro, Olagide Wagner; Duzzioni, Marcelo] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Physiol & Pharmacol, Maceio, Alagoas, Brazil; [Passos, Geraldo Aleixo] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Sao Paulo, Brazil; [Paco-Larson, Maria Luisa] Univ Sao Paulo, Dept Cellular & Mol Biol, Ribeirao Preto Med Sch, Sao Paulo, Brazil	Universidade Federal de Alagoas; Universidade Federal de Sergipe; Universidade Federal de Alfenas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade de Sao Paulo	Gitai, DLG (corresponding author), Univ Fed Alagoas, Dept Cellular & Mol Biol, Inst Biol Sci & Hlth, Maceio, Alagoas, Brazil.	danielgitai@gmail.com	Duzzioni, Marcelo/C-6797-2015; Peixoto-Santos, Jose Eduardo/L-5123-2013; Gitai, Daniel LG/A-7982-2019; Kandratavicius, Ludmyla/H-2494-2013; Leite, Joao/B-9070-2012; Passos, Geraldo A/A-2899-2008; Passos, Geraldo Aleixo/ABE-3251-2020; Castro, Olagide/C-6781-2015; de Araújo, Mykaella Andrade/X-3778-2018; Paço-Larson, Maria L/I-8613-2012; Cairasco, Norberto Garcia/E-3250-2015	Peixoto-Santos, Jose Eduardo/0000-0001-7461-1902; Gitai, Daniel LG/0000-0001-7056-2373; Kandratavicius, Ludmyla/0000-0003-4387-5977; Leite, Joao/0000-0003-0558-3519; Passos, Geraldo A/0000-0002-4408-140X; Passos, Geraldo Aleixo/0000-0002-4408-140X; Castro, Olagide/0000-0002-1874-509X; Cairasco, Norberto Garcia/0000-0001-8857-3775; Araujo, Mykaella/0000-0002-6425-2595	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [484911/2012-0]; Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/17590-3, 2015/208409]; Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA-HCRP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA-HCRP)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant number: 484911/2012-0; DLG, JPL, NGC, MLP; Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL), DLG, TEBSM; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), MM, TEBSM; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant numbers: 2016/17590-3 and 2015/208409, JPL, NGC, MLP; and Fundacao de Apoio ao Ensino Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPA-HCRP), JPL, NGC, MLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsharafi W, 2015, CNS NEUROL DISORD-DR, V14, P1096, DOI 10.2174/1871527314666150317225945; Ashhab MU, 2013, J MOL NEUROSCI, V51, P950, DOI 10.1007/s12031-013-0013-9; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Marques TEBS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071892; Bot AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076051; Coulter DA, 1999, EPILEPSIA, V40, pS23, DOI 10.1111/j.1528-1157.1999.tb00875.x; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; Santos EAD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141121; Dai EY, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau023; de Araujo MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100529; Dogini DB, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00172; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elliott RC, 2003, J NEUROSCI, V23, P2218; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Engel T, 2013, BRAIN, V136, P577, DOI 10.1093/brain/aws337; Engel Tobias, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P97; Fiorenza A, 2016, CEREB CORTEX, V26, P1619, DOI 10.1093/cercor/bhu332; Gaignard P, 2013, GENE, V512, P521, DOI 10.1016/j.gene.2012.09.124; Gall CM, 2004, ADV EXP MED BIOL, V548, P12; Gitai DLG, 2011, BRAIN RES, V1367, P114, DOI 10.1016/j.brainres.2010.10.069; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Gorter JA, 2014, NEUROBIOL DIS, V62, P508, DOI 10.1016/j.nbd.2013.10.026; Hansen KF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06930; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Henshall DC, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00037; Henshall DC, 2013, EPILEPSIA, V54, P17, DOI 10.1111/epi.12267; Hu K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-115; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Hunsberger JG, 2005, MOL BRAIN RES, V141, P95, DOI 10.1016/j.molbrainres.2005.08.005; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jimenez-Mateos EM, 2013, NEUROSCIENCE, V238, P218, DOI 10.1016/j.neuroscience.2013.02.027; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Jimenez-Mateos EM, 2008, NEUROBIOL DIS, V32, P442, DOI 10.1016/j.nbd.2008.08.008; Kandratavicius L, 2014, NEUROPSYCH DIS TREAT, V10, P1693, DOI 10.2147/NDT.S50371; Kim GW, 2009, NEUROBIOL DIS, V36, P169, DOI 10.1016/j.nbd.2009.07.008; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kobow K, 2011, EPILEPSIA, V52, P15, DOI 10.1111/j.1528-1167.2011.03145.x; Kretschmann A, 2015, J MOL NEUROSCI, V55, P466, DOI 10.1007/s12031-014-0368-6; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lauren HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010733; Lee DY, 2015, BIOCHEM BIOPH RES CO, V462, P433, DOI 10.1016/j.bbrc.2015.04.149; Lewis DV, 2005, EPILEPSIA, V46, P39, DOI 10.1111/j.1528-1167.2005.00306.x; Li MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04734; Li N, 2016, ONCOL LETT, V11, P1745, DOI 10.3892/ol.2016.4141; Lukasiuk K, 2003, EUR J NEUROSCI, V17, P271, DOI 10.1046/j.1460-9568.2003.02461.x; Lukiw WJ, 2012, MOL NEUROBIOL, V46, P11, DOI 10.1007/s12035-012-8234-4; Macedo C, 2013, IMMUNOBIOLOGY, V218, P554, DOI 10.1016/j.imbio.2012.06.013; Magwire MM, 2003, NEUROSCIENCE, V18, P2792, DOI [10.1371/journal.pgen.1002337, DOI 10.1371/JOURNAL.PGEN.1002337]; Mazzuferi M, 2013, ANN NEUROL, V74, P560, DOI 10.1002/ana.23940; McClelland S, 2011, ANN NEUROL, V70, P454, DOI 10.1002/ana.22479; McKiernan RC, 2012, EXP NEUROL, V237, P346, DOI 10.1016/j.expneurol.2012.06.029; McKiernan RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035921; MELDRUM B, 1991, EPILEPSY RES, V10, P55, DOI 10.1016/0920-1211(91)90095-W; Miller-Delaney SFC, 2015, BRAIN, V138, P616, DOI 10.1093/brain/awu373; Moon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085617; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Pichardo-Casas I, 2012, BRAIN RES, V1436, P20, DOI 10.1016/j.brainres.2011.12.001; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rami A, 2016, NEUROCHEM RES, V41, P53, DOI 10.1007/s11064-015-1704-0; Reschke CR, 2015, ADV EXP MED BIOL, V888, P41, DOI 10.1007/978-3-319-22671-2_4; Risbud RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053464; Romcy-Pereira RN, 2008, REV ASSOC MED BRAS, V54, P461; Roncon P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14143; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schouten M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12448; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Sun ZZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055124, 10.1371/journal.pone.0055249, 10.1371/journal.pone.0074672]; Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193; Tao J, 2015, NEUROSCIENCE, V305, P1, DOI 10.1016/j.neuroscience.2015.07.064; Torres-Peraza JF, 2013, BRAIN, V136, P1161, DOI 10.1093/brain/awt044; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Weinberg MS, 2013, EXP NEUROL, V247, P429, DOI 10.1016/j.expneurol.2013.01.011; Williams PA, 2007, EPILEPSIA, V48, P157, DOI 10.1111/j.1528-1167.2007.01304.x; Wu X, 2012, PHARMACOL THERAPEUT, V134, P68, DOI 10.1016/j.pharmthera.2011.12.008; Xiao ZH, 2015, J NEUROIMMUNOL, V282, P110, DOI 10.1016/j.jneuroim.2015.04.003; You G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046218; Zhang J, 2011, J BIOL CHEM, V286, P7669, DOI 10.1074/jbc.M110.156299	83	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163855	10.1371/journal.pone.0163855	http://dx.doi.org/10.1371/journal.pone.0163855			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695061	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100057
J	Sawin, EA; Stroup, BM; Murali, SG; O'Neill, LM; Ntambi, JM; Ney, DM				Sawin, Emily A.; Stroup, Bridget M.; Murali, Sangita G.; O'Neill, Lucas M.; Ntambi, James M.; Ney, Denise M.			Differential Effects of Dietary Fat Content and Protein Source on Bone Phenotype and Fatty Acid Oxidation in Female C57Bl/6 Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; WHEY-PROTEIN; BOVINE GLYCOMACROPEPTIDE; ABDOMINAL ADIPOSITY; MINERAL DENSITY; SKELETAL-MUSCLE; RECEPTOR-ALPHA; ENERGY-INTAKE; BODY-MASS; OBESITY	Background Glycomacropeptide (GMP) is a 64-amino acid glycophosphopeptide released from kappa-casein during cheesemaking that promotes satiety, reduces body fat, increases bone mass and infers prebiotic and anti-inflammatory effects. The impact of adiposity and gender on bone health is unclear. Objective To determine how feeding female mice diets providing 60% Fat Kcal (high-fat) or 13% Fat Kcal (control) with either GMP or casein as the protein source impacts: body composition, ex vivo fatty acid oxidation, bone (femoral) biomechanical performance, and the relationship between body composition and bone. Methods Weanling female C57Bl/6 mice were fed high-fat (60% Fat Kcal) or control diets (13% Fat Kcal) with GMP or casein from 3 to 32 weeks of age with assessment of body weight and food intake. Body composition was assessed by dual-energy X-ray absorptiometry (DXA). Fatty acid oxidation was measured in liver, muscle, and fat tissues using 14 C-palmitate. Plasma concentrations of hormones and cytokines were determined. Bone biomechanical performance was assessed by the 3-point bending test. Results Female mice fed high-fat diets showed increased fatty acid oxidation capacity in both gastrocnemius muscle and brown adipose tissue compared to mice fed the control diets with a lower fat content. Despite increased fat mass in mice fed the high-fat diets, there was little evidence of glucose impairment or inflammation. Mice fed the high-fat diets had significantly greater total body bone mineral density (BMD), femoral BMD, and femoral cross-sectional area than mice fed the control diets. Femora of mice fed the high-fat diets had increased yield load and maximum load before fracture, consistent with greater bone strength, but reduced post-yield displacement or ductility, consistent with bone brittleness. Female mice fed a high-fat GMP diet displayed increased fat oxidation capacity in subcutaneous fat relative to mice fed the high-fat casein diet. Regardless of dietary fat content, GMP increased total body bone mineral content and femur length. The prebiotic properties of GMP may mediate the beneficial effects of GMP on bone. Conclusions Female mice adapt to high-fat feeding by increasing oxidative capacity in muscle tissue and to a lesser extent brown adipose tissue. High-fat feeding in female mice leads to development of a bone phenotype where femora show increased BMD and are stronger, yet more brittle. The increased brittleness of bone was associated with increased body fat content due to high-fat feeding. In summary, high-fat feeding in female mice increases mineralization of bone, but negatively impacts bone quality resulting in brittle bones.	[Sawin, Emily A.; Stroup, Bridget M.; Murali, Sangita G.; Ney, Denise M.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA; [O'Neill, Lucas M.; Ntambi, James M.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ney, DM (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	ney@nutrsci.wisc.edu	Stroup, Bridget/AAR-7645-2021	Ney, Denise/0000-0002-2260-5313; Stroup, Bridget M./0000-0001-9755-7937	Wisconsin Alumni Research Foundation; National Institutes of Health [T32 DK 007665]; United States Department of Agriculture HATCH grant [WIS01790]; American Diabetes Association [7-13-BS-540118]; United States Department of Agriculture HATCH [WIS02005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER	Wisconsin Alumni Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture HATCH grant; American Diabetes Association(American Diabetes Association); United States Department of Agriculture HATCH(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by Wisconsin Alumni Research Foundation Accelerator Grant, to DMN; National Institutes of Health T32 DK 007665, to DMN; United States Department of Agriculture HATCH grant WIS01790, to DMN; American Diabetes Association 7-13-BS-540118, to JMN; and United States Department of Agriculture HATCH WIS02005, to JMN. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimutis WR, 2004, J NUTR, V134, p989S, DOI 10.1093/jn/134.4.989S; Becker R, 1988, COMPUTER SCI SERIES; BEUCHER S, 1994, J NUTR BIOCHEM, V5, P578, DOI 10.1016/0955-2863(94)90012-4; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Burns P, 2015, INT DAIRY J, V44, P15, DOI 10.1016/j.idairyj.2014.12.005; Burton-Freeman BM, 2008, PHYSIOL BEHAV, V93, P379, DOI 10.1016/j.physbeh.2007.09.010; Camporez JPG, 2013, ENDOCRINOLOGY, V154, P1021, DOI 10.1210/en.2012-1989; Clark EM, 2006, J CLIN ENDOCR METAB, V91, P2534, DOI 10.1210/jc.2006-0332; Clifton PM, 2009, AUST J DAIRY TECHNOL, V64, P29; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; DELFOUR A, 1965, BIOCHEM BIOPH RES CO, V19, P452, DOI 10.1016/0006-291X(65)90145-2; Etzel MR, 2004, J NUTR, V134, p996S, DOI 10.1093/jn/134.4.996S; FORBES GB, 1983, INT J OBESITY, V7, P99; Franco GEL, 2004, J CLIN DENSITOM, V7, P326; Gautam J, 2014, BRIT J NUTR, V111, P1811, DOI 10.1017/S0007114514000051; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gilsanz V, 2009, J CLIN ENDOCR METAB, V94, P3387, DOI 10.1210/jc.2008-2422; Guilloteau P, 2010, REGUL PEPTIDES, V159, P129, DOI 10.1016/j.regpep.2009.09.003; Hegarty BD, 2002, DIABETES, V51, P1477, DOI 10.2337/diabetes.51.5.1477; Henagan TM, 2015, BRIT J PHARMACOL, V172, P2782, DOI 10.1111/bph.13058; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Ionova-Martin SS, 2010, BONE, V46, P217, DOI 10.1016/j.bone.2009.10.015; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Keogh JB, 2008, AM J CLIN NUTR, V87, P1602, DOI 10.1093/ajcn/87.6.1602; Lam SMSCC, 2009, PHYSIOL BEHAV, V96, P162, DOI 10.1016/j.physbeh.2008.09.022; Lee K, 2008, NUTRITION, V24, P625, DOI 10.1016/j.nut.2008.03.004; Li CJ, 2008, DEV BIOLOGICALS, V132, P391, DOI 10.1159/000317190; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Posadas R, 2010, J NUTR, V140, P2014, DOI 10.3945/jn.109.118448; MacLeod EL, 2010, MOL GENET METAB, V100, P303, DOI 10.1016/j.ymgme.2010.04.003; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Neeser JR E, INVENTORMILK PROTEIN; Nguyen ND, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-11; Nielson CM, 2012, J BONE MINER RES, V27, P1, DOI 10.1002/jbmr.1486; *NRC, 1995, NUTR REQ LAB AN, P80, DOI DOI 10.1038/NATURE08778; Ohlsson C, 2015, TRENDS ENDOCRIN MET, V26, P69, DOI 10.1016/j.tem.2014.11.004; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pettersson US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046057; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Reid IR, 2010, ARCH BIOCHEM BIOPHYS, V503, P20, DOI 10.1016/j.abb.2010.06.027; Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5; Requena P, 2008, BRIT J PHARMACOL, V154, P825, DOI 10.1038/bjp.2008.138; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rogers NH, 2009, ENDOCRINOLOGY, V150, P2161, DOI 10.1210/en.2008-1405; Royle PJ, 2008, BRIT J NUTR, V100, P88, DOI 10.1017/S0007114507883000; Saless N, 2011, BONE, V48, P647, DOI 10.1016/j.bone.2010.10.165; Saless N, 2009, FASEB J, V23, P2142, DOI 10.1096/fj.08-118679; Sawin EA, 2015, AM J PHYSIOL-GASTR L, V309, pG590, DOI 10.1152/ajpgi.00211.2015; Solomon G, 2014, AM J PHYSIOL-ENDOC M, V306, pE14, DOI 10.1152/ajpendo.00155.2013; Solverson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045165; Solverson P, 2012, AM J PHYSIOL-ENDOC M, V302, pE885, DOI 10.1152/ajpendo.00647.2011; Steppan CM, 2000, REGUL PEPTIDES, V92, P73, DOI 10.1016/S0167-0115(00)00152-X; Stroup B, 2015, FASEB J, V29, P274; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Thoma-Worringer C, 2006, INT DAIRY J, V16, P1324, DOI 10.1016/j.idairyj.2006.06.012; Travison TG, 2008, J BONE MINER RES, V23, P189, DOI 10.1359/JBMR.071016; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; van Calcar SC, 2012, J ACAD NUTR DIET, V112, P1201, DOI 10.1016/j.jand.2012.05.004; Veldhorst MAB, 2009, APPETITE, V52, P388, DOI 10.1016/j.appet.2008.11.014; Venables WN, 2002, MODERN APPL STAT S, DOI [10.1007/978-0-387-21708-2, DOI 10.1007/978-0-387-21708-2]; Weaver CM, 2011, J AGR FOOD CHEM, V59, P6501, DOI 10.1021/jf2009777; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu SP, 2013, FOOD CHEM TOXICOL, V56, P1, DOI 10.1016/j.fct.2013.01.027; Yonezawa T, 2007, CELL SIGNAL, V19, P185, DOI 10.1016/j.cellsig.2006.06.004; Yoo HJ, 2012, J BONE MINER METAB, V30, P47, DOI 10.1007/s00774-011-0283-7; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	71	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163234	10.1371/journal.pone.0163234	http://dx.doi.org/10.1371/journal.pone.0163234			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695036	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100026
J	Tawiah, T; Hansen, KS; Baiden, F; Bruce, J; Tivura, M; Delimini, R; Amengo-Etego, S; Chandramohan, D; Owusu-Agyei, S; Webster, J				Tawiah, Theresa; Hansen, Kristian Schultz; Baiden, Frank; Bruce, Jane; Tivura, Mathilda; Delimini, Rupert; Amengo-Etego, Seeba; Chandramohan, Daniel; Owusu-Agyei, Seth; Webster, Jayne			Cost-Effectiveness Analysis of Test-Based versus Presumptive Treatment of Uncomplicated Malaria in Children under Five Years in an Area of High Transmission in Central Ghana	PLOS ONE			English	Article							RAPID DIAGNOSTIC-TESTS; EFFECTIVENESS ACCEPTABILITY CURVES; SUB-SAHARAN AFRICA; COMBINATION THERAPY; BENEFIT-ANALYSIS; CASE-MANAGEMENT; MICROSCOPY; TANZANIA; DEPLOYMENT; ACCURACY	Background The presumptive approach of confirming malaria in health facilities leads to over-diagnosis of malaria, over use of anti-malaria drugs and the risk of drug resistance development. WHO recommends parasitological confirmation before treatment with artemisinin-based combination therapy (ACT) in all suspected malaria patients. The use of malaria rapid diagnostic tests (mRDTs) would make it possible for prescribers to diagnose malaria at point-of-care and better target the use of antimalarials. Therefore, a cost-effectiveness analysis was performed on the introduction of mRDTs for management of malaria in under-five children in a high transmission area in Ghana where presumptive diagnosis was the norm in public health centres. Methods A cluster-randomised controlled trial where thirty-two health centres were randomised into test-based diagnosis of malaria using mRDTs (intervention) or clinical judgement (control) was used to measure the effect of mRDTs on appropriate treatment: 'a child with a positive reference diagnosis prescribed a course of ACT or a child with a negative reference diagnosis not given an ACT'. Cost data was collected from five purposively selected health centres and used to estimate the health sector costs of performing an mRDT and treat children for malaria and other common febrile illnesses. Costs of training healthcare personnel and supervision in the study period were also collected. A sample of caregivers to children participating in the trial was interviewed about household cost incurred on transport, drugs, fees, and special food during a period of one week after the health centre visit as well as days unable to work. A decision model approach was used to calculate the incremental cost-effectiveness ratios (ICERs). Univariate and multivariate sensitivity analyses were applied to assess the robustness of ICERs. Results The availability of mRDTs for malaria diagnosis resulted in fewer ACT treatments compared to the clinical judgement approach (73% versus 81%) and more children appropriately treated (70% versus 57%). The introduction of mRDT-based diagnosis would cost the Ministry of Health US$18.6 per extra appropriately treated child under five compared to clinical judgement while the ICER from a societal perspective was lower at US$11.0 per appropriately treated child. ICERs were sensitive to a decrease in adherence to negative mRDTs, malaria positivity rate and specificity of the mRDT. Conclusion The introduction of mRDTs is likely to be considered cost-effective in this high transmission setting as this intervention increased the number of appropriately treated children at low cost.	[Tawiah, Theresa; Tivura, Mathilda; Delimini, Rupert; Amengo-Etego, Seeba; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo Reg, Ghana; [Hansen, Kristian Schultz] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England; [Hansen, Kristian Schultz] Univ Copenhagen, Sect Hlth Serv Res, Dept Publ Hlth, Copenhagen, Denmark; [Baiden, Frank] Ensign Coll Publ Hlth, Epidemiol Unit, Kpong, Eastern Region, Ghana; [Bruce, Jane; Chandramohan, Daniel; Webster, Jayne] London Sch Hyg & Trop Med, Dept Dis Control, London, England	Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine; University of Copenhagen; University of London; London School of Hygiene & Tropical Medicine	Hansen, KS (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England.; Hansen, KS (corresponding author), Univ Copenhagen, Sect Hlth Serv Res, Dept Publ Hlth, Copenhagen, Denmark.	krha@sund.ku.dk	Baiden, Frank/AAF-7309-2020; Baiden, Frank/Q-2018-2019	Baiden, Frank/0000-0003-0141-6561; Webster, Jayne/0000-0002-0498-8883; Owusu-Agyei, Seth/0000-0002-0807-1781	ACT Consortium through a grant from the Bill and Melinda Gates Foundation; Robert S. McNamara Fellowship Program at the World Bank	ACT Consortium through a grant from the Bill and Melinda Gates Foundation; Robert S. McNamara Fellowship Program at the World Bank	This research was funded by the ACT Consortium (www.actconstortium.org) through a grant from the Bill and Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. Frank Baiden is supported by a grant from the Robert S. McNamara Fellowship Program at the World Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, T3 TEST TREAT TRACK; Ansah EK, 2013, AM J TROP MED HYG, V89, P724, DOI 10.4269/ajtmh.13-0033; Baiden F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152960; Baiden F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028944; Barnish G, 2004, BMJ-BRIT MED J, V328, P1511, DOI 10.1136/bmj.328.7455.1511; Batwala V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-372; Bisoffi Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-226; Bloland PB, 2003, J EXP BIOL, V206, P3761, DOI 10.1242/jeb.00637; Briggs A, 2006, DECISION MODELLING H; Briggs A., 2001, EC EVALUATION HLTH C; Brouwer W, 2001, EC EVALUATION HLTH C; Chanda Pascalina, 2009, Cost Eff Resour Alloc, V7, P5, DOI 10.1186/1478-7547-7-5; Conteh L, 2004, HEALTH POLICY PLANN, V19, P127, DOI 10.1093/heapol/czh015; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Font F, 2001, TROP MED INT HEALTH, V6, P423, DOI 10.1046/j.1365-3156.2001.00727.x; Ghana Statistical Service, 2014, GHAN LIV STAND SURV, P6; Glick H, 2007, EC EVALUATION CLIN T; Hansen KS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0696-1; Kamal-Yanni MM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-414; Lemma Hailemariam, 2011, Cost Eff Resour Alloc, V9, P2, DOI 10.1186/1478-7547-9-2; Lothgren M, 2000, HEALTH ECON, V9, P623, DOI 10.1002/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Lubell Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-21; Mangham-Jefferies L, 2014, VALUE HEALTH, V17, P783, DOI 10.1016/j.jval.2014.07.010; Masanja MI, 2010, AM J TROP MED HYG, V83, P1238, DOI 10.4269/ajtmh.2010.10-0194; Mwangi TW, 2005, TROP MED INT HEALTH, V10, P530, DOI 10.1111/j.1365-3156.2005.01439.x; Mwanziva C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-232; Nosten F, 2004, J Postgrad Med, V50, P35; O'Brien BJ, 2002, STAT METHODS MED RES, V11, P455, DOI 10.1191/0962280202sm304ra; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Phillips V, 2015, HEALTH AFFAIR, V34, P1196, DOI 10.1377/hlthaff.2015.0095; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Uzochukwu BSC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-265; Walker D, 2002, HEALTH POLICY PLANN, V17, P112, DOI 10.1093/heapol/17.1.112; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2016, EVALUATION RAPID DIA; World Health Organization, 2015, WORLD MAL REP 2015 W; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x	42	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164055	10.1371/journal.pone.0164055	http://dx.doi.org/10.1371/journal.pone.0164055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695130	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000385553100082
J	Zhou, QQ; Sun, WJ; Liu, XY; Wang, XL; Xiao, YC; Bi, DR; Yin, JD; Shi, DS				Zhou, Qiongqiong; Sun, Wenjuan; Liu, Xiyan; Wang, Xiliang; Xiao, Yuncai; Bi, Dingren; Yin, Jingdong; Shi, Deshi			Third-Generation Sequencing and Analysis of Four Complete Pig Liver Esterase Gene Sequences in Clones Identified by Screening BAC Library	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; PICHIA-PASTORIS; CLONING; ISOENZYMES; CARBOXYLESTERASE	Aim Pig liver carboxylesterase (PLE) gene sequences in GenBank are incomplete, which has led to difficulties in studying the genetic structure and regulation mechanisms of gene expression of PLE family genes. The aim of this study was to obtain and analysis of complete gene sequences of PLE family by screening from a Rongchang pig BAC library and third-generation PacBio gene sequencing. Methods After a number of existing incomplete PLE isoform gene sequences were analysed, primers were designed based on conserved regions in PLE exons, and the whole pig genome used as a template for Polymerase chain reaction (PCR) amplification. Specific primers were then selected based on the PCR amplification results. A three-step PCR screening method was used to identify PLE-positive clones by screening a Rongchang pig BAC library and PacBio third-generation sequencing was performed. BLAST comparisons and other bioinformatics methods were applied for sequence analysis. Results Five PLE-positive BAC clones, designated BAC-10, BAC-70, BAC-75, BAC-119 and BAC-206, were identified. Sequence analysis yielded the complete sequences of four PLE genes, PLE1, PLE-B9, PLE-C4, and PLE-G2. Complete PLE gene sequences were defined as those containing regulatory sequences, exons, and introns. It was found that, not only did the PLE exon sequences of the four genes show a high degree of homology, but also that the intron sequences were highly similar. Additionally, the regulatory region of the genes contained two 720bps reverse complement sequences that may have an important function in the regulation of PLE gene expression. Significance This is the first report to confirm the complete sequences of four PLE genes. In addition, the study demonstrates that each PLE isoform is encoded by a single gene and that the various genes exhibit a high degree of sequence homology, suggesting that the PLE family evolved from a single ancestral gene. Obtaining the complete sequences of these PLE genes provides the necessary foundation for investigation of the genetic structure, function, and regulatory mechanisms of the PLE gene family.	[Zhou, Qiongqiong; Liu, Xiyan; Wang, Xiliang; Xiao, Yuncai; Bi, Dingren; Shi, Deshi] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Zhou, Qiongqiong; Liu, Xiyan; Wang, Xiliang; Xiao, Yuncai; Bi, Dingren; Shi, Deshi] Huazhong Agr Univ, Coll Vet Med, Key Lab Dev Vet Diagnost Prod, Minist Agr, Wuhan, Hubei, Peoples R China; [Sun, Wenjuan; Yin, Jingdong] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Shi, DS (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.; Shi, DS (corresponding author), Huazhong Agr Univ, Coll Vet Med, Key Lab Dev Vet Diagnost Prod, Minist Agr, Wuhan, Hubei, Peoples R China.; Yin, JD (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China.	yinjd@cau.edu.cn; rock@mail.hzau.edu.cn		Yin, Jingdong/0000-0003-4623-0568	China National Natural Science Foundation of China [31372484]; National Key Technology R&D Program of China [2015BAD03B02]	China National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was supported by: Deshi Shi: China National Natural Science Foundation of China (grant number 31372484) and the National Key Technology R&D Program of China (grant number 2015BAD03B02).	ADLER AJ, 1961, J BIOL CHEM, V236, P3240; Brusehaber E, 2009, BIOORGAN MED CHEM, V17, P7878, DOI 10.1016/j.bmc.2009.10.033; David L, 1998, EUR J BIOCHEM, V257, P142, DOI 10.1046/j.1432-1327.1998.2570142.x; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; FARB D, 1980, ARCH BIOCHEM BIOPHYS, V203, P214, DOI 10.1016/0003-9861(80)90171-X; Hasenpusch D, 2011, J MOL MODEL, V17, P1493, DOI 10.1007/s00894-010-0846-x; Hermann M, 2008, J BIOTECHNOL, V133, P301, DOI 10.1016/j.jbiotec.2007.10.010; Hummel A, 2007, ANGEW CHEM INT EDIT, V46, P8492, DOI 10.1002/anie.200703256; JUNGE W, 1979, EUR J BIOCHEM, V95, P519, DOI 10.1111/j.1432-1033.1979.tb12992.x; Lange S, 2001, CHEMBIOCHEM, V2, P576, DOI 10.1002/1439-7633(20010803)2:7/8<576::AID-CBIC576>3.3.CO;2-P; Liu L, 2010, BIOCHEM BIOPH RES CO, V391, P1280, DOI 10.1016/j.bbrc.2009.12.060; Liu ZQ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0064-8; Morris Andrew P, 2008, Drug Metab Lett, V2, P275, DOI 10.2174/187231208786734111; Musidlowska A, 2001, ANGEW CHEM INT EDIT, V40, P2851, DOI 10.1002/1521-3773(20010803)40:15<2851::AID-ANIE2851>3.0.CO;2-V; Musidlowska-Persson A, 2003, PROTEIN ENG, V16, P1139, DOI 10.1093/protein/gzg120; Roberti M, 2000, TETRAHEDRON-ASYMMETR, V11, P4397, DOI 10.1016/S0957-4166(00)00404-3; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714	17	2	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163295	10.1371/journal.pone.0163295	http://dx.doi.org/10.1371/journal.pone.0163295			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695062	gold, Green Submitted, Green Published			2022-12-27	WOS:000385553100029
J	Siqueira, JF; Antunes, HS; Rocas, IN; Rachid, CTCC; Alves, FRF				Siqueira, Jose F., Jr.; Antunes, Henrique S.; Rocas, Isabela N.; Rachid, Caio T. C. C.; Alves, Flavio R. F.			Microbiome in the Apical Root Canal System of Teeth with Post-Treatment Apical Periodontitis	PLOS ONE			English	Article							FAILED ENDODONTIC TREATMENT; POLYMERASE-CHAIN-REACTION; TREATMENT FAILURE REPORT; TREATED TEETH; ENTEROCOCCUS-FAECALIS; FILLED TEETH; PERIRADICULAR LESIONS; PERIAPICAL LESIONS; MOLECULAR METHODS; RARE BIOSPHERE	Introduction Bacteria present in the apical root canal system are directly involved with the pathogenesis of post-treatment apical periodontitis. This study used a next-generation sequencing approach to identify the bacterial taxa occurring in cryopulverized apical root samples from root canal-treated teeth with post-treatment disease. Methods Apical root specimens obtained during periradicular surgery of ten adequately treated teeth with persistent apical periodontitis were cryogenically ground. DNA was extracted from the powder and the microbiome was characterized on the basis of the V4 hypervariable region of the 16S rRNA gene by using paired-end sequencing on Illumina MiSeq device. Results All samples were positive for the presence of bacterial DNA. Bacterial taxa were mapped to 11 phyla and 103 genera composed by 538 distinct operational taxonomic units (OTUs) at 3% of dissimilarity. Over 85% of the sequences belonged to 4 phyla: Proteobacteria, Firmicutes, Fusobacteria and Actinobacteria. In general, these 4 phyla accounted for approximately 80% of the distinct OTUs found in the apical root samples. Proteobacteria was the most abundant phylum in 6/10 samples. Fourteen genera had representatives identified in all cases. Overall, the genera Fusobacterium and Pseudomonas were the most dominant. Enterococcus was found in 4 cases, always in relatively low abundance. Conclusions This study showed a highly complex bacterial community in the apical root canal system of adequately treated teeth with persistent apical periodontitis. This suggests that this disease is characterized by multispecies bacterial communities and has a heterogeneous etiology, because the community composition largely varied from case to case.	[Siqueira, Jose F., Jr.; Antunes, Henrique S.; Rocas, Isabela N.; Alves, Flavio R. F.] Univ Estacio Sa, Dept Endodont, Fac Dent, Mol Microbiol Lab, Rio De Janeiro, RJ, Brazil; [Antunes, Henrique S.] Grande Rio Univ, Fac Dent, Dept Endodont, Duque De Caxias, RJ, Brazil; [Rachid, Caio T. C. C.] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Rio De Janeiro, Brazil	Universidade Estacio de Sa; Universidade do Grande Rio; Universidade Federal do Rio de Janeiro	Alves, FRF (corresponding author), Univ Estacio Sa, Dept Endodont, Fac Dent, Mol Microbiol Lab, Rio De Janeiro, RJ, Brazil.	flavioferreiraalves@gmail.com	ANTUNES, HENRIQUE DOS SANTOS/Y-8856-2019; Rachid, Caio TCC/J-5001-2016	ANTUNES, HENRIQUE DOS SANTOS/0000-0003-4303-2662; Rachid, Caio TCC/0000-0003-3115-5702; Alves, Flavio/0000-0002-9922-8202	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Governmental Institution; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazilian Governmental Institution	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazilian Governmental Institution(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazilian Governmental Institution(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazilian Governmental Institutions.	Alves FRF, 2009, J ENDODONT, V35, P486, DOI 10.1016/j.joen.2008.12.022; Anderson AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084960; Antunes HS, 2015, J ENDODONT, V41, P1037, DOI 10.1016/j.joen.2015.03.008; Arnold M, 2013, J ENDODONT, V39, P1179, DOI 10.1016/j.joen.2013.04.036; Brundin M, 2010, ORAL SURG ORAL MED O, V110, P789, DOI 10.1016/j.tripleo.2010.07.010; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carr GB, 2009, J ENDODONT, V35, P1303, DOI 10.1016/j.joen.2009.05.035; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gomes BPFA, 2008, J ENDODONT, V34, P537, DOI 10.1016/j.joen.2008.01.016; Higuchi R, 2011, MOLECULAR MICROBIOLOGY: DIAGNOSTIC PRINCIPLES AND PRACTICE, SECOND EDITION, P301; Hong BY, 2013, J ENDODONT, V39, P1136, DOI 10.1016/j.joen.2013.05.001; Kaufman B, 2005, J ENDODONT, V31, P851, DOI 10.1097/01.don.0000164133.04548.26; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Li L, 2010, J DENT RES, V89, P980, DOI 10.1177/0022034510370026; Munson MA, 2002, J DENT RES, V81, P761, DOI 10.1177/154405910208101108; Murad CF, 2014, J ENDODONT, V40, P899, DOI 10.1016/j.joen.2014.02.010; Ng Y.L., 2016, COHENS PATHWAYS PULP, V11th edition, P474; Ozok AR, 2012, INT ENDOD J, V45, P530, DOI 10.1111/j.1365-2591.2011.02006.x; Pinheiro ET, 2003, INT ENDOD J, V36, P1, DOI 10.1046/j.1365-2591.2003.00603.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Ricucci D, 2016, J ENDODONT, V42, P509, DOI 10.1016/j.joen.2015.12.014; Ricucci D, 2015, J ENDODONT, V41, P265, DOI 10.1016/j.joen.2014.08.020; Ricucci D, 2013, J ENDODONT, V39, P712, DOI 10.1016/j.joen.2012.12.008; Ricucci D, 2009, J ENDODONT, V35, P493, DOI 10.1016/j.joen.2008.12.014; Rocas IN, 2008, J CLIN MICROBIOL, V46, P3599, DOI 10.1128/JCM.00431-08; Rocas IN, 2004, ORAL SURG ORAL MED O, V98, P741, DOI 10.1016/j.tripleo.2004.09.006; Rocas IN, 2004, J ENDODONT, V30, P315, DOI 10.1097/00004770-200405000-00004; Rocas IN, 2008, J ENDODONT, V34, P926, DOI 10.1016/j.joen.2008.05.008; Rocas IN, 2012, J CLIN MICROBIOL, V50, P1721, DOI 10.1128/JCM.00531-12; Rocas IN, 2010, J ENDODONT, V36, P1617, DOI 10.1016/j.joen.2010.07.001; Sakamoto M, 2008, ORAL MICROBIOL IMMUN, V23, P275, DOI 10.1111/j.1399-302X.2007.00423.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sedgley C, 2006, J ENDODONT, V32, P173, DOI 10.1016/j.joen.2005.10.037; Siqueira J.F., 2014, ENDOD TOPICS, V30, P3, DOI [10.1111/etp.12060, DOI 10.1111/ETP.12060]; Siqueira JF, 2014, BRIT DENT J, V216, P305, DOI 10.1038/sj.bdj.2014.200; Siqueira JF, 2004, ORAL MICROBIOL IMMUN, V19, P363, DOI 10.1111/j.1399-302x.2004.00170.x; Siqueira JF, 2004, ORAL SURG ORAL MED O, V97, P85, DOI 10.1016/S1079-2104(03)00353-6; Siqueira JF, 2005, J ENDODONT, V31, P488, DOI 10.1097/01.don.0000157990.86638.49; Siqueira JF, 2011, TREATMENT ENDODONTIC; Siqueira JF, 2008, J ENDODONT, V34, P1291, DOI 10.1016/j.joen.2008.07.028; Siqueira JF, 2008, ORAL SURG ORAL MED O, V105, P5, DOI 10.1016/j.tripleo.2007.07.046; Siqueira Jose F Jr, 2012, J Oral Microbiol, V4, DOI 10.3402/jom.v4i0.10743; Siqueira JF, 2011, J ENDODONT, V37, P1499, DOI 10.1016/j.joen.2011.08.012; Siren EK, 1997, INT ENDOD J, V30, P91, DOI 10.1046/j.1365-2591.1997.00057.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sundqvist G, 1998, ORAL SURG ORAL MED O, V85, P86, DOI 10.1016/S1079-2104(98)90404-8; Tennert C, 2014, J ENDODONT, V40, P670, DOI 10.1016/j.joen.2013.10.005; TRONSTAD L, 1990, ENDOD DENT TRAUMATOL, V6, P73; Tzanetakis GN, 2015, J ENDODONT, V41, P1226, DOI 10.1016/j.joen.2015.03.010; Vengerfeldt V, 2014, J ENDODONT, V40, P1778, DOI 10.1016/j.joen.2014.06.017; Vieira AR, 2012, J ENDODONT, V38, P250, DOI 10.1016/j.joen.2011.10.019; Zoletti GO, 2006, J ENDODONT, V32, P722, DOI 10.1016/j.joen.2006.02.001	52	52	52	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0162887	10.1371/journal.pone.0162887	http://dx.doi.org/10.1371/journal.pone.0162887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689802	Green Published, gold, Green Submitted			2022-12-27	WOS:000384329200009
J	Trahtemberg, U; Grau, A; Tabib, A; Atallah, M; Krispin, A; Mevorach, D				Trahtemberg, Uriel; Grau, Amir; Tabib, Adi; Atallah, Mizhir; Krispin, Alon; Mevorach, Dror			Identification and Characterization of Two Human Monocyte-Derived Dendritic Cell Subpopulations with Different Functions in Dying Cell Clearance and Different Patterns of Cell Death	PLOS ONE			English	Article							STEADY-STATE; APOPTOTIC CELLS; T-CELLS; IN-VIVO; SUBSETS; MATURATION; IMMUNITY; MOUSE; SPECIALIZATION; INFLAMMATION	Human monocyte-derived dendritic cells (mdDCs) are versatile cells that are used widely for research and experimental therapies. Although different culture conditions can affect their characteristics, there are no known subpopulations. Since monocytes differentiate into dendritic cells (DCs) in a variety of tissues and contexts, we asked whether they can give rise to different subpopulations. In this work we set out to characterize two human mdDC subpopulations that we identified and termed small (DC-S) and large (DC-L). Morphologically, DC-L are larger, more granular and have a more complex cell membrane. Phenotypically, DC-L show higher expression of a wide panel of surface molecules and stronger responses to maturation stimuli. Transcriptomic analysis confirmed their separate identities and findings were consistent with the phenotypes observed. Although they show similar apoptotic cell uptake, DC-L have different capabilities for phagocytosis, demonstrate better antigen processing, and have significantly better necrotic cell uptake. These subpopulations also have different patterns of cell death, with DC-L presenting an inflammatory, "dangerous" phenotype while DC-S mostly downregulate their surface markers upon cell death. Apoptotic cells induce an immune-suppressed phenotype, which becomes more pronounced among DC-L, especially after the addition of lipopolysaccharide. We propose that these two subpopulations correspond to inflammatory (DC-L) and steady-state (DC-S) DC classes that have been previously described in mice and humans.	[Trahtemberg, Uriel; Grau, Amir; Tabib, Adi; Atallah, Mizhir; Krispin, Alon; Mevorach, Dror] Hadassah Hebrew Univ Med Ctr, Dept Med, Lab Cellular & Mol Immunol, Jerusalem, Israel	Hebrew University of Jerusalem	Mevorach, D (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Med, Lab Cellular & Mol Immunol, Jerusalem, Israel.	mevorachd@hadassah.org.il	Trahtemberg, Uriel/B-3127-2008	Trahtemberg, Uriel/0000-0001-9103-2494				Alonso MN, 2011, BLOOD, V118, P3311, DOI 10.1182/blood-2011-03-341065; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Balagopalan L, 2011, NAT REV IMMUNOL, V11, P21, DOI 10.1038/nri2903; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boltjes A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00131; Chang CCJ, 2000, J IMMUNOL, V165, P3584, DOI 10.4049/jimmunol.165.7.3584; Chen M, 2010, IMMUNOL REV, V236, P11, DOI 10.1111/j.1600-065X.2010.00916.x; Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117; Dalod M, 2014, EMBO J, V33, P1104, DOI 10.1002/embj.201488027; Diaz D, 2006, CYTOM PART A, V69A, P240, DOI 10.1002/cyto.a.20251; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Duperrier K, 2000, J IMMUNOL METHODS, V238, P119, DOI 10.1016/S0022-1759(00)00147-2; Eggermont LJ, 2014, TRENDS BIOTECHNOL, V32, P456, DOI 10.1016/j.tibtech.2014.06.007; Frey T, 1997, CYTOMETRY, V28, P253, DOI 10.1002/(SICI)1097-0320(19970701)28:3<253::AID-CYTO10>3.0.CO;2-O; FREY T, 1995, CYTOMETRY, V21, P265, DOI 10.1002/cyto.990210307; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Griffith TS, 2011, IMMUNITY, V35, P456, DOI 10.1016/j.immuni.2011.08.011; Hammer GE, 2013, ANNU REV IMMUNOL, V31, P743, DOI 10.1146/annurev-immunol-020711-074929; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Krispin A, 2006, BLOOD, V108, P3580, DOI 10.1182/blood-2006-03-013334; Kushwah R, 2010, J IMMUNOL, V185, P795, DOI 10.4049/jimmunol.1000325; Lewis KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007401; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Matzinger P, 1998, SEMIN IMMUNOL, V10, P399, DOI 10.1006/smim.1998.0143; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Mildner A, 2013, ADV IMMUNOL, V120, P69, DOI 10.1016/B978-0-12-417028-5.00003-X; Nunez R, 2004, EXP MOL PATHOL, V77, P104, DOI 10.1016/j.yexmp.2004.05.001; Palucka K, 2013, IMMUNITY, V39, P38, DOI 10.1016/j.immuni.2013.07.004; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pulendran B., 2015, ANN REV IMMUNOLOGY; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Sondergaard JN, 2012, J IMMUNOL METHODS, V386, P112, DOI 10.1016/j.jim.2012.09.005; Stein GM, 2000, CYTOMETRY, V41, P261, DOI 10.1002/1097-0320(20001201)41:4<261::AID-CYTO4>3.0.CO;2-S; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Tisch R, 2010, INT REV IMMUNOL, V29, P111, DOI 10.3109/08830181003602515; Trahtemberg U, 2007, APOPTOSIS, V12, P1769, DOI 10.1007/s10495-007-0097-1; van der Aa E, 2014, SEMINARS CELL DEV BI, DOI 1016/j.tibtech.2014.06.007; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Verbovetski I, 2002, J EXP MED, V196, P1553, DOI 10.1084/jem.20020263; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; Xia CQ, 2002, J IMMUNOL, V168, P1131, DOI 10.4049/jimmunol.168.3.1131	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0162984	10.1371/journal.pone.0162984	http://dx.doi.org/10.1371/journal.pone.0162984			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690130	Green Published, gold, Green Submitted			2022-12-27	WOS:000384329200011
J	Horie, T; Inomata, M; Into, T; Hasegawa, Y; Kitai, N; Yoshimura, F; Murakami, Y				Horie, Toshi; Inomata, Megumi; Into, Takeshi; Hasegawa, Yoshiaki; Kitai, Noriyuki; Yoshimura, Fuminobu; Murakami, Yukitaka			Identification of OmpA-Like Protein of Tannerella forsythia as an O-Linked Glycoprotein and Its Binding Capability to Lectins	PLOS ONE			English	Article							ORAL EPITHELIAL-CELLS; PORPHYROMONAS-GINGIVALIS; DC-SIGN; POSTTRANSLATIONAL MODIFICATION; MYCOBACTERIUM-TUBERCULOSIS; GLYCOSYLATION SYSTEM; SIALIC ACIDS; IN-VIVO; OLIGOSACCHARIDES; RECOGNITION	Bacterial glycoproteins are associated with physiological and pathogenic functions of bacteria. It remains unclear whether bacterial glycoproteins can bind to specific classes of lectins expressed on host cells. Tannerella forsythia is a gram-negative oral anaerobe that contributes to the development of periodontitis. In this study, we aimed to find lectin-binding glycoproteins in T. forsythia. We performed affinity chromatography of wheat germ agglutinin, which binds to N-acetylglucosamine (GlcNAc) and sialic acid (Sia), and identified OmpA-like protein as the glycoprotein that has the highest affinity. Mass spectrometry revealed that OmpA-like protein contains O-type N-acetylhexosamine and hexose. Fluorometry quantitatively showed that OmpA-like protein contains Sia. OmpA-like protein was found to bind to lectins including E-selectin, P-selectin, L-selectin, Siglec-5, Siglec-9, Siglec-10, and DC-SIGN. The binding of OmpA-like protein to these lectins, except for the Siglecs, depends on the presence of calcium. N-acetylneuraminic acid (NeuAc), which is the most abundant Sia, inhibited the binding of OmpA-like protein to all of these lectins, whereas GlcNAc and mannose only inhibited the binding to DC-SIGN. We further found that T. forsythia adhered to human oral epithelial cells, which express E-selectin and Pselectin, and that this adhesion was inhibited by addition of NeuAc. Moreover, adhesion of an OmpA-like protein-deficient T. forsythia strain to the cells was reduced compared to that of the wild-type strain. Our findings indicate that OmpA-like protein of T. forsythia contains O-linked sugar chains that can mediate interactions with specific lectins. This interaction is suggested to facilitate adhesion of T. forsythia to the surface of host cells.	[Horie, Toshi; Inomata, Megumi; Into, Takeshi; Murakami, Yukitaka] Asahi Univ, Sch Dent, Dept Oral Microbiol, Div Oral Infect & Hlth Sci,Mizuho Ku, Gifu, Japan; [Horie, Toshi; Kitai, Noriyuki] Asahi Univ, Sch Dent, Dept Orthodont, Div Oral Struct Funct & Dev,Mizuho Ku, Gifu, Japan; [Hasegawa, Yoshiaki; Yoshimura, Fuminobu] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Nagoya, Aichi, Japan	Asahi University; Asahi University; Aichi Gakuin University	Inomata, M (corresponding author), Asahi Univ, Sch Dent, Dept Oral Microbiol, Div Oral Infect & Hlth Sci,Mizuho Ku, Gifu, Japan.	inomata@dent.asahi-u.ac.jp			 [25861782];  [15K11094]	; 	This study was supported by Grant-in-Aid forYoung Scientists (B; 25861782 to MI) and Grant-in-Aid for Scientific Research (C; 15K11094 to MI)	Abe T, 2011, MOL ORAL MICROBIOL, V26, P374, DOI 10.1111/j.2041-1014.2011.00625.x; Coyne MJ, 2013, MOL MICROBIOL, V88, P772, DOI 10.1111/mmi.12220; Dam TK, 2010, GLYCOBIOLOGY, V20, P270, DOI 10.1093/glycob/cwp186; Dias RD, 2015, MOLECULES, V20, P519, DOI 10.3390/molecules20010519; Doig P, 1996, MOL MICROBIOL, V19, P379, DOI 10.1046/j.1365-2958.1996.370890.x; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Guerry P, 1996, MOL MICROBIOL, V19, P369, DOI 10.1046/j.1365-2958.1996.369895.x; Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000; Herrmann JL, 1996, EMBO J, V15, P3547, DOI 10.1002/j.1460-2075.1996.tb00724.x; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; Inomata M, 2013, BIOCHEM BIOPH RES CO, V437, P509, DOI 10.1016/j.bbrc.2013.06.094; Inomata M, 2012, CELL MOL LIFE SCI, V69, P963, DOI 10.1007/s00018-011-0819-y; Inomata M, 2010, EUR J ORAL SCI, V118, P574, DOI 10.1111/j.1600-0722.2010.00775.x; Into T, 2007, J BIOL CHEM, V282, P8134, DOI 10.1074/jbc.M609962200; Kuo CC, 1996, J CLIN INVEST, V98, P2813, DOI 10.1172/JCI119109; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Masuda T, 2006, APPL ENVIRON MICROB, V72, P3458, DOI 10.1128/AEM.72.5.3458-3467.2006; Miron J, 1999, APPL MICROBIOL BIOT, V51, P491, DOI 10.1007/s002530051422; Mishima E, 2011, MICROBIOL-SGM, V157, P2382, DOI 10.1099/mic.0.048975-0; Murakami Y, 2014, INFECT IMMUN, V82, P4563, DOI 10.1128/IAI.02069-14; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; ONeill RA, 1996, J CHROMATOGR A, V720, P201, DOI 10.1016/0021-9673(95)00502-1; PATEL TP, 1994, METHOD ENZYMOL, V230, P57; Posch G, 2013, GLYCOBIOLOGY, V23, P568, DOI 10.1093/glycob/cws172; Posch G, 2011, J BIOL CHEM, V286, P38714, DOI 10.1074/jbc.M111.284893; Romain F, 1999, INFECT IMMUN, V67, P5567, DOI 10.1128/IAI.67.11.5567-5572.1999; Sakakibara J, 2007, MICROBIOL-SGM, V153, P866, DOI 10.1099/mic.0.29275-0; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SPIRO RG, 1960, J BIOL CHEM, V235, P2860; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Tan FYY, 2015, TRENDS BIOCHEM SCI, V40, P342, DOI 10.1016/j.tibs.2015.03.016; Tang YXP, 2000, INFECT IMMUN, V68, P415, DOI 10.1128/IAI.68.1.415-419.2000; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; VARKI A, 1994, P NATL ACAD SCI USA, V91, P7390, DOI 10.1073/pnas.91.16.7390; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Yu XJ, 2013, J MOL BIOL, V425, P1253, DOI 10.1016/j.jmb.2013.02.006; Zeituni AE, 2010, J BACTERIOL, V192, P4103, DOI 10.1128/JB.00275-10; Zeituni AE, 2009, J IMMUNOL, V183, P5694, DOI 10.4049/jimmunol.0901030; Zhang P, 2006, J IMMUNOL, V177, P4002, DOI 10.4049/jimmunol.177.6.4002	45	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163974	10.1371/journal.pone.0163974	http://dx.doi.org/10.1371/journal.pone.0163974			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711121	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600056
J	Kahana-Zweig, R; Geva-Sagiv, M; Weissbrod, A; Secundo, L; Soroker, N; Sobel, N				Kahana-Zweig, Roni; Geva-Sagiv, Maya; Weissbrod, Aharon; Secundo, Lavi; Soroker, Nachum; Sobel, Noam			Measuring and Characterizing the Human Nasal Cycle	PLOS ONE			English	Article							AIR-FLOW; ACOUSTIC RHINOMETRY; ULTRADIAN RHYTHMS; ACTIVATION; DOMINANCE; PRESSURE; SLEEP; LATERALIZATION; OSCILLATIONS; RESPIRATION	Nasal airflow is greater in one nostril than in the other because of transient asymmetric nasal passage obstruction by erectile tissue. The extent of obstruction alternates across nostrils with periodicity referred to as the nasal cycle. The nasal cycle is related to autonomic arousal and is indicative of asymmetry in brain function. Moreover, alterations in nasal cycle periodicity have been linked to various diseases. There is therefore need for a tool allowing continuous accurate measurement and recording of airflow in each nostril separately. Here we provide detailed instructions for constructing such a tool at minimal cost and effort. We demonstrate application of the tool in 33 right-handed healthy subjects, and derive several statistical measures for nasal cycle characterization. Using these measures applied to 24-hour recordings we observed that: 1: subjects spent slightly longer in left over right nostril dominance (left = 2.63 +/- 0.89 hours, right = 2.17 +/- 0.89 hours, t(32) = 2.07, p < 0.05), 2: cycle duration was shorter in wake than in sleep (wake = 2.02 +/- 1.7 hours, sleep = 4.5 +/- 1.7 hours, (t(30) = 5.73, p < 0.0001). 3: slower breathing was associated with a more powerful cycle (the extent of difference across nostrils) (r = 0.4, p < 0.0001), and 4: the cycle was influenced by body posture such that lying on one side was associated with greater flow in the contralateral nostril (p < 0.002). Finally, we provide evidence for an airflow cycle in each nostril alone. These results provide characterization of an easily obtained measure that may have diagnostic implications for neurological disease and cognitive state.	[Kahana-Zweig, Roni; Geva-Sagiv, Maya; Weissbrod, Aharon; Secundo, Lavi; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Soroker, Nachum] Loewenstein Hosp & Rehabil Ctr, IL-43100 Raanana, Israel; [Soroker, Nachum] Tel Aviv Univ, Sackler Fac Med, IL-69978 Ramat Aviv, Israel	Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine	Kahana-Zweig, R; Sobel, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ronikahana@gmail.com; noam.sobel@weizmann.ac.il	Soroker, Nachum/V-7094-2019	Geva-Sagiv, Maya/0000-0001-9353-5132; Sobel, Noam/0000-0002-3232-9391; Soroker, Nachum/0000-0003-4909-5576	ERC [670798]	ERC(European Research Council (ERC)European Commission)	This work was funded by an ERC grant #670798 to Noam Sobel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by an ERC advanced grant #670798.	Abolmaali N, 2013, CHEMOSENS PERCEPT, V6, P148, DOI 10.1007/s12078-013-9150-3; AMOROSO EC, 1954, J PHYSIOL-LONDON, V126, P86, DOI 10.1113/jphysiol.1954.sp005194; ASAKURA K, 1987, ACTA OTO-LARYNGOL, V104, P533, DOI 10.3109/00016488709128285; Atanasov A, 2014, OPEN J BIOPHYSICS, V4, P93, DOI [10.4236/ojbiphy.2014.43010, DOI 10.4236/OJBIPHY.2014.43010]; BABATOLA F D O, 1986, Rhinology (Utrecht), V24, P271; BACKON J, 1988, Medical Science Research, V16, P1197; BACKON J, 1990, BRIT J OPHTHALMOL, V74, P607, DOI 10.1136/bjo.74.10.607; BACKON J, 1989, INT J NEUROSCI, V46, P53, DOI 10.3109/00207458908991614; BACKON J, 1991, INT J NEUROSCI, V58, P157, DOI 10.3109/00207459108985431; BAMFORD OS, 1982, PFLUG ARCH EUR J PHY, V394, P139, DOI 10.1007/BF00582915; Beickert P., 1951, ARCH OHREN NASEN KEH, V157, P404, DOI [10.1007/BF02102047jphysiol.1954.sp005194, DOI 10.1007/BF02102047]; BLOCK RA, 1989, BRAIN COGNITION, V9, P181, DOI 10.1016/0278-2626(89)90028-6; BOJSENMOLLER F, 1971, J ANAT, V110, P25; CAMPBELL W M, 1981, Rhinology (Utrecht), V19, P127; CANTER RJ, 1986, CLIN OTOLARYNGOL, V11, P329, DOI 10.1111/j.1365-2273.1986.tb00134.x; Casale TB, 2008, J ALLERGY CLIN IMMUN, V121, P105, DOI 10.1016/j.jaci.2007.08.056; Chen JC, 2004, CLIN AUTON RES, V14, P396, DOI 10.1007/s10286-004-0200-4; COLE P, 1986, ANN OTO RHINOL LARYN, V95, P233, DOI 10.1177/000348948609500305; Cordier DGE, 1935, CTR RESP; CVETNIC S, 1980, Rhinology (Utrecht), V18, P47; Dane S, 2007, INT J DEV NEUROSCI, V25, P223, DOI 10.1016/j.ijdevneu.2007.03.005; DIMOND SJ, 1976, NATURE, V261, P690, DOI 10.1038/261690a0; DOUGLAS NJ, 1982, THORAX, V37, P840, DOI 10.1136/thx.37.11.840; Eccles R, 1996, ACTA OTO-LARYNGOL, V116, P77, DOI 10.3109/00016489609137717; Eccles R, 1996, EUR RESPIR J, V9, P371, DOI 10.1183/09031936.96.09020371; ECCLES R, 1978, ACTA OTO-LARYNGOL, V85, P431, DOI 10.3109/00016487809121472; ECCLES R, 1981, ACTA OTO-LARYNGOL, V91, P127, DOI 10.3109/00016488109138490; ECCLES R, 1981, ACTA OTO-LARYNGOL, V92, P357, DOI 10.3109/00016488109133272; Eccles R B, 2000, Acta Otorhinolaryngol Belg, V54, P281; Eliav T, 2015, SOC NEUR ANN M; FAIRBANKS DNF, 1986, OTOLARYNG HEAD NECK, V94, P412, DOI 10.1177/019459988609400337; Finley KH, 1931, ARCH NEURO PSYCHIATR, V26, P754, DOI 10.1001/archneurpsyc.1931.02230100072007; Fisher Edward W., 1993, Rhinology (Utrecht), V31, P57; Flanagan P, 1997, ACTA OTO-LARYNGOL, V117, P590, DOI 10.3109/00016489709113443; FOX GP, 1991, IRISH MED J, V84, P24; Friling L, 2014, VET RADIOL ULTRASOUN, V55, P159, DOI 10.1111/vru.12115; Fukuhara H, 1996, JPN J PSYCHOL, V66, P437, DOI 10.4992/jjpsy.66.437; GALIOTO G, 1991, ANN OTO RHINOL LARYN, V100, P559, DOI 10.1177/000348949110000707; Gallego AJ, 2006, AM J RHINOL, V20, P560, DOI 10.2500/ajr.2006.20.2951; GILBERT AN, 1989, CHRONOBIOL INT, V6, P251, DOI 10.3109/07420528909056926; Grutzenmacher S, 2005, AM J RHINOL, V19, P53, DOI 10.1177/194589240501900109; Gungor A, 1999, OTOLARYNG HEAD NECK, V120, P238, DOI 10.1016/S0194-5998(99)70413-4; HAIGHT J S J, 1983, Rhinology (Utrecht), V21, P67; HAIGHT JSJ, 1989, LARYNGOSCOPE, V99, P538; HAIGHT JSJ, 1986, J OTOLARYNGOL, V15, P9; Hanif J, 2001, AM J RHINOL, V15, P303, DOI 10.1177/194589240101500503; Hanif J, 2000, CLIN OTOLARYNGOL, V25, P461, DOI 10.1046/j.1365-2273.2000.00432.x; HASEGAWA M, 1982, ANN OTO RHINOL LARYN, V91, P112, DOI 10.1177/000348948209100125; HASEGAWA M, 1977, MAYO CLIN PROC, V52, P28; Heetderkds R, 1927, AM J MED SCI, V174; Huang ZL, 2003, OTOLARYNG HEAD NECK, V128, P510, DOI 10.1016/S0194-5998(03)00123-2; ISHII J, 1993, ACTA OTO-LARYNGOL, P51; JELLA SA, 1993, INT J NEUROSCI, V73, P61, DOI 10.3109/00207459308987211; Johnson BN, 2006, CHEM SENSES, V31, P795, DOI 10.1093/chemse/bjl021; Jones BE, 2003, FRONT BIOSCI-LANDMRK, V8, pS438, DOI 10.2741/1074; Kayser R., 1895, ARCH LARYNGOL RHINOL, V8, P101; KENNEDY B, 1986, LIFE SCI, V38, P1203, DOI 10.1016/0024-3205(86)90175-X; Kern E, 2010, 4 PHASE RHINOMANOMET; KERN E B, 1981, Rhinology (Utrecht), V19, P59; Keuning J, 1968, J INT RHINOL, V6, P99; Kimura A, 2013, LARYNGOSCOPE, V123, P2050, DOI 10.1002/lary.23986; KLEIN R, 1986, BIOL PSYCHOL, V23, P127, DOI 10.1016/0301-0511(86)90077-3; KNIGHT LC, 1991, CLIN OTOLARYNGOL, V16, P543, DOI 10.1111/j.1365-2273.1991.tb00969.x; Kotan D, 2013, J INT MED RES, V41, P334, DOI 10.1177/0300060513476433; KRISTOF M, 1981, PHYSIOL BOHEMOSLOV, V30, P73; Lang C, 2003, LARYNGOSCOPE, V113, P284, DOI 10.1097/00005537-200302000-00016; LECLERC J, 1987, Rhinology (Utrecht), V25, P249; Lillie IH, 1923, J IOWA MED SOC, V13, P403; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Mirza N, 1997, LARYNGOSCOPE, V107, P62, DOI 10.1097/00005537-199701000-00014; Mohan Satagopam Mitti, 2001, International Ophthalmology, V24, P305, DOI 10.1023/B:INTE.0000006764.65209.06; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Ohki M, 2005, J OTOLARYNGOL, V34, P346, DOI 10.2310/7070.2005.34509; PREECE M, 1993, ACTA OTO-LARYNGOL, V113, P777, DOI 10.3109/00016489309135900; Proctor DF, 1982, NOSE UPPER AIRWAY PH; Raghuraj P, 2008, APPL PSYCHOPHYS BIOF, V33, P65, DOI 10.1007/s10484-008-9055-0; Rohrmeier C, 2014, LARYNGOSCOPE, V124, P1492, DOI 10.1002/lary.24546; Royer S, 2010, J NEUROSCI, V30, P1777, DOI 10.1523/JNEUROSCI.4681-09.2010; RUSAK B, 1975, ANNU REV PSYCHOL, V26, P137, DOI 10.1146/annurev.ps.26.020175.001033; Saroha D, 2003, CLIN OTOLARYNGOL, V28, P142, DOI 10.1046/j.1365-2273.2003.00679.x; Schiff BB, 1995, BRAIN COGNITION, V29, P217, DOI 10.1006/brcg.1995.1279; Scott J, 2013, J NEUROSCIE IN PRESS, DOI [10.1523/JNEUROSCI.3736-13., DOI 10.1523/JNEUROSCI.3736-13]; Searleman A, 2005, LATERALITY, V10, P111, DOI 10.1080/13576500342000329; SERVIT Z, 1981, EPILEPSIA, V22, P321, DOI 10.1111/j.1528-1157.1981.tb04116.x; Shannahoff-Khalsa D S, 1993, Int J Neurosci, V73, P47, DOI 10.3109/00207459308987210; Shannahoff-Khalsa D, 2015, PSYCHIAT RES, V226, P289, DOI 10.1016/j.psychres.2014.12.065; Shannahoff-Khalsa DS, 2007, CNS SPECTRUMS, V12, P625, DOI 10.1017/S1092852900021428; SHANNAHOFFKHALSA D, 1991, INT J PSYCHOPHYSIOL, V11, P225, DOI 10.1016/0167-8760(91)90017-R; SHANNAHOFFKHALSA D, 1993, INT J NEUROSCI, V70, P285, DOI 10.3109/00207459309000583; ShannahoffKhalsa DS, 1997, AM J PHYSIOL-REG I, V272, pR962, DOI 10.1152/ajpregu.1997.272.3.R962; ShannahoffKhalsa DS, 1996, AM J PHYSIOL-REG I, V270, pR873, DOI 10.1152/ajpregu.1996.270.4.R873; SHANNAHOFFKHALSA DS, 1991, INT J NEUROSCI, V57, P239, DOI 10.3109/00207459109150697; Shilenkova V. V., 2008, Vestnik Otorinolaringologii, P11; Soane RJ, 2001, CLIN OTOLARYNGOL, V26, P9, DOI 10.1046/j.1365-2273.2001.00423.x; Sobel N, 1999, NATURE, V402, P35, DOI 10.1038/46944; SOUBEYRAND L, 1964, Rev Laryngol Otol Rhinol (Bord), V85, P49; STANCAK A, 1994, INT J PSYCHOPHYSIOL, V18, P75, DOI 10.1016/0167-8760(84)90017-5; STOKSTED P, 1953, Acta Otolaryngol Suppl, V109, P159; SZUCS E, 1995, CLIN OTOLARYNGOL, V20, P390, DOI 10.1111/j.1365-2273.1995.tb00068.x; Tahamiler R, 2009, ARCH OTOLARYNGOL, V135, P137, DOI 10.1001/archoto.2008.537; Tatar A., 2014, EUROPEAN J GEN MED; van Cauwenberge P, 1980, Acta Otorhinolaryngol Belg, V34, P145; VANCAUWENBERGE PB, 1984, ARCH OTOLARYNGOL, V110, P108; Veale JF, 2014, LATERALITY, V19, P164, DOI 10.1080/1357650X.2013.783045; VELIKONJA D, 1993, ELECTROEN CLIN NEURO, V87, P38, DOI 10.1016/0013-4694(93)90172-R; Wang Y, 1999, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V13, P485; WEBBER RL, 1987, J COMPUT ASSIST TOMO, V11, P869, DOI 10.1097/00004728-198709000-00024; Werntz, 1981, SEL CORT ACT ALT AUT; Werntz D A, 1983, Hum Neurobiol, V2, P39; WERNTZ DA, 1987, HUM NEUROBIOL, V6, P165; White DE, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0034-4; Williams M, 2016, J LARYNGOL OTOL, V130, P82, DOI 10.1017/S0022215115002881; Williams MR, 2015, ACTA OTO-LARYNGOL, V135, P831, DOI 10.3109/00016489.2015.1028592; ZINREICH SJ, 1988, J COMPUT ASSIST TOMO, V12, P1014, DOI 10.1097/00004728-198811000-00019; ZINREICH SJ, 1988, LARYNGOSCOPE, V98, P928	115	39	39	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0162918	10.1371/journal.pone.0162918	http://dx.doi.org/10.1371/journal.pone.0162918			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711189	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600010
J	Risso, DS; Kozlitina, J; Sainz, E; Gutierrez, J; Wooding, S; Getachew, B; Luiselli, D; Berg, CJ; Drayna, D				Risso, Davide S.; Kozlitina, Julia; Sainz, Eduardo; Gutierrez, Joanne; Wooding, Stephen; Getachew, Betelihem; Luiselli, Donata; Berg, Carla J.; Drayna, Dennis			Genetic Variation in the TAS2R38 Bitter Taste Receptor and Smoking Behaviors	PLOS ONE			English	Article							PHENYLTHIOCARBAMIDE; SENSITIVITY; EVOLUTION; NICOTINE; POLYMORPHISMS; ASSOCIATION; PERCEPTION; DEPENDENCE; PTC	Common TAS2R38 taste receptor gene variants specify the ability to taste phenylthiocarbamide (PTC), 6-n-propylthiouracil (PROP) and structurally related compounds. Tobacco smoke contains a complex mixture of chemical substances of varying structure and functionality, some of which activate different taste receptors. Accordingly, it has been suggested that non-taster individuals may be more likely to smoke because of their inability to taste bitter compounds present in tobacco smoke, but results to date have been conflicting. We studied three cohorts: 237 European-Americans from the state of Georgia, 1,353 European-Americans and 2,363 African-Americans from the Dallas Heart Study (DHS), and 4,973 African-Americans from the Dallas Biobank. Tobacco use data was collected and TAS2R38 polymorphisms were genotyped for all participants, and PTC taste sensitivity was assessed in the Georgia population. In the Georgia group, PTC tasters were less common among those who smoke: 71.5% of smokers were PTC tasters while 82.5% of nonsmokers were PTC tasters (P = 0.03). The frequency of the TAS2R38 PAV taster haplotype showed a trend toward being lower in smokers (38.4%) than in non-smokers (43.1%), although this was not statistically significant (P = 0.31). In the DHS European-Americans, the taster haplotype was less common in smokers (37.0% vs. 44.0% in non-smokers, P = 0.003), and conversely the frequency of the non-taster haplotype was more common in smokers (58.7% vs. 51.5% in non-smokers, P = 0.002). No difference in the frequency of these haplotypes was observed in African Americans in either the Dallas Heart Study or the Dallas Biobank. We conclude that TAS2R38 haplotypes are associated with smoking status in European-Americans but not in African-American populations. PTC taster status may play a role in protecting individuals from cigarette smoking in specific populations.	[Risso, Davide S.; Sainz, Eduardo; Gutierrez, Joanne; Drayna, Dennis] NIDCD, Lab Commun Disorders, NIH, Bethesda, MD 20892 USA; [Risso, Davide S.; Luiselli, Donata] Univ Bologna, Lab Mol Anthropol, Bologna, Italy; [Risso, Davide S.; Luiselli, Donata] Univ Bologna, Ctr Genome Biol, Dept Biol Geol & Environm Sci, Bologna, Italy; [Kozlitina, Julia] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Wooding, Stephen] Univ Calif Merced, Hlth Sci Res Inst, Merced, CA USA; [Getachew, Betelihem; Berg, Carla J.] Emory Univ, Dept Behav Sci & Hlth Educ, Woodruff Hlth Sci Ctr, Atlanta, GA 30322 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Bologna; University of Bologna; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Merced; Emory University	Drayna, D (corresponding author), NIDCD, Lab Commun Disorders, NIH, Bethesda, MD 20892 USA.	drayna@nidcd.nih..gov	Risso, Davide/AAI-4201-2021	Risso, Davide/0000-0001-9848-8996; Kozlitina, Julia/0000-0001-7720-2290; Drayna, Dennis/0000-0002-1730-4532	National Institute on Deafness and Other Communication Disorders Intramural grant [Z1A-000046-16]; National Institutes of Health [HHSN263201300011C-03]; National Cancer Institute [1R01CA179422-01]; Georgia Cancer Coalition grant; National Center for Advancing Translational Sciences [UL1TR001105]; National Institutes of Health; NIH intramural research program; FDA; NATIONAL CANCER INSTITUTE [R01CA179422] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders Intramural grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition grant; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FDA(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by the National Institute on Deafness and Other Communication Disorders Intramural grant number Z1A-000046-16 to DD, by the National Institutes of Health grant (HHSN263201300011C-03; OLAO) to JK, and by National Cancer Institute grant number 1R01CA179422-01 to CB, as well as a Georgia Cancer Coalition grant to CB. The Dallas Heart Study is supported by the National Center for Advancing Translational Sciences award number UL1TR001105, and the Dallas Biobank was funded by the National Institutes of Health. Research reported in this publication was supported by the NIH intramural research program and the FDA through funds obtained under the Family Smoking Prevention and Tobacco Control Act. The content was not reviewed by the Food and Drug Administration, but underwent the standard manuscript clearance process for scientific papers published from the NIH intramural research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aoki M, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-12; Behrens M, 2009, RESULTS PROBL CELL D, V47, P203, DOI 10.1007/400_2008_5; Berg CJ, 2016, AM J HEALTH BEHAV, V40, P310, DOI 10.5993/AJHB.40.3.3; Berg CJ, 2010, NICOTINE TOB RES, V12, P963, DOI 10.1093/ntr/ntq123; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Campbell MC, 2012, MOL BIOL EVOL, V29, P1141, DOI 10.1093/molbev/msr293; Cannon DS, 2005, NICOTINE TOB RES, V7, P853, DOI 10.1080/14622200500330209; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; DASTAN S, 2015, TURJAF, V3, P418; Enoch MA, 2001, ADDICT BEHAV, V26, P399, DOI 10.1016/S0306-4603(00)00117-9; Go Y, 2005, GENETICS, V170, P313, DOI 10.1534/genetics.104.037523; HALL AR, 1945, P NATL ACAD SCI USA, V31, P390, DOI 10.1073/pnas.31.12.390; HUMMEL T, 1992, ELECTROEN CLIN NEURO, V84, P192, DOI 10.1016/0168-5597(92)90025-7; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Keller M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080512; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Mangold JE, 2008, J MED GENET, V45, P578, DOI 10.1136/jmg.2008.057844; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Oncken C, 2015, NICOTINE TOB RES, V17, P1416, DOI 10.1093/ntr/ntv042; Ortega FJ, 2016, MOL NUTR FOOD RES, V60, P1673, DOI 10.1002/mnfr.201500804; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Risso D, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0198-8; Risso DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25506; Risso DS, 2015, NUTR RES, V35, P1122, DOI 10.1016/j.nutres.2015.09.011; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Smith SS, 2010, NICOTINE TOB RES, V12, P489, DOI 10.1093/ntr/ntq032; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; US Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092	33	28	29	8	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164157	10.1371/journal.pone.0164157	http://dx.doi.org/10.1371/journal.pone.0164157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711175	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600089
J	Sarkar, K; Sundaram, H				Sarkar, Kaushik; Sundaram, Hari			Influencing Busy People in a Social Network	PLOS ONE			English	Article							COMPLEX NETWORK; CONTAGION; DIFFUSION; MODEL	We identify influential early adopters in a social network, where individuals are resource constrained, to maximize the spread of multiple, costly behaviors. A solution to this problem is especially important for viral marketing. The problem of maximizing influence in a social network is challenging since it is computationally intractable. We make three contributions. First, we propose a new model of collective behavior that incorporates individual intent, knowledge of neighbors actions and resource constraints. Second, we show that the multiple behavior influence maximization is NP-hard. Furthermore, we show that the problem is submodular, implying the existence of a greedy solution that approximates the optimal solution to within a constant. However, since the greedy algorithm is expensive for large networks, we propose efficient heuristics to identify the influential individuals, including heuristics to assign behaviors to the different early adopters. We test our approach on synthetic and real-world topologies with excellent results. We evaluate the effectiveness under three metrics: unique number of participants, total number of active behaviors and network resource utilization. Our heuristics produce 15-51% increase in expected resource utilization over the naive approach.	[Sarkar, Kaushik] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ 85281 USA; [Sundaram, Hari] Univ Illinois, Dept Comp Sci, Urbana, IL USA	Arizona State University; Arizona State University-Tempe; University of Illinois System; University of Illinois Urbana-Champaign	Sarkar, K (corresponding author), Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ 85281 USA.; Sundaram, H (corresponding author), Univ Illinois, Dept Comp Sci, Urbana, IL USA.	ksarkar1@asu.edu; hs1@illinois.edu		Sundaram, Hari/0000-0003-3315-6055	National Science Foundation (NSF), US [1210856]; NSF	National Science Foundation (NSF), US(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF), US, Title: SoCS: Tipping Collective Action in Social Networks, Grant no: 1210856. NSF provided funding to carry out the research described in this paper; the funding agency played no direct role on the research described in this paper.	Acemoglu D, 2011, REV ECON STUD, V78, P1201, DOI 10.1093/restud/rdr004; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; ARTHUR WB, 1989, ECON J, V99, P116, DOI 10.2307/2234208; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Carnes T., 2007, P 9 INT C EL COMM, P351, DOI DOI 10.1145/1282100.1282167; Chen W, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P199, DOI 10.1145/1557019.1557047; Chierichetti F, 2014, SIAM J COMPUT, V43, P1906, DOI 10.1137/130936580; DEGROOT MH, 1974, J AM STAT ASSOC, V69, P118, DOI 10.2307/2285509; Domingos P., 2002, P 7 INT C KNOWL DIS, P57; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Goel S., P 13 ACM C EL COMM, P623, DOI DOI 10.1145/2229012.2229058; Goyal A., 2010, P 3 ACM INT C WEB SE, P241, DOI DOI 10.1145/1718487.1718518; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Harathi S, 2007, LECT NOTES COMPUT SC, V4858, P306; Hodas NO, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P249, DOI 10.1109/SocialCom-PASSAT.2012.129; Jackson M. O., 2008, SOCIAL EC NETWORKS, V3; Jiang CR, 2010, INT ASIA CONF INFORM, P88, DOI 10.1109/CAR.2010.5456772; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Kempe D, 2003, P 9 ACM SIGKDD INT C, V2003, P137, DOI DOI 10.1145/956750.956769; Leskovec J, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P420; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Martin T., 2014, 15 ACM C EC COMP, P113; Mathioudakis M., 2011, P 17 ACM SIGKDD INT; NEMHAUSER GL, 1978, MATH PROGRAM, V14, P265, DOI 10.1007/BF01588971; Rogers EM, 1962, DIFFUSION INNOVATION; Rubinstein A, 2010, AM ECON J-MICROECON, V2, P112; Saito K, 2008, LECT NOTES ARTIF INT, V5179, P67, DOI 10.1007/978-3-540-85567-5_9; Seeman L, 2013, P IEEE ANN S FDN COM; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Simon A., 1972, DECISION ORG, P161, DOI DOI 10.1093/EREA/27.3.325; Stonedahl F, 2010, NETLOGO ARTIFICIAL A; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Wang Z, 2014, SCI REP-UK, V4, DOI 10.1038/srep03597; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Watts DJ, 2007, J CONSUM RES, V34, P441, DOI 10.1086/518527; Wilensky U., 1999, NETLOGO; Young HP, 2009, AM ECON REV, V99, P1899, DOI 10.1257/aer.99.5.1899	44	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0162014	10.1371/journal.pone.0162014	http://dx.doi.org/10.1371/journal.pone.0162014			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711127	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600005
J	White, AL; Min, TH; Gross, MM; Kajeechiwa, L; Thwin, MM; Hanboonkunupakarn, B; Than, HH; Zin, TW; Rijken, MJ; Hoogenboom, G; McGready, R				White, Adrienne Lynne; Min, Thaw Htwe; Gross, Mechthild M.; Kajeechiwa, Ladda; Thwin, May Myo; Hanboonkunupakarn, Borimas; Than, Hla Hla; Zin, Thet Wai; Rijken, Marcus J.; Hoogenboom, Gabie; McGready, Rose			Accelerated Training of Skilled Birth Attendants in a Marginalized Population on the Thai-Myanmar Border: A Multiple Methods Program Evaluation	PLOS ONE			English	Article							LOW-RESOURCE SETTINGS; PRESERVICE EDUCATION; MIDWIFERY EDUCATION; ASSESSMENT-TOOL; HEALTH; COMPETENCE; CARE; QUALITY; MORTALITY; PREGNANCY	Background To evaluate a skilled birth attendant (SBA) training program in a neglected population on the Thai-Myanmar border, we used multiple methods to show that refugee and migrant health workers can be given effective training in their own environment to become SBAs and teachers of SBAs. The loss of SBAs through resettlement to third countries necessitated urgent training of available workers to meet local needs. Methods and Findings All results were obtained from student records of theory grades and clinical log books. Qualitative evaluation of both the SBA and teacher programs was obtained using semi-structured interviews with supervisors and teachers. We also reviewed perinatal indicators over an eight-year period, starting prior to the first training program until after the graduation of the fourth cohort of SBAs. Results Four SBA training programs scheduled between 2009 and 2015 resulted in 79/88 (90%) of students successfully completing a training program of 250 theory hours and 625 supervised clinical hours. All 79 students were able to: achieve pass grades on theory examination (median 80%, range [70-89]); obtain the required clinical experience within twelve months; achieve clinical competence to provide safe care during childbirth. In 2010-2011, five experienced SBAs completed a train-the-trainer (TOT) program and went on to facilitate further training programs. Perinatal indicators within Shoklo Malaria Research Unit (SMRU), such as place of birth, maternal and newborn outcomes, showed no significant differences before and after introduction of training or following graduate deployment in the local maternity units. Confidence, competence and teamwork emerged from qualitative evaluation by senior SBAs working with and supervising students in the clinics. Conclusions We demonstrate that in resource-limited settings or in marginalized populations, it is possible to accelerate training of skilled birth attendants to provide safe maternity care. Education needs to be tailored to local needs to ensure evidence-based care of women and their families.	[White, Adrienne Lynne] Royal Womens Hosp, Pregnancy Res Ctr, Melbourne, Vic, Australia; [Min, Thaw Htwe; Kajeechiwa, Ladda; Thwin, May Myo; Than, Hla Hla; Zin, Thet Wai; Rijken, Marcus J.; Hoogenboom, Gabie; McGready, Rose] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Gross, Mechthild M.] Hannover Med Sch, Dept Obstet Gynaecol & Reprod Med, Midwifery Res & Educ Unit, Hannover, Germany; [Hanboonkunupakarn, Borimas] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Rijken, Marcus J.] Univ Med Ctr Utrecht, Julius Global Hlth & Dept Woman & Baby, Utrecht, Netherlands; [McGready, Rose] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Hannover Medical School; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Utrecht University; Utrecht University Medical Center; University of Oxford	White, AL (corresponding author), Royal Womens Hosp, Pregnancy Res Ctr, Melbourne, Vic, Australia.	adrienne.white@thewomens.org.au	Gross, Mechthild M/S-4186-2018; McGready, Rose/A-3290-2014	Gross, Mechthild M/0000-0001-6348-0054; McGready, Rose/0000-0003-1621-3257; Rijken, Marcus/0000-0003-0914-5508	Wellcome Trust of Great Britain; Stichting Malariadokters, The Netherlands	Wellcome Trust of Great Britain(Wellcome Trust); Stichting Malariadokters, The Netherlands	The Shoklo Malaria Research Unit is part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant). The funding sources were not involved in the collection, analysis and interpretation of the data, the writing of the article or in submission of the paper for publication. The views expressed in the paper are those of the authors and do not represent the positions of their respective institutions or that of the funding agencies.; Thanks to Stichting Malariadokters, The Netherlands, for financial support during the review of the SMRU Obstetric Manual. iittp://malariadokters.nl/	Adegoke AA, 2015, MIDWIFERY, V31, P946, DOI 10.1016/j.midw.2015.06.010; Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; Adegoke AA, 2013, MIDWIFERY, V29, pE64, DOI 10.1016/j.midw.2012.08.009; Adegoke AA, 2011, MIDWIFERY, V27, P350, DOI 10.1016/j.midw.2011.03.006; Ariff S, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-319; Baker S., 2010, RES GAPS HLTH MIGRAN; Bartlett L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098550; Bhuiyan AB, 2005, INT J GYNECOL OBSTET, V90, P56, DOI 10.1016/j.ijgo.2005.03.031; Carrara VI, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-45; Cooper S, 2012, WOMEN BIRTH, V25, P64, DOI 10.1016/j.wombi.2011.03.004; Crossley J, 2002, MED EDUC, V36, P972, DOI 10.1046/j.1365-2923.2002.01320.x; Dawson AJ, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0096-1; Dawson A, 2014, MIDWIFERY, V30, P391, DOI 10.1016/j.midw.2013.05.009; Day-Stirk F, 2012, INT J GYNECOL OBSTET, V119, pS39, DOI 10.1016/j.ijgo.2012.04.003; Ehiri JE, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23902; Evans CL, 2014, INT J GYNECOL OBSTET, V126, P286, DOI 10.1016/j.ijgo.2014.02.021; Filby A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153391; Fullerton JT, 2016, MIDWIFERY, V34, P36, DOI 10.1016/j.midw.2016.01.008; Fullerton JT, 2013, MIDWIFERY, V29, P1129, DOI 10.1016/j.midw.2013.07.006; Fullerton JT, 2011, MIDWIFERY, V27, P308, DOI 10.1016/j.midw.2010.10.011; Gabrysch S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001340; Hall A, 2012, MYANMAR MIGRANT WORK; Harvey SA, 2004, INT J GYNECOL OBSTET, V87, P203, DOI 10.1016/j.ijgo.2004.06.017; Harvey SA, 2007, B WORLD HEALTH ORGAN, V85, P783, DOI 10.2471/BLT.06.038455; Hofmeyr GJ, 2009, INT J GYNECOL OBSTET, V107, pS21, DOI 10.1016/j.ijgo.2009.07.017; Homer CSE, 2007, MIDWIFERY, V23, P350, DOI 10.1016/j.midw.2006.03.008; Homer CSE, 2014, LANCET, V384, P1146, DOI 10.1016/S0140-6736(14)60790-X; Hoogenboom G, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0444-0; Huguet J., 2012, THAILAND CROSSROADS; Krause S, 2002, LANCET S, V360, DOI [10.1016/S0140-6736(02)11803-4, DOI 10.1016/S0140-6736(02)11803-4]; Krause S, 2000, PROGRAMMATIC RESPONS, V26, DOI [10.2307/2648256, DOI 10.2307/2648256]; Krause S K, 2006, Glob Public Health, V1, P205, DOI 10.1080/17441690600679939; Liljestrand J, 2012, REPROD HEALTH MATTER, V20, P62, DOI 10.1016/S0968-8080(12)39620-1; Lorga T, 2013, INT J GEN MED, V6, P519, DOI 10.2147/IJGM.S44902; Low S, 2014, GLOBAL HEALTH ACTION, V7, P86, DOI 10.3402/gha.v7.24937; Luxemburger C, 2003, T ROY SOC TROP MED H, V97, P251, DOI 10.1016/S0035-9203(03)90134-9; McAuliffe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058415; McGready R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040244; Morrow J, 2016, WOMEN BIRTH, V29, P85, DOI 10.1016/j.wombi.2015.09.001; NOSTEN F, 1991, T ROY SOC TROP MED H, V85, P424, DOI 10.1016/0035-9203(91)90205-D; Nursing and Midwifery Council, 2009, STAND PRER MIDW ED; Nursing Australian and Midwifery Accreditation Council, MIDW ACCR STAND 2014; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Rosskam E, 2013, INT J HEALTH PLAN M, V28, pe62, DOI 10.1002/hpm.2131; Srivastava P., 2009, INT J QUAL METH, V8, P76, DOI [10.1177/160940690900800107, DOI 10.1177/160940690900800107]; Stanley L, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0041-x; Thompson JE, 2002, MIDWIFERY, V18, P256, DOI 10.1054/midw.2002.0329; Turner C, 2013, PLOS ONE, V8, DOI [10.1016/S0035-9203(03)90134-9, DOI 10.1016/S0035-9203(03)90134-9]; United Nations, 2016, SUST DEV GOALS 2016; United Nations High Commissioner for Refugees, 2014, GLOB FACTS FIG REF; United Nations Population Fund, 2021, STATE WORLDS MIDWIFE; United Nations Population Fund, 2014, STAT WORLDS MIDW 201; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; WALRAVEN GEL, 1994, LANCET, V344, P617, DOI 10.1016/S0140-6736(94)92004-4; Whitmill J, 2016, CONFL HEALTH, V10, DOI 10.1186/s13031-016-0069-6; World Health Organization, 2006, PREGN CHILDB POSTP N; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R; Yisma E, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-23; Zainullah P, 2014, MIDWIFERY, V30, P1056, DOI 10.1016/j.midw.2013.10.026	59	10	10	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164363	10.1371/journal.pone.0164363	http://dx.doi.org/10.1371/journal.pone.0164363			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711144	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600122
J	Xiao, Y; Kwong, M; Daemen, A; Belvin, M; Liang, XR; Hatzivassiliou, G; O'Brien, T				Xiao, Yang; Kwong, Mandy; Daemen, Anneleen; Belvin, Marcia; Liang, Xiaorong; Hatzivassiliou, Georgia; O'Brien, Thomas			Metabolic Response to NAD Depletion across Cell Lines Is Highly Variable	PLOS ONE			English	Article							NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE NAMPT; CANCER-CELLS; INHIBITORS; BIOSYNTHESIS; DISCOVERY; LEADS	Nicotinamide adenine dinucleotide (NAD) is a cofactor involved in a wide range of cellular metabolic processes and is a key metabolite required for tumor growth. NAMPT, nicotinamide phosphoribosyltransferase, which converts nicotinamide (NAM) to nicotinamide mononucleotide (NMN), the immediate precursor of NAD, is an attractive therapeutic target as inhibition of NAMPT reduces cellular NAD levels and inhibits tumor growth in vivo. However, there is limited understanding of the metabolic response to NAD depletion across cancer cell lines and whether all cell lines respond in a uniform manner. To explore this we selected two non-small cell lung carcinoma cell lines that are sensitive to the NAMPT inhibitor GNE-617 (A549, NCI-H1334), one that shows intermediate sensitivity (NCI-H441), and one that is insensitive (LC-KJ). Even though NAD was reduced in all cell lines there was surprising heterogeneity in their metabolic response. Both sensitive cell lines reduced glycolysis and levels of di- and tri-nucleotides and modestly increased oxidative phosphorylation, but they differed in their ability to combat oxidative stress. H1334 cells activated the stress kinase AMPK, whereas A549 cells were unable to activate AMPK as they contain a mutation in LKB1, which prevents activation of AMPK. However, A549 cells increased utilization of the Pentose Phosphate pathway (PPP) and had lower reactive oxygen species (ROS) levels than H1334 cells, indicating that A549 cells are better able to modulate an increase in oxidative stress. Inherent resistance of LC-KJ cells is associated with higher baseline levels of NADPH and a delayed reduction of NAD upon NAMPT inhibition. Our data reveals that cell lines show heterogeneous response to NAD depletion and that the underlying molecular and genetic framework in cells can influence the metabolic response to NAMPT inhibition.	[Xiao, Yang; Kwong, Mandy; Belvin, Marcia; Hatzivassiliou, Georgia; O'Brien, Thomas] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Daemen, Anneleen] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA USA; [Liang, Xiaorong] Genentech Inc, Dept Drug Metab & Pharmacokinet, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	O'Brien, T (corresponding author), Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA.	obrien.tom@gene.com			Genentech	Genentech(Roche HoldingGenentech)	All authors were full time employees of Genentech when this work was performed. Genentech provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Del Nagro C, 2014, J BIOL CHEM, V289, P35182, DOI 10.1074/jbc.M114.580159; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hasmann M, 2003, CANCER RES, V63, P7436; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Montecucco F, 2013, CURR DRUG TARGETS, V14, P637; Olesen UH, 2008, BIOCHEM BIOPH RES CO, V367, P799, DOI 10.1016/j.bbrc.2008.01.019; Salway JG., 2004, METABOLISM GLANCE, DOI [10.1146/annurev.nutr.28.061807.155443, DOI 10.1146/ANNUREV.NUTR.28.061807.155443]; Shames DS, 2013, CLIN CANCER RES, V19, P6912, DOI 10.1158/1078-0432.CCR-13-1186; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Tan B, 2015, J BIOL CHEM, V290, P15812, DOI 10.1074/jbc.M114.632141; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Tolstikov V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114019; van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021; van Ravenzwaay B, 2010, TOXICOL LETT, V198, P159, DOI 10.1016/j.toxlet.2010.06.009; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Xiao Y, 2013, NEOPLASIA, V15, P1137, DOI 10.1593/neo.131304; Zheng XZ, 2013, J MED CHEM, V56, P6413, DOI 10.1021/jm4008664	22	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164166	10.1371/journal.pone.0164166	http://dx.doi.org/10.1371/journal.pone.0164166			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711204	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600091
J	Wildegger, T; Humphreys, G; Nobre, AC				Wildegger, Theresa; Humphreys, Glyn; Nobre, Anna C.			Retrospective Attention Interacts with Stimulus Strength to Shape Working Memory Performance	PLOS ONE			English	Article							ORIENTING ATTENTION; REPRESENTATIONS; VARIABILITY; DISCRETE; CAPACITY; INFORMATION; ACCOUNTS; STORAGE; BRAIN	Orienting attention retrospectively to selective contents in working memory (WM) influences performance. A separate line of research has shown that stimulus strength shapes perceptual representations. There is little research on how stimulus strength during encoding shapes WM performance, and how effects of retrospective orienting might vary with changes in stimulus strength. We explore these questions in three experiments using a continuous-recall WM task. In Experiment 1 we show that benefits of cueing spatial attention retrospectively during WM maintenance (retrocueing) varies according to stimulus contrast during encoding. Retrocueing effects emerge for supraliminal but not sub-threshold stimuli. However, once stimuli are supraliminal, performance is no longer influenced by stimulus contrast. In Experiments 2 and 3 we used a mixture-model approach to examine how different sources of error in WM are affected by contrast and retrocueing. For high-contrast stimuli (Experiment 2), retrocues increased the precision of successfully remembered items. For low-contrast stimuli (Experiment 3), retrocues decreased the probability of mistaking a target with distracters. These results suggest that the processes by which retrospective attentional orienting shape WM performance are dependent on the quality of WM representations, which in turn depends on stimulus strength during encoding.	[Wildegger, Theresa; Humphreys, Glyn; Nobre, Anna C.] Univ Oxford, Dept Expt Psychol, Oxford, England; [Wildegger, Theresa; Nobre, Anna C.] Univ Oxford, Oxford Ctr Human Brain Act, Oxford, England	University of Oxford; University of Oxford	Nobre, AC (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.; Nobre, AC (corresponding author), Univ Oxford, Oxford Ctr Human Brain Act, Oxford, England.	kia.nobre@ohba.ox.ac.uk		Nobre, Anna Christina/0000-0001-5762-2802	Wellcome Trust [104571/Z/14/Z]; European Research Council [PePe 323883]; Economic and Social Research Council [ES/ J500112/1]; National Institute for Health Research Oxford Biomedical Research Centre Programme [oxfbrc-2012-1]; Economic and Social Research Council [1214614] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by Wellcome Trust (A.C.N., Grant 104571/Z/14/Z) (https://wellcome.ac.uk/), European Research Council (G.H., Grant PePe 323883) (https://erc.europa.eu/), Economic and Social Research Council (T.W., Grant ES/ J500112/1) (http://www.esrc.ac.uk/), and National Institute for Health Research Oxford Biomedical Research Centre Programme (oxfbrc-2012-1) (http://oxfordbrc.nihr.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars B. J., 1988, COGNITIVE THEORY CON; Bae GY, 2014, J VISION, V14, DOI 10.1167/14.4.7; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Bays PM, 2014, J NEUROSCI, V34, P3632, DOI 10.1523/JNEUROSCI.3204-13.2014; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Fisher N.I., 1993, STAT ANAL SPHERICAL; Fougnie D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2237; Girshick AR, 2011, NAT NEUROSCI, V14, P926, DOI 10.1038/nn.2831; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Gunseli E, 2015, PSYCHON B REV, V22, P1334, DOI 10.3758/s13423-014-0796-x; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Kleiner M, 2007, PERCEPTION, V36, P14; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; Lepsien J, 2005, NEUROIMAGE, V26, P733, DOI 10.1016/j.neuroimage.2005.02.026; Lepsien J, 2006, BRAIN RES, V1105, P20, DOI 10.1016/j.brainres.2006.03.033; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Makovski T, 2015, Q J EXP PSYCHOL, V68, P1735, DOI 10.1080/17470218.2015.1049623; Makovski T, 2012, PSYCHON B REV, V19, P470, DOI 10.3758/s13423-012-0235-9; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Matthey L, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004003; Murray AM, 2013, PSYCHOL SCI, V24, P550, DOI 10.1177/0956797612457782; Myers NE, 2015, J COGNITIVE NEUROSCI, V27, P492, DOI 10.1162/jocn_a_00727; Myers NE, 2014, J NEUROSCI, V34, P7735, DOI 10.1523/JNEUROSCI.4741-13.2014; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; Ramsoy T.Z., 2004, PHENOMENOL COGNIT SC, V3, P1, DOI [10.1023/b:phen.0000041900.30172.e8, DOI 10.1023/B:PHEN.0000041900.30172.E8, 10.1023/B:PHEN.0000041900.30172.e8]; Rerko L, 2014, MEM COGNITION, V42, P712, DOI 10.3758/s13421-013-0392-8; Rerko L, 2013, J EXP PSYCHOL LEARN, V39, P1075, DOI 10.1037/a0031172; Sergent C, 2013, CURR BIOL, V23, P150, DOI 10.1016/j.cub.2012.11.047; Sligte IG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001699; Souza AS, 2016, ATTEN PERCEPT PSYCHO, V78, P1839, DOI 10.3758/s13414-016-1108-5; Souza AS, 2016, J EXP PSYCHOL HUMAN, V42, P890, DOI 10.1037/xhp0000192; Souza AS, 2014, ATTEN PERCEPT PSYCHO, V76, P2080, DOI 10.3758/s13414-014-0687-2; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Sprague TC, 2016, NEURON, V91, P694, DOI 10.1016/j.neuron.2016.07.006; Stokes MG, 2015, TRENDS COGN SCI, V19, P394, DOI 10.1016/j.tics.2015.05.004; Thibault L, 2016, RETROSPECTIVE ATTENT, V11, DOI [10.1371/journal.pone.0148504, DOI 10.1371/JOURNAL.PONE.0148504]; van den Berg R, 2014, PSYCHOL REV, V121, P124, DOI 10.1037/a0035234; van den Berg R, 2012, P NATL ACAD SCI USA, V109, P8780, DOI 10.1073/pnas.1117465109; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; van Moorselaar D, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01053; Van Vugt MK, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00696; Wallis G, 2015, J COGNITIVE NEUROSCI, V27, P2019, DOI 10.1162/jocn_a_00838; Williams M, 2013, PSYCHON B REV, V20, P348, DOI 10.3758/s13423-012-0354-3; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	46	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164174	10.1371/journal.pone.0164174	http://dx.doi.org/10.1371/journal.pone.0164174			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706240	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200095
J	Wiehr, S; Rolle, AM; Warnke, P; Kohlhofer, U; Quintanilla-Martinez, L; Reischl, G; Autenrieth, IB; Pichler, BJ; Autenrieth, SE				Wiehr, Stefan; Rolle, Anna-Maria; Warnke, Philipp; Kohlhofer, Ursula; Quintanilla-Martinez, Leticia; Reischl, Gerald; Autenrieth, Ingo B.; Pichler, Bernd J.; Autenrieth, Stella E.			The Positron Emission Tomography Tracer 3 '-Deoxy-3 '-[F-18] Fluorothymidine ([F-18]FLT) Is Not Suitable to Detect Tissue Proliferation Induced by Systemic Yersinia enterocolitica Infection in Mice	PLOS ONE			English	Article							THYMIDINE CONCENTRATIONS; IMAGING PROLIFERATION; IN-VIVO; PET; TUMOR; MODEL; RODENTS	Most frequently, gram-negative bacterial infections in humans are caused by Enterobacteriaceae and remain a major challenge in medical diagnostics. We non-invasively imaged moderate and severe systemic Yersinia enterocolitica infections in mice using the positron emission tomography (PET) tracer 3'-deoxy-3'-[F-18] fluorothymidine ([F-18]FLT), which is a marker of proliferation, and compared the in vivo results to the ex vivo biodistributions, bacterial loads, and histologies of the corresponding organs. Y. enterocolitica infection is detectable with histology using H&E staining and immunohistochemistry for Ki 67. [F-18]FLT revealed only background uptake in the spleen, which is the main manifestation site of systemic Y. enterocolitica-infected mice. The uptake was independent of the infection dose. Antibody-based thymidine kinase 1 (Tk-1) staining confirmed the negative [F-18]FLT-PET data. Histological alterations of spleen tissue, observed via Ki 67-antibody-based staining, can not be detected by [F-18]FLT-PET in this model. Thus, the proliferation marker [F-18]FLT is not a suitable tracer for the diagnosis of systemic Y. enterocolitica infection in the C57BL/6 animal model of yersiniosis.	[Wiehr, Stefan; Rolle, Anna-Maria; Reischl, Gerald; Pichler, Bernd J.] Univ Tubingen, Dept Preclin Imaging & Radiopharm, Werner Siemens Imaging Ctr, Tubingen, Germany; [Warnke, Philipp; Autenrieth, Ingo B.] Univ Tubingen, Inst Med Microbiol & Hyg, Tubingen, Germany; [Kohlhofer, Ursula; Quintanilla-Martinez, Leticia] Univ Tubingen, Inst Pathol, Tubingen, Germany; [Autenrieth, Stella E.] Univ Tubingen Hosp, Dept Internal Med 2, Tubingen, Germany; [Warnke, Philipp] Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany	Eberhard Karls University of Tubingen; Siemens AG; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Rostock	Autenrieth, SE (corresponding author), Univ Tubingen Hosp, Dept Internal Med 2, Tubingen, Germany.	Stella.Autenrieth@med.uni-tuebingen.de	Autenrieth, Stella/GOG-8744-2022		European Social Fund Baden-Wurttemberg; Deutsche Forschungsgemeinschaft [WI 3777/1-2]; Werner Siemens Foundation	European Social Fund Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Werner Siemens Foundation	The research leading to these results has received funding from the European Social Fund Baden-Wurttemberg (to SEA), from the Deutsche Forschungsgemeinschaft (grant WI 3777/1-2; to SW) and the Werner Siemens Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Autenrieth SE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002552; Bading JR, 2008, J NUCL MED, V49, p64S, DOI 10.2967/jnumed.107.046391; Bates DW, 1997, J INFECT DIS, V176, P1538, DOI 10.1086/514153; Becker W, 2001, Lancet Infect Dis, V1, P326, DOI 10.1016/S1473-3099(01)00146-3; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Buck AK, 2002, CANCER RES, V62, P3331; Buck AK, 2006, CANCER RES, V66, P11055, DOI 10.1158/0008-5472.CAN-06-1955; Bunschoten A, 2013, BIOCONJUGATE CHEM, V24, P1971, DOI 10.1021/bc4003037; Fuchs K, 2013, MOL IMAGING, V12, P1, DOI 10.2310/7290.2012.00042; Fuchs K, 2012, J NUCL MED, V53, P823, DOI 10.2967/jnumed.111.101808; Glaudemans AWJM, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/623036; Glaudemans AWJM, 2012, EUR J NUCL MED MOL I, V39, P745, DOI 10.1007/s00259-012-2060-9; HEESEMANN J, 1993, APMIS, V101, P417, DOI 10.1111/j.1699-0463.1993.tb00130.x; Heinzmann K, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0218-3; Jang SJ, 2012, INT J MED MICROBIOL, V302, P101, DOI 10.1016/j.ijmm.2011.11.002; Krieger-Hinck N, 2006, ANTICANCER RES, V26, P3467; McKinley ET, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108193; McKinley ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058938; Mills B, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0095-1; Ning XH, 2014, ANGEW CHEM INT EDIT, V53, P14096, DOI 10.1002/anie.201408533; NOTTEBROCK H, 1977, BIOCHEM PHARMACOL, V26, P2175, DOI 10.1016/0006-2952(77)90271-4; Porot C, 2014, IEEE ENG MED BIO, P5587, DOI 10.1109/EMBC.2014.6944893; Radu CG, 2008, NAT MED, V14, P783, DOI 10.1038/nm1724; Reischl G, 2006, RADIOCHIM ACTA, V94, P447, DOI 10.1524/ract.2006.94.8.447; Rolle AM, 2016, P NATL ACAD SCI USA, V113, pE1026, DOI 10.1073/pnas.1518836113; Rolle AM, 2015, MOL IMAGING BIOL, V17, P512, DOI 10.1007/s11307-014-0815-3; Santangelo PJ, 2015, NAT METHODS, V12, P427, DOI [10.1038/NMETH.3320, 10.1038/nmeth.3320]; Schindler MKH, 2012, J IMMUNOL, V189, P4900, DOI 10.4049/jimmunol.1201383; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Smyczek-Gargya B, 2004, EUR J NUCL MED MOL I, V31, P720, DOI 10.1007/s00259-004-1462-8; Tan YY, 2014, EXP THER MED, V8, P69, DOI 10.3892/etm.2014.1687; van Waarde A, 2004, J NUCL MED, V45, P695; Wagner M, 2003, CANCER RES, V63, P2681; Wehrl HF, 2014, J NUCL MED, V55, p11S, DOI 10.2967/jnumed.113.129221; Weinstein EA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009815; Wiehr S, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7770; Wiehr S, 2016, ONCOTARGET, V7, P10990, DOI 10.18632/oncotarget.7770; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433	40	2	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164163	10.1371/journal.pone.0164163	http://dx.doi.org/10.1371/journal.pone.0164163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701464	Green Submitted, Green Published, gold			2022-12-27	WOS:000385696900047
J	Dudek, B; Krzyzewska, E; Kapczynska, K; Rybka, J; Pawlak, A; Korzekwa, K; Klausa, E; Bugla-Ploskonska, G				Dudek, Bartlomiej; Krzyzewska, Eva; Kapczynska, Katarzyna; Rybka, Jacek; Pawlak, Aleksandra; Korzekwa, Kamila; Klausa, Elzbieta; Bugla-Ploskonska, Gabriela			Proteomic Analysis of Outer Membrane Proteins from Salmonella Enteritidis Strains with Different Sensitivity to Human Serum	PLOS ONE			English	Article							COMPLEMENT CLASSICAL PATHWAY; ANTIGEN CHAIN-LENGTH; KLEBSIELLA-PNEUMONIAE; O-ANTIGEN; 2-DIMENSIONAL ELECTROPHORESIS; POLYACRYLAMIDE-GELS; ESCHERICHIA-COLI; C1Q BINDING; TYPHIMURIUM; RESISTANCE	Differential analysis of outer membrane composition of S. Enteritidis strains, resistant to 50% normal human serum (NHS) was performed in order to find factors influencing the resistance to higher concentrations of NHS. Ten S. Enteritidis clinical strains, resistant to 50% NHS, all producing very long lipopolysaccharide, were subjected to the challenge of 75% NHS. Five extreme strains: two resistant and three sensitive to 75% NHS, were chosen for the further analysis of outer membrane proteins composition. Substantial differences were found in the levels of particular outer membrane proteins between resistant and sensitive strains, i.e. outer membrane protease E (PgtE) was present mainly in resistant strains, while sensitive strains possessed a high level of flagellar hook-associated protein 2 (FliD) and significantly higher levels of outer membrane protein A (OmpA).	[Dudek, Bartlomiej; Pawlak, Aleksandra; Korzekwa, Kamila; Bugla-Ploskonska, Gabriela] Univ Wroclaw, Fac Biol Sci, Inst Genet & Microbiol, Dept Microbiol, Wroclaw, Poland; [Krzyzewska, Eva; Kapczynska, Katarzyna; Rybka, Jacek] Polish Acad Sci, Hirszfeld Inst Immunol & Expt Therapy, Dept Immunol Infect Dis, Wroclaw, Poland; [Korzekwa, Kamila] Dialab Lab, Wroclaw, Poland; [Klausa, Elzbieta] Reg Ctr Transfus Med, Wroclaw, Poland; [Klausa, Elzbieta] Blood Bank, Wroclaw, Poland	University of Wroclaw; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Bugla-Ploskonska, G (corresponding author), Univ Wroclaw, Fac Biol Sci, Inst Genet & Microbiol, Dept Microbiol, Wroclaw, Poland.	gabriela.bugla-ploskonska@uwr.edu.pl	Helena, Gabriela/D-2336-2017	Helena, Gabriela/0000-0002-1222-201X; Krzyzewska-Dudek, Eva/0000-0002-5581-1690; Kapczynska, Katarzyna/0000-0003-2722-9596; Rybka, Jacek/0000-0003-4499-1574; korzekwa, kamila/0000-0002-2792-8752; Pawlak, Aleksandra/0000-0001-8697-1278; Dudek, Bartlomiej/0000-0002-6181-3772	National Science Center [DEC-2013/11/N/NZ9/00069]; University of Wroclaw [2109/M/IGM/14, 1212/M/IGM/15]	National Science Center(National Science Centre, Poland); University of Wroclaw	The project was financed from the National Science Center Grant No DEC-2013/11/N/NZ9/00069 and co-financed from the University of Wroclaw Grant number 2109/M/IGM/14 and 1212/M/IGM/15.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; ALBERTI S, 1993, INFECT IMMUN, V61, P852; Alberti S, 1996, INFECT IMMUN, V64, P4719; Bednarz-Misa I, 2014, J MICROBIOL METH, V107, P74, DOI 10.1016/j.mimet.2014.09.004; Bengoechea JA, 2004, MOL MICROBIOL, V52, P451, DOI 10.1111/j.1365-2958.2004.03987.x; Bravo D, 2008, J MED MICROBIOL, V57, P938, DOI 10.1099/jmm.0.47848-0; Bugla-Ploskonska G, 2011, MICROB ECOL, V61, P41, DOI 10.1007/s00248-010-9677-7; Bugla-Ploskonska G, 2010, MICROB ECOL, V59, P601, DOI 10.1007/s00248-009-9600-2; Bugla-Ploskonska G, 2009, POL J MICROBIOL, V58, P205; Cho Y, 2015, J MICROBIOL BIOTECHN, V25, P288, DOI 10.4014/jmb.1410.10052; Cho Y, 2014, ELECTROPHORESIS, V35, P888, DOI 10.1002/elps.201300199; Chooneea D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-44; Crawford RW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002918; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Doroszkiewicz Wlodzimierz, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P235; Encheva V, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-42; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; FOMSGAARD A, 1990, J CLIN MICROBIOL, V28, P2627, DOI 10.1128/JCM.28.12.2627-2631.1990; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Gromova I., 2006, CELL BIOL LAB HDB, P219, DOI DOI 10.1016/B978-012164730-8/50212-4; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Ho DK, 2010, J IMMUNOL, V185, P1763, DOI 10.4049/jimmunol.1001244; Hoelzer K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-34; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lahteenmaki K, 2005, CELL MICROBIOL, V7, P529, DOI 10.1111/j.1462-5822.2004.00483.x; Liu B, 2014, FEMS MICROBIOL REV, V38, P56, DOI 10.1111/1574-6976.12034; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Merino S, 1998, INFECT IMMUN, V66, P3825, DOI 10.1128/IAI.66.8.3825-3831.1998; MURPHY TF, 1989, INFECT IMMUN, V57, P2938, DOI 10.1128/IAI.57.10.2938-2941.1989; Murray GL, 2003, MOL MICROBIOL, V47, P1395, DOI 10.1046/j.1365-2958.2003.03383.x; Nishio M, 2005, MICROBIOL-SGM, V151, P863, DOI 10.1099/mic.0.27654-0; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; PRAMOONJAGO P, 1992, J IMMUNOL, V148, P827; Ramu P, 2007, FEBS LETT, V581, P1716, DOI 10.1016/j.febslet.2007.03.049; Riva R, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00063; Sadkowska-Todys M, SALMONELLOSIS POLAND; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh R, 2007, CLIN EXP IMMUNOL, V148, P486, DOI 10.1111/j.1365-2249.2007.03362.x; Skorek K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079525; TOMAS JM, 1986, INFECT IMMUN, V54, P85; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Yi EC, 2000, ANALYST, V125, P651, DOI 10.1039/b000368i; ZOLLINGER WD, 1987, A VAN LEEUW J MICROB, V53, P403, DOI 10.1007/BF00415494	45	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164069	10.1371/journal.pone.0164069	http://dx.doi.org/10.1371/journal.pone.0164069			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695090	Green Submitted, Green Published, gold			2022-12-27	WOS:000385553100085
J	Jakobsen, I; Solomon, TPJ; Karstoft, K				Jakobsen, Ida; Solomon, Thomas P. J.; Karstoft, Kristian			The Acute Effects of Interval-Type Exercise on Glycemic Control in Type 2 Diabetes Subjects: Importance of Interval Length. A Controlled, Counterbalanced, Crossover Study	PLOS ONE			English	Article							ORAL GLUCOSE-TOLERANCE; INSULIN SENSITIVITY; INTENSITY EXERCISE; MODERATE-INTENSITY; PHYSICAL-FITNESS; BODY-COMPOSITION; CONTROLLED-TRIAL; MENSTRUAL-CYCLE; METAANALYSIS; HYPERGLYCEMIA	Interval-type exercise is effective for improving glycemic control, but the optimal approach is unknown. The purpose of this study was to determine the importance of the interval length on changes in postprandial glycemic control following a single exercise bout. Twelve subjects with type 2 diabetes completed a cross-over study with three 1-hour interventions performed in a non-randomized but counter-balanced order: 1) Interval walking consisting of repeated cycles of 3 min slow (aiming for 54% of Peak oxygen consumption rate [VO(2)peak]) and 3 min fast (aiming for 89% of VO(2)peak) walking (IW3); 2) Interval walking consisting of repeated cycles of 1 min slow and 1 min fast walking (IW1) and 3) No walking (CON). The exercise interventions were matched with regards to walking speed, and VO2 and heart rate was assessed throughout all interventions. A 4-hour liquid mixed meal tolerance test commenced 30 min after each intervention, with blood samples taken regularly. IW3 and IW1 resulted in comparable mean VO2 and heart rates. Overall mean postprandial blood glucose levels were lower after IW3 compared to CON (10.3 +/- 3.0 vs. 11.1 +/- 3.3 mmol/L; P < 0.05), with no significant differences between IW1 (10.5 +/- 2.8 mmol/L) and CON or IW3 and IW1 (P > 0.05 for both). Conversely blood glucose levels at specific time points during the MMTT differed significantly following both IW3 and IW1 as compared to CON. Our findings support the previously found blood glucose lowering effect of IW3 and suggest that reducing the interval length, while keeping the walking speed and time spend on fast and slow walking constant, does not result in additional improvements.	[Jakobsen, Ida; Karstoft, Kristian] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark; [Jakobsen, Ida; Karstoft, Kristian] Univ Copenhagen, Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark; [Solomon, Thomas P. J.] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Solomon, Thomas P. J.] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Birmingham; University of Birmingham	Karstoft, K (corresponding author), Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark.; Karstoft, K (corresponding author), Univ Copenhagen, Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark.	k_karstoft@dadlnet.dk	Solomon, Thomas PJ/I-4476-2019	Solomon, Thomas PJ/0000-0002-0579-284X; Karstoft, Kristian/0000-0002-6596-4199	Trygfonden; Danish National Research Foundation [DNRF55]; Bjarne Jensen Foundation; Danish Council for Strategic Research [09-067009, 09-075724]	Trygfonden; Danish National Research Foundation(Danmarks Grundforskningsfond); Bjarne Jensen Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The Centre for Physical Activity Research (CFAS) is supported by a grant from Trygfonden. During the study period, the Centre of Inflammation and Metabolism (CIM) was supported by a grant from the Danish National Research Foundation (DNRF55). The study was further supported by grants from the Bjarne Jensen Foundation (KK). CIM/CFAS is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2015, DIABETES CARE S1, V38; Balducci S, 2010, NUTR METAB CARDIOVAS, V20, P608, DOI 10.1016/j.numecd.2009.04.015; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Boule NG, 2003, DIABETOLOGIA, V46, P1071, DOI 10.1007/s00125-003-1160-2; CEDERHOLM J, 1990, DIABETES RES CLIN PR, V10, P167, DOI 10.1016/0168-8227(90)90040-Z; DiPietro L, 2006, J APPL PHYSIOL, V100, P142, DOI 10.1152/japplphysiol.00474.2005; Faude O, 2009, SPORTS MED, V39, P469, DOI 10.2165/00007256-200939060-00003; Gillen JB, 2012, DIABETES OBES METAB, V14, P575, DOI 10.1111/j.1463-1326.2012.01564.x; Hansen D, 2009, DIABETOLOGIA, V52, P1789, DOI 10.1007/s00125-009-1354-3; Houmard JA, 2004, J APPL PHYSIOL, V96, P101, DOI 10.1152/japplphysiol.00707.2003; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; JARRETT RJ, 1968, BRIT MED J, V2, P528, DOI 10.1136/bmj.2.5604.528; Karstoft K, 2014, J CLIN ENDOCR METAB, V99, P3334, DOI 10.1210/jc.2014-1837; Karstoft K, 2014, DIABETOLOGIA, V57, P2081, DOI 10.1007/s00125-014-3334-5; Karstoft K, 2013, DIABETES CARE, V36, P228, DOI 10.2337/dc12-0658; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Little JP, 2014, APPL PHYSIOL NUTR ME, V39, P835, DOI 10.1139/apnm-2013-0512; Lunt H, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083256, 10.1371/journal.pone.0105360]; Manders RJF, 2010, MED SCI SPORT EXER, V42, P219, DOI 10.1249/MSS.0b013e3181b3b16d; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mitranun W, 2014, SCAND J MED SCI SPOR, V24, pE69, DOI 10.1111/sms.12112; Nemoto K, 2007, MAYO CLIN PROC, V82, P803, DOI 10.4065/82.7.803; O'Donovan G, 2005, EUR J APPL PHYSIOL, V95, P522, DOI 10.1007/s00421-005-0040-5; Oberlin DJ, 2014, MED SCI SPORT EXER, V46, P232, DOI 10.1249/MSS.0b013e3182a54d85; Pedersen BK, 2006, SCAND J MED SCI SPOR, V16, P3, DOI 10.1111/j.1600-0838.2006.00520.x; Price M, 2005, J SPORT SCI, V23, P835, DOI 10.1080/02640410400021971; Smith-Ryan AE, 2015, PHYSICIAN SPORTSMED, V43, P107, DOI 10.1080/00913847.2015.1037231; Snowling NJ, 2006, DIABETES CARE, V29, P2518, DOI 10.2337/dc06-1317; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; WIDOM B, 1992, DIABETES CARE, V15, P213, DOI 10.2337/diacare.15.2.213	33	7	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163562	10.1371/journal.pone.0163562	http://dx.doi.org/10.1371/journal.pone.0163562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695119	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100045
J	Jung, SY; Kim, HY; Park, HS; Yin, XY; Chung, SM; Kim, HS				Jung, Soo Yeon; Kim, Ha Yeong; Park, Hae Sang; Yin, Xiang Yun; Chung, Sung Min; Kim, Han Su			Standardization of A Physiologic Hypoparathyroidism Animal Model	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HIGH PHOSPHORUS DIET; VITAMIN-D; RATS; METABOLISM; THERAPY	Ideal hypoparathyroidism animal models are a prerequisite to developing new treatment modalities for this disorder. The purpose of this study was to evaluate the feasibility of a model whereby rats were parathyroidectomized (PTX) using a fluorescent-identification method and the ideal calcium content of the diet was determined. Thirty male rats were divided into surgical sham (SHAM, n = 5) and PTX plus 0, 0.5, and 2% calcium diet groups (PTX-FC (n = 5), PTX-NC (n = 10), and PTX-HC (n = 10), respectively). Serum parathyroid hormone levels decreased to non-detectable levels in all PTX groups. All animals in the PTX-FC group died within 4 days after the operation. All animals survived when supplied calcium in the diet. However, serum calcium levels were higher in the PTX-HC than the SHAM group. The PTX-NC group demonstrated the most representative modeling of primary hypothyroidism. Serum calcium levels decreased and phosphorus levels increased, and bone volume was increased. All animals survived without further treatment and did not show nephrotoxicity including calcium deposits. These findings demonstrate that PTX animal models produced by using the fluorescent-identification method, and fed a 0.5% calcium diet, are appropriate for hypoparathyroidism treatment studies.	[Jung, Soo Yeon; Chung, Sung Min; Kim, Han Su] Ewha Womans Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Ha Yeong] Ewha Womans Univ, Sch Med, Dept Mol Med, Seoul, South Korea; [Park, Hae Sang] Hallym Univ, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Chunchon, South Korea; [Yin, Xiang Yun] Ajou Univ, Sch Med, Dept Orthopaed Surg, Suwon, South Korea	Ewha Womans University; Ewha Womans University; Hallym University; Ajou University	Kim, HS (corresponding author), Ewha Womans Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	sevent@ewha.ac.kr	Kim, Han Su/AAT-3295-2021	Kim, Han Su/0000-0003-2239-0225; Kim, Ha Yeong/0000-0003-0561-4792; Jung, Soo Yeon/0000-0001-7497-3057	Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health & Welfare, Republic of Korea [HI14C-1557-010015]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2015R1D1A1A09058485]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C-1557-010015, URL: https://www.khidi.or.kr) and by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2015R1D1A1A09058485, URL: http://www.nrf.re.kr/) Grant receiver: HSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carpenter KJ, 1999, J NUTR, V129, P923, DOI 10.1093/jn/129.5.923; Chou FF, 2009, HUM GENE THER, V20, P1344, DOI 10.1089/hum.2009.015; Ferreira JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079721; Hymoller L, 2010, J DAIRY SCI, V93, P2025, DOI 10.3168/jds.2009-2991; Kalueff AV, 2004, PHYSIOL BEHAV, V82, P405, DOI 10.1016/j.physbeh.2004.04.010; Katsumata S, 2004, BIOFACTORS, V22, P33, DOI 10.1002/biof.5520220106; Katsumata S, 2004, BIOSCI BIOTECH BIOCH, V68, P243, DOI 10.1271/bbb.68.243; Lelovas PP, 2008, COMPARATIVE MED, V58, P424; Liao HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133278; Park HS, 2015, EUR ARCH OTO-RHINO-L, V272, P2969, DOI 10.1007/s00405-014-3262-5; Park YS, 2016, ACTA BIOMATER, V35, P215, DOI 10.1016/j.actbio.2016.03.003; Park YS, 2015, BIOMATERIALS, V65, P140, DOI 10.1016/j.biomaterials.2015.06.044; PITKIN RM, 1978, J CLIN ENDOCR METAB, V47, P626, DOI 10.1210/jcem-47-3-626; Rauchenzauner M, 2007, J CLIN ENDOCR METAB, V92, P443, DOI 10.1210/jc.2006-1706; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reeves PG, 1997, J NUTR, V127, pS838; Rejnmark L, 2013, OSTEOPOROSIS INT, V24, P1529, DOI 10.1007/s00198-012-2230-4; Rubin MR, 2010, OSTEOPOROSIS INT, V21, P1927, DOI 10.1007/s00198-009-1149-x; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163911	10.1371/journal.pone.0163911	http://dx.doi.org/10.1371/journal.pone.0163911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695051	Green Submitted, Green Published, gold			2022-12-27	WOS:000385553100064
J	Leyvraz, M; Wirth, JP; Woodruff, BA; Sankar, R; Sodani, PR; Sharma, ND; Aaron, GJ				Leyvraz, Magali; Wirth, James P.; Woodruff, Bradley A.; Sankar, Rajan; Sodani, Prahlad R.; Sharma, Narottam D.; Aaron, Grant J.			High Coverage and Utilization of Fortified Take-Home Rations among Children 6-35 Months of Age Provided through the Integrated Child Development Services Program: Findings from a Cross-Sectional Survey in Telangana, India	PLOS ONE			English	Article								The Integrated Child Development Services (ICDS) in the State of Telangana, India, freely provides a fortified complementary food product, Bal Amrutham, as a take-home ration to children 6-35 months of age. In order to understand the potential for impact of any intervention, it is essential to assess coverage and utilization of the program and to address the barriers to its coverage and utilization. A two-stage, stratified cross-sectional cluster survey was conducted to estimate the coverage and utilization of Bal Amrutham and to identify their barriers and drivers. In randomly selected catchment areas of ICDS centers, children under 36 months of age were randomly selected. A questionnaire, constructed from different validated and standard modules and designed to collect coverage data on nutrition programs, was administered to caregivers. A total of 1,077 children were enrolled in the survey. The coverage of the fortified take-home ration was found to be high among the target population. Nearly all caregivers (93.7%) had heard of Bal Amrutham and 86.8% had already received the product for the target child. Among the children surveyed, 57.2% consumed the product regularly. The ICDS program's services were not found to be a barrier to product coverage. In fact, the ICDS program was found to be widely available, accessible, accepted, and utilized by the population in both urban and rural catchment areas, as well as among poor and non-poor households. However, two barriers to optimal coverage were found: the irregular supply of the product to the beneficiaries and the intra-household sharing of the product. Although sharing was common, the product was estimated to provide the target children with significant proportions of the daily requirements of macro-and micronutrients. Bal Amrutham is widely available, accepted, and consumed among the target population in the catchment areas of ICDS centers. The coverage of the product could be further increased by improving the supply chain.	[Leyvraz, Magali; Aaron, Grant J.] Global Alliance Improved Nutr, Geneva, Switzerland; [Wirth, James P.; Woodruff, Bradley A.] GroundWork, Flasch, Switzerland; [Sankar, Rajan] TATA Trusts, New Delhi, India; [Sodani, Prahlad R.; Sharma, Narottam D.] Indian Inst Hlth Management Res, Jaipur, Rajasthan, India		Leyvraz, M (corresponding author), Global Alliance Improved Nutr, Geneva, Switzerland.	magali.leyvraz@gmail.com	Sodani, Prahlad Rai/CAG-5905-2022	Sodani, Prahlad Rai/0000-0003-4419-1243; Wirth, James P/0000-0002-4733-0379; Rios-Leyvraz, Magali/0000-0003-0455-197X	Bill and Melinda Gates Foundation; Bill & Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the staff of the Indian Institute of Health Management Research which supported the survey. We would also like to thank Ms. Amrapali Katta from the Women Development and Child Welfare Department, Government of Telangana, for her support in conducting the survey and the AWWs for their help and cooperation in collecting the data. This study is part of a nutrition project implemented by AP Foods, the ICDS program, and GAIN, with the support of the Bill & Melinda Gates Foundation.	Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; [Anonymous], 2007, NAT FAM HLTH SURV NF; [Anonymous], 2008, NAT FAM HLTH SURV NF; [Anonymous], 2014, CAS STUD BETT BUS PR; Antony AC, 2003, AM J CLIN NUTR, V78, P3, DOI 10.1093/ajcn/78.1.3; AVSM YS, 1995, J TROP PEDIATRICS, V41, P123, DOI 10.1093/tropej/41.2.123; BEATON GH, 1982, AM J CLIN NUTR, V35, P864, DOI 10.1093/ajcn/35.4.864; Brown K, 2016, MATERN CHILD NUTR, V12, P262, DOI 10.1111/mcn.12141; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Cohuet S, 2012, APPETITE, V59, P698, DOI 10.1016/j.appet.2012.07.019; Ghassemi H, 1992, Asia Pac J Clin Nutr, V1, P195; Gragnolati M., 2006, Economic and Political Weekly, V41, P1193; Group ICoMRE Research ICoM (India) NIoN, 2010, NUTR REQ REC DIET AL; Guevarra E, 2014, FIELD EXCHANGE, V47; Gupta AK, 2014, INT J MANAGEMENT SOC, V3; Kapil Umesh, 2002, Indian Journal of Pediatrics, V69, P597, DOI 10.1007/BF02722688; Kapil U, 2011, INDIAN J PEDIATR, V78, P1069, DOI 10.1007/s12098-011-0379-z; Kodish SR, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12234; National Sample Survey Organization, 2012, 540 NAT SAMPL SURV O; Santos Iná S., 2005, Cad. Saúde Pública, V21, P776, DOI 10.1590/S0102-311X2005000300011; Skau J., 2009, OUTCOME EVALUATION S; TANAHASHI T, 1978, B WORLD HEALTH ORGAN, V56, P295; Wirth JP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158554	24	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0160814	10.1371/journal.pone.0160814	http://dx.doi.org/10.1371/journal.pone.0160814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695118	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100006
J	Muralidharan, S; Dirda, NDA; Katz, EJ; Tang, CM; Bandyopadhyay, S; Kanold, PO; Kao, JPY				Muralidharan, Sukumaran; Dirda, Nathaniel D. A.; Katz, Elizabeth J.; Tang, Cha-Min; Bandyopadhyay, Sharba; Kanold, Patrick O.; Kao, Joseph P. Y.			Ncm, a Photolabile Group for Preparation of Caged Molecules: Synthesis and Biological Application	PLOS ONE			English	Article							ACID ESTER PRODRUGS; ORTHO-NITROBENZYL ESTERS; IN-VITRO; ARYLNITROSO COMPOUNDS; REDUCED GLUTATHIONE; CHEMICAL-STABILITY; PROTECTING GROUP; AUDITORY-CORTEX; DRUG-DELIVERY; THIOLS	Ncm, 6-nitrocoumarin-7-ylmethyl, is a photolabile protective group useful for making "caged" molecules. Ncm marries the reliable photochemistry of 2-nitrobenzyl systems with the excellent stability and spectroscopic properties of the coumarin chromophore. From simple, commercially available starting materials, preparation of Ncm and its caged derivatives is both quick and easy. Photorelease of Ncm-caged molecules occurs on the microsecond time scale, with quantum efficiencies of 0.05-0.08. We report the synthesis and physical properties of Ncm and its caged derivatives. The utility of Ncm-caged glutamate for neuronal photostimulation is demonstrated in cultured hippocampal neurons and in brain slice preparations.	[Muralidharan, Sukumaran; Dirda, Nathaniel D. A.; Kao, Joseph P. Y.] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Muralidharan, Sukumaran; Dirda, Nathaniel D. A.; Kao, Joseph P. Y.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Katz, Elizabeth J.; Tang, Cha-Min; Kao, Joseph P. Y.] Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA; [Katz, Elizabeth J.; Tang, Cha-Min] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Bandyopadhyay, Sharba; Kanold, Patrick O.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Katz, Elizabeth J.] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; US Food & Drug Administration (FDA)	Kao, JPY (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.; Kao, JPY (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.; Kao, JPY (corresponding author), Univ Maryland, Program Neurosci, Baltimore, MD 21201 USA.	jkao@umaryland.edu		Kanold, Patrick/0000-0002-7529-5435; Kao, Joseph/0000-0002-8875-2180	U.S. National Institutes of Health [DC009607, GM056481]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009607] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by Research grants DC009607 (POK) and GM056481 (JPYK) from the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SR, 1993, ANNU REV PHYSIOL, V55, P755, DOI 10.1146/annurev.ph.55.030193.003543; Akahoshi A, 2014, BIOORG MED CHEM LETT, V24, P5369, DOI 10.1016/j.bmcl.2014.10.053; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; BEAUCHAMP LM, 1992, ANTIVIR CHEM CHEMOTH, V3, P157, DOI 10.1177/095632029200300305; Boinapally S, 2014, J ORG CHEM, V79, P7822, DOI 10.1021/jo501425p; Bort G, 2013, ANGEW CHEM INT EDIT, V52, P4526, DOI 10.1002/anie.201204203; Buhr F, 2015, ANGEW CHEM INT EDIT, V54, P3717, DOI 10.1002/anie.201410940; BUNDGAARD H, 1984, INT J PHARM, V18, P79, DOI 10.1016/0378-5173(84)90109-1; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cai X, 2007, J NEUROSCI, V27, P59, DOI 10.1523/JNEUROSCI.4502-06.2007; Callan HE, 2009, CHEM RES TOXICOL, V22, P937, DOI 10.1021/tx900034r; Chow YL, 1982, CHEM AMINO NITRO NIT, P291; DEMAYO P, 1976, CREATION DETECTION E, V4, P139; Deshmukh M, 2010, J MED CHEM, V53, P1038, DOI 10.1021/jm901029n; DIEPOLD C, 1982, ADV EXP MED BIOL, V136, P1173; DOLLE B, 1980, XENOBIOTICA, V10, P527; ELLIS MK, 1992, CHEM-BIOL INTERACT, V82, P151, DOI 10.1016/0009-2797(92)90107-V; EYER P, 1994, ENVIRON HEALTH PERSP, V102, P123, DOI 10.2307/3432165; EYER P, 1983, BIOCHEM PHARMACOL, V32, P1029, DOI 10.1016/0006-2952(83)90621-4; EYER P, 1979, CHEM-BIOL INTERACT, V24, P227, DOI 10.1016/0009-2797(79)90011-5; FIERABRACCI V, 1991, J CHROMATOGR-BIOMED, V570, P285, DOI 10.1016/0378-4347(91)80531-G; GALLEMANN D, 1994, ENVIRON HEALTH PERSP, V102, P137, DOI 10.2307/3432167; Hagen V, 1996, BIOCHEMISTRY-US, V35, P7762, DOI 10.1021/bi952895b; HATCHARD CG, 1956, PROC R SOC LON SER-A, V235, P518, DOI 10.1098/rspa.1956.0102; Heinbockel T, 2005, J NEUROSCI, V25, P9449, DOI 10.1523/JNEUROSCI.2078-05.2005; Hess George P, 2014, Cold Spring Harb Protoc, V2014, DOI 10.1101/pdb.top084152; Huang YHH, 2005, NEUROPHARMACOLOGY, V49, P831, DOI 10.1016/j.neuropharm.2005.07.018; Kao J. P. Y., 1993, OPTICAL MICROSCOPY E, P27; Kao Joseph P Y, 2013, Methods Mol Biol, V995, P57, DOI 10.1007/978-1-62703-345-9_5; KAO JP, 2006, CURR PROTOC NEUROSCI, pCH6, DOI DOI 10.1002/0471142301,NS0620S37; KAPLAN JH, 1978, BIOCHEMISTRY-US, V17, P1929, DOI 10.1021/bi00603a020; KAZANIS S, 1992, J AM CHEM SOC, V114, P3052, DOI 10.1021/ja00034a043; KLEHR H, 1985, BIOL CHEM H-S, V366, P755, DOI 10.1515/bchm3.1985.366.2.755; Landowski CP, 2005, MOL CANCER THER, V4, P659, DOI 10.1158/1535-7163.MCT-04-0290; Lawrence DS, 2005, CURR OPIN CHEM BIOL, V9, P570, DOI 10.1016/j.cbpa.2005.09.002; LIN ST, 1995, J CHEM RES-S, P372; Liu L, 2008, CHEM RES TOXICOL, V21, P2005, DOI 10.1021/tx800215h; Marriott G, 1999, TRENDS PLANT SCI, V4, P330, DOI 10.1016/S1360-1385(99)01452-1; MARRIOTT G, 1994, BIOCHEMISTRY-US, V33, P9092, DOI 10.1021/bi00197a010; MCCRAY JA, 1989, ANNU REV BIOPHYS BIO, V18, P239, DOI 10.1146/annurev.biophys.18.1.239; Meng XY, 2015, CELL REP, V12, P955, DOI 10.1016/j.celrep.2015.07.018; Meng XY, 2014, J NEUROSCI, V34, P8855, DOI 10.1523/JNEUROSCI.0233-14.2014; Montanari S, 1999, J ORG CHEM, V64, P3422, DOI 10.1021/jo981889t; MURALIDHARAN S, 1995, J PHOTOCH PHOTOBIO B, V27, P123, DOI 10.1016/1011-1344(94)07063-T; Nakayama K, 2011, PHOTOCHEM PHOTOBIOL, V87, P1031, DOI 10.1111/j.1751-1097.2011.00957.x; NERBONNE JM, 1984, NATURE, V310, P74, DOI 10.1038/310074a0; Nerbonne JM, 1996, CURR OPIN NEUROBIOL, V6, P379, DOI 10.1016/S0959-4388(96)80123-1; Niu L, 1996, BIOCHEMISTRY-US, V35, P8136, DOI 10.1021/bi952364n; PAGE MI, 1986, J CHEM SOC PERK T 2, P867, DOI 10.1039/p29860000867; RAMESH D, 1993, P NATL ACAD SCI USA, V90, P11074, DOI 10.1073/pnas.90.23.11074; Rautio J, 1999, PHARMACEUT RES, V16, P1172, DOI 10.1023/A:1018981010047; Rossi FM, 1997, J BIOL CHEM, V272, P32933, DOI 10.1074/jbc.272.52.32933; Salierno M, 2010, J INORG BIOCHEM, V104, P418, DOI 10.1016/j.jinorgbio.2009.12.004; Santos MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037542; Sauers DJ, 2010, ACS CHEM BIOL, V5, P313, DOI 10.1021/cb9002305; SCHUPP H, 1987, J PHOTOCHEM, V36, P85, DOI 10.1016/0047-2670(87)87064-8; Shembekar VR, 2005, BIOCHEMISTRY-US, V44, P7107, DOI 10.1021/bi047665o; Shigeri Y, 2001, PHARMACOL THERAPEUT, V91, P85, DOI 10.1016/S0163-7258(01)00148-6; Song XQ, 2005, MOL PHARMACEUT, V2, P157, DOI 10.1021/mp049888e; TANG CM, 1994, NEURON, V13, P1385, DOI 10.1016/0896-6273(94)90423-5; UMEMOTO A, 1988, CHEM-BIOL INTERACT, V68, P57, DOI 10.1016/0009-2797(88)90006-3; Viswanathan S, 2012, J NEUROSCI, V32, P1589, DOI 10.1523/JNEUROSCI.4748-11.2012; WALKER JW, 1988, J AM CHEM SOC, V110, P7170, DOI 10.1021/ja00229a036; Watkins PV, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00015; WHEELER WJ, 1979, J MED CHEM, V22, P657, DOI 10.1021/jm00192a010; WILCOX M, 1990, J ORG CHEM, V55, P1585, DOI 10.1021/jo00292a038; YIP RW, 1991, J PHYS CHEM-US, V95, P6078, DOI 10.1021/j100169a009; YIP RW, 1985, J PHYS CHEM-US, V89, P5328, DOI 10.1021/j100271a002; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zhang ZY, 1999, BIOCONJUGATE CHEM, V10, P1150, DOI 10.1021/bc990087h; Zhao CP, 2009, J NEUROSCI, V29, P15479, DOI 10.1523/JNEUROSCI.4471-09.2009; Zhao J, 2006, BIOCHEMISTRY-US, V45, P4915, DOI 10.1021/bi052082f; ZHU QQ, 1987, J PHOTOCHEM, V39, P317, DOI 10.1016/0047-2670(87)80041-2; ZUMAN P, 1994, CHEM REV, V94, P1621, DOI 10.1021/cr00030a007	74	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163937	10.1371/journal.pone.0163937	http://dx.doi.org/10.1371/journal.pone.0163937			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695074	Green Submitted, Green Published, gold			2022-12-27	WOS:000385553100066
J	Qu, JZ; Ma, C; Feng, JJ; Xu, ST; Wang, L; Li, FF; Li, YB; Zhang, RH; Zhang, XH; Xue, JQ; Guo, DW				Qu, Jianzhou; Ma, Chuang; Feng, Jiaojiao; Xu, Shutu; Wang, Lei; Li, Feifei; Li, Yibo; Zhang, Renhe; Zhang, Xinghua; Xue, Jiquan; Guo, Dongwei			Transcriptome Dynamics during Maize Endosperm Development	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE-EXPRESSION; IDENTIFICATION; METABOLISM; LANDSCAPE; PATTERNS; EMBRYO; SEED	The endosperm is a major organ of the seed that plays vital roles in determining seed weight and quality. However, genome-wide transcriptome patterns throughout maize endosperm development have not been comprehensively investigated to date. Accordingly, we performed a high-throughput RNA sequencing (RNA-seq) analysis of the maize endosperm transcriptome at 5, 10, 15 and 20 days after pollination (DAP). We found that more than 11,000 protein-coding genes underwent alternative splicing (AS) events during the four developmental stages studied. These genes were mainly involved in intracellular protein transport, signal transmission, cellular carbohydrate metabolism, cellular lipid metabolism, lipid biosynthesis, protein modification, histone modification, cellular amino acid metabolism, and DNA repair. Additionally, 7,633 genes, including 473 transcription factors (TFs), were differentially expressed among the four developmental stages. The differentially expressed TFs were from 50 families, including the bZIP, WRKY, GeBP and ARF families. Further analysis of the stage-specific TFs showed that binding, nucleus and ligand-dependent nuclear receptor activities might be important at 5 DAP, that immune responses, signalling, binding and lumen development are involved at 10 DAP, that protein metabolic processes and the cytoplasm might be important at 15 DAP, and that the responses to various stimuli are different at 20 DAP compared with the other developmental stages. This RNA-seq analysis provides novel, comprehensive insights into the transcriptome dynamics during early endosperm development in maize.	[Qu, Jianzhou; Feng, Jiaojiao; Xu, Shutu; Wang, Lei; Li, Feifei; Li, Yibo; Zhang, Renhe; Zhang, Xinghua; Xue, Jiquan; Guo, Dongwei] Northwest A&F Univ, Key Lab Biol & Genet Improvement Maize Arid Area, Minist Agr, Yangling, Shaanxi, Peoples R China; [Ma, Chuang] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China	Xue, JQ; Guo, DW (corresponding author), Northwest A&F Univ, Key Lab Biol & Genet Improvement Maize Arid Area, Minist Agr, Yangling, Shaanxi, Peoples R China.	xjq2934@163.com; gdwei@nwsuaf.edu.cn	Xu, Shutu/HII-5636-2022		Tang Foundation [A212021207]; National Natural Science Foundation of China [31371626]; Shaanxi Province Science and Technology Innovation [2015KTZDNY01-01-01]; Fund of Northwest AF University [Z111021403, Z109021514]	Tang Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province Science and Technology Innovation; Fund of Northwest AF University	This work was supported by Tang Foundation (A212021207), National Natural Science Foundation of China (31371626), Shaanxi Province Science and Technology Innovation coordination Project 2015KTZDNY01-01-01 and the Fund of Northwest A&F University (Z111021403; Z109021514); grant holders: DWG.	Agarwal P, 2011, BIOESSAYS, V33, P189, DOI 10.1002/bies.201000107; Becraft PW, 2001, SEMIN CELL DEV BIOL, V12, P387, DOI 10.1006/scdb.2001.0268; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chen J, 2014, PLANT PHYSIOL, V166, P252, DOI 10.1104/pp.114.240689; Dante RA, 2014, PLANTA, V239, P493, DOI 10.1007/s00425-013-1990-1; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Feng LN, 2009, PLANT MOL BIOL, V69, P649, DOI 10.1007/s11103-008-9444-z; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Jin ZW, 2014, PLANTA, V239, P299, DOI 10.1007/s00425-013-1979-9; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kim E, 2008, BIOESSAYS, V30, P38, DOI 10.1002/bies.20692; Lai JS, 2004, GENOME RES, V14, P1932, DOI 10.1101/gr.2780504; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Leroux BM, 2014, AM J BOT, V101, P1259, DOI 10.3732/ajb.1400083; Li GS, 2014, P NATL ACAD SCI USA, V111, P7582, DOI 10.1073/pnas.1406383111; Lian T, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0578-2; Liu XH, 2008, GENOMICS, V91, P378, DOI 10.1016/j.ygeno.2007.12.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPES MA, 1993, PLANT CELL, V5, P1383, DOI 10.1105/tpc.5.10.1383; Lu XD, 2013, PLANT PHYSIOL, V162, P440, DOI 10.1104/pp.113.214874; LUR HS, 1993, PLANT PHYSIOL, V103, P273, DOI 10.1104/pp.103.1.273; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Olsen OA, 2001, ANNU REV PLANT PHYS, V52, P233, DOI 10.1146/annurev.arplant.52.1.233; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Rogers MF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r4; Rousseau D, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0050-1; Sabelli PA, 2009, SEX PLANT REPROD, V22, P207, DOI 10.1007/s00497-009-0105-4; Sabelli PA, 2009, PLANT PHYSIOL, V149, P14, DOI 10.1104/pp.108.129437; Schluttenhofer C, 2015, PLANT PHYSIOL, V167, P295, DOI 10.1104/pp.114.251769; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Teoh KT, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-19; Thatcher SR, 2014, PLANT CELL, V26, P3472, DOI 10.1105/tpc.114.130773; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vincentz M, 2003, J MOL EVOL, V56, P105, DOI 10.1007/s00239-002-2386-1; Wang XN, 2015, FUNGAL GENET BIOL, V81, P221, DOI 10.1016/j.fgb.2015.03.010; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Woo YM, 2001, PLANT CELL, V13, P2297, DOI 10.1105/tpc.13.10.2297; Wu YR, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00240; Wu YR, 2010, P NATL ACAD SCI USA, V107, P12810, DOI 10.1073/pnas.1004721107; Zhan JP, 2015, PLANT CELL, V27, P513, DOI 10.1105/tpc.114.135657; Zhang W, 2014, MOL GENET GENOMICS, V289, P1061, DOI 10.1007/s00438-014-0867-8; Zou XL, 2011, ANN BOT-LONDON, V108, P1323, DOI 10.1093/aob/mcr223	54	18	19	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163814	10.1371/journal.pone.0163814	http://dx.doi.org/10.1371/journal.pone.0163814			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695101	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100055
J	Willebrand, R; Voehringer, D				Willebrand, Ralf; Voehringer, David			IL-33-Induced Cytokine Secretion and Survival of Mouse Eosinophils Is Promoted by Autocrine GM-CSF	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; SIGLEC-F; IL-13 PRODUCTION; MAST-CELLS; IL-33; SIGNALS; INTERLEUKIN-33; EXPRESSION; TISSUE; VIVO	Eosinophils are major effector cells during allergic responses and helminth infections. Recent studies further highlight eosinophils as important players in many other biological processes. Therefore it is important to understand how these cells can be modulated in terms of survival and effector function. In the present study we investigated how eosinophils respond to the alarmin IL-33. We show that IL-33 promotes eosinophil survival in a ST2- and MyD88-dependent manner. IL-33-mediated protection from apoptosis was dependent on autocrine GM-CSF release. In addition, GM-CSF increased the IL-33-induced secretion of IL-4 and IL-13 from eosinophils. Unexpectedly, this effect was further enhanced by cross-linking of Siglec-F, a proposed inhibitory and apopotosis-inducing receptor on eosinophils. Co-culture experiments with eosinophils and macrophages revealed that the IL-33-induced release of IL-4 and IL-13 from eosinophils was required for differentiation of alternatively activated macrophages (AAMs). The differentiation of AAMs could be further increased in the presence of GM-CSF. These results indicate that cross-talk between Siglec-F and the receptors for IL-33, LPS and GM-CSF plays an important role for efficient secretion of IL-4 and IL-13. Deciphering the molecular details of this cross-talk could lead to the development of new therapeutic option to treat eosinophil-associated diseases.	[Willebrand, Ralf; Voehringer, David] Univ Erlangen Nurnberg, Dept Infect Biol, Univ Hosp Erlangen, Erlangen, Germany	University of Erlangen Nuremberg	Voehringer, D (corresponding author), Univ Erlangen Nurnberg, Dept Infect Biol, Univ Hosp Erlangen, Erlangen, Germany.	davaid.voehringer@uk-erlangen.de	Voehringer, David/K-2776-2019		Deutsche Forschungsgemeinschaft [Vo 944/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (grant Vo 944/7-1) to DV, www.dfg.de.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bouffi C, 2013, J IMMUNOL, V191, P4317, DOI 10.4049/jimmunol.1301465; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Carlens J, 2009, J IMMUNOL, V183, P5600, DOI 10.4049/jimmunol.0801581; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Dibbert B, 1998, BLOOD, V92, P778, DOI 10.1182/blood.V92.3.778.415k38_778_783; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Goh YPS, 2013, P NATL ACAD SCI USA, V110, P9914, DOI 10.1073/pnas.1304046110; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; Hashiguchi M, 2015, EUR J IMMUNOL, V45, P876, DOI 10.1002/eji.201444969; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Holmes DA, 2015, EMBO J, V34, P218, DOI 10.15252/embj.201489456; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Hung LY, 2013, P NATL ACAD SCI USA, V110, P282, DOI 10.1073/pnas.1206587110; Ilmarinen Pinja, 2014, J Cell Death, V7, P1, DOI 10.4137/JCD.S13588; Jacobsen EA, 2015, ALLERGY, V70, P1148, DOI 10.1111/all.12655; Junttila IS, 2013, J ALLERGY CLIN IMMUN, V132, P704, DOI 10.1016/j.jaci.2013.03.033; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Lu JL, 2015, IMMUNOL LETT, V164, P11, DOI 10.1016/j.imlet.2015.01.008; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; McMillan SJ, 2014, IMMUNOL LETT, V160, P11, DOI 10.1016/j.imlet.2014.03.008; Meerschaert J, 2000, AM J RESP CELL MOL, V23, P780, DOI 10.1165/ajrcmb.23.6.4171; Molofsky AB, 2015, IMMUNITY; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Munitz A, 2008, BLOOD, V111, P5694, DOI 10.1182/blood-2007-12-126748; Na HJ, 2012, CYTOKINE, V57, P169, DOI 10.1016/j.cyto.2011.10.007; Ohnmacht C, 2007, J IMMUNOL, V179, P4766, DOI 10.4049/jimmunol.179.7.4766; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schwartz C, 2015, BLOOD, V125, P3896, DOI 10.1182/blood-2014-10-607788; Shik D, 2014, ALLERGY, V69, P719, DOI 10.1111/all.12388; Song DJ, 2009, J IMMUNOL, V183, P5333, DOI 10.4049/jimmunol.0801421; Stolarski B, 2010, J IMMUNOL, V185, P3472, DOI 10.4049/jimmunol.1000730; Suzukawa Maho, 2008, Lab Invest, V88, P1245, DOI 10.1038/labinvest.2008.82; TAKANASKI S, 1994, J EXP MED, V180, P711, DOI 10.1084/jem.180.2.711; Throsby M, 2000, J IMMUNOL, V165, P1965, DOI 10.4049/jimmunol.165.4.1965; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yasuda K, 2012, P NATL ACAD SCI USA, V109, P3451, DOI 10.1073/pnas.1201042109; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255; Zhu YC, 2004, J IMMUNOL, V173, P2918, DOI 10.4049/jimmunol.173.5.2918; Zimmermann N, 2008, ALLERGY, V63, P1156, DOI 10.1111/j.1398-9995.2008.01709.x	44	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163751	10.1371/journal.pone.0163751	http://dx.doi.org/10.1371/journal.pone.0163751			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690378	Green Published, Green Submitted, gold			2022-12-27	WOS:000384329200024
J	Ioannou, S; Morris, P; Terry, S; Baker, M; Gallese, V; Reddy, V				Ioannou, Stephanos; Morris, Paul; Terry, Samantha; Baker, Marc; Gallese, Vittorio; Reddy, Vasudevi			Sympathy Crying: Insights from Infrared Thermal Imaging on a Female Sample	PLOS ONE			English	Article							NASAL TEMPERATURE; SIMULATION; INSULA; MIND	Sympathy crying is an odd and complex mixture of physiological and emotional phenomena. Standard psychophysiological theories of emotion cannot attribute crying to a single subdivision of the autonomic nervous system (ANS) and disagreement exists regarding the emotional origin of sympathy crying. The current experiment examines sympathy crying using functional thermal infrared imaging (FTII), a novel contactless measure of ANS activity. To induce crying female participants were given the choice to decide which film they wanted to cry to. Compared to baseline, temperature started increasing on the forehead, the peri-orbital region, the cheeks and the chin before crying and reached even higher temperatures during crying. The maxillary area showed the opposite pattern and a gradual temperature decrease was observed compared to baseline as a result of emotional sweating. The results suggest that tears of sympathy are part of a complex autonomic interaction between the sympathetic and the parasympathetic nervous systems, with the latter preceding the former. The emotional origin of the phenomenon seems to derive from subjective internal factors that relate to one's personal experiences and attributes with tears arising in the form of catharses or as part of shared sadness.	[Ioannou, Stephanos] Alfaisal Univ, Dept Physiol Sci, Coll Med, Riyadh, Saudi Arabia; [Morris, Paul; Terry, Samantha; Baker, Marc; Reddy, Vasudevi] Univ Portsmouth, Dept Psychol, Ctr Situated Act & Commun, Portsmouth, Hants, England; [Gallese, Vittorio] Univ Parma, Dept Neurosci, Sect Human Physiol, Parma, Italy; [Gallese, Vittorio] Univ London, Inst Philosophy, Sch Adv Study, London, England	Alfaisal University; University of Portsmouth; University of Parma; University of London; University of London School of Advanced Study	Ioannou, S (corresponding author), Alfaisal Univ, Dept Physiol Sci, Coll Med, Riyadh, Saudi Arabia.	sioannou@alfaisal.edu	Gallese, Vittorio/ABD-5097-2021	Gallese, Vittorio/0000-0003-4815-3607; Baker, Marc/0000-0002-3359-0890; Ioannou, Stephanos/0000-0003-4707-5993; morris, paul/0000-0002-3752-6992	Marie Curie Initial Training Network, TESIS: Toward an Embodied Science of Inter-Subjectivity [264828]	Marie Curie Initial Training Network, TESIS: Toward an Embodied Science of Inter-Subjectivity	This work was supported by the Marie Curie Initial Training Network, TESIS: Toward an Embodied Science of Inter-Subjectivity (FP7-PEOPLE-2010-ITN, 264828).	AVERILL JR, 1968, PSYCHOL BULL, V70, P721, DOI 10.1037/h0026824; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; Cornelius RR., 1984, EMOTION ADULT DEV, P213; Cornelius RR, 1988, M E PSYCH ASS BUFF N; Crying Lutz T., 1999, CRYING NATURAL CULTU; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Darwin C., 1965, EXPRESS EMOT MAN; Ebisch S. J., 2012, THERMOLOGY INT, V22, P121; Ebisch SJH, 2008, J COGNITIVE NEUROSCI, V20, P1611, DOI 10.1162/jocn.2008.20111; Frey William H., 1985, CRYING MYSTERY TEARS; FRIJDA NH, 1997, NONEXPRESSION EMOTIO, P1; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 2011, TRENDS COGN SCI, V15, P512, DOI 10.1016/j.tics.2011.09.003; Garbey M, 2007, IEEE T BIO-MED ENG, V54, P1418, DOI 10.1109/TBME.2007.891930; GROSS JJ, 1994, PSYCHOPHYSIOLOGY, V31, P460, DOI 10.1111/j.1469-8986.1994.tb01049.x; Hahn AC, 2012, BIOL LETTERS, V8, P864, DOI 10.1098/rsbl.2012.0338; Hendriks MCP, 2007, EMOTION, V7, P458, DOI 10.1037/1528-3542.7.2.458; Ioannou S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00845; Ioannou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079440; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; Kamei T, 1998, ANAL CHIM ACTA, V365, P319, DOI 10.1016/S0003-2670(97)00642-9; Kano F, 2016, PHYSIOL BEHAV, V155, P83, DOI 10.1016/j.physbeh.2015.11.029; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Kistler A, 1998, INT J PSYCHOPHYSIOL, V29, P35, DOI 10.1016/S0167-8760(97)00087-1; KRAEMER DL, 1988, J SOC CLIN PSYCHOL, V6, P53, DOI 10.1521/jscp.1988.6.1.53; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Kuraoka K, 2011, PHYSIOL BEHAV, V102, P347, DOI 10.1016/j.physbeh.2010.11.029; LABOTT SM, 1988, MOTIV EMOTION, V12, P205, DOI 10.1007/BF00993111; Levine JA, 2001, LANCET, V357, P1757, DOI 10.1016/S0140-6736(00)04936-9; Merla A., 2004, BIOMED TECH, V48, P284; Miceli M, 2002, THEOR PSYCHOL, V12, P335, DOI 10.1177/0959354302012003015; Nakanishi R, 2008, INFANT BEHAV DEV, V31, P137, DOI 10.1016/j.infbeh.2007.09.001; Nakayama K, 2005, PHYSIOL BEHAV, V84, P783, DOI 10.1016/j.physbeh.2005.03.009; Nelson JK, 2000, B MENNINGER CLIN, V64, P509; Nhan BR, 2010, IEEE T BIO-MED ENG, V57, P979, DOI 10.1109/TBME.2009.2035926; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Or Calvin K. L., 2007, Occupational Ergonomics, V7, P83; Pavlidis I, 2007, COMPUT VIS IMAGE UND, V108, P150, DOI 10.1016/j.cviu.2006.11.018; Pavlidis I, 2016, SCI REP-UK, V6, DOI 10.1038/srep25651; Pavlidis I, 2012, SCI REP-UK, V2, DOI 10.1038/srep00305; Philippot P, 2002, COGNITION EMOTION, V16, P605, DOI 10.1080/02699930143000392; PORGES SW, 1992, PEDIATRICS, V90, P498; Porges SW, 2001, INT J PSYCHOPHYSIOL, V42, P123, DOI 10.1016/S0167-8760(01)00162-3; Puri C., 2005, CHI 05 EXTENDED ABST, P1725, DOI DOI 10.1145/1056808.1057007; Rottenberg J, 2003, PSYCHOPHYSIOLOGY, V40, P1, DOI 10.1111/1469-8986.00001; SADOFF RL, 1966, PSYCHIAT QUART, V40, P490, DOI 10.1007/BF01562776; Shastri D, 2012, IEEE T AFFECT COMPUT, V3, P366, DOI 10.1109/T-AFFC.2012.13; Shastri D, 2009, IEEE T BIO-MED ENG, V56, P477, DOI 10.1109/TBME.2008.2003265; Tomkins, 1963, AFFECT IMAGERY CONSC, V2; Vetrugno R, 2003, CLIN AUTON RES, V13, P256, DOI 10.1007/s10286-003-0107-5; Vingerhoets JJM, 2001, ADULT CRYING BIOPSYC; Werb A., 1983, THE LACRIMAL SYSTEM, P23; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Williams DG, 1996, BRIT J PSYCHOL, V87, P479, DOI 10.1111/j.2044-8295.1996.tb02603.x	56	21	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0162749	10.1371/journal.pone.0162749	http://dx.doi.org/10.1371/journal.pone.0162749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UW	27716801	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100004
J	Azar, A; Devlin, K; Mell, JC; Giovannetti, T; Pirrone, V; Nonnemacher, MR; Passic, S; Kercher, K; Williams, JW; Jacobson, JM; Wigdahl, B; Dampier, W; Libon, DJ; Sell, C				Azar, Ashley; Devlin, Kathryn; Mell, Joshua Chang; Giovannetti, Tania; Pirrone, Vanessa; Nonnemacher, Michael R.; Passic, Shendra; Kercher, Katherine; Williams, Jean W.; Jacobson, Jeffery M.; Wigdahl, Brian; Dampier, William; Libon, David J.; Sell, Christian			Mitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected Individuals	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; NEUROCOGNITIVE DISORDERS; HIV-1 INFECTION; DNA HAPLOGROUPS; HUMAN MTDNA; DISEASE; AFRICAN; ERA; SUSCEPTIBILITY; ALZHEIMERS	Evolutionary divergence of the mitochondrial genome has given rise to distinct haplogroups. These haplogroups have arisen in specific geographical locations and are responsible for subtle functional changes in the mitochondria that may provide an evolutionary advantage in a given environment. Based on these functional differences, haplogroups could define disease susceptibility in chronic settings. In this study, we undertook a detailed neuropsychological analysis of a cohort of long-term HIV-1-infected individuals in conjunction with sequencing of their mitochondrial genomes. Stepwise regression analysis showed that the best model for predicting both working memory and declarative memory were age and years since diagnosis. In contrast, years since diagnosis and sub-haplogroup were significantly predictive of psychomotor speed. Consistent with this, patients with haplogroup L3e obtained better scores on psychomotor speed and dexterity tasks when compared to the remainder of the cohort, suggesting that this haplogroup provides a protective advantage when faced with the combined stress of HIV-1 infection and long-term antiretroviral therapies. Differential performance on declarative memory tasks was noted for individuals with other sub-L haplogroups, but these differences were not as robust as the association between L3e and psychomotor speed and dexterity tasks. This work provides evidence that mitochondrial haplogroup is related to neuropsychological test performance among patients in chronic disease settings such as HIV-1 infection.	[Azar, Ashley; Sell, Christian] Drexel Univ, Dept Pathol, Coll Med, Philadelphia, PA 19104 USA; [Devlin, Kathryn; Giovannetti, Tania] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Mell, Joshua Chang; Pirrone, Vanessa; Nonnemacher, Michael R.; Passic, Shendra; Kercher, Katherine; Williams, Jean W.; Wigdahl, Brian; Dampier, William] Drexel Univ, Dept Microbiol & Immunol, Coll Med, Philadelphia, PA 19104 USA; [Mell, Joshua Chang] Drexel Univ, Ctr Genom Sci, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA; [Pirrone, Vanessa; Nonnemacher, Michael R.; Passic, Shendra; Kercher, Katherine; Williams, Jean W.; Wigdahl, Brian; Dampier, William] Drexel Univ, Ctr Mol Virol & Translat Neurosci, Inst Mol Med & Infect Dis, Coll Med, Philadelphia, PA 19104 USA; [Jacobson, Jeffery M.] Temple Univ, Dept Med, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Jacobson, Jeffery M.] Temple Univ, Dept Neurosci, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Wigdahl, Brian] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Libon, David J.] Rowan Univ, Dept Geriatr & Gerontol, New Jersey Inst Successful Aging, Sch Osteopath Med, Stratford, NJ USA	Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Drexel University; Drexel University; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University; Rowan University; Rowan University School of Osteopathic Medicine	Sell, C (corresponding author), Drexel Univ, Dept Pathol, Coll Med, Philadelphia, PA 19104 USA.	christian.sell@drexelmed.edu	Giovannetti, Tania/H-3491-2019	Giovannetti, Tania/0000-0001-5661-152X; Mell, Joshua/0000-0003-0222-5636	Public Health Service, National Institutes of Health through National Institute of Neurological Disorders and Stroke [NS32092, NS46263]; National Institute of Drug Abuse [DA19807, NS089435]; National Institute of Mental Health [P30 MH092177]; National Institute of Mental Health under Ruth L. Kirschstein National Research Service Award [T32 MH079785]; NIH; PA Department of Health, CURE Formula funds [4100062203]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089435] Funding Source: NIH RePORTER	Public Health Service, National Institutes of Health through National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)United States Public Health Service); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Mental Health under Ruth L. Kirschstein National Research Service Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PA Department of Health, CURE Formula funds; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All Funding is from government agencies. These studies were funded in part by the Public Health Service, National Institutes of Health through grants from the National Institute of Neurological Disorders and Stroke, NS32092 and NS46263, the National Institute of Drug Abuse, DA19807 (Dr. Brian Wigdahl, Principal Investigator), NS089435 (Dr. Michael Nonnemacher, Principal Investigator), National Institute of Mental Health, P30 MH092177, and under the Ruth L. Kirschstein National Research Service Award T32 MH079785. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH and PA Department of Health, CURE Formula funds to Drexel University 4100062203. Sponsors had no role in the research.	Ances BM, 2007, SEMIN NEUROL, V27, P86, DOI 10.1055/s-2006-956759; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Chen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046473; Correia SC, 2012, ADV EXP MED BIOL, V724, P205, DOI 10.1007/978-1-4614-0653-2_16; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; DeVaughn S, 2015, NEUROPSYCHOL REV, V25, P424, DOI 10.1007/s11065-015-9305-x; Gannon P, 2011, CURR OPIN NEUROL, V24, P275, DOI 10.1097/WCO.0b013e32834695fb; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 1994, UTILITY CLIN RATINGS; Hulgan T, 2015, CLIN INFECT DIS, V61, P1476, DOI 10.1093/cid/civ527; Kampira E, 2013, JAIDS-J ACQ IMM DEF, V63, P647, DOI 10.1097/QAI.0b013e3182968ea5; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Klave H, 1963, GROOVED PEGBOARD; Lee S, 2013, SKAT SNP SET SEQUENC; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lojek E, 2005, J CLIN EXP NEUROPSYC, V27, P665, DOI 10.1081/13803390490918426; Manfredi R, 2004, AGEING RES REV, V3, P31, DOI 10.1016/j.arr.2003.07.001; MCARTHUR JC, 1993, NEUROLOGY, V43, P2245, DOI 10.1212/WNL.43.11.2245; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mungas D, 2004, PSYCHOL ASSESSMENT, V16, P347, DOI 10.1037/1040-3590.16.4.347; Nacarelli T, 2016, FREE RADICAL BIO MED, V95, P133, DOI 10.1016/j.freeradbiomed.2016.03.008; Nicholls TJ, 2014, EXP GERONTOL, V56, P175, DOI 10.1016/j.exger.2014.03.027; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Ramos A, 2011, ELECTROPHORESIS, V32, P782, DOI 10.1002/elps.201000583; Raule N, 2014, AGING CELL, V13, P401, DOI 10.1111/acel.12186; Reitan R, 1992, TRAIL MAKING TEST; Ridge PG, 2012, MITOCHONDRIAL GENOMI; Rito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080031; Rosa A, 2011, J ANTHROPOL SCI, V89, P25, DOI 10.4436/jass.89006; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Schretlen D.J., 2010, CALIBRATED NEUROPSYC; Silva M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12526; Soares Pedro, 2011, MOL BIOL EVOLUTION; Stoff DM, 2004, AIDS, V18, pS1, DOI 10.1097/00002030-200401001-00001; Valcour V, 2008, J NEUROVIROL, V14, P362, DOI 10.1080/13550280802216494; van Gorp W. G., 1993, NEUROPSYCHOLOGY, V7, P62, DOI DOI 10.1037/0894-4105.7.1.62; Vianello D, 2013, HUM MUTAT, V34, P1189, DOI 10.1002/humu.22356; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wilson TW, 2013, J NEUROIMMUNE PHARM, V8, P965, DOI 10.1007/s11481-013-9477-1; Xu JQ, 2009, J NEUROIMMUNE PHARM, V4, P200, DOI 10.1007/s11481-008-9136-0; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399; Zheng X, 2012, SNPRELATE PARRALLEL, P95	46	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163772	10.1371/journal.pone.0163772	http://dx.doi.org/10.1371/journal.pone.0163772			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711166	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600041
J	Dewey, RB; O'Suilleabhain, PE; Sanghera, M; Patel, N; Khemani, P; Lacritz, LH; Chitnis, S; Whitworth, LA; Dewey, RB				Dewey, Richard B., III; O'Suilleabhain, Padraig E.; Sanghera, Manjit; Patel, Neepa; Khemani, Pravin; Lacritz, Laura H.; Chitnis, Shilpa; Whitworth, Louis A.; Dewey, Richard B., Jr.			Developing a Deep Brain Stimulation Neuromodulation Network for Parkinson Disease, Essential Tremor, and Dystonia: Report of a Quality Improvement Project	PLOS ONE			English	Article							MONTREAL COGNITIVE ASSESSMENT; RATING-SCALE; PATIENT SELECTION; SCREENING TOOL; DBS; RELIABILITY; IMPAIRMENT; VALIDATION; MANAGEMENT; DISORDERS	Objective To develop a process to improve patient outcomes from deep brain stimulation (DBS) surgery for Parkinson disease (PD), essential tremor (ET), and dystonia. Methods We employed standard quality improvement methodology using the Plan-Do-Study-Act process to improve patient selection, surgical DBS lead implantation, postoperative programming, and ongoing assessment of patient outcomes. Results The result of this quality improvement process was the development of a neuromodulation network. The key aspect of this program is rigorous patient assessment of both motor and non-motor outcomes tracked longitudinally using a REDCap database. We describe how this information is used to identify problems and to initiate Plan-Do-Study-Act cycles to address them. Preliminary outcomes data is presented for the cohort of PD and ET patients who have received surgery since the creation of the neuromodulation network. Conclusions Careful outcomes tracking is essential to ensure quality in a complex therapeutic endeavor like DBS surgery for movement disorders. The REDCap database system is well suited to store outcomes data for the purpose of ongoing quality assurance monitoring.	[Dewey, Richard B., III; O'Suilleabhain, Padraig E.; Sanghera, Manjit; Patel, Neepa; Khemani, Pravin; Chitnis, Shilpa; Dewey, Richard B., Jr.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Lacritz, Laura H.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Whitworth, Louis A.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Dewey, RB (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.	Richard.dewey@utsouthwestern.edu	Dewey, Richard B/A-4288-2013	Dewey, Richard B/0000-0002-6615-5035; O'Suilleabhain, Padraig/0000-0002-2981-4791	UT Southwestern; Department of Neurology and Neurotherapeutics	UT Southwestern; Department of Neurology and Neurotherapeutics	UT Southwestern funded the effort of the investigators to perform the QI project described through salary support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mark Goldberg, M.D., chairman of the Department of Neurology and Neurotherapeutics, for his financial support of this QI project. We also thank Benjamin Nguyen, MD for assistance in developing physical therapy assessment protocols and Janet Moeller, Kelly Johnson, Kristen Qualls-Yturralde, and Andrea Hassink for performing PT assessments on patients and entering this data into REDCap; Lesley Childs, MD and Ted Mau, MD, PhD for developing the speech assessment battery and Laura Toles, Janis Deane, and Amy Hamilton for performing speech assessments, and Angela Brodrick-Donohue for entering speech data into REDCap; and Judy Shaw, Leigh Carpenter, Alyssa Lee, and Shradhdha Joshi for entering neuropsychological test data into REDCap.	Bronte-Stewart H, 2011, MOVEMENT DISORD, V26, pS5, DOI 10.1002/mds.23482; BURKE RE, 1985, NEUROLOGY, V35, P73, DOI 10.1212/WNL.35.1.73; Comella CL, 1997, MOVEMENT DISORD, V12, P570, DOI 10.1002/mds.870120414; DeLong M, 2012, ANN NY ACAD SCI, V1265, P1, DOI 10.1111/j.1749-6632.2012.06608.x; Deuschl G, 2002, MOVEMENT DISORD, V17, pS102, DOI 10.1002/mds.10150; Gill DJ, 2008, MOVEMENT DISORD, V23, P1043, DOI 10.1002/mds.22017; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hammond C, 2008, MOVEMENT DISORD, V23, P2111, DOI 10.1002/mds.22120; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Kempster GB, 2009, AM J SPEECH-LANG PAT, V18, P124, DOI 10.1044/1058-0360(2008/08-0017); Kupsch A, 2011, MOVEMENT DISORD, V26, pS41, DOI 10.1002/mds.23624; Lang AE, 2002, MOVEMENT DISORD, V17, pS94, DOI 10.1002/mds.10149; Langley GL, 2009, IMPROVEMENT GUIDE PR, DOI [10.1097/NPT.0b013e31821a620c, DOI 10.1097/NPT.0B013E31821A620C]; Leddy AL, 2011, J NEUROL PHYS THER, V35, P90, DOI 10.1097/NPT.0b013e31821a620c; Mancini M, 2012, J BIOENG BIOMED SC S, VS1, P1, DOI DOI 10.4172/2155-9538.S1-007; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Miocinovic S, 2014, PARKINSONISM RELAT D, V20, P1434, DOI 10.1016/j.parkreldis.2014.10.011; Morishita T, 2011, NEUROLOGIST, V17, P263, DOI 10.1097/NRL.0b013e31822d1069; Moro E, 2010, MOVEMENT DISORD, V25, P578, DOI 10.1002/mds.22735; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pahwa R, 2006, NEUROLOGY, V66, P983, DOI 10.1212/01.wnl.0000215250.82576.87; Rosen CA, 2004, LARYNGOSCOPE, V114, P1549, DOI 10.1097/00005537-200409000-00009; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Shukla AW, 2014, NEUROTHERAPEUTICS, V11, P47, DOI 10.1007/s13311-013-0235-0; Stacy MA, 2007, MOVEMENT DISORD, V22, P833, DOI 10.1002/mds.21412; Wichmann T, 2006, NEURON, V52, P197, DOI 10.1016/j.neuron.2006.09.022; Zrinzo L, 2009, J NEUROSURG, V110, P1283, DOI 10.3171/2008.12.JNS08885	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164154	10.1371/journal.pone.0164154	http://dx.doi.org/10.1371/journal.pone.0164154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711133	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600088
J	Gavett, BE; Gurnani, AS; Saurman, JL; Chapman, KR; Steinberg, EG; Martin, B; Chaisson, CE; Mez, J; Tripodis, Y; Stern, RA				Gavett, Brandon E.; Gurnani, Ashita S.; Saurman, Jessica L.; Chapman, Kimberly R.; Steinberg, Eric G.; Martin, Brett; Chaisson, Christine E.; Mez, Jesse; Tripodis, Yorghos; Stern, Robert A.			Practice Effects on Story Memory and List Learning Tests in the Neuropsychological Assessment of Older Adults	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS ASSOCIATION WORKGROUPS; TEST-RETEST RELIABILITY; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; VERBAL MEMORY; DISEASE; DEMENTIA; NORMS; ROBUST	Two of the most commonly used methods to assess memory functioning in studies of cognitive aging and dementia are story memory and list learning tests. We hypothesized that the most commonly used story memory test, Wechsler's Logical Memory, would generate more pronounced practice effects than a well validated but less common list learning test, the Neuropsychological Assessment Battery (NAB) List Learning test. Two hundred eighty-seven older adults, ages 51 to 100 at baseline, completed both tests as part of a larger neuropsychological test battery on an annual basis. Up to five years of recall scores from participants who were diagnosed as cognitively normal (n = 96) or with mild cognitive impairment (MCI; n = 72) or Alzheimer's disease (AD; n = 121) at their most recent visit were analyzed with linear mixed effects regression to examine the interaction between the type of test and the number of times exposed to the test. Other variables, including age at baseline, sex, education, race, time (years) since baseline, and clinical diagnosis were also entered as fixed effects predictor variables. The results indicated that both tests produced significant practice effects in controls and MCI participants; in contrast, participants with AD declined or remained stable. However, for the delayed D but not the immediate D recall condition, Logical Memory generated more pronounced practice effects than NAB List Learning (b = 0.16, p < .01 for controls). These differential practice effects were moderated by clinical diagnosis, such that controls and MCI participants D but not participants with AD D improved more on Logical Memory delayed recall than on delayed NAB List Learning delayed recall over five annual assessments. Because the Logical Memory test is ubiquitous in cognitive aging and neurodegenerative disease research, its tendency to produce marked practice effects D especially on the delayed recall condition D suggests a threat to its validity as a measure of new learning, an essential construct for dementia diagnosis.	[Gavett, Brandon E.; Gurnani, Ashita S.; Saurman, Jessica L.] Univ Colorado Colorado Springs, Dept Psychol, Colorado Springs, CO USA; [Chapman, Kimberly R.; Steinberg, Eric G.; Mez, Jesse; Stern, Robert A.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Martin, Brett; Chaisson, Christine E.; Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Boston, MA USA	University of Colorado System; University of Colorado at Colorado Springs; Boston University; Boston University	Stern, RA (corresponding author), Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA.	bobstern@bu.edu	, Bob/ABA-8507-2020; Tripodis, Yorghos/GRY-0583-2022	Gavett, Brandon/0000-0003-1938-1854; Tripodis, Yorghos/0000-0003-2190-7608	National Institute on Aging [P30 AG013846]; NATIONAL INSTITUTE ON AGING [K23AG046377, P30AG013846] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institute on Aging (https://www.nia.nih.gov/) grant P30 AG013846. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; Blasi S, 2009, NEUROPSYCHOLOGY, V23, P189, DOI 10.1037/a0014079; Brandt J., 2001, HOPKINS VERBAL LEARN; Budson AE, 2005, NEW ENGL J MED, V352, P692, DOI 10.1056/NEJMra041071; Chapman KR, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0176-z; de Jager CA, 2003, PSYCHOL MED, V33, P1039, DOI 10.1017/S0033291703008031; De Santi S, 2008, NEUROPSYCHOLOGY, V22, P469, DOI 10.1037/0894-4105.22.4.469; Delis DC., 2000, CALIFORNIA VERBAL LE; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Duff K, 2001, ARCH CLIN NEUROPSYCH, V16, P461; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Duff K, 2011, AM J GERIAT PSYCHIAT, V19, P932, DOI 10.1097/JGP.0b013e318209dd3a; Estevez-Gonzalez A, 2003, INT J GERIATR PSYCH, V18, P1021, DOI 10.1002/gps.1010; Fleisher AS, 2007, NEUROLOGY, V68, P1588, DOI 10.1212/01.wnl.0000258542.58725.4c; Gavett BE, 2015, J INT NEUROPSYCH SOC, V21, P558, DOI 10.1017/S1355617715000582; Gavett BE, 2010, J INT NEUROPSYCH SOC, V16, P651, DOI 10.1017/S1355617710000421; Gavett BE, 2009, J INT NEUROPSYCH SOC, V15, P121, DOI 10.1017/S1355617708090176; Goldberg Terry E, 2015, Alzheimers Dement (Amst), V1, P103, DOI 10.1016/j.dadm.2014.11.003; Gurnani AS, NEUROPSYCHO IN PRESS; Hassenstab J, 2015, NEUROPSYCHOLOGY, V29, P940, DOI 10.1037/neu0000208; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Hinton-Bayre AD, 2010, ARCH CLIN NEUROPSYCH, V25, P244, DOI 10.1093/arclin/acq008; HODGES JR, 1995, NEUROPSYCHOLOGIA, V33, P441, DOI 10.1016/0028-3932(94)00127-B; Holtzer R, 2008, ARCH CLIN NEUROPSYCH, V23, P531, DOI 10.1016/j.acn.2008.05.004; Ivnik RJ, 2000, NEUROPSYCHOLOGY, V14, P163, DOI 10.1037/0894-4105.14.2.163; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P405, DOI 10.1016/j.acn.2006.06.001; Johnson DK, 2003, NEUROPSYCHOLOGY, V17, P82, DOI 10.1037/0894-4105.17.1.82; Kaltreider LB, 2000, CLIN NEUROPSYCHOL, V14, P269, DOI 10.1076/1385-4046(200008)14:3;1-P;FT269; Karrasch M, 2005, ACTA NEUROL SCAND, V111, P172, DOI 10.1111/j.1600-0404.2005.00380.x; Kave G, 2004, CLIN NEUROPSYCHOL, V18, P362, DOI 10.1080/13854040490052418; Kent P, 2013, APPL NEUROPSYCH-ADUL, V20, P277, DOI 10.1080/09084282.2012.689267; Kuslansky G, 2004, ARCH CLIN NEUROPSYCH, V19, P89, DOI 10.1016/S0887-6177(02)00217-2; Kuznetsova A., 2015, LMERTEST TESTS IN LI; Lacritz L H, 2001, Appl Neuropsychol, V8, P180, DOI 10.1207/S15324826AN0803_8; Libon DJ, 2015, AM J ALZHEIMERS DIS, V30, P622, DOI 10.1177/1533317515577184; Machulda MM, 2013, CLIN NEUROPSYCHOL, V27, P1247, DOI 10.1080/13854046.2013.836567; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McCaffrey R. J., 2000, PRACTITIONERS GUIDE; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Pedraza O, 2010, ARCH CLIN NEUROPSYCH, V25, P347, DOI 10.1093/arclin/acq030; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Rabin LA, 2009, AGING NEUROPSYCHOL C, V16, P357, DOI 10.1080/13825580902825220; Rey A, 1964, EXAMEN CLIN PSYCHOL, P222; Rubin EH, 1998, ARCH NEUROL-CHICAGO, V55, P395, DOI 10.1001/archneur.55.3.395; Salmon D. P., 2000, HDB NEUROPSYCHOLOGY, V2, P155; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Silva D, 2012, DEMENT GER COGN D EX, V2, P120, DOI 10.1159/000336224; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stern R. A., 2003, NEUROPSYCHOLOGICAL A; STORANDT M, 1989, ARCH NEUROL-CHICAGO, V46, P383, DOI 10.1001/archneur.1989.00520400037017; Sullivan K, 1996, J CLIN EXP NEUROPSYC, V18, P707, DOI 10.1080/01688639608408293; Tremont G, 2000, CLIN NEUROPSYCHOL, V14, P295, DOI 10.1076/1385-4046(200008)14:3;1-P;FT295; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Wilson BA, 2000, J INT NEUROPSYCH SOC, V6, P469, DOI 10.1017/S1355617700644053; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002	66	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164492	10.1371/journal.pone.0164492	http://dx.doi.org/10.1371/journal.pone.0164492			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711147	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697600129
J	Koper, MC; Mathijssen, NMC; Witt, F; Morlock, MM; Vehmeijer, SBW				Koper, M. C.; Mathijssen, N. M. C.; Witt, F.; Morlock, M. M.; Vehmeijer, S. B. W.			Clinical and Wear Analyses of 9 Large Metal-on-Metal Total Hip Prostheses	PLOS ONE			English	Article							ARTHROPLASTY; PSEUDOTUMORS; IMPLANTS; FAILURE; BEARINGS; REPLACEMENTS; RETRIEVAL; JOINTS; RATES	Background Metal-on-Metal (MoM) total hip arthroplasties (THA) are associated with pseudotumor formation and high revision rates. This prospective study analysed the clinical and wear analyses of 9 large Metal-on-Metal (MoM) total hip arthroplasties (THA) to understand the underlying mechanisms of failure. The MoM bearings were revised for multiple reasons; the main reason was pseudotumor formation. Materials and Methods From 2006 till 2010 the Reinier de Graaf Hospital implanted 160 large head M2a-Magnum T (Biomet Inc. Warsaw, Indiana, USA) THAs in 150 patients. The first year, 9 bearings were revised and analysed at the Biomechanics Section, Hamburg University of Technology, Germany. We performed clinical (Harris Hip Score, radiographic analysis, blood cobalt and chromium) and wear analysis (implant, tissue and fluid) of the 9 bearings. Since this study did not fall under the scope of the Medical Research Involving Human Subjects Act in The Netherlands, no ethical approval was necessary. In this prospective study all patient details were anonymized by the corresponding author, all other authors were blinded during the research and wear analyses. Patients with bilateral MoM implants were excluded. Results The 9 bearings had a median (IQR) survival of 41.0 (25) months in situ. From these bearings, three showed no noticeable wear. The median (IQR) head wear volume was 3.2 (3.6) mm 3 and maximum wear depth 0.02 (0.02) mm. For the cup the median (IQR) wear volume was 0.23 (0.3) mm(3) with a maximum wear depth of 0.03 (0.05) mm. Conclusion An early identification of parameters related to failure of the MoM THA, such as pain, decreased range of motion, radiographic changes and high levels of blood cobalt and chromium is of great importance for patient's quality of life. Especially now patients and surgeons face the long term effects of all these bearings still in situ. This study reports the clinical and wear analyses of 9 MoM THA. In the majority of this group the reason for revision was pseudotumor formation. Most bearings showed signs of wear, however with a great diversity in clinical analysis, in inclination angle, serum cobalt and chromium levels as well as wear analysis. For a better understanding of the underlying mechanisms related with failure, more wear analyses of revised MoM bearings are necessary as well as a frequent follow-up of the patients with a MoM bearing.	[Koper, M. C.; Mathijssen, N. M. C.; Vehmeijer, S. B. W.] Reinier de Graaf Hosp, Dept Orthopaed, Reinier de Graafweg 3, NL-2625 AD Delft, Netherlands; [Witt, F.; Morlock, M. M.] Hamburg Univ Technol, Biomech Sect, Denickestr 15, D-21073 Hamburg, Germany	Reinier de Graaf Hospital; Hamburg University of Technology	Koper, MC (corresponding author), Reinier de Graaf Hosp, Dept Orthopaed, Reinier de Graafweg 3, NL-2625 AD Delft, Netherlands.	M.Koper@rdgg.nl		Koper, Maarten/0000-0001-7573-332X; Morlock, Michael/0000-0002-5330-2454				Bishop N, 2013, J ORTHOP RES, V31, P1116, DOI 10.1002/jor.22326; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P2357, DOI 10.1007/s11999-010-1262-3; Campbell P, 2008, J ARTHROPLASTY, V23, P1080, DOI 10.1016/j.arth.2007.09.024; Campbell P, 2006, CLIN ORTHOP RELAT R, P35, DOI 10.1097/01.blo.0000238777.34939.82; Campbell P, 2010, CLIN ORTHOP RELAT R, V468, P2321, DOI 10.1007/s11999-010-1372-y; Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Cohen D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5977; Daniel J, 2012, J BONE JOINT SURG AM, V94A, P86, DOI 10.2106/JBJS.J.01612; De Haan R, 2008, J BONE JOINT SURG BR, V90B, P1291, DOI 10.1302/0301-620X.90B10.20533; de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672; Ebramzadeh E, 2015, CLIN ORTHOP RELAT R, V473, P487, DOI 10.1007/s11999-014-3874-5; Elkins JM, 2014, CLIN ORTHOP RELAT R, V472, P529, DOI 10.1007/s11999-013-3244-8; Glyn-Jones S, 2011, J BONE JOINT SURG AM, V93A, P2180, DOI 10.2106/JBJS.J.01206; Hart AJ, 2013, J BONE JOINT SURG AM, V95A, P678, DOI 10.2106/JBJS.J.01447; Koper MC, 2016, HIP INT, V26, P50, DOI 10.5301/hipint.5000293; Kwon YM, 2010, J BONE JOINT SURG BR, V92B, P356, DOI 10.1302/0301-620X.92B3.23281; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Lavernia CJ, 2015, J ARTHROPLASTY, V30, P1085, DOI 10.1016/j.arth.2015.01.021; Malviya A, 2010, J BONE JOINT SURG AM, V92A, P1675, DOI 10.2106/JBJS.I.01426; Malviya A, 2009, ACTA ORTHOP BELG, V75, P477; Morlock MM, 2008, J BONE JOINT SURG AM, V90A, P89, DOI 10.2106/JBJS.H.00621; Morlock MM, 2006, P I MECH ENG H, V220, P333, DOI 10.1243/095441105X69015; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Pastides PS, 2013, WORLD J ORTHOP, V4, P161, DOI 10.5312/wjo.v4.i4.161; Rieker CB, 2004, J ARTHROPLASTY, V19, P5, DOI 10.1016/j.arth.2004.09.017; Sieber HP, 1999, J BONE JOINT SURG BR, V81B, P46, DOI 10.1302/0301-620X.81B1.9047; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; van Lingen CP, 2013, HIP INT, V23, P441, DOI 10.5301/hipint.5000054; Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp; Witt F, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01199	30	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163438	10.1371/journal.pone.0163438	http://dx.doi.org/10.1371/journal.pone.0163438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711119	Green Published, gold			2022-12-27	WOS:000385697600026
J	Xia, H; Zhang, LB; Wu, G; Fu, CH; Long, Y; Xiang, J; Gan, JP; Zhou, YH; Yu, LJ; Li, MT				Xia, Heng; Zhang, Libin; Wu, Gang; Fu, Chunhua; Long, Yan; Xiang, Jun; Gan, Jianping; Zhou, Yanhong; Yu, Longjiang; Li, Maoteng			Genome-Wide Identification and Characterization of MicroRNAs and Target Genes in Lonicera japonica	PLOS ONE			English	Article							SMALL RNAS; DISCOVERY; PROTEINS; BINDING; ROLES	MiRNAs function in post-transcriptional regulation of gene expression and play very important roles in plant development. Lonicera japonica is one of the important medicinal plants in China. However, few studies on the discovery of conserved and novel miRNAs from L. japonica were reported. In this study, we employed deep sequencing technology to identify miRNAs in leaf and flower tissues of L. japonica. A total of 22.97 million clean reads from flower and leaf tissues were obtained, which generated 146 conserved miRNAs distributed in 20 families and 110 novel miRNAs. Accordingly, 72 differentially expressed miRNAs (P <= 0.001) between leaves and flowers and their potential target genes were identified and validated. The qRT-PCR validation showed that majority of the differentially expressed miRNAs showed significant tissue-specific expression in L. japonica. Furthermore, the miRNA-mRNA and mRNA-mRNA regulatory networks were constructed using Cytoscape software. Taken together, this study identified a large number of miRNAs and target genes in L. japonica, which not only provides the first global miRNA expression profiles, but also sheds light on functional genomics research on L. japonica in the future.	[Xia, Heng; Zhang, Libin; Wu, Gang; Fu, Chunhua; Zhou, Yanhong; Yu, Longjiang; Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Long, Yan; Li, Maoteng] Chinese Acad Agr Sci, Inst Biotechnol, Beijing 100081, Peoples R China; [Xiang, Jun; Gan, Jianping] Huanggang Normal Univ, Hubei Key Lab Econ Forest Germplasm Improvement &, Huanggang 438000, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Agricultural Sciences; Huanggang Normal University	Li, MT (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China.; Li, MT (corresponding author), Chinese Acad Agr Sci, Inst Biotechnol, Beijing 100081, Peoples R China.	limaoteng426@mail.hust.edu.cn	Gan, Jianping/AAJ-6821-2021	Gan, Jianping/0000-0001-9827-7929	National Natural Science Foundation of China [31270373, 31540083]; open project of the Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture; Wuhan Botanical Garden; Chinese Academy of Sciences [Y052801t03]; Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains [2015TD03]; New Century Talents Support Program by the Ministry of Education of China [NCET110172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); open project of the Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture; Wuhan Botanical Garden(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains; New Century Talents Support Program by the Ministry of Education of China	The research was supported by the National Natural Science Foundation of China (31270373, 31540083), the open project of the Key Laboratory of Plant Germplasm Enhancement and Specialty Agriculture, Wuhan Botanical Garden, Chinese Academy of Sciences (Y052801t03), Hubei Collaborative Innovation Center for the Characteristic Resources Exploitation of Dabie Mountains (2015TD03) and New Century Talents Support Program by the Ministry of Education of China (NCET110172).	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Birkenbihl RP, 2005, J MOL BIOL, V352, P585, DOI 10.1016/j.jmb.2005.07.013; Bolle C, 2004, PLANTA, V218, P683, DOI 10.1007/s00425-004-1203-z; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo AY, 2008, GENE, V418, P1, DOI 10.1016/j.gene.2008.03.016; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Heddad M, 2000, P NATL ACAD SCI USA, V97, P3741, DOI 10.1073/pnas.050391397; Kazuoka T, 2000, PLANT J, V24, P191, DOI 10.1046/j.1365-313x.2000.00864.x; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schierenbeck KA, 2004, CRIT REV PLANT SCI, V23, P391, DOI 10.1080/07352680490505141; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Thakur V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-108; Wang FD, 2012, MOL GENET GENOMICS, V287, P555, DOI 10.1007/s00438-012-0699-3; Wang ZJ, 2012, PLANTA, V236, P613, DOI 10.1007/s00425-012-1634-x; Xie FL, 2010, PLANTA, V232, P417, DOI 10.1007/s00425-010-1182-1; Xu MY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-421; Zhang BH, 2006, FEBS LETT, V580, P3753, DOI 10.1016/j.febslet.2006.05.063; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095489; Zhang WW, 2009, COMPUT BIOL CHEM, V33, P84, DOI 10.1016/j.compbiolchem.2008.07.006; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1	40	12	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164140	10.1371/journal.pone.0164140	http://dx.doi.org/10.1371/journal.pone.0164140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711182	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600085
J	Zhao, MH; Zhang, H; Liu, GF; Wang, L; Wang, J; Gao, ZQ; Dong, YH; Zhang, LB; Gong, Y				Zhao, Mohan; Zhang, Heng; Liu, Guangfeng; Wang, Li; Wang, Jian; Gao, Zengqiang; Dong, Yuhui; Zhang, Linbo; Gong, Yong			Structural Insights into the Methylation of C1402 in 16S rRNA by Methyltransferase RsmI	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRYSTAL; ENZYME	RsmI and RsmH are conserved S-Adenosylmethionine (AdoMet)-dependent methyltransferases (MTases) that are responsible for the 2'-O-methylation and N-4-methylation of C1402 in bacterial 16S rRNA, respectively. Methylation of m(4)Cm1402 plays a role in fine-tuning the shape and functions of the P-site to increase the decoding fidelity, and was recently found to contribute to the virulence of Staphylococcus aureus in host animals. Here we report the 2.20-angstrom crystal structure of homodimeric RsmI from Escherichia coli in complex with the cofactor AdoMet. RsmI consists of an N-terminal putative RNA-binding domain (NTD) and a C-terminal catalytic domain (CTD) with a Rossmann-like fold, and belongs to the class III MTase family. AdoMet is specifically bound into a negatively charged deep pocket formed by both domains by making extensive contacts. Structure-based mutagenesis and isothermal titration calorimetry (ITC) assays revealed Asp100 and Ala124 are vital for AdoMet-binding. Although the overall fold of RsmI shows remarkable similarities to the characterized MTases involved in vitamin B12 biosynthesis, it exhibits a distinct charge distribution especially around the AdoMet-binding pocket because of different substrate specificity. The docking model of RsmI-AdoMet-RNA ternary complex suggested a possible base-flipping mechanism of the substrate RNA that has been observed in several known RNA MTases. Our structural and biochemical studies provide novel insights into the catalytic mechanism of C1402 methylation in 16S rRNA.	[Zhao, Mohan; Zhang, Heng; Gao, Zengqiang; Dong, Yuhui; Gong, Yong] Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing, Peoples R China; [Wang, Li; Wang, Jian; Zhang, Linbo] Jilin Agr Univ, Coll Life Sci, Changchun, Peoples R China; [Liu, Guangfeng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Jilin Agricultural University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Gong, Y (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Beijing Synchrotron Radiat Facil, Beijing, Peoples R China.; Zhang, LB (corresponding author), Jilin Agr Univ, Coll Life Sci, Changchun, Peoples R China.	cczlb2011@hotmail.com; yonggong@ihep.ac.cn	ZHANG, LIN/GYD-9123-2022	Dong, Yuhui/0000-0002-4422-4685; Zhang, Heng/0000-0003-3208-6489; Gong, Yong/0000-0002-4294-964X; Gao, Zengqiang/0000-0002-9100-9929	National Natural Science Foundation of China [10979005, 31200552, 31270791]; National Basic Research Program of China [2012CB917203, 2012CB911103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn, 10979005, 31200552 and 31270791) and the National Basic Research Program of China (http://www.most.gov.cn/, 2012CB917203 and 2012CB911103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2005, CCP4 NEWSL, V42; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494; Connolly K, 2008, MOL MICROBIOL, V70, P1062, DOI 10.1111/j.1365-2958.2008.06485.x; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Demirci H, 2008, J BIOL CHEM, V283, P26548, DOI 10.1074/jbc.M804005200; Douthwaite S, 2005, FINE TUNING RNA FUNC; Dunkle JA, 2014, P NATL ACAD SCI USA, V111, P6275, DOI 10.1073/pnas.1402789111; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank S, 2007, J BIOL CHEM, V282, P23957, DOI 10.1074/jbc.M703827200; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; JEMIOLO DK, 1985, NUCLEIC ACIDS RES, V13, P8631, DOI 10.1093/nar/13.23.8631; Kimura S, 2010, NUCLEIC ACIDS RES, V38, P1341, DOI 10.1093/nar/gkp1073; Kyuma T, 2015, FEBS J, V282, P2570, DOI 10.1111/febs.13302; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEIER N, 1986, FEBS LETT, V204, P89, DOI 10.1016/0014-5793(86)81392-8; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ofengand J, 2004, ECOSAL ESCHERICHIA C; Ofengand J., 1998, MODIFICATION EDITING, P229, DOI DOI 10.1128/9781555818296.CH12; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; SCHUBERT HL, 1995, PROTEIN SCI, V4, P1904, DOI 10.1002/pro.5560040924; Schubert HL, 1998, NAT STRUCT BIOL, V5, P585, DOI 10.1038/846; Sergeeva OV, 2015, BIOCHIMIE, V117, P110, DOI 10.1016/j.biochi.2014.11.019; Tran E, 2004, TRENDS BIOCHEM SCI, V29, P343, DOI 10.1016/j.tibs.2004.05.001; Wei Y, 2012, J STRUCT BIOL, V179, P29, DOI 10.1016/j.jsb.2012.04.011; Zhang H, 2012, J MOL BIOL, V423, P576, DOI 10.1016/j.jmb.2012.08.016; Zhao MH, 2014, ACTA CRYSTALLOGR F, V70, P1256, DOI 10.1107/S2053230X14016999	31	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163816	10.1371/journal.pone.0163816	http://dx.doi.org/10.1371/journal.pone.0163816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711192	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600042
J	Axenov-Gribanov, D; Bedulina, D; Shatilina, Z; Jakob, L; Vereshchagina, K; Lubyaga, Y; Gurkov, A; Shchapova, E; Luckenbach, T; Lucassen, M; Sartoris, FJ; Portner, HO; Timofeyev, M				Axenov-Gribanov, Denis; Bedulina, Daria; Shatilina, Zhanna; Jakob, Lena; Vereshchagina, Kseniya; Lubyaga, Yulia; Gurkov, Anton; Shchapova, Ekaterina; Luckenbach, Till; Lucassen, Magnus; Sartoris, Franz Josef; Poertner, Hans-Otto; Timofeyev, Maxim			Thermal Preference Ranges Correlate with Stable Signals of Universal Stress Markers in Lake Baikal Endemic and Holarctic Amphipods	PLOS ONE			English	Article							TEMPERATURE-DEPENDENT BIOGEOGRAPHY; CLIMATE-CHANGE; OXYGEN LIMITATION; LIEBIGS LAW; HSP70 GENES; TOLERANCE; RESPONSES; EXPRESSION; PATTERNS; MINIMUM	Temperature is the most pervasive abiotic environmental factor for aquatic organisms. Fluctuations in temperature range lead to changes in metabolic performance. Here, we aimed to identify whether surpassing the thermal preference zones is correlated with shifts in universal cellular stress markers of protein integrity, responses to oxidative stress and lactate content, as indicators of anaerobic metabolism. Exposure of the Lake Baikal endemic amphipod species Eulimnogammarus verrucosus (Gerstfeldt, 1858), Ommatogammarus flavus (Dybowski, 1874) and of the Holarctic amphipod Gammarus lacustris Sars 1863 (Amphipoda, Crustacea) to increasing temperatures resulted in elevated heat shock protein 70 (Hsp70) and lactate content, elevated antioxidant enzyme activities (i.e., catalase and peroxidase), and reduced lactate dehydrogenase and glutathione S-transferase activities. Thus, the zone of stability (absence of any significant changes) of the studied molecular and biochemical markers correlated with the behaviorally preferred temperatures. We conclude that the thermal behavioral responses of the studied amphipods are directly related to metabolic processes at the cellular level. Thus, the determined thermal ranges may possibly correspond to the thermal optima. This relationship between species-specific behavioral reactions and stress response metabolism may have significant ecological consequences that result in a thermal zone-specific distribution (i.e., depths, feed spectrum, etc.) of species. As a consequence, by separating species with different temperature preferences, interspecific competition is reduced, which, in turn, increases a species' Darwinian fitness in its environment.	[Axenov-Gribanov, Denis; Bedulina, Daria; Shatilina, Zhanna; Vereshchagina, Kseniya; Lubyaga, Yulia; Gurkov, Anton; Shchapova, Ekaterina; Timofeyev, Maxim] Irkutsk State Univ, Inst Biol, Irkutsk, Russia; [Jakob, Lena; Lucassen, Magnus; Sartoris, Franz Josef; Poertner, Hans-Otto] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bremerhaven, Germany; [Luckenbach, Till] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany; [Jakob, Lena; Poertner, Hans-Otto] Univ Bremen, Bremen, Germany; [Axenov-Gribanov, Denis; Shatilina, Zhanna] Baikal Res Ctr, Irkutsk, Russia	Irkutsk State University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Bremen	Timofeyev, M (corresponding author), Irkutsk State Univ, Inst Biol, Irkutsk, Russia.	m.a.timofeyev@gmail.com	Lucassen, Magnus/ABA-8396-2021; Axenov-Gribanov, Denis V./F-7360-2017; Lubyaga, Yuliya A./H-1034-2017; Vereshchagina, Kseniya/R-7060-2016; Pörtner, Hans-O./K-9429-2016; Timofeyev, Maxim/F-2071-2010; Lucassen, Magnus/E-8433-2011; Shatilina, Zhanna Mikhailovna/CAF-0020-2022; Gurkov, Anton/M-8708-2014; Luckenbach, Till/G-6482-2015; Axenov-Gribanov, Denis/J-5204-2019	Lucassen, Magnus/0000-0003-4276-4781; Axenov-Gribanov, Denis V./0000-0003-2020-6084; Vereshchagina, Kseniya/0000-0002-4843-5287; Pörtner, Hans-O./0000-0001-6535-6575; Timofeyev, Maxim/0000-0002-5250-6818; Lucassen, Magnus/0000-0003-4276-4781; Gurkov, Anton/0000-0002-8390-1570; Luckenbach, Till/0000-0001-6204-1033; Axenov-Gribanov, Denis/0000-0003-2020-6084; Lubyaga, Yulia/0000-0002-2494-8723; Shchapova, Ekaterina/0000-0001-9084-7675; Sartoris, Franz-Josef/0000-0001-7228-3220; Shatilina, Zhanna/0000-0002-5926-4612; Jakob, Lena/0000-0002-1762-4704	Russian Science Foundation [N 14-14-00400]; Russian Foundation for Basic Research [N 14-04-00501, 15-04-06685, 16-34-60060, 15-29-01003]; Goszadanie project [1354-2014/51, 6.731.2016DAAD, 6.734.2016DAAD, 6.742.2016DAAD]; "LabEglo" project - program "Helmholtz-Russia Joint Research Groups" (HRJRG) [HRJRG-221]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Goszadanie project; "LabEglo" project - program "Helmholtz-Russia Joint Research Groups" (HRJRG)	This research was primary supported by the Russian Science Foundation (projects N 14-14-00400), and Russian Foundation for Basic Research (projects N 14-04-00501, 15-04-06685, 16-34-60060,15-29-01003), Goszadanie project (1354-2014/51, 6.731.2016DAAD, 6.734.2016DAAD, 6.742.2016DAAD) and within the "LabEglo" project HRJRG-221 financed by the bilateral funding program "Helmholtz-Russia Joint Research Groups" (HRJRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Afonso LOB, 2008, J FISH BIOL, V72, P157, DOI 10.1111/j.1095-8649.2007.01697.x; Alabaster J.S., 2013, WATER QUALITY CRITER; Axenov-Gribanov DV, 2014, COMP BIOCHEM PHYS B, V167, P16, DOI 10.1016/j.cbpb.2013.09.006; Bedulina DS, 2013, MOL ECOL, V22, P1416, DOI 10.1111/mec.12136; Bergmeyer H., 1985, METHODS ENZYMATIC AN, VVI; Brown A, 2014, BIOL REV, V89, P406, DOI 10.1111/brv.12061; Chown SL, 2006, PHYSIOL BIOCHEM ZOOL, V79, P314, DOI 10.1086/499989; Cottin D, 2015, J COMP PHYSIOL B, V185, P303, DOI 10.1007/s00360-014-0885-1; Cottin D, 2012, COMP BIOCHEM PHYS A, V162, P357, DOI 10.1016/j.cbpa.2012.04.005; Danger M, 2008, OIKOS, V117, P1741, DOI 10.1111/j.1600-0706.2008.16793.x; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; DROTAR A, 1985, PLANT SCI, V42, P35, DOI 10.1016/0168-9452(85)90025-1; Elder LE, 2015, COMP BIOCHEM PHYS A, V187, P20, DOI 10.1016/j.cbpa.2015.04.008; FORWARD RB, 1990, BIOL BULL-US, V178, P195, DOI 10.2307/1541819; Galaziy G.I., 1987, BAIKAL QUESTIONS ANS; GERRITSEN J, 1982, LIMNOL OCEANOGR, V27, P254, DOI 10.4319/lo.1982.27.2.0254; Gonçalves Rodrigo J, 2010, Ecol. austral, V20, P129; Grieshaber M K, 1994, Rev Physiol Biochem Pharmacol, V125, P43, DOI 10.1007/BFb0030909; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Herberich E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009788; Hiddink JG, 2005, ECOGRAPHY, V28, P264, DOI 10.1111/j.0906-7590.2005.04063.x; HOCHACHKA PW, 2014, BIOCH ADAPTATION; Hofmann GE, 2000, J EXP BIOL, V203, P2331; Hofmann GE, 2005, INTEGR COMP BIOL, V45, P247, DOI 10.1093/icb/45.2.247; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jakob L, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1308; Jost JA, 2012, ENHANCING THERMAL TO; Kaarniranta K, 1998, P NATL ACAD SCI USA, V95, P2319, DOI 10.1073/pnas.95.5.2319; Kamaltynov RM, 1999, CRUSTACEANA, V72, P933, DOI 10.1163/156854099503834; Kim KT, 2010, SCI TOTAL ENVIRON, V408, P2268, DOI 10.1016/j.scitotenv.2010.01.041; Kozhova O. M., 1998, LAKE BAIKAL EVOLUTIO; Lagerspetz KYH, 2006, BIOL REV, V81, P237, DOI 10.1017/S1464793105006998; Larade K., 2002, CELL MOL RESPONSES S, P27, DOI DOI 10.1016/S1568-1254(02)80005-5; Lenz PH, 2005, BIOL BULL-US, V209, P75, DOI 10.2307/3593143; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Madeira D, 2012, CELL STRESS CHAPERON, V17, P707, DOI 10.1007/s12192-012-0345-3; Nelson D.L, 2013, LEHNINGER PRINCIPLES, V6th; Newell RC., 2013, ADAPTATION ENV ESSAY; Peng J, 2014, COMP BIOCHEM PHYS A, V176, P32, DOI 10.1016/j.cbpa.2014.07.005; Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961; Piscart C, 2010, BIOL INVASIONS, V12, P853, DOI 10.1007/s10530-009-9506-4; Pohlmann K, 2011, CELL STRESS CHAPERON, V16, P621, DOI 10.1007/s12192-011-0272-8; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Proviz VI, 2011, ANNOTATED LIST FAUNA; Rusinek O. T., 2012, BAICALOGY, V1; Safronov GP, 1993, COMPOSITION ECOLOGY; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shatilina ZM, 2011, J THERM BIOL, V36, P142, DOI 10.1016/j.jtherbio.2010.12.008; SHELFORD V. E., 1931, ECOLOGY, V12, P455, DOI 10.2307/1928991; Sokolova IM, 2003, J EXP BIOL, V206, P195, DOI 10.1242/jeb.00054; Sung YY, 2011, REV AQUACULT, V3, P120, DOI 10.1111/j.1753-5131.2011.01049.x; Sutcliffe D.W., 1992, Freshwater Forum, V2, P102; Takhteev VV, 2015, ARTHROPODA SEL, V24, P335; Takhteev VV, 2000, ESSAYS LAKE BAIKAL A; Timofeyev M, 2006, COMP BIOCHEM PHYS B, V145, P197, DOI 10.1016/j.cbpb.2006.07.004; Timofeyev M. A., 2001, Arthropoda Selecta, V10, P93; Timofeyev MA, 2010, ECOLOGICAL PHYSL ASP; Timofeyev M, 2007, CRUSTACEANA, V80, P129, DOI 10.1163/156854007780121393; Timofeyev MA, 2009, J THERM BIOL, V34, P281, DOI 10.1016/j.jtherbio.2009.03.008; Timoshkin OA, 2001, INDEX ANIMAL SPECIES, V1; Timoshkin OA, 2008, LIF DEV RESP AB CHAN, P344; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Verbitsky V B, 2014, Dokl Biol Sci, V455, P91, DOI 10.1134/S0012496614020069; Weinberg IV, 1995, WATER RES, V22, P446; WILSON DL, 1994, MECH AGEING DEV, V74, P15, DOI 10.1016/0047-6374(94)90095-7; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]	71	24	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164226	10.1371/journal.pone.0164226	http://dx.doi.org/10.1371/journal.pone.0164226			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706227	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200099
J	Doring, K; Gruning, BA; Telukunta, KK; Thomas, P; Gunther, S				Doering, Kersten; Gruening, Bjorn A.; Telukunta, Kiran K.; Thomas, Philippe; Guenther, Stefan			PubMedPortable: A Framework for Supporting the Development of Text Mining Applications	PLOS ONE			English	Article							DRUG-METABOLISM; WEB SERVICES; NORMALIZATION; TOOLS	Information extraction from biomedical literature is continuously growing in scope and importance. Many tools exist that perform named entity recognition, e.g. of proteins, chemical compounds, and diseases. Furthermore, several approaches deal with the extraction of relations between identified entities. The BioCreative community supports these developments with yearly open challenges, which led to a standardised XML text annotation format called BioC. PubMed provides access to the largest open biomedical literature repository, but there is no unified way of connecting its data to natural language processing tools. Therefore, an appropriate data environment is needed as a basis to combine different software solutions and to develop customised text mining applications. PubMedPortable builds a relational database and a full text index on PubMed citations. It can be applied either to the complete PubMed data set or an arbitrary subset of downloaded PubMed XML files. The software provides the infrastructure to combine stand-alone applications by exporting different data formats, e.g. BioC. The presented workflows show how to use PubMedPortable to retrieve, store, and analyse a disease-specific data set. The provided use cases are well documented in the PubMedPortable wiki. The open-source software library is small, easy to use, and scalable to the user's system requirements. It is freely available for Linux on the web at https://github.com/KerstenDoering/PubMedPortable and for other operating systems as a virtual container. The approach was tested extensively and applied successfully in several projects.	[Doering, Kersten; Guenther, Stefan] Univ Freiburg, Inst Pharmaceut Sci, Pharmaceut Bioinformat, D-79104 Freiburg, Germany; [Gruening, Bjorn A.; Telukunta, Kiran K.] Univ Freiburg, Inst Comp Sci, Bioinformat, D-79110 Freiburg, Germany; [Thomas, Philippe] DFKI GmbH, German Res Ctr Artificial Intelligence, Language Technol Lab, D-10559 Berlin, Germany	University of Freiburg; University of Freiburg; German Research Center for Artificial Intelligence (DFKI)	Gunther, S (corresponding author), Univ Freiburg, Inst Pharmaceut Sci, Pharmaceut Bioinformat, D-79104 Freiburg, Germany.	stefan.guenther@pharmazie.uni-freiburg.de	Günther, Stefan/AAY-8944-2020	Gruning, Bjorn/0000-0002-3079-6586; Telukunta, Kiran Kumar/0000-0002-3219-9240	German National Research Foundation (DFG) [Lis45]; German Research Foundation (DFG); University of Freiburg	German National Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	SG received funding for this project by the German National Research Foundation (DFG, Lis45). The article processing charge was funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing.	Abbasian E, 2015, GENETUKIT PIPELINE; Alias-i, 2008, LINGPIPE4 1 0; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; [Anonymous], 2015, P 5 BIOCREATIVE CHAL; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Burnham D, 2014, COORDINATION STANDAR, P1, DOI [10.1109/ICSDA.2014.7051412, DOI 10.1109/ICSDA.2014.7051412]; Cassidy S, 2014, P 9 INT C LANG RES E, P1; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Comeau DC, 2014, DATABASE-OXFORD 0616, V2014, DOI [10.1093/database/bau056, DOI 10.1093/DATABASE/BAU056]; Comeau DC, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau072; Comeau DC, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat064; Cunningham H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002854; Dawborn T, 2014, P COLING 2014 25 INT, P762; Doring K, 2016, WORKFLOWS PREDICT FU; Fernandez -Cruz L., 2001, SURG TREATMENT EVIDE; Ferrucci D., 2004, Natural Language Engineering, V10, P327, DOI 10.1017/S1351324904003523; Garrido-Laguna I, 2015, NAT REV CLIN ONCOL, V12, P319, DOI 10.1038/nrclinonc.2015.53; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gruning BA, 2011, BIOINFORMATICS, V27, P1341, DOI 10.1093/bioinformatics/btr130; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Jonquet Clement, 2009, Summit Transl Bioinform, V2009, P56; Kano Y, 2009, BIOINFORMATICS, V25, P1997, DOI 10.1093/bioinformatics/btp289; Khare R, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau073; Khare R, 2014, METHODS MOL BIOL, V1159, P11, DOI 10.1007/978-1-4939-0709-0_2; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Leaman R, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/1758-2946-7-S1-S3; Leaman R, 2013, BIOINFORMATICS, V29, P2909, DOI 10.1093/bioinformatics/btt474; Merkel D, 2014, LINUX J, V2014; Oliver DE, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-146; Rak R, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau064; Rinaldi F, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S14-S6; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Sayers E., 2015, E UTILITIES IN DEPTH; Senger C, 2012, BIOINFORMATICS, V28, P709, DOI 10.1093/bioinformatics/bts026; SimTK, 2000, MMEDLINE PARS LOAD X; Tari L, 2010, BIOINFORMATICS, V26, pi547, DOI 10.1093/bioinformatics/btq382; Tikk D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-12; Wei CH, 2016, BIOINFORMATICS, V32, P1907, DOI 10.1093/bioinformatics/btv760; Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441; Yoo Danny, 2006, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0907s13; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	42	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163794	10.1371/journal.pone.0163794	http://dx.doi.org/10.1371/journal.pone.0163794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706202	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200061
J	Jordanous, A; Keller, B				Jordanous, Anna; Keller, Bill			Modelling Creativity: Identifying Key Components through a Corpus-Based Approach	PLOS ONE			English	Article							GENERATION; SCIENCE; FUTURE	Creativity is a complex, multi-faceted concept encompassing a variety of related aspects, abilities, properties and behaviours. If we wish to study creativity scientifically, then a tractable and well-articulated model of creativity is required. Such a model would be of great value to researchers investigating the nature of creativity and in particular, those concerned with the evaluation of creative practice. This paper describes a unique approach to developing a suitable model of how creative behaviour emerges that is based on the words people use to describe the concept. Using techniques from the field of statistical natural language processing, we identify a collection of fourteen key components of creativity through an analysis of a corpus of academic papers on the topic. Words are identified which appear significantly often in connection with discussions of the concept. Using a measure of lexical similarity to help cluster these words, a number of distinct themes emerge, which collectively contribute to a comprehensive and multi-perspective model of creativity. The components provide an ontology of creativity: a set of building blocks which can be used to model creative practice in a variety of domains. The components have been employed in two case studies to evaluate the creativity of computational systems and have proven useful in articulating achievements of this work and directions for further research.	[Jordanous, Anna] Univ Kent, Sch Comp, Chatham, Kent, England; [Keller, Bill] Univ Sussex, Dept Informat, Brighton, E Sussex, England	University of Kent; University of Sussex	Jordanous, A (corresponding author), Univ Kent, Sch Comp, Chatham, Kent, England.; Keller, B (corresponding author), Univ Sussex, Dept Informat, Brighton, E Sussex, England.	a.k.jordanous@kent.ac.uk; billk@sussex.ac.uk	Jordanous, Anna/AAF-7976-2020	Jordanous, Anna/0000-0003-2076-8642; Keller, Bill/0000-0001-7781-7703	School of Informatics, University of Sussex	School of Informatics, University of Sussex	The author(s) received no specific funding for this work. Anna Jordanous undertook part of this work during her PhD, which was part funded by a stipend provided by the School of Informatics, University of Sussex.	Amabile TM, 1996, CREATIVITY CONTEXT, P198, DOI [10.1093/aristotelian/56.1.167, DOI 10.1093/ARISTOTELIAN/56.1.167]; Baer J, 1998, CREATIVITY RES J, V11, P173, DOI 10.1207/s15326934crj1102_7; Baer J., 2010, CAMBRIDGE HDB CREATI, P321, DOI [10.1017/CBO9780511763205.021, DOI 10.1017/CBO9780511763205.021]; Biemann Chris, 2006, P 1 WORKSH GRAPH BAS, P73, DOI DOI 10.3115/1654758.1654774; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Boden M.A., 2004, CREATIVE MIND MYTHS; Boden MA, 1999, AISB Q D, V102, P11; Briscoe Ted, 2006, P COLING ACL INT PRE, P77, DOI DOI 10.3115/1225403.1225423; Bryan-Kinns N, 2009, P 7 ACM C CREAT COGN, piii; Cardoso A, 2009, AI MAG, V30, P15, DOI 10.1609/aimag.v30i3.2252; Colton S, 2012, FRONT ARTIF INTEL AP, V242, P21, DOI 10.3233/978-1-61499-098-7-21; Colton Simon, 2008, P AAAI SPRING S CREA, P14; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Dunning T., 1993, Computational Linguistics, V19, P61; Fellbaum Christiane, 1998, WORDNET ELECT DATABA; Firth J. R., 1957, STUDIES LINGUISTIC A, V1952-59, P1; Gabora L, 2012, PSYCHOL AESTHET CREA, V6, P351, DOI 10.1037/a0030193; GALLIE WB, 1956, P ARISTOTELIAN SOC, V56, P167; GARFIELD E, 1972, SCIENCE, V178, P471, DOI 10.1126/science.178.4060.471; GOLDMAN RJ, 1964, EDUC RES, V7, P3, DOI 10.1080/0013188640070101; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Guilford J.P., 1967, NATURE HUMAN INTELLI; Hadamard J., 1945, ESSAY PSYCHOL INVENT; Harris Zellig S., 1968, MATH STRUCTURES LANG; Hennessey BA, 2010, ANNU REV PSYCHOL, V61, P569, DOI 10.1146/annurev.psych.093008.100416; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Ivcevic Z, 2009, PSYCHOL AESTHET CREA, V3, P17, DOI 10.1037/a0014918; Jordanous A., 2012, THESIS U SUSSEX BRIG; Jordanous A, 2015, P 6 INT C COMP CREAT, P110; Jordanous A, 2016, P AISB S COMP CREAT, P16; Jordanous A., 2016, CONNECTION SCI; Jordanous A., 2010, P INT C COMP CREAT L, P278; Jordanous A, 2012, J INTERDISCIPLINARY, V6, P151, DOI DOI 10.4407/JIMS.2014.02.003; Jordanous A, 2012, COGN COMPUT, V4, P246, DOI 10.1007/s12559-012-9156-1; Kaufman JC., 2009, PSYCH 1010 SERIES; Kilgarriff A., 2000, P 2 C LANG RES EV LR, P1371; Kilgarriff A, 2006, MACMILIAN ENGLIS JAN; Kilgarriff Adam., 2001, INT J CORPUS LINGUIS, V6, P97, DOI [DOI 10.1075/IJCL.6.1.05KIL, 10.1075/ijcl.6.1.05kil]; Lakoff George, 2003, METAPHOR WE LIVE BY; Leech G., 1992, LANGUAGE RES, V28, P1; Leon C, 2010, MIND MACH, V20, P615, DOI 10.1007/s11023-010-9205-z; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Manning C.D., 1999, FDN STAT NATURAL LAN; Mayer R.E., 1999, HDB CREAT, P449, DOI DOI 10.1017/CBO9780511807916.024; McCarthy D, 2009, LANG RESOUR EVAL, V43, P139, DOI 10.1007/s10579-009-9084-1; McCormack J, 2007, P 4 INT JOINT WORKSH, P129; Miller P, 2008, CEUR WS, V369, P8; Mooney R.L., 1963, SCI CREATIVITY ITS R, P331; Oakes Michael, 1998, STAT CORPUS LINGUIST; Odena O, 2009, PSYCHOL MUSIC, V37, P416, DOI 10.1177/0305735608100374; Pease A, 2001, P WORKSH PROGR ICCBR, P129; Peinado F, 2006, NEW GENERAT COMPUT, V24, P289, DOI 10.1007/BF03037336; Perez R, 1999, THESIS; Plucker J.A., 2004, CREATIVITY POTENTIAL, P153, DOI [DOI 10.1037/10692-009, 10.1037/10692-009]; Plucker JA, 2004, EDUC PSYCHOL-US, V39, P83, DOI 10.1207/s15326985ep3902_1; Plucker JA, 1998, CREATIVITY RES J, V11, P179, DOI 10.1207/s15326934crj1102_8; Poincare H, 1929, FDN SCI SCI HYPOTHES, P383; Rayson P., 2000, ASS COMPUTATIONAL LI, P1, DOI 10.3115/1117729.1117730; RHODES M, 1961, PHI DELTA KAPPAN, V42, P305; Ritchie G, 2007, MIND MACH, V17, P67, DOI 10.1007/s11023-007-9066-2; Roslansky, 1970, CREATIVITY DISCUSSIO, P17; Sosa R, 2009, C & C 09: PROCEEDINGS OF THE 2009 ACM SIGCHI CONFERENCE ON CREATIVITY AND COGNITION, P295; Stein M. I., 1963, SCI CREATIVITY ITS R, P217; Sternberg R.J., 1999, HDB CREAT, V1, P3; Torrance E. P., 1988, NATURE CREATIVITY, P43; Torrance E. P., 1967, CREATIVITY LEARNING, P73; Torrance EP, 1974, TORRANCE TESTS CREAT; Vartanian O, 2014, PSYCHOL AESTHET CREA, V8, P15, DOI 10.1037/a0035723; Wallas G., 1926, ART THOUGHT; Weeds J, 2003, P 2 INT C CORP LING, P879; Weeds J, 2003, THESIS; Weisberg R., 1988, NATURE CREATIVITY CO, P148; Widmer G, 2009, AI MAG, V30, P35, DOI 10.1609/aimag.v30i3.2249; Wiggins GA, 2006, NEW GENERAT COMPUT, V24, P209, DOI 10.1007/BF03037332; Wittgenstein L., 1958, PHILOS INVESTIGATION; Women Lakoff G., 1987, FIRE DANGEROUS THING	76	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162959	10.1371/journal.pone.0162959	http://dx.doi.org/10.1371/journal.pone.0162959			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706185	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000385697200026
J	Louw-du Toit, R; Perkins, MS; Snoep, JL; Storbeck, KH; Africander, D				Louw-du Toit, Renate; Perkins, Meghan S.; Snoep, Jacky L.; Storbeck, Karl-Heinz; Africander, Donita			Fourth-Generation Progestins Inhibit 3 beta-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids	PLOS ONE			English	Article							DOSE MEDROXYPROGESTERONE ACETATE; BREAST-CANCER; CELL-LINE; SYNTHETIC PROGESTINS; ADRENAL STEROIDOGENESIS; NORETHISTERONE ACETATE; NOMEGESTROL ACETATE; ORAL-CONTRACEPTIVES; ANDROGEN RECEPTOR; GENE-EXPRESSION	Progestins used in contraception and hormone replacement therapy are synthetic compounds designed to mimic the actions of the natural hormone progesterone and are classed into four consecutive generations. The biological actions of progestins are primarily determined by their interactions with steroid receptors, and factors such as metabolism, pharmacokinetics, bioavailability and the regulation of endogenous steroid hormone biosynthesis are often overlooked. Although some studies have investigated the effects of select progestins on a few steroidogenic enzymes, studies comparing the effects of progestins from different generations are lacking. This study therefore explored the putative modulatory effects of progestins on de novo steroid synthesis in the adrenal by comparing the effects of select progestins from the respective generations, on endogenous steroid hormone production by the H295R human adrenocortical carcinoma cell line. Ultra-performance liquid chromatography/tandem mass spectrometry analysis showed that the fourth-generation progestins, nestorone (NES), nomegestrol acetate (NoMAC) and drospirenone (DRSP), unlike the progestins selected from the first three generations, modulate the biosynthesis of several endogenous steroids. Subsequent assays performed in COS-1 cells expressing human 3 beta HSD2, suggest that these progestins modulate the biosynthesis of steroid hormones by inhibiting the activity of 3 beta HSD2. The K-i values determined for the inhibition of human 3 beta HSD2 by NES (9.5 +/- 0.96 nM), NoMAC (29 +/- 7.1 nM) and DRSP (232 +/- 38 nM) were within the reported concentration ranges for the contraceptive use of these progestins in vivo. Taken together, our results suggest that newer, fourth-generation progestins may exert both positive and negative physiological effects via the modulation of endogenous steroid hormone biosynthesis.	[Louw-du Toit, Renate; Perkins, Meghan S.; Snoep, Jacky L.; Storbeck, Karl-Heinz; Africander, Donita] Univ Stellenbosch, Dept Biochem, Private Bag X1, ZA-7602 Matieland, South Africa	Stellenbosch University	Africander, D (corresponding author), Univ Stellenbosch, Dept Biochem, Private Bag X1, ZA-7602 Matieland, South Africa.	drho@sun.ac.za	Perkins, Meghan/I-3256-2018; Storbeck, Karl/AAF-5126-2020; Perkins, Meghan/R-9497-2019; Snoep, Jacky/ABI-6302-2020	Perkins, Meghan/0000-0002-7046-8747; Perkins, Meghan/0000-0002-7046-8747; Snoep, Jacky/0000-0002-0405-8854; Storbeck, Karl-Heinz/0000-0003-1669-6383	National Research Foundation (NRF) in South Africa [85233]; Stellenbosch University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD083026] Funding Source: NIH RePORTER	National Research Foundation (NRF) in South Africa(National Research Foundation - South Africa); Stellenbosch University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant to RLdT from the National Research Foundation (NRF) in South Africa (grant number 85233; www.nrf.ac.za), and grants to KS and DA from Stellenbosch University (www.sun.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors, and therefore the NRF does not accept any liability in regard thereto.	Africander D, 2013, BIOCHEM BIOPH RES CO, V433, P305, DOI 10.1016/j.bbrc.2013.02.086; Africander D, 2011, CONTRACEPTION, V84, P423, DOI 10.1016/j.contraception.2011.06.006; Africander D, 2011, STEROIDS, V76, P636, DOI 10.1016/j.steroids.2011.03.001; Africander DJ, 2014, J STEROID BIOCHEM, V143, P404, DOI 10.1016/j.jsbmb.2014.05.007; Agren UM, 2011, EUR J CONTRACEP REPR, V16, P458, DOI 10.3109/13625187.2011.614363; ARAKAWA S, 1989, ENDOCRINOL JAPON, V36, P387; Bahamondes L, 2014, INT J WOMENS HEALTH, V6, P221, DOI 10.2147/IJWH.S46811; BARBIERI RL, 1980, ACTA ENDOCRINOL-COP, V94, P419, DOI 10.1530/acta.0.0940419; Berrino F, 1996, JNCI-J NATL CANCER I, V88, P291, DOI 10.1093/jnci/88.5.291; Birrell SN, 2007, FASEB J, V21, P2285, DOI 10.1096/fj.06-7518com; Blode H, 2001, EUR J CONTRACEP REPR, V6, P167, DOI 10.1080/713604233; Blode H, 2012, EUR J CONTRACEP REPR, V17, P284, DOI 10.3109/13625187.2012.677076; Brache V, 2001, CONTRACEPTION, V63, P257, DOI 10.1016/S0010-7824(01)00199-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chrousos GP, 1998, J CLIN ENDOCR METAB, V83, P1842, DOI 10.1210/jc.83.6.1842; De Leo V, 2007, FERTIL STERIL, V88, P113, DOI 10.1016/j.fertnstert.2006.11.137; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Dorgan JF, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2779; DOWSETT M, 1987, BRIT J CANCER, V55, P311, DOI 10.1038/bjc.1987.61; Eliassen AH, 2006, J CLIN ONCOL, V24, P1823, DOI 10.1200/JCO.2005.03.7432; Focan C, 2001, BRIT J CANCER, V85, P1, DOI 10.1054/bjoc.2001.1829; Fournier A, 2005, INT J CANCER, V114, P448, DOI 10.1002/ijc.20710; Freshney RI, 1987, CULTURE ANIMAL CELLS, P81, DOI [10.1021/jf063588n, DOI 10.1021/JF063588N]; Fuhrmann U, 1996, CONTRACEPTION, V54, P243, DOI 10.1016/S0010-7824(96)00195-3; GAZDAR AF, 1990, CANCER RES, V50, P5488; Gerrits MGF, 2013, CONTRACEPTION, V87, P193, DOI 10.1016/j.contraception.2012.07.001; Gronich N, 2011, CAN MED ASSOC J, V183, pE1319, DOI 10.1503/cmaj.110463; Hapgood JP, 2014, J STEROID BIOCHEM, V142, P39, DOI 10.1016/j.jsbmb.2013.08.001; Hassan-Smith ZK, 2015, J CLIN ENDOCR METAB, V100, P2673, DOI 10.1210/jc.2015-1516; Hecker M, 2006, TOXICOL APPL PHARM, V217, P114, DOI 10.1016/j.taap.2006.07.007; HELLMAN L, 1976, J CLIN ENDOCR METAB, V42, P912, DOI 10.1210/jcem-42-5-912; Hilscherova K, 2004, TOXICOL SCI, V81, P78, DOI 10.1093/toxsci/kfh191; Hu J, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-47; Ishibashi H, 2003, J CLIN ENDOCR METAB, V88, P2309, DOI 10.1210/jc.2002-021353; Ito F, 2016, EUR J OBSTET GYN R B, V201, P113, DOI 10.1016/j.ejogrb.2016.03.044; JONES JR, 1974, CONTRACEPTION, V10, P1, DOI 10.1016/0010-7824(74)90127-9; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Kovalevsky G, 2010, FERTIL STERIL, V93, P1997, DOI 10.1016/j.fertnstert.2008.12.095; Krattenmacher R, 2000, CONTRACEPTION, V62, P29, DOI 10.1016/S0010-7824(00)00133-5; LABRIE F, 1992, J STEROID BIOCHEM, V43, P805, DOI 10.1016/0960-0760(92)90308-6; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; LANG I, 1990, CANCER, V66, P1949, DOI 10.1002/1097-0142(19901101)66:9<1949::AID-CNCR2820660917>3.0.CO;2-E; Lee TC, 1999, J CLIN ENDOCR METAB, V84, P2104, DOI 10.1210/jc.84.6.2104; Louw-du Toit R, 2014, J BIOL CHEM, V289, P31136, DOI 10.1074/jbc.M114.587311; Massai MR, 2001, CONTRACEPTION, V64, P369, DOI 10.1016/S0010-7824(01)00259-1; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; MIZUTANI T, 1992, ENDOCRINOL JAPON, V39, P615; Overturf MD, 2014, AQUAT TOXICOL, V148, P152, DOI 10.1016/j.aquatox.2014.01.012; Parkin L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2139; Payne AH, 1997, STEROIDS, V62, P169, DOI 10.1016/S0039-128X(96)00177-8; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POTTS GO, 1978, STEROIDS, V32, P257, DOI 10.1016/0039-128X(78)90010-7; Proverbs-Singh T, 2015, ENDOCR-RELAT CANCER, V22, pR87, DOI 10.1530/ERC-14-0543; Quanson JL, 2016, J CHROMATOGR B, V1031, P131, DOI 10.1016/j.jchromb.2016.07.024; RAINEY WE, 1994, MOL CELL ENDOCRINOL, V100, P45, DOI 10.1016/0303-7207(94)90277-1; Rijk JCW, 2012, CHEM RES TOXICOL, V25, P1720, DOI 10.1021/tx3001779; Robbins A, 1997, ANN NY ACAD SCI, V828, P38, DOI 10.1111/j.1749-6632.1997.tb48522.x; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; SATYASWAROOP PG, 1978, ENDOCRINOLOGY, V102, P1761, DOI 10.1210/endo-102-6-1761; Schindler AE, 2003, MATURITAS, V46, pS7, DOI 10.1016/j.maturitas.2003.09.014; Schloms L, 2012, J STEROID BIOCHEM, V128, P128, DOI 10.1016/j.jsbmb.2011.11.003; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Sitruk-Ware R, 2006, HUM REPROD UPDATE, V12, P169, DOI 10.1093/humupd/dmi046; Sitruk-Ware R, 2004, DRUG AGING, V21, P865, DOI 10.2165/00002512-200421130-00004; Sitruk-Ware R, 2008, MATURITAS, V61, P151, DOI 10.1016/j.maturitas.2004.01.001; Speroff L., 1996, CLIN GUIDE CONTRACEP; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; Stanczyk Frank Z, 2002, Rev Endocr Metab Disord, V3, P211, DOI 10.1023/A:1020072325818; Thigpen JT, 1999, J CLIN ONCOL, V17, P1736, DOI 10.1200/JCO.1999.17.6.1736; Thomas JL, 2010, J STEROID BIOCHEM, V120, P192, DOI 10.1016/j.jsbmb.2010.04.015; Tomlinson JW, 2005, NAT CLIN PRACT ENDOC, V1, P92, DOI 10.1038/ncpendmet0023; VanItallie TB, 2002, METABOLISM, V51, P1, DOI 10.1053/meta.2002.33182; VANVEELEN H, 1984, CANCER CHEMOTH PHARM, V12, P83, DOI 10.1007/BF00254594; Verhoog NJD, 2007, J AGR FOOD CHEM, V55, P4371, DOI 10.1021/jf063588n; Vinson GP, 2007, MED HYPOTHESES, V68, P1200, DOI 10.1016/j.mehy.2006.09.065; Wenzel J, 2009, AM J PHYSIOL-REG I, V297, pR1601, DOI 10.1152/ajpregu.91034.2008; Wu CQ, 2013, BJOG-INT J OBSTET GY, V120, P801, DOI 10.1111/1471-0528.12210	78	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164170	10.1371/journal.pone.0164170	http://dx.doi.org/10.1371/journal.pone.0164170			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706226	Green Published, gold			2022-12-27	WOS:000385697200093
J	Martinelli, AG; Soares, MB; Schwanke, C				Martinelli, Agustin G.; Soares, Marina Bento; Schwanke, Cibele			Two New Cynodonts (Therapsida) from the Middle-Early Late Triassic of Brazil and Comments on South American Probainognathians	PLOS ONE			English	Article							GRANDE-DO-SUL; SANTA-MARIA FORMATION; ISCHIGUALASTO FORMATION; NONMAMMALIAN CYNODONTS; FAUNA; TRITHELEDONTIDAE; EUCYNODONTIA; ASSEMBLAGE; ARGENTINA; ORIGIN	We describe two new cynodonts from the early Late Triassic of southern Brazil. One taxon, Bonacynodon schultzi gen. et sp. nov., comes from the lower Carnian Dinodontosaurus AZ, being correlated with the faunal association at the upper half of the lower member of the Chanares Formation (Ischigualasto-Villa Union Basin, Argentina). Phylogenetically, Bonacynodon is a closer relative to Probainognathus jenseni than to any other probainognathian, bearing conspicuous canines with a denticulate distal margin. The other new taxon is Santacruzgnathus abdalai gen. et sp. nov. from the Carnian Santacruzodon AZ. Although based exclusively on a partial lower jaw, it represents a probainognathian close to Prozostrodon from the Hyperodapedon AZ and to Brasilodon, Brasilitherium and Botucaraitherium from the Riograndia AZ. The two new cynodonts and the phylogenetic hypothesis presented herein indicate the degree to which our knowledge on probainognathian cynodonts is incomplete and also the relevance of the South American fossil record for understanding their evolutionary significance. The taxonomic diversity and abundance of probainognathians from Brazil and Argentina will form the basis of deep and complex studies to address the evolutionary transformations of cynodonts leading to mammals.	[Martinelli, Agustin G.; Soares, Marina Bento] Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Lab Paleontol Vertebrados, Ave Bento Goncalves 9500, BR-91540000 Porto Alegre, RS, Brazil; [Schwanke, Cibele] Inst Fed Educ Ciencia & Tecnol Rio Grande Sul, Ctr Hist, Campus Porto Alegre,Rua Coronel Vicente 281, BR-90030040 Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Instituto Federal do Rio Grande do Sul (IFRS)	Martinelli, AG (corresponding author), Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Lab Paleontol Vertebrados, Ave Bento Goncalves 9500, BR-91540000 Porto Alegre, RS, Brazil.	agustin_martinelli@yahoo.com.ar	Soares, Marina Bento/M-9477-2017; Soares, Marina/AAN-8513-2020; Martinelli, Agustin G./D-4632-2015	Soares, Marina Bento/0000-0002-8393-2406; Soares, Marina/0000-0002-8393-2406; Martinelli, Agustin/0000-0003-4489-0888	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [304143/2012-0]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	Funds were provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 304143/2012-0) and the Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS).	Abdala F, 2003, ZOOL J LINN SOC-LOND, V139, P529, DOI 10.1111/j.1096-3642.2003.00096.x; Abdala F, 2002, PALAEONTOLOGY, V45, P1151, DOI 10.1111/1475-4983.00280; Abdala F, 2001, NEUES JAHRB GEOL P-M, P669; Abdala F, 2000, AMEGHINIANA, V37, P463; Abdala F., 1996, THESIS; Abdala F, 2007, PALAEONTOLOGY, V50, P591, DOI 10.1111/j.1475-4983.2007.00646.x; Abdala F, 2013, J VERTEBR PALEONTOL, V33, P1408, DOI 10.1080/02724634.2013.775140; Abdala F, 2010, PALAEOGEOGR PALAEOCL, V286, P202, DOI 10.1016/j.palaeo.2010.01.011; Abdala F, 2009, J VERTEBR PALEONTOL, V29, P837, DOI 10.1671/039.029.0303; Abdala Fernando, 2000, Geodiversitas, V22, P589; ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; [Anonymous], 1980, AN 31 C BRAS GEOL CA; Barberena M.C., 1977, PESQUISAS, V7, P111; Barberena MC, 1978, PESQUISAS, V9; BATTAIL B, 1991, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V13, P17; Battail B., 1982, GEOBIOS MEMOIRE SPEC, V6, P157; BeltrAo R, 1965, B I CIENCIAS NATURAI, V2, P5; Bonaparte J.F., 1994, Revista del Museo Argentino de Ciencias Naturales "Bernardino Rivadavia" e Instituto Nacional de Investigacion de las Ciencias Naturales Paleontologia, V5, P1; Bonaparte J.F., 2006, Bulletin of the New Mexico Museum of Natural History and Science, V37, P599; Bonaparte J.F., 1978, Opera Lilloana, V26, P1; Bonaparte J. F., 1966, Acta Geologica Lilloana, V8, P157; BONAPARTE J F, 1972, Ameghiniana, V9, P343; Bonaparte J.F, 1970, P PAP 2 GONDW S S AF, P665; Bonaparte J.F., 1971, OPERA LILLOANA, V22, P1; Bonaparte J.F., 1980, 2 C ARG PAL BIOESTR, P123; BONAPARTE JF, 1975, J PALEONTOL, V49, P931; Bonaparte JF, 2001, PALAEONTOLOGY, V44, P623, DOI 10.1111/1475-4983.00194; Bonaparte JF, 2015, PROTOMAMIFEROS MAMIF; Bonaparte JF, 2002, LEXICO ESTRATIGRAF B, V26, P250; Bonaparte JF, 2000, B ACAD NACL CIENCIAS, V64, P147; Bonaparte Jose F., 2005, Revista Brasileira de Paleontologia, V8, P25; Bonaparte Jose F., 2003, Revista Brasileira de Paleontologia, V5, P5; Bonaparte Jose F., 2012, Historia Natural (Corrientes), V2, P5; Bonaparte JF, 2013, HIST BIOL, V25, P643, DOI 10.1080/08912963.2012.731154; Bonaparte JF, 2012, HIST BIOL, V24, P43, DOI 10.1080/08912963.2011.559079; Bonaparte JF, 2010, REV BRAS PALEONTOLOG, V13, P233, DOI 10.4072/rbp.2010.3.07; Bonaparte Jose F., 2001, Bulletin of the Museum of Comparative Zoology, V156, P59; Brink KS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4269; Clack JA, 2004, SPR HDB AUD, V22, P128; Crompton A.W., 1972, P231; CROMPTON A. W., 1963, ANN S AFRICAN MUS, V46, P479; Crompton A.W., 1979, P59; CROMPTON A. W., 1955, PROC ZOOL SOC LONDON, V125, P617; CROMPTON AW, 1993, MAMMAL PHYLOGENY, P30; Das DP, 2012, J GEOL SOC INDIA, V79, P175, DOI 10.1007/s12594-012-0022-2; Datta PM, 2004, ANN CARNEGIE MUS, V73, P72; De Oliveira TV, 2011, ZOOTAXA, P19; Dias-da-Silva S, 2013, B N MEX MUS NAT HIST, V61, P1; Fernandez E, 2011, AMEGHINIANA SR, V48, P107; Fiorelli LE, 2013, SCI REP-UK, V3, DOI 10.1038/srep03348; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gordon Jr M, 1947, NOTAS PRELIMINARES E, V38, P1; GOW CE, 1980, PROC R SOC SER B-BIO, V208, P461, DOI 10.1098/rspb.1980.0063; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1, DOI 10.1016/B978-0-444-59425-9.00001-9; Hahn G., 1984, Bulletin de la Societe Belge de Geologie, V93, P357; Hahn G, 1987, MEM EXPL CARTES GEOL, V25, P1; Hahn Gerhard, 1994, Geologica et Palaeontologica, V28, P141; Hopson J.A., 1991, P635; Hopson J.A., 1986, P83; HOPSON J A, 1972, Palaeontologia Africana, V14, P71; Hopson James A., 2001, Bulletin of the Museum of Comparative Zoology, V156, P5; Horn BLD, 2014, J S AM EARTH SCI, V55, P123, DOI 10.1016/j.jsames.2014.07.007; Huene F. von, 1936, LIEFERUNG, V2, P93; Kemp TS, 2009, J VERTEBR PALEONTOL, V29, P1188, DOI 10.1671/039.029.0430; KEMP TS, 1979, PHILOS T ROY SOC B, V285, P73, DOI 10.1098/rstb.1979.0001; Kermack DM, 1984, EVOLUTION MAMMALIAN; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kokogian DA., 2001, FUNDACION MUSEO PLAT, P23; Lacerda MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118563; Langer M. C., 2007, NEW MEXICO MUSEUM NA, V41, P201; Langer MC, 2005, J S AM EARTH SCI, V19, P205, DOI 10.1016/j.jsames.2005.04.003; Liu J, 2010, J MAMM EVOL, V17, P151, DOI 10.1007/s10914-010-9136-8; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; LUO ZX, 1994, J VERTEBR PALEONTOL, V14, P341, DOI 10.1080/02724634.1994.10011564; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; LUO ZX, 1994, IN THE SHADOW OF THE DINOSAURS, P98; Marsicano C., 2001, SISTEMA TRIASICO ARG, P131; Marsicano CA, 2016, P NATL ACAD SCI USA, V113, P509, DOI 10.1073/pnas.1512541112; Martinelli AG, 2005, AMEGHINIANA, V42, P191; Martinelli AG, DINOSAURIOS PALEONTO, P179; Martinelli AG, 2016, CONTRIB MUS ARG CIEN, V6, P183; Martinelli AG, 2007, J VERTEBR PALEONTOL, V27, P442, DOI 10.1671/0272-4634(2007)27[442:OCMETF]2.0.CO;2; Martinez RN, 2015, AMEGHINIANA, V52, P379, DOI 10.5710/AMGH.27.04.2015.2889; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P10, DOI 10.1080/02724634.2013.818546; Martinez RN, 2013, REV BRAS PALEONTOLOG, V16, P61, DOI 10.4072/rbp.2013.1.05; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P271, DOI 10.1080/02724634.1996.10011314; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P285, DOI 10.1080/02724634.1996.10011315; Melo TP, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.1002562; Oliveira EV, 2006, GEODIVERSITAS, V28, P447; Oliveira T.V., 2011, PALAEONTOL Z, V85, P67, DOI DOI 10.1007/S12542-010-0078-5; Oliveira TV, ACTA PALAEONTOL POL; Oliveira TV, 2010, ZOOTAXA, V2382, P1; PAGE RDM, 2000, NEXUS DATA EDITOR WI; Philipp R.P., 2013, AN 8 S INT TECT 14 S, P154; Price L.I., 1947, B DIVISAO GEOLOGIA M, V122, P7; QUIROGA JC, 1984, J HIRNFORSCH, V25, P285; QUIROGA JC, 1980, J HIRNFORSCH, V21, P299; Raugust T, 2013, GEOL SOC SPEC PUBL, V379, P303, DOI 10.1144/SP379.22; Rodrigues PG, 2014, PALAEONTOL Z, V88, P329, DOI 10.1007/s12542-013-0200-6; Rodrigues PG, 2013, J MAMM EVOL, V20, P291, DOI 10.1007/s10914-012-9221-2; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Romer A.S., 1973, Breviora, VNo. 401, P1; Romer A. S., 1969, Breviora, VNo. 332, P1; Romer A. S., 1970, Breviora, VNo. 344, P1; Romer A.S., 1969, BREVIORA, V333, P1; Rougier G.W., 1992, Journal of Vertebrate Paleontology, V12, P188; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Ruff I, 2014, ANAT REC, V297, P2018; Ruta M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2414; Schultz C. L., 2000, REV BRASILEIRA GEOCI, V30, P491; Schwanke C, 2009, VERTEBRADOS FOSSEIS, P279; Shapiro Michael D., 2001, Bulletin of the Museum of Comparative Zoology, V156, P49; Sindor CA, 2006, J PALEONTOL, V80, P333; Soares MB, 2014, AN ACAD BRAS CIENC, V86, P1673, DOI 10.1590/0001-3765201420140455; Soares MB, 2011, AN ACAD BRAS CIENC, V83, P329, DOI 10.1590/S0001-37652011000100021; Soares MB, 2011, GEODIVERSITAS, V33, P265, DOI 10.5252/g2011n2a4; SUES H-D, 1986, Bulletin of the Museum of Comparative Zoology, V151, P217; Sues Hans-Dieter, 2001, Bulletin of the Museum of Comparative Zoology, V156, P37; Wible J.R., 1991, Journal of Vertebrate Paleontology, V11, P1; Zavattieri AM, 2007, AMEGHINIANA, V44, P133; Zerfass H, 2003, SEDIMENT GEOL, V161, P85, DOI 10.1016/S0037-0738(02)00397-4	123	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162945	10.1371/journal.pone.0162945	http://dx.doi.org/10.1371/journal.pone.0162945			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706191	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697200025
J	Zhao, K; Ren, FF; Han, FT; Liu, QW; Wu, GG; Xu, Y; Zhang, J; Wu, X; Wang, JB; Li, P; Shi, W; Zhu, H; Lv, JJ; Zhao, X; Tang, XM				Zhao, Kai; Ren, Fangfang; Han, Fangting; Liu, Qiwen; Wu, Guogan; Xu, Yan; Zhang, Jian; Wu, Xiao; Wang, Jinbin; Li, Peng; Shi, Wei; Zhu, Hong; Lv, Jianjun; Zhao, Xiao; Tang, Xueming			Edible Safety Assessment of Genetically Modified Rice T1C-1 for Sprague Dawley Rats through Horizontal Gene Transfer, Allergenicity and Intestinal Microbiota	PLOS ONE			English	Article							TRANSGENIC PLANTS; RESISTANT; PROTEIN; MAIZE; DNA; DIGESTIBILITY; CRY1C; CROPS; FATE; MICE	In this study, assessment of the safety of transgenic rice T1C-1 expressing Cry1C was carried out by: (1) studying horizontal gene transfer (HGT) in Sprague Dawley rats fed transgenic rice for 90 d; (2) examining the effect of Cry1C protein in vitro on digestibility and allergenicity; and (3) studying the changes of intestinal microbiota in rats fed with transgenic rice T1C-1 in acute and subchronic toxicity tests. Sprague Dawley rats were fed a diet containing either 60% GM Bacillus thuringiensis (Bt) rice T1C-1 expressing Cry1C protein, the parental rice Minghui 63, or a basic diet for 90 d. The GM Bt rice T1C-1 showed no evidence of HGT between rats and transgenic rice. Sequence searching of the Cry1C protein showed no homology with known allergens or toxins. Cry1C protein was rapidly degraded in vitro with simulated gastric and intestinal fluids. The expressed Cry1C protein did not induce high levels of specific IgG and IgE antibodies in rats. The intestinal microbiota of rats fed T1C-1 was also analyzed in acute and subchronic toxicity tests by DGGE. Cluster analysis of DGGE profiles revealed significant individual differences in the rats' intestinal microbiota.	[Zhao, Kai; Wu, Guogan; Wu, Xiao; Wang, Jinbin; Li, Peng; Zhu, Hong; Tang, Xueming] Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai, Peoples R China; [Zhao, Kai; Wu, Guogan; Wu, Xiao; Wang, Jinbin; Li, Peng; Tang, Xueming] Shanghai Acad Agr Sci, Key Lab Agr Genet & Breeding, Shanghai, Peoples R China; [Ren, Fangfang; Han, Fangting; Liu, Qiwen; Xu, Yan; Shi, Wei] Shanghai Normal Univ, Coll Life & Environm Sci, Shanghai, Peoples R China; [Zhang, Jian] Alberta Innovates Technol Futures, Vegreville, AB, Canada; [Lv, Jianjun] Beijing Econ Technol Dev Area, Natl Ctr Safety Evaluat Drugs, Beijing, Peoples R China; [Zhao, Xiao] Ningxia Univ, Life Sci Coll, Yinchuan, Ningxia, Peoples R China	Shanghai Academy of Agricultural Sciences; Shanghai Academy of Agricultural Sciences; Shanghai Normal University; Alberta Innovates; Ningxia University	Tang, XM (corresponding author), Shanghai Acad Agr Sci, Biotechnol Res Inst, Shanghai, Peoples R China.; Tang, XM (corresponding author), Shanghai Acad Agr Sci, Key Lab Agr Genet & Breeding, Shanghai, Peoples R China.	saas_xmtang@foxmail.com		wang, jinbin/0000-0001-7080-4264	Shanghai Agricultural Science Committee foundation of China [6-4]; Shanghai Agricultural Science Key Research Foundation [1-8]; Public Research Platform Foundation of Shanghai Science and Technology Committee [13DZ2290700]; Science and Technology Development Programme of Shanghai Acedemy of Agricultural Sciences [2013(14), 2012(8)]	Shanghai Agricultural Science Committee foundation of China; Shanghai Agricultural Science Key Research Foundation; Public Research Platform Foundation of Shanghai Science and Technology Committee; Science and Technology Development Programme of Shanghai Acedemy of Agricultural Sciences	This work was supported by Shanghai Agricultural Science Committee foundation of China, grant no.6-4 (2009),http://e-nw.shac.gov.cn/index.html. Shanghai Agricultural Science Key Research Foundation grant no.1-8 (2011), http://e-nw.shac.gov.cn/index.html. The Public Research Platform Foundation of Shanghai Science and Technology Committee, grant no. 13DZ2290700, http.//www.stcsm.gov.cn/. The Science and Technology Development Programme of Shanghai Acedemy of Agricultural Sciences,2013(14), http://www.saas.sh.cn/. The Science and Technology Development Programme of Shanghai Acedemy of Agricultural Sciences,2012(8), http://www.saas.sh.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash J, 2000, POULT SCI S1, V79, P26; Cao J, 1999, MOL BREEDING, V5, P131, DOI 10.1023/A:1009619924620; Cao SS, 2010, REGUL TOXICOL PHARM, V58, P474, DOI 10.1016/j.yrtph.2010.08.018; Chambers PA, 2002, J ANTIMICROB CHEMOTH, V49, P161, DOI 10.1093/jac/49.1.161; Chesson A, 2003, WORLD POULTRY SCI J, V59, P201, DOI 10.1079/WPS20030012; Codex Alimentarius Commission, 2009, FOODS DER MOD BIOT, V2nd, P1; Ellstrand NC, 2001, PLANT PHYSIOL, V125, P1543, DOI 10.1104/pp.125.4.1543; FISCHER SG, 1979, CELL, V16, P191, DOI 10.1016/0092-8674(79)90200-9; Flachowsky G, 2001, J ANIM FEED SCI, V10, P181, DOI 10.22358/jafs/70020/2001; Fu TT, 2002, J AGR FOOD CHEM, V50, P7154, DOI 10.1021/jf020599h; Gatehouse AMR, 1998, PESTIC SCI, V52, P165, DOI 10.1002/(SICI)1096-9063(199802)52:2&lt;165::AID-PS679&gt;3.0.CO;2-7; Gendel SM, 1998, ADV FOOD NUTR RES, V42, P45, DOI 10.1016/S1043-4526(08)60092-3; Guo Xing, 2010, Journal of Agricultural Biotechnology, V18, P346; Han LZ, 2007, J INVERTEBR PATHOL, V96, P71, DOI 10.1016/j.jip.2007.02.015; Hernandez M, 2004, J CEREAL SCI, V39, P99, DOI 10.1016/S0733-5210(03)00071-7; Jennings I, 2003, J THROMB HAEMOST, V1, P1112, DOI 10.1046/j.1538-7836.2003.00215.x; Khush G, 2003, NUTR REV, V61, pS114, DOI 10.1301/nr.2003.jun.S114-S116; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; MCCLINTOCK JT, 1995, PESTIC SCI, V45, P95, DOI 10.1002/ps.2780450202; MONETTE R, 1994, J INSECT PHYSIOL, V40, P273, DOI 10.1016/0022-1910(94)90067-1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Papst C, 2005, AGRON J, V97, P219; Phipps RH, 2002, LIVEST PROD SCI, V74, P269, DOI 10.1016/S0301-6226(02)00038-6; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rohlf FJ, 2003, J HUM EVOL, V44, P665, DOI 10.1016/S0047-2484(03)00047-2; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Sambrook J, 1999, MOL CLONING LAB MANU, P1723; Sambrook JF, 1999, MOL CLONING LAB MANU, P1252; Schubbert R, 1998, MOL GEN GENET, V259, P569, DOI 10.1007/s004380050850; Schubbert R, 1997, P NATL ACAD SCI USA, V94, P961, DOI 10.1073/pnas.94.3.961; Sinagawa-Garcia SR, 2004, J AGR FOOD CHEM, V52, P2709, DOI 10.1021/jf035487k; Snow AA, 2002, NAT BIOTECHNOL, V20, P542, DOI 10.1038/nbt0602-542; Strizhov N, 1996, P NATL ACAD SCI USA, V93, P15012, DOI 10.1073/pnas.93.26.15012; Tang W, 2006, MOL BREEDING, V18, P1, DOI 10.1007/s11032-006-9002-9; VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0; Xu WT, 2009, FOOD CHEM TOXICOL, V47, P1459, DOI 10.1016/j.fct.2009.03.029	37	5	6	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163352	10.1371/journal.pone.0163352	http://dx.doi.org/10.1371/journal.pone.0163352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706188	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200039
J	Garcia-Rubio, R; Gil, H; Monteiro, MC; Pelaez, T; Mellado, E				Garcia-Rubio, Rocio; Gil, Horacio; Candida Monteiro, Maria; Pelaez, Teresa; Mellado, Emilia			A New Aspergillus fumigatus Typing Method Based on Hypervariable Tandem Repeats Located within Exons of Surface Protein Coding Genes (TRESP)	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; MOLECULAR EPIDEMIOLOGY; RANDOM AMPLIFICATION; RESISTANCE; OUTBREAK; UTILITY; ASSAY	Aspergillus fumigatus is a saprotrophic mold fungus ubiquitously found in the environment and is the most common species causing invasive aspergillosis in immunocompromised individuals. For A. fumigatus genotyping, the short tandem repeat method (STRAf) is widely accepted as the first choice. However, difficulties associated with PCR product size and required technology have encouraged the development of novel typing techniques. In this study, a new genotyping method based on hypervariable tandem repeats within exons of surface protein coding genes (TRESP) was designed. A. fumigatus isolates were characterized by PCR amplification and sequencing with a panel of three TRESP encoding genes: cell surface protein A; MP-2 antigenic galactomannan protein; and hypothetical protein with a CFEM domain. The allele sequence repeats of each of the three targets were combined to assign a specific genotype. For the evaluation of this method, 126 unrelated A. fumigatus strains were analyzed and 96 different genotypes were identified, showing a high level of discrimination [Simpson's index of diversity (D) 0.994]. In addition, 49 azole resistant strains were analyzed identifying 26 genotypes and showing a lower D value (0.890) among them. This value could indicate that these resistant strains are closely related and share a common origin, although more studies are needed to confirm this hypothesis. In summary, a novel genotyping method for A. fumigatus has been developed which is reproducible, easy to perform, highly discriminatory and could be especially useful for studying outbreaks.	[Garcia-Rubio, Rocio; Gil, Horacio; Candida Monteiro, Maria; Mellado, Emilia] Inst Salud Carlos III, Ctr Nacl Microbiol, Mycol Deparment, Madrid, Spain; [Garcia-Rubio, Rocio; Pelaez, Teresa] Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain; [Gil, Horacio] European Program Publ Hlth Microbiol Training EUP, European Ctr Dis Prevent & Control, ECDC, Stockholm, Sweden	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); General University Gregorio Maranon Hospital; European Centre for Disease Prevention & Control	Mellado, E (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Mycol Deparment, Madrid, Spain.	emellado@isciii.es	Garcia-Rubio, Rocio/AAD-8119-2021	Garcia-Rubio, Rocio/0000-0003-4610-2996; Mellado, Emilia/0000-0002-9801-0260; Gil, Horacio/0000-0002-7114-6686				Abdolrasouli A, 2015, MBIO, V6, DOI 10.1128/mBio.00536-15; Alcazar-Fuoli L, 2008, ANTIMICROB AGENTS CH, V52, P1244, DOI 10.1128/AAC.00942-07; [Anonymous], 1994, MOL BIOL PATHOGENIC; AUFAUVREBROWN A, 1992, J CLIN MICROBIOL, V30, P2991, DOI 10.1128/JCM.30.11.2991-2993.1992; Bain JM, 2007, J CLIN MICROBIOL, V45, P1469, DOI 10.1128/JCM.00064-07; Balajee SA, 2008, J MICROBIOL METH, V73, P252, DOI 10.1016/j.mimet.2008.02.011; Balajee SA, 2007, EUKARYOT CELL, V6, P1392, DOI 10.1128/EC.00164-07; Bart-Delabesse E, 1998, J CLIN MICROBIOL, V36, P2413, DOI 10.1128/JCM.36.9.2413-2418.1998; Bart-Delabesse E, 2001, J CLIN MICROBIOL, V39, P2683, DOI 10.1128/JCM.39.7.2683-2686.2001; Bertout S, 2001, J CLIN MICROBIOL, V39, P1731, DOI 10.1128/JCM.39.5.1731-1737.2001; Camps SMT, 2012, J CLIN MICROBIOL, V50, P2674, DOI 10.1128/JCM.00335-12; Cerqueira GC, 2013, NUCLEIC ACIDS RES, V4, P705; de Ruiter MT, 2007, J MICROBIOL METH, V70, P528, DOI 10.1016/j.mimet.2007.06.009; de Valk HA, 2009, CLIN MICROBIOL INFEC, V15, P180, DOI 10.1111/j.1469-0691.2008.02656.x; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Escribano P, 2015, J CLIN MICROBIOL, V53, P667, DOI 10.1128/JCM.02636-14; Gao LJ, 2013, MED MYCOL, V51, P683, DOI 10.3109/13693786.2013.770609; Guinea J, 2011, J CLIN MICROBIOL, V49, P3498, DOI 10.1128/JCM.01159-11; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kidd SE, 2009, J MICROBIOL METH, V78, P223, DOI 10.1016/j.mimet.2009.06.003; Klaassen CHW, 2007, STUD MYCOL, P47, DOI 10.3114/sim.2007.59.06; Klaassen CHW, 2009, J MICROBIOL METH, V77, P292, DOI 10.1016/j.mimet.2009.03.004; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Levdansky E, 2007, EUKARYOT CELL, V6, P1380, DOI 10.1128/EC.00229-06; Levdansky Emma, 2008, Fungal Biology Reviews, V22, P85, DOI 10.1016/j.fbr.2008.08.001; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; LOUDON KW, 1993, J CLIN MICROBIOL, V31, P1117, DOI 10.1128/JCM.31.5.1117-1121.1993; Mondon P, 1997, FEMS IMMUNOL MED MIC, V17, P95, DOI 10.1111/j.1574-695X.1997.tb01001.x; Neuveglise C, 1996, NUCLEIC ACIDS RES, V24, P1428, DOI 10.1093/nar/24.8.1428; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Warris A, 2003, J CLIN MICROBIOL, V41, P4101, DOI 10.1128/JCM.41.9.4101-4106.2003	34	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163869	10.1371/journal.pone.0163869	http://dx.doi.org/10.1371/journal.pone.0163869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701437	Green Published, gold			2022-12-27	WOS:000385696900025
J	Qiao, Y; Jiao, J; Rao, Y; Ma, HM				Qiao, Yan; Jiao, Jun; Rao, Yuan; Ma, Huimin			Adaptive Path Selection for Link Loss Inference in Network Tomography Applications	PLOS ONE			English	Article								In this study, we address the problem of selecting the optimal end-to-end paths for link loss inference in order to improve the performance of network tomography applications, which infer the link loss rates from the path loss rates. Measuring the path loss rates using end-to-end probing packets may incur additional traffic overheads for networks, so it is important to select the minimum path set carefully while maximizing their performance. The usual approach is to select the maximum independent paths from the candidates simultaneously, while the other paths can be replaced by linear combinations of them. However, this approach ignores the fact that many paths always exist that do not lose any packets, and thus it is easy to determine that all of the links of these paths also have 0 loss rates. Not considering these good paths will inevitably lead to inefficiency and high probing costs. Thus, we propose an adaptive path selection method that selects paths sequentially based on the loss rates of previously selected paths. We also propose a theorem as well as a graph construction and decomposition approach to efficiently find the most valuable path during each round of selection. Our new method significantly outperforms the classical path selection method based on simulations in terms of the probing cost, number of accurate links determined, and the running speed.	[Qiao, Yan; Jiao, Jun; Rao, Yuan; Ma, Huimin] Anhui Agr Univ, Sch Informat & Comp Sci, Hefei, Anhui, Peoples R China; [Qiao, Yan] Beijing Univ Posts & Telecommun, State Key Lab Networking & Switching Technol, Beijing, Peoples R China	Anhui Agricultural University; Beijing University of Posts & Telecommunications	Qiao, Y (corresponding author), Anhui Agr Univ, Sch Informat & Comp Sci, Hefei, Anhui, Peoples R China.; Qiao, Y (corresponding author), Beijing Univ Posts & Telecommun, State Key Lab Networking & Switching Technol, Beijing, Peoples R China.	qiaoyan101@gmail.com						[Anonymous], 2012, P ACM IMC; Chen AY, 2010, IEEE T SIGNAL PROCES, V58, P6029, DOI 10.1109/TSP.2010.2068294; Chen Y., 2004, ACM SIGCOMM; Coates M, 2002, ACM; Cohen E, 2014, PERFORM EVALUATION, V79, P73, DOI 10.1016/j.peva.2014.07.005; Ghita D., 2010, P IEEE INT C COMP CO, P1; Ghita DG, 2012, GEN INFORM, P22; Golub GH, 1983, MATH GAZ, V47, P392; He J, 2008, IEEE NETWORK, V22, P16, DOI 10.1109/MNET.2008.4476066; Jeswani D, 2015, J NETW SYST MANAG, V23, P950, DOI 10.1007/s10922-014-9330-8; Ma L, 2013, INT CON DISTR COMP S, P581, DOI 10.1109/ICDCS.2013.24; Malboubi M, 2013, IEEE GLOB COMM CONF, P1557, DOI 10.1109/GLOCOM.2013.6831295; Nguyen HX, 2007, IEEE INFOCOM SER, P2117, DOI 10.1109/INFCOM.2007.245; Nguyen HX, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P227; Padmanabhan V. N., 2003, P IEEE INT C COMP CO, V1, P145; Qiao Y, 2013, J NETW SYST MANAG, V21, P169, DOI 10.1007/s10922-012-9231-7; Qiao Y, 2012, 2012 IEEE SYMPOSIUM ON COMPUTERS AND COMMUNICATIONS (ISCC), P569, DOI 10.1109/ISCC.2012.6249357; Stern R, 2014, APPL INTELL, V41, P167, DOI 10.1007/s10489-013-0514-9; Tati S, 2014, INT CON DISTR COMP S, P481, DOI 10.1109/ICDCS.2014.56; Zhang Y, 2009, SIGCOMM 2009, P267; Zhao Y, 2009, IEEE ACM T NETWORK, V17, P1724, DOI 10.1109/TNET.2009.2022158; Zheng Q., 2010, IEEE T COMPUT, P510	22	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163706	10.1371/journal.pone.0163706	http://dx.doi.org/10.1371/journal.pone.0163706			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701447	Green Submitted, gold, Green Published			2022-12-27	WOS:000385696900016
J	Key, AJM				Key, Alastair J. M.			Manual Loading Distribution During Carrying Behaviors: Implications for the Evolution of the Hominin Hand	PLOS ONE			English	Article							CHIMPANZEE PAN-TROGLODYTES; 3RD METACARPAL; WEST TURKANA; STONE TOOLS; APES VIEW; OLDOWAN; TRANSPORT; HUMANS; GRIPS; PLEISTOCENE	The human hand is unparalleled amongst primates in its ability to manipulate objects forcefully and dexterously. Previous research has predominantly sought to explain the evolution of these capabilities through an adaptive relationship between more modern human-like anatomical features in the upper limb and increased stone tool production and use proficiency. To date, however, we know little about the influence that other manipulatively demanding behaviors may have had upon the evolution of the human hand. The present study addresses one aspect of this deficiency by examining the recruitment of the distal phalanges during a range of manual transportation (i.e., carrying) events related to hominin behavioral repertoires during the Plio-Pleistocene. Specifically, forces on the volar pad of each digit are recorded during the transportation of stones and wooden branches that vary in weight and size. Results indicate that in most instances, the index and middle fingers are recruited to a significantly greater extent than the other three digits during carrying events. Relative force differences between digits were, however, dependent upon the size and weight of the object transported. Carrying behaviors therefore appear unlikely to have contributed to the evolution of the robust thumb anatomy observed in the human hand. Rather, results suggest that the manual transportation of objects may plausibly have influenced the evolution of the human gripping capabilities and the 3rd metacarpal styloid process.	[Key, Alastair J. M.] Univ Kent, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England	University of Kent	Key, AJM (corresponding author), Univ Kent, Sch Anthropol & Conservat, Canterbury CT2 7NR, Kent, England.	a.j.m.key@kent.ac.uk		Key, Alastair/0000-0001-5576-1200				Aiello LC, 2002, ANNU REV ANTHROPOL, V31, P323, DOI 10.1146/annurev.anthro.31.040402.085403; Alba DM, 2003, J HUM EVOL, V44, P225, DOI 10.1016/S0047-2484(02)00207-5; Almecija S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8717; Almecija S, 2014, J HUM EVOL, V73, P88, DOI 10.1016/j.jhevol.2014.02.006; Almecija S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011727; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Backwell LR, 2001, P NATL ACAD SCI USA, V98, P1358, DOI 10.1073/pnas.021551598; BAMFORTH DB, 1986, AM ANTIQUITY, V51, P38, DOI 10.2307/280392; Blumenschine RJ, 2008, J ARCHAEOL SCI, V35, P76, DOI 10.1016/j.jas.2007.02.009; BOESCH C, 1984, Primates, V25, P160, DOI 10.1007/BF02382388; Boesch C., 1993, HANDS PRIMATES, P109, DOI [10.1007/978-3-7091-6914-8_4, DOI 10.1007/978-3-7091-6914-8_4]; Boesch C, 2009, J HUM EVOL, V56, P560, DOI 10.1016/j.jhevol.2009.04.001; Braun DR, 2008, J ARCHAEOL SCI, V35, P2329, DOI 10.1016/j.jas.2008.03.004; Bunn HT, 2010, QUATERNARY RES, V74, P355, DOI 10.1016/j.yqres.2010.06.004; Campbell SC, 2000, INT J IND ERGONOM, V25, P349, DOI 10.1016/S0169-8141(99)00023-2; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2012, CURR BIOL, V22, pR180, DOI 10.1016/j.cub.2012.01.052; Close AE, 1996, CURR ANTHROPOL, V37, P545, DOI 10.1086/204517; Costa AG, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P23, DOI 10.1007/978-1-4419-6861-6_2; CROMPTON RH, 1993, J HUM EVOL, V25, P175, DOI 10.1006/jhev.1993.1043; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Diogo R, 2012, J HUM EVOL, V63, P64, DOI 10.1016/j.jhevol.2012.04.001; Ditchfield K, 2016, J ARCHAEOL SCI, V65, P44, DOI 10.1016/j.jas.2015.10.012; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2001, J HUM EVOL, V40, P289, DOI 10.1006/jhev.2000.0466; Dominguez-Rodrigo M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8987; Eren MI, 2013, AM ANTIQUITY, V78, P166, DOI 10.7183/0002-7316.78.1.166; Faisal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013718; Gowlett JAJ, 2009, J HUM EVOL, V57, P401, DOI 10.1016/j.jhevol.2009.04.011; Hamrick MW, 1998, J HUM EVOL, V34, P123, DOI 10.1006/jhev.1997.0177; Harmand S, 2015, NATURE, V521, P310, DOI 10.1038/nature14464; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; HEWES GW, 1961, AM ANTHROPOL, V63, P687, DOI 10.1525/aa.1961.63.4.02a00020; Hiscock P, 2015, LITHIC TECHNOL, V40, P342, DOI 10.1179/2051618515Y.0000000021; Humle T., 1999, GUINEA PAN AFRICA NE, V6, P3; Isaac G., 1983, EARLY STAGES EVOLUTI; ISAAC GL, 1981, PHILOS T R SOC B, V292, P177, DOI 10.1098/rstb.1981.0026; KELLY RL, 1983, J ANTHROPOL RES, V39, P277, DOI 10.1086/jar.39.3.3629672; Key AJM, 2017, ARCHAEOL ANTHROP SCI, V9, P737, DOI 10.1007/s12520-015-0300-1; Key AJM, 2016, ETHNOARCHAEOLOGY, V8, P69, DOI 10.1080/19442890.2016.1150626; Key AJM, 2015, J HUM EVOL, V78, P60, DOI 10.1016/j.jhevol.2014.08.006; Key AJM, 2011, J ARCHAEOL SCI, V38, P1663, DOI 10.1016/j.jas.2011.02.032; Kinoshita H, 1996, ERGONOMICS, V39, P1163, DOI 10.1080/00140139608964536; Kivell TL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0105; Kivell TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9431; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Komi ER, 2007, P I MECH ENG C-J MEC, V221, P1687, DOI 10.1243/09544062JMES700; Kramer PA, 2004, RES ECON ANTHROPOL, V23, P249, DOI 10.1016/S0190-1281(04)23010-4; KUHN SL, 1992, J ANTHROPOL RES, V48, P185, DOI 10.1086/jar.48.3.3630634; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; Lorenzo C, 2015, J HUM EVOL, V78, P114, DOI 10.1016/j.jhevol.2014.08.007; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Maki Julia, 2011, Paleoanthropology, V2011, P62; Marzke MW, 2015, AM J PHYS ANTHROPOL, V156, P317, DOI 10.1002/ajpa.22651; Marzke MW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0414; Marzke MW, 1998, AM J PHYS ANTHROPOL, V105, P315, DOI 10.1002/(SICI)1096-8644(199803)105:3<315::AID-AJPA3>3.3.CO;2-D; MARZKE MW, 1986, J HUM EVOL, V15, P439, DOI 10.1016/S0047-2484(86)80027-6; Marzke MW, 1997, AM J PHYS ANTHROPOL, V102, P91; Marzke MW, 1996, INT J PRIMATOL, V17, P117, DOI 10.1007/BF02696162; Marzke MW, 2000, J ANAT, V197, P121, DOI 10.1046/j.1469-7580.2000.19710121.x; MARZKE MW, 1987, AM J PHYS ANTHROPOL, V73, P415, DOI 10.1002/ajpa.1330730403; Mittra ES, 2007, AM J PHYS ANTHROPOL, V134, P449, DOI 10.1002/ajpa.20687; Moya-Sola S, 2008, FOLIA PRIMATOL, V79, P215, DOI 10.1159/000113458; Mrotek LA, 2004, EXP BRAIN RES, V155, P413, DOI 10.1007/s00221-003-1748-2; NAPIER J, 1962, NATURE, V196, P409, DOI 10.1038/196409a0; Napier J.R., 1980, HANDS; Neufuss J, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22589; Neufuss J, 2015, FOLIA PRIMATOL, V86, P329; Ng PK, 2014, THEOR ISS ERGON SCI, V15, P305, DOI 10.1080/1463922X.2012.729619; Niewoehner WA, 2001, P NATL ACAD SCI USA, V98, P2979, DOI 10.1073/pnas.041588898; OCONNELL JF, 1988, J ANTHROPOL RES, V44, P113, DOI 10.1086/jar.44.2.3630053; POTTS R, 1991, J ANTHROPOL RES, V47, P153, DOI 10.1086/jar.47.2.3630323; Pouydebat E, 2011, BEHAV BRAIN RES, V218, P21, DOI 10.1016/j.bbr.2010.11.021; Pruetz JD, 2007, CURR BIOL, V17, P412, DOI 10.1016/j.cub.2006.12.042; Rein R, 2013, AM J PHYS ANTHROPOL, V150, P539, DOI 10.1002/ajpa.22224; Rolian C, 2011, J HUM EVOL, V61, P26, DOI 10.1016/j.jhevol.2011.01.008; Roux V., 2005, STONE KNAPPING NECES, P243; Saladie P, 2011, J HUM EVOL, V61, P425, DOI 10.1016/j.jhevol.2011.05.012; Sanz C, 2009, BIOL LETTERS, V5, P293, DOI 10.1098/rsbl.2008.0786; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; Shea J., 2007, EVOLUTION HUMAN DIET, P212; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; Sirianni G, 2015, ANIM BEHAV, V100, P152, DOI 10.1016/j.anbehav.2014.11.022; Skinner MM, 2015, SCIENCE, V347, P395, DOI 10.1126/science.1261735; Steudel-Numbers KL, 2007, J HUM EVOL, V53, P191, DOI 10.1016/j.jhevol.2007.04.001; Steudel-Numbers KL, 2006, J HUM EVOL, V51, P445, DOI 10.1016/j.jhevol.2006.05.001; Stout D, 2008, PHILOS T R SOC B, V363, P1939, DOI 10.1098/rstb.2008.0001; SUSMAN RL, 1988, SCIENCE, V240, P781, DOI 10.1126/science.3129783; Susman RL, 1998, J HUM EVOL, V35, P23, DOI 10.1006/jhev.1998.0220; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; Tocheri MW, 2003, AM J PHYS ANTHROPOL, V122, P101, DOI 10.1002/ajpa.10235; TOTH N, 1985, J ARCHAEOL SCI, V12, P101, DOI 10.1016/0305-4403(85)90056-1; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Videan EN, 2002, AM J PHYS ANTHROPOL, V118, P184, DOI 10.1002/ajpa.10058; Villa P, 2001, J HUM EVOL, V41, P69, DOI 10.1006/jhev.2001.0479; Visalberghi E, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0351; Wall-Scheffler CM, 2007, AM J PHYS ANTHROPOL, V133, P841, DOI 10.1002/ajpa.20603; Wang WJ, 2004, J ANAT, V204, P417, DOI 10.1111/j.0021-8782.2004.00295.x; Ward CV, 2014, P NATL ACAD SCI USA, V111, P121, DOI 10.1073/pnas.1316014110; Watson J, 2009, FOLIA PRIMATOL, V80, P309, DOI 10.1159/000258646; Watson JC, 2008, J HUM EVOL, V54, P675, DOI 10.1016/j.jhevol.2007.10.004; Williams EM, 2010, AM J PHYS ANTHROPOL, V143, P134, DOI 10.1002/ajpa.21302; Williams EM, 2012, J HUM EVOL, V62, P520, DOI 10.1016/j.jhevol.2012.02.005; Wood M., 2003, MAKING SENSE STAT NO; WYNN T, 1989, MAN, V24, P383, DOI 10.2307/2802697; Wynn T, 2011, EVOL ANTHROPOL, V20, P181, DOI 10.1002/evan.20323; Young RW, 2003, J ANAT, V202, P165, DOI 10.1046/j.1469-7580.2003.00144.x	107	11	11	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163801	10.1371/journal.pone.0163801	http://dx.doi.org/10.1371/journal.pone.0163801			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695044	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000385553100054
J	Chen, ZZ; Qiao, HH; Guo, Y; Li, JC; Miao, HZ; Wen, CY; Wen, XD; Zhang, XF; Yang, XD; Chen, CC				Chen, Zhengzhen; Qiao, Huihuang; Guo, Yu; Li, Jiance; Miao, Huizhong; Wen, Caiyun; Wen, Xindong; Zhang, Xiaofen; Yang, Xindong; Chen, Chengchun			Visualization of Anatomic Variation of the Anterior Septal Vein on Susceptibility-Weighted Imaging	PLOS ONE			English	Article							TRANSCALLOSAL-TRANSFORAMINAL APPROACH; VENOUS VARIATIONS; COLLOID CYSTS; 3RD-VENTRICLE TUMORS; MEDULLARY VEINS; MR VENOGRAPHY; REGION; RESECTION; LESIONS; SPACE	Background and Purpose Understanding the anatomy of the anterior septal vein (ASV) is critical for minimally invasive procedures to the third ventricle and for assessing lesion size and venous drainage in the anterior cranial fossa. Accordingly, this study evaluated topographic anatomy and anatomic variation of the ASV using susceptibility-weighted imaging (SWI). Methods Sixty volunteers were examined using a 3.0T MR system. The diameter of the ASV and distance between bilateral septal points were measured. ASVs were divided into types 1 (only drains frontal lobe) and 2 (drains both frontal lobe and head of the caudate nucleus). We evaluated the ASV-internal cerebral vein (ICV) junction based on its positional relationship with the appearance of a venous angle or a false venous angle and the foramen of Monro. Fused SW and T1-weighted images were used to observe positional relationships between the course of the ASV and the surrounding brain structures. Results The ASV and its small tributaries were clearly visualized in 120 hemispheres (100%). The average diameter of ASVs was 1.05+/-0.17 mm (range 0.9-1.6 mm). The average distance between bilateral septal points was 2.23+/-1.03 mm (range 1.3-6.6 mm). The ASV types 1 and 2 were in 77 (64.2%) and 43 (35.8%) hemispheres, respectively. In 83 (69.2%) hemispheres, the ASV-ICV junction was situated at the venous angle and the posterior margin of the foramen of Monro. In 37 (30.8%) hemispheres, the ASV-ICV junction was situated beyond the posterior margin of the foramen of Monro. The average distance between the posteriorly located ASV-ICV junction and the posterior margin of the foramen of Monro was 6.41+/-3.95 mm (range 2.4-15.9 mm). Conclusion Using SWI, the topographic anatomy and anatomic variation of the ASV were clearly demonstrated. Preoperative assessment of anatomic variation of the ASV may be advantageous for minimally invasive neurosurgical procedures.	[Chen, Zhengzhen; Guo, Yu; Miao, Huizhong; Zhang, Xiaofen; Yang, Xindong; Chen, Chengchun] Wenzhou Med Univ, Dept Human Anat, Wenzhou, Zhejiang, Peoples R China; [Qiao, Huihuang] 2nd Hosp Huangshi, Dept Radiol, Huangshi, Hubei, Peoples R China; [Li, Jiance; Wen, Caiyun; Wen, Xindong] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Chen, CC (corresponding author), Wenzhou Med Univ, Dept Human Anat, Wenzhou, Zhejiang, Peoples R China.	cccwzmc@126.com			Natural Science Foundation of Zhejiang Province, China [LY15C110001]	Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province)	This work was supported by the Natural Science Foundation of Zhejiang Province, China (NO.LY15C110001).	Agley CC, 2012, J HISTOCHEM CYTOCHEM, V60, P428, DOI 10.1369/0022155412442897; Asabella AN, 2013, ANN NUCL MED, V27, P942, DOI 10.1007/s12149-013-0758-9; Cai M, 2015, NEURORADIOLOGY, V57, P163, DOI 10.1007/s00234-014-1450-z; Chen CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131118; Cimsit NC, 2003, NEURORADIOLOGY, V45, P900, DOI 10.1007/s00234-003-1103-0; Faure M, 2014, JBR-BTR, V97, P17, DOI 10.5334/jbr-btr.6; Fujii S, 2010, AM J NEURORADIOL, V31, P55, DOI 10.3174/ajnr.A1752; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HUANG YP, 1964, AMER J ROENTGENOL RA, V92, P739; Iacoangeli M, 2014, J NEUROSURG, V120, P1471, DOI 10.3171/2014.1.JNS131102; Ibanez-Botella G, 2014, NEUROSURG REV, V37, P227, DOI 10.1007/s10143-014-0529-7; Kawsar KA, 2015, J NEUROSURG, V123, P1414, DOI 10.3171/2014.11.JNS14395; Mahvash M, 2014, CLIN NEUROL NEUROSUR, V124, P151, DOI 10.1016/j.clineuro.2014.06.041; Mohammed W, 2013, CANCER IMAGING, V13, P186, DOI 10.1102/1470-7330.2013.0020; Mucke J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120801; Noguchi K, 2010, AM J NEURORADIOL, V31, P1903, DOI 10.3174/ajnr.A2231; Okudera T, 1999, NEUROPATHOLOGY, V19, P93, DOI 10.1046/j.1440-1789.1999.00215.x; Patel P, 2014, J NEUROSURG-PEDIATR, V14, P365, DOI 10.3171/2014.6.PEDS1452; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Roth J, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f7427e; Sheikh AB, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.06.024; Symss Nigel P, 2014, Asian J Neurosurg, V9, P51, DOI 10.4103/1793-5482.136708; Tomasello F, 2013, ACTA NEUROCHIR, V155, P1031, DOI 10.1007/s00701-013-1714-0; Ture U, 1997, J NEUROSURG, V87, P706, DOI 10.3171/jns.1997.87.5.0706; Wang J, 2010, SURG RADIOL ANAT, V32, P669, DOI 10.1007/s00276-010-0669-6; Winkler PA, 2000, NEUROSURGERY, V46, P879, DOI 10.1097/00006123-200004000-00020; Xia XB, 2013, J NEURORADIOLOGY, V40, P355, DOI 10.1016/j.neurad.2013.03.005; Yan SQ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00144; Zhang X, 2015, BIOMED RES INT, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0141513; ZIMMER AE, 1966, RADIOLOGY, V87, P813, DOI 10.1148/87.5.813	30	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164221	10.1371/journal.pone.0164221	http://dx.doi.org/10.1371/journal.pone.0164221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716782	Green Submitted, gold, Green Published			2022-12-27	WOS:000385698100035
J	Chatterjee, S; Humby, T; Davies, W				Chatterjee, Sohini; Humby, Trevor; Davies, William			Behavioural and Psychiatric Phenotypes in Men and Boys with X-Linked Ichthyosis: Evidence from a Worldwide Online Survey	PLOS ONE			English	Article							STEROID SULFATASE DEFICIENCY; CONTIGUOUS-GENE-SYNDROME; HYPERACTIVITY; SPECTRUM; AUTISM; SCALE; DISORDERS; ENDOPHENOTYPES; DIFFICULTIES; PREVALENCE	Background X-linked ichthyosis (XLI) is a rare dermatological condition arising from deficiency for the enzyme steroid sulfatase (STS). Preliminary evidence in boys with XLI, and animal model studies, suggests that individuals lacking STS are at increased risk of developmental disorders and associated traits. However, the behavioural profile of children with XLI is poorly-characterised, and the behavioural profile of adults with XLI has not yet been documented at all. Materials and Methods Using an online survey, advertised worldwide, we collected detailed self-or parent-reported information on behaviour in adult (n = 58) and younger (<= 18yrs, n = 24) males with XLI for comparison to data from their non-affected brothers, and age/gender-matched previously-published normative data. The survey comprised demographic and background information (including any prior clinical diagnoses) and validated questionnaires assaying phenotypes of particular interest (Adult ADHD Self-Report Scale v1.1, Barrett Impulsiveness Scale-11, adult and adolescent Autism Quotient, Kessler Psychological Distress Scales, and Disruptive Behaviour Disorder Rating Scale). Results Individuals with XLI generally exhibited normal sensory function. Boys with XLI were at increased risk of developmental disorder, whilst adults with the condition were at increased risk of both developmental and mood disorders. Both adult and younger XLI groups scored significantly more highly than male general population norms on measures of inattention, impulsivity, autism-related traits, psychological distress and disruptive behavioural traits. Conclusions These findings indicate that both adult and younger males with XLI exhibit personality profiles that are distinct from those of males within the general population, and suggest that individuals with XLI may be at heightened risk of psychopathology. The data are consistent with the notion that STS is important in neurodevelopment and ongoing brain function, and with previous work suggesting high rates of developmental disorders in boys with XLI. Our results suggest that individuals with XLI may require medical care from multidisciplinary teams, and should help to inform genetic counselling for the condition.	[Chatterjee, Sohini; Davies, William] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales; [Chatterjee, Sohini; Davies, William] Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales; [Humby, Trevor; Davies, William] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales; [Humby, Trevor; Davies, William] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University; Cardiff University	Davies, W (corresponding author), Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales.; Davies, W (corresponding author), Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff, S Glam, Wales.; Davies, W (corresponding author), Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales.; Davies, W (corresponding author), Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff, S Glam, Wales.	daviesw4@cardiff.ac.uk		Davies, William/0000-0002-7714-2440; HUMBY, trevor/0000-0002-1840-1799	Medical Research Council (MRC) United Kingdom Centre [MR/L010305/1]; Cardiff University; Medical Research Council [MR/L010305/1] Funding Source: researchfish	Medical Research Council (MRC) United Kingdom Centre; Cardiff University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by Medical Research Council (MRC) United Kingdom Centre Grant MR/L010305/1 (www.mrc.ac.uk) and Cardiff University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LA, 2011, J CLIN PSYCHIAT, V72, P1008, DOI [10.4088/JCP.10063ah1, 10.4088/JCP.10081tx1c, 10.4088/JCP.10081tx2c]; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2006, J AUTISM DEV DISORD, V36, P343, DOI 10.1007/s10803-006-0073-6; Bjornsdotter A, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-40; Brookes KJ, 2008, AM J MED GENET B, V147B, P1531, DOI 10.1002/ajmg.b.30873; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Craig WY, 2010, PRENATAL DIAG, V30, P893, DOI 10.1002/pd.2588; Davies W, 2014, NEUROPSYCHOPHARMACOL, V39, P2622, DOI 10.1038/npp.2014.115; Davies W, 2009, BIOL PSYCHIAT, V66, P360, DOI 10.1016/j.biopsych.2009.01.001; Doherty MJ, 2003, EPILEPSIA, V44, P1529, DOI 10.1111/j.0013-9580.2003.61702.x; DuPaul GJ, 1998, J PSYCHOPATHOL BEHAV, V20, P83, DOI 10.1023/A:1023087410712; Evans SW, 2013, J CLIN CHILD ADOLESC, V42, P197, DOI 10.1080/15374416.2012.738456; Fernandes NF, 2010, J AM ACAD DERMATOL, V62, P480, DOI 10.1016/j.jaad.2009.04.028; Gatt JM, 2015, J PSYCHIATR RES, V60, P1, DOI 10.1016/j.jpsychires.2014.09.014; Hand JL, 2015, J AM ACAD DERMATOL, V72, P617, DOI 10.1016/j.jaad.2014.12.020; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Kent L, 2008, J MED GENET, V45, P519, DOI 10.1136/jmg.2008.057729; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Lonardo F, 2007, EUR J MED GENET, V50, P301, DOI 10.1016/j.ejmg.2007.04.005; Mendlowicz MV, 2000, J PSYCHIAT RES, V34, P221, DOI 10.1016/S0022-3956(00)00014-5; Ong AD, 2000, J APPL SOC PSYCHOL, V30, P1691, DOI 10.1111/j.1559-1816.2000.tb02462.x; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Peiper N, 2015, PSYCHOL ASSESSMENT, V27, P228, DOI 10.1037/pas0000025; Perou R, 2013, MMWR-MORBID MORTAL W, V62, P1; Ruzich E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141229; Silva RR, 2005, PSYCHIAT QUART, V76, P327, DOI 10.1007/s11126-005-4966-x; Slade T, 2011, AUST NZ J PSYCHIAT, V45, P308, DOI 10.3109/00048674.2010.543653; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Stergiakouli E, 2011, GENES BRAIN BEHAV, V10, P334, DOI 10.1111/j.1601-183X.2010.00672.x; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; Tobias ES, 2001, J MED GENET, V38, P466, DOI 10.1136/jmg.38.7.466; Trent S, 2013, WORLD J TRANSLATIONA, V2, P1, DOI DOI 10.5528/WJTM.V2.I1.1); Trent S, 2013, PSYCHONEUROENDOCRINO, V38, P1370, DOI 10.1016/j.psyneuen.2012.12.002; Trent S, 2012, NEUROPSYCHOPHARMACOL, V37, P1267, DOI 10.1038/npp.2011.314; Trent S, 2012, PSYCHONEUROENDOCRINO, V37, P221, DOI 10.1016/j.psyneuen.2011.06.006; Wingate M, 2014, MMWR SURVEILL SUMM, V63	38	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164417	10.1371/journal.pone.0164417	http://dx.doi.org/10.1371/journal.pone.0164417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711218	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600125
J	Eminov, S; Brandt, A; Wilton-Ely, JDET; Hallett, JP				Eminov, Sanan; Brandt, Agnieszka; Wilton-Ely, James D. E. T.; Hallett, Jason P.			The Highly Selective and Near-Quantitative Conversion of Glucose to 5-Hydroxymethylfurfural Using Ionic Liquids	PLOS ONE			English	Article							LIGNOCELLULOSIC BIOMASS; SUPERCRITICAL WATER; CELLULOSIC ETHANOL; PRETREATMENT; DEHYDRATION; FRUCTOSE; CATALYSTS; ACID; SOLVENTS; TRANSFORMATION	A number of ionic liquids have been shown to be excellent solvents for lignocellulosic biomass processing, and some of these are particularly effective in the production of the versatile chemical building block 5-hydroxymethylfurfural (HMF). In this study, the production of HMF from the simple sugar glucose in ionic liquid media is discussed. Several aspects of the selective catalytic formation of HMF from glucose have been elucidated using metal halide salts in two distinct ionic liquids, 1-butyl-3-methylimidazolium chloride and 1-butyl-3-methylimidazolium hydrogen sulfate as well as mixtures of these, revealing key features for accelerating the desired reaction and suppressing byproduct formation. The choice of ionic liquid anion is revealed to be of particular importance, with low HMF yields in the case of hydrogen sulfate-based salts, which are reported to be effective for HMF production from fructose. The most successful system investigated in this study led to almost quantitative conversion of glucose to HMF (90% in only 30 minutes using 7 mol% catalyst loading at 120 degrees C) in a system which is selective for the desired product, has low energy intensity and is environmentally benign.	[Eminov, Sanan; Wilton-Ely, James D. E. T.] Imperial Coll London, Dept Chem, London SW7 2AZ, England; [Eminov, Sanan; Brandt, Agnieszka; Hallett, Jason P.] Imperial Coll London, Dept Chem Engn, London SW7 2AZ, England	Imperial College London; Imperial College London	Wilton-Ely, JDET (corresponding author), Imperial Coll London, Dept Chem, London SW7 2AZ, England.; Hallett, JP (corresponding author), Imperial Coll London, Dept Chem Engn, London SW7 2AZ, England.	j.wilton-ely@imperial.ac.uk; j.hallett@imperial.ac.uk	Hallett, Jason P./A-3281-2012; Brandt-Talbot, Agnieszka/P-7069-2019; Brandt, Agnieszka/H-5966-2011; Wilton-Ely, James D/K-7014-2012	Hallett, Jason P./0000-0003-3431-2371; Brandt-Talbot, Agnieszka/0000-0002-5805-0233; Brandt, Agnieszka/0000-0002-5805-0233; Wilton-Ely, James D/0000-0002-5192-3038	SOCAR; Ministry of Education of the Azerbaijan Republic; UK Engineering and Physical Sciences Research Council [EP/K014676/1]; Engineering and Physical Sciences Research Council [EP/K014676/1] Funding Source: researchfish; EPSRC [EP/K014676/1] Funding Source: UKRI	SOCAR(State Oil Company of the Azerbaijan Republic (SOCAR)); Ministry of Education of the Azerbaijan Republic; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank SOCAR and The Ministry of Education of the Azerbaijan Republic for the provision of funding (S.E.). A.B. and J.P.H. wish to acknowledge the UK Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) for financial support (EP/K014676/1).	Agbor VB, 2011, BIOTECHNOL ADV, V29, P675, DOI 10.1016/j.biotechadv.2011.05.005; ANTAL MJ, 1990, CARBOHYD RES, V199, P91, DOI 10.1016/0008-6215(90)84096-D; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P173, DOI 10.1081/CLT-100102418; Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c; Brandt A, 2013, GREEN CHEM, V15, P550, DOI 10.1039/c2gc36364j; Chen L, 2014, GREEN CHEM, V16, P3098, DOI 10.1039/c4gc00016a; Lopes AMD, 2013, J AGR FOOD CHEM, V61, P7874, DOI 10.1021/jf401980p; de Jong E, 2012, ACS SYM SER, V1105, P1; Dee SJ, 2011, CHEMSUSCHEM, V4, P1166, DOI 10.1002/cssc.201000426; Eminov S, 2014, ACS SUSTAIN CHEM ENG, V2, P978, DOI 10.1021/sc400553q; Freemantle M, 1998, CHEM ENG NEWS, V76, P32, DOI 10.1021/cen-v076n013.p032; Hallett JP, 2011, CHEM REV, V111, P3508, DOI 10.1021/cr1003248; Hansen TS, 2009, CARBOHYD RES, V344, P2568, DOI 10.1016/j.carres.2009.09.036; Hu L, 2014, CHEM ENG J, V244, P137, DOI 10.1016/j.cej.2014.01.057; Hu L, 2012, J TAIWAN INST CHEM E, V43, P718, DOI 10.1016/j.jtice.2012.04.001; Hu SQ, 2009, GREEN CHEM, V11, P1746, DOI 10.1039/b914601f; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Jiang F, 2011, J MOL CATAL A-CHEM, V334, P8, DOI 10.1016/j.molcata.2010.10.006; Jimenez-Morales I, 2014, APPL CATAL B-ENVIRON, V154, P190, DOI 10.1016/j.apcatb.2014.02.024; Jimenez-Morales I, 2014, FUEL, V118, P265, DOI 10.1016/j.fuel.2013.10.079; Jonsson LJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-16; Kabyemela BM, 1999, IND ENG CHEM RES, V38, P2888, DOI 10.1021/ie9806390; Kabyemela BM, 1997, IND ENG CHEM RES, V36, P1552, DOI 10.1021/ie960250h; Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g; Li CZ, 2009, TETRAHEDRON LETT, V50, P5403, DOI 10.1016/j.tetlet.2009.07.053; Osatiashtiani A, 2014, CATAL SCI TECHNOL, V4, P333, DOI 10.1039/c3cy00409k; Otomo R, 2014, APPL CATAL A-GEN, V470, P318, DOI 10.1016/j.apcata.2013.11.012; Pagan-Torres YJ, 2012, ACS CATAL, V2, P930, DOI 10.1021/cs300192z; Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947; Qi XH, 2012, BIORESOURCE TECHNOL, V109, P224, DOI 10.1016/j.biortech.2012.01.034; Qi XH, 2011, IND ENG CHEM RES, V50, P7985, DOI 10.1021/ie200488k; Qu YS, 2012, BIORESOURCE TECHNOL, V121, P462, DOI 10.1016/j.biortech.2012.06.081; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Remsing RC, 2006, CHEM COMMUN, P1271, DOI 10.1039/b600586c; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; Rosatella AA, 2011, GREEN CHEM, V13, P754, DOI 10.1039/c0gc00401d; Sievers C, 2009, CHEMSUSCHEM, V2, P665, DOI 10.1002/cssc.200900092; Srokol Z, 2004, CARBOHYD RES, V339, P1717, DOI 10.1016/j.carres.2004.04.018; Sun XF, 2015, GREEN CHEM, V17, P2719, DOI 10.1039/c5gc00092k; Torr KM, 2012, GREEN CHEM, V14, P778, DOI 10.1039/c2gc16362d; Tyrlik SK, 1999, CARBOHYD RES, V315, P268, DOI 10.1016/S0008-6215(99)00037-3; van Zandvoort I, 2013, CHEMSUSCHEM, V6, P1745, DOI 10.1002/cssc.201300332; Watanabe M, 2005, CARBOHYD RES, V340, P1925, DOI 10.1016/j.carres.2005.06.017; Xu Q, 2014, BIORESOURCES, V9, P303; Yang B, 2008, BIOFUEL BIOPROD BIOR, V2, P26, DOI 10.1002/bbb.49; Zakrzewska ME, 2011, CHEM REV, V111, P397, DOI 10.1021/cr100171a; Zhang YM, 2011, CHEM-EUR J, V17, P5281, DOI 10.1002/chem.201003645; Zhang ZH, 2011, CHEMSUSCHEM, V4, P131, DOI 10.1002/cssc.201000279; Zhao HB, 2007, SCIENCE, V316, P1597, DOI 10.1126/science.1141199; Zhong SH, 2010, ENERG FUEL, V24, P2891, DOI 10.1021/ef901575a; Zhu JY, 2010, BIORESOURCE TECHNOL, V101, P4992, DOI 10.1016/j.biortech.2009.11.007	51	27	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163835	10.1371/journal.pone.0163835	http://dx.doi.org/10.1371/journal.pone.0163835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711238	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600044
J	Keizer, A; van Elburg, A; Helms, R; Dijkerman, HC				Keizer, Anouk; van Elburg, Annemarie; Helms, Rossa; Dijkerman, H. Chris			A Virtual Reality Full Body Illusion Improves Body Image Disturbance in Anorexia Nervosa	PLOS ONE			English	Article							EATING-DISORDERS; SIZE ESTIMATION; ILLUSORY OWNERSHIP; PERCEPTION; RECOVERY; HAND; REPRESENTATION; ANTICIPATION; MAINTENANCE; PATHOLOGY	Background Patients with anorexia nervosa (AN) have a persistent distorted experience of the size of their body. Previously we found that the Rubber Hand Illusion improves hand size estimation in this group. Here we investigated whether a Full Body Illusion (FBI) affects body size estimation of body parts more emotionally salient than the hand. In the FBI, analogue to the RHI, participants experience ownership over an entire virtual body in VR after synchronous visuo-tactile stimulation of the actual and virtual body. Methods and Results We asked participants to estimate their body size (shoulders, abdomen, hips) before the FBI was induced, directly after induction and at similar to 2 hour 45 minutes follow-up. The results showed that AN patients (N = 30) decrease the overestimation of their shoulders, abdomen and hips directly after the FBI was induced. This effect was strongest for estimates of circumference, and also observed in the asynchronous control condition of the illusion. Moreover, at follow-up, the improvements in body size estimation could still be observed in the AN group. Notably, the HC group (N = 29) also showed changes in body size estimation after the FBI, but the effect showed a different pattern than that of the AN group. Conclusion The results lead us to conclude that the disturbed experience of body size in AN is flexible and can be changed, even for highly emotional body parts. As such this study offers novel starting points from which new interventions for body image disturbance in AN can be developed.	[Keizer, Anouk; Helms, Rossa; Dijkerman, H. Chris] Univ Utrecht, Expt Psychol Helmholtz Inst, Utrecht, Netherlands; [van Elburg, Annemarie] Altrecht Mental Hlth Inst, Altrecht Ctr Eating Disorders Rintveld, Zeist, Netherlands; [van Elburg, Annemarie] Univ Utrecht, Clin Psychol, Utrecht, Netherlands; [Dijkerman, H. Chris] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University; Utrecht University Medical Center	Keizer, A (corresponding author), Univ Utrecht, Expt Psychol Helmholtz Inst, Utrecht, Netherlands.	a.keizer@uu.nl						[Anonymous], 2011, WAIST CIRCUMFERENCE; APA, 2000, DIAGN STAT MAN MENT; Bachner-Melman R, 2006, J NERV MENT DIS, V194, P697, DOI 10.1097/01.nmd.0000235795.51683.99; Banakou D, 2013, P NATL ACAD SCI USA, V110, P12846, DOI 10.1073/pnas.1306779110; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Carter JC, 2004, PSYCHOL MED, V34, P671, DOI 10.1017/S0033291703001168; Case LK, 2012, EXP BRAIN RES, V217, P79, DOI 10.1007/s00221-011-2974-7; Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Eshkevari E, 2014, INT J EAT DISORDER, V47, P400, DOI 10.1002/eat.22219; Espeset Ester M S, 2011, Eat Disord, V19, P175, DOI 10.1080/10640266.2011.551635; Exterkate CC, 2009, EAT BEHAV, V10, P16, DOI 10.1016/j.eatbeh.2008.10.002; Fairburn Christopher G., 1993, P317; Farrell C, 2006, EUR EAT DISORD REV, V14, P289, DOI 10.1002/erv.693; Federici A, 2008, EUR EAT DISORD REV, V16, P1, DOI 10.1002/erv.813; Gallagher S., 2005, BODY SHAPES MIND; Gardner RM, 2014, PSYCHIAT RES, V219, P407, DOI 10.1016/j.psychres.2014.06.029; Garner DM, 1991, EATING DISORDER INVE; Gaudio S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110087; Grunwald M, 2001, INT J EAT DISORDER, V29, P417, DOI 10.1002/eat.1038; Guardia D, 2012, PSYCHIAT RES, V195, P56, DOI 10.1016/j.psychres.2011.08.003; Guardia D, 2010, NEUROPSYCHOLOGIA, V48, P3961, DOI 10.1016/j.neuropsychologia.2010.09.004; Haggard P., 2005, HIGHER ORDER MOTOR D; Haggard P, 2009, PERCEPTION, V38, P1796, DOI 10.1068/p6399; Keizer A, 2014, NEUROPSYCHOLOGIA, V62, P26, DOI 10.1016/j.neuropsychologia.2014.07.003; Keizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064602; Keizer A, 2012, PSYCHIAT RES, V200, P530, DOI 10.1016/j.psychres.2012.05.001; Keizer A, 2011, PSYCHIAT RES, V190, P115, DOI 10.1016/j.psychres.2011.04.031; Killen JD, 1996, J CONSULT CLIN PSYCH, V64, P936, DOI 10.1037/0022-006X.64.5.936; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Lang K, 2014, WORLD J BIOL PSYCHIA, V15, P586, DOI 10.3109/15622975.2014.909606; Linkenauger SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068594; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2015, EUR PSYCHOL, V20, P6, DOI 10.1027/1016-9040/a000198; Longo MR, 2012, ACTA PSYCHOL, V141, P164, DOI 10.1016/j.actpsy.2012.07.015; Longo MR, 2010, NEUROPSYCHOLOGIA, V48, P655, DOI 10.1016/j.neuropsychologia.2009.08.022; Longo MR, 2009, ACTA PSYCHOL, V132, P166, DOI 10.1016/j.actpsy.2009.02.003; Lopez C, 2008, PSYCHOL MED, V38, P1393, DOI 10.1017/S0033291708003486; Maselli A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00083; Meister L, 2015, TRENDS COGN SCI, V19, P6, DOI 10.1016/j.tics.2014.11.001; Miller SP, 2003, CHILD PSYCHIAT HUM D, V33, P295, DOI 10.1023/A:1023036329399; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; Osimo SA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13899; Overas M, 2014, EUR EAT DISORD REV, V22, P109, DOI 10.1002/erv.2276; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Piryankova IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103428; Preston C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085773; Probst M., 1995, EAT DISORD, V3, P133, DOI [10.1080/10640269508249156, DOI 10.1080/10640269508249156]; Serino S, 2016, CYBERPSYCH BEH SOC N, V19, P127, DOI 10.1089/cyber.2015.0229; Skrzypek S, 2001, EUR CHILD ADOLES PSY, V10, P215, DOI 10.1007/s007870170010; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Smeets MAM, 1997, EUR EAT DISORD REV, V5, P75; Stice E, 2002, PSYCHOL BULL, V128, P825, DOI 10.1037//0033-2909.128.5.825; Stice E, 2002, J PSYCHOSOM RES, V53, P985, DOI 10.1016/S0022-3999(02)00488-9; Strigo IA, 2013, INT J EAT DISORDER, V46, P23, DOI 10.1002/eat.22045; Tuschen-Caffier B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145886	61	112	114	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163921	10.1371/journal.pone.0163921	http://dx.doi.org/10.1371/journal.pone.0163921			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711234	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600051
J	Nygaard, TK; Kobayashi, SD; Freedman, B; Porter, AR; Voyich, JM; Otto, M; Schneewind, O; DeLeo, FR				Nygaard, Tyler K.; Kobayashi, Scott D.; Freedman, Brett; Porter, Adeline R.; Voyich, Jovanka M.; Otto, Michael; Schneewind, Olaf; DeLeo, Frank R.			Interaction of Staphylococci with Human B cells	PLOS ONE			English	Article							COMPLEMENT RECEPTOR 2; IMMUNE EVASION; HUMAN NEUTROPHILS; BINDING PROTEIN; INNATE IMMUNITY; IN-VIVO; AUREUS; C3D; ANTIGEN; BLOOD	Staphylococcus aureus is a leading cause of human infections worldwide. The pathogen produces numerous molecules that can interfere with recognition and binding by host innate immune cells, an initial step required for the ingestion and subsequent destruction of microbes by phagocytes. To better understand the interaction of this pathogen with human immune cells, we compared the association of S. aureus and S. epidermidis with leukocytes in human blood. We found that a significantly greater proportion of B cells associated with S. epidermidis relative to S. aureus. Complement components and complement receptors were important for the binding of B cells with S. epidermidis. Experiments using staphylococci inactivated by ultraviolet radiation and S. aureus isogenic deletion mutants indicated that S. aureus secretes molecules regulated by the SaeR/S two-component system that interfere with the ability of human B cells to bind this bacterium. We hypothesize that the relative inability of B cells to bind S. aureus contributes to the microbe's success as a human pathogen.	[Nygaard, Tyler K.; Kobayashi, Scott D.; Freedman, Brett; Porter, Adeline R.; DeLeo, Frank R.] NIAID, Bacteriol Lab, Rocky Mt Labs, NIH, Hamilton, MT USA; [Voyich, Jovanka M.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Otto, Michael] NIAID, Bacteriol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Montana State University System; Montana State University Bozeman; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Chicago	DeLeo, FR (corresponding author), NIAID, Bacteriol Lab, Rocky Mt Labs, NIH, Hamilton, MT USA.	fdeleo@niaid.nih.gov		DeLeo, Frank/0000-0003-3150-2516; Kobayashi, Scott/0000-0002-5705-1381; Nygaard, Tyler/0000-0002-4736-0156; Otto, Michael/0000-0002-2222-4115	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institutes of Health [NIH-R01A1090046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038897, R01AI052474] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health and a grant from the National Institutes of Health (NIH-R01A1090046 to JMV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boackle SA, 1998, J IMMUNOL, V161, P6537; Burman JD, 2008, J BIOL CHEM, V283, P17579, DOI 10.1074/jbc.M800265200; Cary S, 1999, MOL IMMUNOL, V36, P769, DOI 10.1016/S0161-5890(99)00085-1; Centers for Disease Control and Prevention, 2014, ACT BACT COR SURV AB; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; DOSSETT JH, 1969, J IMMUNOL, V103, P1405; Falugi F, 2013, MBIO, V4, DOI 10.1128/mBio.00575-13; FEARON DT, 1985, J INVEST DERMATOL, V85, pS53, DOI 10.1111/1523-1747.ep12275473; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Fowler VG, 2014, CLIN MICROBIOL INFEC, V20, P66, DOI 10.1111/1469-0691.12570; Garcia BL, 2012, ADV EXP MED BIOL, V946, P113, DOI 10.1007/978-1-4614-0106-3_7; Goodyear CS, 2003, J EXP MED, V197, P1125, DOI 10.1084/jem.20020552; GREENBERG L, 1968, J PHARM SCI-US, V57, P1546, DOI 10.1002/jps.2600570917; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Koch TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047638; Landrum ML, 2012, JAMA-J AM MED ASSOC, V308, P50, DOI 10.1001/jama.2012.7139; Link A, 2012, J IMMUNOL, V188, P3724, DOI 10.4049/jimmunol.1103312; Lu T, 2014, J INNATE IMMUN, V6, P639, DOI 10.1159/000360478; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Nakashima M, 2012, J LEUKOCYTE BIOL, V91, P537, DOI 10.1189/jlb.0411214; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Nygaard TK, 2013, J LEUKOCYTE BIOL, V94, P971, DOI 10.1189/jlb.0213080; Nygaard TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036532; Nygaard TK, 2010, J INFECT DIS, V201, P241, DOI 10.1086/649570; Parra D, 2012, J LEUKOCYTE BIOL, V91, P525, DOI 10.1189/jlb.0711372; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; ROGERS DE, 1952, J EXP MED, V95, P209, DOI 10.1084/jem.95.2.209; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366; SJODAHL J, 1977, EUR J BIOCHEM, V73, P343, DOI 10.1111/j.1432-1033.1977.tb11324.x; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; THORNTON BP, 1994, J IMMUNOL, V152, P1727; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; WEIS JJ, 1984, P NATL ACAD SCI-BIOL, V81, P881, DOI 10.1073/pnas.81.3.881; Woehl JL, 2014, J IMMUNOL, V193, P6161, DOI 10.4049/jimmunol.1401600	45	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164410	10.1371/journal.pone.0164410	http://dx.doi.org/10.1371/journal.pone.0164410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711145	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600124
J	Schaefer, BA; Flanagan, JM; Alvarez, OA; Nelson, SC; Aygun, B; Nottage, KA; George, A; Roberts, CW; Piccone, CM; Howard, TA; Davis, BR; Ware, RE				Schaefer, Beverly A.; Flanagan, Jonathan M.; Alvarez, Ofelia A.; Nelson, Stephen C.; Aygun, Banu; Nottage, Kerri A.; George, Alex; Roberts, Carla W.; Piccone, Connie M.; Howard, Thad A.; Davis, Barry R.; Ware, Russell E.			Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia	PLOS ONE			English	Article							HYDROXYUREA TREATMENT; CHRONIC TRANSFUSION; ADVERSE OUTCOMES; DEFICIENT MICE; RENAL-DISEASE; SALUSIN-ALPHA; RISK; NEPHROPATHY; APOL1; MICROALBUMINURIA	Discovery and validation of genetic variants that influence disease severity in children with sickle cell anemia (SCA) could lead to early identification of high-risk patients, better screening strategies, and intervention with targeted and preventive therapy. We hypothesized that newly identified genetic risk factors for the general African American population could also impact laboratory biomarkers known to contribute to the clinical disease expression of SCA, including variants influencing the white blood cell count and the development of albuminuria and abnormal glomerular filtration rate. We first investigated candidate genetic polymorphisms in well-characterized SCA pediatric cohorts from three prospective NHLBI-supported clinical trials: HUSTLE, SWiTCH, and TWiTCH. We also performed whole exome sequencing to identify novel genetic variants, using both a discovery and a validation cohort. Among candidate genes, DARC rs2814778 polymorphism regulating Duffy antigen expression had a clear influence with significantly increased WBC and neutrophil counts, but did not affect the maximum tolerated dose of hydroxyurea therapy. The APOL1 G1 polymorphism, an identified risk factor for non-diabetic renal disease, was associated with albuminuria. Whole exome sequencing discovered several novel variants that maintained significance in the validation cohorts, including ZFHX4 polymorphisms affecting both the leukocyte and neutrophil counts, as well as AGGF1, CYP4B1, CUBN, TOR2A, PKD1L2, and CD163 variants affecting the glomerular filtration rate. The identification of robust, reliable, and reproducible genetic markers for disease severity in SCA remains elusive, but new genetic variants provide avenues for further validation and investigation.	[Schaefer, Beverly A.; Howard, Thad A.; Ware, Russell E.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Flanagan, Jonathan M.; George, Alex] Baylor Coll Med, Houston, TX 77030 USA; [Alvarez, Ofelia A.] Univ Miami, Miami, FL USA; [Nelson, Stephen C.] Childrens Hosp & Clin Minnesota, Minneapolis, MN USA; [Aygun, Banu] Cohen Childrens Med Ctr, New Hyde Pk, NY USA; [Nottage, Kerri A.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Roberts, Carla W.] Univ South Carolina, Columbia, SC USA; [Piccone, Connie M.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Davis, Barry R.] Univ Texas Sch Publ Hlth, Houston, TX USA	Cincinnati Children's Hospital Medical Center; Baylor College of Medicine; University of Miami; Children's Hospitals & Clinics of Minnesota; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; St Jude Children's Research Hospital; University of South Carolina System; University of South Carolina Columbia; Case Western Reserve University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Schaefer, BA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA.	beverly.schaefer@cchmc.org	Flanagan, Jonathan/J-6284-2019		Doris Duke Charitable Foundation [2015132, 2010036]; National Institutes of Health Center Cores P30 Grant [DK090971]; National Institutes of Health National Heart, Lung, and Blood Institute [R01-HL-090941, R01-HL-078787, R01-HL-095647]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095647, U01HL078787, R01HL090941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090971] Funding Source: NIH RePORTER	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health Center Cores P30 Grant; National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Doris Duke Charitable Foundation (http:/www.ddcf.org/) 2015132 and 2010036, the National Institutes of Health Center Cores P30 Grant (http://grants.nih.gov/grants/funding) (DK090971) and National Institutes of Health National Heart, Lung, and Blood Institute (http://www.nhlbi.nih.gov) R01-HL-090941, R01-HL-078787, and R01-HL-095647 (RW). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Afenyi-Annan A, 2008, TRANSFUSION, V48, P917, DOI 10.1111/j.1537-2995.2007.01622.x; Alvarez O, 2008, PEDIATR BLOOD CANCER, V50, P1236, DOI 10.1002/pbc.21520; Alvarez O, 2006, PEDIATR BLOOD CANCER, V47, P71, DOI 10.1002/pbc.20645; Alvarez O, 2012, PEDIATR BLOOD CANCER, V59, P668, DOI 10.1002/pbc.24100; Ashley-Koch AE, 2011, BRIT J HAEMATOL, V155, P386, DOI 10.1111/j.1365-2141.2011.08832.x; Atay AE, 2014, CLIN NEPHROL, V81, P105, DOI 10.5414/CN108138; Aygun B, 2011, PEDIATR NEPHROL, V26, P1285, DOI 10.1007/s00467-011-1857-2; Carpenter SL, 2008, AM J HEMATOL, V83, P800, DOI 10.1002/ajh.21264; Choi AI, 2009, AM J MED, V122, P672, DOI 10.1016/j.amjmed.2008.11.021; Chudnovsky Y, 2014, CELL REP, V6, P313, DOI 10.1016/j.celrep.2013.12.032; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Flanagan JM, 2013, BLOOD, V121, P3237, DOI 10.1182/blood-2012-10-464156; Freedman BI, 2010, J AM SOC NEPHROL, V21, P1422, DOI 10.1681/ASN.2010070730; GILL FM, 1989, PEDIATRICS, V83, P827; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Hemmi K, 2006, BIOL PHARM BULL, V29, P1830, DOI 10.1248/bpb.29.1830; Hsu LL, 2003, J PEDIAT HEMATOL ONC, V25, P622, DOI 10.1097/00043426-200308000-00007; Hu FY, 2013, CELL SIGNAL, V25, P1645, DOI 10.1016/j.cellsig.2013.04.007; KILARU P, 1994, J HUM HYPERTENS, V8, P809; Koya T, 2012, AM J PHYSIOL-HEART C, V303, pH96, DOI 10.1152/ajpheart.00009.2012; Lan XQ, 2014, AM J PHYSIOL-RENAL, V307, pF326, DOI 10.1152/ajprenal.00647.2013; Limou S, 2014, ADV CHRONIC KIDNEY D, V21, P426, DOI 10.1053/j.ackd.2014.06.005; McMahon GM, 2014, NEPHROL DIAL TRANSPL, V29, P342, DOI 10.1093/ndt/gft386; Miller ST, 2000, NEW ENGL J MED, V342, P83, DOI 10.1056/NEJM200001133420203; Nagashima M, 2010, ATHEROSCLEROSIS, V212, P70, DOI 10.1016/j.atherosclerosis.2010.04.027; Nickel RS, 2015, BRIT J HAEMATOL, V169, P574, DOI 10.1111/bjh.13326; Okada Y, 2010, HUM MOL GENET, V19, P2079, DOI 10.1093/hmg/ddq080; Palmer ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088273; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Quinn CT, 2008, BLOOD, V111, P544, DOI 10.1182/blood-2007-07-100719; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Saraf SL, 2015, HAEMATOLOGICA, V100, P1275, DOI 10.3324/haematol.2015.124875; Schaer CA, 2006, CIRC RES, V99, P943, DOI 10.1161/01.RES.0000247067.34173.1b; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Sheehan VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110740; Sheehan VA, 2013, AM J HEMATOL, V88, P571, DOI 10.1002/ajh.23457; Stacey SN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7825; Wang M, 2016, MOL CELL ENDOCRINOL, V426, P136, DOI 10.1016/j.mce.2016.02.020; Ware RE, 2002, BLOOD, V99, P10, DOI 10.1182/blood.V99.1.10; Ware RE, 2015, HEMATOL-AM SOC HEMAT, P436, DOI 10.1182/asheducation-2015.1.436; Ware RE, 2016, LANCET, V387, P661, DOI 10.1016/S0140-6736(15)01041-7; Ware RE, 2012, BLOOD, V119, P3925, DOI 10.1182/blood-2011-11-392340; Ware RE, 2011, BLOOD, V118, P4985, DOI 10.1182/blood-2011-07-364190; Ware RE, 2010, BLOOD, V115, P5300, DOI 10.1182/blood-2009-04-146852; Ware RE, 2010, J PEDIATR-US, V156, P66, DOI 10.1016/j.jpeds.2009.06.060; Watanabe T, 2008, CIRCULATION, V117, P638, DOI 10.1161/CIRCULATIONAHA.107.712539; WEST MS, 1992, J CLIN EPIDEMIOL, V45, P893; Williams WW, 2013, NEW ENGL J MED, V369, P2260, DOI 10.1056/NEJMe1312797; Yee MM, 2011, CLIN J AM SOC NEPHRO, V6, P2628, DOI 10.2215/CJN.01600211; Yuasa T, 2004, GENOMICS, V84, P126, DOI 10.1016/j.ygeno.2004.02.008; Zhou BS, 2016, BBA-MOL BASIS DIS, V1862, P1203, DOI 10.1016/j.bbadis.2016.02.002	55	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164364	10.1371/journal.pone.0164364	http://dx.doi.org/10.1371/journal.pone.0164364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711207	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600123
J	Moafian, Z; Khoshaman, K; Oryan, A; Kurganov, BI; Yousefi, R				Moafian, Zeinab; Khoshaman, Kazem; Oryan, Ahmad; Kurganov, Boris I.; Yousefi, Reza			Protective Effects of Acetylation on the Pathological Reactions of the Lens Crystallins with Homocysteine Thiolactone	PLOS ONE			English	Article							ALPHA-A-CRYSTALLIN; HUMAN-SERUM ALBUMIN; CHAPERONE ACTIVITY; BETA-CRYSTALLIN; N-HOMOCYSTEINYLATION; STRUCTURAL-CHANGES; ASPIRIN PREVENTS; IN-VITRO; PROTEINS; AGGREGATION	Various post-translational lens crystallins modifications result in structural and functional insults, contributing to the development of lens opacity and cataract disorders. Lens crystallins are potential targets of homocysteinylation, particularly under hyperhomocysteinemia which has been indicated in various eye diseases. Since both homocysteinylation and acetylation primarily occur on protein free amino groups, we applied different spectroscopic methods and gel mobility shift analysis to examine the possible preventive role of acetylation against homocysteinylation. Lens crystallins were extensively acetylated in the presence of acetic anhydride and then subjected to homocysteinylation in the presence of homocysteine thiolactone (HCTL). Extensive acetylation of the lens crystallins results in partial structural alteration and enhancement of their stability, as well as improvement of alpha-crystallin chaperone-like activity. In addition, acetylation partially prevents HCTL-induced structural alteration and aggregation of lens crystallins. Also, acetylation protects against HCTL-induced loss of alpha-crystallin chaperone activity. Additionally, subsequent acetylation and homocysteinylation cause significant proteolytic degradation of crystallins. Therefore, further experimentation is required in order to judge effectively the preventative role of acetylation on the structural and functional insults induced by homocysteinylation of lens crystallins.	[Moafian, Zeinab; Khoshaman, Kazem; Yousefi, Reza] Shiraz Univ, Coll Sci, Dept Biol, Prot Chem Lab, Shiraz, Iran; [Oryan, Ahmad] Shiraz Univ, Sch Vet Med, Dept Pathol, Shiraz, Iran; [Kurganov, Boris I.] Russian Acad Sci, Biotechnol Res Ctr, Bach Inst Biochem, Leninsky Pr 33, Moscow 119071, Russia	Shiraz University; Shiraz University; Research Center of Biotechnology RAS; Russian Academy of Sciences	Yousefi, R (corresponding author), Shiraz Univ, Coll Sci, Dept Biol, Prot Chem Lab, Shiraz, Iran.	ryousefi@shirazu.ac.ir	Kurganov, Boris/M-1286-2019; Yousefi, Reza/S-8243-2017; Oryan, Ahmad/J-6539-2014	Yousefi, Reza/0000-0001-7396-7720; Oryan, Ahmad/0000-0003-1697-2376	Iran National Science Foundation (INSF) [92001695]	Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF))	This study was financially supported by Iran National Science Foundation (INSF, www.insf.org) (grant no. 92001695), and RY received this funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, J AM CHEM SOC, V124, P9278, DOI 10.1021/ja0167710; Ajith TA, 2015, CLIN CHIM ACTA, V450, P316, DOI 10.1016/j.cca.2015.09.007; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Booth AA, 1997, J BIOL CHEM, V272, P5430, DOI 10.1074/jbc.272.9.5430; Callis PR, 2003, CHEM PHYS LETT, V369, P409, DOI 10.1016/S0009-2614(02)02046-8; Chwatko G, 2005, CLIN CHEM, V51, P408, DOI 10.1373/clinchem.2004.042531; Chwatko G, 2007, FASEB J, V21, P1707, DOI 10.1096/fj.06-7435com; CROMPTON M, 1985, EXP EYE RES, V40, P297, DOI 10.1016/0014-4835(85)90014-4; DAVID LL, 1994, INVEST OPHTH VIS SCI, V35, P785; DiMauro MA, 2014, BIOCHEMISTRY-US, V53, P7269, DOI 10.1021/bi501004y; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Fayle SE, 2001, ELECTROPHORESIS, V22, P1518, DOI 10.1002/1522-2683(200105)22:8&lt;1518::AID-ELPS1518&gt;3.0.CO;2-U; Finamore F, 2014, EUPA OPEN PROTEOMICS, V3, P100, DOI DOI 10.1016/J.EUPR0T.2014.02.001; HARRINGTON CR, 1994, NATURE, V370, P247, DOI 10.1038/370247a0; HAWKINS D, 1969, J CLIN INVEST, V48, P536, DOI 10.1172/JCI106011; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; Jakubowski H, 2004, CELL MOL LIFE SCI, V61, P470, DOI 10.1007/s00018-003-3204-7; Jakubowski H, 2000, J NUTR, V130, p377S, DOI 10.1093/jn/130.2.377S; Jakubowski H, 2006, J NUTR, V136, p1741S, DOI 10.1093/jn/136.6.1741S; Khalili-Hezarjaribi H, 2012, PROTEIN PEPTIDE LETT, V19, P450, DOI 10.2174/092986612799789396; Khazaei S, 2012, PROTEIN J, V31, P717, DOI 10.1007/s10930-012-9451-4; Khoshaman K, 2015, FREE RADICAL BIO MED, V89, P819, DOI 10.1016/j.freeradbiomed.2015.09.013; Kurganov BI, 2002, BIOCHEMISTRY-MOSCOW+, V67, P409, DOI 10.1023/A:1015277805345; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapko VN, 2001, PROTEIN SCI, V10, P1130, DOI 10.1110/ps.40901; Lin PPP, 1998, PROTEIN SCI, V7, P1451, DOI 10.1002/pro.5560070622; LUBSEN NH, 1988, PROG BIOPHYS MOL BIO, V51, P47, DOI 10.1016/0079-6107(88)90010-7; Maron BA, 2009, ANNU REV MED, V60, P39, DOI 10.1146/annurev.med.60.041807.123308; Meehan S, 2007, J MOL BIOL, V372, P470, DOI 10.1016/j.jmb.2007.06.060; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Munishkina LA, 2007, BBA-BIOMEMBRANES, V1768, P1862, DOI 10.1016/j.bbamem.2007.03.015; Nagaraj RH, 2012, BBA-MOL BASIS DIS, V1822, P120, DOI 10.1016/j.bbadis.2011.11.011; Nahomi RB, 2013, BIOCHEMISTRY-US, V52, P8126, DOI 10.1021/bi400638s; Nahomi RB, 2013, BBA-MOL BASIS DIS, V1832, P195, DOI 10.1016/j.bbadis.2012.08.015; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paoli P, 2010, J MOL BIOL, V400, P889, DOI 10.1016/j.jmb.2010.05.039; Perna AF, 2006, KIDNEY INT, V69, P869, DOI 10.1038/sj.ki.5000070; Plaxco KW, 2000, BIOCHEMISTRY-US, V39, P11177, DOI 10.1021/bi000200n; Ponce A, 2006, MOL VIS, V12, P879; RAO GN, 1988, BIOCHEM BIOPH RES CO, V151, P991, DOI 10.1016/S0006-291X(88)80463-7; Schaefer H, 2003, ANAL BIOANAL CHEM, V376, P966, DOI 10.1007/s00216-003-1983-1; Schmid FX, 2001, ENCY LIFE SCI, P1, DOI [10.1038/npg.els.0003142, DOI 10.1038/NPG.ELS.0003142]; Sharma GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116386; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Sharma KK, 1998, J BIOL CHEM, V273, P15474, DOI 10.1074/jbc.273.25.15474; Stirban A, 2014, MOL METAB, V3, P94, DOI 10.1016/j.molmet.2013.11.006; Stroylova YY, 2012, ARCH BIOCHEM BIOPHYS, V526, P29, DOI 10.1016/j.abb.2012.06.008; Stroylova YY, 2011, BBA-PROTEINS PROTEOM, V1814, P1234, DOI 10.1016/j.bbapap.2011.05.017; Trivedi MV, 2009, CURR PROTEIN PEPT SC, V10, P614, DOI 10.2174/138920309789630534; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; TRUSCOTT RJW, 1977, EXP EYE RES, V25, P139, DOI 10.1016/0014-4835(77)90126-9; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Undas A, 2004, STROKE, V35, P1299, DOI 10.1161/01.STR.0000128412.59768.6e; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Yan H, 2003, EYE, V17, P637, DOI 10.1038/sj.eye.6700419; Yousefi R, 2013, PROTEIN PEPTIDE LETT, V20, P932, DOI 10.2174/0929866511320080011; YVON M, 1988, FEBS LETT, V239, P237, DOI 10.1016/0014-5793(88)80924-4; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou C, 2015, ANAL BIOCHEM, V472, P7, DOI 10.1016/j.ab.2014.11.016	61	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164139	10.1371/journal.pone.0164139	http://dx.doi.org/10.1371/journal.pone.0164139			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706231	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200090
J	Nakase, T; Tobisawa, M; Sasaki, M; Suzuki, A				Nakase, Taizen; Tobisawa, Maiko; Sasaki, Masahiro; Suzuki, Akifumi			Outstanding Symptoms of Poststroke Depression during the Acute Phase of Stroke	PLOS ONE			English	Article							REPORT QIDS-SR; LESION LOCATION; SELF-REPORT; PSYCHOMETRIC EVALUATION; QUICK INVENTORY; FOLLOW-UP; SYMPTOMATOLOGY; MOOD	Poststroke depression (PSD) is a critical complication which might lead to unfavorable outcomes. However, most cases of PSD in the acute phase, during the 2 or 3 weeks following a stroke, are neglected because of the variable comorbid conditions. In this study, aimed at revealing the outstanding symptoms of PSD during the acute phase, consecutive patients with intracranial hemorrhage (ICH) or brain infarction (BI) were asked to fill out a depression questionnaire (Quick Inventory of Depressive Symptomatology Self-Report: QIDS-SR) at 1 week and 1 month following stroke onset. Patients with disturbed consciousness or aphasia were excluded from this study. Forty-nine ICH patients and 222 BI patients completed the QIDS-SR at 1 week and 27 of ICH and 62 of BI at 1 month. The PSD rate was 67% and 46% at 1 week in ICH and BI, respectively. Although sleep disturbance was the most frequent symptom of PSD, psychomotor agitation and appetite disturbance were the most distinguishing symptoms in ICH at 1 week and fatigue at 1 month. On the other hand, most of the depressive symptoms addressed in QIDS-SR were observed in PSD of BI patients both at 1 week and 1 month. In conclusion, while sleep disturbance was a frequent but non-specific symptom, appetite disturbance and fatigue might be critical symptoms to suggest PSD during the acute phase of stroke.	[Nakase, Taizen; Tobisawa, Maiko; Sasaki, Masahiro; Suzuki, Akifumi] Res Inst Brain & Blood Vessels, Dept Stroke Sci, Akita, Japan		Nakase, T (corresponding author), Res Inst Brain & Blood Vessels, Dept Stroke Sci, Akita, Japan.	nakase@akita-noken.jp	Nakase, Taizen/AAP-5288-2020	Nakase, Taizen/0000-0002-1796-5859				Benaim C, 2004, STROKE, V35, P1692, DOI 10.1161/01.STR.0000130591.95710.20; Berg A, 2003, STROKE, V34, P138, DOI 10.1161/01.STR.0000048149.84268.07; Berg A, 2009, STROKE, V40, P523, DOI 10.1161/STROKEAHA.108.527705; Capaldi VF, 2010, PSYCHOL RES BEHAV MA, V3, P109, DOI 10.2147/PRBM.S10035; Carson AJ, 2000, LANCET, V356, P122, DOI 10.1016/S0140-6736(00)02448-X; de Coster L, 2005, INT J GERIATR PSYCH, V20, P358, DOI 10.1002/gps.1290; Hackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35; HERRMANN M, 1995, STROKE, V26, P850, DOI 10.1161/01.STR.26.5.850; HERRMANN M, 1993, J NEUROL NEUROSUR PS, V56, P672, DOI 10.1136/jnnp.56.6.672; Jiang XG, 2014, EUR REV MED PHARMACO, V18, P1315; *JOINT COMM GUID M, 2009, JAP GUID MAN STROK 2; Jorge RE, 2003, AM J PSYCHIAT, V160, P1823, DOI 10.1176/appi.ajp.160.10.1823; Kouwenhoven SE, 2011, DISABIL REHABIL, V33, P539, DOI 10.3109/09638288.2010.505997; Laska AC, 2007, CEREBROVASC DIS, V24, P74, DOI 10.1159/000103119; Lokk J, 2010, NEUROPSYCH DIS TREAT, V6, P539, DOI 10.2147/NDT.S7637; Morris PLP, 1996, J NEUROPSYCH CLIN N, V8, P153; Morris PLP, 1996, J NEUROPSYCH CLIN N, V8, P399; Narushima K, 2003, J NERV MENT DIS, V191, P645, DOI 10.1097/01.nmd.0000092197.97693.d2; Nishiyama Y, 2010, J STROKE CEREBROVASC, V19, P184, DOI 10.1016/j.jstrokecerebrovasdis.2009.04.002; Paolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145; Rush AJ, 2006, PSYCHIAT SERV, V57, P829, DOI 10.1176/appi.ps.57.6.829; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; SCHWARTZ JA, 1993, BIOL PSYCHIAT, V33, P694, DOI 10.1016/0006-3223(93)90118-W; Shimoda K, 1999, BIOL PSYCHIAT, V45, P187, DOI 10.1016/S0006-3223(98)00178-4; Singh A, 2000, STROKE, V31, P637, DOI 10.1161/01.STR.31.3.637; Singh A, 1998, CAN J PSYCHIAT, V43, P921, DOI 10.1177/070674379804300907; Skaner Y, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-61; Sneed JR, 2006, BIOL PSYCHIAT, V60, P1295, DOI 10.1016/j.biopsych.2006.06.018; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Whyte EM, 2002, BIOL PSYCHIAT, V52, P253, DOI 10.1016/S0006-3223(02)01424-5	30	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163038	10.1371/journal.pone.0163038	http://dx.doi.org/10.1371/journal.pone.0163038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706193	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200031
J	Liu, YK; Yao, YY; Li, H; Qiao, F; Wu, JL; Du, ZY; Zhang, M				Liu, Yukun; Yao, Yayun; Li, Huan; Qiao, Fang; Wu, Junlin; Du, Zhen-yu; Zhang, Meiling			Influence of Endogenous and Exogenous Estrogenic Endocrine on Intestinal Microbiota in Zebrafish	PLOS ONE			English	Article							SEX-DIFFERENCES; GUT MICROBIOME; EXPOSURE; BACTERIA; BEHAVIOR; GENES	Gender is one of the factors influencing the intestinal microbial composition in mammals, but whether fish also have gender-specific intestinal microbial patterns remains unknown. In this decade, endocrine disrupting chemicals in surface and ground water of many areas and increasing observation of freshwater male fish displaying female sexual characteristics have been reported. Here we identified the difference in intestinal microbiota between male and female zebrafish, and revealed the influence of endocrine disrupting chemicals on zebrafish intestinal microbiota by using high-throughput sequencing. The results indicated that Fusobacteria, Bacteroidetes and Proteobacteria were dominant in the gut of zebrafish and there were no obvious gender-specific intestinal microbial patterns. Two endocrine disrupting chemicals, Estradiol (E2) and Bisphenol A (BPA), were selected to treat male zebrafish for 5 weeks. E2 and BPA increased vitellogenin expression in the liver of male zebrafish and altered the intestinal microbial composition with the abundance of the phylum CKC4 increased significantly. Our results suggested that because of the developmental character and living environment, gender did not influence the assembly of intestinal microbiota in zebrafish as it does in mammals, but exposure extra to endocrine disrupting chemicals disturbed the intestinal microbial composition, which may be related to changes in host physiological metabolism.	[Liu, Yukun; Yao, Yayun; Qiao, Fang; Wu, Junlin; Du, Zhen-yu; Zhang, Meiling] East China Normal Univ, Sch Life Sci, Lab Aquaculture Nutr & Environm Hlth, Shanghai 200241, Peoples R China; [Li, Huan] Next Biosci Co Ltd, Wuhan 430073, Peoples R China	East China Normal University	Du, ZY; Zhang, M (corresponding author), East China Normal Univ, Sch Life Sci, Lab Aquaculture Nutr & Environm Hlth, Shanghai 200241, Peoples R China.	zydu@bio.ecnu.edu.cn; mlzhang@bio.ecnu.edu.cn	Zhang, Meiling/AEQ-4299-2022	Du, Zhen-Yu/0000-0001-6581-5313				ADLERCREUTZ H, 1984, J STEROID BIOCHEM, V20, P217, DOI 10.1016/0022-4731(84)90208-5; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Apprill A, 2011, ENV MICROBIOL REP, V3, P223, DOI 10.1111/j.1758-2229.2010.00213.x; Arentsen Tim, 2015, Microbial Ecology in Health and Disease, V26, P29719, DOI 10.3402/mehd.v26.29719; Bhandari RK, 2015, GEN COMP ENDOCR, V214, P195, DOI 10.1016/j.ygcen.2014.09.014; Bjerregaard LB, 2008, ECOTOXICOLOGY, V17, P252, DOI 10.1007/s10646-008-0192-2; Boursi B, 2015, EUR J CANCER, V51, P2655, DOI 10.1016/j.ejca.2015.08.015; Cani PD, 2016, NAT REV ENDOCRINOL, V12, P133, DOI 10.1038/nrendo.2015.211; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cong XM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152751; Dkhil MA, 2015, PARASITOL RES; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Engen PA, 2015, ALCOHOL RES-CURR REV, V37, P223; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Flak MB, 2013, SCIENCE, V339, P1044, DOI 10.1126/science.1236226; Gilbert N, 2012, NATURE, V491, P503, DOI 10.1038/491503a; Gomez A, 2015, CLIN IMMUNOL, V159, P154, DOI 10.1016/j.clim.2015.04.016; Gunimaladevi I, 2006, FISH SHELLFISH IMMUN, V21, P393, DOI 10.1016/j.fsi.2006.01.004; Haro C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154090; Hevia A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01285; Inagaki T, 2016, NEUROTOXICOLOGY, V52, P188, DOI 10.1016/j.neuro.2015.12.003; Leifheit-Limson EC, 2015, J AM COLL CARDIOL, V66, P1949, DOI 10.1016/j.jacc.2015.08.859; Luzio A, 2015, AQUAT TOXICOL, V166, P83, DOI 10.1016/j.aquatox.2015.07.015; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Miller PG, 2015, J IMMUNOL, V195, P4668, DOI 10.4049/jimmunol.1501664; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Saili KS, 2012, TOXICOLOGY, V291, P83, DOI 10.1016/j.tox.2011.11.001; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shastri P, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0031-0; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singh P, 2016, ANN EPIDEMIOL, V26, P380, DOI 10.1016/j.annepidem.2016.03.007; Staples CA, 1998, CHEMOSPHERE, V36, P2149, DOI 10.1016/S0045-6535(97)10133-3; Stephens WZ, 2016, ISME J, V10, P644, DOI 10.1038/ismej.2015.140; Sun DL, 2013, APPL ENVIRON MICROB, V79, P5962, DOI 10.1128/AEM.01282-13; Trinder P., 1969, ANN CLIN BIOCHEM, V6, p24?27, DOI DOI 10.1177/000456326900600108; Valencia A, 2017, GEN COMP ENDOCR, V245, P10, DOI 10.1016/j.ygcen.2016.06.017; Whary MT, 2014, MICROBES INFECT, V16, P345, DOI 10.1016/j.micinf.2014.01.005; Witorsch RJ, 2002, REGUL TOXICOL PHARM, V36, P118, DOI 10.1006/rtph.2002.1564; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Ye L, 2014, ISME J, V8, P541, DOI 10.1038/ismej.2013.181; Zheng WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053562	44	43	45	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163895	10.1371/journal.pone.0163895	http://dx.doi.org/10.1371/journal.pone.0163895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701432	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900028
J	Pujari-Palmer, M; Pujari-Palmer, S; Lu, X; Lind, T; Melhus, H; Engstrand, T; Karlsson-Ott, M; Engqvist, H				Pujari-Palmer, Michael; Pujari-Palmer, Shiuli; Lu, Xi; Lind, Thomas; Melhus, Hakan; Engstrand, Thomas; Karlsson-Ott, Marjam; Engqvist, Hakan			Pyrophosphate Stimulates Differentiation, Matrix Gene Expression and Alkaline Phosphatase Activity in Osteoblasts	PLOS ONE			English	Article							CALCIUM-PHOSPHATE; DIHYDRATE CRYSTALS; INORGANIC PYROPHOSPHATE; VASCULAR CALCIFICATION; ASCORBIC-ACID; IN-VITRO; CELLS; BONE; MINERALIZATION; FIBROBLASTS	Pyrophosphate is a potent mitogen, capable of stimulating proliferation in multiple cell types, and a critical participant in bone mineralization. Pyrophosphate can also affect the resorption rate and bioactivity of orthopedic ceramics. The present study investigated whether calcium pyrophosphate affected proliferation, differentiation and gene expression in early (MC3T3 pre-osteoblast) and late stage (SAOS-2 osteosarcoma) osteoblasts. Pyrophosphate stimulated peak alkaline phosphatase activity by 50% and 150% at 100 mu M and 0.1 mu M in MC3T3, and by 40% in SAOS-2. The expression of differentiation markers collagen 1 (COL1), alkaline phosphatase (ALP), osteopontin (OPN), and osteocalcin (OCN) were increased by an average of 1.5, 2, 2 and 3 fold, by high concentrations of sodium pyrophosphate (100 mu M) after 7 days of exposure in MC3T3. COX-2 and ANK expression did not differ significantly from controls in either treatment group. Though both high and low concentrations of pyrophosphate stimulate ALP activity, only high concentrations (100 mu M) stimulated osteogenic gene expression. Pyrophosphate did not affect proliferation in either cell type. The results of this study confirm that chronic exposure to pyrophosphate exerts a physiological effect upon osteoblast differentiation and ALP activity, specifically by stimulating osteoblast differentiation markers and extracellular matrix gene expression.	[Pujari-Palmer, Michael; Pujari-Palmer, Shiuli; Lu, Xi; Karlsson-Ott, Marjam; Engqvist, Hakan] Uppsala Univ, Div Appl Mat Sci, Dept Engn Sci, Uppsala, Sweden; [Lind, Thomas; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Engstrand, Thomas] Karolinska Univ Hosp, Stockholm Craniofacial Ctr, Dept Reconstruct Plast Surg, Stockholm, Sweden; [Engstrand, Thomas] Uppsala Univ, Polymer sect, Dept Chem Mat, Uppsala, Sweden	Uppsala University; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Uppsala University	Karlsson-Ott, M (corresponding author), Uppsala Univ, Div Appl Mat Sci, Dept Engn Sci, Uppsala, Sweden.	marjam.ott@angstrorm.uu.se	Pujari-Palmer, michael/W-4362-2018	Pujari-Palmer, michael/0000-0001-7004-2853; Lind, Thomas/0000-0003-2791-688X				Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; ANDERSON HC, 1973, DEV BIOL, V34, P211, DOI 10.1016/0012-1606(73)90351-5; Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1; BENNETT RM, 1975, J CLIN INVEST, V56, P1571, DOI 10.1172/JCI108239; Berzina-Cimdina L, 2012, INFRARED SPECTROSCOPY - MATERIALS SCIENCE, ENGINEERING AND TECHNOLOGY, P123; Bouchard L, 2002, J IMMUNOL, V168, P5310, DOI 10.4049/jimmunol.168.10.5310; Carr G, 2009, CELL PHYSIOL BIOCHEM, V24, P595, DOI 10.1159/000257515; Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043; CHEUNG HS, 1984, ARTHRITIS RHEUM-US, V27, P668, DOI 10.1002/art.1780270610; Engstrand T, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000467; Engstrand T, 2014, J NEUROSURG, V120, P273, DOI 10.3171/2013.6.JNS1360; EVANS RW, 1984, CALCIFIED TISSUE INT, V36, P645, DOI 10.1007/BF02405384; FLEISCH H, 1962, NATURE, V195, P911, DOI 10.1038/195911a0; Gbureck U, 2008, J MATER SCI-MATER M, V19, P1559, DOI 10.1007/s10856-008-3373-x; Golub EE., 2007, CURR OPIN ORTHOP, V18, P444, DOI [10.1097/BCO.0b013e3282630851, 10.1084/jem.93.5.415, DOI 10.1084/JEM.93.5.415]; Gras P, 2013, EUR J INORG CHEM, P5886, DOI 10.1002/ejic.201300955; Grover LM, 2013, BIOMATERIALS, V34, P6631, DOI 10.1016/j.biomaterials.2013.05.001; HARADA S, 1991, J BONE MINER RES, V6, P903; Higuchi C, 2009, J BONE MINER METAB, V27, P158, DOI 10.1007/s00774-009-0037-y; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Kapustin AN, 2011, ARTERIOSCL THROM VAS, V31, P2169, DOI 10.1161/ATVBAHA.111.233601; Kim HJ, 2010, J BONE MINER RES, V25, P1771, DOI 10.1002/jbmr.60; Kim MK, 2004, J ORG CHEM, V69, P8186, DOI 10.1021/jo049101w; Leeuwen MV K., 2012, RSC ADV, V2, P2534, DOI [10.1039/c2ra00449f, DOI 10.1039/C2RA00449F]; Li JQ, 2016, J BONE MINER METAB, V34, P367, DOI 10.1007/s00774-015-0734-7; LIN FH, 1995, BIOMATERIALS, V16, P793, DOI 10.1016/0142-9612(95)99642-Y; Lomashvili KA, 2004, J AM SOC NEPHROL, V15, P1392, DOI 10.1097/01.ASN.0000128955.83129.9C; Lomashvili KA, 2014, KIDNEY INT, V85, P1351, DOI 10.1038/ki.2013.521; Molloy ES, 2008, RHEUMATOLOGY, V47, P965, DOI 10.1093/rheumatology/ken144; Okada S, 2013, TOHOKU J EXP MED, V231, P145, DOI 10.1620/tjem.231.145; Pi M, 2005, J BIOL CHEM, V280, P40201, DOI 10.1074/jbc.M505186200; Polewski MD, 2010, BONE, V46, P81, DOI 10.1016/j.bone.2009.08.055; Reuben PM, 2004, J BIOL CHEM, V279, P35719, DOI 10.1074/jbc.M403406200; RUBIN AH, 1979, J CELL PHYSIOL, V98, P81, DOI 10.1002/jcp.1040980110; RUBIN H, 1977, P NATL ACAD SCI USA, V74, P5026, DOI 10.1073/pnas.74.11.5026; Safronova TV, 2013, PROCESS APPL CERAM, V7, P9, DOI 10.2298/PAC1301009S; SAUER GR, 1988, J BIOL CHEM, V263, P13718; Shinozaki T, 1996, J RHEUMATOL, V23, P677; Sun JS, 2004, BIOMATERIALS, V25, P607, DOI 10.1016/S0142-9612(03)00567-2; Sun YB, 2003, BIOCHEM BIOPH RES CO, V312, P1053, DOI 10.1016/j.bbrc.2003.11.048; Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5; Thouverey C, 2009, OSTEOARTHR CARTILAGE, V17, P64, DOI 10.1016/j.joca.2008.05.020; Whited BM, 2006, J BIOMED MATER RES A, V76A, P596, DOI 10.1002/jbm.a.30573; Whited BM, 2011, BIOMATERIALS, V32, P2294, DOI 10.1016/j.biomaterials.2010.12.003; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; XU Y, 1991, J RHEUMATOL, V18, P1606; Zhou XY, 2012, INT J BIOL SCI, V8, P778, DOI 10.7150/ijbs.4538; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	50	35	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163530	10.1371/journal.pone.0163530	http://dx.doi.org/10.1371/journal.pone.0163530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701417	Green Submitted, Green Published, gold			2022-12-27	WOS:000385696900011
J	Tellez, GF; Willemse, BWM; Brouwer, U; Nijboer-Brinksma, S; Vandepoele, K; Noordhoek, JA; Heijink, I; de Vries, M; Smithers, NP; Postma, DS; Timens, W; Wiffen, L; van Roy, F; Holloway, JW; Leckie, PM; Nawijn, MC; Koppelman, GH				Tellez, Grissel Faura; Willemse, Brigitte W. M.; Brouwer, Uilke; Nijboer-Brinksma, Susan; Vandepoele, Karl; Noordhoek, Jacobien A.; Heijink, Irene; de Vries, Maaike; Smithers, Natalie P.; Postma, Dirkje S.; Timens, Wim; Wiffen, Laura; van Roy, Frans; Holloway, John W.; Leckie, Peter M.; Nawijn, Martijn C.; Koppelman, Gerard H.			Protocadherin-1 Localization and Cell-Adhesion Function in Airway Epithelial Cells in Asthma	PLOS ONE			English	Article							BARRIER FUNCTION; ECZEMA; CADHERIN; FAMILY; GENE; DIFFERENTIATION; POLYMORPHISMS; POPULATION; EXPRESSION; CHILDHOOD	Background The asthma gene PCDH1 encodes Protocadherin-1, a putative adhesion molecule of unknown function expressed in the airway epithelium. Here, we characterize the localization, differential expression, homotypic adhesion specificity and function of PCDH1 in airway epithelial cells in asthma. Methods We performed confocal fluorescence microscopy to determine subcellular localization of PCDH1 in 16HBE cells and primary bronchial epithelial cells (PBECs) grown at air-liquid interface. Next, to compare PCDH1 expression and localization in asthma and controls we performed qRT-PCR and fluorescence microscopy in PBECs and immunohistochemistry on airway wall biopsies. We examined homotypic adhesion specificity of HEK293T clones overexpressing fluorescently tagged-PCDH1 isoforms. Finally, to evaluate the role for PCDH1 in epithelial barrier formation and repair, we performed siRNA knockdown-studies and measured epithelial resistance. Results PCDH1 localized to the cell membrane at cell-cell contact sites, baso-lateral to adherens junctions, with increasing expression during epithelial differentiation. No differences in gene expression or localization of PCDH1 isoforms expressing the extracellular domain were observed in either PBECs or airway wall biopsies between asthma patients and controls. Overexpression of PCDH1 mediated homotypic interaction, whereas downregulation of PCDH1 reduced epithelial barrier formation, and impaired repair after wounding. Conclusions In conclusion, PCDH1 is localized to the cell membrane of bronchial epithelial cells basolateral to the adherens junction. Expression of PCDH1 is not reduced nor delocalized in asthma even though PCDH1 contributes to homotypic adhesion, epithelial barrier formation and repair.	[Tellez, Grissel Faura; Willemse, Brigitte W. M.; Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp, Groningen, Netherlands; [Tellez, Grissel Faura; Brouwer, Uilke; Nijboer-Brinksma, Susan; Noordhoek, Jacobien A.; Heijink, Irene; de Vries, Maaike; Nawijn, Martijn C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Expt Pulmonol & Inflammat Res, Groningen, Netherlands; [Tellez, Grissel Faura; Willemse, Brigitte W. M.; Brouwer, Uilke; Nijboer-Brinksma, Susan; Noordhoek, Jacobien A.; Heijink, Irene; de Vries, Maaike; Postma, Dirkje S.; Timens, Wim; Nawijn, Martijn C.; Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Vandepoele, Karl; van Roy, Frans] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Vandepoele, Karl; van Roy, Frans] VIB, Inflammat Res Ctr, Ghent, Belgium; [Vandepoele, Karl] Ghent Univ Hosp, Lab Mol Diagnost Hematol, Ghent, Belgium; [Tellez, Grissel Faura; Wiffen, Laura; Holloway, John W.; Leckie, Peter M.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton, Hants, England; [Wiffen, Laura; Holloway, John W.] Univ Southampton, Fac Med, Human Genet & Genom Med, Human Dev & Hlth, Southampton, Hants, England; [de Vries, Maaike; Smithers, Natalie P.] Univ Southampton, Fac Med, Southampton Univ Hosp, Brooke Lab,Acad Unit Clin & Expt Sci, Southampton, Hants, England; [Noordhoek, Jacobien A.; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Timens, Wim] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University Hospital; University of Southampton; University of Southampton; University of Southampton; University of Groningen; University of Groningen	Koppelman, GH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp, Groningen, Netherlands.; Koppelman, GH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands.	g.h.koppelman@umcg.nl	van Roy, Frans M/C-6123-2009; Koppelman, Gerard/AAG-9187-2020; Timens, Wim/K-5570-2013; Vandepoele, Karl/C-1197-2009; Holloway, John W/B-5424-2009	van Roy, Frans M/0000-0003-4358-1039; Timens, Wim/0000-0002-4146-6363; Vandepoele, Karl/0000-0002-0025-5594; Holloway, John W/0000-0001-9998-0464; Wiffen, Laura/0000-0003-3688-7662; Koppelman, Gerard/0000-0001-8567-3252; Nawijn, Martijn/0000-0003-3372-6521; Holloway, Courtney Jean/0000-0003-3661-1957; de Vries, Maaike/0000-0001-7210-8174	Asthma UK [11/010] Funding Source: researchfish	Asthma UK		Bochkov YA, 2015, P NATL ACAD SCI USA, V112, P5485, DOI 10.1073/pnas.1421178112; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; BRITTEN KM, 1993, BIOTECH HISTOCHEM, V68, P271, DOI 10.3109/10520299309105629; Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179, DOI 10.1165/ajrcmb.27.2.4699; COZENS AL, 1992, IN VITRO CELL DEV-AN, V28A, P735; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Heijink IH, 2014, CLIN EXP ALLERGY, V44, P620, DOI 10.1111/cea.12296; Heijink IH, 2010, EUR RESPIR J, V35, P894, DOI 10.1183/09031936.00065809; Heijink IH, 2007, J IMMUNOL, V178, P7678, DOI 10.4049/jimmunol.178.12.7678; HURD SZ, 1991, J ALLERGY CLIN IMMUN, V88, P808; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Knight DA, 2011, J ALLERGY CLIN IMMUN, V128, P557, DOI 10.1016/j.jaci.2011.07.031; Koning H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098197; Koning H, 2012, PEDIAT ALLERG IMM-UK, V23, P270, DOI 10.1111/j.1399-3038.2011.01201.x; Koning H, 2012, FASEB J, V26, P439, DOI 10.1096/fj.11-185207; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Kozu Y, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0078-z; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Mortensen LJ, 2014, EUR RESPIR J, V43, P792, DOI 10.1183/09031936.00021613; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Roth HM, 2012, PULM PHARMACOL THER, V25, P420, DOI 10.1016/j.pupt.2012.09.004; Saburi S, 2012, DEVELOPMENT, V139, P1806, DOI 10.1242/dev.077461; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Tellez GF, 2015, AM J PHYSIOL-LUNG C, V309, pL725, DOI 10.1152/ajplung.00346.2014; Tellez GF, 2014, EUR RESPIR J, V43, P671, DOI 10.1183/09031936.00179713; Toncheva AA, 2012, PEDIAT ALLERG IMM-UK, V23, P636, DOI 10.1111/j.1399-3038.2012.01334.x; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	31	13	14	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163967	10.1371/journal.pone.0163967	http://dx.doi.org/10.1371/journal.pone.0163967			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701444	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000385696900038
J	Thompson, RB; Pagano, JJ; Mathewson, KW; Paterson, I; Dyck, JR; Kitzman, DW; Haykowsky, MJ				Thompson, Richard B.; Pagano, Joseph J.; Mathewson, Kory W.; Paterson, Ian; Dyck, Jason R.; Kitzman, Dalane W.; Haykowsky, Mark J.			Differential Responses of Post-Exercise Recovery of Leg Blood Flow and Oxygen Uptake Kinetics in HFpEF versus HFrEF	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; MAGNETIC-RESONANCE; SUBMAXIMAL EXERCISE; MAXIMAL EXERCISE; CARDIAC-OUTPUT; OFF-TRANSIENT; ON-TRANSIENT; CAPACITY; REPRODUCIBILITY; SPECTROSCOPY	The goals of the current study were to compare leg blood flow, oxygen extraction and oxygen uptake (VO2) after constant load sub-maximal unilateral knee extension (ULKE) exercise in patients with heart failure with reduced ejection fraction (HFrEF) compared to those with preserved ejection fraction (HFpEF). Previously, it has been shown that prolonged whole body VO2 recovery kinetics are directly related to disease severity and all-cause mortality in HFrEF patients. To date, no study has simultaneously measured muscle-specific blood flow and oxygen extraction post exercise recovery kinetics in HFrEF or HFpEF patients; therefore it is unknown if muscle VO2 recovery kinetics, and more specifically, the recovery kinetics of blood flow and oxygen extraction at the level of the muscle, differ between HF phenotypes. Ten older (68 +/- 10yrs) HFrEF (n = 5) and HFpEF (n = 5) patients performed sub-maximal (85% of maximal weight lifted during an incremental test) ULKE exercise for 4 minutes. Femoral venous blood flow and venous O-2 saturation were measured continuously from the onset of end-exercise, using a novel MRI method, to determine off-kinetics (mean response times, MRT) for leg VO2 and its determinants. HFpEF and HFrEF patients had similar end-exercise leg blood flow (1.1 +/- 0.6 vs. 1.2 +/- 0.6 L/min, p>0.05), venous saturation (42 +/- 12 vs. 41 +/- 11%, p>0.05) and VO2 (0.13 +/- 0.08 vs. 0.11 +/- 0.05 L/min, p>0.05); however HFrEF had significantly delayed recovery MRT for flow (292 +/- 135sec. vs 105 +/- 63sec., p = 0.004) and VO2 (95 +/- 37sec. vs. 47 +/- 15sec., p = 0.005) compared to HFpEF. Impaired muscle VO2 recovery kinetics following ULKE exercise differentiated HFrEF from HFpEF patients and suggests distinct underlying pathology and potential therapeutic approaches in these populations.	[Thompson, Richard B.; Pagano, Joseph J.; Mathewson, Kory W.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Paterson, Ian] Univ Alberta, Mazankowski Alberta Heart Inst, Div Cardiol, Edmonton, AB, Canada; [Dyck, Jason R.] Univ Alberta, Dept Pediat & Pharmacol, Edmonton, AB, Canada; [Kitzman, Dalane W.] Wake Forest Sch Med, Cardiol & Geriatr, Winston Salem, NC USA; [Haykowsky, Mark J.] Univ Texas Arlington, Coll Nursing & Hlth Innovat, Arlington, TX 76019 USA	University of Alberta; University of Alberta; University of Alberta; Wake Forest University; University of Texas System; University of Texas Arlington	Thompson, RB (corresponding author), Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.	richard.thompson@ualberta.ca		Paterson, David Ian/0000-0003-4529-3102; Dyck, Jason/0000-0002-7045-2884; Thompson, Richard/0000-0003-3319-4377; Haykowsky, Mark/0000-0002-7217-2747	NATIONAL INSTITUTE ON AGING [R37AG018915] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG018915] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Belardinelli R, 1997, AM J CARDIOL, V80, P1319, DOI 10.1016/S0002-9149(97)00672-3; Bhella PS, 2011, EUR J HEART FAIL, V13, P1296, DOI 10.1093/eurjhf/hfr133; COHENSOLAL A, 1995, CIRCULATION, V91, P2924, DOI 10.1161/01.CIR.91.12.2924; deGroote P, 1996, J AM COLL CARDIOL, V28, P168, DOI 10.1016/0735-1097(96)00126-X; Esposito F, 2010, J AM COLL CARDIOL, V55, P1945, DOI 10.1016/j.jacc.2009.11.086; Ezekowitz JA, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-91; Fernandez-Seara MA, 2006, MAGN RESON MED, V55, P967, DOI 10.1002/mrm.20892; Fortin M, 2015, CAN J CARDIOL, V31, P1259, DOI 10.1016/j.cjca.2015.02.015; Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3; Hanada A, 2000, HEART, V83, P161, DOI 10.1136/heart.83.2.161; Haykowsky MJ, 2015, J APPL PHYSIOL, V119, P739, DOI 10.1152/japplphysiol.00049.2015; Haykowsky MJ, 2013, AM J CARDIOL, V111, P1466, DOI 10.1016/j.amjcard.2013.01.303; Kemps HM, 2010, INT J CARDIOL, V142, P138, DOI 10.1016/j.ijcard.2008.12.088; Kemps HMC, 2007, EUR J APPL PHYSIOL, V100, P45, DOI 10.1007/s00421-007-0398-7; Kemps HMC, 2010, CLIN SCI, V118, P203, DOI 10.1042/CS20090220; Kilding AE, 2005, EUR J APPL PHYSIOL, V93, P588, DOI 10.1007/s00421-004-1232-0; Mathewson KW, 2015, MAGN RESON MED, V74, P1640, DOI 10.1002/mrm.25564; Nanas S, 2001, EUR J HEART FAIL, V3, P685, DOI 10.1016/S1388-9842(01)00187-8; Ozyener F, 2001, J PHYSIOL-LONDON, V533, P891, DOI 10.1111/j.1469-7793.2001.t01-1-00891.x; Pavia L, 1999, CHEST, V116, P808, DOI 10.1378/chest.116.3.808; Poole DC, 2012, COMPR PHYSIOL, V2, P933, DOI 10.1002/cphy.c100072; Puntawangkoon C, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-48; Scrutinio D, 1998, INT J CARDIOL, V64, P117, DOI 10.1016/S0167-5273(98)00019-9; Tanabe Y, 2000, J AM COLL CARDIOL, V35, P1228, DOI 10.1016/S0735-1097(00)00517-9; TAYLOR DJ, 1984, GERONTOLOGY, V30, P2, DOI 10.1159/000212599; Thompson RB, 2003, MAGNET RESON MED, V50, P1248, DOI 10.1002/mrm.10637; Tomczak CR, 2011, J APPL PHYSIOL, V110, P398, DOI 10.1152/japplphysiol.01114.2010; van Beest PA, 2012, CRIT CARE MED, V40, P3196, DOI 10.1097/CCM.0b013e3182657591; YOSHIDA T, 1993, EUR J APPL PHYSIOL O, V66, P494, DOI 10.1007/BF00634298	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163513	10.1371/journal.pone.0163513	http://dx.doi.org/10.1371/journal.pone.0163513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701422	Green Published, Green Submitted, gold			2022-12-27	WOS:000385696900010
J	Wen, GY; Lui, XC; Huang, LH; Shu, JX; Xu, NN; Chen, RF; Huang, ZJ; Yang, GP; Wang, XM; Xiang, YX; Lu, Y; Yuan, H				Wen, Gaiyan; Lui, Xinchun; Huang, Lihua; Shu, Jingxian; Xu, Nana; Chen, Ruifang; Huang, Zhijun; Yang, Guoping; Wang, Xiaomin; Xiang, Yuxia; Lu, Yao; Yuan, Hong			Readability and Content Assessment of Informed Consent Forms for Phase II-IV Clinical Trials in China	PLOS ONE			English	Article							PARTICIPANTS; COMPREHENSION; PERCEPTIONS; INFORMATION; PHYSICIANS; DOCUMENTS; QUALITY; RECALL	Purpose To explore the readability and content integrity of informed consent forms (ICFs) used in China and to compare the quality of Chinese local ICFs with that of international ICFs. Methods The length, readability and content of 155 consent documents from phase II-IV drug clinical trials from the Third Xiangya Hospital Ethics Committee from November 2009 to January 2015 were evaluated. Reading difficulty was tested using a readability formula adapted for the Chinese language. An ICF checklist containing 27 required elements was successfully constructed to evaluate content integrity. The description of alternatives to participation was assessed. The quality of ICFs from different sponsorships were also compared. Results Among the 155 evaluable trials, the ICFs had a median length of 5286 words, corresponding to 7 pages. The median readability score was 4.31 (4.02-4.41), with 63.9% at the 2nd level and 36.1% at the 3rd level. Five of the 27 elements were frequently neglected. The average score for the description of alternatives to participation was 1.06, and 27.7% of the ICFs did not mention any alternatives. Compared with Chinese local ICFs, international ICFs were longer, more readable and contained more of the required elements (P < 0.05). Conclusion The ICFs used in China were difficult to read for most participants. These forms had poor description of alternatives to participation, and failed to provide a high degree of information disclosure, including an explanation of informed consent, follow-up processing of the data/sample, inclusion/exclusion criteria, double blinding, and unpredictable risks. International ICFs had better readability and content integrity than Chinese local ICFs. More efforts should thus be made to improve the quality of consent documents in China.	[Wen, Gaiyan; Shu, Jingxian; Xu, Nana; Huang, Zhijun; Yang, Guoping; Wang, Xiaomin; Lu, Yao; Yuan, Hong] Cent S Univ, Xiangya Hosp 3, Eth Comm, Changsha, Hunan, Peoples R China; [Wen, Gaiyan; Lui, Xinchun; Shu, Jingxian; Xu, Nana; Chen, Ruifang; Huang, Zhijun; Xiang, Yuxia; Lu, Yao; Yuan, Hong] Cent S Univ, Xiangya Hosp 3, Clin Pharmacol Ctr, Changsha, Hunan, Peoples R China; [Huang, Lihua] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Lu, Y; Yuan, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Eth Comm, Changsha, Hunan, Peoples R China.; Lu, Y; Yuan, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Clin Pharmacol Ctr, Changsha, Hunan, Peoples R China.	luyao0719@163.com; yuanhongxy3@163.com			Fundamental Research Funds for the Central Universities of Central South University [2015zzts320, 2016zzts153]; National Natural Science Foundation of China [81470535]	Fundamental Research Funds for the Central Universities of Central South University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Hong Yuan received the National Natural Science Foundation of China (81470535), Gaiyan Wen received the Fundamental Research Funds for the Central Universities of Central South University (2015zzts320), and Yao Lu received the Fundamental Research Funds for the Central Universities of Central South University (2016zzts153); Hong Yuan and Yao Lu were employed in the study design, Gaiyan Wen were employed in the manuscript preparation.	Benatar JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047023; Brockett RG, 1983, LIFELONG LEARN, V7, P16; Cahana Alex, 2008, Pain Pract, V8, P446, DOI 10.1111/j.1533-2500.2008.00241.x; Chakma J, 2014, NEW ENGL J MED, V370, P3, DOI 10.1056/NEJMp1311068; Cheung WY, 2010, AM J CLIN ONCOL-CANC, V33, P387, DOI 10.1097/COC.0b013e3181b20641; DAUGHERTY C, 1995, J CLIN ONCOL, V13, P1062, DOI 10.1200/JCO.1995.13.5.1062; Calle-Urra JE, 2015, REV ESP SALUD PUBLIC, V89, P307, DOI 10.4321/S1135-57272015000300008; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Foe G, 2016, J EMPIR RES HUM RES, V11, P31, DOI 10.1177/1556264616637483; Friedman Daniela B, 2008, Prev Chronic Dis, V5, pA07; Fry E, 2002, READ TEACH, V56, P286; Gillies K, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-62; Griffin JM, 2006, CONTEMP CLIN TRIALS, V27, P441, DOI 10.1016/j.cct.2006.04.006; GROSSMAN SA, 1994, J CLIN ONCOL, V12, P2211, DOI 10.1200/JCO.1994.12.10.2211; Gunning Robert, 1968, TECHNIQUE CLEAR WRIT; Harmer A, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-15; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Houts PS, 2001, PATIENT EDUC COUNS, V43, P231, DOI 10.1016/S0738-3991(00)00171-3; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Koonrungsesomboon N, 2016, EUR J CLIN PHARMACOL, V72, P413, DOI 10.1007/s00228-015-2000-2; Li Y., 2015, CHIN J HLTH ED, V31, P99, DOI [DOI 10.16168/J.CNKI.ISSN.1002-9982.2015.02.001, 10.16168/j.cnki.issn.1002-9982.2015.02.001]; Liao JQ, 1996, CHIN J ERGON, V1, P38; Menoni V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018484; Meropol NJ, 2003, J CLIN ONCOL, V21, P2589, DOI 10.1200/JCO.2003.10.072; Tam NT, 2015, B WORLD HEALTH ORGAN, V93, P186, DOI 10.2471/BLT.14.141390; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; Pandiya Anvita, 2010, Perspect Clin Res, V1, P98; Resnik DB, 2010, CONTEMP CLIN TRIALS, V31, P18, DOI 10.1016/j.cct.2009.11.001; Ramos JR, 2015, CUAD BIOET, V26, P129; Sharp SM, 2004, AM J CLIN ONCOL-CANC, V27, P570, DOI 10.1097/01.coc.0000135925.83221.b3; Sharp SM, 2001, APPL CLIN RES, V10, P74; Stryker JE, 2006, PATIENT EDUC COUNS, V63, P104, DOI 10.1016/j.pec.2005.09.006; Vucemilo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138017; Yang XJ, 1974, MASS COMMUN RES, V13, P55	35	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164251	10.1371/journal.pone.0164251	http://dx.doi.org/10.1371/journal.pone.0164251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701471	gold, Green Published, Green Submitted			2022-12-27	WOS:000385696900053
J	Yhnell, E; Dunnett, SB; Brooks, SP				Yhnell, Emma; Dunnett, Stephen B.; Brooks, Simon P.			A Longitudinal Operant Assessment of Cognitive and Behavioural Changes in the Hdh(Q111) Mouse Model of Huntington's Disease	PLOS ONE			English	Article							KNOCK-IN MOUSE; QUALITY-OF-LIFE; LEARNING-TASK SILT; REACTION-TIME-TASK; ATTENTIONAL DEFICITS; TRANSGENIC MICE; PREDICT-HD; PERFORMANCE; IMPLICIT; PHENOTYPE	Huntington's disease (HD) is characterised by motor symptoms which are often preceded by cognitive and behavioural changes, that can significantly contribute to disease burden for people living with HD. Numerous knock-in mouse models of HD are currently available for scientific research. However, before their use, they must be behaviourally characterised to determine their suitability in recapitulating the symptoms of the human condition. Thus, we sought to longitudinally characterise the nature, severity and time course of cognitive and behavioural changes observed in Hdh(Q111) heterozygous knock-in mice. To determine changes in cognition and behaviour an extensive battery of operant tests including: fixed ratio, progressive ratio, the five choice serial reaction time task and the serial implicit learning task, were applied longitudinally to Hdh(Q111) and wild type mice. The operant test battery was conducted at 6, 12 and 18 months of age. Significant deficits were observed in Hdh(Q111) animals in comparison to wild type animals in all operant tests indicating altered cognition (attentional and executive function) and motivation. However, the cognitive and behavioural deficits observed were not shown to be progressive over time in the longitudinal testing paradigm that was utilised. The results therefore demonstrate that the Hdh(Q111) mouse model of HD reflects some features of the cognitive and behavioural changes shown in the human condition of HD. Although, the cognitive and behavioural deficits demonstrated were not shown to be progressive over time.	[Yhnell, Emma] Cardiff Univ, Neurosci & Mental Hlth Res Inst, 3rd Floor,Hadyn Ellis Bldg,Maindy Rd, Cardiff CF24 4HQ, S Glam, Wales; [Yhnell, Emma; Dunnett, Stephen B.; Brooks, Simon P.] Cardiff Univ, Brain Repair Grp, Sch Biosci, Sir Martin Evans Bldg,Museum Ave, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Yhnell, E (corresponding author), Cardiff Univ, Neurosci & Mental Hlth Res Inst, 3rd Floor,Hadyn Ellis Bldg,Maindy Rd, Cardiff CF24 4HQ, S Glam, Wales.; Yhnell, E (corresponding author), Cardiff Univ, Brain Repair Grp, Sch Biosci, Sir Martin Evans Bldg,Museum Ave, Cardiff CF10 3AX, S Glam, Wales.	YhnellE@cardiff.ac.uk	Dunnett, Stephen B/A-5869-2010	Dunnett, Stephen B/0000-0003-1826-1578; Yhnell, Emma/0000-0003-3960-5181; Brooks, Simon/0000-0001-9853-6177	Medical Research Council [MR/K500859/1]; MRC [MC_PC_15043] Funding Source: UKRI; Medical Research Council [1221455] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to thank the Medical Research Council for funding this work via a PhD studentship (grant number MR/K500859/1) awarded to E.Y.	Aron AR, 2003, J COGNITIVE NEUROSCI, V15, P629, DOI 10.1162/jocn.2003.15.5.629; Balci F, 2009, BEHAV NEUROSCI, V123, P1353, DOI 10.1037/a0017650; BRADSHAW JL, 1992, J CLIN EXP NEUROPSYC, V14, P179, DOI 10.1080/01688639208402822; Brooks S, 2012, BRAIN RES BULL, V88, P182, DOI 10.1016/j.brainresbull.2010.05.004; Brooks S, 2012, BRAIN RES BULL, V88, P148, DOI 10.1016/j.brainresbull.2010.05.003; Brooks S, 2012, BRAIN RES BULL, V88, P113, DOI 10.1016/j.brainresbull.2010.05.005; Brooks SP, 2012, BRAIN RES BULL, V88, P130, DOI 10.1016/j.brainresbull.2011.06.008; Brooks SP, 2012, BRAIN RES BULL, V88, P121, DOI 10.1016/j.brainresbull.2011.05.010; Brooks SP, 2012, BRAIN RES BULL, V88, P94, DOI 10.1016/j.brainresbull.2011.01.010; Brooks SP, 2006, BRAIN RES BULL, V69, P452, DOI 10.1016/j.brainresbull.2006.02.011; Brown RG, 2001, BRAIN, V124, P2188, DOI 10.1093/brain/124.11.2188; BURNS A, 1990, J NERV MENT DIS, V178, P20, DOI 10.1097/00005053-199001000-00004; BYLSMA FW, 1991, NEUROPSYCHOLOGIA, V29, P1213, DOI 10.1016/0028-3932(91)90035-7; Claus JJ, 1996, ACTA NEUROL SCAND, V93, P346; COLE BJ, 1989, BEHAV BRAIN RES, V33, P165, DOI 10.1016/S0166-4328(89)80048-8; Delval A, 2008, MOVEMENT DISORD, V23, P684, DOI 10.1002/mds.21896; DIAMOND R, 1992, J CLIN EXP NEUROPSYC, V14, P961, DOI 10.1080/01688639208402547; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; Finke K, 2006, BRAIN, V129, P1137, DOI 10.1093/brain/awl040; Ghilardi MF, 2008, PARKINSONISM RELAT D, V14, P457, DOI 10.1016/j.parkreldis.2007.11.009; Giralt A, 2012, HUM MOL GENET, V21, P1203, DOI 10.1093/hmg/ddr552; HEFTER H, 1987, BRAIN, V110, P585, DOI 10.1093/brain/110.3.585; HEINDEL WC, 1988, BEHAV NEUROSCI, V102, P141, DOI 10.1037/0735-7044.102.1.141; Helder DI, 2001, MOVEMENT DISORD, V16, P325, DOI 10.1002/mds.1056; Ho AK, 2009, MOVEMENT DISORD, V24, P574, DOI 10.1002/mds.22412; Kirkwood SC, 2000, J NEUROL NEUROSUR PS, V69, P773, DOI 10.1136/jnnp.69.6.773; KNOPMAN D, 1991, NEUROPSYCHOLOGIA, V29, P245, DOI 10.1016/0028-3932(91)90085-M; Kremer H, 1996, UNIFIED HUNTINGTONS; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lelos MJ, 2012, EUR J NEUROSCI, V36, P3420, DOI 10.1111/j.1460-9568.2012.08256.x; Lione LA, 1999, J NEUROSCI, V19, P10428; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Murphy KPSJ, 2000, J NEUROSCI, V20, P5115; Oakeshott S, 2012, PLOS CURR, V4, DOI [10.1371/4f972cffe82c0, DOI 10.1371/4F972CFFE82C0]; Orvoen S, 2012, NEUROSCI LETT, V507, P127, DOI 10.1016/j.neulet.2011.11.063; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Paulsen JS, 2001, J NEUROL NEUROSUR PS, V71, P310, DOI 10.1136/jnnp.71.3.310; Ready RE, 2008, MOVEMENT DISORD, V23, P721, DOI 10.1002/mds.21920; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; SPRENGELMEYER R, 1995, BRAIN, V118, P145, DOI 10.1093/brain/118.1.145; Thompson JC, 2002, J NEUROPSYCH CLIN N, V14, P37, DOI 10.1176/appi.neuropsych.14.1.37; Thompson JC, 2010, NEUROPSYCHOLOGIA, V48, P171, DOI 10.1016/j.neuropsychologia.2009.09.002; Trueman RC, 2012, BRAIN RES BULL, V88, P163, DOI 10.1016/j.brainresbull.2011.10.019; Trueman RC, 2012, BRAIN RES BULL, V88, P156, DOI 10.1016/j.brainresbull.2011.03.012; Trueman RC, 2009, BEHAV BRAIN RES, V203, P215, DOI 10.1016/j.bbr.2009.05.006; Trueman RC, 2008, BEHAV BRAIN RES, V189, P317, DOI 10.1016/j.bbr.2008.01.020; Trueman RC, 2007, EUR J NEUROSCI, V25, P551, DOI 10.1111/j.1460-9568.2007.05307.x; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Wahlin TBR, 2007, NEUROPSYCHOLOGY, V21, P31, DOI 10.1037/0894-4105.21.1.31; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; WILLINGHAM DB, 1993, PSYCHOBIOLOGY, V21, P173; Yhnell E, 2016, J HUNTINGTONS DIS, V5, P149, DOI 10.3233/JHD-160191; Yhnell E, 2016, EXP NEUROL, V282, P19, DOI 10.1016/j.expneurol.2016.05.008; Yhnell E, 2016, J NEUROSCI METH, V265, P72, DOI 10.1016/j.jneumeth.2015.08.022	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164072	10.1371/journal.pone.0164072	http://dx.doi.org/10.1371/journal.pone.0164072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701442	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000385696900041
J	Stollar, F; Gervaix, A; Argiroffo, CB				Stollar, Fabiola; Gervaix, Alain; Argiroffo, Constance Barazzone			Safely Discharging Infants with Bronchiolitis from an Emergency Department: A Five Step Guide for Pediatricians	PLOS ONE			English	Article							LENGTH-OF-STAY; PROSPECTIVE-MULTICENTER; OXYGEN-SATURATION; EQUIVALENCE TRIAL; CLINICAL-PRACTICE; OBSERVATION UNIT; PULSE OXIMETRY; DOUBLE-BLIND; MANAGEMENT; CHILDREN	Recent publications have established the pulse oxygen saturation (SpO(2)) threshold of 90% for the hospitalization and discharge of infant patients with bronchiolitis. However, there is no clear recommendation regarding the Emergency Department (ED) observation period necessary before allowing safe home discharge for patients with SpO(2) above 90%-92%. Our primary aims were to evaluate the risk factors associated with delayed desaturation in infants with SpO(2) >= 92% on arrival at the ED as well as the ED observation period necessary before allowing safe home discharge. A secondary aim was to identify the risk factors for ED readmission. Of 581 episodes of bronchiolitis in patients < 1 year old admitted to the ED, only 47 (8%) had SpO(2) < 92% on arrival there, although 106 (18%) exhibited a delayed desaturation (to < 92%) during ED observation. Female sex, age < 3 months old, ED readmission, more severe initial clinical presentation, and higher pCO(2) level (> 6KPa) were risk factors for delayed desaturation with OR varying from 1.7 to 7.5. In patients < 3 months old, mean desaturation occured later than in older patients [6.0 hours (IQR 3.0-14.0) vs. 3.0 hours (IQR 2.0-6.0), P = 0.0018]. In 95% of patients with a delayed desaturation this decrease occurred within 25 hours for patients < 3 months old and within 11 hours for patients >= 3 months old. In patients < 3 months old with respiratory rates above the normal range for their age the desaturation occurred earlier than in patients < 3 months with normal respiratory rates [4.4 hours (IQR 3.0-11.7) vs. 14.6 hours (IQR 7.6-22.2), P = 0.037]. Based on the present study's results, we propose a five step guide for pediatricians on discharging children with bronchiolitis from the ED. By using the threshold of an 11 hour ED observation period for patients >= 3 months old and a 25 hour period for patients >= 3 months old we are able to detect 95% of the patients with bronchiolitis who are at risk of delayed desaturation.	[Stollar, Fabiola] Univ Hosp Geneva, Childrens Hosp, Div Gen Pediat, Geneva, Switzerland; [Gervaix, Alain] Univ Hosp Geneva, Childrens Hosp, Pediat Emergency Div, Geneva, Switzerland; [Argiroffo, Constance Barazzone] Univ Hosp Geneva, Childrens Hosp, Pediat Pulmonol Unit, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Stollar, F (corresponding author), Univ Hosp Geneva, Childrens Hosp, Div Gen Pediat, Geneva, Switzerland.	fabipediatria@hotmail.com			Platform for Clinical Research of the Children's Hospital; University Hospitals of Geneva, Switzerland	Platform for Clinical Research of the Children's Hospital; University Hospitals of Geneva, Switzerland	We would like to thank the Platform for Clinical Research of the Children's Hospital, University Hospitals of Geneva, Switzerland, for its support in the early stages of this study.	Alpern ER, 2008, PEDIATR EMERG CARE, V24, P589, DOI 10.1097/PEC.0b013e3181850c80; Bacharier LB, 2008, ALLERGY, V63, P5, DOI 10.1111/j.1398-9995.2007.01586.x; Barben J, 2008, THORAX, V63, P1103, DOI 10.1136/thx.2007.094706; Barben J, 2003, SWISS MED WKLY, V133, P9; Brown Lance, 2003, CJEM, V5, P239; Corneli HM, 2012, PEDIATR EMERG CARE, V28, P99, DOI 10.1097/PEC.0b013e3182440b9b; Cunningham S, 2015, LANCET, V386, P1041, DOI 10.1016/S0140-6736(15)00163-4; Cunningham S, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19710; Damore D, 2008, ACAD EMERG MED, V15, P887, DOI 10.1111/j.1553-2712.2008.00245.x; Fernandes RM, 2015, PEDIATRICS, V135, pE1399, DOI 10.1542/peds.2014-3557; Gadomski AM, 2015, J PEDIATR-US, V166, P778, DOI 10.1016/j.jpeds.2014.12.047; Hunt CE, 1999, J PEDIATR-US, V135, P580, DOI 10.1016/S0022-3476(99)70056-9; Jacob R, 2016, RESP MED, V113, P37, DOI 10.1016/j.rmed.2016.02.007; Lashkeri T, 2012, PEDIATR EMERG CARE, V28, P895, DOI 10.1097/PEC.0b013e318267c5b6; Mallory MD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e45; Mansbach JM, 2008, PEDIATRICS, V121, P680, DOI 10.1542/peds.2007-1418; Mansbach JM, 2015, J HOSP MED, V10, P205, DOI 10.1002/jhm.2318; Mansbach JM, 2009, PEDIATR EMERG CARE, V25, P636, DOI 10.1097/PEC.0b013e3181b920e1; McCallum GB, 2013, PEDIATR PULM, V48, P797, DOI 10.1002/ppul.22627; MULHOLLAND EK, 1990, LANCET, V335, P1259, DOI 10.1016/0140-6736(90)91314-Z; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nitu ME, 2009, PEDIATR REV, V30, P470, DOI 10.1542/pir.30-12-470; Norwood A, 2010, ACAD EMERG MED, V17, P376, DOI 10.1111/j.1553-2712.2010.00699.x; Principi T, 2016, JAMA PEDIAT, P1; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Reuter S, 2014, PEDIATR REV, V35, P417, DOI 10.1542/pir.35-10-417; Roback MG, 1997, PEDIATR EMERG CARE, V13, P9, DOI 10.1097/00006565-199702000-00003; Sandweiss DR, 2010, PEDIATR EMERG CARE, V26, P892, DOI 10.1097/PEC.0b013e3181fe911d; Schuh S, 2014, JAMA-J AM MED ASSOC, V312, P712, DOI 10.1001/jama.2014.8637; Sommer Constanze, 2011, Open Microbiol J, V5, P144, DOI 10.2174/1874285801105010144; Stollar F, 2014, EUR J PEDIATR, V173, P1429, DOI 10.1007/s00431-014-2334-2; Zavorsky GS, 2007, RESP PHYSIOL NEUROBI, V155, P268, DOI 10.1016/j.resp.2006.07.002	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163217	10.1371/journal.pone.0163217	http://dx.doi.org/10.1371/journal.pone.0163217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690359	gold, Green Published			2022-12-27	WOS:000384329200014
J	Brandstorp-Boesen, J; Falk, RS; Evensen, JF; Boysen, M; Brondbo, K				Brandstorp-Boesen, Jesper; Falk, Ragnhild Sorum; Evensen, Jan Folkvard; Boysen, Morten; Brondbo, Kjell			Risk of Recurrence in Laryngeal Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FOLLOW-UP; GLOTTIC CARCINOMA; LASER MICROSURGERY; PROGNOSTIC FACTORS; RADIATION-THERAPY; RADIOTHERAPY; STAGE; HEAD; NECK	A cohort study was undertaken to analyze the risk of recurrence among 1616 patients with primary squamous cell carcinoma of the larynx from 1983 to 2010 at a single, tertiary academic center in Oslo, Norway. The cohort was followed from the date of diagnosis to September 2011. Competing risk regression analysis assessed the association between various risk factors and the risk of recurrence, where death was considered a competing event. Recurrence was observed in 368 patients (23%) during the study period. The majority (71%) of recurrences involved the location of the primary tumor. The overall risk of recurrence during the first three years after initiating treatment was 20.5%. Increased risk of recurrence was observed in patients with supraglottic cancer, younger patients, those with T2-T3 tumors and in patients treated in the earlier part of the study period. Significant factors for recurrence in glottic carcinomas were age, treatment in the earlier part of the study and T-status, whereas age was a significant factor in supraglottic cancer. N-status appeared less significant. In conclusion, follow-up of laryngeal squamous cell carcinoma should place particular emphasis on the site of the primary tumor, younger patients, cases of supraglottic cancer and T2-T4 primary tumors, especially during the first three years after treatment. More studies are needed to assess the impact of surgical versus non-surgical treatment, and eventually the significance of recurrence, for disease-specific and overall survival in cases of advanced laryngeal squamous cell carcinoma.	[Brandstorp-Boesen, Jesper; Boysen, Morten; Brondbo, Kjell] Oslo Univ Hosp, Dept Otorhinolaryngol, Div Surg & Clin Neurosci, Oslo, Norway; [Falk, Ragnhild Sorum] Oslo Univ Hosp, Res Support Serv, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Evensen, Jan Folkvard] Radiumhosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Brandstorp-Boesen, Jesper; Brondbo, Kjell] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Brandstorp-Boesen, J (corresponding author), Oslo Univ Hosp, Dept Otorhinolaryngol, Div Surg & Clin Neurosci, Oslo, Norway.; Brandstorp-Boesen, J (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	jesper.brandstorp-boesen@medisin.uio.no	Falk, Ragnhild Sørum/H-5613-2019	Falk, Ragnhild Sørum/0000-0001-8398-3492				Al-Mamgani A, 2013, CLIN OTOLARYNGOL, V38, P306, DOI 10.1111/coa.12139; Ambrosch Petra, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P82, DOI 10.1097/MOO.0b013e3280147336; [Anonymous], 2015, DAHANCA RADIOTHERAPY; BAHADUR S, 1985, J LARYNGOL OTOL, V99, P763, DOI 10.1017/S0022215100097620; Barthel SW, 2001, OTOLARYNG HEAD NECK, V124, P35, DOI 10.1067/mhn.2001.112574; BOYSEN M, 1992, EUR J CANCER, V28A, P426, DOI 10.1016/S0959-8049(05)80068-1; Brandstorp-Boesen J, 2014, EUR ARCH OTO-RHINO-L, V271, P3233, DOI 10.1007/s00405-014-3100-9; Brenner B, 2001, HEAD NECK-J SCI SPEC, V23, P531, DOI 10.1002/hed.1074; Brouwer J, 2004, EUR ARCH OTO-RHINO-L, V261, P417, DOI 10.1007/s00405-003-0708-6; Brouwer J, 2008, HEAD NECK-J SCI SPEC, V30, P889, DOI 10.1002/hed.20790; Burke LS, 1997, INT J RADIAT ONCOL, V38, P1001, DOI 10.1016/S0360-3016(97)00150-8; Cancer Registry of Norway, 2015, CANC NORW 2014 CANC; Chen JJ, 2015, LARYNGOSCOPE, V125, P2093, DOI 10.1002/lary.25338; Corp I, 2013, REL 2013 IBM SPSS ST; de Bree R, 2015, RADIOTHER ONCOL; DEVISSCHER AVM, 1994, ARCH OTOLARYNGOL, V120, P934; Elegbede AI, 2015, JAMA OTOLARYNGOL, V141, P1111, DOI 10.1001/jamaoto.2015.0663; Ferlito A, 2000, ACTA OTO-LARYNGOL, V120, P456; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Ganly I, 2006, ARCH OTOLARYNGOL, V132, P59, DOI 10.1001/archotol.132.1.59; Ganly I, 2009, HEAD NECK-J SCI SPEC, V31, P1489, DOI 10.1002/hed.21113; Grant DG, 2008, OTOLARYNG HEAD NECK, V138, P606, DOI 10.1016/j.otohns.2007.12.046; Haapaniemi A, 2016, HEAD NECK-J SCI SPEC, V38, P36, DOI 10.1002/hed.23834; Haas I, 2001, EUR ARCH OTO-RHINO-L, V258, P177, DOI 10.1007/s004050100333; Hinerman RW, 2007, AM J CLIN ONCOL-CANC, V30, P181, DOI 10.1097/01.coc.0000251368.57302.cc; Jackel MC, 2007, LARYNGOSCOPE, V117, P350, DOI 10.1097/01.mlg.0000251165.48830.89; Jung YH, 2014, HEAD NECK-J SCI SPEC, V36, P715, DOI 10.1002/hed.23364; Kim HT, 2007, CLIN CANCER RES, V13, P559, DOI 10.1158/1078-0432.CCR-06-1210; Kothari P, 2011, EUR ARCH OTO-RHINO-L, V268, P1191, DOI 10.1007/s00405-010-1461-2; Lester SE, 2009, CLIN OTOLARYNGOL, V34, P546, DOI 10.1111/j.1749-4486.2009.02033.x; Lyhne NM, 2015, RADIOTHER ONCOL, V117, P91, DOI 10.1016/j.radonc.2015.07.004; McCoul ED, 2009, ARCH OTOLARYNGOL, V135, P479, DOI 10.1001/archoto.2009.47; Nguyen-Tan PF, 2001, INT J RADIAT ONCOL, V50, P1172, DOI 10.1016/S0360-3016(01)01538-3; PEPE MS, 1993, STAT MED, V12, P737, DOI 10.1002/sim.4780120803; Roedel RMW, 2010, AURIS NASUS LARYNX, V37, P340, DOI 10.1016/j.anl.2009.07.004; Rosenthal DI, 2015, CANCER-AM CANCER SOC, V121, P1608, DOI 10.1002/cncr.29241; StataCorp, 2013, STATA STAT SOFTW REL; Zbaren P, 2007, HEAD NECK-J SCI SPEC, V29, P26, DOI 10.1002/hed.20502; Zbaren P, 2013, EUR ARCH OTO-RHINO-L, V270, P2787, DOI 10.1007/s00405-013-2564-3	39	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164068	10.1371/journal.pone.0164068	http://dx.doi.org/10.1371/journal.pone.0164068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716797	Green Submitted, gold, Green Published			2022-12-27	WOS:000385698100018
J	Muller, J; Reichel, R; Vogt, S; Muller, SP; Sauerwein, W; Brandau, W; Eggert, A; Schramm, A				Mueller, Jan; Reichel, Robin; Vogt, Sebastian; Mueller, Stefan P.; Sauerwein, Wolfgang; Brandau, Wolfgang; Eggert, Angelika; Schramm, Alexander			Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2	PLOS ONE			English	Article							ANTI-GD2 MONOCLONAL-ANTIBODIES; HIGH-RISK NEUROBLASTOMA; THERAPEUTIC TARGET; RADIONUCLIDE THERAPY; MATRIX PROTEINS; GANGLIOSIDE GD2; PHAGE DISPLAY; IN-VIVO; CELLS; IMMUNOTHERAPY	Neuroectodermal tumours are characterized by aberrant processing of disialogangliosides concomitant with high expression of GD2 or GD3 on cell surfaces. Antibodies targeting GD2 are already in clinical use for therapy of neuroblastoma, a solid tumour of early childhood. Here, we set out to identify peptides with high affinity to human disialoganglioside GD2. To this end, we performed a combined in vivo and in vitro screen using a recombinant phage displayed peptide library. We isolated a phage displaying the peptide sequence WHWRLPS that specifically binds to the human disialoganglioside GD2. Binding specificity was confirmed by mutational scanning and by comparative analyses using structurally related disialogangliosides. In vivo, significant enrichment of phage binding to xenografts of human neuroblastoma cells in mice was observed. Tumour-specific phage accumulation could be blocked by intravenous coinjection of the corresponding peptide. Comparative pharmacokinetic analyses revealed higher specific accumulation of 68 Ga-labelled GD2-binding peptide compared to 111 In-labelled peptide in xenografts of human neuroblastoma. In contrast to 124 I-MIBG, which is currently evaluated as a neuroblastoma marker in PET/CT, 68 Ga-labelled GD2-specific peptide spared the thyroid but was enriched in the kidneys, which could be partially blocked by infusion of amino acids. In summary, we here report on a novel tumour-homing peptide that specifically binds to the disialoganglioside GD2, accumulates in xenografts of neuroblastoma cells in mice and bears the potential for tumour detection using PET/CT. Thus, this peptide may serve as a new scaffold for diagnosing GD2-positive tumours of neuroectodermal origin.	[Mueller, Jan; Vogt, Sebastian; Schramm, Alexander] Univ Duisburg Essen, Univ Childrens Hosp Essen, Pediat Oncol & Hematol, Essen, Germany; [Reichel, Robin; Mueller, Stefan P.; Brandau, Wolfgang] Univ Duisburg Essen, Univ Hosp Essen, Nucl Med, Essen, Germany; [Sauerwein, Wolfgang] Univ Duisburg Essen, Univ Hosp Essen, Radiat Oncol, Essen, Germany; [Eggert, Angelika] Charite, Pediat Oncol & Hematol, Berlin, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schramm, A (corresponding author), Univ Duisburg Essen, Univ Childrens Hosp Essen, Pediat Oncol & Hematol, Essen, Germany.	alexander.schramm@uni-due.de	Eggert, Angelika/AAE-6907-2022; Schramm, Alexander/G-5688-2010	Eggert, Angelika/0000-0003-3476-8184; Schramm, Alexander/0000-0001-7670-7529	Germany Ministry of Education and Research (BMBF)	Germany Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from Germany Ministry of Education and Research (BMBF) to Angelika Eggert and Alexander Schramm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2014, FEBS LETT, V588, P288, DOI 10.1016/j.febslet.2013.11.030; Aixinjueluo W, 2005, J BIOL CHEM, V280, P29828, DOI 10.1074/jbc.M414041200; Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Arap Wadih, 1998, Current Opinion in Oncology, V10, P560, DOI 10.1097/00001622-199811000-00014; Bernstein ML, 2011, CANCER-AM CANCER SOC, V117, P2268, DOI 10.1002/cncr.26050; BURNS GF, 1988, J CELL BIOL, V107, P1225, DOI 10.1083/jcb.107.3.1225; CHERESH DA, 1986, J CELL BIOL, V102, P688, DOI 10.1083/jcb.102.3.688; Czaplicki D, 2009, ACTA BIOCHIM POL, V56, P423; Dearling JLJ, 2011, NUCL MED BIOL, V38, P29, DOI 10.1016/j.nucmedbio.2010.07.003; Dobrenkov K, 2014, SEMIN ONCOL, V41, P589, DOI 10.1053/j.seminoncol.2014.07.003; Doronin II, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-295; Eleveld TF, 2015, NAT GENET, V47, P864, DOI 10.1038/ng.3333; Essler M, 2002, P NATL ACAD SCI USA, V99, P2252, DOI 10.1073/pnas.251687998; Furukawa K, 2008, PROTEOMICS, V8, P3312, DOI 10.1002/pmic.200800228; Furukawa K, 2012, GLYCOCONJUGATE J, V29, P579, DOI 10.1007/s10719-012-9423-0; Gautam A, 2014, CURR MED CHEM, V21, P2367, DOI 10.2174/0929867321666140217122100; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Hatok J, 2009, CLIN EXP MED, V9, P1, DOI 10.1007/s10238-008-0011-3; Kailayangiri S, 2012, BRIT J CANCER, V106, P1123, DOI 10.1038/bjc.2012.57; Kjaer A, 2015, SCAND J GASTROENTERO, V50, P740, DOI 10.3109/00365521.2015.1033454; Ko K, 2006, ONCOGENE, V25, P6924, DOI 10.1038/sj.onc.1209683; Kowalczyk A, 2009, CANCER LETT, V281, P171, DOI 10.1016/j.canlet.2009.02.040; Larimer BM, 2014, MOL IMAGING BIOL, V16, P449, DOI 10.1007/s11307-014-0724-5; Laurent VE, 2010, MOL MED REP, V3, P253, DOI 10.3892/mmr_00000248; Daniotti JL, 2011, IUBMB LIFE, V63, P513, DOI 10.1002/iub.477; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; Modak S, 2007, CANCER INVEST, V25, P67, DOI 10.1080/07357900601130763; Molenaar TJM, 2002, VIROLOGY, V293, P182, DOI 10.1006/viro.2001.1254; MOORE PG, 1957, BIOMETRIKA, V44, P482, DOI 10.1093/biomet/44.3-4.482; Mueller J, 2009, MOL CANCER RES, V7, P1078, DOI 10.1158/1541-7786.MCR-08-0538; Ora I, 2011, SEMIN CANCER BIOL, V21, P217, DOI 10.1016/j.semcancer.2011.07.002; Peifer M, 2015, NATURE, V526, P700, DOI 10.1038/nature14980; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rolleman EJ, 2010, EUR J NUCL MED MOL I, V37, P1018, DOI 10.1007/s00259-009-1282-y; Roth M, 2014, CANCER-AM CANCER SOC, V120, P548, DOI 10.1002/cncr.28461; Schramm A, 2015, NAT GENET, V47, P872, DOI 10.1038/ng.3349; Schwermer M, 2015, ONCOTARGET, V6, P15425, DOI 10.18632/oncotarget.3908; Sharp SE, 2009, J NUCL MED, V50, P1237, DOI 10.2967/jnumed.108.060467; Simon T, 2011, PEDIATR BLOOD CANCER, V56, P578, DOI 10.1002/pbc.22693; Suzuki M, 2015, EXPERT OPIN THER TAR, V19, P349, DOI 10.1517/14728222.2014.986459; VALENTINO L, 1990, BLOOD, V75, P1564; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Vavere AL, 2012, J NUCL MED, V53, P1772, DOI 10.2967/jnumed.112.104208; Vegt E, 2010, J NUCL MED, V51, P1049, DOI 10.2967/jnumed.110.075101; Virgolini I, 2010, EUR J NUCL MED MOL I, V37, P2004, DOI 10.1007/s00259-010-1512-3; Yoshida S, 2001, CANCER RES, V61, P4244; Ziebarth AJ, 2012, CANCER IMMUNOL IMMUN, V61, P1149, DOI 10.1007/s00262-012-1267-8	48	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0163648	10.1371/journal.pone.0163648	http://dx.doi.org/10.1371/journal.pone.0163648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716771	gold, Green Published, Green Submitted			2022-12-27	WOS:000385698100008
J	zu Horste, GM; Cordes, S; Pfaff, J; Mathys, C; Mausberg, AK; Bendszus, M; Pham, M; Hartung, HP; Kieseier, BC				zu Horste, Gerd Meyer; Cordes, Steffen; Pfaff, Johannes; Mathys, Christian; Mausberg, Anne K.; Bendszus, Martin; Pham, Mirko; Hartung, Hans-Peter; Kieseier, Bernd C.			Predicting the Response to Intravenous Immunoglobulins in an Animal Model of Chronic Neuritis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE NEURITIS; FC PORTION; CELLS; DEMYELINATION; PATHOGENESIS; 10-PERCENT; EXPRESSION; DISEASE; BLOOD; CIDP	Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a disabling autoimmune disorder of the peripheral nervous system (PNS). Intravenous immunoglobulins (IVIg) are effective in CIDP, but the treatment response varies greatly between individual patients. Understanding this interindividual variability and predicting the response to IVIg constitute major clinical challenges in CIDP. We previously established intercellular adhesion molecule (ICAM)-1 deficient non-obese diabetic (NOD) mice as a novel animal model of CIDP. Here, we demonstrate that similar to human CIDP patients, ICAM-1 deficient NOD mice respond to IVIg treatment by clinical and histological measures. Nerve magnetic resonance imaging and histology demonstrated that IVIg ameliorates abnormalities preferentially in distal parts of the sciatic nerve branches. The IVIg treatment response also featured great heterogeneity allowing us to identify IVIg responders and non-responders. An increased production of interleukin (IL)-17 positively predicted IVIg treatment responses. In human sural nerve biopsy sections, high numbers of IL-17 producing cells were associated with younger age and shorter disease duration. Thus, our novel animal model can be utilized to identify prognostic markers of treatment responses in chronic inflammatory neuropathies and we identify IL-17 production as one potential such prognostic marker.	[zu Horste, Gerd Meyer; Cordes, Steffen; Mausberg, Anne K.; Hartung, Hans-Peter; Kieseier, Bernd C.] Univ Dusseldorf, Dept Neurol, Fac Med, Dusseldorf, Germany; [zu Horste, Gerd Meyer] Univ Hosp Munster, Dept Neurol, Munster, Germany; [Pfaff, Johannes; Bendszus, Martin; Pham, Mirko] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany; [Mathys, Christian] Univ Dusseldorf, Inst Neuroradiol, Fac Med, Dusseldorf, Germany; [Cordes, Steffen] Charite, Dept Med, Div Hematol Oncol & Tumor Immunol, Berlin, Germany	Heinrich Heine University Dusseldorf; University of Munster; Ruprecht Karls University Heidelberg; Heinrich Heine University Dusseldorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	zu Horste, GM (corresponding author), Univ Dusseldorf, Dept Neurol, Fac Med, Dusseldorf, Germany.; zu Horste, GM (corresponding author), Univ Hosp Munster, Dept Neurol, Munster, Germany.	gerd.meyerzuhoerste@ukmuenster.de	Horste, Gerd Meyer zu/O-9549-2016; Pham, Mirko/AAI-8713-2020; Pfaff, Johannes Alex Rolf/P-6272-2019	Horste, Gerd Meyer zu/0000-0002-4341-4719; Pfaff, Johannes Alex Rolf/0000-0003-0672-5718	Deutsche Forschungsgemeinschaft (DFG) [ME4050/1-1]; National Multiple Sclerosis Society (NMSS) [FG 20118-A-1]; Ministerium fur Innovation, Wissenschaft and Forschung des Landes Nordrhein-Westfalen (MIWF NRW); Peripheral Nerve Society	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Ministerium fur Innovation, Wissenschaft and Forschung des Landes Nordrhein-Westfalen (MIWF NRW); Peripheral Nerve Society	G.M.z.H. was funded in part by grants from the Deutsche Forschungsgemeinschaft (DFG grant number ME4050/1-1), from the National Multiple Sclerosis Society (NMSS) (postdoctoral fellowship grant number FG 20118-A-1), from the Ministerium fur Innovation, Wissenschaft and Forschung des Landes Nordrhein-Westfalen (MIWF NRW), and by a project grant from the Peripheral Nerve Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendszus M, 2005, NAT CLIN PRACT NEURO, V1, P45, DOI 10.1038/ncpneuro0017; Bendszus M, 2005, ANN NEUROL, V57, P388, DOI 10.1002/ana.20404; Bosboom WMJ, 2001, BRAIN, V124, P2427, DOI 10.1093/brain/124.12.2427; Bril V, 2010, MUSCLE NERVE, V42, P492, DOI 10.1002/mus.21733; Campbell IK, 2014, J IMMUNOL, V192, P5031, DOI 10.4049/jimmunol.1301611; Chi LJ, 2010, J PERIPHER NERV SYST, V15, P345, DOI 10.1111/j.1529-8027.2010.00294.x; Chi LJ, 2008, J PERIPHER NERV SYST, V13, P54, DOI 10.1111/j.1529-8027.2008.00158.x; Dalakas MC, 2011, NAT REV NEUROL, V7, P507, DOI 10.1038/nrneurol.2011.121; Dalakas MC, 2004, PHARMACOL THERAPEUT, V102, P177, DOI 10.1016/j.pharmthera.2004.04.002; Gabriel CM, 1997, BRAIN, V120, P1533, DOI 10.1093/brain/120.9.1533; Gold R, 2000, MOL MED TODAY, V6, P88, DOI 10.1016/S1357-4310(99)01639-1; Horste GMZ, 2007, NAT CLIN PRACT NEURO, V3, P198, DOI 10.1038/ncpneuro0452; Horste GMZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108756; Horste GMZ, 2014, J IMMUNOL, V193, P2678, DOI 10.4049/jimmunol.1400367; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 2008, LANCET NEUROL, V7, P136, DOI 10.1016/S1474-4422(07)70329-0; Jacob S, 2009, CURR NEUROPHARMACOL, V7, P337, DOI 10.2174/157015909790031166; Kieseier BC, 2000, J NEUROIMMUNOL, V110, P121, DOI 10.1016/S0165-5728(00)00323-4; Koller H, 2005, NEW ENGL J MED, V352, P1343, DOI 10.1056/nejmra041347; Kollmer J, 2015, CLIN NEURORADIOL, V25, P283, DOI 10.1007/s00062-015-0412-0; Lehmann HC, 2010, EXP NEUROL, V223, P238, DOI 10.1016/j.expneurol.2009.10.012; Lin HH, 2007, J NEUROIMMUNOL, V186, P133, DOI 10.1016/j.jneuroim.2007.03.016; Lunemann JD, 2015, NAT REV NEUROL, V11, P80, DOI 10.1038/nrneurol.2014.253; Madia F, 2009, J PERIPHER NERV SYST, V14, P107, DOI 10.1111/j.1529-8027.2009.00220.x; Martin S, 2001, J AUTOIMMUN, V17, P109, DOI 10.1006/jaut.2001.0526; Mei FJ, 2005, J NEUROL SCI, V228, P75, DOI 10.1016/j.jns.2004.10.001; Merkies ISJ, 2009, NEUROLOGY, V72, P1337, DOI 10.1212/WNL.0b013e3181a0fd80; Horste GMZ, 2007, ANN NEUROL, V61, P61, DOI 10.1002/ana.21026; Miyagi F, 1997, J NEUROIMMUNOL, V78, P127, DOI 10.1016/S0165-5728(97)00090-8; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; St-Amour I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-54; Stoll G, 2006, EXP NEUROL, V197, P150, DOI 10.1016/j.expneurol.2005.09.003; Stoll G, 2004, J NEUROIMMUNOL, V149, P142, DOI 10.1016/j.jneuroim.2003.12.024; Stoll G, 2009, J CEREBR BLOOD F MET, V29, P331, DOI 10.1038/jcbfm.2008.129; Tackenberg B, 2009, P NATL ACAD SCI USA, V106, P4788, DOI 10.1073/pnas.0807319106; Vallat JM, 2010, LANCET NEUROL, V9, P402, DOI 10.1016/S1474-4422(10)70041-7; Weise G, 2011, EXP NEUROL, V229, P494, DOI 10.1016/j.expneurol.2011.03.020; Wessig C, 2008, EXP NEUROL, V210, P137, DOI 10.1016/j.expneurol.2007.10.014; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95	40	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164099	10.1371/journal.pone.0164099	http://dx.doi.org/10.1371/journal.pone.0164099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711247	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600076
J	Clusa, L; Ardura, A; Gower, F; Miralles, L; Tsartsianidou, V; Zaiko, A; Garcia-Vazquez, E				Clusa, Laura; Ardura, Alba; Gower, Fiona; Miralles, Laura; Tsartsianidou, Valentina; Zaiko, Anastasija; Garcia-Vazquez, Eva			An Easy Phylogenetically Informative Method to Trace the Globally Invasive Potamopyrgus Mud Snail from River's eDNA	PLOS ONE			English	Article							NEW-ZEALAND MUDSNAILS; ANTIPODARUM HYDROBIIDAE; ENVIRONMENTAL DNA; MITOCHONDRIAL-DNA; MOLLUSCA; SALINITY; INVERTEBRATES; BIODIVERSITY; GASTROPOD; ABUNDANCE	Potamopyrgus antipodarum (New Zealand mud snail) is a prosobranch mollusk native to New Zealand with a wide invasive distribution range. Its non-indigenous populations are reported from Australia, Asia, Europe and North America. Being an extremely tolerant species, Potamopyrgus is capable to survive in a great range of salinity and temperature conditions, which explains its high invasiveness and successful spread outside the native range. Here we report the first finding of Potamopyrgus antipodarum in a basin of the Cantabrian corridor in North Iberia (Bay of Biscay, Spain). Two haplotypes already described in Europe were found in different sectors of River Nora (Nalon basin), suggesting the secondary introductions from earlier established invasive populations. To enhance the surveillance of the species and tracking its further spread in the region, we developed a specific set of primers for the genus Potamopyrgus that amplify a fragment of 16S rDNA. The sequences obtained from PCR on DNA extracted from tissue and water samples (environmental DNA, eDNA) were identical in each location, suggesting clonal reproduction of the introduced individuals. Multiple introduction events from different source populations were inferred from our sequence data. The eDNA tool developed here can serve for tracing New Zealand mud snail populations outside its native range, and for inventorying mud snail population assemblages in the native settings if high throughput sequencing methodologies are employed.	[Clusa, Laura; Miralles, Laura; Tsartsianidou, Valentina; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, C Julian Claveria S-N, E-33006 Oviedo, Spain; [Ardura, Alba] Univ Perpignan, CBETM, CRIOBE CNRS EPHE UPVD USR3278, Lab Excellence CORAIL, 58 Rue Paul Alduy, F-66860 Perpignan, France; [Gower, Fiona; Zaiko, Anastasija] Cawthron Inst, Coastal & Freshwater Grp, 98 Halifax St East, Nelson 7010, New Zealand; [Zaiko, Anastasija] Klaipeda Univ, Marine Sci & Technol Ctr, H Manto 84, LT-92294 Klaipeda, Lithuania	University of Oviedo; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Cawthron Institute; Klaipeda University	Clusa, L (corresponding author), Univ Oviedo, Dept Funct Biol, C Julian Claveria S-N, E-33006 Oviedo, Spain.	lauraclusa@gmail.com	Garcia-Vazquez, Eva/Y-7293-2019	Miralles, Laura/0000-0002-7146-9776; Garcia-Vazquez, Eva/0000-0002-8429-838X; Ardura Gutierrez, Alba/0000-0003-2598-6534; Clusa, Laura/0000-0002-3503-2331	Spanish project [MINECO-13-CGL2013-42415-R]; Asturias Regional Grant [GRUPIN-2014-093]; PCTI Grant from the Asturias Regional Government [BP14-145]; Marie Curie grant COFUND-CLARIN	Spanish project(Spanish Government); Asturias Regional Grant; PCTI Grant from the Asturias Regional Government; Marie Curie grant COFUND-CLARIN	This work was supported by the Spanish project MINECO-13-CGL2013-42415-R and the Asturias Regional Grant GRUPIN-2014-093. Laura Clusa holds a PCTI Grant from the Asturias Regional Government, referenced BP14-145. Alba Ardura holds a regional postdoctoral Marie Curie grant COFUND-CLARIN.	Alonso A, 2008, HYDROBIOLOGIA, V614, P107, DOI 10.1007/s10750-008-9529-3; Alonso Alvaro, 2012, NeoBiota, V14, P67; Alonso A, 2012, AQUAT SCI, V74, P375, DOI 10.1007/s00027-012-0254-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ardura A, 2015, MAR ENVIRON RES, V112, P48, DOI 10.1016/j.marenvres.2015.09.013; Bersine K, 2008, BIOL INVASIONS, V10, P1381, DOI 10.1007/s10530-007-9213-y; Blanchet S, 2012, FISHERIES MANAG ECOL, V19, P120, DOI 10.1111/j.1365-2400.2011.00832.x; Bruce RL, 2009, N AM J AQUACULT, V71, P287, DOI 10.1577/A08-033.1; Cambray JA, 2003, HYDROBIOLOGIA, V500, P217, DOI 10.1023/A:1024648719995; Chown SL, 2015, EVOL APPL, V8, P23, DOI 10.1111/eva.12234; Costil K, 2001, BIODIVERS CONSERV, V10, P1, DOI 10.1023/A:1016670708413; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Davidson Timothy M., 2008, Aquatic Invasions, V3, P349, DOI 10.3391/ai.2008.3.3.12; Devloo-Delva F, 2016, MARINE POLLUTION B; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gerard C, 2003, HYDROBIOLOGIA, V493, P167, DOI 10.1023/A:1025443910836; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Grant A, 1998, MAR POLLUT BULL, V36, P540, DOI 10.1016/S0025-326X(98)00012-5; Gustavson MS, 2015, J FISH BIOL, V87, P1254, DOI 10.1111/jfb.12781; Hall R, 2003, FRONT ECOL ENVIRON, V1, P407, DOI 10.1890/1540-9295(2003)001[0407:ESDNAC]2.0.CO;2; Hall RO, 2006, ECOL APPL, V16, P1121, DOI 10.1890/1051-0761(2006)016[1121:EHSPOI]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamada K, 2013, LIMNOLOGY, V14, P223, DOI 10.1007/s10201-013-0405-0; Hoy M, 2012, AQUAT ECOL, V46, P249, DOI 10.1007/s10452-012-9396-x; Jacobsen R, 1997, FUNCT ECOL, V11, P260, DOI 10.1046/j.1365-2435.1997.00082.x; Larson MD, 2016, HYDROBIOLOGIA, V763, P147, DOI 10.1007/s10750-015-2369-z; LASSEN HH, 1975, OECOLOGIA, V19, P1, DOI 10.1007/BF00377585; Leprieur Fabien, 2008, PLoS Biol, V6, pe28, DOI 10.1371/journal.pbio.0060028; Loo SE, 2007, ECOL APPL, V17, P181, DOI 10.1890/1051-0761(2007)017[0181:FNZMIR]2.0.CO;2; Marchetti MP, 2004, ECOL APPL, V14, P587, DOI 10.1890/02-5301; Milwright R. D. P., 2006, Ringing & Migration, V23, P21; Moffitt CM, 2012, FRESHW SCI, V31, P1035, DOI 10.1899/11-160.1; Murria C, 2008, FUND APPL LIMNOL, V171, P131, DOI 10.1127/1863-9135/2008/0171-0131; Naser Murtada D., 2009, Aquatic Invasions, V4, P369, DOI 10.3391/ai.2009.4.2.11; Olenin S, 2011, MAR POLLUT BULL, V62, P2598, DOI 10.1016/j.marpolbul.2011.08.011; Palumbi SR, 1991, SIMPLE FOOLS GUIDE P, P28; Radea Canella, 2008, Aquatic Invasions, V3, P341, DOI 10.3391/ai.2008.3.3.10; Riley LA, 2015, FRESHWATER BIOL, V60, P1308, DOI 10.1111/fwb.12566; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sanderson BL, 2009, BIOSCIENCE, V59, P245, DOI 10.1525/bio.2009.59.3.9; Schmidlin S, 2012, HYDROBIOLOGIA, V679, P233, DOI 10.1007/s10750-011-0889-8; Schreiber E. S. G., 2002, Biological Invasions, V4, P317, DOI 10.1023/A:1020925022843; Shimada Kumiko, 2003, Venus (Tokyo), V62, P39; Spyra A, 2015, ENVIRON MANAGE, V56, P233, DOI 10.1007/s00267-015-0483-3; Stadler T, 2005, MOL ECOL, V14, P2465, DOI 10.1111/j.1365-294X.2005.02603.x; Strayer DL, 2010, FRESHWATER BIOL, V55, P152, DOI 10.1111/j.1365-2427.2009.02380.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Telleria JL, 2009, J BIOGEOGR, V36, P220, DOI 10.1111/j.1365-2699.2008.01983.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomsen MS, 2009, HELGOLAND MAR RES, V63, P159, DOI 10.1007/s10152-008-0142-7; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Vinson MR, 2008, N AM J FISH MANAGE, V28, P701, DOI 10.1577/M06-039.1; WINTERBOURN M, 1970, Malacologia, V10, P283; Zaiko A, 2015, MAR ENVIRON RES, V112, P64, DOI 10.1016/j.marenvres.2015.07.002; Zaranko DT, 1997, CAN J FISH AQUAT SCI, V54, P809, DOI 10.1139/cjfas-54-4-809	58	18	20	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162899	10.1371/journal.pone.0162899	http://dx.doi.org/10.1371/journal.pone.0162899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706172	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200022
J	Imai, R; Tsuda, Y; Matsumoto, S; Ebihara, A; Watano, Y				Imai, Ryosuke; Tsuda, Yoshiaki; Matsumoto, Sadamu; Ebihara, Atsushi; Watano, Yasuyuki			The Relationship between Mating System and Genetic Diversity in Diploid Sexual Populations of Cyrtomium falcatum in Japan	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; LONG-DISTANCE DISPERSAL; SELF-FERTILIZATION; MICROSATELLITE MARKERS; BETULA-MAXIMOWICZIANA; DIFFERENTIATION; EVOLUTION; SOFTWARE; HISTORY; RANGE	The impact of variation in mating system on genetic diversity is a well-debated topic in evolutionary biology. The diploid sexual race of Cyrtomium falcatum (Japanese holly fern) shows mating system variation, i.e., it displays two different types of sexual expression (gametangia formation) in gametophytes: mixed (M) type and separate (S) type. We examined whether there is variation in the selfing rate among populations of this species, and evaluated the relationship between mating system, genetic diversity and effective population size using microsatellites. In this study, we developed eight new microsatellite markers and evaluated genetic diversity and structure of seven populations (four M-type and three S-type). Past effective population sizes (Ne) were inferred using Approximate Bayesian computation (ABC). The values of fixation index (F-IS), allelic richness (A(R)) and gene diversity (h) differed significantly between the M-type (F-IS: 0.626, A(R): 1.999, h: 0.152) and the S-type (F-IS: 0.208, A(R): 2.718, h: 0.367) populations (when admixed individuals were removed from two populations). Although evidence of past bottleneck events was detected in all populations by ABC, the current N-e of the M-type populations was about a third of that of the S-type populations. These results suggest that the M-type populations have experienced more frequent bottlenecks, which could be related to their higher colonization ability via gametophytic selfing. Although high population differentiation among populations was detected (F-ST = 0.581, F-ST' = 0.739), there was no clear genetic differentiation between the M- and S-types. Instead, significant isolation by distance was detected among all populations. These results suggest that mating system variation in this species is generated by the selection for single spore colonization during local extinction and recolonization events and there is no genetic structure due to mating system.	[Imai, Ryosuke; Watano, Yasuyuki] Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba, Japan; [Tsuda, Yoshiaki] Univ Tsukuba, Sugadaira Montane Res Ctr, Ueda, Nagano, Japan; [Matsumoto, Sadamu; Ebihara, Atsushi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan	Chiba University; University of Tsukuba; National Museum of Nature and Science	Watano, Y (corresponding author), Chiba Univ, Grad Sch Sci, Dept Biol, Inage Ku, Chiba, Japan.	watano@faculty.chiba-u.jp		Watano, Yasuyuki/0000-0001-5814-9658	Research Support Program Fund from Chiba University; Ministry of Education, Science and Culture of Japan [15K07180]	Research Support Program Fund from Chiba University; Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Research Support Program Fund 2014 to YW from Chiba University and a Grant-in-Aid (No. 15K07180 to YW) from the Ministry of Education, Science and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; Busch JW, 2012, ANN BOT-LONDON, V109, P553, DOI 10.1093/aob/mcr219; Bystriakova N, 2014, ANN BOT-LONDON, V113, P453, DOI 10.1093/aob/mct274; Chung MY, 2013, AM J BOT, V100, P2240, DOI 10.3732/ajb.1300134; Chung MY, 2012, AM FERN J, V102, P256, DOI 10.1640/0002-8444-102.4.256; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Darwin CR, 1876, EFFECTS CROSS SELF F; David C., 1989, EVOLUTION, V43, P258, DOI [10.2307/2409206, DOI 10.2307/2409206]; De Groot GA, 2012, ANN BOT-LONDON, V109, P965, DOI 10.1093/aob/mcs013; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; HEDRICK PW, 1987, EVOLUTION, V41, P1282, DOI 10.1111/j.1558-5646.1987.tb02466.x; Huang YM, 2004, ANN BOT-LONDON, V94, P229, DOI 10.1093/aob/mch142; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Iwaizumi MG, 2013, FOREST ECOL MANAG, V304, P407, DOI 10.1016/j.foreco.2013.05.026; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jimenez A, 2010, ANN BOT-LONDON, V106, P149, DOI 10.1093/aob/mcq094; Klekowski EJ, 1969, BOT J LINN SOC, V62, P347, DOI DOI 10.1111/J.1095-8339.1969.TB01972.X; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lian CL, 2006, J PLANT RES, V119, P415, DOI 10.1007/s10265-006-0274-2; Lian CL, 2001, J PLANT RES, V114, P381, DOI 10.1007/PL00014001; MASUYAMA S, 1975, Science Reports of the Tokyo Kyoiku Daigaku Section B, V16, P47; Matsumoto S., 2003, ANN TSUKUBA BOT GARD, V22, P1; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Morgan MT, 2005, EVOLUTION, V59, P1143, DOI 10.1111/j.0014-3820.2005.tb01050.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nordborg M, 2000, GENETICS, V154, P923; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; POLLAK E, 1987, GENETICS, V117, P353; Pritchard JK, 2000, GENETICS, V155, P945; Ranker TA, 2002, AM FERN J, V92, P112, DOI 10.1640/0002-8444(2002)092[0112:IGSITL]2.0.CO;2; Ranker TA, 2000, EVOLUTION, V54, P828; Rousset F, 1997, GENETICS, V145, P1219; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakaguchi S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2182; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Semerikov VL, 2013, MOL ECOL, V22, P4958, DOI 10.1111/mec.12433; Sessa EB, 2016, NEW PHYTOL, V211, P1108, DOI 10.1111/nph.13985; Shepherd LD, 2011, J PLANT RES, V124, P311, DOI 10.1007/s10265-010-0379-5; Shimizu KK, 2015, ANNU REV ECOL EVOL S, V46, P593, DOI 10.1146/annurev-ecolsys-112414-054249; SOLTIS P S, 1990, Plant Species Biology, V5, P1, DOI 10.1111/j.1442-1984.1990.tb00187.x; Takayama K, 2011, TAXON, V60, P1442, DOI 10.1002/tax.605019; Tsuda Y, 2005, MOL ECOL, V14, P3929, DOI 10.1111/j.1365-294X.2005.02715.x; Tsuda Y, 2015, MOL ECOL, V24, P1403, DOI 10.1111/mec.13123; Tsuda Y, 2010, TREE GENET GENOMES, V6, P377, DOI 10.1007/s11295-009-0256-3; WATANO Y., 1986, MODERN ASPECTS SPECI, P211; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1943, GENETICS, V28, P114; Wubs ERJ, 2010, ANN BOT-LONDON, V106, P583, DOI 10.1093/aob/mcq157; Yampolsky C., 1922, BIBLIOTHECA GENETICA, V3, P1; Yuzawa Y., 2012, J PHYTOGEOGR TAXON, V61, P1	64	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163683	10.1371/journal.pone.0163683	http://dx.doi.org/10.1371/journal.pone.0163683			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706257	gold, Green Submitted, Green Published			2022-12-27	WOS:000385697200053
J	Lee, MH; Jung, SY; Kang, SH; Song, EJ; Park, IH; Kong, SY; Kwon, YM; Lee, KS; Kang, HS; Lee, ES				Lee, Moo Hyun; Jung, So-Youn; Kang, Sun Hee; Song, Eun Jin; Park, In Hae; Kong, Sun-Young; Kwon, Young Mee; Lee, Keun Seok; Kang, Han-Sung; Lee, Eun Sook			The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients	PLOS ONE			English	Article							EXTRACELLULAR DOMAIN; PROGNOSTIC-SIGNIFICANCE; CLINICAL UTILITY; PREDICTIVE-VALUE; HER-2/NEU; CHEMOTHERAPY; TRASTUZUMAB; RECEPTOR; PROTEIN; ONCOPROTEIN	Purpose This study evaluated the association of serum HER2 (sHER2) levels at diagnosis with clinicopathologic parameters and disease free survival (DFS) in operable breast cancer patients according to intrinsic subtype. Methods The sHER2 levels were measured using a chemiluminescence immunoassay. The HER2 status in all tumor tissues was determined by immunohistochemistry, and confirmed in equivocal cases by fluorescence in situ. Results There were 436 consecutive stage I-III breast cancer patients with sHER2 result at diagnosis between Nov 2004 and Dec 2011. High sHER2 levels (>= 15 ng/ml) were reported in 52 patients (11.9%) and HER2 overexpression in tumor tissue was observed in 111 patients (25.5%). High sHER2 levels were associated significantly with advanced stage (P < 0.001), mastectomy (P = 0.012), neoadjuvant chemotherapy (P < 0.001), anti-HER2 therapy (P < 0.001) and hormone therapy (P = 0.022). The patients with high sHER2 levels had a worse DFS (P < 0.001). In multivariate analysis, high sHER2 levels were associated significantly with worse DFS (HR = 2.25, 95% CI 1.27-3.99, P = 0.005). High sHER2 levels were associated with worse DFS in the HR+/HER2-, HR+/HER2+ and HR-/HER2+ subtypes (P = 0.043, 0.003 and 0.041, respectively). Conclusions These results show that the sHER2 level at diagnosis is a useful prognostic factor in patients with operable breast cancer, especially in the HR+/HER2-, HR+/HER2+ and HR-/ HER2+ subtypes.	[Lee, Moo Hyun; Jung, So-Youn; Song, Eun Jin; Park, In Hae; Kwon, Young Mee; Lee, Keun Seok; Kang, Han-Sung; Lee, Eun Sook] Natl Canc Ctr, Res Inst & Hosp, Ctr Breast Canc, Goyang, Gyeonggi, South Korea; [Kang, Sun Hee] Keimyung Univ, Sch Med, Dept Surg, Daegu, South Korea; [Kong, Sun-Young] Natl Canc Ctr, Res Inst & Hosp, Ctr Diagnost Oncol, Dept Lab Med, Goyang, South Korea	National Cancer Center - Korea (NCC); Keimyung University; National Cancer Center - Korea (NCC)	Lee, ES (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Ctr Breast Canc, Goyang, Gyeonggi, South Korea.	eslee@ncc.re.kr	Kong, Sun-Young/ABB-7914-2021	Lee, Moo Hyun/0000-0003-3634-5230	National Cancer Center, Korea [NCC-1410691-2]	National Cancer Center, Korea	ESL was supported by the National Cancer Center, Korea (NCC-1410691-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baselga J, 2001, CLIN CANCER RES, V7, P2605; Bramwell VHC, 2009, BREAST CANCER RES TR, V114, P503, DOI 10.1007/s10549-008-0033-2; Carney WP, 2003, CLIN CHEM, V49, P1579, DOI 10.1373/49.10.1579; Christianson TA, 1998, CANCER RES, V58, P5123; Codony-Servat J, 1999, CANCER RES, V59, P1196; Cook GB, 2001, ANTICANCER RES, V21, P1465; Garoufali A, 2008, J BUON, V13, P409; Harris LN, 2001, J CLIN ONCOL, V19, P1698, DOI 10.1200/JCO.2001.19.6.1698; Hayes DF, 2001, CLIN CANCER RES, V7, P2703; Kang SH, 2010, J KOREAN SURG SOC, V78, P271, DOI 10.4174/jkss.2010.78.5.271; Kong Sun-Young, 2006, Cancer Res Treat, V38, P35, DOI 10.4143/crt.2006.38.1.35; Krainer M, 1997, ONCOLOGY, V54, P475; Lee JS, 2012, J BREAST CANCER, V15, P189, DOI 10.4048/jbc.2012.15.2.189; Lee SB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-929; Lipton A, 2002, J CLIN ONCOL, V20, P1467, DOI 10.1200/JCO.20.6.1467; Ludovini V, 2008, ANN ONCOL, V19, P883, DOI 10.1093/annonc/mdm585; Mehta RR, 1998, J CLIN ONCOL, V16, P2409, DOI 10.1200/JCO.1998.16.7.2409; Molina MA, 2002, CLIN CANCER RES, V8, P347; Molina MA, 2001, CANCER RES, V61, P4744; Molina R, 2003, ANTICANCER RES, V23, P1043; Moreno-Aspitia A, 2013, CANCER-AM CANCER SOC, V119, P2675, DOI 10.1002/cncr.28130; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Saghatchian M, 2004, INT J BIOL MARKER, V19, P14, DOI 10.1177/172460080401900102; Schwartz MK, 2000, INT J BIOL MARKER, V15, P324, DOI 10.1177/172460080001500409; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Willsher PC, 1996, BREAST CANCER RES TR, V40, P251, DOI 10.1007/BF01806813; Witzel I, 2012, BRIT J CANCER, V107, P956, DOI 10.1038/bjc.2012.353	28	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163370	10.1371/journal.pone.0163370	http://dx.doi.org/10.1371/journal.pone.0163370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706242	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200041
J	Li, SJ; Cao, W; Ren, HY; Lu, L; Zhuang, DF; Liu, QY				Li, Shujuan; Cao, Wei; Ren, Hongyan; Lu, Liang; Zhuang, Dafang; Liu, Qiyong			Time Series Analysis of Hemorrhagic Fever with Renal Syndrome: A Case Study in Jiaonan County, China	PLOS ONE			English	Article							UNITED-STATES; TRANSMISSION; VARIABILITY	Exact prediction of Hemorrhagic fever with renal syndrome (HFRS) epidemics must improve to establish effective preventive measures in China. A Seasonal Autoregressive Integrated Moving Average (SARIMA) model was applied to establish a highly predictive model of HFRS. Meteorological factors were considered external variables through a cross correlation analysis. Then, these factors were included in the SARIMA model to determine if they could improve the predictive ability of HFRS epidemics in the region. The optimal univariate SARIMA model was identified as (0,0,2)(1,1,1)(12). The R-2 of the prediction of HFRS cases from January 2014 to December 2014 was 0.857, and the Root mean square error (RMSE) was 2.708. However, the inclusion of meteorological variables as external regressors did not significantly improve the SARIMA model. This result is likely because seasonal variations in meteorological variables were included in the seasonal characteristics of the HFRS itself.	[Li, Shujuan; Cao, Wei; Ren, Hongyan; Zhuang, Dafang] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, 11A Datun Rd, Beijing 100101, Peoples R China; [Li, Shujuan] Univ Chinese Acad Sci, Coll Resources & Environm, 19 Yuquan Rd, Beijing 100049, Peoples R China; [Lu, Liang; Liu, Qiyong] China CDC, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, 5 Changbai Rd, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Ren, HY (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, 11A Datun Rd, Beijing 100101, Peoples R China.	renhy@igsnrr.ac.cn			National Program on Major Scientific Research Project - MOST of China [2012CB955500-955504]; Key Laboratory of Public Health Safety (Fudan Univeristy), Ministry of Education, China [GW2014-4]	National Program on Major Scientific Research Project - MOST of China; Key Laboratory of Public Health Safety (Fudan Univeristy), Ministry of Education, China	This work was supported by the National Program on Major Scientific Research Project granted by MOST of China (Grant No. 2012CB955500-955504), http://www.most.gov.cn/, H.R.; the funder conceived and designed the experiments, and also contributed to the writing of the manuscript; and by Key Laboratory of Public Health Safety (Fudan Univeristy), Ministry of Education, China (Grant No. GW2014-4), http://sph.fudan.edu.cn/, H.R.; the funder conceived and designed the experiments, and also contributed to the writing of the manuscript.	Bi P, 2003, JAMA-J AM MED ASSOC, V289, P176, DOI 10.1001/jama.289.2.176-d; Bi P, 2002, INT J EPIDEMIOL, V31, P189, DOI 10.1093/ije/31.1.189; Chen Y, 2008, MODERN PREVENTIVE ME, V35, P1414; Fang LQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000789; Fang LQ, 2009, EMERG INFECT DIS, V15, P2043, DOI 10.3201/eid1512.081078; Fang LQ, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-77; Gaudart J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-61; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Lee HW, 1989, PROG MED VIROL, V41; Li SJ, 2014, INT J ENV RES PUB HE, V11, P12129, DOI 10.3390/ijerph111212129; Lin HL, 2014, INT J BIOMETEOROL, V58, P1031, DOI 10.1007/s00484-013-0688-1; Lin HL, 2012, INT J PUBLIC HEALTH, V57, P289, DOI 10.1007/s00038-011-0236-x; Lin HL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-130; Lin HL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-207; Liu QY, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-218; Liu XD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-331; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Song YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117296; Tao B, 2009, PREV MED TRIB, V15, P4; Xiao H, 2013, EPIDEMIOL INFECT, V141, P1867, DOI 10.1017/S0950268812002555; Yan L, 2007, EMERG INFECT DIS, V13, P1301, DOI 10.3201/eid1309.061481; Yi Jing, 2007, Zhonghua Yufang Yixue Zazhi, V41, P118; Zhang S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-384	25	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163771	10.1371/journal.pone.0163771	http://dx.doi.org/10.1371/journal.pone.0163771			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706256	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200056
J	Machowska, A; Sun, J; Qureshi, AR; Isoyama, N; Leurs, P; Anderstam, B; Heimburger, O; Barany, P; Stenvinkel, P; Lindholm, B				Machowska, Anna; Sun, Jia; Qureshi, Abdul Rashid; Isoyama, Naohito; Leurs, Paul; Anderstam, Bjorn; Heimburger, Olof; Barany, Peter; Stenvinkel, Peter; Lindholm, Bengt			Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; OXIDATION PROTEIN PRODUCTS; PERITONEAL-DIALYSIS PATIENTS; CARDIOVASCULAR RISK-FACTORS; INCREASED SERUM-LEVELS; C-REACTIVE PROTEIN; HEMODIALYSIS-PATIENTS; TOTAL HOMOCYSTEINE; RENAL-FAILURE; ALL-CAUSE	Background Circulating advanced glycated end-products (AGEs) including pentosidine accumulating in chronic kidney disease (CKD) patients due to retention and increased formation are thought to contribute to cardiovascular disease (CVD). Here we evaluated factors linked to increased plasma pentosidine and its association with mortality in patients with different stages of CKD and undergoing different treatments. Methods Plasma pentosidine, biomarkers of inflammation, oxidative stress and nutritional status were investigated in CKD 1-2 (n = 37), CKD 3-4 (n = 54), CKD 5 non-dialyzed (CKD5-ND; n = 386), peritoneal dialysis (PD; n = 74) and hemodialysis (HD; n = 195) patients. Factors predicting plasma pentosidine were analysed by multivariate regression analysis and mortality risk was assessed by GENMOD procedure. Results Plasma pentosidine levels, which were higher in CKD5-ND, PD and HD groups than in CKD 1-2 group, were significantly lower in PD than in HD patients, and not different between PD patients and CKD5-ND patients. Pentosidine associated inversely with glomerular filtration rate (GFR), and additionally in PD with 8-hydroxy-2'-deoxyguanosine (8-OHdG), and interleukin 6 (IL-6); in HD with age, IL-6 and body mass index (BMI); in CKD5-ND with age, 8-OHdG, IL-6, high-sensitive C-reactive protein (hsCRP), and soluble vascular cell adhesion protein-1 (sVCAM-1); in CKD 3-4 with 8-OHdG and sVCAM-1; and in CKD 1-2 with age and sVCAM-1. In multivariate analysis, age (one standard deviation, 1-SD higher), malnutrition (subjective global assessment, SGA), oxidative stress (8-OHdG, 1-SD higher), and belonging to CKD5-ND, HD and PD cohorts associated with 1-SD higher pentosidine. In GENMOD, 1-SD higher pentosidine independently predicted all-cause mortality (relative risk, RR = 1.04; 95% confidence interval, CI, 1.01-1.08, p = 0.01) and CVD mortality (RR = 1.03; 95% CI, 1.01-1.06, p = 0.03) after adjusting for all confounders. Conclusions Plasma pentosidine is markedly elevated in CKD and associates with low GFR, oxidative stress and inflammation, and is an independent predictor of mortality in CKD patients.	[Machowska, Anna; Sun, Jia; Qureshi, Abdul Rashid; Isoyama, Naohito; Leurs, Paul; Anderstam, Bjorn; Heimburger, Olof; Barany, Peter; Stenvinkel, Peter; Lindholm, Bengt] Karolinska Inst, Renal Med & Baxter Novum, Stockholm, Sweden; [Isoyama, Naohito] Yamaguchi Univ, Dept Urol, Ube, Yamaguchi, Japan; [Leurs, Paul] Admiraal de Ruyter Hosp, Goes, Netherlands	Karolinska Institutet; Yamaguchi University	Lindholm, B (corresponding author), Karolinska Inst, Renal Med & Baxter Novum, Stockholm, Sweden.	Bengt.Lindholm@ki.se	; Lindholm, Bengt/P-1334-2017	Stenvinkel, Peter/0000-0002-8785-4820; Heimburger, Olof/0000-0003-0901-4145; Lindholm, Bengt/0000-0003-4269-4293; Barany, Peter/0000-0001-6501-8293				BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Busch M, 2004, KIDNEY INT, V66, P338, DOI 10.1111/j.1523-1755.2004.00736.x; Furuya R, 2012, CLIN EXP NEPHROL, V16, P421, DOI 10.1007/s10157-011-0573-3; Furuya R, 2009, NEPHRON CLIN PRACT, V112, pC255, DOI 10.1159/000224792; Ghanavatian S, 2014, ANGIOLOGY, V65, P443, DOI 10.1177/0003319713483000; Kilhovd BK, 2007, DIABETOLOGIA, V50, P1409, DOI 10.1007/s00125-007-0687-z; Kilhovd BK, 2009, ATHEROSCLEROSIS, V205, P590, DOI 10.1016/j.atherosclerosis.2008.12.041; Kooman JP, 2014, NAT REV NEPHROL, V10, P732, DOI 10.1038/nrneph.2014.185; Koyama H, 2010, EUR J CLIN INVEST, V40, P623, DOI 10.1111/j.1365-2362.2010.02298.x; Leurs P, 2013, ARCH MED RES, V44, P601, DOI 10.1016/j.arcmed.2013.11.002; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Machowska A, 2016, TRANSL RES, V167, P204, DOI 10.1016/j.trsl.2015.06.012; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Meerwaldt R, 2009, AM J KIDNEY DIS, V53, P138, DOI 10.1053/j.ajkd.2008.08.031; Miyata T, 1996, J AM SOC NEPHROL, V7, P1198; Nakayama M, 1997, KIDNEY INT, V51, P182, DOI 10.1038/ki.1997.22; Nin JW, 2011, DIABETES CARE, V34, P442, DOI 10.2337/dc10-1087; Pachaly MA, 2008, BLOOD PURIFICAT, V26, P204, DOI 10.1159/000117438; Park SH, 2012, J RENAL NUTR, V22, P120, DOI 10.1053/j.jrn.2011.10.021; Qureshi AR, 1998, KIDNEY INT, V53, P773, DOI 10.1046/j.1523-1755.1998.00812.x; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Semba RD, 2009, J AM GERIATR SOC, V57, P1874, DOI 10.1111/j.1532-5415.2009.02438.x; Snaedal S, 2009, AM J KIDNEY DIS, V53, P1024, DOI 10.1053/j.ajkd.2009.02.008; Stein G, 2003, AM J KIDNEY DIS, V41, pS52, DOI 10.1053/ajkd.2003.50085; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Sugiyama S, 1998, J AM SOC NEPHROL, V9, P1681; Suliman ME, 2006, CLIN NEPHROL, V66, P418; Suliman ME, 2003, J AM SOC NEPHROL, V14, P1614, DOI 10.1097/01.ASN.0000067413.32377.CF; Sun J, 2016, CLIN J AM SOC NEPHRO, V11, P1163, DOI 10.2215/CJN.10441015; Utescu MS, 2013, HYPERTENSION, V62, P154, DOI 10.1161/HYPERTENSIONAHA.113.01200; Xu H, 2015, PERITON DIALYSIS INT, V35, P460, DOI 10.3747/pdi.2013.00064; Zhou YL, 2010, ARTIF ORGANS, V34, P193, DOI 10.1111/j.1525-1594.2009.00801.x; Zoccali C, 2001, J NEPHROL, V14, P293	34	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163826	10.1371/journal.pone.0163826	http://dx.doi.org/10.1371/journal.pone.0163826			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701453	Green Submitted, Green Published, gold			2022-12-27	WOS:000385696900023
J	Thamm, K; Graupner, S; Werner, C; Huttner, WB; Corbeil, D				Thamm, Kristina; Graupner, Sylvi; Werner, Carsten; Huttner, Wieland B.; Corbeil, Denis			Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133)	PLOS ONE			English	Article							POLYTOPIC MEMBRANE-PROTEIN; HUMAN HEMATOPOIETIC STEM; CENTRAL-NERVOUS-SYSTEM; EPITHELIAL-CELLS; SPLICE VARIANTS; MARKER CD133; NEURAL PROGENITORS; DISTINCT MEMBER; KIDNEY PROMININ; GENE-EXPRESSION	The pentaspan membrane glycoprotein prominin-1 (CD133) is widely used in medicine as a cell surface marker of stem and cancer stem cells. It has opened new avenues in stem cell-based regenerative therapy and oncology. This molecule is largely used with human samples or the mouse model, and consequently most biological tools including antibodies are directed against human and murine prominin-1. Although the general structure of prominin-1 including its membrane topology is conserved throughout the animal kingdom, its primary sequence is poorly conserved. Thus, it is unclear if anti-human and -mouse prominin-1 antibodies cross-react with their orthologs in other species, especially dog. Answering this issue is imperative in light of the growing number of studies using canine prominin-1 as an antigenic marker. Here, we address this issue by cloning the canine prominin-1 and use its overexpression as a green fluorescent protein fusion protein in Madin-Darby canine kidney cells to determine its immunoreactivity with antibodies against human or mouse prominin-1. We used immunocytochemistry, flow cytometry and immunoblotting techniques and surprisingly found no cross-species immunoreactivity. These results raise some caution in data interpretation when anti-prominin-1 antibodies are used in interspecies studies.	[Thamm, Kristina; Graupner, Sylvi; Corbeil, Denis] Tech Univ Dresden, Tissue Engn Labs, Biotechnol Ctr BIOTEC, Dresden, Germany; [Werner, Carsten; Corbeil, Denis] Tech Univ Dresden, DFG Res Ctr, Dresden, Germany; [Werner, Carsten; Corbeil, Denis] Tech Univ Dresden, Cluster Excellence Regenerat Therapies Dresden CR, Dresden, Germany; [Werner, Carsten] Leibniz Inst Polymer Res Dresden, Inst Biofunct Polymer Mat, Dresden, Germany; [Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Leibniz Institut fur Polymerforschung Dresden; Max Planck Society	Corbeil, D (corresponding author), Tech Univ Dresden, Tissue Engn Labs, Biotechnol Ctr BIOTEC, Dresden, Germany.; Corbeil, D (corresponding author), Tech Univ Dresden, DFG Res Ctr, Dresden, Germany.; Corbeil, D (corresponding author), Tech Univ Dresden, Cluster Excellence Regenerat Therapies Dresden CR, Dresden, Germany.	corbeil@biotec.tu-dresden.de	Corbeil, Denis/A-6519-2010; Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/L-2340-2019; Werner, Carsten/F-8127-2010; Huttner, Wieland B./P-4080-2018; Werner, Carsten/AAF-1510-2019	Corbeil, Denis/0000-0003-1181-3659; Werner, Carsten/0000-0003-0189-3448; 	Deutsche Forschungsgemeinschaft (DFG) [SFB655-B3, CO298/5-1]; Bundesministerium fur Bildung und Forschung (BMBF) [01DN13019]; Sachsisches Staatsministerium fur Wissenschaft und Kunst [4-7531.60/29/31]; DFG [SFB655]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Sachsisches Staatsministerium fur Wissenschaft und Kunst; DFG(German Research Foundation (DFG))	DC was supported by Deutsche Forschungsgemeinschaft (DFG, SFB655-B3; CO298/5-1), Bundesministerium fur Bildung und Forschung (BMBF, 01DN13019) and Sachsisches Staatsministerium fur Wissenschaft und Kunst (4-7531.60/29/31). CW and WBH were supported by DFG (SFB655-B2, SFB655-A2, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Belicchi M, 2004, J NEUROSCI RES, V77, P475, DOI 10.1002/jnr.20151; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Blacking TM, 2012, VET COMP ONCOL, V10, P252, DOI 10.1111/j.1476-5829.2011.00293.x; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Cocola C, 2009, REPROD DOMEST ANIM, V44, P214, DOI 10.1111/j.1439-0531.2009.01413.x; Cogliati B, 2010, VET COMP ONCOL, V8, P112, DOI 10.1111/j.1476-5829.2010.00210.x; Corbeil D, 1999, J CELL SCI, V112, P1023; Corbeil D, 1998, BLOOD, V91, P2625, DOI 10.1182/blood.V91.7.2625.2625_2625_2626; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2014, P NATL ACAD SCI USA, V111, pE1451, DOI 10.1073/pnas.1400195111; Corbeil D, 2013, ADV EXP MED BIOL, V777, P3, DOI 10.1007/978-1-4614-5894-4_1; Corbeil D, 2009, GLIA, V57, P860, DOI 10.1002/glia.20812; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fargeas CA, 2004, J CELL SCI, V117, P4301, DOI 10.1242/jcs.01315; Fargeas CA, 2003, J BIOL CHEM, V278, P8586, DOI 10.1074/jbc.M210640200; Fargeas CA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00091; Fargeas CA, 2011, WORLD J GASTROENTERO, V17, P4149, DOI 10.3748/wjg.v17.i36.4149; Fernandez F, 2016, VET J, V209, P125, DOI 10.1016/j.tvjl.2015.10.039; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Fujimoto A, 2013, J VET MED SCI, V75, P831, DOI 10.1292/jvms.12-0549; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Goldberg AFX, 2016, PROG RETIN EYE RES, V55, P52, DOI 10.1016/j.preteyeres.2016.05.003; Gorden BH, 2014, AM J PATHOL, V184, P985, DOI 10.1016/j.ajpath.2013.12.025; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Green CL, 2000, LEUKEMIA, V14, P770, DOI 10.1038/sj.leu.2401736; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Gurudev N, 2013, ADV EXP MED BIOL, V777, P55, DOI 10.1007/978-1-4614-5894-4_4; Guth AM, 2014, VET IMMUNOL IMMUNOP, V161, P132, DOI 10.1016/j.vetimm.2014.07.006; Han Z, 2011, MOL VIS, V17, P1381; Hermansen SK, 2011, J HISTOCHEM CYTOCHEM, V59, P391, DOI 10.1369/0022155411400867; Immervoll H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-48; Ito D, 2011, J VET INTERN MED, V25, P890, DOI 10.1111/j.1939-1676.2011.0756.x; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jaszai J, 2015, NEURAL SURFACE ANTIG, P113; Jaszai J, 2008, HISTOCHEM CELL BIOL, V130, P749, DOI 10.1007/s00418-008-0445-4; Jaszai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063457; Jaszai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017590; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Kemper K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012325; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Lamerato-Kozicki AR, 2006, EXP HEMATOL, V34, P870, DOI 10.1016/j.exphem.2006.04.013; Lardon J, 2008, PANCREAS, V36, pE1, DOI 10.1097/mpa.0b013e318149f2dc; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Liu W, 2015, ANTICANCER RES, V35, P1917; Lorico A, 2013, ADV EXP MED BIOL, V777, P197, DOI 10.1007/978-1-4614-5894-4_13; MADIN SH, 1958, P SOC EXP BIOL MED, V98, P574, DOI 10.3181/00379727-98-24111; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; McGrail M, 2010, DEV DYNAM, V239, P1849, DOI 10.1002/dvdy.22307; McMahill BG, 2015, STEM CELL REV REP, V11, P180, DOI 10.1007/s12015-014-9553-9; Michishita M, 2014, RES VET SCI, V96, P315, DOI 10.1016/j.rvsc.2014.01.004; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Miraglia S, 1998, BLOOD, V91, P4390, DOI 10.1182/blood.V91.11.4390; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Moulay M, 2013, ANTICANCER RES, V33, P5421; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Osmond TL, 2010, INT J MOL MED, V25, P883, DOI 10.3892/ijmm_00000418; Potgens AJG, 2002, J HISTOCHEM CYTOCHEM, V50, P1131, DOI 10.1177/002215540205000814; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Schmohl JU, 2016, TOXINS, V8, DOI 10.3390/toxins8060165; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Stoica G, 2009, VET PATHOL, V46, P391, DOI 10.1354/vp.08-VP-0218-S-FL; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Suzuki S, 2015, VET PATHOL, V52, P456, DOI 10.1177/0300985814546051; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Tabu K, 2013, ADV EXP MED BIOL, V777, P73, DOI 10.1007/978-1-4614-5894-4_5; Tanabe A, 2016, VET COMP ONCOL, V14, pE93, DOI 10.1111/vco.12110; Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Valenzuela MJ, 2008, STEM CELLS DEV, V17, P1087, DOI 10.1089/scd.2008.0008; Walton RM, 2013, HISTOCHEM CELL BIOL, V139, P415, DOI 10.1007/s00418-012-1053-x; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wu YF, 2006, ANN VASC SURG, V20, P387, DOI 10.1007/s10016-006-9047-6; Xia J, 2013, SCI REP-UK, V3, DOI 10.1038/srep03320; Xia L, 2009, J PHYSIOL SCI, V59, P429, DOI 10.1007/s12576-009-0053-7; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128	97	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164079	10.1371/journal.pone.0164079	http://dx.doi.org/10.1371/journal.pone.0164079			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701459	gold, Green Published, Green Submitted			2022-12-27	WOS:000385696900042
J	Silva, LFGE; Thomaz, EBAF; Freitas, HV; Pereira, ALP; Ribeiro, CCC; Alves, CMC				Gomes e Silva, Luciana Freitas; Abreu Fonseca Thomaz, Erika Barbara; Freitas, Heloiza Viana; Pozzobon Pereira, Alex Luiz; Costa Ribeiro, Cecilia Claudia; Coelho Alves, Claudia Maria			Impact of Malocclusion on the Quality of Life of Brazilian Adolescents: A Population-Based Study	PLOS ONE			English	Article							ORTHODONTIC TREATMENT NEED; ORAL-HEALTH STATUS; SOCIOECONOMIC-STATUS; DENTAL AESTHETICS; SOUTHERN BRAZIL; SELF-PERCEPTION; CHILDREN; SCHOOLCHILDREN; ESTEEM; INDEX	The objective of this study was to evaluate the impact of malocclusion on the quality of life (QOL) of adolescents in Brazil. We carried out a cross-sectional study in a sample population of 1015 schoolchildren aged 12 to 15 years from Sao Luis, Maranhao, Brazil. The explanatory variable was malocclusion, evaluated on the basis of the normative need or the adolescent's self-perceived need for dental treatment. Normative need for dental treatment was determined by professional diagnosis, made on the basis of Angle's classification, the Dental Aesthetic Index, and other morphological deviations (e.g., posterior crossbite, posterior open bite, and deep overbite). We analyzed the impact of malocclusion on the QOL using the Portuguese version of the Oral Health Impact Profile-14. Associations were estimated by using the prevalence ratio (PR) in Poisson regression analysis, with hierarchized modeling. An alpha of 5% was adopted as the criterion for statistical significance. The QOL of adolescents was impacted by malocclusion, classified by a normative need for treatment according to the Dental Aesthetic Index (PR = 1.27; 95% confidence interval [CI] = 1.03-1.56) or by the self-perceived need for treatment (PR = 2.54; 95% CI = 1.81-3.56). Certain sociodemographic variables, including the head of the family (PR = 1.52; 95% CI = 1.02-2.23), greater educational level of the head of the family (PR = 0.32; 95% CI = 0.17-0.61), and female sex (PR = 1.40; 95% CI = 1.05-1.89), had negative associations with QOL. We conclude that malocclusion has a negative impact on the QOL of adolescents, associated with socioeconomic conditions and the cosmetic effects of malocclusion.	[Gomes e Silva, Luciana Freitas] CEUMA Univ, Grad Program Dent, Sao Luis, Maranhao, Brazil; [Abreu Fonseca Thomaz, Erika Barbara; Freitas, Heloiza Viana; Pozzobon Pereira, Alex Luiz; Costa Ribeiro, Cecilia Claudia; Coelho Alves, Claudia Maria] Univ Fed Maranhao, Grad Program Dent, Sao Luis, Maranhao, Brazil; [Abreu Fonseca Thomaz, Erika Barbara; Freitas, Heloiza Viana; Pozzobon Pereira, Alex Luiz; Costa Ribeiro, Cecilia Claudia; Coelho Alves, Claudia Maria] Univ Fed Maranhao, Grad Program Publ Hlth, Sao Luis, Maranhao, Brazil	Universidade Ceuma; Universidade Federal do Maranhao; Universidade Federal do Maranhao	Silva, LFGE (corresponding author), CEUMA Univ, Grad Program Dent, Sao Luis, Maranhao, Brazil.	lucianafgs@gmail.com	Alves, Cláudia MC/H-2194-2016; THOMAZ, ERIKA/AAU-7762-2021; Ribeiro, Cecilia CC/H-2198-2016; Ribeiro, Cecilia Claudia Costa/AAI-2855-2021; THOMAZ, ERIKA/AAU-7752-2021	Ribeiro, Cecilia CC/0000-0003-0041-7618; THOMAZ, ERIKA/0000-0003-4156-4067	Federal University of Maranhao [09/2009]; Coordination for the Improvement of Higher Education Personnel (CAPES); Foundation for Research Support and Scientific and Technological Development of Maranhao (FAPEMA)	Federal University of Maranhao; Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for Research Support and Scientific and Technological Development of Maranhao (FAPEMA)	The authors would like to thank the Federal University of Maranhao for providing support through a Scientific Initiative Grant (no. 09/2009), the Coordination for the Improvement of Higher Education Personnel (CAPES) for the scholarship and the Foundation for Research Support and Scientific and Technological Development of Maranhao (FAPEMA) for supporting the translation and publication of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Federal University of Maranhao for providing support through a Scientific Initiative Grant (no. 09/2009), the Coordination for the Improvement of Higher Education Personnel (CAPES) for the scholarship and the Foundation for Research Support and Scientific and Technological Development of Maranhao (FAPEMA) for supporting the translation and publication of this article.	Agou S, 2008, AM J ORTHOD DENTOFAC, V134, P484, DOI 10.1016/j.ajodo.2006.11.021; Almeida Anderson Barbosa de, 2014, Dental Press J. Orthod., V19, P120, DOI 10.1590/2176-9451.19.3.120-126.oar; Angle EH, 1899, DENT COSMOS, VXLI, P249; Associacao Brasileira de Empresas de Pesquisa-ABEP, 2008, CRITERIO PADRAO DE C; Badran SA, 2014, ANGLE ORTHOD, V84, P588, DOI 10.2319/062913-482.1; Benson PE, 2015, EUR J ORTHODONT, V37, P481, DOI 10.1093/ejo/cju076; Bernabe E, 2006, ANGLE ORTHOD, V76, P417; Bernabe E, 2008, ANGLE ORTHOD, V78, P241, DOI 10.2319/030307-111.1; Brasil Ministerio da Saude, 2016, PROG MELH AC QUAL CE; Carr AJ, 2001, BMJ-BRIT MED J, V322, P1240, DOI 10.1136/bmj.322.7296.1240; CONS NC, 1983, INT DENT J, V33, P200; Davey Smith G., 1994, EUR J PUBLIC HEALTH, V4, P131, DOI [DOI 10.1093/EURPUB/4.2.131, 10.1093/eurpub/4.2.131]; de Oliveira BH, 2005, COMMUNITY DENT ORAL, V33, P307, DOI 10.1111/j.1600-0528.2005.00225.x; de Paula DF, 2009, ANGLE ORTHOD, V79, P1188, DOI [10.2319/082608-452R.1, 10.2319/082608-452.1]; DEAN AG, 1994, EPI INFO VERSION 6; Eiser C, 2001, J DEV BEHAV PEDIATR, V22, P248, DOI 10.1097/00004703-200108000-00007; Farzanegan Fahimeh, 2014, Dent Res J (Isfahan), V11, P684; Feldens CA, 2015, ANGLE ORTHOD, V85, P224, DOI 10.2319/021014-105.1; Feu D, 2010, AM J ORTHOD DENTOFAC, V138, P152, DOI 10.1016/j.ajodo.2008.09.033; Filstrup Sara L, 2003, Pediatr Dent, V25, P431; Ghijselings I, 2014, EUR J ORTHODONT, V36, P179, DOI 10.1093/ejo/cjt042; Hamdan AM, 2007, EUR J ORTHODONT, V29, P366, DOI 10.1093/ejo/cjm035; IBGE-Instituto Brasileiro de Geografia e Estatistica, SINT IND SOC AN COND; Klages U, 2002, EUR J ORTHODONT, V24, P53, DOI [10.1093/ejo/26.5.507, DOI 10.1093/EJO/26.5.507]; Kragt L, 2016, CLIN ORAL INVEST, V20, P1881, DOI 10.1007/s00784-015-1681-3; Mandall NA, 2008, EUR J ORTHODONT, V30, P40, DOI 10.1093/ejo/cjm077; Mandall NA, 2000, EUR J ORTHODONT, V22, P175, DOI 10.1093/ejo/22.2.175; Marques Leandro Silva, 2005, Cad. Saúde Pública, V21, P1099, DOI 10.1590/S0102-311X2005000400012; Marques LS, 2006, AM J ORTHOD DENTOFAC, V129, P424, DOI 10.1016/j.ajodo.2005.11.003; Martins AS, 2008, ORTODONTIA DIAGNOSTI, P99; Oliveira DC, 2015, ORAL HLTH PREV DENT, V13, P417, DOI 10.3290/j.ohpd.a33922; Organizacao Mundial de Saude, LEV BAS SAUD BUC; Pahel BT, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-6; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Paula JS, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-6; Peres KG, 2002, REV SAUDE PUBL, V36, P230, DOI 10.1590/S0034-89102002000200016; Piovesan C, 2010, QUAL LIFE RES, V19, P1359, DOI 10.1007/s11136-010-9692-7; Proffit WR, 2007, ORTODONTIA CONT; Ramos-Jorge ML, 2007, DENT TRAUMATOL, V23, P114, DOI 10.1111/j.1600-9657.2005.00409.x; Santos PCF, 2008, REV CLIN ORTODON DEN, V7, P34; Sardenberg F, 2013, ANGLE ORTHOD, V83, P83, DOI 10.2319/010912-20.1; Scapini A, 2013, ANGLE ORTHOD, V83, P512, DOI 10.2319/062012-509.1; Shekar BRC, 2011, ANN TROP MED PUBLIC, V4, P99, DOI 10.4103/1755-6783.85761; Slade GD, 1997, COMMUNITY DENT ORAL, V25, P284, DOI 10.1111/j.1600-0528.1997.tb00941.x; Tuchtenhagen S, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/1472-6831-15-15; Ukra A, 2013, N Z Dent J, V109, P18; Vargas Andréa Maria Duarte, 2005, Ciênc. saúde coletiva, V10, P1015, DOI 10.1590/S1413-81232005000400024	47	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0162715	10.1371/journal.pone.0162715	http://dx.doi.org/10.1371/journal.pone.0162715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DX4CZ	27690356	gold, Green Published, Green Submitted			2022-12-27	WOS:000384329200005
J	Ojeda, D; Le Rolle, V; Romero-Ugalde, HM; Gallet, C; Bonnet, JL; Henry, C; Bel, A; Mabo, P; Carrault, G; Hernandez, AI				Ojeda, David; Le Rolle, Virginie; Romero-Ugalde, Hector M.; Gallet, Clement; Bonnet, Jean-Luc; Henry, Christine; Bel, Alain; Mabo, Philippe; Carrault, Guy; Hernandez, Alfredo I.			Sensitivity Analysis of Vagus Nerve Stimulation Parameters on Acute Cardiac Autonomic Responses: Chronotropic, Inotropic and Dromotropic Effects	PLOS ONE			English	Article							VAGAL-STIMULATION; HEART-RATE; FIBERS	Although the therapeutic effects of Vagus Nerve Stimulation (VNS) have been recognized in pre-clinical and pilot clinical studies, the effect of different stimulation configurations on the cardiovascular response is still an open question, especially in the case of VNS delivered synchronously with cardiac activity. In this paper, we propose a formal mathematical methodology to analyze the acute cardiac response to different VNS configurations, jointly considering the chronotropic, dromotropic and inotropic cardiac effects. A latin hypercube sampling method was chosen to design a uniform experimental plan, composed of 75 different VNS configurations, with different values for the main parameters (current amplitude, number of delivered pulses, pulse width, interpulse period and the delay between the detected cardiac event and VNS onset). These VNS configurations were applied to 6 healthy, anesthetized sheep, while acquiring the associated cardiovascular response. Unobserved VNS configurations were estimated using a Gaussian process regression (GPR) model. In order to quantitatively analyze the effect of each parameter and their combinations on the cardiac response, the Sobol sensitivity method was applied to the obtained GPR model and inter-individual sensitivity markers were estimated using a bootstrap approach. Results highlight the dominant effect of pulse current, pulse width and number of pulses, which explain respectively 49.4%, 19.7% and 6.0% of the mean global cardiovascular variability provoked by VNS. More interestingly, results also quantify the effect of the interactions between VNS parameters. In particular, the interactions between current and pulse width provoke higher cardiac effects than the changes on the number of pulses alone (between 6 and 25% of the variability). Although the sensitivity of individual VNS parameters seems similar for chronotropic, dromotropic and inotropic responses, the interacting effects of VNS parameters provoke significantly different cardiac responses, showing the feasibility of a parameter-based functional selectivity. These results are of primary importance for the optimal, subject-specific definition of VNS parameters for a given therapy and may lead to new closed-loop methods allowing for the optimal adaptation of VNS therapy through time.	[Ojeda, David; Le Rolle, Virginie; Romero-Ugalde, Hector M.; Gallet, Clement; Mabo, Philippe; Carrault, Guy; Hernandez, Alfredo I.] INSERM, U1099, Rennes, France; [Ojeda, David; Le Rolle, Virginie; Romero-Ugalde, Hector M.; Gallet, Clement; Mabo, Philippe; Carrault, Guy; Hernandez, Alfredo I.] Univ Rennes 1, LTSI, Rennes, France; [Bonnet, Jean-Luc; Henry, Christine] Sorin CRM SAS, Clamart, France; [Bel, Alain] INSERM, UMR970, Paris Cardiovasc Res Ctr, Paris, France; [Bel, Alain] Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, Paris, France; [Bel, Alain] Paris Descartes Univ, PRES Paris Sorbonne, Paris, France; [Mabo, Philippe] CHU Rennes, Dept Cardiol, Rennes, France; [Mabo, Philippe] INSERM, CIC IT 1414, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hernandez, AI (corresponding author), INSERM, U1099, Rennes, France.; Hernandez, AI (corresponding author), Univ Rennes 1, LTSI, Rennes, France.	Alfredo.Hernandez@inserm.fr	Le Rolle, Virginie/AAQ-7010-2020; carrault, guy/ABC-4463-2020; Hernández, Alfredo I/K-4933-2015	Le Rolle, Virginie/0000-0003-1068-5587; carrault, guy/0000-0003-1482-2067; Hernández, Alfredo I/0000-0003-0765-2311; Romero Ugalde, Hector Manuel/0000-0002-7614-6474	BPIFRANCE	BPIFRANCE	This work was supported by BPIFRANCE within the framework of the French "Investments for the future program (http://investissementsdavenir.bpifrance.fr) - INTENSE project. SORIN CRM SAS did not support financially the project. JLB and CH are employed by SORIN CRM SAS. No other authors received a salary or gratification from SORIN CRM SAS for their contribution to this work. The specific roles of the authors are articulated in the "author contributions" section.; This work was supported by BPIFRANCE within the framework of the French "Investments for the future" program-INTENSE project.	Andreu D, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026001; Ardell JL, 2015, AM J PHYSIOL-HEART C, V309, pH1740, DOI 10.1152/ajpheart.00557.2015; BENMENACHEM E, 1994, EPILEPSIA, V35, P616, DOI 10.1111/j.1528-1157.1994.tb02482.x; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Buschman HP, 2006, NEUROMODULATION, V9, P214, DOI 10.1111/j.1525-1403.2006.00062.x; Castoro MA, 2011, EXP NEUROL, V227, P62, DOI 10.1016/j.expneurol.2010.09.011; Chen SA, 1998, J CARDIOVASC ELECTR, V9, P245, DOI 10.1111/j.1540-8167.1998.tb00909.x; De Ferrari GM, 2014, J CARDIOVASC TRANSL, V7, P310, DOI 10.1007/s12265-014-9540-1; DONG E, 1970, CIRC RES, V27, P635, DOI 10.1161/01.RES.27.5.635; Dumont J, 2010, IEEE T BIO-MED ENG, V57, P607, DOI 10.1109/TBME.2008.2002157; Guiraud D, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/041002; HENNING RJ, 1989, AM J PHYSIOL, V256, pH428, DOI 10.1152/ajpheart.1989.256.2.H428; Hernandez AI, 2000, T I MEAS CONTROL, V22, P231; Kleijnen JPC, 2009, EUR J OPER RES, V192, P707, DOI 10.1016/j.ejor.2007.10.013; Klein HU, 2010, CARDIOL J, V17, P638; Kong SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042799; LEVY MN, 1969, CIRC RES, V24, P303, DOI 10.1161/01.RES.24.3.303; MARTIN P, 1982, AM J PHYSIOL, V243, pH219, DOI 10.1152/ajpheart.1982.243.2.H219; Premchand RK, 2016, J CARD FAIL, V22, P639, DOI 10.1016/j.cardfail.2015.11.002; Pujol G, 2016, SENSITIVITY GLOBAL S; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rousselet L, 2014, IEEE ENG MED BIO, P526, DOI 10.1109/EMBC.2014.6943644; Roustant O, 2012, J STAT SOFTW, V51, P1; Rush AJ, 2000, BIOL PSYCHIAT, V47, P276, DOI 10.1016/S0006-3223(99)00304-2; Saltelli A., 2008, GLOBAL SENSITIVITY A; Schwartz PJ, 2009, HEART RHYTHM, V6, pS76, DOI 10.1016/j.hrthm.2009.08.012; Sobol IM, 2007, RELIAB ENG SYST SAFE, V92, P957, DOI 10.1016/j.ress.2006.07.001; Stocki R., 2005, COMPUT ASSIST MECH E, V12, P87; Thompson GW, 1998, ANN THORAC SURG, V65, P637, DOI 10.1016/S0003-4975(97)01351-9; Ugalde HMR, 2016, IEEE T BIO-MED ENG, V63, P1551, DOI 10.1109/TBME.2015.2498878; Ugalde HMR, 2015, I IEEE EMBS C NEUR E, P462, DOI 10.1109/NER.2015.7146659; Ugalde HR, 2014, IEEE ENG MED BIO, P6262, DOI 10.1109/EMBC.2014.6945060; VANOLI E, 1991, CIRC RES, V68, P1471, DOI 10.1161/01.RES.68.5.1471; WALLICK DW, 1979, AM J PHYSIOL, V237, pH275, DOI 10.1152/ajpheart.1979.237.3.H275; Yamakawa K, 2015, AM J PHYSIOL-HEART C, V309, pH1579, DOI 10.1152/ajpheart.00558.2015; YANG T, 1984, AM J PHYSIOL, V246, pH585, DOI 10.1152/ajpheart.1984.246.4.H585; YANG TN, 1990, CIRC RES, V67, P844, DOI 10.1161/01.RES.67.4.844; Yoo PB, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12689; Zannad F, 2015, EUR HEART J, V36, P425, DOI 10.1093/eurheartj/ehu345	39	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163734	10.1371/journal.pone.0163734	http://dx.doi.org/10.1371/journal.pone.0163734			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690312	Green Published, Green Submitted, gold			2022-12-27	WOS:000384329200022
J	Vasu, MM; Anitha, A; Takahashi, T; Thanseem, I; Iwata, K; Asakawa, T; Suzuki, K				Vasu, Mahesh Mundalil; Anitha, Ayyappan; Takahashi, Taro; Thanseem, Ismail; Iwata, Keiko; Asakawa, Tetsuya; Suzuki, Katsuaki			Fluoxetine Increases the Expression of miR-572 and miR-663a in Human Neuroblastoma Cell Lines	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; MICRORNAS; BRAIN; GENE; SEROTONIN; EXPOSURE; RECEPTOR; ANTIDEPRESSANTS; PREGNANCY; PATTERNS	Evidence suggests neuroprotective effects of fluoxetine, a selective serotonin reuptake inhibitor (SSRI), on the developed neurons in the adult brain. In contrast, the drug may be deleterious to immature or undifferentiated neural cells, although the mechanism is unclear. Recent investigations have suggested that microRNAs (miRNA) may be critical for effectiveness of psychotropic drugs including SSRI. We investigated whether fluoxetine could modulate expressions of neurologically relevant miRNAs in two neuroblastoma SK-N-SH and SH-SY5Y cell lines. Initial screening results revealed that three (miR-489, miR-572 and miR-663a) and four (miR-320a, miR-489, miR-572 and miR-663a) miRNAs were up-regulated in SK-N-SH cells and SH-SY5Y cells, respectively, after 24 hours treatment of fluoxetine (1 - 25 mu M). Cell viability was reduced according to the dose of fluoxetine. The upregulation of miR-572 and miR-663a was consistent in both the SH-SY5Y and SK-N-SH cells, confirmed by a larger scale culture condition. Our data is the first in vitro evidence that fluoxetine could increase the expression of miRNAs in undifferentiated neural cells, and that putative target genes of those miRNAs have been shown to be involved in fundamental neurodevelopmental processes.	[Vasu, Mahesh Mundalil; Asakawa, Tetsuya] Hamamatsu Univ Sch Med, Dept Psychiat, Hamamatsu, Shizuoka, Japan; [Anitha, Ayyappan; Thanseem, Ismail] Inst Commun & Cognit Neurosci ICCONS, Kavalapara, Kerala, India; [Takahashi, Taro] Hamamatsu Univ Sch Med, Dept Child & Adolescent Psychiat, Hamamatsu, Shizuoka, Japan; [Iwata, Keiko] Univ Fukui, Res Ctr Child Mental Dev, Fukui, Japan; [Suzuki, Katsuaki] Hamamatsu Univ Sch Med, Dept Biofunct Imaging, Preeminent Med Photon Educ & Res Ctr, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; University of Fukui; Hamamatsu University School of Medicine	Suzuki, K (corresponding author), Hamamatsu Univ Sch Med, Dept Biofunct Imaging, Preeminent Med Photon Educ & Res Ctr, Hamamatsu, Shizuoka, Japan.	katsuaki-suzuki@ams.odn.ne.jp	Asakawa, Tetsuya/ABE-5307-2020	Asakawa, Tetsuya/0000-0002-2300-3509; Suzuki, Katsuaki/0000-0003-0446-3355; Anitha, Ayyappan/0000-0001-6767-2694	Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [15K15426] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan and by a grant from the Takeda Science Foundation. None of these funding sources played any role in the design or conduct of the study; the collection, management, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.	Abu-Elneel K, 2008, NEUROGENETICS, V9, P153, DOI 10.1007/s10048-008-0133-5; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Barak B, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.77; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Bolo NR, 2000, NEUROPSYCHOPHARMACOL, V23, P428, DOI 10.1016/S0893-133X(00)00116-0; Boukhris T, 2016, JAMA PEDIATR, V170, P117, DOI 10.1001/jamapediatrics.2015.3356; Cheer SM, 2001, DRUGS, V61, P81, DOI 10.2165/00003495-200161010-00010; Choi MR, 2012, PSYCHIAT INVEST, V9, P180, DOI 10.4306/pi.2012.9.2.180; Dallerac G, 2011, LEARN MEMORY, V18, P306, DOI 10.1101/lm.2154311; De Santis G, 2010, J NEUROIMMUNOL, V226, P165, DOI 10.1016/j.jneuroim.2010.06.009; Fan HM, 2015, MED GENET, V32, P641, DOI DOI 10.3760/CMA.J.ISSN.1003-9406.2015.05.007; Forero DA, 2010, HUM MUTAT, V31, P1195, DOI 10.1002/humu.21344; Herr AS, 2003, NEUROENDOCRINOLOGY, V78, P12, DOI 10.1159/000071701; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kristensen JH, 1999, BRIT J CLIN PHARMACO, V48, P521, DOI 10.1046/j.1365-2125.1999.00040.x; Lai CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021635; Li SR, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/528678; Maciag D, 2006, NEUROPSYCHOPHARMACOL, V31, P47, DOI 10.1038/sj.npp.1300823; Man KKC, 2015, NEUROSCI BIOBEHAV R, V49, P82, DOI 10.1016/j.neubiorev.2014.11.020; Mancuso R, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0504-2; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Mun AR, 2013, ANTICANCER RES, V33, P3691; O'Connor RM, 2012, MOL PSYCHIATR, V17, P359, DOI 10.1038/mp.2011.162; Olsen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007225; Owens MJ, 1997, J PHARMACOL EXP THER, V283, P1305; Pariante CM, 2003, BRIT J PHARMACOL, V139, P1111, DOI 10.1038/sj.bjp.0705357; Riksen EA, 2010, EUR J ORAL SCI, V118, P566, DOI 10.1111/j.1600-0722.2010.00778.x; Sarachana T, 2010, GENOME MED, V2, DOI 10.1186/gm144; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Shi Y, 2014, CLIN CANCER RES, V20, P1803, DOI 10.1158/1078-0432.CCR-13-2284; Shu R, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.10; Siegel G, 2011, CURR OPIN GENET DEV, V21, P491, DOI 10.1016/j.gde.2011.04.008; Smalheiser NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033201; Stepulak A, 2008, CANCER BIOL THER, V7, P1685, DOI 10.4161/cbt.7.10.6664; STOLL AL, 1991, J CLIN PSYCHOPHARM, V11, P225; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Sun BK, 2015, INT J MOL SCI, V16, P16655, DOI 10.3390/ijms160716655; Talebizadeh Z, 2008, AUTISM RES, V1, P240, DOI 10.1002/aur.33; Vasu MM, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-40; VORHEES CV, 1994, FUND APPL TOXICOL, V23, P194, DOI 10.1006/faat.1994.1098; Xu B, 2010, BRAIN RES, V1338, P78, DOI 10.1016/j.brainres.2010.03.109; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Yu X., 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1016/J.JCV.2015.05.015	49	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164425	10.1371/journal.pone.0164425	http://dx.doi.org/10.1371/journal.pone.0164425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716787	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100051
J	Colak, D; Alaiya, AA; Kaya, N; Muiya, NP; AlHarazi, O; Shinwari, Z; Andres, E; Dzimiri, N				Colak, Dilek; Alaiya, Ayodele A.; Kaya, Namik; Muiya, Nzioka P.; AlHarazi, Olfat; Shinwari, Zakia; Andres, Editha; Dzimiri, Nduna			Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy	PLOS ONE			English	Article							GENE-EXPRESSION; HEART-FAILURE; MESSENGER-RNA; SUPEROXIDE-DISMUTASE; MYOCARDIAL INJURY; MICROARRAY; DATABASE; DYSFUNCTION; DEFICIENCY; THERAPY	Aims The disease pathways leading to idiopathic dilated cardiomyopathy (DCM) are still elusive. The present study investigated integrated global transcriptional and translational changes in human DCM for disease biomarker discovery. Methods We used identical myocardial tissues from five DCM hearts compared to five non-failing (NF) donor hearts for both transcriptome profiling using the ABI high-density oligonucleotide microarrays and proteome expression with One-Dimensional Nano Acquity liquid chromatography coupled with tandem mass spectrometry on the Synapt G2 system. Results We identified 1262 differentially expressed genes (DEGs) and 269 proteins (DEPs) between DCM cases and healthy controls. Among the most significantly upregulated (>5-fold) proteins were GRK5, APOA2, IGHG3, ANXA6, HSP90AA1, and ATP5C1 (p< 0.01). On the other hand, the most significantly downregulated proteins were GSTM5, COX17, CAV1 and ANXA3. At least ten entities were concomitantly upregulated on the two analysis platforms: GOT1, ALDH4A1, PDHB, BDH1, SLC2A11, HSP90AA1, HSP90AB1, H2AFV, HSPA5 and NDUFV1. Gene ontology analyses of DEGs and DEPs revealed significant overlap with enrichment of genes/proteins related to metabolic process, biosynthetic process, cellular component organization, oxidative phosphorylation, alterations in glycolysis and ATP synthesis, Alzheimer's disease, chemokine-mediated inflammation and cytokine signalling pathways. Conclusion The concomitant use of transcriptome and proteome expression to evaluate global changes in DCM has led to the identification of sixteen commonly altered entities as well as novel genes, proteins and pathways whose cardiac functions have yet to be deciphered. This data should contribute towards better management of the disease.	[Colak, Dilek; AlHarazi, Olfat] King Faisal Specialist Hosp & Res Ctr, Biostat Epidemiol & Sci Comp Dept, Riyadh 11211, Saudi Arabia; [Alaiya, Ayodele A.; Shinwari, Zakia] King Faisal Specialist Hosp & Res Ctr, Prote Unit, Stem Cell Tissue Reengn Program, Riyadh 11211, Saudi Arabia; [Kaya, Namik; Muiya, Nzioka P.; Andres, Editha; Dzimiri, Nduna] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center	Dzimiri, N (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	dzimiri@kfshrc.edu.sa	Andres, E/AAY-3767-2020	Dzimiri, Nduna/0000-0003-3395-5754; Colak, Dilek/0000-0001-6485-8768	Royal Research Grant through the King Faisal Specialist Hospital and Research Centre [2100020]; National Plan for Science, Technology and Innovation program / King Abdulaziz City for Science and Technology [11-6102072-20]	Royal Research Grant through the King Faisal Specialist Hospital and Research Centre; National Plan for Science, Technology and Innovation program / King Abdulaziz City for Science and Technology	This work was supported by the Royal Research Grant 2100020 through the King Faisal Specialist Hospital and Research Centre and National Plan for Science, Technology and Innovation program / King Abdulaziz City for Science and Technology grant 11-6102072-20. The authors would like to express their gratitude to the King Faisal Specialist Hospital and Research Centre for the financial support and National Plan for Science, Technology and Innovation program (NSTIP/KACST) for supporting Dr. Dilek Colak.; This work was supported by the Royal Research Grant 2100020 through the King Faisal Specialist Hospital and Research Centre and National Plan for Science, Technology and Innovation program/King Abdulaziz City for Science and Technology grant 11-BI02072-20. The authors would like to express their gratitude the King Faisal Specialist Hospital and Research Centre for the financial support and National Plan for Science, Technology and Innovation program (NSTIP/KACST) for supporting Dr. Dilek Colak.	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Al-Moghrabi N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-830; Alaiya A, 2014, CANCER GENOM PROTEOM, V11, P39; Arimura T, 2007, Acta Myol, V26, P153; Barrans JD, 2002, AM J PATHOL, V160, P2035, DOI 10.1016/S0002-9440(10)61153-4; Barrett AB, 2008, IEEE ENG MED BIO, P5660, DOI 10.1109/IEMBS.2008.4650498; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; Charniot JC, 2011, FREE RADICAL RES, V45, P379, DOI 10.3109/10715762.2010.532792; Chuang LY, 2009, 2 STAGE FEATURE SELE; Colak D, 2009, GENOMICS, V94, P20, DOI 10.1016/j.ygeno.2009.03.003; Datta A, 2013, J PROTEOMICS, V91, P556, DOI 10.1016/j.jprot.2013.08.017; Denham J, 2015, J APPL PHYSL; Dzimiri N, 1999, PHARMACOL REV, V51, P465; Engebretsen KVT, 2013, J APPL PHYSIOL, V114, P988, DOI 10.1152/japplphysiol.00793.2012; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hiroi S, 1999, BIOCHEM BIOPH RES CO, V261, P332, DOI 10.1006/bbrc.1999.1036; Kaab S, 2004, J MOL MED, V82, P308, DOI 10.1007/s00109-004-0527-2; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li LH, 2009, AM J PHYSIOL-HEART C, V297, pH1504, DOI 10.1152/ajpheart.00194.2009; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liang YF, 2011, LAB INVEST, V91, P12, DOI 10.1038/labinvest.2010.156; Liu TT, 2014, LIFE SCI, V101, P27, DOI 10.1016/j.lfs.2014.02.004; Liu YC, 2015, GENOMICS, V105, P83, DOI 10.1016/j.ygeno.2014.12.002; Mahmoudabady M, 2008, J CARD FAIL, V14, P703, DOI 10.1016/j.cardfail.2008.05.003; McCloskey DT, 2008, AM J PHYSIOL-HEART C, V294, pH205, DOI 10.1152/ajpheart.00829.2007; Mittmann C, 1998, CARDIOVASC RES, V39, P267, DOI 10.1016/S0008-6363(98)00139-4; Ono H, 2010, INTERNAL MED, V49, P2039, DOI 10.2169/internalmedicine.49.3710; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Pedotti P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-124; Princen F, 2009, MOL CELL BIOL, V29, P378, DOI 10.1128/MCB.01661-08; Rodriguez-Iturbe B, 2007, J APPL PHYSIOL, V102, P255, DOI 10.1152/japplphysiol.00513.2006; Ross J, 2002, CIRC J, V66, P219, DOI 10.1253/circj.66.219; Sacconi S, 2003, PEDIATR RES, V53, P224, DOI 10.1203/01.PDR.0000048100.91730.6A; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Singh KK, 2014, J THORAC CARDIOV SUR, V147, P1065, DOI 10.1016/j.jtcvs.2013.04.042; Singla Sandeep, 2011, Ther Adv Cardiovasc Dis, V5, P305, DOI 10.1177/1753944711429715; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tavi P, 2001, TRENDS PHARMACOL SCI, V22, P254, DOI 10.1016/S0165-6147(00)01679-5; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Wu ZJ, 2005, J COMPUT BIOL, V12, P882, DOI 10.1089/cmb.2005.12.882; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Yeung ES, 2011, ANGEW CHEM INT EDIT, V50, P583, DOI 10.1002/anie.201005969	49	25	26	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0162669	10.1371/journal.pone.0162669	http://dx.doi.org/10.1371/journal.pone.0162669			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711126	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600008
J	Dahan, A; Noy, L; Hart, Y; Mayo, A; Alon, U				Dahan, Assi; Noy, Lior; Hart, Yuval; Mayo, Avi; Alon, Uri			Exit from Synchrony in Joint Improvised Motion	PLOS ONE			English	Article							TO-FACE INTERACTION; PHASE-TRANSITIONS; INTERPERSONAL COORDINATION; SOCIAL COORDINATION; MOVEMENT SYNCHRONY; RHYTHMIC MOVEMENT; MANUAL TRACKING; MODEL; BEHAVIOR; MOTHER	Motion synchrony correlates with effective and well-rated human interaction. However, people do not remain locked in synchrony; Instead, they repeatedly enter and exit synchrony. In many important interactions, such as therapy, marriage and parent-infant communication, it is the ability to exit and then re-enter synchrony that is thought to build strong relationship. The phenomenon of entry into zero-phase synchrony is well-studied experimentally and in terms of mathematical modeling. In contrast, exit-from-synchrony is understudied. Here, we focus on human motion coordination, and examine the exit-from-synchrony phenomenon using experimental data from the mirror game paradigm, in which people perform joint improvised motion, and from human tracking of computer-generated stimuli. We present a mathematical mechanism that captures aspects of exit-from-synchrony in human motion. The mechanism adds a random motion component when the accumulated velocity error between the players is small. We introduce this mechanism to several models for human coordinated motion, including the widely studied HKB model, and the predictor-corrector model of Noy, Dekel and Alon. In all models, the new mechanism produces realistic simulated behavior when compared to experimental data from the mirror game and from tracking of computer generated stimuli, including repeated entry and exit from zero-phase synchrony that generates a complexity of motion similar to that of human players. We hope that these results can inform future research on exit-from-synchrony, to better understand the dynamics of coordinated	[Dahan, Assi; Noy, Lior; Hart, Yuval; Mayo, Avi; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Dahan, Assi; Noy, Lior; Hart, Yuval; Mayo, Avi; Alon, Uri] Weizmann Inst Sci, Theatre Lab, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.; Alon, U (corresponding author), Weizmann Inst Sci, Theatre Lab, Rehovot, Israel.	uri.alon@weizmann.ac.il	mayo, avi/N-3756-2019; Hart, Yuval/HGD-6424-2022; Noy, Lior/GQZ-3657-2022	mayo, avi/0000-0002-4479-3423; 	Humanities, at the Weizmann Institute of Science	Humanities, at the Weizmann Institute of Science	We thank the Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science, for support. Uri Alon is the incumbent of the Abisch-Frenkel Professorial Chair.	Bardy BG, 2014, IEEE SYS MAN CYBERN, P772, DOI 10.1109/SMC.2014.6974004; BERNIERI FJ, 1988, J NONVERBAL BEHAV, V12, P120, DOI 10.1007/BF00986930; Bingham GP, 2004, ECOL PSYCHOL, V16, P45, DOI 10.1207/s15326969eco1601_6; Brennan SE, 2010, PSYCHOL LEARN MOTIV, V53, P301, DOI 10.1016/S0079-7421(10)53008-1; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Chao Zhai FA, 2014, NOVEL COGNITIVE ARCH, DOI [10.1109/SMC.2014.6974001, DOI 10.1109/SMC.2014.6974001]; COHN JF, 1987, DEV PSYCHOL, V23, P68, DOI 10.1037/0012-1649.23.1.68; COHN JF, 1988, DEV PSYCHOL, V24, P386, DOI 10.1037/0012-1649.24.3.386; CONDON WS, 1974, SCIENCE, V183, P99, DOI 10.1126/science.183.4120.99; CONDON WS, 1966, J NERV MENT DIS, V143, P338, DOI 10.1097/00005053-196610000-00005; Crown C. L., 1991, J LANG SOC PSYCHOL, V10, P29, DOI DOI 10.1177/0261927X91101002; Dellu F, 1996, NEUROPSYCHOBIOLOGY, V34, P136, DOI 10.1159/000119305; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; ECKERMAN CO, 1990, DEV PSYCHOL, V26, P370, DOI 10.1037/0012-1649.26.3.370; Feldman R, 2007, CURR DIR PSYCHOL SCI, V16, P340, DOI 10.1111/j.1467-8721.2007.00532.x; Feldman R, 2011, INFANT BEHAV DEV, V34, P569, DOI 10.1016/j.infbeh.2011.06.008; Fogel A, 1993, DEV RELATIONSHIPS OR; Galantucci B, 2009, TOP COGN SCI, V1, P255, DOI 10.1111/j.1756-8765.2009.01017.x; Garrod S, 2004, TRENDS COGN SCI, V8, P8, DOI 10.1016/j.tics.2003.10.016; Garrod S, 2009, TOP COGN SCI, V1, P292, DOI 10.1111/j.1756-8765.2009.01020.x; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Hari R, 2013, TRENDS COGN SCI, V17, P105, DOI 10.1016/j.tics.2013.01.003; Hart Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087213; Hoffman G, 2010, IEEE INT CONF ROBOT, P582, DOI 10.1109/ROBOT.2010.5509182; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Issartel J, 2007, NEUROSCI LETT, V411, P174, DOI 10.1016/j.neulet.2006.09.086; Johnstone Keith, 1987, IMPRO IMPROVISATION; KAY BA, 1987, J EXP PSYCHOL HUMAN, V13, P178, DOI 10.1037/0096-1523.13.2.178; KELSO JAS, 1987, PHYS SCRIPTA, V35, P79, DOI 10.1088/0031-8949/35/1/020; Kelso S., 1995, DYNAMIC PATTERNS SEL; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Khoramshahi M., 2014, 2014 IEEE INT C SYST; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; Lakens D, 2011, SOC COGNITION, V29, P1, DOI 10.1521/soco.2011.29.1.1; Lewis JM, 2000, AM J PSYCHIAT, V157, P1375, DOI 10.1176/appi.ajp.157.9.1375; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; Masumoto J, 2013, J NEUROPHYSIOL, V109, P1307, DOI 10.1152/jn.00776.2012; McNeill W. H., 1995, KEEPING TOGETHER TIM; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; MIALL RC, 1985, NEUROSCIENCE, V16, P511, DOI 10.1016/0306-4522(85)90189-7; Miyake Y, 2009, IEEE T ROBOT, V25, P638, DOI 10.1109/TRO.2009.2020350; Nagaoka C, 2008, IEICE T INF SYST, VE91D, P1634, DOI 10.1093/ietisy/e91-d.6.1634; Noy L, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3339/fnhum.2015.00187, 10.3389/fnhum.2015.00187]; Noy L, 2015, EXP BRAIN RES, V233, P1307, DOI 10.1007/s00221-015-4204-1; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Paxton A, 2013, BEHAV RES METHODS, V45, P329, DOI 10.3758/s13428-012-0249-2; Ramseyer F., 2008, SIMULTANEITY TEMPORA, P329, DOI DOI 10.1142/9789812792426_0020; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Richardson MJ, 2007, J EXP PSYCHOL HUMAN, V33, P845, DOI 10.1037/0096-1523.33.4.845; Sawyer R, 2001, CREATING CONVERSATIO, DOI [10.1177/0261927X91101002, DOI 10.1177/0261927X91101002]; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; SCHMIDT RC, 1990, J EXP PSYCHOL HUMAN, V16, P227, DOI 10.1037/0096-1523.16.2.227; Schmidt RC, 2008, UNDERST COMPLEX SYST, P281, DOI 10.1007/978-3-540-74479-5_14; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Slowinski P, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1093; Snapp-Childs W, 2011, EXP BRAIN RES, V215, P89, DOI 10.1007/s00221-011-2874-x; Stephens GJ, 2010, P NATL ACAD SCI USA, V107, P14425, DOI 10.1073/pnas.1008662107; Tanaka F, 2004, RO-MAN 2004: 13TH IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, PROCEEDINGS, P419, DOI 10.1109/ROMAN.2004.1374797; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Tognoli E, 2014, NEURON, V81, P35, DOI 10.1016/j.neuron.2013.12.022; TRONICK EZ, 1989, CHILD DEV, V60, P85, DOI 10.2307/1131074; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Yun K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00959; Zhai C., 2014, ADAPTIVE TRACKING CO; Zhang JJ, 2013, IEEE INT CONF ROBOT, P2201, DOI 10.1109/ICRA.2013.6630873	72	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0160747	10.1371/journal.pone.0160747	http://dx.doi.org/10.1371/journal.pone.0160747			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711185	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600002
J	Foley, AM; Hewitt, DG; DeYoung, CA; DeYoung, RW; Schnupp, MJ				Foley, Aaron M.; Hewitt, David G.; DeYoung, Charles A.; DeYoung, Randy W.; Schnupp, Matthew J.			Modeled Impacts of Chronic Wasting Disease on White-Tailed Deer in a Semi-Arid Environment	PLOS ONE			English	Article							FENCE-LINE CONTACT; MULE DEER; SOUTH TEXAS; ODOCOILEUS-VIRGINIANUS; HELICOPTER SURVEYS; DYNAMICS; WILDLIFE; TRANSMISSION; POPULATION; ELK	White-tailed deer are a culturally and economically important game species in North America, especially in South Texas. The recent discovery of chronic wasting disease (CWD) in captive deer facilities in Texas has increased concern about the potential emergence of CWD in free-ranging deer. The concern is exacerbated because much of the South Texas region is a semi-arid environment with variable rainfall, where precipitation is strongly correlated with fawn recruitment. Further, the marginally productive rangelands, in combination with erratic fawn recruitment, results in populations that are frequently density-independent, and thus sensitive to additive mortality. It is unknown how a deer population in semi-arid regions would respond to the presence of CWD. We used long-term empirical datasets from a lightly harvested (2% annual harvest) population in conjunction with 3 prevalence growth rates from CWD afflicted areas (0.26%, 0.83%, and 2.3% increases per year) via a multistage partially deterministic model to simulate a deer population for 25 years under four scenarios: 1) without CWD and without harvest, 2) with CWD and without harvest, 3) with CWD and male harvest only, and 4) with CWD and harvest of both sexes. The modeled populations without CWD and without harvest averaged a 1.43% annual increase over 25 years; incorporation of 2% annual harvest of both sexes resulted in a stable population. The model with slowest CWD prevalence rate growth (0.26% annually) without harvest resulted in stable populations but the addition of 1% harvest resulted in population declines. Further, the male age structure in CWD models became skewed to younger age classes. We incorporated fawn: doe ratios from three CWD afflicted areas in Wisconsin and Wyoming into the model with 0.26% annual increase in prevalence and populations did not begin to decline until similar to 10%, similar to 16%, and similar to 26% of deer were harvested annually. Deer populations in variable environments rely on high adult survivorship to buffer the low and erratic fawn recruitment rates. The increase in additive mortality rates for adults via CWD negatively impacted simulated population trends to the extent that hunter opportunity would be greatly reduced. Our results improve understanding of the potential influences of CWD on deer populations in semi-arid environments with implications for deer managers, disease ecologists, and policy makers.	[Foley, Aaron M.; Hewitt, David G.; DeYoung, Charles A.; DeYoung, Randy W.] Texas A&M Univ Kingsville, Caesar Kleberg Wildlife Res Inst, Kingsville, TX 78363 USA; [Schnupp, Matthew J.] King Ranch Inc, Kingsville, TX USA	Texas A&M University System; Texas A&M University Kingsville	Foley, AM (corresponding author), Texas A&M Univ Kingsville, Caesar Kleberg Wildlife Res Inst, Kingsville, TX 78363 USA.	amfoley55@hotmail.com						Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; BARRETT M W, 1982, Wildlife Society Bulletin, V10, P108; BEASOM SL, 1974, J WILDLIFE MANAGE, V38, P854, DOI 10.2307/3800056; BEASOM SL, 1986, WILDLIFE SOC B, V14, P364; Blanchong JA, 2006, WILDLIFE SOC B, V34, P725, DOI 10.2193/0091-7648(2006)34[725:WDHFTC]2.0.CO;2; Caswell H., 2001, MATRIX POPULATION MO, DOI [10.1002/9780470057339.vam006m, DOI 10.1002/9780470057339.VAM006M]; Clutton-Brock TH, 2002, PHILOS T R SOC B, V357, P1285, DOI 10.1098/rstb.2002.1128; COCHEBA DJ, 1978, LAND ECON, V54, P490, DOI 10.2307/3146173; COHEN JE, 1979, THEOR POPUL BIOL, V16, P159, DOI 10.1016/0040-5809(79)90011-X; COHEN WE, 1989, J RANGE MANAGE, V42, P361, DOI 10.2307/3899538; Conner MM, 2007, ECOL APPL, V17, P140, DOI 10.1890/1051-0761(2007)017[0140:AMAFEM]2.0.CO;2; Conner MM, 2000, J WILDLIFE DIS, V36, P691, DOI 10.7589/0090-3558-36.4.691; Cook N., 2014, THESIS; COOK RS, 1971, J WILDLIFE MANAGE, V35, P47, DOI 10.2307/3799870; Decker D. J., 2006, Human Dimensions of Wildlife, V11, P151, DOI 10.1080/10871200600669908; DeYoung C., 2011, BIOL MANAGEMENT WHIT, P43; DEYOUNG CA, 1985, WILDLIFE SOC B, V13, P146; DEYOUNG CA, 1989, J WILDLIFE MANAGE, V53, P513, DOI 10.2307/3809170; DEYOUNG CA, 1989, WILDLIFE SOC B, V17, P275; DeYoung Charles A., 2007, P203; DeYoung RW, 2009, J MAMMAL, V90, P946, DOI 10.1644/08-MAMM-A-227.1; Dodd E. P., 2009, THESIS; Dulberger J, 2010, J WILDLIFE DIS, V46, P1086, DOI 10.7589/0090-3558-46.4.1086; Evans TS, 2014, J FISH WILDL MANAG, V5, P387, DOI 10.3996/032014-JFWM-021; Foley A. M., 2012, THESIS; Foley Aaron M., 2008, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V62, P25; Frost CJ, 2009, ECOL MODEL, V220, P2481, DOI 10.1016/j.ecolmodel.2009.06.028; Fulbright T.E., 2013, WHITE TAILED DEER HA, Vsecond; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gann K., 2014, DROUGHT S TEXAS IMPL, DOI [10.1016/j.str.2015.11.00626724998, DOI 10.1016/J.STR.2015.11.00626724998]; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; Gilch S, 2011, TOP CURR CHEM, V305, P51, DOI 10.1007/128_2011_159; Ginnett TF, 2000, J WILDLIFE MANAGE, V64, P713, DOI 10.2307/3802741; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; Gould F. W., 1969, TEXAS PLANTS CHECK L; Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2; Grear DA, 2010, J APPL ECOL, V47, P532, DOI 10.1111/j.1365-2664.2010.01813.x; Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899; Habib TJ, 2011, ECOL MODEL, V222, P2722, DOI 10.1016/j.ecolmodel.2011.05.007; Harveson LA, 2000, SOUTHWEST NAT, V45, P472, DOI 10.2307/3672595; HAWKINS RE, 1970, J WILDLIFE MANAGE, V34, P407, DOI 10.2307/3799027; Heberlein T.A., 2004, HUM DIMENSIONS WILDL, V9, P165, DOI [10.1080/10871200490479954, DOI 10.1080/10871200490479954]; Heisey DM, 2010, ECOL MONOGR, V80, P221, DOI 10.1890/09-0052.1; Hibbs W., 2014, JOB COMPLETION REPOR, P117; Hicks M, 2014, JOB COMPLETION REPOR, P281; Hirth DH, 1977, WILDLIFE MONOGR, V53, P3, DOI DOI 10.2307/3830446; Holsman R. H., 2010, Human Dimensions of Wildlife, V15, P180, DOI 10.1080/10871201003718029; Jacobson HA, 2011, Biology and Management of White-Tailed Deer, P453; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Joly DO, 2009, J WILDLIFE DIS, V45, P989, DOI 10.7589/0090-3558-45.4.989; Jones A, 2000, WEST N AM NATURALIST, V60, P155; Krausman PR, 2006, WILDLIFE SOC B, V34, P563, DOI 10.2193/0091-7648(2006)34[563:DWFWSP]2.0.CO;2; Krumm CE, 2010, BIOL LETTERS, V6, P209, DOI 10.1098/rsbl.2009.0742; Krumm CE, 2005, J WILDLIFE DIS, V41, P503, DOI 10.7589/0090-3558-41.3.503; Lewis JA, 2010, THESIS; LINK WA, 1994, OIKOS, V69, P539, DOI 10.2307/3545869; LIVENGOOD KR, 1983, LAND ECON, V59, P287, DOI 10.2307/3145730; Magle SB, 2012, NORTHEAST NAT, V19, P67, DOI 10.1656/045.019.0105; Marshal JP, 2002, J WILDLIFE MANAGE, V66, P1283, DOI 10.2307/3802961; McCoy E, 2005, THESIS; McCullough DR, 1999, J MAMMAL, V80, P1130, DOI 10.2307/1383164; Miller C, 2003, HUMAN DIMENSIONS WIL, V8, P229, DOI DOI 10.1080/10871200304312; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 2005, J WILDLIFE DIS, V41, P275, DOI 10.7589/0090-3558-41.2.275; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Miller R, 2003, J WILDLIFE DIS, V39, P84, DOI 10.7589/0090-3558-39.1.84; Monello RJ, 2014, J WILDLIFE MANAGE, V78, P214, DOI 10.1002/jwmg.665; Needham M.D., 2004, HUM DIMENSIONS WILDL, V9, P211, DOI [10.1080/10871200490479990, DOI 10.1080/10871200490479990]; NOONAN P F, 1982, Wildlife Society Bulletin, V10, P46; NORWINE J, 2007, CHANGING CLIMATE S T; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; OZOGA JJ, 1982, J WILDLIFE MANAGE, V46, P281, DOI 10.2307/3808640; Parent CJ, 2016, J WILDLIFE MANAGE, V80, P7, DOI 10.1002/jwmg.992; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Parks Texas and Department Wildlife, 2015, DEER MAN PERM; Parks Texas and Department Wildlife, 2016, INT DEER BREED CWD P; Pope C. A. III, 1985, Southern Journal of Agricultural Economics, V17, P177; POPE CA, 1985, AM J AGR ECON, V67, P81, DOI 10.2307/1240826; POPE CA, 1984, J LEISURE RES, V16, P51, DOI 10.1080/00222216.1984.11969572; Potapov A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151039; R: Development C. Team, 2014, LANG ENV STAT COMP; Rosenstock SS, 1999, J RANGE MANAGE, V52, P302, DOI 10.2307/4003538; Salman MD, 2003, J VET MED SCI, V65, P761, DOI 10.1292/jvms.65.761; Sargeant GA, 2011, J WILDLIFE MANAGE, V75, P171, DOI 10.1002/jwmg.27; Saunders SE, 2011, J VIROL, V85, P5476, DOI 10.1128/JVI.00282-11; Schauber EM, 2003, WILDLIFE SOC B, V31, P610; Schramm PT, 2006, REV MINERAL GEOCHEM, V64, P135, DOI 10.2138/rmg.2006.64.5; Sorensen A, 2014, PREV VET MED, V113, P356, DOI 10.1016/j.prevetmed.2013.11.010; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Storm DJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00141.1; Vaske J. J., 2004, HUMAN DIMENSIONS WIL, V9, P193, DOI DOI 10.1080/10871200490479981; Vercauteren KC, 2007, J WILDLIFE MANAGE, V71, P1594, DOI 10.2193/2006-178; Vercauteren KC, 2007, J WILDLIFE MANAGE, V71, P1603, DOI 10.2193/2006-179; Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x; Webb SL, 2007, J WILDLIFE MANAGE, V71, P555, DOI 10.2193/2006-189; Webb SL, 2006, SOUTHWEST NAT, V51, P368, DOI 10.1894/0038-4909(2006)51[368:WQASUO]2.0.CO;2; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Williams ES, 2002, J WILDLIFE MANAGE, V66, P551, DOI 10.2307/3803123; Wisconsin Department of Natural Resources, 2016, PREV SURV; Wisconsin Department of Natural Resources, 2011, 5 YEAR WAV FAWN DOE; Zaiglin R. E., 1989, TEX J AGR NAT RESOUR, V3, P39	102	7	7	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163592	10.1371/journal.pone.0163592	http://dx.doi.org/10.1371/journal.pone.0163592			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711208	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600030
J	Rajashekar, D; Srinivasa, G; Vinekar, A				Rajashekar, Deepthi; Srinivasa, Gowri; Vinekar, Anand			Comprehensive Retinal Image Analysis for Aggressive Posterior Retinopathy of Prematurity	PLOS ONE			English	Article							TELE-MEDICINE; PLUS DISEASE; INDIA; DIAGNOSIS	Computer aided analysis plays a nontrivial role in assisting the diagnosis of various eye pathologies. In this paper, we propose a framework to help diagnose the presence of Aggressive Posterior Retinopathy Of Prematurity (APROP), a pathology that is characterised by rapid onset and increased tortuosity of blood vessels close to the optic disc (OD). We quantify vessel characteristics that are of clinical relevance to APROP such as tortuosity and the extent of branching i.e., vessel segment count in the defined diagnostic region. We have adapted three vessel segmentation techniques: matched filter response, scale space theory and morphology with local entropy based thresholding. The proposed feature set equips us to build a linear discriminant classifier to discriminate APROP images from clinically healthy images. We have studied 36 images from 21 APROP subjects against a control group of 15 clinically healthy age matched infants. All subjects are age matched ranging from 33-40 weeks of post menstrual age. Experimental results show that we attain 100% recall and 95.45% precision, when the vessel network obtained from morphology is used for feature extraction.	[Rajashekar, Deepthi; Srinivasa, Gowri] PESIT, PES Ctr Pattern Recognit, Bangalore South Campus, Bengaluru, Karnataka, India; [Srinivasa, Gowri] PESIT, Dept Comp Sci & Engn, Bangalore South Campus, Bengaluru, Karnataka, India; [Vinekar, Anand] Narayana Nethralaya Post Grad Inst Ophthalmol, Dept Pediat Retina, Bengaluru, Karnataka, India; [Rajashekar, Deepthi] Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada	PES University; PES University; Dalhousie University	Srinivasa, G (corresponding author), PESIT, PES Ctr Pattern Recognit, Bangalore South Campus, Bengaluru, Karnataka, India.; Srinivasa, G (corresponding author), PESIT, Dept Comp Sci & Engn, Bangalore South Campus, Bengaluru, Karnataka, India.	gsrinivasa@pes.edu	Srinivasa, Gowri/ABP-9131-2022	Srinivasa, Gowri/0000-0002-3568-6749				Azad R, 2011, TXB RETINOPATHY PERM; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; Budai A., 2009, INVESTIG OPHTHALMOL, V50, P325; Cardin S, 2010, RETINAL VASCULATURE; Chanwimaluang T., 2003, INT C IM PROC ICIP S, VV, P1; Fielder AR, 2003, ARCH OPHTHALMOL-CHIC, V121, P1769, DOI 10.1001/archopht.121.12.1769; Gelman R, 2005, INVEST OPHTH VIS SCI, V46, P4734, DOI 10.1167/iovs.05-0646; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; HENKIND P, 1974, BRIT J OPHTHALMOL, V58, P413, DOI 10.1136/bjo.58.4.413; Hungi B, 2012, INDIAN J PEDIATR, V79, P911, DOI 10.1007/s12098-012-0707-y; Kanski JJ, 2011, CLIN OPHTHALMOLOGY S; Keck KM, 2013, RETINA-J RET VIT DIS, V33, P1700, DOI 10.1097/IAE.0b013e3182845c39; Panitsuk P., 2009, INT C ROB INF INT CO, P11; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Pejawar R, 2010, RETINOPATHY PREMATUR, P253; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Thongnuch V, 2007, SURANAREE J SCI TECH, V14, P223; Tsai CL, 2008, IEEE T INF TECHNOL B, V12, P480, DOI 10.1109/TITB.2007.908790; Vinekar A., 2012, WORLD OPHTH C FEB 16; Vinekar A, 2015, SEMIN FETAL NEONAT M, V20, P335, DOI 10.1016/j.siny.2015.05.002; Vinekar A, 2014, INDIAN J OPHTHALMOL, V62, P41, DOI 10.4103/0301-4738.126178	21	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163923	10.1371/journal.pone.0163923	http://dx.doi.org/10.1371/journal.pone.0163923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711231	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600052
J	Vela-Corcia, D; Bautista, R; de Vicente, A; Spanu, PD; Perez-Garcia, A				Vela-Corcia, David; Bautista, Rocio; de Vicente, Antonio; Spanu, Pietro D.; Perez-Garcia, Alejandro			De novo Analysis of the Epiphytic Transcriptome of the Cucurbit Powdery Mildew Fungus Podosphaera xanthii and Identification of Candidate Secreted Effector Proteins	PLOS ONE			English	Article							INDUCED POINT MUTATION; BLUMERIA-GRAMINIS; SACCHAROMYCES-CEREVISIAE; GENE; OBLIGATE; SEQUENCE; PATHOGEN; GENOME; VIRULENCE; REVEALS	The cucurbit powdery mildew fungus Podosphaera xanthii is a major limiting factor for cucurbit production worldwide. Despite the fungus's agronomic and economic importance, very little is known about fundamental aspects of P. xanthii biology, such as obligate biotrophy or pathogenesis. To design more durable control strategies, genomic information about P. xanthii is needed. Powdery mildews are fungal pathogens with large genomes compared with those of other fungi, which contain vast amounts of repetitive DNA sequences, much of which is composed of retrotransposons. To reduce genome complexity, in this work we aimed to obtain and analyse the epiphytic transcriptome of P. xanthii as a starting point for genomic research. Total RNA was isolated from epiphytic fungal material, and the corresponding cDNA library was sequenced using a 454 GS FLX platform. Over 676,562 reads were obtained and assembled into 37,241 contigs. Annotation data identified 8,798 putative genes with different orthologues. As described for other powdery mildew fungi, a similar set of missing core ascomycete genes was found, which may explain obligate biotrophy. To gain insight into the plant-pathogen relationships, special attention was focused on the analysis of the secretome. After this analysis, 137 putative secreted proteins were identified, including 53 candidate secreted effector proteins (CSEPs). Consistent with a putative role in pathogenesis, the expression profile observed for some of these CSEPs showed expression maxima at the beginning of the infection process at 24 h after inoculation, when the primary appressoria are mostly formed. Our data mark the onset of genomics research into this very important pathogen of cucurbits and shed some light on the intimate relationship between this pathogen and its host plant.	[Vela-Corcia, David; de Vicente, Antonio; Perez-Garcia, Alejandro] Univ Malaga, Inst Hortofruticultura Subtrop & Mediterranea La, Consejo Super Invest Cient IHSM UMA CSIC, Dept Microbiol,Fac Ciencias, Malaga, Spain; [Bautista, Rocio] Plataforma Andaluza Bioinformat, Edificio Bioinnovac,Parque Tecnol Andalucia, Malaga, Spain; [Spanu, Pietro D.] Imperial Coll London, Dept Life Sci, London, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); Imperial College London	Perez-Garcia, A (corresponding author), Univ Malaga, Inst Hortofruticultura Subtrop & Mediterranea La, Consejo Super Invest Cient IHSM UMA CSIC, Dept Microbiol,Fac Ciencias, Malaga, Spain.	aperez@uma.es	Spanu, Pietro/P-5859-2019; VELA-CORCIA, DAVID/B-7163-2019; de Vicente, Antonio/G-4405-2011; Moreno, Rocío Bautista/P-7143-2019; Perez-Garcia, Alejandro/D-9373-2013; Bautista, Rocio/L-1155-2014	Spanu, Pietro/0000-0001-8928-6049; VELA-CORCIA, DAVID/0000-0002-8641-9288; de Vicente, Antonio/0000-0003-2716-9861; Moreno, Rocío Bautista/0000-0003-1685-8119; Perez-Garcia, Alejandro/0000-0002-1065-0360; Bautista, Rocio/0000-0003-1685-8119	Ministerio de Economia y Competitividad (MINECO) by FEDER funds (EU) [AGL2013-41939-R]; FPI program of MICINN; BBSRC [BB/E000983/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000983/1] Funding Source: researchfish	Ministerio de Economia y Competitividad (MINECO) by FEDER funds (EU); FPI program of MICINN; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by funding from the former "Ministerio de Ciencia e Innovacion (MICINN)" (AGL2010-21848-CO2-01/ AGR) and current "Ministerio de Economia y Competitividad (MINECO)" (AGL2013-41939-R), both cofinanced by FEDER funds (EU). DVC was supported by a PhD fellowship from the FPI program of MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Both M, 2005, PLANT CELL, V17, P2107, DOI 10.1105/tpc.105.032631; Both M, 2005, MOL PLANT MICROBE IN, V18, P125, DOI 10.1094/MPMI-18-0125; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Caracuel Z, 2005, MOL PLANT MICROBE IN, V18, P1140, DOI 10.1094/MPMI-18-1140; Chevreux B, 1999, GER C BIOINF, DOI DOI 10.1093/DNARES/DSS036; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOPER TG, 1987, J BACTERIOL, V169, P4660, DOI 10.1128/jb.169.10.4660-4667.1987; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; del Pino D, 2002, PHYTOPARASITICA, V30, P459, DOI 10.1007/BF02979750; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Ellis JG, 2009, CURR OPIN PLANT BIOL, V12, P399, DOI 10.1016/j.pbi.2009.05.004; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Ortuno D, 2006, EUR J PLANT PATHOL, V115, P215, DOI 10.1007/s10658-006-9014-7; Garcia-Mayoral MF, 2007, STRUCTURE, V15, P485, DOI 10.1016/j.str.2007.03.006; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Glawe DA, 2008, ANNU REV PHYTOPATHOL, V46, P27, DOI 10.1146/annurev.phyto.46.081407.104740; Godfrey D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-317; Grell MN, 2003, GENE, V311, P181, DOI 10.1016/S0378-1119(03)00610-3; Guerrero-Fernandez D., 2012, 11 JORN BIOINF BARC, P38; Guyon K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-336; Hane JK, 2015, FUNG BIOL-US, P55, DOI 10.1007/978-3-319-10503-1_4; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Jain M, 2011, CURR SCI INDIA, V101, P1435; Jones L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1081; Koski LB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-151; Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leuthner B, 2005, MOL GENET GENOMICS, V272, P639, DOI 10.1007/s00438-004-1085-6; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; MASSELOT M, 1975, MOL GEN GENET, V139, P121, DOI 10.1007/BF00264692; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; Pain A, 2004, FUNGAL GENET BIOL, V41, P443, DOI 10.1016/j.fgb.2003.12.003; Pazzagli L, 1999, J BIOL CHEM, V274, P24959, DOI 10.1074/jbc.274.35.24959; Pedersen C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-694; Perez-Garcia A, 2006, J PHYTOPATHOL, V154, P190, DOI 10.1111/j.1439-0434.2006.01086.x; Perez-Garcia A, 2009, MOL PLANT PATHOL, V10, P153, DOI 10.1111/j.1364-3703.2008.00527.x; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sacristan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007463; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sbrana F, 2007, EUR BIOPHYS J BIOPHY, V36, P727, DOI 10.1007/s00249-007-0159-x; Schneiter Roger, 2013, Biomol Concepts, V4, P519, DOI 10.1515/bmc-2013-0021; SINGER MJ, 1995, MOL CELL BIOL, V15, P5586; Soanes DM, 2006, MOL PLANT PATHOL, V7, P61, DOI 10.1111/J.1364-3703.2005.00317.X; Sohn J, 2000, MOL PLANT MICROBE IN, V13, P629, DOI 10.1094/MPMI.2000.13.6.629; Spanu PD, 2012, ANNU REV PHYTOPATHOL, V50, P91, DOI 10.1146/annurev-phyto-081211-173024; Spanu PD, 2012, NEW PHYTOL, V195, P20, DOI 10.1111/j.1469-8137.2012.04173.x; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas SW, 2001, FUNGAL GENET BIOL, V33, P195, DOI 10.1006/fgbi.2001.1281; Tollenaere C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052492; Torus, 1997, B N SANIDAD VEGETAL, V23, P283; Vela-Corcia D, 2014, FUNGAL BIOL-UK, V118, P228, DOI 10.1016/j.funbio.2013.12.001; Wessling R, 2012, FUNGAL GENET BIOL, V49, P470, DOI 10.1016/j.fgb.2012.04.001; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Wicker T, 2013, NAT GENET, V45, P1092, DOI 10.1038/ng.2704; Zhang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4849	61	25	27	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163379	10.1371/journal.pone.0163379	http://dx.doi.org/10.1371/journal.pone.0163379			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711117	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600023
J	Wyllie, J; Lucas, B; Carlson, J; Kitchens, B; Kozary, B; Zaki, M				Wyllie, Jessica; Lucas, Benjamin; Carlson, Jamie; Kitchens, Brent; Kozary, Ben; Zaki, Mohamed			An Examination of Not-For-Profit Stakeholder Networks for Relationship Management: A Small-Scale Analysis on Social Media	PLOS ONE			English	Article							SERVICE	Using a small-scale descriptive network analysis approach, this study highlights the importance of stakeholder networks for identifying valuable stakeholders and the management of existing stakeholders in the context of mental health not-for-profit services. We extract network data from the social media brand pages of three health service organizations from the U.S., U.K., and Australia, to visually map networks of 579 social media brand pages (represented by nodes), connected by 5,600 edges. This network data is analyzed using a collection of popular graph analysis techniques to assess the differences in the way each of the service organizations manage stakeholder networks. We also compare node meta-information against basic topology measures to emphasize the importance of effectively managing relationships with stakeholders who have large external audiences. Implications and future research directions are also discussed.	[Wyllie, Jessica; Carlson, Jamie] Univ Newcastle, Newcastle Business Sch, Callaghan, NSW, Australia; [Lucas, Benjamin] Maastricht Univ, Sch Business & Econ, Dept Mkt & Supply Chain Management, Maastricht, Netherlands; [Lucas, Benjamin] BISS Inst, Maastricht, Netherlands; [Kitchens, Brent] Univ Virginia, McIntire Sch Commerce, Charlottesville, VA USA; [Kozary, Ben] Forethought, Melbourne, Vic, Australia; [Zaki, Mohamed] Univ Cambridge, Dept Engn, Inst Mfg, Cambridge Serv Alliance, Cambridge, England; [Carlson, Jamie] Univ Newcastle, Newcastle Business Sch, Level 3,Univ House,Corner King & Auckland St, Newcastle, NSW 2300, Australia	University of Newcastle; Maastricht University; University of Virginia; University of Cambridge; University of Newcastle	Carlson, J (corresponding author), Univ Newcastle, Newcastle Business Sch, Callaghan, NSW, Australia.; Carlson, J (corresponding author), Univ Newcastle, Newcastle Business Sch, Level 3,Univ House,Corner King & Auckland St, Newcastle, NSW 2300, Australia.	Jamie.Carlson@newcastle.edu.au	Zaki, Mohamed/W-5494-2019; Carlson, Jamie/AAP-5387-2020; Carlson, Jamie/G-7535-2013	Zaki, Mohamed/0000-0003-0264-2691; Carlson, Jamie/0000-0002-1622-5939; Wyllie, Jessica/0000-0001-5178-8860				Akaka MA, 2015, J SERV MARK, V29, P453, DOI 10.1108/JSM-03-2015-0126; Andermo S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122125; Arnett DB, 2003, J MARKETING, V67, P89, DOI 10.1509/jmkg.67.2.89.18614; Backstrom L., 2014, P 17 ACM C COMPUTER, P831, DOI DOI 10.1145/2531602.2531642; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Berry LL, 2010, BUS HORIZONS, V53, P157, DOI 10.1016/j.bushor.2009.11.002; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Blue Beyond, NEWS J HAYN TEAMS NO; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Bortree DS, 2009, PUBLIC RELAT REV, V35, P317, DOI 10.1016/j.pubrev.2009.05.002; Brownlow J, 2015, WORKING PAPER; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chen CM, 2003, INFOVIS 2002: IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2003, PROCEEDINGS, P67, DOI 10.1109/INFVIS.2003.1249010; Chen ZQ, 2015, ENTROPY-SWITZ, V17, P3710, DOI 10.3390/e17063710; Cormen T., 2009, INTRO ALGORITHMS; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; de Vries NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122133; Dehmer M, 2019, DISCRETE APPL MATH, V252, P17, DOI 10.1016/j.dam.2016.02.024; Dehmer M, 2015, APPL MATH COMPUT, V266, P623, DOI 10.1016/j.amc.2015.05.072; Dehmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094985; Emmert-Streib F, 2016, INFORM SCIENCES, V346, P180, DOI 10.1016/j.ins.2016.01.074; Fan WG, 2014, COMMUN ACM, V57, P74, DOI 10.1145/2602574; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Friggeri A, 2014, AAI C WEBL SOC MED J; Goldsmith-Pinkham P, 2013, J BUS ECON STAT, V31, P253, DOI 10.1080/07350015.2013.801251; Grabowicz PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092196; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Harrison JS, 2010, STRATEGIC MANAGE J, V31, P58, DOI 10.1002/smj.801; Hartmann P. M., 2014, WORKING PAPER; Homburg C, 2017, J ACAD MARKET SCI, V45, P377, DOI 10.1007/s11747-015-0460-7; Huang MH, 2013, J SERV RES-US, V16, P251, DOI 10.1177/1094670513481853; Kazadi K, 2016, J BUS RES, V69, P525, DOI 10.1016/j.jbusres.2015.05.009; Kitchens B, 2014, DECIS SUPPORT SYST, V57, P454, DOI 10.1016/j.dss.2012.10.050; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; Kuchaiev O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-24; Makarem SC, 2014, J SERV RES-US, V17, P399, DOI 10.1177/1094670514541965; Menezes VSA, 2008, LECT NOTES COMPUT SC, V5333, P18; Mental Health America Illinois, 2015, MHAI AB US; Metters R, 2007, DECISION SCI, V38, P195, DOI 10.1111/j.1540-5915.2007.00156.x; Mills BJ, 2013, P NATL ACAD SCI USA, V110, P5785, DOI 10.1073/pnas.1219966110; Mind, 2016, NEWS ZOELL BEC 1 DIG; Ostrom AL, 2015, J SERV RES-US, V18, P127, DOI 10.1177/1094670515576315; Pant G, 2015, INFORM SYST RES, V26, P188, DOI 10.1287/isre.2014.0563; Reider B, 2013, WEBSCI 13; Ronen S, 2014, P NATL ACAD SCI USA, V111, pE5616, DOI 10.1073/pnas.1410931111; Rowley TJ, 1997, ACAD MANAGE REV, V22, P887, DOI 10.2307/259248; Ruhnau B, 2000, SOC NETWORKS, V22, P357, DOI 10.1016/S0378-8733(00)00031-9; Rust RT, 2014, MARKET SCI, V33, P206, DOI 10.1287/mksc.2013.0836; Sedereviciute K., 2011, INT J STRATEGIC COMM, V5, P221, DOI DOI 10.1080/1553118X.2011.592170; Tantalo C, 2016, STRATEGIC MANAGE J, V37, P314, DOI 10.1002/smj.2337; Tomasello MV, 2014, SCI REP-UK, V4, DOI 10.1038/srep05679; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Vanni T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093376; Vargo SL, 2015, IND MARKET MANAG, V44, P63, DOI 10.1016/j.indmarman.2014.10.008; Verleye K, 2014, J SERV RES-US, V17, P68, DOI 10.1177/1094670513494015; Waters RD, 2009, PUBLIC RELAT REV, V35, P102, DOI 10.1016/j.pubrev.2009.01.006; Weng LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118410; World Health Organization, 2011, ATL MENT HTLH ATL; Young PL, VALUE HLTH CARE ACCO, DOI 10.17226/12566	60	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163914	10.1371/journal.pone.0163914	http://dx.doi.org/10.1371/journal.pone.0163914			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711236	Green Published, gold			2022-12-27	WOS:000385697600049
J	Biswas, H; Longmore, GD				Biswas, Hirak; Longmore, Gregory D.			Action of SNAIL1 in Cardiac Myofibroblasts Is Important for Cardiac Fibrosis following Hypoxic Injury	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MYOCARDIAL-INFARCTION; COLLAGEN; FIBROBLASTS; EXPRESSION; CELLS; MATRIX; RED	Hypoxic injury to the heart results in cardiac fibrosis that leads to cardiac dysfunction and heart failure. SNAIL1 is a zinc finger transcription factor implicated in fibrosis following organ injury and cancer. To determine if the action of SNAIL1 contributed to cardiac fibrosis following hypoxic injury, we used an endogenous SNAIL1 bioluminescence reporter mice, and SNAIL1 knockout mouse models. Here we report that SNAIL1 expression is upregulated in the infarcted heart, especially in the myofibroblasts. Utilizing primary cardiac fibroblasts in ex vivo cultures we find that pro-fibrotic factors and collagen I increase SNAIL1 protein level. SNAIL1 is required in cardiac fibroblasts for the adoption of myofibroblast fate, collagen I expression and expression of fibrosis-related genes. Taken together this data suggests that SNAIL1 expression is induced in the cardiac fibroblasts after hypoxic injury and contributes to myofibroblast phenotype and a fibrotic scar formation. Resultant collagen deposition in the scar can maintain elevated SNAIL1 expression in the myofibroblasts and help propagate fibrosis.	[Longmore, Gregory D.] Washington Univ, Dept Med, St Louis, MO 63110 USA; [Biswas, Hirak; Longmore, Gregory D.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Biswas, Hirak; Longmore, Gregory D.] Washington Univ, ICCE Inst, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Longmore, GD (corresponding author), Washington Univ, Dept Med, St Louis, MO 63110 USA.; Longmore, GD (corresponding author), Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Longmore, GD (corresponding author), Washington Univ, ICCE Inst, St Louis, MO 63110 USA.	glongmore@wustl.edu			American Heart Association (AHA) [14PRE18680005]; NIH [GM080673-09]; Komen Foundation [KG110889]; NATIONAL CANCER INSTITUTE [R01CA196205, T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK052574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080673] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HB was supported by an American Heart Association predoctoral fellowship (AHA Award #14PRE18680005). This work was supported, in part, by NIH grant GM080673-09 (GDL) and the Komen Foundation KG110889 (GDL).	CARVER W, 1991, CIRC RES, V69, P116, DOI 10.1161/01.RES.69.1.116; Chen CZC, 2009, BRIT J PHARMACOL, V158, P1196, DOI 10.1111/j.1476-5381.2009.00387.x; Czubryt MP, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-19; Hsu DSS, 2014, CANCER CELL, V26, P534, DOI 10.1016/j.ccell.2014.09.002; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Lee SW, 2013, MOL THER, V21, P1767, DOI 10.1038/mt.2013.146; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Liu YJ, 2012, ACTA BIOCH BIOPH SIN, V44, P902, DOI 10.1093/abbs/gms085; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Lopez-Sanchez LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099143; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; O'Connor JW, 2015, J CELL PHYSIOL, V230, P1829, DOI 10.1002/jcp.24895; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Small EM, 2012, J CARDIOVASC TRANSL, V5, P794, DOI 10.1007/s12265-012-9397-0; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Stanisavljevic J, 2015, CANCER RES, V75, P284, DOI 10.1158/0008-5472.CAN-14-1903; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; Tran HD, 2014, CANCER RES, V74, P6330, DOI 10.1158/0008-5472.CAN-14-0923; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wehrend A, 2004, ANAT HISTOL EMBRYOL, V33, P180, DOI 10.1111/j.1439-0264.2004.00532.x; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhang K, 2016, J CELL SCI, V129, P1989, DOI 10.1242/jcs.180539; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	31	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162636	10.1371/journal.pone.0162636	http://dx.doi.org/10.1371/journal.pone.0162636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706205	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200017
J	Correa, MS; Giacobbo, BL; Vedovelli, K; de Lima, DB; Ferrari, P; Argimon, IID; Walz, JC; Bromberg, E				Correa, Marcio Silveira; Giacobbo, Bruno Lima; Vedovelli, Kelem; de Lima, Daiane Borba; Ferrari, Pamela; de Lima Argimon, Irani Iracema; Walz, Julio Cesar; Bromberg, Elke			Age Effects on Cognitive and Physiological Parameters in Familial Caregivers of Alzheimer's Disease Patients	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; DEHYDROEPIANDROSTERONE DHEA; SALIVARY CORTISOL; MAJOR DEPRESSION; CHRONIC STRESS; SERUM-LEVELS; BDNF LEVELS; BRAIN; DEMENTIA; GENDER	Objectives Older familial caregivers of Alzheimer's disease patients are subjected to stress-related cognitive and psychophysiological dysfunctions that may affect their quality of life and ability to provide care. Younger caregivers have never been properly evaluated. We hypothesized that they would show qualitatively similar cognitive and psychophysiological alterations to those of older caregivers. Method The cognitive measures of 17 young (31-58 years) and 18 old (63-84 years) caregivers and of 17 young (37-57 years) and 18 old (62-84 years) non-caregiver controls were evaluated together with their salivary cortisol and dehydroepiandrosterone (DHEA) levels, as measured by radioimmunoassays and ELISA assays of brain-derived neurotrophic factor (BDNF) in serum. Results Although younger caregivers had milder impairments in memory and executive functions than older caregivers, their performances fell to the same or lower levels as those of the healthy older controls. Decreases in DHEA and BDNF levels were correlated with the cognitive dysfunctions observed in the older and younger caregivers, respectively. Cortisol at 10PM increased in both caregiver groups. Discussion Younger caregivers were prone to cognitive impairments similar to older caregivers, although the degree and the neuropsychological correlates of the cognitive dysfunctions were somewhat different between the two groups. This work has implications for caregiver and care-recipient health and for research on the neurobiology of stress-related cognitive dysfunctions.	[Correa, Marcio Silveira; Giacobbo, Bruno Lima; Vedovelli, Kelem; de Lima, Daiane Borba; Bromberg, Elke] Pontificia Univ Catolica Rio Grande do Sul, Lab Biol & Desenvolvimento Sistema Nervoso, Fac Biociencias, Porto Alegre, RS, Brazil; [Correa, Marcio Silveira; Giacobbo, Bruno Lima; de Lima, Daiane Borba; Bromberg, Elke] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Vedovelli, Kelem; de Lima Argimon, Irani Iracema; Bromberg, Elke] Pontificia Univ Catolica Rio Grande do Sul, Inst Geriatriae & Gerontol, Porto Alegre, RS, Brazil; [Ferrari, Pamela; Walz, Julio Cesar] Hosp Clin Porto Alegre, Lab Psiquiatria Mol, Porto Alegre, RS, Brazil; [Correa, Marcio Silveira; Giacobbo, Bruno Lima; Vedovelli, Kelem; de Lima, Daiane Borba; Ferrari, Pamela; Walz, Julio Cesar; Bromberg, Elke] INCT TM, Porto Alegre, RS, Brazil; [Walz, Julio Cesar] Fac Unilasalle, Canoas, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Centro Universitario La Salle	Bromberg, E (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Lab Biol & Desenvolvimento Sistema Nervoso, Fac Biociencias, Porto Alegre, RS, Brazil.; Bromberg, E (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil.; Bromberg, E (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Inst Geriatriae & Gerontol, Porto Alegre, RS, Brazil.; Bromberg, E (corresponding author), INCT TM, Porto Alegre, RS, Brazil.	bromberg@pucrs.br	Bromberg, Elke/G-4512-2012	Bromberg, Elke/0000-0002-2900-3673; S. Correa, Marcio/0000-0002-8866-8384	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq) [485015/2012-9]; FAPERGS/CAPES fellowship	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS/CAPES fellowship	Financial support for this study was provided by Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (CNPq) to Elke Bromberg (grant number 485015/2012-9, http://cnpqbr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support for this study was provided by a CNPq grant (485015/2012-9) awarded to E. Bromberg. I.I. Argimon and E. Bromberg are CNPq research fellows. M.S. Correa is funded by a FAPERGS/CAPES fellowship. K. Vedovelli and B.L. Giacobbo have a CAPES fellowship. We thank Dr. Flavio Kapczinski for help with ELISA assays and Mrs. Iara Portugal for her support in recruiting the caregivers at the ABRAZ-Porto Alegre.	Abbott A, 2011, NATURE, V475, pS2, DOI 10.1038/475S2a; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bedrosian TA, 2013, EXP NEUROL, V243, P67, DOI 10.1016/j.expneurol.2012.05.005; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Calabrese F., 2009, PSYCHONEUROENDOCRINO, V34, pS208, DOI DOI 10.1016/J.PSYNEUEN.2009.05.014; Carlino D, 2011, J PSYCHIATR RES, V45, P273, DOI 10.1016/j.jpsychires.2010.06.012; Caswell LW, 2003, EXP AGING RES, V29, P303, DOI 10.1080/03610730303721; Collins LG, 2011, AM FAM PHYSICIAN, V83, P1309; Correa MS, 2015, NEUROSCIENCE, V286, P371, DOI 10.1016/j.neuroscience.2014.11.052; Correa MS, 2012, BIOL PSYCHOL, V89, P293, DOI 10.1016/j.biopsycho.2011.11.001; Cunha ABM, 2006, NEUROSCI LETT, V398, P215, DOI 10.1016/j.neulet.2005.12.085; Cunha J, 2001, CASA DO PSICOLOGO; Daughters SB, 2013, J ABNORM CHILD PSYCH, V41, P749, DOI 10.1007/s10802-013-9713-4; de Vugt ME, 2013, PROG NEUROBIOL, V110, P54, DOI 10.1016/j.pneurobio.2013.04.005; de Vugt ME, 2006, AGE AGEING, V35, P160, DOI 10.1093/ageing/afj044; de Vugt ME, 2005, J NEUROPSYCH CLIN N, V17, P201, DOI 10.1176/appi.neuropsych.17.2.201; Dias Rachel, 2015, Trends Psychiatry Psychother., V37, P12, DOI 10.1590/2237-6089-2014-0032; Evans PD, 2011, INT J PSYCHOPHYSIOL, V79, P371, DOI 10.1016/j.ijpsycho.2010.12.006; Ferrara M, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-93; Ferrari E, 2008, AGEING RES REV, V7, P225, DOI 10.1016/j.arr.2008.07.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallagher-Thompson D, 2006, AM J GERIAT PSYCHIAT, V14, P334, DOI 10.1097/01.JGP.0000206485.73618.87; Guazzo EP, 1996, J CLIN ENDOCR METAB, V81, P3951, DOI 10.1210/jc.81.11.3951; Guerrero-Berroa E, 2014, INT J GERIATR PSYCH, V29, P299, DOI 10.1002/gps.4008; Hucklebridge F, 2005, PSYCHONEUROENDOCRINO, V30, P51, DOI 10.1016/j.psyneuen.2004.04.007; Iughetti L, 2011, NEUROPEPTIDES, V45, P205, DOI 10.1016/j.npep.2011.02.002; Jeanneteau F, 2013, NEUROSCIENCE, V239, P173, DOI 10.1016/j.neuroscience.2012.09.017; Klein AB, 2011, INT J NEUROPSYCHOPH, V14, P347, DOI 10.1017/S1461145710000738; Kozlov AI, 2004, HUM PHYSL, V40, P224; Lee S, 2004, J NERV MENT DIS, V192, P51, DOI 10.1097/01.nmd.0000106000.02232.30; Lennartsson AK, 2012, BIOL PSYCHOL, V90, P143, DOI 10.1016/j.biopsycho.2012.03.003; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Lupien S, 1996, NEUROBIOL AGING, V17, P95, DOI 10.1016/0197-4580(95)02005-5; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mackenzie CS, 2009, J GERONTOL B-PSYCHOL, V64, P742, DOI 10.1093/geronb/gbp076; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; Matrisciano F, 2008, J PSYCHIATR RES, V43, P247, DOI 10.1016/j.jpsychires.2008.03.014; Mattson MP, 2004, TRENDS NEUROSCI, V27, P589, DOI 10.1016/j.tins.2004.08.001; Mausbach BT, 2013, AM J GERIAT PSYCHIAT, V21, P5, DOI 10.1016/j.jagp.2012.10.001; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Jeckel CMM, 2010, NEUROIMMUNOMODULAT, V17, P9, DOI 10.1159/000243080; Norton MC, 2010, GREATER RISK DEMENTI, P895; Oken BS, 2011, J GERIATR PSYCH NEUR, V24, P191, DOI 10.1177/0891988711422524; Oral E, 2012, BRAIN RES BULL, V88, P454, DOI 10.1016/j.brainresbull.2012.03.005; Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054; Perna G, 2016, ARE ANXIETY DISORDER, V2016; Pivonello R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00129; Pluchino N, 2013, NEUROSCIENCE, V239, P271, DOI 10.1016/j.neuroscience.2013.01.025; RABBITT P, 1995, PSYCHOL AGING, V10, P307, DOI 10.1037/0882-7974.10.3.307; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Richardson TJ, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0367-2; Seeman TE, 1997, J CLIN ENDOCR METAB, V82, P2458, DOI 10.1210/jc.82.8.2458; Shansky RM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00123; Strauss E, 2006, COMPENDIUM NEUROPSYC; Suri D, 2013, NEUROSCIENCE, V239, P196, DOI 10.1016/j.neuroscience.2012.08.065; Tornhage CJ, 2009, NEUROIMMUNOMODULAT, V16, P284, DOI 10.1159/000216186; Trajkovska V, 2007, BRAIN RES BULL, V73, P143, DOI 10.1016/j.brainresbull.2007.03.009; Ventriglia M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/901082; Vitaliano PP, 2011, J AM GERIATR SOC, V59, P900, DOI 10.1111/j.1532-5415.2011.03368.x; Vitaliano PP, 2010, J AM GERIATR SOC, V58, P976, DOI 10.1111/j.1532-5415.2010.02843.x; Vitaliano PP, 2005, AM J GERIAT PSYCHIAT, V13, P834, DOI 10.1176/appi.ajgp.13.10.834; Wahbeh H, 2008, ALZ DIS ASSOC DIS, V22, P181, DOI 10.1097/WAD.0b013e31815a9dff; Webster MJ, 2002, DEV BRAIN RES, V139, P139, DOI 10.1016/S0165-3806(02)00540-0; Wechsler D, 1997, ADM SCORING GUIDE WA, V3; Wechsler D, 1987, MANUAL WESCHSLER MEM; Palma KAXA, 2011, ALZ DIS ASSOC DIS, V25, P262, DOI 10.1097/WAD.0b013e318209e453; Young AH, 2002, AM J PSYCHIAT, V159, P1237, DOI 10.1176/appi.ajp.159.7.1237	69	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162619	10.1371/journal.pone.0162619	http://dx.doi.org/10.1371/journal.pone.0162619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706235	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200016
J	Mika, A; Oleksy, L; Kielnar, R; Wodka-Natkaniec, E; Twardowska, M; Kaminski, K; Malek, Z				Mika, Anna; Oleksy, Lukasz; Kielnar, Renata; Wodka-Natkaniec, Ewa; Twardowska, Magdalena; Kaminski, Kamil; Malek, Zbigniew			Comparison of Two Different Modes of Active Recovery on Muscles Performance after Fatiguing Exercise in Mountain Canoeist and Football Players	PLOS ONE			English	Article							SPRINT SWIMMING PERFORMANCE; PASSIVE RECOVERY; SUBSEQUENT PERFORMANCE; NEUROMUSCULAR FATIGUE; SUPRAMAXIMAL EXERCISE; DYNAMIC CONTRACTIONS; RESISTANCE EXERCISE; LACTATE REMOVAL; BLOOD LACTATE; PEAK TORQUE	Background The aim of this study is to assess if the application of different methods of active recovery (working the same or different muscle groups from those which were active during fatiguing exercise) results in significant differences in muscle performance and if the efficiency of the active recovery method is dependent upon the specific sport activity (training loads). Design A parallel group non-blinded trial with repeated measurements. Methods Thirteen mountain canoeists and twelve football players participated in this study. Measurements of the bioelectrical activity, torque, work and power of the vastus lateralis oblique, vastus medialis oblique, and rectus femoris muscles were performed during isokinetic tests at a velocity of 90 degrees/s. Results Active legs recovery in both groups was effective in reducing fatigue from evaluated muscles, where a significant decrease in fatigue index was observed. The muscles peak torque, work and power parameters did not change significantly after both modes of active recovery, but in both groups significant decrease was seen after passive recovery. Conclusions We suggest that 20 minutes of post-exercise active recovery involving the same muscles that were active during the fatiguing exercise is more effective in fatigue recovery than active exercise using the muscles that were not involved in the exercise. Active arm exercises were less effective in both groups which indicates a lack of a relationship between the different training regimens and the part of the body which is principally used during training.	[Mika, Anna; Oleksy, Lukasz] Univ Phys Educ Krakow, Dept Clin Rehabil, Krakow, Poland; [Oleksy, Lukasz] Oleksy Physiotherapy Clin, Rzeszow, Poland; [Kielnar, Renata] Univ Rzeszow, Inst Physiotherapy, Fac Med, Rzeszow, Poland; [Wodka-Natkaniec, Ewa] Jagiellonian Univ, Dept Orthopaed, Coll Med, Krakow, Poland; [Twardowska, Magdalena; Malek, Zbigniew] State Higher Vocat Sch Nowy Sacz, Inst Phys Educ, Nowy Sacz, Poland; [Kaminski, Kamil] Physiotherapy Clin Effect Rehabil, Warsaw, Poland	University of Rzeszow; Jagiellonian University; Collegium Medicum Jagiellonian University	Mika, A (corresponding author), Univ Phys Educ Krakow, Dept Clin Rehabil, Krakow, Poland.	anna.mika@awf.krakow.pl	Mika, Anna/P-1926-2015; Oleksy, Łukasz/AAQ-1244-2021	Mika, Anna/0000-0002-4366-5091; Oleksy, Łukasz/0000-0002-0589-0554; Kielnar, Renata/0000-0002-1355-2010				Ahmaidi S, 1996, MED SCI SPORT EXER, V28, P450, DOI 10.1097/00005768-199604000-00009; Baker S J, 1991, Br J Sports Med, V25, P165; Barnett A, 2006, SPORTS MED, V36, P781, DOI 10.2165/00007256-200636090-00005; Bogdanis GC, 1996, EUR J APPL PHYSIOL, V74, P461; CHOI D, 1994, MED SCI SPORT EXER, V26, P992; Cifrek M, 2000, MEASUREMENT, V27, P85, DOI 10.1016/S0263-2241(99)00059-7; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; Coffey V, 2004, J SCI MED SPORT, V7, P1, DOI 10.1016/S1440-2440(04)80038-0; Corder KP, 2000, J STRENGTH COND RES, V14, P151; DE LUCA CJ, 1984, CRIT REV BIOMED ENG, V11, P251; Esposito F, 1998, EUR J APPL PHYSIOL, V78, P494, DOI 10.1007/s004210050451; Fairchild TJ, 2003, MED SCI SPORT EXER, V35, P595, DOI 10.1249/01.MSS.0000058436.46584.8E; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gates DH, 2008, EXP BRAIN RES, V187, P573, DOI 10.1007/s00221-008-1326-8; Gupta S, 1996, INT J SPORTS MED, V17, P106, DOI 10.1055/s-2007-972816; HAKKINEN K, 1993, INT J SPORTS MED, V14, P53, DOI 10.1055/s-2007-1021146; HAKKINEN K, 1986, EUR J APPL PHYSIOL O, V55, P588, DOI 10.1007/BF00423202; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Lariviere C, 2003, EUR J APPL PHYSIOL, V89, P171, DOI 10.1007/s00421-002-0769-z; Larsson B, 1999, J ELECTROMYOGR KINES, V9, P351, DOI 10.1016/S1050-6411(99)00006-1; Larsson B, 2003, J ELECTROMYOGR KINES, V13, P281, DOI 10.1016/S1050-6411(03)00022-1; Lattier G, 2004, INT J SPORTS MED, V25, P450, DOI 10.1055/s-2004-820939; Lau S, 2001, J STRENGTH COND RES, V15, P367; Lopes FAS, 2014, J HUM KINET, V40, P161, DOI 10.2478/hukin-2014-0018; McAinch A, 2004, INT J SPORT NUTR EXE, V14, P185, DOI 10.1123/ijsnem.14.2.185; Merletti R., 2004, ELECTROMYOGRAPHY PHY; Mika A, 2007, AM J PHYS MED REHAB, V86, P474, DOI 10.1097/PHM.0b013e31805b7c79; MILLER RG, 1987, MUSCLE NERVE, V10, P810, DOI 10.1002/mus.880100906; Monedero J, 2000, INT J SPORTS MED, V21, P593, DOI 10.1055/s-2000-8488; Seiler S, 2005, MED SCI SPORT EXER, V37, P1601, DOI 10.1249/01.mss.0000177560.18014.d8; Spierer DK, 2004, INT J SPORTS MED, V25, P109; Taoutaou Z, 1996, EUR J APPL PHYSIOL O, V73, P465, DOI 10.1007/BF00334425; THIRIET P, 1993, J SPORT MED PHYS FIT, V33, P118; Tiidus PM, 1997, J ORTHOP SPORT PHYS, V25, P107, DOI 10.2519/jospt.1997.25.2.107; TIIDUS PM, 1995, INT J SPORTS MED, V16, P478, DOI 10.1055/s-2007-973041; Toubekis AG, 2005, EUR J APPL PHYSIOL, V93, P694, DOI 10.1007/s00421-004-1244-9; Toubekis AG, 2006, APPL PHYSIOL NUTR ME, V31, P709, DOI [10.1139/H06-075, 10.1139/h06-075]; Vaz M. A., 1996, J ELECTROMYOGR CLIN, V36, P221; Watts PB, 2000, INT J SPORTS MED, V21, P185, DOI 10.1055/s-2000-302; WELTMAN A, 1983, INT J SPORTS MED, V4, P184, DOI 10.1055/s-2008-1026032; WELTMAN A, 1979, J APPL PHYSIOL, V47, P677, DOI 10.1152/jappl.1979.47.4.677; Zarrouk N, 2011, J ATHL TRAINING, V46, P386	43	8	10	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164216	10.1371/journal.pone.0164216	http://dx.doi.org/10.1371/journal.pone.0164216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706260	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697200098
J	Staiger, JF; Loucif, AJC; Schubert, D; Mock, M				Staiger, Jochen F.; Loucif, Alexandre J. C.; Schubert, Dirk; Moeck, Martin			Morphological Characteristics of Electrophysiologically Characterized Layer Vb Pyramidal Cells in Rat Barrel Cortex	PLOS ONE			English	Article							IV SPINY NEURONS; SOMATOSENSORY CORTEX; VISUAL-CORTEX; PHYSIOLOGICAL-PROPERTIES; REGULAR SPIKING; FUNCTIONAL CONNECTIVITY; NEOCORTICAL NEURONS; INTRINSIC CIRCUITRY; CEREBRAL-CORTEX; SMI CORTEX	Layer Vb pyramidal cells are the major output neurons of the neocortex and transmit the outcome of cortical columnar signal processing to distant target areas. At the same time they contribute to local tactile information processing by emitting recurrent axonal collaterals into the columnar microcircuitry. It is, however, not known how exactly the two types of pyramidal cells, called slender-tufted and thick-tufted, contribute to the local circuitry. Here, we investigated in the rat barrel cortex the detailed quantitative morphology of biocytin-filled layer Vb pyramidal cells in vitro, which were characterized for their intrinsic electrophysiology with special emphasis on their action potential firing pattern. Since we stained the same slices for cytochrome oxidase, we could also perform layer-and column-related analyses. Our results suggest that in layer Vb the unambiguous action potential firing patterns "regular spiking (RS)" and "repetitive burst spiking (RB)" (previously called intrinsically burst spiking) correlate well with a distinct morphology. RS pyramidal cells are somatodendritically of the slender-tufted type and possess numerous local intralaminar and intracolumnar axonal collaterals, mostly reaching layer I. By contrast, their transcolumnar projections are less well developed. The RB pyramidal cells are somatodendritically of the thick-tufted type and show only relatively sparse local axonal collaterals, which are preferentially emitted as long horizontal or oblique infragranular collaterals. However, contrary to many previous slice studies, a substantial number of these neurons also showed axonal collaterals reaching layer I. Thus, electrophysiologically defined pyramidal cells of layer Vb show an input and output pattern which suggests RS cells to be more "locally segregating" signal processors whereas RB cells seem to act more on a "global integrative" scale.	[Staiger, Jochen F.; Moeck, Martin] Univ Gottingen, Univ Med Ctr, Inst Neuroanat, Gottingen, Germany; [Loucif, Alexandre J. C.] Univ Freiburg, Inst Neuroanat, Freiburg, Germany; [Schubert, Dirk] Radboud Univ Nijmegen, Med Ctr, Ctr Neurosci, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Loucif, Alexandre J. C.] Pfizer Worldwide Res & Dev, Neurosci & Pain Res, Portway Bldg,Granta Pk, Cambridge, England	University of Gottingen; University of Freiburg; Radboud University Nijmegen; Pfizer	Staiger, JF (corresponding author), Univ Gottingen, Univ Med Ctr, Inst Neuroanat, Gottingen, Germany.	jochen.staiger@med.uni-goettingen.de	Schubert, Dirk/B-4339-2011	Schubert, Dirk/0000-0002-1202-4363	Deutsche Forschungsgemeinschaft [STA 431/5-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (STA 431/5-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo MC, 1999, J NEUROSCI, V19, P1566; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Balduzzi D, 2013, THEOR BIOSCI, V132, P27, DOI 10.1007/s12064-012-0165-0; Brown SP, 2009, NATURE, V457, P1133, DOI 10.1038/nature07658; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V62, P1149, DOI 10.1152/jn.1989.62.5.1149; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; Cho RH, 2004, NEUROSCI RES, V50, P381, DOI 10.1016/j.neures.2004.08.006; Christophe E, 2005, J NEUROPHYSIOL, V94, P3357, DOI 10.1152/jn.00076.2005; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Constantinople CM, 2013, SCIENCE, V340, P1591, DOI 10.1126/science.1236425; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Diamond ME, 2008, NAT REV NEUROSCI, V9, P601, DOI 10.1038/nrn2411; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Douglas RJ, 2007, NEURON, V56, P226, DOI 10.1016/j.neuron.2007.10.017; Egger R, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00129; Egger V, 2008, CEREB CORTEX, V18, P876, DOI 10.1093/cercor/bhm126; Feldmeyer D, 2013, PROG NEUROBIOL, V103, P3, DOI 10.1016/j.pneurobio.2012.11.002; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Gottlieb JP, 1997, EXP BRAIN RES, V115, P47, DOI 10.1007/PL00005684; Harris KD, 2015, NAT NEUROSCI, V18, P170, DOI 10.1038/nn.3917; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hefti BJ, 2000, J NEUROPHYSIOL, V83, P2626, DOI 10.1152/jn.2000.83.5.2626; Jacob V, 2012, NEURON, V73, P391, DOI 10.1016/j.neuron.2011.11.034; Jones E. G., 1984, CELLULAR COMPONENTS, P521; Karagiannis A, 2009, J NEUROSCI, V29, P3642, DOI 10.1523/JNEUROSCI.0058-09.2009; KASPER EM, 1994, J COMP NEUROL, V339, P459, DOI 10.1002/cne.903390402; LARKMAN A, 1990, J NEUROSCI, V10, P1407; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Lorincz ML, 2015, J NEUROSCI, V35, P5442, DOI 10.1523/JNEUROSCI.3603-14.2015; Lubke J, 1996, J NEUROSCI, V16, P3209; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1990, J NEUROSCI, V10, P1415; Meyer HS, 2013, P NATL ACAD SCI USA, V110, P19113, DOI 10.1073/pnas.1312691110; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Narayanan RT, 2015, CEREB CORTEX, V25, P4450, DOI 10.1093/cercor/bhv053; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Oberlaender M, 2011, P NATL ACAD SCI USA, V108, P4188, DOI 10.1073/pnas.1100647108; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Ramaswamy S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00233; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2003, J NEUROSCI, V23, P2961; Schubert D, 2007, BRAIN STRUCT FUNCT, V212, P107, DOI 10.1007/s00429-007-0147-z; Schwindt P, 1997, J NEUROPHYSIOL, V77, P2484, DOI 10.1152/jn.1997.77.5.2484; Staiger JF, 2000, NEUROSCIENCE, V99, P7, DOI 10.1016/S0306-4522(00)00166-4; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Staiger JF, 2015, BRAIN STRUCT FUNCT, V220, P1317, DOI 10.1007/s00429-014-0726-8; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; TSENG GF, 1993, J COMP NEUROL, V335, P92, DOI 10.1002/cne.903350107; VANBREDERODE JFM, 1992, NEUROSCIENCE, V50, P315, DOI 10.1016/0306-4522(92)90426-3; Wagener RJ, 2010, J NEUROSCI, V30, P15700, DOI 10.1523/JNEUROSCI.3707-10.2010; WANG Z, 1993, J NEUROSCI, V13, P2199; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WHITE EL, 1987, J COMP NEUROL, V262, P13, DOI 10.1002/cne.902620103; WHITE EL, 1994, J COMP NEUROL, V342, P1, DOI 10.1002/cne.903420102; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wright AK, 2001, NEUROSCIENCE, V103, P87, DOI 10.1016/S0306-4522(00)00564-9; Wright N, 2010, J NEUROPHYSIOL, V103, P709, DOI 10.1152/jn.00560.2009	64	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164004	10.1371/journal.pone.0164004	http://dx.doi.org/10.1371/journal.pone.0164004			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706253	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200074
J	Vogan, PJ; Schoettle, AW				Vogan, Patrick J.; Schoettle, Anna W.			Carbon Costs of Constitutive and Expressed Resistance to a Non-Native Pathogen in Limber Pine	PLOS ONE			English	Article							GENE-MEDIATED RESISTANCE; BLISTER RUST; WHITE-PINE; DISEASE RESISTANCE; FITNESS COSTS; GROWTH; CONSEQUENCES; COEVOLUTION; METABOLISM; INFECTION	Increasing the frequency of resistance to the non-native fungus Cronartium ribicola (causative agent of white pine blister rust, WPBR) in limber pine populations is a primary management objective to sustain high-elevation forest communities. However, it is not known to what extent genetic disease resistance is costly to plant growth or carbon economy. In this study, we measured growth and leaf-level physiology in (1) seedling families from seed trees that have previously been inferred to carry or not carry Cr4, the dominant R gene allele conferring complete, gene-for-gene resistance to WPBR in limber pine, and (2) populations that were and were not infected with C. ribicola. We found that, in the absence of C. ribicola exposure, there was no significant difference in carbon relations between families born from seed trees that harbor the resistance allele compared to those that lack it, either to plant growth and phenology or leaf-level photosynthetic traits. However, post-infection with C. ribicola, growth was significantly reduced in inoculation survivors expressing complete resistance compared to uninoculated seedlings. Furthermore, inoculation survivors exhibited significant increases in a suite of traits including photosynthetic rate, respiration rate, leaf N, and stomatal conductance and a decrease in photosynthetic water-use efficiency. The lack of constitutive carbon costs associated with Cr4 resistance in non-stressed limber pine is consistent with a previous report that the R gene allele is not under selection in the absence of C. ribicola and suggests that host resistance may not bear a constitutive cost in pathosystems that have not coevolved. However, under challenge by C. ribicola, complete resistance to WPBR in limber pine has a significant cost to plant growth, though enhanced carbon acquisition post-infection may offset this somewhat. These costs and effects on performance further complicate predictions of this species' response in warmer future climates in the presence of WPBR.	[Vogan, Patrick J.] Mt Studies Inst, POB 426, Silverton, CO 81433 USA; [Vogan, Patrick J.; Schoettle, Anna W.] US Forest Serv, USDA, Rocky Mt Res Stn, 240 West Prospect Rd, Ft Collins, CO 80526 USA	United States Department of Agriculture (USDA); United States Forest Service	Schoettle, AW (corresponding author), US Forest Serv, USDA, Rocky Mt Res Stn, 240 West Prospect Rd, Ft Collins, CO 80526 USA.	aschoettle@fs.fed.us			United States Department of Agriculture Forest Service, Rocky Mountain Research Station; United States Department of Interior National Park Service, Rocky Mountain National Park	United States Department of Agriculture Forest Service, Rocky Mountain Research Station; United States Department of Interior National Park Service, Rocky Mountain National Park	Funding was provided by United States Department of Agriculture Forest Service, Rocky Mountain Research Station to AWS, and United States Department of Interior National Park Service, Rocky Mountain National Park to AWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander PJ, 2007, MOL ECOL NOTES, V7, P5, DOI 10.1111/j.1471-8286.2006.01549.x; Anderson KM, 2011, J ECON ENTOMOL, V104, P1393, DOI 10.1603/EC11004; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Bergelson J, 2001, SCIENCE, V292, P2281, DOI 10.1126/science.1061337; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Brown JKM, 2013, PLANT PATHOL, V62, P83, DOI 10.1111/ppa.12163; Brown JKM, 2011, ANNU REV PHYTOPATHOL, V49, P345, DOI 10.1146/annurev-phyto-072910-095301; Brown JKM, 2003, TRENDS GENET, V19, P667, DOI 10.1016/j.tig.2003.10.008; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Burns KS, 2008RMRSGTR206 USDA; Cleaver CM, 2015, FOREST ECOL MANAG, V358, P139, DOI 10.1016/j.foreco.2015.09.010; Dietrich R, 2005, PLANT CELL ENVIRON, V28, P211, DOI 10.1111/j.1365-3040.2004.01265.x; Egger B, 1996, PHYSIOL PLANTARUM, V96, P91, DOI 10.1111/j.1399-3054.1996.tb00188.x; Ennos RA, 2015, FORESTRY, V88, P41, DOI 10.1093/forestry/cpu048; Gibson K, 2008R108020 USDA FOR; Government of Alberta, 2010, SPEC RISK PUBL REG S; Hoch G, 2005, FUNCT ECOL, V19, P941, DOI 10.1111/j.1365-2435.2005.01040.x; Hoch G, 2003, OECOLOGIA, V135, P10, DOI 10.1007/s00442-002-1154-7; Jermstad KD, 2011, TREE GENET GENOMES, V7, P457, DOI 10.1007/s11295-010-0347-1; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Keane RE, 2012RMRSGTR279 USDA; Keith R, 2013, PLANT PATHOL, V62, P122, DOI 10.1111/ppa.12134; Kinloch BB, 2003, PHYTOPATHOLOGY, V93, P691, DOI 10.1094/PHYTO.2003.93.6.691; Kinloch BB, 2002, PHYTOPATHOLOGY, V92, P278, DOI 10.1094/PHYTO.2002.92.3.278; Korner C, 1999, ALPINE PLANT LIFE FU; Korves T, 2004, AM NAT, V163, P489, DOI 10.1086/382552; Krist F.J., 2014, 2013 2027 NATL INSEC; Li MH, 2008, PLANT CELL ENVIRON, V31, P1377, DOI 10.1111/j.1365-3040.2008.01848.x; Liu J-J, 2015, ANN C AM PHYT SOC AP; MacQueen A, 2016, J EXP BOT, V67, P2093, DOI 10.1093/jxb/erv530; Mcdowell JM, 2006, MOL PLANT PATHOL, V7, P437, DOI 10.1111/j.1364-3703.2006.00342.x; Mielke P. W., 2001, PERMUTATION METHODS; Moyes AB, 2013, OECOLOGIA, V171, P271, DOI 10.1007/s00442-012-2410-0; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Reinhardt K, 2011, TREE PHYSIOL, V31, P615, DOI 10.1093/treephys/tpr055; Samman SA, 1982, BREEDING INSECT DIS, P133; Schoettle AW, 2014, PHYTOPATHOLOGY, V104, P163, DOI 10.1094/PHYTO-04-13-0092-R; Schoettle AW, 2007, J FOREST RES-JPN, V12, P327, DOI 10.1007/s10310-007-0024-x; SMEDEGAARDPETERSEN V, 1980, PHYTOPATHOL Z, V99, P54; SMEDEGAARDPETERSEN V, 1981, PHYTOPATHOLOGY, V71, P396, DOI 10.1094/Phyto-71-396; Smith CM, 2013, CAN J FOREST RES, V43, P919, DOI 10.1139/cjfr-2013-0072; Smith WK, 2003, TREE PHYSIOL, V23, P1101, DOI 10.1093/treephys/23.16.1101; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Susi H, 2015, J ECOL, V103, P303, DOI 10.1111/1365-2745.12373; Susi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6975; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; Vila-Aiub MM, 2011, HEREDITY, V107, P386, DOI 10.1038/hdy.2011.29; Vogan PJ, 2015, FOREST ECOL MANAG, V344, P110, DOI 10.1016/j.foreco.2015.01.029; Vogan PJ, 2011, PLANT CELL ENVIRON, V34, P1415, DOI 10.1111/j.1365-3040.2011.02340.x; Wang XZ, 2001, P NATL ACAD SCI USA, V98, P2479, DOI 10.1073/pnas.051622998; Way DA, 2008, GLOBAL CHANGE BIOL, V14, P624, DOI 10.1111/j.1365-2486.2007.01513.x; Yang DL, 2012, P NATL ACAD SCI USA, V109, pE1192, DOI 10.1073/pnas.1201616109; Zhu QH, 2013, GENE, V512, P259, DOI 10.1016/j.gene.2012.10.036	59	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162913	10.1371/journal.pone.0162913	http://dx.doi.org/10.1371/journal.pone.0162913			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706249	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200024
J	Zurcher, K; Zwahlen, M; Ballif, M; Rieder, HL; Egger, M; Fenner, L				Zurcher, Kathrin; Zwahlen, Marcel; Ballif, Marie; Rieder, Hans L.; Egger, Matthias; Fenner, Lukas			Influenza Pandemics and Tuberculosis Mortality in 1889 and 1918: Analysis of Historical Data from Switzerland	PLOS ONE			English	Article							SEASONAL-VARIATION; VIRUS-INFECTION; VITAMIN-D	Background Tuberculosis (TB) mortality declined in the northern hemisphere over the last 200 years, but peaked during the Russian (1889) and the Spanish (1918) influenza pandemics. We studied the impact of these two pandemics on TB mortality. Methods We retrieved historic data from mortality registers for the city of Bern and countrywide for Switzerland. We used Poisson regression models to quantify the excess pulmonary TB (PTB) mortality attributable to influenza. Results Yearly PTB mortality rates increased during both influenza pandemics. Monthly influenza and PTB mortality rates peaked during winter and early spring. In Bern, for an increase of 100 influenza deaths (per 100,000 population) monthly PTB mortality rates increased by a factor of 1.5 (95% Cl 1.4-1.6, p<0.001) during the Russian, and 3.6 (95% Cl 0.7-18.0, p = 0.13) during the Spanish pandemic. Nationally, the factor was 2.0 (95% Cl 1.8-2.2, p<0.001) and 1.5 (95% Cl 1.1-1.9, p = 0.004), respectively. We did not observe any excess cancer or extrapulmonary TB mortality (as a negative control) during the influenza pandemics. Conclusions We demonstrate excess PTB mortality during historic influenza pandemics in Switzerland, which supports a role for influenza vaccination in PTB patients in high TB incidence countries.	[Zurcher, Kathrin; Zwahlen, Marcel; Ballif, Marie; Egger, Matthias; Fenner, Lukas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Fenner, Lukas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Fenner, Lukas] Univ Basel, Basel, Switzerland; [Rieder, Hans L.] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Zurich	Fenner, L (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.; Fenner, L (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Fenner, L (corresponding author), Univ Basel, Basel, Switzerland.	lukas.fenner@ispm.unibe.ch	Zwahlen, Marcel/AFF-8559-2022	Zwahlen, Marcel/0000-0002-6772-6346; Zurcher, Kathrin/0000-0002-7915-3194; Egger, Matthias/0000-0001-7462-5132; Fenner, Lukas/0000-0003-3309-4835				[Anonymous], 2008, HIST STAT SCHWEIZ ON; [Anonymous], 1927, TODESFALLE TODESURSA; Bern Statistisches Amt, 1918, HALBJ BEV WIRTSCH VE; Biggs HM, 1907, 6 AVENUE 55 STREET A; Brinkhof MWG, 2006, SWISS MED WKLY, V136, P302; Bryder L, 1996, SOC HIST MED, V9, P253, DOI 10.1093/shm/9.2.253; DANIELS M, 1949, BMJ-BRIT MED J, V2, P1135, DOI 10.1136/bmj.2.4637.1135; Drolet GJ, 1952, HALF CENTURYS PROGR, V1952, P1; Drolet GJ, 1924, TUBERCLE, V5, P232; ESPERSEN E, 1954, Acta Tuberc Scand, V29, P125; Fares A, 2011, J GLOB INFECT DIS, V3, P46, DOI 10.4103/0974-777X.77296; Florido M, 2013, J IMMUNOL, V191, P302, DOI 10.4049/jimmunol.1202824; Freudiger H, STAT AMT STADT BERN; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P151; Guggenheim R, 1920, AARGAUISCHEN HEILSTA; Jarvis JN, 2010, AIDS, V24, P612, DOI 10.1097/QAD.0b013e32833547f7; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Mabaera B, 2009, INT HEALTH, V1, P53, DOI 10.1016/j.inhe.2009.06.006; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Naranbat N, 2009, EUR RESPIR J, V34, P921, DOI 10.1183/09031936.00035309; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; Noymer A, 2011, VACCINE, V29, pB38, DOI 10.1016/j.vaccine.2011.02.053; Noymer A, 2009, SOC SCI MED, V68, P1599, DOI 10.1016/j.socscimed.2009.02.021; Oei W, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/124861; Potter CW, 2011, J INFECTION, V63, P252, DOI 10.1016/j.jinf.2011.04.013; Potter CW, 2001, J APPL MICROBIOL, V91, P572, DOI 10.1046/j.1365-2672.2001.01492.x; Redeker F, 1958, HBD TUBERCULOSE, P407; Redford PS, 2014, J INFECT DIS, V209, P270, DOI 10.1093/infdis/jit424; Rieder HL, 1998, SOZ PRAVENTIV MED, V43, P162, DOI 10.1007/BF01359724; Roth S, 2013, INFLUENZA OTHER RESP, V7, P244, DOI 10.1111/j.1750-2659.2012.00413.x; Schmid F, 1895, INFLUENZA SCHWEIZ JA; Schomaker M, 2013, JAIDS-J ACQ IMM DEF, V63, P142, DOI 10.1097/QAI.0b013e318288b39d; Schweiz Statistisches Bureau, 1928, GEB TOD SCHWEIZ BEV; Schweiz Statistisches Bureau, 1916, GEB TOD SCHWEIZ BEV; Schweiz Statistisches Bureau, 1895, GEB TOD SCHWEIZ BEV; Smith W, 1933, LANCET, V2, P66, DOI 10.1016/S0140-6736(00)78541-2; Valleron AJ, 2010, P NATL ACAD SCI USA, V107, P8778, DOI 10.1073/pnas.1000886107; Walaza S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129173; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2009, WHO INF TUB PAND INF; Wingfield T, 2014, J INFECT DIS, V210, P774, DOI 10.1093/infdis/jiu121; Zurcher K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149195	43	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162575	10.1371/journal.pone.0162575	http://dx.doi.org/10.1371/journal.pone.0162575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706149	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000385697200012
J	Zhao, T; Yang, HF; Sui, HX; Salvi, SS; Wang, Y; Sun, YC				Zhao, Tian; Yang, Huifang; Sui, Huaxin; Salvi, Satyajeet Sudhir; Wang, Yong; Sun, Yuchun			Accuracy of a Real-Time, Computerized, Binocular, Three-Dimensional Trajectory-Tracking Device for Recording Functional Mandibular Movements	PLOS ONE			English	Article								Objective Developments in digital technology have permitted researchers to study mandibular movements. Here, the accuracy of a real-time, computerized, binocular, three-dimensional (3D) trajectory-tracking device for recording functional mandibular movements was evaluated. Methods An occlusal splint without the occlusal region was created based on a plaster cast of the lower dentition. The splint was rigidly connected with a target on its labial side and seated on the cast. The cast was then rigidly attached to the stage of a high-precision triaxial electronic translator, which was used to move the target-cast-stage complex. Half-circular movements (5.00-mm radius) in three planes (XOY, XOZ, YOZ) and linear movements along the x-axis were performed at 5.00 mm/s. All trajectory points were recorded with the binocular 3D trajectory-tracking device and fitted to arcs or lines, respectively, with the Imageware software. To analyze the accuracy of the trajectory-tracking device, the mean distances between the trajectory points and the fitted arcs or lines were measured, and the mean differences between the lengths of the fitted arcs' radii and a set value (5.00 mm) were then calculated. A one-way analysis of variance was used to evaluate the spatial consistency of the recording accuracy in three different planes. Results The mean distances between the trajectory points and fitted arcs or lines were 0.076 +/- 0.033 mm or 0.089 +/- 0.014 mm. The mean difference between the lengths of the fitted arcs' radii and the set value (5.00 mm) was 0.025 +/- 0.071 mm. A one-way ANOVA showed that the recording errors in three different planes were not statistically significant. Conclusion These results suggest that the device can record certain movements at 5.00 mm/s, which is similar to the speed of functional mandibular movements. In addition, the recordings had an error of <0.1 mm and good spatial consistency. Thus, the device meets some of the requirements necessary for recording human mandibular movements.	[Zhao, Tian; Yang, Huifang; Sui, Huaxin; Wang, Yong; Sun, Yuchun] Peking Univ, Sch & Hosp Stomatol, Ctr Digital Dent, Beijing, Peoples R China; [Zhao, Tian; Yang, Huifang; Sui, Huaxin; Wang, Yong; Sun, Yuchun] Peking Univ, Sch & Hosp Stomatol, Fac Prosthodont, Beijing, Peoples R China; [Zhao, Tian; Yang, Huifang; Sui, Huaxin; Wang, Yong; Sun, Yuchun] Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Zhao, Tian; Yang, Huifang; Sui, Huaxin; Salvi, Satyajeet Sudhir; Wang, Yong; Sun, Yuchun] Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing, Peoples R China; [Zhao, Tian; Yang, Huifang; Sui, Huaxin; Wang, Yong; Sun, Yuchun] Beijing Key Lab Digital Stomatol, Beijing, Peoples R China	Peking University; Peking University	Wang, Y; Sun, YC (corresponding author), Peking Univ, Sch & Hosp Stomatol, Ctr Digital Dent, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Peking Univ, Sch & Hosp Stomatol, Fac Prosthodont, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Minist Hlth, Res Ctr Engn & Technol Digital Dent, Beijing, Peoples R China.; Wang, Y; Sun, YC (corresponding author), Beijing Key Lab Digital Stomatol, Beijing, Peoples R China.	kqcadc@bjmu.edu.cn; polarshining@163.com	, 孙玉春/AAX-5280-2020					Feng HL, 2005, PROSTHODONTICS; JANKELSON B, 1975, J AM DENT ASSOC, V90, P834, DOI 10.14219/jada.archive.1975.0164; Kim DS, 2010, ORAL SURG ORAL MED O, V110, P648, DOI 10.1016/j.tripleo.2010.06.007; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095912; Santana-Mora U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059980; Yuan FS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137507	6	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163934	10.1371/journal.pone.0163934	http://dx.doi.org/10.1371/journal.pone.0163934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701462	gold, Green Published, Green Submitted			2022-12-27	WOS:000385696900035
J	Martho, KFC; de Melo, AT; Takahashi, JPF; Guerra, JM; Santos, DCD; Purisco, SU; Melhem, MDC; Fazioli, RD; Phanord, C; Sartorelli, P; Vallim, MA; Pascon, RC				Cruz Martho, Kevin Felipe; de Melo, Amanda Teixeira; Fernandes Takahashi, Juliana Possato; Guerra, Juliana Mariotti; da Silva Santos, Dayane Cristina; Purisco, Sonia Ueda; Carvalho Melhem, Marcia de Souza; Fazioli, Raquel dos Anjos; Phanord, Clerlune; Sartorelli, Patricia; Vallim, Marcelo A.; Pascon, Renata C.			Amino Acid Permeases and Virulence in Cryptococcus neoformans	PLOS ONE			English	Article							HUMAN FUNGAL PATHOGEN; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; GENE; TRANSPORTERS; METABOLISM; ADAPTATION; SYNTHASE; GROWTH; FILAMENTATION	Fungal opportunistic pathogens colonize various environments, from plants and wood to human and animal tissue. Regarding human pathogens, one great challenge during contrasting niche occupation is the adaptation to different conditions, such as temperature, osmolarity, salinity, pressure, oxidative stress and nutritional availability, which may constitute sources of stress that need to be tolerated and overcome. As an opportunistic pathogen, C. neoformans faces exactly these situations during the transition from the environment to the human host, encountering nutritional constraints. Our previous and current research on amino acid biosynthetic pathways indicates that amino acid permeases are regulated by the presence of the amino acids, nitrogen and temperature. Saccharomyces cerevisiae and Candida albicans have twenty-four and twenty-seven genes encoding amino acid permeases, respectively; conversely, they are scarce in number in Basidiomycetes (C. neoformans, Coprinopsis cinerea and Ustilago maydis), where nine to ten permease genes can be found depending on the species. In this study, we have demonstrated that two amino acid permeases are essential for virulence in C. neoformans. Our data showed that C. neoformans uses two global and redundant amino acid permeases, Aap4 and Aap5 to respond correctly to thermal and oxidative stress. Double deletion of these permeases causes growth arrest in C. neoformans at 37 degrees C and in the presence of hydrogen peroxide. The inability to uptake amino acid at a higher temperature and under oxidative stress also led to virulence attenuation in vivo. Our data showed that thermosensitivity caused by the lack of permeases Aap4 and Aap5 can be remedied by alkaline conditions (higher pH) and salinity. Permeases Aap4 and Aap5 are also required during fluconazole stress and they are the target of the plant secondary metabolite eugenol, a potent antifungal inhibitor that targets amino acid permeases. In summary, our work unravels (i) interesting physiological property of C. neoformans regarding its amino acid uptake system; (ii) an important aspect of virulence, which is the need for amino acid permeases during thermal and oxidative stress resistance and, hence, host invasion and colonization; and (iii) provides a convenient prototype for antifungal development, which are the amino acid permeases Aap4/Aap5 and their inhibitor.	[Cruz Martho, Kevin Felipe; de Melo, Amanda Teixeira; Phanord, Clerlune; Sartorelli, Patricia; Vallim, Marcelo A.; Pascon, Renata C.] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Rua Arthur Ridel 275, Diadema, SP, Brazil; [Fernandes Takahashi, Juliana Possato; Guerra, Juliana Mariotti] Adolfo Lutz Inst, Quantitat Pathol Unit, Sao Paulo, Brazil; [da Silva Santos, Dayane Cristina; Purisco, Sonia Ueda; Carvalho Melhem, Marcia de Souza; Fazioli, Raquel dos Anjos] Secretary Hlth, Adolfo Lutz Inst, Mycol Unit, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Instituto Adolfo Lutz; Instituto Adolfo Lutz	Pascon, RC (corresponding author), Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Rua Arthur Ridel 275, Diadema, SP, Brazil.	Renata.pascon@gmail.com	Sartorelli, Patricia/AAN-2911-2020; Pascon, Renata/E-1494-2012; de melo, amanda teixeira/U-1811-2019; Guerra, Juliana/H-5310-2012; Vallim, Marcelo/J-2624-2013	Pascon, Renata/0000-0001-9902-9396; de melo, amanda teixeira/0000-0003-3867-8522; Guerra, Juliana/0000-0002-0326-7187; Vallim, Marcelo/0000-0002-6929-0566; Sartorelli, Patricia/0000-0002-1624-8145	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/51298-4, 2015/04400-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2011/51298-4 (RCP); and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2015/04400-9 (MAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Alspaugh JA, 1998, FUNGAL GENET BIOL, V25, P1, DOI 10.1006/fgbi.1998.1079; Antinori Spinello, 2013, ISRN AIDS, V2013, P471363, DOI 10.1155/2013/471363; Ballou ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003687; Berger S., 2009, CLASSICS SPECTROSCOP; Biswas K, 2003, GENE, V323, P43, DOI 10.1016/j.gene.2003.09.005; Brega E, 2004, EUKARYOT CELL, V3, P135, DOI 10.1128/EC.3.1.135-143.2004; Chang YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131865; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Cox GM, 2003, INFECT IMMUN, V71, P173, DOI 10.1128/IAI.71.1.173-180.2003; Dantas AD, 2015, BIOMOLECULES, V5, P142, DOI 10.3390/biom5010142; Darvishi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076028; Dichtl K, 2016, CELL MICROBIOL, V18, P1228, DOI 10.1111/cmi.12612; Do E, 2016, BIOCHEM BIOPH RES CO, V477, P706, DOI 10.1016/j.bbrc.2016.06.123; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; Ene IV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019695; GRENSON M, 1970, J BACTERIOL, V103, P770, DOI 10.1128/JB.103.3.770-777.1970; Han K, 2012, J MICROBIOL BIOTECHN, V22, P1644, DOI 10.4014/jmb.1209.09019; Hu GG, 2008, MOL MICROBIOL, V69, P1456, DOI 10.1111/j.1365-2958.2008.06374.x; Isnard AD, 1996, J MOL BIOL, V262, P473, DOI 10.1006/jmbi.1996.0529; Janbon G, 2004, FEMS YEAST RES, V4, P765, DOI 10.1016/j.femsyr.2004.04.003; Kaiser JC, 2015, INFECT IMMUN, V83, P1019, DOI 10.1128/IAI.02542-14; Kamatou GP, 2012, MOLECULES, V17, P6953, DOI 10.3390/molecules17066953; Karkowska-Kuleta J, 2009, ACTA BIOCHIM POL, V56, P211; Kim Min Su, 2012, Methods Mol Biol, V845, P67, DOI 10.1007/978-1-61779-539-8_5; Kingsbury JM, 2004, MICROBIOL-SGM, V150, P1547, DOI 10.1099/mic.0.26928-0; Kingsbury JM, 2004, EUKARYOT CELL, V3, P752, DOI 10.1128/EC.3.3.752-763.2004; Kingsbury JM, 2008, MICROBIOL-SGM, V154, P2767, DOI 10.1099/mic.0.2008/019729-0; Kingsbury JM, 2010, EUKARYOT CELL, V9, P729, DOI 10.1128/EC.00045-10; Kingsbury JM, 2010, MICROBIOL-SGM, V156, P929, DOI 10.1099/mic.0.034348-0; Komalapriya C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137750; Kosugi A, 2001, BIOSCI BIOTECH BIOCH, V65, P728, DOI 10.1271/bbb.65.728; Kraidlova L, 2011, EUKARYOT CELL, V10, P1219, DOI 10.1128/EC.05026-11; Kretschmer M, 2014, INFECT IMMUN, V82, P2697, DOI 10.1128/IAI.01607-14; Kronstad J, 2012, EUKARYOT CELL, V11, P109, DOI 10.1128/EC.05273-11; Lee IR, 2011, GENETICS, V188, P309, DOI 10.1534/genetics.111.128538; Li Shu Shun, 2010, Proc Am Thorac Soc, V7, P186, DOI 10.1513/pats.200907-063AL; Lin XR, 2006, ANNU REV MICROBIOL, V60, P69, DOI 10.1146/annurev.micro.60.080805.142102; Lin XR, 2009, INFECT GENET EVOL, V9, P401, DOI 10.1016/j.meegid.2009.01.013; Liu TB, 2012, VIRULENCE, V3, P173, DOI 10.4161/viru.18685; Liu TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060346; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Martinez P, 2004, MOL MICROBIOL, V51, P371, DOI 10.1046/j.1365-2958.2003.03845.x; Mathieu C, 2014, BIOCHEM J, V463, P9, DOI 10.1042/BJ20140719; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Nichols CB, 2015, EUKARYOT CELL, V14, P626, DOI 10.1128/EC.00010-15; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; O'Meara TR, 2014, MOL CELL BIOL, V34, P673, DOI 10.1128/MCB.01359-13; Ost KS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005159; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pascon RC, 2004, MICROBIOL-SGM, V150, P3013, DOI 10.1099/mic.0.27235-0; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; Pramod K, 2010, NAT PROD COMMUN, V5, P1999; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Fernandes JDS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132369; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Schwartzman JA, 2016, TRENDS MICROBIOL, V24, P414, DOI 10.1016/j.tim.2016.02.012; Schweikhard ES, 2012, CURR TOP MEMBR, V70, P1, DOI 10.1016/B978-0-12-394316-3.00001-6; Shor E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004668; Skowyra Michael L, 2012, Methods Mol Biol, V845, P165, DOI 10.1007/978-1-61779-539-8_11; Smith DG, 2003, MOL MICROBIOL, V50, P259, DOI 10.1046/j.1365-2958.2003.03680.x; Srikanta D, 2014, YEAST, V31, P47, DOI 10.1002/yea.2997; Sui Y, 2015, APPL ENVIRON MICROB, V81, P2968, DOI 10.1128/AEM.04203-14; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Voelz K, 2010, EUKARYOT CELL, V9, P835, DOI 10.1128/EC.00039-10; Wang P, 1999, CURR OPIN MICROBIOL, V2, P358, DOI 10.1016/S1369-5274(99)80063-0; Wipf D, 2002, TRENDS BIOCHEM SCI, V27, P139, DOI 10.1016/S0968-0004(01)02054-0; Yang ZH, 2002, MICROBIOL-SGM, V148, P2617, DOI 10.1099/00221287-148-8-2617; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003	73	23	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163919	10.1371/journal.pone.0163919	http://dx.doi.org/10.1371/journal.pone.0163919			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695080	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100065
J	Guggenheim, EJ; Khan, A; Pike, J; Chang, L; Lynch, I; Rappoport, JZ				Guggenheim, Emily J.; Khan, Abdullah; Pike, Jeremy; Chang, Lynne; Lynch, Iseult; Rappoport, Joshua Z.			Comparison of Confocal and Super-Resolution Reflectance Imaging of Metal Oxide Nanoparticles	PLOS ONE			English	Article							DUAL-MODE REFLECTANCE; GOLD NANOPARTICLES; MICROSCOPY; CELLS; LIGHT; FLUORESCENCE; RESOLUTION; QUANTIFICATION; NANOMATERIALS; TRANSPORT	The potential for human exposure to manufactured nanoparticles (NPs) has increased in recent years, in part through the incorporation of engineered particles into a wide range of commercial goods and medical applications. NP are ideal candidates for use as therapeutic and diagnostic tools within biomedicine, however concern exists regarding their efficacy and safety. Thus, developing techniques for the investigation of NP uptake into cells is critically important. Current intracellular NP investigations rely on the use of either Transmission Electron Microscopy (TEM), which provides ultrahigh resolution, but involves cumbersome sample preparation rendering the technique incompatible with live cell imaging, or fluorescent labelling, which suffers from photobleaching, poor bioconjugation and, often, alteration of NP surface properties. Reflected light imaging provides an alternative non-destructive label free technique well suited, but not limited to, the visualisation of NP uptake within model systems, such as cells. Confocal reflectance microscopy provides optical sectioning and live imaging capabilities, with little sample preparation. However confocal microscopy is diffraction limited, thus the X-Y resolution is restricted to similar to 250 nm, substantially larger than the < 100 nm size of NPs. Techniques such as super-resolution light microscopy overcome this fundamental limitation, providing increased X-Y resolution. The use of Reflectance SIM (R-SIM) for NP imaging has previously only been demonstrated on custom built microscopes, restricting the widespread use and limiting NP investigations. This paper demonstrates the use of a commercial SIM microscope for the acquisition of super-resolution reflectance data with X-Y resolution of 115 nm, a greater than two-fold increase compared to that attainable with RCM. This increase in resolution is advantageous for visualising small closely spaced structures, such as NP clusters, previously unresolvable by RCM. This is advantageous when investigating the subcellular trafficking of NP within fluorescently labelled cellular compartments. NP signal can be observed using RCM, R-SIM and TEM and a direct comparison is presented. Each of these techniques has its own benefits and limitations; RCM and R-SIM provide novel complementary information while the combination of modalities provides a unique opportunity to gain additional information regarding NP uptake. The use of multiple imaging methods therefore greatly enhances the range of NPs that can be studied under label-free conditions.	[Guggenheim, Emily J.; Pike, Jeremy] DTC, PSIBS, Birmingham, Edgbaston, England; [Guggenheim, Emily J.; Khan, Abdullah; Pike, Jeremy] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Chang, Lynne] Nikon Instruments Inc, Melville, NY USA; [Lynch, Iseult] Univ Birmingham, Sch Geog Earth & Environm Sci, Edgbaston, England; [Rappoport, Joshua Z.] Northwestern Univ, Feinberg Sch Med, Ctr Adv Microscopy, Chicago, IL 60611 USA; [Rappoport, Joshua Z.] Northwestern Univ, Feinberg Sch Med, Nikon Imaging Ctr, Chicago, IL 60611 USA	University of Birmingham; University of Birmingham; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Rappoport, JZ (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Adv Microscopy, Chicago, IL 60611 USA.; Rappoport, JZ (corresponding author), Northwestern Univ, Feinberg Sch Med, Nikon Imaging Ctr, Chicago, IL 60611 USA.	joshua.rappoport@northwestern.edu	Pike, Jeremy/B-3995-2017; Lynch, Iseult/I-3915-2014	Pike, Jeremy/0000-0003-4163-0335; Lynch, Iseult/0000-0003-4250-4584; Khan, Abdullah/0000-0003-0825-3179; Guggenheim, Emily/0000-0002-4426-0053	Welcome Trust ISSF Mobility Fund; University of Birmingham North American Travel Fund; Engineering and Physical Sciences Research Council (EPSRC) [EP/F50053X/1]; NERC [NE/I008314/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1239412] Funding Source: researchfish; Natural Environment Research Council [NE/I008314/1] Funding Source: researchfish	Welcome Trust ISSF Mobility Fund; University of Birmingham North American Travel Fund; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors are grateful to the Welcome Trust (http://www.wellcome.ac.uk/) ISSF Mobility Fund and the University of Birmingham North American Travel Fund for supporting EJG's work in Chicago. EJG gratefully acknowledges financial support from the Engineering and Physical Sciences Research Council (EPSRC) (https://www.epsrc.ac.uk/) who provided funding though a studentship from the Physical Science of Imagingin the Biomedical Sciences (PSIBS) Doctoral Training Centre (EP/F50053X/1).	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/ BF02956173, DOI 10.1007/BF02956173]; Aillon KL, 2009, ADV DRUG DELIVER REV, V61, P457, DOI 10.1016/j.addr.2009.03.010; Aitken RJ, 2006, OCCUP MED-OXFORD, V56, P300, DOI 10.1093/occmed/kql051; Bartczak D, 2015, TOXICOL RES-UK, V4, P169, DOI 10.1039/c4tx00105b; Bose K, 2014, PART PART SYST CHAR, V31, P439, DOI 10.1002/ppsc.201300308; Calzavara-Pinton P, 2008, PHOTOCHEM PHOTOBIOL, V84, P1421, DOI 10.1111/j.1751-1097.2008.00443.x; Carlson AL, 2007, J MICROSC-OXFORD, V228, P11, DOI 10.1111/j.1365-2818.2007.01818.x; Chang BJ, 2011, OPT LETT, V36, P4773, DOI 10.1364/OL.36.004773; Chen H, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.27463; Cox G, 2004, MICROSC RES TECHNIQ, V63, P18, DOI 10.1002/jemt.10423; De Jong WH, 2013, BIOMATERIALS, V34, P8333, DOI 10.1016/j.biomaterials.2013.06.048; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dunn AK, 1996, APPL OPTICS, V35, P3441, DOI 10.1364/AO.35.003441; Elsaesser A, 2010, NANOMEDICINE-UK, V5, P1447, DOI [10.2217/nnm.10.118, 10.2217/NNM.10.118]; FAULK WP, 1971, IMMUNOCHEMISTRY, V8, P1081; Forster SP, 2011, INT J NANOTECHNOL; FREEMAN MW, 1960, J APPL PHYS, V31, pS404, DOI 10.1063/1.1984765; Gaspar I, 2009, CELL MOTIL CYTOSKEL, V66, P68, DOI 10.1002/cm.20334; Goodwin S, 1999, J MAGN MAGN MATER, V194, P132, DOI 10.1016/S0304-8853(98)00584-8; Gunn J, 2009, BIOPHYS J, V97, P2640, DOI 10.1016/j.bpj.2009.08.013; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; GUSNARD D, 1977, J MICROSC-OXFORD, V110, P51, DOI 10.1111/j.1365-2818.1977.tb00012.x; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jin YH, 2012, COLLOID SURFACE B, V94, P184, DOI 10.1016/j.colsurfb.2012.01.032; KANEKO Y, 1995, J ELECTRON MICROSC, V44, P104; KOESTER CJ, 1993, J OPT SOC AM A, V10, P1670, DOI 10.1364/JOSAA.10.001670; Kohler N, 2005, LANGMUIR, V21, P8858, DOI 10.1021/la0503451; Le Trequesser Q, 2014, ANAL CHEM, V86, P7311, DOI 10.1021/ac501318c; Li YY, 2005, J INVEST DERMATOL, V125, P798, DOI 10.1111/j.0022-202X.2005.23786.x; Liu JF, 2012, TRAC-TREND ANAL CHEM, V33, P95, DOI 10.1016/j.trac.2011.10.010; Mazzolini J, 2016, BIOL BULL; Mortensen LJ, 2011, BIOMED OPT EXPRESS, V2, P1610, DOI 10.1364/BOE.2.001610; Muhlfeld Christian, 2007, Part Fibre Toxicol, V4, P11, DOI 10.1186/1743-8977-4-11; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Nie S, 2010, NANOMEDICINE-UK, V54, P523; Nie SM, 2010, NANOMEDICINE-UK, V5, P523, DOI 10.2217/NNM.10.23; Nielsen S, 1997, J NEUROSCI, V17, P171; Park B, 2008, INHAL TOXICOL, V20, P547, DOI [10.1080/08958370801915309, 10.1080/08958370801915309 ]; Patskovsky S, 2014, ANALYST, V139, P5247, DOI 10.1039/c4an01063a; Petroll WM, 2013, CORNEA, V32, pE36, DOI 10.1097/ICO.0b013e31825ec44e; Truong PL, 2014, NANOSCALE, V6, P2307, DOI 10.1039/c3nr05211g; Quan QM, 2011, MOL PHARMACEUT, V8, P1669, DOI 10.1021/mp200006f; RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215; Rayleigh L., 1903, J R MICROSC SOC, V23, P474, DOI [DOI 10.1111/J.1365-2818.1903.TB04831.X, 10.1111/j.1365-2818.1903.tb04831.x]; Rego EH, 2012, P NATL ACAD SCI USA, V109, pE135, DOI 10.1073/pnas.1107547108; Sandin P, 2012, ACS NANO, V6, P1513, DOI 10.1021/nn204448x; Sannomiya T, 2013, J OPT RES, V15, P73; Santra S, 2009, SMALL, V5, P1862, DOI 10.1002/smll.200900389; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Shang L, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-5; Sheppard Colin J. R., 1995, P363; Sigmund W., 2008, PARTICULATE SYSTEMS; Smijs TG, 2011, NANOTECHNOL SCI APPL, DOI 10.2147/NSA.S19419; Smijs TG, 2011, NANOTECHNOL SCI APPL, V4, P95, DOI 10.2147/NSA.S19419; Smith PJ, 2012, INT J NANOMED, V7, P2045, DOI 10.2147/IJN.S29334; Sokolov K, 2003, CANCER RES, V63, P1999; Uboldi C, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-18; Veksler BA, 2011, OPT SPECTROSC+, V110, P483, DOI 10.1134/S0030400X11030246; Veksler BA, 2011, OPT SPECTROSC, V110, P438, DOI 10.1134/s0030400x11030246; Verdat M. E., 1869, LECONS OPTIQUE PHYS, V1, DOI 10.1126/science; Wang YXJ, 2015, WORLD J GASTROENTERO, V21, P13400, DOI 10.3748/wjg.v21.i47.13400; Wojcik MM, 2015, CHEM-EUR J, V21, P10082, DOI 10.1002/chem.201406262; Wright J, 2014, NATURE, V509, pS58, DOI 10.1038/509S58a; Yang YH, 2004, ANAL CHIM ACTA, V525, P213, DOI 10.1016/j.aca.2004.07.071; Yin C, 2003, BIOMATERIALS, V24, P837, DOI 10.1016/S0142-9612(02)00416-7; Yoshii Y, 2011, BIOMATERIALS, V32, P6052, DOI 10.1016/j.biomaterials.2011.04.076; Zhang HZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10525; Zhang JF, 2013, ENVIRON SCI TECHNOL, V47, P13077, DOI 10.1021/es402140u	71	26	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0159980	10.1371/journal.pone.0159980	http://dx.doi.org/10.1371/journal.pone.0159980			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695038	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100005
J	Ji, X; Feng, YM; Tian, H; Meng, W; Wang, WL; Liu, N; Zhang, J; Wang, LS; Wang, J; Gao, HQ				Ji, Xiang; Feng, Yimin; Tian, Hui; Meng, Wei; Wang, Weiling; Liu, Na; Zhang, Jun; Wang, Lingshu; Wang, Jian; Gao, Haiqing			The Mechanism of Proinflammatory HDL Generation in Sickle Cell Disease Is Linked to Cell-Free Hemoglobin via Haptoglobin	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; LIPOPROTEIN CHOLESTEROL LEVELS; LOW-DENSITY-LIPOPROTEIN; HEMOLYSIS; RECEPTOR; MICE; IDENTIFICATION; INFLAMMATION; TRANSPORT; BINDING	In sickle cell disease (SCD), the inflammatory properties of high-density lipoprotein (HDL) can be changed by cell-free hemoglobin (Hb), which is released into the blood during hemolysis. Hb in the plasma of SCD patients or mice can bind with HDL specifically inducing an inflammatory reaction. In our study, we found increased amounts of inflammatory factor proteins in the chronic oxidative state of SCD with higher levels of Hb, haptoglobin (Hp) and hemopexin (Hx) in the apolipoprotein A-I (ApoA-1) particles of HDL and the role of HDL is changed from being anti-inflammatory to proinflammatory. Our results also suggest Hp and Hx, the scavengers of Hb in HDL, are positively associated with inflammatory levels in SCD patients. HDL retained its inflammatory inhibition role in Hp-/- mice, with less Hb accumulation. Hx may further prevent inflammatory reaction because its level will be even higher when lack of Hx. We therefore demonstrated that Hp is indispensable during the process whereby Hb associates with HDL and plays a clear proinflammatory role. Therefore, it is essential to break the binding between Hb and Hp for treatment. The dissociation of Hb/Hp/Hx complexes may also play an important role in the study of other inflammatory angiogenesis-related diseases.	[Ji, Xiang; Wang, Weiling; Zhang, Jun; Wang, Jian; Gao, Haiqing] Shandong Univ, Shandong Key Lab Prote, Qilu Hosp, Dept Geriatr, Jinan 250012, Shandong, Peoples R China; [Feng, Yimin] Shandong Univ, Clin Lab, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Tian, Hui] Qiingdao Univ, ICU, Affiliated Hosp, Qingdao 266012, Shandong, Peoples R China; [Meng, Wei] Shandong Univ, Dept Cardiol, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Liu, Na] Shandong Univ, Pharmacol Lab, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Wang, Lingshu] Shandong Univ, Dept Endocrinol, Qilu Hosp, Jinan 250012, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Gao, HQ (corresponding author), Shandong Univ, Shandong Key Lab Prote, Qilu Hosp, Dept Geriatr, Jinan 250012, Shandong, Peoples R China.	gaohaiqing52@126.com			Shandong Province Outstanding Young Scientist Award Fund [BS2014YY021]	Shandong Province Outstanding Young Scientist Award Fund	This paper was supported by Shandong Province Outstanding Young Scientist Award Fund (BS2014YY021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTRUDA F, 1985, NUCLEIC ACIDS RES, V13, P3841, DOI 10.1093/nar/13.11.3841; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; BOWMAN BH, 1982, ADV HUM GENET, V12, P189; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Corsetti JP, 2010, ARTERIOSCL THROM VAS, V30, P1657, DOI 10.1161/ATVBAHA.110.207977; Fredenrich A, 2003, DIABETES METAB, V29, P201, DOI 10.1016/S1262-3636(07)70029-0; Frei AC, 2008, BLOOD, V112, P398, DOI 10.1182/blood-2007-12-126714; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V205, P1072, DOI 10.1006/bbrc.1994.2775; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Ji X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091089, 10.1371/journal.pone.0107460]; Jison ML, 2003, AM J RESP CRIT CARE, V168, P3, DOI 10.1164/rccm.2304002; KUNITAKE ST, 1994, BIOCHEMISTRY-US, V33, P1988, DOI 10.1021/bi00174a003; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Navab M, 2000, J LIPID RES, V41, P1481; Navab M, 2001, ARTERIOSCL THROM VAS, V21, P481, DOI 10.1161/01.ATV.21.4.481; Navab M, 2012, J LIPID RES, V53, P437, DOI 10.1194/jlr.M023523; Navab M, 2009, J LIPID RES, V50, P1538, DOI 10.1194/jlr.M800539-JLR200; Nicholls S. J., 2016, 65 ANN SCI SESS EXP; Ou JS, 2005, CIRC RES, V97, P1190, DOI 10.1161/01.RES.0000190634.60042.cb; Porta A, 1999, ZYGOTE, V7, P67, DOI 10.1017/S0967199499000416; PUPPO A, 1988, BIOCHEM J, V249, P185, DOI 10.1042/bj2490185; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Seixas MO, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-91; Spagnuolo MS, 2005, J BIOL CHEM, V280, P1193, DOI 10.1074/jbc.M411390200; TPaszty C, 1997, SCIENCE, V278, P876; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Wang WL, 2010, J LIPID RES, V51, P2560, DOI 10.1194/jlr.M004549; Watanabe J, 2007, J BIOL CHEM, V282, P23698, DOI 10.1074/jbc.M702163200; WEINSTEIN MB, 1984, BIOCHEM BIOPH RES CO, V123, P489, DOI 10.1016/0006-291X(84)90257-2	32	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164264	10.1371/journal.pone.0164264	http://dx.doi.org/10.1371/journal.pone.0164264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716784	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100037
J	Siper, PM; Zemon, V; Gordon, J; George-Jones, J; Lurie, S; Zweifach, J; Tavassoli, T; Wang, AT; Jamison, J; Buxbaum, JD; Kolevzon, A				Siper, Paige M.; Zemon, Vance; Gordon, James; George-Jones, Julia; Lurie, Stacey; Zweifach, Jessica; Tavassoli, Teresa; Wang, A. Ting; Jamison, Jesslyn; Buxbaum, Joseph D.; Kolevzon, Alexander			Rapid and Objective Assessment of Neural Function in Autism Spectrum Disorder Using Transient Visual Evoked Potentials	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; CONTRAST MECHANISMS; RETT-SYNDROME; DEFICITS; INHIBITION; BIOMARKERS; CHILDREN; MODEL; VEP; COMPONENT	Objective There is a critical need to identify biomarkers and objective outcome measures that can be used to understand underlying neural mechanisms in autism spectrum disorder (ASD). Visual evoked potentials (VEPs) offer a noninvasive technique to evaluate the functional integrity of neural mechanisms, specifically visual pathways, while probing for disease pathophysiology. Methods Transient VEPs (tVEPs) were obtained from 96 unmedicated children, including 37 children with ASD, 36 typically developing (TD) children, and 23 unaffected siblings (SIBS). A conventional contrast-reversing checkerboard condition was compared to a novel short-duration condition, which was developed to enable objective data collection from severely affected populations who are often excluded from electroencephalographic (EEG) studies. Results Children with ASD showed significantly smaller amplitudes compared to TD children at two of the earliest critical VEP components, P-60-N-75 and N-75-P-100. SIBS showed intermediate responses relative to ASD and TD groups. There were no group differences in response latency. Frequency band analyses indicated significantly weaker responses for the ASD group in bands encompassing gamma-wave activity. Ninety-two percent of children with ASD were able to complete the short-duration condition compared to 68% for the standard condition. Conclusions The current study establishes the utility of a short-duration tVEP test for use in children at varying levels of functioning and describes neural abnormalities in children with idiopathic ASD. Implications for excitatory/inhibitory balance as well as the potential application of VEP for use in clinical trials are discussed.	[Siper, Paige M.; George-Jones, Julia; Lurie, Stacey; Zweifach, Jessica; Wang, A. Ting; Jamison, Jesslyn; Buxbaum, Joseph D.; Kolevzon, Alexander] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Siper, Paige M.; George-Jones, Julia; Wang, A. Ting; Jamison, Jesslyn; Buxbaum, Joseph D.; Kolevzon, Alexander] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Zemon, Vance; Lurie, Stacey; Zweifach, Jessica] Yeshiva Univ, Ferkauf Grad Sch Psychol, Bronx, NY USA; [Gordon, James] Hunter Coll, New York, NY USA; [Wang, A. Ting; Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Wang, A. Ting; Buxbaum, Joseph D.; Kolevzon, Alexander] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Buxbaum, Joseph D.; Kolevzon, Alexander] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Kolevzon, Alexander] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Tavassoli, Teresa] UCL, UCL Inst Educ, Ctr Res Autism & Educ CRAE, London, England	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yeshiva University; City University of New York (CUNY) System; Hunter College (CUNY); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of London; University College London; UCL Institute of Education	Siper, PM (corresponding author), Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA.; Siper, PM (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.	paige.siper@mssm.edu	Buxbaum, Joseph D/G-6001-2010	Tavassoli, Teresa/0000-0002-7898-2994; Buxbaum, Joseph/0000-0001-8898-8313	Autism Speaks [8685]; National Institute of Mental Health [R21 MH107839]; Beatrice and Samuel A. Seaver Foundation	Autism Speaks; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Beatrice and Samuel A. Seaver Foundation	This study was supported by grants from Autism Speaks (https://www.autismspeaks.org/) Grant #8685 awarded to Paige Siper, the National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml) R21 MH107839 awarded to Paige Siper, Teresa Tavassoli, Joseph Buxbaum and Alexander Kolevzon, and the Beatrice and Samuel A. Seaver Foundation (https://fconline.foundationcenter.org/grantmaker-profile/?collection=grantmakers&activity=result&key=SEAV003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Blatt GJ, 2011, ANAT REC, V294, P1646, DOI 10.1002/ar.21252; Boeschoten MA, 2007, CLIN NEUROPHYSIOL, V118, P2076, DOI 10.1016/j.clinph.2007.05.004; Bozdagi O, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-9; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Casanova MF, 2006, ACTA NEUROPATHOL, V112, P287, DOI 10.1007/s00401-006-0085-5; Constantino JN., 2012, SRS2 SOCIAL RESPONSI, V2nd ed; Creutzfeldt OD, 1973, HDB SENSORY PHYSL, V7; Dawson G, 2012, J AM ACAD CHILD PSY, V51, P1150, DOI 10.1016/j.jaac.2012.08.018; De Rubeis S, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0553-1; Duffy FH, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-70; Edgar JC, 2015, J AUTISM DEV DISORD, V45, P395, DOI 10.1007/s10803-013-1904-x; Elliott C, 2007, DIFFERENTIAL ABILITY; Garcia-Quispe LA, 2009, OPTOMETRY VISION SCI, V86, P708, DOI 10.1097/OPX.0b013e3181a61673; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Gross C, 2015, NEUROTHERAPEUTICS, V12, P584, DOI 10.1007/s13311-015-0355-9; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Kawakubo Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006881; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Knoth IS, 2014, INT J DEV NEUROSCI, V36, P90, DOI 10.1016/j.ijdevneu.2014.05.003; Kornmeier J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090993; Lajiness-O'Neill R, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-15; LeBlanc JJ, 2015, ANN NEUROL, V78, P775, DOI 10.1002/ana.24513; Levin AR, 2015, NEUROTHERAPEUTICS, V12, P546, DOI 10.1007/s13311-015-0350-1; Lim S, 2013, NAT NEUROSCI, V16, P1306, DOI 10.1038/nn.3492; Lord C., 2012, AUTISM DIAGNOSTIC 1; McPartland JC, 2016, CURR OPIN NEUROL, V29, P118, DOI 10.1097/WCO.0000000000000300; Milne E, 2009, BIOL PSYCHIAT, V65, P22, DOI 10.1016/j.biopsych.2008.07.017; Moseley RL, 2015, NEUROIMAGE-CLIN, V9, P140, DOI 10.1016/j.nicl.2015.07.015; MOSKOWITZ A, 1983, ELECTROEN CLIN NEURO, V56, P1, DOI 10.1016/0013-4694(83)90002-0; Mullen E. M, 1995, MULLEN SCALES EARLY; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Pei F, 2014, J VISION, V14, DOI 10.1167/14.11.3; Porcaro C, 2011, NEUROIMAGE, V56, P1059, DOI 10.1016/j.neuroimage.2011.03.008; Port Russell G., 2015, Yale Journal of Biology and Medicine, V88, P25; PURPURA DP, 1959, INT REV NEUROBIOL, V1, P47, DOI 10.1016/S0074-7742(08)60314-1; Roid GH., 2003, STANFORD BINET INTEL, V5th; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rutter M., 2003, AUTISM DIAGNOSTIC IN, DOI DOI 10.1002/aur.1329; Sannita WG, 2007, INVEST OPHTH VIS SCI, V48, P4534, DOI 10.1167/iovs.07-0234; SAUNDERS KJ, 1995, DEV MED CHILD NEUROL, V37, P496; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Siper PM, 2015, INT M AUT RES SALT L; Sparrow S.S., 2005, VINELAND ADAPTIVE BE, DOI DOI 10.1093/scan/nsl018; Varcin KJ, 2016, J CHILD NEUROL, V31, P195, DOI 10.1177/0883073815587328; Weinger PM, 2014, NEUROPSYCHOLOGIA, V63, P10, DOI 10.1016/j.neuropsychologia.2014.07.031; Zemon V, 1997, OPTOMETRY VISION SCI, V74, P708, DOI 10.1097/00006324-199709000-00018; ZEMON V, 1980, P NATL ACAD SCI-BIOL, V77, P7476, DOI 10.1073/pnas.77.12.7476; ZEMON V, 1982, P NATL ACAD SCI-BIOL, V79, P5723, DOI 10.1073/pnas.79.18.5723; Zemon V, 1986, FRONTIERS CLIN NEURO, V3, P287; Zemon V.M., 2009, INVEST OPHTHALMOL, V50, P5880; Zemon V, 2006, VISION RES, V46, P4163, DOI 10.1016/j.visres.2006.07.007; Zemon VM, 2012, INVEST OPHTHALMOL, V53, P5719	56	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164422	10.1371/journal.pone.0164422	http://dx.doi.org/10.1371/journal.pone.0164422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UW	27716799	Green Published, gold, Green Accepted			2022-12-27	WOS:000385698100050
J	Arras, SDM; Chua, SMH; Wizrah, MSI; Faint, JA; Yap, AS; Fraser, JA				Arras, Samantha D. M.; Chua, Sheena M. H.; Wizrah, Maha S. I.; Faint, Joshua A.; Yap, Amy S.; Fraser, James A.			Targeted Genome Editing via CRISPR in the Pathogen Cryptococcus neoformans	PLOS ONE			English	Article							GENE DELETION; HOMOLOGOUS RECOMBINATION; VIRULENCE FACTOR; CAS SYSTEMS; DNA; ELECTROPORATION; SEQUENCE; REPEATS; TRANSFORMATION; DISRUPTION	Low rates of homologous integration have hindered molecular genetic studies in Cryptococcus neoformans over the past 20 years, and new tools that facilitate genome manipulation in this important pathogen are greatly needed. To this end, we have investigated the use of a Class 2 CRISPR system in C. neoformans (formerly C. neoformans var. grubii). We first expressed a derivative of the Streptococcus pyogenes Cas9 nuclease in C. neoformans, and showed that it has no effect on growth, production of virulence factors in vitro, or virulence in a murine inhalation model. In proof of principle experiments, we tested the CAS9 construct in combination with multiple self-cleaving guide RNAs targeting the well-characterized phosphoribosylaminoamidazole carboxylase-encoding ADE2 gene. Utilizing combinations of transient and stable expression of our constructs, we revealed that functionality of our CRISPR constructs in C. neoformans is dependent upon the CAS9 construct being stably integrated into the genome, whilst transient expression of the guide RNA is sufficient to enhance rates of homologous recombination in the CAS9 genetic background. Given that the presence of the CRISPR nuclease does not influence virulence in a murine inhalation model, we have successfully demonstrated that this system is compatible with studies of C. neoformans pathogenesis and represents a powerful tool that can be exploited by researchers in the field.	[Arras, Samantha D. M.; Chua, Sheena M. H.; Wizrah, Maha S. I.; Faint, Joshua A.; Yap, Amy S.; Fraser, James A.] Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Arras, Samantha D. M.; Chua, Sheena M. H.; Wizrah, Maha S. I.; Faint, Joshua A.; Yap, Amy S.; Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Fraser, JA (corresponding author), Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.; Fraser, JA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	jafraser@uq.edu.au	Fraser, James A/B-4918-2012; Yap, Alpha S./J-1554-2014	Fraser, James A/0000-0001-5724-5285; Yap, Alpha S./0000-0002-1038-8956; Chua, Sheena/0000-0003-1501-7254	National Health and Medical Research Council [455980]; ARC Australian Postgraduate Award	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Australian Postgraduate Award(Australian Research Council)	This work was supported by the National Health and Medical Research Council (http://www.nhmrc.gov.au/) 455980 (JA Fraser) and ARC Australian Postgraduate Award (https://www.education.gov.au/australian-postgraduate-awards) (SDMA).	AOKI S, 1994, MYCOPATHOLOGIA, V128, P143, DOI 10.1007/BF01138475; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; CHASKES S, 1975, J CLIN MICROBIOL, V1, P509, DOI 10.1128/JCM.1.6.509-514.1975; Chen SCA, 1997, J INFECT DIS, V175, P414, DOI 10.1093/infdis/175.2.414; Chen SCA, 2002, J ANTIMICROB CHEMOTH, V49, P57, DOI 10.1093/jac/49.suppl_1.57; Chen Y, 2014, MBIO, V5, DOI 10.1128/mBio.01087-13; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Ding C, 2013, CELL HOST MICROBE, V13, P265, DOI 10.1016/j.chom.2013.02.002; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; EDMAN JC, 1990, MOL CELL BIOL, V10, P4538, DOI 10.1128/MCB.10.9.4538; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Fuller KK, 2015, EUKARYOT CELL, V14, P1073, DOI 10.1128/EC.00107-15; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; Hagen F, 2015, FUNGAL GENET BIOL, V78, P16, DOI 10.1016/j.fgb.2015.02.009; Idnurm A, 2015, FUNGAL GENET BIOL, V78, P1, DOI 10.1016/j.fgb.2015.05.002; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaneko T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142755; Lin XR, 2015, MED MYCOL, V53, P225, DOI 10.1093/mmy/myu083; Liu OW, 2008, CELL, V135, P174, DOI 10.1016/j.cell.2008.07.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; McDade HC, 2001, MED MYCOL, V39, P151, DOI 10.1080/714030997; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MOJICA FJM, 1993, MOL MICROBIOL, V9, P613, DOI 10.1111/j.1365-2958.1993.tb01721.x; Neafsey DE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-119; Nelson RT, 2003, FUNGAL GENET BIOL, V38, P1, DOI 10.1016/S1087-1845(02)00510-8; Park J, 2014, MYCOSES, V57S1; Perfect JR, 2014, J CLIN INVEST, V124, P1893, DOI 10.1172/JCI75241; PERFECT JR, 1993, INFECT IMMUN, V61, P4446, DOI 10.1128/IAI.61.10.4446-4451.1993; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Shinmyo Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20611; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Vyas VK, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500248; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31145; Wang ZA, 2014, EUKARYOT CELL, V13, P832, DOI 10.1128/EC.00054-14; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003; Zhang ZY, 2015, ADV MATH COMMUN, V9, P9, DOI 10.3934/amc.2015.9.9	55	42	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164322	10.1371/journal.pone.0164322	http://dx.doi.org/10.1371/journal.pone.0164322			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711143	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600119
J	Cienska, M; Labus, K; Lewanczuk, M; Kozlecki, T; Liesiene, J; Bryjak, J				Cienska, Malgorzata; Labus, Karolina; Lewanczuk, Marcin; Kozlecki, Tomasz; Liesiene, Jolanta; Bryjak, Jolanta			Effective L-Tyrosine Hydroxylation by Native and Immobilized Tyrosinase	PLOS ONE			English	Article							AGARICUS-BISPORUS TYROSINASE; L-DOPA PRODUCTION; SUICIDE-INACTIVATION; MUSHROOM TYROSINASE; CROSS-LINKING; EFFICIENT; CHITOSAN; CELLS; MECHANISM; MEMBRANE	Hydroxylation of L-tyrosine to 3,4-dihydroxyphenylalanine (L-DOPA) by immobilized tyrosinase in the presence of ascorbic acid (AH(2)), which reduces DOPA-quinone to L-DOPA, is characterized by low reaction yields that are mainly caused by the suicide inactivation of tyrosinase by L-DOPA and AH(2). The main aim of this work was to compare processes with native and immobilized tyrosinase to identify the conditions that limit suicide inactivation and produce substrate conversions to L-DOPA of above 50% using HPLC analysis. It was shown that immobilized tyrosinase does not suffer from partitioning and diffusion effects, allowing a direct comparison of the reactions performed with both forms of the enzyme. In typical processes, additional aeration was applied and boron ions to produce the L-DOPA and AH(2) complex and hydroxylamine to close the cycle of enzyme active center transformations. It was shown that the commonly used pH 9 buffer increased enzyme stability, with concomitant reduced reactivity of 76%, and that under these conditions, the maximal substrate conversion was approximately 25 (native) to 30% (immobilized enzyme). To increase reaction yield, the pH of the reaction mixture was reduced to 8 and 7, producing L-DOPA yields of approximately 95% (native enzyme) and 70% (immobilized). A three-fold increase in the bound enzyme load achieved 95% conversion in two successive runs, but in the third one, tyrosinase lost its activity due to strong suicide inactivation caused by L-DOPA processing. In this case, the cost of the immobilized enzyme preparation is not overcome by its reuse over time, and native tyrosinase may be more economically feasible for a single use in L-DOPA production. The practical importance of the obtained results is that highly efficient hydroxylation of monophenols by tyrosinase can be obtained by selecting the proper reaction pH and is a compromise between complexation and enzyme reactivity.	[Cienska, Malgorzata; Labus, Karolina; Lewanczuk, Marcin; Bryjak, Jolanta] Wroclaw Univ Technol, Dept Bioorgan Chem, Wroclaw, Poland; [Kozlecki, Tomasz] Wroclaw Univ Technol, Dept Chem Engn, Wroclaw, Poland; [Liesiene, Jolanta] Kaunas Univ Technol, Dept Polymer Chem & Technol, Kaunas, Lithuania	Wroclaw University of Science & Technology; Wroclaw University of Science & Technology; Kaunas University of Technology	Bryjak, J (corresponding author), Wroclaw Univ Technol, Dept Bioorgan Chem, Wroclaw, Poland.	jolanta.bryjak@pwr.edu.pl		Bryjak, Jolanta/0000-0003-2158-2954; Labus, Karolina/0000-0001-5705-8906	project "Biotransformations for pharmaceutical and cosmetics industry" [POIG.01.03.01-00-158/09-01]; European Union within the European Regional Development Fund; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) [452290]	project "Biotransformations for pharmaceutical and cosmetics industry"; European Union within the European Regional Development Fund; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This study was supported by the project "Biotransformations for pharmaceutical and cosmetics industry", No. POIG.01.03.01-00-158/09-01, (http://www.biotransformacje.ch.pwr.wroc.pl) and was partially financed by the European Union within the European Regional Development Fund and the project was supported by Wroclaw Centre of Biotechnology (http://know.wroc.pl/), programme The Leading National Research Centre (KNOW) for years 2014-2018; No.: 452290. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algieri C, 2012, BIOCHEM ENG J, V66, P14, DOI 10.1016/j.bej.2012.03.013; Apetrei IM, 2015, J FOOD ENG, V149, P1, DOI 10.1016/j.jfoodeng.2014.09.036; Ates S, 2007, ENZYME MICROB TECH, V40, P683, DOI 10.1016/j.enzmictec.2006.05.031; Ba S, 2014, SCI TOTAL ENVIRON, V487, P748, DOI 10.1016/j.scitotenv.2013.10.004; BARUAH P, 1953, BIOCHEM J, V55, P392, DOI 10.1042/bj0550392; Carvalho GMJ, 2000, APPL BIOCHEM BIOTECH, V84-6, P791, DOI 10.1385/ABAB:84-86:1-9:791; Chen TH, 2000, BIOTECHNOL BIOENG, V70, P564, DOI 10.1002/1097-0290(20001205)70:5<564::AID-BIT11>3.0.CO;2-W; Cienska M., 2013, PHD INTERDISCIPLINAR, V1, P13; Garcia-Molina MD, 2014, BIOORGAN MED CHEM, V22, P3360, DOI 10.1016/j.bmc.2014.04.048; Donato L, 2012, J MEMBRANE SCI, V407, P86, DOI 10.1016/j.memsci.2012.03.034; Duran N, 2002, ENZYME MICROB TECH, V31, P907, DOI 10.1016/S0141-0229(02)00214-4; Marin-Zamora ME, 2009, J BIOTECHNOL, V139, P163, DOI 10.1016/j.jbiotec.2008.10.014; Espin JC, 2001, J AGR FOOD CHEM, V49, P1187, DOI 10.1021/jf001258b; Espin JC, 2000, EUR J BIOCHEM, V267, P1270, DOI 10.1046/j.1432-1327.2000.01013.x; Faria RO, 2007, FOOD TECHNOL BIOTECH, V43, P287; FLING M, 1963, J BIOL CHEM, V238, P2045; Guazzaroni M, 2012, BIOORGAN MED CHEM, V20, P157, DOI 10.1016/j.bmc.2011.11.018; Halaouli S, 2006, J APPL MICROBIOL, V100, P219, DOI 10.1111/j.1365-2672.2006.02866.x; JOLLEY RL, 1974, J BIOL CHEM, V249, P335; Kampmann M, 2016, J MOL CATAL B-ENZYM, V123, P113, DOI 10.1016/j.molcatb.2015.11.012; Kampmann M, 2014, WATER RES, V57, P295, DOI 10.1016/j.watres.2014.03.054; Karim F, 2012, REV ENVIRON SCI BIO, V11, P261, DOI 10.1007/s11157-012-9268-9; Koyanagi T, 2005, J BIOTECHNOL, V115, P303, DOI 10.1016/j.jbiotec.2004.08.016; Kuijpers TFM, 2013, FEBS J, V280, P6184, DOI 10.1111/febs.12539; Labus K, 2015, J MOL CATAL B-ENZYM, V120, P136, DOI 10.1016/j.molcatb.2015.05.019; Labus K, 2011, BIOCHEM ENG J, V56, P232, DOI 10.1016/j.bej.2011.07.003; Land EJ, 2007, TOHOKU J EXP MED, V212, P341, DOI 10.1620/tjem.212.341; Le Roes-Hill M, 2015, J MOL CATAL B-ENZYM, V122, P353, DOI 10.1016/j.molcatb.2015.10.012; Lee SH, 2016, BIOTECHNOL BIOENG, V113, P735, DOI 10.1002/bit.25855; Liu Y, 2014, BIOCHEM ENG J, V89, P21, DOI 10.1016/j.bej.2013.11.016; Munoz-Munoz JL, 2010, IUBMB LIFE, V62, P539, DOI 10.1002/iub.348; Munoz-Munoz JL, 2009, BBA-PROTEINS PROTEOM, V1794, P244, DOI 10.1016/j.bbapap.2008.10.002; Min K, 2015, APPL MICROBIOL BIOT, V99, P575, DOI 10.1007/s00253-014-6215-4; Min K, 2010, J BIOTECHNOL, V146, P40, DOI 10.1016/j.jbiotec.2010.01.002; Mukherjee S, 2013, REV ENVIRON SCI BIO, V12, P61, DOI 10.1007/s11157-012-9302-y; Penalver MJ, 2002, BBA-PROTEIN STRUCT M, V1597, P140, DOI 10.1016/S0167-4838(02)00264-9; Pialis P, 1998, ENZYME MICROB TECH, V22, P261, DOI 10.1016/S0141-0229(97)00195-6; Qin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109398; Rahman SF, 2012, J MICROBIOL BIOTECHN, V22, P1446, DOI 10.4014/jmb.1206.06043; Ramsden CA, 2014, BIOORGAN MED CHEM, V22, P2388, DOI 10.1016/j.bmc.2014.02.048; Seetharam G, 2002, ENZYME MICROB TECH, V31, P747, DOI 10.1016/S0141-0229(02)00182-5; Tuncagil S, 2009, J MOL CATAL B-ENZYM, V58, P187, DOI 10.1016/j.molcatb.2008.12.014; Wichers HJ, 1996, PHYTOCHEMISTRY, V43, P333, DOI 10.1016/0031-9422(96)00309-3; Wu LQ, 2001, BIOTECHNOL BIOENG, V76, P325, DOI 10.1002/bit.10099; Xu DY, 2012, BIOCHEM ENG J, V63, P88, DOI 10.1016/j.bej.2011.11.009; Yamazaki S, 2003, J AM CHEM SOC, V125, P13034, DOI 10.1021/ja036425d; Yildiz HB, 2013, INT J BIOL MACROMOL, V56, P34, DOI 10.1016/j.ijbiomac.2013.01.031; Zynek K, 2010, J MOL CATAL B-ENZYM, V66, P172, DOI 10.1016/j.molcatb.2010.05.003	48	17	18	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164213	10.1371/journal.pone.0164213	http://dx.doi.org/10.1371/journal.pone.0164213			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711193	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600098
J	Ju, A; Cho, YC; Kim, BR; Park, SG; Kim, JH; Kim, K; Lee, J; Park, BC; Cho, S				Ju, Anna; Cho, Young-Chang; Kim, Ba Reum; Park, Sung Goo; Kim, Jeong-Hoon; Kim, Kwonseop; Lee, Jaehwi; Park, Byoung Chul; Cho, Sayeon			Scaffold Role of DUSP22 in ASK1-MKK7-JNK Signaling Pathway	PLOS ONE			English	Article							DUAL-SPECIFICITY PHOSPHATASE; MAP KINASES; TRANSDUCTION PATHWAY; JNK; PROTEIN; ACTIVATION; APOPTOSIS; CASCADES; TRANSCRIPTION; COMPLEX	Mitogen-activated protein kinases (MAPKs) are involved in a variety of intracellular events such as gene expression, cell proliferation, and programmed cell death. MAPKs are activated by dual phosphorylation on threonine and tyrosine residues through sequential activation of protein kinases. Recent studies have shown that the protein kinases involved in MAPK signal transductions might be organized into signaling complexes by scaffold proteins. These scaffold proteins are essential regulators that function by assembling the relevant molecular components in mammalian cells. In this study, we report that dual-specificity phosphatase 22 (DUSP22), a member of the protein tyrosine phosphatase family, acts as a distinct scaffold protein in c-Jun N-terminal kinase (JNK) signaling. DUSP22 increased the phosphorylation in the activation loop of JNK regardless of its phosphatase activity but had no effect on phosphorylation levels of ERK and p38 in mammalian cells. Furthermore, DUSP22 selectively associated with apoptosis signal-regulating kinase 1 (ASK1), MAPK kinase 7 (MKK7), and JNK1/2. Both JNK phosphorylation and JNK-mediated apoptosis increased in a concentration-dependent manner regardless of DUSP22 phosphatase activity at low DUSP22 concentrations, but then decreased at higher DUSP22 concentrations, which is the prominent feature of a scaffold protein. Thus, our data suggest that DUSP22 regulates cell death by acting as a scaffold protein for the ASK1-MKK7-JNK signal transduction pathway independently of its phosphatase activity.	[Ju, Anna; Cho, Young-Chang; Kim, Ba Reum; Lee, Jaehwi; Cho, Sayeon] Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea; [Park, Sung Goo; Park, Byoung Chul] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Daejeon 34141, South Korea; [Kim, Jeong-Hoon] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon 34141, South Korea; [Kim, Kwonseop] Chonnam Natl Univ, Coll Pharm, Gwangju 61186, South Korea; [Kim, Kwonseop] Chonnam Natl Univ, Res Inst Drug Dev, Gwangju 61186, South Korea	Chung Ang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chonnam National University; Chonnam National University	Cho, S (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 06974, South Korea.	parkbc@kribb.re.kr; sycho@cau.ac.kr		Kim, Ba Reum/0000-0001-7732-3949	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2011-0030029, NRF-2015R1A2A2A11001446, NRF-2015R1A5A1008958]; National Research Council of Science and Technology grant [NTC2351511]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; National Research Council of Science and Technology grant	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT & Future Planning (NRF-2011-0030029, NRF-2015R1A2A2A11001446, and NRF-2015R1A5A1008958) and by the National Research Council of Science and Technology grant (NTC2351511).	Alonso A, 2002, J BIOL CHEM, V277, P5524, DOI 10.1074/jbc.M107653200; Barford D, 1995, CURR OPIN STRUC BIOL, V5, P728, DOI 10.1016/0959-440X(95)80004-2; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen AJ, 2002, J BIOL CHEM, V277, P36592, DOI 10.1074/jbc.M200453200; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Green MR, 2012, MOL CLONING LAB MANU, V1; Hatai T, 2000, J BIOL CHEM, V275, P26576, DOI 10.1074/jbc.M003412200; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Ikeda A, 2001, J BIOCHEM-TOKYO, V130, P773, DOI 10.1093/oxfordjournals.jbchem.a003048; Ito M, 1999, MOL CELL BIOL, V19, P7539; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kondoh K, 2007, BBA-MOL CELL RES, V1773, P1227, DOI 10.1016/j.bbamcr.2006.12.002; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schwertassek U, 2010, FEBS J, V277, P2463, DOI 10.1111/j.1742-4658.2010.07661.x; Sekine Y, 2007, ONCOGENE, V26, P6038, DOI 10.1038/sj.onc.1210426; Sekine Y, 2006, ONCOGENE, V25, P5801, DOI 10.1038/sj.onc.1209578; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Takagaki K, 2004, BIOCHEM J, V383, P447, DOI 10.1042/BJ20040498; Tierno MB, 2007, NAT PROTOC, V2, P1134, DOI 10.1038/nprot.2007.155; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tournier C, 2001, GENE DEV, V15, P1419, DOI 10.1101/gad.888501; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Yu D, 2015, TUMOR BIOL, V36, P8531, DOI 10.1007/s13277-015-3588-7; Zama T, 2002, J BIOL CHEM, V277, P23909, DOI 10.1074/jbc.M200837200; Zama T, 2002, J BIOL CHEM, V277, P23919, DOI 10.1074/jbc.M200838200	39	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164259	10.1371/journal.pone.0164259	http://dx.doi.org/10.1371/journal.pone.0164259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711255	gold, Green Submitted, Green Published			2022-12-27	WOS:000385697600108
J	Yan, G; Zhang, T; Dai, ZZ; Yi, MZ; Jia, YL; Nie, TT; Zhang, HD; Xiao, G; Wu, RH				Yan, Gen; Zhang, Tao; Dai, Zhuozhi; Yi, Meizhi; Jia, Yanlong; Nie, Tingting; Zhang, Handi; Xiao, Gang; Wu, Renhua			A Potential Magnetic Resonance Imaging Technique Based on Chemical Exchange Saturation Transfer for In Vivo gamma-Aminobutyric Acid Imaging	PLOS ONE			English	Article							TRANSFER CEST; HUMAN BRAIN; ALZHEIMERS-DISEASE; GLUTAMATE; WATER; GABA; MRI; QUANTIFICATION; GLUCEST; H-1-MRS	Purpose We developed a novel magnetic resonance imaging (MRI) technique based on chemical exchange saturation transfer (CEST) for GABA imaging and investigated the concentration-dependent CEST effect ofGABA in a rat model of brain tumor with blood-brain barrier (BBB) disruption. Materials and Methods All MRI studies were performed using a 7.0-T Agilent MRI scanner. Z-spectra for GABA were acquired at 7.0 T, 37 degrees C, and a pH of 7.0 using varying B-1 amplitudes. CEST images of phantoms with different concentrations of GABA solutions (pH, 7.0) and other metabolites (glutamine, myoinositol, creatinine, and choline) were collected to investigate the concentration-dependent CEST effect of GABA and the potential contribution from other brain metabolites. CEST maps for GABA in rat brains with tumors were collected at baseline and 50 min, 1.5 h, and 2.0 h after the injection of GABA solution. Results The CEST effect of GABA was observed at approximately 2.75 parts per million(ppm) downfield from bulk water, and this effect increased with an increase in the B-1 amplitude and remained steady after the B-1 amplitude reached 6.0 mu T (255 Hz). The CEST effect of GABA was proportional to the GABA concentration in vitro. CEST imaging of GABA in a rat brain with a tumor and compromised BBB showed a gradual increase in the CEST effect after GABA injection. Conclusion The findings of this study demonstrate the feasibility and potential of CEST MRI with the optimal B-1 amplitude, which exhibits excellent spatial and temporal resolutions, to map changes in GABA.	[Yan, Gen] Jiangnan Univ, Dept Radiol, Affiliated Hosp, Wuxi 214062, Peoples R China; [Yan, Gen; Zhang, Tao; Dai, Zhuozhi; Yi, Meizhi; Jia, Yanlong; Nie, Tingting; Wu, Renhua] Shantou Univ, Coll Med, Dept Med Imaging, Affiliated Hosp 2, Shantou 515041, Peoples R China; [Zhang, Handi] Shantou Univ, Coll Med, Mental Hlth Ctr, Shantou, Peoples R China; [Xiao, Gang] Hanshan Normal Univ, Dept Math & Stat, Chaozhou 521041, Peoples R China	Jiangnan University; Shantou University; Shantou University; Hanshan Normal University	Wu, RH (corresponding author), Shantou Univ, Coll Med, Dept Med Imaging, Affiliated Hosp 2, Shantou 515041, Peoples R China.; Xiao, G (corresponding author), Hanshan Normal Univ, Dept Math & Stat, Chaozhou 521041, Peoples R China.	xiao.math@foxmail.com; rhwu@stu.edu.cn			National High Technology Research and Development Program of China [2014AA021101]; NSFC [30930027]; NCF of Guangdong Province, China [S2013010013372]; NCF of Jiangsu province, China [BK20151106]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NSFC(National Natural Science Foundation of China (NSFC)); NCF of Guangdong Province, China; NCF of Jiangsu province, China	Renhua Wu acknowledges the financial support from the National High Technology Research and Development Program of China (2014AA021101) and NSFC (30930027). Gang Xiao was supported by a NCF of Guangdong Province, China (S2013010013372). Gen Yan was supported by a NCF of Jiangsu province, China (BK20151106).	Cai KJ, 2013, NMR BIOMED, V26, P1278, DOI 10.1002/nbm.2949; Cai K, 2012, NEUROPSYCHOPHARMACOL, V37, P2764, DOI 10.1038/npp.2012.142; Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Chang L, 2003, J CLIN PSYCHIAT, V64, P7; CHRISTIANSEN P, 1993, MAGN RESON IMAGING, V11, P107, DOI 10.1016/0730-725X(93)90418-D; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Haris M, 2013, NMR BIOMED, V26, P386, DOI 10.1002/nbm.2875; Haris M, 2013, J NEUROSCI METH, V212, P87, DOI 10.1016/j.jneumeth.2012.09.025; Haris M, 2011, NEUROIMAGE, V54, P2079, DOI 10.1016/j.neuroimage.2010.10.017; Hua J, 2007, MAGN RESON MED, V58, P786, DOI 10.1002/mrm.21387; Jiang XW, 2011, J CARDIOVASC MED, V12, P732, DOI 10.2459/JCM.0b013e32834a6697; Jin T, 2013, MAGN RESON MED, V69, P760, DOI 10.1002/mrm.24315; Jones CK, 2006, MAGN RESON MED, V56, P585, DOI 10.1002/mrm.20989; Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873; KOBAYASHI N, 1980, J NEUROSURG, V53, P808, DOI 10.3171/jns.1980.53.6.0808; Kogan F, 2014, MAGN RESON MED, V71, P164, DOI 10.1002/mrm.24641; Kogan F, 2013, NEUROIMAGE, V77, P262, DOI 10.1016/j.neuroimage.2013.03.072; Ling W, 2008, P NATL ACAD SCI USA, V105, P2266, DOI 10.1073/pnas.0707666105; Liu DP, 2013, MAGN RESON MED, V70, P1070, DOI 10.1002/mrm.24560; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Nasrallah FA, 2013, J CEREBR BLOOD F MET, V33, P1270, DOI 10.1038/jcbfm.2013.79; Petroff OAC, 2002, NEUROSCIENTIST, V8, P562, DOI 10.1177/1073858402238515; ROSSOR MN, 1982, BRAIN, V105, P313, DOI 10.1093/brain/105.2.313; Shen ZW, 2012, WORLD J GASTROENTERO, V18, P1130, DOI 10.3748/wjg.v18.i10.1130; Sun PZ, 2011, MAGN RESON MED, V65, P588, DOI 10.1002/mrm.22628; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Zhao XN, 2011, MAGN RESON MED, V66, P1033, DOI 10.1002/mrm.22891; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	30	16	16	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163765	10.1371/journal.pone.0163765	http://dx.doi.org/10.1371/journal.pone.0163765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711138	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600040
J	Been, SK; van de Vijver, DAMC; Nieuwkerk, PT; Brito, I; Stutterheim, SE; Bos, AER; Wolfers, MEG; Pogany, K; Verbon, A				Been, Sabrina K.; van de Vijver, David A. M. C.; Nieuwkerk, Pythia T.; Brito, Ines; Stutterheim, Sarah E.; Bos, Arjan E. R.; Wolfers, Mireille E. G.; Pogany, Katalin; Verbon, Annelies			Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SELF-REPORTED ADHERENCE; HIV-1-INFECTED PATIENTS; VIROLOGICAL RESPONSE; CLINICAL-TRIALS; COHORT; PREDICTORS; OUTCOMES; AFRICAN; PEOPLE	In the Netherlands, immigrant people living with HIV (PLWH) have poorer psychological and treatment outcomes than Dutch PLWH. This cross-sectional field study examined risk factors for non-adherence to combination Antiretroviral Therapy (cART) among immigrant PLWH. First and second generation immigrant PLWH attending outpatient clinics at two HIV-treatment centers in Rotterdam were selected for this study. Socio-demographic and clinical characteristics for all eligible participants were collected from an existing database. Trained interviewers subsequently completed questionnaires together with consenting participants (n = 352) to gather additional data on socio-demographic characteristics, psychosocial variables, and self-reported adherence to cART. Univariable and multivariable logistic regression analyses were conducted among 301 participants who had used cART >= 6 months prior to inclusion. Independent risk factors for self-reported non-adherence were (I) not having attended formal education or only primary school (OR = 3.25; 95% CI: 1.28-8.26, versus University), (II) experiencing low levels of social support (OR = 2.56; 95% CI: 1.37-4.82), and (III) reporting low treatment adherence self-efficacy (OR = 2.99; 95% CI: 1.59-5.64). Additionally, HIV-RNA >50 copies/ml and internalized HIV-related stigma were marginally associated (P<0.10) with non-adherence (OR = 2.53; 95% CI: 0.91-7.06 and OR = 1.82; 95% CI: 0.97-3.43). The findings that low educational attainment, lack of social support, and low treatment adherence self-efficacy are associated with non-adherence point to the need for tailored supportive interventions. Establishing contact with peer immigrant PLWH who serve as role models might be a successful intervention for this specific population.	[Been, Sabrina K.; Brito, Ines; Verbon, Annelies] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [van de Vijver, David A. M. C.] Erasmus Univ, Med Ctr, Dept Virol, Rotterdam, Netherlands; [Nieuwkerk, Pythia T.] Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [Stutterheim, Sarah E.; Bos, Arjan E. R.] Open Univ Netherlands, Fac Psychol & Educ Sci, Heerlen, Netherlands; [Wolfers, Mireille E. G.] Municipal Publ Hlth Serv Rotterdam Rijnmond, Infect Dis Control Div, Rotterdam, Netherlands; [Pogany, Katalin] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Open University Netherlands; Maasstad Hospital	Been, SK (corresponding author), Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands.	s.been@erasmusmc.nl	Nieuwkerk, Pythia/S-4084-2017	Nieuwkerk, Pythia/0000-0002-2616-1414; Stutterheim, Sarah/0000-0001-9336-5022; van de Vijver, David/0000-0001-5877-8526; Been, Sabrina/0000-0002-5755-3306; Bos, Arjan/0000-0003-1000-5852	Dutch Aids Fonds [2011107]	Dutch Aids Fonds	This study was supported by a grant from the Dutch Aids Fonds. Grant number: 2011107. Website: http://www.aidsfonds.nl/about/organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammassari A, 2002, JAIDS, V31, pS123, DOI 10.1097/00126334-200212153-00007; Berg KM, 2012, AIDS BEHAV, V16, P461, DOI 10.1007/s10461-010-9864-z; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; de Bruin M, 2010, ARCH INTERN MED, V170, P240, DOI 10.1001/archinternmed.2009.536; de Bruin M, 2009, HEALTH PSYCHOL, V28, P668, DOI 10.1037/a0015989; Glass TR, 2010, JAIDS-J ACQ IMM DEF, V54, P197, DOI 10.1097/QAI.0b013e3181ca48bf; Gras L, 2014, MONITORING REPORT 20; Health R., MED OUTCOMES STUDY S; Johnson MO, 2007, J BEHAV MED, V30, P359, DOI 10.1007/s10865-007-9118-3; Kalichman SC, 2009, AIDS CARE, V21, P87, DOI 10.1080/09540120802032627; Kokkevi A., 1995, EUR ADDICT RES, V1, P208, DOI [10.1159/000259089, DOI 10.1159/000259089]; Langebeek N, 2014, BMC MED, V12, DOI [10.1186/s12916-014-0142-1, 10.1186/PREACCEPT-1453408941291432]; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Moser A, 2012, J CLIN EPIDEMIOL, V65, P1107, DOI 10.1016/j.jclinepi.2012.04.007; Nellen JFJB, 2009, AIDS CARE, V21, P842, DOI 10.1080/09540120802612816; Nellen JF, 2004, JAIDS-J ACQ IMM DEF, V36, P943, DOI 10.1097/00126334-200408010-00008; Nieuwkerk P, 2001, ANTIVIR THER, V6, P97; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Nieuwkerk PT, 2010, ANTIVIR THER, V15, P913, DOI 10.3851/IMP1644; O'Connor JL, 2013, J INFECT DIS, V208, P40, DOI 10.1093/infdis/jis731; Pasternak AO, 2012, J INFECT DIS, V206, P1443, DOI 10.1093/infdis/jis502; Schouten Marjolijn, 2013, Ned Tijdschr Geneeskd, V157, pA5731; Shuter J, 2008, J ANTIMICROB CHEMOTH, V61, P769, DOI 10.1093/jac/dkn020; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Staehelin C, 2012, JAIDS-J ACQ IMM DEF, V59, P79, DOI 10.1097/QAI.0b013e318236be70; Stutterheim SE, 2012, PSYCHOL HEALTH, V27, P395, DOI 10.1080/08870446.2011.585426; Stutterheim SE, 2011, AIDS CARE, V23, P195, DOI 10.1080/09540121.2010.498873; Sumari-de Boer IM, 2012, AIDS BEHAV, V16, P1681, DOI 10.1007/s10461-011-0112-y; van den Berg JB, 2005, HIV MED, V6, P299, DOI 10.1111/j.1468-1293.2005.00304.x; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162800	10.1371/journal.pone.0162800	http://dx.doi.org/10.1371/journal.pone.0162800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706251	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200021
J	Du, RJ; Dong, GG; Tian, LX; Wang, MG; Fang, GC; Shao, S				Du, Ruijin; Dong, Gaogao; Tian, Lixin; Wang, Minggang; Fang, Guochang; Shao, Shuai			Spatiotemporal Dynamics and Fitness Analysis of Global Oil Market: Based on Complex Network	PLOS ONE			English	Article							RANDOM-MATRIX THEORY; TRADE RELATIONSHIPS; EVOLUTION; SECURITY; PATTERNS; FEATURES; CHINA	We study the overall topological structure properties of global oil trade network, such as degree, strength, cumulative distribution, information entropy and weight clustering. The structural evolution of the network is investigated as well. We find the global oil import and export networks do not show typical scale-free distribution, but display disassortative property. Furthermore, based on the monthly data of oil import values during 2005.01-2014.12, by applying random matrix theory, we investigate the complex spatiotemporal dynamic from the country level and fitness evolution of the global oil market from a demand-side analysis. Abundant information about global oil market can be obtained from deviating eigenvalues. The result shows that the oil market has experienced five different periods, which is consistent with the evolution of country clusters. Moreover, we find the changing trend of fitness function agrees with that of gross domestic product (GDP), and suggest that the fitness evolution of oil market can be predicted by forecasting GDP values. To conclude, some suggestions are provided according to the results.	[Du, Ruijin; Dong, Gaogao; Tian, Lixin] Jiangsu Univ, Nonlinear Sci Res Ctr, Zhenjiang, Jiangsu, Peoples R China; [Tian, Lixin; Wang, Minggang] Nanjing Normal Univ, Sch Math Sci, Nanjing, Jiangsu, Peoples R China; [Fang, Guochang] Nanjing Univ Finance & Econ, Sch Econ, Nanjing 210023, Jiangsu, Peoples R China; [Shao, Shuai] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Shao, Shuai] Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA	Jiangsu University; Nanjing Normal University; Nanjing University of Finance & Economics; Boston University; Boston University	Dong, GG; Tian, LX (corresponding author), Jiangsu Univ, Nonlinear Sci Res Ctr, Zhenjiang, Jiangsu, Peoples R China.; Tian, LX (corresponding author), Nanjing Normal Univ, Sch Math Sci, Nanjing, Jiangsu, Peoples R China.	gago999@126.com; tianlx@ujs.edu.cn	Wang, Minggang/R-7570-2019; fang, guochang/HHY-9120-2022	Wang, Minggang/0000-0002-0572-7204	National Natural Science Foundation of China [61403171, 71403105, 71303095, 71303205, 71503132]; Major Research plan of the National Natural Science Foundation of China [91546118]; Natural Science Foundation of Jiangsu Province [BK20140569, 14KJB120001]; Jiangsu Postdoctoral Science Foundation [140207713, 1501100B]; China Postdoctoral Science Foundation [2015M581738, 2015M80519]; Senior talents Foundation of Jiangsu University [14JDG143, 14JDG144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Research plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Senior talents Foundation of Jiangsu University	This work was supported by National Natural Science Foundation of China (Grant Nos. 61403171, 71403105, 71303095, 71303205, 71503132), Major Research plan of the National Natural Science Foundation of China (No. 91546118), Natural Science Foundation of Jiangsu Province (Grant Nos. BK20140569, 14KJB120001), Jiangsu Postdoctoral Science Foundation (Grant Nos. 140207713, 1501100B), China Postdoctoral Science Foundation (Grant Nos. 2015M581738, 2015M80519) and Senior talents Foundation of Jiangsu University (Grant Nos. 14JDG143, 14JDG144).	An HZ, 2014, APPL ENERG, V136, P1067, DOI 10.1016/j.apenergy.2014.07.081; An HZ, 2014, ENERGY, V74, P254, DOI 10.1016/j.energy.2014.06.095; Bai M, 2015, INT REV ECON FINANC, V39, P90, DOI 10.1016/j.iref.2015.06.005; Ben Fradj N, 2016, LAND USE POLICY, V52, P195, DOI 10.1016/j.landusepol.2015.12.027; Billio M, 2012, J FINANC ECON, V104, P535, DOI 10.1016/j.jfineco.2011.12.010; Cheng LF, 2004, COMPUT CHEM ENG, V28, P897, DOI 10.1016/j.compchemeng.2003.09.025; Dahlin J, 2015, RESOUR CONSERV RECY, V104, P152, DOI 10.1016/j.resconrec.2015.08.013; Fan Y, 2010, J POLICY MODEL, V32, P505, DOI 10.1016/j.jpolmod.2010.05.008; Feher K, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1667; Gao CX, 2015, APPL ENERG, V156, P542, DOI 10.1016/j.apenergy.2015.07.054; Giussani B., 1991, PAP REG SCI, V70, P201, DOI DOI 10.1007/BF01434329; Ji Q, 2014, ENERG CONVERS MANAGE, V85, P856, DOI 10.1016/j.enconman.2013.12.072; Kenny Henry J., 2004, ASIA PACIFIC REV, V11, P36, DOI DOI 10.1080/1343900042000292533; Kim YS, 2012, J HOUS ECON, V21, P169, DOI 10.1016/j.jhe.2012.01.002; Kritzman M, 2009, J FINANC ECON, V37, P112; Kumar S, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026101; Leiby P.N, 2007, ORNLTM2007028; Lever J, 2012, J RURAL STUD, V28, P528, DOI 10.1016/j.jrurstud.2012.06.004; Lu WW, 2014, ENERG POLICY, V74, P406, DOI 10.1016/j.enpol.2014.08.037; Meng H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03655; Munnix MC, 2010, PHYSICA A, V389, P767, DOI 10.1016/j.physa.2009.10.033; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; Plerou V, 2000, PHYSICA A, V287, P374, DOI 10.1016/S0378-4371(00)00376-9; Potters M, 2005, ACTA PHYS POL B, V36, P2767; Pukthuanthong K, 2009, J FINANC ECON, V94, P214, DOI 10.1016/j.jfineco.2008.12.004; Serrano MA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.015101; [谭跃进 Tan Yuejin], 2004, [系统工程理论与实践, Systems Engineering-Theory & Practice], V24, P1; Wishart J, 1928, BIOMETRIKA, V20A, P32, DOI 10.2307/2331939; Yergin D, 2006, FOREIGN AFF, V85, P69, DOI 10.2307/20031912; Zhang HY, 2014, ENERG POLICY, V73, P312, DOI 10.1016/j.enpol.2014.06.020; Zhang HY, 2013, ENERG ECON, V38, P87, DOI 10.1016/j.eneco.2013.03.014; Zhang YG, 2010, ENERG ECON, V32, P186, DOI 10.1016/j.eneco.2009.09.016; Zhong WQ, 2014, PHYSICA A, V413, P42, DOI 10.1016/j.physa.2014.06.055	34	8	9	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162362	10.1371/journal.pone.0162362	http://dx.doi.org/10.1371/journal.pone.0162362			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706147	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200011
J	Kia, E; Mackenzie, BW; Middleton, D; Lau, A; Waite, DW; Lewis, G; Chan, YK; Silvestre, M; Cooper, GJS; Poppitt, SD; Taylor, MW				Kia, Elahe; Mackenzie, Brett Wagner; Middleton, Danielle; Lau, Anna; Waite, David W.; Lewis, Gillian; Chan, Yih-Kai; Silvestre, Marta; Cooper, Garth J. S.; Poppitt, Sally D.; Taylor, Michael W.			Integrity of the Human Faecal Microbiota following Long-Term Sample Storage	PLOS ONE			English	Article								In studies of the human microbiome, faecal samples are frequently used as a non-invasive proxy for the study of the intestinal microbiota. To obtain reliable insights, the need for bacterial DNA of high quality and integrity following appropriate faecal sample collection and preservation steps is paramount. In a study of dietary mineral balance in the context of type 2 diabetes (T2D), faecal samples were collected from healthy and T2D individuals throughout a 13-day residential trial. These samples were freeze-dried, then stored mostly at -20 degrees C from the trial date in 2000/2001 until the current research in 2014. Given the relative antiquity of these samples (similar to 14 years), we sought to evaluate DNA quality and comparability to freshly collected human faecal samples. Following the extraction of bacterial DNA, gel electrophoresis indicated that our DNA extracts were more sheared than extracts made from freshly collected faecal samples, but still of sufficiently high molecular weight to support amplicon-based studies. Likewise, spectrophotometric assessment of extracts revealed that they were of high quality and quantity. A subset of bacterial 16S rRNA gene amplicons were sequenced using Illumina MiSeq and compared against publicly available sequence data representing a similar cohort analysed by the American Gut Project (AGP). Notably, our bacterial community profiles were highly consistent with those from the AGP data. Our results suggest that when faecal specimens are stored appropriately, the microbial profiles are preserved and robust to extended storage periods.	[Kia, Elahe; Middleton, Danielle; Lau, Anna; Waite, David W.; Lewis, Gillian; Chan, Yih-Kai; Silvestre, Marta; Cooper, Garth J. S.; Poppitt, Sally D.; Taylor, Michael W.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Mackenzie, Brett Wagner] Univ Auckland, Dept Surg, Auckland, New Zealand; [Chan, Yih-Kai; Silvestre, Marta; Poppitt, Sally D.] Univ Auckland, Human Nutr Unit, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland	Taylor, MW (corresponding author), Univ Auckland, Sch Biol Sci, Auckland, New Zealand.	mw.taylor@auckland.ac.nz	Cooper, Garth JS/I-3201-2015; Lewis, Gillian/P-5538-2016	Cooper, Garth JS/0000-0001-5241-3163; Taylor, Michael/0000-0002-0463-7813; Lewis, Gillian/0000-0003-2904-7956; Wagner Mackenzie, Brett/0000-0002-5318-1808; Chan, Yih-Kai/0000-0003-3836-8145; Paulino Silvestre, Marta/0000-0001-9327-2897; Waite, David/0000-0002-0184-2942				Bahl MI, 2012, FEMS MICROBIOL LETT, V329, P193, DOI 10.1111/j.1574-6968.2012.02523.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clarke KR, 2015, PRIMER V7 USER MANUA; Cooper GJS, 2005, DIABETES, V54, P1468, DOI 10.2337/diabetes.54.5.1468; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mackenzie BW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00130; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Song SJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00021-16; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	16	28	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163666	10.1371/journal.pone.0163666	http://dx.doi.org/10.1371/journal.pone.0163666			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701448	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900015
J	Lyu, J; Cao, JF; Zhang, PM; Liu, Y; Cheng, HT				Lyu, Jie; Cao, Jinfeng; Zhang, Peiming; Liu, Yang; Cheng, Hongtao			Coupled Hybrid Continuum-Discrete Model of Tumor Angiogenesis and Growth	PLOS ONE			English	Article							NUMERICAL-SIMULATION; MICROENVIRONMENT; ENDOSTATIN; MORPHOLOGY	The processes governing tumor growth and angiogenesis are codependent. To study the relationship between them, we proposed a coupled hybrid continuum-discrete model. In this model, tumor cells, their microenvironment (extracellular matrixes, matrix-degrading enzymes, and tumor angiogenic factors), and their network of blood vessels, described by a series of discrete points, were considered. The results of numerical simulation reveal the process of tumor growth and the change in microenvironment from avascular to vascular stage, indicating that the network of blood vessels develops gradually as the tumor grows. Our findings also reveal that a tumor is divided into three regions: necrotic, semi-necrotic, and well-vascularized. The results agree well with the previous relevant studies and physiological facts, and this model represents a platform for further investigations of tumor therapy.	[Lyu, Jie; Zhang, Peiming; Liu, Yang; Cheng, Hongtao] Shanghai Univ Med & Hlth Sci, Med Instrumentat Sch, Shanghai 201318, Peoples R China; [Cao, Jinfeng] Shanghai Univ, Periodicals Agcy, Shanghai 200444, Peoples R China	Shanghai University of Medicine & Health Sciences; Shanghai University	Cao, JF (corresponding author), Shanghai Univ, Periodicals Agcy, Shanghai 200444, Peoples R China.	jfcao@shu.edu.cn	LYU, Jie/GYU-4137-2022	LYU, Jie/0000-0001-6926-1864				Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; AndersonAR ChaplainMA, 2000, J THEORETICAL MED, V2, P129, DOI DOI 10.1080/10273660008833042; Cai Y, 2013, APPL MATH MECH-ENGL, V34, P1055, DOI 10.1007/s10483-013-1727-x; Cai Y, 2011, J THEOR BIOL, V279, P90, DOI 10.1016/j.jtbi.2011.02.017; Cai Y, 2009, APPL MATH MECH-ENGL, V30, P1247, DOI 10.1007/s10483-009-1004-z; Chaplain MAJ, 2000, J NEURO-ONCOL, V50, P37, DOI 10.1023/A:1006446020377; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Lyu J, 2013, APPL MATH MECH-ENGL, V34, P1237, DOI 10.1007/s10483-013-1741-8; Rieger H, 2015, WIRES SYST BIOL MED, V7, P113, DOI 10.1002/wsbm.1295; Smallbone K, 2007, J THEOR BIOL, V244, P703, DOI 10.1016/j.jtbi.2006.09.010; Wu JH, 2009, THESIS; Wu J, 2011, APPL MATH MECH-ENGL, V32, P437, DOI 10.1007/s10483-011-1428-7; Wu Jie, 2008, Molecular & Cellular Biomechanics, V5, P217; Wu J, 2009, J BIOMECH, V42, P712, DOI 10.1016/j.jbiomech.2009.01.009; Zhou Y, 2013, APPL MATH MECH-ENGL, V34, P327, DOI 10.1007/s10483-013-1673-6	19	10	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163173	10.1371/journal.pone.0163173	http://dx.doi.org/10.1371/journal.pone.0163173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701426	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900004
J	Brahimi, F; Maira, M; Barcelona, PF; Galan, A; Aboulkassim, T; Teske, K; Rogers, ML; Bertram, L; Wang, J; Yousefi, M; Rush, R; Fabian, M; Cashman, N; Saragovi, HU				Brahimi, Fouad; Maira, Mario; Barcelona, Pablo F.; Galan, Alba; Aboulkassim, Tahar; Teske, Katrina; Rogers, Mary-Louise; Bertram, Lisa; Wang, Jing; Yousefi, Masoud; Rush, Robert; Fabian, Marc; Cashman, Neil; Saragovi, H. Uri			The Paradoxical Signals of Two TrkC Receptor Isoforms Supports a Rationale for Novel Therapeutic Strategies in ALS	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SPINAL-CORD; NEUROTROPHIN RECEPTORS; SKELETAL-MUSCLE; NERVOUS-SYSTEM; P75; DEATH; ACTIVATION; SURVIVAL; VIVO	Full length TrkC (TrkC-FL) is a receptor tyrosine kinase whose mRNA can be spliced to a truncated TrkC. T1 isoform lacking the kinase domain. Neurotrophin-3 (NT-3) activates TrkC-FL to maintain motor neuron health and function and TrkC. T1 to produce neurotoxic TNF-alpha; hence resulting in opposing pathways. In mouse and human ALS spinal cord, the reduction of miR-128 that destabilizes TrkC. T1 mRNA results in up-regulated TrkC. T1 and TNF-alpha in astrocytes. We exploited conformational differences to develop an agonistic mAb 2B7 that selectively activates TrkC-FL, to circumvent TrkC. T1 activation. In mouse ALS, 2B7 activates spinal cord TrkC-FL signals, improves spinal cord motor neuron phenotype and function, and significantly prolongs life-span. Our results elucidate biological paradoxes of receptor isoforms and their role in disease progression, validate the concept of selectively targeting conformational epitopes in naturally occurring isoforms, and may guide the development of pro-neuroprotective (TrkC-FL) and anti-neurotoxic (TrkC.T1) therapeutic strategies.	[Brahimi, Fouad; Maira, Mario; Barcelona, Pablo F.; Galan, Alba; Aboulkassim, Tahar; Teske, Katrina; Fabian, Marc; Saragovi, H. Uri] McGill Univ, Lady Davis Inst, Translat Ctr, Jewish Gen Hosp, Montreal, PQ, Canada; [Saragovi, H. Uri] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Fabian, Marc] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Rogers, Mary-Louise; Rush, Robert] Flinders Univ S Australia, Dept Human Physiol, Ctr Neurosci, Adelaide, SA, Australia; [Bertram, Lisa; Wang, Jing; Yousefi, Masoud; Cashman, Neil] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; Flinders University South Australia; University of British Columbia	Saragovi, HU (corresponding author), McGill Univ, Lady Davis Inst, Translat Ctr, Jewish Gen Hosp, Montreal, PQ, Canada.; Saragovi, HU (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	Uri.Saragovi@mcgill.ca	Barcelona, Pablo Federico/AAJ-8440-2020	Barcelona, Pablo/0000-0001-8248-2282; Rogers, Mary-Louise/0000-0002-3482-8741	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (Pharmacology, to HUS; and Proof-of-Principle, to HUS and NC).	Aboulkassim T, 2011, MOL PHARMACOL, V80, P498, DOI 10.1124/mol.111.071332; Bai YJ, 2010, J BIOL CHEM, V285, P39392, DOI 10.1074/jbc.M110.147801; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Barcelona PF, 2015, MOL CELL BIOL, V35, P3396, DOI 10.1128/MCB.00544-15; BARINAGA M, 1994, SCIENCE, V264, P772, DOI 10.1126/science.8171331; Bartus RT, 2012, NEUROBIOL DIS, V48, P153, DOI 10.1016/j.nbd.2012.04.004; Brahimi F, 2010, BBA-GEN SUBJECTS, V1800, P1018, DOI 10.1016/j.bbagen.2010.06.007; Brahimi F, 2009, PEPTIDES, V30, P1833, DOI 10.1016/j.peptides.2009.07.015; Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010; Chen DJ, 2009, ACS CHEM BIOL, V4, P769, DOI 10.1021/cb9001415; Coles CH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6209; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; Enomoto M, 2013, EXP NEUROL, V248, P170, DOI 10.1016/j.expneurol.2013.06.013; Esteban PF, 2006, J CELL BIOL, V173, P291, DOI 10.1083/jcb.200512013; Franz CK, 2009, NEUROBIOL DIS, V33, P473, DOI 10.1016/j.nbd.2008.12.003; Guidi M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-95; Guillemard V, 2010, DEV NEUROBIOL, V70, P150, DOI 10.1002/dneu.20776; Haase G, 1998, J NEUROL SCI, V160, pS97, DOI 10.1016/S0022-510X(98)00207-X; Haase G, 2008, CURR OPIN NEUROBIOL, V18, P284, DOI 10.1016/j.conb.2008.07.013; Hurko O, 2000, J NEUROL SCI, V180, P21, DOI 10.1016/S0022-510X(00)00419-6; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Ivanisevic L, 2003, ONCOGENE, V22, P5677, DOI 10.1038/sj.onc.1206864; Josephy-Hernandez S, 2017, NEUROBIOL DIS, V97, P139, DOI 10.1016/j.nbd.2016.08.004; KERKHOFF H, 1991, ACTA NEUROPATHOL, V81, P649, DOI 10.1007/BF00296375; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LeSauteur L, 1996, J NEUROSCI, V16, P1308; Maliartchouk S, 2000, J BIOL CHEM, V275, P9946, DOI 10.1074/jbc.275.14.9946; Maliartchouk S, 1997, J NEUROSCI, V17, P6031; Messi ML, 2007, EXP NEUROL, V207, P52, DOI 10.1016/j.expneurol.2007.05.016; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Park S, 2009, EXP MOL MED, V41, P487, DOI 10.3858/emm.2009.41.7.054; Pehar M, 2006, EUR J NEUROSCI, V24, P1575, DOI 10.1111/j.1460-9568.2006.05040.x; Reichardt LF, 2004, CELL, V118, P141, DOI 10.1016/j.cell.2004.07.008; Saragovi HU, 2009, CURR ALZHEIMER RES, V6, P419, DOI 10.2174/156720509789207912; Saragovi HU, 2000, TRENDS PHARMACOL SCI, V21, P93, DOI 10.1016/S0165-6147(99)01444-3; Saragovi HU, 2002, CURR PHARM DESIGN, V8, P2201, DOI 10.2174/1381612023393215; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Sendtner M, 1996, NEUROCHEM RES, V21, P831, DOI 10.1007/BF02532307; Shepheard SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087398; Sorenson EJ, 2008, NEUROLOGY, V71, P1770, DOI 10.1212/01.wnl.0000335970.78664.36; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Turner BJ, 2004, J NEUROSCI RES, V78, P193, DOI 10.1002/jnr.20256; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Wyatt TJ, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/207230; YAN Q, 1988, J NEUROSCI, V8, P3481; Yanpallewar SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039946; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200; Zhou LJ, 2003, J NEUROSCI, V23, P1424, DOI 10.1523/JNEUROSCI.23-04-01424.2003	52	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162307	10.1371/journal.pone.0162307	http://dx.doi.org/10.1371/journal.pone.0162307			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695040	Green Published, gold			2022-12-27	WOS:000385553100012
J	Dalton, AC; Shlamkovitch, T; Papo, N; Barton, WA				Dalton, Annamarie C.; Shlamkovitch, Tomer; Papo, Niv; Barton, William A.			Constitutive Association of Tie1 and Tie2 with Endothelial Integrins is Functionally Modulated by Angiopoietin-1and Fibronectin	PLOS ONE			English	Article							GROWTH-FACTOR; ALPHA(V)BETA(3) INTEGRIN; ALPHA-5-BETA-1 INTEGRIN; CRYSTAL-STRUCTURES; CELL-CELL; ANGIOGENESIS; ACTIVATION; MIGRATION; ALPHA(5)BETA(1); BETA-1-INTEGRIN	Functional cross-talk between Tie2 and Integrin signaling pathways is essential to coordinate endothelial cell adhesion and migration in response to the extracellular matrix, yet the mechanisms behind this phenomenon are unclear. Here, we examine the possibility that receptor cross-talk is driven through uncharacterized Tie-integrin interactions on the endothelial surface. Using a live cell FRET-based proximity assay, we monitor Tie-integrin receptor recognition and demonstrate that both Tie1 and Tie2 readily associate with integrins alpha(5)beta(1) and alpha(V)beta(3) through their respective ectodomains. Although not required, Tie2-integrin association is significantly enhanced in the presence of the extracellular component and integrin ligand fibronectin. In vitro binding assays with purified components reveal that Tie-integrin recognition is direct, and further demonstrate that the receptor binding domain of the Tie2 ligand Ang-1, but not the receptor binding domain of Ang-2, can independently associate with alpha(5)beta(1) or alpha(V)beta(3). Finally, we reveal that cooperative Tie/integrin interactions selectively stimulate ERK/MAPK signaling in the presence of both Ang-1 and fibronectin, suggesting a molecular mechanism to sensitize Tie2 to extracellular matrix. We provide a mechanistic model highlighting the role of receptor localization and association in regulating distinct signaling cascades and in turn, the angiogenic switch.	[Dalton, Annamarie C.; Barton, William A.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Shlamkovitch, Tomer; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-8410501 Beer Sheva, Israel; [Shlamkovitch, Tomer; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-8410501 Beer Sheva, Israel	Virginia Commonwealth University; Ben Gurion University; Ben Gurion University	Barton, WA (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	william.barton@vcuhealth.org	Papo, Niv/R-3946-2017		National Cancer Institute of the National Institutes of Health [CA127501, F31CA165673]; NATIONAL CANCER INSTITUTE [F31CA165673] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA127501, http://www.cancer.gov, National Cancer Institute of the National Institutes of Health WAB. F31CA165673 http://www.cancer.gov National Cancer Institute of the National Institutes of Health ACD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Bogdanovic E, 2006, J CELL SCI, V119, P3551, DOI 10.1242/jcs.03077; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Chen XY, 2009, NEUROSCI RES, V64, P348, DOI 10.1016/j.neures.2009.04.007; Chen Y, 2006, J FLUORESC, V16, P95, DOI 10.1007/s10895-005-0024-1; Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6; Dallabrida SM, 2008, FASEB J, V22, P3010, DOI 10.1096/fj.07-100966; Dong XC, 2012, BIOCHEMISTRY-US, V51, P8814, DOI 10.1021/bi300734n; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Hakanpaa L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6962; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Lee EH, 2013, J CELL PHYSIOL, V228, P1038, DOI 10.1002/jcp.24251; Lee HS, 2014, J BIOL CHEM, V289, P31330, DOI 10.1074/jbc.M114.572594; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Mehta RJ, 1998, BIOCHEM J, V330, P861; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Napione L, 2007, AUTOIMMUN REV, V7, P18, DOI 10.1016/j.autrev.2007.03.007; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Porat RM, 2004, CIRC RES, V94, P394, DOI 10.1161/01.RES.0000111803.92923.D6; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Savant S, 2015, CELL REP, V12, P1761, DOI 10.1016/j.celrep.2015.08.024; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Stepensky D, 2007, BIOCHEM BIOPH RES CO, V359, P752, DOI 10.1016/j.bbrc.2007.05.180; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Taherian A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-293; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tanjore H, 2008, DEV DYNAM, V237, P75, DOI 10.1002/dvdy.21385; Thomas M, 2010, J BIOL CHEM, V285, P23842, DOI 10.1074/jbc.M109.097543; van der Flier A, 2010, DEVELOPMENT, V137, P2439, DOI 10.1242/dev.049551; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Velez-Montoya R, 2014, RETINA-J RET VIT DIS, V34, P423, DOI 10.1097/IAE.0000000000000036; Wick MJ, 2000, J BIOL CHEM, V275, P40400, DOI 10.1074/jbc.M003937200; Woo KV, 2011, TRENDS CARDIOVAS MED, V21, P118, DOI 10.1016/j.tcm.2012.03.009; Woo KV, 2011, J CLIN INVEST, V121, P1624, DOI 10.1172/JCI42040; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Yu XH, 2013, P NATL ACAD SCI USA, V110, P7205, DOI 10.1073/pnas.1216890110; Yuan HT, 2007, FASEB J, V21, P3171, DOI 10.1096/fj.07-8487com; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	58	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163732	10.1371/journal.pone.0163732	http://dx.doi.org/10.1371/journal.pone.0163732			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695111	Green Published, gold			2022-12-27	WOS:000385553100050
J	Li, XY; Peeters, R				Li, Xinyu; Peeters, Ronald			Cheap Talk with Multiple Strategically Interacting Audiences: An Experimental Study	PLOS ONE			English	Article							INFORMATION-TRANSMISSION; GAMES; DECEPTION; CONSEQUENCES; COORDINATION; ENTRY	We consider a cheap-talk setting that mimics the situation where an incumbent firm (the sender) is endowed with incentives to understate the true size of the market demand to two potential entrants (the receivers). Although our experimental data reveals that the senders' messages convey truthful information and this is picked up by the receivers, this overcommunication (relative to standard theoretical prediction) does not enhance efficient entry levels (and payoffs) to beyond what can be achieved without communication. The reason is that receivers fail to optimally translate the information received in their entry decision, possibly due to overcautiousness.	[Li, Xinyu] Univ Paderborn, Fac Business Adm & Econ, Managerial Econ, Paderborn, Germany; [Peeters, Ronald] Maastricht Univ, Dept Econ, Sch Business & Econ, Maastricht, Netherlands	University of Paderborn; Maastricht University	Peeters, R (corresponding author), Maastricht Univ, Dept Econ, Sch Business & Econ, Maastricht, Netherlands.	r.peeters@maastrichtuniversity.nl	Peeters, Ronald/H-4070-2015	Peeters, Ronald/0000-0001-5261-1119; Li, Xinyu/0000-0002-2741-2721; Li, Xinyu/0000-0001-7239-1555	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The second author thanks the Netherlands Organisation for Scientific Research (NWO) for financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranov M, 2012, AM ECON J-MICROECON, V4, P77, DOI 10.1257/mic.4.2.77; Battaglini M, 2014, GAME ECON BEHAV, V83, P147, DOI 10.1016/j.geb.2013.11.004; Cai HB, 2006, GAME ECON BEHAV, V56, P7, DOI 10.1016/j.geb.2005.04.001; Camerer C, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.1.306; Clots-Figueras I, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00109; CRAWFORD VP, 1982, ECONOMETRICA, V50, P1431, DOI 10.2307/1913390; DICKHAUT JW, 1995, ECON THEORY, V6, P389, DOI 10.1007/BF01211783; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Drugov Mikhail, 2013, WORKING PAPER; Erat S, 2012, MANAGE SCI, V58, P723, DOI 10.1287/mnsc.1110.1449; FARRELL J, 1989, AM ECON REV, V79, P1214; Feldman RS., 1978, LAW HUMAN BEHAV, V2, P313, DOI [10.1007/BF01038984, DOI 10.1007/BF01038984]; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Gneezy U, 2005, AM ECON REV, V95, P384, DOI 10.1257/0002828053828662; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Sanchez-Pages S, 2007, GAME ECON BEHAV, V61, P86, DOI 10.1016/j.geb.2006.10.014; Sobel J., 2009, ENCY COMPLEXITY SYST, V19, P8125, DOI [10.1007/978-0-387-30440-3_481, DOI 10.1007/978-0-387-30440-3_481]; SUNDALI JA, 1995, ORGAN BEHAV HUM DEC, V64, P203, DOI 10.1006/obhd.1995.1100; Wang JTY, 2010, AM ECON REV, V100, P984, DOI 10.1257/aer.100.3.984	19	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163783	10.1371/journal.pone.0163783	http://dx.doi.org/10.1371/journal.pone.0163783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695082	Green Submitted, Green Published, gold			2022-12-27	WOS:000385553100053
J	Manicardi, V; Russo, G; Napoli, A; Torlone, E; Li Volsi, P; Giorda, CB; Musacchio, N; Nicolucci, A; Suraci, C; Lucisano, G; Rossi, MC				Manicardi, Valeria; Russo, Giuseppina; Napoli, Angela; Torlone, Elisabetta; Li Volsi, Patrizia; Giorda, Carlo Bruno; Musacchio, Nicoletta; Nicolucci, Antonio; Suraci, Concetta; Lucisano, Giuseppe; Rossi, Maria Chiara		AMD Annals Study Grp	Gender-Disparitiesin Adults with Type 1 Diabetes: More Than a Quality of Care Issue. A Cross-Sectional Observational Study from the AMD Annals Initiative	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; SEX-SPECIFIC-DIFFERENCES; GLYCEMIC CONTROL; METABOLIC-CONTROL; EVENTS; ADOLESCENTS; MORTALITY; PREDICTS	We evaluated gender-differences in quality of type 1 diabetes (T1DM) care. Starting from electronic medical records of 300 centers, 5 process indicators, 3 favorable and 6 unfavorable intermediate outcomes, 6 treatment intensity/appropriateness measures and an overall quality score were measured. The likelihood of women vs. men (reference class) to be monitored, to reach outcomes, or to be treated has been investigated through multilevel logistic regression analyses; results are expressed as Odd Ratios (ORs) and 95% confidence intervals (95% CIs). The inter-center variability in the achievement of the unfavorable outcomes was also investigated. Overall, 28,802 subjects were analyzed (45.5% women). Women and men had similar age (44.5 +/- 16.0 vs. 45.0 +/- 17.0 years) and diabetes duration (18.3 +/- 13.0 vs. 18.8 +/- 13.0 years). No between-gender differences were found in process indicators. As for intermediate outcomes, women showed 33% higher likelihood of having HbA1c >= 8.0% (OR = 1.33; 95% CI: 1.25 +/- 1.43), 29% lower risk of blood pressure >= 140/90 mmHg (OR = 0.71; 95% CI: 0.65 +/- 0.77) and 27% lower risk of micro/macroalbuminuria (OR = 0.73; 95% CI: 0.65 +/- 0.81) than men, while BMI, LDL-c and GFR did not significantly differ; treatment intensity/appropriateness was not systematically different between genders; overall quality score was similar in men and women. Consistently across centers a larger proportion of women than men had HbA1c >= 8.0%, while a smaller proportion had BP >= 140/90 mmHg. No gender-disparities were found in process measures and improvements are required in both genders. The systematic worse metabolic control in women and worse blood pressure in men suggest that pathophysiologic differences rather than the care provided might explain these differences.	[Manicardi, Valeria] Montecchio Hosp Local Hlth Author Reggio Emilia, Dept Internal Med, Reggio Emilia, Italy; [Russo, Giuseppina] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Napoli, Angela] Sapienza Univ, Dept Clin & Mol Med, Fac Med & Psychol, S Andrea Hosp, Rome, Italy; [Torlone, Elisabetta] Osped S Maria Misericordia, Dept Internal Med Endocrinol & Metab, Perugia, Italy; [Li Volsi, Patrizia] AAS5, SSD Diabet Unit, Pordenone, Italy; [Giorda, Carlo Bruno] ASL TO5, Diabet & Metab Unit, Chieri, Italy; [Musacchio, Nicoletta] AO ICP, UOS Integrating Primary & Specialist Care, Milan, Italy; [Nicolucci, Antonio; Lucisano, Giuseppe; Rossi, Maria Chiara] CORESEARCH SRL Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy; [Suraci, Concetta] Sandro Pertini Hosp, Diabet & Metab Unit, Rome, Italy	University of Messina; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Hospital Santa Maria della Misericordia; Ospedale Sandro Pertini	Rossi, MC (corresponding author), CORESEARCH SRL Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy.	rossi@coresearch.it	Napoli, Angela/AAN-2409-2020; Giorda, Carlo B/D-4485-2018; torlone, elisabetta/J-4479-2019	Giorda, Carlo B/0000-0002-4709-8696; 	EliLilly-Italy; CORESEARCH	EliLilly-Italy(Eli Lilly); CORESEARCH	We received non conditional funding from a commercial source, i.e. EliLilly-Italy. EliLilly-Italy had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CORESEARCH srl is the Clinical Research Organization which was commissioned by AMD to plan and perform statistical analysis and prepare the manuscript in collaboration with AMD. CORESEARCH srl provided support in the form of salaries for authors [AN, GL, MCR]. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2011, EPIDEMIOL PREV, V35, P18, DOI DOI 10.1162/COMJ_A_00066; Bohn B, 2016, DIABETES RES CLIN PR, V115, P31, DOI 10.1016/j.diabres.2016.03.008; Collier A, 2015, DIABETIC MED, V32, P42, DOI 10.1111/dme.12569; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; De Berardis G, 2008, NUTR METAB CARDIOVAS, V18, P57, DOI 10.1016/j.numecd.2006.04.009; Earley A, 2012, ANN INTERN MED, V156, P785, DOI 10.7326/0003-4819-156-11-201203200-00391; Franzini L, 2013, NUTR METAB CARDIOVAS, V23, P235, DOI 10.1016/j.numecd.2011.12.003; Giorda CB, 2014, DIABETIC MED, V31, P615, DOI 10.1111/dme.12366; Huxley RR, 2015, LANCET DIABETES ENDO, V3, P198, DOI 10.1016/S2213-8587(14)70248-7; Kaplan SH, 2009, MED CARE, V47, P378, DOI 10.1097/MLR.0b013e31818dce07; Kautzky-Willer A, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-78; Kautzky-Willer A, 2010, GENDER MED, V7, P571, DOI 10.1016/j.genm.2010.12.001; Kekalainen P, 2016, DIABETES RES CLIN PR, V115, P9, DOI 10.1016/j.diabres.2016.03.005; Krishnan S, 2012, GENDER MED, V9, P251, DOI 10.1016/j.genm.2012.05.003; Lind M, 2014, NEW ENGL J MED, V371, P1972, DOI 10.1056/NEJMoa1408214; McKnight JA, 2015, DIABETIC MED, V32, P1036, DOI 10.1111/dme.12676; Miller KM, 2015, DIABETES CARE, V38, P971, DOI 10.2337/dc15-0078; Norhammar A, 2013, DIABETOLOGIA, V56, P1, DOI 10.1007/s00125-012-2694-y; Penno G, 2013, J INTERN MED, V274, P176, DOI 10.1111/joim.12073; Rossi MCE, 2008, DIABETES CARE, V31, P2166, DOI 10.2337/dc08-0469; Rossi MCE, 2011, DIABETES CARE, V34, P347, DOI 10.2337/dc10-1709; Rossi MC, 2015, ACTA DIABETOL, V52, P557, DOI 10.1007/s00592-014-0688-6; Rossi MC, 2013, DIABETES CARE, V36, P3162, DOI 10.2337/dc13-0184; Russo G, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/957105; Schwab KO, 2006, DIABETES CARE, V29, P218, DOI 10.2337/diacare.29.02.06.dc05-0724	25	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162960	10.1371/journal.pone.0162960	http://dx.doi.org/10.1371/journal.pone.0162960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695110	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100018
J	Zhao, Z; Xue, YD; Yang, HL; Li, HM; Sun, GY; Zhao, XF; Ding, D; Tang, JH				Zhao, Zhan; Xue, Yadong; Yang, Huili; Li, Huimin; Sun, Gaoyang; Zhao, Xiaofeng; Ding, Dong; Tang, Jihua			Genome-Wide Identification of miRNAs and Their Targets Involved in the Developing Internodes under Maize Ears by Responding to Hormone Signaling	PLOS ONE			English	Article							ARABIDOPSIS GENE MONOPTEROS; BOX PROTEIN TIR1; TRANSCRIPTION FACTOR; PLANT HEIGHT; ABIOTIC STRESS; DWARF MUTANT; AUXIN; ROOT; MICRORNAS; RICE	Internode length is one of the decisive factors affecting plant height (PH) and ear height (EH), which are closely associated with the lodging resistance, biomass and grain yield of maize. miRNAs, currently recognized as important transcriptional/post-transcriptional regulators, play an essential role in plant growth and development. However, their roles in developing internodes under maize ears remain unclear. To identify the roles of miRNAs and their targets in the development of internodes under maize ears, six miRNA and two degradome libraries were constructed using the 7th, 8th and 9th internodes of two inbred lines, 'Xun928' and 'Xun9058', which had significantly different internode lengths. A total of 45 and 54 miRNAs showed significant changes for each pairwise comparison among the 7th, 8th and 9th internodes of 'Xun9058' and 'Xun928', respectively. The expression of 31 miRNAs showed significant changes were common to the corresponding comparison groups of the 7th, 8th and 9th internodes of 'Xun9058' and 'Xun928'. For the corresponding internodes of 'Xun9058' and 'Xun928', compared with the expression of miRNAs in the 7th, 8th and 9th internodes of 'Xun928', the numbers of up-regulated and down-regulated miRNAs were 11 and 36 in the 7th internode, 9 and 45 in the 8th internode, and 9 and 25 in the 9th internode of 'Xun9058', respectively. Moreover, 10 miRNA families containing 45 members showed significant changes at least in two internodes of 'Xun928' by comparing with the corresponding internodes of 'Xun9058'. Based on the sequencing data, 20 miRNAs related to hormone signaling among the candidates, belonging to five conserved miRNA families, were selected for expression profiling using quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The five miRNA families, zma-miR160, zma-miR167, zma-miR164, zma-miR169 and zma-miR393, targeted the genes encoding auxin response factor, N-acetylcysteine domain containing protein, nuclear transcription factor Y and auxin signaling F-BOX 2 through degradome sequencing. The miRNAs might regulate their targets to respond to hormone signaling, thereby regulating the internode elongation and development under maize ear. These results provide valuable reference for understanding the possible regulation mechanism of the ILs under the ear.	[Zhao, Zhan; Xue, Yadong; Yang, Huili; Li, Huimin; Sun, Gaoyang; Zhao, Xiaofeng; Ding, Dong; Tang, Jihua] Henan Agr Univ, Collaborat Innovat Ctr Henan Grain Crops, Coll Agron, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Henan, Peoples R China; [Tang, Jihua] Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou 434023, Hubei, Peoples R China	Henan Agricultural University; Yangtze University	Tang, JH (corresponding author), Henan Agr Univ, Collaborat Innovat Ctr Henan Grain Crops, Coll Agron, Natl Key Lab Wheat & Maize Crop Sci, Zhengzhou 450002, Henan, Peoples R China.; Tang, JH (corresponding author), Yangtze Univ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou 434023, Hubei, Peoples R China.	tangjihua1@163.com			National Nature Foundation of China [31370033]; State Key Basic Research and Development Plan of China [2014CB138203]	National Nature Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research and Development Plan of China(National Basic Research Program of China)	This work was supported by a grant from the National Nature Foundation of China (31370033) and the State Key Basic Research and Development Plan of China (2014CB138203).	Abdul Ghani, 2013, Pure and Applied Biology, V2, P104; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Aida M, 2002, DEVELOPMENT, V129, P3965; Leyva-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048138; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baksa I, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2209-6; Baloch I. A., 2014, Pure and Applied Biology, V3, P72; Baloch IA, 2013, PURE APPL BIOL, V2, P83, DOI DOI 10.19045/BSPAB.2013.23002; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Chandler JW, 2015, PLANT CELL ENVIRON; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; D'haeseleer K, 2011, NEW PHYTOL, V191, P647, DOI 10.1111/j.1469-8137.2011.03719.x; Debernardi JM, 2014, PLANT J, V79, P413, DOI 10.1111/tpj.12567; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Flint-Garcia SA, 2003, CROP SCI, V43, P23, DOI 10.2135/cropsci2003.0023; FUJIOKA S, 1988, P NATL ACAD SCI USA, V85, P9031, DOI 10.1073/pnas.85.23.9031; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gyenes-Hegyi Z., 2002, Acta Agronomica Hungarica, V50, P75, DOI 10.1556/AAgr.50.2002.1.9; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hagen G, 2015, ESSAYS BIOCHEM, V58, P1, DOI [10.1042/BSE0580001, 10.1042/bse0580001]; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Jiang FK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037040; Johri MM, 1996, GENETICA, V97, P291, DOI 10.1007/BF00055315; Iglesias MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107678; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Khaksefidi RE, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00741; Knoller AS, 2010, J EXP BOT, V61, P3689, DOI 10.1093/jxb/erq180; Kosetsu K, 2010, PLANT CELL, V22, P3778, DOI 10.1105/tpc.110.077164; Kustchera U, 2015, PROTOPLASMA; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; Lv HK, 2014, PLANT MOL BIOL, V84, P243, DOI 10.1007/s11103-013-0129-x; MARTIN MJ, 1984, CROP SCI, V24, P746, DOI 10.2135/cropsci1984.0011183X002400040028x; Mori M, 2002, PLANT PHYSIOL, V130, P1152, DOI 10.1104/pp.007179; MORRISON TA, 1994, CROP SCI, V34, P1055, DOI 10.2135/cropsci1994.0011183X003400040040x; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Ni ZY, 2013, PLANT MOL BIOL, V82, P113, DOI 10.1007/s11103-013-0040-5; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Parry G, 2009, P NATL ACAD SCI USA, V106, P22540, DOI 10.1073/pnas.0911967106; Pilu R, 2007, MOL BREEDING, V20, P83, DOI 10.1007/s11032-006-9073-7; Pinthis M. J., 1973, Advances in Agronomy, V25, P209; Przemeck GKH, 1996, PLANTA, V200, P229, DOI 10.1007/BF00208313; Qi YH, 2012, NEW PHYTOL, V193, P109, DOI 10.1111/j.1469-8137.2011.03910.x; Saha J, 2013, COMPUT BIOL CHEM, V47, P81, DOI 10.1016/j.compbiolchem.2013.08.001; SAUTER M, 1992, PLANTA, V188, P362, DOI 10.1007/BF00192803; Sessions A, 1997, DEVELOPMENT, V124, P4481; Setter TL, 1997, FIELD CROP RES, V49, P95, DOI 10.1016/S0378-4290(96)01058-1; Siriwardana CL, 2014, PLANT MOL BIOL REP, V32, P971, DOI 10.1007/s11105-014-0704-6; Spray CR, 1996, P NATL ACAD SCI USA, V93, P10515, DOI 10.1073/pnas.93.19.10515; Sun XM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00595; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Takahashi N, 2005, PLANT J, V42, P13, DOI 10.1111/j.1365-313X.2005.02357.x; Tang JH, 2007, EUPHYTICA, V155, P117, DOI 10.1007/s10681-006-9312-3; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; van der Knaap E, 2000, PLANT PHYSIOL, V122, P695, DOI 10.1104/pp.122.3.695; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang WF, 2014, CURR OPIN PLANT BIOL, V21, P147, DOI 10.1016/j.pbi.2014.07.012; Wang YH, 2006, PROG NAT SCI, V16, P701; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang WJ, 2014, J INTEGR AGR, V13, P63, DOI 10.1016/S2095-3119(13)60388-3; Zhang ZM, 2006, RUSS J GENET+, V42, P306, DOI 10.1134/S1022795406030112	77	14	15	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164026	10.1371/journal.pone.0164026	http://dx.doi.org/10.1371/journal.pone.0164026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695059	Green Submitted, gold, Green Published			2022-12-27	WOS:000385553100077
J	Guerrant, RL; Leite, AM; Pinkerton, R; Medeiros, PHQS; Cavalcante, PA; DeBoer, M; Kosek, M; Duggan, C; Gewirtz, A; Kagan, JC; Gauthier, AE; Swann, J; Mayneris-Perxachs, J; Bolick, DT; Maier, EA; Guedes, MM; Moore, SR; Petri, WA; Havt, A; Lima, IF; Prata, MDG; Michaleckyj, JC; Scharf, RJ; Sturgeon, C; Fasano, A; Lima, AAM				Guerrant, Richard L.; Leite, Alvaro M.; Pinkerton, Relana; Medeiros, Pedro H. Q. S.; Cavalcante, Paloma A.; DeBoer, Mark; Kosek, Margaret; Duggan, Christopher; Gewirtz, Andrew; Kagan, Jonathan C.; Gauthier, Anna E.; Swann, Jonathan; Mayneris-Perxachs, Jordi; Bolick, David T.; Maier, Elizabeth A.; Guedes, Marjorie M.; Moore, Sean R.; Petri, William A.; Havt, Alexandre; Lima, Ila F.; Gondim Prata, Mara de Moura; Michaleckyj, Josyf C.; Scharf, Rebecca J.; Sturgeon, Craig; Fasano, Alessio; Lima, Aldo A. M.			Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast Brazil	PLOS ONE			English	Article							EARLY-CHILDHOOD DIARRHEA; CATCH-UP GROWTH; FAT DISTRIBUTION; INTESTINAL INFLAMMATION; PERSISTENT DIARRHEA; GENDER-DIFFERENCES; AFRICAN-AMERICAN; BARRIER FUNCTION; LINEAR GROWTH; BODY-FAT	Critical to the design and assessment of interventions for enteropathy and its developmental consequences in children living in impoverished conditions are non-invasive biomarkers that can detect intestinal damage and predict its effects on growth and development. We therefore assessed fecal, urinary and systemic biomarkers of enteropathy and growth predictors in 375 6-26 month-old children with varying degrees of malnutrition (stunting or wasting) in Northeast Brazil. 301 of these children returned for followup anthropometry after 2-6m. Biomarkers that correlated with stunting included plasma IgA anti-LPS and anti-FliC, zonulin (if >12m old), and intestinal FABP (I-FABP, suggesting prior barrier disruption); and with citrulline, tryptophan and with lower serum amyloid A (SAA) (suggesting impaired defenses). In contrast, subsequent growth was predicted in those with higher fecal MPO or A1AT and also by higher L/M, plasma LPS, I-FABP and SAA (showing intestinal barrier disruption and inflammation). Better growth was predicted in girls with higher plasma citrulline and in boys with higher plasma tryptophan. Interactions were also seen with fecal MPO and neopterin in predicting subsequent growth impairment. Biomarkers clustered into markers of 1) functional intestinal barrier disruption and translocation, 2) structural intestinal barrier disruption and inflammation and 3) systemic inflammation. Principle components pathway analyses also showed that L/M with % L, I-FABP and MPO associate with impaired growth, while also (like MPO) associating with a systemic inflammation cluster of kynurenine, LBP, sCD14, SAA and K/T. Systemic evidence of LPS translocation associated with stunting, while markers of barrier disruption or repair (A1AT and Reg1 with low zonulin) associated with fecal MPO and neopterin. We conclude that key noninvasive biomarkers of intestinal barrier disruption, LPS translocation and of intestinal and systemic inflammation can help elucidate how we recognize, understand, and assess effective interventions for enteropathy and its growth and developmental consequences in children in impoverished settings.	[Guerrant, Richard L.; Pinkerton, Relana; DeBoer, Mark; Petri, William A.; Michaleckyj, Josyf C.; Scharf, Rebecca J.] Univ Virginia, Sch Med, Dept Med, Dept Pediat,Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA; [Guerrant, Richard L.; Pinkerton, Relana; DeBoer, Mark; Bolick, David T.; Petri, William A.; Michaleckyj, Josyf C.; Scharf, Rebecca J.] Univ Virginia, Sch Med, Ctr Global Hlth, Charlottesville, VA 22908 USA; [Leite, Alvaro M.; Medeiros, Pedro H. Q. S.; Cavalcante, Paloma A.; Havt, Alexandre; Lima, Ila F.; Gondim Prata, Mara de Moura; Lima, Aldo A. M.] Univ Fed Ceara, Clin Res Unit, Fortaleza, Ceara, Brazil; [Duggan, Christopher; Kagan, Jonathan C.; Gauthier, Anna E.] Harvard Univ, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Gewirtz, Andrew] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Sturgeon, Craig; Fasano, Alessio] Harvard Univ, Massachusetts Gen Hosp Children, Mucosal Immunol & Biol Res Ctr, Boston, MA 02115 USA; [Sturgeon, Craig; Fasano, Alessio] Harvard Univ, Massachusetts Gen Hosp Children, Div Pediat Gastroenterol & Nutr, Boston, MA 02115 USA; [Swann, Jonathan; Mayneris-Perxachs, Jordi] Imperial Coll, London, England; [Maier, Elizabeth A.; Guedes, Marjorie M.; Moore, Sean R.] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Kosek, Margaret] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of Virginia; University of Virginia; Universidade Federal do Ceara; Harvard University; Boston Children's Hospital; University System of Georgia; Georgia State University; Harvard University; Harvard University; Imperial College London; Cincinnati Children's Hospital Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Guerrant, RL (corresponding author), Univ Virginia, Sch Med, Dept Med, Dept Pediat,Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA.; Guerrant, RL (corresponding author), Univ Virginia, Sch Med, Ctr Global Hlth, Charlottesville, VA 22908 USA.	rlg9@virgmia.edu	Lima, Aldo AM/D-8251-2018; Petri, William/AAL-3642-2020; Mayneris-Perxachs, Jordi/B-2589-2018; Fasano, Alessio/K-5486-2016; Bolick, David/A-3467-2017; Mayneris-Perxachs, Jordi/AAG-7724-2020; Havt, Alexandre/AAM-8585-2020; Petri, William A./D-3639-2019	Lima, Aldo AM/0000-0002-0299-1747; Petri, William/0000-0002-7268-1218; Mayneris-Perxachs, Jordi/0000-0003-3788-3815; Fasano, Alessio/0000-0002-2134-0261; Mayneris-Perxachs, Jordi/0000-0003-3788-3815; Moore, Sean/0000-0003-1150-6632; Kosek, Margaret/0000-0001-6340-4852; Scharf, Rebecca/0000-0002-3381-5594; Havt, Alexandre/0000-0002-4546-2976; Swann, Jonathan/0000-0002-6485-4529	Bill & Melinda Gates Foundation Biomarker Grants [OPP1066140, OPP 1066146, OPP 1099111]; National Institutes of Health (NIH) [DK048373]; NIH [DK048373, K02TW008767]; case-control component of the "Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development" Project (MAL-ED) - Bill & Melinda Gates Foundation; Foundation for the NIH; National Institutes of Health, Fogarty International Center; Doris Duke Charitable Foundation; FOGARTY INTERNATIONAL CENTER [K02TW008767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK048373] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation Biomarker Grants; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); case-control component of the "Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development" Project (MAL-ED) - Bill & Melinda Gates Foundation; Foundation for the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Bill & Melinda Gates Foundation Biomarker Grants No. OPP1066140 entitled, "Novel metabonomic biomarkers of gut function and health: Modeling enteropathy (EE) and field validation," and in part by OPP 1066146 and OPP 1099111 "Production of a Reg1B fecal enzyme immunoassay as a potential biomarker of childhood stunting," by the National Institutes of Health (NIH) grant DK048373 entitled "Zot, Zonulin, and Pathophysiology of Intestinal Tight Junctions," by NIH grant K02TW008767, and in part as a case-control component of the "Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development" Project (MAL-ED) carried out as a collaborative project supported by the Bill & Melinda Gates Foundation, the Foundation for the NIH, and the National Institutes of Health, Fogarty International Center. The authors thank the staff and participants of the MAL-ED Network for their important contributions. No authors declare a conflict of interest. RJS has a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.; This work was supported by the Bill & Melinda Gates Foundation Biomarker Grants No. OPP1066140 entitled, "Novel metabonomic biomarkers of gut function and health: Modeling enteropathy (EE) and field validation", and in part by OPP 1066146 and OPP 1099111 "Production of a Reg1B fecal enzyme immunoassay as a potential biomarker of childhood stunting," by the NIH grant DK048373 entitled "Zot, Zonulin, and Pathophysiology of Intestinal Tight Junctions, by NIH grant K02TW008767, and in part as a case-control component of the "Etiology, Risk Factors and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development" Project (MAL-ED) carried out as a collaborative project supported by the Bill & Melinda Gates Foundation, the Foundation for the NIH, and the National Institutes of Health, Fogarty International Center. The authors thank the staff and participants of the MAL-ED Network for their important contributions. No authors declare a conflict of interest. RJS has a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.	Ajjampur SSR, 2010, AM J TROP MED HYG, V83, P1110, DOI 10.4269/ajtmh.2010.09-0644; [Anonymous], 2013, GUID UPD MAN SEV AC; Arfai K, 2002, RADIOLOGY, V224, P338, DOI 10.1148/radiol.2242011369; Benzoni Nicole, 2015, BMC Res Notes, V8, P258, DOI 10.1186/s13104-015-1238-1; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bolick DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106902; Bolick DT, 2013, J MED MICROBIOL, V62, P896, DOI 10.1099/jmm.0.046300-0; Brown EM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8806; Burgess SL, 2014, MBIO, V5, DOI 10.1128/mBio.01817-14; Campbell DI, 2004, J PEDIATR GASTR NUTR, V39, P153, DOI 10.1097/00005176-200408000-00005; Campbell DI, 2003, J NUTR, V133, P1332; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Costa LB, 2012, J INFECT DIS, V205, P1464, DOI 10.1093/infdis/jis216; Cowell CT, 1997, HORM RES, V48, P93, DOI 10.1159/000191336; Crenn P, 2008, CLIN NUTR, V27, P328, DOI 10.1016/j.clnu.2008.02.005; El Asmar R, 2002, GASTROENTEROLOGY, V123, P1607, DOI 10.1053/gast.2002.36578; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; GUERRANT RL, 1992, AM J TROP MED HYG, V47, P28, DOI 10.4269/ajtmh.1992.47.28; He Q, 2002, J CLIN ENDOCR METAB, V87, P2164, DOI 10.1210/jc.87.5.2164; Herd SL, 2001, INT J OBESITY, V25, P198, DOI 10.1038/sj.ijo.0801524; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Horlick M, 2000, J BONE MINER RES, V15, P1393, DOI 10.1359/jbmr.2000.15.7.1393; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Keusch GT, 2013, FOOD NUTR BULL, V34, P357, DOI 10.1177/156482651303400308; Kitchens RL, 2005, J ENDOTOXIN RES, V11, P225, DOI 10.1179/096805105X46565; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; Kosek M, 2013, AM J TROP MED HYG, V88, P390, DOI 10.4269/ajtmh.2012.12-0549; Kosek M, 2009, J HEALTH POPUL NUTR, V27, P319; Lima AAM, 2000, J INFECT DIS, V181, P1643, DOI 10.1086/315423; Lima AAM, 2014, CLIN INFECT DIS, V59, pS287, DOI 10.1093/cid/ciu438; Lin A, 2013, AM J TROP MED HYG, V89, P130, DOI 10.4269/ajtmh.12-0629; LINDENBAUM J, 1966, ANN INTERN MED, V65, P1201, DOI 10.7326/0003-4819-65-6-1201; Liu J, 2014, LANCET INFECT DIS, V14, P716, DOI 10.1016/S1473-3099(14)70808-4; LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M; Mast M, 1998, INT J OBESITY, V22, P878, DOI 10.1038/sj.ijo.0800675; Mata LJ, 1978, CHILDREN SANTA MARIA; Mayneris-Perxachs J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19780; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; Mitamura R, 2000, J CLIN ENDOCR METAB, V85, P1074, DOI 10.1210/jc.85.3.1074; Moore SR, 2010, GASTROENTEROLOGY, V139, P1156, DOI 10.1053/j.gastro.2010.05.076; Naylor C, 2015, EBIOMEDICINE; Naylor C, 2015, EBIOMEDICINE, V2, P1759, DOI 10.1016/j.ebiom.2015.09.036; Niehaus MD, 2002, AM J TROP MED HYG, V66, P590, DOI 10.4269/ajtmh.2002.66.590; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Peterson KM, 2013, AM J CLIN NUTR, V97, P1129, DOI 10.3945/ajcn.112.048306; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Prata Mara de Moura Gondim, 2016, J Transl Sci, V2, P134; Rahaman MM WA, 1983, DIARRHEA MALNUTRITIO, P155; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Scrimshaw N S, 1968, Monogr Ser World Health Organ, V57, P3; Soendergaard C, 2015, INFLAMM BOWEL DIS, V21, P1077, DOI 10.1097/MIB.0000000000000348; Stein AD, 2008, ARCH PEDIAT ADOL MED, V162, P612, DOI 10.1001/archpedi.162.7.612; Suzuki H, 2014, SCIENCE, V344, P304, DOI 10.1126/science.1248571; Taylor RW, 1997, INT J OBESITY, V21, P1082, DOI 10.1038/sj.ijo.0800522; Thuijls Geertje, 2010, J Clin Gastroenterol, V44, pe14, DOI 10.1097/MCG.0b013e31819f5652; van der Sluis IM, 2002, ARCH DIS CHILD, V87, P341, DOI 10.1136/adc.87.4.341; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Wada M, 2013, GASTROENTEROLOGY, V144, P369, DOI 10.1053/j.gastro.2012.10.035; Wongdee K, 2013, J MOL HISTOL, V44, P103, DOI 10.1007/s10735-012-9451-x; Yan Q, 2014, CELL SIGNAL, V26, P1783, DOI 10.1016/j.cellsig.2014.03.025; Ye RD, 2015, J LEUKOCYTE BIOL, V98, P923, DOI 10.1189/jlb.3VMR0315-080R	69	111	112	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0158772	10.1371/journal.pone.0158772	http://dx.doi.org/10.1371/journal.pone.0158772			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690129	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000384329200002
J	Li, L; Catala-Lopez, F; Alonso-Arroyo, A; Tian, JH; Aleixandre-Benavent, R; Pieper, D; Ge, L; Yao, L; Wang, Q; Yang, KH				Li, Lun; Catala-Lopez, Ferran; Alonso-Arroyo, Adolfo; Tian, Jinhui; Aleixandre-Benavent, Rafael; Pieper, Dawid; Ge, Long; Yao, Liang; Wang, Quan; Yang, Kehu			The Global Research Collaboration of Network Meta-Analysis: A Social Network Analysis	PLOS ONE			English	Article							COUNTRIES; MEDICINE; OUTCOMES; IMPACT	Background and Objective Research collaborations in biomedical research have evolved over time. No studies have addressed research collaboration in network meta-analysis (NMA). In this study, we used social network analysis methods to characterize global collaboration patterns of published NMAs over the past decades. Methods PubMed, EMBASE, Web of Science and the Cochrane Library were searched (at 9th July, 2015) to include systematic reviews incorporating NMA. Two reviewers independently selected studies and cross-checked the standardized data. Data was analyzed using Uci-net 6.0 and SPSS 17.0. NetDraw software was used to draw social networks. Results 771 NMAs published in 336 journals from 3459 authors and 1258 institutions in 49 countries through the period 1997-2015 were included. More than three-quarters (n = 625; 81.06%) of the NMAs were published in the last 5-years. The BMJ (4.93%), Current Medical Research and Opinion (4.67%) and PLOS One (4.02%) were the journals that published the greatest number of NMAs. The UK and the USA (followed by Canada, China, the Netherlands, Italy and Germany) headed the absolute global productivity ranking in number of NMAs. The top 20 authors and institutions with the highest publication rates were identified. Overall, 43 clusters of authors (four major groups: one with 37 members, one with 12 members, one with 11 members and one with 10 members) and 21 clusters of institutions (two major groups: one with 62 members and one with 20 members) were identified. The most prolific authors were affiliated with academic institutions and private consulting firms. 181 consulting firms and pharmaceutical industries (14.39% of institutions) were involved in 199 NMAs (25.81% of total publications). Although there were increases in international and inter-institution collaborations, the research collaboration by authors, institutions and countries were still weak and most collaboration groups were small sizes. Conclusion Scientific production on NMA is increasing worldwide with research leadership of Western countries (most notably, the UK, the USA and Canada). More authors, institutions and nations are becoming involved in research collaborations, but frequently with limited international collaborations.	[Li, Lun] Cent South Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha, Hunan, Peoples R China; [Li, Lun; Tian, Jinhui; Ge, Long; Yao, Liang; Yang, Kehu] Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou, Gansu, Peoples R China; [Catala-Lopez, Ferran] Univ Valencia, INCLIVA Hlth Res Inst, Dept Med, Valencia, Spain; [Catala-Lopez, Ferran] CIBERSAM, Valencia, Spain; [Catala-Lopez, Ferran] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Alonso-Arroyo, Adolfo] Univ Valencia, Dept Hist Sci & Documentat, Valencia, Spain; [Aleixandre-Benavent, Rafael] Ingenio Spanish Natl Res Council CSIC, Valencia, Spain; [Aleixandre-Benavent, Rafael] Univ Valencia, UISYS, Valencia, Spain; [Pieper, Dawid] Univ Witten Herdecke, Inst Res Operat Med, Dept Evidence Based Hlth Serv Res, Cologne, Germany; [Wang, Quan] Four Mil Med Univ, Xijing Hosp, Xijing Hosp Digest Dis, Dept Gastrointestinal Surg, Xian, Shaanxi, Peoples R China	Central South University; Lanzhou University; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Ottawa; Ottawa Hospital Research Institute; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Gestion de la Innovacion y del Conocimiento (INGENIO); University of Valencia; Witten Herdecke University; Air Force Military Medical University	Li, L (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha, Hunan, Peoples R China.; Li, L (corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou, Gansu, Peoples R China.	guo19880101@163.com	Catalá-López, Ferrán/N-6018-2018; Ge, Long/G-8876-2017; Pieper, Dawid/P-1014-2016; Li, LILUNlilun871116@/R-8202-2019; Aleixandre-Benavent, Rafael/G-1011-2015; Alonso-Arroyo, Adolfo/K-8182-2013	Catalá-López, Ferrán/0000-0002-3833-9312; Ge, Long/0000-0002-3555-1107; Aleixandre-Benavent, Rafael/0000-0002-6678-8844; Alonso-Arroyo, Adolfo/0000-0002-5084-2818	Generalitat Valenciana [PROMETEOII/2015/021]	Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	Ferran Catala-Lopez is partially supported by the Generalitat Valenciana (PROMETEOII/2015/021).; We thank Ms. Becky Skidmore who peer-reviewed the search strategy for us, Brian Hutton and David Moher who were involved in study design, Misty Pratt who was involved in study selection. We also thank the peer-reviewers who contributed to this article. Ferran Catala-Lopez is partially supported by the Generalitat Valenciana (PROMETEOII/2015/021), which has nothing to do with this research.	Ades AE, 2013, MED DECIS MAKING, V33, P679, DOI 10.1177/0272989X13485156; Bafeta A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1741; Bafeta A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3675; Bakkalbasi N, 2006, P AM SOC INFO SCI TE, V43, P1, DOI DOI 10.1002/MEET.14504301148; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Bozdogan H, 2013, INFORM SERVICES USE, V33, P219; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Catala-Lopez F, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-15; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chambers JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121715; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Coleman C. I., 2012, USE MIXED TREATMENT; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Donegan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011054; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Ettarh RR, 2015, CARDIOVASC DIAGN THE, V5, P311, DOI 10.3978/j.issn.2223-3652.2015.07.04; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257; Gong P, 2012, NATURE, V481, P411, DOI 10.1038/481411a; Greco T, 2015, HEART LUNG VESSEL, V7, P133; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Hutton B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092508; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Li L, 2014, J CLIN EPIDEMIOL, V67, P1001, DOI 10.1016/j.jclinepi.2014.04.003; Li TJ, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-79; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Marks J, 2013, J OBES, V2013, DOI 10.1155/2013/919287; Moher D, 2016, LANCET, V387, P1573, DOI 10.1016/S0140-6736(15)00307-4; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Page MJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002028; Patsopoulos NA, 2006, BMJ-BRIT MED J, V332, P1061, DOI 10.1136/bmj.38768.420139.80; Penders B., 2015, COLLABORATION HLTH R; Price A, 2015, ANN NEUROSCI, V22, P127, DOI 10.5214/ans.0972.7531.220301; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Sismondo S, 2008, SOC SCI MED, V66, P1909, DOI 10.1016/j.socscimed.2008.01.010; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001; Zhang CC, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-52	45	18	18	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2016	11	9							e0163239	10.1371/journal.pone.0163239	http://dx.doi.org/10.1371/journal.pone.0163239			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CV	27685998	Green Published, Green Submitted, gold			2022-12-27	WOS:000384328500032
J	Peng, DL; Song, B; Yang, Y; Niu, Y; Sun, H				Peng, De-Li; Song, Bo; Yang, Yang; Niu, Yang; Sun, Hang			Overlapping Leaves Covering Flowers in the Alpine Species Eriophyton wallichii (Lamiaceae): Key Driving Factors and Their Potential Impact on Pollination	PLOS ONE			English	Article							QINGHAI-TIBET PLATEAU; RHEUM-NOBILE; SAUSSUREA-MEDUSA; PROTECTS POLLEN; HIGH-ELEVATION; PLANT; INFLORESCENCES; ACCUMULATION; POLYGONACEAE; GENTIANACEAE	Extrafloral structures are supposed to have evolved to protect flowers from harsh physical environments but might have effects on pollination. Overlapping leaves cover flowers in Eriophyton wallichii, an alpine perennial endemic to the Himalaya-Hengduan Mountains. In previous study, it has showed that these extrafloral leaves can protect interior flowers from temperature fluctuations caused by drastic solar radiation fluctuations, but these leaves may also protect interior flowers from rain wash and UVB damage, and we do not know which one is the main function. In this study, we investigated whether rain and UVB protection are the main functions of overlapping leaves covering flowers and their potential impact on pollination. We first measured the intensities of UVB radiation in open air, beneath leaves and corollas, and then examined pollen susceptibility to different intensities of UVB and rain in the laboratory to estimate whether corollas per se protect interior pollen from UVB and rain damage. We also carried out pollination treatments and observed pollinator visitation of flowers with and without leaves in the field to assess whether the overlapping leaves covering flowers impair pollinator attraction. Our results showed that (1) water and strong UVB significantly decreased pollen germinability, but corollas per se could protect pollen from UVB and rain damage; (2) no autonomous self-pollination and apomixis occurred, and pollinators were essential for the reproduction of E. wallichii; however, flower coverage by overlapping leaves did not limit pollination. We suggested that rain and UVB protection was not the main function of overlapping leaves covered flowers, given that this protection can be provided by corollas per se. Alternatively, this extrafloral structure in E. wallichii may have evolved in response to extreme high temperatures associated with the strong solar radiation fluctuations. This indicates that, even in alpine plants, extreme high temperature may affect the evolution of plant extrafloral structures.	[Peng, De-Li; Song, Bo; Yang, Yang; Niu, Yang; Sun, Hang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Niu, Y; Sun, H (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.	niuyang@mail.kib.ac.cn; hsun@mail.kib.ac.cn	Niu, Yang/GPX-1099-2022		Natural National Science Foundation of China [U1136601]; Strategic Priority Research Program of the Chinese Academy of Science [XDB03030112]; CAS/SAFEA International Partnership Program for Creative Research Teams	Natural National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Science(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	This study was supported by the Natural National Science Foundation of China (U1136601 to H. Sun), the Strategic Priority Research Program (B) of the Chinese Academy of Science (XDB03030112 to H. Sun) and the CAS/SAFEA International Partnership Program for Creative Research Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bynum MR, 2001, AM J BOT, V88, P1088, DOI 10.2307/2657092; Chen JG, 2013, PLANT ECOL DIVERS, V6, P487, DOI 10.1080/17550874.2012.702793; Dietrich L, 2014, ALPINE BOT, V124, P27, DOI 10.1007/s00035-014-0123-1; Duan YW, 2005, ACTA OECOL, V27, P225, DOI 10.1016/j.actao.2005.01.003; Fulkerson JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032790; He YP, 2005, PLANT SYST EVOL, V256, P17, DOI 10.1007/s00606-005-0345-1; Hou Qin-Zheng, 2009, Chinese Journal of Plant Ecology, V33, P1156, DOI 10.3773/j.issn.1005-264x.2009.06.016; Huang SQ, 2002, AM J BOT, V89, P1599, DOI 10.3732/ajb.89.10.1599; KEVAN P G, 1972, Canadian Field-Naturalist, V86, P41; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Mao YY, 2009, NEW PHYTOL, V183, P892, DOI 10.1111/j.1469-8137.2009.02925.x; Omori Y, 1996, BOT J LINN SOC, V122, P269, DOI 10.1111/j.1095-8339.1996.tb02076.x; PASW, 2009, PASW STAT 18 0 0; Patino S, 2002, PLANT CELL ENVIRON, V25, P41, DOI 10.1046/j.0016-8025.2001.00801.x; Peng DL, 2015, J PLANT ECOL, V8, P159, DOI 10.1093/jpe/rtv014; Peng DL, 2015, RES REPROD ADAPTATIO; Song B, 2014, NEW PHYTOL, V203, P1109, DOI 10.1111/nph.12856; Song B, 2013, OECOLOGIA, V172, P359, DOI 10.1007/s00442-012-2518-2; Strauss S. Y., 2006, ECOLOGY EVOLUTION FL; Sun H, 2014, J SYST EVOL, V52, P378, DOI 10.1111/jse.12092; Tsukaya H, 2002, J PLANT RES, V115, P263, DOI 10.1007/s10265-002-0030-1; Tsukaya H, 2001, PLANT BIOLOGY, V3, P536, DOI 10.1055/s-2001-17727; Von Hase A, 2006, PLANT ECOL, V184, P75, DOI 10.1007/s11258-005-9053-8; Wang Y., 2006, YUNNAN MOUNTAIN CLIM; Wang Y, 2010, AM J BOT, V97, P1618, DOI 10.3732/ajb.1000010; Yang Y, 2008, FUNCTIONAL HIGHLY SP; Yang Y, 2008, ARCT ANTARCT ALP RES, V40, P250, DOI 10.1657/1523-0430(07-009)[YANG]2.0.CO;2; Yang Y, 2010, J VEG SCI, V21, P1048, DOI 10.1111/j.1654-1103.2010.01215.x; Yang Y, 2009, ARCT ANTARCT ALP RES, V41, P515, DOI 10.1657/1938-4246-41.4.515; Zhang C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04520	30	0	0	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164177	10.1371/journal.pone.0164177	http://dx.doi.org/10.1371/journal.pone.0164177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716786	gold, Green Published, Green Submitted			2022-12-27	WOS:000385698100028
J	Fulham, MA; Mandrekar, P				Fulham, Melissa A.; Mandrekar, Pranoti			Sexual Dimorphism in Alcohol Induced Adipose Inflammation Relates to Liver Injury	PLOS ONE			English	Article							DIET-INDUCED OBESITY; FATTY LIVER; TISSUE MACROPHAGES; METABOLIC DISEASE; IMAGE-ANALYSIS; KUPFFER CELLS; ETHANOL; ADIPONECTIN; MICE; ACTIVATION	Alcoholic liver disease occurs due to chronic, heavy drinking and is driven both by metabolic alterations and immune cell activation. Women are at a higher risk than men for developing alcohol induced liver injury and this dimorphism is reflected in animal models of alcoholic liver disease. The importance of adipose tissue in alcoholic liver disease is emerging. Chronic alcohol consumption causes adipose tissue inflammation, which can influence liver injury. Sex differences in body fat composition are well known. However, it is still unclear if alcohol-induced adipose tissue inflammation occurs in a sex-dependent manner. Here we have employed the clinically relevant NIAAA model of chronic-binge alcohol consumption to investigate this sexual dimorphism. We report that female mice have greater liver injury than male mice despite lower alcohol consumption. Chronic-binge alcohol induces adipose tissue inflammation in vivo in female mice, which is illustrated by increased expression of TNF alpha, IL-6, and CCL2, compared to only IL-6 induction in male adipose tissue. Further, macrophage activation markers such as CD68 as well as the pro-inflammatory activation markers CD11b and CD11c were higher in female adipose tissue. Interestingly, alcohol induced expression of TLR2, 3, 4, and 9 in female but not male adipose tissue, without affecting the TLR adaptor, MyD88. Higher trends of serum endotoxin in female mice may likely contribute to adipose tissue inflammation. In vitro chronic alcohol-mediated sensitization of macrophages to endotoxin is independent of sex. In summary, we demonstrate for the first time that there is a sexual dimorphism in alcohol-induced adipose tissue inflammation and female mice exhibit a higher degree of inflammation than male mice.	[Fulham, Melissa A.; Mandrekar, Pranoti] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Fulham, Melissa A.] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Mandrekar, P (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	Pranoti.Mandrekar@umassmed.edu			National Institutes of Health [AA017986-06A1, AA022770-02]; Department of Defense [DAMD/W81xWH-13-1-0498]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	PM was supported by grants from the National Institutes of Health (AA017986-06A1 and AA022770-02) and from the Department of Defense (DAMD/W81xWH-13-1-0498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227; ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Ambade A, 2014, J HEPATOL, V61, P903, DOI 10.1016/j.jhep.2014.05.024; Ambade A, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/853175; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Baraona E, 2001, ALCOHOL CLIN EXP RES, V25, P502, DOI 10.1097/00000374-200104000-00004; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Bertola A, 2013, HEPATOLOGY, V58, P1814, DOI 10.1002/hep.26419; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Buechler C, 2009, J GASTROEN HEPATOL, V24, P558, DOI 10.1111/j.1440-1746.2008.05693.x; Chen XC, 2007, AM J PHYSIOL-ENDOC M, V292, pE621, DOI 10.1152/ajpendo.00387.2006; Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811; Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041; Dugum M, 2015, J CLIN TRANSL HEPATO, V3, P109, DOI 10.14218/JCTH.2015.00008; Enomoto N, 1999, AM J PHYSIOL-GASTR L, V277, pG671, DOI 10.1152/ajpgi.1999.277.3.G671; FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205; Galli A, 2001, J BIOL CHEM, V276, P68, DOI 10.1074/jbc.M008791200; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Iimuro Y, 1997, AM J PHYSIOL-GASTR L, V272, pG1186, DOI 10.1152/ajpgi.1997.272.5.G1186; Ikejima K, 1998, AM J PHYSIOL-GASTR L, V274, pG669, DOI 10.1152/ajpgi.1998.274.4.G669; Kalafateli M, 2015, WORLD J GASTROENTERO, V21, P3020, DOI 10.3748/wjg.v21.i10.3020; Kang L, 2007, ALCOHOL CLIN EXP RES, V31, P1581, DOI 10.1111/j.1530-0277.2007.00452.x; Kasztelan-Szczerbinska B, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/148526; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Kono H, 2000, AM J PHYSIOL-GASTR L, V278, pG652, DOI 10.1152/ajpgi.2000.278.4.G652; Kwon HJ, 2014, HEPATOLOGY, V60, P146, DOI 10.1002/hep.27036; Lin HZ, 1998, ALCOHOL CLIN EXP RES, V22, p231S, DOI 10.1111/j.1530-0277.1998.tb04008.x; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Mandrekar P, 2009, J IMMUNOL, V183, P1320, DOI 10.4049/jimmunol.0803206; Mann RE, 2003, ALCOHOL RES HEALTH, V27, P209; MARSHALL AW, 1983, HEPATOLOGY, V3, P701; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Naveau S, 2010, J HEPATOL, V52, P895, DOI 10.1016/j.jhep.2010.01.029; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Parlesak A, 2000, J HEPATOL, V32, P742, DOI 10.1016/S0168-8278(00)80242-1; Rogers CQ, 2008, IUBMB LIFE, V60, P790, DOI 10.1002/iub.124; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebastian BM, 2011, J BIOL CHEM, V286, P35989, DOI 10.1074/jbc.M111.254201; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Singer K, 2015, J BIOL CHEM, V290, P13250, DOI 10.1074/jbc.M114.634568; Sun XH, 2012, AM J PHYSIOL-GASTR L, V302, pG548, DOI 10.1152/ajpgi.00342.2011; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Voican CS, 2015, LIVER INT, V35, P967, DOI 10.1111/liv.12575; Wang M, 2014, J LEUKOCYTE BIOL, V96, P657, DOI 10.1189/jlb.6A0114-004RR; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; Yin M, 2000, HEPATOLOGY, V31, P117, DOI 10.1002/hep.510310119; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; You M, 2009, EXP BIOL MED, V234, P850, DOI 10.3181/0902-MR-61	56	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164225	10.1371/journal.pone.0164225	http://dx.doi.org/10.1371/journal.pone.0164225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711160	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600099
J	Shen, HH; Liu, GS; Chow, SH; Wang, JH; He, Z; Nguyen, C; Lin, TW; Bui, BV				Shen, Hsin-Hui; Liu, Guei-Sheung; Chow, Seong Hoong; Wang, Jiang-Hui; He, Zheng; Nguyen, Christine; Lin, Tsung-Wu; Bui, Bang V.			Intraocular Pressure Induced Retinal Changes Identified Using Synchrotron Infrared Microscopy	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CORNEAL STEM-CELLS; LIPID-PEROXIDATION; OXIDATIVE STRESS; MICROSPECTROSCOPY; SPECTROSCOPY; RADIATION; TISSUE; DEATH; IR	Infrared (IR) spectroscopy has been used to quantify chemical and structural characteristics of a wide range of materials including biological tissues. In this study, we examined spatial changes in the chemical characteristics of rat retina in response to intraocular pressure (IOP) elevation using synchrotron infrared microscopy (SIRM), a non-destructive imaging approach. IOP elevation was induced by placing a suture around the eye of anaesthetised rats. Retinal sections were collected onto transparent CaF2 slides 10 days following IOP elevation. Using combined SIRM spectra and chemical mapping approaches it was possible to quantify IOP induced changes in protein conformation and chemical distribution in various layers of the rat retina. We showed that 10 days following IOP elevation there was an increase in lipid and protein levels in the inner nuclear layer (INL) and ganglion cell layer (GCL). IOP elevation also resulted in an increase in nucleic acids in the INL. Analysis of SIRM spectra revealed a shift in amide peaks to lower vibrational frequencies with a more prominent second shoulder, which is consistent with the presence of cell death in specific layers of the retina. These changes were more substantial in the INL and GCL layers compared with those occurring in the outer nuclear layer. These outcomes demonstrate the utility of SIRM to quantify the effect of IOP elevation on specific layers of the retina. Thus SIRM may be a useful tool for the study of localised tissue changes in glaucoma and other eye diseases.	[Shen, Hsin-Hui] Monash Univ, Fac Engn, Dept Mat Sci & Engn, Clayton, Vic, Australia; [Shen, Hsin-Hui; Chow, Seong Hoong] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Shen, Hsin-Hui; Chow, Seong Hoong] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Liu, Guei-Sheung; Wang, Jiang-Hui] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Liu, Guei-Sheung; Wang, Jiang-Hui] Univ Melbourne, Dept Surg, Ophthalmol, East Melbourne, Vic, Australia; [He, Zheng; Nguyen, Christine; Bui, Bang V.] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic, Australia; [Lin, Tsung-Wu] Tunghai Univ, Dept Chem, Taichung, Taiwan	Monash University; Monash University; Monash University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Melbourne; Tunghai University	Shen, HH (corresponding author), Monash Univ, Fac Engn, Dept Mat Sci & Engn, Clayton, Vic, Australia.; Shen, HH (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.; Shen, HH (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Bui, BV (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic, Australia.	hsin-hui.shen@monash.edu; bvb@unimelb.edu.au	Liu, Guei-Sheung/Q-6472-2018; Wang, Jiang-Hui/AAW-4653-2020; Bui, Bang/AAD-2679-2021; Chow, Seong Hoong/AAA-4698-2020	Liu, Guei-Sheung/0000-0003-3379-724X; Wang, Jiang-Hui/0000-0002-1551-9660; Bui, Bang/0000-0001-7298-1352; Chow, Seong Hoong/0000-0002-4392-3863; Shen, Hsin-Hui/0000-0002-8541-4370; Nguyen, Christine/0000-0002-3298-3086	National Health and Medical Research Council of Australia [1106798, 11081072, 1061912]; NHMRC [1106798, 1046203]; Australian Research Council [FT130100338]; Victorian Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Government	This work was supported by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) # 1106798 (HHS) #11081072 (GSL) #1061912 (JHW) NHMRC #1046203 (BVB) #1106798. BVB is supported by an Australian Research Council (www.arc.gov.au/) Future Fellowship (FT130100338). This work was also supported The Centre for Eye Research Australia receives Operational Infrastructure Support from the Victorian Government. (www.vic.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABIZHAYEV MA, 1989, ACTA OPHTHALMOL, V67, P371; Baker MJ, 2014, NAT PROTOC, V9, P1771, DOI 10.1038/nprot.2014.110; Bentley AJ, 2007, MOL VIS, V13, P237; Bui BV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070513; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; Calkins DJ, 2012, INVEST OPHTH VIS SCI, V53, P2482, DOI 10.1167/iovs.12-9483i; Choo LP, 1996, BIOPHYS J, V71, P1672, DOI 10.1016/S0006-3495(96)79411-0; Della Santina L, 2013, J NEUROSCI, V33, P17444, DOI 10.1523/JNEUROSCI.5461-12.2013; Dritsa V, 2012, INFRARED SPECTROSCOPY - LIFE AND BIOMEDICAL SCIENCES, P271; Faschinger C, 2006, OPHTHALMOLOGE, V103, P953, DOI 10.1007/s00347-006-1399-3; Feng L, 2013, INVEST OPHTH VIS SCI, V54, P1106, DOI 10.1167/iovs.12-10791; Fogarty SW, 2013, ANALYST, V138, P240, DOI 10.1039/c2an36197c; German MJ, 2006, INVEST OPHTH VIS SCI, V47, P2417, DOI 10.1167/iovs.05-1254; HARIS PI, 1992, TRENDS BIOCHEM SCI, V17, P328, DOI 10.1016/0968-0004(92)90305-S; Holman HN, 2000, BIOPOLYMERS, V57, P329; Huang W, 2005, AM J PATHOL, V167, P673, DOI 10.1016/S0002-9440(10)62042-1; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; Jamin N, 2003, BIOPOLYMERS, V72, P366, DOI 10.1002/bip.10435; Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837; Kastyak-Ibrahim MZ, 2012, NEUROIMAGE, V60, P376, DOI 10.1016/j.neuroimage.2011.11.069; Liu HH, 2015, INVEST OPHTH VIS SCI, V56, P2811, DOI 10.1167/iovs.14-16009; Liu M, 2011, EXP EYE RES, V92, P244, DOI 10.1016/j.exer.2011.01.014; Mattson EC, 2012, ANAL CHEM, V84, P6173, DOI 10.1021/ac301080h; Miller LM, 1998, CELL MOL BIOL, V44, P117; Nakamura T, 2010, MOL VIS, V16, P359; Naumann D, 2001, APPL SPECTROSC REV, V36, P239, DOI 10.1081/ASR-100106157; Pang JJ, 2015, P NATL ACAD SCI USA, V112, P2593, DOI 10.1073/pnas.1419921112; Peticolas WL, 1994, METHOD ENZYMOL, V246, P389, DOI [10.1016/0076-6879(95)46019-5, DOI 10.1016/0076-6879(95)46019-5]; Qu J, 2010, EXP EYE RES, V91, P48, DOI 10.1016/j.exer.2010.04.002; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Siebert F, 1994, METHOD ENZYMOL, V246, P501, DOI [10.1016/0076-6879(95)46022-5, DOI 10.1016/0076-6879(95)46022-5]; SILLS RH, 1994, ANAL BIOCHEM, V218, P118, DOI 10.1006/abio.1994.1149; Stitt DM, 2012, VIB SPECTROSC, V60, P16, DOI 10.1016/j.vibspec.2011.10.016; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; SUSI H, 1986, METHOD ENZYMOL, V130, P290; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Tobin MJ, 2004, FARADAY DISCUSS, V126, P27, DOI 10.1039/b306689d; Torii Hajime, 1996, P1; Weber AJ, 2005, INVEST OPHTH VIS SCI, V46, P3197, DOI 10.1167/iovs.04-0834; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wetzel DL, 2002, VIB SPECTROSC, V30, P101, DOI 10.1016/S0924-2031(02)00044-9; Williams PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072282; WONG PTT, 1991, APPL SPECTROSC, V45, P1563, DOI 10.1366/0003702914335580	43	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164035	10.1371/journal.pone.0164035	http://dx.doi.org/10.1371/journal.pone.0164035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711151	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600068
J	Gero, S; Whitehead, H				Gero, Shane; Whitehead, Hal			Critical Decline of the Eastern Caribbean Sperm Whale Population	PLOS ONE			English	Article							PHYSETER-MACROCEPHALUS; SOCIAL UNITS; TOUR BOATS; NOISE; BEHAVIOR; CETACEANS	Sperm whale (Physeter macrocephalus) populations were expected to rebuild following the end of commercial whaling. We document the decline of the population in the eastern Caribbean by tracing demographic changes of well-studied social units. We address hypotheses that, over a ten-year period of dedicated effort (2005-2015), unit size, numbers of calves and/or calving rates have each declined. Across 16 units, the number of adults decreased in 12 units, increased in two, and showed no change in two. The number of adults per unit decreased at -0.195 individuals/yr (95% CI: -0.080 to -0.310; P = 0.001). The number of calves also declined, but the decline was not significant. This negative trend of -4.5% per year in unit size started in about 2010, with numbers being fairly stable until then. There are several natural and anthropogenic threats, but no well-substantiated cause for the decline.	[Gero, Shane] Aarhus Univ, Inst Biosci, Zoophysiol, Aarhus, Denmark; [Whitehead, Hal] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Aarhus University; Dalhousie University	Gero, S (corresponding author), Aarhus Univ, Inst Biosci, Zoophysiol, Aarhus, Denmark.	shane.gero@bios.au.dk	Gero, Shane/G-8675-2015	Gero, Shane/0000-0001-6854-044X	Danish Council for Independent Research; Natural Sciences and Engineering Research Council of Canada	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	SG received an FNU fellowship from the Danish Council for Independent Research, supplemented by a Sapere Aude Research Talent Award (http://ufm.dk/en/), Carlsberg Foundation Field Expedition Grant (http://www.carlsbergfondet.dk/?sc_lang=en), and Killam Trusts (CA). HW received operating and equipment grants from the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes R, 2011, ANIM BEHAV, V81, P723, DOI 10.1016/j.anbehav.2010.12.019; ARNBOM T, 1987, REPORT INT WHALING C, V37, P201; Baker C. S., 2002, ENCY GLOBAL ENV CHAN, P446; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Best P.B., 1984, Reports of the International Whaling Commission Special Issue, P51; Carrillo Manuel, 2010, Journal of Cetacean Research and Management, V11, P131; Carroll G, 2014, ENDANGER SPECIES RES, V24, P33, DOI 10.3354/esr00584; Chiquet RA, 2013, ECOL MODEL, V248, P71, DOI 10.1016/j.ecolmodel.2012.09.023; Christal J, 1998, CAN J ZOOL, V76, P1431, DOI 10.1139/cjz-76-8-1431; Coat S, 2006, AQUAT LIVING RESOUR, V19, P181, DOI 10.1051/alr:2006016; Constantine R, 2004, BIOL CONSERV, V117, P299, DOI 10.1016/j.biocon.2003.12.009; Engelhaupt D, 2009, MOL ECOL, V18, P4193, DOI 10.1111/j.1365-294X.2009.04355.x; Fais A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150660; Gero S, 2008, BEHAV ECOL SOCIOBIOL, V63, P143, DOI 10.1007/s00265-008-0645-x; Gero Shane, 2007, Journal of Cetacean Research and Management, V9, P143; Gero S, 2007, MAR MAMMAL SCI, V23, P398, DOI 10.1111/j.1748-7692.2007.00113.x; Gero S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160061; Gero S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150372; Gero S, 2015, ANIM BEHAV, V102, P15, DOI 10.1016/j.anbehav.2015.01.008; Gero S, 2014, MAR MAMMAL SCI, V30, P905, DOI 10.1111/mms.12086; Gero S, 2009, BEHAV ECOL, V20, P838, DOI 10.1093/beheco/arp068; Hoyt E, 2002, COAST MANAGE, V30, P381, DOI 10.1080/089207502900273; Jacobsen JK, 2010, MAR POLLUT BULL, V60, P765, DOI 10.1016/j.marpolbul.2010.03.008; Jimenez J, 2014, MAMMAL REV, V44, P177, DOI [10.1111/mam.12021, DOI 10.1111/MAM.12021]; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Lusseau D, 2003, MAR ECOL PROG SER, V257, P267, DOI 10.3354/meps257267; Moore JE, 2014, ENDANGER SPECIES RES, V25, P141, DOI 10.3354/esr00633; Nowacek DP, 2007, MAMMAL REV, V37, P81, DOI 10.1111/j.1365-2907.2007.00104.x; Panigada S, 2009, SC61BC2 IWC; Robbins J., 2004, 43EANF030121 NE FISH; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Schulz TM, 2011, MAR MAMMAL SCI, V27, P149, DOI 10.1111/j.1748-7692.2010.00399.x; Schulz TM, 2008, ANIM BEHAV, V76, P1977, DOI 10.1016/j.anbehav.2008.07.032; Soto NA, 2006, MAR MAMMAL SCI, V22, P690, DOI 10.1111/j.1748-7692.2006.00044.x; Tyack PL, 2008, J MAMMAL, V89, P549, DOI 10.1644/07-MAMM-S-307R.1; Veirs S, 2016, PEERJ, V4, DOI 10.7717/peerj.1657; Vidal Omar, 1994, Reports of the International Whaling Commission Special Issue, V15, P221; Weilgart LS, 2007, CAN J ZOOL, V85, P1091, DOI 10.1139/Z07-101; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295; Whitehead H, 2015, ENDANGER SPECIES RES, V27, P207, DOI 10.3354/esr00657; Whitehead H, 2014, METHODS ECOL EVOL, V5, P27, DOI 10.1111/2041-210X.12124; Whitehead H, 2012, INT J PRIMATOL, V33, P1142, DOI 10.1007/s10764-012-9598-z; Whitt AD, 2015, AQUAT MAMM, V41, P252, DOI 10.1578/AM.41.3.2015.252; Williams R, 2011, CONSERV LETT, V4, P228, DOI 10.1111/j.1755-263X.2011.00168.x	44	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162019	10.1371/journal.pone.0162019	http://dx.doi.org/10.1371/journal.pone.0162019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706153	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200006
J	Hosseiny, A; Bahrami, M; Palestrini, A; Gallegati, M				Hosseiny, Ali; Bahrami, Mohammad; Palestrini, Antonio; Gallegati, Mauro			Metastable Features of Economic Networks and Responses to Exogenous Shocks	PLOS ONE			English	Article							KINETIC ISING-MODEL; DEPENDENCE; STATES; FIELD	It is well known that a network structure plays an important role in addressing a collective behavior. In this paper we study a network of firms and corporations for addressing metastable features in an Ising based model. In our model we observe that if in a recession the government imposes a demand shock to stimulate the network, metastable features shape its response. Actually we find that there exists a minimum bound where any demand shock with a size below it is unable to trigger the market out of recession. We then investigate the impact of network characteristics on this minimum bound. We surprisingly observe that in a Watts-Strogatz network, although the minimum bound depends on the average of the degrees, when translated into the language of economics, such a bound is independent of the average degrees. This bound is about 0.44 Delta GDP, where Delta GDP is the gap of GDP between recession and expansion. We examine our suggestions for the cases of the United States and the European Union in the recent recession, and compare them with the imposed stimulations. While the stimulation in the US has been above our threshold, in the EU it has been far below our threshold. Beside providing a minimum bound for a successful stimulation, our study on the metastable features suggests that in the time of crisis there is a "golden time passage" in which the minimum bound for successful stimulation can be much lower. Hence, our study strongly suggests stimulations to arise within this time passage.	[Hosseiny, Ali; Bahrami, Mohammad] Shahid Beheshti Univ, GC, Dept Phys, Tehran 19839, Iran; [Palestrini, Antonio; Gallegati, Mauro] Univ Politecn Marche, Dept Econ, Ancona, Italy	Shahid Beheshti University; Marche Polytechnic University	Hosseiny, A (corresponding author), Shahid Beheshti Univ, GC, Dept Phys, Tehran 19839, Iran.	al_hosseiny@sbu.ac.ir		Bahrami, Mohammad/0000-0002-1071-3296				Acemoglu D, 2012, ECONOMETRICA, V80, P1977, DOI 10.3982/ECTA9623; ACHARYYA M, 1995, PHYS REV B, V52, P6550, DOI 10.1103/PhysRevB.52.6550; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Aoyama H., 2010, ECONOPHYSICS CO STAT; Battiston S, 2012, J ECON DYN CONTROL, V36, P1121, DOI 10.1016/j.jedc.2012.04.001; Baxter GJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.248701; Binder K., 1976, PHASE TRANSITIONS CR, V17b; Brock WA, 2001, REV ECON STUD, V68, P235, DOI 10.1111/1467-937X.00168; Catullo E, 2015, J ECON DYN CONTROL, V50, P78, DOI 10.1016/j.jedc.2014.08.011; Chakrabarti BK, 1999, REV MOD PHYS, V71, P847, DOI 10.1103/RevModPhys.71.847; Christiano L, 2011, J POLIT ECON, V119, P78, DOI 10.1086/659312; Contreras MGA, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062812; Di Matteo T, 2004, PHYSICA A, V339, P181, DOI 10.1016/j.physa.2004.03.041; Durlauf SN, 2010, ANNU REV ECON, V2, P451, DOI 10.1146/annurev.economics.050708.143312; Fujisaka H, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.036109; Gallegati M, 2016, INEQUALITY MULTIPLIE; Gatti DD, 2005, J ECON BEHAV ORGAN, V56, P489, DOI 10.1016/j.jebo.2003.10.012; Gould H, 2010, STATISTICAL AND THERMAL PHYSICS: WITH COMPUTER APPLICATIONS, P1; Gurtner G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094414; Jesus E-E, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0126503, DOI 10.1371/JOURNAL.PONE.0126503]; Korniss G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.016120; LANGER JS, 1969, ANN PHYS-NEW YORK, V54, P258, DOI 10.1016/0003-4916(69)90153-5; Lee KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018443; Misra A, 1997, PHYSICA A, V246, P510, DOI 10.1016/S0378-4371(97)00371-3; Nekovee M, 2007, PHYSICA A, V374, P457, DOI 10.1016/j.physa.2006.07.017; Newman M., 2006, CLASSES SMALL WORLD; Onnela JP, 2004, EUR PHYS J B, V38, P353, DOI 10.1140/epjb/e2004-00128-7; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; RAY TS, 1990, PHYSICA A, V167, P580, DOI 10.1016/0378-4371(90)90276-X; RIKVOLD PA, 1994, PHYS REV E, V49, P5080, DOI 10.1103/PhysRevE.49.5080; Safdari H, 2016, PHYSICA A, V444, P744, DOI 10.1016/j.physa.2015.10.072; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Sides SW, 1999, PHYS REV E, V59, P2710, DOI 10.1103/PhysRevE.59.2710; Stauffer D., 1992, International Journal of Modern Physics C (Physics and Computers), V3, P1059, DOI 10.1142/S0129183192000695; STOLL EP, 1977, PHYSICA B & C, V86, P1419, DOI 10.1016/0378-4363(77)90936-6; TOMITA H, 1992, PHYS REV B, V46, P8886, DOI 10.1103/PhysRevB.46.8886; Woodford M, 2011, AM ECON J-MACROECON, V3, P1, DOI 10.1257/mac.3.1.1; Yakovenko VM, 2009, REV MOD PHYS, V81, P1703, DOI 10.1103/RevModPhys.81.1703; Zhang X, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60525-3; Zhou WX, 2007, EUR PHYS J B, V55, P175, DOI 10.1140/epjb/e2006-00391-6	40	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0160363	10.1371/journal.pone.0160363	http://dx.doi.org/10.1371/journal.pone.0160363			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706166	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200002
J	Li, X; Li, YB; Hong, L				Li, Xin; Li, Yanbo; Hong, Li			A Novel Self-Assembling DNA Nano Chip for Rapid Detection of Human Papillomavirus Genes	PLOS ONE			English	Article							NANOSCALE SHAPES; FOLDING DNA; HPV DNA; ORIGAMI; CARCINOMA; TILES; RNA	Rapid detection of tumor-associated DNA such as Human Papillomavirus (HPV) has important clinical value for the early screening of tumors. By attaching oligonucleotides or cDNA onto the chip surface, DNA chip technology provides a rapid method to analyze gene expression. However, challenges remain regarding increasing probe density and improving detection time. To address these challenges, we proposed a DNA chip that was self-assembled from single stranded DNA in combination with high probe density and a rapid detection method. Over 200 probes could be attached to the surface of this 100-nm diameter DNA chip. For detection, the chips were adsorbed onto a mica surface and then incubated for ten minutes with HPV-DNA; the results were directly observable using atomic force microscopy (AFM). This bottom-up fabricated DNA nano chip combined with high probe density and direct AFM detection at the single molecule level will likely have numerous potential clinical applications for gene screening and the early diagnosis of cancer.	[Li, Xin; Li, Yanbo; Hong, Li] Wuhan Univ, Renmin Hosp, Dept Gynecol 2, Wuhan 430060, Hubei, Peoples R China	Wuhan University	Li, X; Hong, L (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gynecol 2, Wuhan 430060, Hubei, Peoples R China.	lixinwhu@189.cn; hongliwhu@189.cn			National Natural Science Foundation of China [61272071, 61572213]; Natural Science Foundation of Hubei Province [2014CFB730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the National Natural Science Foundation of China (61272071, 61572213) and the Natural Science Foundation of Hubei Province (2014CFB730).	Agorastos T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119755; An HJ, 2003, CANCER-AM CANCER SOC, V97, P1672, DOI 10.1002/cncr.11235; Andersen ES, 2008, ACS NANO, V2, P1213, DOI 10.1021/nn800215j; Aslan F. G., 2015, TAF Preventive Medicine Bulletin, V14, P222, DOI 10.5455/pmb.1-1417459055; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Ding BQ, 2010, J AM CHEM SOC, V132, P3248, DOI 10.1021/ja9101198; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Ke YG, 2008, CHEM COMMUN, P5622, DOI 10.1039/b811332g; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; Kuzyk A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/23/235305; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Mei Q, 2013, NANO RES, V6, P712, DOI 10.1007/s12274-013-0347-1; Mellin H, 2000, INT J CANCER, V89, P300, DOI 10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Rinker S, 2008, NAT NANOTECHNOL, V3, P418, DOI 10.1038/nnano.2008.164; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sacca B, 2010, ANGEW CHEM INT EDIT, V49, P9378, DOI 10.1002/anie.201005931; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Sharma J, 2006, ANGEW CHEM INT EDIT, V45, P730, DOI 10.1002/anie.200503208; Shen WQ, 2009, J AM CHEM SOC, V131, P6660, DOI 10.1021/ja901407j; Shi LJ, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/14/145704; Voigt NV, 2010, NAT NANOTECHNOL, V5, P200, DOI [10.1038/nnano.2010.5, 10.1038/NNANO.2010.5]; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Zhang C, 2007, J AM CHEM SOC, V129, P14134, DOI 10.1021/ja075791k; Zhang Z, 2010, SMALL, V6, P1854, DOI 10.1002/smll.201000908; Zhang Z, 2010, ADV MATER, V22, P2672, DOI 10.1002/adma.201000151; Zhu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069856	28	5	4	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162975	10.1371/journal.pone.0162975	http://dx.doi.org/10.1371/journal.pone.0162975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706184	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200027
J	Shoeva, OY; Mock, HP; Kukoeva, TV; Borner, A; Khlestkina, EK				Shoeva, Olesya Yu; Mock, Hans-Peter; Kukoeva, Tatjana V.; Boerner, Andreas; Khlestkina, Elena K.			Regulation of the Flavonoid Biosynthesis Pathway Genes in Purple and Black Grains of Hordeum vulgare	PLOS ONE			English	Article							CONTROLLING ANTHOCYANIN PIGMENTATION; CHALCONE SYNTHASE; STRUCTURAL GENES; PROANTHOCYANIDIN SYNTHESIS; MICROSATELLITE MARKERS; GRAPE BERRIES; BARLEY ANT1; EXPRESSION; SEQUENCE; MAIZE	Barley grain at maturity can have yellow, purple, blue, and black pigmentations which are suggested to play a protective role under stress conditions. The first three types of the colors are caused by phenolic compounds flavonoids; the last one is caused by phytomelanins, oxidized and polymerized phenolic compounds. Although the genetic basis of the flavonoid biosynthesis pathway in barley has been thoroughly studied, there is no data yet on its regulation in purple and black barley grains. In the current study, genetic model of Hordeum vulgare 'Bowman' near-isogenic lines (NILs) was used to investigate the regulation of the flavonoid biosynthesis in white, purple, and black barley grains. Microsatellite genotyping revealed donor segments in the purple-and black-grained lines on chromosomes 2H (in region of the Ant2 gene determining purple color of grains) and 1H (in region of the Blp gene determining black lemma and pericarp), respectively. The isolated dominant Ant2 allele of the purple-grained line has high level of sequence similarity with the recessive Bowman's ant2 in coding region, whereas an insertion of 179 bp was detected in promoter region of ant2. This structural divergence between Ant2 and ant2 alleles may underlie their different expression in grain pericarp: Bowman's Ant2 is not transcribed, whereas it was up-regulated in the purple-grained line with coordinately co-expressed flavonoid biosynthesis structural genes (Chs, Chi, F3h, F3' h, Dfr, Ans). This led to total anthocyain content increase in purple-grained line identified by ultra-performance liquid chromatography (HPLC). Collectively, these results proved the regulatory function of the Ant2 gene in anthocyanin biosynthesis in barley grain pericarp. In the black-grained line, the specific transcriptional regulation of the flavonoid biosynthesis pathway genes was not detected, suggesting that flavonoid pigments are not involved in development of black lemma and pericarp trait.	[Shoeva, Olesya Yu; Kukoeva, Tatjana V.; Khlestkina, Elena K.] Russian Acad Sci, Siberian Branch, ICG, Novosibirsk, Russia; [Mock, Hans-Peter; Boerner, Andreas] Leibniz Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany; [Khlestkina, Elena K.] Novosibirsk State Univ, Food Secur Res Ctr, Novosibirsk, Russia	Russian Academy of Sciences; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Novosibirsk State University	Shoeva, OY (corresponding author), Russian Acad Sci, Siberian Branch, ICG, Novosibirsk, Russia.	olesya_ter@bionet.nsc.ru	Shoeva, Olesya/H-6767-2012; Mock, Hans-Peter/C-8202-2019; Khlestkina, Elena/T-2734-2017	Shoeva, Olesya/0000-0001-5289-8631; Mock, Hans-Peter/0000-0002-3983-3099; Khlestkina, Elena/0000-0002-8470-8254; Borner, Andreas/0000-0003-3301-9026	Russian Foundation for Basic Research [16-34-60052]; Institute of Cytology and Genetics SB RAS project [0324-2015-0005]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Institute of Cytology and Genetics SB RAS project	This work was supported by Russian Foundation for Basic Research (grant no. 16-34-60052, http://www.rfbr.ru/rffi/eng, OYuS) and Institute of Cytology and Genetics SB RAS project (No 0324-2015-0005, http://www.bionet.nsc.ru, EKK, TVK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASTRUP S, 1984, CARLSBERG RES COMMUN, V49, P105, DOI 10.1007/BF02913969; [Аджиева В.Ф. Adzhieva V.F.], 2015, [Вавиловский журнал генетики и селекции, Russian Journal of Genetics: Applied Research, Vavilovskii zhurnal genetiki i selektsii], V19, P561, DOI 10.18699/VJ15.073; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Choo TM, 2015, CROP SCI, V55, P1096, DOI 10.2135/cropsci2014.05.0405; Choo TM, 2005, GENET RESOUR CROP EV, V52, P121, DOI 10.1007/s10722-003-3086-4; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Christensen AB, 1998, PLANT MOL BIOL, V37, P849, DOI 10.1023/A:1006031822141; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Colmsee C, 2015, MOL PLANT, V8, P964, DOI 10.1016/j.molp.2015.03.009; CONE KC, 1993, PLANT CELL, V5, P1795, DOI 10.1105/tpc.5.12.1795; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DOONER HK, 1983, MOL GEN GENET, V189, P136, DOI 10.1007/BF00326066; Druka A, 2003, GENE, V302, P171, DOI 10.1016/S0378-1119(02)01105-8; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; FINCH RA, 1978, Z PFLANZENZUCHT, V81, P40; Franckowiak JD, 1997, BARLEY GENETICS NEWS, V26, P22; Garvin DF, 1998, CROP SCI, V38, P1250, DOI 10.2135/cropsci1998.0011183X003800050023x; Harlan HV, 1914, USDA B, P137, DOI [10.5962/bhl.title.109258, DOI 10.5962/BHL.TITLE.109258]; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Himi E, 2015, MOL GENET GENOMICS, V290, P1287, DOI 10.1007/s00438-015-0991-0; Himi E, 2012, EUPHYTICA, V188, P141, DOI 10.1007/s10681-011-0552-5; Honda C, 2002, PLANT PHYSIOL BIOCH, V40, P955, DOI 10.1016/S0981-9428(02)01454-7; Jana B.K., 2014, J PHARM BIOL, V4, P131; Jende-Strid B., 1984, Barley Genetics Newsletter, V14, P76; Jende-Strid B., 1978, Barley Genetics Newsletter, V8, P57; JENDESTRID B, 1993, HEREDITAS, V119, P187, DOI 10.1111/j.1601-5223.1993.00187.x; Jia QJ, 2016, EUPHYTICA, V208, P215, DOI 10.1007/s10681-015-1593-y; Khlestkina EK, 2013, CEREAL RES COMMUN, V41, P185, DOI 10.1556/CRC.2013.0004; Khlestkina EK, 2011, EUPHYTICA, V179, P333, DOI 10.1007/s10681-010-0337-2; Kim MJ, 2007, J AGR FOOD CHEM, V55, P4802, DOI 10.1021/jf0701943; KRISTIANSEN KN, 1991, MOL GEN GENET, V230, P49, DOI 10.1007/BF00290650; Lahaye T, 1998, THEOR APPL GENET, V97, P526, DOI 10.1007/s001220050927; Li JZ, 2003, THEOR APPL GENET, V107, P1021, DOI 10.1007/s00122-003-1345-6; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; MARTIN C, 1991, PLANT J, V1, P37, DOI 10.1111/j.1365-313X.1991.00037.x; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; MELDGAARD M, 1992, THEOR APPL GENET, V83, P695, DOI 10.1007/BF00226687; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Offerman J.D., 2003, INTRO BIOINFORMATICS, P345, DOI DOI 10.1007/978-1-59259-335-4; Pandey AK, 2001, CURR SCI INDIA, V80, P933; Pecchioni N, 1999, PLANT BREEDING, V118, P29, DOI 10.1046/j.1439-0523.1999.118001029.x; Petridis A, 2016, NEW PHYTOL, V211, P912, DOI 10.1111/nph.13986; Peukert M, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-97; PLASCHKE J, 1995, THEOR APPL GENET, V91, P1001, DOI 10.1007/BF00223912; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; Ramazzotti S, 2008, VITIS, V47, P147; Ramsay L, 2000, GENETICS, V156, P1997; Roder MS, 1998, GENETICS, V149, P2007; ROHDE W, 1991, PLANT MOL BIOL, V16, P1103, DOI 10.1007/BF00016087; Rohde W, 1987, BARLEY GENET, P553; Sakulsingharoj C, 2014, THAI J GENET, V7, P173, DOI 10.14456/tjg.2014.24; Sharma M, 2011, GENETICS, V188, P69, DOI 10.1534/genetics.110.126136; Shih CH, 2008, PLANTA, V228, P1043, DOI 10.1007/s00425-008-0806-1; Shoeva OY, 2015, PLANT BREEDING, V134, P400, DOI 10.1111/pbr.12277; Siebenhandl S, 2007, J AGR FOOD CHEM, V55, P8541, DOI 10.1021/jf072021j; Tarahovsky YS, 2013, FLAVONOIDS BIOCH BIO; Tereshchenko OY, 2013, J CEREAL SCI, V57, P10, DOI 10.1016/j.jcs.2012.09.010; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; WISE RP, 1990, PLANT MOL BIOL, V14, P277, DOI 10.1007/BF00018568; Xu ZS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0262-y; Yildiz M, 2013, THEOR APPL GENET, V126, P1689, DOI 10.1007/s00122-013-2084-y; Zhao ZC, 2012, MOL BIOL REP, V39, P6409, DOI 10.1007/s11033-011-1303-3	66	55	57	7	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163782	10.1371/journal.pone.0163782	http://dx.doi.org/10.1371/journal.pone.0163782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706214	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200060
J	Carlini, F; Ferreira, V; Buhler, S; Tous, A; Eliaou, JF; Rene, C; Chiaroni, J; Picard, C; Di Cristofaro, J				Carlini, Federico; Ferreira, Virginia; Buhler, Stephane; Tous, Audrey; Eliaou, Jean-Francois; Rene, Celine; Chiaroni, Jacques; Picard, Christophe; Di Cristofaro, Julie			Association of HLA-A and Non-Classical HLA Class I Alleles	PLOS ONE			English	Article							CELL-SURFACE; LINKAGE DISEQUILIBRIUM; OPEN CONFORMERS; GRAFT-SURVIVAL; NK CELLS; GENE; MHC; EXPRESSION; POLYMORPHISM; RECEPTORS	The HLA-A locus is surrounded by HLA class Ib genes: HLA-E, HLA-H, HLA-G and HLA-F. HLA class Ib molecules are involved in immuno-modulation with a central role for HLA-G and HLA-E, an emerging role for HLA-F and a yet unknown function for HLA-H. Thus, the principal objective of this study was to describe the main allelic associations between HLAA and HLA-H, -G, -F and -E. Therefore, HLA-A, -E, -G, -H and -F coding polymorphisms, as well as HLA-G UnTranslated Region haplotypes (referred to as HLA-G UTRs), were explored in 191 voluntary blood donors. Allelic frequencies, Global Linkage Disequilibrium (GLD), Linkage Disequilibrium (LD) for specific pairs of alleles and two-loci haplotype frequencies were estimated. We showed that HLA-A, HLA-H, HLA-F, HLA-G and HLA-G UTRs were all in highly significant pairwise GLD, in contrast to HLA-E. Moreover, HLA-A displayed restricted associations with HLA-G UTR and HLA-H. We also confirmed several associations that were previously found to have a negative impact on transplantation outcome. In summary, our results suggest complex functional and clinical implications of the HLA-A genetic region.	[Carlini, Federico; Tous, Audrey; Chiaroni, Jacques; Picard, Christophe; Di Cristofaro, Julie] Etab Francais Sang Alpes Mediterranee, Marseille, France; [Carlini, Federico; Ferreira, Virginia; Tous, Audrey; Chiaroni, Jacques; Picard, Christophe; Di Cristofaro, Julie] Aix Marseille Univ, CNRS, EFS, ADES,Biol Grp Sanguins, Marseille, France; [Buhler, Stephane] Univ Geneva, Lab Anthropol Genet & Peopling Hist AGP, Dept Genet, Geneva, Switzerland; [Buhler, Stephane] Univ Geneva, Evolut Anthropol Unit, Geneva, Switzerland; [Buhler, Stephane] Univ Hosp Geneva, Transplantat Immunol Unit, Geneva, Switzerland; [Buhler, Stephane] Univ Hosp Geneva, Natl Reference Lab Histocompatibil, Dept Genet & Lab Med, Geneva, Switzerland; [Eliaou, Jean-Francois; Rene, Celine] Univ Hosp St Eloi, CHRU Montpellier, Dept Immunol, Montpellier, France; [Eliaou, Jean-Francois; Rene, Celine] Univ Montpellier I, Fac Med, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite; University of Geneva; University of Geneva; University of Geneva; University of Geneva; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier	Di Cristofaro, J (corresponding author), Etab Francais Sang Alpes Mediterranee, Marseille, France.; Di Cristofaro, J (corresponding author), Aix Marseille Univ, CNRS, EFS, ADES,Biol Grp Sanguins, Marseille, France.	julie.dicristofaro@efs.sante.fr	Chiaroni, Jacques/ABA-2944-2021; Carlini, Federico/AAA-9050-2019	Chiaroni, Jacques/0000-0002-3133-8990; Carlini, Federico/0000-0003-3503-5169; Buhler, Stephane/0000-0001-6675-5287; Di Cristofaro, Julie/0000-0001-7867-6455				Agresti A, 2007, INTRO CATEGORICAL DA; Aldrich CL, 2001, MOL HUM REPROD, V7, P1167, DOI 10.1093/molehr/7.12.1167; Allan DSJ, 2002, J IMMUNOL METHODS, V268, P43, DOI 10.1016/S0022-1759(02)00199-0; Balan V, 2008, HEPATOLOGY, V48, P878, DOI 10.1002/hep.22435; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Boyson JE, 2002, P NATL ACAD SCI USA, V99, P16180, DOI 10.1073/pnas.212643199; BUCIN D, 1992, TRANSPLANT P, V24, P2473; Buhler S, 2010, TISSUE ANTIGENS, V75, P500, DOI 10.1111/j.1399-0039.2010.01469.x; Carlini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082517; Castelli EC, 2011, MOL BIOL EVOL, V28, P3069, DOI 10.1093/molbev/msr138; Comiskey M, 2007, HUM IMMUNOL, V68, P1, DOI 10.1016/j.humimm.2006.09.005; Di Cristofaro J, 2015, AM J TRANSPLANT, V15, P2413, DOI 10.1111/ajt.13305; Di Cristofaro J, 2013, HUM IMMUNOL, V74, P203, DOI 10.1016/j.humimm.2012.10.027; Donadi EA, 2011, CELL MOL LIFE SCI, V68, P369, DOI 10.1007/s00018-010-0580-7; ELKAHLOUN A, 1992, IMMUNOGENETICS, V35, P183; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Foroni I, 2014, HLA ASS IMPORTANT DI; GERAGHTY DE, 1992, J IMMUNOL, V149, P1934; GERAGHTY DE, 1987, P NATL ACAD SCI USA, V84, P9145, DOI 10.1073/pnas.84.24.9145; GERAGHTY DE, 1992, P NATL ACAD SCI USA, V89, P2669, DOI 10.1073/pnas.89.7.2669; GERAGHTY DE, 1992, HUM IMMUNOL, V33, P174, DOI 10.1016/0198-8859(92)90069-Y; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Goodridge JP, 2013, J IMMUNOL, V191, P1567, DOI 10.4049/jimmunol.1300080; Goodridge JP, 2010, J IMMUNOL, V184, P6199, DOI 10.4049/jimmunol.1000078; Grimsley C, 1998, MOL BIOL EVOL, V15, P1581, DOI 10.1093/oxfordjournals.molbev.a025886; Grimsley C, 1997, HUM IMMUNOL, V52, P33, DOI 10.1016/S0198-8859(96)00241-8; Hayes D, 2016, J HEART LUNG TRANSPL, V35, P186, DOI 10.1016/j.healun.2015.08.022; HEINRICHS H, 1990, IMMUNOL RES, V9, P265, DOI 10.1007/BF02935526; Jucaud V, 2016, CLIN EXP IMMUNOL, V183, P326, DOI 10.1111/cei.12724; Jucaud V RM, 2015, SOJ IMMUNOL, V3, P1, DOI [10.15226/2372-0948/3/4/00137, DOI 10.15226/2372-0948/3/4/00137]; Julie DC, 2011, TISSUE ANTIGENS, V77, P193, DOI 10.1111/j.1399-0039.2010.01599.x; Kamoun M, 2008, P NATL ACAD SCI USA, V105, P18883, DOI 10.1073/pnas.0810308105; Kochan G, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26491; Kolte AM, 2010, HUM IMMUNOL, V71, P482, DOI 10.1016/j.humimm.2010.02.001; Kraemer T, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/352160; Kuroki K, 2007, EUR J IMMUNOL, V37, P1727, DOI 10.1002/eji.200737515; Lee N, 2010, EUR J IMMUNOL, V40, P2308, DOI 10.1002/eji.201040348; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Maier S, 2000, HUM IMMUNOL, V61, P1059, DOI 10.1016/S0198-8859(00)00190-7; Makhadiyeva D, 2012, IMMUNOLOGY, V135, P133, DOI 10.1111/j.1365-2567.2011.03518.x; Misra MK, 2014, HUM IMMUNOL, V75, P833, DOI 10.1016/j.humimm.2014.06.005; Morandi F, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00394; Moreau P, 2008, BIOL REPROD, V79, P459, DOI 10.1095/biolreprod.108.068874; Nunes JM, 2014, TISSUE ANTIGENS, V83, P307, DOI 10.1111/tan.12356; Nunes JM, 2014, FIGSHARE; Nunes JM, 2015, EVOL BIOINFORM, V11, P19, DOI 10.4137/EBO.S32415; Ober C, 1996, J REPROD IMMUNOL, V32, P111, DOI 10.1016/S0165-0378(96)01000-5; Pabon MA, 2014, TRANSPL P, V46, P2957, DOI 10.1016/j.transproceed.2014.07.010; Pascolo S, 2005, INT IMMUNOL, V17, P117, DOI 10.1093/intimm/dxh191; Pratheek B M, 2014, Indian J Hum Genet, V20, P129, DOI 10.4103/0971-6866.142855; Ravindranath MH, 2013, BLOOD, V121, P2013, DOI 10.1182/blood-2012-08-447771; Rebmann V, 2001, TISSUE ANTIGENS, V57, P15, DOI 10.1034/j.1399-0039.2001.057001015.x; Rebmann V, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/297073; Riteau B, 2001, J IMMUNOL, V166, P5018, DOI 10.4049/jimmunol.166.8.5018; Rizzo R, 2013, MOL CELL BIOCHEM, V381, P243, DOI 10.1007/s11010-013-1708-5; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Roelen DL, 2001, HUM IMMUNOL, V62, P661, DOI 10.1016/S0198-8859(01)00263-4; SCHMIDT CM, 1991, HUM IMMUNOL, V31, P180, DOI 10.1016/0198-8859(91)90024-4; Shao WS, 2006, HUM IMMUNOL, V67, pS118, DOI 10.1016/j.humimm.2006.08.180; SHUKLA H, 1991, GENOMICS, V10, P905, DOI 10.1016/0888-7543(91)90178-H; Tamouza R, 2007, HUM IMMUNOL, V68, P849, DOI 10.1016/j.humimm.2007.08.260; Tan CY, 2008, MOL HUM REPROD, V14, P317, DOI 10.1093/molehr/gan013; Vargas RG, 2011, HUM IMMUNOL, V72, P479, DOI 10.1016/j.humimm.2011.02.011; Veiga-Castelli LC, 2012, TISSUE ANTIGENS, V79, P15, DOI 10.1111/j.1399-0039.2011.01801.x; Walpole NG, 2010, J MOL BIOL, V397, P467, DOI 10.1016/j.jmb.2010.01.052; ZEMMOUR J, 1990, J IMMUNOL, V144, P3619; Zhang WQ, 2014, HUM IMMUNOL, V75, P182, DOI 10.1016/j.humimm.2013.11.001; Zhao LM, 2014, CELL IMMUNOL, V287, P23, DOI 10.1016/j.cellimm.2013.11.005	69	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163570	10.1371/journal.pone.0163570	http://dx.doi.org/10.1371/journal.pone.0163570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701438	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900012
J	Huang, XD; Bai, RP; Jin, XK; Fu, HP				Huang, Xiangdong; Bai, Ruipeng; Jin, Xukang; Fu, Haipeng			Robust and Efficient Frequency Estimator for Undersampled Waveforms Based on Frequency Offset Recognition	PLOS ONE			English	Article							CHINESE REMAINDER THEOREM; ALGORITHM; REAL	This paper proposes an efficient frequency estimator based on Chinese Remainder Theorem for undersampled waveforms. Due to the emphasis on frequency offset recognition (i.e., frequency shift and compensation) of small-point DFT remainders, compared to estimators using large-point DFT remainders, it can achieve higher noise robustness in low signal-to-noise ratio (SNR) cases and higher accuracy in high SNR cases. Numerical results show that, by incorporating a remainder screening method and the Tsui spectrum corrector, the proposed estimator not only lowers the SNR threshold of detection, but also provides a higher accuracy than the large-point DFT estimator when the DFT size decreases to 1/90 of the latter case.	[Huang, Xiangdong; Bai, Ruipeng; Jin, Xukang; Fu, Haipeng] Tianjin Univ, Sch Elect Informat Engn, Tianjin, Peoples R China	Tianjin University	Fu, HP (corresponding author), Tianjin Univ, Sch Elect Informat Engn, Tianjin, Peoples R China.	hpfu@tju.edu..cn						Candan C, 2013, IEEE SIGNAL PROC LET, V20, P913, DOI 10.1109/LSP.2013.2273616; Goh VT, 2008, IEEE T COMMUN, V56, P325, DOI 10.1109/TCOMM.2008.050401; Li WC, 2013, IEEE T SIGNAL PROCES, V61, P1676, DOI 10.1109/TSP.2013.2238934; Li XW, 2009, IEEE T SIGNAL PROCES, V57, P4314, DOI 10.1109/TSP.2009.2025079; Li XW, 2008, IEEE SIGNAL PROC LET, V15, P665, DOI 10.1109/LSP.2008.2002926; TSUI J. B., 2004, DIGITAL TECHNIQUES W, V2a; Wang GY, 2004, IEEE T AERO ELEC SYS, V40, P345, DOI 10.1109/TAES.2004.1292173; Wang WJ, 2015, IEEE T SIGNAL PROCES, V63, P3317, DOI 10.1109/TSP.2015.2413378; Wang WJ, 2010, IEEE T SIGNAL PROCES, V58, P5655, DOI 10.1109/TSP.2010.2066974; Xia XG, 1999, IEEE T SIGNAL PROCES, V47, P3417, DOI 10.1109/78.806088; Xia XG, 2015, IEEE SIGNAL PROCESS, V22, P1055, DOI [10.1109/LSP.2014.2385086, DOI 10.1109/LSP.2014.2385086]; Xiao L, 2015, SIGNAL PROCESS, V117, P242, DOI 10.1016/j.sigpro.2015.05.017	13	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163871	10.1371/journal.pone.0163871	http://dx.doi.org/10.1371/journal.pone.0163871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701456	Green Published, Green Submitted, gold			2022-12-27	WOS:000385696900026
J	Moosa, MR; Maree, JD; Chirehwa, MT; Benatar, SR				Moosa, Mohammed Rafique; Maree, Jonathan David; Chirehwa, Maxwell T.; Benatar, Solomon R.			Use of the 'Accountability for Reasonableness' Approach to Improve Fairness in Accessing Dialysis in a Middle-Income Country	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; HEALTH-CARE; PATIENT SURVIVAL; GRAFT-SURVIVAL; LONG-TERM; TRANSPLANT RECIPIENTS; COST-EFFECTIVENESS; HIV; OUTCOMES	Universal access to renal replacement therapy is beyond the economic capability of most low and middle-income countries due to large patient numbers and the high recurrent cost of treating end stage kidney disease. In countries where limited access is available, no systems exist that allow for optimal use of the scarce dialysis facilities. We previously reported that using national guidelines to select patients for renal replacement therapy resulted in biased allocation. We reengineered selection guidelines using the 'Accountability for Reasonableness' (procedural fairness) framework in collaboration with relevant stakeholders, applying these in a novel way to categorize and prioritize patients in a unique hierarchical fashion. The guidelines were primarily premised on patients being transplantable. We examined whether the revised guidelines enhanced fairness of dialysis resource allocation. This is a descriptive study of 1101 end stage kidney failure patients presenting to a tertiary renal unit in a middle-income country, evaluated for dialysis treatment over a seven-year period. The Assessment Committee used the accountability for reasonableness-based guidelines to allocate patients to one of three assessment groups. Category 1 patients were guaranteed renal replacement therapy, Category 3 patients were palliated, and Category 2 were offered treatment if resources allowed. Only 25.2% of all end stage kidney disease patients assessed were accepted for renal replacement treatment. The majority of patients (48%) were allocated to Category 2. Of 134 Category 1 patients, 98% were accepted for treatment while 438 (99.5%) Category 3 patients were excluded. Compared with those palliated, patients accepted for dialysis treatment were almost 10 years younger, employed, married with children and not diabetic. Compared with our previous selection process our current method of priority setting based on procedural fairness arguably resulted in more equitable allocation of treatment but, more importantly, it is a model that is morally, legally and ethically more defensible.	[Moosa, Mohammed Rafique] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Med, Div Nephrol, Cape Town, South Africa; [Moosa, Mohammed Rafique; Maree, Jonathan David] Tygerberg Acad Hosp, Renal Unit, Cape Town, South Africa; [Chirehwa, Maxwell T.] Univ Stellenbosch, Fac Med & Hlth Sci, Dept Interdisciplinary Hlth Sci, Biostat Unit,Ctr Evidence Based Hlth Care, Cape Town, South Africa; [Benatar, Solomon R.] Univ Cape Town, Ctr Bioeth, Cape Town, South Africa	Stellenbosch University; Stellenbosch University; University of Cape Town	Moosa, MR (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Dept Med, Div Nephrol, Cape Town, South Africa.; Moosa, MR (corresponding author), Tygerberg Acad Hosp, Renal Unit, Cape Town, South Africa.	rmm@sun.ac.za	Chirehwa, Maxwell T/P-5740-2018	Chirehwa, Maxwell T/0000-0002-1685-4882; Moosa, Mohammed/0000-0003-1696-0113				Aalten J, 2006, TRANSPLANT INT, V19, P901, DOI 10.1111/j.1432-2277.2006.00367.x; Alexander S., 1962, LIFE, P102; Bamgboye Ebun L, 2009, Ethn Dis, V19, pS1; Barsoum RS, 2003, KIDNEY INT, V63, P111, DOI 10.1046/j.1523-1755.63.s83.23.x; Bass D, 2005, SAMJ S AFR MED J, V95, P42; Benatar S, 2006, CAMB Q HEALTHC ETHIC, V15, P322; Benatar SR, 2011, AM J PUBLIC HEALTH, V101, P646, DOI 10.2105/AJPH.2009.188458; Benatar SR, 2004, NEW ENGL J MED, V351, P81, DOI 10.1056/NEJMhpr033471; Benatar SR, 2015, REFERENCE MODULE BIO, DOI [10.1097/01.ASN.0000120370.35927.40, DOI 10.1097/01.ASN.0000120370.35927.40]; Byskov Jens, 2009, Health Res Policy Syst, V7, P23, DOI 10.1186/1478-4505-7-23; Callahan D., 1995, SETTING LIMITS MED G; Carson RC, 2009, CLIN J AM SOC NEPHRO, V4, P1611, DOI 10.2215/CJN.00510109; Cosio FG, 2008, AM J TRANSPLANT, V8, P593, DOI 10.1111/j.1600-6143.2007.02101.x; Cosio FG, 2002, KIDNEY INT, V62, P1440, DOI 10.1111/j.1523-1755.2002.kid582.x; Cosio FG, 1999, CLIN TRANSPLANT, V13, P336, DOI 10.1034/j.1399-0012.1999.130410.x; Curran SP, 2014, TRANSPLANTATION, V97, P64, DOI 10.1097/TP.0b013e3182a688a4; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Daniels N, 1998, HEALTH AFFAIR, V17, P50, DOI 10.1377/hlthaff.17.5.50; Daniels N., 2002, SETTING LIMITS FAIRL, DOI [10.1093/acprof:oso/9780195149364.001.0001, DOI 10.1093/ACPROF:OSO/9780195149364.001.0001]; Denhaerynck K, 2007, AM J TRANSPLANT, V7, P108, DOI 10.1111/j.1600-6143.2006.01611.x; Dogan E, 2005, NEPHROLOGY, V10, P516, DOI 10.1111/j.1440-1797.2005.00433.x; Eggers PW, 2011, CURR OPIN NEPHROL HY, V20, P241, DOI 10.1097/MNH.0b013e3283454319; Etheredge HR, 2013, CLIN TRANSPLANT, V27, P684, DOI 10.1111/ctr.12200; Fabrizii V, 2004, J AM SOC NEPHROL, V15, P1052, DOI 10.1097/01.ASN.0000120370.35927.40; Faravardeh A, 2013, TRANSPLANTATION, V96, P1089, DOI 10.1097/TP.0b013e3182a688e5; Gane E, 2002, TRANSPLANTATION, V74, P427, DOI 10.1097/00007890-200208270-00001; Garcia-Garcia G, 2005, KIDNEY INT, V68, pS58, DOI 10.1111/j.1523-1755.2005.09710.x; Gibson Jennifer, 2006, J Health Serv Res Policy, V11, P32, DOI 10.1258/135581906775094280; Gore JL, 2006, AM J TRANSPLANT, V6, P357, DOI 10.1111/j.1600-6143.2005.01198.x; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; HARNETT JD, 1987, TRANSPLANTATION, V44, P369, DOI 10.1097/00007890-198709000-00009; Hurst FP, 2011, TRANSPLANTATION, V92, P1101, DOI 10.1097/TP.0b013e3182336095; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kevany S, 2013, GLOB PUBLIC HEALTH, V8, P570, DOI 10.1080/17441692.2013.790461; Kher V, 2002, KIDNEY INT, V62, P350, DOI 10.1046/j.1523-1755.2002.00426.x; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Maluka S, 2010, SOC SCI MED, V71, P751, DOI 10.1016/j.socscimed.2010.04.035; Marckmann G, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00023; Martin D, 2003, HEALTH CARE ANAL, V11, P59, DOI 10.1023/A:1025338013629; Mayosi BM, 2014, NEW ENGL J MED, V371, P1344, DOI 10.1056/NEJMsr1405012; Moosa MR, 2006, KIDNEY INT, V70, P1107, DOI 10.1038/sj.ki.5001750; Moosa MR, 2016, SAMJ S AFR MED J, V106, P156, DOI [10.7196/SAMJ.2016.v106i2.9928, 10.7196/SAMJ.2016.V106I2.9928]; Moosa M. R., 2014, KIDNEY TRANSPLANTATI, P643; Moosa MR, 2003, SAMJ S AFR MED J, V93, P689; Moosa MR, 2013, GUIDELINE PRIORITY S; Muller E, 2010, NEW ENGL J MED, V362, P2336, DOI 10.1056/NEJMc0900837; Murphy D, 2016, ANN INTERN MED, V165, P473, DOI 10.7326/M16-0273; Naicker S, 2005, KIDNEY DIS DEV WORLD, P137, DOI [10.1201/b14128-8, DOI 10.1201/B14128-8]; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Norheim OF, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0624-4; Norheim OF, 2014, COST EFFECT RESOUR A, V12, DOI 10.1186/1478-7547-12-18; Norman Daniels, 1988, AM MY PARENTS KEEPER; Nugent RA, 2011, NEPHRON CLIN PRACT, V118, pC269, DOI 10.1159/000321382; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Revanur VK, 2001, CLIN TRANSPLANT, V15, P89, DOI 10.1034/j.1399-0012.2001.150202.x; Roland ME, 2008, AM J TRANSPLANT, V8, P355, DOI 10.1111/j.1600-6143.2007.02061.x; Rutecki GW., 2016, ETHIC MED, V27, P99; Sakhuja V, 2003, KIDNEY INT, V63, P115, DOI 10.1046/j.1523-1755.63.s83.24.x; Sakhuja Vinay, 2006, Ethn Dis, V16, pS2; Saudan P, 2001, NEPHROL DIAL TRANSPL, V16, P824, DOI 10.1093/ndt/16.4.824; Scheper-Hughes N, 2003, LANCET, V361, P1645, DOI 10.1016/S0140-6736(03)13305-3; Shaheen FAM, 2005, KIDNEY INT, V68, pS37, DOI 10.1111/j.1523-1755.2005.09807.x; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Stock PG, 2010, NEW ENGL J MED, V363, P2004, DOI 10.1056/NEJMoa1001197; United States Renal Data System, 2015, USRDS ANN DAT REP EP; Vachharajani TJ, 2014, NAT REV NEPHROL, V10, P116, DOI 10.1038/nrneph.2013.256; White SL, 2008, B WORLD HEALTH ORGAN, V86, P229, DOI 10.2471/BLT.07.041715; Williams A, 1997, BRIT MED J, V314, P820, DOI 10.1136/bmj.314.7083.820; Yap DYH, 2014, WORLD J GASTROENTERO, V20, P468, DOI 10.3748/wjg.v20.i2.468; Yap DYH, 2010, TRANSPLANTATION, V90, P325, DOI 10.1097/TP.0b013e3181e5b811	70	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164201	10.1371/journal.pone.0164201	http://dx.doi.org/10.1371/journal.pone.0164201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701466	Green Published, gold			2022-12-27	WOS:000385696900049
J	Sanchez-Taltavull, D; Ramachandran, P; Lau, N; Perkins, TJ				Sanchez-Taltavull, Daniel; Ramachandran, Parameswaran; Lau, Nelson; Perkins, Theodore J.			Bayesian Correlation Analysis for Sequence Count Data	PLOS ONE			English	Article							EXPRESSION; CANCER	Evaluating the similarity of different measured variables is a fundamental task of statistics, and a key part of many bioinformatics algorithms. Here we propose a Bayesian scheme for estimating the correlation between different entities' measurements based on high-throughput sequencing data. These entities could be different genes or miRNAs whose expression is measured by RNA-seq, different transcription factors or histone marks whose expression is measured by ChIP-seq, or even combinations of different types of entities. Our Bayesian formulation accounts for both measured signal levels and uncertainty in those levels, due to varying sequencing depth in different experiments and to varying absolute levels of individual entities, both of which affect the precision of the measurements. In comparison with a traditional Pearson correlation analysis, we show that our Bayesian correlation analysis retains high correlations when measurement confidence is high, but suppresses correlations when measurement confidence is low D especially for entities with low signal levels. In addition, we consider the influence of priors on the Bayesian correlation estimate. Perhaps surprisingly, we show that naive, uniform priors on entities' signal levels can lead to highly biased correlation estimates, particularly when different experiments have widely varying sequencing depths. However, we propose two alternative priors that provably mitigate this problem. We also prove that, like traditional Pearson correlation, our Bayesian correlation calculation constitutes a kernel in the machine learning sense, and thus can be used as a similarity measure in any kernel-based machine learning algorithm. We demonstrate our approach on two RNA-seq datasets and one miRNA-seq dataset.	[Sanchez-Taltavull, Daniel; Ramachandran, Parameswaran; Lau, Nelson; Perkins, Theodore J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Sanchez-Taltavull, Daniel; Ramachandran, Parameswaran; Perkins, Theodore J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Perkins, TJ (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON, Canada.; Perkins, TJ (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	tperkins@ohri.ca		Sanchez-Taltavull, Daniel/0000-0002-4944-0360; Perkins, Theodore J./0000-0002-6622-8003				Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bishop C. M, 2006, PATTERN RECOGNITION; Butte A J, 2000, Pac Symp Biocomput, P418; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frazee AC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-449; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Scholkopf B., 2004, KERNEL METHODS COMPU; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi LH, 2014, HUM MOL GENET, V23, P4528, DOI 10.1093/hmg/ddu167; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163595	10.1371/journal.pone.0163595	http://dx.doi.org/10.1371/journal.pone.0163595			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701449	Green Published, Green Submitted, gold			2022-12-27	WOS:000385696900013
J	Gagliardi, AR; Ducey, A; Lehoux, P; Rosso, S; Trbovich, P; Easty, A; Bells, C; Takata, J; Pabinger, C; Urbach, DR				Gagliardi, Anna R.; Ducey, Ariel; Lehoux, Pascale; Rosso, Sue; Trbovich, Patricia; Easty, Anthony; Bells, Chaim; Takata, Julie; Pabinger, Christof; Urbach, David R.			Meta-Review of the Quantity and Quality of Evidence for Knee Arthroplasty Devices	PLOS ONE			English	Review							IMPLANTS; HIP	Introduction Some cardiovascular devices are licensed based on limited evidence, potentially exposing patients to devices that are not safe or effective. Research is needed to ascertain if the same is true of other types of medical devices. Knee arthroplasty is a widely-used surgical procedure yet implant failures are not uncommon. The purpose of this study was to characterize available evidence on the safety and effectiveness of knee implants. Methods A review of primary studies included in health technology assessments (HTA) on total (TKA) and unicompartmental knee arthroplasty (UKA) was conducted. MEDLINE, EMBASE, CINAHL, Cochrane Library and Biotechnology & BioEngineering Abstracts were searched from 2005 to 2014, plus journal tables of contents and 32 HTA web sites. Patients were aged 18 and older who underwent primary TKA or UKA assessed in cohort or randomized controlled studies. Summary statistics were used to report study characteristics. Results A total of 265 eligible primary studies published between 1986 and 2014 involving 59,217 patients were identified in 10 HTAs (2 low, 7 moderate, 1 high risk of bias). Most evaluated TKA (198, 74.5%). The quality of evidence in primary studies was limited. Most studies were industry-funded (23.8%) or offered no declaration of funding or conflict of interest (44.9%); based on uncontrolled single cohorts (58.5%), enrolled fewer than 100 patients (66.4%), and followed patients for 2 years or less (UKA: single cohort 29.8%, comparative cohort 16.7%, randomized trial 25.0%; TKA: single cohort 25.0%, comparative cohort 31.4%, randomized trial 48.6%). Furthermore, most devices were evaluated in only one study (55.3% TKA implants, 61.1% UKA implants). Conclusions Patients, physicians, hospitals and payers rely on poor-quality evidence to support decisions about knee implants. Further research is needed to explore how decisions about the use of devices are currently made, and how the evidence base for device safety and effectiveness can be strengthened.	[Gagliardi, Anna R.; Trbovich, Patricia; Takata, Julie; Urbach, David R.] Univ Hlth Network, Toronto, ON, Canada; [Ducey, Ariel] Univ Calgary, Calgary, AB, Canada; [Lehoux, Pascale] Univ Montreal, Montreal, PQ, Canada; [Rosso, Sue] Univ Alberta, Edmonton, AB, Canada; [Easty, Anthony] Univ Toronto, Toronto, ON, Canada; [Bells, Chaim] Mt Sinai Hosp, Toronto, ON, Canada; [Pabinger, Christof] Med Univ Innsbruck, Innsbruck, Austria	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Calgary; Universite de Montreal; University of Alberta; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Medical University of Innsbruck	Gagliardi, AR (corresponding author), Univ Hlth Network, Toronto, ON, Canada.	anna.gaglardi@uhnresearch.ca	Lehoux, Pascale/Q-6370-2019; Lehoux, Pascale/M-9363-2013	Lehoux, Pascale/0000-0001-9482-1800; Lehoux, Pascale/0000-0001-9482-1800; Pabinger, Christof/0000-0003-4622-9399	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (www.cihr.ca). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CADTH, 2013, KNEE IMPL SYST REV C; Cerbo M, 2009, PROSTHESES PRIMARY T; Danjoux NM, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-182; Ethgen O, 2004, J BONE JOINT SURG AM; Griffin T, 2005, 44 ROYAL AUSTR COLL; Hofstede SN, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003130.pub3; Kane RL, 2003, AHRQ PUBLICATION; Kim SJ, 2014, KNEE SURG SPORT TR A, V22, P1895, DOI 10.1007/s00167-013-2644-3; Kramer DB, 2010, AM J THER, V17, P2, DOI 10.1097/MJT.0b013e3181ca8105; Langton DJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-007847; Lehoux P, 2008, J HEALTH SERV RES PO, V13, P251, DOI 10.1258/jhsrp.2008.007173; Maisel WH, 2004, ANN INTERN MED, V140, P296, DOI 10.7326/0003-4819-140-4-200402170-00012; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Medical Advisory Secretariat, 2005, TOT KNEE REPL EV BAS; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nieuwenhuijse MJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5133; Pabinger C, 2013, OSTEOARTHR CARTILAGE, V21, P263, DOI 10.1016/j.joca.2012.11.014; Pabinger C, 2015, ACTA ORTHOP, V86, P58, DOI 10.3109/17453674.2014.961119; Rathi VK, 2015, JAMA-J AM MED ASSOC, V314, P604, DOI 10.1001/jama.2015.8761; Ross S, 2015, HEALTH POLICY TECHN, V4, P168, DOI 10.1016/j.hlpt.2015.02.008; Sharma R, 2011, J BONE JOINT SURG AM, V93A, P2304, DOI [10.2106/JBJSJ.01289, 10.2106/JBJS.J.01289]; Shea BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001350; Skou ST, 2015, NEW ENGL J MED, V373, P1597, DOI 10.1056/NEJMoa1505467; Smith TO, 2009, ORTHOP TRAUMATOL-SUR, V95, P599, DOI 10.1016/j.otsr.2009.10.006; Wilson NA, 2008, HEALTH AFFAIR, V27, P1587, DOI 10.1377/hlthaff.27.6.1587; World Health Organization, 2011, WHO HLTH TECHN ASS M	26	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163032	10.1371/journal.pone.0163032	http://dx.doi.org/10.1371/journal.pone.0163032			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695077	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100021
J	Poole, D; Cortegiani, A; Chieregato, A; Russo, E; Pellegrini, C; De Blasio, E; Mengoli, F; Volpi, A; Grossi, S; Gianesello, L; Orzalesi, V; Fossi, F; Chiara, O; Coniglio, C; Gordini, G				Poole, Daniele; Cortegiani, Andrea; Chieregato, Arturo; Russo, Emanuele; Pellegrini, Concetta; De Blasio, Elvio; Mengoli, Francesca; Volpi, Annalisa; Grossi, Silvia; Gianesello, Lara; Orzalesi, Vanni; Fossi, Francesca; Chiara, Osvaldo; Coniglio, Carlo; Gordini, Giovanni		Trauma Update Working Grp	Blood Component Therapy and Coagulopathy in Trauma: A Systematic Review of the Literature from the Trauma Update Group	PLOS ONE			English	Review							FRESH-FROZEN PLASMA; LOGISTIC-REGRESSION; TRANSFUSION; MORTALITY; MODELS; QUALITY; RATIOS; MULTICENTER; STATISTICS; PLATELETS	Background Traumatic coagulopathy is thought to increase mortality and its treatment to reduce preventable deaths. However, there is still uncertainty in this field, and available literature results may have been overestimated. Methods We searched the MEDLINE database using the PubMed platform. We formulated four queries investigating the prognostic weight of traumatic coagulopathy defined according to conventional laboratory testing, and the effectiveness in reducing mortality of three different treatments aimed at contrasting coagulopathy (high fresh frozen plasma/packed red blood cells ratios, fibrinogen, and tranexamic acid administration). Randomized controlled trials were selected along with observational studies that used a multivariable approach to adjust for confounding. Strict criteria were adopted for quality assessment based on a two-step approach. First, we rated quality of evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria. Then, this rating was downgraded if other three criteria were not met: high reporting quality according to shared standards, absence of internal methodological and statistical issues not detailed by the GRADE system, and absence of external validity issues. Results With few exceptions, the GRADE rating, reporting and methodological quality of observational studies was "very low", with frequent external validity issues. The only two randomized trials retrieved were, instead, of high quality. Only weak evidence was found for a relation between coagulopathy and mortality. Very weak evidence was found supporting the use of fibrinogen administration to reduce mortality in trauma. On the other hand, we found high evidence that the use of 1: 1 vs. 1: 2 high fresh frozen plasma/packed red blood cells ratios failed to obtain a 12% mortality reduction. This does not exclude lower mortality rates, which have not been investigated. The use of tranexamic acid in trauma was supported by "high" quality evidence according to the GRADE classification but was downgraded to "moderate" for external validity issues. Conclusions Tranexamic acid is effective in reducing mortality in trauma. The other transfusion practices we investigated have been inadequately studied in the literature, as well as the independent association between mortality and coagulopathy measured with traditional laboratory testing. Overall, in this field of research literature quality is poor.	[Poole, Daniele] San Martino Hosp, Anesthesia & Intens Care Operat Unit, Belluno, Italy; [Cortegiani, Andrea] Univ Palermo, Sect Anesthesia Analgesia Intens Care & Emergency, Policlin P Giaccone, Dept Biopathol & Med Biotechnol DIBIMED, Palermo, Italy; [Chieregato, Arturo; Fossi, Francesca] ASST Great Metropolitan Niguarda Hosp, Neurointens Care Unit, Milan, Italy; [Russo, Emanuele] Bufalini Hosp, Surg & Severe Trauma Dept, Anaesthesia & Intens Care Unit, Cesena, Italy; [Pellegrini, Concetta; De Blasio, Elvio] AO Rummo, Anesthesia & Intens Care, Benevento, Italy; [Mengoli, Francesca; Coniglio, Carlo; Gordini, Giovanni] Maggiore Hosp, UOC Intens Care & Terr Emergency Dept, Bologna, Italy; [Volpi, Annalisa; Grossi, Silvia] AOU Parma, Anesthesia & Intens Care, Parma, Italy; [Gianesello, Lara] AOU Careggi, Dept Struct Anesthesia & Intens Care Orthoped Sur, Florence, Italy; [Orzalesi, Vanni] AOU Careggi, CTO, Neuroanesthesia & Neurointens Care, Florence, Italy; [Chiara, Osvaldo] ASST Great Metropolitan Niguarda Hosp, Trauma Ctr Dept, Milan, Italy	ULSS 1 Dolomiti; Ospedale di Belluno; University of Palermo; AUSL di Bologna; University of Parma; University Hospital of Parma; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi	Poole, D (corresponding author), San Martino Hosp, Anesthesia & Intens Care Operat Unit, Belluno, Italy.	daniele.poole@alice.it	Cortegiani, Andrea/H-4902-2016; Gordini, Giovanni/AAB-8170-2022; Volpi, Annalisa/AHH-5394-2022; Russo, Emanuele/AAP-5645-2020; Coniglio, Carlo/AAB-7128-2022; Poole, Daniele/X-7210-2019; chiara, osvaldo/R-6151-2018	Cortegiani, Andrea/0000-0003-1416-9993; Gordini, Giovanni/0000-0003-4518-0204; Volpi, Annalisa/0000-0001-5337-9155; Russo, Emanuele/0000-0002-6531-5527; Coniglio, Carlo/0000-0002-8207-0525; Poole, Daniele/0000-0001-5279-9844; chiara, osvaldo/0000-0003-2409-2109; Sanson, Gianfranco/0000-0001-8319-635X				ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Austin PC, 2004, J CLIN EPIDEMIOL, V57, P1138, DOI 10.1016/j.jclinepi.2004.04.003; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Bagley SC, 2001, J CLIN EPIDEMIOL, V54, P979, DOI 10.1016/S0895-4356(01)00372-9; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Borgman MA, 2011, VOX SANG, V101, P44, DOI 10.1111/j.1423-0410.2011.01466.x; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Cap A, 2014, CURR OPIN CRIT CARE, V20, P638, DOI 10.1097/MCC.0000000000000158; Collins GS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-103; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hagemo JS, 2014, CRIT CARE, V18, DOI 10.1186/cc13798; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Holcomb JB, 2011, J TRAUMA, V71, pS318, DOI 10.1097/TA.0b013e318227edbb; Hunt BJ, 2015, BRIT J HAEMATOL, V170, P788, DOI 10.1111/bjh.13580; Inaba K, 2010, J AM COLL SURGEONS, V210, P957, DOI 10.1016/j.jamcollsurg.2010.01.031; Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410; Ioannidis JPA, 2016, J CLIN EPIDEMIOL, V73, P82, DOI 10.1016/j.jclinepi.2016.02.012; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Katz MH, 2003, ANN INTERN MED, V138, P644, DOI 10.7326/0003-4819-138-8-200304150-00012; LACHIN JM, 1981, CONTROL CLIN TRIALS, V2, P93, DOI 10.1016/0197-2456(81)90001-5; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Mallett S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-20; Mitra B, 2010, INJURY, V41, P35, DOI 10.1016/j.injury.2009.09.029; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moss M, 2003, CHEST, V123, P923, DOI 10.1378/chest.123.3.923; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Pham HP, 2013, BRIT J ANAESTH, V111, P71, DOI 10.1093/bja/aet376; Poole D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113676; Poole D, 2014, INTENS CARE MED, V40, P1927, DOI 10.1007/s00134-014-3510-6; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; Sambasivan CN, 2011, J TRAUMA, V71, pS329, DOI 10.1097/TA.0b013e318227edd3; Scalea TM, 2008, ANN SURG, V248, P578, DOI 10.1097/SLA.0b013e31818990ed; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Stinger HK, 2008, J TRAUMA, V64, pS79, DOI 10.1097/TA.0b013e318160a57b; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Sylvestre MP, 2006, ANN INTERN MED, V145, P361, DOI 10.7326/0003-4819-145-5-200609050-00009; Teixeira PGR, 2009, J TRAUMA, V66, P693, DOI 10.1097/TA.0b013e31817e5c77; Theusinger OM, 2014, CURR OPIN CRIT CARE, V20, P646, DOI 10.1097/MCC.0000000000000152; Wafaisade A, 2011, J TRAUMA, V70, P81, DOI 10.1097/TA.0b013e3182032e0b; World Health Organization, 2015, GLOB STAT REP ROAD S	45	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164090	10.1371/journal.pone.0164090	http://dx.doi.org/10.1371/journal.pone.0164090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695109	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100088
J	Sha, JP; Dong, W; Liu, SL; Chen, XW; Zhao, N; Luo, MY; Dong, YY; Zhang, ZR				Sha, Jianping; Dong, Wei; Liu, Shelan; Chen, Xiaowen; Zhao, Na; Luo, Mengyun; Dong, Yuanyuan; Zhang, Zhiruo			Differences in the Epidemiology of Childhood Infections with Avian Influenza A H7N9 and H5N1 Viruses	PLOS ONE			English	Article							TO-PERSON TRANSMISSION; RISK-FACTORS; ZHEJIANG PROVINCE; A(H7N9); CHINA; CHILDREN; MILD; CLUSTERS; A/H7N9; MARKET	The difference between childhood infections with avian influenza viruses A(H5N1) and A (H7N9) remains an unresolved but critically important question. We compared the epidemiological characteristics of 244 H5N1 and 41 H7N9 childhood cases (<15 years old), as well as the childhood cluster cases of the two viruses. Our findings revealed a higher proportion of H5N1 than H7N9 childhood infections (31.1% vs. 6.4%, p = 0.000). However, the two groups did not differ significantly in age (median age: 5.0 vs. 5.5 y, p = 0.0651). The proportion of clustered cases was significantly greater among children infected with H5N1 than among children infected with H7N9 [46.7% (71/152) vs. 23.6% (13/55), p = 0.005], and most of the childhood cases were identified as secondary cases [46.4% (45/97) vs. 33.3% (10/30), p = 0.000]. Mild status accounted for 79.49% and 22.66%, severe status for 17.95% and 2.34%, and fatal cases for 2.56% and 75.00% of the H7N9 and H5N1 childhood infection cases (all p<0.05), respectively. The fatality rates for the total, index and secondary childhood cluster cases were 52.86% (37/70), 88.5% (23/26) and 33.33% (15/45), respectively, in the H5N1 group, whereas no fatal H7N9 childhood cluster cases were identified. In conclusion, lower severity and greater transmission were found in the H7N9 childhood cases than in the H5N1 childhood cases.	[Sha, Jianping] Chinese Peoples Liberat Army, Hosp 421, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [Dong, Wei; Luo, Mengyun; Dong, Yuanyuan; Zhang, Zhiruo] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai, Peoples R China; [Liu, Shelan] Zhejiang Prov Ctr Dis Control & Prevent, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Chen, Xiaowen] 421 Hosp Chinese Peoples Liberat Army, Dept Senior Cadres, Guangzhou, Guangdong, Peoples R China; [Zhao, Na] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Natl Res Ctr Wildlife Born Dis, Beijing, Peoples R China	Shanghai Jiao Tong University; Zhejiang Provincial Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Zoology, CAS	Zhang, ZR (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai, Peoples R China.	zhangzhiruo@sjtu.edu.cn		Luo, Mengyun/0000-0002-6482-7299	Key Program grant from the Science Technology Department of Zhejiang Province in China [2014C03039]; Zhejiang Provincial Health, and Family Planning Commission; Anhui Province of International Science and Technology Cooperation Program [1503062008]	Key Program grant from the Science Technology Department of Zhejiang Province in China; Zhejiang Provincial Health, and Family Planning Commission; Anhui Province of International Science and Technology Cooperation Program	This research was supported by the Key Program grant from the Science Technology Department of Zhejiang Province in China (grant numbers 2014C03039); epidemiology supporting grant from Zhejiang Provincial Health, and Family Planning Commission; and the Anhui Province of International Science and Technology Cooperation Program (grant number 1503062008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a Key Program grant from the Science Technology Department of Zhejiang Province in China (grant numbers 2014C03039), an epidemiology supporting grant from Zhejiang Provincial Health and Family Planning Commission, and the Anhui Province of International Science and Technology Cooperation Program (grant number 1503062008).	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Areechokchai D, 2006, GLOBAL EPIDEMIOLOGY, V55, P3; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Centers for Disease Control and Prevention (CDC), 2010, MMWR MORBIDITY MORTA, V59; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Chen ZQ, 2014, EMERG INFECT DIS, V20, P1535, DOI 10.3201/eid2009.140424; Chowell G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-214; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Ding H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0698-6; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Jernigan DB, 2015, ANNU REV MED, V66, P361, DOI 10.1146/annurev-med-010714-112311; Jie ZJ, 2013, AM J RESP CRIT CARE, V188, P114, DOI 10.1164/rccm.201304-0797LE; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kawachi S, 2009, J INFECT DIS, V200, P510, DOI 10.1086/605034; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu B, 2014, CLIN INFECT DIS, V59, P787, DOI 10.1093/cid/ciu423; Liu SL, 2013, J INFECTION, V67, P595, DOI 10.1016/j.jinf.2013.08.007; Liu YS, 2015, J INFECT DEV COUNTR, V9, P122, DOI 10.3855/jidc.6759; Ma MJ, 2014, J CLIN VIROL, V59, P242, DOI 10.1016/j.jcv.2014.01.009; Mei Z, 2013, EMERG INFECT DIS, V19, P1179, DOI 10.3201/eid1907.130523; Nicoll A, 2008, ARCH DIS CHILD, V93, P433, DOI 10.1136/adc.2006.101477; Oner AF, 2012, CLIN INFECT DIS, V55, P26, DOI 10.1093/cid/cis295; Parry J, 2004, BRIT MED J, V328, P308, DOI 10.1136/bmj.328.7435.308; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Qin Y, 2015, CLIN INFECT DIS, V61, P563, DOI 10.1093/cid/civ345; Rudge JW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4730; Tang RB, 2013, J CHIN MED ASSOC, V76, P245, DOI 10.1016/j.jcma.2013.04.003; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; Wang C, 2014, CLIN INFECT DIS, V58, P1095, DOI 10.1093/cid/ciu053; Wang CM, 2014, J INFECT DIS, V209, P34, DOI 10.1093/infdis/jit478; Wang XH, 2014, INTERNATIONAL CONFERENCE ON ELECTRICAL, CONTROL AND AUTOMATION (ICECA 2014), P8; World Health Organization, 2014, HUM INF AV INFL A H7; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Yi LN, 2015, J CLIN MICROBIOL, V53, P22, DOI 10.1128/JCM.02322-14; Yu HJ, 2014, LANCET, V383, P541, DOI 10.1016/S0140-6736(13)61904-2; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Yu XL, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.41; Yupiana Y, 2010, INT J INFECT DIS, V14, pE800, DOI 10.1016/j.ijid.2010.03.014; Zeng XQ, 2015, PEDIATR INFECT DIS J, V34, P104, DOI 10.1097/INF.0000000000000492; Zhang Y, 2015, INT J ENV RES PUB HE, V12, P816, DOI 10.3390/ijerph120100816; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	46	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0161925	10.1371/journal.pone.0161925	http://dx.doi.org/10.1371/journal.pone.0161925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695069	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100009
J	Yli-Huumo, J; Ko, D; Choi, S; Park, S; Smolander, K				Yli-Huumo, Jesse; Ko, Deokyoon; Choi, Sujin; Park, Sooyong; Smolander, Kari			Where Is Current Research on Blockchain Technology?-A Systematic Review	PLOS ONE			English	Review								Blockchain is a decentralized transaction and data management technology developed first for Bitcoin cryptocurrency. The interest in Blockchain technology has been increasing since the idea was coined in 2008. The reason for the interest in Blockchain is its central attributes that provide security, anonymity and data integrity without any third party organization in control of the transactions, and therefore it creates interesting research areas, especially from the perspective of technical challenges and limitations. In this research, we have conducted a systematic mapping study with the goal of collecting all relevant research on Blockchain technology. Our objective is to understand the current research topics, challenges and future directions regarding Blockchain technology from the technical perspective. We have extracted 41 primary papers from scientific databases. The results show that focus in over 80% of the papers is on Bitcoin system and less than 20% deals with other Blockchain applications including e.g. smart contracts and licensing. The majority of research is focusing on revealing and improving limitations of Blockchain from privacy and security perspectives, but many of the proposed solutions lack concrete evaluation on their effectiveness. Many other Blockchain scalability related challenges including throughput and latency have been left unstudied. On the basis of this study, recommendations on future research directions are provided for researchers.	[Yli-Huumo, Jesse] Lappeenranta Univ Technol, Dept Innovat & Software, Lappeenranta, Finland; [Ko, Deokyoon; Park, Sooyong] Sogang Univ, Dept Comp Sci Engn, Seoul, South Korea; [Smolander, Kari] Aalto Univ, Dept Comp Sci, Helsinki, Finland; [Choi, Sujin] Sogang Univ, Sogang Inst Adv Technol, Seoul, South Korea	Lappeenranta University of Technology; Sogang University; Aalto University; Sogang University	Choi, S (corresponding author), Sogang Univ, Sogang Inst Adv Technol, Seoul, South Korea.	sujinchoi@sogang.ac.kr	Sánchez-Gómez, Nicolás/K-3758-2014	Choi, Sujin/0000-0001-7684-3387; Yli-Huumo, Jesse/0000-0003-2882-7088				Ali ST, 2015, LECT NOTES COMPUT SC, V8976, P34, DOI 10.1007/978-3-662-48051-9_3; Androulaki Elli, 2014, Trust and Trustworthy Computing. 7th International Conference, TRUST 2014. Proceedings: LNCS 8564, P161, DOI 10.1007/978-3-319-08593-7_11; Andrychowicz M, 2015, LECT NOTES COMPUT SC, V8976, P1, DOI 10.1007/978-3-662-48051-9_1; Andrychowicz M, 2015, LECT NOTES COMPUT SC, V9216, P379, DOI 10.1007/978-3-662-48000-7_19; [Anonymous], 2008, INFORM SOFTWARE TECH, V50, P833; Armknecht F, 2015, LECT NOTES COMPUT SC, V9229, P163, DOI 10.1007/978-3-319-22846-4_10; Ateniese G, 2014, LECT NOTES COMPUT SC, V8479, P80, DOI 10.1007/978-3-319-07536-5_6; Autonomous Spontaneous Security and Security Assurance, 2015, LECT NOTES COMPUTER, V8872, P3; Bamert T, 2014, LECT NOTES COMPUT SC, V8743, P65, DOI 10.1007/978-3-319-11851-2_5; Barkatullah J, 2015, IEEE MICRO, V35, P68, DOI 10.1109/MM.2015.13; Beikverdi A., 2015, P EN 2015 IEEE ACIS, P1; Bigi G, 2015, LECT NOTES COMPUT SC, V9465, P142, DOI 10.1007/978-3-319-25527-9_11; Bos JW, 2014, LECT NOTES COMPUT SC, V8437, P157, DOI 10.1007/978-3-662-45472-5_11; Butun I, 2016, IEEE COMMUN MAG, V54, P47, DOI 10.1109/MCOM.2016.7452265; Cordeschi N, 2015, VEH COMMUN, V2, P1, DOI 10.1016/j.vehcom.2014.08.004; Decker C, 2015, LECT NOTES COMPUT SC, V9327, P561, DOI 10.1007/978-3-319-24177-7_28; Decker C, 2014, LECT NOTES COMPUT SC, V8713, P313, DOI 10.1007/978-3-319-11212-1_18; Dev Jega Anish, 2014, EL COMP ENG CCECE 20, P1, DOI DOI 10.1109/CCECE.2014.6900989; Di Battista G., 2015, VIS CYB SEC VIZSEC 2, P1, DOI DOI 10.1109/VIZSEC.2015.7312773; Eyal I, 2014, LECT NOTES COMPUT SC, V8437, P436, DOI 10.1007/978-3-662-45472-5_28; Feld S, 2014, PROCEDIA COMPUT SCI, V32, P1121, DOI 10.1016/j.procs.2014.05.542; Fernandez A, 2011, INFORM SOFTWARE TECH, V53, P789, DOI 10.1016/j.infsof.2011.02.007; Garay J, 2015, LECT NOTES COMPUT SC, V9057, P281, DOI 10.1007/978-3-662-46803-6_10; Herrera-Joancomarti J, 2015, LECT NOTES COMPUT SC, V8872, P3, DOI 10.1007/978-3-319-17016-9_1; Housley R., 2004, PUBLIC KEY INFRASTRU; Kishigami J, 2015, PROCEEDINGS 2015 IEEE FIFTH INTERNATIONAL CONFERENCE ON BIG DATA AND CLOUD COMPUTING BDCLOUD 2015, P187, DOI 10.1109/BDCloud.2015.60; Kitchenham B., 2007, GUIDELINES PERFORMIN; Kondor D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086197; Koshy P, 2014, LECT NOTES COMPUT SC, V8437, P469, DOI 10.1007/978-3-662-45472-5_30; Lim IK, 2014, LECT NOTES COMPUT SC, V8582, P720, DOI 10.1007/978-3-319-09147-1_52; Luu L, 2015, CCS'15: PROCEEDINGS OF THE 22ND ACM SIGSAC CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P706, DOI 10.1145/2810103.2813659; Mann C, 2015, LECT NOTES COMPUT SC, V9331, P155, DOI 10.1007/978-3-319-24858-5_10; Meiklejohn S, 2015, LECT NOTES COMPUT SC, V8976, P127, DOI 10.1007/978-3-662-48051-9_10; Moser M., 2013, P 2013 APWG ECRIME R, P1, DOI DOI 10.1109/ECRS.2013.6805780; Nakamoto S., 2008, CONSULTED, V2008, P21260; Paul G, 2014, LECT NOTES COMPUT SC, V8880, P185, DOI 10.1007/978-3-319-13841-1_11; Petersen K., 2008, EASE 08, P68, DOI [10.14236/ewic/ease2008.8, DOI 10.14236/EWIC/EASE2008.8]; Ruffing T, 2014, LECT NOTES COMPUT SC, V8713, P345, DOI 10.1007/978-3-319-11212-1_20; Saxena A, 2014, LECT NOTES COMPUT SC, V8438, P122, DOI 10.1007/978-3-662-44774-1_9; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Spagnuolo M, 2014, LECT NOTES COMPUT SC, V8437, P457, DOI 10.1007/978-3-662-45472-5_29; Swan M, 2015, BLUEPRINT NEW EC; Valenta L, 2015, LECT NOTES COMPUT SC, V8976, P112, DOI 10.1007/978-3-662-48051-9_9; Vandervort D, 2015, LECT NOTES COMPUT SC, V8976, P78, DOI 10.1007/978-3-662-48051-9_6; Vandervort D, 2014, LECT NOTES COMPUT SC, V8438, P33, DOI 10.1007/978-3-662-44774-1_3; Vasek M, 2015, LECT NOTES COMPUT SC, V8975, P44, DOI 10.1007/978-3-662-47854-7_4; Vasek M, 2014, LECT NOTES COMPUT SC, V8438, P57, DOI 10.1007/978-3-662-44774-1_5; Wan Z., 2015, LECT NOTES COMPUTER, P386, DOI [10.1007/978-3-319-25645-0_27.2015, DOI 10.1007/978-3-319-25645-0]; Wang LQ, 2015, LECT NOTES COMPUT SC, V8995, P290, DOI 10.1007/978-3-319-15509-8_22; Wilson D., 2015, INT C NETWORK SYSTEM, P368, DOI DOI 10.1007/978-3-319-25645-0_25; Zhang Y, 2015, INT CONF INTELL NEXT, P184, DOI 10.1109/ICIN.2015.7073830; Ziegeldorf J.H., 2015, P 5 ACM C DAT APPL S, P75, DOI [DOI 10.1145/2699026.2699100, 10.1145/2699026.2699100]	52	770	786	55	1329	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163477	10.1371/journal.pone.0163477	http://dx.doi.org/10.1371/journal.pone.0163477			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695049	Green Submitted, Green Published, gold			2022-12-27	WOS:000385553100035
J	Almeida, OP; McCaul, K; Hankey, GJ; Yeap, BB; Golledge, J; Flicker, L				Almeida, Osvaldo P.; McCaul, Kieran; Hankey, Graeme J.; Yeap, Bu B.; Golledge, Jonathan; Flicker, Leon			Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson's Disease	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; EPIDEMIOLOGY; DEPRESSION; MORTALITY	Background Dementia and affective and psychotic symptoms are commonly associated with Parkinson's disease, but information about their prevalence and incidence in community representative samples remains sparse. Methods We recruited a community-representative sample 38173 older men aged 65 +/- 85 years in 1996 and used data linkage to ascertain the presence of PD, affective disorders, psychotic disorders and dementia. Diagnoses followed the International Classification of Disease coding system. Age was recorded in years. Follow up data were available until December 2011. Results The mean age of participants was 72.5 years and 333 men (0.9%) had PD at study entry. Affective and psychotic disorders and dementia were more frequent in men with than without PD (respective odds ratios: 6.3 [95% CI = 4.7, 8.4]; 14.2 [95% CI = 8.4, 24.0] and 18.2 [95% CI = 13.4, 24.6]). Incidence rate ratios of affective and psychotic disorders were higher among men with than without PD, although ratios decreased with increasing age. The age-adjusted hazard ratio (HR) of an affective episode associated with PD was 5.0 (95% CI = 4.2, 5.9). PD was associated with an age-adjusted HR of 8.6 (95% CI = 6.1, 12.0) for psychotic disorders and 6.1 (95% CI = 5.5, 6.8) for dementia. PD and dementia increased the HR of depressive and psychotic disorders. Conclusions PD increases the risk of affective and psychotic disorders, as well as dementia, among community dwelling older men. The risk of a recorded diagnosis of affective and psychotic disorders decreases with increasing age.	[Almeida, Osvaldo P.] Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA, Australia; [Almeida, Osvaldo P.; McCaul, Kieran; Flicker, Leon] Harry Perkins Inst Med Res, Med Res Ctr, WA Ctr Hlth & Ageing, Perth, WA, Australia; [Almeida, Osvaldo P.] Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia; [Hankey, Graeme J.; Yeap, Bu B.; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia; [Hankey, Graeme J.] Sir Charles Gairdner Hosp, Dept Neurol, Perth, WA, Australia; [Yeap, Bu B.] Fiona Stanley Hosp, Dept Endocrinol, Perth, WA, Australia; [Golledge, Jonathan] James Cook Univ, Coll Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld, Australia; [Golledge, Jonathan] Townsville Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA, Australia	University of Western Australia; Harry Perkins Institute of Medical Research; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; James Cook University; Royal Perth Hospital; University of Western Australia	Almeida, OP (corresponding author), Univ Western Australia, Sch Psychiat & Clin Neurosci, Perth, WA, Australia.; Almeida, OP (corresponding author), Harry Perkins Inst Med Res, Med Res Ctr, WA Ctr Hlth & Ageing, Perth, WA, Australia.; Almeida, OP (corresponding author), Royal Perth Hosp, Dept Psychiat, Perth, WA, Australia.	osvaldo.almeida@uwa.edu.au	McCaul, Kieran A/B-8751-2008; golledge, jonathan/I-2371-2013; Hankey, Graeme J/H-4968-2014; Flicker, Leon/AAE-1530-2022; Almeida, Osvaldo P./A-4925-2008	Hankey, Graeme J/0000-0002-6044-7328; Flicker, Leon/0000-0002-3650-0475; Almeida, Osvaldo P./0000-0002-8689-6199; golledge, jonathan/0000-0002-5779-8848	National Health and Medical Research Council of Australia (NHMRC) [279408, 379600, 403963, 513823, 540403, 540504, 540405, 634492, 1021416, 1045710, 1060557]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded through competitive project grants from the National Health and Medical Research Council of Australia (NHMRC), numbers 279408, 379600, 403963, 513823, 540403, 540504, 540405, 634492, 1021416, 1045710 and 1060557 (nhmrc.gov.au). The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Aarsland D, 2003, ARCH NEUROL-CHICAGO, V60, P387, DOI 10.1001/archneur.60.3.387; Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; ABS, 2015, 34120 ABS; [Anonymous], 2015, LIVING WITH PARKINSO; Baker WL, 2009, PARKINSONISM RELAT D, V15, P287, DOI 10.1016/j.parkreldis.2008.07.004; Berg D, 2013, LANCET NEUROL, V12, P514, DOI 10.1016/S1474-4422(13)70047-4; de Lau LML, 2005, ARCH NEUROL-CHICAGO, V62, P1265, DOI 10.1001/archneur.62.8.1265; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Fenelon G, 2010, J NEUROL SCI, V289, P12, DOI 10.1016/j.jns.2009.08.014; Forsaa EB, 2010, NEUROLOGY, V75, P1270, DOI 10.1212/WNL.0b013e3181f61311; Forsaa EB, 2010, ARCH NEUROL-CHICAGO, V67, P996, DOI 10.1001/archneurol.2010.166; Friedman JH, 2010, PARKINSONISM RELAT D, V16, P553, DOI 10.1016/j.parkreldis.2010.05.004; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Hughes TA, 2004, ACTA NEUROL SCAND, V110, P118, DOI 10.1111/j.1600-0404.2004.00292.x; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Jablensky AV, 2005, AM J PSYCHIAT, V162, P79, DOI 10.1176/appi.ajp.162.1.79; Jacob EL, 2010, PARKINSONISM RELAT D, V16, P576, DOI 10.1016/j.parkreldis.2010.06.014; McLennan W, 1996, AUSTR SOCIAL TRENDS; Norman PE, 2009, INT J EPIDEMIOL, V38, P48, DOI 10.1093/ije/dyn041; Reid WGJ, 2011, J NEUROL NEUROSUR PS, V82, P1033, DOI 10.1136/jnnp.2010.232678; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Shin IS, 2005, AM J GERIAT PSYCHIAT, V13, P469, DOI 10.1176/appi.ajgp.13.6.469; Smith K, 2008, NEUROLOGY, V71, P1470, DOI 10.1212/01.wnl.0000320508.11013.4f; van der Flier WM, 2005, J NEUROL NEUROSUR PS, V76, pV2, DOI 10.1136/jnnp.2005.082867; Vanderheyden JE, 2010, ACTA NEUROL BELG, V110, P148; Westreich D, 2012, EPIDEMIOLOGY, V23, P159, DOI 10.1097/EDE.0b013e31823b6296; Yip AG, 2006, AGE AGEING, V35, P154, DOI 10.1093/ageing/afj030	30	4	4	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163781	10.1371/journal.pone.0163781	http://dx.doi.org/10.1371/journal.pone.0163781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689715	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000384329200026
J	Del Fava, E; Rimseliene, G; Flem, E; de Blasio, BF; Tomba, GS; Manfredi, P				Del Fava, Emanuele; Rimseliene, Grazina; Flem, Elmira; de Blasio, Birgitte Freiesleben; Tomba, Gianpaolo Scalia; Manfredi, Piero			Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models	PLOS ONE			English	Article							HERPES-ZOSTER; UNITED-STATES; POPULATION PREVALENCE; VACCINATION; CHILDREN; ANTIBODY; MEASLES; SEROEPIDEMIOLOGY; SEROPREVALENCE; RUBELLA	This study applies mixture modelling to examine age-specific immunity to varicella zoster virus (VZV) infection in Norway based on the first large-scale serological study in the general population. We estimated the seropositive proportions at different ages and calculated the underlying force of infection by using a sample of 2103 residual sera obtained from patients seeking primary and hospital care. A rapid increase in the VZV-associated immunity is observed in the first years of life with 63% of children being immune by age 5. The increase in the immunity levels slows down thereafter, with a large proportion of adults still susceptible by age 20 (around 14.5%), thus at risk of serious sequelae of varicella infection. The corresponding force of infection peaks during the preschool period, subsequently declines to a minimum between ages 10 and 20 years, and afterwards moderately increases to reach a plateau lasting throughout the childbearing period. In comparison with the traditional cut-off approach, mixture modelling used the whole data without producing any inconclusive cases, led to an unbiased classification of individuals between susceptible and immune, and provided a smoother immune profile by age. These findings represent an important step towards any decision about the introduction of varicella vaccination in Norway, as they are a primary input for mathematical transmission models aimed at evaluating potential vaccination scenarios.	[Del Fava, Emanuele] Bocconi Univ, Carlo F Dondena Ctr Res Social Dynam & Publ Polic, Milan, Italy; [Rimseliene, Grazina; Flem, Elmira] Norwegian Inst Publ Hlth, Dept Vaccines, Oslo, Norway; [de Blasio, Birgitte Freiesleben] Univ Oslo, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [de Blasio, Birgitte Freiesleben] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Oslo, Norway; [Tomba, Gianpaolo Scalia] Univ Roma Tor Vergata, Dept Math, Rome, Italy; [Manfredi, Piero] Univ Pisa, Dept Econ & Management, Pisa, Italy	Bocconi University; Norwegian Institute of Public Health (NIPH); University of Oslo; Norwegian Institute of Public Health (NIPH); University of Rome Tor Vergata; University of Pisa	Del Fava, E (corresponding author), Bocconi Univ, Carlo F Dondena Ctr Res Social Dynam & Publ Polic, Milan, Italy.	emanuele.delfava@unibocconi.it	Del Fava, Emanuele/D-6181-2014; Flem, Elmira/GOG-9451-2022; Flem, Elmira/AFS-7695-2022	Del Fava, Emanuele/0000-0001-7352-8525; Flem, Elmira/0000-0002-5099-1960; Flem, Elmira/0000-0002-5099-1960	Norwegian Institute of Public Health	Norwegian Institute of Public Health	The study was fully funded by the Norwegian Institute of Public Health.	[Anonymous], 2014, WKLY EPIDEMIOL REC; Arvin AM, 1996, ADV VIRUS RES, V46, P263, DOI 10.1016/S0065-3527(08)60074-3; AZZALINI A, 1985, SCAND J STAT, V12, P171; Baughman AL, 2006, STAT MED, V25, P2994, DOI 10.1002/sim.2442; Bollaerts K, 2012, STAT MODEL, V12, P441, DOI 10.1177/1471082X12457495; Bonanni P, 2009, BMC MED, V7, P26, DOI DOI 10.1186/1741-7015-7-26; Brisson M, 2002, VACCINE, V20, P2500, DOI 10.1016/S0264-410X(02)00180-9; Carrillo-Santisteve P, 2014, CLIN MICROBIOL INFEC, V20, P86, DOI 10.1111/1469-0691.12580; Del Fava E, 2012, EPIDEMICS-NETH, V4, P124, DOI 10.1016/j.epidem.2012.05.001; DIEBOLT J, 1994, J ROY STAT SOC B MET, V56, P363; Evans RB, 2004, STAT MED, V23, P2227, DOI 10.1002/sim.1792; Follmann D, 2014, J R STAT SOC C-APPL, V63, P621, DOI 10.1111/rssc.12051; Fruhwirth-Schnatter S, 2010, BIOSTATISTICS, V11, P317, DOI 10.1093/biostatistics/kxp062; Fumanelli L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002673; Gay N, 1996, STAT MED, V15, P1567, DOI 10.1002/(SICI)1097-0258(19960730)15:14<1567::AID-SIM289>3.0.CO;2-G; GELFAND AE, 1991, BIOMETRIKA, V78, P657; Goldman GS, 2013, VACCINE, V31, P1680, DOI 10.1016/j.vaccine.2012.05.050; Hardelid P, 2008, EPIDEMIOL INFECT, V136, P1698, DOI 10.1017/S0950268808000393; Heininger U, 2006, LANCET, V368, P1365, DOI 10.1016/S0140-6736(06)69561-5; Hens N, 2013, MODELING INFECT DIS, DOI [10.1007/978-1-4614-4072-7, DOI 10.1007/978-1-4614-4072-7]; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Karhunen M, 2010, EPIDEMIOL INFECT, V138, P469, DOI 10.1017/S0950268809990768; Koskiniemi M, 2007, CLIN VACCINE IMMUNOL, V14, P1057, DOI 10.1128/CVI.00348-06; Leung J, 2011, CLIN INFECT DIS, V52, P332, DOI 10.1093/cid/ciq077; Marin M, 2008, PEDIATRICS, V122, pE744, DOI 10.1542/peds.2008-0567; McLachlan G., 2000, WILEY SER PROB STAT; Nardone A, 2007, VACCINE, V25, P7866, DOI 10.1016/j.vaccine.2007.07.036; Ogunjimi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066485; Ogunjimi B, 2011, VIRAL IMMUNOL, V24, P151, DOI 10.1089/vim.2010.0031; Ohuma EO, 2009, EPIDEMIOL INFECT, V137, P227, DOI 10.1017/S0950268808000848; Oxman MN, 2009, J AM OSTEOPATH ASSOC, V109, pS13; PARKER RA, 1990, J VIROL METHODS, V27, P135, DOI 10.1016/0166-0934(90)90130-8; Poletti P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060732; Prymula R, 2014, LANCET, V383, P1313, DOI 10.1016/S0140-6736(12)61461-5; Rimseliene G, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1581-4; Rota MC, 2008, VACCINE, V26, P4403, DOI 10.1016/j.vaccine.2008.05.094; Santermans E, 2015, EPIDEMICS-NETH, V11, P14, DOI 10.1016/j.epidem.2014.12.005; Schuette MC, 1999, B MATH BIOL, V61, P1031, DOI 10.1006/bulm.1999.0126; Socan M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-360; Svahn A, 2006, J CLIN VIROL, V37, P118, DOI 10.1016/j.jcv.2006.07.012; Talukder YS, 2007, EPIDEMIOL INFECT, V135, P1344, DOI 10.1017/S0950268807008497; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; van Hoek AJ, 2011, VACCINE, V29, P2411, DOI 10.1016/j.vaccine.2011.01.037; Vyse AJ, 2006, EPIDEMIOL INFECT, V134, P1303, DOI 10.1017/S0950268806006340; Vyse AJ, 2004, EPIDEMIOL INFECT, V132, P1129, DOI 10.1017/S0950268804003140	45	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163636	10.1371/journal.pone.0163636	http://dx.doi.org/10.1371/journal.pone.0163636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689800	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200018
J	Gupte, N; Kinikar, A; McIntire, KN; Bhosale, R; Patil, S; Suryavanshi, N; Mave, V; Kulkarni, V; Bollinger, RC; Gupta, A				Gupte, Nikhil; Kinikar, Aarti; McIntire, Katherine N.; Bhosale, Ramesh; Patil, Sandesh; Suryavanshi, Nishi; Mave, Vidya; Kulkarni, Vandana; Bollinger, Robert C.; Gupta, Amita			Efficacy of Six-Week Extended-Dose Nevirapine Varies by Infant Birth Weight with Greatest Relative Efficacy in Low Birth Weight Infants	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; MILK HIV-1 TRANSMISSION; ANTIRETROVIRAL DRUGS; COST-EFFECTIVENESS; CONTROLLED-TRIAL; DOUBLE-BLIND; PREVENTION; PROPHYLAXIS; ZIDOVUDINE; SINGLE	Latest World Health Organization guidelines recommend weight-based nevirapine prophylaxis for all HIV-exposed infants in resource-limited settings, yet low birth weight (LBW) infants (< 2500 g) have been understudied. Using data from the NIH-funded India six-week extended-dose nevirapine (SWEN) study, a randomized clinical trial of SWEN versus single-dose nevirapine (SD) for prevention of breast-milk HIV-1 transmission, we examined the relative impact of SWEN among 737 mother-infant pairs stratified by infant birth weight. Birth weight groups were defined as very LBW (VLBW) <= 2000 g, moderate LBW (MLBW) > 2000 g and <= 2500 g, and normal birth weight (NBW) > 2500 g. Outcomes were HIV-1 infection, HIV-1 infection or death by 12 months, and severe adverse events (SAEs). The Kaplan-Meier method was used to estimate probability of efficacy outcomes in birth weight groups, and differential effects of SWEN by birth weight group were examined using Cox proportional hazards models adjusting for independent risk factors for HIV maternal-to-child transmission and significant covariates. Among 50 VLBW, 249 MLBW, and 433 NBW infants, 50% were randomized to SWEN; median gestational age was 36, 38 and 38 weeks, respectively; and there was no difference in breastfeeding duration (p = 0.99). Compared to SD: SWEN-treated VLBW had lower estimates of HIV-1 infection (13% vs. 38%, p = 0.004) and HIV-1 infection or death (13% vs. 41%, p = 0.002); SWEN-treated MLBW had lower estimated HIV-1 infection (13% vs. 17%, p = 0.042); and efficacy endpoints were similar by treatment arm in NBW. In multivariate analysis, SWEN was associated with reduced risk of HIV-1 infection or death by 83% (p = 0.03) in VLBW versus 45% (p = 0.05) in MLBW. SAE frequency was similar by treatment arm in VLBW (68% vs. 76%, p = 0.53) and MLBW (37% vs. 36%, p = 0.93). SWEN may safely increase HIV-free survival among HIV-exposed LBW infants with greatest protective advantage among infants <= 2000 g.	[Gupte, Nikhil; McIntire, Katherine N.; Mave, Vidya; Bollinger, Robert C.; Gupta, Amita] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Gupte, Nikhil; Kinikar, Aarti; Bhosale, Ramesh; Patil, Sandesh; Suryavanshi, Nishi; Mave, Vidya; Kulkarni, Vandana; Bollinger, Robert C.; Gupta, Amita] Biramji Jeejeebhoy Govt Med Coll, Byramji Jeejeebhoy Govt Med Coll Johns Hopkins Un, Pune, Maharashtra, India; [Kinikar, Aarti; Bhosale, Ramesh] Byramji Jeejeebhoy Govt Med Coll, Pune, Maharashtra, India; [Kinikar, Aarti; Bhosale, Ramesh] Sassoon Gen Hosp, Pune, Maharashtra, India; [Bollinger, Robert C.; Gupta, Amita] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Gupte, N (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.; Gupte, N (corresponding author), Biramji Jeejeebhoy Govt Med Coll, Byramji Jeejeebhoy Govt Med Coll Johns Hopkins Un, Pune, Maharashtra, India.	ngupte1@jhmi.edu		Gupta, Amita/0000-0001-7036-2718; Bollinger, Robert/0000-0002-6798-6834	United States National Institutes of Health [R01A145462]; Fogarty International Center National Institutes of Health Program of International Training Grants in Epidemiology Related to AIDS [D43-TW000010-22]; National Institutes of Health Byramji Jeejeebhoy Medical College HIV Clinical Trials Unit [U01AI069497]; Gilead Foundation; Ujala Foundation	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center National Institutes of Health Program of International Training Grants in Epidemiology Related to AIDS; National Institutes of Health Byramji Jeejeebhoy Medical College HIV Clinical Trials Unit; Gilead Foundation(Gilead Sciences); Ujala Foundation	This work was supported by the United States National Institutes of Health [R01A145462 to RCB]; the Fogarty International Center National Institutes of Health Program of International Training Grants in Epidemiology Related to AIDS [D43-TW000010-22]; the National Institutes of Health Byramji Jeejeebhoy Medical College HIV Clinical Trials Unit [U01AI069497 to AG, NG, VK, VM, SP, and RCB]; the Gilead Foundation to AG, RCB, NG, and VM; and the Ujala Foundation to AG, RCB, NG, and VM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Charurat M, 2009, INT J GYNECOL OBSTET, V106, P8, DOI 10.1016/j.ijgo.2009.02.017; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Dabis F, 2005, AIDS, V19, P309; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hudgens MG, 2013, CLIN INFECT DIS, V56, P131, DOI 10.1093/cid/cis808; Jamieson DJ, 2012, LANCET, V379, P2449, DOI 10.1016/S0140-6736(12)60321-3; Kearns GL, 2003, NEW ENGL J MED, V349, P1157, DOI 10.1056/NEJMra035092; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Markson LE, 1996, J ACQ IMMUN DEF SYND, V13, P227, DOI 10.1097/00042560-199611010-00004; Moorthy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004096; Mugabo P, 2011, SAMJ S AFR MED J, V101, P655; Okafor II, 2014, ANN MED HEALTH SCI R, V4, P615, DOI 10.4103/2141-9248.139344; Omer SB, 2011, AIDS, V25, P767, DOI 10.1097/QAD.0b013e328344c12a; Parekh N, 2011, INT J GYNECOL OBSTET, V115, P20, DOI 10.1016/j.ijgo.2011.04.008; Persaud D, 2011, AIDS RES HUM RETROV, V27, P823, DOI [10.1089/aid.2010.0346, 10.1089/AID.2010.0346]; Taha TE, 2011, JAIDS-J ACQ IMM DEF, V57, P319, DOI 10.1097/QAI.0b013e318217877a; Tweya H, 2016, AIDS, V30, P953, DOI 10.1097/QAD.0000000000001009; UNICEF, 4 UNICEF; VanDeusen A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0859-2; WHO, 2013 CONS GUID USE A; WHO, GUIDELINES ON HIV AN; WHO UNICEF, LOW BIRTH WEIGHT COU; World Health Organization, ANT DRUGS TREAT PREG; World Health Organization, 2015, GUID START ANT THER	31	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0162979	10.1371/journal.pone.0162979	http://dx.doi.org/10.1371/journal.pone.0162979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689883	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200010
J	Stratis, PN; Karatzas, GP; Papadopoulou, EP; Zakynthinaki, MS; Saridakis, YG				Stratis, Paris N.; Karatzas, George P.; Papadopoulou, Elena P.; Zakynthinaki, Maria S.; Saridakis, Yiannis G.			Stochastic Optimization for an Analytical Model of Saltwater Intrusion in Coastal Aquifers	PLOS ONE			English	Article							VISUAL RECEPTIVE-FIELDS; SHARP-INTERFACE MODELS; SEAWATER INTRUSION; OPTIMAL-DESIGN; MANAGEMENT; GROUNDWATER; NETWORKS; ALGORITHM; SYSTEMS; ALOPEX	The present study implements a stochastic optimization technique to optimally manage freshwater pumping from coastal aquifers. Our simulations utilize the well-known sharp interface model for saltwater intrusion in coastal aquifers together with its known analytical solution. The objective is to maximize the total volume of freshwater pumped by the wells from the aquifer while, at the same time, protecting the aquifer from saltwater intrusion. In the direction of dealing with this problem in real time, the ALOPEX stochastic optimization method is used, to optimize the pumping rates of the wells, coupled with a penalty-based strategy that keeps the saltwater front at a safe distance from the wells. Several numerical optimization results, that simulate a known real aquifer case, are presented. The results explore the computational performance of the chosen stochastic optimization method as well as its abilities to manage freshwater pumping in real aquifer environments.	[Stratis, Paris N.; Saridakis, Yiannis G.] Tech Univ Crete, Sch Prod Engn & Management, Khania 73100, Greece; [Karatzas, George P.] Tech Univ Crete, Sch Environm Engn, Khania 73100, Greece; [Papadopoulou, Elena P.] Tech Univ Crete, Sch Mineral Resources, Khania 73100, Greece; [Stratis, Paris N.; Papadopoulou, Elena P.; Zakynthinaki, Maria S.; Saridakis, Yiannis G.] Tech Univ Crete, Appl Math & Comp Lab, Khania 73100, Greece	Technical University of Crete; Technical University of Crete; Technical University of Crete; Technical University of Crete	Saridakis, YG (corresponding author), Tech Univ Crete, Sch Prod Engn & Management, Khania 73100, Greece.; Saridakis, YG (corresponding author), Tech Univ Crete, Appl Math & Comp Lab, Khania 73100, Greece.	y.saridakis@amcl.tuc.gr	KARATZAS, GEORGE/AAE-7162-2019	KARATZAS, GEORGE/0000-0001-8581-7498	European Union (European Social Fund ESF); Greek national funds through the Operational Program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES [MIS 379416]	European Union (European Social Fund ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES	The present research work has been co-financed by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF) - Research Funding Program: THALES (MIS 379416). Investing in knowledge society through the European Social Fund.; The present research work has been co-financed by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program Education and Lifelong Learning of the National Strategic Reference Framework (NSRF)-Research Funding Program: THALES (MIS 379416). Investing in knowledge society through the European Social Fund.	Alley WM, 1999, SUSTAINABILITY GROUN, V1186; Aly AH, 1999, WATER RESOUR RES, V35, P2523, DOI 10.1029/98WR02368; Bhattacharjya R, 2005, WATER RESOUR MANAG, V19, P295, DOI 10.1007/s11269-005-3180-9; Cheng AD, 2004, COASTAL AQUITER MANA; Cheng AHD, 2000, WATER RESOUR RES, V36, P2155, DOI 10.1029/2000WR900149; Custodio E., 1987, STUDIES REPORTS HYDR, V45, P1; Dagan G, 1998, J CONTAM HYDROL, V29, P185, DOI 10.1016/S0169-7722(97)00013-2; Diersch HJG, 2002, ADV WATER RESOUR, V25, P899, DOI 10.1016/S0309-1708(02)00063-5; Fetter C. W., 2001, APPL HYDROGEOLOGY; HARTH E, 1974, VISION RES, V14, P1475, DOI 10.1016/0042-6989(74)90024-8; Harth E, 1990, U S Patent, Patent No. [4912624, 4 912 624]; Herrera I., 1999, SEAWATER INTRUSION C, DOI [10.1007/978-94-017-2969-7_13, DOI 10.1007/978-94-017-2969-7_13, 10.1007/978-94-017-2969-7]; Iribar V, 1997, J HYDROL, V198, P226, DOI 10.1016/S0022-1694(96)03290-8; Kalogeropoulos TE, 1997, COMPUT PHYS COMMUN, V99, P255, DOI 10.1016/S0010-4655(96)00101-4; Karterakis SM, 2007, J HYDROL, V342, P270, DOI 10.1016/j.jhydrol.2007.05.027; Katsifarakis KL, 2008, WATER RESOUR MANAG, V22, P1089, DOI 10.1007/s11269-007-9212-x; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kourakos G, 2011, WATER RESOUR MANAG, V25, P1063, DOI 10.1007/s11269-010-9677-x; Llopis-Albert C, 2014, HYDROL PROCESS, V28, P3642, DOI 10.1002/hyp.9908; Mahesha A, 1996, J IRRIG DRAIN ENG, V122, P314, DOI 10.1061/(ASCE)0733-9437(1996)122:5(314); Mantoglou A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001891; Mantoglou A, 2004, J HYDROL, V297, P209, DOI 10.1016/j.jhydrol.2004.04.011; Mantoglou A, 2008, J HYDROL, V361, P52, DOI 10.1016/j.jhydrol.2008.07.022; Masciopinto C, 2006, ENVIRON MODELL SOFTW, V21, P85, DOI 10.1016/j.envsoft.2004.09.028; MELISSARATOS L, 1989, Journal of Medical Systems, V13, P243, DOI 10.1007/BF00996458; Micheli-Tzanakou E, 1999, SUPERVISED UNSUPERVI, DOI [10.1201/9781420049770, DOI 10.1201/9781420049770]; Molina JL, 2011, WATER RESOUR MANAG, V25, P3883, DOI 10.1007/s11269-011-9893-z; Naji A, 1999, ENG ANAL BOUND ELEM, V23, P529, DOI 10.1016/S0955-7997(99)00012-0; Pandya AS, 1999, NEUROCOMPUTING, V24, P1, DOI 10.1016/S0925-2312(98)00088-5; PANDYA AS, 1994, IEICE T INF SYST, VE77D, P376; Park CH, 2004, J HYDROL, V290, P80, DOI 10.1016/j.jhydrol.2003.11.025; Paster A, 2006, J HYDROL, V323, P154, DOI 10.1016/j.jhydrol.2005.08.018; Qahman K, 2005, STOCH ENV RES RISK A, V19, P99, DOI 10.1007/s00477-004-0218-0; Rao SVN, 2004, J WATER RES PLAN MAN, V130, P255, DOI 10.1061/(ASCE)0733-9496(2004)130:3(255); REILLY TE, 1985, J HYDROL, V80, P125, DOI 10.1016/0022-1694(85)90078-2; Shintani H, 2007, INT J KNOWL-BASED IN, V11, P371; Sidiropoulos E., 2004, WATER AIR SOIL POLL, V4, P227, DOI [10.1023/B:WAFO.0000044801.47725.b6, DOI 10.1023/B:WAFO.0000044801.47725.B6]; Strack O.D.L., 1989, GROUNDWATER MECH; STRACK ODL, 1976, WATER RESOUR RES, V12, P1165, DOI 10.1029/WR012i006p01165; Stratis PN, 2014, J PHYS CONF SER, V490, DOI 10.1088/1742-6596/490/1/012112; TZANAKOU E, 1979, BIOL CYBERN, V35, P161, DOI 10.1007/BF00337061; Unnikrishnan A, 1992, NEURAL COMPUT, V6, P469, DOI [10.1162/neco.1994.6.3.469, DOI 10.1162/NECO.1994.6.3.469]; Zakynthinaki M, 2001, THESIS; Zakynthinaki MS, 2011, COMPUT PHYS COMMUN, V182, P683, DOI 10.1016/j.cpc.2010.11.027; Zakynthinaki MS, 2003, COMPUT PHYS COMMUN, V150, P274, DOI 10.1016/S0010-4655(02)00681-1	45	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0162783	10.1371/journal.pone.0162783	http://dx.doi.org/10.1371/journal.pone.0162783			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689362	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200007
J	Krill, JL; Dawson-Scully, K				Krill, Jennifer L.; Dawson-Scully, Ken			cGMP-Dependent Protein Kinase Inhibition Extends the Upper Temperature Limit of Stimulus-Evoked Calcium Responses in Motoneuronal Boutons of Drosophila melanogaster Larvae	PLOS ONE			English	Article							CYSTEINE-STRING PROTEIN; SYNAPTIC THERMOPROTECTION; NEUROMUSCULAR-JUNCTION; SPREADING DEPRESSION; SIGNALING PATHWAY; NATURAL VARIATION; ADULT DROSOPHILA; OXIDATIVE STRESS; BASAL FOREBRAIN; NEURAL FUNCTION	While the mammalian brain functions within a very narrow range of oxygen concentrations and temperatures, the fruit fly, Drosophila melanogaster, has employed strategies to deal with a much wider range of acute environmental stressors. The foraging (for) gene encodes the cGMP-dependent protein kinase (PKG), has been shown to regulate thermotolerance in many stress-adapted species, including Drosophila, and could be a potential therapeutic target in the treatment of hyperthermia in mammals. Whereas previous thermotolerance studies have looked at the effects of PKG variation on Drosophila behavior or excitatory postsynaptic potentials at the neuromuscular junction (NMJ), little is known about PKG effects on presynaptic mechanisms. In this study, we characterize presynaptic calcium ([Ca2+](i)) dynamics at the Drosophila larval NMJ to determine the effects of high temperature stress on synaptic transmission. We investigated the neuroprotective role of PKG modulation both genetically using RNA interference (RNAi), and pharmacologically, to determine if and how PKG affects presynaptic [Ca2+](i) dynamics during hyperthermia. We found that PKG activity modulates presynaptic neuronal Ca2+ responses during acute hyperthermia, where PKG activation makes neurons more sensitive to temperature-induced failure of Ca2+ flux and PKG inhibition confers thermotolerance and maintains normal Ca2+ dynamics under the same conditions. Targeted motoneuronal knockdown of PKG using RNAi demonstrated that decreased PKG expression was sufficient to confer thermo-protection. These results demonstrate that the PKG pathway regulates presynaptic motoneuronal Ca2+ signaling to influence thermotolerance of presynaptic function during acute hyperthermia.	[Krill, Jennifer L.; Dawson-Scully, Ken] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Dawson-Scully, K (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA.	ken.dawson-scully@fau.edu						Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Armstrong GAB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028994; Armstrong GAB, 2010, BRAIN RES, V1311, P64, DOI 10.1016/j.brainres.2009.11.038; Armstrong GAB, 2009, J NEUROSCI, V29, P8225, DOI 10.1523/JNEUROSCI.1652-09.2009; Armstrong LE, 2002, REV NEUROSCIENCE, V13, P271; Barclay JW, 2003, J NEUROBIOL, V56, P360, DOI 10.1002/neu.10247; BRAND AH, 1993, DEVELOPMENT, V118, P401; Caplan SL, 2013, J NEUROPHYSIOL, V109, P649, DOI 10.1152/jn.00784.2011; Chai Y, 2008, PFLUG ARCH EUR J PHY, V456, P897, DOI 10.1007/s00424-008-0447-z; Chen A, 2011, J COMP PHYSIOL A, V197, P1113, DOI 10.1007/s00359-011-0672-3; Dawson-Scully K, 2010, J EXP BIOL, V213, P2410, DOI 10.1242/jeb.041319; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; Dawson-Scully K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000773; Dawson-Scully K, 2007, SYNAPSE, V61, P1, DOI 10.1002/syn.20335; DIEROLF BM, 1969, Z VERGL PHYSIOL, V62, P284, DOI 10.1007/BF00395741; Donlea J, 2012, P NATL ACAD SCI USA, V109, P2613, DOI 10.1073/pnas.1112623109; Feder Martin E., 1997, V83, P155; HEINRICH B, 1974, SCIENCE, V185, P747, DOI 10.1126/science.185.4153.747; KATZ B, 1970, J PHYSIOL-LONDON, V207, P789, DOI 10.1113/jphysiol.1970.sp009095; Khatri N, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00199; Klose MK, 2008, J NEUROPHYSIOL, V99, P2420, DOI 10.1152/jn.01251.2007; Klose MK, 2009, J NEUROPHYSIOL, V102, P901, DOI 10.1152/jn.91209.2008; Li P, 2007, J APPL PHYSIOL, V102, P390, DOI 10.1152/japplphysiol.00468.2006; LLINAS R, 1981, BIOPHYS J, V33, P323, DOI 10.1016/S0006-3495(81)84899-0; Macleod Gregory T, 2012, Cold Spring Harb Protoc, V2012, P802, DOI 10.1101/pdb.prot070110; Macleod GT, 2004, J NEUROSCI, V24, P2496, DOI 10.1523/JNEUROSCI.5372-03.2004; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Milton SL, 2013, FUTUR NEUROL, V8, P287, DOI 10.2217/FNL.13.12; Money TGA, 2009, J NEUROPHYSIOL, V102, P285, DOI 10.1152/jn.91174.2008; Newman AEM, 2005, J NEUROBIOL, V64, P170, DOI 10.1002/neu.20132; Petrov AM, 2008, J NEUROSCI, V28, P13216, DOI 10.1523/JNEUROSCI.2947-08.2008; Ramachandran Preethi, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5469; Renger JJ, 1999, J NEUROSCI, V19; Robertson RM, 2004, J THERM BIOL, V29, P351, DOI 10.1016/j.jtherbio.2004.08.073; Rodgers CI, 2010, J INSECT PHYSIOL, V56, P980, DOI 10.1016/j.jinsphys.2010.03.030; Rodgers CI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001366; Rodgers CI, 2009, J INSECT PHYSIOL, V55, P599, DOI 10.1016/j.jinsphys.2009.03.004; RUTH P, 1991, EUR J BIOCHEM, V202, P1339, DOI 10.1111/j.1432-1033.1991.tb16509.x; Secondo A, 2007, CELL CALCIUM, V42, P521, DOI 10.1016/j.ceca.2007.01.006; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Singh THV, 2009, NEUROSCIENCE, V159, P1283, DOI 10.1016/j.neuroscience.2009.01.074; Spong KE, 2016, J EXP BIOL, V219, P626, DOI 10.1242/jeb.132456; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; SUKO J, 1993, BIOCHIM BIOPHYS ACTA, V1175, P193, DOI 10.1016/0167-4889(93)90023-I; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Toyoda H, 2008, J NEUROPHYSIOL, V99, P2126, DOI 10.1152/jn.01051.2007; Toyoda H, 2010, J NEUROSCI, V30, P5677, DOI 10.1523/JNEUROSCI.5407-09.2010; Wei JY, 1996, BIOCHEMISTRY-US, V35, P16815, DOI 10.1021/bi961763v; Wu BS, 2002, J EXP BIOL, V205, P815; Yamanaka R, 2013, FEBS LETT, V587, P2643, DOI 10.1016/j.febslet.2013.06.049; Yang KT, 2004, FASEB J, V18, P1442, DOI 10.1096/fj.03-1038fje; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zhong N, 2001, J NEUROSCI, V21, P9598, DOI 10.1523/JNEUROSCI.21-24-09598.2001; Zilberberg N, 2000, J GEN PHYSIOL, V116, P721, DOI 10.1085/jgp.116.5.721	55	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164114	10.1371/journal.pone.0164114	http://dx.doi.org/10.1371/journal.pone.0164114			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711243	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600079
J	Ombura, IP; Onyango, N; Odera, S; Mutua, F; Nyagol, J				Ombura, Ida Pam; Onyango, Noel; Odera, Susan; Mutua, Florence; Nyagol, Joshua			Prevalence of Drug Resistance Mycobacterium Tuberculosis among Patients Seen in Coast Provincial General Hospital, Mombasa, Kenya	PLOS ONE			English	Article							NONTUBERCULOUS MYCOBACTERIA; PULMONARY TUBERCULOSIS; HIV COINFECTION; MANAGEMENT	Background Although prevention and control of spread of multi-drug resistant tuberculosis strains is a global challenge, there is paucity of data on the prevalence of DR-TB in patients diagnosed with TB in referral hospitals in Kenya. The present study assessed patients' characteristics and prevalence of drug resistant TB in sputa smear positive TB patients presenting to Coast Provincial General Hospital (CPGH) in Mombasa, Kenya. Methods Drug resistance was evaluated in 258 randomly selected sputa smear TB positive cases between the periods of November 2011 to February 2012 at the CPGH-Mombasa. Basic demographic data was obtained using administered questionnaires, and clinical history extracted from the files. For laboratory analyses, 2mls of sputum was obtained, decontaminated and subjected to mycobacteria DNA analyses. Detection of first line drug resistance genes was done using MDRTDR plus kit. This was followed with random selection of 83 cases for second line drug resistance genes testing using Genotype MDRTBsl probe assay kit (HAINS Lifesciences, GmbH, Germany), in which ethambutol mutation probes were included. The data was then analyzed using SPSS statistical package version 19.0. Results Male to female ratio was 1:2. Age range was 9 to 75 years, with median of 30 years. New treatment cases constituted 253(98%), among which seven turned out to be PTB negative, and further grouped as 4 (1.6%) PTB negative and 3(1.1%) NTM. 237(91.7%) new cases were fully susceptible to INH and RIF. The remaining, 8 (3.1%) and 1(0.4%) had mono-resistance to INH and RIF, respectively. All the retreatment cases were fully susceptible to the first line drugs. HIV positivity was found in 48 (18.6%) cases, of which 46(17.8%) were co-infected with TB. Of these, 44 (17.1%) showed full susceptibility to TB drugs, while 2 (0.8%) were INH resistant. For the second line drugs, one case each showed mono resistance to both and FQ. Also, one case each showed drug cross poly resistance to both ETH and FQ, with second line injectable antibiotics. However, no significant statistical correlation was established between TB and resistance to the second line drugs p = 0.855. Conclusion The findings of this study showed the existence of resistance to both first and second line anti-tubercular drugs, but no MDR-TB and XDR-TB was detected among patients attending TB clinic at CPGH using molecular techniques.	[Ombura, Ida Pam; Odera, Susan; Mutua, Florence] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Nyagol, Joshua] Univ Nairobi, Dept Human Pathol, Immunol Unit, Nairobi, Kenya; [Onyango, Noel] Univ Nairobi, Dept Clin Med & Therapeut, Med Oncol Unit, Nairobi, Kenya	University of Nairobi; University of Nairobi; University of Nairobi	Nyagol, J (corresponding author), Univ Nairobi, Dept Human Pathol, Immunol Unit, Nairobi, Kenya.	joshua.nyagol@uonbi.ac.ke	MIZEKA, PANU/A-3952-2017		University of Nairobi, department of Medical Microbiology	University of Nairobi, department of Medical Microbiology	This work was supported by a Seed grant for post-graduate student's support, University of Nairobi, department of Medical Microbiology.	Ballif M, 2014, INT J TUBERC LUNG D, V18, P1327, DOI 10.5588/ijtld.14.0106; Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09; Eduardo P, 2011, MOL BASIS MECH DRUG, P1417; Gopinath K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000615; Jezmir J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154142; Katoch VM, 2004, INDIAN J MED RES, V120, P290; Khan R, 2013, STATISTICS-ABINGDON, P1; Ling Daphne I, 2008, Expert Rev Respir Med, V2, P583, DOI 10.1586/17476348.2.5.583; Maheswaran H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030457; Mekonnen F, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1202-7; Migliori GB, 2010, TROP MED INT HEALTH, V15, P1052, DOI 10.1111/j.1365-3156.2010.02581.x; Muwonge A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064745; National AIDS and SIIs Control Programme (NASCOP), 2013, KEN AIDS IND SURV 20, V20; Ndung'u PW, 2012, J INFECT DEV COUNTR, V6, P33, DOI 10.3855/jidc.2281; Nyamogoba HDN, 2012, AFR HEALTH SCI, V12, P305, DOI 10.4314/ahs.v12i3.9; O'Grady J, 2011, CURR OPIN PULM MED, V17, P134, DOI 10.1097/MCP.0b013e3283452346; Ogaro T.D., 2012, AFRICAN J HLTH SCI, V20, P21; Palomino JC, 2011, J ANTIMICROB CHEMOTH, V66, P1417, DOI DOI 10.1093/JAC/DKR173; Pontali E, 2015, EXPERT OPIN PHARMACO, V16, P2737, DOI 10.1517/14656566.2015.1100169; Said HM, 2012, INT J TUBERC LUNG D, V16, P104, DOI 10.5588/ijtld.10.0600; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Sia IG, 2011, MAYO CLIN PROC, V86, P348, DOI 10.4065/mcp.2010.0820; Tripathi K., 2014, INT J RECENT TRENDS, V10, P461; UNAIDS, 2013, UNAIDSJC25021E; Wells WA, 2013, LANCET INFECT DIS, V13, P449, DOI 10.1016/S1473-3099(13)70025-2; WHO, 2014, GLOB TUB REP 2014; World Health Organization, 2010, MULT EXT DRUG RES TB, P57; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	29	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163994	10.1371/journal.pone.0163994	http://dx.doi.org/10.1371/journal.pone.0163994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711122	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600058
J	Torres, DJ; Cannon, JL; Ricoy, UM; Johnson, C				Torres, David J.; Cannon, Judy L.; Ricoy, Ulises M.; Johnson, Christopher			Self-Contained Statistical Analysis of Gene Sets	PLOS ONE			English	Article							FALSE DISCOVERY RATE; EXPRESSION DATA; GLOBAL TEST; ENCYCLOPEDIA; ASSOCIATION; LEUKEMIA; SUBTYPE; TESTS	Microarrays are a powerful tool for studying differential gene expression. However, lists of many differentially expressed genes are often generated, and unraveling meaningful biological processes from the lists can be challenging. For this reason, investigators have sought to quantify the statistical probability of compiled gene sets rather than individual genes. The gene sets typically are organized around a biological theme or pathway. We compute correlations between different gene set tests and elect to use Fisher's self-contained method for gene set analysis. We improve Fisher's differential expression analysis of a gene set by limiting the p-value of an individual gene within the gene set to prevent a small percentage of genes from determining the statistical significance of the entire set. In addition, we also compute dependencies among genes within the set to determine which genes are statistically linked. The method is applied to T-ALL (T-lineage Acute Lymphoblastic Leukemia) to identify differentially expressed gene sets between T-ALL and normal patients and T-ALL and AML (Acute Myeloid Leukemia) patients.	[Torres, David J.] Northern New Mexico Coll, Dept Math & Phys Sci, Espanola, NM 87532 USA; [Cannon, Judy L.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Ricoy, Ulises M.] Northern New Mexico Coll, Dept Biol Chem & Environm Sci, Espanola, NM USA; [Johnson, Christopher] Northern New Mexico Coll, Coll Engn, Espanola, NM USA	University of New Mexico; University of New Mexico's Health Sciences Center	Torres, DJ (corresponding author), Northern New Mexico Coll, Dept Math & Phys Sci, Espanola, NM 87532 USA.	davytorres@nnmc.edu	Torres, David/ABB-9663-2021	Torres, David/0000-0003-2469-5284; Ricoy, Ulises/0000-0002-8545-0865	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103451]; National Institute of General Medical Sciences of the National Institutes of Health [RL5GM118969]; NIH NIAID [R01 AI097202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [UL1GM118970, P50GM085273, P20GM103451, RL5GM118969] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103451 (DJT, JLC, UMR, CJ); National Institute of General Medical Sciences of the National Institutes of Health under award number RL5GM118969 (DJT); and NIH NIAID R01 AI097202 (JLC). The funders had no role in the study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1932, STAT METHODS RES WOR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballerini P, 2002, BLOOD, V100, P991, DOI 10.1182/blood-2001-11-0093; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barry WT, 2004, BIOINFORMATICS, V21, P1943, DOI [10.1093/bioinformatics/bf260, DOI 10.1093/BIOINFORMATICS/BF260]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Chai HS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-102; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Ferrando AA, 2003, SEMIN HEMATOL, V40, P274, DOI 10.1016/S0037-1963(03)00195-1; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Fridley BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012693; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Goeman JJ, 2007, BIOINFORMATICS, V23, P980, DOI 10.1093/bioinformatics/btm051; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kohlmann A, 2008, BRIT J HAEMATOL, V142, P802, DOI 10.1111/j.1365-2141.2008.07261.x; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Kong SW, 2006, BIOINFORMATICS, V22, P2373, DOI 10.1093/bioinformatics/btl401; Kuhnl A, 2010, BLOOD, V115, P3737, DOI 10.1182/blood-2009-09-241943; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu WM, 2006, J THEOR BIOL, V243, P273, DOI 10.1016/j.jtbi.2006.06.017; Maiorov EG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210253; Mansmann U, 2005, METHOD INFORM MED, V44, P449; Newton MA, 2015, ANNU REV STAT APPL, V2, P95, DOI 10.1146/annurev-statistics-010814-020335; Pallini A, 1994, METRON, V52, P53; Pui CH, 2008, LANCET ONCOL, V9, P257, DOI 10.1016/S1470-2045(08)70070-6; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Stouffer S. A., 1949, AM SOLDIER, V1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor J, 2006, BIOSTATISTICS, V7, P167, DOI 10.1093/biostatistics/kxj009; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	40	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163918	10.1371/journal.pone.0163918	http://dx.doi.org/10.1371/journal.pone.0163918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711232	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600050
J	Olatunji, MA; Khandaker, MU; Amin, YM; Mahmud, HNME				Olatunji, Michael Adekunle; Khandaker, Mayeen Uddin; Amin, Yusoff Mohd; Mahmud, Habibun Nabi Muhammad Ekramul			Cadmium-109 Radioisotope Adsorption onto Polypyrrole Coated Sawdust of Dryobalanops aromatic: Kinetics and Adsorption Isotherms Modelling	PLOS ONE			English	Article							AQUEOUS-SOLUTIONS; CADMIUM REMOVAL; ION	A radiotracer study was conducted to investigate the removal characteristics of cadmium (Cd-109) from aqueous solution by polypyrrole/ sawdust composite. Several factors such as solution pH, sorbent dosage, initial concentration, contact time, temperature and interfering metal ions were found to have influence on the adsorption process. The kinetics of adsorption was relatively fast, reaching equilibrium within 3 hours. A lowering of the solution pH reduced the removal efficiency from 99.3 to similar to 46.7% and an ambient temperature of 25 degrees C was found to be optimum for maximum adsorption. The presence of sodium and potassium ions inhibited Cd-109 removal from its aqueous solution. The experimental data for Cd-109 adsorption showed a very good agreement with the Langmuir isotherm and a pseudo-first order kinetic model. The surface condition of the adsorbent before and after cadmium loading was investigated using BET, FESEM and FTIR. Considering the low cost of the precursor's materials and the toxicity of Cd-109 radioactive metal, polypyrrole synthesized on the sawdust of Dryobalanops aromatic could be used as an efficient adsorbent for the removal of Cd-109 radioisotope from radionuclide-containing effluents.	[Olatunji, Michael Adekunle; Khandaker, Mayeen Uddin; Amin, Yusoff Mohd] Univ Malaya, Dept Phys, Appl Radiat Lab, Kuala Lumpur, Malaysia; [Mahmud, Habibun Nabi Muhammad Ekramul] Univ Malaya, Dept Chem, Polymer Lab, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Khandaker, MU (corresponding author), Univ Malaya, Dept Phys, Appl Radiat Lab, Kuala Lumpur, Malaysia.; Mahmud, HNME (corresponding author), Univ Malaya, Dept Chem, Polymer Lab, Kuala Lumpur, Malaysia.	mu_khandaker@um.edu.my; ekramul@um.edu.my	Mahmud, H. N. M. Ekramul/AAR-4953-2021; Mahmud, H. N. M. Ekramul/F-6696-2011; Olatunji, Michael/L-4701-2017; Khandaker, Mayeen Uddin/F-5376-2011	Mahmud, H. N. M. Ekramul/0000-0002-6294-2082; Mahmud, H. N. M. Ekramul/0000-0002-6294-2082; Olatunji, Michael/0000-0003-4400-7741; Khandaker, Mayeen Uddin/0000-0003-3772-294X	University of Malaya [PG027A-2014]	University of Malaya(Universiti Malaya)	This work was supported by the University of Malaya Research grant (Grant No PG027A-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achak M, 2009, J HAZARD MATER, V166, P117, DOI 10.1016/j.jhazmat.2008.11.036; Ansari R, 2007, REACT FUNCT POLYM, V67, P367, DOI 10.1016/j.reactfunctpolym.2007.02.001; Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6; Deng X, 2007, J HAZARD MATER, V139, P340, DOI 10.1016/j.jhazmat.2006.06.043; Feng YA, 2010, CHEM ENG J, V162, P487, DOI 10.1016/j.cej.2010.05.049; Ghorbani M, 2010, DESALINATION, V263, P279, DOI 10.1016/j.desal.2010.06.072; Hao ZQ, 1999, APPL ENVIRON MICROB, V65, P4741; Javadian H, 2014, APPL SURF SCI, V289, P487, DOI 10.1016/j.apsusc.2013.11.020; Kalkan E, 2013, POL J ENVIRON STUD, V22, P417; Karthikeyan M, 2009, J HAZARD MATER, V167, P300, DOI 10.1016/j.jhazmat.2008.12.141; Khandaker MU, 2015, RADIAT PROT DOSIM, V167, P196, DOI 10.1093/rpd/ncv243; Kim SK, 2005, J BIOSCI BIOENG, V99, P109, DOI 10.1263/jbb.99.109; Kolodynska D, 2012, CHEM ENG J, V197, P295, DOI 10.1016/j.cej.2012.05.025; Li SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043328; MAHMUD HNME, 2014, INT J TECHNICAL RES, V11, P04; Mansour MS, 2011, DESALINATION, V272, P301, DOI 10.1016/j.desal.2011.01.037; Memon SQ, 2007, J HAZARD MATER, V139, P116, DOI 10.1016/j.jhazmat.2006.06.013; Olatunji MA, 2015, RSC ADV, V5, P71658, DOI 10.1039/c5ra10598f; Olatunji MA, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/12/125002; Omraei M, 2011, DESALINATION, V271, P248, DOI 10.1016/j.desal.2010.12.038; Pignatello JJ, 2011, WILEY-IUPAC SER BIOP, P3; Rao RAK, 2016, ARAB J CHEM, V9, pS1233, DOI 10.1016/j.arabjc.2012.01.010; Regmi P, 2012, J ENVIRON MANAGE, V109, P61, DOI 10.1016/j.jenvman.2012.04.047; Salim R, 2008, CHEM ENG J, V102, P249; Seid L, 2014, J TAIWAN INST CHEM E, V45, P2969, DOI 10.1016/j.jtice.2014.08.030; Semerjian L, 2010, J HAZARD MATER, V173, P236, DOI 10.1016/j.jhazmat.2009.08.074; Taty-Costodes VC, 2003, J HAZARD MATER, V105, P121, DOI 10.1016/j.jhazmat.2003.07.009; Wahab MA, 2010, BIORESOURCE TECHNOL, V101, P5070, DOI 10.1016/j.biortech.2010.01.121; Weidlich C, 2005, ELECTROCHIM ACTA, V50, P5247, DOI 10.1016/j.electacta.2005.02.083; Weidlich C, 2001, ELECTROCHIM ACTA, V47, P741, DOI 10.1016/S0013-4686(01)00754-X; Xia GS, 2001, ENVIRON SCI TECHNOL, V35, P84, DOI 10.1021/es001320l; Yu B, 2000, J HAZARD MATER, V80, P33, DOI 10.1016/S0304-3894(00)00278-8	32	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164119	10.1371/journal.pone.0164119	http://dx.doi.org/10.1371/journal.pone.0164119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706232	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697200086
J	Tassia, MG; Cannon, JT; Konikoff, CE; Shenkar, N; Halanych, KM; Swalla, BJ				Tassia, Michael G.; Cannon, Johanna T.; Konikoff, Charlotte E.; Shenkar, Noa; Halanych, Kenneth M.; Swalla, Billie J.			The Global Diversity of Hemichordata	PLOS ONE			English	Review							ACORN WORM HEMICHORDATA; DEUTEROSTOME PHYLOGENY; SPECIES HEMICHORDATA; MOLECULAR PHYLOGENY; 18S RDNA; ENTEROPNEUSTA; HARRIMANIIDAE; RHABDOPLEURA; EXPRESSION; EVOLUTION	Phylum Hemichordata, composed of worm-like Enteropneusta and colonial Pterobranchia, has been reported to only contain about 100 species. However, recent studies of hemichordate phylogeny and taxonomy suggest the species number has been largely underestimated. One issue is that species must be described by experts, and historically few taxonomists have studied this group of marine invertebrates. Despite this previous lack of coverage, interest in hemichordates has piqued in the past couple of decades, as they are critical to understanding the evolution of chordates-as acorn worms likely resemble the deuterostome ancestor more closely than any other extant animal. This review provides an overview of our current knowledge of hemichordates, focusing specifically on their global biodiversity, geographic distribution, and taxonomy. Using information available in the World Register of Marine Species and published literature, we assembled a list of 130 described, extant species. The majority (83%) of these species are enteropneusts, and more taxonomic descriptions are forthcoming. Ptychoderidae contained the greatest number of species (41 species), closely followed by Harrimaniidae (40 species), of the recognized hemichordate families. Hemichordates are found throughout the world's oceans, with the highest reported numbers by regions with marine labs and diligent taxonomic efforts (e. g. North Pacific and North Atlantic). Pterobranchs are abundant in Antarctica, but have also been found at lower latitudes. We consider this a baseline report and expect new species of Hemichordata will continue to be discovered and described as new marine habitats are characterized and explored.	[Tassia, Michael G.; Konikoff, Charlotte E.; Shenkar, Noa; Swalla, Billie J.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Tassia, Michael G.; Cannon, Johanna T.; Shenkar, Noa; Halanych, Kenneth M.; Swalla, Billie J.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA; [Tassia, Michael G.; Cannon, Johanna T.; Halanych, Kenneth M.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Cannon, Johanna T.] Nat Hist Riksmuseet, Dept Zool, SE-10405 Stockholm, Sweden; [Shenkar, Noa] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, Tel Aviv, Israel	University of Washington; University of Washington Seattle; University of Washington; Auburn University System; Auburn University; Tel Aviv University	Swalla, BJ (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.; Swalla, BJ (corresponding author), Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA.	bjswalla@u.washington.edu	Cannon, Johanna/V-3842-2019	Cannon, Johanna/0000-0002-3920-7741; Tassia, Michael/0000-0002-5485-8155				Allman G.J., 1869, REP BR ASS ADVMT SCI, V1868, P311; Andersson K, 1907, SCI RESULTS SWEDISH, V5, P1; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Barrington E. J., 1965, BIOL HEMICHORDATA PR; Bateson W, 1885, Q J MICROSC SCI, V25, P81; BEKLEMISHEV V. N., 1951, USPEKHI SOVREMENNOI BIOL, V32, P256; Benito-Gutierrez E, 2009, CURR BIOL, V19, pR640, DOI 10.1016/j.cub.2009.06.020; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Brown FD, 2008, GENESIS, V46, P605, DOI 10.1002/dvg.20471; Cameron CB, 2010, ZOOTAXA, P1; Cameron CB, 2005, CAN J ZOOL, V83, P196, DOI 10.1139/Z04-190; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Cameron CB, 2002, BIOL BULL, V202, P182, DOI 10.2307/1543654; Cameron CB, 2002, BIOL BULL, V202, P192, DOI 10.2307/1543655; Cannon JT, 2014, CURR BIOL, V24, P2827, DOI 10.1016/j.cub.2014.10.016; Cannon JT, 2013, BIOL BULL-US, V225, P194, DOI 10.1086/BBLv225n3p194; Cannon JT, 2009, MOL PHYLOGENET EVOL, V52, P17, DOI 10.1016/j.ympev.2009.03.027; Caron JB, 2013, NATURE, V495, P503, DOI 10.1038/nature12017; Crowther P.R., 1981, Special Papers in Palaeontology, P1; Davidson B, 2004, MODULARITY IN DEVELOPMENT AND EVOLUTION, P443; Deland C, 2010, ZOOTAXA, P1; Department of Invertebrate Zoology, 2011, RES COLL INF SYST; ESCHSCHoLTZ J.F., 1825, ISIS OKEN, V16-17, P733; Gerhart J, 2005, CURR OPIN GENET DEV, V15, P461, DOI 10.1016/j.gde.2005.06.004; Gillis JA, 2012, P ROY SOC B-BIOL SCI, V279, P237, DOI 10.1098/rspb.2011.0599; GILMOUR THJ, 1979, CAN J ZOOL, V57, P1136, DOI 10.1139/z79-143; Giray C, 1996, P BIOL SOC WASH, V109, P430; Halanych KM, 1995, MOL PHYLOGENET EVOL, V4, P72, DOI 10.1006/mpev.1995.1007; Halanych KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3738; Halanych KM, 1996, BIOL BULL-US, V190, P1, DOI 10.2307/1542669; HALANYCH KM, 1993, BIOL BULL, V185, P417, DOI 10.2307/1542482; Harmer S., 1905, SIBOGA EXPEDITION MO, P1; HART MW, 1994, MAR BIOL, V120, P521, DOI 10.1007/BF00350072; Holland LZ, 2001, DEV BIOL, V232, P493, DOI 10.1006/dbio.2001.0160; Holland ND, 2005, NATURE, V434, P374, DOI 10.1038/nature03382; Holland ND, 2012, P BIOL SOC WASH, V125, P228, DOI 10.2988/12-11.1; Holland ND, 2012, J MORPHOL, V273, P661, DOI 10.1002/jmor.20013; Holland ND, 2009, ZOOSYSTEMA, V31, P333, DOI 10.5252/z2009n2a6; Hou XG, 2011, CURR BIOL, V21, P612, DOI 10.1016/j.cub.2011.03.005; Humphreys T, 2010, ZOOL SCI, V27, P91, DOI 10.2108/zsj.27.91; Hyman LH., 1959, INVERTEBRATES, VV; International Oceanic Commission of UNESCO, 2007, OC BIOG INF SYST 200; Jones DOB, 2013, DEEP-SEA RES PT II, V98, P374, DOI 10.1016/j.dsr2.2013.05.009; KING GM, 1994, P BIOL SOC WASH, V107, P383; KING GM, 1995, MAR BIOL, V123, P369, DOI 10.1007/BF00353628; KOZLOWSKI R, 1949, CR HEBD ACAD SCI, V228, P1505; Lankester R., 1877, HDB ZOOLOGIE ORDER B, P1; LESTER SM, 1985, MAR BIOL, V85, P263, DOI 10.1007/BF00393246; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Luttrell S, 2012, INTEGR COMP BIOL, V52, P829, DOI 10.1093/icb/ics117; Maletz J, 2014, PALAEOGEOGR PALAEOCL, V398, P16, DOI 10.1016/j.palaeo.2013.06.010; Metschnikoff V. E., 1881, ZOOL ANZ, V4, P139; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; MIntosh W.C., 1887, CHALLENGER REPORTS Z, V20, P1; Mitchell CE, 2013, LETHAIA, V46, P34, DOI 10.1111/j.1502-3931.2012.00319.x; Murray J., 1895, SUMMARY SCI RESULTS; Nakajima Y, 2004, ZOOL SCI, V21, P69, DOI 10.2108/zsj.21.69; NEWELL GE, 1952, P ZOOL SOC LOND, V121, P741; NOAA/NOS/NCCOS/CCMA/Biogeography Branch, 2011, USVI FISH ASS MON DA; Nomaksteinsky M, 2009, CURR BIOL, V19, P1264, DOI 10.1016/j.cub.2009.05.063; O'Hara TD, 2014, CURR BIOL, V24, P1874, DOI 10.1016/j.cub.2014.06.060; Okuda S., 1939, Journal of the Faculty of Science Hokkaido University Zoology, V7, P17; Osborn KJ, 2013, BIOL BULL-US, V225, P113, DOI 10.1086/BBLv225n2p113; Osborn KJ, 2012, P ROY SOC B-BIOL SCI, V279, P1646, DOI 10.1098/rspb.2011.1916; Palomares M, 2011, SEALIFEBASE VANCOUVE; Peterson KJ, 2013, J EXP ZOOL PART B, V320, P368, DOI 10.1002/jez.b.22510; Peterson KJ, 1999, DEVELOPMENT, V126, P85; Priede IG, 2012, INVERTEBR BIOL, V131, P244, DOI 10.1111/j.1744-7410.2012.00266.x; Punnett R., 1903, FAUNA GEOGRAPHY MALD, VII, P631; Ritter W. E., 1900, P WASH ACAD SCI, V2, P111; Ruggiero M, 2011, SPECIES 2000 ITIS CA; Rychel AL, 2008, DEV DYNAM, V237, P3222, DOI 10.1002/dvdy.21747; Rychel AL, 2009, STEM CELLS IN MARINE ORGANISMS, P245, DOI 10.1007/978-90-481-2767-2_10; Sato A, 2008, J MAR BIOL ASSOC UK, V88, P1033, DOI 10.1017/S0025315408001604; Sato A, 2009, P NATL ACAD SCI USA, V106, P7491, DOI 10.1073/pnas.0810430106; Sato A, 2008, LETHAIA, V41, P303, DOI 10.1111/j.1502-3931.2008.00123.x; Sato A, 2008, GENESIS, V46, P587, DOI 10.1002/dvg.20395; SATO TADAO, 1936, ZOOL ANZ, V115, P97; SAWAYA P, 1951, NATURE, V167, P730, DOI 10.1038/167730b0; SCHELTEMA RS, 1970, MAR BIOL, V7, P47, DOI 10.1007/BF00346807; Shenkar N, 2015, HEMICHORDATA WORLD D; Smith AB, 2008, EVOL DEV, V10, P493, DOI 10.1111/j.1525-142X.2008.00260.x; Smith SE, 2003, CAN J ZOOL, V81, P133, DOI 10.1139/Z02-228; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spengel J.W., 1893, ENTEROPNEUSTEN GOLFE; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; Swalla BJ, 2007, PRINICPLES DEV GENET, DOI [1016/j.ympev.2009.03.027, 10.1098/rspb.2011.1916, DOI 10.1098/RSPB.2011.1916]; Takacs CM, 2002, EVOL DEV, V4, P405, DOI 10.1046/j.1525-142X.2002.02029.x; TURBEVILLE JM, 1994, MOL BIOL EVOL, V11, P648; Urata M, 2004, ZOOL SCI, V21, P533, DOI 10.2108/zsj.21.533; Urata M, 2014, EVOL DEV, V16, P149, DOI 10.1111/ede.12075; van der Horst C., 1939, BRONNS KLASSEN ORDNU; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; WELSCH U, 1970, Z ZELLFORSCH MIK ANA, V107, P234, DOI 10.1007/BF00335227; Willey A., 1899, WILLEYS ZOOLOGICAL R, VIII, P32, DOI DOI 10.5962/BHL.TITLE.82497; Woodwick Keith H., 1996, P251; WOODWICK KH, 1985, P BIOL SOC WASH, V98, P351; WoRMS Editorial Board, 2015, WORLD REGISTER MARIN; Worsaae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048529; Xu C, 2006, GEOL J, V41, P289, DOI 10.1002/gj.1051	100	22	22	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0162564	10.1371/journal.pone.0162564	http://dx.doi.org/10.1371/journal.pone.0162564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701429	Green Submitted, Green Published, gold			2022-12-27	WOS:000385696900002
J	Zhou, H; Wang, YP; Lv, QY; Zhang, J; Wang, Q; Gao, F; Hou, HL; Zhang, H; Zhang, W; Li, LJ				Zhou, Hong; Wang, Yapei; Lv, Qiongying; Zhang, Juan; Wang, Qing; Gao, Fei; Hou, Haoli; Zhang, Hao; Zhang, Wei; Li, Lijia			Overexpression of Ribosomal RNA in the Development of Human Cervical Cancer Is Associated with rDNA Promoter Hypomethylation	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; DNA METHYLATION; HISTONE MODIFICATION; GENE; HYPERMETHYLATION; PROTEIN; EPIGENETICS; SUPPRESSION; EXPRESSION; TUMORS	The ribosomal RNA (rRNA) gene encodes rRNA for protein synthesis. Aberrant expression of the rRNA gene has been generally observed in tumor cells and levels of its promoter methylation as an epigenetic regulator affect rRNA gene transcription. The possible relationship between expression and promoter methylation of rDNA has not been examined in human clinical cervical cancer. Here we investigate rRNA gene expression by quantitative real time PCR, and promoter methylation levels by HpaII/MspI digestion and sodium bisulfite sequencing in the development of human cervical cancer. We find that indeed rRNA levels are elevated in most of cervical intraepithelial neoplasia (CIN) specimens as compared with non-cancer tissues. The rDNA promoter region in cervical intraepithelial neoplasia (CIN) tissues reveals significant hypomethylation at cytosines in the context of CpG dinucleotides, accompanied with rDNA chromatin decondensation. Furthermore treatment of HeLa cells with the methylation inhibitor drug 5-aza-2'-deoxycytidine (DAC) demonstrates the negative correlation between the expression of 45S rDNA and the methylation level in the rDNA promoter region. These data suggest that a decrease in rDNA promoter methylation levels can result in an increase of rRNA synthesis in the development of human cervical cancer.	[Zhou, Hong; Wang, Yapei; Wang, Qing; Gao, Fei; Hou, Haoli; Zhang, Hao; Li, Lijia] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Peoples R China; [Lv, Qiongying; Zhang, Juan; Zhang, Wei] Wuhan Univ, Zhongnan Hosp, Dept Gynecol & Obstet, Wuhan, Peoples R China	Wuhan University; Wuhan University	Li, LJ (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan, Peoples R China.; Zhang, W (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Gynecol & Obstet, Wuhan, Peoples R China.	zw6676@163.com; ljli@who.edu.cn			National Natural Science Foundation of China [31171186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31171186).	Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BIRD A, 1981, CELL, V26, P381, DOI 10.1016/0092-8674(81)90207-5; Chan MWY, 2005, CLIN CANCER RES, V11, P7376, DOI 10.1158/1078-0432.CCR-05-1100; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Colot V, 1998, J SOC BIOL, V193, P29; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Derenzini M, 1998, AM J PATHOL, V152, P1291; Diesch J, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-43; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Esteller M, 1999, CANCER RES, V59, P67; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Gorski JJ, 2007, EMBO J, V26, P1560, DOI 10.1038/sj.emboj.7601601; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hamperl S, 2013, BBA-GENE REGUL MECH, V1829, P405, DOI 10.1016/j.bbagrm.2012.12.007; Huang M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone., DOI 10.1371/JOURNAL.PONE]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karahan G, 2015, ONCOL REP, V33, P3131, DOI 10.3892/or.2015.3940; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Kobayashi T, 2008, BIOESSAYS, V30, P267, DOI 10.1002/bies.20723; Kobayashi T, 2006, GENES GENET SYST, V81, P155, DOI 10.1266/ggs.81.155; Lawrence RJ, 2004, MOL CELL, V13, P599, DOI 10.1016/S1097-2765(04)00064-4; Lim KY, 2000, CHROMOSOMA, V109, P161; Lima de Faria A, 1976, HEREDITAS; Lu YJ, 2009, CELL CYCLE, V8, P2101, DOI 10.4161/cc.8.13.8927; MacCARTY WM. CARPENTER, 1936, AMER JOUR CANCER, V26, P529; Majumder S, 2006, J BIOL CHEM, V281, P22062, DOI 10.1074/jbc.M601155200; Maloisel L, 1998, GENE DEV, V12, P1381, DOI 10.1101/gad.12.9.1381; McCLINTOCK BARBARA, 1934, ZEITSCHR ZELLJORSCH U MIKROSK ANAT, V21, P294, DOI 10.1007/BF00374060; McGowan PO, 2008, PROMOTER WIDE HYPERM; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Poortinga G, 2015, ONCOGENE, V34, P403, DOI 10.1038/onc.2014.13; Powell MA, 2002, CANCER-AM CANCER SOC, V94, P2941, DOI 10.1002/cncr.10559; Raval A, 2012, BLOOD, V120, P4812, DOI 10.1182/blood-2012-04-423111; Reddy KS, 1998, HUM GENET, V102, P653, DOI 10.1007/s004390050758; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Santoro R, 2005, MOL CELL BIOL, V25, P2539, DOI 10.1128/MCB.25.7.2539-2546.2005; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Stancheva I, 1997, NUCLEIC ACIDS RES, V25, P1727, DOI 10.1093/nar/25.9.1727; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; Tchurikov NA, 2015, J MOL CELL BIOL, V7, P366, DOI 10.1093/jmcb/mju038; Trinh BN, 2002, MOL CELL BIOL, V22, P2906, DOI 10.1128/MCB.22.9.2906-2917.2002; Uemura M, 2012, ONCOGENE, V31, P1254, DOI 10.1038/onc.2011.319; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Williamson D, 2006, GENE CHROMOSOME CANC, V45, P839, DOI 10.1002/gcc.20347; WORTON RG, 1988, SCIENCE, V239, P64, DOI 10.1126/science.3336775; Yu AD, 1998, HUM MOL GENET, V7, P609, DOI 10.1093/hmg/7.4.609	54	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163340	10.1371/journal.pone.0163340	http://dx.doi.org/10.1371/journal.pone.0163340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695092	gold, Green Submitted, Green Published			2022-12-27	WOS:000385553100030
J	Luchters, S; Bosire, W; Feng, A; Richter, ML; King'ola, N; Ampt, F; Temmerman, M; Chersich, MF				Luchters, Stanley; Bosire, Wilkister; Feng, Amy; Richter, Marlise L.; King'ola, Nzioki; Ampt, Frances; Temmerman, Marleen; Chersich, Matthew F.			"A Baby Was an Added Burden": Predictors and Consequences of Unintended Pregnancies for Female Sex Workers in Mombasa, Kenya: A Mixed-Methods Study	PLOS ONE			English	Article							4 AFRICAN COUNTRIES; SUB-SAHARAN AFRICA; HIV-INFECTION; RELATIONSHIP POWER; SOUTH-AFRICA; RISK-FACTORS; SERVICES; CONDOM; NEED; INTERVENTIONS	Introduction Female sex workers (FSW) have high rates of unintended pregnancy, sexually transmitted infections including HIV, and other adverse sexual and reproductive health outcomes. Few services for FSWs include contraception. This mixed-methods study aimed to determine the rate, predictors and consequences of unintended pregnancy among FSWs in Mombasa, Kenya. Methods A prospective cohort study of non-pregnant FSWs was conducted. Quantitative data were collected quarterly, including a structured questionnaire and testing for pregnancy and HIV. Predictors of unintended pregnancy were investigated using multivariate logistic regression. Qualitative data were gathered through focus group discussions and in-depth interviews with FSWs who became pregnant during the study, and interviews with five key informants. These data were transcribed, translated and analysed thematically. Results Four hundred women were enrolled, with 92% remaining in the cohort after one year. Fifty-seven percent reported using a modern contraceptive method (including condoms when used consistently). Over one-third (36%) of women were using condoms inconsistently without another method. Twenty-four percent had an unintended pregnancy during the study. Younger age, having an emotional partner and using traditional or no contraception, or condoms only, were independent predictors of unintended pregnancy. Women attributed pregnancy to forgetting to use contraception and being pressured not to by clients and emotional partners, as well as "bad luck". They described numerous negative consequences of unintended pregnancy. Conclusion Modern contraceptive uptake is surprisingly low in this at-risk population, which in turn has a high rate of unintended pregnancy. The latter may result in financial hardship, social stigma, risk of abandonment, or dangerous abortion practices. FSWs face considerable barriers to the adoption of dual method contraceptive use, including low levels of control in their emotional and commercial relationships. Reproductive health services need to be incorporated into programs for sexually transmitted infections and HIV, which address the socially-determined barriers to contraceptive use.	[Luchters, Stanley; Ampt, Frances] Burnet Inst, Melbourne, Vic, Australia; [Luchters, Stanley; Temmerman, Marleen; Chersich, Matthew F.] Univ Ghent, Dept Obstet & Gynaecol, Int Ctr Reprod Hlth, Ghent, Belgium; [Luchters, Stanley; Ampt, Frances] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Bosire, Wilkister; King'ola, Nzioki] Int Ctr Reprod Hlth, Mombasa, Kenya; [Feng, Amy] Royal Womens Hosp, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Richter, Marlise L.] Univ Cape Town, Dept Publ Hlth & Family Med, Cape Town, South Africa; [Richter, Marlise L.] Univ Witwatersrand, African Ctr Migrat & Soc, Johannesburg, South Africa; [Temmerman, Marleen] WHO, Dept Reprod Hlth Res, Geneva, Switzerland; [Chersich, Matthew F.] Univ Witwatersrand, Ctr Hlth Policy, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Chersich, Matthew F.] Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa	Burnet Institute; Ghent University; Monash University; University of Cape Town; University of Witwatersrand; World Health Organization; University of Witwatersrand; University of Witwatersrand	Luchters, S (corresponding author), Burnet Inst, Melbourne, Vic, Australia.; Luchters, S (corresponding author), Univ Ghent, Dept Obstet & Gynaecol, Int Ctr Reprod Hlth, Ghent, Belgium.; Luchters, S (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	sluchters@burnet.edu.au		chersich, matthew/0000-0002-4320-9168; Ampt, Frances/0000-0001-9419-3007; Luchters, Stanley/0000-0001-5235-5629	Ministry of Health, Government of Kenya; National Health and Medical Research Council of Australia (NHMRC) [GNT1087006]; International Partnership for Microbicides (IPM)	Ministry of Health, Government of Kenya; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); International Partnership for Microbicides (IPM)	Financial support for this study was provided by the International Partnership for Microbicides (IPM: http://www.ipmglobal.org/), the National Health and Medical Research Council of Australia (NHMRC) (project grant GNT1087006, and Career Development Fellowship to S. Luchters). The authors also gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program; The authors thank the Ministry of Health, Government of Kenya, and Dr Annalene Nel of the International Partnership for Microbicides, for their support. We also gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute, and the support provided by the National Health and Medical Research Council of Australia (NHMRC) (Project grant GNT1087006, and Career Development Fellowship to S. Luchters). We would like to sincerely thank the entire ICRH research team in Mombasa for their commendable contributions to the study, the staff at the Chaani clinic and the Kisauni drop-in centre, and all the study participants for their invaluable contribution.	African Population Health Research Center, 2013, INC COMPL UNS AB KEN; Azjen I, 1980, UNDERSTANDING ATTITU; Bandura S, 1986, SOCIAL FDN THOUGHT A; Boudreau CL, 2015, ANN GLOB HEALTH, V81, P217, DOI [10.1016/j.aogh.2015.02.997, DOI 10.1016/J.AOGH.2015.02.997]; Braunstein SL, 2011, SEX TRANSM DIS, V38, P385, DOI 10.1097/OLQ.0b013e31820b8eba; Chersich MF, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-22; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Darroch JE, 2013, LANCET, V381, P1756, DOI 10.1016/S0140-6736(13)60597-8; Delvaux T, 2003, REPROD HEALTH MATTER, V11, P88, DOI 10.1016/S0968-8080(03)02163-3; Deschamps MM, 2016, JAIDS-J ACQ IMM DEF, V71, P70, DOI 10.1097/QAI.0000000000000796; Dhana A, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-46; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Elmore-Meegan M, 2004, REPROD HEALTH MATTER, V12, P50, DOI 10.1016/S0968-8080(04)23125-1; Erickson M, 2015, INT J GYNECOL OBSTET, V131, P91, DOI 10.1016/j.ijgo.2015.04.029; Feldblum PJ, 2007, CONTRACEPTION, V76, P105, DOI 10.1016/j.contraception.2007.04.009; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Hawken MP, 2002, SEX TRANSM INFECT, V78, P271, DOI 10.1136/sti.78.4.271; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute, 2015, KEN DEM HLTH SURV 20; Kenya National Bureau of Statistics; Ministry of Health; National AIDS Control Council; The DHS Program ICF International KDHS, 2003, KEN DEM HLTH SURV 20; Khan MR, 2009, CONTRACEPTION, V79, P221, DOI 10.1016/j.contraception.2008.09.011; Kyalo J, 2015, IMPACT NOW APPL KENY; Luchters S, 2007, EUR J CONTRACEP REPR, V12, P345, DOI 10.1080/13625180701516989; Luchters S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068855; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Luchters SMF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-18; Maher L, 2013, GLOB PUBLIC HEALTH, V8, P270, DOI 10.1080/17441692.2013.767930; Musyoki H, 2015, AIDS BEHAV, V19, pS46, DOI 10.1007/s10461-014-0919-4; Mwaikambo L, 2011, STUD FAMILY PLANN, V42, P67, DOI 10.1111/j.1728-4465.2011.00267.x; National AIDS and STI Control Programme National AIDS Council Kenya, 2012, GEOGR MAPP MOST RISK; Ngethe PN, 2014, FAMILY PLANNING KENY; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Okal J, 2008, CULT HEALTH SEX, V10, P13, DOI 10.1080/13691050701519730; Okal J, 2011, AIDS CARE, V23, P612, DOI 10.1080/09540121.2010.525605; Onyango MA, 2014, UNDERSTANDIN RELATIO, P1; Papworth E, 2015, JAIDS-J ACQ IMM DEF, V68, pS154, DOI 10.1097/QAI.0000000000000454; Policar M., 2011, CONTRACEPTIVE TECHNO; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Richter M, 2013, SAMJ S AFR MED J, V103, P246, DOI [10.7196/SAMJ.6170, 10.7196/samj.6170]; Schwartz S, 2015, JAIDS-J ACQ IMM DEF, V68, pS91, DOI 10.1097/QAI.0000000000000448; Scorgie F, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-33; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Sutherland EG, 2011, EUR J CONTRACEP REPR, V16, P173, DOI 10.3109/13625187.2011.564683; Thomsen SC, 2006, SEX TRANSM INFECT, V82, P397, DOI 10.1136/sti.2006.019992; Traore IT, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20088; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Wall KM, 2013, JAIDS-J ACQ IMM DEF, V63, P86, DOI 10.1097/QAI.0b013e31827ee19c; Weldegebreal R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1366-5; WHO. AUDIT, 2009, ALC DIS ID TEST GUID; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Yam EA, 2013, HEALTH CARE WOMEN IN, V34, P249, DOI 10.1080/07399332.2012.736576	51	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0162871	10.1371/journal.pone.0162871	http://dx.doi.org/10.1371/journal.pone.0162871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DX4CZ	27689699	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200008
J	Binder, NK; Evans, J; Salamonsen, LA; Gardner, DK; Kaitu'u-Lino, TJ; Hannan, NJ				Binder, Natalie K.; Evans, Jemma; Salamonsen, Lois A.; Gardner, David K.; Kaitu'u-Lino, Tu'uhevaha J.; Hannan, Natalie J.			Placental Growth Factor Is Secreted by the Human Endometrium and Has Potential Important Functions during Embryo Development and Implantation	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; FACTOR VEGF; CELL-LINE; EXPRESSION; ANGIOGENESIS; FIBRONECTIN; ADHESION; INTERLEUKIN-11; EPITHELIUM; MEDIATORS	Embryo implantation requires synchronized dialogue between the receptive endometrium and activated blastocyst via locally produced soluble mediators. During the mid-secretory (MS) phase of the menstrual cycle, increased glandular secretion into the uterine lumen provides important mediators that modulate the endometrium and support the conceptus during implantation. Previously we demonstrated the importance of vascular endothelial growth factor (VEGF) in the human uterus, particularly with respect to embryo implantation. In the current study, proteomic analysis of human uterine lavage fluid identified the presence of placental growth factor (PlGF) a homolog of VEGF, that binds the VEGF receptor 1 (VEGFR1). Analysis of immunostaining for PlGF in human endometrial tissue across the menstrual cycle (from both fertile and infertile women) revealed PlGF was predominantly localised to glandular and luminal epithelial cells, with staining in the decidualising stromal cells surrounding the maternal spiral arteries in the secretory phase of the menstrual cycle. Immunoreactive PlGF was also detected in subpopulations of endometrial leukocytes. Functional studies demonstrated that culturing mouse embryos with recombinant human (rh) PlGF enhanced blastocyst cell number and outgrowth. Furthermore, treatment of human endometrial epithelial cells (EEC) with rhPlGF enhanced EEC adhesion. Taken together, these data demonstrate that PlGF is abundant in the human endometrium, and secreted into the uterine lumen where it mediates functional changes in cellular adhesion with important roles in implantation.	[Binder, Natalie K.; Kaitu'u-Lino, Tu'uhevaha J.; Hannan, Natalie J.] Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic 3084, Australia; [Binder, Natalie K.; Gardner, David K.; Hannan, Natalie J.] Univ Melbourne, Sch BioSci, Parkville, Vic 3010, Australia; [Evans, Jemma; Salamonsen, Lois A.] Hudson Inst Med Res, 27-31 Wright St, Clayton, Vic 3168, Australia; [Evans, Jemma] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Salamonsen, Lois A.] Monash Univ, Dept Obstet & Gynecol, Clayton, Vic 3168, Australia	University of Melbourne; University of Melbourne; Hudson Institute of Medical Research; Monash University; Monash University	Hannan, NJ (corresponding author), Univ Melbourne, Mercy Hosp Women, Dept Obstet & Gynaecol, Translat Obstet Grp, Heidelberg, Vic 3084, Australia.; Hannan, NJ (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic 3010, Australia.	nhannan@unimelb.edu.au	Salamonsen, Lois/J-9822-2019	Salamonsen, Lois/0000-0003-0558-7325; Kaitu'u-Lino, Tu'uhevaha/0000-0001-6233-9737; Hannan, Natalie/0000-0001-8446-2250; evans, jemma/0000-0002-3300-8127; Binder, Natalie K/0000-0002-8943-2269	University of Melbourne [601040]; National Health and Medical Research Council of Australia [1002028, 628927, 1047056]; Monash IVF Research and Education Foundation; Victorian Government's Operational Infrastructure Program; Australian Postgraduate Award	University of Melbourne(University of Melbourne); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Monash IVF Research and Education Foundation; Victorian Government's Operational Infrastructure Program; Australian Postgraduate Award(Australian Government)	This work was supported by a University of Melbourne Early Career Researcher Grant #601040 and the National Health and Medical Research Council of Australia Fellowships (#1002028 to LAS, # 628927 to NJH) and project (#1047056) grants. Work at the Hudson Institute was also supported by Monash IVF Research and Education Foundation and the Victorian Government's Operational Infrastructure Program. NKB was supported by an Australian Postgraduate Award.	Aplin J, 2000, SEMIN CELL DEV BIOL, V11, P115, DOI 10.1006/scdb.2000.0157; Binder NK, 2014, HUM REPROD, V29, P2278, DOI 10.1093/humrep/deu211; Binder NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052304; Boomsma CM, 2009, REPROD BIOMED ONLINE, V18, P85, DOI 10.1016/S1472-6483(10)60429-4; Bottomley MJ, 2000, CLIN EXP IMMUNOL, V119, P182, DOI 10.1046/j.1365-2249.2000.01097.x; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Chen XY, 2015, FERTIL STERIL, V104, P1030, DOI 10.1016/j.fertnstert.2015.06.021; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; DESAI NN, 1994, FERTIL STERIL, V61, P760; Dimitriadis E, 2006, J REPROD IMMUNOL, V69, P53, DOI 10.1016/j.jri.2005.07.004; Gardner David K, 2014, Methods Mol Biol, V1092, P167, DOI 10.1007/978-1-60327-292-6_11; Gardner DK, 2007, IN VITRO FERTILIZATI, P221; Girling JE, 2009, REPRODUCTION, V138, P883, DOI 10.1530/REP-09-0147; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Gray CA, 2001, BIOL REPROD, V65, P1311, DOI 10.1095/biolreprod65.5.1311; Hannan NJ, 2012, REPROD SCI, V19, P1125, DOI 10.1177/1933719112443879; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hannan NJ, 2010, J PROTEOME RES, V9, P6256, DOI 10.1021/pr1004828; Hannan NJ, 2009, J PROTEOME RES, V8, P1099, DOI 10.1021/pr800811y; Hempstock Joanne, 2004, Reprod Biol Endocrinol, V2, P58, DOI 10.1186/1477-7827-2-58; Khaliq A, 1996, GROWTH FACTORS, V13, P243, DOI 10.3109/08977199609003225; King AE, 2002, MOL HUM REPROD, V8, P341, DOI 10.1093/molehr/8.4.341; Lane M, 2004, LAB GUIDE MAMMALIAN, P24; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Loke YW, 2000, J REPROD FERTIL, P83; MAGLIONE D, 1993, GROWTH FACTORS, V8, P141, DOI 10.3109/08977199309046934; Mikolajczyk M, 2006, HUM REPROD, V21, P3054, DOI 10.1093/humrep/del225; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Moller B, 2001, MOL HUM REPROD, V7, P65, DOI 10.1093/molehr/7.1.65; Navot D., 1991, ANN NY ACAD SCI, V622, P212, DOI 10.1111/j.1749-6632.1991.tb37864.x; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; PARK JE, 1994, J BIOL CHEM, V269, P25646; Persico MG, 1999, CURR TOP MICROBIOL, V237, P31; Shimomura Y, 2006, MOL HUM REPROD, V12, P491, DOI 10.1093/molehr/gal019; Simon C, 1996, J REPROD IMMUNOL, V31, P165, DOI 10.1016/0165-0378(96)00982-5; Singh H, 2009, J ANAT, V215, P3, DOI 10.1111/j.1469-7580.2008.01034.x; Spencer T E, 2004, J Anim Sci, V82 E-Suppl, pE4; THORSTEINSDOTTIR S, 1992, ANAT RECORD, V232, P141, DOI 10.1002/ar.1092320116; VIGLIETTO G, 1995, ONCOGENE, V11, P1569; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Vuorela P, 1997, BIOL REPROD, V56, P489, DOI 10.1095/biolreprod56.2.489; Wang J, 2002, DEV BIOL, V245, P270, DOI 10.1006/dbio.2002.0644; White FJ, 2006, REPRODUCTION, V132, P919, DOI 10.1530/REP-06-0068	46	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163096	10.1371/journal.pone.0163096	http://dx.doi.org/10.1371/journal.pone.0163096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711226	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600013
J	Diwan, V; Gustafsson, C; Klintz, SR; Joshi, SC; Joshi, R; Sharma, M; Shah, H; Pathak, A; Tamhankar, AJ; Lundborg, CS				Diwan, Vishal; Gustafsson, Charlotte; Klintz, Senia Rosales; Joshi, Sudhir Chandra; Joshi, Rita; Sharma, Megha; Shah, Harshada; Pathak, Ashish; Tamhankar, Ashok J.; Lundborg, Cecilia Stalsby			Understanding Healthcare Workers Self-Reported Practices, Knowledge and Attitude about Hand Hygiene in a Medical Setting in Rural India	PLOS ONE			English	Article							ROLE-MODELS; ADHERENCE; BEHAVIOR; PERCEPTIONS; CAMPAIGNS; INFECTION; DESIGN; UNITS; RISK	Aim To describe self-reported practices and assess knowledge and attitudes regarding hand hygiene among healthcare workers in a rural Indian teaching hospital. Setting A rural teaching hospital and its associated medical and nursing colleges in the district of Ujjain, India. Method The study population consisted of physicians, nurses, teaching staff, clinical instructors and nursing students. Self-administered questionnaires based on the World Health Organization Guidelines on Hand Hygiene in Healthcare were used. Results Out of 489 healthcare workers, 259 participated in the study (response rate = 53%). The proportion of healthcare workers that reported to 'always' practice hand hygiene in the selected situations varied from 40-96% amongst categories. Reported barriers to maintaining good hand hygiene were mainly related to high workload, scarcity of resources, lack of scientific information and the perception that priority is not given to hand hygiene, either on an individual or institutional level. Previous training on the topic had a statistically significant association with self-reported practice (p = 0.001). Ninety three per cent of the respondents were willing to attend training on hand hygiene in the near future. Conclusion Self-reported knowledge and adherence varied between situations, but hand hygiene practices have the potential to improve if the identified constraints could be reduced. Future training should focus on enhancing healthcare workers' knowledge and understanding regarding the importance of persistent practice in all situations.	[Diwan, Vishal; Gustafsson, Charlotte; Klintz, Senia Rosales; Sharma, Megha; Pathak, Ashish; Tamhankar, Ashok J.; Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Diwan, Vishal] RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India; [Diwan, Vishal] RD Gardi Med Coll, Int Ctr Hlth Res, Ujjain, Madhya Pradesh, India; [Joshi, Sudhir Chandra] RD Gardi Med Coll, Dept Community Med, Ujjain, Madhya Pradesh, India; [Joshi, Rita; Shah, Harshada] RD Gardi Med Coll, Dept Microbiol, Ujjain, Madhya Pradesh, India; [Sharma, Megha] RD Gardi Med Coll, Dept Pharmacol, Ujjain, Madhya Pradesh, India; [Pathak, Ashish] RD Gardi Med Coll, Dept Pediat, Ujjain, Madhya Pradesh, India; [Pathak, Ashish] Uppsala Univ, Dept Women & Childrens Hlth, Int Maternal & Child Hlth Unit, Uppsala, Sweden; [Tamhankar, Ashok J.] RD Gardi Med Coll, Dept Environm Med, Indian Initiat Management Antibiot Resistance, Ujjain, Madhya Pradesh, India	Karolinska Institutet; Uppsala University	Diwan, V (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.; Diwan, V (corresponding author), RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India.; Diwan, V (corresponding author), RD Gardi Med Coll, Int Ctr Hlth Res, Ujjain, Madhya Pradesh, India.	vishaldiwan@hotmail.com	Pathak, Ashish/N-2303-2019; Pathak, Ashish/Y-1821-2019; Sharma, Megha/AAJ-1119-2021	Pathak, Ashish/0000-0002-7576-895X; Sharma, Megha/0000-0001-9165-9393; Stalsby Lundborg, Cecilia/0000-0001-6525-1861; Diwan, Vishal/0000-0001-7948-8579; Rosales Klintz, Senia/0000-0002-2897-6123	Swedish Research Council [K2007-70X-20514-01-3]; Erasmus Mundus External Co-operation Window Lot 15 India postdoctoral scholarship at Karolinska Institutet; Swedish Institute; Erasmus Mundus External Co-operation Window Lot 15 India; Swedish Research School for Global Health at Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Erasmus Mundus External Co-operation Window Lot 15 India postdoctoral scholarship at Karolinska Institutet; Swedish Institute; Erasmus Mundus External Co-operation Window Lot 15 India; Swedish Research School for Global Health at Karolinska Institutet	This study is part of a project funded by the Swedish Research Council (K2007-70X-20514-01-3). VD and MS received an Erasmus Mundus External Co-operation Window Lot 15 India postdoctoral scholarship at Karolinska Institutet. VD received a scholarship from the Swedish Institute. AP received scholarships from Erasmus Mundus External Co-operation Window Lot 15 India and the Swedish Research School for Global Health for doctoral studies at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegranzi B, 2010, INFECT CONT HOSP EP, V31, P133, DOI 10.1086/649796; Alp Emine, 2011, J Infect Public Health, V4, P80, DOI 10.1016/j.jiph.2011.03.001; Anargh V, 2013, Med J Armed Forces India, V69, P54, DOI 10.1016/j.mjafi.2012.08.011; Anwar Muhammad Ali, 2009, JPMA Journal of the Pakistan Medical Association, V59, P631; Ayub Afreen, 2013, Med J Armed Forces India, V69, P107, DOI 10.1016/j.mjafi.2012.07.021; Biswal M, 2014, AM J INFECT CONTROL, V42, P1009, DOI 10.1016/j.ajic.2014.05.025; Biswal M, 2013, AM J INFECT CONTROL, V41, P1114, DOI 10.1016/j.ajic.2013.05.026; Biswas P, 2014, INDIAN J PEDIATR, V81, P967, DOI 10.1007/s12098-013-1150-4; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Chacko LK, 2014, J PATIENT SAFETY INF, V2, P55, DOI [10.1016/j.jpsic.2014.06.006, DOI 10.1016/J.JPSIC.2014.06.006]; Chakravarthy M, 2015, J INFECT PUBLIC HEAL, V8, P177, DOI 10.1016/j.jiph.2014.08.004; Chavali S, 2014, INDIAN J CRIT CARE M, V18, P689, DOI 10.4103/0972-5229.142179; Cohen B, 2003, PEDIATR INFECT DIS J, V22, P494, DOI 10.1097/00006454-200306000-00003; Creedon Sile A, 2006, Clin Nurs Res, V15, P6, DOI 10.1177/1054773805282445; Damani N, 2011, IFIC BASIC CONCEPTS, P361; Daniels IR, 1999, ANN ROY COLL SURG, V81, P117; de Costa A, 2007, HEALTH POLICY, V84, P269, DOI 10.1016/j.healthpol.2007.04.004; Erasmus V, 2009, INFECT CONT HOSP EP, V30, P415, DOI 10.1086/596773; Harris AD, 2000, J HOSP INFECT, V45, P318, DOI 10.1053/jhin.2000.0781; Jenner EA, 2006, J HOSP INFECT, V63, P418, DOI 10.1016/j.jhin.2006.03.012; Joshi SC, 2012, J HOSP INFECT, V80, P340, DOI 10.1016/j.jhin.2011.12.017; Lam BCC, 2004, PEDIATRICS, V114, pE565, DOI 10.1542/peds.2004-1107; Lankford MG, 2003, EMERG INFECT DIS, V9, P217; Lundborg CS, 2014, UPSALA J MED SCI, V119, P125, DOI 10.3109/03009734.2014.905664; Mahfouz AA, 2014, J EPIDEMIOL GLOB HEA, V4, P315, DOI 10.1016/j.jegh.2014.05.002; Mathai E, 2010, INDIAN J MED MICROBI, V28, P100, DOI 10.4103/0255-0857.62483; Mathur Purva, 2011, Indian J Med Res, V134, P611, DOI 10.4103/0971-5916.90985; Mathur P, 2011, AM J INFECT CONTROL, V39, P705, DOI 10.1016/j.ajic.2011.01.017; Moret L, 2004, AM J INFECT CONTROL, V32, P384, DOI 10.1016/j.ajic.2004.02.004; Nair Sreejith Sasidharan, 2014, ISRN Prev Med, V2014, P608927, DOI 10.1155/2014/608927; Pittet D, 2000, INFECT CONT HOSP EP, V21, P381, DOI 10.1086/501777; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4; Rotter ML, 1999, HOSP EPIDEMIOL INFEC, P1339; Salati Sajad Ahmad, 2014, Int Sch Res Notices, V2014, P591879, DOI 10.1155/2014/591879; Salmon S, 2014, AM J INFECT CONTROL, V42, P71, DOI 10.1016/j.ajic.2013.07.011; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Sax H, 2007, INFECT CONT HOSP EP, V28, P1267, DOI 10.1086/521663; Sharma Sarit, 2011, Indian J Community Med, V36, P217, DOI 10.4103/0970-0218.86524; Snow M, 2006, AM J INFECT CONTROL, V34, P18, DOI 10.1016/j.ajic.2005.05.009; Wendt C, 2004, INFECT CONT HOSP EP, V25, P203, DOI 10.1086/502378; Whitby M, 2006, INFECT CONT HOSP EP, V27, P484, DOI 10.1086/503335; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; WHO, 2011, WHO LIB CAT PUBL DAT; World Health Organization, 2009, WHO GUID HAND HYG HL	47	20	20	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163347	10.1371/journal.pone.0163347	http://dx.doi.org/10.1371/journal.pone.0163347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711173	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600021
J	Han, SB; Yoon, YC; Kwon, JW				Han, Sol Bee; Yoon, Young Cheol; Kwon, Jong Won			Comparison Study between Conventional Sequence and Slice-Encoding Metal Artifact Correction (SEMAC) in the Diagnosis of Postoperative Complications in Patients Receiving Lumbar Inter-Body Fusion and Pedicle Screw Fixation Surgery	PLOS ONE			English	Article							MRI; SPINE; ARTHROPLASTY; IMPLANTS; REDUCTION; HARDWARE; DTPA	Background and Purpose Slice-Encoding Metal Artifact Correction (SEMAC) sequence is one of the metal artifact reduction techniques of anatomical structure, but there has been no report about evaluation of post-operative complications. The purpose of this article is to compare the anatomical visibility between fast spin echo (FSE) and FSE-SEMAC and to evaluate the additional value of FSE-SEMAC in diagnostic confidence of the complications. Materials and Methods We conducted a retrospective study with 54 patients who received lumbar spinal surgery and MR images including FSE-SEMAC. For the semi-quantitative evaluation, the visibility of anatomical structures (neural foramen, bone-inter-body cage interface, central canal, nerve root in epidural space, back muscle, and bone-pedicle screw interface) was evaluated. For qualitative evaluation, we evaluated FSE and FSE with FSE-SEMAC independently, and recorded the diagnostic confidence level of post-operative complications. Generalized estimating equation regression analysis was used for statistical analysis, and a weighted kappa was used for inter-observer agreement. Results Scores of 6 imaging findings with FSE-SEMAC were significantly higher than that of FSE (P-value < .0001). Inter-observer agreements show good reliability (weighted kappa = 0.45-0.75). Both reviewers deemed 37 (reviewer 1) or 19 more (reviewer 2) post-operative complications with FSE plus FSE-SEMAC, compared to FSE only. Except for central canal stenosis (P-value = .2408), diagnostic confidence level for other post-operative complications were significantly higher with FSE plus FSE-SEMAC (P-value = .0000) than FSE. Conclusions FSE-SEMAC significantly reduces image distortion, compared to FSE sequence in 3.0-T MR. Also, diagnostic confidence for post-operative complications was higher when FSE with additional FSE-SEMAC compared to FSE only.	[Han, Sol Bee; Yoon, Young Cheol; Kwon, Jong Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Yoon, YC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.	youngcheol.yoon@gmail.com	Yoon, Young Cheol/AAG-4301-2020; Yoon, Young Cheol/AAG-4310-2020	Yoon, Young Cheol/0000-0002-7822-5344; 				Bradley W G, 1999, Magn Reson Imaging Clin N Am, V7, P439; Cha JG, 2011, RADIOLOGY, V259, P885, DOI 10.1148/radiol.11101856; Chen CA, 2011, J MAGN RESON IMAGING, V33, P1121, DOI 10.1002/jmri.22534; Hayashi D, 2012, AM J ROENTGENOL, V199, pW123, DOI 10.2214/AJR.11.6497; Hayter CL, 2011, AM J ROENTGENOL, V197, pW405, DOI 10.2214/AJR.11.6659; HUEFTLE MG, 1988, RADIOLOGY, V167, P817, DOI 10.1148/radiology.167.3.2966418; Koch KM, 2011, MAGN RESON MED, V65, P71, DOI 10.1002/mrm.22523; Koch KM, 2010, J MAGN RESON IMAGING, V32, P773, DOI 10.1002/jmri.22313; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee GY, 2011, SKELETAL RADIOL, V40, P1127, DOI 10.1007/s00256-011-1153-z; Lee JB, 2013, SKELETAL RADIOL, V42, P239, DOI 10.1007/s00256-012-1449-7; Lee S, 2010, AM J ROENTGENOL, V194, P1095, DOI 10.2214/AJR.09.2772; Lee YH, 2014, MAGN RESON IMAGING, V32, P1001, DOI 10.1016/j.mri.2014.04.009; Lee YH, 2013, MAGN RESON IMAGING, V31, P703, DOI 10.1016/j.mri.2012.11.004; Lu WM, 2009, MAGN RESON MED, V62, P66, DOI 10.1002/mrm.21967; ROSS JS, 1989, AM J ROENTGENOL, V152, P825, DOI 10.2214/ajr.152.4.825; Rutherford EE, 2007, RADIOGRAPHICS, V27, P1737, DOI 10.1148/rg.276065205; Shafaie Farid F., 1997, P223; Song KD, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120524; Stradiotti P, 2009, EUR SPINE J, V18, pS102, DOI 10.1007/s00586-009-0998-5; Sutter R, 2013, AM J ROENTGENOL, V201, P1315, DOI 10.2214/AJR.13.10531; Sutter R, 2012, RADIOLOGY, V265, P204, DOI 10.1148/radiol.12112408; Van Goethem JWM, 2002, NEURORADIOLOGY, V44, P723, DOI 10.1007/s00234-002-0790-2; Viano AM, 2000, MAGN RESON IMAGING, V18, P287, DOI 10.1016/S0730-725X(99)00135-6	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163745	10.1371/journal.pone.0163745	http://dx.doi.org/10.1371/journal.pone.0163745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711137	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600038
J	Harris, LW; Davies, TJ				Harris, Liam W.; Davies, T. Jonathan			A Complete Fossil-Calibrated Phylogeny of Seed Plant Families as a Tool for Comparative Analyses: Testing the 'Time for Speciation' Hypothesis	PLOS ONE			English	Article							ANGIOSPERM DIVERSIFICATION; SPECIES RICHNESS; EVOLUTION; RATES; AGE; PATTERNS; CLADES; DNA; CLASSIFICATION; RADIATIONS	Explaining the uneven distribution of species richness across the branches of the tree of life has been a major challenge for evolutionary biologists. Advances in phylogenetic reconstruction, allowing the generation of large, well-sampled, phylogenetic trees have provided an opportunity to contrast competing hypotheses. Here, we present a new time-calibrated phylogeny of seed plant families using Bayesian methods and 26 fossil calibrations. While there are various published phylogenetic trees for plants which have a greater density of species sampling, we are still a long way from generating a complete phylogeny for all similar to 300,000+ plants. Our phylogeny samples all seed plant families and is a useful tool for comparative analyses. We use this new phylogenetic hypothesis to contrast two alternative explanations for differences in species richness among higher taxa: time for speciation versus ecological limits. We calculated net diversification rate for each clade in the phylogeny and assessed the relationship between clade age and species richness. We then fit models of speciation and extinction to individual branches in the tree to identify major rate-shifts. Our data suggest that the majority of lineages are diversifying very slowly while a few lineages, distributed throughout the tree, are diversifying rapidly. Diversification is unrelated to clade age, no matter the age range of the clades being examined, contrary to both the assumption of an unbounded lineage increase through time, and the paradigm of fixed ecological limits. These findings are consistent with the idea that ecology plays a role in diversification, but rather than imposing a fixed limit, it may have variable effects on per lineage diversification rates through time.	[Harris, Liam W.; Davies, T. Jonathan] McGill Univ, Dept Biol, 1205 Docteur Penfield Ave, Montreal, PQ H3A 1B1, Canada; [Davies, T. Jonathan] Univ Johannesburg, African Ctr DNA Barcoding, POB 524,Auckland Pk, ZA-2006 Johannesburg, South Africa	McGill University; University of Johannesburg	Davies, TJ (corresponding author), Univ Johannesburg, African Ctr DNA Barcoding, POB 524,Auckland Pk, ZA-2006 Johannesburg, South Africa.	j.davies@mcgill.ca		Harris, Liam/0000-0002-4995-904X	NSERC Discovery grant	NSERC Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	JD was supported by an NSERC Discovery grant.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Augusto L, 2014, ECOL LETT, V17, P1326, DOI 10.1111/ele.12323; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bininda-Emonds O. R. P., 2004, PHYLOGENETIC SUPERTR, V4; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; Britton T, 2006, PATHD8 A NEW METHOD; Bromham L, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-126; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Coiffard C, 2013, TAXON, V62, P141, DOI 10.1002/tax.621012; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davies TJ, 2007, SYST ASSOC SPEC VOL, V72, P149; Davies TJ, 2005, AM NAT, V166, P418, DOI 10.1086/432022; Davies TJ, 2004, PHILOS T R SOC B, V359, P1645, DOI 10.1098/rstb.2004.1524; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; de Queiroz A, 2002, SYST BIOL, V51, P917, DOI 10.1080/10635150290155980; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ERIKSSON O, 1992, EVOLUTION, V46, P258, DOI [10.2307/2409820, 10.1111/j.1558-5646.1992.tb02000.x]; Farjon A, 2001, WORLD CHECKLIST BIBL; FUSCO G, 1995, J THEOR BIOL, V175, P235, DOI 10.1006/jtbi.1995.0136; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lanfear R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2836; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; MACARTHUR RH, 1965, BIOL REV, V40, P510, DOI 10.1111/j.1469-185X.1965.tb00815.x; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Morlon H, 2015, RPANDA R PACKAGE MAC; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Neinhuis C., 1998, FAMILIES GENERA VASC, P198; Paton AJ, 2008, TAXON, V57, P602, DOI 10.2307/25066027; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; R Core Team, 2021, R LANGUAGE ENV STAT; Rabosky DL, 2015, EVOLUTION, V69, P3207, DOI 10.1111/evo.12817; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Rabosky DL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001381; Rabosky DL, 2010, P NATL ACAD SCI USA, V107, P22178, DOI 10.1073/pnas.1007606107; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rambaut A., 2007, TRACER V1 4; RAUP DM, 1973, J GEOL, V81, P525, DOI 10.1086/627905; Salamin N., 2004, COMPU BIOL, V4; Sanderson MJ, 1998, TRENDS ECOL EVOL, V13, P105, DOI 10.1016/S0169-5347(97)01242-1; Schaefer H, 2011, TAXON, V60, P122, DOI 10.1002/tax.601011; Silvestro D, 2015, NEW PHYTOL, V207, P425, DOI 10.1111/nph.13247; SLOWINSKI JB, 1993, AM NAT, V142, P1019, DOI 10.1086/285586; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Stadler T, 2014, AM NAT, V184, P447, DOI 10.1086/677676; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STANLEY SM, 1975, P NATL ACAD SCI USA, V72, P646, DOI 10.1073/pnas.72.2.646; Steel M, 2010, APPL MATH LETT, V23, P1315, DOI 10.1016/j.aml.2010.06.021; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Tank DC, 2015, NEW PHYTOL, V207, P454, DOI 10.1111/nph.13491; Thomas GH, 2013, METHODS ECOL EVOL, V4, P1011, DOI 10.1111/2041-210X.12117; Vamosi JC, 2010, ECOL LETT, V13, P1270, DOI 10.1111/j.1461-0248.2010.01521.x; VOS RA, 2004, COMPU BIOL, V4, P281; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Wolfe AD, 1998, MOL BIOL EVOL, V15, P1243, DOI 10.1093/oxfordjournals.molbev.a025853; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872; Zhang ZH, 2009, J SYST EVOL, V47, P297, DOI 10.1111/j.1759-6831.2009.00035.x	77	21	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162907	10.1371/journal.pone.0162907	http://dx.doi.org/10.1371/journal.pone.0162907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706173	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200023
J	Vilajeliu-Pons, A; Baneras, L; Puig, S; Molognoni, D; Vila-Rovira, A; Hernandez-del Amo, E; Balaguer, MD; Colprim, J				Vilajeliu-Pons, Anna; Baneras, Lluis; Puig, Sebastia; Molognoni, Daniele; Vila-Rovira, Albert; Hernandez-del Amo, Elena; Balaguer, Maria D.; Colprim, Jesus			External Resistances Applied to MFC Affect Core Microbiome and Swine Manure Treatment Efficiencies	PLOS ONE			English	Article							DIRECT ELECTRON-TRANSFER; DOMESTIC WASTE-WATER; FUEL-CELL; BIOELECTROCHEMICAL SYSTEMS; ELECTRICITY-GENERATION; SHEWANELLA-ONEIDENSIS; COMMUNITY STRUCTURE; FLUID-DYNAMICS; RECOVERY; PERFORMANCE	Microbial fuel cells (MFCs) can be designed to combine water treatment with concomitant electricity production. Animal manure treatment has been poorly explored using MFCs, and its implementation at full-scale primarily relies on the bacterial distribution and activity within the treatment cell. This study reports the bacterial community changes at four positions within the anode of two almost identically operated MFCs fed swine manure. Changes in the microbiome structure are described according to the MFC fluid dynamics and the application of a maximum power point tracking system (MPPT) compared to a fixed resistance system (Ref-MFC). Both external resistance and cell hydrodynamics are thought to heavily influence MFC performance. The microbiome was characterised both quantitatively (qPCR) and qualitatively (454-pyrosequencing) by targeting bacterial 16S rRNA genes. The diversity of the microbial community in the MFC biofilm was reduced and differed from the influent swine manure. The adopted electric condition (MPPT vs fixed resistance) was more relevant than the fluid dynamics in shaping the MFC microbiome. MPPT control positively affected bacterial abundance and promoted the selection of putatively exoelectrogenic bacteria in the MFC core microbiome (Sedimentibacter sp. and gammaproteobacteria). These differences in the microbiome may be responsible for the two-fold increase in power production achieved by the MPPT-MFC compared to the Ref-MFC.	[Vilajeliu-Pons, Anna; Puig, Sebastia; Vila-Rovira, Albert; Balaguer, Maria D.; Colprim, Jesus] Univ Girona, Inst Environm, LEQUiA, Girona, Spain; [Baneras, Lluis; Hernandez-del Amo, Elena] Univ Girona, Mol Microbial Ecol Grp, Inst Aquat Ecol, Girona, Spain; [Molognoni, Daniele] Univ Pavia, Dept Civil Engn & Architecture DIC Ar, Pavia, Italy	Universitat de Girona; Universitat de Girona; University of Pavia	Baneras, L (corresponding author), Univ Girona, Mol Microbial Ecol Grp, Inst Aquat Ecol, Girona, Spain.	lluis.banyeras@udg.edu	Amo, Elena Hernández-del/AAR-7099-2020; Puig, Sebastià/L-8562-2014; Balaguer, M. Dolors/AAC-6114-2019; Colprim, Jesús/L-3087-2014; Rovira, Albert Vilà/Z-5665-2019; Bañeras, Lluis/K-6736-2017	Amo, Elena Hernández-del/0000-0001-9190-4221; Puig, Sebastià/0000-0003-2995-1443; Balaguer, M. Dolors/0000-0001-6231-2163; Colprim, Jesús/0000-0002-6000-069X; Rovira, Albert Vilà/0000-0002-3379-6346; Bañeras, Lluis/0000-0001-6908-3658				Aelterman P, 2006, ENVIRON SCI TECHNOL, V40, P3388, DOI 10.1021/es0525511; American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Blanchet E, 2015, BIORESOURCE TECHNOL, V185, P106, DOI 10.1016/j.biortech.2015.02.097; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Borsje C, 2016, J POWER SOURCES, V325, P690, DOI 10.1016/j.jpowsour.2016.06.092; Bosshard PP, 2002, INT J SYST EVOL MICR, V52, P1263, DOI [10.1099/ijs.0.02056-0, 10.1099/00207713-52-4-1263]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Celmer D, 2008, WATER RES, V42, P3057, DOI 10.1016/j.watres.2008.02.031; Cotta MA, 2003, ENVIRON MICROBIOL, V5, P737, DOI 10.1046/j.1467-2920.2003.00467.x; Dolfing J, 2014, ISME J, V8, P4, DOI 10.1038/ismej.2013.198; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Feng YJ, 2014, BIORESOURCE TECHNOL, V156, P132, DOI 10.1016/j.biortech.2013.12.104; Garcia-Pena EI, 2011, BIORESOURCE TECHNOL, V102, P9447, DOI 10.1016/j.biortech.2011.07.068; Gardel EJ, 2012, ENVIRON SCI TECHNOL, V46, P5222, DOI 10.1021/es204622m; Han I, 2011, APPL MICROBIOL BIOT, V89, P835, DOI 10.1007/s00253-010-2893-8; Heidrich ES, 2013, APPL MICROBIOL BIOT, V97, P6979, DOI 10.1007/s00253-012-4456-7; Heidrich ES, 2014, BIORESOURCE TECHNOL, V173, P87, DOI 10.1016/j.biortech.2014.09.083; Jia JN, 2013, BIORESOURCE TECHNOL, V144, P94, DOI 10.1016/j.biortech.2013.06.072; Kelly PT, 2014, BIORESOURCE TECHNOL, V153, P351, DOI 10.1016/j.biortech.2013.12.046; Kim J, 2014, WATER SCI TECHNOL, V69, P1447, DOI 10.2166/wst.2014.041; Kim JR, 2012, J POWER SOURCES, V213, P382, DOI 10.1016/j.jpowsour.2012.03.040; Koch C, 2013, NAT PROTOC, V8, P190, DOI 10.1038/nprot.2012.149; Lee TK, 2010, APPL MICROBIOL BIOT, V87, P2335, DOI 10.1007/s00253-010-2680-6; Lesnik KL, 2014, APPL MICROBIOL BIOT, V98, P4187, DOI 10.1007/s00253-013-5502-9; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Logan BE, 2006, ENVIRON SCI TECHNOL, V40, P5181, DOI 10.1021/es0605016; Logan BE, 2006, TRENDS MICROBIOL, V14, P512, DOI 10.1016/j.tim.2006.10.003; Lovley DR, 2011, ENV MICROBIOL REP, V3, P27, DOI 10.1111/j.1758-2229.2010.00211.x; Lovley DR, 2008, CURR OPIN BIOTECH, V19, P564, DOI 10.1016/j.copbio.2008.10.005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; McGlynn SE, 2015, NATURE, V526, P531, DOI 10.1038/nature15512; Michie IS, 2014, BIORESOURCE TECHNOL, V165, P13, DOI 10.1016/j.biortech.2014.03.069; Min B, 2005, WATER RES, V39, P4961, DOI 10.1016/j.watres.2005.09.039; Miran W, 2015, ENVIRON SCI POLLUT R, V22, P13477, DOI 10.1007/s11356-015-4582-8; Molognoni D, 2016, J CHEM TECHNOL BIOT, V91, P1720, DOI 10.1002/jctb.4760; Molognoni D, 2014, J POWER SOURCES, V269, P403, DOI 10.1016/j.jpowsour.2014.07.033; Morton ER, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005658; Muyzer G., 1998, MOL MICROBIAL ECOLOG, P1; Narihiro T, 2015, ENVIRON MICROBIOL, V17, P1707, DOI 10.1111/1462-2920.12616; Oliveira VB, 2013, BIOCHEM ENG J, V73, P53, DOI 10.1016/j.bej.2013.01.012; Patil SA, 2009, BIORESOURCE TECHNOL, V100, P5132, DOI 10.1016/j.biortech.2009.05.041; Pinto RP, 2011, WATER RES, V45, P1571, DOI 10.1016/j.watres.2010.11.033; Premier GC, 2011, J POWER SOURCES, V196, P2013, DOI 10.1016/j.jpowsour.2010.09.071; Puig S, 2011, J HAZARD MATER, V185, P763, DOI 10.1016/j.jhazmat.2010.09.086; Rabaey K, 2004, APPL ENVIRON MICROB, V70, P5373, DOI 10.1128/AEM.70.9.5373-5382.2004; Radajewski S, 2000, NATURE, V403, P646, DOI 10.1038/35001054; Regueiro L, 2014, J BIOTECHNOL, V192, P179, DOI 10.1016/j.jbiotec.2014.10.007; Rosenbaum M, 2010, BIOTECHNOL BIOENG, V105, P880, DOI 10.1002/bit.22621; Ross DE, 2007, APPL ENVIRON MICROB, V73, P5797, DOI 10.1128/AEM.00146-07; Sangcharoen A, 2015, PROCESS BIOCHEM, V50, P1648, DOI 10.1016/j.procbio.2015.06.013; Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x; Shen YJ, 2013, BIORESOURCE TECHNOL, V136, P707, DOI 10.1016/j.biortech.2013.02.069; Siegert M, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00778; Sleutels THJA, 2011, BIORESOURCE TECHNOL, V102, P11172, DOI 10.1016/j.biortech.2011.09.078; Sutton AL, 1999, J ANIM SCI, V77, P430; Tao QQ, 2015, DESALINATION, V365, P92, DOI 10.1016/j.desal.2015.02.021; Trias R, 2012, APPL ENVIRON MICROB, V78, P318, DOI 10.1128/AEM.05904-11; Velasquez-Orta SB, 2011, BIORESOURCE TECHNOL, V102, P5105, DOI 10.1016/j.biortech.2011.01.059; Velvizhi G, 2015, WATER RES, V70, P52, DOI 10.1016/j.watres.2014.11.002; Velvizhi G, 2012, INT J HYDROGEN ENERG, V37, P5969, DOI 10.1016/j.ijhydene.2011.12.112; Vila-Rovira A, 2015, RSC ADV, V5, P78994, DOI 10.1039/c5ra11995b; Vilajeliu-Pons A, 2015, J HAZARD MATER, V288, P60, DOI 10.1016/j.jhazmat.2015.02.014; Vilar-Sanz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063460; Wagner M, 2015, NATURE, V526, P513, DOI 10.1038/526513a; Watanabe K, 2011, APPL MICROBIOL BIOT, V92, P1307, DOI 10.1007/s00253-011-3598-3; Wrighton KC, 2008, ISME J, V2, P1146, DOI 10.1038/ismej.2008.48; Zhang YF, 2015, BIOTECHNOL BIOENG, V112, P1478, DOI 10.1002/bit.25549; Zhang YF, 2015, BIORESOURCE TECHNOL, V177, P233, DOI 10.1016/j.biortech.2014.11.079; Zhuang L, 2012, BIORESOURCE TECHNOL, V106, P82, DOI 10.1016/j.biortech.2011.11.019	69	24	25	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164044	10.1371/journal.pone.0164044	http://dx.doi.org/10.1371/journal.pone.0164044			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701451	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900040
J	Wang, B; Yang, J; Xiao, B				Wang, Bin; Yang, Jie; Xiao, Bin			MicroRNA-20b (miR-20b) Promotes the Proliferation, Migration, Invasion, and Tumorigenicity in Esophageal Cancer Cells via the Regulation of Phosphatase and Tensin Homologue Expression	PLOS ONE			English	Article							HUMAN OVARIAN-CANCER; PTEN EXPRESSION; DOWN-REGULATION; CARCINOMA-CELLS; GROWTH; PATHWAY; RNA; CHROMOSOME-10; HIF-1-ALPHA; RESISTANCE	Increasing evidence has indicated that many microRNAs participate in the development and progression of esophageal cancer and gene expression regulation. MicroRNA-20b (miR-20b) has been reported to be aberrantly expressed in various cancers, but its exact role in esophageal cancer cells remains unclear so far. Therefore, we detected the levels of miR-20b in esophageal tumor tissues and their adjacent normal tissues, and various esophageal cancer cell lines by qRT-PCR. We also explored the effects of miR-20b on cell proliferation, migration, invasion and tumorigenicity of esophageal carcinoma cells through transfection with miR-20b mimics or inhibitor to upregulate or downregulate miR-20b expression in the esophageal cancer cells Eca-109 and KYSE-150, respectively. Additionally, the 3'-untranslated region (3'-UTR) of phosphatase and tensin homologue (PTEN) binding with miR-20b was analyzed by dual-luciferase reporter assays. The results indicated that miR-20b expression level in esophageal tumor tissues was significantly increased compared with their neighboring normal tissues, but its expression was inverse with PTEN protein expression. Luciferase assays confirmed that the 3'-UTR of PTEN was a target of miR-20b in esophageal cancer cells. MiR-20b upregulation promoted cell proliferation, migration, invasiveness, and tumor growth, and decreased apoptosis, and reduced PTEN protein level but not mRNA expression in Eca-109 cells. Conversely, downregulation of miR-20b suppressed these processes in KYSE-150 cells, and enhanced PTEN protein expression. These data indicate that miR-20b plays important roles in tumorigenesis of esophageal cancer possibly via regulation of PTEN expression, and it may be a potential therapeutic target for esophageal cancer treatment.	[Wang, Bin] Hubei Univ Med, Dept Gastroenterol, Renmin Hosp, Shiyan 442000, Hubei Province, Peoples R China; [Yang, Jie] Hubei Univ Med, Dept Med Care Ctr, Renmin Hosp, Shiyan 442000, Hubei Province, Peoples R China; [Xiao, Bin] Hubei Univ Med, Ultrason Imaging Div, Renmin Hosp, Shiyan 442000, Hubei Province, Peoples R China	Hubei University of Medicine; Hubei University of Medicine; Hubei University of Medicine	Xiao, B (corresponding author), Hubei Univ Med, Ultrason Imaging Div, Renmin Hosp, Shiyan 442000, Hubei Province, Peoples R China.	xiao_bin168@126.com						Ahmad A, 2015, ONCOTARGET, V6, P12188, DOI 10.18632/oncotarget.3664; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bertram J, 2006, CANCER RES, V66, P4781, DOI 10.1158/0008-5472.CAN-05-3173; Cascio S, 2010, J CELL PHYSIOL, V224, P242, DOI 10.1002/jcp.22126; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Chung JH, 2005, CANCER RES, V65, P4108, DOI 10.1158/0008-5472.CAN-05-0124; Doi Y, 2012, ANN SURG ONCOL, V19, P2733, DOI 10.1245/s10434-011-2181-6; Dong YS, 2012, J BIOL CHEM, V287, P32172, DOI 10.1074/jbc.M112.393462; Giraud-Triboult K, 2011, PHYSIOL GENOMICS, V43, P77, DOI 10.1152/physiolgenomics.00077.2010; Hjelmeland AB, 2005, CANCER RES, V65, P11276, DOI 10.1158/0008-5472.CAN-05-3016; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Kang M, 2013, INT J MOL MED, V32, P51, DOI 10.3892/ijmm.2013.1384; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Li DP, 2013, ONCOTARGET, V4, P1373, DOI 10.18632/oncotarget.1165; Li JC, 2013, ASIAN PAC J CANCER P, V14, P4891, DOI 10.7314/APJCP.2013.14.8.4891; Li JY, 2012, ASIAN PAC J CANCER P, V13, P1901, DOI 10.7314/APJCP.2012.13.5.1901; Liang DG, 2011, CELL RES, V21, P793, DOI 10.1038/cr.2011.5; Liu CZ, 2010, J HEPATOL, V53, P98, DOI 10.1016/j.jhep.2010.02.021; Liu Y, 2015, TUMOR BIOL, V36, P7997, DOI 10.1007/s13277-015-3528-6; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Sawai H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-56; Sun Y, 2009, BREAST CANCER RES TR, V118, P185, DOI 10.1007/s10549-008-0171-6; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Wang ZG, 2012, BIOCHEM BIOPH RES CO, V427, P444, DOI 10.1016/j.bbrc.2012.06.123; Weng WH, 2013, ANTICANCER RES, V33, P5407; Wu WY, 2013, GENE CHROMOSOME CANC, V52, P1133, DOI 10.1002/gcc.22108; Wu WY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-30; Xie YE, 2006, WORLD J GASTROENTERO, V12, P7472, DOI 10.3748/wjg.v12.i46.7472; Xue TM, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/325176; Xue TM, 2015, ONCOTARGETS THER, V8, P1871, DOI 10.2147/OTT.S85236; Yamaguchi T, 2014, ONCOLOGY-BASEL, V87, P58, DOI 10.1159/000363303; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang ZH, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-31; Yu TT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1031-5; Zhang HF, 2014, CARCINOGENESIS, V35, P292, DOI 10.1093/carcin/bgt320; Zhou WD, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-62; Zhu ED, 2014, J IMMUNOL, V192, P5599, DOI 10.4049/jimmunol.1303488; Zhu SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123519	40	30	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164105	10.1371/journal.pone.0164105	http://dx.doi.org/10.1371/journal.pone.0164105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701465	gold, Green Published, Green Submitted			2022-12-27	WOS:000385696900044
J	Zhao, JJ; Li, XM				Zhao, Jijun; Li, Xinmin			Determinants of the Transmission Variation of Hand, Foot and Mouth Disease in China	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; MEASLES; DYNAMICS; PATTERNS; IMPACT; POLIO	Severe outbreaks of hand, foot and mouth disease (HFMD) have occurred in China for decades. Our understanding of the HFMD transmission process and its determinants is still limited. In this paper, factors that affect the local variation of HFMD transmission process were studied. Three classes of factors, including meteorological, demographic and public health intervention factors, were carefully selected and their effects on HFMD transmission were investigated with Pearson's correlation coefficient and multiple linear regression models. The determining factors for the variation of HFMD transmission were different for the southeastern and the northwestern regions of China. In the northwest, fadeouts occurred yearly, and the average age at infection and the fadeout were negatively correlated with the population density. In the southeast, HFMD transmission was governed by the combined effects of the birth rate, the relative humidity and the interaction of the Health System Performance and the log of the population density. When the Health System Performance was low, HFMD transmission increased with the population density, but when the Health System Performance was high, the better health performance counteracted the transmission increase due to the higher population density.	[Zhao, Jijun] Qingdao Univ, Inst Complex Sci, Qingdao, Peoples R China; [Li, Xinmin] Qingdao Univ, Sch Math & Stat, Qingdao, Peoples R China	Qingdao University; Qingdao University	Zhao, JJ (corresponding author), Qingdao Univ, Inst Complex Sci, Qingdao, Peoples R China.	jjzhao@qdu.edu.cn	Ibrahim, Essam Hassan/G-1960-2018; Li, Xinmin/AGW-3734-2022	Ibrahim, Essam Hassan/0000-0003-0130-2257; Li, Xinmin/0000-0002-2573-5236				ANDERSON R M, 1991; [Anonymous], 1989, APPL LINEAR REGRESSI; Bo YC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-358; Ferrari MJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0141; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Hosoya M, 2006, PEDIATR INFECT DIS J, V25, P691, DOI 10.1097/01.inf.0000227959.89339.c3; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Huang JX, 2014, INT J ENV RES PUB HE, V11, P3407, DOI 10.3390/ijerph110303407; Huang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-134; Li S, 2009, AM J EPIDEMIOL, V170, P257, DOI 10.1093/aje/kwp116; Liu WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131311; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Ma E, 2010, EPIDEMIOL INFECT, V138, P1779, DOI 10.1017/S0950268810002256; Ma E, 2010, JPN J INFECT DIS, V63, P422; Manfredi Piero, 2005, Popul Health Metr, V3, P1, DOI 10.1186/1478-7954-3-1; Martinez-Bakker M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002172; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P111, DOI 10.1017/S0950268800065614; MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P419, DOI 10.1017/S0950268800067170; Metcalf CJE, 2011, EPIDEMIOL INFECT, V139, P1029, DOI 10.1017/S0950268810002165; Pica N, 2012, CURR OPIN VIROL, V2, P90, DOI 10.1016/j.coviro.2011.12.003; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Sabanathan S, 2014, J EPIDEMIOL COMMUN H, V68, P500, DOI 10.1136/jech-2014-203836; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Wang JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092745; Wang JF, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-25; Wang Y., 2009, ADV NEURAL INFORM PR, P2008, DOI DOI 10.1097/EDE.0B013E318231D67A; Webster P, 2005, LANCET, V366, P359, DOI 10.1016/S0140-6736(05)67008-0; Williams JR, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-23; Xie YH, 2015, EPIDEMIOL INFECT, V143, P1432, DOI 10.1017/S0950268814002301; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Zhao J, BMC INFECT IN PRESS; Zhao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051984	34	11	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163789	10.1371/journal.pone.0163789	http://dx.doi.org/10.1371/journal.pone.0163789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701445	gold, Green Published, Green Submitted			2022-12-27	WOS:000385696900020
J	Cheung, MB; Sampayo-Escobar, V; Green, R; Moore, ML; Mohapatra, S; Mohapatra, SS				Cheung, Michael B.; Sampayo-Escobar, Viviana; Green, Ryan; Moore, Martin L.; Mohapatra, Subhra; Mohapatra, Shyam S.			Respiratory Syncytial Virus-Infected Mesenchymal Stem Cells Regulate Immunity via Interferon Beta and Indoleamine-2,3-Dioxygenase	PLOS ONE			English	Article							HUMAN BONE-MARROW; PATTERN-RECOGNITION RECEPTORS; 2,3-DIOXYGENASE IDO ACTIVITY; IN-VITRO EXPANSION; INDOLEAMINE 2,3-DIOXYGENASE; STROMAL CELLS; PERIPHERAL-BLOOD; DENDRITIC CELLS; INNATE IMMUNITY; PROTEIN	Respiratory syncytial virus (RSV) has been reported to infect human mesenchymal stem cells (MSCs) but the consequences are poorly understood. MSCs are present in nearly every organ including the nasal mucosa and the lung and play a role in regulating immune responses and mediating tissue repair. We sought to determine whether RSV infection of MSCs enhances their immune regulatory functions and contributes to RSV-associated lung disease. RSV was shown to replicate in human MSCs by fluorescence microscopy, plaque assay, and expression of RSV transcripts. RSV-infected MSCs showed differentially altered expression of cytokines and chemokines such as IL-1 beta, IL6, IL-8 and SDF-1 compared to epithelial cells. Notably, RSV-infected MSCs exhibited significantly increased expression of IFN-beta (similar to 100-fold) and indoleamine-2,3-dioxygenase (IDO) (similar to 70-fold) than in mock-infected MSCs. IDO was identified in cytosolic protein of infected cells by Western blots and enzymatic activity was detected by tryptophan catabolism assay. Treatment of PBMCs with culture supernatants from RSV-infected MSCs reduced their proliferation in a dose dependent manner. This effect on PBMC activation was reversed by treatment of MSCs with the IDO inhibitors 1-methyltryptophan and vitamin K-3 during RSV infection, a result we confirmed by CRISPR/Cas9-mediated knockout of IDO in MSCs. Neutralizing IFN-beta prevented IDO expression and activity. Treatment of MSCs with an endosomal TLR inhibitor, as well as a specific inhibitor of the TLR3/dsRNA complex, prevented IFN-beta and IDO expression. Together, these results suggest that RSV infection of MSCs alters their immune regulatory function by upregulating IFN-beta and IDO, affecting immune cell proliferation, which may account for the lack of protective RSV immunity and for chronicity of RSV-associated lung diseases such as asthma and COPD.	[Cheung, Michael B.; Sampayo-Escobar, Viviana; Mohapatra, Subhra; Mohapatra, Shyam S.] James A Haley Vet Affairs Hosp, Tampa, FL 33613 USA; [Cheung, Michael B.; Sampayo-Escobar, Viviana; Green, Ryan; Mohapatra, Subhra; Mohapatra, Shyam S.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA; [Mohapatra, Shyam S.] Univ S Florida, Coll Pharm, Tampa, FL 33620 USA; [Moore, Martin L.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Moore, Martin L.] Childrens Healthcare Atlanta, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Emory University; Children's Healthcare of Atlanta (CHOA)	Mohapatra, SS (corresponding author), James A Haley Vet Affairs Hosp, Tampa, FL 33613 USA.; Mohapatra, SS (corresponding author), Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL 33620 USA.; Mohapatra, SS (corresponding author), Univ S Florida, Coll Pharm, Tampa, FL 33620 USA.	smohapat@health.usf.edu	Cheung, Michael/G-5459-2011	Cheung, Michael/0000-0002-0021-3802	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; Research Career Scientist and Veterans Affairs Merit Review awards [51016X000954-02]; NIH [R01AI087798, U19AI095227]; American Heart Association [US 15PRE25760005]	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); Research Career Scientist and Veterans Affairs Merit Review awards; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development. The contents of this report do not represent the views of the Department of Veterans Affairs or the United States Government. This research was financially supported by Research Career Scientist and Veterans Affairs Merit Review awards to Dr. Shyam Mohapatra (51016X000954-02). Dr. Martin L. Moore was supported by NIH R01AI087798 and NIH U19AI095227. Mr. Ryan Green was supported by the American Heart Association (US 15PRE25760005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaree M, 2012, STEM CELL REV REP, V8, P375, DOI 10.1007/s12015-011-9312-0; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ajamian F, 2015, CLIN EXP ALLERGY, V45, P644, DOI 10.1111/cea.12498; Ajamian F, 2010, ALLERGY ASTHMA CL IM, V6, P1, DOI [10.1186/1710-1492-6-s3-p8, DOI 10.1186/1710-1492-6-S3-P8]; Arrevillaga G, 2012, INTERVIROLOGY, V55, P442, DOI 10.1159/000335548; Baglio SR, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0116-z; Bassi EJ, 2012, STEM CELL REV REP, V8, P329, DOI 10.1007/s12015-011-9311-1; Bassi Enio Jose, 2011, World J Stem Cells, V3, P1, DOI 10.4252/wjsc.v3.i1.1; Bem RA, 2011, AM J PHYSIOL-LUNG C, V301, pL148, DOI 10.1152/ajplung.00065.2011; Bentley JK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-127; Beyer Nardi N, 2006, HANDB EXP PHARM, V174, P249; Borse RH, 2014, J PEDIAT INF DIS SOC, V3, P201, DOI 10.1093/jpids/pit072; Boyapalle S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029386; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Cassatella MA, 2011, STEM CELLS, V29, P1001, DOI 10.1002/stem.651; Chen GY, 2009, J VIROL, V83, P10548, DOI 10.1128/JVI.01250-09; Chen J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/985814; Chen WJ, 2011, NAT IMMUNOL, V12, P809, DOI 10.1038/ni.2088; Cheng K, 2011, J AM CHEM SOC, V133, P3764, DOI 10.1021/ja111312h; Cho KS, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt404; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; DelaRosa O, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00182; Delorme B, 2010, STEM CELLS DEV, V19, P853, DOI 10.1089/scd.2009.0267; Domachowske Joseph B, 2004, Pediatr Infect Dis J, V23, pS228, DOI 10.1097/01.inf.0000144672.81955.a4; Eisenhut M, 2006, CRIT CARE, V10, DOI 10.1186/cc4984; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Fields B. N., 2001, FIELDS VIROLOGY, V4; Fox JM, 2014, J LEUKOCYTE BIOL, V96, P447, DOI 10.1189/jlb.3AB0114-046RR; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Girard SD, 2011, JOVE-J VIS EXP, DOI 10.3791/2762; Giuliani M, 2014, STEM CELLS, V32, P290, DOI 10.1002/stem.1563; Guerrero-Plata A, 2004, VIRUS RES, V99, P95, DOI 10.1016/j.virusres.2003.10.005; Guerrero-Plata A, 2001, VIRAL IMMUNOL, V14, P19, DOI 10.1089/08828240151061347; Hackstein H, 2011, CELL IMMUNOL, V271, P401, DOI 10.1016/j.cellimm.2011.08.008; Haddad N. EI, 2011, MESENCHYMAL STEM CEL; Halfhide CP, 2011, J INFECT DIS, V204, P451, DOI 10.1093/infdis/jir280; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Haynes LM, 2001, J VIROL, V75, P10730, DOI 10.1128/JVI.75.22.10730-10737.2001; Hobson L, 2008, CLIN EXP IMMUNOL, V151, P359, DOI 10.1111/j.1365-2249.2007.03560.x; Hotard AL, 2012, VIROLOGY, V434, P129, DOI 10.1016/j.virol.2012.09.022; Jakob M, 2010, STEM CELLS DEV, V19, P635, DOI 10.1089/scd.2009.0245; Jorquera PA, 2013, EXPERT REV RESP MED, V7, P411, DOI 10.1586/17476348.2013.814409; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Kim E, 2014, J VIROL, V88, P5100, DOI 10.1128/JVI.03194-13; Kong XY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-3; Kumar S, 2008, J MED CHEM, V51, P1706, DOI 10.1021/jm7014155; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Larsen S, 2011, PATHOLOGY, V43, P592, DOI 10.1097/PAT.0b013e32834ab72d; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lee RH, 2011, J CELL BIOCHEM, V112, P3073, DOI 10.1002/jcb.23250; Lenert PS, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/986596; Lin HX, 2007, J PHARM SCI-US, V96, P341, DOI 10.1002/jps.20803; Lindemans CA, 2006, J IMMUNOL, V176, P5529, DOI 10.4049/jimmunol.176.9.5529; Ling WF, 2014, CANCER RES, V74, P1576, DOI 10.1158/0008-5472.CAN-13-1656; Ling Z, 2009, J VIROL, V83, P3734, DOI 10.1128/JVI.02434-08; Littel-van den Hurk SV, 2012, CURR OPIN VIROL, V2, P300, DOI 10.1016/j.coviro.2012.01.008; Mallela J, 2013, STEM CELLS, V31, P1321, DOI 10.1002/stem.1376; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Meisel R, 2011, LEUKEMIA, V25, P648, DOI 10.1038/leu.2010.310; Mesentier-Louro LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110722; Meyerholz DK, 2004, MICROBES INFECT, V6, P1312, DOI 10.1016/j.micinf.2004.08.006; Miller L., 2010, ANAL GELS W BLOTS IM; Moore ML, 2009, J VIROL, V83, P4185, DOI 10.1128/JVI.01853-08; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; O'Donnell DR, 1998, J PEDIATR-US, V133, P272, DOI 10.1016/S0022-3476(98)70234-3; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Papin JF, 2013, INFANT BABOONS INFEC; Piedimonte G, 2002, RESP MED, V96, pS25, DOI 10.1053/rmed.2002.1297; Qi J, 2011, J IMMUNOL, V186, P6417, DOI 10.4049/jimmunol.1001241; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Rankin SM, 2010, J LEUKOCYTE BIOL, V88, P241, DOI 10.1189/jlb.0210112; Rasband W.S., 1997, IMAGEJ; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Respiratory Syncytial Virus Activity-United States, 2011, 8 CDCP OFF SURV E LA; Respiratory syncytial virus-United States, 2007, 35 CDCP; Rezaee F, 2010, AM J RESP CRIT CARE, V181; Rezaee F, 2011, AM J RESP CELL MOL, V45, P277, DOI 10.1165/rcmb.2010-0121OC; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Sage LK, 2014, VIRAL IMMUNOL, V27, P112, DOI 10.1089/vim.2013.0105; Schmidt SV, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00384; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Stunz LL, 2002, EUR J IMMUNOL, V32, P1212, DOI 10.1002/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO;2-D; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tasso R, 2012, INVEST OPHTH VIS SCI, V53, P786, DOI 10.1167/iovs.11-8211; Ugonna K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091855; Wong TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088764; You DH, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-107; Yui I, 2003, J MED VIROL, V70, P481, DOI 10.1002/jmv.10421	93	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163709	10.1371/journal.pone.0163709	http://dx.doi.org/10.1371/journal.pone.0163709			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695127	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100049
J	Daher, AM; AlMashoor, SHA; Winn, T				Daher, Aqil M.; AlMashoor, Syed Hassan A.; Winn, Than			Performance of the Malay Audit of Diabetes Dependent Quality of Life-18 and Associates of Quality of Life among Patients with Type 2 Diabetes Mellitus from Major Ethnic Groups of Malaysia	PLOS ONE			English	Article							INSULIN GLARGINE; QUESTIONNAIRE; PREVALENCE; MANAGEMENT; THERAPY; IMPACT; PREDICTORS; VALIDITY; ADULTS; ASIA	Introduction Diabetes Mellitus (DM) is notorious for its metabolic effect, acute and chronic complications and impact on Quality of Life (QoL). Successful intervention to improve QoL necessitates a valid and reliable measurement tool to identify areas of concern to patients with diabetes. Objectives To (1) assess the factor structure of the Malay Audit of Diabetes Dependent Quality of Life-18 (ADDQoL-18) questionnaire; (2) determine the impact of DM on QoL; and (3) identify areas of concern to patients with type 2 DM from three major ethnic groups in Malaysia. Methods Data was obtained from a cross sectional study involving 256 patients with type 2 DM attending the diabetes clinic of the National University of Malaysia Medical Centre. The Malay version of ADDQoL-18 survey was translated from its English version according to standard guidelines and administered by a trained research assistant. Exploratory Factor Analysis (EFA) with oblimin rotation was used to determine factor structure of the data. Confirmatory Factor Analysis (CFA) was used to confirm the factor structure. Hierarchical liner regression was used to determine factors associated with QoL. Results Unforced factor solution yielded two factors for the whole sample. Forced one factor solution was ascertained for the whole sample and for each ethnic group. Loadings ranged between 0.588 and 0.949. Reliability coefficients were all higher than 0.955. CFA showed that the two factor model had better fit statistics. QoL was associated with the use of insulin and desired glycaemic control, longer diabetes duration, worry about diabetes, and diabetes complications. Conclusions The Malay ADDQoL-18 is a valid tool to be used among patients with diabetes from different ethnic groups in Malaysia. The use of insulin to achieve desired glycaemic control had more negative impact on QoL than the use of tablets and/or dietary changes.	[Daher, Aqil M.] Natl Def Univ Malaysia, Fac Med & Def Hlth, Dept Community Med, Kuala Lumpur, Malaysia; [AlMashoor, Syed Hassan A.] Univ Teknol MARA, Dept Psychiat, Fac Med, Batu Caves, Selangor, Malaysia; [Winn, Than] MAHSA Univ, Dept Community Med, Fac Med, Kuala Lumpur, Malaysia	Universiti Pertahanan Nasional Malaysia; Mahsa University	Daher, AM (corresponding author), Natl Def Univ Malaysia, Fac Med & Def Hlth, Dept Community Med, Kuala Lumpur, Malaysia.	Aqil702001@yahoo.com	DAHER, AQIL M/A-5821-2018	DAHER, AQIL M/0000-0002-3504-4340				Akinci F, 2008, DIABETES RES CLIN PR, V79, P117, DOI 10.1016/j.diabres.2007.07.003; Al-Habori M, 2004, DIABETES RES CLIN PR, V65, P275, DOI 10.1016/j.diabres.2004.02.001; Baiyewu O., 2006, HONG KONG J PSYCHIAT, V16, P27; Banegas JR, 2007, EUR J CARDIOV PREV R, V14, P456, DOI 10.1097/HJR.0b013e3280803f29; Bowden A, 2003, SOC SCI MED, V57, P1289, DOI 10.1016/S0277-9536(02)00503-8; Bradley C, 2001, LANCET, V357, P7, DOI 10.1016/S0140-6736(00)03562-5; Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chiew KQ, 1999, META, V44, P604; Cohen J., 2013, APPL MULTIPLE REGRES; Costa Filipa Alves, 2006, Pharm Pract (Granada), V4, P123; de Grauw WJC, 2001, BRIT J GEN PRACT, V51, P527; Department of Statistics, 2011, POP DISTR BAS DEM CH; Diabet Control Complications Trial Res Grp, 1996, DIABETES CARE, V19, P195; Eljedi A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-268; Fischer JS, 2004, CURR MED RES OPIN, V20, P1703, DOI 10.1185/030079904X5526; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Gurkova E, 2009, J CLIN NURS, V18, P1276, DOI 10.1111/j.1365-2702.2008.02602.x; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Houlden R, 2007, DIABETES RES CLIN PR, V78, P254, DOI 10.1016/j.diabres.2007.03.021; Imran M. Kamarul, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P398; Institute for Public Health, 2011, NAT HLTH MORB SURV 2, V1; International Diabetes Federation, 2011, DIAB ATL BRUSS; International Diabetes Federation, 2013, DIAB ATL BRUSS; International Diabetes Federation, 2014, DIAB ATL BRUSS; Jayawardena R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-380; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Kolotkin RL, 2003, DIABETES RES CLIN PR, V61, P125, DOI 10.1016/S0168-8227(03)00113-X; Lau C Y, 2004, J Postgrad Med, V50, P189; letchuman G. R., 2010, Medical Journal of Malaysia, V65, P173; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Ostini R, 2012, QUAL LIFE RES, V21, P1471, DOI 10.1007/s11136-011-0043-0; Papadopoulos AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-186; Phan TP, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000012; Pibernik-Okanovic M, 1998, PHARMACOECONOMICS, V14, P201, DOI 10.2165/00019053-199814020-00008; Quandt SA, 2007, ETHNIC DIS, V17, P471; Rhee MK, 2005, DIABETES EDUCATOR, V31, P240, DOI 10.1177/0145721705274927; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Shiu ATY, 2008, J CLIN NURS, V17, P125, DOI 10.1111/j.1365-2702.2007.02036.x; SNELL SA, 1992, ACAD MANAGE J, V35, P467, DOI 10.2307/256484; Speight J, 2013, DIABETIC MED, V30, P74, DOI 10.1111/j.1464-5491.2012.03748.x; Watkins K, 2004, PHARMACOECONOMICS, V22, P1109, DOI 10.2165/00019053-200422170-00002; Wee HL, 2006, PHARMACOECONOMICS, V24, P673, DOI 10.2165/00019053-200624070-00006; Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; WHO, 2012, COUNTR REG DAT DIAB	46	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163701	10.1371/journal.pone.0163701	http://dx.doi.org/10.1371/journal.pone.0163701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695086	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100048
J	Sin, YW; Newman, C; Dugdale, HL; Buesching, C; Mannarelli, ME; Annavi, G; Burke, T; Macdonald, DW				Sin, Yung Wa; Newman, Chris; Dugdale, Hannah L.; Buesching, Christina; Mannarelli, Maria-Elena; Annavi, Geetha; Burke, Terry; Macdonald, David W.			No Compensatory Relationship between the Innate and Adaptive Immune System in Wild-Living European Badgers	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; SUBCAUDAL GLAND SECRETION; IMMUNOCOMPETENCE HANDICAP HYPOTHESIS; LEUKOCYTE COPING CAPACITY; MELES-MELES; CLASS-I; OXIDATIVE STRESS; MHC GENES; MULTIMODEL INFERENCE; POPULATION-DYNAMICS	The innate immune system provides the primary vertebrate defence system against pathogen invasion, but it is energetically costly and can have immune pathological effects. A previous study in sticklebacks found that intermediate major histocompatibility complex (MHC) diversity correlated with a lower leukocyte coping capacity (LCC), compared to individuals with fewer, or many, MHC alleles. The organization of the MHC genes in mammals, however, differs to the highly duplicated MHC genes in sticklebacks by having far fewer loci. Using European badgers (Meles meles), we therefore investigated whether innate immune activity, estimated functionally as the ability of an individual's leukocytes to produce a respiratory burst, was influenced by MHC diversity. We also investigated whether LCC was influenced by factors such as age-class, sex, body condition, season, year, neutrophil and lymphocyte counts, and intensity of infection with five different pathogens. We found that LCC was not associated with specific MHC haplotypes, MHC alleles, or MHC diversity, indicating that the innate immune system did not compensate for the adaptive immune system even when there were susceptible MHC alleles/haplotypes, or when the MHC diversity was low. We also identified a seasonal and annual variation of LCC. This temporal variation of innate immunity was potentially due to physiological trade-offs or temporal variation in pathogen infections. The innate immunity, estimated as LCC, does not compensate for MHC diversity suggests that the immune system may function differently between vertebrates with different MHC organizations, with implications for the evolution of immune systems in different taxa.	[Sin, Yung Wa; Newman, Chris; Buesching, Christina; Annavi, Geetha; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House,Abingdon Rd, Abingdon OX13 5QL, Oxon, England; [Sin, Yung Wa; Mannarelli, Maria-Elena; Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, NERC Biomol Anal Facil, Sheffield S10 2TN, S Yorkshire, England; [Sin, Yung Wa] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA; [Dugdale, Hannah L.] Univ Groningen, Groningen Inst Evolutionary Life Sci, POB 11103, NL-9700 CC Groningen, Netherlands; [Dugdale, Hannah L.] Univ Leeds, Fac Biol Sci, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Mannarelli, Maria-Elena] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Annavi, Geetha] Univ Putra Malaysia, Fac Sci, Dept Biol, Serdang 43400, Selangor, Malaysia	University of Oxford; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Sheffield; Harvard University; University of Groningen; University of Leeds; University of East Anglia; Universiti Putra Malaysia	Sin, YW (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House,Abingdon Rd, Abingdon OX13 5QL, Oxon, England.; Sin, YW (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, NERC Biomol Anal Facil, Sheffield S10 2TN, S Yorkshire, England.; Sin, YW (corresponding author), Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA.	yungwa.sin@gmail.com	Burke, Terry/B-3196-2011; Dugdale, Hannah L/C-7138-2008	Burke, Terry/0000-0003-3848-1244; Dugdale, Hannah L/0000-0001-8769-0099; Sin, Simon Yung Wa/0000-0003-2484-2897	Croucher Foundation (Hong Kong); Ministry of Education Malaysia; Netherlands Organization for Scientific Research (NWO); NERC [NE/I021748/1]; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NE/I021748/1, NBAF010001] Funding Source: researchfish	Croucher Foundation (Hong Kong); Ministry of Education Malaysia(Ministry of Education, Malaysia); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	YWS was supported by the Croucher Foundation (Hong Kong), GA by the Ministry of Education Malaysia, and HD by the Netherlands Organization for Scientific Research (NWO) and a NERC fellowship (NE/I021748/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Anderson D. R., 2008, MODEL BASED INFERENC; Annavi G, 2014, J EVOLUTION BIOL, V27, P2191, DOI 10.1111/jeb.12473; Barton K, 2020, MUMIN MULTIMODEL INF; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Becker L, 2009, IMMUNOGENETICS, V61, P281, DOI 10.1007/s00251-009-0362-2; Bilham K, 2013, ETHOL ECOL EVOL, V25, P330, DOI 10.1080/03949370.2013.767861; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Blagojevic Dusko P, 2011, Front Biosci (Schol Ed), V3, P416, DOI 10.2741/s161; Bonneaud C, 2005, IMMUNOGENETICS, V57, P782, DOI 10.1007/s00251-005-0046-5; Bowen L, 2004, IMMUNOGENETICS, V56, P12, DOI 10.1007/s00251-004-0655-4; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Buesching CD, 2002, J CHEM ECOL, V28, P41, DOI 10.1023/A:1013558718057; Buesching CD, 2002, MAMM BIOL, V67, P147, DOI 10.1078/1616-5047-00022; Buesching CD, 2009, J COMP PHYSIOL A, V195, P865, DOI 10.1007/s00359-009-0465-0; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Buttemer WA, 2010, FUNCT ECOL, V24, P971, DOI 10.1111/j.1365-2435.2010.01740.x; CALLAHAN HL, 1988, PARASITOL TODAY, V4, P218, DOI 10.1016/0169-4758(88)90162-7; Casto JM, 2001, AM NAT, V157, P408, DOI 10.1086/319318; Charbonnel N, 2010, EVOL APPL, V3, P279, DOI 10.1111/j.1752-4571.2009.00108.x; Chiumiento L, 2009, PARASITOL RES, V105, P593, DOI 10.1007/s00436-009-1483-0; Costantini D, 2010, FUNCT ECOL, V24, P950, DOI 10.1111/j.1365-2435.2010.01746.x; Cox R, 1999, J INSECT BEHAV, V12, P245, DOI 10.1023/A:1020923001987; Culshaw S, 2008, IMMUNOL LETT, V118, P49, DOI 10.1016/j.imlet.2008.02.008; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Doxiadis GGM, 2001, IMMUNOL REV, V183, P76, DOI 10.1034/j.1600-065x.2001.1830106.x; Duffy DL, 2000, BEHAV ECOL, V11, P654, DOI 10.1093/beheco/11.6.654; Dugdale HL, 2011, ANIM BEHAV, V82, P1287, DOI 10.1016/j.anbehav.2011.09.008; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Evsikov V. I., 1994, ADV BIOSCIENCES CHEM, V93, P303; Foreyt W.J, 2001, VET PARASITOLOGY REF, V5th; French SS, 2009, INTEGR COMP BIOL, V49, P246, DOI 10.1093/icb/icp032; Galipaud M, 2014, METHODS ECOL EVOL, V5, P983, DOI 10.1111/2041-210X.12251; Gelling M, 2009, ANIM WELFARE, V18, P1; Gelman A, 2009, ARM DATA ANAL USING; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Grueber CE, 2011, MOL ECOL, V20, P67, DOI 10.1111/j.1365-294X.2010.04930.x; Hidano A, 2014, INSECT MOL BIOL, V23, P466, DOI 10.1111/imb.12101; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Kennedy MW, 2006, TRENDS ECOL EVOL, V21, P653, DOI 10.1016/j.tree.2006.09.017; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; LAWLOR DA, 1990, ANNU REV IMMUNOL, V8, P23, DOI 10.1146/annurev.iy.08.040190.000323; Lifjeld JT, 2002, OECOLOGIA, V130, P185, DOI 10.1007/s004420100798; Lozano GA, 2003, P ROY SOC B-BIOL SCI, V270, P1203, DOI 10.1098/rspb.2002.2309; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Macdonald DW, 2009, J MAMMAL, V90, P1392, DOI 10.1644/08-MAMM-A-356R1.1; Macdonald DW, 1999, J ZOOL, V247, P65, DOI 10.1111/j.1469-7998.1999.tb00193.x; Macdonald DW, 2002, J ZOOL, V256, P121, DOI 10.1017/S0952836902000158; Macdonald DW, 2002, ECOLOGY, V83, P2056, DOI 10.2307/3071787; MAKHATADZE NJ, 1995, HUM IMMUNOL, V42, P189, DOI 10.1016/0198-8859(94)00090-D; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martin LB, 2008, PHILOS T R SOC B, V363, P321, DOI 10.1098/rstb.2007.2142; Mazerolle MJ, 2011, AICCMODAVG MODEL SEL; McLaren GW, 2005, VET ANAESTH ANALG, V32, P367, DOI 10.1111/j.1467-2995.2005.00206.x; McLaren GW, 2003, EXP PHYSIOL, V88, P541, DOI 10.1113/eph8802571; Montes I, 2007, LEUKOCYTE COPING CAP; Nelson RJ, 2004, TRENDS IMMUNOL, V25, P187, DOI 10.1016/j.it.2004.02.001; Newman C, 2001, PARASITOLOGY, V123, P133, DOI 10.1017/S0031182001008265; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Oliver MK, 2009, P ROY SOC B-BIOL SCI, V276, P1119, DOI 10.1098/rspb.2008.1525; Owen-Ashley NT, 2004, AM NAT, V164, P490, DOI 10.1086/423714; Paterson S, 1998, P NATL ACAD SCI USA, V95, P3714, DOI 10.1073/pnas.95.7.3714; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Potter NS, 2001, J IMMUNOL, V167, P2538, DOI 10.4049/jimmunol.167.5.2538; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Richardson DS, 2005, P ROY SOC B-BIOL SCI, V272, P759, DOI 10.1098/rspb.2004.3028; Roberts ML, 2004, ANIM BEHAV, V68, P227, DOI 10.1016/j.anbehav.2004.05.001; Sato A, 1998, MOL MAR BIOL BIOTECH, V7, P221; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sharp G. J. E., 1993, Fish & Shellfish Immunology, V3, P119, DOI 10.1006/fsim.1993.1013; Sin YW, 2015, MOL ECOL, V24, P3138, DOI 10.1111/mec.13217; Sin YW, 2014, MOL ECOL, V23, P5072, DOI 10.1111/mec.12917; Sin YW, 2012, ECOL EVOL, V2, P1644, DOI 10.1002/ece3.285; Sin YW, 2012, FEMS MICROBIOL ECOL, V81, P648, DOI 10.1111/j.1574-6941.2012.01396.x; Sin YW, 2012, IMMUNOGENETICS, V64, P313, DOI 10.1007/s00251-011-0578-9; Sin YW, 2014, MAJOR HISTOCOMPATIBI; SMITH JA, 1994, J LEUKOCYTE BIOL, V56, P672, DOI 10.1002/jlb.56.6.672; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Takahashi K, 2000, J HERED, V91, P198, DOI 10.1093/jhered/91.3.198; Tate MD, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-57; Travers Paul, 1994, IMMUNOBIOLOGY; VIDOVIC D, 1988, NATURE, V336, P222, DOI 10.1038/336222a0; Wagner JL, 1999, J HERED, V90, P35, DOI 10.1093/jhered/90.1.35; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wedekind C, 1998, J CHEM ECOL, V24, P787, DOI 10.1023/A:1022365315836; Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; Westerdahl H, 2005, P ROY SOC B-BIOL SCI, V272, P1511, DOI 10.1098/rspb.2005.3113; Woelfing B, 2009, PHILOS T R SOC B, V364, P117, DOI 10.1098/rstb.2008.0174; Yamaguchi N, 2006, Q REV BIOL, V81, P33, DOI 10.1086/503923; Yuhki N, 2003, GENOME RES, V13, P1169, DOI 10.1101/gr.976103; Zuur Alain F., 2009, P1	97	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163773	10.1371/journal.pone.0163773	http://dx.doi.org/10.1371/journal.pone.0163773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695089	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100052
J	Golderman, V; Shavit-Stein, E; Tamarin, I; Rosman, Y; Shrot, S; Rosenberg, N; Maggio, N; Chapman, J; Eisenkraft, A				Golderman, Valery; Shavit-Stein, Efrat; Tamarin, Ilia; Rosman, Yossi; Shrot, Shai; Rosenberg, Nurit; Maggio, Nicola; Chapman, Joab; Eisenkraft, Arik			The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro	PLOS ONE			English	Article							MEDICAL-MANAGEMENT; ENZYMES; SYSTEM; SARIN	Organophosphates (OPs) are potentially able to affect serine proteases by reacting with their active site. The potential effects of OPs on coagulation factors such as thrombin and on coagulation tests have been only partially characterized and potential interactions with OPs antidotes such as oximes and muscarinic blockers have not been addressed. In the current study, we investigated the in vitro interactions between coagulation, thrombin, the OP paraoxon, and its antidotes obidoxime and atropine. The effects of these substances on thrombin activity were measured in a fluorescent substrate and on coagulation by standard tests. Both paraoxon and obidoxime but not atropine significantly inhibited thrombin activity, and prolonged prothrombin time, thrombin time, and partial thromboplastin time. When paraoxon and obidoxime were combined, a significant synergistic effect was found on both thrombin activity and coagulation tests. In conclusion, paraoxon and obidoxime affect thrombin activity and consequently alter the function of the coagulation system. Similar interactions may be clinically relevant for coagulation pathways in the blood and possibly in the brain.	[Golderman, Valery] Sheba Med Ctr, Lab Neurol Res, Tel Hashomer, Israel; [Shavit-Stein, Efrat; Maggio, Nicola; Chapman, Joab] Chaim Sheba Med Ctr, Dept Neurol, Tel Hashomer, Israel; [Tamarin, Ilia; Rosenberg, Nurit] Sheba Med Ctr, Dept Hematol, Coagulat Lab, Tel Hashomer, Israel; [Rosman, Yossi; Shrot, Shai; Eisenkraft, Arik] Israel Def Force Med Corps, Surgeon Gen Headquarters, Tel Hashomer, Ramat Gan, Israel; [Rosman, Yossi] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Shrot, Shai] MedStar Georgetown Univ Hosp, Dept Radiol, Washington, DC USA; [Maggio, Nicola; Chapman, Joab] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, Tel Aviv, Israel; [Maggio, Nicola; Chapman, Joab] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Chapman, Joab] Tel Aviv Univ, Robert & Martha Harden Chair Mental & Neurol Dis, Sackler Fac Med, Tel Aviv, Israel; [Eisenkraft, Arik] IMoD, NBC Protect Div, Tel Aviv, Israel; [Eisenkraft, Arik] Hebrew Univ Jerusalem, Inst Res Mil Med, Jerusalem, Israel	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Georgetown University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem	Eisenkraft, A (corresponding author), Israel Def Force Med Corps, Surgeon Gen Headquarters, Tel Hashomer, Ramat Gan, Israel.; Eisenkraft, A (corresponding author), IMoD, NBC Protect Div, Tel Aviv, Israel.; Eisenkraft, A (corresponding author), Hebrew Univ Jerusalem, Inst Res Mil Med, Jerusalem, Israel.	aizenkra@gmail.com	Chapman, Joab/E-4598-2010; shrot, shai/ABF-7714-2021	shrot, shai/0000-0001-8954-3244; Chapman, Joab/0000-0002-2161-9764	Israel Defense Forces	Israel Defense Forces	This study was financed by a scientific grant of the Israel Defense Forces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates SM, 2005, CIRCULATION, V112, pE53, DOI 10.1161/CIRCULATIONAHA.104.478222; Beilin O, 2001, NEUROREPORT, V12, P2347, DOI 10.1097/00001756-200108080-00013; Burlingham BT, 2003, J CHEM EDUC, V80, P214, DOI 10.1021/ed080p214; Bushi D, 2013, J MOL NEUROSCI, V51, P844, DOI 10.1007/s12031-013-0072-y; Chapman J, 2013, SEMIN THROMB HEMOST, V39, P876, DOI 10.1055/s-0033-1357482; Collombet JM, 2011, TOXICOL APPL PHARM, V255, P229, DOI 10.1016/j.taap.2011.07.003; Eisenkraft A, 2013, NEUROTOX RES, V24, P265, DOI 10.1007/s12640-013-9388-1; Gupta B, 2014, ARCH TOXICOL, V88, P381, DOI 10.1007/s00204-013-1136-z; Ikegami Y, 2003, AM J EMERG MED, V21, P509, DOI 10.1016/S0735-6757(03)00089-5; Jastrzebski Jacek, 1994, Materia Medica Polona, V26, P33; Kiderlen D, 2005, BIOCHEM PHARMACOL, V69, P1853, DOI 10.1016/j.bcp.2005.04.003; Ma Hongbao JY, 2008, NATURE SCI, V6, P90; Markel G, 2008, ISR MED ASSOC J, V10, P761; MOUNTER LA, 1963, J BIOL CHEM, V238, P1979; MURRAY JC, 1994, PEDIATR EMERG CARE, V10, P289, DOI 10.1097/00006565-199410000-00012; Petroianu G, 1999, CHEM-BIOL INTERACT, V119, P489, DOI 10.1016/S0009-2797(99)00062-9; Quistad GB, 2000, J BIOCHEM MOL TOXIC, V14, P51, DOI 10.1002/(SICI)1099-0461(2000)14:1<51::AID-JBT7>3.0.CO;2-W; SHUSTER J, 1959, CAN J BIOCHEM PHYS, V37, P895; THOMPSON AR, 1970, BIOCHIM BIOPHYS ACTA, V198, P392, DOI 10.1016/0005-2744(70)90073-2; YANG YC, 1992, CHEM REV, V92, P1729, DOI 10.1021/cr00016a003	20	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163787	10.1371/journal.pone.0163787	http://dx.doi.org/10.1371/journal.pone.0163787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689805	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200027
J	Lee, KH; Baik, SY; Lee, SY; Park, CH; Park, PJ; Kim, JH				Lee, Kye Hwa; Baik, Su Youn; Lee, Soo Youn; Park, Chan Hee; Park, Paul J.; Kim, Ju Han			Genome Sequence Variability Predicts Drug Precautions and Withdrawals from the Market	PLOS ONE			English	Article							GENETIC-VARIANTS; PHARMACOGENETICS; INFORMATION; MUTATIONS; MEDICINE	Despite substantial premarket efforts, a significant portion of approved drugs has been withdrawn from the market for safety reasons. The deleterious impact of nonsynonymous substitutions predicted by the SIFT algorithm on structure and function of drug-related proteins was evaluated for 2504 personal genomes. Both withdrawn (n = 154) and precautionary (Beers criteria (n = 90), and US FDA pharmacogenomic biomarkers (n = 96)) drugs showed significantly lower genomic deleteriousness scores (P < 0.001) compared to others (n = 752). Furthermore, the rates of drug withdrawals and precautions correlated significantly with the deleteriousness scores of the drugs (P < 0.01); this trend was confirmed for all drugs included in the withdrawal and precaution lists by the United Nations, European Medicines Agency, DrugBank, Beers criteria, and US FDA. Our findings suggest that the person-to-person genome sequence variability is a strong independent predictor of drug withdrawals and precautions. We propose novel measures of drug safety based on personal genome sequence analysis.	[Lee, Kye Hwa; Baik, Su Youn; Lee, Soo Youn; Park, Chan Hee; Kim, Ju Han] Seoul Natl Univ, Seoul Natl Univ Biomed Informat, Div Biomed Informat, Coll Med, Seoul 110799, South Korea; [Kim, Ju Han] Seoul Natl Univ Hosp, Biomed Informat Training & Educ Ctr, Seoul 110744, South Korea; [Park, Paul J.] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Nevada System of Higher Education (NSHE); University of Nevada Reno	Kim, JH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Biomed Informat, Div Biomed Informat, Coll Med, Seoul 110799, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ Hosp, Biomed Informat Training & Educ Ctr, Seoul 110744, South Korea.	juhan@snu.ac.kr		Lee, Kye Hwa/0000-0002-7593-7020	Korean Health Technology R&D Project, Ministry of Health and Welfare [HI13C2164, HI16C11280000]	Korean Health Technology R&D Project, Ministry of Health and Welfare	This research was supported by the grants of the Korean Health Technology R&D Project, Ministry of Health and Welfare (HI13C2164, HI16C11280000). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Abernethy DR, 2011, CLIN PHARMACOL THER, V89, P793, DOI 10.1038/clpt.2011.55; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], GUID IND COLL RAC ET; [Anonymous], 2009, ANN REP EUR MED AG; BEERS MH, 1991, ARCH INTERN MED, V151, P1825; Berlin JA, 2008, AM J PUBLIC HEALTH, V98, P1366, DOI 10.2105/AJPH.2007.124537; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, 2009, CONS LIST PROD WHOS; Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, 2003, CONS LIST PROD WHOS; Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, 2004, CONS LIST PROD WHOS; Consolidated List of Products Whose Consumption and/or Sale Have Been Banned, 2005, CONS LIST PROD WHOS; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Daggumalli JSV, 2012, DRUG INF J, V46, P694, DOI 10.1177/0092861512458776; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lexchin Joel, 2014, Open Med, V8, pe14; Ma Q, 2011, PHARMACOL REV, V63, P437, DOI 10.1124/pr.110.003533; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Osler W., 1909, PRINCIPLES PRACTICE, DOI [10.2307/3403146, DOI 10.2307/3403146]; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Shah RR, 2006, PHARMACOGENOMICS, V7, P889, DOI 10.2217/14622416.7.6.889; Shihab H.A., 2013, BIOINFORMATICS, DOI DOI 10.1371/JOURNAL.PCBI.1001025; Strom BL, 2006, JAMA-J AM MED ASSOC, V295, P2072, DOI 10.1001/jama.295.17.2072; Team RDC, 2010, R LANG ENV STAT COMP; US FDA, 2015, TABL PHARM BIOM DRUG; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Wertheimer, 2012, INNOV PHARM, V3, P1; Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wittig U, 2012, NUCLEIC ACIDS RES, V40, pD790, DOI 10.1093/nar/gkr1046; Wysowski DK, 2005, ARCH INTERN MED, V165, P1363, DOI 10.1001/archinte.165.12.1363	49	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0162135	10.1371/journal.pone.0162135	http://dx.doi.org/10.1371/journal.pone.0162135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690231	gold, Green Submitted, Green Published			2022-12-27	WOS:000384329200003
J	Mitiku, I; Tefera, F				Mitiku, Israel; Tefera, Fasika			Knowledge about Cervical Cancer and Associated Factors among 15-49 Year Old Women in Dessie Town, Northeast Ethiopia	PLOS ONE			English	Article							MORTALITY	Background Cervical cancer is one of the leading causes of morbidity and mortality amongst female cancer worldwide, especially in developing countries, including Ethiopia. The level of women's knowledge about cervical cancer is not well documented in Ethiopia. The current study sought to assess women's knowledge about cervical cancer and associated factors. Method A community based cross-sectional survey was conducted with a sample of 620 women aged 15-49 years residing in Dessie town, Northeast Ethiopia. Respondents were selected using a multistage sampling technique. The women were interviewed at home by trained data collectors using a structured questionnaire on cervical cancer knowledge. Knowledge about cervical cancer was measured using an eight item instrument. The maximum possible score was 8; those scoring 5 or more were categorized as having "sufficient" knowledge. Binary and multiple logistic regressions were employed to determine factors associated with knowledge about cervical cancer. Results A total of 51% of the participants had sufficient knowledge about cervical cancer. After adjusting for covariates, having sufficient knowledge about cervical cancer was positively associated with better educational level and income. Women with primary education (Adjusted Odds Ratio (AOR): 3.4; 95% CI: 2.2-5.1) and those who had secondary and above education (AOR: 8.7; 95% CI: 5.5-13.7) were more likely to have sufficient knowledge about cervical cancer compared to those who had no formal education. Furthermore, women earning an average household monthly income above 1500 Ethiopian birr (ETB) (similar to 75 U.S. dollars) were more likely to have sufficient knowledge (AOR: 2.3; 95% CI: 1.3-3.9) than women with an average household monthly income less than 500 ETB (similar to 25 U.S. dollars). Conclusion This study shows a suboptimal knowledge about cervical cancer regarding its risk factors, signs and symptoms, prevention and treatment among women in the study site. The level of education and economic status were found to be important determinants for knowledge about cervical cancer. Prevention programs should focus cervical cancer educational resources on women with less education and women with lower economic status groups.	[Mitiku, Israel] Wollo Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia; [Tefera, Fasika] Ethiopian Family Guidance Assoc, Addis Ababa, Ethiopia	University of Gondar	Mitiku, I (corresponding author), Wollo Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia.	israelmitiku@yahoo.com						Ali-Risasi C, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-30; Anttila A, 1999, INT J CANCER, V83, P59, DOI 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.3.CO;2-E; Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Arbyn M, 2010, TUMORI J, V96, P517, DOI 10.1177/030089161009600402; Ayinde O A, 2004, Afr J Reprod Health, V8, P68, DOI 10.2307/3583394; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Bruni L., 2015, ICO INFORM CTR HPV C; Chew GK, 2005, BRIT J CANCER, V93, P1301, DOI 10.1038/sj.bjc.6602855; Denny L, 2006, VACCINE, V24, P71, DOI 10.1016/j.vaccine.2006.05.121; Everlyne NM, 2014, KENYA BMC HLTH SERVI, V14, P335, DOI [10.1186/1472-6963-14-335, DOI 10.1186/1472-6963-14-335]; Federal Democratic Republic of Ethiopia Central Statistical Agency, 2013, POP PROJ ETH ALL REG; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; Hamad HMA, 2006, ANN ONCOL, V17, P32, DOI 10.1093/annonc.mdl985; Hoque Monjurul, 2008, East Afr J Public Health, V5, P111; Jeronimo J, 2014, INT J GYNECOL CANCER, V24, P576, DOI 10.1097/IGC.0000000000000084; Jia Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067005; Lyimo FS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-22; Ministry of Health, 2015, ETH NAT CANC CONTR P; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Nene B, 2007, B WORLD HEALTH ORGAN, V85, P264, DOI 10.2471/BLT.06.031195; Peto J, 2004, LANCET, V364, P249, DOI 10.1016/S0140-6736(04)16674-9; ROSENSTOCK IM, 1966, MILBANK FUND Q, V44, P94, DOI 10.2307/3348967; Varughese Joyce, 2010, Rev Obstet Gynecol, V3, P122	25	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163136	10.1371/journal.pone.0163136	http://dx.doi.org/10.1371/journal.pone.0163136			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690311	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200013
J	Ahlen, KM; Ortqvist, AK; Gong, T; Wallas, A; Ye, WM; Lundholm, C; Almqvist, C				Ahlen, Katia M.; Ortqvist, Anne K.; Gong, Tong; Wallas, Alva; Ye, Weimin; Lundholm, Cecilia; Almqvist, Catarina			Antibiotic Treatment and Length of Hospital Stay in Relation to Delivery Mode and Prematurity	PLOS ONE			English	Article							EARLY-LIFE EXPOSURE; SECONDARY ANALYSIS; PRETERM BIRTH; CHILDHOOD; BACTERIAL; INFANT; HEALTH; ASTHMA; EPIDEMIOLOGY; REGISTER	Aim To investigate how 1) maternal delivery mode and 2) prematurity in infants are associated to antibiotic treatment and length of hospital stay. Methods Women having given birth and infants 0-12 months discharged from hospital between July 2005 and November 2011 were identified from the Swedish National Patient Register. Medical records were reviewed for 203 women and 527 infants. The risk ratio (RR) between antibiotic treatment and 1) delivery mode in women; 2) prematurity in infants was calculated. Length of stay and days of antibiotic therapy were compared by Wilcoxon rank-sum test. Results Women: There was an association between emergency caesarean section (CS) and antibiotic treatment (RR 5.0 95% confidence interval (CI) 2.2-11.5), but not for elective CS. Length of stay was longer for CS (emergency and elective) compared to vaginal delivery (p< 0.01). Infants: RR for antibiotic treatment in preterm compared to term infants was 1.4 (95% CI 1.0-1.9). Length of stay (p< 0.01), but not days of therapy (p = 0.17), was higher in preterm compared to term infants. Conclusion We found that emergency CS increased the probability of maternal antibiotic treatment during hospitalisation, but no difference was found between term and preterm infants. The results are well aligned with current guidelines and may be considered in future studies on the effects of antibiotics.	[Ahlen, Katia M.; Ortqvist, Anne K.; Gong, Tong; Ye, Weimin; Lundholm, Cecilia; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Wallas, Alva] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Lung & Allergy Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Ahlen, KM (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	katia.ahlen@gmail.com	Gong, Tong/HDM-8653-2022; Örtqvist, Anne Kristina/P-6618-2019	Lundholm, Cecilia/0000-0002-6546-3650; ye, weimin/0000-0002-6859-4648	Swedish Research Council (Vetenskapsradet) [2011-3060]; Swedish Initiative for Research on Microdata in the Social And Medical Sciences [80748301, 340-2013-5867]; Stockholm County Council (Stockholms Lans Landsting) ALF-projects [502262, 520344, 530422]; Strategic Research Program in Epidemiology at Karolinska Institutet; Swedish Heart-Lung Foundation	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Initiative for Research on Microdata in the Social And Medical Sciences; Stockholm County Council (Stockholms Lans Landsting) ALF-projects; Strategic Research Program in Epidemiology at Karolinska Institutet; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation)	This work was supported by the grants from a) the Swedish Research Council (Vetenskapsradet) Grant number 2011-3060 (http://www.vr.se/) to CA; b) the Swedish Initiative for Research on Microdata in the Social And Medical Sciences Grants no 80748301 and 340-2013-5867) (http://simsam.nu/) to CA and WY; c) Stockholm County Council (Stockholms Lans Landsting) ALF-projects award numbers 502262, 520344 and 530422 (http://www.sll.se/) to CA; d) the Strategic Research Program in Epidemiology at Karolinska Institutet (www.ki.se) to CA; e) the Swedish Heart-Lung Foundation (https://www.hjart-lungfonden.se/) to CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2015, ACTA PAEDIATR, V104, P392, DOI 10.1111/apa.12916; Almqvist C, 2012, CLIN EXP ALLERGY, V42, P104, DOI 10.1111/j.1365-2222.2011.03850.x; [Anonymous], 2010, ANT VID KIR INGR SYS; [Anonymous], 2013, GRAV FORL NYF BARN M; [Anonymous], 1956, P 3 BERK S, V4, P135; [Anonymous], 2010, ACTA PAEDIATR, V99, P978, DOI DOI 10.1111/J.1651-2227.2010.01846.X; Azad MB, 2014, INT J OBESITY, V38, P1290, DOI 10.1038/ijo.2014.119; Bergstrom M, ANTIBIOTIKAANVANDNIN; Byington CL, 2004, PEDIATRICS, V113, P1662, DOI 10.1542/peds.113.6.1662; Cantey JB, 2014, PEDIATR INFECT DIS J, DOI [10.1097/int.0000000000000542, DOI 10.1097/INT.0000000000000542]; Cuzick J, WILCOXON TYPE TEST T; Erntell M, 2004, POINT PREVALENCE STU; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hakansson S, 2013, NEONATAL SEPSIS EPID; Hellman J, 2012, SWEDRES SVARM 2012; Kimland E, 2012, ACTA PAEDIATR, V101, P772, DOI 10.1111/j.1651-2227.2012.02656.x; Kummeling I, 2007, PEDIATRICS, V119, pE225, DOI 10.1542/peds.2006-0896; Liabsuetrakul T, 2014, INT J GYNECOL OBSTET, V124, P240, DOI 10.1016/j.ijgo.2013.07.039; Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P66, DOI 10.1111/1471-0528.12632; Ortqvist AK, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6979; Ringborg A, 2006, ACTA PAEDIATR, V95, P1550, DOI 10.1080/08035250600778636; Russell ARB, 2006, BJOG-INT J OBSTET GY, V113, P758, DOI 10.1111/j.1471-0528.2006.00952.x; Shane AL, 2013, AM J PERINAT, V30, P131, DOI 10.1055/s-0032-1333413; Sharma AA, 2012, CLIN IMMUNOL, V145, P61, DOI 10.1016/j.clim.2012.08.006; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Stokholm J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082932; Sudo N, 1997, J IMMUNOL, V159, P1739; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Tsakok T, 2013, BRIT J DERMATOL, V169, P983, DOI 10.1111/bjd.12476; van Schalkwyk J, 2010, J OBSTET GYNAECOL CA, V32, P878, DOI 10.1016/S1701-2163(16)34662-X; Wee MYK, 2005, INT J OBSTET ANESTH, V14, P147, DOI 10.1016/j.ijoa.2004.09.008; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Zingg W, 2011, PEDIATR INFECT DIS J, V30, P365, DOI 10.1097/INF.0b013e31820243d3	33	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164126	10.1371/journal.pone.0164126	http://dx.doi.org/10.1371/journal.pone.0164126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716779	Green Submitted, Green Published, gold			2022-12-27	WOS:000385698100024
J	Darrigo, C; Guillemet, E; Dervyn, R; Ramarao, N				Darrigo, Claire; Guillemet, Elisabeth; Dervyn, Rozenn; Ramarao, Nalini			The Bacterial Mfd Protein Prevents DNA Damage Induced by the Host Nitrogen Immune Response in a NER-Independent but RecBC-Dependent Pathway	PLOS ONE			English	Article							REPAIR COUPLING FACTOR; BACILLUS-CEREUS BACTEREMIA; ESCHERICHIA-COLI; NITRIC-OXIDE; SUBTILIS CELLS; MACROPHAGES; RECOMBINATION; THURINGIENSIS; STRAINS; REPLICATION	Production of reactive nitrogen species is an important component of the host immune defence against bacteria. Here, we show that the bacterial protein Mfd (Mutation frequency decline), a highly conserved and ubiquitous bacterial protein involved in DNA repair, confers bacterial resistance to the eukaryotic nitrogen response produced by macrophage cells and during mice infection. In addition, we show that RecBC is also necessary to survive this stress. The inactivation of recBC and mfd genes is epistatic showing that Mfd follows the RecBC repair pathway to protect the bacteria against the genotoxic effect of nitrite. Surprisingly given the role of Mfd in transcription-coupled repair, UvrA is not necessary to survive the nitrite response. Taken together, our data reveal that during the eukaryotic nitrogen response, Mfd is required to maintain bacterial genome integrity in a NER-independent but RecBC-dependent pathway.	[Darrigo, Claire; Guillemet, Elisabeth; Dervyn, Rozenn; Ramarao, Nalini] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Ramarao, N (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France.	nalini.rama-rao@inra.fr	Rama Rao, Nalini/GRR-7800-2022					Amoroso A, 2008, Curr Mol Pharmacol, V1, P162; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Ayora S, 1996, J MOL BIOL, V256, P301, DOI 10.1006/jmbi.1996.0087; Baharoglu Z, 2014, FEMS MICROBIOL REV, V38, P1126, DOI 10.1111/1574-6976.12077; BRIDGES BA, 1995, MUTAT RES-FUND MOL M, V329, P49, DOI 10.1016/0027-5107(95)00016-C; BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x; Cadot C, 2010, J CLIN MICROBIOL, V48, P1358, DOI 10.1128/JCM.02123-09; Callegan MC, 2005, INVEST OPHTH VIS SCI, V46, P3233, DOI 10.1167/iovs.05-0410; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Decousser JW, 2013, AM J INFECT CONTROL, V41, P918, DOI 10.1016/j.ajic.2013.01.043; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Epshtein V, 2014, NATURE, V505, P372, DOI 10.1038/nature12928; GEORGE DL, 1975, MUTAT RES, V28, P347, DOI 10.1016/0027-5107(75)90229-8; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Glasset B, 2016, EUROSURVEIL IN PRESS; Guillemet E, 2016, SCI REP-UK, V6, DOI 10.1038/srep29349; Guillemet E, 2010, J BACTERIOL, V192, P286, DOI 10.1128/JB.00264-09; Han J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000083; Hao N, 2014, NUCLEIC ACIDS RES, V42, P8861, DOI 10.1093/nar/gku627; Hilliard NJ, 2003, J CLIN MICROBIOL, V41, P3441, DOI 10.1128/JCM.41.7.3441-3444.2003; INVS, 2016, COLL FOOD POIS INVS; Kamar R, 2013, J CLIN MICROBIOL, V51, P320, DOI 10.1128/JCM.02848-12; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Lee GH, 2009, DIAGN MICR INFEC DIS, V65, P454, DOI 10.1016/j.diagmicrobio.2009.08.007; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; LERECLUS D, 1992, MOL MICROBIOL, V6, P35, DOI 10.1111/j.1365-2958.1992.tb00835.x; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Million-Weaver S, 2015, P NATL ACAD SCI USA, V112, pE1096, DOI 10.1073/pnas.1416651112; Miyagi K, 1997, INFECT IMMUN, V65, P4108, DOI 10.1128/IAI.65.10.4108-4113.1997; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Pomerantz RI, 2010, SCIENCE; Pybus C, 2010, J BACTERIOL, V192, P3321, DOI 10.1128/JB.00354-10; Ramarao N, 2005, CELL MICROBIOL, V7, P1357, DOI 10.1111/j.1462-5822.2005.00562.x; Ramarao N, 2006, MICROBES INFECT, V8, P1483, DOI 10.1016/j.micinf.2006.01.005; Ramarao N, 2014, AM J INFECT CONTROL, V42, P694, DOI 10.1016/j.ajic.2014.01.025; Ramarao N, 2013, TOXINS, V5, P1119, DOI 10.3390/toxins5061119; Ramirez-Guadiana FH, 2013, MOL MICROBIOL, V90, P1088, DOI 10.1111/mmi.12417; Rejasse A, 2012, APPL ENVIRON MICROB, V78, P2553, DOI 10.1128/AEM.07446-11; Richardson AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000451; Roberts J, 2004, CURR OPIN MICROBIOL, V7, P120, DOI 10.1016/j.mib.2004.02.014; Ross C, 2006, J BACTERIOL, V188, P7512, DOI 10.1128/JB.00980-06; Sanchis V, 1996, J BIOTECHNOL, V48, P81, DOI 10.1016/0168-1656(96)01404-6; Savery NJ, 2007, TRENDS MICROBIOL, V15, P326, DOI 10.1016/j.tim.2007.05.005; Schalow BJ, 2012, J BACTERIOL, V194, P2637, DOI 10.1128/JB.06725-11; Schapiro JM, 2003, P NATL ACAD SCI USA, V100, P8496, DOI 10.1073/pnas.1033133100; Tran SL, 2013, FEMS MICROBIOL LETT, V347, P1, DOI 10.1111/1574-6968.12209; SELBY CP, 1995, J BIOL CHEM, V270, P4890, DOI 10.1074/jbc.270.9.4890; Sidorkina O, 1997, MUTAGENESIS, V12, P23, DOI 10.1093/mutage/12.1.23; Spek EJ, 2001, J BACTERIOL, V183, P131, DOI 10.1128/JB.183.1.131-138.2001; Spek EJ, 2002, J BACTERIOL, V184, P3501, DOI 10.1128/JB.184.13.3501-3507.2002; Tran SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022876; Tran SL, 2011, CELL MICROBIOL, V13, P92, DOI 10.1111/j.1462-5822.2010.01522.x; Veysseyre F, 2015, MED MALADIES INFECT, V45, P436, DOI 10.1016/j.medmal.2015.09.011; VILLAFANE R, 1987, J BACTERIOL, V169, P4822, DOI 10.1128/jb.169.10.4822-4829.1987; Wang YS, 2008, CHEM RES TOXICOL, V21, P276, DOI 10.1021/tx700411g; Willing SE, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0611-5; Zaki MH, 2005, J PHARMACOL SCI, V98, P117, DOI 10.1254/jphs.CRJ05004X	59	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163321	10.1371/journal.pone.0163321	http://dx.doi.org/10.1371/journal.pone.0163321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711223	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600020
J	Fasugba, O; Mitchell, BG; Mnatzaganian, G; Das, A; Collignon, P; Gardner, A				Fasugba, Oyebola; Mitchell, Brett G.; Mnatzaganian, George; Das, Anindita; Collignon, Peter; Gardner, Anne			Five-Year Antimicrobial Resistance Patterns of Urinary Escherichia coli at an Australian Tertiary Hospital: Time Series Analyses of Prevalence Data	PLOS ONE			English	Article							TRACT-INFECTIONS; ANTIBIOTIC USE; COMMUNITY; CARE; SURVEILLANCE; UROPATHOGENS; SEASONALITY; TRENDS; ADULT; ONSET	This study describes the antimicrobial resistance temporal trends and seasonal variation of Escherichia coli (E. coli) urinary tract infections (UTIs) over five years, from 2009 to 2013, and compares prevalence of resistance in hospital-and community-acquired E. coli UTI. A cross sectional study of E. coli UTIs from patients attending a tertiary referral hospital in Canberra, Australia was undertaken. Time series analysis was performed to illustrate resistance trends. Only the first positive E. coli UTI per patient per year was included in the analysis. A total of 15,022 positive cultures from 8724 patients were identified. Results are based on 5333 first E. coli UTIs, from 4732 patients, of which 84.2% were community-acquired. Five-year hospital and community resistance rates were highest for ampicillin (41.9%) and trimethoprim (20.7%). Resistance was lowest for meropenem (0.0%), nitrofurantoin (2.7%), piperacillin-tazobactam (2.9%) and ciprofloxacin (6.5%). Resistance to amoxycillin-clavulanate, cefazolin, gentamicin and piperacillin-tazobactam were significantly higher in hospital-compared to community-acquired UTIs (9.3% versus 6.2%; 15.4% versus 9.7%; 5.2% versus 3.7% and 5.2% versus 2.5%, respectively). Trend analysis showed significant increases in resistance over five years for amoxycillin-clavulanate, trimethoprim, ciprofloxacin, nitrofurantoin, trimethoprim-sulphamethoxazole, cefazolin, ceftriaxone and gentamicin (P<0.05, for all) with seasonal pattern observed for trimethoprim resistance (augmented Dickey-Fuller statistic = 4.136; P = 0.006). An association between ciprofloxacin resistance, cefazolin resistance and ceftriaxone resistance with older age was noted. Given the relatively high resistance rates for ampicillin and trimethoprim, these anti-microbials should be reconsidered for empirical treatment of UTIs in this patient population. Our findings have important implications for UTI treatment based on setting of acquisition.	[Fasugba, Oyebola; Mitchell, Brett G.; Gardner, Anne] Australian Catholic Univ, Fac Hlth Sci, Canberra, ACT, Australia; [Mitchell, Brett G.] Avondale Coll Higher Educ, Fac Arts Nursing & Theol, Wahroonga, NSW, Australia; [Mnatzaganian, George] La Trobe Univ, La Trobe Rural Hlth Sch, Coll Sci Hlth & Engn, Bundoora, Vic 3086, Australia; [Das, Anindita; Collignon, Peter] Canberra Hosp & Hlth Serv, Australian Capital Terr Pathol, Garran, ACT, Australia; [Collignon, Peter] Australian Natl Univ, Sch Med, Acton, ACT, Australia	Australian Catholic University; La Trobe University; Australian National University	Fasugba, O (corresponding author), Australian Catholic Univ, Fac Hlth Sci, Canberra, ACT, Australia.	oyebola.fasugba@myacu.edu.au	Collignon, Peter/U-4846-2019; Mnatzaganian, George/AAF-7753-2021; Gardner, Anne/G-8505-2012	Mnatzaganian, George/0000-0002-7698-5091; Mitchell, Brett/0000-0003-4220-8291; Collignon, Peter/0000-0001-8648-9203; Gardner, Anne/0000-0003-2021-5642	Australian Catholic University Postgraduate Award	Australian Catholic University Postgraduate Award	This study was carried out as part of a doctoral research program. OF is supported by an Australian Catholic University Postgraduate Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2013, J ANTIMICROB CHEMOTH, V68, pi31, DOI 10.1093/jac/dkt024; [Anonymous], 2014, M100S24 CLIN LAB STA, P34; Antibiotic Expert Groups, 2014, THER GUID ANT VERS 1; Australian Capital Territory Pathology, 2013, MICR DEP UR MAN; Australian Group for Antimicrobial Resistance, 2012, 2011 ANT SUSC REP GR; Bergman M, 2009, ANTIMICROB AGENTS CH, V53, P912, DOI 10.1128/AAC.00856-08; Blaettler L, 2009, INFECTION, V37, P534, DOI 10.1007/s15010-009-8457-0; Bouchillon SK, 2013, CLIN THER, V35, P872, DOI 10.1016/j.clinthera.2013.03.022; Buttner P, 2011, EPIDEMIOLOGY; Centers for Disease Control and Prevention National Center for Health Statistics, 2015, 2009 2010 COMB YEAR; Cheng AC, 2012, EMERG INFECT DIS, V18, P1453, DOI 10.3201/eid1809.111515; Cornaglia G, 2004, CLIN MICROBIOL INFEC, V10, P349, DOI 10.1111/j.1198-743X.2004.00887.x; Costelloe Ceire, 2010, BMJ, V340, pc2096, DOI 10.1136/bmj.c2096; Coxeter P, 2013, AUST NZ J PUBL HEAL, V37, P403, DOI 10.1111/1753-6405.12137; Cullen IM, 2012, BJU INT, V109, P1198, DOI 10.1111/j.1464-410X.2011.10528.x; Dagan R, 2008, J INFECT DIS, V197, P1094, DOI 10.1086/528995; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Falagas M, 2009, EXTENDED SPECTRUM HO, V73, P345, DOI [10.1016/j.jhin.2009.02.021, DOI 10.1016/J.JHIN.2009.02.021]; Fasugba O, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1282-4; Freeman JT, 2009, CLIN MICROBIOL INFEC, V15, P951, DOI 10.1111/j.1469-0691.2009.02866.x; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gupta K, 2001, CLIN INFECT DIS, V33, P89, DOI 10.1086/320880; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Howard DH, 2003, CLIN INFECT DIS, V36, pS4, DOI 10.1086/344656; Hsu LY, 2010, ANTIMICROB AGENTS CH, V54, P1173, DOI 10.1128/AAC.01076-09; Karlowsky JA, 2002, ANTIMICROB AGENTS CH, V46, P2540, DOI 10.1128/AAC.46.8.2540-2545.2002; Kennedy KJ, 2008, MED J AUSTRALIA, V188, P209, DOI 10.5694/j.1326-5377.2008.tb01586.x; Laupland KB, 2007, INFECTION, V35, P150, DOI 10.1007/s15010-007-6180-2; Linhares I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-19; Ma KL, 2013, AM J INFECT CONTROL, V41, P601, DOI 10.1016/j.ajic.2012.09.015; McGregor JC, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-25; Mitchell BG, 2016, INFECT DIS HEALTH, V21, P26, DOI 10.1016/j.idh.2016.03.001; Nicolle LE, 2008, UROL CLIN N AM, V35, P1, DOI 10.1016/j.ucl.2007.09.004; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; Perrin M, 1999, J HOSP INFECT, V41, P273, DOI 10.1053/jhin.1998.0521; Sannes MR, 2004, FEMS IMMUNOL MED MIC, V42, P213, DOI 10.1016/j.femsim.2004.05.004; Sun L, 2012, CLIN INFECT DIS, V55, P687, DOI 10.1093/cid/cis509; Swami SK, 2012, MAYO CLIN PROC, V87, P753, DOI 10.1016/j.mayocp.2012.02.025; Vellinga A, 2010, J ANTIMICROB CHEMOTH, V65, P1514, DOI 10.1093/jac/dkq149; Wang YC, 2014, J ANTIBIOT, V67, P799, DOI 10.1038/ja.2014.72; Wilson ML, 2004, CLIN INFECT DIS, V38, P1150, DOI 10.1086/383029; Wong PHP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-393; Zarb P, 2012, EUROSURVEILLANCE, V17, P4	44	34	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164306	10.1371/journal.pone.0164306	http://dx.doi.org/10.1371/journal.pone.0164306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711250	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600113
J	Adachi, H; Nakayama, K; Hayashi, N; Matsui, Y; Fujimoto, K; Yamaya, H; Tonami, H; Yokoyama, H				Adachi, Hiroki; Nakayama, Kanae; Hayashi, Norifumi; Matsui, Yuki; Fujimoto, Keiji; Yamaya, Hideki; Tonami, Hisao; Yokoyama, Hitoshi			Adiponectin Fractions Influence the Development of Posttransplant Diabetes Mellitus and Cardiovascular Disease in Japanese Renal Transplant Recipients	PLOS ONE			English	Article							MOLECULAR-WEIGHT ADIPONECTIN; CORONARY-ARTERY-DISEASE; SUCCESSFUL KIDNEY-TRANSPLANTATION; ADIPOSE-SPECIFIC PROTEIN; INSULIN-RESISTANCE; VISCERAL ADIPOSITY; PLASMA; ASSOCIATION; AMERICANS; OBESITY	Background A few studies have investigated the role of adiponectin fraction for cardiovascular disease (CVD) in RTx recipients. Subjects and Methods We studied 57 adult subjects (39 males, 18 females; 10 cadaveric donors) with at least three years of allograft survival (median 251 months). We examined clinical backgrounds such as treated drugs, blood pressure (BP, mmHg), body mass index (BMI), and blood chemistry including cholesterol (total, LDL-C, HDL-C), glucose, glycated hemoglobin (HbA1c), and serum high and low-molecular-weight (HMW/LMW) ADPN fractions with regard to the associations of the visceral and subcutaneous fat areas on CT scan. We also analyzed the associations of CVD and post-transplant diabetes (PTDM) with ADPN fractions and the fat areas. Results The visceral fat area was inversely correlated with serum HMW and LMW ADPN levels and HMW ADPN ratio (r = -0.400, p = 0.002 and r = -0.296, p = 0.025 and r = -0.444, p<0.001, respectively). Furthermore, the visceral fat area was positively with the LMW ADPN ratio (r = 0.467, p<0.001), but no significant correlation was noted between the subcutaneous fat area and the ADPN ratio. On multiple regression analysis, eGFR and the visceral fat area were significant reducing factors of HMW ADPN levels, and the alteration of eGFR was identified as an increasing factor of HMW ADPN levels. Patients with CVD had larger visceral fat area (p = 0.004), lower HMW ADPN ratio (p = 0.022) and higher LMW ADPN ratio (p = 0.049). In addition, the higher HMW ADPN ratio and statin treatment were identified as reducing factors of the development of CVD, but the LDL-C level was an aggravating factor. Moreover, the higher LMW ADPN ratio and the visceral fat area were aggravating factors of PTDM. Conclusion Even in Japanese renal transplant recipients, visceral fat area and ADPN fractions were significant factors for the development of both CVD and PTDM.	[Adachi, Hiroki; Nakayama, Kanae; Hayashi, Norifumi; Matsui, Yuki; Fujimoto, Keiji; Yamaya, Hideki; Yokoyama, Hitoshi] Kanazawa Med Univ, Sch Med, Dept Nephrol, Uchinada, Ishikawa, Japan; [Tonami, Hisao] Kanazawa Med Univ, Sch Med, Dept Radiol, Uchinada, Ishikawa, Japan	Kanazawa Medical University; Kanazawa Medical University	Adachi, H (corresponding author), Kanazawa Med Univ, Sch Med, Dept Nephrol, Uchinada, Ishikawa, Japan.	m5240a@kanazawa-med.ac.jp			Japan Society for the Promotion of Science [25461237, 24406029, 2530502]; Ministry of Health, Labour and Welfare of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science; (C) no. 25461237, (B) no. 24406029, and (B) no. 2530502. This study was also supported by a Grant-in-Aid for Intractable Renal Diseases Research, Research on rare and intractable diseases, Health and Labour Sciences Research and by grants from the Ministry of Health, Labour and Welfare of Japan (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2007, CLIN NEPHROL, V67, P381; Adamczak M, 2009, SEMIN DIALYSIS, V22, P391, DOI 10.1111/j.1525-139X.2009.00587.x; Aoqui C, 2013, EUR J CLIN NUTR, V67, P610, DOI 10.1038/ejcn.2013.66; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Aso Y, 2006, DIABETES, V55, P1954, DOI 10.2337/db05-1525; Cantarin MPM, 2013, KIDNEY INT, V83, P487, DOI 10.1038/ki.2012.421; Chudek J, 2003, TRANSPL P, V35, P2186, DOI 10.1016/j.transproceed.2003.08.001; Colvin RB, 2003, NEW ENGL J MED, V349, P2288, DOI 10.1056/NEJMp038178; Costacou T, 2008, KIDNEY INT, V74, P549, DOI 10.1038/ki.2008.262; Goto M, 2014, OBESITY, V22, P401, DOI 10.1002/oby.20553; Graessler J, 2011, GERONTOLOGY, V57, P316, DOI 10.1159/000316575; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Hayashi T, 2008, DIABETES, V57, P1269, DOI 10.2337/db07-1378; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Kishida K, 2011, J ATHEROSCLER THROMB, V18, P592, DOI 10.5551/jat.7625; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nakashima R, 2006, J CLIN ENDOCR METAB, V91, P3873, DOI 10.1210/jc.2006-1158; Oh J, 2013, KIDNEY INT, V83, P546, DOI 10.1038/ki.2012.479; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Pascual M, 2002, NEW ENGL J MED, V346, P580, DOI 10.1056/NEJMra011295; Saijo Y, 2004, DIABETES OBES METAB, V6, P249, DOI 10.1111/j.1462-8902.2003.0342.x; Saito T, 2012, ENDOCR J, V59, P39, DOI 10.1507/endocrj.EJ11-0132; Satoh M, 2009, CLIN THER, V31, P2113, DOI 10.1016/j.clinthera.2009.10.010; Schober F, 2007, BIOCHEM BIOPH RES CO, V361, P968, DOI 10.1016/j.bbrc.2007.07.106; Shen YY, 2007, METABOLISM, V56, P1201, DOI 10.1016/j.metabol.2007.04.016; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Wang ZV, 2008, HYPERTENSION, V51, P8, DOI 10.1161/HYPERTENSIONAHA.107.099424; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075535	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163899	10.1371/journal.pone.0163899	http://dx.doi.org/10.1371/journal.pone.0163899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706207	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200070
J	Dean, DC; Sojkova, J; Hurley, S; Kecskemeti, S; Okonkwo, O; Bendlin, BB; Theisen, F; Johnson, SC; Alexander, AL; Gallagher, CL				Dean, Douglas C., III; Sojkova, Jitka; Hurley, Samuel; Kecskemeti, Steven; Okonkwo, Ozioma; Bendlin, Barbara B.; Theisen, Frances; Johnson, Sterling C.; Alexander, Andrew L.; Gallagher, Catherine L.			Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging Study	PLOS ONE			English	Article							WHITE-MATTER; BRAIN MICROSTRUCTURE; MULTIPLE-SCLEROSIS; NERVOUS-SYSTEM; WATER; RELAXATION; DIFFUSION; MODEL; STATE; REGISTRATION	Alterations to myelin may be a core pathological feature of neurodegenerative diseases. Although white matter microstructural differences have been described in Parkinson's disease (PD), it is unknown whether such differences include alterations of the brain's myelin content. Thus, the objective of the current study is to measure and compare brain myelin content between PD patients and age-matched controls. In this cross-sectional study, 63 participants from the Longitudinal MRI in Parkinson's Disease study underwent brain MRI, Unified Parkinson's Disease Rating Scale (UPDRS) scoring, and cognitive asessments. Subjects were imaged with the mcDEPSOT (multi-component driven equilibrium single pulse observation of T1 and T2), a multicomponent relaxometry technique that quantifies longitudinal and transverse relaxation rates (R-1 and R-2, respectively) and the myelin water fraction (VFM), a surrogate for myelin content. A voxel-wise approach was used to compare R-1, R-2, and VFM measures between PD and control groups, and to evaluate relationships with age as well as disease duration, UPDRS scores, and daily levodopa equivalent dose. PD subjects had higher VFM than controls in frontal and temporal white matter and bilateral thalamus. Greater age was strongly associated with lower VFM in both groups, while an age-by-group interaction suggested a slower rate of VFM decline in the left putamen with aging in PD. Within the PD group, measures of disease severity, including UPDRS, daily levodopa equivalent dose, and disease duration, were observed to be related with myelin content in diffuse brain regions. The age-by-group interaction suggests that either PD or dopaminergic therapies allay observed age-related myelin changes. The relationships between VFM and disease severity measures suggests that VFM may provide a surrogate marker for microstructural changes related to Parkinson's disease.	[Dean, Douglas C., III; Kecskemeti, Steven; Alexander, Andrew L.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Sojkova, Jitka; Theisen, Frances; Johnson, Sterling C.; Gallagher, Catherine L.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA; [Sojkova, Jitka; Theisen, Frances; Gallagher, Catherine L.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Hurley, Samuel] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, Oxon, England; [Okonkwo, Ozioma; Bendlin, Barbara B.; Johnson, Sterling C.; Gallagher, Catherine L.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Dis Res Ctr, Madison, WI 53706 USA; [Alexander, Andrew L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Phys, Madison, WI USA; [Alexander, Andrew L.] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Oxford; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Gallagher, CL (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA.; Gallagher, CL (corresponding author), Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.; Gallagher, CL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Dis Res Ctr, Madison, WI 53706 USA.	gallagher@neurology.wisc.edu	Alexander, Andrew/ABA-2806-2020; Hurley, Samuel A/H-7251-2019	Hurley, Samuel A/0000-0003-3965-9649	U.S. Department of Veterans Affairs [101CX000555]; National Institute of Child Health and Human Development [T32 HD007489, P30 HD003352, R21 HD078119]; National Institute on Aging [R01 AG027161, P50 AG033514, R01 AG037639]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352, R21HD078119, T32HD007489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG037639, R01AG037639, P50AG033514, R01AG027161] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000555] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the U.S. Department of Veterans Affairs 101CX000555 to CLG; National Institute of Child Health and Human Development T32 HD007489 to DCD; National Institute of Child Health and Human Development P30 HD003352 Waisman Center; National Institute on Aging R01 AG027161 to SCJ; National Institute on Aging P50 AG033514 University of Wisconsin Madison; National Institute of Child Health and Human Development R21 HD078119 to ALA and the National Institute on Aging R01 AG037639 to BBB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Auning E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003976; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Bartzokis G, 2004, NEUROBIOL AGING, V25, P49, DOI 10.1016/j.neurobiolaging.2003.08.001; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2012, SCHIZOPHR RES, V140, P122, DOI 10.1016/j.schres.2012.06.036; Bartzokis G, 2011, NEUROBIOL AGING, V32, P1341, DOI 10.1016/j.neurobiolaging.2009.08.007; Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Berg D, 2001, J NEUROCHEM, V79, P225, DOI 10.1046/j.1471-4159.2001.00608.x; Bertrand JA, 2012, MOVEMENT DISORD, V27, P1781, DOI 10.1002/mds.25272; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Brandies R, 2008, NEUROSCI BIOBEHAV R, V32, P611, DOI 10.1016/j.neubiorev.2007.09.004; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; De Santis S, 2014, NEUROIMAGE, V89, P35, DOI 10.1016/j.neuroimage.2013.12.003; Dean DC, 2015, BRAIN STRUCT FUNCT, V220, P1921, DOI 10.1007/s00429-014-0763-3; Dean DC, 2014, JAMA NEUROL, V71, P11, DOI 10.1001/jamaneurol.2013.4544; Dean DC, 2014, NEUROIMAGE, V84, P742, DOI 10.1016/j.neuroimage.2013.09.058; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Deoni SCL, 2015, MAGN RESON MED, V73, P161, DOI 10.1002/mrm.25108; Deoni SCL, 2013, MAGN RESON MED, V70, P147, DOI 10.1002/mrm.24429; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Deoni Sean C L, 2010, Top Magn Reson Imaging, V21, P101, DOI 10.1097/RMR.0b013e31821e56d8; Deoni SCL, 2011, METHODS MOL BIOL, V711, P65, DOI 10.1007/978-1-61737-992-5_4; Deoni SCL, 2009, J MAGN RESON IMAGING, V30, P411, DOI 10.1002/jmri.21849; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Deshmukh VA, 2013, NATURE, V502, P327, DOI 10.1038/nature12647; Elbaz A, 2002, J CLIN EPIDEMIOL, V55, P25, DOI 10.1016/S0895-4356(01)00425-5; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; Ferrario JE, 2004, J NEUROCHEM, V90, P1348, DOI 10.1111/j.1471-4159.2004.02595.x; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fields RD, 2005, NEUROSCIENTIST, V11, P528, DOI 10.1177/1073858405282304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallagher C, 2013, J INT NEUROPSYCH SOC, V19, P349, DOI 10.1017/S1355617712001373; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Haroutunian V, 2014, GLIA, V62, P1856, DOI 10.1002/glia.22716; Herz DM, 2015, BRAIN, V138, P1658, DOI 10.1093/brain/awv096; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hurley S. A., 2010, P 18 ANN M ISMRM STO, V18, P4516; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kitzler HH, 2012, NEUROIMAGE, V59, P2670, DOI 10.1016/j.neuroimage.2011.08.052; Kolind S, 2013, AMYOTROPH LAT SCL FR, V14, P562, DOI 10.3109/21678421.2013.794843; Kolind S, 2012, NEUROIMAGE, V60, P263, DOI 10.1016/j.neuroimage.2011.11.070; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lee JE, 2009, NEUROIMAGE, V44, P870, DOI 10.1016/j.neuroimage.2008.09.041; Lewis MM, 2007, NEUROSCIENCE, V147, P224, DOI 10.1016/j.neuroscience.2007.04.006; Li CT, 2014, SYNAPSE, V68, P325, DOI 10.1002/syn.21745; Liu Y, 2013, DRUGS R&D, V13, P29, DOI 10.1007/s40268-012-0002-4; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; MacKay AL, 2009, NEUROIMAG CLIN N AM, V19, P1, DOI 10.1016/j.nic.2008.09.007; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Nagae LM, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00017; Novak G, 2013, SYNAPSE, V67, P179, DOI 10.1002/syn.21628; Odrobina EE, 2005, NMR BIOMED, V18, P277, DOI 10.1002/nbm.951; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; Sacolick LI, 2010, MAGN RESON MED, V63, P1315, DOI 10.1002/mrm.22357; Schuff N, 2015, MOVEMENT DISORD, V30, P1885, DOI 10.1002/mds.26325; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spader HS, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.1.FOCUS12426; Team RC, 2014, R LANG ENV STAT COMP; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Vavasour IM, 2011, J MAGN RESON IMAGING, V33, P713, DOI 10.1002/jmri.22441; Wang HN, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv088; Worsley KJ, 1999, HUM BRAIN MAPP, V8, P98, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<98::AID-HBM5>3.3.CO;2-6; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang J, 2013, MAGN RESON MED, V73, P223; Zhang Y, 2015, MOVEMENT DISORD, V30, P1229, DOI 10.1002/mds.26251; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	77	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163774	10.1371/journal.pone.0163774	http://dx.doi.org/10.1371/journal.pone.0163774			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706215	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200057
J	Deng, F; Sjostedt, N; Kidron, H				Deng, Feng; Sjostedt, Noora; Kidron, Heidi			The Effect of Albumin on MRP2 and BCRP in the Vesicular Transport Assay	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; IN VIVO EXTRAPOLATION; DUBIN-JOHNSON-SYNDROME; BOVINE SERUM-ALBUMIN; K-M VALUES; DRUG CLEARANCE; FATTY-ACIDS; ABC TRANSPORTER; VITRO DATA; V-MAX	The ABC transporters multidrug resistance associated protein 2 (MRP2) and breast cancer resistance protein (BCRP) are of interest in drug development, since they affect the pharmacokinetics of several drugs. Membrane vesicle transport assays are widely used to study interactions with these proteins. Since albumin has been found to affect the kinetics of metabolic enzymes in similar membrane preparations, we investigated whether albumin affects the kinetic parameters of efflux transport. We found that albumin increased the V-max of 5(6)-carboxy-2',7'-dichlorofluorescein (CDCF) and estradiol-17-beta-D-glucuronide uptake into MRP2 vesicles in the presence of 0.1% bovine serum albumin (BSA) by 2 and 1.5-fold, respectively, while BSA increased Lucifer yellow uptake by 30% in BCRP vesicles. K-m values increased slightly, but the change was not statistically significant. The effect of BSA on substrate uptake was dependent on the vesicle amount, while increasing BSA concentration did not significantly improve substrate uptake. These results indicate a minor effect of albumin on MRP2 and BCRP, but it should be considered if albumin is added to transporter assays for example as a solubilizer, since the effect may be substrate or transporter specific.	[Deng, Feng; Sjostedt, Noora; Kidron, Heidi] Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci, Ctr Drug Res, Helsinki, Finland	University of Helsinki	Kidron, H (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci, Ctr Drug Res, Helsinki, Finland.	heidi.kidron@helsinki.fi	; Kidron, Heidi/A-5826-2015	Deng, Feng/0000-0002-9173-6923; Sjostedt, Noora/0000-0001-6960-7757; Kidron, Heidi/0000-0001-6427-8042	Suomen Akatemia [257786]; University; Biocenter Finland	Suomen Akatemia(Academy of Finland); University; Biocenter Finland	HK: Suomen Akatemia, 257786, http://www.aka.fi/en/. NS: University funded Doctoral Programme in Drug Research doctoral candidate position, http://blogs.helsinki.fi/reenila/.; We would like to thank Dr Linda Ahonen and M.Sc Marja Hagstrom for the LC/MS analysis, lab coordinator Timo Oksanen for the UPLC analysis, Sami Tyrjy for technical assistance and Dr Moshe Finel for helpful discussions. We acknowledge the Drug Discovery and Chemical Biology Network, funded by Biocenter Finland, for providing access to screening instrumentation.	Arouri A, 2013, PROG LIPID RES, V52, P130, DOI 10.1016/j.plipres.2012.09.002; Aspenstrom-Fagerlund B, 2012, FOOD CHEM TOXICOL, V50, P3635, DOI 10.1016/j.fct.2012.07.015; Bodo A, 2003, J BIOL CHEM, V278, P23529, DOI 10.1074/jbc.M303515200; Brouwer KLR, 2013, CLIN PHARMACOL THER, V94, P95, DOI 10.1038/clpt.2013.81; Carlile DJ, 1999, BRIT J CLIN PHARMACO, V47, P625, DOI 10.1046/j.1365-2125.1999.00935.x; Chu XY, 2004, J PHARMACOL EXP THER, V309, P156, DOI 10.1124/jpet.103.062091; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Elsby R, 2011, XENOBIOTICA, V41, P764, DOI 10.3109/00498254.2011.578761; European Medicines Agency, GUID INV DRUG INT; Glavinas H, 2008, EXPERT OPIN DRUG MET, V4, P721, DOI 10.1517/17425255.4.6.721 ; Groer C, 2013, J PHARMACEUT BIOMED, V85, P253, DOI 10.1016/j.jpba.2013.07.031; He L, 2014, EUR J PHARMACOL, V724, P185, DOI 10.1016/j.ejphar.2013.12.008; Heredi-Szabo K, 2009, DRUG METAB DISPOS, V37, P794, DOI 10.1124/dmd.108.023895; Heredi-Szabo K, 2008, J BIOMOL SCREEN, V13, P295, DOI 10.1177/1087057108316702; Hillgren KM, 2013, CLIN PHARMACOL THER, V94, P52, DOI 10.1038/clpt.2013.74; Hulot JS, 2005, PHARMACOGENET GENOM, V15, P277, DOI 10.1097/01213011-200505000-00002; Ito K, 2005, PHARM RES-DORDR, V22, P103, DOI 10.1007/s11095-004-9015-1; Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741; Keskitalo JE, 2009, CLIN PHARMACOL THER, V86, P197, DOI 10.1038/clpt.2009.79; Kidron H, 2012, EUR J PHARM SCI, V46, P100, DOI 10.1016/j.ejps.2012.02.016; Kilford PJ, 2009, DRUG METAB DISPOS, V37, P82, DOI 10.1124/dmd.108.023853; Kivisto KT, 2005, DRUG METAB DISPOS, V33, P1593, DOI 10.1124/dmd.105.006262; Kruijtzer CMF, 2002, J CLIN ONCOL, V20, P2943, DOI 10.1200/JCO.2002.12.116; Ludden LK, 1997, J PHARMACOL EXP THER, V282, P391; Maliepaard M, 2001, CANCER RES, V61, P3458; Manevski N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054767; Manevski N, 2011, DRUG METAB DISPOS, V39, P2117, DOI 10.1124/dmd.111.041418; Mao QC, 2015, AAPS J, V17, P65, DOI 10.1208/s12248-014-9668-6; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Niemi M, 2006, PHARMACOGENET GENOM, V16, P801, DOI 10.1097/01.fpc.0000230422.50962.91; Pal A, 2007, J PHARMACOL EXP THER, V321, P1085, DOI 10.1124/jpet.106.119289; Pedersen JM, 2008, J MED CHEM, V51, P3275, DOI 10.1021/jm7015683; Rowland A, 2008, DRUG METAB DISPOS, V36, P1056, DOI 10.1124/dmd.108.021105; Rowland A, 2008, DRUG METAB DISPOS, V36, P870, DOI 10.1124/dmd.107.019885; Rowland A, 2007, J PHARMACOL EXP THER, V321, P137, DOI 10.1124/jpet.106.118216; Rowland A, 2006, DRUG METAB DISPOS, V34, P1055, DOI 10.1124/dmd.106.009340; Schaub TP, 1999, J AM SOC NEPHROL, V10, P1159; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Telbisz A, 2007, BBA-BIOMEMBRANES, V1768, P2698, DOI 10.1016/j.bbamem.2007.06.026; Toh S, 1999, AM J HUM GENET, V64, P739, DOI 10.1086/302292; Uchaipichat V, 2006, BRIT J CLIN PHARMACO, V61, P427, DOI 10.1111/j.1365-2125.2006.02588.x; US Food and Drug Administration, 2012, DRUG INT ST IN PRESS; Wada M, 1998, HUM MOL GENET, V7, P203, DOI 10.1093/hmg/7.2.203; Walsky RL, 2012, DRUG METAB DISPOS, V40, P1051, DOI 10.1124/dmd.111.043117; Wang L, 2015, DRUG METAB DISPOS, V43, P367, DOI 10.1124/dmd.114.061580; Wattanachai N, 2012, DRUG METAB DISPOS, V40, P982, DOI 10.1124/dmd.111.044057; Wattanachai N, 2011, EUR J CLIN PHARMACOL, V67, P815, DOI 10.1007/s00228-011-1001-z; Woodward OM, 2009, P NATL ACAD SCI USA, V106, P10338, DOI 10.1073/pnas.0901249106; Zelcer N, 2003, J BIOL CHEM, V278, P23538, DOI 10.1074/jbc.M303504200	50	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163886	10.1371/journal.pone.0163886	http://dx.doi.org/10.1371/journal.pone.0163886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706255	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200068
J	Levesque, S; Lalancette, C; Bernard, K; Pacheco, AL; Dion, R; Longtin, J; Tremblay, C				Levesque, Simon; Lalancette, Cindy; Bernard, Kathryn; Pacheco, Ana Luisa; Dion, Rejean; Longtin, Jean; Tremblay, Cecile			Molecular Typing of Legionella pneumophila Isolates in the Province of Quebec from 2005 to 2015	PLOS ONE			English	Article							NOSOCOMIAL LEGIONNAIRES-DISEASE; ENVIRONMENTAL WATER SOURCES; SEQUENCE-BASED SCHEME; SEROGROUP 1; UNITED-STATES; NATIONAL SURVEILLANCE; DISTRIBUTION-SYSTEMS; STRAINS; COLONIZATION; HOSPITALS	Legionella is found in natural and man-made aquatic environments, such as cooling towers and hot water plumbing infrastructures. Legionella pneumophila serogroup 1 (Lp1) is the most common etiological agent causing waterborne disease in the United States and Canada. This study reports the molecular characterization of Lp strains during a 10 year period. We conducted sequence-based typing (SBT) analysis on a large set of Lp isolates (n = 284) to investigate the province of Quebec sequence types (STs) distribution in order to identify dominant clusters. From 2005 to 2015, 181 clinical Lp isolates were typed by SBT (141 sporadic cases and 40 outbreak related cases). From the same period of time, 103 environmental isolates were also typed. Amongst the 108 sporadic cases of Lp1 typed, ST-62 was the most frequent (16.6%), followed by ST-213 (10.2%), ST-1 (8.3%) and ST-37 (8.3%). Amongst other serogroups (SG), ST-1327 (SG5) (27.3%) and ST-378 (SG10) (12.2%) were the most frequent. From the environmental isolates, ST-1 represent the more frequent SBT type (26.5%). Unweighted pair group method with arithmetic mean (UPGMA) dendrogram from the 108 sporadic cases of SG1 contains 4 major clusters (A to D) of related STs. Cluster B contains the majority of the strains (n = 61) and the three most frequent STs in our database (ST-62, ST-213 and ST-1). During the study period, we observed an important increase in the incidence rate in Quebec. All the community associated outbreaks, potentially or confirmed to be associated with a cooling tower were caused by Lp1 strains, by opposition to hospital associated outbreaks that were caused by serogroups of Lp other than SG1. The recent major Quebec City outbreak caused by ST-62, and the fact that this genotype is the most common in the province supports whole genome sequencing characterization of this particular sequence type in order to understand its evolution and associated virulence factors.	[Levesque, Simon; Lalancette, Cindy; Dion, Rejean; Longtin, Jean] Inst Natl St Publ Quebec, Lab St Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Levesque, Simon; Tremblay, Cecile] Univ Montreal, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada; [Levesque, Simon; Tremblay, Cecile] Univ Montreal, Ctr Rech, Ctr Hosp, Quebec City, PQ, Canada; [Bernard, Kathryn; Pacheco, Ana Luisa] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Dion, Rejean] Univ Montreal, Ecole St Publ, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Longtin, Jean] Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada	Universite de Montreal; Laval University; Universite de Montreal; Public Health Agency of Canada; Universite de Montreal; Laval University	Levesque, S (corresponding author), Inst Natl St Publ Quebec, Lab St Publ Quebec, Ste Anne De Bellevue, PQ, Canada.; Levesque, S (corresponding author), Univ Montreal, Dept Microbiol Infectiol & Immunol, Quebec City, PQ, Canada.; Levesque, S (corresponding author), Univ Montreal, Ctr Rech, Ctr Hosp, Quebec City, PQ, Canada.	simon.levesque@inspq.qc.ca		Levesque, Simon/0000-0002-4356-9702	Ministere de la sante et des services sociaux du Quebec; Fonds de recherche du Quebec-Sante	Ministere de la sante et des services sociaux du Quebec; Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This study was in part funded by Ministere de la sante et des services sociaux du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the excellent technical assistance of the LSPQ employees. We also thank Patricia Corrado for English revision. Simon Levesque is a postdoctoral scholarship from Fonds de recherche du Quebec-Sante. Cecile Tremblay is a scholar from the Fonds de Recherche du Quebec-Sante and the Pfizer/University of Montreal Chair on HIV translational research.	ALARY M, 1992, J INFECT DIS, V165, P565, DOI 10.1093/infdis/165.3.565; Borchardt J, 2008, EUR J CLIN MICROBIOL, V27, P29, DOI 10.1007/s10096-007-0392-3; Brunkard Joan M., 2011, Morbidity and Mortality Weekly Report, V60, P38; Casini B, 2008, WATER SCI TECHNOL, V58, P683, DOI 10.2166/wst.2008.434; Chang FY, 1996, J INFECT DIS, V174, P1116, DOI 10.1093/infdis/174.5.1116; Chasqueira MJ, 2014, EUROSURVEILLANCE, V19, P33, DOI 10.2807/1560-7917.ES2014.19.46.20965; Craun GF, 2010, CLIN MICROBIOL REV, V23, P507, DOI 10.1128/CMR.00077-09; Cunha BA, 2016, LANCET, V387, P376, DOI 10.1016/S0140-6736(15)60078-2; Farhat C, 2011, J CLIN MICROBIOL, V49, P4052, DOI 10.1128/JCM.00687-11; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Ferreira AP, 2004, INT J ENVIRON HEAL R, V14, P453, DOI 10.1080/09603120400012827; Fontana S, 2014, INT J MED MICROBIOL, V304, P597, DOI 10.1016/j.ijmm.2014.04.004; Fragou K, 2012, INT J ENVIRON HEAL R, V22, P340, DOI 10.1080/09603123.2011.643229; Gaia V, 2003, J CLIN MICROBIOL, V41, P2932, DOI 10.1128/JCM.41.7.2932-2939.2003; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Guo JY, 2015, INFECT GENET EVOL, V29, P35, DOI 10.1016/j.meegid.2014.10.023; Harrison TG, 2007, CLIN MICROBIOL INFEC, V13, P78, DOI 10.1111/j.1469-0691.2006.01558.x; Helbig JH, 2003, J CLIN MICROBIOL, V41, P838, DOI 10.1128/JCM.41.2.838-840.2003; Hicks LA, 2012, AM J TRANSPLANT, V12, P250, DOI 10.1111/j.1600-6143.2011.03938.x; Hicks Lauri A., 2011, Morbidity and Mortality Weekly Report, V60, P1083; Kanatani J, 2013, J INFECT CHEMOTHER, V19, P644, DOI 10.1007/s10156-012-0537-x; Katsiaflaka A, 2016, APPL ENVIRON MICROB, V82, P6102, DOI 10.1128/AEM.01672-16; Kool JL, 1999, INFECT CONT HOSP EP, V20, P798, DOI 10.1086/501587; Kozak-Muiznieks NA, 2014, J CLIN MICROBIOL, V52, P201, DOI 10.1128/JCM.01973-13; Lee HK, 2010, APPL ENVIRON MICROB, V76, P6547, DOI 10.1128/AEM.00422-10; Leoni E, 2005, J APPL MICROBIOL, V98, P373, DOI 10.1111/j.1365-2672.2004.02458.x; Levesque S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103852; LIU WK, 1993, J HOSP INFECT, V24, P1, DOI 10.1016/0195-6701(93)90084-D; Luck Christian, 2013, Methods Mol Biol, V954, P119, DOI 10.1007/978-1-62703-161-5_6; LUCK PC, 1995, APPL ENVIRON MICROB, V61, P2000; Napoli C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-660; Neil K, 2008, CLIN INFECT DIS, V47, P591, DOI 10.1086/590557; OTT M, 1991, J CLIN MICROBIOL, V29, P813, DOI 10.1128/JCM.29.4.813-815.1991; Perola O, 2002, APMIS, V110, P863, DOI 10.1034/j.1600-0463.2002.1101204.x; Qin T, 2016, SCI REP-UK, V6, DOI 10.1038/srep21356; Quebec, 2021, ACC SERV MED PREM LI; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Reimer AR, 2010, EUR J CLIN MICROBIOL, V29, P191, DOI 10.1007/s10096-009-0840-3; Sabria M, 2001, INFECT CONT HOSP EP, V22, P673, DOI 10.1086/501843; Sanchez-Buso L, 2015, APPL ENVIRON MICROB, V81, P7106, DOI 10.1128/AEM.02196-15; Scaturro A, 2005, J CLIN MICROBIOL, V43, P5348, DOI 10.1128/JCM.43.10.5348-4350.2005; SCHOONMAKER D, 1992, J CLIN MICROBIOL, V30, P1491, DOI 10.1128/JCM.30.6.1491-1498.1992; Stout JE, 2007, INFECT CONT HOSP EP, V28, P818, DOI 10.1086/518754; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; Tijet N, 2010, EMERG INFECT DIS, V16, P447, DOI 10.3201/eid1603.081689; TRAM C, 1990, J CLIN MICROBIOL, V28, P242, DOI 10.1128/JCM.28.2.242-245.1990; Underwood AP, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-302; Unit for Surveillance and Control of Communicable Diseases, 2009, EURO SURVEILL, V14; Vekens E, 2012, EUROSURVEILLANCE, V17, P9; VICKERS RM, 1987, INFECT CONT HOSP EP, V8, P357, DOI 10.1017/S0195941700067412; Visca P, 1999, J CLIN MICROBIOL, V37, P2189, DOI 10.1128/JCM.37.7.2189-2196.1999; World Health Organization, 2007, LEGIONELLA PREVENTIO	52	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163818	10.1371/journal.pone.0163818	http://dx.doi.org/10.1371/journal.pone.0163818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706210	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200062
J	Masset, G; Mathias, KC; Vlassopoulos, A; Molenberg, F; Lehmann, U; Gibney, M; Drewnowski, A				Masset, Gabriel; Mathias, Kevin C.; Vlassopoulos, Antonis; Molenberg, Famke; Lehmann, Undine; Gibney, Mike; Drewnowski, Adam			Modeled Dietary Impact of Pizza Reformulations in US Children and Adolescents	PLOS ONE			English	Article							CHILDHOOD OBESITY; NUTRIENT INTAKE; REDUCTION; ENERGY; FOOD; HEALTH	Background and Objective Approximately 20% of US children and adolescents consume pizza on any given day; and pizza intake is associated with higher intakes of energy, sodium, and saturated fat. The reformulation of pizza products has yet to be evaluated as a viable option to improve diets of the US youth. This study modeled the effect on nutrient intakes of two potential pizza reformulation strategies based on the standards established by the Nestle A Nutritional Profiling System (NNPS). Methods Dietary intakes were retrieved from the first 24hr-recall of the National Health and Nutrition Examination Survey (NHANES) 2011-12, for 2655 participants aged 4-19 years. The composition of pizzas in the NHANES food database (n = 69) were compared against the NNPS standards for energy, total fat, saturated fat, sodium, added sugars, and protein. In a reformulation scenario, the nutrient content of pizzas was adjusted to the NNPS standards if these were not met. In a substitution scenario, pizzas that did not meet the standards were replaced by the closest pizza, based on nutrient content, that met all of the NNPS standards. Results Pizzas consistent with all the NNPS standards (29% of all pizzas) were significantly lower in energy, saturated fat and sodium than pizzas that were not. Among pizza consumers, modeled intakes in the reformulation and substitution scenarios were lower in energy (-14 and -45kcal, respectively), saturated fat (-1.2 and -2.7g), and sodium (-143 and -153mg) compared to baseline. Conclusions Potential industry wide reformulation of a single food category or intra-category food substitutions may positively impact dietary intakes of US children and adolescents. Further promotion and support of these complimentary strategies may facilitate the adoption and implementation of reformulation standards.	[Masset, Gabriel; Mathias, Kevin C.; Vlassopoulos, Antonis; Molenberg, Famke; Lehmann, Undine] Nestle Res Ctr, Publ Hlth Nutr, Lausanne, Switzerland; [Molenberg, Famke] Univ Wageningen & Res Ctr, Dept Human Nutr, Wageningen, Netherlands; [Gibney, Mike] Univ Coll Dublin, Inst Food & Hlth, Dublin, Ireland; [Gibney, Mike] Univ Ulster, Sch Biomed Sci, Coleraine, Londonderry, North Ireland; [Drewnowski, Adam] Univ Washington, Ctr Publ Hlth Nutr, Seattle, WA 98195 USA	Nestle SA; Wageningen University & Research; University College Dublin; Ulster University; University of Washington; University of Washington Seattle	Masset, G (corresponding author), Nestle Res Ctr, Publ Hlth Nutr, Lausanne, Switzerland.	gabriel.masset@rdls.nestle.com	Drewnowski, Adam/HCI-4117-2022; Masset, Gabriel/I-4636-2019	Masset, Gabriel/0000-0001-6977-0247; Vlassopoulos, Antonis/0000-0001-7136-1039; Lehmann, Undine/0000-0001-8104-0490; Molenberg, Famke/0000-0002-5305-9730	Nestec SA	Nestec SA	The research presented herein was funded by Nestec SA. The funder provided support in the form of salaries for authors GM, KCM, AV, FM, and UL, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funder agreed on the publication of the present study.	[Anonymous], 2014, FOOD NUTR DAT DIET S; Bruins MJ, 2015, NUTRIENTS, V7, P8010, DOI 10.3390/nu7095375; Buttriss JL, 2013, P NUTR SOC, V72, P61, DOI 10.1017/S0029665112002868; Choices Programme, 2016, POS LOG PRES THEMS T, VInternet; Cochrane T, 2016, AUST NZ J PUBL HEAL, V40, P62, DOI 10.1111/1753-6405.12474; Combet E, 2014, PUBLIC HEALTH NUTR, V17, P2577, DOI 10.1017/S1368980013002814; Combris P, 2011, PUBLIC HEALTH, V125, P717, DOI 10.1016/j.puhe.2011.07.004; Downs SM, 2013, B WORLD HEALTH ORGAN, V91, P262, DOI 10.2471/BLT.12.111468; Dutch Presidency EU Conference for Food Product Improvement, 2016, DUTCH PRES EU C FOOD; Gortmaker SL, 2015, HEALTH AFFAIR, V34, P1932, DOI 10.1377/hlthaff.2015.0631; Insitute of Medicine, 2015, TABL DRI VAL SUMM; Kloss L., 2015, NFS Journal, V1, P9, DOI 10.1016/j.nfs.2015.03.001; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Leroy P, 2016, EUR J CLIN NUTR, V70, P694, DOI 10.1038/ejcn.2015.201; Ma Y, 2016, LANCET DIABETES ENDO, V4, P105, DOI 10.1016/S2213-8587(15)00477-5; Manickavasagan A., 2013, Food Science and Human Wellness, V2, P105; Marteau TM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5863; McColl K., 2015, NUTR PROFILING CHANG; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Powell LM, 2015, PEDIATRICS, V135, P322, DOI 10.1542/peds.2014-1844; Requillart V, 2014, EUR REV AGRIC ECON, V41, P375, DOI 10.1093/erae/jbu010; Rhodes DG, 2014, 11 NHANES; Roodenburg AJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072378; Slining MM, 2013, J ACAD NUTR DIET, V113, P1683, DOI 10.1016/j.jand.2013.06.001; Thompson F., 2014, OVERCOMING OBESITY I; Trichterborn J, 2012, EUR J CLIN NUTR, V66, P466, DOI 10.1038/ejcn.2011.180; Tritt A, 2015, PUBLIC HEALTH NUTR, V18, P1407, DOI 10.1017/S1368980014001724; US Department of Agriculture and US Department of Health and Human Services, 2010, DIET GUID AM 2010; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; USDA Agricultural Research Service, 2014, FOOD PATT EQ DAT DAT; Vlassopoulos A, 2015, FASEB J, V29; Vlassopoulos A, 2017, EUR J NUTR, V56, P1105, DOI 10.1007/s00394-016-1161-9; Wang DD, 2015, HEALTH AFFAIR, V34, P1916, DOI 10.1377/hlthaff.2015.0640; Wang YC, 2012, AM J PREV MED, V42, P437, DOI 10.1016/j.amepre.2012.01.018; WHO, 2008, WHO EUR ACT PLAN FOO; World Health Organization, 2004, GLOB STRAT DIET PHYS	36	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164197	10.1371/journal.pone.0164197	http://dx.doi.org/10.1371/journal.pone.0164197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706221	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200097
J	Wang, NL; Lu, YL; Zhang, P; Zhang, MH; Gong, JY; Lu, Y; Xie, XB; Qiu, YL; Yan, YY; Wu, BB; Wang, JS				Wang, Neng-Li; Lu, Yu-Lan; Zhang, Ping; Zhang, Mei-Hong; Gong, Jing-Yu; Lu, Yi; Xie, Xin-Bao; Qiu, Yi-Ling; Yan, Yan-Yan; Wu, Bing-bing; Wang, Jian-She			A Specially Designed Multi-Gene Panel Facilitates Genetic Diagnosis in Children with Intrahepatic Cholestasis: Simultaneous Test of Known Large Insertions/Deletions	PLOS ONE			English	Article							MEDICAL GENETICS; AMERICAN-COLLEGE; MUTATIONS; ASSOCIATION; GUIDELINES; STANDARDS	Background and Aims Large indels are commonly identified in patients but are not detectable by routine Sanger sequencing and panel sequencing. We specially designed a multi-gene panel that could simultaneously test known large indels in addition to ordinary variants, and reported the diagnostic yield in patients with intrahepatic cholestasis. Methods The panel contains 61 genes associated with cholestasis and 25 known recurrent large indels. The amplicon library was sequenced on Ion PGM system. Sequencing data were analyzed using a routine data analysis protocol and an internal program encoded for large indels test simultaneously. The validation phase was performed using 54 patients with known genetic diagnosis, including 5 with large insertions. At implement phase, 141 patients with intrahepatic cholestasis were evaluated. Results At validation phase, 99.6% of the variations identified by Sanger sequencing could be detected by panel sequencing. Following the routine protocol, 99.8% of false positives could be filtered and 98.8% of retained variations were true positives. Large insertions in the 5 patients with known genetic diagnosis could be correctly detected using the internal program. At implementation phase, 96.9% of the retained variations, following the routine protocol, were confirmed to be true. Twenty-nine patients received a potential genetic diagnosis when panel sequencing data were analyzed using the routine protocol. Two additional patients, who were found to harbor large insertions in SLC25A13, obtained a potential genetic diagnosis when sequencing data were further analyzed using the internal program. A total of 31 (22.0%) patients obtained a potential genetic diagnosis. Nine different genetic disorders were diagnosed, and citrin deficiency was the commonest. Conclusion Specially designed multi-gene panel can correctly detect large indels simultaneously. By using it, we assigned a potential genetic diagnosis to 22.0% of patients with intrahepatic cholestasis.	[Wang, Neng-Li; Zhang, Mei-Hong; Gong, Jing-Yu; Yan, Yan-Yan] Fudan Univ, Jinshan Hosp, Dept Pediat, Shanghai, Peoples R China; [Lu, Yu-Lan; Zhang, Ping; Wu, Bing-bing] Fudan Univ, Childrens Hosp, Pediat Res Inst, Shanghai Key Lab Birth Defects,Mol Genet Diag Ctr, Shanghai, Peoples R China; [Lu, Yi; Xie, Xin-Bao; Qiu, Yi-Ling; Wang, Jian-She] Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Wu, BB (corresponding author), Fudan Univ, Childrens Hosp, Pediat Res Inst, Shanghai Key Lab Birth Defects,Mol Genet Diag Ctr, Shanghai, Peoples R China.; Wang, JS (corresponding author), Fudan Univ, Childrens Hosp, Ctr Pediat Liver Dis, Shanghai, Peoples R China.	bingbingwu2010@163.com; jshwang@shmu.edu.cn	wang, Jian-She/F-1154-2011	Wang, Neng-Li/0000-0001-6967-9873; wang, jianshe/0000-0003-0823-586X	National Natural Science Foundation of China [81361128006]; Shanghai Municipal Commission of Health and Family Planning [2013-27]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning	This work was funded by National Natural Science Foundation of China (NO. 81361128006) to Jian-She Wang, and Shanghai Municipal Commission of Health and Family Planning (NO.2013-27) to Jian-She Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balistreri WF, 2005, HEPATOLOGY, V42, P222, DOI 10.1002/hep.20729; Beck J, 2014, NEUROBIOL AGING, V35, P261, DOI 10.1016/j.neurobiolaging.2013.07.017; Buckley RH, 2005, J CLIN INVEST, V115, P2974, DOI 10.1172/JCI26956; CHANG MH, 1987, J PEDIATR GASTR NUTR, V6, P203, DOI 10.1097/00005176-198703000-00006; Fang LJ, 2012, J PEDIATR GASTR NUTR, V55, P150, DOI 10.1097/MPG.0b013e31824ef36f; Gomez-Ospina N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10713; Gordo-Gilart R, 2015, GUT, V64, P147, DOI 10.1136/gutjnl-2014-306896; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Herbst SM, 2015, MOL CELL PROBE, V29, P291, DOI 10.1016/j.mcp.2015.03.001; Hinrichs JWJ, 2015, AM J CLIN PATHOL, V143, P573, DOI 10.1309/AJCP40XETVYAMJPY; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Khalaf R, 2016, PEDIATR GASTROENTERO, V19, P1, DOI 10.5223/pghn.2016.19.1.1; Li LT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130355; Lin WX, 2016, SCI REP-UK, V6, DOI 10.1038/srep29732; Liu C, 2007, GASTROENTEROLOGY, V132, P119, DOI 10.1053/j.gastro.2006.10.034; Matte U, 2010, J PEDIATR GASTR NUTR, V51, P488, DOI 10.1097/MPG.0b013e3181dffe8f; McKiernan P, 2012, CLIN RES HEPATOL GAS, V36, P287, DOI 10.1016/j.clinre.2012.03.028; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Song YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074544; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Tabata A, 2008, J HUM GENET, V53, P534, DOI 10.1007/s10038-008-0282-2; Tarabeux J, 2014, EUR J HUM GENET, V22, P535, DOI 10.1038/ejhg.2013.181; Togawa T, 2016, J PEDIATR-US, V171, P171, DOI 10.1016/j.jpeds.2016.01.006; Tomaiuolo R, 2008, J CYST FIBROS, V7, P347, DOI 10.1016/j.jcf.2007.12.004; Wang JS, 2006, EUR J PEDIATR, V165, P795, DOI 10.1007/s00431-006-0175-3; Wang NL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153114; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089267; Zheng QQ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4124263; Zollner G, 2008, CLIN LIVER DIS, V12, P1, DOI 10.1016/j.cld.2007.11.010	30	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164058	10.1371/journal.pone.0164058	http://dx.doi.org/10.1371/journal.pone.0164058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706244	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200082
J	Xie, MX; Jiang, Q; Li, L; Zhu, JJ; Zhu, LX; Zhou, D; Zheng, YL; Yang, XD; Zhu, MY; Sun, JN; Xie, WZ; Ye, XJ				Xie, Mixue; Jiang, Qi; Li, Li; Zhu, Jingjing; Zhu, Lixia; Zhou, De; Zheng, Yanlong; Yang, Xiudi; Zhu, Mingyu; Sun, Jianai; Xie, Wanzhuo; Ye, Xiujin			HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; LOW-DOSE CYTARABINE; MESSENGER-RNA EXPRESSION; ELDERLY-PATIENTS; MYELOGENOUS LEUKEMIA; INDUCED APOPTOSIS; GRANULOCYTE; INDUCTION; CHEMOTHERAPY; ACLARUBICIN	Background In China, the combination of homoharringtonine, cytarabine, and G-CSF (HAG) has been extensively applied for treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Methods We performed a meta-analysis of 2,314 patients (AML, n = 1754; MDS, n = 560) to determine the overall safety and efficacy of this regimen. Results The complete response (CR) rate of AML patients (53%) was significantly higher than that of MDS/transformed-AML patients (45%; P = 0.007). The CR rate of patients with newly diagnosed AML (62%) was significantly higher than in patients with relapsed/refractory AML (50%; P = 0.001). There were no significant difference in CR rates between elderly AML patients (54%) and all AML patients (P = 0.721). When compared with non-HAG regimens for AML/MDS induction therapy, the CR rate of patients treated with HAG was significantly higher than in treated with intensive chemotherapy (P = 0.000). No significant differences in CR rates were observed between patients treated with HAG and those treated with CAG (cytarabine, aclarubicin, G-CSF) regimens (P = 0.073). HAG regimen was well tolerated, with early death (ED) in 2%, grade IV myelosurrpression in 52% and infection in 50%. Reports of ED and rates of myelosuppression were reduced as compared with intensive chemotherapy (P = 0.000 and P = 0.000, respectively). Conclusion The HAG regimen is an effective and safe regimen for the treatment of AML and MDS, and appears to be more effective and better tolerated than intensive chemotherapy. Future randomized controlled trials and further meta-analyses are strongly needed to confirm its efficacy and safety, especially in comparison with intensive chemotherapy.	[Xie, Mixue; Li, Li; Zhu, Jingjing; Zhu, Lixia; Zhou, De; Zheng, Yanlong; Yang, Xiudi; Zhu, Mingyu; Sun, Jianai; Xie, Wanzhuo; Ye, Xiujin] Zhejiang Univ, Senior Dept Haematol, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Qi] Zhejiang Univ, Dept Med Oncol, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ye, XJ (corresponding author), Zhejiang Univ, Senior Dept Haematol, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.	wsxmxhh00@163.com						Bai A, 1999, EXP HEMATOL, V27, P259, DOI 10.1016/S0301-472X(98)00041-1; BOEKHORST PAWT, 1993, LEUKEMIA, V7, P1191; Cai Z, 2005, CHINESE MED J-PEKING, V118, P548; Chen C, 2015, LEUKEMIA LYMPHOMA, V56, P141, DOI 10.3109/10428194.2014.910774; CHEN JYZDL, 1990, CANCER RES, V50, P2031; Chen YE, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON AUTOMATION AND LOGISTICS, VOLS 1-6, P1, DOI 10.1109/ICAL.2008.4636109; Chen YJ, 2007, PROGR MODERN BIOMED, P1520; Chen YJ, 2010, CHIN J GERONTOL, P2913; Deng L, 2014, HEBEI MEDJ, P1328; DILLMAN RO, 1991, BLOOD, V78, P2520; Freireich EJ, 1998, LEUKEMIA, V12, pS54; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; Gu LF, 2011, J CANCER RES CLIN, V137, P997, DOI 10.1007/s00432-010-0947-z; Guan JM, 2010, J CHIN PRACT DIAGN T, P1015; Guo SS, 2010, MEDINNOV CHIN, P80; Guo ZQ, 2013, CHIN J MODERN DRUG, P82; Han QY, 2011, WORLD J INTEGRATED T, P222; Huang K, 2010, CURRENT PHYS, P105; Ji Yu-Ying, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P213; Jia T, 2014, MODERN J INTEGRATED, P1997; Juliusson G, 2009, BLOOD, V113, P4179, DOI 10.1182/blood-2008-07-172007; LEGHA SS, 1984, CANCER TREAT REP, V68, P1085; Li DH, 2007, JMUDANJIANG MED COLL, P52; Li HL, 2012, J GANNAN MED U, P93; Li J, 2010, CHIN JGEN PRACT, P556; Li Q, 2013, J COMPUTER APPL SOFT, P28; Li SY, 2010, ZHEJIANG MED J, V32, P275; Li Y, 2013, JMODERN ONCOL, P1840; Liao AJ, 2007, CHIN J PRACT INTERN, P59; Liu DB, 2006, J FUJIAN MED U, P274; Liu Hong, 2012, Zhonghua Yi Xue Za Zhi, V92, P689; Liu JQ, 2008, SHANDONG MED J, P95; Long BB, 2014, CHIN J PRACTICAL MED, P75; Ma XR, 2009, CHIN J MODERN MED, P22; Mai WY, 2005, CHINESE MED J-PEKING, V118, P487; Naina HVK, 2009, NEW ENGL J MED, V361, P2578, DOI 10.1056/NEJMc0910366; OBRIEN S, 1995, BLOOD, V86, P3322, DOI 10.1182/blood.V86.9.3322.bloodjournal8693322; POWELL R G, 1970, Tetrahedron Letters, V11, P815, DOI 10.1016/S0040-4039(01)97839-6; Rombouts EJC, 2004, BLOOD, V104, P550, DOI 10.1182/blood-2004-02-0566; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Shen Jian-ping, 2012, Zhejiang Da Xue Xue Bao Yi Xue Ban, V41, P485; Shu HE, 2007, CHINJMISDIAGN, P331; Sierra MDLL, 2007, BLOOD, V110, P2276, DOI 10.1182/blood-2007-03-081448; Su J., 2014, CHIN PHARM, P114; Su Ji-Ying, 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V17, P459; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sun RY, 2010, JMODERN ONCOL, P2055; Sun SF, 2011, J GUIYANG MED COLL; Sun XH, 2010, MED J IND ENTERP, P13; Sun XH, 2009, J CLIN HEMATOL, P382; TAKEMURA Y, 1985, CANCER CHEMOTH PHARM, V14, P206; Tong JS, 2009, CHIN J GERONTOL, P362; Wang JM, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-32; Wang JL, 2011, JLEUKEMIA LYMPHOMA, V20, P151; Wei GQ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-46; Wei XD, 2006, CHIN JHEMATOL, P64; Wu CH, 2010, J NANCHANG U, P104; Wu LY, 2011, J CANCER RES CLIN, V137, P1563, DOI 10.1007/s00432-011-1020-2; Wu LY, 2009, LEUKEMIA LYMPHOMA, V50, P1461, DOI 10.1080/10428190903096719; Xie WZ, 2006, AM J CHINESE MED, V34, P233, DOI 10.1142/S0192415X06003795; Xie Y, 2010, CHIN MED HERALD, P148; Xu J, 2009, J JIAXING U, P129; YAMADA K, 1995, LEUKEMIA, V9, P10; Yang LH., 2009, CHIN J MODERN MED, P2866; Yang YL, 2009, J BENGBU MED COLL, P307; Ye CM, 2008, J N CHINA COAL MED C, P636; Ye Xiu-jin, 2004, J Zhejiang Univ Sci, V5, P230, DOI 10.1631/jzus.2004.0230; Yi HY., 2009, CHIN J MIS DIAGN, P538; Yuan JH, 2008, MED J COMMUNICAT, P671; Zhan XR, 2009, SHANDONG MED J, P78; Zhang L, 2011, JMODERN ONCOL, P1663; Zhang L, 2009, J CLIN HEMATOL, P502; Zhang P, 2014, CHIN J PHARM EC, P141; Zhang WG, 2008, AM J HEMATOL, V83, P185, DOI 10.1002/ajh.20903; Zhang X.Y., 2014, CHINA SOFT SCI NO, V6, P142; Zhang XH, 2014, J INTER INTENSIVE ME, P170; Zhang YH., 2014, CHIN JCONTROL ENDEMI, P185; Zheng SY, 2011, J MODERN ONCOL, P994; Zhou J, 2011, CHIN J TRAUMA DISABI, P19; Zhou W, 2008, J CLIN HEMATOL, P563	80	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164238	10.1371/journal.pone.0164238	http://dx.doi.org/10.1371/journal.pone.0164238			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706258	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200100
J	Yuan, F; Kolb, R; Pandey, G; Li, W; Sun, L; Liu, FY; Sutterwala, FS; Liu, YH; Zhang, WZ				Yuan, Fang; Kolb, Ryan; Pandey, Gaurav; Li, Wei; Sun, Lin; Liu, Fuyou; Sutterwala, Fayyaz S.; Liu, Yinghong; Zhang, Weizhou			Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; INFLAMMASOME ACTIVATION; BACTERIAL LIGANDS; RECEPTOR; INJURY; TRANSCRIPTION; RECOGNITION; MACROPHAGES; EXPRESSION	Diabetic nephropathy (DN) is the leading cause of end-stage kidney disease worldwide but current treatments remain suboptimal. The role of inflammation in DN has only recently been recognized. It has been shown that the NLRP3-inflammasome contributes to DN development by inducing interleukin (IL)-1 beta processing and secretion. In an effort to understand other IL-1 beta activating mechanism during DN development, we examined the role of the NLRC4-inflammasome in DN and found that NLRC4 is a parallel mechanism, in addition to the NLRP3-inflammasome, to induce pro-IL-1 beta processing and activation. We found that the expression of NLRC4 is elevated in DN kidneys. NLRC4-deficiency results in diminished DN disease progression, as manifested by a decrease in blood glucose and albumin excretion, as well as preserved renal histology. We further found that DN kidneys have increased F4/80(+) macrophages, increased IL-1 beta production, and other signaling pathways related to kidney pathology such as activation of NF-kappa B and MAP kinase pathways, all of which were rescued by NLRC4-deficiency. This study demonstrates NLRC4-driven IL-1 beta production as critical for the progression of DN, which underscores the importance to target this pathway to alleviate this devastating disease.	[Yuan, Fang; Sun, Lin; Liu, Fuyou; Liu, Yinghong] Cent S Univ, Res Inst Nephrol, Xiangya Hosp 2, Dept Nephrol, Changsha, Hunan, Peoples R China; [Yuan, Fang; Kolb, Ryan; Pandey, Gaurav; Li, Wei; Liu, Yinghong; Zhang, Weizhou] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Kolb, Ryan; Zhang, Weizhou] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Sutterwala, Fayyaz S.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Zhang, Weizhou] Univ Iowa, Med Scientist Training Program, Carver Coll Med, Iowa City, IA 52242 USA; [Zhang, Weizhou] Univ Iowa, Free Rad & Radiat Biol Program, Carver Coll Med, Iowa City, IA 52242 USA; [Zhang, Weizhou] Univ Iowa, Canc Genes & Pathway Holden Comprehens Canc Ctr, Carver Coll Med, Iowa City, IA 52242 USA	Central South University; University of Iowa; University of Iowa; Cedars Sinai Medical Center; University of Iowa; University of Iowa; University of Iowa	Liu, YH (corresponding author), Cent S Univ, Res Inst Nephrol, Xiangya Hosp 2, Dept Nephrol, Changsha, Hunan, Peoples R China.; Liu, YH; Zhang, WZ (corresponding author), Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA.; Zhang, WZ (corresponding author), Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.; Zhang, WZ (corresponding author), Univ Iowa, Med Scientist Training Program, Carver Coll Med, Iowa City, IA 52242 USA.; Zhang, WZ (corresponding author), Univ Iowa, Free Rad & Radiat Biol Program, Carver Coll Med, Iowa City, IA 52242 USA.; Zhang, WZ (corresponding author), Univ Iowa, Canc Genes & Pathway Holden Comprehens Canc Ctr, Carver Coll Med, Iowa City, IA 52242 USA.	liuyingh2002@139.com; weizhou-zhang@uiowa.edu	Sutterwala, Fayyaz/AAH-5859-2021; liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022; Cassel, Suzanne/AAI-3947-2021	Cassel, Suzanne/0000-0003-2492-1923; Kolb, Ryan/0000-0001-6305-2885	National Institutes of Health [K99/R00 CA158055, CA200673, CD203834]; V Foundation for Cancer Research; AI/NIAID [T32 AI007260]; NATIONAL CANCER INSTITUTE [R00CA158055, R01CA200673, R01CA203834, K99CA158055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; AI/NIAID; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	WZ was supported by National Institutes of Health grants K99/R00 CA158055, CA200673, and CD203834, the V Scholar Award from the V Foundation for Cancer Research. RK was supported by T32 AI007260 AI/NIAID.	Abais JM, 2013, ANTIOXID REDOX SIGN, V18, P1537, DOI 10.1089/ars.2012.4666; Awad AS, 2011, AM J PHYSIOL-RENAL, V301, pF1358, DOI 10.1152/ajprenal.00332.2011; Chen KH, 2013, INT J BIOCHEM CELL B, V45, P932, DOI 10.1016/j.biocel.2013.02.009; Chow F, 2004, KIDNEY INT, V65, P116, DOI 10.1111/j.1523-1755.2004.00367.x; Chow FY, 2006, KIDNEY INT, V69, P73, DOI 10.1038/sj.ki.5000014; Chow FY, 2005, J AM SOC NEPHROL, V16, P1711, DOI 10.1681/ASN.2004070612; De Borst MH, 2007, J PATHOL, V213, P219, DOI 10.1002/path.2228; de Borst MH, 2009, J PHARMACOL EXP THER, V331, P896, DOI 10.1124/jpet.109.154179; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Henquin JC, 2008, DIABETES OBES METAB, V10, P1, DOI 10.1111/j.1463-1326.2008.00968.x; Hinamoto N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107934; Janowski AM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00370; Kaneto H, 2007, CURR MOL MED, V7, P674, DOI 10.2174/156652407782564408; Kim SM, 2015, AM J PHYSIOL-RENAL, V308, pF993, DOI 10.1152/ajprenal.00637.2014; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kolb R, 2014, PROTEIN CELL, V5, P12, DOI 10.1007/s13238-013-0001-4; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lim AKH, 2010, DIABETOLOGIA, V53, P1772, DOI 10.1007/s00125-010-1757-1; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Liu P, 2014, DIABETES RES CLIN PR, V105, P206, DOI 10.1016/j.diabres.2014.04.020; Makino H, 1996, DIABETES, V45, P488, DOI 10.2337/diabetes.45.4.488; Morii T, 2003, J DIABETES COMPLICAT, V17, P11, DOI 10.1016/S1056-8727(02)00176-9; Moriya R, 2004, DIABETOLOGIA, V47, P82, DOI 10.1007/s00125-003-1253-y; Murphy AJ, 2016, CELL METAB, V23, P155, DOI 10.1016/j.cmet.2015.09.024; Navarro JF, 1999, AM J KIDNEY DIS, V33, P458, DOI 10.1016/S0272-6386(99)70182-4; Navarro JF, 2003, AM J KIDNEY DIS, V42, P53, DOI 10.1016/S0272-6386(03)00408-6; Navarro JF, 2005, NEPHROL DIAL TRANSPL, V20, P2601, DOI 10.1093/ndt/gfi155; Nguyen D, 2006, NEPHROLOGY, V11, P226, DOI 10.1111/j.1440-1797.2006.00576.x; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Rayamajhi M, 2013, J IMMUNOL, V191, P3986, DOI 10.4049/jimmunol.1301549; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Tenthorey JL, 2014, MOL CELL, V54, P17, DOI 10.1016/j.molcel.2014.02.018; UEDA A, 1994, J IMMUNOL, V153, P2052; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038285; Wu CC, 2012, ADV CLIN CHEM, V56, P55, DOI 10.1016/B978-0-12-394317-0.00014-5; Yang SM, 2014, DIABETOLOGIA, V57, P424, DOI 10.1007/s00125-013-3115-6; Yuan F, 2014, MOL MED REP, V9, P2293, DOI 10.3892/mmr.2014.2133; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572	42	33	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164135	10.1371/journal.pone.0164135	http://dx.doi.org/10.1371/journal.pone.0164135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706238	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200089
J	Esposito, F; Jacquemyn, H; Waud, M; Tyteca, D				Esposito, Fabiana; Jacquemyn, Hans; Waud, Michael; Tyteca, Daniel			Mycorrhizal Fungal Diversity and Community Composition in Two Closely Related Platanthera (Orchidaceae) Species	PLOS ONE			English	Article							SYMBIOTIC GERMINATION; SPECIFICITY; SPECIATION; ASSOCIATIONS; COEXISTENCE; SEQUENCES; PRIMERS; FORESTS; RECORDS; BIFOLIA	While it is generally acknowledged that orchid species rely on mycorrhizal fungi for completion of their life cycle, little is yet known about how mycorrhizal fungal diversity and community composition vary within and between closely related orchid taxa. In this study, we used 454 amplicon pyrosequencing to investigate variation in mycorrhizal communities between pure (allopatric) and mixed (sympatric) populations of two closely related Platanthera species (Platanthera bifolia and P. chlorantha) and putative hybrids. Consistent with previous research, the two species primarily associated primarily with members of the Ceratobasidiaceae and, to a lesser extent, with members of the Sebacinales and Tulasnellaceae. In addition, a large number of ectomycorrhizal fungi belonging to various families were observed. Although a considerable number of mycorrhizal fungi were common to both species, the fungal communities were significantly different between the two species. Individuals with intermediate morphology showed communities similar to P. bifolia, confirming previous results based on the genetic architecture and fragrance composition that putative hybrids essentially belonged to one of the parental species (P. bifolia). Differences in mycorrhizal communities between species were smaller in mixed populations than between pure populations, suggesting that variation in mycorrhizal communities was largely controlled by local environmental conditions. The small differences in mycorrhizal communities in mixed populations suggests that mycorrhizal fungi are most likely not directly involved in maintaining species boundaries between the two Platanthera species. However, seed germination experiments are needed to unambiguously assess the contribution of mycorrhizal divergence to reproductive isolation.	[Esposito, Fabiana; Tyteca, Daniel] Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, Croix Sud 4-5 L7-07-04, B-1348 Louvain La Neuve, Belgium; [Jacquemyn, Hans; Waud, Michael] KULeuven, Dept Biol Plant Conservat & Populat Biol, B-3001 Leuven, Belgium	Universite Catholique Louvain; KU Leuven	Tyteca, D (corresponding author), Catholic Univ Louvain, Earth & Life Inst, Biodivers Res Ctr, Croix Sud 4-5 L7-07-04, B-1348 Louvain La Neuve, Belgium.	daniel.tyteca@uclouvain.be	Jacquemyn, Hans/AAC-4875-2019	Jacquemyn, Hans/0000-0001-9600-5794; Esposito, Fabiana/0000-0002-6119-4174	European Research Council [260601 - MYCASOR]	European Research Council(European Research Council (ERC)European Commission)	This research was supported by the European Research Council (ERC Starting Grant 260601 - MYCASOR awarded to HJ). The operating budget of UCL (University catholique de Louvain) was used for operating expenses of FE and DT.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arditti J, 2000, NEW PHYTOL, V145, P367, DOI 10.1046/j.1469-8137.2000.00587.x; Bateman R. M., 2008, Watsonia, V27, P1; Bateman R. M., 2012, New Journal of Botany, V2, P110, DOI 10.1179/2042349712Y.0000000013; Bateman RM, 2014, AM J BOT, V101, P979, DOI 10.3732/ajb.1300430; Batty AL, 2001, NEW PHYTOL, V152, P511, DOI 10.1046/j.0028-646X.2001.00277.x; Baumann H, 1998, FARN BLUTENPFLANZEN; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bidartondo MI, 2008, MOL ECOL, V17, P3707, DOI 10.1111/j.1365-294X.2008.03848.x; Bidartondo MI, 2004, P ROY SOC B-BIOL SCI, V271, P1799, DOI 10.1098/rspb.2004.2807; BIONDINI ME, 1988, VEGETATIO, V75, P161; Chen X. Q., 2009, FLORA CHINA, V25, P101; Claessens J., 2006, J EUROPAISCHER ORCHI, V38, P3; CURRAH RS, 1987, CAN J BOT, V65, P2473, DOI 10.1139/b87-336; CURRAH RS, 1990, CAN J BOT, V68, P1171, DOI 10.1139/b90-149; Darwin C., 1862, VARIOUS CONTRIVANCES, DOI [10.1017/CBO9780511910197, DOI 10.1017/CBO9780511910197]; Dearnaley JDW, 2012, FUNGAL ASS, VIX, P207, DOI DOI 10.1007/978-3-642-30826-0_12; Delforge P., 2006, ORCHIDS EUROPE N AFR; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Esposito F, INTERMEDIATE P UNPUB; Hapeman Jeffrey R., 1997, P433; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; INOUE K, 1983, Journal of the Faculty of Science University of Tokyo Section III Botany, V13, P285; Jacquemyn H, 2016, ANN BOT-LONDON, V118, P105, DOI 10.1093/aob/mcw015; Jacquemyn H, 2015, NEW PHYTOL, V206, P1127, DOI 10.1111/nph.13281; Jacquemyn H, 2014, NEW PHYTOL, V202, P616, DOI 10.1111/nph.12640; Jacquemyn H, 2012, J ECOL, V100, P1328, DOI 10.1111/j.1365-2745.2012.01998.x; Jacquemyn H, 2012, NEW PHYTOL, V193, P454, DOI 10.1111/j.1469-8137.2011.03913.x; Jacquemyn H, 2010, MOL ECOL, V19, P4086, DOI 10.1111/j.1365-294X.2010.04785.x; Jin XH, 2012, NORD J BOT, V30, P291, DOI 10.1111/j.1756-1051.2011.01229.x; Lajtha K, 1999, LT EC RES NETWK SER, V2, P115; Leake JR, 2010, NEW PHYTOL, V185, P601, DOI 10.1111/j.1469-8137.2009.03153.x; Lievens B, 2010, J MICROBIOL METH, V80, P76, DOI 10.1016/j.mimet.2009.11.004; Lowry DB, 2008, PHILOS T R SOC B, V363, P3009, DOI 10.1098/rstb.2008.0064; Maad J, 2004, BIOL J LINN SOC, V83, P481, DOI 10.1111/j.1095-8312.2004.00406.x; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCormick MK, 2014, NEW PHYTOL, V202, P392, DOI 10.1111/nph.12639; Muller H., 1868, VERHANDLUNGEN NATURH, V25, P36; Neiland MRM, 1998, AM J BOT, V85, P1657, DOI 10.2307/2446499; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; NILSSON LA, 1983, BOT J LINN SOC, V87, P325, DOI 10.1111/j.1095-8339.1983.tb00997.x; NILSSON LA, 1985, NORD J BOT, V5, P407; Nosil P, 2005, EVOLUTION, V59, P705; Oja J, 2015, NEW PHYTOL, V205, P1608, DOI 10.1111/nph.13223; Pandey M, 2013, MOL ECOL, V22, P2341, DOI 10.1111/mec.12249; Prat D., 2005, ORCHIDEES FRANCE BEL; Rasmussen HN, 2009, OIKOS, V118, P334, DOI 10.1111/j.1600-0706.2008.17116.x; Rasmussen HN., 1995, TERRESTRIAL ORCHIDS, DOI [10.1017/CBO9780511525452, DOI 10.1017/CBO9780511525452]; Robertson GP, 1999, LT EC RES NETWK SER, V2, P258; Roy M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-51; Sharma J, 2003, SYMBIOSIS, V34, P145; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stokl J, 2008, AM J BOT, V95, P472, DOI 10.3732/ajb.95.4.472; Swarts ND, 2010, MOL ECOL, V19, P3226, DOI 10.1111/j.1365-294X.2010.04736.x; Taylor DL, 2008, NEW PHYTOL, V177, P1020, DOI 10.1111/j.1469-8137.2007.02320.x; Tesitelova T, 2013, NEW PHYTOL, V199, P1022, DOI 10.1111/nph.12348; Tesitelova T, 2012, AM J BOT, V99, P1020, DOI 10.3732/ajb.1100503; Tremblay RL, 2005, BIOL J LINN SOC, V84, P1, DOI 10.1111/j.1095-8312.2004.00400.x; van der Niet T, 2012, TRENDS ECOL EVOL, V27, P353, DOI 10.1016/j.tree.2012.02.002; van dersCingel N. A., 1995, ATLAS ORCHID POLLINA; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; Waterman RJ, 2011, AM NAT, V177, pE54, DOI 10.1086/657955; Waud M, 2016, FUNGAL ECOL, V20, P155, DOI 10.1016/j.funeco.2015.12.008; Waud M, 2014, MOL ECOL RESOUR, V14, P679, DOI 10.1111/1755-0998.12229; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zelmer Carla D., 1996, Mycoscience, V37, P439, DOI 10.1007/BF02461001; Zelmer CD, 1995, CAN J BOT, V73, P1981, DOI 10.1139/b95-212; Zettler LW, 2011, AM MIDL NAT, V166, P29, DOI 10.1674/0003-0031-166.1.29	71	22	28	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164108	10.1371/journal.pone.0164108	http://dx.doi.org/10.1371/journal.pone.0164108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695108	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100090
J	Hwang, JH; Park, SW				Hwang, Jun Hyun; Park, Soon-Woo			Association between Peer Cigarette Smoking and Electronic Cigarette Smoking among Adolescent Nonsmokers: A National Representative Survey	PLOS ONE			English	Article							NICOTINE DELIVERY-SYSTEMS; SMOKELESS TOBACCO USE; RISK-FACTORS; PERCEPTIONS; PREDICTORS; INITIATION; PARENTS; FRIENDS; YOUTH	We assessed the association between electronic cigarette (e-cigarette) use and peer cigarette smoking, a major risk factor for the initiation of cigarette smoking in adolescents. Data from the 2013 Korea Youth Risk Behavior Web-based Survey of 65,753 nonsmokers aged 13-18 years were analyzed using multiple logistic regression. A total of 3.8% of the Korean adolescents were 'ever e-cigarette' users and 1.2% were current users. Adjusted odds ratios (ORs) for current and ever e-cigarette use compared to those whose closest friends were non-smokers ranged from 2.05 (95% confidence interval [CI], 1.82-2.30) to 5.50 (95% CI, 4.77-6.34), and from 2.23 (95% CI, 1.77-2.81) to 7.82 (95% CI, 5.97-10.25) for those who had 'some' close friends to 'most/all' friends who smoked, respectively. The slopes of the adjusted ORs for e-cigarette use in 'never smokers' were more than twice as steep as those in 'former smokers', showing a significant interaction effect between the proportion of smoking closest friends and cigarette smoking status (never or former smokers) (p<0.001 for interaction). Peer cigarette smoking had a significant association with e-cigarette use in adolescent nonsmokers, and this association was greater on never smokers than former smokers.	[Hwang, Jun Hyun; Park, Soon-Woo] Catholic Univ, Dept Prevent Med, Daegu Sch Med, Daegu, South Korea	Catholic University of Daegu	Park, SW (corresponding author), Catholic Univ, Dept Prevent Med, Daegu Sch Med, Daegu, South Korea.	parksw@cu.ac.kr			Catholic University of Daegu [20115006]	Catholic University of Daegu	This work was supported by research grants from the Catholic University of Daegu in 2011 (20115006).	Ambrose BK, 2014, AM J PREV MED, V47, pS53, DOI 10.1016/j.amepre.2014.04.016; Barrington-Trimis JL, 2015, PEDIATRICS, V136, P308, DOI 10.1542/peds.2015-0639; Blumenthal R, 2014, GATEWAY ADDICTION SU; Bricker JB, 2006, NICOTINE TOB RES, V8, P217, DOI 10.1080/14622200600576339; Bunnell RE, 2015, NICOTINE TOB RES, V17, P228, DOI 10.1093/ntr/ntu166; Chatham-Stephens K, 2014, MMWR-MORBID MORTAL W, V63, P292; Coleman BN, 2015, NICOTINE TOB RES, V17, P212, DOI 10.1093/ntr/ntu211; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Czoli CD, 2015, E CIGARETTES CANADA; Czoli CD, 2014, CAN J PUBLIC HEALTH, V105, pE97, DOI 10.17269/cjph.105.4119; de Vries H, 2003, HEALTH EDUC RES, V18, P627, DOI 10.1093/her/cyg032; Dutra LM, 2014, JAMA PEDIATR, V168, P684, DOI 10.1001/jamapediatrics.2013.5488; Etter JF, 2011, TOB CONTROL, V20, P243, DOI 10.1136/tc.2010.042168; Fairchild AL, 2014, NEW ENGL J MED, V370, P293, DOI 10.1056/NEJMp1313940; Gmel G, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14271; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Hanewinkel R, 2015, PREV MED, V74, P59, DOI 10.1016/j.ypmed.2015.03.006; Henningfield JE, 2010, TOB CONTROL, V19, P89, DOI 10.1136/tc.2009.035279; Holman LR, 2013, ADDICTION, V108, P1327, DOI 10.1111/add.12164; Kalkhoran S, 2016, LANCET RESP MED, V4, P116, DOI 10.1016/S2213-2600(15)00521-4; Kim Y, 2016, INT J EPIDEMIOL, V45, DOI 10.1093/ije/dyw070; Larsen E, 2013, ADDICT BEHAV, V38, P2288, DOI 10.1016/j.addbeh.2013.02.007; Lee S, 2014, J ADOLESCENT HEALTH, V54, P684, DOI 10.1016/j.jadohealth.2013.11.003; Lee Sungkyu, 2011, J Prev Med Public Health, V44, P235, DOI 10.3961/jpmph.2011.44.6.235; Lee Sungkyu, 2010, J Prev Med Public Health, V43, P283, DOI 10.3961/jpmph.2010.43.4.283; Leventhal AM, 2015, JAMA-J AM MED ASSOC, V314, P700, DOI 10.1001/jama.2015.8950; Malone RE, 2012, TOB CONTROL, V21, P162, DOI 10.1136/tobaccocontrol-2011-050200; McCarthy M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2871; McMillen RC, 2015, NICOTINE TOB RES, V17, P1195, DOI 10.1093/ntr/ntu213; Ministry of Education Ministry of Health and Welfare Korea Centers for Disease Control and Prevention. The tenth Korea youth risk behavior web-based survey, 2014, 10 KOR YOUTH RISK BE; Organization for Economic Cooperation and Development (OECD), 2014, PEN FIX WIR BRAODB S; Orimadegun AE, 2012, J PUBLIC HEALTH-HEID, V20, P631, DOI 10.1007/s10389-012-0506-y; Piko B, 2001, ADDICT BEHAV, V26, P201, DOI 10.1016/S0306-4603(00)00101-5; Primack BA, 2015, JAMA PEDIATR, V169, P1018, DOI 10.1001/jamapediatrics.2015.1742; Richardson A, 2015, TOB CONTROL, V24, P341, DOI 10.1136/tobaccocontrol-2013-051246; Wills TA, 2016, TOB CONTROL, V25, pE52, DOI 10.1136/tobaccocontrol-2015-052349; World Health Organization (WHO), 2008, EL GUID IMPL ART 12; Yamin CK, 2010, ANN INTERN MED, V153, P607, DOI 10.7326/0003-4819-153-9-201011020-00011	38	10	10	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162557	10.1371/journal.pone.0162557	http://dx.doi.org/10.1371/journal.pone.0162557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695093	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100014
J	Laux, G; Musselmann, B; Kiel, M; Szecsenyi, J; Joos, S				Laux, Gunter; Musselmann, Berthold; Kiel, Marion; Szecsenyi, Joachim; Joos, Stefanie			Differences between Practice Patterns of Conventional and Naturopathic GPs in Germany	PLOS ONE			English	Article							PRIMARY-CARE; ALTERNATIVE MEDICINE; COMPLEMENTARY; PRACTITIONERS	Background Limited evidence exists whether practice patterns of general practitioners (GPs) who have additionally completed training in naturopathy are different from those of conventional GPs. We aimed to assess and compare practice patterns of GPs in conventional and naturopathic GPs. Methods Routine data from 41 GPs (31 with and 11 without additional qualification in NP, respectively) and 180,789 patients, drawn from the CONTinuous morbidity registration Epidemiologic NeTwork (CONTENT)-registry and collected between 2009 and 2014, were used. To assess practice patterns determinants of (non-) phytopharmaceutical prescriptions, referrals and hospitalizations were analyzed using mixed-effects Poisson regression models. As explanatory variables, the qualification of the GP in NM, the age group and sex of the patient, as well as bivariate interactions between these variables were considered. Results GPs additionally qualified in naturopathy exhibited higher rates of phytopharmaceutical prescriptions (p<0.034; independent effect) compared to conventional GPs. This association was not observed with respect to non-phytopharmaceutical prescriptions. However, interaction effects between qualification and age group as well as sex were present with respect to both phytopharmaceutical and non-phytopharmaceutical prescriptions (all p<0.001). No further independent association existed between qualification and either referral rates or hospitalization rates, but again interactions between qualification and age group and sex (only referrals) were statistically significant (all p<0.0001). Conclusion The results show that the rate of phyto-pharmaceutical prescriptions are generally higher when the GP has an additional qualification in naturopathy. Further differences in practice patterns between conventional and naturopathy GPs could be subject to certain age groups and sex. However, the magnitude of these differences seem to be rather small.	[Laux, Gunter; Musselmann, Berthold; Kiel, Marion; Szecsenyi, Joachim; Joos, Stefanie] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Laux, G (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	g.laux@med.uni-heidelberg.de	Laux, Gunter/AAL-9020-2021		"Komitee Forschung Naturmedzin e.V." (KFN) [4/2001]; German Federal Ministry of Research and Education (BMBF) [01GK0301]	"Komitee Forschung Naturmedzin e.V." (KFN); German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	Financial support for this study was received from the "Komitee Forschung Naturmedzin e.V." (KFN) (grant number 4/2001, to Prof. Dr. Gunter Laux). The implementation of CONTENT registry was funded by the German Federal Ministry of Research and Education (BMBF) (grant number 01GK0301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiner A, 2010, J ANTIMICROB CHEMOTH, V65, P1521, DOI 10.1093/jac/dkq151; Baars Erik W, 2014, BMJ Open, V4, pe005332, DOI 10.1136/bmjopen-2014-005332; Ben-Arye E, 2008, PATIENT EDUC COUNS, V70, P395, DOI 10.1016/j.pec.2007.11.019; De Sutter AI, 2001, FAM PRACT, V18, P209, DOI 10.1093/fampra/18.2.209; Eardley S, 2012, FORSCH KOMPLEMENTMED, V19, P18, DOI 10.1159/000342708; Fischer F, 2014, FORSCH KOMPLEMENTMED, V21, pE1, DOI 10.1159/000360744; Fleming SA, 2010, PRIMARY CARE, V37, P119, DOI 10.1016/j.pop.2009.09.002; Herman PM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001046; Joos S, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/294638; Joos S, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-131; Joos S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep019; Kooreman P, 2012, EUR J HEALTH ECON, V13, P769, DOI 10.1007/s10198-011-0330-2; Kraft K, 2009, LEHRBUCH NATURHEILVE; Laux Gunter, 2005, Inform Prim Care, V13, P249; Laux G, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-14; National Center for Complementary and Integrative Health (NCCIH), NAT WHAT NAT PRACT D; Stroup W.W., 2012, GEN LINEAR MIXED MOD; Studer HP, 2011, FORSCH KOMPLEMENTMED, V18, P315, DOI 10.1159/000334797; Thanner M, 2014, GESUNDHEITSWESEN, V76, P715, DOI 10.1055/s-0033-1364013; WHO Collaborating Centre for Drug Statistics Methodology, AN THER CHEM ATC CLA	20	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163519	10.1371/journal.pone.0163519	http://dx.doi.org/10.1371/journal.pone.0163519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695071	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100041
J	Chen, CM; Yang, YH; Chang, CH; Chen, CC; Chen, PC				Chen, Chien-Min; Yang, Yao-Hsu; Chang, Chia-Hao; Chen, Chih-Cheng; Chen, Pau-Chung			The Utilization of Rehabilitation in Patients with Hemophilia A in Taiwan: A Nationwide Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; ACTIVATED FACTOR-VII; INTRACRANIAL HEMORRHAGE; HEALTH INSURANCE; EXERCISE PROGRAM; ECONOMIC BURDEN; COST-ANALYSIS; ON-DEMAND; PHYSIOTHERAPY; INHIBITORS	Introduction Rehabilitation plays an important role in the physical health of patients with hemophilia. However, comprehensive information regarding the utilization of rehabilitation for such patients remains scarce. Aim This population-based study aimed to examine the characteristics, trends, and most important factors affecting rehabilitation usage in patients with hemophilia A using a nationwide database in Taiwan. Methods Data from 777 patients with hemophilia A who were registered in the National Health Insurance Research Database between 1998 and 2008 were analyzed using SAS 9.0. Results Musculoskeletal or nervous system-related surgical procedures and clotting factor VIII concentrate costs were identified as factors affecting rehabilitation usage; musculoskeletal or nervous system-related surgical procedures (odds ratio = 3.788; P < 0.001) were the most important predictor of whether a patient with hemophilia A would use rehabilitation services. Joint disorders, arthropathies, bone and cartilage disorders, intracranial hemorrhage, and brain trauma were common diagnoses during rehabilitation use. The costs of physical therapy (physiotherapy) comprised the majority (71.2%) of rehabilitation therapy categories. Increasingly, rehabilitation therapy was performed at physician clinics. The total rehabilitation costs were <0.1% of the total annual medical costs. Conclusion Musculoskeletal or nervous system-related surgical procedures and increased use of clotting factor VIII concentrate affect the rehabilitation utilization of patients with hemophilia A the most. The findings in this study could help clinicians comprehensively understand the rehabilitation utilization of patients with hemophilia A.	[Chen, Chien-Min] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Chen, Chien-Min; Chen, Chih-Cheng] Chang Gung Univ, Sch Med, Coll Med, Taoyuan, Taiwan; [Chen, Chien-Min; Chen, Chih-Cheng] Chang Gung Mem Hosp, Hemophilia & Thrombosis Treatment Ctr, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu; Chen, Pau-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Ctr Excellence Chang Gung Res Datalink, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Chang, Chia-Hao] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi Campus, Chiayi, Taiwan; [Chen, Chih-Cheng] Chang Gung Mem Hosp, Dept Med, Div Hematol & Oncol, Chiayi, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chen, CC (corresponding author), Chang Gung Univ, Sch Med, Coll Med, Taoyuan, Taiwan.; Chen, CC (corresponding author), Chang Gung Mem Hosp, Hemophilia & Thrombosis Treatment Ctr, Chiayi, Taiwan.; Chen, CC (corresponding author), Chang Gung Mem Hosp, Dept Med, Div Hematol & Oncol, Chiayi, Taiwan.	ccchen1968@gmail.com	Chen, Pau-Chung/H-5686-2011; 楊, 曜旭/A-3450-2019	Chen, Pau-Chung/0000-0002-6242-5974; 楊, 曜旭/0000-0002-8080-0504; Chen, Chien-Min/0000-0001-9838-0096	Chang Gung Memorial Hospital Research Project Grant, Taiwan [CMRPG 6E0221, 6E0222]	Chang Gung Memorial Hospital Research Project Grant, Taiwan	This work was supported by a grant from the Chang Gung Memorial Hospital Research Project Grant, Taiwan (Contract No. CMRPG 6E0221 and 6E0222). URL:https://www.cgmh.org.tw/eng2002/index.asp. Recipient: Chien-Min Chen (CMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballal RD, 2008, CURR MED RES OPIN, V24, P753, DOI 10.1185/030079908X273048; Bladen M, 2009, HAEMOPHILIA, V15, P184, DOI 10.1111/j.1365-2516.2008.01815.x; Blamey G, 2010, HAEMOPHILIA, V16, P136, DOI 10.1111/j.1365-2516.2010.02312.x; Brown HC, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.36; Carlsson KS, 2004, HAEMOPHILIA, V10, P515, DOI 10.1111/j.1365-2516.2004.00952.x; Chang CY, 2014, HAEMOPHILIA, V20, P535, DOI 10.1111/hae.12373; Chen CM, 2015, HAEMOPHILIA, V21, pE176, DOI 10.1111/hae.12644; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cuesta-Barriuso R, 2014, HAEMOPHILIA, V20, P866, DOI 10.1111/hae.12447; Cuesta-Barriuso R, 2014, HAEMOPHILIA, V20, pE71, DOI 10.1111/hae.12320; D'Young AI, 2009, HAEMOPHILIA, V15, P253, DOI 10.1111/j.1365-2516.2008.01855.x; De Kleijn P, 2006, HAEMOPHILIA, V12, P108, DOI 10.1111/j.1365-2516.2006.01266.x; De Kleijn P, 2011, HAEMOPHILIA, V17, P971, DOI 10.1111/j.1365-2516.2011.02527.x; Fama ME, 2016, TOP STROKE REHABIL, V23, P276, DOI 10.1080/10749357.2016.1155277; Geerts E, 2008, HAEMOPHILIA, V14, P1007, DOI 10.1111/j.1365-2516.2008.01798.x; Globe DR, 2004, HAEMOPHILIA, V10, P63, DOI 10.1111/j.1355-0691.2004.00881.x; Goto M, 2014, HAEMOPHILIA, V20, pE121, DOI 10.1111/hae.12355; Gringeri A, 2003, BLOOD, V102, P2358, DOI 10.1182/blood-2003-03-0941; Harris S, 2006, HAEMOPHILIA, V12, P237, DOI 10.1111/j.1365-2516.2006.01214.x; Henrard S, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-39; Khan U, 2010, HAEMOPHILIA, V16, P322, DOI 10.1111/j.1365-2516.2009.02125.x; Liao PA, 2012, J RURAL HEALTH, V28, P84, DOI 10.1111/j.1748-0361.2011.00363.x; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; Lin MH, 2011, TAIWAN J PUBLIC HLTH, V30, P347, DOI DOI 10.6288/TJPH2011-30-04-05; Lin YJ, 2011, HEALTH POLICY, V103, P236, DOI 10.1016/j.healthpol.2011.08.007; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Ljung RCR, 2008, BRIT J HAEMATOL, V140, P378, DOI 10.1111/j.1365-2141.2007.06949.x; Matsui H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104957; Mulvany R, 2010, PHYS THER, V90, P509, DOI 10.2522/ptj.20080202; Santavirta N, 2001, RHEUMATOL INT, V21, P15; Tu TC, 2013, YONSEI MED J, V54, P358, DOI 10.3349/ymj.2013.54.2.358; Villarrubia R, 2015, HAEMOPHILIA, V21, P320, DOI 10.1111/hae.12681; Witkop M, 2011, HAEMOPHILIA, V17, P612, DOI 10.1111/j.1365-2516.2010.02479.x; Witmer CM, 2015, HAEMOPHILIA, V21, pE359, DOI 10.1111/hae.12716; Yan YH, 2013, HEALTH-LONDON, V5, P1; Young G, 2014, HAEMOPHILIA, V20, pE113, DOI 10.1111/hae.12349; Zakas PM, 2011, J GENET SYNDR GENE T, V1, P2410, DOI [10.4172/2157-7412.S1-003, DOI 10.4172/2157-7412.S1-003]	37	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							0164009	10.1371/journal.pone.0164009	http://dx.doi.org/10.1371/journal.pone.0164009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DX4CZ	27690229	gold, Green Submitted, Green Published			2022-12-27	WOS:000384329200039
J	Korostelev, YD; Zharov, IA; Mironov, AA; Rakhmaininova, AB; Gelfand, MS				Korostelev, Yuriy D.; Zharov, Ilya A.; Mironov, Andrey A.; Rakhmaininova, Alexandra B.; Gelfand, Mikhail S.			Identification of Position-Specific Correlations between DNA-Binding Domains and Their Binding Sites. Application to the MerR Family of Transcription Factors	PLOS ONE			English	Article							STRESS SENSOR SOXR; MUTUAL INFORMATION; CRYSTAL-STRUCTURE; DETERMINING RESIDUES; COMPARATIVE GENOMICS; STRUCTURAL-ANALYSIS; BACILLUS-SUBTILIS; NUCLEIC-ACIDS; PROTEIN; SEQUENCE	The large and increasing volume of genomic data analyzed by comparative methods provides information about transcription factors and their binding sites that, in turn, enables statistical analysis of correlations between factors and sites, uncovering mechanisms and evolution of specific protein-DNA recognition. Here we present an online tool, Prot-DNAKorr, designed to identify and analyze crucial protein-DNA pairs of positions in a family of transcription factors. Correlations are identified by analysis of mutual information between columns of protein and DNA alignments. The algorithm reduces the effects of common phylogenetic history and of abundance of closely related proteins and binding sites. We apply it to five closely related subfamilies of the MerR family of bacterial transcription factors that regulate heavy metal resistance systems. We validate the approach using known 3D structures of MerR-family proteins in complexes with their cognate DNA binding sites and demonstrate that a significant fraction of correlated positions indeed form specific side-chain-tobase contacts. The joint distribution of amino acids and nucleotides hence may be used to predict changes of specificity for point mutations in transcription factors.	[Korostelev, Yuriy D.; Zharov, Ilya A.; Mironov, Andrey A.; Rakhmaininova, Alexandra B.; Gelfand, Mikhail S.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, 19-1 Bolshoy Karetny Pereulok, Moscow 127994, Russia; [Korostelev, Yuriy D.; Mironov, Andrey A.; Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, 1-73 Vorobievy Gory, Moscow 119991, Russia	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Gelfand, MS (corresponding author), Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, 19-1 Bolshoy Karetny Pereulok, Moscow 127994, Russia.; Gelfand, MS (corresponding author), Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, 1-73 Vorobievy Gory, Moscow 119991, Russia.	gelfand@iitp.ru	Gelfand, Mikhail S/F-3425-2012	Gelfand, Mikhail/0000-0003-4181-0846	Russian Ministry of Science and Education grant [11.G34.31.0008]; Russian Science Foundation [14-24-00155]; Russian Ministry of Science and Education [11.G34.31.0008]	Russian Ministry of Science and Education grant; Russian Science Foundation(Russian Science Foundation (RSF)); Russian Ministry of Science and Education(Ministry of Education and Science, Russian Federation)	This work was supported by Russian Science Foundation (http//www.rscf.ru/en/), grant No 14-24-00155 (received by YDK, IAZ, MSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Georgii A. Bazykin for useful discussions. We also thank Prof. A.S. Kondrashov for sharing computational facilities provided under Russian Ministry of Science and Education grant [11.G34.31.0008].	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; AHMED M, 1995, J BACTERIOL, V177, P3904, DOI 10.1128/jb.177.14.3904-3910.1995; Bachas S, 2011, P NATL ACAD SCI USA, V108, P11046, DOI 10.1073/pnas.1104850108; Baker CM, 2007, BIOPOLYMERS, V85, P456, DOI 10.1002/bip.20682; Benos PV, 2002, BIOESSAYS, V24, P466, DOI 10.1002/bies.10073; Benos PV, 2002, J MOL BIOL, V323, P701, DOI 10.1016/S0022-2836(02)00917-8; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-42; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Berger Michael F., 2006, V338, P245; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; BUCCA G, 1995, MOL MICROBIOL, V17, P663, DOI 10.1111/j.1365-2958.1995.mmi_17040663.x; Camas FM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000989; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Chen PR, 2008, CURR OPIN CHEM BIOL, V12, P214, DOI 10.1016/j.cbpa.2007.12.010; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Contreras-Moreira B, 2010, NUCLEIC ACIDS RES, V38, pD91, DOI 10.1093/nar/gkp781; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Masi F, 2011, NUCLEIC ACIDS RES, V39, P4553, DOI 10.1093/nar/gkr070; Desai TA, 2009, NUCLEIC ACIDS RES, V37, P2493, DOI 10.1093/nar/gkp079; DESJARLAIS JR, 1993, P NATL ACAD SCI USA, V90, P2256, DOI 10.1073/pnas.90.6.2256; Diaz-Perez AL, 2004, APPL ENVIRON MICROB, V70, P5102, DOI 10.1128/AEM.70.9.5102-5110.2004; Donald JE, 2005, NUCLEIC ACIDS RES, V33, P4455, DOI 10.1093/nar/gki755; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fedonin GG, 2011, MOL BIOL+, V45, P667, DOI 10.1134/S0026893311040054; Fisher SH, 1999, MOL MICROBIOL, V32, P223, DOI 10.1046/j.1365-2958.1999.01333.x; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; GERSTEIN M, 1994, J MOL BIOL, V236, P1067, DOI 10.1016/0022-2836(94)90012-4; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Godsey MH, 2001, J BIOL CHEM, V276, P47178, DOI 10.1074/jbc.M105819200; Grau J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002962; Hall BM, 2005, J MOL BIOL, V350, P667, DOI 10.1016/j.jmb.2005.05.025; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hayashi T, 2013, BIOCHEM BIOPH RES CO, V435, P28, DOI 10.1016/j.bbrc.2013.04.017; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; Henikoff JG, 1996, METHOD ENZYMOL, V266, P88; Huang N, 2009, STRUCTURE, V17, P939, DOI 10.1016/j.str.2009.05.012; Huyen NTT, 2009, MOL MICROBIOL, V71, P876, DOI 10.1111/j.1365-2958.2008.06568.x; Jones S, 2003, NUCLEIC ACIDS RES, V31, P7189, DOI 10.1093/nar/gkg922; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Kazakov AE, 2007, NUCLEIC ACIDS RES, V35, pD407, DOI 10.1093/nar/gkl865; Kazakov AE, 2009, J BACTERIOL, V191, P52, DOI 10.1128/JB.01175-08; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Kidd SP, 2005, MOL MICROBIOL, V57, P1676, DOI 10.1111/j.1365-2958.2005.04773.x; Kirsanov DD, 2013, NUCLEIC ACIDS RES, V41, pD517, DOI 10.1093/nar/gks1199; Kumaraswami M, 2010, J MOL BIOL, V398, P264, DOI 10.1016/j.jmb.2010.03.011; Liu X, 2005, GENOME RES, V15, P421, DOI 10.1101/gr.3256505; Luscombe NM, 2000, GENOME BIOL, V1; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; MacArthur S, 2004, MOL BIOL EVOL, V21, P1064, DOI 10.1093/molbev/msh105; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mahony S, 2007, BIOINFORMATICS, V23, pI297, DOI 10.1093/bioinformatics/btm215; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mazin PV, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-29; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; McEwan AG, 2011, ADV MICROB PHYSIOL, V58, P1, DOI 10.1016/B978-0-12-381043-4.00001-5; Milk L, 2010, PROTEIN SCI, V19, P1162, DOI 10.1002/pro.389; Mirny LA, 2002, J MOL BIOL, V321, P7, DOI 10.1016/S0022-2836(02)00587-9; Mirny LA, 2002, NUCLEIC ACIDS RES, V30, P1704, DOI 10.1093/nar/30.7.1704; Mironov A. A., 2000, Molekulyarnaya Biologiya (Moscow), V34, P253; Morozov AV, 2007, P NATL ACAD SCI USA, V104, P7068, DOI 10.1073/pnas.0701356104; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nakagawa S, 2013, P NATL ACAD SCI USA, V110, P12349, DOI 10.1073/pnas.1310430110; Newberry KJ, 2008, J BIOL CHEM, V283, P26795, DOI 10.1074/jbc.M804191200; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Novichkov PS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-745; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Ogasawara H, 2010, FEMS MICROBIOL LETT, V312, P160, DOI 10.1111/j.1574-6968.2010.02112.x; OLIPHANT AR, 1989, MOL CELL BIOL, V9, P2944, DOI 10.1128/MCB.9.7.2944; Pabo CO, 2000, J MOL BIOL, V301, P597, DOI 10.1006/jmbi.2000.3918; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Perez-Marin MC, 2008, MOL MICROBIOL, V67, P804, DOI 10.1111/j.1365-2958.2007.06086.x; Perez-Quintero AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068464; Permina EA, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-49; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Ravcheev DA, 2012, J BACTERIOL, V194, P1145, DOI 10.1128/JB.06412-11; Rigali S, 2004, NUCLEIC ACIDS RES, V32, P3418, DOI 10.1093/nar/gkh673; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Sahota G, 2010, BIOINFORMATICS, V26, P2672, DOI 10.1093/bioinformatics/btq501; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; Sarai A, 2005, ANNU REV BIOPH BIOM, V34, P379, DOI 10.1146/annurev.biophys.34.040204.144537; Schumacher MA, 2015, GENE DEV, V29, P451, DOI 10.1101/gad.254714.114; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Sera T, 2009, ADV DRUG DELIVER REV, V61, P513, DOI 10.1016/j.addr.2009.03.012; Shackelford G, 2007, PROTEINS, V69, P159, DOI 10.1002/prot.21791; Siggers TW, 2005, J MOL BIOL, V345, P1027, DOI 10.1016/j.jmb.2004.11.010; Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x; Summers AO, 2009, CURR OPIN MICROBIOL, V12, P138, DOI 10.1016/j.mib.2009.02.003; SUZUKI M, 1995, PROTEIN ENG, V8, P319, DOI 10.1093/protein/8.4.319; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tungtur S, 2011, PROTEINS, V79, P1589, DOI 10.1002/prot.22985; Tungtur S, 2010, J MOL BIOL, V395, P785, DOI 10.1016/j.jmb.2009.10.001; van Bakel H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1144; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105; Watanabe S, 2006, ACTA CRYSTALLOGR F, V62, P1275, DOI 10.1107/S1744309106048482; Woolridge DP, 1999, BIOCHEM J, V340, P753, DOI 10.1042/0264-6021:3400753; WU H, 1995, P NATL ACAD SCI USA, V92, P344, DOI 10.1073/pnas.92.2.344; Yan CH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-262; Yang S, 2011, BIOINFORMATICS, V27, P2972, DOI 10.1093/bioinformatics/btr503; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zharov IA, 2011, MOL BIOL+, V45, P658, DOI 10.1134/S002689331103023X; Zomer A, 2009, J BACTERIOL, V191, P7039, DOI 10.1128/JB.00897-09	108	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0162681	10.1371/journal.pone.0162681	http://dx.doi.org/10.1371/journal.pone.0162681			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690309	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200004
J	Ranjitkar, S; Sujakhu, NM; Merz, J; Kindt, R; Xu, JC; Matin, MA; Ali, M; Zomer, RJ				Ranjitkar, Sailesh; Sujakhu, Nani M.; Merz, Juerg; Kindt, Roeland; Xu, Jianchu; Matin, Mir A.; Ali, Mostafa; Zomer, Robert J.			Suitability Analysis and Projected Climate Change Impact on Banana and Coffee Production Zones in Nepal	PLOS ONE			English	Article							AGRICULTURE; FUTURE; BIODIVERSITY; SYSTEMS; YUNNAN; SHIFTS; MAIZE	The Government of Nepal has identified opportunities in agricultural commercialization, responding to a growing internal demand and expansion of export markets to reduce the immense trade deficit. Several cash crops, including coffee and bananas, have been identified in the recently approved Agriculture Development Strategy. Both of these crops have encouraged smallholder farmers to convert their subsistence farming practices to more commercial cultivation. Identification of suitable agro-ecological zones and understanding climate-related issues are important for improved production and livelihoods of smallholder farmers. Here, the suitability of coffee and banana crops is analyzed for different agro-ecological zones represented by Global Environmental Stratification (GEnS). Future shifts in these suitability zones are also predicted. Plantation sites in Nepal were geo-referenced and used as input in species distribution modelling. The multi-model ensemble model suggests that climate change will reduce the suitable growing area for coffee by about 72% across the selected emission scenarios from now to 2050. Impacts are low for banana growing, with a reduction in suitability by about 16% by 2050. Bananas show a lot of potential for playing an important role in Nepal as a sustainable crop in the context of climate change, as this study indicates that the amount of area suited to banana growing will grow by 40% by 2050. Based on our analysis we recommend possible new locations for coffee plantations and one method for mitigating climate change-related problems on existing plantations. These findings are expected to support planning and policy dialogue for mitigation and support better informed and scientifically based decision-making relating to these two crops.	[Ranjitkar, Sailesh; Sujakhu, Nani M.; Xu, Jianchu; Zomer, Robert J.] Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650201, Peoples R China; [Ranjitkar, Sailesh; Xu, Jianchu; Zomer, Robert J.] World Agroforestry Ctr East & Cent Asia, Kunming 650201, Peoples R China; [Merz, Juerg] HELVETAS Swiss Intercooperat, Lalitpur 44700, Nepal; [Kindt, Roeland] World Agroforestry Ctr, United Nations Ave,Gigiri 30677, Nairobi 00100, Kenya; [Matin, Mir A.; Ali, Mostafa] Int Ctr Integrated Mt Dev, Lalitpur 44700, Nepal	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; CGIAR; World Agroforestry (ICRAF)	Ranjitkar, S (corresponding author), Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650201, Peoples R China.; Ranjitkar, S (corresponding author), World Agroforestry Ctr East & Cent Asia, Kunming 650201, Peoples R China.	sailesh.ranjitkar@gmail.com	Xu, Jianchu/Y-2890-2019; Ranjitkar, Sailesh/I-9307-2014; Zomer, Robert/AGZ-2675-2022; Kindt, Roeland/AAV-3346-2020	Ranjitkar, Sailesh/0000-0002-4741-3975; Zomer, Robert/0000-0002-2259-3359; Kindt, Roeland/0000-0002-7672-0712	SERVIR Himalayas small grant project "Spatial Modeling of Climate Change Impacts on Two Major Cash Crops in Nepal", International Centre for Integrated Mountain Development; IDRC project, International Development Research Centre [107085-002]; NSFC project, National Science Foundation China, JX [31270524]; CGIAR research program "Forests, Trees and Agroforestry" on technical aspects of the research [CRP6]	SERVIR Himalayas small grant project "Spatial Modeling of Climate Change Impacts on Two Major Cash Crops in Nepal", International Centre for Integrated Mountain Development; IDRC project, International Development Research Centre; NSFC project, National Science Foundation China, JX; CGIAR research program "Forests, Trees and Agroforestry" on technical aspects of the research(CGIAR)	This work was supported by SERVIR Himalayas small grant project "Spatial Modeling of Climate Change Impacts on Two Major Cash Crops in Nepal", International Centre for Integrated Mountain Development (http://www.icimod.org/?q=15157); IDRC project number: 107085-002, International Development Research Centre; and NSFC project number: 31270524, National Science Foundation China, JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support from the CGIAR research program "Forests, Trees and Agroforestry" (CRP6) on technical aspects of the research. We would like to thank the Kala Budha Magar, Saraswati Rimal, Santosh Rana, and the Elam and the Coffee Promotion Program team, HELVETAS Nepal for providing crop plantation data, and Andrew Stevenson for English editing.	Alexander P, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0656; Bellamy AS, 2013, AMBIO, V42, P334, DOI 10.1007/s13280-012-0341-y; Bunn C, 2015, CLIMATIC CHANGE, V129, P89, DOI 10.1007/s10584-014-1306-x; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; de Jesus WC, 2008, SCI AGR, V65, P40, DOI 10.1590/S0103-90162008000700008; Descroix F., 2008, COFFEE GROWING PROCE, P164, DOI DOI 10.1002/9783527619627.CH6; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fischer G, 2005, PHILOS T R SOC B, V360, P2067, DOI 10.1098/rstb.2005.1744; Fukuda S, 2013, ENVIRON MODELL SOFTW, V47, P1, DOI 10.1016/j.envsoft.2013.04.005; Fuller D. Q., 2009, ETHNOBOTANY RES APPL, V7, P333, DOI DOI 10.17348/ERA.7.0.333-351; GoN/MFSC, 2002, NEP BIOD STRAT; Government of Nepal, 2015, AGR DEV STRAT 2015 2; Hijioka Y, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1327; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Howden SM, 2007, P NATL ACAD SCI USA, V104, P19691, DOI 10.1073/pnas.0701890104; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Iglesias A, 2011, EUR REV AGRIC ECON, V38, P427, DOI 10.1093/erae/jbr037; Iizumi T, 2015, GLOB FOOD SECUR-AGR, V4, P46, DOI 10.1016/j.gfs.2014.11.003; Jassogne L., 2013, IMPACT CLIMATE CHANG; Jones PG, 2003, GLOBAL ENVIRON CHANG, V13, P51, DOI 10.1016/S0959-3780(02)00090-0; Kindt R., 2014, GUI BIODIVERSITY SUI; Krishnamurthy P.K., 2013, 48 CCAFS CGIAR RES P; Luedeling E, 2014, CURR OPIN ENV SUST, V6, P1, DOI 10.1016/j.cosust.2013.07.013; Machovina B, 2013, ECOL ECON, V95, P83, DOI 10.1016/j.ecolecon.2013.08.004; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Mbogga MS, 2010, J APPL ECOL, V47, P731, DOI 10.1111/j.1365-2664.2010.01830.x; Mbow C, 2014, CURR OPIN ENV SUST, V6, P8, DOI 10.1016/j.cosust.2013.09.002; Metzger MJ, 2013, GLOBAL ECOL BIOGEOGR, V22, P630, DOI 10.1111/geb.12022; MOAD, 2012, VAL CHAIN DEV PLAN O; MoAD NTCDB HELVETAS, 2014, COFF DAT NEP; MoALD, 2014, STAT INF NEP AGR 201; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Nelson G.C., 2009, CLIMATE CHANGE IMPAC, DOI [DOI 10.2499/0896295354, 10.2499/0896295354]; Nelson S.C, 2006, MUSA SPECIES BANANA; Pawson SM, 2013, BIODIVERS CONSERV, V22, P1203, DOI 10.1007/s10531-013-0458-8; Poudel S, 2013, CLIMATIC CHANGE, V116, P327, DOI 10.1007/s10584-012-0491-8; Nguyen Q, 2013, CLIMATIC CHANGE, V117, P241, DOI 10.1007/s10584-012-0550-1; Ranjitkar S, 2015, PROJECTED CLIMATIC C; Ranjitkar S, 2014, GLOB ECOL CONSERV, V1, P2, DOI 10.1016/j.gecco.2014.07.001; Ranjitkar S, 2016, ENVIRON MODELL SOFTW, V75, P263, DOI 10.1016/j.envsoft.2015.10.027; Ranjitkar S, 2014, ECOL MODEL, V282, P18, DOI 10.1016/j.ecolmodel.2014.03.003; Rao M. Srinivasa, 2012, Journal of Insect Science (Tucson), V12, P1; Rogerson PA, 2001, STAT METHODS GEOGRAP, DOI [10.1890/11-0826.1, DOI 10.1890/11-0826.1]; Rogerson PeterA, 2001, STAT METHODS GEOGRAP; Roudier P, 2011, GLOBAL ENVIRON CHANG, V21, P1073, DOI 10.1016/j.gloenvcha.2011.04.007; Seo SN, 2008, ECOL ECON, V67, P109, DOI 10.1016/j.ecolecon.2007.12.007; Shrestha TB, 2010, INITIAT, V2, P1, DOI [10.3126/init.v2i1.2512, DOI 10.3126/INIT.V2I1.2512]; Smit B., 2002, Mitigation and Adaptation Strategies for Global Change, V7, P85, DOI 10.1023/A:1015862228270; Stearn W.T., 1960, B BRIT MUS NAT HIST, V2, P161; Sujakhu NM, 2016, MT RES DEV, V36, P15, DOI 10.1659/MRD-JOURNAL-D-15-00032.1; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tubiello FN, 2002, CLIM RES, V20, P259, DOI 10.3354/cr020259; Uddin K, 2015, J ENVIRON MANAGE, V148, P82, DOI 10.1016/j.jenvman.2014.07.047; van Asten PJA, 2011, AGR SYST, V104, P326, DOI 10.1016/j.agsy.2010.12.004; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Vij S, 2007, PLANT BIOTECHNOL J, V5, P361, DOI 10.1111/j.1467-7652.2007.00239.x; White MA, 2006, P NATL ACAD SCI USA, V103, P11217, DOI 10.1073/pnas.0603230103; Zomer RJ, 2015, ICRAF WORKING PAPER, P50; Zomer RJ, 2014, CLIMATIC CHANGE, V125, P445, DOI 10.1007/s10584-014-1176-2; Zomer RJ, 2014, BIOL CONSERV, V170, P264, DOI 10.1016/j.biocon.2013.11.028	62	39	39	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163916	10.1371/journal.pone.0163916	http://dx.doi.org/10.1371/journal.pone.0163916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DX4CZ	27689354	Green Submitted, gold, Green Published			2022-12-27	WOS:000384329200034
J	Augustin, M; Fialova, S; Himmel, T; Gloesmann, M; Lengheimer, T; Harper, DJ; Plasenzotti, R; Pircher, M; Hitzenberger, CK; Baumann, B				Augustin, Marco; Fialova, Stanislava; Himmel, Tanja; Gloesmann, Martin; Lengheimer, Theresia; Harper, Danielle J.; Plasenzotti, Roberto; Pircher, Michael; Hitzenberger, Christoph K.; Baumann, Bernhard			Multi-Functional OCT Enables Longitudinal Study of Retinal Changes in a VLDLR Knockout Mouse Model	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MACULAR DEGENERATION; SUBRETINAL NEOVASCULARIZATION; CHOROIDAL NEOVASCULARIZATION; ANGIOMATOUS PROLIFERATION; ANIMAL-MODEL; BLOOD-FLOW; HIGH-SPEED; HUMAN EYE; ANGIOGRAPHY	We present a multi-functional optical coherence tomography (OCT) imaging approach to study retinal changes in the very-low-density-lipoprotein-receptor (VLDLR) knockout mouse model with a threefold contrast. In the retinas of VLDLR knockout mice spontaneous retinal-chorodoidal neovascularizations form, having an appearance similar to choroidal and retinal neovascularizations (CNV and RNV) in neovascular age-related macular degeneration (AMD) or retinal angiomatous proliferation (RAP). For this longitudinal study, the mice were imaged every 4 to 6 weeks starting with an age of 4 weeks and following up to the age of 11 months. Significant retinal changes were identified by the multi-functional imaging approach offering a threefold contrast: reflectivity, polarization sensitivity (PS) and motion contrast based OCT angiography (OCTA). By use of this intrinsic contrast, the long-term development of neovascularizations was studied and associated processes, such as the migration of melanin pigments or retinal-choroidal anastomosis, were assessed in vivo. Furthermore, the in vivo imaging results were validated with histological sections at the endpoint of the experiment. Multi-functional OCT proves as a powerful tool for longitudinal retinal studies in preclinical research of ophthalmic diseases. Intrinsic contrast offered by the functional extensions of OCT might help to describe regulative processes in genetic animal models and potentially deepen the understanding of the pathogenesis of retinal diseases such as wet AMD.	[Augustin, Marco; Fialova, Stanislava; Harper, Danielle J.; Pircher, Michael; Hitzenberger, Christoph K.; Baumann, Bernhard] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Himmel, Tanja; Gloesmann, Martin] Univ Vet Med Vienna, Core Facil Res & Technol, Vienna, Austria; [Lengheimer, Theresia; Plasenzotti, Roberto] Med Univ Vienna, Div Biomed Res, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; Medical University of Vienna	Augustin, M (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.	marco.augustin@meduniwien.ac.at	Glösmann, Martin/F-9349-2019; plasenzotti, roberto/AAE-5049-2020; Himmel, Tanja/Q-2139-2019	Glösmann, Martin/0000-0002-2094-3247; plasenzotti, roberto/0000-0001-7652-1249; Himmel, Tanja/0000-0001-9443-8967; Harper, Danielle J./0000-0003-2768-3684; Hitzenberger, Christoph/0000-0002-6608-8821; Augustin, Marco/0000-0002-1019-0907; Michael, Pircher/0000-0001-9285-7527; Baumann, Bernhard/0000-0001-6419-1932	Austrian Science Fund (FWF) [P25823-B24]; European Research Council [ERC StG 640396 OPTIMALZ]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission)	This work was funded by the Austrian Science Fund (FWF grant P25823-B24 to BB; https://www.fwf.ac.at/) and the European Research Council (ERC StG 640396 OPTIMALZ to BB; https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Baumann B, 2015, INVEST OPHTH VIS SCI, V56, P7462, DOI 10.1167/iovs.15-17742; Bouhenni RA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/692609; Chen SY, 2015, BIOMED OPT EXPRESS, V6, P2840, DOI 10.1364/BOE.6.002840; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Choi W, 2012, BIOMED OPT EXPRESS, V3, P1047, DOI 10.1364/BOE.3.001047; Chou TH, 2011, INVEST OPHTH VIS SCI, V52, P3604, DOI 10.1167/iovs.10-6340; de Boer JF, 1999, OPT LETT, V24, P300, DOI 10.1364/OL.24.000300; de Carlo TE, 2015, OPHTHALMOLOGY, V122, P1228, DOI 10.1016/j.ophtha.2015.01.029; deBoer JF, 1997, OPT LETT, V22, P934, DOI 10.1364/OL.22.000934; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Fialova S, 2016, BIOMED OPT EXPRESS, V7, P1479, DOI 10.1364/BOE.7.001479; Gotzinger E, 2011, OPT EXPRESS, V19, P14568, DOI 10.1364/OE.19.014568; Gotzinger E, 2008, OPT EXPRESS, V16, P16410, DOI 10.1364/OE.16.016410; Gorczynska I, 2016, BIOMED OPT EXPRESS, V7, P911, DOI 10.1364/BOE.7.000911; Grossniklaus HE, 2010, PROG RETIN EYE RES, V29, P500, DOI 10.1016/j.preteyeres.2010.05.003; Hariri S, 2012, INVEST OPHTH VIS SCI, V53, P1982, DOI 10.1167/iovs.11-8395; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; HEE MR, 1992, J OPT SOC AM B, V9, P903, DOI 10.1364/JOSAB.9.000903; Hitzenberger CK, 2001, OPT EXPRESS, V9, P780, DOI 10.1364/OE.9.000780; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Hua J, 2011, INVEST OPHTH VIS SCI, V52, P2809, DOI 10.1167/iovs.10-6496; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Izatt JA, 1997, OPT LETT, V22, P1439, DOI 10.1364/OL.22.001439; Jia YL, 2014, OPHTHALMOLOGY, V121, P1435, DOI 10.1016/j.ophtha.2014.01.034; Johnson V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132013; Kennedy BF, 2011, OPT EXPRESS, V19, P6623, DOI 10.1364/OE.19.006623; Kim J, 2015, BIOCHEM BIOPH RES CO, V456, P53, DOI 10.1016/j.bbrc.2014.11.033; Lai AKW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/106594; Leahy C, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.2.020502; Leitgeb RA, 2014, PROG RETIN EYE RES, V41, P26, DOI 10.1016/j.preteyeres.2014.03.004; Li C, 2007, ARCH OPHTHALMOL-CHIC, V125, P795, DOI 10.1001/archopht.125.6.795; Liu WZ, 2015, OPT LETT, V40, P5782, DOI 10.1364/OL.40.005782; Makita S, 2006, OPT EXPRESS, V14, P7821, DOI 10.1364/OE.14.007821; Mazzanti ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021607; Moreno MC, 2005, EXP EYE RES, V81, P71, DOI 10.1016/j.exer.2005.01.008; Pircher M, 2011, PROG RETIN EYE RES, V30, P431, DOI 10.1016/j.preteyeres.2011.06.003; Rakoczy PE, 2006, EXP EYE RES, V82, P741, DOI 10.1016/j.exer.2005.10.012; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Russell W. M. S, 1959, THE PRINCIPLES OF HU; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Soetikno BT, 2015, SCI REP-UK, V5, DOI 10.1038/srep16752; Srinivasan PP, 2014, BIOMED OPT EXPRESS, V5, P348, DOI 10.1364/BOE.5.000348; Srinivasan VJ, 2006, INVEST OPHTH VIS SCI, V47, P5522, DOI 10.1167/iovs.06-0195; Sugita M, 2015, BIOMED OPT EXPRESS, V6, P1030, DOI 10.1364/BOE.6.001030; Weinreb RN, 2005, J GLAUCOMA, V14, P302, DOI 10.1097/01.ijg.0000169395.47921.02; Westenskow PD, 2013, J CLIN INVEST, V123, P4900, DOI 10.1172/JCI70230; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yi J, 2013, OPT LETT, V38, P1796, DOI 10.1364/OL.38.001796; Zhang AQ, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.10.100901; Zhi ZW, 2014, INVEST OPHTH VIS SCI, V55, P1024, DOI 10.1167/iovs.13-12864; Zhi ZW, 2011, BIOMED OPT EXPRESS, V2, P579, DOI 10.1364/BOE.2.000579	52	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164419	10.1371/journal.pone.0164419	http://dx.doi.org/10.1371/journal.pone.0164419			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711217	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697600126
J	Busan, P; Del Ben, G; Bernardini, S; Natarelli, G; Bencich, M; Monti, F; Manganotti, P; Battaglini, PP				Busan, Pierpaolo; Del Ben, Giovanni; Bernardini, Simona; Natarelli, Giulia; Bencich, Marco; Monti, Fabrizio; Manganotti, Paolo; Battaglini, Piero Paolo			Altered Modulation of Silent Period in Tongue Motor Cortex of Persistent Developmental Stuttering in Relation to Stuttering Severity	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; BASAL GANGLIA ACTIVITY; FRONTAL ASLANT TRACT; FUNCTIONAL CONNECTIVITY; CORTICAL EXCITABILITY; SYLLABLE PRODUCTION; STATISTICAL POWER; FLUENT SPEECH; ADULTS; INHIBITION	Motor balance in developmental stuttering (DS) was investigated with Transcranial Magnetic Stimulation (TMS), with the aim to define novel neural markers of persistent DS in adulthood. Eleven DS adult males were evaluated with TMS on tongue primary motor cortex, compared to 15 matched fluent speakers, in a "state" condition (i.e. stutterers vs. fluent speakers, no overt stuttering). Motor and silent period thresholds (SPT), recruitment curves, and silent period durations were acquired by recording tongue motor evoked potentials. Tongue silent period duration was increased in DS, especially in the left hemisphere (P< 0.05; Hedge's g or Cohen's d(unbiased) = 1.054, i.e. large effect size), suggesting a state condition of higher intracortical inhibition in left motor cortex networks. Differences in motor thresholds (different excitatory/inhibitory ratios in DS) were evident, as well as significant differences in SPT. In fluent speakers, the left hemisphere may be marginally more excitable than the right one in motor thresholds at lower muscular activation, while active motor thresholds and SPT were higher in the left hemisphere of DS with respect to the right one, resulting also in a positive correlation with stuttering severity. Pre-TMS electromyography data gave overlapping evidence. Findings suggest the existence of a complex intracortical balance in DS tongue primary motor cortex, with a particular interplay between excitatory and inhibitory mechanisms, also in neural substrates related to silent periods. Findings are discussed with respect to functional and structural impairments in stuttering, and are also proposed as novel neural markers of a stuttering "state" in persistent DS, helping to define more focused treatments (e.g. neuro-modulation).	[Busan, Pierpaolo] IRCCS Fdn Osped San Camillo, Venice, Italy; [Del Ben, Giovanni; Bencich, Marco; Battaglini, Piero Paolo] Univ Trieste, Dept Life Sci, BRAIN Ctr Neurosci, Trieste, Italy; [Bernardini, Simona] ABC Balbuzie, Turin, Italy; [Natarelli, Giulia] Univ Padua, Dept Dev & Social Psychol, Padua, Italy; [Monti, Fabrizio; Manganotti, Paolo] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy	IRCCS Ospedale San Camillo; University of Trieste; University of Padua; University of Trieste	Busan, P (corresponding author), IRCCS Fdn Osped San Camillo, Venice, Italy.	pbusan@units.it	Manganotti, Paolo/L-1763-2018	Manganotti, Paolo/0000-0001-5305-6268; DEL BEN, GIOVANNI/0000-0002-6082-1332; Battaglini, Piero Paolo/0000-0003-4697-8648	Beneficentia Stiftung; Vaduz; Liechtenstein	Beneficentia Stiftung; Vaduz; Liechtenstein	Funding was provided by Beneficentia Stiftung,Vaduz, Liechtenstein (no grant number and/or website available) to PB. ABC Balbuzie is a commercial affiliation, and it provided support in the form of salaries for author SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm PA, 2004, J COMMUN DISORD, V37, P325, DOI 10.1016/j.jcomdis.2004.03.001; Alm PA, 2007, J COMMUN DISORD, V40, P1, DOI 10.1016/j.jcomdis.2006.04.001; Alm PA, 2014, J FLUENCY DISORD, V40, P5, DOI 10.1016/j.jfludis.2014.01.004; Alm PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076824; Barwood C. H. S., 2013, SPEECH LANGUAGE HEAR, V16, P18, DOI DOI 10.1179/2050571X12Z.0000000001; Beck AT., 1996, MANUAL BECK DEPRESSI; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berardelli A, 1996, BRAIN, V119, P71, DOI 10.1093/brain/119.1.71; Bleek B, 2011, J COMMUN DISORD, V44, P218, DOI 10.1016/j.jcomdis.2010.11.001; Bloodstein O., 2008, HDB STUTTERING; Boldrini M, 2003, INT J NEUROPSYCHOPH, V6, P311, DOI 10.1017/S1461145703003584; Borenstein M., 2009, HDB RES SYNTHESIS ME, VVolume 2, P221, DOI DOI 10.7758/9781610441384; Borenstein M., 2009, INTRO METAANALYSIS; Bosshardt HG, 2002, J FLUENCY DISORD, V27, P93, DOI 10.1016/S0094-730X(02)00113-4; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Brown S, 2005, HUM BRAIN MAPP, V25, P105, DOI 10.1002/hbm.20140; Budde KS, 2014, BRAIN LANG, V139, P99, DOI 10.1016/j.bandl.2014.10.002; Busan P, 2013, CORTEX, V49, P781, DOI 10.1016/j.cortex.2011.12.002; Busan P, 2009, CLIN NEUROPHARMACOL, V32, P183, DOI 10.1097/WNF.0b013e31819817eb; Butler JE, 2012, CLIN NEUROPHYSIOL, V123, P1409, DOI 10.1016/j.clinph.2011.11.034; Cai S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00054; Cantello R, 2002, BRAIN RES REV, V38, P309, DOI 10.1016/S0165-0173(01)00158-8; Chang SE, 2008, NEUROIMAGE, V39, P1333, DOI 10.1016/j.neuroimage.2007.09.067; Chang SE, 2015, BRAIN, V138, P694, DOI 10.1093/brain/awu400; Chang SE, 2013, BRAIN, V136, P3709, DOI 10.1093/brain/awt275; Chang SE, 2011, CEREB CORTEX, V21, P2507, DOI 10.1093/cercor/bhr028; Chang SE, 2009, NEUROIMAGE, V46, P201, DOI 10.1016/j.neuroimage.2009.01.066; Civier O, 2015, BRAIN LANG, V143, P20, DOI 10.1016/j.bandl.2015.01.012; Classen J, 1997, BRAIN, V120, P605, DOI 10.1093/brain/120.4.605; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craig A, 2009, J FLUENCY DISORD, V34, P61, DOI 10.1016/j.jfludis.2009.05.002; Craig-McQuaide A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00884; Curra A, 2000, NEUROLOGY, V54, P130, DOI 10.1212/WNL.54.1.130; Cykowski MD, 2010, NEUROIMAGE, V52, P1495, DOI 10.1016/j.neuroimage.2010.05.011; D'Ausilio A, 2011, NEUROPSYCHOLOGIA, V49, P3670, DOI 10.1016/j.neuropsychologia.2011.09.022; Daliri A, 2014, J SPEECH LANG HEAR R, V57, P2131, DOI 10.1044/2014_JSLHR-S-13-0333; Daliri A, 2013, J SPEECH LANG HEAR R, V56, P1774, DOI 10.1044/1092-4388(2013/12-0134); Davis S, 2007, J COMMUN DISORD, V40, P398, DOI 10.1016/j.jcomdis.2006.10.003; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Espay AJ, 2006, ANN NEUROL, V59, P825, DOI 10.1002/ana.20837; Etchell AC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00467; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Farzan F, 2013, NEUROIMAGE, V83, P120, DOI 10.1016/j.neuroimage.2013.06.059; Fisher SE, 2010, NEW ENGL J MED, V362, P750, DOI 10.1056/NEJMe0912594; Forster DC, 2001, DEV NEUROPSYCHOL, V19, P125, DOI 10.1207/S15326942DN1902_1; Fox PT, 2000, BRAIN, V123, P1985, DOI 10.1093/brain/123.10.1985; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Giraud AL, 2008, BRAIN LANG, V104, P190, DOI 10.1016/j.bandl.2007.04.005; Glass G. V., 1981, METAANALYSIS SOCIAL; Hallett M., 2005, MAGNETIC STIMULATION, V2nd; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Ingham RJ, 2004, J SPEECH LANG HEAR R, V47, P321, DOI 10.1044/1092-4388(2004/026); Ingham RJ, 2012, BRAIN LANG, V122, P11, DOI 10.1016/j.bandl.2012.04.002; Inghilleri M, 2004, CLIN NEUROPHYSIOL, V115, P1063, DOI 10.1016/j.clinph.2003.12.003; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; Iverach L, 2010, J COMMUN DISORD, V43, P120, DOI 10.1016/j.jcomdis.2009.12.001; Jancke L, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-23; Jones M, 2002, J SPEECH LANG HEAR R, V45, P243, DOI 10.1044/1092-4388(2002/019); Kallioniemi E, 2014, CLIN NEUROPHYSIOL, V125, P2247, DOI 10.1016/j.clinph.2014.03.012; Kang C, 2010, NEW ENGL J MED, V362, P677, DOI 10.1056/NEJMoa0902630; Kell CA, 2009, BRAIN, V132, P2747, DOI 10.1093/brain/awp185; KELLY EM, 1995, J SPEECH HEAR RES, V38, P1025, DOI 10.1044/jshr.3805.1025; Kemerdere R, 2016, J NEUROL, V263, P157, DOI 10.1007/s00415-015-7949-3; Khedr EM, 2006, NEUROPHYSIOL CLIN, V36, P13, DOI 10.1016/j.neucli.2006.01.007; Kinoshita M, 2015, BRAIN STRUCT FUNCT, V220, P3399, DOI 10.1007/s00429-014-0863-0; Kronfeld-Duenias V, 2016, BRAIN STRUCT FUNCT, V221, P365, DOI 10.1007/s00429-014-0912-8; Kumar A, 2007, CLIN NEUROPHARMACOL, V30, P58, DOI 10.1097/01.WNF.0000240950.18821.19; Lang N, 2008, NEUROPSYCHOPHARMACOL, V33, P2517, DOI 10.1038/sj.npp.1301645; Lo YL, 2005, J CLIN NEUROPHYSIOL, V22, P176; Lu CM, 2010, CORTEX, V46, P49, DOI 10.1016/j.cortex.2009.02.017; Maguire GA, 2000, J CLIN PSYCHOPHARM, V20, P479, DOI 10.1097/00004714-200008000-00013; Maguire G, 2010, J CLIN PSYCHOPHARM, V30, P48, DOI 10.1097/JCP.0b013e3181caebbe; Maguire Gerald A, 2004, Ann Clin Psychiatry, V16, P63, DOI 10.1080/10401230490452834; Max L, 2005, J SPEECH LANG HEAR R, V48, P524, DOI 10.1044/1092-4388(2005/036); McDonald J.H, 2014, HDB BIOL STAT, V3rd; McGregor KM, 2011, BEHAV BRAIN RES, V222, P158, DOI 10.1016/j.bbr.2011.03.042; Mulligan HF, 2003, PARKINSONISM RELAT D, V9, P281, DOI 10.1016/S1353-8020(03)00002-6; Murdoch BE, 2013, SPEECH LANG HEAR, V16, P56, DOI [10.1179/2050571X13Z.0000000009, DOI 10.1179/2050571X13Z.0000000009]; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Narayana S, 2012, NEUROIMAGE, V62, P250, DOI 10.1016/j.neuroimage.2012.04.060; Neef NE, 2011, CLIN NEUROPHYSIOL, V122, P1802, DOI 10.1016/j.clinph.2011.02.003; Neef NE, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0579-4; Neef NE, 2015, BRAIN, V138, P712, DOI 10.1093/brain/awu390; Neef NE, 2011, CORTEX, V47, P945, DOI 10.1016/j.cortex.2010.06.007; Neumann K, 2003, J FLUENCY DISORD, V28, P381, DOI 10.1016/j.jfludis.2003.07.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orth M, 2009, J PSYCHOSOM RES, V67, P591, DOI 10.1016/j.jpsychores.2009.07.014; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Poston B, 2012, EUR J NEUROSCI, V36, P2964, DOI 10.1111/j.1460-9568.2012.08212.x; POULOS MG, 1991, J SPEECH HEAR RES, V34, P5, DOI 10.1044/jshr.3401.05; Preibisch C, 2003, NEUROIMAGE, V20, P1356, DOI 10.1016/S1053-8119(03)00376-8; RIDDING MC, 1995, J NEUROL NEUROSUR PS, V59, P493, DOI 10.1136/jnnp.59.5.493; Riley G., 2009, STUTTERING SEVERITY, V4th; Rogic Vidakovic M, 2015, C BRAIN STIM 1 INT B, V8, P317; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Saisanen L, 2008, J NEUROSCI METH, V169, P231, DOI 10.1016/j.jneumeth.2007.12.005; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; Smits-Bandstra S, 2007, J FLUENCY DISORD, V32, P251, DOI 10.1016/j.jfludis.2007.06.001; Sommer M, 2003, MOVEMENT DISORD, V18, P826, DOI 10.1002/mds.10443; Sommer M, 2002, LANCET, V360, P380, DOI 10.1016/S0140-6736(02)09610-1; Sommer M, 2009, MOVEMENT DISORD, V24, P769, DOI 10.1002/mds.22383; Suresh R, 2006, AM J HUM GENET, V78, P554, DOI 10.1086/501370; Tavano A, 2011, J CLIN PSYCHOPHARM, V31, P131, DOI 10.1097/JCP.0b013e318205694f; Toyomura A, 2015, NEUROIMAGE, V109, P458, DOI 10.1016/j.neuroimage.2015.01.024; Toyomura A, 2011, NEUROIMAGE, V57, P1507, DOI 10.1016/j.neuroimage.2011.05.039; Vanryckeghem M, 2012, J COMMUN DISORD, V45, P340, DOI 10.1016/j.jcomdis.2012.06.001; Vidakovic MR, 2016, COGN PROCESS, V17, P429, DOI 10.1007/s10339-016-0766-5; Walsh B, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9123-8; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; WEBSTER WG, 1990, J MOTOR BEHAV, V22, P553; West B. T., 2014, LINEAR MIXED MODELS; Wu JC, 1997, NEUROREPORT, V8, P767, DOI 10.1097/00001756-199702100-00037; WU JC, 1995, NEUROREPORT, V6, P501, DOI 10.1097/00001756-199502000-00024; Wymbs NF, 2013, BRAIN LANG, V124, P153, DOI 10.1016/j.bandl.2012.11.013; Xuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030570; Ziemann U, 1997, ELECTROMYOGR MOTOR C, V105, P430, DOI 10.1016/S0924-980X(97)00050-7; Zlatar ZZ, 2013, J INT NEUROPSYCH SOC, V19, P625, DOI 10.1017/S1355617713000246; Zotti A.M., 1997, CBA 2 0 COGNITIVE BE	121	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163959	10.1371/journal.pone.0163959	http://dx.doi.org/10.1371/journal.pone.0163959			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711148	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600054
J	Campos, NG; Sharma, M; Clark, A; Kim, JJ; Resch, SC				Campos, Nicole G.; Sharma, Monisha; Clark, Andrew; Kim, Jane J.; Resch, Stephen C.			Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; SUB-SAHARAN AFRICA; MODEL-BASED IMPACT; COST-EFFECTIVENESS; HPV-18 VACCINATION; VISUAL INSPECTION; ECONOMIC-IMPACT; POSITIVE WOMEN; RURAL INDIA; ACETIC-ACID	Background Cervical cancer is the fourth leading cause of cancer death in women, with 85% of cases and deaths occurring in developing countries. While organized screening programs have reduced cervical cancer incidence in high-income countries through detection and treatment of precancerous lesions, the implementation of organized screening has not been effective in low-resource settings due to lack of infrastructure and limited budgets. Our objective was to estimate the cost of comprehensive primary and secondary cervical cancer prevention in low-and middle-income countries. Methods and Findings We performed a modeling analysis to estimate 1) for girls aged 10 years, the cost of 2-dose human papillomavirus (HPV) vaccination; and 2) for women aged 30 to 49 years, the cost of cervical cancer screening (with visual inspection with acetic acid (VIA), HPV testing, or cytology) and preventive treatment in 102 low-and middle-income countries from 2015 to 2024. We used an Excel-based costing and service utilization model to estimate financial costs (2013 US$) based on prevalence of HPV, prevalence of precancerous lesions, and screening test performance. Where epidemiologic data were unavailable, we extrapolated from settings with data using an individual-based microsimulation model of cervical carcinogenesis (calibrated to 20 settings) and multivariate regression. Total HPV vaccination costs ranged from US$8.6 billion to US$24.2 billion for all scenarios considered (immediate, 5-year, or 10-year roll-out; price per dose US$4.55-US$70 by country income level). The total cost of screening and preventive treatment ranged from US$5.1 billion (10-year roll-out, screening once at age 35 years) to US$42.3 billion (immediate roll-out, high intensity screening). Limitations of this analysis include the assumption of standardized protocols by country income level that did not account for the potential presence of multiple screening modalities or management strategies within a country, and extrapolation of cost and epidemiologic data to settings where data were limited. Conclusions The estimated cost of comprehensive cervical cancer prevention with 2-dose HPV vaccination of 10-year-old girls and screening of women aged 30 to 49 years ranges from US$13.7 billion to US$66.5 billion, depending on speed of roll-out, vaccine price per dose, and screening test and frequency. Findings demonstrate the substantial impact of vaccine price in middle-income countries that are not eligible for assistance from Gavi, the Vaccine Alliance. Replacing routine cytology with HPV-based screening may reduce total costs. Data on the health impact and relative cost-effectiveness of strategies are needed to determine the best value for public health dollars.	[Campos, Nicole G.; Kim, Jane J.; Resch, Stephen C.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA; [Sharma, Monisha] Univ Washington, Dept Global Hlth, Int Clin Res Ctr, 908 Jefferson St, Seattle, WA 98104 USA; [Clark, Andrew] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England	Harvard University; Harvard T.H. Chan School of Public Health; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine	Campos, NG (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA.	ncampos@hsph.harvard.edu			American Cancer Society [16300]	American Cancer Society(American Cancer Society)	The authors were supported by a grant from the American Cancer Society (16300) (www.cancer.org). The funders had no role in the collection, analysis, and interpretation of data; in the writing of the manuscript; or in the decision to submit the paper for publication.	[Anonymous], 2014, WKLY EPIDEMIOL REC, V89, P221; Campos NG, 2015, INT J CANCER, V137, P893, DOI 10.1002/ijc.29438; Campos NG, 2012, INT J CANCER, V130, P2672, DOI 10.1002/ijc.26269; Cremer M, 2011, INT J GYNECOL OBSTET, V113, P68, DOI 10.1016/j.ijgo.2010.10.018; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Denny LA, 2013, VACCINE, V31, pF73, DOI 10.1016/j.vaccine.2012.11.077; Deodhar K, 2012, INT J CANCER, V131, pE954, DOI 10.1002/ijc.27633; Diaz M, 2008, BRIT J CANCER, V99, P230, DOI 10.1038/sj.bjc.6604462; Dieleman JL, 2016, LANCET; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Forman D, 2013, CANC INCIDENCE 5 CON, VX; Gage JC, 2012, INT J CANCER, V131, P2903, DOI 10.1002/ijc.27563; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Goldie SJ, 2007, VACCINE, V25, P6257, DOI 10.1016/j.vaccine.2007.05.058; Goldie SJ, 2012, REV PANAM SALUD PUBL, V32, P426, DOI 10.1590/S1020-49892012001400006; Hutubessy R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-136; Jeronimo J, 2014, INT J GYNECOL CANCER, V24, P576, DOI 10.1097/IGC.0000000000000084; Kim JJ, 2008, VACCINE, V26, P4015, DOI 10.1016/j.vaccine.2008.05.038; Kim JJ, 2013, VACCINE, V31, pF60, DOI 10.1016/j.vaccine.2012.07.093; Kim JJ, 2013, VACCINE, V31, pG65, DOI 10.1016/j.vaccine.2012.06.096; Levin CE, 2013, B WORLD HEALTH ORGAN, V91, P585, DOI 10.2471/BLT.12.113837; Muwonge R, 2014, INT J CANCER, V134, P2902, DOI 10.1002/ijc.28627; Muwonge R, 2010, INT J GYNECOL OBSTET, V111, P68, DOI 10.1016/j.ijgo.2010.04.024; Mvundura M, 2014, INT J GYNECOL OBSTET, V126, P151, DOI 10.1016/j.ijgo.2014.02.012; Ngoma T, 2010, INT J GYNECOL OBSTET, V109, P100, DOI 10.1016/j.ijgo.2009.11.025; Padmanabhan S, 2010, NAT BIOTECHNOL, V28, P671, DOI 10.1038/nbt0710-671; Programme for Research and Capacity Building in Sexual and Reproductive Health and HIV in Developing Countries, 2013, COSTS CERV CANC SCRE; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Qiao YL, 2014, INT J CANCER, V134, P2891, DOI 10.1002/ijc.28616; Quentin W, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-137; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sharma M, 2012, BJOG-INT J OBSTET GY, V119, P166, DOI 10.1111/j.1471-0528.2011.02974.x; Sharma M, 2013, INT J CANCER, V132, P1895, DOI 10.1002/ijc.27835; Shastri SS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju009; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; WHO, 2013, WHO GUID SCREEN TREA; World Bank, WORLD DEV IND	39	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164000	10.1371/journal.pone.0164000	http://dx.doi.org/10.1371/journal.pone.0164000			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711124	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000385697600060
J	Matsuno, H; Kudoh, M; Watakabe, A; Yamamori, T; Shigemoto, R; Nagao, S				Matsuno, Hitomi; Kudoh, Moeko; Watakabe, Akiya; Yamamori, Tetsuo; Shigemoto, Ryuichi; Nagao, Soichi			Distribution and Structure of Synapses on Medial Vestibular Nuclear Neurons Targeted by Cerebellar Flocculus Purkinje Cells and Vestibular Nerve in Mice: Light and Electron Microscopy Studies	PLOS ONE			English	Article							RETROGRADE AXONAL-TRANSPORT; GAMMA-AMINOBUTYRIC-ACID; LONG-TERM DEPRESSION; HORSERADISH-PEROXIDASE; VESTIBULOOCULAR REFLEX; PREPOSITUS-HYPOGLOSSI; PIGMENTED RABBITS; OCULAR REFLEX; LENTIVIRAL VECTORS; TRANSGENIC MICE	Adaptations of vestibulo-ocular and optokinetic response eye movements have been studied as an experimental model of cerebellum-dependent motor learning. Several previous physiological and pharmacological studies have consistently suggested that the cerebellar flocculus (FL) Purkinje cells (P-cells) and the medial vestibular nucleus (MVN) neurons targeted by FL (FL-targeted MVN neurons) may respectively maintain the memory traces of short-and long-term adaptation. To study the basic structures of the FL-MVN synapses by light microscopy (LM) and electron microscopy (EM), we injected green florescence protein (GFP)-expressing lentivirus into FL to anterogradely label the FL P-cell axons in C57BL/6J mice. The FL P-cell axonal boutons were distributed in the magnocellular MVN and in the border region of parvocellular MVN and prepositus hypoglossi (PrH). In the magnocellular MVN, the FL-P cell axons mainly terminated on somata and proximal dendrites. On the other hand, in the parvocellular MVN/PrH, the FL P-cell axonal synaptic boutons mainly terminated on the relatively small-diameter (< 1 mu m) distal dendrites of MVN neurons, forming symmetrical synapses. The majority of such parvocellular MVN/PrH neurons were determined to be glutamatergic by immunocytochemistry and in-situ hybridization of GFP expressing transgenic mice. To further examine the spatial relationship between the synapses of FL P-cells and those of vestibular nerve on the neurons of the parvocellular MVN/PrH, we added injections of biotinylated dextran amine into the semicircular canal and anterogradely labeled vestibular nerve axons in some mice. The MVN dendrites receiving the FL P-cell axonal synaptic boutons often closely apposed vestibular nerve synaptic boutons in both LM and EM studies. Such a partial overlap of synaptic boutons of FL P-cell axons with those of vestibular nerve axons in the distal dendrites of MVN neurons suggests that inhibitory synapses of FL P-cells may influence the function of neighboring excitatory synapses of vestibular nerve in the parvocellular MVN/PrH neurons.	[Matsuno, Hitomi; Kudoh, Moeko; Nagao, Soichi] Riken Brain Sci Inst, Lab Motor Learning Control, Hirosawa 2-1, Wako, Saitama 3510198, Japan; [Watakabe, Akiya; Yamamori, Tetsuo] RIKEN Brain Sci Inst, Lab Mol Anal Higher Brain Funct, Hirosawa 2-1, Wako, Saitama 3510198, Japan; [Shigemoto, Ryuichi] Natl Inst Physiol Sci, Div Cerebral Struct, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan; [Matsuno, Hitomi] Natl Ctr Neurol & Psychiat, Tokyo 1878551, Japan; [Shigemoto, Ryuichi] IST Austria, A-3400 Klosterneuburg, Austria; [Nagao, Soichi] Nozomi Hosp Higher Brain Funct Lab, Komuro 3170, Saitama 3620806, Japan	RIKEN; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Center for Neurology & Psychiatry - Japan; Institute of Science & Technology - Austria	Matsuno, H; Nagao, S (corresponding author), Riken Brain Sci Inst, Lab Motor Learning Control, Hirosawa 2-1, Wako, Saitama 3510198, Japan.; Matsuno, H (corresponding author), Natl Ctr Neurol & Psychiat, Tokyo 1878551, Japan.; Nagao, S (corresponding author), Nozomi Hosp Higher Brain Funct Lab, Komuro 3170, Saitama 3620806, Japan.	matsuno@brain.riken.jp; nagaos@brain.riken.jp	Yamamori, Tetsuo/N-6536-2015; Shigemoto, Ryuichi/E-3628-2013	Yamamori, Tetsuo/0000-0001-5016-0078; Shigemoto, Ryuichi/0000-0001-8761-9444	RIKEN; Japan Society for the Promotion of Science [22300112]	RIKEN; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by RIKEN[to SN]; Grant-in-Aid from the Japan Society for the Promotion of Science, https://www.jsps.go.jp/english/e-grants/ [22300112 to SN]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 2003, J NEUROPHYSIOL, V89, P1738, DOI 10.1152/jn.01043.2002; Anzai M, 2010, NEUROSCI RES, V68, P191, DOI 10.1016/j.neures.2010.07.2038; Arts MP, 2000, J NEUROPHYSIOL, V84, P2552, DOI 10.1152/jn.2000.84.5.2552; Aziz W, 2014, P NATL ACAD SCI USA, V111, pE194, DOI 10.1073/pnas.1303317110; Bagnall MW, 2009, J NEUROSCI, V29, P10104, DOI 10.1523/JNEUROSCI.2087-09.2009; BALABAN CD, 1981, NEUROSCI LETT, V27, P101, DOI 10.1016/0304-3940(81)90251-2; Barmack NH, 2000, J COMP NEUROL, V427, P235, DOI 10.1002/1096-9861(20001113)427:2<235::AID-CNE6>3.0.CO;2-6; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; BRODAL A, 1964, Arch Ital Biol, V102, P1; BRODAL A, 1957, J ANAT, V91, P438; CHANPALAY V, 1982, P NATL ACAD SCI-BIOL, V79, P3355, DOI 10.1073/pnas.79.10.3355; DEZEEUW CI, 1995, EUR J NEUROSCI, V7, P2322; DUFOSSE M, 1978, BRAIN RES, V150, P611, DOI 10.1016/0006-8993(78)90825-9; Eccles J C, 1964, PHYSL SYNAPSES, DOI [10.1007/978-3-642-64950-9, DOI 10.1007/978-3-642-64950-9]; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gidon A, 2012, NEURON, V75, P330, DOI 10.1016/j.neuron.2012.05.015; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grinevich V, 2005, J NEUROSCI, V25, P8250, DOI 10.1523/JNEUROSCI.2235-05.2005; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Highstein SM, 2006, PROG BRAIN RES, V151, P157, DOI 10.1016/S0079-6123(05)51006-9; Hisano S, 2002, MOL BRAIN RES, V107, P23, DOI 10.1016/S0169-328X(02)00442-4; ITO M, 1977, J PHYSIOL-LONDON, V265, P833, DOI 10.1113/jphysiol.1977.sp011747; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 1984, CEREBELLUM NEURAL CO, DOI [10.1001/archneur.1985.04060040016006, DOI 10.1001/ARCHNEUR.1985.04060040016006]; Ito M, 2011, CEREBELLUM BRAIN IMP, DOI [10.1093/arclin/acs054, DOI 10.1093/ARCLIN/ACS054]; Ito M, 2014, PROG BRAIN RES, V210, P1, DOI 10.1016/B978-0-444-63356-9.00001-7; Kassardjian CD, 2005, J NEUROSCI, V25, P7979, DOI 10.1523/JNEUROSCI.2215-05.2005; KAWAGUCHI Y, 1985, Neuroscience Research, V2, P434, DOI 10.1016/0168-0102(85)90016-1; Kodama T, 2012, J NEUROSCI, V32, P7819, DOI 10.1523/JNEUROSCI.0543-12.2012; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; LANGER T, 1986, J COMP NEUROL, V245, P379, DOI 10.1002/cne.902450307; LANGER T, 1985, J COMP NEUROL, V235, P26, DOI 10.1002/cne.902350103; McElvain LE, 2010, NEURON, V68, P763, DOI 10.1016/j.neuron.2010.09.025; MCMASTERS RE, 1966, AM J ANAT, V118, P163, DOI 10.1002/aja.1001180109; Menzies JRW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013182; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; MUGNAINI E, 1967, EXP BRAIN RES, V4, P187; MUGNAINI E, 1967, EXP BRAIN RES, V4, P212; NAGAO S, 1989, EXP BRAIN RES, V77, P531; NAGAO S, 1988, EXP BRAIN RES, V73, P489, DOI 10.1007/BF00406606; Nagao S, 1997, NEUROSCI RES, V27, P257, DOI 10.1016/S0168-0102(97)01160-7; NAGAO S, 1983, EXP BRAIN RES, V53, P36; Nagao S, 1989, EXP BRAIN RES, V80, P451; Okamoto T, 2011, NEUROSCI LETT, V504, P53, DOI 10.1016/j.neulet.2011.08.056; Okamoto T, 2011, J NEUROSCI, V31, P8958, DOI 10.1523/JNEUROSCI.1151-11.2011; Paxinos G F K, 2012, MOUSE BRAIN STEROTAX, P10786, DOI [10.1523/JNEUROSCI.0768-11.2011, DOI 10.1523/JNEUROSCI.0768-11.2011]; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; SATO F, 1993, J COMP NEUROL, V333, P554, DOI 10.1002/cne.903330408; SATO F, 1989, J COMP NEUROL, V290, P423, DOI 10.1002/cne.902900310; SATO Y, 1988, BRAIN RES, V446, P225, DOI 10.1016/0006-8993(88)90881-5; SATO Y, 1982, BRAIN RES, V232, P1, DOI 10.1016/0006-8993(82)90606-0; Schonewille M, 2006, J COMP NEUROL, V497, P670, DOI 10.1002/cne.21036; Sekirnjak C, 2003, J NEUROSCI, V23, P6392; Shin M, 2011, J NEUROSCI, V31, P10776, DOI 10.1523/JNEUROSCI.0768-11.2011; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; STAHL JS, 1995, J NEUROPHYSIOL, V73, P1396, DOI 10.1152/jn.1995.73.4.1396; Sugihara I, 2009, J COMP NEUROL, V512, P282, DOI 10.1002/cne.21889; Sultan F, 2003, J COMP NEUROL, V455, P139, DOI 10.1002/cne.10443; Takazawa T, 2004, J NEUROPHYSIOL, V92, P3106, DOI 10.1152/jn.00494.2004; Tamamaki N, 2000, NEUROSCI RES, V38, P231, DOI 10.1016/S0168-0102(00)00176-0; Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X; Todaka H, 2013, EUR J NEUROSCI, V37, P339, DOI 10.1111/ejn.12051; Torashima T, 2006, BRAIN RES, V1082, P11, DOI 10.1016/j.brainres.2006.01.104; UMETANI T, 1992, BRAIN RES, V586, P91, DOI 10.1016/0006-8993(92)91376-P; Uusisaari MY, 2012, CEREBELLUM, V11, P420, DOI 10.1007/s12311-011-0350-6; van den Pol AN, 1998, J NEUROSCI, V18, P10640; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Wang W, 2014, P NATL ACAD SCI USA, V111, pE188, DOI 10.1073/pnas.1315541111; WATANABE E, 1985, Neuroscience Research, V3, P20, DOI 10.1016/0168-0102(85)90036-7; YAMAMOTO M, 1978, NEUROSCI LETT, V7, P197, DOI 10.1016/0304-3940(78)90167-2; YAMAMOTO M, 1977, NEUROSCI LETT, V5, P279, DOI 10.1016/0304-3940(77)90079-9; Yamazaki T, 2015, P NATL ACAD SCI USA, V112, P3541, DOI 10.1073/pnas.1413798112; YINGCHAROEN K, 1983, EXP BRAIN RES, V51, P192; Zhang W, 2006, J NEUROSCI, V26, P6935, DOI 10.1523/JNEUROSCI.0784-06.2006	75	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164037	10.1371/journal.pone.0164037	http://dx.doi.org/10.1371/journal.pone.0164037			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711146	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600069
J	Nijenkamp, R; Nieuwenstein, MR; de Jong, R; Lorist, MM				Nijenkamp, Rob; Nieuwenstein, Mark R.; de Jong, Ritske; Lorist, Monicque M.			Do Resit Exams Promote Lower Investments of Study Time? Theory and Data from a Laboratory Study	PLOS ONE			English	Article							COGNITIVE REFLECTION; REPEATED GAMBLES; RISK; PERFORMANCE; DECISION	Although many educational institutions allow students to resit exams, a recently proposed mathematical model suggests that this could lead to a dramatic reduction in study-time investment, especially in rational students. In the current study, we present a modification of this model in which we included some well-justified assumptions about learning and performance on multiple-choice tests, and we tested its predictions in two experiments in which participants were asked to invest fictional study time for a fictional exam. Consistent with our model, the prospect of a resit exam was found to promote lower investments of study time for a first exam and this effect was stronger for participants scoring higher on the cognitive reflection test. We also found that the negative effect of resit exams on study-time investment was attenuated when access to the resit was made uncertain by making it probabilistic or dependent on obtaining a minimal, non-passing grade for the first attempt. Taken together, these results suggest that offering students resit exams may compromise the achievement of learning goals, and they raise the more general implication that second chances promote risky behavior.	[Nijenkamp, Rob; Nieuwenstein, Mark R.; de Jong, Ritske; Lorist, Monicque M.] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands; [Lorist, Monicque M.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr Groningen, Groningen, Netherlands; [Nijenkamp, Rob; Nieuwenstein, Mark R.; de Jong, Ritske; Lorist, Monicque M.] Univ Groningen, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Nijenkamp, R (corresponding author), Univ Groningen, Dept Expt Psychol, Groningen, Netherlands.; Nijenkamp, R (corresponding author), Univ Groningen, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands.	r.nijenkamp@rug.nl	Nijenkamp, Rob/F-7168-2015	Nijenkamp, Rob/0000-0001-8321-1134; Nieuwenstein, M.R./0000-0002-9602-3463; Lorist, Monicque M./0000-0002-7361-093X				Al-Bayatti M, 2003, BERA; Avrahami J, 2011, J BEHAV DECIS MAKING, V24, P515, DOI 10.1002/bdm.707; Benartzi S, 1999, MANAGE SCI, V45, P364, DOI 10.1287/mnsc.45.3.364; Bjork RA, 2013, ANNU REV PSYCHOL, V64, P417, DOI 10.1146/annurev-psych-113011-143823; BLOOM BS, 1974, AM PSYCHOL, V29, P682, DOI 10.1037/h0037632; CARROLL JB, 1963, TEACH COLL REC, V64, P723; Forstmann BU, 2016, ANNU REV PSYCHOL, V67, P641, DOI 10.1146/annurev-psych-122414-033645; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; GRABE M, 1994, CONTEMP EDUC PSYCHOL, V19, P45, DOI 10.1006/ceps.1994.1005; Huang SC, 2013, J PERS SOC PSYCHOL, V104, P236, DOI 10.1037/a0031039; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kareev Y, 2014, J EXP PSYCHOL GEN, V143, P1112, DOI 10.1037/a0034641; KEREN G, 1987, J EXP PSYCHOL LEARN, V13, P387, DOI 10.1037/0278-7393.13.3.387; Kooreman P, 2013, ECON LETT, V121, P141, DOI 10.1016/j.econlet.2013.07.005; Kooreman P, 2013, ECON LETT, V118, P213, DOI 10.1016/j.econlet.2012.10.015; Kruglanski AW, 2011, EUR J SOC PSYCHOL, V41, P344, DOI 10.1002/ejsp.780; KULIK CLC, 1990, REV EDUC RES, V60, P265, DOI 10.2307/1170612; Love J, 2015, JASP; MCMANUS IC, 1992, MED EDUC, V26, P157, DOI 10.1111/j.1365-2923.1992.tb00142.x; Michaelis J, 2016, ECON LETT, V145, P65, DOI 10.1016/j.econlet.2016.05.019; Murre JMJ, 2014, PSYCHON B REV, V21, P344, DOI 10.3758/s13423-013-0522-0; Napolitano CM, 2016, PERSPECT PSYCHOL SCI, V11, P56, DOI 10.1177/1745691615596991; Pell G, 2009, ASSESS EVAL HIGH EDU, V34, P243, DOI 10.1080/02602930801955994; REDELMEIER DA, 1992, PSYCHOL SCI, V3, P191, DOI 10.1111/j.1467-9280.1992.tb00025.x; Ricketts C, 2010, ASSESS EVAL HIGH EDU, V35, P351, DOI 10.1080/02602931003763954; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; SAMUELSON PA, 1963, SCIENTIA, V98, P108; Scott EP, 2012, ASSESS EDUC, V19, P431, DOI 10.1080/0969594X.2012.714741; Shin J, 2014, BACKUP PLANS CAN HAR; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1	31	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0161708	10.1371/journal.pone.0161708	http://dx.doi.org/10.1371/journal.pone.0161708			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711140	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600003
J	Pucker, B; Holtgrawe, D; Sorensen, TR; Stracke, R; Viehover, P; Weisshaar, B				Pucker, Boas; Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Stracke, Ralf; Viehoever, Prisca; Weisshaar, Bernd			A De Novo Genome Sequence Assembly of the Arabidopsis thaliana Accession Niederzenz-1 Displays Presence/Absence Variation and Strong Synteny	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; TRANSPOSABLE ELEMENTS; INFORMATION RESOURCE; STRUCTURAL VARIATION; CENTROMERIC REGION; CYTOSINE RESIDUES; GENE PREDICTION; REPETITIVE DNA; IDENTIFICATION; ORGANIZATION	Arabidopsis thaliana is the most important model organism for fundamental plant biology. The genome diversity of different accessions of this species has been intensively studied, for example in the 1001 genome project which led to the identification of many small nucleotide polymorphisms (SNPs) and small insertions and deletions (InDels). In addition, presence/absence variation (PAV), copy number variation (CNV) and mobile genetic elements contribute to genomic differences between A. thaliana accessions. To address larger genome rearrangements between the A. thaliana reference accession Columbia-0 (Col-0) and another accession of about average distance to Col-0, we created a de novo next generation sequencing (NGS)-based assembly from the accession Niederzenz-1 (Nd-1). The result was evaluated with respect to assembly strategy and synteny to Col-0. We provide a high quality genome sequence of the A. thaliana accession (Nd-1, LXSY01000000). The assembly displays an N50 of 0.590 Mbp and covers 99% of the Col-0 reference sequence. Scaffolds from the de novo assembly were positioned on the basis of sequence similarity to the reference. Errors in this automatic scaffold anchoring were manually corrected based on analyzing reciprocal best BLAST hits (RBHs) of genes. Comparison of the final Nd-1 assembly to the reference revealed duplications and deletions (PAV). We identified 826 insertions and 746 deletions in Nd-1. Randomly selected candidates of PAV were experimentally validated. Our Nd-1 de novo assembly allowed reliable identification of larger genic and intergenic variants, which was difficult or error-prone by short read mapping approaches alone. While overall sequence similarity as well as synteny is very high, we detected short and larger (affecting more than 100 bp) differences between Col-0 and Nd-1 based on bi-directional comparisons. The de novo assembly provided here and additional assemblies that will certainly be published in the future will allow to describe the pangenome of A. thaliana.	[Pucker, Boas; Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Stracke, Ralf; Viehoever, Prisca; Weisshaar, Bernd] Univ Bielefeld, Fac Biol, Bielefeld, Germany; [Pucker, Boas; Holtgraewe, Daniela; Soerensen, Thomas Rosleff; Stracke, Ralf; Viehoever, Prisca; Weisshaar, Bernd] Univ Bielefeld, Ctr Biotechnol, Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Weisshaar, B (corresponding author), Univ Bielefeld, Fac Biol, Bielefeld, Germany.; Weisshaar, B (corresponding author), Univ Bielefeld, Ctr Biotechnol, Bielefeld, Germany.	bernd.weisshaar@uni-bielefeld.de	Weisshaar, Bernd/B-3859-2014; Pucker, Boas/B-6549-2019	Weisshaar, Bernd/0000-0002-7635-3473; Pucker, Boas/0000-0002-3321-7471; Stracke, Ralf/0000-0002-9261-2279; Holtgrawe, Daniela/0000-0002-1062-4576	Chair of Genome Research at Bielefeld University; German Research Foundation (DFG); Bielefeld University	Chair of Genome Research at Bielefeld University; German Research Foundation (DFG)(German Research Foundation (DFG)); Bielefeld University	This work was supported by institutional funds of the Chair of Genome Research at Bielefeld University. We acknowledge the financial support of the German Research Foundation (DFG) and the Open Access Publication Fund of Bielefeld University for the article processing charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; Altenhoff AM, 2015, NUCLEIC ACIDS RES, V43, pD240, DOI 10.1093/nar/gku1158; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bennetzen JL, 2005, CURR OPIN GENET DEV, V15, P621, DOI 10.1016/j.gde.2005.09.010; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buisine N, 2008, GENOMICS, V91, P467, DOI 10.1016/j.ygeno.2008.01.005; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; CARLSON JE, 1991, THEOR APPL GENET, V83, P194, DOI 10.1007/BF00226251; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Copenhaver GP, 1996, PLANT J, V9, P273, DOI 10.1046/j.1365-313X.1996.09020273.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Deslandes L, 2002, P NATL ACAD SCI USA, V99, P2404, DOI 10.1073/pnas.032485099; Deslandes L, 1998, MOL PLANT MICROBE IN, V11, P659, DOI 10.1094/MPMI.1998.11.7.659; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Friedberg EC, 2006, DNA REPAIR AND MUTAG; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Hastie AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055864; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Haupt W, 2001, PLANT J, V27, P285, DOI 10.1046/j.1365-313x.2001.01087.x; Hunt M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r47; Ishihara H, 2016, J EXP BOT, V67, P1505, DOI 10.1093/jxb/erv546; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim KE, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.45; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014; Krishnakumar V, 2015, NUCLEIC ACIDS RES, V43, pD1003, DOI 10.1093/nar/gku1200; Kumekawa N, 2001, DNA RES, V8, P285, DOI 10.1093/dnares/8.6.285; Kumekawa N, 2000, DNA RES, V7, P315, DOI 10.1093/dnares/7.6.315; LAIBACH F., 1943, BOT ARCH [LEIPZIG], V44, P439; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Layat E, 2012, PLANT CELL PHYSIOL, V53, P267, DOI 10.1093/pcp/pcr177; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Lloyd J, 2012, PLANT PHYSIOL, V158, P1115, DOI 10.1104/pp.111.192393; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Lu F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7914; Macas J, 2002, BIOINFORMATICS, V18, P28, DOI 10.1093/bioinformatics/18.1.28; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Marroni F, 2014, CURR OPIN PLANT BIOL, V18, P31, DOI 10.1016/j.pbi.2014.01.003; MARTINEZZAPATER JM, 1986, MOL GEN GENET, V204, P417, DOI 10.1007/BF00331018; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Munoz-Amatriain M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r58; Nagaki K, 2003, GENETICS, V163, P1221; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; O'Connell J, 2015, BIOINFORMATICS, V31, P2035, DOI 10.1093/bioinformatics/btv057; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Reinert K, 2015, ANNU REV GENOM HUM G, V16, P133, DOI 10.1146/annurev-genom-090413-025358; RICHARDS EJ, 1991, NUCLEIC ACIDS RES, V19, P3351, DOI 10.1093/nar/19.12.3351; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; Saez-Vasquez J, 2010, MOL PLANT, V3, P678, DOI 10.1093/mp/ssq034; Schmid KJ, 2003, GENOME RES, V13, P1250, DOI 10.1101/gr.728603; Schmuths H, 2004, ANN BOT-LONDON, V93, P317, DOI 10.1093/aob/mch037; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Seoighe C, 2003, CURR OPIN GENET DEV, V13, P636, DOI 10.1016/j.gde.2003.10.005; Stadermann KB, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0726-6; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thompson HL, 1996, NUCLEIC ACIDS RES, V24, P3017, DOI 10.1093/nar/24.15.3017; Thudi M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0690-3; VanBuren R, 2015, NATURE, V527, P508, DOI 10.1038/nature15714; Ward N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101850; Weigel D, 2015, ANNU REV GENET, V49, P315, DOI 10.1146/annurev-genet-120213-092110; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Yang CH, 1998, PHYTOPATHOLOGY, V88, P330, DOI 10.1094/PHYTO.1998.88.4.330; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697; Zhang SJ, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.45; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476; Zytnicki M, 2014, BIOINFORMATICS, V30, P2656, DOI 10.1093/bioinformatics/btu365	89	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164321	10.1371/journal.pone.0164321	http://dx.doi.org/10.1371/journal.pone.0164321			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711162	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600118
J	Seidler, D; Griffin, M; Nymon, A; Koeppen, K; Ashare, A				Seidler, Darius; Griffin, Mary; Nymon, Amanda; Koeppen, Katja; Ashare, Alix			Throat Swabs and Sputum Culture as Predictors of P. aeruginosa or S. aureus Lung Colonization in Adult Cystic Fibrosis Patients	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; RANDOMIZED CONTROLLED-TRIAL; PSEUDOMONAS-AERUGINOSA; OROPHARYNGEAL CULTURES; INFECTION-CONTROL; YOUNG-CHILDREN; INFLAMMATION; MICROBIOME; PATHOGENS; INFANTS	Background Due to frequent infections in cystic fibrosis (CF) patients, repeated respiratory cultures are obtained to inform treatment. When patients are unable to expectorate sputum, clinicians obtain throat swabs as a surrogate for lower respiratory cultures. There is no clear data in adult subjects demonstrating the adequacy of throat swabs as a surrogate for sputum or BAL. Our study was designed to determine the utility of throat swabs in identifying lung colonization with common organisms in adults with CF. Methods Adult CF subjects (n = 20) underwent bronchoscopy with BAL. Prior to bronchoscopy, a throat swab was obtained. A sputum sample was obtained from subjects who were able to spontaneously expectorate. All samples were sent for standard microbiology culture. Results Using BAL as the gold standard, we found the positive predictive value for Pseudomonas aeruginosa to be 100% in both sputum and throat swab compared to BAL. However, the negative predictive value for P. aeruginosa was 60% and 50% in sputum and throat swab, respectively. Conversely, the positive predictive value for Staphylococcus aureus was 57% in sputum and only 41% in throat swab and the negative predictive value of S. aureus was 100% in sputum and throat swab compared to BAL. Conclusions Our data show that positive sputum and throat culture findings of P. aeruginosa reflect results found on BAL fluid analysis, suggesting these are reasonable surrogates to determine lung colonization with P. aeruginosa. However, sputum and throat culture findings of S. aureus do not appear to reflect S. aureus colonization of the lung.	[Seidler, Darius; Griffin, Mary; Nymon, Amanda; Ashare, Alix] Dartmouth Hitchcock Med Ctr, Pulm & Crit Care Med, Lebanon, NH 03766 USA; [Koeppen, Katja; Ashare, Alix] Geisel Sch Med Dartmouth, Microbiol & Immunol, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Ashare, A (corresponding author), Dartmouth Hitchcock Med Ctr, Pulm & Crit Care Med, Lebanon, NH 03766 USA.; Ashare, A (corresponding author), Geisel Sch Med Dartmouth, Microbiol & Immunol, Hanover, NH 03755 USA.	alix.ashare@dartmouth.edu			Dartmouth Lung Biology Center (NIH) [COBRE P30GM106394]; Cystic Fibrosis Foundation [STANTO19R0, STANTO16GO]; National Heart, Lung and Blood Institute of the National Institutes of Health [R01HL074175, R01HL122372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074175, R01HL122372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106394] Funding Source: NIH RePORTER	Dartmouth Lung Biology Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was funded by a pilot grant from the Dartmouth Lung Biology Center (funded by NIH COBRE P30GM106394 to B.A. Stanton), the Cystic Fibrosis Foundation (STANTO19R0, STANTO16GO) and the National Heart, Lung and Blood Institute of the National Institutes of Health (R01HL074175 to Stanton and R01HL122372 to Ashare). Apart from initial advice on study design in conjunction with the pilot grant funding, the funding sources played no role in study conduct, data analysis, manuscript preparation or manuscript review.	Ahmed B, 2014, ARCH DIS CHILDHOOD-E, V99, P181, DOI 10.1136/archdischild-2012-303408; Armstrong DS, 1996, PEDIATR PULM, V21, P267, DOI 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K; Caverly LJ, 2015, PEDIATR PULM, V50, pS31, DOI 10.1002/ppul.23243; Dasenbrook EC, 2008, AM J RESP CRIT CARE, V178, P814, DOI 10.1164/rccm.200802-327OC; Dasenbrook EC, 2010, JAMA-J AM MED ASSOC, V303, P2386, DOI 10.1001/jama.2010.791; Emiralioglu N, 2016, J CLIN PHARM THER, V41, P419, DOI 10.1111/jcpt.12407; Franzosa EA, 2015, NAT REV MICROBIOL, V13, P360, DOI 10.1038/nrmicro3451; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hogan DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149998; Huang YJ, 2016, CLIN CHEST MED, V37, P59, DOI 10.1016/j.ccm.2015.10.003; Jennings MT, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-223; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; RAMSEY BW, 1991, AM REV RESPIR DIS, V144, P331, DOI 10.1164/ajrccm/144.2.331; Rosenfeld M, 1999, PEDIATR PULM, V28, P321, DOI 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sagel SD, 2001, AM J RESP CRIT CARE, V164, P1425, DOI 10.1164/ajrccm.164.8.2104075; Saiman L, 2003, JAMA-J AM MED ASSOC, V290, P1749, DOI 10.1001/jama.290.13.1749; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Saiman L, 2003, AM J INFECT CONTROL, V31, pS6, DOI 10.1067/mic.2003.78; Saiman Lisa, 2004, Paediatr Respir Rev, V5 Suppl A, pS367, DOI 10.1016/S1526-0542(04)90065-6; Team RDC, 2019, R LANG ENV STAT COMP; Zampoli M, 2016, J CYST FIBROS, V15, P605, DOI 10.1016/j.jcf.2016.01.001; Zemanick ET, 2015, ANN AM THORAC SOC, V12, P221, DOI 10.1513/AnnalsATS.201407-310OC	24	22	22	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164232	10.1371/journal.pone.0164232	http://dx.doi.org/10.1371/journal.pone.0164232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711152	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600101
J	Takabatake, M; Blyth, BJ; Daino, K; Imaoka, T; Nishimura, M; Fukushi, M; Shimada, Y				Takabatake, Masaru; Blyth, Benjamin J.; Daino, Kazuhiro; Imaoka, Tatsuhiko; Nishimura, Mayumi; Fukushi, Masahiro; Shimada, Yoshiya			DNA Methylation Patterns in Rat Mammary Carcinomas Induced by Pre- and Post-Pubertal Irradiation	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; BREAST-CANCER; TRANSCRIPTIONAL REGULATION; MOLECULAR SUBTYPES; EPITHELIAL-CELLS; GENE-EXPRESSION; RADIATION; AGE; TUMORS; GLAND	Several lines of evidence indicate one's age at exposure to radiation strongly modifies the risk of radiation-induced breast cancer. We previously reported that rat mammary carcinomas induced by pre- and post-pubertal irradiation have distinct gene expression patterns, but the changes underlying these differences have not yet been characterized. The aim of this investigation was to see if differences in CpG DNA methylation were responsible for the differences in gene expression between age at exposure groups observed in our previous study. DNA was obtained from the mammary carcinomas arising in female Sprague-Dawley rats that were either untreated or irradiated (gamma-rays, 2 Gy) during the pre-or post-pubertal period (3 or 7 weeks old). The DNA methylation was analyzed using CpG island microarrays and the results compared to the gene expression data from the original study. Global DNA hypomethylation in tumors was accompanied by gene-specific hypermethylation, and occasionally, by unique tumor-specific patterns. We identified methylation-regulated gene expression candidates that distinguished the pre- and post-pubertal irradiation tumors, but these represented only 2 percent of the differentially expressed genes, suggesting that methylation is not a major or primary mechanism underlying the phenotypes. Functional analysis revealed that the candidate methylation-regulated genes were enriched for stem cell differentiation roles, which may be important in mammary cancer development and worth further investigation. However, the heterogeneity of human breast cancer means that the interpretation of molecular and phenotypic differences should be cautious, and take into account the co-variates such as hormone receptor status and cell-of-origin that may influence the associations.	[Takabatake, Masaru; Blyth, Benjamin J.; Daino, Kazuhiro; Imaoka, Tatsuhiko; Nishimura, Mayumi; Shimada, Yoshiya] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Radiat Effects Res, Chiba, Japan; [Takabatake, Masaru; Imaoka, Tatsuhiko; Fukushi, Masahiro; Shimada, Yoshiya] Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Tokyo, Japan	National Institutes for Quantum Science & Technology; Tokyo Metropolitan University	Shimada, Y (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Radiat Effects Res, Chiba, Japan.; Shimada, Y (corresponding author), Tokyo Metropolitan Univ, Grad Sch Human Hlth Sci, Dept Radiol Sci, Tokyo, Japan.	shimada.yoshiya@qst.go.jp	Imaoka, Tatsuhiko/E-5134-2012	Imaoka, Tatsuhiko/0000-0003-1507-585X; Blyth, Benjamin/0000-0003-4754-6249	Ministry of Health, Labor, and Welfare of Japan;  [24-7555]; Grants-in-Aid for Scientific Research [15H01834] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for the Third Comprehensive 10-year Strategy for Cancer Control and for Cancer Research from the Ministry of Health, Labor, and Welfare of Japan (http://www.mhlw.go.jp) to KD, and for the Japan Society for the Promotion of Science Fellows (https.//www.jsps.go.jp) to MT (No. 24-7555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardowell SA, 2013, BREAST CANCER RES TR, V142, P365, DOI 10.1007/s10549-013-2738-0; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Bloushtain-Qimron N, 2008, P NATL ACAD SCI USA, V105, P14076, DOI 10.1073/pnas.0805206105; Blyth BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130666; BOICE JD, 1991, RADIAT RES, V125, P214, DOI 10.2307/3577890; Chaligne R, 2014, FEBS LETT, V588, P2514, DOI 10.1016/j.febslet.2014.06.023; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; de Candia P, 2004, ADV CANCER RES, V92, P81; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Enroth S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5684; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Holm K, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2590; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Huh SJ, 2015, STEM CELL REP, V4, P297, DOI 10.1016/j.stemcr.2014.12.009; Iizuka D, 2010, RADIAT RES, V174, P206, DOI 10.1667/RR2006.1; Imaoka T, 2011, MOL CARCINOGEN, V50, P539, DOI 10.1002/mc.20746; Ishida Y, 2010, CARCINOGENESIS, V31, P1694, DOI 10.1093/carcin/bgq145; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jang SM, 2015, BIOCHEM BIOPH RES CO, V463, P961, DOI 10.1016/j.bbrc.2015.06.042; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kakinuma S, 2012, MUTAT RES-FUND MOL M, V737, P43, DOI 10.1016/j.mrfmmm.2012.06.001; Kovalchuk IP, 2014, RADIAT RES, V182, P683, DOI 10.1667/RR13697.1; Kulis M, 2013, BBA-GENE REGUL MECH, V1829, P1161, DOI 10.1016/j.bbagrm.2013.08.001; Lanigan F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2621; Matsuu-Matsuyama M, 2015, J RADIAT RES, V56, P493, DOI 10.1093/jrr/rrv003; Oikawa M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-168; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; Ronckers CM, 2005, BREAST CANCER RES, V7, P21, DOI 10.1186/bcr970; Russo J, 2015, TOXICOL PATHOL, V43, P145, DOI 10.1177/0192623314532036; Schellong G, 2014, DTSCH ARZTEBL INT, V111, P3, DOI 10.3238/arztebl.2014.0003; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shen QA, 2010, MOL CANCER RES, V8, P939, DOI 10.1158/1541-7786.MCR-09-0523; SHIMADA Y, 1994, RADIAT RES, V137, P118, DOI 10.2307/3578800; Simian M, 2001, DEVELOPMENT, V128, P3117; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stein T, 2010, AM J PATHOL, V177, P2323, DOI 10.2353/ajpath.2010.100209; Sunaoshi M, 2015, MUTAT RES-FUND MOL M, V779, P58, DOI 10.1016/j.mrfmmm.2015.06.004; Tang J, 2014, STEM CELLS, V32, P649, DOI 10.1002/stem.1533; Unger K, 2008, ONCOGENE, V27, P4592, DOI 10.1038/onc.2008.99; Zhai Y, 2011, ONCOGENE, V30, P4152, DOI 10.1038/onc.2011.123; Zhang Z, 2015, CANCER LETT, V361, P240, DOI 10.1016/j.canlet.2015.03.008	45	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164194	10.1371/journal.pone.0164194	http://dx.doi.org/10.1371/journal.pone.0164194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711132	Green Published, gold			2022-12-27	WOS:000385697600096
J	Wild, E; Cojocaru, MG				Wild, Erin; Cojocaru, Monica Gabriela			Runaway Competition: A Correction and Extension of Results for a Model of Competitive Helping	PLOS ONE			English	Article							BIOLOGICAL MARKETS; PRISONERS-DILEMMA; PARTNER CHOICE; COOPERATION; EVOLUTION; ALTRUISM; RECIPROCITY	We investigate and generalize an existing model of competitive helping within a biological market, first introduced for a population of competing individuals in which one individual provides help to all others; the rest compete for the help available from this individual by providing help themselves. Our generalized model comprises two strategies in which each individual of a specific type provides the same amount of help as all other individuals of that type. Each individual's fitness function is dependent on this level of help, the cost of providing the help, and the fact that help is proportionally reciprocated by other individuals. Competitive helping occurs when individuals actively try to help more than other individuals. To assess the emergence of equilibrium help strategies as adopted by proportions of the population, we examine the competition over available help within two settings: replicator dynamics and agent-based numerical simulations. To move one step further in our generalization, we use the agent-based model to study the N-person competitive helping game, where all individuals in the population are heterogeneous with respect to help provided. Our results show that helping does not increase indefinitely with the population size, as concluded previously, and while there are some instances of an increase in help provided as a result of competition, this competition can be detrimental to all individuals and in most cases, one type simply gives up (thus evolving to a "no help" strategy). The degree to which an individual's help is reciprocated by the others in the population has strong implications in the long-term behaviour of equilibrium help levels of types of individuals (and of individuals themselves); these equilibrium help levels diverge from existing conjectures in current literature. Lastly, small amounts of passively provided (costless) help results in runaway competition among all individuals.	[Wild, Erin; Cojocaru, Monica Gabriela] Univ Guelph, Dept Math & Stat, Guelph, ON, Canada	University of Guelph	Wild, E (corresponding author), Univ Guelph, Dept Math & Stat, Guelph, ON, Canada.	ewild@uoguelph.ca		Wild, Erin/0000-0003-1349-5850	Natural Sciences and Engineering Research Council of Canada [400684]; Ontario Graduate Scholarship, University of Guelph	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship, University of Guelph	This work was supported by Natural Sciences and Engineering Research Council of Canada - Discovery Grant - 400684 (http://www.nserc-crsng.gc.ca/Professors-Professeurs/Grants-Subs/DGIGP-PSIGP_eng.asp), MGC; and Ontario Graduate Scholarship, University of Guelph (https.//www.uoguelph.ca/graduatestudies/current/funding/scholarships/gov-fundedawards/ogs), EW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barclay P, 2007, P ROY SOC B-BIOL SCI, V274, P749, DOI 10.1098/rspb.2006.0209; Barclay P, 2011, J THEOR BIOL, V281, P47, DOI 10.1016/j.jtbi.2011.04.023; Barclay P, 2010, BRIT J PSYCHOL, V101, P123, DOI 10.1348/000712609X435733; BAUM WM, 1981, J EXP ANAL BEHAV, V36, P387, DOI 10.1901/jeab.1981.36-387; BAUM WM, 1979, J EXP ANAL BEHAV, V32, P269, DOI 10.1901/jeab.1979.32-269; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; CONNOR RC, 1995, TRENDS ECOL EVOL, V10, P84, DOI 10.1016/S0169-5347(00)88988-0; DOMJAN M, 1993, PRINCIPLES LEARNING; Harkin ME, 2015, INT ENCY SOCIAL BEHA, V17, P11885; Luke S, 2004, MERSENNE TWISTER JAV; Matsumoto M, 1998, ACM T MODELING COMPU, V8; NOE R, 1990, ANIM BEHAV, V39, P78, DOI 10.1016/S0003-3472(05)80728-6; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; SEYFARTH RM, 1977, J THEOR BIOL, V65, P671, DOI 10.1016/0022-5193(77)90015-7; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Tooby J., 1996, P BRIT ACAD, P119, DOI DOI 10.1002/(SICI)1520-6300(1998)10:5<681::AID-; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vogel G, 2004, SCIENCE, V303, P1128, DOI 10.1126/science.303.5661.1128; WEARDEN JH, 1982, J EXP ANAL BEHAV, V38, P339, DOI 10.1901/jeab.1982.38-339; Williams B.A., 1988, STEVENS HDB EXPT PSY, V2, P167	27	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164188	10.1371/journal.pone.0164188	http://dx.doi.org/10.1371/journal.pone.0164188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711174	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600095
J	Kanojia, G; ten Have, R; Bakker, A; Wagner, K; Frijlink, HW; Kersten, GFA; Amorij, JP				Kanojia, Gaurav; ten Have, Rimko; Bakker, Arjen; Wagner, Koen; Frijlink, Henderik W.; Kersten, Gideon F. A.; Amorij, Jean-Pierre			The Production of a Stable Infliximab Powder: The Evaluation of Spray and Freeze-Drying for Production	PLOS ONE			English	Article							GLASS-TRANSITION TEMPERATURE; MONOCLONAL-ANTIBODY; SCALE-UP; FORMULATIONS; STABILIZATION; STABILITY; DESIGN; PROTEINS; BEHAVIOR; QUALITY	In prospect of developing an oral dosage form of Infliximab, for treatment of Crohn's disease and rheumatoid arthritis, freeze-drying (vial vs Lyoguard trays) and spray-drying were investigated as production method for stable powders. Dextran and inulin were used in combination with sucrose as stabilizing excipients. The drying processes did not affect Infliximab in these formulations, i.e. both the physical integrity and biological activity (TNF binding) were retained. Accelerated stability studies (1 month at 60 degrees C) showed that the TNF binding ability of Infliximab was conserved in the freeze-dried formulations, whereas the liquid counterpart lost all TNF binding. After thermal treatment, the dried formulations showed some chemical modification of the IgG in the dextran-sucrose formulation, probably due to Maillard reaction products. This study indicates that, with the appropriate formulation, both spray-drying and freeze-drying may be useful for (bulk) powder production of Infliximab.	[Kanojia, Gaurav; ten Have, Rimko; Kersten, Gideon F. A.; Amorij, Jean-Pierre] Intravacc Inst Translat Vaccinol, Bilthoven, Netherlands; [Kanojia, Gaurav; Frijlink, Henderik W.] Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands; [Kersten, Gideon F. A.] Leiden Acad Ctr Drug Res, Drug Delivery Technol, Leiden, Netherlands; [Bakker, Arjen; Wagner, Koen] AIMM Therapeut, Amsterdam, Netherlands	University of Groningen	Kanojia, G (corresponding author), Intravacc Inst Translat Vaccinol, Bilthoven, Netherlands.; Kanojia, G (corresponding author), Univ Groningen, Dept Pharmaceut Technol & Biopharm, Groningen, Netherlands.	gaurav.kanojia@intravacc.nl	Frijlink, Henderik Willem/AAD-7382-2020	Frijlink, Henderik Willem/0000-0001-7901-8198	AIMM therapeutics	AIMM therapeutics	The commercial company (AIMM therapeutics) provided support in form of a small project fee. In addition to it, co-authors from AIMM (AB and KW) were actively involved in experimental analysis and revision of the manuscript. The specific role of each author is articulated in the "author contributions" section.	Ahmadi M, 2015, PHARM RES-DORDR, V32, P1383, DOI 10.1007/s11095-014-1541-x; Amorij JP, 2008, PHARM RES-DORDR, V25, P1256, DOI 10.1007/s11095-008-9559-6; Bowen M, 2013, DRY TECHNOL, V31, P1441, DOI 10.1080/07373937.2013.796968; CARPENTER JF, 1989, BIOCHEMISTRY-US, V28, P3916, DOI 10.1021/bi00435a044; Carpenter John F, 2002, Pharm Biotechnol, V13, P109; DRABER P, 1995, J IMMUNOL METHODS, V181, P37, DOI 10.1016/0022-1759(94)00326-R; Duddu SP, 1997, PHARM RES-DORDR, V14, P596, DOI 10.1023/A:1012196826905; Etzl EE, 2014, PHARM DEV TECHNOL, V19, P213, DOI 10.3109/10837450.2013.769567; Gikanga Benson, 2015, PDA J Pharm Sci Technol, V69, P59, DOI 10.5731/pdajpst.2015.01003; Grasmeijer N, 2013, BBA-PROTEINS PROTEOM, V1834, P763, DOI 10.1016/j.bbapap.2013.01.020; Guerra I, 2014, CLIN EXP GASTROENTER, V7, P359, DOI 10.2147/CEG.S45297; Gutka H, 2015, LYOPHILIZED BIOL VAC, P299; Heljo VP, 2013, EUR J PHARM BIOPHARM, V85, P752, DOI 10.1016/j.ejpb.2013.03.033; Hinrichs WLJ, 2001, INT J PHARMACEUT, V215, P163, DOI 10.1016/S0378-5173(00)00677-3; Hinz DC, 2007, J PHARMACEUT BIOMED, V43, P779, DOI 10.1016/j.jpba.2006.08.002; Katja S., 2011, THESIS; Maa Y F, 1997, Pharm Dev Technol, V2, P213, DOI 10.3109/10837459709031441; Maa Yuh-Fun, 2000, Current Pharmaceutical Biotechnology, V1, P283, DOI 10.2174/1389201003378898; Masters K., 1991, SPRAY DRYING HDB, Vfifth; Maurer JM, 2016, INT J PHARMACEUT, V505, P175, DOI 10.1016/j.ijpharm.2016.03.027; MAY JC, 1992, DEV BIOLOGICALS, V74, P153; Mensink MA, 2015, CARBOHYD POLYM, V130, P405, DOI 10.1016/j.carbpol.2015.05.026; Molina MD, 2004, J PHARM SCI-US, V93, P2259, DOI 10.1002/jps.20138; Moroz E, 2016, ADV DRUG DELIVER REV, V101, P108, DOI 10.1016/j.addr.2016.01.010; Patel SM, 2011, AAPS PHARMSCITECH, V12, P372, DOI 10.1208/s12249-011-9599-9; Pisano R, 2013, AAPS PHARMSCITECH, V14, P1137, DOI 10.1208/s12249-013-0003-9; Pisano R, 2013, PHARM DEV TECHNOL, V18, P280, DOI 10.3109/10837450.2012.734512; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Schule S, 2008, EUR J PHARM BIOPHARM, V69, P793, DOI 10.1016/j.ejpb.2008.02.010; Tsinontides SC, 2004, INT J PHARM, V280, P1, DOI 10.1016/j.ijpharm.2004.04.018; Vehring R, 2008, PHARM RES-DORDR, V25, P999, DOI 10.1007/s11095-007-9475-1; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727	33	16	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163109	10.1371/journal.pone.0163109	http://dx.doi.org/10.1371/journal.pone.0163109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706175	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200033
J	Yoo, HJ; Lee, JS; Kim, JE; Gu, J; Koh, Y; Kim, I; Kim, HK				Yoo, Hyun Ju; Lee, Jee-Soo; Kim, Ji-Eun; Gu, JaYoon; Koh, Youngil; Kim, Inho; Kim, Hyun Kyung			Extracellular Histone Released from Leukemic Cells Increases Their Adhesion to Endothelium and Protects them from Spontaneous and Chemotherapy-Induced Leukemic Cell Death	PLOS ONE			English	Article							APOPTOSIS	Introduction When leukocytes are stimulated by reactive oxygen species (ROS), they release nuclear contents into the extracellular milieu, called by extracellular traps (ET). The nuclear contents are mainly composed of the histone-DNA complex and neutrophil elastase. This study investigated whether leukemic cells could release ET and the released histone could induce endothelial activation, eventually resulting in leukemic progression. Methods The circulating ET were measured in 80 patients with hematologic diseases and 40 healthy controls. ET formation and ROS levels were investigated during leukemic cell proliferation in vitro. Histone-induced endothelial adhesion molecules expression and cell survival were measured by flow cytometry. Results Acute leukemia patients had high levels of ET, which correlated with peripheral blast count. Leukemic cells produced high ROS levels and released extracellular histone, which was significantly blocked by antioxidants. Histone significantly induced 3 endothelial adhesion molecules expression, and promoted leukemic cell adhesion to endothelial cells, which was inhibited by histone inhibitors (heparin, polysialic acid, and activated protein C), neutralizing antibodies against these adhesion molecules, and a Toll like receptor(TLR) 9 antagonist. When leukemic cells were co-cultured with endothelial cells, adherent leukemic cells showed better survival than the non-adherent ones, demonstrating that histone-treated endothelial cells protected leukemic cells from both spontaneous and chemotherapy-induced death. Conclusion Our data demonstrate for the first time that extracellular histone can be released from leukemic cells through a ROS-dependent mechanism. The released histone promotes leukemic cell adhesion by inducting the surface expression of endothelial adhesion molecules and eventually protects leukemic cells from cell death.	[Yoo, Hyun Ju; Lee, Jee-Soo; Kim, Ji-Eun; Gu, JaYoon; Kim, Hyun Kyung] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Yoo, Hyun Ju; Kim, Ji-Eun; Gu, JaYoon; Koh, Youngil; Kim, Inho; Kim, Hyun Kyung] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Koh, Youngil; Kim, Inho] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, HK (corresponding author), Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.; Kim, HK (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	lukekhk@snu.ac.kr			National Research Foundation of Korea [2013-068572]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea 2013-068572 M.D., to PhD Hyun Kyung Kim. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; COLLINS RJ, 1989, BRIT J HAEMATOL, V71, P343; Esmon CT, 2013, THROMB HAEMOSTASIS, V109, P416, DOI 10.1160/TH12-08-0634; Goldmann O, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00420; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Kawata J, 2014, BIOTECHNOL LETT, V36, P241, DOI 10.1007/s10529-013-1364-6; Kim JE, 2015, THROMB RES, V135, P1064, DOI 10.1016/j.thromres.2015.03.014; Kim JE, 2011, BLOOD COAGUL FIBRIN, V22, P132, DOI 10.1097/MBC.0b013e32834356b6; Kirchner T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/849136; Maffei R, 2012, HAEMATOL-HEMATOL J, V97, P952, DOI 10.3324/haematol.2011.054924; Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Nakayama T, 2015, CELL BIOL INT, V39, P355, DOI 10.1002/cbin.10396; PAL PK, 1983, THROMB RES, V31, P69, DOI 10.1016/0049-3848(83)90008-7; Pezeshkian B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060823; Poulos MG, 2014, EXP HEMATOL, V42, P976, DOI 10.1016/j.exphem.2014.08.003; Stucki A, 2001, BLOOD, V97, P2121, DOI 10.1182/blood.V97.7.2121; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053	20	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163982	10.1371/journal.pone.0163982	http://dx.doi.org/10.1371/journal.pone.0163982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706246	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200073
J	Chae, JW; Ng, T; Yeo, HL; Shwe, M; Gan, YX; Ho, HK; Chan, A				Chae, Jung-Woo; Ng, Terence; Yeo, Hui Ling; Shwe, Maung; Gan, Yan Xiang; Ho, Han Kiat; Chan, Alexandre			Impact of TNF-alpha (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; PROMOTER POLYMORPHISM; GENETIC POLYMORPHISMS; FATIGUE-SYNDROME; CHEMOTHERAPY; CYTOKINES; INTERLEUKIN-6; SYMPTOMS; ASSOCIATION; TRANSCRIPTION	Objective Expression of pro-inflammatory cytokines is influenced by single nucleotide polymorphisms (SNPs) in the promoter regions of the pro-inflammatory cytokine genes, and cytokines are associated with the occurrence of post-chemotherapy cognitive impairment. Hence, the aim of this study was to evaluate the associations between two common pro-inflammatory cytokine gene polymorphisms namely, IL6-174 (rs1800795 G>C) and TNF-308 (rs1800629 G> A), and chemotherapy-associated cognitive impairment (CACI) among Asian earlystage breast cancer patients. In addition, the differential effect of these SNPs on plasma IL-6 and TNF-alpha levels, and the associations of plasma IL-6 and TNF-alpha levels with CACI were also assessed. Methods Asian early-stage breast cancer patients (Stage I to III) receiving chemotherapy were prospectively recruited from two cancer centers in Singapore. Patients' cognitive function was longitudinally assessed using the validated FACT-Cog (ver. 3) and an objective computerized battery, Headminder (TM) at three-time points. Plasma IL-6 and TNF-alpha levels were analyzed using the multiplex immunoassay, and genotyping was performed using Sanger sequencing. Regression analyses and generalized estimating equation were utilized for statistical analysis. Results A total of 125 patients were included (mean age: 50.3; Chinese: 80.8%; post-menopausal: 48.0%; 68.0% received anthracycline-based chemotherapy). 36.8% patients experienced self-perceived cognitive impairment, detected in memory (32.8%) and attention (34.2%) domains. Patients with higher levels of anxiety (p< 0.001) and insomnia (p = 0.003) also reported more self-perceived cognitive impairment. Higher plasma concentrations of IL-6 were associated with greater severity of self-perceived cognitive impairment (p = 0.001). Polymorphisms of cytokine genes were not associated with expression of plasma cytokines. Conclusion Present findings further contribute to the growing evidence that supports the role of the pro-inflammatory cytokine IL-6 in the occurrence of cognitive impairment post-chemotherapy. However, genetic polymorphism of these cytokines did not play a major role to the cytokine fluctuations as well as cognitive impairment in this cohort. With an increasing evidence to support the cytokine hypothesis, future studies should investigate the role of anti-inflammatory agents in mitigating the cognitive impairment associated with chemotherapy.	[Chae, Jung-Woo; Ng, Terence; Yeo, Hui Ling; Shwe, Maung; Ho, Han Kiat; Chan, Alexandre] Natl Univ Singapore, Dept Pharm, Singapore, Singapore; [Gan, Yan Xiang; Chan, Alexandre] Natl Canc Ctr Singapore, Dept Pharm, Singapore, Singapore; [Chan, Alexandre] Duke NUS Grad Med Sch Singapore, Singapore, Singapore	National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore	Chan, A (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore, Singapore.; Chan, A (corresponding author), Natl Canc Ctr Singapore, Dept Pharm, Singapore, Singapore.; Chan, A (corresponding author), Duke NUS Grad Med Sch Singapore, Singapore, Singapore.	phaac@nus.edu.sg	Chan, Alexandre/D-5035-2016	Chan, Alexandre/0000-0003-4391-4219; CHAE, JUNG-WOO/0000-0001-6026-7063	National Medical Research Council Singapore [NMRC/CIRG/1386/2014]	National Medical Research Council Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by research grants awarded by the National Medical Research Council Singapore (NMRC/CIRG/1386/2014) (http://www.nmrc.gov.sg/content/nmrc_internet/home.html) (Project investigatorAC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Bhat AH, 2015, BIOMED PHARMACOTHER, V74, P101, DOI 10.1016/j.biopha.2015.07.025; Billing-Ross P, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0771-6; Bower JE, 2013, J CLIN ONCOL, V31, P1656, DOI 10.1200/JCO.2012.46.2143; Castellon SA, 2004, J CLIN EXP NEUROPSYC, V26, P955, DOI 10.1080/13803390490510905; Cheung YT, 2015, ANN ONCOL, V26, P1446, DOI 10.1093/annonc/mdv206; Cheung YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081234; Chu Hongxia, 2012, J Cardiovasc Dis Res, V3, P84, DOI 10.4103/0975-3583.95359; Delbarba A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5923938; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Ganz PA, 2013, BRAIN BEHAV IMMUN, V30, pS99, DOI 10.1016/j.bbi.2012.07.015; Gao SP, 2014, INT J CLIN EXP MED, V7, P2851; Han XM, 2011, NEUROSCI LETT, V504, P4, DOI 10.1016/j.neulet.2011.06.055; Janelsins MC, 2012, SUPPORT CARE CANCER, V20, P831, DOI 10.1007/s00520-011-1158-0; Kesler S, 2013, BRAIN BEHAV IMMUN, V30, pS109, DOI 10.1016/j.bbi.2012.05.017; Kim JM, 2013, J AFFECT DISORDERS, V148, P57, DOI 10.1016/j.jad.2012.11.048; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Lee BN, 2004, NEUROIMMUNOMODULAT, V11, P279, DOI 10.1159/000079408; Lee JW, 2010, CLIN CHIM ACTA, V411, P592, DOI 10.1016/j.cca.2010.01.024; Liu HL, 2008, EUR J CLIN PHARMACOL, V64, P663, DOI 10.1007/s00228-008-0483-9; Luo N, 2005, QUAL LIFE RES, V14, P1181, DOI 10.1007/s11136-004-4782-z; Mendoza TR, 1999, CANCER-AM CANCER SOC, V85, P1186, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0.CO;2-N; Merriman JD, 2014, BIOL RES NURS, V16, P152, DOI 10.1177/1099800413479441; Myers JS, 2010, ADV EXP MED BIOL, V678, P119; Myhill S, 2009, INT J CLIN EXP MED, V2, P1; Ng T, 2016, NEURO-ONCOLOGY, V18, P244, DOI 10.1093/neuonc/nov162; Olomolaiye O, 1998, EUR J IMMUNOGENET, V25, P267, DOI 10.1111/j.1744-313X.1998.tb01147.x; Pan M, 2011, J INVEST MED, V59, P272, DOI 10.231/JIM.0b013e318206ffad; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Tannock IF, 2004, J CLIN ONCOL, V22, P2233, DOI 10.1200/JCO.2004.08.094; Tarrant JM, 2010, TOXICOL SCI, V117, P4, DOI 10.1093/toxsci/kfq134; Tartter M, 2015, BRAIN BEHAV IMMUN, V46, P104, DOI 10.1016/j.bbi.2015.01.003; Wang XM, 2015, CYTOKINE, V72, P86, DOI 10.1016/j.cyto.2014.12.006; Yang YH, 2015, INT J CLIN EXP PATHO, V8, P13739; Yoon SZ, 2009, J CARDIOTHOR VASC AN, V23, P646, DOI 10.1053/j.jvca.2009.03.004	36	27	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164204	10.1371/journal.pone.0164204	http://dx.doi.org/10.1371/journal.pone.0164204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701469	Green Published, gold			2022-12-27	WOS:000385696900050
J	Saaresranta, T; Hedner, J; Bonsignore, MR; Riha, RL; McNicholas, WT; Penzel, T; Anttalainen, U; Kvamme, JA; Pretl, M; Sliwinski, P; Verbraecken, J; Grote, L				Saaresranta, Tarja; Hedner, Jan; Bonsignore, Maria R.; Riha, Renata L.; McNicholas, Walter T.; Penzel, Thomas; Anttalainen, Ulla; Kvamme, John Arthur; Pretl, Martin; Sliwinski, Pawel; Verbraecken, Johan; Grote, Ludger		ESADA Study Grp	Clinical Phenotypes and Comorbidity in European Sleep Apnoea Patients	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; CARDIOVASCULAR-DISEASE; INSOMNIA SYMPTOMS; COMMON; HYPERTENSION; PREVALENCE; DEPRESSION; HYPOPNEA; THERAPY; DAYTIME	Background Clinical presentation phenotypes of obstructive sleep apnoea (OSA) and their association with comorbidity as well as impact on adherence to continuous positive airway pressure (CPAP) treatment have not been established. Methods A prospective follow-up cohort of adult patients with OSA (apnoea-hypopnoea index (AHI) of >= 5/h) from 17 European countries and Israel (n = 6,555) was divided into four clinical presentation phenotypes based on daytime symptoms labelled as excessive daytime sleepiness ("EDS") and nocturnal sleep problems other than OSA (labelled as "insomnia"): 1) EDS (daytime+/nighttime-), 2) EDS/insomnia (daytime+/nighttime+), 3) non-EDS/noninsomnia (daytime-/nighttime-), 4) and insomnia (daytime-/nighttime+) phenotype. Results The EDS phenotype comprised 20.7%, the non-EDS/non-insomnia type 25.8%, the EDS/insomnia type 23.7%, and the insomnia phenotype 29.8% of the entire cohort. Thus, clinical presentation phenotypes with insomnia symptoms were dominant with 53.5%, but only 5.6% had physician diagnosed insomnia. Cardiovascular comorbidity was less prevalent in the EDS and most common in the insomnia phenotype (48.9% vs. 56.8%, p<0.001) despite more severe OSA in the EDS group (AHI 35.0 +/- 25.5/h vs. 27.9 +/- 22.5/h, p<0.001, respectively). Psychiatric comorbidity was associated with insomnia like OSA phenotypes independent of age, gender and body mass index (HR 1.5 (1.188-1.905), p<0.001). The EDS phenotype tended to associate with higher CPAP usage (22.7 min/d, p = 0.069) when controlled for age, gender, BMI and sleep apnoea severity. Conclusions Phenotypes with insomnia symptoms comprised more than half of OSA patients and were more frequently linked with comorbidity than those with EDS, despite less severe OSA. CPAP usage was slightly higher in phenotypes with EDS.	[Saaresranta, Tarja; Anttalainen, Ulla] Turku Univ Hosp, Div Med, Dept Pulm Dis, Turku, Finland; [Saaresranta, Tarja; Anttalainen, Ulla] Univ Turku, Dept Physiol, Sleep Res Ctr, Turku, Finland; [Hedner, Jan; Grote, Ludger] Sahlgrens Univ Hosp, Dept Sleep Med, Gothenburg, Sweden; [Hedner, Jan; Grote, Ludger] Gothenburg Univ, Sahlgrenska Acad, Gothenburg, Sweden; [Bonsignore, Maria R.] Univ Palermo, Biomed Dept Internal & Specialist Med DIBIMIS, Palermo, Italy; [Bonsignore, Maria R.] CNR, Inst Biomed & Mol Immunol, Palermo, Italy; [Riha, Renata L.] Royal Infirm Edinburgh NHS Trust, Dept Sleep Med, Edinburgh, Midlothian, Scotland; [McNicholas, Walter T.] St Vincents Univ Hosp, Dept Resp & Sleep Med, Dublin, Ireland; [McNicholas, Walter T.] Univ Coll Dublin, Conway Res Inst, Dublin, Ireland; [Penzel, Thomas] Charite, Schlafmed Zentrum, Berlin, Germany; [Penzel, Thomas] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Kvamme, John Arthur] Forde Cent Hosp, Dept ENT, Forde, Norway; [Pretl, Martin] Charles Univ Prague, Fac Med 1, Dept Neurol, Ctr Sleep & Waking Disorders, Prague, Czech Republic; [Pretl, Martin] Inspamed, Neurol & Sleep Lab, Prague, Czech Republic; [Sliwinski, Pawel] Inst TB & Lung Dis, Dept Resp Med 4th, Warsaw, Poland; [Verbraecken, Johan] Univ Antwerp Hosp, Multidisciplinary Sleep Disorders Ctr, Antwerp, Belgium; [Verbraecken, Johan] Univ Antwerp, Antwerp, Belgium	University of Turku; University of Turku; Sahlgrenska University Hospital; University of Gothenburg; University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Royal Infirmary of Edinburgh; University of Edinburgh; University College Dublin; Saint Vincent's University Hospital; University College Dublin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; St Anne's University Hospital Brno (FNUSA-ICRC); Charles University Prague; University of Antwerp; University of Antwerp	Saaresranta, T (corresponding author), Turku Univ Hosp, Div Med, Dept Pulm Dis, Turku, Finland.; Saaresranta, T (corresponding author), Univ Turku, Dept Physiol, Sleep Res Ctr, Turku, Finland.	tasaare@utu.fi	Verbraecken, Johan/ABD-8801-2021; Penzel, Thomas/M-2344-2014; LEVY, Patrick/AAX-2802-2020; Bonsignore, Maria/T-3983-2019; Bonsignore, Maria/U-6440-2017; Riha, Renata/AAN-9066-2020; Parati, Gianfranco/K-7151-2016; Barbe, Ferran/A-5988-2010	Penzel, Thomas/0000-0002-4304-0112; LEVY, Patrick/0000-0003-3174-7935; Bonsignore, Maria/0000-0002-4875-7796; Riha, Renata/0000-0001-8983-9985; MONTSERRAT, Josep Maria/0000-0003-3098-4605; Parati, Gianfranco/0000-0001-9402-7439; Barbe, Ferran/0000-0002-2340-8928; Ryan, Silke/0000-0003-0963-255X; Marrone, Oreste/0000-0001-6819-7928; Lombardi, Carolina/0000-0003-1033-6053; Varoneckas, Giedrius/0000-0001-8073-4335; Saaresranta, Tarja/0000-0001-9328-963X				AMBROGETTI A, 1991, AUST NZ J MED, V21, P863, DOI 10.1111/j.1445-5994.1991.tb01408.x; Anttalainen U, 2010, SLEEP MED, V11, P49, DOI 10.1016/j.sleep.2008.12.015; Bailly S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157318; Bjornsdottir E, 2013, SLEEP, V36, P1901, DOI 10.5665/sleep.3226; Bonsignore MR, 2012, EUR RESPIR J, V39, P1136, DOI 10.1183/09031936.00151110; Campos-Rodriguez F, 2012, ANN INTERN MED, V156, P115, DOI 10.7326/0003-4819-156-2-201201170-00006; Chai-Coetzer CL, 2013, SLEEP, V36, P1929, DOI 10.5665/sleep.3232; de Zambotti M, 2014, INT J PSYCHOPHYSIOL, V93, P332, DOI 10.1016/j.ijpsycho.2014.06.014; Eckert DJ, 2013, AM J RESP CRIT CARE, V188, P996, DOI 10.1164/rccm.201303-0448OC; Fietze I, 2011, SLEEP MED, V12, P190, DOI 10.1016/j.sleep.2010.10.003; Franklin KA, 2013, EUR RESPIR J, V41, P610, DOI 10.1183/09031936.00212711; GUILLEMINAULT C, 1976, ANNU REV MED, V27, P465, DOI 10.1146/annurev.me.27.020176.002341; Halaris A, 2013, MOD TR PHARMACOPSYCH, V28, P144, DOI 10.1159/000343981; Hedner J, 2011, EUR RESPIR J, V38, P635, DOI 10.1183/09031936.00046710; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kent BD, 2014, CHEST, V146, P982, DOI 10.1378/chest.13-2403; Kent BD, 2014, EUR RESPIR J, V44, P130, DOI 10.1183/09031936.00162713; Krakow B, 2001, CHEST, V120, P1923, DOI 10.1378/chest.120.6.1923; Krakow B, 2006, SLEEP BREATH, V10, P16, DOI 10.1007/s11325-005-0037-7; Krakow B, 2008, J CLIN SLEEP MED, V4, P212; Lee RWW, 2010, SLEEP, V33, P1249, DOI 10.1093/sleep/33.9.1249; LUGARESI E, 1987, SEMIN NEUROL, V7, P259, DOI 10.1055/s-2008-1041426; Luyster FS, 2010, J CLIN SLEEP MED, V6, P196; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; McNicholas WT, 2007, EUR RESPIR J, V29, P156, DOI 10.1183/09031936.00027406; Montemurro LT, 2014, J CLIN SLEEP MED, V10, P271, DOI 10.5664/jcsm.3526; Owens RL, 2015, SLEEP, V38, P961, DOI 10.5665/sleep.4750; Pedrosa Rodrigo P, 2014, Chest, V146, P66, DOI 10.1378/chest.14-0097; Peker Y, 2006, EUR RESPIR J, V28, P596, DOI 10.1183/09031936.06.00107805; Pieh C, 2013, SLEEP BREATH, V17, P99, DOI 10.1007/s11325-012-0655-9; Punjabi NM, 2005, J APPL PHYSIOL, V99, P1998, DOI 10.1152/japplphysiol.00695.2005; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; Smith S, 2004, SLEEP MED, V5, P449, DOI 10.1016/j.sleep.2004.03.005; Terrill PI, 2015, EUR RESPIR J, V45, P408, DOI 10.1183/09031936.00062914; THORPY M, 1994, SLEEP, V17, P372; Tkacova R, 2014, EUR RESPIR J, V44, P931, DOI 10.1183/09031936.00225113; Utriainen KT, 2013, EUR RESPIR J, V41, P616, DOI 10.1183/09031936.00227611; Vavougios GD, 2016, J SLEEP RES, V25, P31, DOI 10.1111/jsr.12344; Ye LC, 2014, EUR RESPIR J, V44, P1600, DOI 10.1183/09031936.00032314	40	90	92	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163439	10.1371/journal.pone.0163439	http://dx.doi.org/10.1371/journal.pone.0163439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701416	gold, Green Published, Green Submitted			2022-12-27	WOS:000385696900007
J	Tezval, H; Dubrowinskaja, N; Peters, I; Reese, C; Serth, K; Atschekzei, F; Hennenlotter, J; Stenzl, A; Kuczyk, MA; Serth, J				Tezval, Hossein; Dubrowinskaja, Natalia; Peters, Inga; Reese, Christel; Serth, Katrin; Atschekzei, Faranaz; Hennenlotter, Joerg; Stenzl, Arnulf; Kuczyk, Markus A.; Serth, Juergen			Tumor Specific Epigenetic Silencing of Corticotropin Releasing Hormone -Binding Protein in Renal Cell Carcinoma: Association of Hypermethylation and Metastasis	PLOS ONE			English	Article							CPG ISLAND METHYLATION; DISEASE; CANCER; GROWTH	The relevance of Corticotropin Releasing Hormone (CRH)-system in human malignancies is a question of growing interest. Here we investigated hypermethylation and epigenetic silencing of the CRH-Binding Protein (CRHBP) gene in clear cell renal cell cancer (ccRCC). Relative methylation of the CRHBP CpG island (CGI) was determined in 17 tumor cell lines as well as 86 ccRCC samples and 66 paired normal tissues using pyrosequencing and quantitative methylation specific PCR of bisulfite converted DNA. Results were statistically compared with relative mRNA expression levels of CRHBP and clinicopathological parameters of patients. Re-expression of CRHBP following 5-aza-2'-deoxycytidine treatment was investigated by quantitative mRNA expression analysis. Real-time impedance analysis was applied for analysis of invasiveness of renal tumor cells following si-RNA knockdown of CRHBP expression or ectopic expression of CRHBP. We found the CRHBP CGI to be frequently methylated in tumor cell lines of renal, prostatic, and bladder cancer. Comparison of methylation in normal and paired renal cancer tissue specimens revealed hypermethylation of the CRHBP CGI in tumors (p<1*10(-12)). DNA methylation and decreased mRNA expression were correlated (R = 0.83, p<1*10(-12)). Tumor cell lines showed 5-aza-2'-deoxycytidine dependent reduction of methylation and re-expression of CRHBP was associated with altered cellular invasiveness of renal cancer cells in real-time impedance invasion assays. Hypermethylation and inverse relationship with mRNA expression were validated in silico using the TCGA network data. We describe for the first time tumor specific epigenetic silencing of CRHBP and statistical association with aggressive tumors thus suggesting the CRH system to contribute to the development of kidney cancer.	[Tezval, Hossein; Dubrowinskaja, Natalia; Peters, Inga; Reese, Christel; Atschekzei, Faranaz; Kuczyk, Markus A.; Serth, Juergen] Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany; [Serth, Katrin] Hannover Med Sch, Dept Mol Biol, Hannover, Germany; [Hennenlotter, Joerg; Stenzl, Arnulf] Univ Tubingen, Dept Urol, Tubingen, Germany	Hannover Medical School; Hannover Medical School; Eberhard Karls University of Tubingen	Serth, J (corresponding author), Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany.	serth.juergen@mh-hannover.de						Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Gebauer K, 2013, BRIT J CANCER, V108, P131, DOI 10.1038/bjc.2012.537; Hao ZR, 2008, P NATL ACAD SCI USA, V105, P3939, DOI 10.1073/pnas.0712366105; Ibanez de Caceres I, 2006, CANCER RES, V66, P5021, DOI 10.1158/0008-5472.CAN-05-3365; Issa JP, 2014, J CLIN INVEST, V124, P24, DOI 10.1172/JCI69735; Jin L, 2011, J MOL ENDOCRINOL, V47, P219, DOI 10.1530/JME-11-0048; Kageyama K, 1999, ENDOCRINOLOGY, V140, P5651, DOI 10.1210/en.140.12.5651; Kaprara A, 2010, CELL MOL LIFE SCI, V67, P1293, DOI 10.1007/s00018-010-0265-2; Larkin J, 2012, NAT REV UROL, V9, P147, DOI 10.1038/nrurol.2011.236; Morris MR, 2008, BRIT J CANCER, V98, P496, DOI 10.1038/sj.bjc.6604180; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Peters I, 2012, BJU INT, V110, pE144, DOI 10.1111/j.1464-410X.2011.10862.x; Sterrenburg L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028128; Tezval H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-199; Tezval H, 2009, WORLD J UROL, V27, P825, DOI 10.1007/s00345-009-0417-x; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Waalkes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-503; Wang JJ, 2008, CANCER INVEST, V26, P359, DOI 10.1080/07357900701788106; Yang YZ, 2007, FASEB J, V21, P543, DOI 10.1096/fj.06-6694com; Zhu C, 2014, CELL SIGNAL, V26, P1125, DOI 10.1016/j.cellsig.2014.02.002	25	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163873	10.1371/journal.pone.0163873	http://dx.doi.org/10.1371/journal.pone.0163873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695045	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100059
J	Woodfine, JD; Thiruchelvam, D; Redelmeier, DA				Woodfine, Jason D.; Thiruchelvam, Deva; Redelmeier, Donald A.			Off-Road Vehicle Crash Risk during the Six Months after a Birthday	PLOS ONE			English	Article							ALL-TERRAIN-VEHICLE; SNOWMOBILE INJURIES; AGGRESSIVE-BEHAVIOR; PHYSICAL-ACTIVITY; YOUNG-CHILDREN; UNITED-STATES; HELMET USE; HEALTH; ADOLESCENT; ASSOCIATIONS	Background Off-road vehicles are popular and thrilling for youth outside urban settings, yet sometimes result in a serious crash that requires emergency medical care. The relation between birthdays and the subsequent risk of an off-road vehicle crash is unknown. Methods We conducted a population-based before-and-after longitudinal analysis of youth who received emergency medical care in Ontario, Canada, due to an off-road vehicle crash between April 1, 2002, and March 31, 2014. We identified youth injured in an off-road vehicle crash through population-based health-care databases of individuals treated for medical emergencies. We included youth aged 19 years or younger, distinguishing juniors (age <= 15 years) from juveniles (age >= 16 years). Results A total 32,777 youths accounted for 35,202 emergencies due to off-road vehicle crashes within six months of their nearest birthday. Comparing the six months following a birthday to the six months prior to a birthday, crashes increased by about 2.7 events per 1000 juniors (18.3 vs 21.0, p < 0.0001). The difference equaled a 15% increase in relative risk (95% confidence interval 12 to 18). The increase extended for months following a birthday, was not observed for traffic crashes due to on-road vehicles, and was partially explained by a lack of helmet wearing. As expected, off-road crash risks did not change significantly following a birthday among juveniles (19.2 vs 19.8, p = 0.61). Conclusions Off-road vehicle crashes leading to emergency medical care increase following a birthday in youth below age 16 years. An awareness of this association might inform public health messages, gift-giving practices, age-related parental permissions, and prevention by primary care physicians.	[Woodfine, Jason D.; Redelmeier, Donald A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Woodfine, Jason D.; Thiruchelvam, Deva; Redelmeier, Donald A.] Sunnybrook Res Inst, Evaluat Clin Sci Program, Toronto, ON, Canada; [Woodfine, Jason D.; Thiruchelvam, Deva; Redelmeier, Donald A.] Inst Clin Evaluat Sci Ontario, Toronto, ON, Canada; [Redelmeier, Donald A.] Sunnybrook Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada; [Redelmeier, Donald A.] Ctr Leading Injury Prevent Practice Educ & Res, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Redelmeier, DA (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Redelmeier, DA (corresponding author), Sunnybrook Res Inst, Evaluat Clin Sci Program, Toronto, ON, Canada.; Redelmeier, DA (corresponding author), Inst Clin Evaluat Sci Ontario, Toronto, ON, Canada.; Redelmeier, DA (corresponding author), Sunnybrook Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada.; Redelmeier, DA (corresponding author), Ctr Leading Injury Prevent Practice Educ & Res, Toronto, ON, Canada.	dar@ices.on.ca			Canada Research Chair in Medical Decision Sciences; Canadian Institutes of Health Research; Comprehensive Research Experience for Medical Students Program of the University of Toronto	Canada Research Chair in Medical Decision Sciences(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Comprehensive Research Experience for Medical Students Program of the University of Toronto	This project was supported by a Canada Research Chair in Medical Decision Sciences, the Canadian Institutes of Health Research, and the Comprehensive Research Experience for Medical Students Program of the University of Toronto. The lead author (DAR) received all noted funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LE, 2013, J TRAUMA ACUTE CARE, V75, pS296, DOI 10.1097/TA.0b013e318292421f; Agence France-Presse, 2014, POL CHARG J BIEB ASS; Aitken ME, 2004, INJURY PREV, V10, P303, DOI 10.1136/ip.2003.004176; [Anonymous], 2008, ONT ROAD SAF ANN REP; [Anonymous], 1996, PATTERNS HLTH CARE O; Asbridge M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e536; Bansal V, 2008, AM J SURG, V195, P789, DOI 10.1016/j.amjsurg.2007.05.049; Bell CC, 2010, JAMA-J AM MED ASSOC, V304, P565, DOI 10.1001/jama.2010.1058; Bell DL, 2013, PEDIATRICS, V132, P535, DOI 10.1542/peds.2012-3414; Blecker N, 2012, PEDIATR EMERG CARE, V28, P443, DOI 10.1097/PEC.0b013e3182531d20; Borse NN, 2008, CDC CHILDHOOD INJURY, DOI [10.1097/01.FCH.0000347986.44810.59, DOI 10.1097/01.FCH.0000347986.44810.59]; Brann M, 2012, INJURY PREV, V18, P234, DOI 10.1136/injuryprev-2011-040132; Brown RL, 2002, J PEDIATR SURG, V37, P375, DOI 10.1053/jpsu.2002.30826; Bull MJ, 2000, PEDIATRICS, V105, P1352, DOI 10.1542/peds.105.6.1352; Burd R, 2009, J PEDIATR SURG, V44, P1638, DOI 10.1016/j.jpedsurg.2009.03.026; Canadian Institute for Health Information, 2008, CIHI DAT QUAL STUD E, V2; Christakis DA, 2013, PEDIATRICS, V131, P431, DOI 10.1542/peds.2012-1493; Clarke S, 2005, J OCCUP ORGAN PSYCH, V78, P355, DOI 10.1348/096317905X26183; Collins CL, 2007, PEDIATRICS, V120, P134, DOI 10.1542/peds.2006-3612; Coon JT, 2011, ENVIRON SCI TECHNOL, V45, P1761, DOI 10.1021/es102947t; Council on Communications and Media, 2010, Pediatrics, V126, P576, DOI 10.1542/peds.2010-1544; Denning GM, 2013, ACCIDENT ANAL PREV, V52, P64, DOI 10.1016/j.aap.2012.12.015; Deyton L, 2010, NEW ENGL J MED, V362, P1753, DOI 10.1056/NEJMp1004152; Diekema DS, 2012, NEW ENGL J MED, V366, P391, DOI 10.1056/NEJMp1113008; DOLAN MA, 1989, PEDIATRICS, V84, P694; Duke NN, 2010, PEDIATRICS, V125, pE778, DOI 10.1542/peds.2009-0597; Dunlop SM, 2010, INJURY PREV, V16, P315, DOI 10.1136/ip.2009.025999; Dunlop SM, 2010, J ADOLESCENT HEALTH, V46, P90, DOI 10.1016/j.jadohealth.2009.06.005; Ellis S, 2013, CHILDRENS DEV SOCIAL; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Fonseca AH, 2005, AM SURGEON, V71, P937; Gardner HG, 2007, PEDIATRICS, V119, P202, DOI 10.1542/peds.2006-2899; Gentile DA, 2014, JAMA PEDIATR, V168, P450, DOI 10.1001/jamapediatrics.2014.63; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Gittelman MA, 2006, PEDIATRICS, V117, P2190, DOI 10.1542/peds.2005-2603; Glazier RH, 2003, CAN J PUBLIC HEALTH, V94, P140, DOI 10.1007/BF03404588; Grimes DA, 2002, LANCET, V359, P248, DOI 10.1016/S0140-6736(02)07451-2; Hafner JW, 2012, PEDIATR EMERG CARE, V28, P739, DOI 10.1097/PEC.0b013e31826249f9; Hayek FA, 2012, LAW LEGISLATION LIBE, P72, DOI [10.1021/es102947tPMID:21291246, DOI 10.1021/ES102947T]; Hooper C, 2012, J MED ETHICS, V38, P338, DOI 10.1136/medethics-2011-100085; Iosua EE, 2014, J ADOLESCENT HEALTH, V55, P542, DOI 10.1016/j.jadohealth.2014.03.018; Iron K, 1995, CONCORDANCE HOSP DIS; Iron K, 2008, LIVING DYING ONTARIO; Jonah BA, 1997, ACCIDENT ANAL PREV, V29, P651, DOI 10.1016/S0001-4575(97)00017-1; Juurlink D, 2006, CANADIAN I HLTH INFO; KAHNEMAN D, 1973, PSYCHOL REV, V80, P237, DOI 10.1037/h0034747; Karhausen LR, 2001, INT J EPIDEMIOL, V30, P704, DOI 10.1093/ije/30.4.704; Kass NE, 2001, AM J PUBLIC HEALTH, V91, P1776, DOI 10.2105/AJPH.91.11.1776; Keenan HT, 2004, PEDIATRICS, V113, pE330, DOI 10.1542/peds.113.4.e330; Kendler KS, 2014, JAMA PSYCHIAT, V71, P439, DOI 10.1001/jamapsychiatry.2013.4166; Khambalia A, 2005, PEDIATRICS, V116, P939, DOI 10.1542/peds.2005-0518; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; Krauss EM, 2010, J TRAUMA, V69, P1338, DOI 10.1097/TA.0b013e3181fc5e7b; Landen MG, 2003, PEDIATRICS, V111, P328, DOI 10.1542/peds.111.2.328; Larson AN, 2012, MED SPORT SCI, V58, P158, DOI 10.1159/000338728; Lee RD, 2013, PEDIATRICS, V131, pE1188, DOI 10.1542/peds.2012-0627; Lewis MA, 2008, PSYCHOL ADDICT BEHAV, V22, P176, DOI 10.1037/0893-164X.22.2.176; Li KG, 2014, PEDIATRICS, V133, P620, DOI 10.1542/peds.2013-2786; Lord S, 2010, CAN J NEUROL SCI, V37, P343, DOI 10.1017/S0317167100010234; Macpherson AK., 2005, INJURIES ONTARIO ICE; Mann MJ, 2009, LEISURE SCI, V31, P384, DOI 10.1080/01490400902988317; Masten SV, 2011, JAMA-J AM MED ASSOC, V306, P1098, DOI 10.1001/jama.2011.1277; McBride AS, 2011, PEDIATR EMERG CARE, V27, P97, DOI 10.1097/PEC.0b013e31820942f8; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; National Safe Kids Campaign, 2005, FOLL LEAD NAT STUD S; Njoroge WFM, 2013, JAMA PEDIATR, V167, P739, DOI 10.1001/jamapediatrics.2013.75; Novak JA, 2013, J PRIM CARE COMMUNIT, V4, P8, DOI 10.1177/2150131912446374; Ontario Medical Association, 2009, POS PAP ALL TERR VEH; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Ouimet MC, 2014, JAMA PEDIATR, V168, P517, DOI 10.1001/jamapediatrics.2013.5387; Owen R, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003985.pub3; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Pelletier JS, 2012, CAN J SURG, V55, P249, DOI 10.1503/cjs.036210; Pierz JJ, 2003, CLIN ORTHOP RELAT R, P29, DOI 10.1097/01.blo.0000057781.10364.c9; Ranney ML, 2010, ACCIDENT ANAL PREV, V42, P2057, DOI 10.1016/j.aap.2010.06.017; Redelmeier DA, 2014, CAN MED ASSOC J, V186, P742, DOI 10.1503/cmaj.131650; Redelmeier DA, 2013, J CLIN EPIDEMIOL, V66, P955, DOI 10.1016/j.jclinepi.2013.05.003; Rice MR, 2000, PEDIATRICS, V105, P615, DOI 10.1542/peds.105.3.615; Robertson DW, 2014, ACCIDENT ANAL PREV, V70, P314, DOI 10.1016/j.aap.2014.04.011; Rodgers GB, 2001, AM J EPIDEMIOL, V153, P1112, DOI 10.1093/aje/153.11.1112; ROWE B, 1992, CAN MED ASSOC J, V146, P147; Rutledge PC, 2008, J CONSULT CLIN PSYCH, V76, P511, DOI 10.1037/0022-006X.76.3.511; Rutter DR, 1998, BRIT J PSYCHOL, V89, P681, DOI 10.1111/j.2044-8295.1998.tb02710.x; Sandler G, 2012, PEDIATR EMERG CARE, V28, P1328, DOI 10.1097/PEC.0b013e318276b0d2; Santos RG, 2014, JAMA PEDIATR, V168, P330, DOI 10.1001/jamapediatrics.2013.3688; Schoenhals M, 1998, SOC FORCES, V77, P723, DOI 10.2307/3005545; Scutchfield SB, 2003, CLIN ORTHOP RELAT R, P61, DOI 10.1097/01.blo.0000060441.40507.3e; Sessions SY, 2010, JAMA-J AM MED ASSOC, V303, P2078, DOI 10.1001/jama.2010.654; Shulruf B, 2010, ACCIDENT ANAL PREV, V42, P612, DOI 10.1016/j.aap.2009.10.007; Shults RA, 2013, PEDIATRICS, V132, P282, DOI 10.1542/peds.2013-0751; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Specialty Vehicle Institute of America, 2012, STAT ALL TERR VEH RE; Statistics Canada, LAND FRESHW AR PROV; Statistics Canada, EST POP AG GROUP SEX; Strasburger VC, 2010, PEDIATRICS, V126, P791, DOI 10.1542/peds.2010-1635; ter Bogt TFM, 2013, PEDIATRICS, V131, pE380, DOI 10.1542/peds.2012-0708; Trauma Comm Canadian Assoc Pediat, 2008, J PEDIATR SURG, V43, P938, DOI 10.1016/j.jpedsurg.2007.12.044; U.S. Government Accountability Office, 2010, USITC PUBL; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Weiss H, 2010, PEDIATRICS, V126, P1149, DOI 10.1542/peds.2010-0902; Whitaker RC, 2003, ARCH PEDIAT ADOL MED, V157, P725, DOI 10.1001/archpedi.157.8.725; Whitehill JM, 2014, JAMA PEDIATR, V168, P618, DOI 10.1001/jamapediatrics.2013.5300; WHO, 2010, INT STAT CLASS DIS R; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Wilkins R, 1993, Health Rep, V5, P157; Wilkins R., 2004, AUTOMATED GEOGRAPHIC; Williams JI, 1996, INVENTORY STUDIES AC; Williams RS, 2011, J RURAL HEALTH, V27, P255, DOI 10.1111/j.1748-0361.2010.00327.x; World Health Organization, 2013, WHO GLOB STAT REP RO; World Health Organization, 2015, WHO GLOB STAT REP RO; Wu BC, 2005, PEDIATR EMERG CARE, V21, P730, DOI 10.1097/01.pec.0000186426.69517.24; Yanchar NL, 2012, PAED CHILD HEALT-CAN, V17, P513, DOI 10.1093/pch/17.9.513; Yuma Paula J, 2006, J Pediatr Health Care, V20, P67, DOI 10.1016/j.pedhc.2005.10.002; Zahrt DM, 2011, PEDIATR REV, V32, P325, DOI 10.1542/pir.32-8-325	115	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0149536	10.1371/journal.pone.0149536	http://dx.doi.org/10.1371/journal.pone.0149536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695070	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100001
J	Yue, YL; Ke, SS; Zhou, W; Chang, J				Yue, Yuanlei; Ke, Shanshan; Zhou, Wei; Chang, Jin			In Vivo Imaging Reveals Composite Coding for Diagonal Motion in the Drosophila Visual System	PLOS ONE			English	Article							ORIENTATION SELECTIVITY; CORTEX; NEURONS; CIRCUIT; BEHAVIOR; VISION; FLIES; CAT	Understanding information coding is important for resolving the functions of visual neural circuits. The motion vision system is a classic model for studying information coding as it contains a concise and complete information-processing circuit. In Drosophila, the axon terminals of motion-detection neurons (T4 and T5) project to the lobula plate, which comprises four regions that respond to the four cardinal directions of motion. The lobula plate thus represents a topographic map on a transverse plane. This enables us to study the coding of diagonal motion by investigating its response pattern. By using in vivo two-photon calcium imaging, we found that the axon terminals of T4 and T5 cells in the lobula plate were activated during diagonal motion. Further experiments showed that the response to diagonal motion is distributed over the following two regions compared to the cardinal directions of motion-a diagonal motion selective response region and a non-selective response region-which overlap with the response regions of the two vector-correlated cardinal directions of motion. Interestingly, the sizes of the nonselective response regions are linearly correlated with the angle of the diagonal motion. These results revealed that the Drosophila visual system employs a composite coding for diagonal motion that includes both independent coding and vector decomposition coding.	[Yue, Yuanlei; Ke, Shanshan; Zhou, Wei; Chang, Jin] Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China; [Yue, Yuanlei; Ke, Shanshan; Zhou, Wei; Chang, Jin] Huazhong Univ Sci & Technol, MoE Key Lab Biomed Photon, Dept Biomed Engn, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chang, J (corresponding author), Huazhong Univ Sci & Technol, Wuhan Natl Lab Optoelect, Britton Chance Ctr Biomed Photon, Wuhan 430074, Peoples R China.; Chang, J (corresponding author), Huazhong Univ Sci & Technol, MoE Key Lab Biomed Photon, Dept Biomed Engn, Wuhan 430074, Peoples R China.	changjin@mail.hust.edu.cn	Ke, Shanshan/HDL-7396-2022		National Basic Research Programme of China [2015CB352006]; Science Fund for Creative Research Group of China [61421064]; China Postdoctoral Science Foundation [2013M542010, 2015T80788]; Fundamental Research Funds for the Central Universities/HUST [2016YXMS034, 2014TS015]; Director Fund of WNLO; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Basic Research Programme of China(National Basic Research Program of China); Science Fund for Creative Research Group of China(Science Fund for Creative Research Groups); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities/HUST(Fundamental Research Funds for the Central Universities); Director Fund of WNLO; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Basic Research Programme of China (Grant No. 2015CB352006), Science Fund for Creative Research Group of China (Grant No. 61421064), China Postdoctoral Science Foundation founded project (2013M542010, 2015T80788), Fundamental Research Funds for the Central Universities/HUST (2016YXMS034, 2014TS015), and the Director Fund of WNLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Borst A, 2014, NAT REV NEUROSCI, V15, P590, DOI 10.1038/nrn3799; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Fisher YE, 2015, NEURON, V88, P390, DOI 10.1016/j.neuron.2015.09.033; GILBERT C, 1995, J COMP NEUROL, V361, P285, DOI 10.1002/cne.903610207; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Gutig R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053063; Hopp E, 2014, J COMP PHYSIOL A, V200, P359, DOI 10.1007/s00359-014-0893-3; Hupe JM, 2004, VISION RES, V44, P489, DOI 10.1016/j.visres.2003.07.013; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Kremkow J, 2016, NATURE, V533, P52, DOI 10.1038/nature17936; Lee KS, 2016, NATURE, V533, P90, DOI 10.1038/nature17941; Lee YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126265; Maisak MS, 2013, NATURE, V500, P212, DOI 10.1038/nature12320; Mauss AS, 2015, CELL, V162, P351, DOI 10.1016/j.cell.2015.06.035; Muijres FT, 2014, SCIENCE, V344, P172, DOI 10.1126/science.1248955; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Shinomiya K, 2014, CURR BIOL, V24, P1062, DOI 10.1016/j.cub.2014.03.051; Spalthoff C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-36; Sun WZ, 2016, NAT NEUROSCI, V19, P308, DOI 10.1038/nn.4196; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Tanabe S, 2013, NEUROSCI RES, V76, P101, DOI 10.1016/j.neures.2013.03.010; van Hemmen JL, 2008, BIOL CYBERN, V98, P509, DOI 10.1007/s00422-008-0215-3; Van Hooser SD, 2005, J NEUROSCI, V25, P19, DOI 10.1523/JNEUROSCI.4042-04.2005; Wasserman SM, 2015, CURR BIOL, V25, P467, DOI 10.1016/j.cub.2014.12.012; Ziskind AJ, 2015, J NEUROPHYSIOL, V113, P2555, DOI 10.1152/jn.00646.2014	32	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164020	10.1371/journal.pone.0164020	http://dx.doi.org/10.1371/journal.pone.0164020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695103	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100076
J	Huang, S; Xu, LL; Sun, YX; Lin, S; Gu, WD; Liu, YM; Zhang, JF; Chen, L; Li, G				Huang, Shuo; Xu, Liangliang; Sun, Yuxin; Lin, Sien; Gu, Weidong; Liu, Yamei; Zhang, Jinfang; Chen, Lin; Li, Gang			Systemic Administration of Allogeneic Mesenchymal Stem Cells Does Not Halt Osteoporotic Bone Loss in Ovariectomized Rats	PLOS ONE			English	Article							MARROW STROMAL CELLS; INHIBITS OSTEOCLASTOGENESIS; PROMOTE; THERAPY; MICE; PROLIFERATION; INTERLEUKIN-6; EXPRESSION; INCREASE; DISEASE	Mesenchymal stem cells (MSCs) have innate ability to self-renew and immunosuppressive functions, and differentiate into various cell types. They have become a promising cell source for treating many diseases, particular for bone regeneration. Osteoporosis is a common metabolic bone disorder with elevated systemic inflammation which in turn triggers enhanced bone loss. We hypothesize that systemic infusion of MSCs may suppress the elevated inflammation in the osteoporotic subjects and slow down bone loss. The current project was to address the following two questions: (1) Will a single dose systemic administration of allogenic MSCs have any effect on osteoporotic bone loss? (2) Will multiple administration of allogenic MSCs from single or multiple donors have similar effect on osteoporotic bone loss? 18 ovariectomized (OVX) rats were assigned into 3 groups: the PBS control group, MSCs group 1 (receiving 2x10(6) GFP-MSCs at Day 10, 46, 91 from the same donor following OVX) and MSCs group 2 (receiving 2x10(6) GFP-MSCs from three different donors at Day 10, 46, 91). Examinations included Micro-CT, serum analysis, mechanical testing, immunofluorescence staining and bone histomorphometry analysis. Results showed that BV/TV at Day 90, 135, BMD of TV and trabecular number at Day 135 in the PBS group were significantly higher than those in the MSCs group 2, whereas trabecular spacing at Day 90, 135 was significantly smaller than that in MSCs group 2. Mechanical testing data didn't show significant difference among the three groups. In addition, the ELISA assay showed that level of Rantes in serum in MSCs group 2 was significantly higher than that of the PBS group, whereas IL-6 and IL-10 were significantly lower than those of the PBS group. Bone histomorphometry analysis showed that Oc.S/BS and Oc.N/BS in the PBS group were significant lower than those in MSCs group 2; Ob.S/BS and Ob.N/BS did not show significant difference among the three groups. The current study demonstrated that systemic administration of allogenic MSCs had no obvious effect on osteoporotic bone loss in OVX rats when using the cells from the same donor; and repeated injection of allogeneic MSCs from different donors might promote bone loss in OVX rats. These findings indicate that despite allogenic MSCs systemic infusion is safe, their administration alone may not be an effective mean for preventing osteoporotic bone loss.	[Huang, Shuo; Chen, Lin] Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury,Dapi, Dept Rehabil Med,Ctr Bone Metab & Repair,Trauma C, Chongqing, Peoples R China; [Huang, Shuo; Xu, Liangliang; Sun, Yuxin; Lin, Sien; Zhang, Jinfang; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China; [Xu, Liangliang; Sun, Yuxin; Lin, Sien; Li, Gang] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Prince Wales Hosp, Stem Cells & Regenerat Med Lab, Shatin, Hong Kong, Peoples R China; [Xu, Liangliang; Lin, Sien; Li, Gang] Chinese Univ Hong Kong, CUHK ACC Space Med Ctr Hlth Maintenance Musculosk, Shenzhen Res Inst, Shenzhen, Peoples R China; [Gu, Weidong] Changzhou Seventh Peoples Hosp, Orthopaed Res Lab, Changzhou, Jiangshu Provin, Peoples R China; [Liu, Yamei] Guang Zhou Univ Tradit Chinese Med, Coll Fundamental Med Sci, Guangzhou, Guangdong, Peoples R China	Army Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong, Shenzhen	Chen, L (corresponding author), Third Mil Med Univ, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury,Dapi, Dept Rehabil Med,Ctr Bone Metab & Repair,Trauma C, Chongqing, Peoples R China.; Li, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Fac Med, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China.; Li, G (corresponding author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Prince Wales Hosp, Stem Cells & Regenerat Med Lab, Shatin, Hong Kong, Peoples R China.; Li, G (corresponding author), Chinese Univ Hong Kong, CUHK ACC Space Med Ctr Hlth Maintenance Musculosk, Shenzhen Res Inst, Shenzhen, Peoples R China.	linchen70@163.com; gangli@cuhk.edu.hk	Liangliang, XU/K-9185-2019; Lin, Sien/J-7773-2018; H, Leo/AAK-9668-2020; Li, Gang/J-7830-2018	Liangliang, XU/0000-0002-5249-7480; Lin, Sien/0000-0002-7292-7062; H, Leo/0000-0001-9495-4339; Li, Gang/0000-0002-3981-2239; Liu, Yamei/0000-0002-0770-8381	Hong Kong Government Research Grant Council, General Research Fund [CUHK470813, CUHK14119115]; China Shenzhen City Science and Technology Bureau under Shenzhen City Knowledge Innovation Plan [GJHZ20140419120051680]; SMART program, Lui Che Woo Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong	Hong Kong Government Research Grant Council, General Research Fund; China Shenzhen City Science and Technology Bureau under Shenzhen City Knowledge Innovation Plan; SMART program, Lui Che Woo Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong	This work is supported by a grant from Hong Kong Government Research Grant Council, General Research Fund (CUHK470813 and CUHK14119115), and a grant from China Shenzhen City Science and Technology Bureau under the Shenzhen City Knowledge Innovation Plan, Research Project (GJHZ20140419120051680) to Gang Li. This study was also supported in part by SMART program, Lui Che Woo Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong. This research project was made possible by resources donated by Lui Che Woo Foundation Limited.	[Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; [Anonymous], 2003, World Health Organ Tech Rep Ser, V921, P1; Asari S, 2009, EXP HEMATOL, V37, P604, DOI 10.1016/j.exphem.2009.01.005; BELLIDO T, 1995, J CLIN INVEST, V95, P2886, DOI 10.1172/JCI117995; Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202; Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; Cao L, 2012, J BIOMED MATER RES B, V100B, P1229, DOI 10.1002/jbm.b.32687; Capozzi A, 2013, CLIN CASES MINER BON, V10, P199, DOI 10.11138/ccmbm/2013.10.3.199; Chan JKY, 2013, CANCER GENE THER, V20, P539, DOI 10.1038/cgt.2013.59; Cole JH, 2011, CLIN ORTHOP RELAT R, V469, P2139, DOI 10.1007/s11999-011-1784-3; Evans KE, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-4; Guan M, 2012, NAT MED, V18, P456, DOI 10.1038/nm.2665; Kassem M, 2008, CELL TISSUE RES, V331, P157, DOI 10.1007/s00441-007-0509-0; Kendler D, 2011, CLIMACTERIC, V14, P604; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Lapinet JA, 2000, INFECT IMMUN, V68, P6917, DOI 10.1128/IAI.68.12.6917-6923.2000; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Leung KS, 2009, J ORTHOP RES, V27, P458, DOI 10.1002/jor.20753; Li H, 2008, STEM CELLS, V26, P2531, DOI 10.1634/stemcells.2008-0146; Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Meyer KC, 2014, EXPERT REV RESP MED, V8, P263, DOI 10.1586/17476348.2014.880054; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Park BL, 2004, J BIOCHEM MOL BIOL, V37, P691; Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Wintges K, 2013, J BONE MINER RES, V28, P2070, DOI 10.1002/jbmr.1937; XU LX, 1995, J CELL PHYSIOL, V165, P624, DOI 10.1002/jcp.1041650321; Yu TM, 2014, MAYO CLIN PROC, V89, P888, DOI 10.1016/j.mayocp.2014.02.017; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910; Zhang T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt221; Zhou Y, 2014, BIOTECHNOL J, V9, P944, DOI 10.1002/biot.201300310	41	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163131	10.1371/journal.pone.0163131	http://dx.doi.org/10.1371/journal.pone.0163131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711227	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600014
J	Patel, MA; Mener, DJ; Garcia-Esquinas, E; Navas-Acien, A; Agrawal, Y; Lin, SY				Patel, Mira A.; Mener, David J.; Garcia-Esquinas, Esther; Navas-Acien, Ana; Agrawal, Yuri; Lin, Sandra Y.			Tobacco Smoke Exposure and Eustachian Tube Disorders in US Children and Adolescents	PLOS ONE			English	Article							MIDDLE-EAR EFFUSION; ACUTE OTITIS-MEDIA; PARENTAL SMOKING; PASSIVE SMOKING; CIGARETTE-SMOKE; RISK-FACTORS; CHILDHOOD; DISEASE; CARE	Objectives To describe the association between active, environmental tobacco smoke (ETS) exposure and the prevalence of eustachian tube dysfunction (ETD) in the U.S. pediatric population. Study Design Cross-sectional. Setting U.S. representative demographic and audiometric data from the National Health and Nutrition Examination Survey (NHANES); 2005-2010. Subjects and Methods The study consisted of 2,977 children aged 12-19 years. ETD was defined as middle ear pressure < 100mm H20. ETS was defined as non-active smoking in individuals with serum cotinine over the limit of detection (>= 0.015 ng/ mL) and < 10 ng/ mL(N = 1559). Results The prevalence of ETD was 6.1%. After multivariate adjustment for age, sex, body mass index, education level, ethnicity, or having a cold, sinus problem or earache during the last 24 hours, compared to unexposed children, the odds ratios (95% confidence interval) of ETD for those exposed to ETS ages 12-15 in the first, second and third tertile of cotinine concentrations were, respectively, 1.38 (0.53-3.60), 0.99 (0.53-3.60) and 2.67 (1.12-6.34). Similarly, the odds ratios (95% confidence interval) of ETD for those exposed to ETS ages 16-19 in the first, second and third tertile of cotinine concentrations were, respectively, 1.28 (0.48-3.41), 0.99 (0.40-2.48) and 2.86 (1.19-6.88). Conclusion These data suggest that children and adolescents exposed to high concentrations of ETS may have an increased prevalence of ETD.	[Patel, Mira A.; Mener, David J.; Agrawal, Yuri; Lin, Sandra Y.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Garcia-Esquinas, Esther; Navas-Acien, Ana] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci & Epidemiol, Baltimore, MD USA; [Garcia-Esquinas, Esther] Univ Autonoma Madrid IdiPaz, Sch Med, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Garcia-Esquinas, Esther] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Lin, SY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	slin30@jhmi.edu	garcia, esther/AAR-8372-2021	Patel, Mira/0000-0002-4926-5128; garcia-esquinas, Esther/0000-0002-8688-5174				Alpert HR, 2011, TOB CONTROL, V20, P207, DOI 10.1136/tc.2010.038711; BARR GS, 1991, BRIT MED J, V303, P1032, DOI 10.1136/bmj.303.6809.1032; Bennett KE, 1998, J EPIDEMIOL COMMUN H, V52, P786, DOI 10.1136/jech.52.12.786; Benowitz Neal L, 2009, Handb Exp Pharmacol, P29, DOI 10.1007/978-3-540-69248-5_2; BLAKLEY BW, 1995, OTOLARYNG HEAD NECK, V112, P441; Bluestone CD, 1996, PEDIATR INFECT DIS J, V15, P281, DOI 10.1097/00006454-199604000-00002; Csakanyi Z, 2012, INT J PEDIATR OTORHI, V76, P989, DOI 10.1016/j.ijporl.2012.03.017; da Costa JL, 2004, INT J EPIDEMIOL, V33, P573, DOI 10.1093/ije/dyh071; Dubin MG, 2002, OTOLARYNG HEAD NECK, V126, P14, DOI 10.1067/mhn.2002.121320; ETZEL RA, 1992, PEDIATRICS, V90, P228; Gryczynska D, 1999, INT J PEDIATR OTORHI, V49, pS275; GULYA AJ, 1994, OTOLARYNG HEAD NECK, V111, P6, DOI 10.1177/019459989411100103; Haberg SE, 2010, ACTA PAEDIATR, V99, P99, DOI 10.1111/j.1651-2227.2009.01506.x; Hammaren-Malmi S, 2005, ACTA OTO-LARYNGOL, V125, P1051, DOI 10.1080/00016480510038040; HINTON AE, 1989, J LARYNGOL OTOL, V103, P559, DOI 10.1017/S0022215100109326; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Jones LL, 2012, ARCH PEDIAT ADOL MED, V166, P18, DOI 10.1001/archpediatrics.2011.158; Kaufmann R. B., 2010, Morbidity and Mortality Weekly Report, V59, P1141; Kong SK, 2009, AM J OTOLARYNG, V30, P376, DOI 10.1016/j.amjoto.2008.07.009; KRAEMER MJ, 1983, JAMA-J AM MED ASSOC, V249, P1022, DOI 10.1001/jama.249.8.1022; Lasisi AO, 2007, INT J PEDIATR OTORHI, V71, P1549, DOI 10.1016/j.ijporl.2007.06.005; Lee IW, 2006, OTOL NEUROTOL, V27, P433, DOI 10.1097/00129492-200604000-00023; Office on Smoking and Health, 2006, HLTH CONS INV EXP TO; OWEN MJ, 1993, J PEDIATR-US, V123, P702, DOI 10.1016/S0022-3476(05)80843-1; Preciado D, 2010, LARYNGOSCOPE, V120, P2508, DOI 10.1002/lary.21014; ROWEJONES JM, 1992, INT J PEDIATR OTORHI, V24, P19, DOI 10.1016/0165-5876(92)90062-T; STENSTROM R, 1993, INT J PEDIATR OTORHI, V27, P127, DOI 10.1016/0165-5876(93)90128-P; STRACHAN DP, 1990, J LARYNGOL OTOL, V104, P4, DOI 10.1017/S0022215100111648; STRACHAN DP, 1989, BRIT MED J, V298, P1549, DOI 10.1136/bmj.298.6687.1549; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086397	30	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163926	10.1371/journal.pone.0163926	http://dx.doi.org/10.1371/journal.pone.0163926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711178	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600053
J	Ye, HX; Huang, HG; Cao, F; Chen, MT; Zheng, XJ; Zhan, RY				Ye, Hongxing; Huang, Hongguang; Cao, Fei; Chen, Mantao; Zheng, Xiujue; Zhan, Renya			HSPB1 Enhances SIRT2-Mediated G6PD Activation and Promotes Glioma Cell Proliferation	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; HSP27; PROTEINS; SURVIVAL; RESISTANCE; DISEASE; CANCER; ALPHA; DEATH	Heat shock proteins belong to a conserved protein family and are involved in multiple cellular processes. Heat shock protein 27 (Hsp27), also known as heat HSPB1, participates in cellular responses to not only heat shock, but also oxidative or chemical stresses. However, the contribution of HSPB1 to anti-oxidative response remains unclear. Here, we show that HSPB1 activates G6PD in response to oxidative stress or DNA damage. HSPB1 enhances the binding between G6PD and SIRT2, leading to deacetylation and activation of G6PD. Besides, HSPB1 activates G6PD to sustain cellular NADPH and pentose production in glioma cells. High expression of HSPB1 correlates with poor survivalrate of glioma patients. Together, our study uncovers the molecular mechanism by which HSPB1 activates G6PD to protect cells from oxidative and DNA damage stress.	[Ye, Hongxing; Huang, Hongguang; Cao, Fei; Chen, Mantao; Zheng, Xiujue; Zhan, Renya] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhan, RY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China.	xiujzheng@gmail.com; zhanryneurosurgery@163.com			Zhejiang Provincial Science and Technology Plan [2013C33248]; Zhejiang Provincial Traditional Chinese Medicine Science and Technology Plan [2016ZA122]; Zhejiang Provincial Medical and Health Science and Technology Plan [2016KYA085]	Zhejiang Provincial Science and Technology Plan; Zhejiang Provincial Traditional Chinese Medicine Science and Technology Plan; Zhejiang Provincial Medical and Health Science and Technology Plan	This work was supported by grants of Zhejiang Provincial Science and Technology Plan (no. 2013C33248), Zhejiang Provincial Traditional Chinese Medicine Science and Technology Plan (no. 2016ZA122), and Zhejiang Provincial Medical and Health Science and Technology Plan (no. 2016KYA085).	Brophy CM, 2002, WORLD J SURG, V26, P779, DOI 10.1007/s00268-002-4052-6; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Golembieski WA, 2008, GLIA, V56, P1061, DOI 10.1002/glia.20679; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Jaattela M, 1999, EXP CELL RES, V248, P30, DOI 10.1006/excr.1999.4455; Kato K, 1996, J NEUROCHEM, V66, P946; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li JY, 2012, J NEURO-ONCOL, V110, P187, DOI 10.1007/s11060-012-0963-8; Richards EH, 1996, CANCER RES, V56, P2446; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Ursini MV, 1997, BIOCHEM J, V323, P801, DOI 10.1042/bj3230801; Vallat L, 2003, BLOOD, V101, P4598, DOI 10.1182/blood-2002-06-1743; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224; Wang YP, 2015, MOL CELL, V57, P662, DOI 10.1016/j.molcel.2014.12.023; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xu SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep32734	23	28	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164285	10.1371/journal.pone.0164285	http://dx.doi.org/10.1371/journal.pone.0164285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711253	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600111
J	Corona, G; Giorda, CB; Cucinotta, D; Guida, P; Nada, E				Corona, Giovanni; Giorda, Carlo B.; Cucinotta, Domenico; Guida, Piero; Nada, Elisa		SUBITO-DE Study Grp	Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors	PLOS ONE			English	Article							LATE-ONSET HYPOGONADISM; REPORTED ERECTILE DYSFUNCTION; SILDENAFIL CITRATE VIAGRA(R); QUALITY-OF-LIFE; DOUBLE-BLIND; TESTOSTERONE SUPPLEMENTATION; CARDIOVASCULAR RISK; OLDER MEN; PREVALENCE; PARTNERS	Aims To present the longitudinal data of the SUBITO-DE study, a prospective survey involving male patients with new or recently diagnosed type 2 diabetes mellitus (T2DM) (<24 months). Materials and Methods Sexual function was assessed in male patients with T2DM at baseline (phase 1) and after a mean follow-up of 18 months (phase 2). Standard metabolic parameters and sexual and depressive symptoms were evaluated. Results Six of the 499 enrolled patients died of different causes during phase 1. Of the 493 surviving men invited to participate in phase 2, 450 (mean age 59.0 +/- 9.0 years) (90.2%) accepted and 43 (8.2%) were lost to follow-up. As compared to baseline, the proportion of the men who reported improvement in erectile dysfunction (ED) at follow-up was nearly double that of the men who reported worsening of ED (22.6% vs. 12.8%). The increase in frequency of sexual activity the men reported at follow-up assessment indicates that many never treated before baseline were taking an ED drug during the study period (106 subjects). Phosphodiesterase type 5 inhibitors (PDE5i) were the ED drugs most commonly taken at both baseline and follow-up. An overall improvement over baseline values was observed in metabolic targets for T2DM and depressive symptoms. Conversely, no change in lifestyle behaviors was recorded during the study. Conclusions Sexual dysfunction is a major concern in men with T2DM. The SUBITO-DE study demonstrates that, when combined with adequate counseling and tailored PDE5i therapy, an integrated approach to achieving metabolic targets in men with T2DM can improve sexual function as well as depressive symptoms.	[Corona, Giovanni] Major Hosp, Endocrinol Unit, Bologna, Italy; [Giorda, Carlo B.] ASL Turin 5, Metab & Diabet Unit, Chieri, Italy; [Cucinotta, Domenico] Policl Messina, Dept Med, Messina, Italy; [Guida, Piero] Stat Consultant Assoc Med Diabetol, Rome, Italy; [Nada, Elisa] Chaira Med Assoc, Chieri, Italy	AOU Policlinico Gaetano Martino	Corona, G (corresponding author), Major Hosp, Endocrinol Unit, Bologna, Italy.	jocorona@libero.it	Giorda, Carlo B/D-4485-2018; Clemente, Gennaro/AAY-6148-2020	Giorda, Carlo B/0000-0002-4709-8696; Clemente, Gennaro/0000-0001-5163-5557; Guarino, Giuseppina/0000-0002-5057-9650; CUCINOTTA, Domenico Maria/0000-0002-8159-5709	Bayer Healthcare	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals)	Bayer Healthcare provided an unrestricted grant. Bayer had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aversa A, 2015, NAT REV UROL, V12, P641, DOI 10.1038/nrurol.2015.238; Ballotari P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1403-4; Bancroft J, 2003, ARCH SEX BEHAV, V32, P193, DOI 10.1023/A:1023420431760; Bjerggaard M, 2015, SEX MED-UK, V3, P302, DOI 10.1002/sm2.91; Boddi V, 2015, ANDROLOGY IN PRESS; Bruno G, 2011, NUTR METAB CARDIOVAS, V21, P302, DOI 10.1016/j.numecd.2010.08.009; Burri A, 2015, INT J IMPOT RES, V27, P191, DOI 10.1038/ijir.2015.14; Buvat J, 2013, J SEX MED, V10, P245, DOI 10.1111/j.1743-6109.2012.02783.x; Carvalheira AA, 2012, J SEX MED, V9, P2361, DOI 10.1111/j.1743-6109.2012.02787.x; Chevret-Measson M, 2009, J SEX MED; Conaglen HM, 2008, J SEX MED, V5, P1198, DOI 10.1111/j.1743-6109.2008.00774.x; Conaglen HM, 2008, SEX RELATSH THER, V23, P147, DOI [10.1080/14681990801918680, DOI 10.1080/14681990801918680]; Conaglen JV, 2009, J SEX MED, V6, P456, DOI 10.1111/j.1743-6109.2008.01043.x; Corona G, 2015, MOL CELL ENDOCRINOL, V418, P120, DOI 10.1016/j.mce.2015.06.031; Corona G, 2013, J ENDOCRINOL INVEST, V36, P864, DOI 10.3275/8969; Corona G, 2013, ANDROLOGY-US, V1, P864, DOI 10.1111/j.2047-2927.2013.00139.x; Corona G, 2013, BEST PRACT RES CL EN, V27, P557, DOI 10.1016/j.beem.2013.05.002; Corona G, 2011, J ENDOCRINOL INVEST, V34, P232, DOI [10.3275/7501, 10.1007/BF03347072]; Corona G, 2008, J ENDOCRINOL INVEST, V31, P799, DOI 10.1007/BF03349261; Corona G, 2016, MINERVA END IN PRESS; Corona G, 2008, J SEX MED, V5, P2623, DOI 10.1111/j.1743-6109.2008.00982.x; Corona G, 2016, EUR J ENDOCRINOL, V174, pR99, DOI 10.1530/EJE-15-0262; Corona G, 2014, J SEX MED, V11, P2065, DOI 10.1111/jsm.12601; Corona G, 2014, J SEX MED, V11, P1577, DOI 10.1111/jsm.12536; Corona G, 2013, BEST PRACT RES CL EN, V27, P581, DOI 10.1016/j.beem.2013.05.007; Corona G, 2013, EUR J ENDOCRINOL, V168, P829, DOI 10.1530/EJE-12-0955; Corona G, 2013, J SEX MED, V10, P1074, DOI 10.1111/jsm.12043; Corona G, 2012, J SEX MED, V9, P2017, DOI 10.1111/j.1743-6109.2012.02762.x; Corona G, 2012, EXPERT OPIN EMERG DR, V17, P239, DOI 10.1517/14728214.2012.683411; Corona G, 2012, ASIAN J ANDROL, V14, P251, DOI 10.1038/aja.2011.138; Corona G, 2010, J SEX MED, V7, P1918, DOI 10.1111/j.1743-6109.2010.01744.x; Corona G, 2010, J SEX MED, V7, P1362, DOI 10.1111/j.1743-6109.2009.01601.x; Corona G, 2009, J SEX MED, V6, P2591, DOI 10.1111/j.1743-6109.2009.01352.x; De Berardis G, 2002, DIABETES CARE, V25, P284, DOI 10.2337/diacare.25.2.284; De Berardis G, 2007, J UROLOGY, V177, P252, DOI 10.1016/j.juro.2006.08.102; Diabetes Association, 2007, UND REJSN BLANDT DIA; Dogan S, 2008, INT J IMPOT RES, V20, P218, DOI 10.1038/sj.ijir.3901615; Fedele D, 2001, J UROLOGY, V166, P1368, DOI 10.1016/S0022-5347(05)65771-0; Fedele D, 2000, INT J EPIDEMIOL, V29, P524, DOI 10.1093/ije/29.3.524; Fisher WA, 2005, J SEX MED, V2, P699, DOI 10.1111/j.1743-6109.2005.00119.x; Fisher WA, 2005, J SEX MED, V2, P675, DOI 10.1111/j.1743-6109.2005.00118.x; Ford AH, 2016, PSYCHONEUROENDOCRINO, V64, P57, DOI 10.1016/j.psyneuen.2015.11.012; Goldstein I, 2005, J SEX MED, V2, P819, DOI 10.1111/j.1743-6109.2005.00147.x; Gupta BP, 2011, ARCH INTERN MED, V171, P1797, DOI 10.1001/archinternmed.2011.440; Hackett G, 2011, J SEX MED, V8, P433; Hall SA, 2010, AM J CARDIOL, V105, P192, DOI 10.1016/j.amjcard.2009.08.671; Hassan A, 2008, J SEX MED, V5, P2381, DOI 10.1111/j.1743-6109.2007.00697.x; Hatzimouratidis K, 2007, EUR UROL, V51, P75, DOI 10.1016/j.eururo.2006.07.020; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Heiman JR, 2007, BJOG-INT J OBSTET GY, V114, P437, DOI 10.1111/j.1471-0528.2006.01228.x; Hundertmark J, 2007, J SEX MED, V4, P1126, DOI 10.1111/j.1743-6109.2007.00536.x; Jannini EA, 2009, J SEX MED, V6, P2640, DOI 10.1111/j.1743-6109.2009.01477.x; Jiann BP, 2006, INT J IMPOT RES, V18, P146, DOI 10.1038/sj.ijir.3901379; Kaya E, 2015, J SEX MED, V12, P856, DOI 10.1111/jsm.12828; Klein R, 2005, J DIABETES COMPLICAT, V19, P35, DOI 10.1016/j.jdiacomp.2003.12.005; Klotz T, 2005, INT J IMPOT RES, V17, P2, DOI 10.1038/sj.ijir.3901252; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kostis JB, 2014, J SEX MED, V11, P1626, DOI 10.1111/jsm.12521; Lo WH, 2014, ASIAN J ANDROL, V16, P755, DOI 10.4103/1008-682X.127823; Low WY, 2004, ASIAN J ANDROL, V6, P99; Mulhall J, 2008, J SEX MED, V5, P788, DOI 10.1111/j.1743-6109.2007.00765.x; Oberg K, 2005, J SEX MED, V2, P169, DOI 10.1111/j.1743-6109.2005.20226.x; Olsson AM, 2000, INT J CLIN PRACT, V54, P561; PERSSON G, 1981, ACTA PSYCHIAT SCAND, V64, P244, DOI 10.1111/j.1600-0447.1981.tb00780.x; Salonia A, 2012, J SEX MED, V9, P3239, DOI 10.1111/j.1743-6109.2012.02953.x; Son H, 2004, ASIAN J ANDROL, V6, P117; Talib RA, 2014, UROL J, V11, P1813; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vancampfort D, 2015, DEPRESS ANXIETY, V32, P763, DOI 10.1002/da.22387; Waldinger Marcel D, 2015, Handb Clin Neurol, V130, P469, DOI 10.1016/B978-0-444-63247-0.00027-4; Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101; Yamada T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043673	73	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0157915	10.1371/journal.pone.0157915	http://dx.doi.org/10.1371/journal.pone.0157915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706160	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200001
J	Fukuda, T; Tanaka, T; Hamaguchi, Y; Kawanami, T; Nomiyama, T; Yanase, T				Fukuda, Takashi; Tanaka, Tomoko; Hamaguchi, Yuriko; Kawanami, Takako; Nomiyama, Takashi; Yanase, Toshihiko			Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line	PLOS ONE			English	Article							ISOLATED PITUITARY-ADENOMAS; TUMOR CELLS; AIP GENE; SOMATOSTATIN ANALOGS; ZAC1 EXPRESSION; CLONAL STRAINS; GH3 CELLS; MUTATIONS; PREVALENCE; OCTREOTIDE	Aryl hydrocarbon receptor interacting protein (AIP) is thought to be a tumor suppressor gene, as indicated by a mutational analysis of pituitary somatotroph adenomas. However, the physiological significance of AIP inactivation in somatotroph cells remains unclear. Using CRISPR/Cas9, we identified a GH3 cell clone (termed GH3-FTY) in which Aip was genetically disrupted, and subsequently investigated its character with respect to growth hormone (Gh) synthesis and proliferation. Compared with GH3, GH3-FTY cells showed remarkably increased Gh production and a slight increase in cell proliferation. Gh-induced Stat3 phosphorylation is known to be a mechanism of Gh oversecretion in GH3. Interestingly, phosphorylated-Stat3 expression in GH3-FTY cells was increased more compared with GH3 cells, suggesting a stronger drive for this mechanism in GH3-FTY. The phenotypes of GH3-FTY concerning Gh overproduction, cell proliferation, and increased Stat3 phosphorylation were significantly reversed by the exogenous expression of Aip. GH3-FTY cells were less sensitive to somatostatin than GH3 cells in the suppression of cell proliferation, which might be associated with the reduced expression of somatostatin receptor type 2. GH3-FTY xenografts in BALB/c nude mice (GH3-FTY mice) formed more mitotic somatotroph tumors than GH3 xenografts (GH3 mice), as also evidenced by increased Ki67 scores. GH3-FTY mice were also much larger and had significantly higher plasma Gh levels than GH3 mice. Furthermore, GH3-FTY mice showed relative insulin resistance compared with GH3 mice. In conclusion, we established a somatotroph cell line, GH3-FTY, which possessed prominent Gh secretion and mitotic features associated with the disruption of Aip.	[Fukuda, Takashi; Tanaka, Tomoko; Hamaguchi, Yuriko; Kawanami, Takako; Nomiyama, Takashi; Yanase, Toshihiko] Fukuoka Univ, Fac Med, Dept Endocrinol & Diabet Mellitus, Fukuoka, Japan; [Tanaka, Tomoko; Nomiyama, Takashi; Yanase, Toshihiko] Fukuoka Univ, Fac Med, Dept Bioregulatory Sci Life Related Dis, Fukuoka, Japan	Fukuoka University; Fukuoka University	Yanase, T (corresponding author), Fukuoka Univ, Fac Med, Dept Endocrinol & Diabet Mellitus, Fukuoka, Japan.; Yanase, T (corresponding author), Fukuoka Univ, Fac Med, Dept Bioregulatory Sci Life Related Dis, Fukuoka, Japan.	tyanase@fukuoka-u.ac.jp		Tanaka, Tomoko/0000-0002-3826-3653	Ministry of Health, Labour and Welfare, Japan [27070201]; Foundation for Growth Science, Japan; Department of Bioregulatory Science of Life-related Diseases of Fukuoka University (Fukuoka, Japan); Grants-in-Aid for Scientific Research [16K09815] Funding Source: KAKEN	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Foundation for Growth Science, Japan; Department of Bioregulatory Science of Life-related Diseases of Fukuoka University (Fukuoka, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was partially supported by an Intractable Disease Research Grant from the Ministry of Health, Labour and Welfare, Japan (ID: 27070201, URL: http://www.mhlw.go.jp) (TY), and by the Forum on Growth Hormone Research Grant (2016) from the Foundation for Growth Science, Japan (TF). The Department of Bioregulatory Science of Life-related Diseases of Fukuoka University (Fukuoka, Japan) was supported financially by a donation from MSD K. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; BARRECA A, 1995, CLIN ENDOCRINOL, V42, P161, DOI 10.1111/j.1365-2265.1995.tb01857.x; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; BOOCKFOR FR, 1985, ENDOCRINOLOGY, V117, P418, DOI 10.1210/endo-117-1-418; Busto R, 2000, REGUL PEPTIDES, V95, P53, DOI 10.1016/S0167-0115(00)00129-4; Cazabat L, 2012, J CLIN ENDOCR METAB, V97, pE663, DOI 10.1210/jc.2011-2291; Chahal HS, 2012, J CLIN ENDOCR METAB, V97, pE1411, DOI 10.1210/jc.2012-1111; Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Daly AF, 2010, J CLIN ENDOCR METAB, V95, pE373, DOI 10.1210/jc.2009-2556; Fieffe S, 2011, EUR J ENDOCRINOL, V164, P877, DOI 10.1530/EJE-10-1050; Florio T, 1999, MOL ENDOCRINOL, V13, P24, DOI 10.1210/me.13.1.24; Formosa R, 2013, ENDOCR-RELAT CANCER, V20, P495, DOI 10.1530/ERC-13-0043; Grozinsky-Glasberg S, 2008, NEUROENDOCRINOLOGY, V87, P168, DOI 10.1159/000111501; Gupta S, 2010, PROSTATE, V70, P1575, DOI 10.1002/pros.21193; Iacovazzo D, 2016, EUR J ENDOCRINOL, V174, P241, DOI 10.1530/EJE-15-0832; Iwata T, 2014, ENDOCR PATHOL, V25, P273, DOI 10.1007/s12022-014-9318-7; Jaffrain-Rea ML, 2009, ENDOCR-RELAT CANCER, V16, P1029, DOI 10.1677/ERC-09-0094; Jenkins PJ, 2006, CLIN ENDOCRINOL, V64, P115, DOI 10.1111/j.1365-2265.2005.02404.x; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; LAPP CA, 1987, IN VITRO CELL DEV B, V23, P686, DOI 10.1007/BF02620981; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Melmed S, 2009, J CLIN INVEST, V119, P3189, DOI 10.1172/JCI39375; Morgan RML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053339; Nomiyama T, 2014, DIABETES, V63, P3891, DOI 10.2337/db13-1169; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Tanaka T, 2007, J MOL ENDOCRINOL, V39, P343, DOI 10.1677/JME-07-0076; TASHJIAN AH, 1970, J CELL BIOL, V47, P61, DOI 10.1083/jcb.47.1.61; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; Theodoropoulou M, 2006, CANCER RES, V66, P1576, DOI 10.1158/0008-5472.CAN-05-1189; Theodoropoulou M, 2010, MOL CELL ENDOCRINOL, V326, P60, DOI 10.1016/j.mce.2010.01.033; Theodoropoulou M, 2009, INT J CANCER, V125, P2122, DOI 10.1002/ijc.24602; Tichomirowa MA, 2011, EUR J ENDOCRINOL, V165, P509, DOI 10.1530/EJE-11-0304; Tuominen I, 2015, ONCOGENE, V34, P1174, DOI 10.1038/onc.2014.50; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Zhou CQ, 2015, J CLIN INVEST, V125, P1692, DOI 10.1172/JCI78173	37	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164131	10.1371/journal.pone.0164131	http://dx.doi.org/10.1371/journal.pone.0164131			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706259	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200088
J	Jaeger, VK; Wirz, EG; Allanore, Y; Rossbach, P; Riemekasten, G; Hachulla, E; Distler, O; Airo, P; Carreira, PE; Gurman, AB; Tikly, M; Vettori, S; Damjanov, N; Muller-Ladner, U; Distler, JHW; Li, MT; Walker, UA				Jaeger, Veronika K.; Wirz, Elina G.; Allanore, Yannick; Rossbach, Philipp; Riemekasten, Gabriela; Hachulla, Eric; Distler, Oliver; Airo, Paolo; Carreira, Patricia E.; Gurman, Alexandra Balbir; Tikly, Mohammed; Vettori, Serena; Damjanov, Nemanja; Mueller-Ladner, Ulf; Distler, Joerg H. W.; Li, Mangtao; Walker, Ulrich A.		EUSTAR	Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study	PLOS ONE			English	Article							EULAR SCLERODERMA TRIALS; RESEARCH GROUP DATABASE; TOPOISOMERASE-I ANTIBODY; DISEASE PROGRESSION; SKIN THICKNESS; INVOLVEMENT; COHORT; MORTALITY; SSC	Objective Systemic sclerosis (SSc) is a rare and clinically heterogeneous autoimmune disorder characterised by fibrosis and microvascular obliteration of the skin and internal organs. Organ involvement mostly manifests after a variable period of the onset of Raynaud's phenomenon (RP). We aimed to map the incidence and predictors of pulmonary, cardiac, gastrointestinal (GI) and renal involvement in the early course of SSc. Methods In the EUSTAR cohort, patients with early SSc were identified as those who had a visit within the first year after RP onset. Incident SSc organ manifestations and their risk factors were assessed using Kaplan-Meier methods and Cox regression analysis. Results Of the 695 SSc patients who had a baseline visit within 1 year after RP onset, the incident non-RP manifestations (in order of frequency) were: skin sclerosis (75%) GI symptoms (71%), impaired diffusing capacity for monoxide<80% predicted (65%), DU (34%), cardiac involvement (32%), FVC<80% predicted (31%), increased PAPsys>40mmHg (14%), and renal crisis (3%). In the heart, incidence rates were highest for diastolic dysfunction, followed by conduction blocks and pericardial effusion. While the main baseline risk factor for a short timespan to develop FVC impairment was diffuse skin involvement, for PAPsys>40mmHg it was higher patient age. The main risk factors for incident cardiac manifestations were anti-topoisomerase autoantibody positivity and older age. Male sex, anti-RNA-polymerase-III positivity, and older age were risk factors associated with incident renal crisis. Conclusion In SSc patients presenting early after RP onset, approximately half of all incident organ manifestations occur within 2 years and have a simultaneous rather than a sequential onset. These findings have implications for the design of new diagnostic and therapeutic strategies aimed to 'widen' the still very narrow 'window of opportunity'. They may also enable physicians to counsel and manage patients presenting early in the course of SSc more accurately.	[Jaeger, Veronika K.; Wirz, Elina G.; Rossbach, Philipp; Walker, Ulrich A.] Univ Basel Hosp, Dept Rheumatol, Basel, Switzerland; [Wirz, Elina G.] Univ Basel Hosp, Dept Dermatol, Basel, Switzerland; [Allanore, Yannick] Paris Descartes Univ, Cochin Hosp, Dept Rheumatol A, Paris, France; [Riemekasten, Gabriela] Univ Clin Schleswig Holstein, Dept Rheumatol, Lubeck, Germany; [Hachulla, Eric] Univ Lille, Hop Huriez, Serv Med Interne, Lille, France; [Distler, Oliver] Univ Zurich Hosp, Dept Rheumatol, Zurich, Switzerland; [Airo, Paolo] Spedali Civil Brescia, UO Reumatol & Immunol Clin, Brescia, Italy; [Carreira, Patricia E.] Hosp Univ 12 Octubre, Serv Reumatol, Madrid, Spain; [Gurman, Alexandra Balbir] Technion Israel Inst Technol, Rappaport Fac Med, B Shine Rheumatol Unit, Rambam Hlth Care Campus, Haifa, Israel; [Tikly, Mohammed] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Div Rheumatol, Johannesburg, South Africa; [Vettori, Serena] Univ Naples 2, Dept Rheumatol, Naples, Italy; [Damjanov, Nemanja] Univ Belgrade, Sch Med, Inst Rheumatol, Belgrade, Serbia; [Mueller-Ladner, Ulf] Univ Giessen, Kerckhoff Clin, Dept Rheumatol & Clin Immunol, Bad Nauheim, Germany; [Distler, Joerg H. W.] Univ Erlangen Nurnberg, Dept Internal Med 3, Erlangen, Germany; [Li, Mangtao] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing, Peoples R China	University of Basel; University of Basel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Kiel; Schleswig Holstein University Hospital; Universite de Lille - ISITE; CHU Lille; Universite de Lille; University of Zurich; University Zurich Hospital; Hospital Spedali Civili Brescia; Hospital Universitario 12 de Octubre; Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Witwatersrand; Universita della Campania Vanvitelli; University of Belgrade; Justus Liebig University Giessen; Kerckhoff Clinic; University of Erlangen Nuremberg; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Walker, UA (corresponding author), Univ Basel Hosp, Dept Rheumatol, Basel, Switzerland.	ulrich.walker@usb.ch	Distler, Oliver/AAE-6225-2019; Selmi, Carlo/ABG-4899-2021; Vettori, Serena/A-8641-2016; Riemekasten, Gabriela/B-5019-2017; Tikly, Mohammed/R-1885-2019; Riccieri, Valeria/AAC-6079-2022; Lapadula, Giovanni GL/K-6158-2016; HACHULLA, ERIC/R-8488-2018; Carreira, Patricia E/D-4429-2018; Kowal-Bielecka, Otylia/T-3378-2018; Codullo, Veronica/AAC-7384-2022	Distler, Oliver/0000-0002-0546-8310; Selmi, Carlo/0000-0002-0323-0376; Vettori, Serena/0000-0001-5617-9829; Tikly, Mohammed/0000-0001-7850-3538; Riccieri, Valeria/0000-0002-7507-5483; Lapadula, Giovanni GL/0000-0002-8427-6092; HACHULLA, ERIC/0000-0001-7432-847X; Carreira, Patricia E/0000-0001-8279-3806; Novak, Srdan/0000-0001-8870-4704; Veale, Douglas/0000-0003-2802-4971; SAMPAIO-BARROS, PERCIVAL/0000-0001-9843-6686; Jaeger, Veronika/0000-0002-6913-0976; Rosato, Edoardo/0000-0002-7417-8093; Kowal-Bielecka, Otylia/0000-0002-0613-1306; Codullo, Veronica/0000-0003-2557-8514; ANCUTA, CODRINA MIHAELA/0000-0002-1777-8121				Alba MA, 2014, MEDICINE, V93, P73, DOI 10.1097/MD.0000000000000018; Allanore Y, 2010, ANN RHEUM DIS, V69, P218, DOI 10.1136/ard.2008.103382; Assassi S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3125; Avouac J, 2016, ANN RHEUM DIS, V75, P103, DOI 10.1136/annrheumdis-2014-205295; Elhai M, 2016, ANN RHEUM DIS, V75, P163, DOI 10.1136/annrheumdis-2014-206386; Faludi R, 2014, SEMIN ARTHRITIS RHEU, V44, P220, DOI 10.1016/j.semarthrit.2014.04.001; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Graf SW, 2012, INT J RHEUM DIS, V15, P102, DOI 10.1111/j.1756-185X.2011.01688.x; Hachulla E, 2009, CHEST, V136, P1211, DOI 10.1378/chest.08-3042; Hasegawa M, 2013, J DERMATOL, V40, P89, DOI 10.1111/1346-8138.12030; Hugle T, 2011, RHEUMATOLOGY, V50, P161, DOI 10.1093/rheumatology/keq321; Kahan A, 2006, RHEUMATOLOGY, V45, P14, DOI 10.1093/rheumatology/kel312; Komocsi A, 2012, RHEUMATOLOGY, V51, P1027, DOI 10.1093/rheumatology/ker357; KUWANA M, 1993, J CLIN INVEST, V91, P1399, DOI 10.1172/JCI116343; Manno RL, 2011, J RHEUMATOL, V38, P1317, DOI 10.3899/jrheum.100956; MASI AT, 1980, ARTHRITIS RHEUM-US, V23, P875; Matucci-Cerinic M, 2013, ANN RHEUM DIS, V72, P319, DOI 10.1136/annrheumdis-2012-202295; Mayes MD, 2003, RHEUM DIS CLIN N AM, V29, P239, DOI 10.1016/S0889-857X(03)00022-X; Meier FMP, 2012, ANN RHEUM DIS, V71, P1355, DOI 10.1136/annrheumdis-2011-200742; Minier T, 2014, ANN RHEUM DIS, V73, P2087, DOI 10.1136/annrheumdis-2013-203716; Nguyen B, 2011, ARTHRITIS RHEUM-US, V63, P530, DOI 10.1002/art.30111; Nihtyanova SI, 2014, ARTHRITIS RHEUMATOL, V66, P1625, DOI 10.1002/art.38390; Nikpour M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3544; Omair MA, 2012, J RHEUMATOL, V39, P992, DOI 10.3899/jrheum.110826; Perera A, 2007, ARTHRITIS RHEUM, V56, P2740, DOI 10.1002/art.22747; RODNAN GP, 1979, ARTHRITIS RHEUM, V22, P130, DOI 10.1002/art.1780220205; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Valentini G, 2015, AUTOIMMUN REV, V14, P210, DOI 10.1016/j.autrev.2014.11.002; Walker UA, 2007, ANN RHEUM DIS, V66, P754, DOI 10.1136/ard.2006.062901	31	112	118	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163894	10.1371/journal.pone.0163894	http://dx.doi.org/10.1371/journal.pone.0163894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706206	Green Published, Green Accepted, gold			2022-12-27	WOS:000385697200069
J	Kim, EY; Kim, N; Kim, YS; Seo, JY; Park, I; Ahn, HK; Jeong, YM; Kim, JH				Kim, Eun Young; Kim, Nambeom; Kim, Young Saing; Seo, Ja-Young; Park, Inkeun; Ahn, Hee Kyung; Jeong, Yu Mi; Kim, Jeong Ho			Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_Comparison with Original ALI	PLOS ONE			English	Article							SYSTEMIC INFLAMMATION; MGPS PREDICTS; SARCOPENIA; SURVIVAL; PREVALENCE; CACHEXIA; OBESITY; SCORES	Background Advanced lung cancer inflammation index (ALI, body mass index [BMI] x serum albumin/neutrophil-lymphocyte ratio [NLR]) has been shown to predict overall survival (OS) in small cell lung cancer (SCLC). CT enables skeletal muscle to be quantified, whereas BMI cannot accurately reflect body composition. The purpose was to evaluate prognostic value of modified ALI (mALI) using CT-determined L3 muscle index (L3MI, muscle area at L3/height(2)) beyond original ALI. Methods L3MIs were calculated using the CT images of 186 consecutive patients with SCLC taken at diagnosis, and mALI was defined as L3MI x serum albumin/NLR. Using chi-squared test determined maximum cut-offs for low ALI and low mALI, the prognostic values of low ALI and low mALI were tested using Kaplan-Meier method and Cox proportional hazards analysis. Finally, deviance statistics was used to test whether the goodness of fit of the prognostic model is improved by adding mALI as an extra variable. Results Patients with low ALI (cut-off, 31.1, n = 94) had shorter OS than patients with high ALI (median, 6.8 months vs. 15.8 months; p < 0.001), and patients with low mALI (cut-off 67.7, n = 94) had shorter OS than patients with high mALI (median, 6.8 months vs. 16.5 months; p < 0.001). There was no significant difference in estimates of median survival time between low ALI and low mALI (z = 0.000, p = 1.000) and between high ALI and high mALI (z = 0.330, p = 0.740). Multivariable analysis showed that low ALI was an independent prognostic factor for shorter OS (HR, 1.67, p = 0.004), along with advanced age (HR, 1.49, p = 0.045), extensive disease (HR, 2.27, p < 0.001), supportive care only (HR, 7.86, p < 0.001), and elevated LDH (HR, 1.45, p = 0.037). Furthermore, goodness of fit of this prognostic model was not significantly increased by adding mALI as an extra variable (LR difference = 2.220, p = 0.136). Conclusion The present study confirms mALI using CT-determined L3MI has no additional prognostic value beyond original ALI using BMI. ALI is a simple and useful prognostic indicator in SCLC.	[Kim, Eun Young; Jeong, Yu Mi; Kim, Jeong Ho] Gachon Univ, Gil Med Ctr, Dept Radiol, Inchon, South Korea; [Kim, Nambeom] Gachon Univ, Neurosci Res Inst, Inchon, South Korea; [Kim, Young Saing; Park, Inkeun; Ahn, Hee Kyung] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol & Oncol, Inchon, South Korea; [Seo, Ja-Young] Gachon Univ, Gil Med Ctr, Dept Lab Med, Inchon, South Korea	Gachon University; Gachon University; Gachon University; Gachon University	Kim, YS (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol & Oncol, Inchon, South Korea.	zoomboom@hanmail.net	Kim, Jeong Ho/AAA-7538-2022; Kim, Nambeom/AAR-8047-2021	Kim, Nambeom/0000-0003-4960-1256; Kim, Young Saing/0000-0003-0207-2617				Azad N, 2008, J TOXICOL ENV HEAL B, V11, P1, DOI 10.1080/10937400701436460; Brunelli A, 2006, J THORAC CARDIOV SUR, V131, P1243, DOI 10.1016/j.jtcvs.2006.02.002; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fruh M, 2013, ANN ONCOL, V24, P99, DOI 10.1093/annonc/mdt178; Fukushima H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115895; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; He XB, 2015, CLIN LUNG CANCER, V16, pE165, DOI 10.1016/j.cllc.2015.03.005; Huillard O, 2013, BRIT J CANCER, V108, P1034, DOI 10.1038/bjc.2013.58; Kalemkerian GP, 2013, J NATL COMPR CANC NE, V11, P99, DOI 10.6004/jnccn.2013.0012; Kim EY, 2015, J THORAC ONCOL, V10, P1795, DOI 10.1097/JTO.0000000000000690; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Lucia Simone, 2012, Critical Reviews in Oncogenesis, V17, P315; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Meza-Junco J, 2013, J CLIN GASTROENTEROL, V47, P861, DOI 10.1097/MCG.0b013e318293a825; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Proctor MJ, 2011, BRIT J CANCER, V104, P726, DOI 10.1038/sj.bjc.6606087; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Shafique K, 2012, PROSTATE CANCER P D, V15, P195, DOI 10.1038/pcan.2011.60; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Villasenor A, 2012, J CANCER SURVIV, V6, P398, DOI 10.1007/s11764-012-0234-x; Zhou T, 2015, TUMOR BIOL, V36, P337, DOI 10.1007/s13277-014-2623-4	24	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164056	10.1371/journal.pone.0164056	http://dx.doi.org/10.1371/journal.pone.0164056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706243	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200081
J	Maher, IE; Higgins, DP				Maher, Iona E.; Higgins, Damien P.			Altered Immune Cytokine Expression Associated with KoRV B Infection and Season in Captive Koalas	PLOS ONE			English	Article							PHASCOLARCTOS-CINEREUS GOLDFUSS; NEW-SOUTH-WALES; SAN-DIEGO-ZOO; HIV-1 INFECTION; CHLAMYDIA-TRACHOMATIS; IFN-GAMMA; ENDOGENOUS RETROVIRUSES; REHABILITATION FACILITY; FELINE RETROVIRUSES; LYMPHOID NEOPLASIA	Koala (Phascolarctos cinereus) populations are increasingly vulnerable and one of the main threats is chlamydial infection. Koala retrovirus (KoRV) has been proposed as an underlying cause of the koala's susceptibility to infection with Chlamydia and high rates of lymphoid neoplasia; however, the regionally ubiquitous, endogenous nature of this virus suggests that KoRV A infection is not sufficient for immune suppression to occur. A recently discovered exogenous variant of KoRV, KoRV B, has several structural elements that cause increased pathogenicity in related retroviruses and was associated with lymphoid neoplasia in one study. The present study assesses whether KoRV B infection is associated with alterations in immune function. Cytokine gene expression by mitogen stimulated lymphocytes of KoRV B positive (n = 5-6) and negative (n = 6-7) captive koalas was evaluated by qPCR four times (April 2014-February 2015) to control for seasonal variation. Key immune genes in the Th1 pathway (IFN gamma, TNF alpha), Th2 pathway (IL 10, IL4, IL6) and Th17 pathway (IL17A), along with CD4: CD8 ratio, were assessed. KoRV B positive koalas showed significantly increased up-regulation of IL17A and IL10 in three out of four sampling periods and IFN gamma, IL6, IL4 and TNF alpha in two out of four. IL17A is an immune marker for chlamydial pathogenesis in the koala; increased expression of IL17A in KoRV B positive koalas, and concurrent immune dysregulation, may explain the differences in susceptibility to chlamydial infection and severity of disease seen between individuals and populations. There was also marked seasonal variation in up-regulation for most of the cytokines and the CD4: CD8 ratio. The up-regulation in both Th1 and Th2 cytokines mirrors changes associated with immune dysregulation in humans and felids as a result of retroviral infections. This is the first report of altered immune expression in koalas infected by an exogenous variant of KoRV and also the first report of seasonal variation in cytokine up-regulation and CD4: CD8 ratio in marsupials.	[Maher, Iona E.; Higgins, Damien P.] Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Sydney, NSW 2006, Australia	University of Sydney	Higgins, DP (corresponding author), Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.	damien.higgins@sydney.edu.au	Higgins, Damien P/A-9601-2011	Higgins, Damien/0000-0003-1215-6523	Australian Research Council [LP0989701]; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Australian Postgraduate Award(Australian Government)	DH received an Australian Research Council Grant (no: LP0989701) (http://www.arc.gov.au/). IM PhD is supported by an Australian Postgraduate Award (https://www.education.gov.au/australian-postgraduate-awards). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Hosking C, 2011, WILDLIFE RES, V38, P122, DOI 10.1071/WR10156; Andrew DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076664; Blattner WA, 1999, P ASSOC AM PHYSICIAN, V111, P563, DOI 10.1046/j.1525-1381.1999.99210.x; Bolin LL, 2011, VIRUSES-BASEL, V3, P1681, DOI 10.3390/v3091681; Brown M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2701-7; CANFIELD PJ, 1987, AUST VET J, V64, P325, DOI 10.1111/j.1751-0813.1987.tb06059.x; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; Connolly JH, 1998, AUST VET J, V76, P819, DOI 10.1111/j.1751-0813.1998.tb12337.x; Denner J, 1998, ANN NY ACAD SCI, V862, P75, DOI 10.1111/j.1749-6632.1998.tb09119.x; Denner J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-108; Department of Sustainability E Water Population and Communities, 2013, KOAL POP QUEENSL NEW; Diehl LJ, 1996, J VIROL, V70, P2503, DOI 10.1128/JVI.70.4.2503-2507.1996; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; Fiebig U, 2015, VIRUS RES, V198, P30, DOI 10.1016/j.virusres.2015.01.002; Fonfara S, 2007, J MAR BIOL ASSOC UK, V87, P305, DOI 10.1017/S0025315407055567; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Gillett Amber K., 2014, Technical Reports of the Australian Museum Online, V24, P39, DOI 10.3853/j.1835-4211.24.2014.1612; GORDON G, 1988, AUST J ECOL, V13, P451, DOI 10.1111/j.1442-9993.1988.tb00993.x; Graham EM, 2003, J IMMUNOL METHODS, V279, P69, DOI 10.1016/S0022-1759(03)00244-8; Griffith JE, 2012, AUST VET J, V90, P457, DOI 10.1111/j.1751-0813.2012.00963.x; Griffith JE, 2013, J WILDLIFE DIS, V49, P18, DOI 10.7589/2012-05-135; Hanger JJ, 2000, J VIROL, V74, P4264, DOI 10.1128/JVI.74.9.4264-4272.2000; Hartmann K, 2012, VIRUSES-BASEL, V4, P2684, DOI 10.3390/v4112684; Hobbs M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-786; Holland MJ, 1996, CLIN EXP IMMUNOL, V105, P429, DOI 10.1046/j.1365-2249.1996.d01-792.x; Ishida Y, 2015, VIROLOGY, V475, P28, DOI 10.1016/j.virol.2014.10.036; Ishida Y, 2015, MOL BIOL EVOL, V32, P109, DOI 10.1093/molbev/msu275; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Klatt NR, 2010, CURR OPIN HIV AIDS, V5, P135, DOI 10.1097/COH.0b013e3283364846; Lau Q, 2012, VET IMMUNOL IMMUNOP, V147, P35, DOI 10.1016/j.vetimm.2012.04.010; Leal RO, 2015, RES VET SCI, V99, P87, DOI 10.1016/j.rvsc.2015.02.008; Linenberger ML, 1999, VET IMMUNOL IMMUNOP, V72, P343, DOI 10.1016/S0165-2427(99)00147-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunney D., 2012, KOALAS CLIMATE CHANG, P150, DOI DOI 10.7882/FS.2012.0221016/J.VETMIC.2013.02.026; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; MAES M, 1994, EXPERIENTIA, V50, P821, DOI 10.1007/BF01956463; Maher IE, 2014, PEERJ, V2, DOI 10.7717/peerj.280; Mann DR, 2000, CELL IMMUNOL, V200, P105, DOI 10.1006/cimm.2000.1623; Margolick JB, 2006, JAIDS-J ACQ IMM DEF, V42, P620, DOI 10.1097/01.qai.0000223028.55080.9d; Mathew M, 2014, DEV COMP IMMUNOL, V46, P423, DOI 10.1016/j.dci.2014.05.015; Mathew M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059958; McKinnon LR, 2015, JAIDS-J ACQ IMM DEF, V68, P6, DOI 10.1097/QAI.0000000000000389; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Moore BD, 2000, AUST J ZOOL, V48, P317, DOI 10.1071/ZO99034; Myrianthefs P, 2003, CYTOKINE, V24, P286, DOI 10.1016/j.cyto.2003.08.005; Nelson RJ, 2004, TRENDS IMMUNOL, V25, P187, DOI 10.1016/j.it.2004.02.001; Nelson RJ, 1995, J PINEAL RES, V19, P149, DOI 10.1111/j.1600-079X.1995.tb00184.x; Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52; OBENDORF DL, 1983, J WILDLIFE DIS, V19, P123, DOI 10.7589/0090-3558-19.2.123; Oliveira NM, 2007, P NATL ACAD SCI USA, V104, P17506, DOI 10.1073/pnas.0704313104; Patterson JLS, 2015, J WILDLIFE DIS, V51, P309, DOI 10.7589/2014-07-176; Perry LL, 1997, J IMMUNOL, V158, P3344; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; Pye GW, 2008, J ZOO WILDLIFE MED, V39, P61, DOI 10.1638/2007-0106.1; Pye GW, 2009, J ZOO WILDLIFE MED, V40, P453, DOI 10.1638/2008-0107.1; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimode S, 2014, FEBS LETT, V588, P41, DOI 10.1016/j.febslet.2013.10.046; Shojima T, 2013, J VIROL, V87, P9943, DOI 10.1128/JVI.01385-13; Simmons GS, 2012, AUST VET J, V90, P404, DOI 10.1111/j.1751-0813.2012.00964.x; Spencer AJ, 1996, J ZOO WILDLIFE MED, V27, P303; Su H, 1997, INFECT IMMUN, V65, P1993, DOI 10.1128/IAI.65.6.1993-1999.1997; Tarlinton R, 2005, J GEN VIROL, V86, P783, DOI 10.1099/vir.0.80547-0; Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; Termorshuizen F, 2002, INT J HYG ENVIR HEAL, V205, P379, DOI 10.1078/1438-4639-00172; Tompkins MB, 2008, VET IMMUNOL IMMUNOP, V123, P45, DOI 10.1016/j.vetimm.2008.01.011; Turner AK, 2013, PARASITE IMMUNOL, V35, P386, DOI 10.1111/pim.12036; Waugh C, 2016, BIOL CONSERV, V197, P247, DOI 10.1016/j.biocon.2016.03.018; Wilen CB, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006866; Wilson DP, 2015, J WILDLIFE DIS, V51, P833, DOI 10.7589/2014-12-278; Xu WQ, 2015, VIRUSES-BASEL, V7, P1258, DOI 10.3390/v7031258; Xu WQ, 2013, P NATL ACAD SCI USA, V110, P11547, DOI 10.1073/pnas.1304704110	76	28	28	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163780	10.1371/journal.pone.0163780	http://dx.doi.org/10.1371/journal.pone.0163780			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706211	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200059
J	Hobara, H; Hashizume, S; Kobayashi, Y; Mochmaru, M				Hobara, Hiroaki; Hashizume, Satoru; Kobayashi, Yoshiyuki; Mochmaru, Masaaki			Spatiotemporal Parameters of 100-m Sprint in Different Levels of Sprinters with Unilateral Transtibial Amputation	PLOS ONE			English	Article							AMPUTEE SPRINTERS; STEP LENGTH; VARIABLES; STIFFNESS	The aim of this study was to investigate differences of the spatiotemporal parameters in a 100m sprint among elite, sub-elite, and non-elite sprinters with a unilateral transtibial amputation. Using publicly available Internet broadcasts, we analyzed 125, 19, and 33 records from 30 elite, 12 sub-elite, and 22 non-elite sprinters, respectively. For each sprinter's run, the average velocity, step frequency, and step length were calculated using the number of steps in conjunction with the official race time. Average velocity was greatest in elite sprinters (8.71 +/- 0.32 m/s), followed by the sub-elite (8.09 +/- 0.06 m/s) and non-elite groups (7.72 +/- 0.27 m/s). Although there was a significant difference in average step frequency between the three groups, the effect size was small and the relative difference among the three groups was 3.1%. Statistical analysis also revealed that the average step length was longest in elite sprinters, followed by the sub-elite and non-elite groups. These results suggest that the differences in sprint performance between the three groups is mainly due to the average step length rather than step frequency.	[Hobara, Hiroaki; Hashizume, Satoru; Kobayashi, Yoshiyuki; Mochmaru, Masaaki] Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Hobara, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Informat Res Inst, Tokyo, Japan.	hobara-hiroaki@aist.go.jp	Hobara, Hiroaki/Q-5333-2016; Kobayashi, Yoshiyuki/Q-5314-2016	Hobara, Hiroaki/0000-0003-4710-9962; Kobayashi, Yoshiyuki/0000-0001-7941-6575				Baum BS, 2013, ARCH PHYS MED REHAB, V94, P1776, DOI 10.1016/j.apmr.2013.03.010; Bezodis I., 2008, P 26 INT C BIOM SPOR, P537; Bruggemann Gert-Peter., 2008, SPORTS TECHNOLOGY, V1, P220, DOI [10.1002/jst.63, DOI 10.1002/JST.63, DOI 10.1080/19346182.2008.9648476]; Fortier S, 2005, J SPORT SCI MED, V4, P134; Gajer B., 1999, NEW STUD ATHL, V14, P43; Hobara H, 2016, INT J SPORTS MED, V37, P165, DOI 10.1055/s-0035-1564171; Hobara H, 2015, INT J SPORTS MED, V36, P494, DOI 10.1055/s-0034-1387794; Hobara H, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1983-1; Hobara H, 2016, J APPL BIOMECH, V32, P93, DOI 10.1123/jab.2014-0297; Hobara H, 2015, PROSTHET ORTHOT INT, V39, P519, DOI 10.1177/0309364614564026; Hobara H, 2013, J BIOMECH, V46, P2483, DOI 10.1016/j.jbiomech.2013.07.009; Hunter JP, 2004, MED SCI SPORT EXER, V36, P261, DOI 10.1249/01.MSS.0000113664.15777.53; McGowan CP, 2012, J R SOC INTERFACE, V9, P1975, DOI 10.1098/rsif.2011.0877; Nagahara R, 2014, INT J SPORTS MED, V35, P755, DOI 10.1055/s-0033-1363252; Nolan Lee, 2008, Foot Ankle Surg, V14, P125, DOI 10.1016/j.fas.2008.05.007; Noroozi S, 2014, P I MECH ENG P-J SPO, V228, P24, DOI 10.1177/1754337113501491; Rabita G, 2015, SCAND J MED SCI SPOR, V25, P583, DOI 10.1111/sms.12389; Salo AIT, 2011, MED SCI SPORT EXER, V43, P1055, DOI 10.1249/MSS.0b013e318201f6f8; Slawinski J, 2010, J STRENGTH COND RES, V24, P896, DOI 10.1519/JSC.0b013e3181ad3448; Weyand PG, 2009, J APPL PHYSIOL, V107, P903, DOI 10.1152/japplphysiol.00174.2009; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991	21	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163712	10.1371/journal.pone.0163712	http://dx.doi.org/10.1371/journal.pone.0163712			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701443	gold, Green Submitted, Green Published			2022-12-27	WOS:000385696900018
J	Jana, S; Chatterjee, K; Ray, AK; DasMahapatra, P; Swarnakar, S				Jana, Sayantan; Chatterjee, Kasturi; Ray, Amlan K.; DasMahapatra, Pramathes; Swarnakar, Snehasikta			Regulation of Matrix Metalloproteinase-2 Activity by COX-2-PGE2-pAKT Axis Promotes Angiogenesis in Endometriosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TISSUE INHIBITORS; PERITONEAL-FLUID; VEGF; MATRIX-METALLOPROTEINASE-9; MACROPHAGES; ACTIVATION; EXPRESSION; MELATONIN; CURCUMIN	Endometriosis is characterized by the ectopic development of the endometrium which relies on angiogenesis. Although studies have identified the involvement of different matrix metalloproteinases (MMPs) in endometriosis, no study has yet investigated the role of MMP-2 in endometriosis-associated angiogenesis. The present study aims to understand the regulation of MMP-2 activity in endothelial cells and on angiogenesis during progression of ovarian endometriosis. Histological and biochemical data showed increased expressions of vascular endothelial growth factor (VEGF), VEGF receptor-2, cycloxygenase (COX)-2, von Willebrand factor along with angiogenesis during endometriosis progression. Women with endometriosis showed decreased MMP-2 activity in eutopic endometrium as compared to women without endometriosis. However, ectopic ovarian endometrioma showed significantly elevated MMP-2 activity with disease severity. In addition, increased MT1MMP and decreased tissue inhibitors of metalloproteinases (TIMP)-2 expressions were found in the late stages of endometriosis indicating more MMP-2 activation with disease progression. In vitro study using human endothelial cells showed that prostaglandin E2 (PGE2) significantly increased MMP-2 activity as well as tube formation. Inhibition of COX-2 and/or phosphorylated AKT suppressed MMP-2 activity and endothelial tube formation suggesting involvement of PGE2 in regulation of MMP-2 activity during angiogenesis. Moreover, specific inhibition of MMP-2 by chemical inhibitor significantly reduced cellular migration, invasion and tube formation. In ovo assay showed decreased angiogenic branching upon MMP-2 inhibition. Furthermore, a significant reduction of lesion numbers was observed upon inhibition of MMP-2 and COX-2 in mouse model of endometriosis. In conclusion, our study establishes the involvement of MMP-2 activity via COX-2-PGE2pAKT axis in promoting angiogenesis during endometriosis progression.	[Jana, Sayantan; Chatterjee, Kasturi; Swarnakar, Snehasikta] CSIR, Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India; [Ray, Amlan K.; DasMahapatra, Pramathes] Spectrum Clin & Endoscopy Res Inst, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Swarnakar, S (corresponding author), CSIR, Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, W Bengal, India.	snehasiktas@hotmail.com		Ray, Amlan/0000-0001-9428-1699; Swarnakar, Snehasikta/0000-0002-7139-9683; JANA, SAYANTAN/0000-0003-2855-1560	Council of Scientific and Industrial Research, India [BSC0111-INDEPTH, BSC0119-HUM]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by the Council of Scientific and Industrial Research, India [grant number BSC0111-INDEPTH & BSC0119-HUM]. The funders were not involved in the study design, data collection, data analysis, manuscript preparation and/or publication decisions.	Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bernardo MM, 2003, BIOCHEM J, V374, P739, DOI 10.1042/BJ20030557; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Brosens I, 2012, REPROD BIOMED ONLINE, V24, P496, DOI 10.1016/j.rbmo.2012.01.022; Bruner KL, 1997, J CLIN INVEST, V99, P2851, DOI 10.1172/JCI119478; Bulun SE, 1999, ENDOCR-RELAT CANCER, V6, P293, DOI 10.1677/erc.0.0060293; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Contois L, 2009, SEMIN CANCER BIOL, V19, P318, DOI 10.1016/j.semcancer.2009.05.002; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Donnez J, 1998, HUM REPROD, V13, P1686, DOI 10.1093/humrep/13.6.1686; Fagotti A, 2004, HUM REPROD, V19, P393, DOI 10.1093/humrep/deh054; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Huang HF, 2004, FERTIL STERIL, V81, P1235, DOI 10.1016/j.fertnstert.2003.10.027; Jana S, 2012, INDIAN J BIOCHEM BIO, V49, P342; Jana S, 2012, BIOCHEM PHARMACOL, V83, P797, DOI 10.1016/j.bcp.2011.12.030; Karck U, 1996, PROSTAG OTH LIPID M, V51, P49, DOI 10.1016/0090-6980(95)00159-X; Kinoshita T, 1998, J BIOL CHEM, V273, P16098, DOI 10.1074/jbc.273.26.16098; Li Zhi-gang, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P598; Lurlaro M, 1999, EUR J CLIN INVEST, V29, P793; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; McLaren J, 2000, HUM REPROD UPDATE, V6, P45, DOI 10.1093/humupd/6.1.45; Nap AW, 2004, HUM REPROD, V19, P2180, DOI 10.1093/humrep/deh408; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osteen KG, 2003, SEMIN REPROD MED, V21, P155; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Paul S, 2008, J PINEAL RES, V44, P439, DOI 10.1111/j.1600-079X.2007.00547.x; Paul S, 2010, J PINEAL RES, V49, P156, DOI 10.1111/j.1600-079X.2010.00780.x; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rocha AL, 2013, OBSTET GYNECOL INT, V2013, P26; Rocha ALL, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/859619; Sacco K, 2012, GYNECOL ENDOCRINOL, V28, P134, DOI 10.3109/09513590.2011.588753; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	38	62	69	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163540	10.1371/journal.pone.0163540	http://dx.doi.org/10.1371/journal.pone.0163540			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695098	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100043
J	Kim, H; Choi, KI				Kim, HyunJin; Choi, Kang-Il			A Pipelined Non-Deterministic Finite Automaton-BasedString Matching Scheme Using Merged State Transitions in an FPGA	PLOS ONE			English	Article							PATTERN; ALGORITHM	This paper proposes a pipelined non-deterministic finite automaton (NFA)-based string matching scheme using field programmable gate array (FPGA) implementation. The characteristics of the NFA such as shared common prefixes and no failure transitions are considered in the proposed scheme. In the implementation of the automaton-based string matching using an FPGA, each state transition is implemented with a look-up table (LUT) for the combinational logic circuit between registers. In addition, multiple state transitions between stages can be performed in a pipelined fashion. In this paper, it is proposed that multiple one-to-one state transitions, called merged state transitions, can be performed with an LUT. By cutting down the number of used LUTs for implementing state transitions, the hardware overhead of combinational logic circuits is greatly reduced in the proposed pipelined NFA-based string matching scheme.	[Kim, HyunJin] Dankook Univ, Sch Elect & Elect Engn, Yongin, South Korea; [Choi, Kang-Il] Elect & Telecommun Res Inst, Adv Commun Res Lab, Daejeon, South Korea	Dankook University; Electronics & Telecommunications Research Institute - Korea (ETRI)	Kim, H (corresponding author), Dankook Univ, Sch Elect & Elect Engn, Yongin, South Korea.	hyunjin2kim@gmail.com		Kim, HyunJin/0000-0001-5017-3995	ICT R&D program of Institute for Information & communications Technology Promotion (IITP); Ministry of Science, ICT & Future Planning (MSIP) [B0101-16-0233]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - MSIP [2012R1A1A1002993]	ICT R&D program of Institute for Information & communications Technology Promotion (IITP); Ministry of Science, ICT & Future Planning (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - MSIP	This work was partly supported by the ICT R&D program of Institute for Information & communications Technology Promotion (IITP) and the Ministry of Science, ICT & Future Planning (MSIP) (B0101-16-0233, Smart Networking Core Technology Development) and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by MSIP (2012R1A1A1002993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO AV, 1975, COMMUN ACM, V18, P333, DOI 10.1145/360825.360855; Altera Santa Clara CA USA, 2015, STRAT 5 DEV OV; [Anonymous], 2001, BOOST GRAPH LIB USER; Baker ZK, 2004, ANN IEEE SYM FIELD P, P135, DOI 10.1109/FCCM.2004.6; Bourgeault M, 2011, ALTERAS PARTIAL RECO; Chen CC, 2013, ACM T ARCHIT CODE OP, V10, DOI 10.1145/2541228.2541232; Clark CR, 2004, ANN IEEE SYM FIELD P, P249, DOI 10.1109/fccm.2004.50; Hartenstein RW, 1896, ROADM REC COMP 10 IN; Hutchings BL, 2002, ANN IEEE SYM FIELD P, P111, DOI 10.1109/FPGA.2002.1106666; HyunJin Kim, 2015, Information Science and Applications, P157, DOI 10.1007/978-3-662-46578-3_19; Jiang WR, 2013, 2013 ACM/IEEE SYMPOSIUM ON ARCHITECTURES FOR NETWORKING AND COMMUNICATIONS SYSTEMS (ANCS), P71, DOI 10.1109/ANCS.2013.6665177; Kao C., 2005, XCELL J, V55, P65; Kim HJ, 2011, IEEE T PARALL DISTR, V22, P1904, DOI 10.1109/TPDS.2011.85; Kim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126517; Kim H, 2012, IEICE T COMMUN, VE95B, P3594, DOI 10.1587/transcom.E95.B.3594; Kim H, 2010, IEICE ELECTRON EXPR, V7, P377, DOI 10.1587/elex.7.377; Kim H, 2010, IEEE COMMUN LETT, V14, P878, DOI 10.1109/LCOMM.2010.080210.092347; Kim H, 2010, IEICE T COMMUN, VE93B, P1612, DOI 10.1587/transcom.E93.B.1612; Kouzinopoulos CS, 2009, 13TH PANHELLENIC CONFERENCE ON INFORMATICS, PROCEEDINGS, P14, DOI 10.1109/PCI.2009.47; Kuon I, 2007, FOUND TRENDS ELECTRO, V2, P135, DOI 10.1561/1000000005; Le H, 2013, IEEE T COMPUT, V62, P844, DOI 10.1109/TC.2012.38; Lee CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139301; Lin CH, 2013, IEEE T COMPUT, V62, P1906, DOI 10.1109/TC.2012.254; Lin Cheng-Hung, 2010, GLOB TEL C GLOBECOM, p[1, 6], DOI DOI 10.1109/GLOCOM.2010.5683320; Pao D., 2008, COMPUTER ARCHITECTUR, V7, P33, DOI DOI 10.1109/L-CA.2008.5; Pao D, 2011, IEEE T COMPUT, V60, P1596, DOI 10.1109/TC.2010.250; Pao D, 2010, ACM T ARCHIT CODE OP, V7, DOI 10.1145/1839667.1839672; Piyachon P, 2007, DES AUT CON, P493, DOI 10.1109/DAC.2007.375215; Roesch M, 1999, USENIX ASSOCIATION PROCEEDINGS OF THE THIRTEENTH SYSTEMS ADMINISTRATION CONFERENCE (LISA XIII), P229; Sidhu R., 2001, FIELD PROGR CUST COM, P227, DOI DOI 10.1109/FCCM.2001.22; Sourdis I, 2003, LECT NOTES COMPUT SC, V2778, P880; Tan L., 2006, ACM T ARCHIT CODE OP, V3, P3, DOI DOI 10.1145/1132462.1132464; Vasiliadis G, 2008, LECT NOTES COMPUT SC, V5230, P116, DOI 10.1007/978-3-540-87403-4_7; Xilinx, 2014, 7 SER FPGAS CONF LOG 7 SER FPGAS CONF LOG; Xilinx, 2012, ISE DES SUIT	35	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163535	10.1371/journal.pone.0163535	http://dx.doi.org/10.1371/journal.pone.0163535			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695114	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100042
J	Lee, Y; Shin, H; Bae, E; Lim, H				Lee, Yoonsun; Shin, Hyunsoo; Bae, Eunjoo; Lim, Hyunjung			Aspects of Health-Related Factors and Nutritional Care Needs by Survival Stage among Female Cancer Patients in South Korea	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM SURVIVORS; BREAST-CANCER; POSTTRAUMATIC GROWTH; DIETARY CHANGE; BEHAVIORS; WOMEN	Purpose This study examined diet-related problems and needs associated with nutritional care according to survival stage in Korean female cancer survivors. Methods 186 outpatients (breast or gynecologic cancer survivors) recruited. Subjects were classified as (1) extended stage (ES, 2-5 years from diagnosis) and (2) long-term stage (LS, >= 5 years from diagnosis). Eating habits, changes in health related factors, nutritional needs, and quality of life were investigated. Results 43% of ES survivors had diet-related problems (p = .031); ES group reported dyspepsia and LS group reported anorexia/nausea as the major problem. Half of ES survivors had taste change, decreasing amount of intake, and reduced quality of life (p < .05). The LS group had a greater preference for sweet tastes than the ES group. According to their diagnosis, ES survivors with breast cancer gained weight (27.1%), whereas ES survivors with gynecologic cancer lost their body weight (34.5%) significantly. LS breast cancer patients showed great food preference for vegetables, whereas those with gynecologic cancer showed an increased preference for fish, meat and grain. Approximately 90% of survivors demanded nutritional care regarding restricted foods, preventing recurrence, particularly in ES survivors (p < .01). Moreover, main factors for nutritional care needs were body weight control for breast cancer and food environment for gynecologic cancer. Conclusion Survivors have different aspects of diet-related problems by survival stage as dyspepsia in ES and anorexia in LS. ES stage had changes in dietary patterns and their food consumption have decreased. Most of survivors have demanded nutritional care regardless of survival stage. These features of each stage should be considered to improve their health.	[Lee, Yoonsun; Lim, Hyunjung] Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, Gyenggi Do, South Korea; [Lee, Yoonsun; Lim, Hyunjung] Kyung Hee Univ, Res Inst Med Nutr, Seoul 02447, South Korea; [Shin, Hyunsoo] CHA Univ, Dept Radiat Oncol, CHA Bundang Med Ctr, Bundang 13496, Gyenggi Do, South Korea; [Bae, Eunjoo] CHA Univ, CHA Bundang Med Ctr, Dept Food & Nutr Serv, Bundang 13496, Gyenggi Do, South Korea	Kyung Hee University; Kyung Hee University; Pochon Cha University; Pochon Cha University	Lim, H (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Dept Med Nutr, Yongin 17104, Gyenggi Do, South Korea.; Lim, H (corresponding author), Kyung Hee Univ, Res Inst Med Nutr, Seoul 02447, South Korea.	hjlim@khu.ac.kr	Lim, Hyunjung/AAJ-4089-2020	Lim, Hyunjung/0000-0001-7632-7315				Alfano CM, 2009, PSYCHO-ONCOL, V18, P128, DOI 10.1002/pon.1378; Blanchard CM, 2008, J CLIN ONCOL, V26, P2198, DOI 10.1200/JCO.2007.14.6217; Bussell VA, 2010, J PSYCHOSOC ONCOL, V28, P61, DOI 10.1080/07347330903438958; Choe MA, 2001, INT J NURS STUD, V38, P557, DOI 10.1016/S0020-7489(00)00102-4; Demark-Wahnefried W, 2000, CANCER-AM CANCER SOC, V88, P674, DOI 10.1002/(SICI)1097-0142(20000201)88:3&lt;674::AID-CNCR26&gt;3.0.CO;2-R; Demark-Wahnefried W, 2003, SEMIN ONCOL, V30, P789, DOI 10.1053/j.seminoncol.2003.08.023; Demark-Wahnefried W, 1997, J AM DIET ASSOC, V97, P159, DOI [10.1016/s0002-8223(97), DOI 10.1016/S0002-8223(97)]; Ganz PA, 2002, JNCI-J NATL CANCER I, V94, P39; 임정원, 2008, [Korean Journal of Social Welfare, 한국사회복지학], V60, P5; Health Insurance Review and Assessment Service, POL HOSP PALL CAR TE; Hong SJ, 2013, J NATUROPATHY, V2, P154; Kroenke CH, 2005, J CLIN ONCOL, V23, P9295, DOI 10.1200/JCO.2005.02.0198; Lee ES, 2013, KOREAN J ADULT NURS, V25, P312, DOI [10.7475/kjan.2013.25.3.312, DOI 10.7475/KJAN.2013.25.3.312, 10.7475/KJAN.2013.25.3.312]; Maunsell E, 2002, J CLIN ONCOL, V20, P1017, DOI 10.1200/JCO.20.4.1017; Miaskowski C, 1995, Oncol Nurs Forum, V22, P791; Min HS, 2008, J KOREAN ACAD NURS, V38, P187, DOI 10.4040/jkan.2008.38.2.187; MULLAN F, 1985, NEW ENGL J MED, V313, P270, DOI 10.1056/NEJM198507253130421; National Cancer Center, 2015, POL HOSP PALL CAR TE; National Cancer Information Center;, 1993, 5 YEARS SURV RAT CAN; Park JS., 2002, KOREAN J ADULTS NURS, V14, P233; 김은경, 2010, [The Korean Journal of Rehabilitation Nursing, 재활간호학회지], V13, P114; Patterson RE, 2003, J AM DIET ASSOC, V103, P323, DOI 10.1053/jada.2003.50045; Pedro LW, 2001, CANCER NURS, V24, P1, DOI 10.1097/00002820-200102000-00001; Rock Cheryl L, 2012, CA Cancer J Clin, V62, P243, DOI 10.3322/caac.21142; Song SiHan, 2015, Korean Journal of Community Nutrition, V20, P129, DOI 10.5720/kjcn.2015.20.2.129; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weiss T, 2002, J PSYCHOSOC ONCOL, V20, P65, DOI 10.1300/J077v20n02_04; 이인정, 2012, [Health and Social Welfare Review, 보건사회연구], V32, P522	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163281	10.1371/journal.pone.0163281	http://dx.doi.org/10.1371/journal.pone.0163281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695041	Green Submitted, Green Published, gold			2022-12-27	WOS:000385553100028
J	Losilevskii, G				Losilevskii, Gil			Hydrodynamics of a Flexible Soft-Rayed Caudal Fin	PLOS ONE			English	Article							MUSCLE RECRUITMENT; FISH; TEMPERATURE; PERFORMANCE; AMPLITUDE; VELOCITY; SPEED	The paper addresses hydrodynamic performance of a slender swimmer furnished with a flexible small-aspect-ratio soft-rayed caudal fin. The recoil of the fin is found by solving the coupled hydro-elastic problem, in which the structure of the fin is modeled by a cantilever of variable cross section and the hydrodynamic forces acting on it are modeled using the elongated body theory. It is shown that the recoil has practically no effect on the propulsion efficiency of anguilliform swimmers, but has a profound effect on the efficiency of carangiform swimmers, which can increase almost four-fold between low-speed (low-thrust) cruise and high-speed (high-thrust) burst. Whilst the magnitude of this effect furnishes a plausible argument in favor of burst-and-coast locomotion strategies, it also infers that carangiform swimmers cannot rely on elastic recoil of the caudal fin to be efficient throughout the usable speed range, and must actively flex it at low speeds.	[Losilevskii, Gil] Technion, Fac Aerosp Engn, Haifa, Israel	Technion Israel Institute of Technology	Losilevskii, G (corresponding author), Technion, Fac Aerosp Engn, Haifa, Israel.	igil@technion.ac.il		Iosilevskii, Gil/0000-0002-4114-3214				BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; Bisplinghoff R, 1996, AEROELASTICITY, p[68, 69, 157]; BREDER C. M., 1926, ZOOLOGICA, V4, P159; Esposito CJ, 2012, J EXP BIOL, V215, P56, DOI 10.1242/jeb.062711; Fish FE, 2006, BIOINSPIR BIOMIM, V1, pS42, DOI 10.1088/1748-3182/1/4/S06; Flammang BE, 2008, J EXP BIOL, V211, P587, DOI 10.1242/jeb.012096; GEERLINK PJ, 1987, NETH J ZOOL, V37, P59; Iosilevskii G, 2016, J THEOR BIOL, V399, P159, DOI 10.1016/j.jtbi.2016.04.001; Iosilevskii G, 2012, J THEOR BIOL, V294, P172, DOI 10.1016/j.jtbi.2011.11.008; KATZ J, 1979, J FLUID MECH, V90, P713, DOI 10.1017/S0022112079002494; LIGHTHILL MJ, 1970, J FLUID MECH, V44, P265, DOI 10.1017/S0022112070001830; LIGHTHILL MJ, 1960, J FLUID MECH, V9, P305, DOI 10.1017/S0022112060001110; Newman JN, 1973, J FLUID MECH, V57, P673, DOI 10.1017/S0022112073001953; ROME LC, 1990, J EXP BIOL, V154, P163; ROME LC, 1992, J EXP BIOL, V163, P259; VIDELER J J, 1975, Netherlands Journal of Zoology, V25, P143; Videler JJ, 1993, FISH SWIMMING, p[48, 56]; WU TYT, 1971, J FLUID MECH, V46, P545, DOI 10.1017/S0022112071000697; Yates GT, 1983, FISH BIOMECHANICS, P207	19	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163517	10.1371/journal.pone.0163517	http://dx.doi.org/10.1371/journal.pone.0163517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695043	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100040
J	Mason, LMK; Wagemakers, A; van 't Veer, C; Oei, A; van der Pot, WJ; Ahmed, K; van der Poll, T; Geijtenbeek, TBH; Hovius, JWR				Mason, Lauren M. K.; Wagemakers, Alex; van 't Veer, Cornelis; Oei, Anneke; van der Pot, Wouter J.; Ahmed, Kalam; van der Poll, Tom; Geijtenbeek, Teunis B. H.; Hovius, Joppe W. R.			Borrelia burgdorferi Induces TLR2-Mediated Migration of Activated Dendritic Cells in an Ex Vivo Human Skin Model	PLOS ONE			English	Article							LANGERHANS CELLS; IMMUNE-RESPONSES; CUTTING EDGE; LIPOPROTEINS; FIBROBLASTS; EXPRESSION; INDUCTION; RESIDENT; DISTINCT; DISEASE	Borrelia burgdorferi is transmitted into the skin of the host where it encounters and interacts with two dendritic cell (DC) subsets; Langerhans cells (LCs) and dermal DCs (DDCs). These cells recognize pathogens via pattern recognition receptors, mature and migrate out of the skin into draining lymph nodes, where they orchestrate adaptive immune responses. In order to investigate the response of skin DCs during the early immunopathogenesis of Lyme borreliosis, we injected B. burgdorferi intradermally into full-thickness human skin and studied the migration of DCs out of the skin, the activation profile and phenotype of migrated cells. We found a significant increase in the migration of LCs and DDCs in response to B. burgdorferi. Notably, migration was prevented by blocking TLR2. DCs migrated from skin inoculated with higher numbers of spirochetes expressed significantly higher levels of CD83 and produced pro-inflammatory cytokines. No difference was observed in the expression of HLA-DR, CD86, CD38, or CCR7. To conclude, we have established an ex vivo human skin model to study DC-B. burgdorferi interactions. Using this model, we have demonstrated that B. burgdorferi-induced DC migration is mediated by TLR2. Our findings underscore the utility of this model as a valuable tool to study immunity to spirochetal infections.	[Mason, Lauren M. K.; Wagemakers, Alex; van 't Veer, Cornelis; van der Poll, Tom; Hovius, Joppe W. R.] Acad Med Ctr, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Oei, Anneke] Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [van der Pot, Wouter J.; Ahmed, Kalam] Kennemer Gasthuis, Dept Plast Surg, Haarlem, Netherlands; [van der Poll, Tom; Hovius, Joppe W. R.] Acad Med Ctr, Div Infect Dis, Amsterdam, Netherlands; [Geijtenbeek, Teunis B. H.] Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Spaarne Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Mason, LMK (corresponding author), Acad Med Ctr, Ctr Expt & Mol Med, Amsterdam, Netherlands.	l.m.mason@amc.uva.nl	Hovius, Joppe/GZL-6894-2022	Hovius, Joppe/0000-0003-0066-2437	"Veni" grant from The Netherlands Organisation for health research and development (ZonMw) [91611065]	"Veni" grant from The Netherlands Organisation for health research and development (ZonMw)	This work was supported by a "Veni" grant (91611065) from JWH received from The Netherlands Organisation for health research and development (ZonMw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Dai XJ, 2011, J ALLERGY CLIN IMMUN, V127, P806, DOI 10.1016/j.jaci.2010.12.006; Filgueira L, 1996, J IMMUNOL, V157, P2998; Flacher V, 2006, J IMMUNOL, V177, P7959, DOI 10.4049/jimmunol.177.11.7959; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Haniffa M, 2015, J DERMATOL SCI, V77, P85, DOI 10.1016/j.jdermsci.2014.08.012; Hartiala P, 2007, J LEUKOCYTE BIOL, V82, P33, DOI 10.1189/jlb.1106709; Hartiala P, 2010, J IMMUNOL, V184, P5732, DOI 10.4049/jimmunol.0803944; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; HULINSKA D, 1994, ZBL BAKT-INT J MED M, V280, P348, DOI 10.1016/S0934-8840(11)80597-9; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Klechevsky E, 2008, IMMUNITY, V29, P497, DOI 10.1016/j.immuni.2008.07.013; Lebre MC, 2007, J INVEST DERMATOL, V127, P331, DOI 10.1038/sj.jid.5700530; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Marchal C, 2011, INFECT IMMUN, V79, P774, DOI 10.1128/IAI.00482-10; Marchal CMP, 2009, J INVEST DERMATOL, V129, P2515, DOI 10.1038/jid.2009.73; Mason LMK, 2015, IMMUNOBIOLOGY, V220, P1141, DOI 10.1016/j.imbio.2015.06.006; Mason LMK, 2014, TRENDS PARASITOL, V30, P95, DOI 10.1016/j.pt.2013.12.003; Meng GX, 2004, J CLIN INVEST, V113, P1473, DOI 10.1172/JCI200420762; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Partida-Sanchez S, 2007, ADV EXP MED BIOL, V590, P171; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Saalbach A, 2010, J INVEST DERMATOL, V130, P444, DOI 10.1038/jid.2009.253; Salazar JC, 2005, CLIN DIAGN LAB IMMUN, V12, P949, DOI 10.1128/CDLI.12.8.949-958.2005; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Schneider LP, 2012, VACCINE, V30, P4216, DOI 10.1016/j.vaccine.2012.04.051; Schramm F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040046; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Shin OS, 2008, INFECT IMMUN, V76, P2341, DOI 10.1128/IAI.01600-07; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Suhonen J, 2003, SCAND J IMMUNOL, V58, P67, DOI 10.1046/j.1365-3083.2003.01284.x; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; van der Aar AMG, 2007, J IMMUNOL, V178, P1986, DOI 10.4049/jimmunol.178.4.1986; Wagemakers A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-418; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613	39	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164040	10.1371/journal.pone.0164040	http://dx.doi.org/10.1371/journal.pone.0164040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695100	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100079
J	Seino, H; Arai, Y; Nagao, N; Ozawa, N; Hamada, K				Seino, Haruyoshi; Arai, Yukari; Nagao, Norio; Ozawa, Noriyasu; Hamada, Kazuhiko			Efficient Percutaneous Delivery of the Antimelanogenic Agent Glabridin Using Cationic Amphiphilic Chitosan Micelles	PLOS ONE			English	Article							TYROSINASE ACTIVITY; DRUG-DELIVERY; HAIR CYCLE; HUMAN-SKIN; IN-VITRO; MELANOGENESIS; DERIVATIVES; CELLS; PIGMENTATION; PENETRATION	Partially myristoylated chitosan pyrrolidone carboxylate (PMCP) is a cationic amphiphilic chitosan derivative. Glabridin (Glab) from licorice root extracts is a hydrophobic antimelanogenic agent. Here we assessed the effects of cationic Glab-containing polymeric micelles derived from PMCP (Glab/PMCP-PM) on the ability of Glab to penetrate the skin and inhibit melanogenesis using a human skin model. The amount of Glab absorbed 24 h after the application of Glab/PMCP-PM was approximately four times higher than that of conventional oil-in-water micelles (control) prepared using Tween 60. Further, the release of IL-1 alpha, a mediator of inflammation, was not detected. Treatment with Glab/PMCP-PM significantly increased the inhibition of melanogenesis compared with control. The inhibition of melanogenesis depends upon the enhanced ability of Glab to penetrate the skin, particularly the epidermis. Moreover, the inhibition of melanogenesis and the cationic potential of the Glab/PMCP-PM levels were increased by the cationic phospholipid copolymer. Therefore, Glab/PMCP-PM shows potential as an effective transdermal delivery system for treating skin hyperpigmentation.	[Seino, Haruyoshi; Arai, Yukari; Ozawa, Noriyasu; Hamada, Kazuhiko] Pias Corp, Cent Res Lab, Nishi Ku, 1-3-1 Murotani, Kobe, Hyogo, Japan; [Nagao, Norio] Prefectural Univ Hiroshima, Fac Life & Environm Sci, 562 Nanatsuka, Shobara, Japan		Seino, H (corresponding author), Pias Corp, Cent Res Lab, Nishi Ku, 1-3-1 Murotani, Kobe, Hyogo, Japan.; Nagao, N (corresponding author), Prefectural Univ Hiroshima, Fac Life & Environm Sci, 562 Nanatsuka, Shobara, Japan.	hseino@pias.co.jp; nagao@pu-hiroshima.ac.jp		Seino, Haruyoshi/0000-0001-9293-5409	 [Pias Corporation]		The funder (Pias Corporation) provided support in the form of salaries for authors Haruyoshi Seino, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Norio Nagao conducted joint research to instruct about this study. The specific roles of these authors are articulated in the 'author contributions' section.	Acosta N, 2003, MACROMOL BIOSCI, V3, P546, DOI 10.1002/mabi.200300009; Bajaj G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030899; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; BURNETTE RR, 1987, J PHARM SCI, V76, P765, DOI 10.1002/jps.2600761003; CABANES J, 1994, J PHARM PHARMACOL, V46, P982, DOI 10.1111/j.2042-7158.1994.tb03253.x; Chen R. H., 2000, INT J COSMETIC SCI, V22, P349, DOI [DOI 10.1111/J.1467-2494.2000.00036.X, 10.1111/j.1467-2494.2000.00036.x]; Fujimori H, 2010, BIOSCI BIOTECH BIOCH, V74, P918, DOI 10.1271/bbb.90700; Goh MJ, 2012, PHYTOTHER RES, V26, P1107, DOI 10.1002/ptr.3682; HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5; HIRANO S, 1987, CARBOHYD RES, V165, P120, DOI 10.1016/0008-6215(87)80085-X; Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012; Hsieh MJ, 2014, BRIT J PHARMACOL, V171, P3037, DOI 10.1111/bph.12626; Jiang GB, 2006, MOL PHARMACEUT, V3, P152, DOI 10.1021/mp050010c; Jin YH, 1999, ARCH PHARM RES, V22, P232, DOI 10.1007/BF02976355; Joly-Tonetti N, 2016, EXP DERMATOL, V25, P501, DOI 10.1111/exd.13016; Kameyama K, 1996, J AM ACAD DERMATOL, V34, P29, DOI 10.1016/S0190-9622(96)90830-0; Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102; Michalczyk D, 2009, ACTA BIOCHIM POL, V56, P343; Michalczyk-Wetula D, 2013, ACTA BIOCHIM POL, V60, P313; Miwa A, 1998, PHARMACEUT RES, V15, P1844, DOI 10.1023/A:1011901921995; Nakajima M, 1998, PIGM CELL RES, V11, P12, DOI 10.1111/j.1600-0749.1998.tb00705.x; Nerya O, 2003, J AGR FOOD CHEM, V51, P1201, DOI 10.1021/jf020935u; Ni-Komatsu L, 2008, MOL PHARMACOL, V74, P1576, DOI 10.1124/mol.108.050633; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Nokhodchi A, 2003, INT J PHARM, V250, P359, DOI 10.1016/S0378-5173(02)00554-9; Nonaka K, 2001, J OLEO SCI, V50, P773, DOI [DOI 10.5650/JOS.50.773, 10.5650/jos.50.773]; Perez-Bernal A, 2000, Am J Clin Dermatol, V1, P261; SEINO H, 1991, AGR BIOL CHEM TOKYO, V55, P2421, DOI 10.1271/bbb1961.55.2421; Seino H, 2002, J JPN COSMETIC SCI S, V26, P71; Silva SS, 2013, ACTA BIOMATER, V9, P6790, DOI 10.1016/j.actbio.2013.02.027; SLOMINSKI A, 1990, J THEOR BIOL, V143, P123, DOI 10.1016/S0022-5193(05)80292-9; Slominski A, 1998, ANTICANCER RES, V18, P3709; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Som I, 2012, J PHARM BIOALLIED SC, V4, P2, DOI 10.4103/0975-7406.92724; Welss T, 2004, TOXICOL IN VITRO, V18, P231, DOI 10.1016/j.tiv.2003.09.009; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Yokota T, 1998, PIGM CELL RES, V11, P355, DOI 10.1111/j.1600-0749.1998.tb00494.x; YOSHIOKA H, 1995, BIOSCI BIOTECH BIOCH, V59, P1901, DOI 10.1271/bbb.59.1901; Zhang C, 2007, COLLOID SURFACE B, V55, P192, DOI 10.1016/j.colsurfb.2006.11.031; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053314	41	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164061	10.1371/journal.pone.0164061	http://dx.doi.org/10.1371/journal.pone.0164061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695112	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100083
J	Singh, SB; Kang, L; Nawrocki, AR; Zhou, D; Wu, M; Previs, S; Miller, C; Liu, HY; Hines, CDG; Madeira, M; Cao, J; Herath, K; Wang, LS; Kelley, DE; Li, C; Guan, HP				Singh, Sheo B.; Kang, Ling; Nawrocki, Andrea R.; Zhou, Dan; Wu, Margaret; Previs, Stephen; Miller, Corey; Liu, Haiying; Hines, Catherine D. G.; Madeira, Maria; Cao, Jin; Herath, Kithsiri; Wang, Liangsu; Kelley, David E.; Li, Cai; Guan, Hong-Ping			The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys	PLOS ONE			English	Article							GLUCAGON RECEPTOR; DESATURATION CAPACITY; EXTRAHEPATIC TISSUES; ADIPOSE-TISSUE; KNOCKOUT MICE; DISEASE; LIPOGENESIS; DIET; HOMEOSTASIS; REDUCTION	Objectives Platensimycin (PTM) is a natural antibiotic produced by Streptomyces platensis that selectively inhibits bacterial and mammalian fatty acid synthase (FAS) without affecting synthesis of other lipids. Recently, we reported that oral administration of PTM in mouse models (db/db and db/+) with high de novo lipogenesis (DNL) tone inhibited DNL and enhanced glucose oxidation, which in turn led to net reduction of liver triglycerides (TG), reduced ambient glucose, and improved insulin sensitivity. The present study was conducted to explore translatability and the therapeutic potential of FAS inhibition for the treatment of diabetes in humans. Methods We tested PTM in animal models with different DNL tones, i.e. intrinsic synthesis rates, which vary among species and are regulated by nutritional and disease states, and confirmed glucose-lowering efficacy of PTM in lean NHPs with quantitation of liver lipid by MRS imaging. To understand the direct effect of PTM on liver metabolism, we performed ex vivo liver perfusion study to compare FAS inhibitor and carnitine palmitoyltransferase 1 (CPT1) inhibitor. Results The efficacy of PTM is generally reproduced in preclinical models with DNL tones comparable to humans, including lean and established diet-induced obese (eDIO) mice as well as non-human primates (NHPs). Similar effects of PTM on DNL reduction were observed in lean and type 2 diabetic rhesus and lean cynomolgus monkeys after acute and chronic treatment of PTM. Mechanistically, PTM lowers plasma glucose in part by enhancing hepatic glucose uptake and glycolysis. Teglicar, a CPT1 inhibitor, has similar effects on glucose uptake and glycolysis. In sharp contrast, Teglicar but not PTM significantly increased hepatic TG production, thus caused liver steatosis in eDIO mice. Conclusions These findings demonstrate unique properties of PTM and provide proof-of-concept of FAS inhibition having potential utility for the treatment of diabetes and related metabolic disorders.	[Singh, Sheo B.] Merck Res Labs, Dept Discovery Chem, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA; [Kang, Ling; Wu, Margaret; Previs, Stephen; Herath, Kithsiri; Wang, Liangsu; Kelley, David E.; Guan, Hong-Ping] Merck Res Labs, Dept Cardiometab Dis, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA; [Nawrocki, Andrea R.; Zhou, Dan; Li, Cai] Merck Res Labs, Dept Pharmacol, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA; [Miller, Corey; Liu, Haiying; Cao, Jin] Merck Res Labs, Dept Imaging & Biomarker, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA; [Madeira, Maria] Merck Res Labs, Dept PKPD, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA; [Hines, Catherine D. G.] Merck Res Labs, Dept Translat Imaging Biomarkers, 770 Sumneytown Pike, West Point, PA 19486 USA	Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Singh, SB (corresponding author), Merck Res Labs, Dept Discovery Chem, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.; Guan, HP (corresponding author), Merck Res Labs, Dept Cardiometab Dis, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	sbsingh101@gmail.com; Hong-Ping_Guan@merck.com			Merck Research Laboratories	Merck Research Laboratories(Merck & Company)	This work was funded by Merck Research Laboratories. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Rincon-Cervera MA, 2016, NUTRITION, V32, P1254, DOI 10.1016/j.nut.2016.04.006; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cohen SM, 2006, BIOORGAN MED CHEM, V14, P1506, DOI 10.1016/j.bmc.2005.10.008; Conti R, 2011, DIABETES, V60, P644, DOI 10.2337/db10-0346; Deems RO, 1998, AM J PHYSIOL-REG I, V274, pR524, DOI 10.1152/ajpregu.1998.274.2.R524; Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Dorn C, 2010, INT J CLIN EXP PATHO, V3, P505; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; Floettmann E, 2010, TOXICOL PATHOL, V38, P393, DOI 10.1177/0192623310362707; Guan HP, 2015, J LIPID RES, V56, P2183, DOI 10.1194/jlr.M060897; Han S, 2013, J LIPID RES, V54, P2615, DOI 10.1194/jlr.M035592; HEMS DA, 1975, BIOCHEM J, V150, P167, DOI 10.1042/bj1500167; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; JAYAKUMAR A, 1995, P NATL ACAD SCI USA, V92, P8695, DOI 10.1073/pnas.92.19.8695; LEITCH CA, 1991, BIOL MASS SPECTROM, V20, P392, DOI 10.1002/bms.1200200611; Moore JB, 2014, NUTRIENTS, V6, P5679, DOI 10.3390/nu6125679; Peng L, 2011, J CARDIOVASC PHARM, V58, P102, DOI 10.1097/FJC.0b013e31821d1168; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Previs SF, 2015, METHOD ENZYMOL, V561, P331, DOI 10.1016/bs.mie.2015.06.021; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; Shah V, 2010, ANAL BIOCHEM, V404, P235, DOI 10.1016/j.ab.2010.05.010; TRAYHURN P, 1990, BIOCHIM BIOPHYS ACTA, V1047, P168, DOI 10.1016/0005-2760(90)90043-W; Valentini G, 2008, DIABETOLOGIA, V51, pS23; Valenzuela R, 2015, PROSTAG LEUKOTR ESS, V98, P7, DOI 10.1016/j.plefa.2015.04.002; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Wu M, 2011, P NATL ACAD SCI USA, V108, P5378, DOI 10.1073/pnas.1002588108	31	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164133	10.1371/journal.pone.0164133	http://dx.doi.org/10.1371/journal.pone.0164133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695056	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100092
J	Yu, SB; Verges-Armstrong, LM; Chu, YX; Zmuda, JM; Zhang, YZ				Yu, Shibing; Verges-Armstrong, Laura M.; Chu, Yanxia; Zmuda, Joseph M.; Zhang, Yingze			Transcriptional Regulation of Frizzled-1 in Human Osteoblasts by Sp1	PLOS ONE			English	Article							BINDING-SITE POLYMORPHISM; BONE-DENSITY; OSTEOPOROTIC FRACTURES; GENE-EXPRESSION; MITHRAMYCIN; DIFFERENTIATION; INHIBITION; PROMOTER; SAOS-2; GROWTH	The wingless pathway has a powerful influence on bone metabolism and is a therapeutic target in skeletal disorders. Wingless signaling is mediated in part through the Frizzled (FZD) receptor family. FZD transcriptional regulation is poorly understood. Herein we tested the hypothesis that Sp1 plays an important role in the transcriptional regulation of FZD1 expression in osteoblasts and osteoblast mineralization. To test this hypothesis, we conducted FZD1 promoter assays in Saos2 cells with and without Sp1 overexpression. We found that Sp1 significantly up-regulates FZD1 promoter activity in Saos2 cells. Chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift (EMSA) assays identified a novel and functional Sp1 binding site at -44 to -40 from the translation start site in the FZD1 promoter. The Sp1-dependent activation of the FZD1 promoter was abolished by mithramycin A (MMA), an antibiotic affecting both Sp1 binding and Sp1 protein levels in Saos2 cells. Similarly, down-regulation of Sp1 in hFOB cells resulted in less FZD1 expression and lower alkaline phosphatase activity. Moreover, over-expression of Sp1 increased FZD1 expression and Saos2 cell mineralization while MMA decreased Sp1 and FZD1 expression and Saos2 cell mineralization. Knockdown of FZD1 prior to Sp1 overexpression partially abolished Sp1 stimulation of osteoblast differentiation markers. Taken together, our results suggest that Sp1 plays a role in human osteoblast differentiation and mineralization, which is at least partially mediated by Sp1-dependent transactivation of FZD1.	[Yu, Shibing; Chu, Yanxia; Zhang, Yingze] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA; [Verges-Armstrong, Laura M.; Zmuda, Joseph M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Zmuda, Joseph M.; Zhang, Yingze] Univ Pittsburgh, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Verges-Armstrong, Laura M.] Univ Maryland, Sch Med, Program Personalized & Genom Med, College Pk, MD 20742 USA; [Verges-Armstrong, Laura M.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, College Pk, MD 20742 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Zhang, YZ (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15260 USA.; Zhang, YZ (corresponding author), Univ Pittsburgh, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA 15260 USA.	zhangy@upmc.edu		Zhang, YIngze/0000-0001-8042-6105	National Institute on Aging [R01-AG033618, T32-AG00181]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR049747]; National Osteoporosis Foundation; Western Pennsylvania Arthritis Foundation	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Osteoporosis Foundation; Western Pennsylvania Arthritis Foundation	This study was supported by grants R01-AG033618 from the National Institute on Aging, R01-AR049747 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases and funding from the National Osteoporosis Foundation and Western Pennsylvania Arthritis Foundation. Laura M. Yerges-Armstrong was supported by National Institute on Aging grant T32-AG00181. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; Choi ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep07162; Chu SJ, 2005, GENE, V348, P1, DOI 10.1016/j.gene.2005.01.013; Chupreta S, 2000, AM J PHYSIOL-CELL PH, V278, pC697, DOI 10.1152/ajpcell.2000.278.4.C697; Deniaud E, 2006, ONCOGENE, V25, P7096, DOI 10.1038/sj.onc.1209696; Feng X, 2000, J BIOL CHEM, V275, P8331, DOI 10.1074/jbc.275.12.8331; Garnero P, 1998, J BONE MINER RES, V13, P813, DOI 10.1359/jbmr.1998.13.5.813; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Haidweger E, 2001, J MOL BIOL, V306, P201, DOI 10.1006/jmbi.2000.4406; Hantusch B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-20; Hirose T, 2013, NATURE, V500, P354, DOI 10.1038/nature12329; Ji CH, 1997, J BIOL CHEM, V272, P21260, DOI 10.1074/jbc.272.34.21260; Jia ZL, 2010, CANCER RES, V70, P1111, DOI 10.1158/0008-5472.CAN-09-3282; Langdahl BL, 1998, J BONE MINER RES, V13, P1384, DOI 10.1359/jbmr.1998.13.9.1384; Liu JZ, 2005, J CELL BIOCHEM, V96, P716, DOI 10.1002/jcb.20569; Malek A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035130; Maneix L, 2014, J MOL MED, V92, P1179, DOI 10.1007/s00109-014-1195-5; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; McGuigan FEA, 2000, OSTEOPOROSIS INT, V11, P338, DOI 10.1007/s001980070123; MCQUILLAN DJ, 1995, BONE, V16, P415; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Otjacques E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062818; RAY R, 1989, J CLIN INVEST, V83, P2003, DOI 10.1172/JCI114110; RODAN SB, 1987, CANCER RES, V47, P4961; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Suuriniemi M, 2006, BONE, V39, P591, DOI 10.1016/j.bone.2006.02.053; Uitterlinden AG, 1998, NEW ENGL J MED, V338, P1016, DOI 10.1056/NEJM199804093381502; Wang LW, 2008, INT J ONCOL, V33, P161; Williams LJS, 2000, J MOL ENDOCRINOL, V25, P309, DOI 10.1677/jme.0.0250309; YARBRO JW, 1966, CANCER RES, V26, P36; Yerges LM, 2009, J BONE MINER RES, V24, P87, DOI [10.1359/jbmr.080816, 10.1359/JBMR.080816]; Yu SB, 2015, BIOCHEM J, V465, P395, DOI 10.1042/BJ20140668; Yu SB, 2013, BONE, V56, P234, DOI 10.1016/j.bone.2013.06.019; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200; Zhang YZ, 2010, BONE, V46, P1131, DOI 10.1016/j.bone.2009.12.026	39	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163277	10.1371/journal.pone.0163277	http://dx.doi.org/10.1371/journal.pone.0163277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695039	Green Submitted, Green Published, gold			2022-12-27	WOS:000385553100027
J	Zhang, MM; Fu, HR; Lai, XY; Tan, YM; Zheng, WY; Shi, JM; Zhao, YM; Lin, MF; He, JS; Cai, Z; Luo, Y; Huang, H				Zhang, Mingming; Fu, Huarui; Lai, Xiaoyu; Tan, Yamin; Zheng, Weiyan; Shi, Jimin; Zhao, Yanmin; Lin, Maofang; He, Jingsong; Cai, Zhen; Luo, Yi; Huang, He			Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; STANDARD; MRD	We evaluated the prognostic effect of minimal residual disease at first achievement of complete remission (MRD at CR1) in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). A total of 97 patients received treatment in our center between 2007 and 2012 were retrospectively reviewed in this study. Patients were divided into two arms according to the post-remission therapy (chemotherapy alone or allogeneic hematopoietic stem cell transplantation (allo-HSCT)) they received. MRD was detected by four-color flow cytometry. We chose 0.02% and 0.2% as the cut-off points of MRD at CR1 for risk stratification using receiver operating characteristic analysis. The 3-year overall survival (OS) and leukemia free survival (LFS) rates for the whole cohort were 46.2% and 40.5%. MRD at CR1 had a significantly negative correlation with survival in both arms. Three-year OS rates in the chemotherapy arm were 70.0%, 25.2%, 0% (P = 0.003) for low, intermediate, and high levels of MRD at CR1, respectively. Three-year OS rates in the transplant arm were 81.8%, 64.3%, 27.3% (P = 0.005) for low, intermediate, and high levels of MRD at CR1, respectively. Multivariate analysis confirmed that higher level of MRD at CR1 was a significant adverse factor for OS and LFS. Compared with chemotherapy alone, allo-HSCT significantly improved LFS rates in patients with intermediate (P = 0.005) and high (P = 0.022) levels of MRD at CR1, but not patients with low level of MRD at CR1 (P = 0.851). These results suggested that MRD at CR1 could strongly predict the outcome of adult ALL. Patients with intermediate and high levels of MRD at CR1 would benefit from allo-HSCT.	[Zhang, Mingming; Fu, Huarui; Lai, Xiaoyu; Tan, Yamin; Zheng, Weiyan; Shi, Jimin; Zhao, Yanmin; Lin, Maofang; He, Jingsong; Cai, Zhen; Luo, Yi; Huang, He] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Luo, Y; Huang, H (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Zhejiang, Peoples R China.	luoyijr@163.com; huanghe@zju.edu.co	zhao, yan/GWC-9174-2022	huang, he/0000-0002-2723-1621	Key Project of the National Natural Science Foundation of China [81230014]; National Natural Science Foundation of China [81370644, 81470307]	Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded in part by the Key Project of the National Natural Science Foundation of China (81230014, HH), and the National Natural Science Foundation of China (81370644, YL; 81470307 YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassan R, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.48; Bassan R, 2011, J CLIN ONCOL, V29, P532, DOI 10.1200/JCO.2010.30.1382; Bassan R, 2009, BLOOD, V113, P4153, DOI 10.1182/blood-2008-11-185132; Beldjord K, 2014, BLOOD, V123, P3739, DOI 10.1182/blood-2014-01-547695; Bruggemann M, 2006, BLOOD, V107, P1116, DOI 10.1182/blood-2005-07-2708; Dhedin N, 2015, BLOOD, V125, P2486, DOI 10.1182/blood-2014-09-599894; Fielding AK, 2007, BLOOD, V109, P944, DOI 10.1182/blood-2006-05-018192; Gokbuget N, 2012, BLOOD, V120, P1868, DOI 10.1182/blood-2011-09-377713; Gokbuget N, 2009, SEMIN HEMATOL, V46, P64, DOI 10.1053/j.seminhematol.2008.09.003; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; Holowiecki J, 2008, BRIT J HAEMATOL, V142, P227, DOI 10.1111/j.1365-2141.2008.07185.x; Luo Y, 2014, BLOOD, V124, P2735, DOI 10.1182/blood-2014-04-571570; Patel B, 2010, BRIT J HAEMATOL, V148, P80, DOI 10.1111/j.1365-2141.2009.07941.x; Ribera JM, 2014, J CLIN ONCOL, V32, P1595, DOI 10.1200/JCO.2013.52.2425; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; van Dongen JJM, 2015, BLOOD, V125, P3996, DOI 10.1182/blood-2015-03-580027	16	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163599	10.1371/journal.pone.0163599	http://dx.doi.org/10.1371/journal.pone.0163599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695097	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100046
J	Pouwels, KB; Bozdemir, SE; Yegenoglu, S; Celebi, S; McIntosh, ED; Unal, S; Postma, MJ; Hacimustafaoglu, M				Pouwels, Koen B.; Bozdemir, Sefika E.; Yegenoglu, Selen; Celebi, Solmaz; McIntosh, E. David; Unal, Serhat; Postma, Maarten J.; Hacimustafaoglu, Mustafa			Potential Cost-Effectiveness of RSV Vaccination of Infants and Pregnant Women in Turkey: An Illustration Based on Bursa Data	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; UNITED-STATES; HIGH-RISK; INFECTION; CHILDREN; INFLUENZA; MORTALITY; HOSPITALIZATION; PROPHYLAXIS; FREQUENCY	Background Worldwide, respiratory syncytial virus (RSV) is considered to be the most important viral cause of respiratory morbidity and mortality among infants and young children. Although no active vaccine is available on the market yet, there are several active vaccine development programs in various stages. To assess whether one of these vaccines might be a future asset for national immunization programs, modeling the costs and benefits of various vaccination strategies is needed. Objectives To evaluate the potential cost-effectiveness of RSV vaccination of infants and/or pregnant women in Turkey. Methods A multi-cohort static Markov model with cycles of one month was used to compare the cost-effectiveness of vaccinated cohorts versus non-vaccinated cohorts. The 2014 Turkish birth cohort was divided by twelve to construct twelve monthly birth cohorts of equal size (111,459 new-borns). Model input was based on clinical data from a multicenter prospective study from Bursa, Turkey, combined with figures from the (inter) national literature and publicly available data from the Turkish Statistical Institute (TUIK). Incremental cost-effectiveness ratios (ICERs) were expressed in Turkish Lira (TL) per quality-adjusted life year (QALY) gained. Results Vaccinating infants at 2 and 4 months of age would prevent 145,802 GP visits, 8,201 hospitalizations and 48 deaths during the first year of life, corresponding to a total gain of 1650 QALYs. The discounted ICER was estimated at 51,969 TL (26,220 US $ in 2013) per QALY gained. Vaccinating both pregnant women and infants would prevent more cases, but was less attractive from a pure economic point of view with a discounted ICER of 61,653 TL (31,106 US $ in 2013) per QALY. Vaccinating only during pregnancy would result in fewer cases prevented than infant vaccination and a less favorable ICER. Conclusion RSV vaccination of infants and/or pregnant women has the potential to be cost-effective in Turkey. Although using relatively conservative assumptions, all evaluated strategies remained slightly below the threshold of 3 times the GDP per capita.	[Pouwels, Koen B.; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands; [Pouwels, Koen B.] Publ Hlth England, Modelling & Econ Unit, Ctr Infect Dis Surveillance & Control, London, England; [Bozdemir, Sefika E.; Celebi, Solmaz; Hacimustafaoglu, Mustafa] Uludag Univ, Fac Med, Div Pediat Infect Dis, Bursa, Turkey; [Yegenoglu, Selen] Hacettepe Univ, Dept Pharm Management, Fac Pharm, Ankara, Turkey; [McIntosh, E. David] Imperial Coll London, Dept Med, London, England; [Unal, Serhat] Hacettepe Univ, Dept Infect Dis & Clin Microbiol, Fac Med, Ankara, Turkey; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & HealthcaRE SHARE, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; Public Health England; Uludag University; Hacettepe University; Imperial College London; Hacettepe University; University of Groningen; University of Groningen	Pouwels, KB (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands.; Pouwels, KB (corresponding author), Publ Hlth England, Modelling & Econ Unit, Ctr Infect Dis Surveillance & Control, London, England.	k.b.pouwels@gmail.com	UNAL, SERHAT/I-9034-2013; Pouwels, Koen B./F-2081-2013	UNAL, SERHAT/0000-0003-1184-4711; Pouwels, Koen B./0000-0001-7097-8950; Postma, Maarten/0000-0002-6306-3653				Acedo L, 2010, EPIDEMIOL INFECT, V138, P853, DOI 10.1017/S0950268809991373; Acosta PL, 2016, CLIN VACCINE IMMUNOL, V23, P189, DOI 10.1128/CVI.00609-15; Ajayi-Obe EK, 2008, EPIDEMIOL INFECT, V136, P1046, DOI 10.1017/S0950268807009557; Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; [Anonymous], 1999, PEDIATR INFECT DIS J, V18, P173; Assink MDM, 2009, VACCINE, V27, P1119, DOI 10.1016/j.vaccine.2008.11.070; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Bakir M, 2013, VACCINE, V31, P979, DOI 10.1016/j.vaccine.2012.11.071; Bakir M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-386; Bentley A, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-18; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Breese C, 2013, PEDIATRICS, V132, pE341, DOI 10.1542/peds.2013-0303; Byington CL, 2015, PEDIATRICS, V135, pE24, DOI 10.1542/peds.2014-2151; Cilla G, 2006, EPIDEMIOL INFECT, V134, P506, DOI 10.1017/S0950268805005571; Drysdale SB, 2016, EXPERT REV VACCINES, V15, P149, DOI 10.1586/14760584.2016.1114419; Gessner BD, 2000, VACCINE, V18, P1485, DOI 10.1016/S0264-410X(99)00425-9; Greenough A, 2004, ARCH DIS CHILD, V89, P673, DOI 10.1136/adc.2003.036129; Hacimustafaoglu M, 2008, J PEDIATR INFECT, V2, P156; Hacimustafaoglu M, 2004, ARCH DIS CHILD, V89, P52, DOI 10.1136/adc.2002.017780; Hacimustafaoglu M, 2013, TURKISH J PEDIATR, V55, P130; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hall CB, 2000, PRINCIPLES PRACTICE, P1782; HENDERSON FW, 1979, NEW ENGL J MED, V300, P530, DOI 10.1056/NEJM197903083001004; Jartti T, 2014, PEDIATR INFECT DIS J, V33, P829, DOI 10.1097/INF.0000000000000313; Jit M, 2010, VACCINE, V29, P115, DOI 10.1016/j.vaccine.2010.08.078; Kinyanjui TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138018; Matias G, 2014, INFLUENZA OTHER RESP, V8, P507, DOI 10.1111/irv.12258; Meijboom MJ, 2013, VACCINE, V31, P6254, DOI 10.1016/j.vaccine.2013.10.023; Meijboom MJ, 2012, VACCINE, V30, P4691, DOI 10.1016/j.vaccine.2012.04.072; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nuijten MJC, 2007, PHARMACOECONOMICS, V25, P55, DOI 10.2165/00019053-200725010-00006; ONeill J., 2014, REV ANTIMICROBIAL RE; Piedimonte G, 2014, CURR OPIN PHARMACOL, V16, P82, DOI 10.1016/j.coph.2014.03.008; Poletti P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0283-x; Regnier SA, 2013, VACCINE, V31, P4347, DOI 10.1016/j.vaccine.2013.07.024; Regnier SA, 2013, PEDIATR INFECT DIS J, V32, P820, DOI 10.1097/INF.0b013e31829061e8; Rietveld E, 2006, PEDIATR INFECT DIS J, V25, P201, DOI 10.1097/01.inf.0000202135.24485.f8; Roy LM, DERIVING HLTH UTILIT; Roy LM, 2014, ALLERGY ASTHMA CL IM, V10, DOI [10.1186/1710-1492-10-S1-A64, DOI 10.1186/1710-1492-10-S1-A64, 10.1186/ 1710-1492-10-S1-A64]; Tempia S, 2014, CLIN INFECT DIS, V58, P1241, DOI 10.1093/cid/ciu095; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Turkish Neonatal Soc, 2012, TURKISH J PEDIATR, V54, P216; Vesa S, 2001, PEDIATR INFECT DIS J, V20, P574, DOI 10.1097/00006454-200106000-00006; Welliver RC, 2010, CURR MED RES OPIN, V26, P2175, DOI 10.1185/03007995.2010.505126; Wheeler SM, 2015, EMERG INFECT DIS, V21, P1951, DOI 10.3201/eid2111.150497; Wren C, 2001, HEART, V85, P438, DOI 10.1136/heart.85.4.438; Wybo I, 2009, 19 EUR C CLIN MICR I; Yilmaz G, 1999, PEDIATR INFECT DIS J, V18, P173, DOI 10.1097/00006454-199902000-00022	49	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163567	10.1371/journal.pone.0163567	http://dx.doi.org/10.1371/journal.pone.0163567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689356	Green Published, Green Submitted, gold			2022-12-27	WOS:000384329200016
J	Cheng, LB; Li, SY; Chen, SN; Wang, Y; Yu, MZ; Chen, XH; Li, LJ; Yin, JJ				Cheng, Libao; Li, Shuyan; Chen, Sainan; Wang, Yan; Yu, Meizhen; Chen, Xuehao; Li, Liangjun; Yin, Jingjing			Transcriptome Analysis of Gene Expression during Chinese Water Chestnut Storage Organ Formation	PLOS ONE			English	Article							TUBER FORMATION; JASMONIC ACID; ALCOHOL-DEHYDROGENASE; PHOTOPERIODIC CONTROL; CARBON-DIOXIDE; ABSCISIC-ACID; POTATO; CALMODULIN; INDUCTION; ETHYLENE	The product organ (storage organ; corm) of the Chinese water chestnut has become a very popular food in Asian countries because of its unique nutritional value. Corm formation is a complex biological process, and extensive whole genome analysis of transcripts during corm development has not been carried out. In this study, four corm libraries at different developmental stages were constructed, and gene expression was identified using a high-throughput tag sequencing technique. Approximately 4.9 million tags were sequenced, and 4,371,386, 4,372,602, 4,782,494, and 5,276,540 clean tags, including 119,676, 110,701, 100,089, and 101,239 distinct tags, respectively, were obtained after removal of low-quality tags from each library. More than 39% of the distinct tags were unambiguous and could be mapped to reference genes, while 40% were unambiguous tag-mapped genes. After mapping their functions in existing databases, a total of 11,592, 10,949, 10,585, and 7,111 genes were annotated from the B1, B2, B3, and B4 libraries, respectively. Analysis of the differentially expressed genes (DEGs) in B1/B2, B2/B3, and B3/B4 libraries showed that most of the DEGs at the B1/B2 stages were involved in carbohydrate and hormone metabolism, while the majority of DEGs were involved in energy metabolism and carbohydrate metabolism at the B2/B3 and B3/B4 stages. All of the upregulated transcription factors and 9 important genes related to product organ formation in the above four stages were also identified. The expression changes of nine of the identified DEGs were validated using a quantitative PCR approach. This study provides a comprehensive understanding of gene expression during corm formation in the Chinese water chestnut.	[Cheng, Libao; Chen, Sainan; Wang, Yan; Yu, Meizhen; Chen, Xuehao; Li, Liangjun; Yin, Jingjing] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China; [Li, Shuyan] Yangzhou Univ, Guangling Coll, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Chen, XH; Li, LJ (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China.	xhchen@yzu.edu.cn; ljli@yzu.edu.cn			Natural Science Foundation of Jiangsu Province, China [BK20151307]; Natural Science Fund for Colleges and Universities in Jiangsu Province, China [14KJB210012]; China Postdoctoral Science Foundation [2013M541738]; Interdisciplinary Subject Fund of Yangzhou University, China [jcxk2015-15]; Science and Technology Support Project of Jangsu Province [BE2013388]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Natural Science Fund for Colleges and Universities in Jiangsu Province, China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Interdisciplinary Subject Fund of Yangzhou University, China; Science and Technology Support Project of Jangsu Province	This work was supported by the Natural Science Foundation of Jiangsu Province, China (BK20151307), the Natural Science Fund for Colleges and Universities in Jiangsu Province, China (14KJB210012), the China Postdoctoral Science Foundation funded project (2013M541738) and Interdisciplinary Subject Fund of Yangzhou University, China (jcxk2015-15), and the Science and Technology Support Project of Jangsu Province (BE2013388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelenda JA, 2011, CURR OPIN BIOTECH, V22, P287, DOI 10.1016/j.copbio.2010.11.013; Abeles F, 1992, ETHYLENE PLANT BIOL; Baksh SI, 2006, AM J BOT, V93, P707, DOI 10.3732/ajb.93.5.707; BALAMANI V, 1986, PLANT PHYSIOL, V80, P856, DOI 10.1104/pp.80.4.856; Banerjee AK, 2006, PLANT CELL, V18, P3443, DOI 10.1105/tpc.106.042473; Baudry A, 2010, PLANT CELL, V22, P606, DOI 10.1105/tpc.109.072843; Baxter-Burrell A, 2003, ANN BOT-LONDON, V91, P129, DOI 10.1093/aob/mcf119; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Carrera E, 2000, PLANT J, V22, P247, DOI 10.1046/j.1365-313x.2000.00736.x; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Cheng LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067116; Cheng LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054573; Crawford RMM, 1996, J EXP BOT, V47, P145, DOI 10.1093/jxb/47.2.145; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Debeljak N, 2002, PLANT GROWTH REGUL, V36, P253, DOI 10.1023/A:1016570319387; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fernie AR, 2001, PLANT PHYSIOL, V127, P1459, DOI [10.1104/pp.127.4.1459, 10.1104/pp.010764]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grichko VP, 2001, PLANT PHYSIOL BIOCH, V39, P1, DOI 10.1016/S0981-9428(00)01213-4; Han S. S., 1993, Korean Journal of Weed Science, V13, P138; HANNAPEL DJ, 1985, PLANT PHYSIOL, V78, P700, DOI 10.1104/pp.78.4.700; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hoeren FU, 1998, GENETICS, V149, P479; Hummel M, 2004, J AQUAT PLANT MANAGE, V42, P17; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Inui H, 2010, FEBS LETT, V584, P2393, DOI 10.1016/j.febslet.2010.04.031; Ishizawa K, 1999, PLANT CELL ENVIRON, V22, P505, DOI 10.1046/j.1365-3040.1999.00439.x; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Jackson SD, 1999, PLANT PHYSIOL, V119, P1, DOI 10.1104/pp.119.1.1; Jackson SD, 1996, PLANT J, V9, P159, DOI 10.1046/j.1365-313X.1996.09020159.x; Jasik J, 2006, J PLANT GROWTH REGUL, V25, P45, DOI 10.1007/s00344-005-0048-4; Jung SH, 2003, PLANT MOL BIOL, V52, P553, DOI 10.1023/A:1024866716987; Kim KJ, 2005, ACTA HORTIC, P661, DOI 10.17660/ActaHortic.2005.673.91; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; KODA Y, 1992, INT REV CYTOL, V135, P155, DOI 10.1016/S0074-7696(08)62040-9; Kolomiets MV, 2001, PLANT CELL, V13, P613, DOI 10.1105/tpc.13.3.613; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; KUIPERS AGJ, 1994, PLANT CELL, V6, P43, DOI 10.1105/tpc.6.1.43; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Mach J, 2011, PLANT CELL, V23, P3668, DOI 10.1105/tpc.111.231111; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Meng XiangBing, 2005, Plant Molecular Biology Reporter, V23, P301, DOI 10.1007/BF02772762; MINGOCASTEL AM, 1976, PLANT PHYSIOL, V57, P480, DOI 10.1104/pp.57.4.480; Mueller MJ, 1997, PHYSIOL PLANTARUM, V100, P653, DOI 10.1034/j.1399-3054.1997.1000329.x; MULLERROBER B, 1992, EMBO J, V11, P1229, DOI 10.1002/j.1460-2075.1992.tb05167.x; Neuteboom CE, 2001, PGRSAQ, V30, P77; PAIVA E, 1983, PLANT PHYSIOL, V71, P161, DOI 10.1104/pp.71.1.161; Park WM, 1983, PLANT MOL BIOL REP, V1, P61, DOI [10.1007/BF02680300, DOI 10.1007/BF02680300]; PERATA P, 1993, PLANT SCI, V93, P1, DOI 10.1016/0168-9452(93)90029-Y; Poovaiah BW, 1996, J PLANT PHYSIOL, V149, P553, DOI 10.1016/S0176-1617(96)80333-6; Qi XH, 2012, GENOMICS, V99, P160, DOI 10.1016/j.ygeno.2011.12.008; RAVNIKAR M, 1993, J PLANT GROWTH REGUL, V12, P73, DOI 10.1007/BF00193236; Rayirath UP, 2011, PLANT CELL TISS ORG, V105, P253, DOI 10.1007/s11240-010-9861-y; Reddy ASN, 1996, J BIOL CHEM, V271, P7052, DOI 10.1074/jbc.271.12.7052; SEMBDNER G, 1993, ANNU REV PLANT PHYS, V44, P569, DOI 10.1146/annurev.pp.44.060193.003033; Shiao TI, 2002, BIOTECHNOL BIOENG, V77, P455, DOI 10.1002/bit.10147; SUBBAIAH CC, 1994, PLANT PHYSIOL, V105, P369, DOI 10.1104/pp.105.1.369; SUGE H, 1975, PLANT CELL PHYSIOL, V16, P65, DOI 10.1093/oxfordjournals.pcp.a075128; TSUCHIYA T, 1979, WATER AIR SOIL POLL, V12, P503, DOI 10.1007/BF01046870; TSUCHIYA T, 1993, AQUAT BOT, V46, P317, DOI 10.1016/0304-3770(93)90011-K; Vartapetian BB, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; VREUGDENHIL D, 1989, PHYSIOL PLANTARUM, V75, P525, DOI 10.1111/j.1399-3054.1989.tb05619.x; Wang FD, 2012, GENOMICS, V99, P299, DOI 10.1016/j.ygeno.2012.02.005; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wu SJ, 2015, FOOD CHEM, V181, P15, DOI 10.1016/j.foodchem.2015.02.066; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Xie ZD, 2010, PLANT J, V64, P731, DOI 10.1111/j.1365-313X.2010.04364.x; Xu X, 1998, PLANT PHYSIOL, V117, P575, DOI 10.1104/pp.117.2.575; Yamakawa S., 1981, Weed Research, Japan, V26, P118; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009; Zhan G, 2014, EUR FOOD RES TECHNOL, V238, P789, DOI 10.1007/s00217-013-2151-2; Zhang HW, 2004, PLANTA, V220, P262, DOI 10.1007/s00425-004-1347-x; Zhu Y, 2003, J BIOL CHEM, V278, P47803, DOI 10.1074/jbc.M302806200	76	6	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164223	10.1371/journal.pone.0164223	http://dx.doi.org/10.1371/journal.pone.0164223			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716802	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100036
J	Metcalfe, C; Ramasubramoni, A; Pula, G; Harper, MT; Mundell, SJ; Coxon, CH				Metcalfe, Clive; Ramasubramoni, Anjana; Pula, Giordano; Harper, Matthew T.; Mundell, Stuart J.; Coxon, Carmen H.			Thioredoxin Inhibitors Attenuate Platelet Function and Thrombus Formation	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; FORMATION IN-VIVO; CANCER; BONDS; REDUCTASE; RECEPTOR; ENDOTHELIUM; ASSOCIATION; PROGRESSION; EXPRESSION	Thioredoxin (Trx) is an oxidoreductase with important physiological function. Imbalances in the NADPH/thioredoxin reductase/thioredoxin system are associated with a number of pathologies, particularly cancer, and a number of clinical trials for thioredoxin and thioredoxin reductase inhibitors have been carried out or are underway. Due to the emerging role and importance of oxidoreductases for haemostasis and the current interest in developing inhibitors for clinical use, we thought it pertinent to assess whether inhibition of the NADPH/thioredoxin reductase/thioredoxin system affects platelet function and thrombosis. We used small molecule inhibitors of Trx (PMX 464 and PX-12) to determine whether Trx activity influences platelet function, as well as an unbiased proteomics approach to identify potential Trx substrates on the surface of platelets that might contribute to platelet reactivity and function. Using LC-MS/MS we found that PMX 464 and PX-12 affected the oxidation state of thiols in a number of cell surface proteins. Key surface receptors for platelet adhesion and activation were affected, including the collagen receptor GPVI and the von Willebrand factor receptor, GPIb. To experimentally validate these findings we assessed platelet function in the presence of PMX 464, PX-12, and rutin (a selective inhibitor of the related protein disulphide isomerase). In agreement with the proteomics data, small molecule inhibitors of thioredoxin selectively inhibited GPVI-mediated platelet activation, and attenuated ristocetin-induced GPIb-vWF-mediated platelet agglutination, thus validating the findings of the proteomics study. These data reveal a novel role for thioredoxin in regulating platelet reactivity via proteins required for early platelet responses at sites of vessel injury (GPVI and GPIb). This work also highlights a potential opportunity for repurposing of PMX 464 and PX-12 as antiplatelet agents.	[Metcalfe, Clive; Ramasubramoni, Anjana] Oxford Mol & Pathol Inst, South Parks Rd, Oxford OX1 3RE, England; [Pula, Giordano] Univ Bath, Dept Pharm & Pharmacol, Claverton Down, Bath BA2 7AY, Avon, England; [Harper, Matthew T.] Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England; [Mundell, Stuart J.; Coxon, Carmen H.] Univ Bristol, Dept Physiol Pharmacol & Neurosci, Med Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England	University of Bath; University of Cambridge; University of Bristol	Mundell, SJ (corresponding author), Univ Bristol, Dept Physiol Pharmacol & Neurosci, Med Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England.	s.j.mundell@bristol.ac.uk	Pula, Giordano/ABE-8596-2020; Harper, Matthew T/G-5630-2013	Harper, Matthew T/0000-0002-4740-637X; Mundell, Stuart/0000-0001-7754-3271; Metcalfe, Clive/0000-0002-7856-8574	MRC [G9826026]; British Heart Foundation Centre of Research Excellence; British Heart Foundation Fellowship [FS/11/49/28751]; British Heart Foundation [FS/11/49/28751, PG/13/94/30594] Funding Source: researchfish; Medical Research Council [G9826026] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation Centre of Research Excellence(British Heart Foundation); British Heart Foundation Fellowship(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors received no specific funding for this work, but indirect funding was received through MRC Grant No G9826026 (to CM), a British Heart Foundation Centre of Research Excellence-funded Vacation Studentship (to AR), and British Heart Foundation Fellowship FS/11/49/28751 (to CHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimi I, 2010, J BIOL CHEM, V285, P40072, DOI 10.1074/jbc.M110.185371; Azimi I, 2011, ANTIOXID REDOX SIGN, V14, P113, DOI 10.1089/ars.2010.3620; Baker AF, 2006, J LAB CLIN MED, V147, P83, DOI 10.1016/j.lab.2005.09.001; Burgess JK, 2000, J BIOL CHEM, V275, P9758, DOI 10.1074/jbc.275.13.9758; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Cerutti N, 2014, J BIOL CHEM, V289, P10455, DOI 10.1074/jbc.M113.539353; Chen VM, 2006, J THROMB HAEMOST, V4, P2533, DOI 10.1111/j.1538-7836.2006.02236.x; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; Cho J, 2012, BLOOD, V120, P647, DOI 10.1182/blood-2011-08-372532; Cook KM, 2013, J BIOL CHEM, V288, P34920, DOI 10.1074/jbc.M113.523506; Coxon CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049543; Dutting S, 2012, TRENDS PHARMACOL SCI, V33, P583, DOI 10.1016/j.tips.2012.07.004; Flaumenhaft R, 2015, ARTERIOSCL THROM VAS, V35, P16, DOI 10.1161/ATVBAHA.114.303410; Goebel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066960; Hahm E, 2013, BLOOD, V121, P3789, DOI 10.1182/blood-2012-11-467985; Hogg PJ, 2009, J THROMB HAEMOST, V7, P13, DOI 10.1111/j.1538-7836.2009.03364.x; Hogg PJ, 2013, NAT REV CANCER, V13, P425, DOI 10.1038/nrc3519; Jasuja R, 2012, J CLIN INVEST, V122, P2104, DOI 10.1172/JCI61228; Jasuja R, 2010, BLOOD, V116, P4665, DOI 10.1182/blood-2010-04-278184; Kellett-Clarke H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138137; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Lu J, 2014, ANTIOXID REDOX SIGN, V21, P457, DOI 10.1089/ars.2014.5849; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Lu J, 2012, ANTIOXID REDOX SIGN, V17, P1738, DOI 10.1089/ars.2012.4650; LUNDSTROM J, 1990, J BIOL CHEM, V265, P9114; Matsumoto K, 2002, BIOCHEM BIOPH RES CO, V295, P663, DOI 10.1016/S0006-291X(02)00727-1; Metcalfe C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110036; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Nakamura H, 2000, CANCER DETECT PREV, V24, P53; Naranjo-Suarez S, 2013, MOL CELLS, V36, P151, DOI 10.1007/s10059-013-0121-y; Nieswandt B, 2011, J PHYSIOL-LONDON, V589, P4115, DOI 10.1113/jphysiol.2011.212886; Passam FH, 2010, J THROMB HAEMOST, V8, P1754, DOI 10.1111/j.1538-7836.2010.03944.x; Raffel J, 2003, J LAB CLIN MED, V142, P46, DOI 10.1016/S0022-2143(03)00068-4; Ramanathan RK, 2011, CANCER CHEMOTH PHARM, V67, P503, DOI 10.1007/s00280-010-1343-8; Ruan KH, 2004, EUR J BIOCHEM, V271, P3006, DOI 10.1111/j.1432-1033.2004.04232.x; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schonberger T, 2012, AM J PHYSIOL-CELL PH, V303, pC757, DOI 10.1152/ajpcell.00060.2012; Sengupta Rajib, 2014, World J Biol Chem, V5, P68, DOI 10.4331/wjbc.v5.i1.68; Shelar SB, 2015, FREE RADICAL BIO MED, V87, P125, DOI 10.1016/j.freeradbiomed.2015.06.029; Swiatkowska M, 2008, FEBS J, V275, P1813, DOI 10.1111/j.1742-4658.2008.06339.x; Taylor L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101209; Ungerer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071193; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	44	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0163006	10.1371/journal.pone.0163006	http://dx.doi.org/10.1371/journal.pone.0163006			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716777	Green Published, gold			2022-12-27	WOS:000385698100005
J	Bonner, NS; O'Halloran, PD; Bernhardt, J; Cumming, TB				Bonner, Nicholas S.; O'Halloran, Paul D.; Bernhardt, Julie; Cumming, Toby B.			Developing the Stroke Exercise Preference Inventory (SEPI)	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; AFFECTIVE RESPONSE; PARTICIPATION; INTERVENTIONS; RELIABILITY; COMMUNITY; INTERVIEW; SURVIVORS; VALIDITY; OUTCOMES	Background Physical inactivity is highly prevalent after stroke, increasing the risk of poor health outcomes including recurrent stroke. Tailoring of exercise programs to individual preferences can improve adherence, but no tools exist for this purpose in stroke. Methods We identified potential questionnaire items for establishing exercise preferences via: (i) our preliminary Exercise Preference Questionnaire in stroke, (ii) similar tools used in other conditions, and (iii) expert panel consultations. The resulting 35-item questionnaire (SEPI-35) was administered to stroke survivors, along with measures of disability, depression, anxiety, fatigue and self-reported physical activity. Exploratory factor analysis was used to identify a factor structure in exercise preferences, providing a framework for item reduction. Associations between exercise preferences and personal characteristics were analysed using multivariable regression. Results A group of 134 community-dwelling stroke survivors (mean age 64.0, SD 13.3) participated. Analysis of the SEPI-35 identified 7 exercise preference factors (Supervision-support, Confidence-challenge, Health-wellbeing, Exercise context, Home-alone, Similar others, Music-TV). Item reduction processes yielded a 13-item version (SEPI-13); in analysis of this version, the original factor structure was maintained. Lower scores on Confidence-challenge were significantly associated with disability (p = 0.002), depression (p = 0.001) and fatigue (p = 0.001). Self-reported barriers to exercise were particularly prevalent in those experiencing fatigue and anxiety. Conclusions The SEPI-13 is a brief instrument that allows assessment of exercise preferences and barriers in the stroke population. This new tool can be employed by health professionals to inform the development of individually tailored exercise interventions.	[Bonner, Nicholas S.; O'Halloran, Paul D.] La Trobe Univ, Sch Psychol & Publ Hlth, Bundoora, Vic, Australia; [Bernhardt, Julie; Cumming, Toby B.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia	La Trobe University; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Cumming, TB (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia.	toby.cumming@florey.edu.au	Campailla, Jasmin/AAK-2420-2021; Bernhardt, Julie/F-9538-2015	Bernhardt, Julie/0000-0002-2787-8484				[Anonymous], PRACTICAL ASSESS RES; Banks G, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/890946; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Bouchard C., 2007, PHYS ACTIVITY HLTH, Vsecond ed.; BOUTCHER SH, 1990, J SPORT EXERCISE PSY, V12, P167, DOI 10.1123/jsep.12.2.167; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cumming TB, INT J STROK IN PRESS; Daley AJ, 2003, PSYCHOL SPORT EXERC, V4, P347, DOI 10.1016/S1469-0292(02)00018-3; Delgado-Rico E, 2012, INT J CLIN HLTH PSYC, V12, P449; Eng JJ, 2014, CLIN REHABIL, V28, P731, DOI 10.1177/0269215514523631; English C, 2014, PHYS THER, V94, P185, DOI 10.2522/ptj.20130175; Hays RD, 2000, MED CARE, V38, P28; Kwan BM, 2010, BRIT J HEALTH PSYCH, V15, P115, DOI 10.1348/135910709X433267; Lee LL, 2008, INT J NURS STUD, V45, P1690, DOI 10.1016/j.ijnurstu.2008.02.012; Mead G, 2007, STROKE, V38, P2090, DOI 10.1161/STROKEAHA.106.478941; Morris J, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/195249; Morris JH, 2014, ARCH PHYS MED REHAB, V95, P956, DOI 10.1016/j.apmr.2013.12.016; Razon S, 2009, PSYCHOL SPORT EXERC, V10, P636, DOI 10.1016/j.psychsport.2009.03.007; Resnick B, 2008, TOP STROKE REHABIL, V15, P494, DOI 10.1310/tsr1505-494; Richards J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010392.pub2; Rogers LQ, 2009, PSYCHO-ONCOLOGY, V18, P412, DOI 10.1002/pon.1497; Ruland CM, 2001, PATIENT EDUC COUNS, V44, P283, DOI 10.1016/S0738-3991(00)00189-0; Sapnas Kathryn G, 2002, J Nurs Meas, V10, P135; Saunders DH, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub3; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Touillet A., 2010, Annals of Physical and Rehabilitation Medicine, V53, P250, DOI 10.1016/j.rehab.2010.03.005; Turner A, 2012, STROKE, V43, P1000, DOI 10.1161/STROKEAHA.111.643296; Wilcox S, 1999, J AGING PHYS ACTIV, V7, P386, DOI 10.1123/japa.7.4.386; Williams DM, 2008, PSYCHOL SPORT EXERC, V9, P231, DOI 10.1016/j.psychsport.2007.04.002; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD	31	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164120	10.1371/journal.pone.0164120	http://dx.doi.org/10.1371/journal.pone.0164120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711242	Green Published, gold			2022-12-27	WOS:000385697600081
J	Liu, S; Cadaneanu, RM; Zhang, BH; Huo, LH; Lai, K; Li, XM; Galet, C; Grogan, TR; Elashoff, D; Freedland, SJ; Rettig, M; Aronson, WJ; Knudsen, BS; Lewis, MS; Garraway, IP				Liu, Sandy; Cadaneanu, Radu M.; Zhang, Baohui; Huo, Lihong; Lai, Kevin; Li, Xinmin; Galet, Colette; Grogan, Tristan R.; Elashoff, David; Freedland, Stephen J.; Rettig, Matthew; Aronson, William J.; Knudsen, Beatrice S.; Lewis, Michael S.; Garraway, Isla P.			Keratin 13 Is Enriched in Prostate Tubule-Initiating Cells and May Identify Primary Prostate Tumors that Metastasize to the Bone	PLOS ONE			English	Article							EPITHELIAL-CELLS; GENE-EXPRESSION; BREAST-CANCER; BASAL-CELLS; IN-VIVO; IDENTIFICATION; SUBPOPULATION; REGENERATION; POPULATIONS; PROGRESSION	Background Benign human prostate tubule-initiating cells (TIC) and aggressive prostate cancer display common traits, including tolerance of low androgen levels, resistance to apoptosis, and microenvironment interactions that drive epithelial budding and outgrowth. TIC can be distinguished from epithelial and stromal cells that comprise prostate tissue via cell sorting based upon Epcam, CD44, and CD49f antigenic profiles. Fetal prostate epithelial cells (FC) possess a similar antigenic profile to adult TIC and are capable of inducing tubule formation. To identify the TIC niche in human prostate tissue, differential keratin (KRT) expression was evaluated. Results Gene expression data generated from Affymetrix Gene Chip human U133 Plus 2.0 array of sorted adult and fetal epithelial cells revealed KRT13 to be significantly enriched in FC and TIC compared to basal cells (BC) and luminal cells (LC) (p<0.001). Enriched KRT13 expression was confirmed by RT-PCR and cytospin immunostaining. Immunohistochemical analysis of KRT13 expression revealed rare KRT13(+) epithelia throughout prostatic ducts/acini in adult tissue specimens and differentiated tubules in 24-week recombinant grafts, In contrast, abundant KRT13 expression was observed in developing ducts/acini in fetal prostate and cord-like structures composing 8-week recombinant grafts. Immunostaining of a prostate tissue microarray revealed KRT13(+) tumor foci in approximately 9% of cases, and this subset displayed significantly shorter time to recurrence (p = 0.031), metastases (p = 0.032), and decreased overall survival (p = 0.004). Diagnostic prostate needle biopsies (PNBX) from untreated patients with concurrent bone metastases (clinical stage M1) displayed KRT13(+) tumor foci, as did bone metastatic foci. Conclusions The expression profile of KRT13 in benign fetal and adult prostate tissue and in recombinant grafts, as well as the frequency of KRT13 expression in primary and metastatic prostate cancer indicates that it may be a marker of a stem/progenitor-like cell state that is co-opted in aggressive tumor cells. KRT13 is enriched in benign stem-like cells that display androgen-resistance, apoptosis-resistance, and branching morphogenesis properties. Collectively our data demonstrate that KRT13 expression is associated with poor prognosis at multiple stages of disease progression and may represent an important biomarker of adverse outcome in patients with prostate cancer.	[Liu, Sandy] Univ Calif Los Angeles, David Geffen Sch Med, Dept Hematol Oncol, Los Angeles, CA 90095 USA; [Cadaneanu, Radu M.; Zhang, Baohui; Huo, Lihong; Lai, Kevin; Galet, Colette; Rettig, Matthew; Aronson, William J.; Garraway, Isla P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Li, Xinmin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Grogan, Tristan R.; Elashoff, David] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med Stat Core, Los Angeles, CA 90095 USA; [Freedland, Stephen J.] Durham VA Med Ctr, Dept Surg, Urol Sect, Durham, NC USA; [Rettig, Matthew; Aronson, William J.; Garraway, Isla P.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Aronson, William J.; Garraway, Isla P.] Greater Los Angeles Vet Affairs Healthcare Syst, Dept Surg, Urol Sect, Los Angeles, CA 90073 USA; [Knudsen, Beatrice S.] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Lewis, Michael S.] Greater Los Angeles Vet Affairs Hlth Syst, Dept Pathol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Cedars Sinai Medical Center	Garraway, IP (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA.; Garraway, IP (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA.; Garraway, IP (corresponding author), Greater Los Angeles Vet Affairs Healthcare Syst, Dept Surg, Urol Sect, Los Angeles, CA 90073 USA.	igarraway@mednet.ucla.edu	Huo, Lihong/ABI-4909-2020; galet, colette/AAG-2464-2020	galet, colette/0000-0002-5931-2143; Huo, Lihong/0000-0001-7901-6758	Jean Perkins Foundation; Prostate Cancer Foundation (PCF) Creativity Award; Movember/PCF GAP1 Unique TMAs Project; Stephen Spielberg Team Science Award; DOD [PC131996, PC130244, PC030868]; NIH/NCI [P01 CA098912-09, U54 CA143931, P50CA09231]; NIH [R01CA131255, P50CA092131]; NIH/NCATS UCLA CTSI [UL1TR000124]; National Institutes of Health [CA-16042, AI-28697]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; NATIONAL CANCER INSTITUTE [P01CA098912, P30CA016042, P50CA092131] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Jean Perkins Foundation; Prostate Cancer Foundation (PCF) Creativity Award; Movember/PCF GAP1 Unique TMAs Project; Stephen Spielberg Team Science Award; DOD(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS UCLA CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Jean Perkins Foundation (IG); Prostate Cancer Foundation (PCF) Creativity Award (BK); Movember/PCF GAP1 Unique TMAs Project (IG, ML, and BK); Stephen Spielberg Team Science Award (BK); DOD PC131996 (IG, ML, and BK); DOD PC130244 (IG and ML); NIH/NCI P01 CA098912-09 (IG and BK); NIH/NCI U54 CA143931 (IG); NIH R01CA131255 and P50CA092131 (BK); NIH/NCATS UCLA CTSI Grant UL1TR000124 (TG and DE); DOD PC030868 (MR); NIH/NCI P50CA09231 (WA and MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Flow cytometry/FACS was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and is supported by National Institutes of Health awards CA-16042 and AI-28697, and by the JCCC, the UCLA AIDS Institute, and the David Geffen School of Medicine at UCLA. Procurement of fetal tissues is supported by the Center for AIDS Research at UCLA, under the leadership of Dr. Dong Sun An.	Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Alanazi I, 2013, APOPTOSIS, V18, P1291, DOI 10.1007/s10495-013-0887-6; Alix-Panabieres C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2326; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Cai WP, 2014, META GENE, V2, P374, DOI 10.1016/j.mgene.2014.04.008; Canon J, 2010, BONE, V46, P1613, DOI 10.1016/j.bone.2010.03.001; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Frank SB, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00273; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Goldstein AS, 2011, NAT PROTOC, V6, P656, DOI 10.1038/nprot.2011.317; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Gollapudi K, 2013, AM J CANCER RES, V3, P523; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034219; Helpap B, 1998, VIRCHOWS ARCH, V433, P397, DOI 10.1007/s004280050266; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Kuga T, 2013, J CELL SCI, V126, P4721, DOI 10.1242/jcs.129684; Lee JK, 2016, CANCER CELL, V29, P536, DOI 10.1016/j.ccell.2016.03.001; Liu F, 2008, NEOPLASIA, V10, P1275, DOI 10.1593/neo.08810; Liu F, 2008, LIFE SCI, V83, P496, DOI 10.1016/j.lfs.2008.07.017; Liu HB, 2015, PROSTATE, V75, P764, DOI 10.1002/pros.22959; Lunacek A, 2007, BJU INT, V99, P151, DOI 10.1111/j.1464-410X.2006.06512.x; MALECHA MJ, 1991, VIRCHOWS ARCH A, V418, P249, DOI 10.1007/BF01606063; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Sakamoto K, 2011, HISTOPATHOLOGY, V58, P531, DOI 10.1111/j.1365-2559.2011.03759.x; Sheng S, 2008, MOL CELL ENDOCRINOL, V296, P1, DOI 10.1016/j.mce.2008.09.022; Stoyanova T, 2013, P NATL ACAD SCI USA, V110, P20111, DOI 10.1073/pnas.1320565110; Tran CP, 2002, MOL CANCER RES, V1, P113; TRASK DK, 1990, P NATL ACAD SCI USA, V87, P2319, DOI 10.1073/pnas.87.6.2319; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P180, DOI 10.1016/j.urolonc.2008.09.041; Waseem A, 1998, GENE, V215, P269, DOI 10.1016/S0378-1119(98)00297-2; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100	35	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163232	10.1371/journal.pone.0163232	http://dx.doi.org/10.1371/journal.pone.0163232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711225	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600019
J	Takeshita, K; Ikeda, T; Takahashi, H; Yoshida, T; Igota, H; Matsuura, Y; Kaji, K				Takeshita, Kazutaka; Ikeda, Takashi; Takahashi, Hiroshi; Yoshida, Tsuyoshi; Igota, Hiromasa; Matsuura, Yukiko; Kaji, Koichi			Comparison of Drive Counts and Mark-Resight As Methods of Population Size Estimation of Highly Dense Sika Deer (Cervus nippon) Populations	PLOS ONE			English	Article							ABUNDANCE INDEXES; EASTERN HOKKAIDO; PROGRAM MARK; INDICATOR; IMPACTS; ELAPHUS	Assessing temporal changes in abundance indices is an important issue in the management of large herbivore populations. The drive counts method has been frequently used as a deer abundance index in mountainous regions. However, despite an inherent risk for observation errors in drive counts, which increase with deer density, evaluations of the utility of drive counts at a high deer density remain scarce. We compared the drive counts and mark-resight (MR) methods in the evaluation of a highly dense sika deer population (MR estimates ranged between 11 and 53 individuals/km(2)) on Nakanoshima Island, Hokkaido, Japan, between 1999 and 2006. This deer population experienced two large reductions in density; approximately 200 animals in total were taken from the population through a large-scale population removal and a separate winter mass mortality event. Although the drive counts tracked temporal changes in deer abundance on the island, they overestimated the counts for all years in comparison to the MR method. Increased overestimation in drive count estimates after the winter mass mortality event may be due to a double count derived from increased deer movement and recovery of body condition secondary to the mitigation of density-dependent food limitations. Drive counts are unreliable because they are affected by unfavorable factors such as bad weather, and they are cost-prohibitive to repeat, which precludes the calculation of confidence intervals. Therefore, the use of drive counts to infer the deer abundance needs to be reconsidered.	[Takeshita, Kazutaka; Ikeda, Takashi; Kaji, Koichi] Tokyo Univ Agr & Technol, Lab Wildlife Management, Fuchu, Tokyo, Japan; [Takahashi, Hiroshi] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Kyoto, Kyoto, Japan; [Yoshida, Tsuyoshi; Igota, Hiromasa] Rakuno Gakuen Univ, Dept Environm & Symbiot Sci, Ebetsu, Hokkaido, Japan; [Matsuura, Yukiko] Forestry & Forest Prod Res Inst, Hokkaido Res Ctr, Sapporo, Hokkaido, Japan; [Ikeda, Takashi] Hokkaido Univ, Course Anim Ecol, Sapporo, Hokkaido, Japan	Tokyo University of Agriculture & Technology; Forestry & Forest Products Research Institute - Japan; Rakuno Gakuen University; Forestry & Forest Products Research Institute - Japan; Hokkaido University	Takeshita, K (corresponding author), Tokyo Univ Agr & Technol, Lab Wildlife Management, Fuchu, Tokyo, Japan.	kazutaka.takeshita.0716@gmail.com	Koichi, Kaji/C-8355-2013; Takeshita, Kazutaka/AAW-5187-2020; Yoshida, Tsuyoshi/N-4049-2018	Koichi, Kaji/0000-0001-6578-9995; Takeshita, Kazutaka/0000-0002-6866-6074; Yoshida, Tsuyoshi/0000-0001-9297-8716; Ikeda, Takashi/0000-0003-3217-3275	Japan Society for the Promotion of Science (JSPS) KAKENHI [19380084, 21248019, 25292085]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was founded by Hokkaido Gorvenment (http://www.pref.hokkaido.lg.jp), Agriculture, Forestry and Fisheries Research Council (http://www.s.affrc.go.jp), the Japan Society for the Promotion of Science (JSPS) KAKENHI Grants (19380084, 21248019 & 25292085 to K. Kaji, https://kaken.nii.ac.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2008, J ZOOL, V276, P37, DOI 10.1111/j.1469-7998.2008.00464.x; Amos M, 2014, WILDLIFE BIOL, V20, P362, DOI 10.2981/wlb.00080; Asano Makoto, 2004, Japanese Journal of Zoo and Wildlife Medicine, V9, P131; Borkowski J, 2011, ACTA THERIOL, V56, P239, DOI 10.1007/s13364-010-0023-8; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Collier BA, 2013, J WILDLIFE MANAGE, V77, P165, DOI 10.1002/jwmg.444; Corlatti L, 2016, WILDLIFE BIOL, V22, P268, DOI 10.2981/wlb.00244; Corlatti L, 2015, POPUL ECOL, V57, P409, DOI 10.1007/s10144-015-0481-6; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Dale Virginia H., 2001, Ecological Indicators, V1, P3, DOI 10.1016/S1470-160X(01)00003-6; Gaillard JM, 1996, J WILDLIFE MANAGE, V60, P29, DOI 10.2307/3802036; Garel M, 2005, EUR J WILDLIFE RES, V51, P69, DOI 10.1007/s10344-004-0075-7; Garel M, 2010, WILDLIFE BIOL, V16, P77, DOI 10.2981/09-022; Iijima H, 2015, ECOL INDIC, V48, P457, DOI 10.1016/j.ecolind.2014.09.009; Iijima H, 2013, J WILDLIFE MANAGE, V77, P1038, DOI 10.1002/jwmg.556; Ikeda T, 2015, MAMM STUDY, V40, P199; Japan Meteorological Agency, 2015, DAT DOWNL SERV WEATH; Kaji K, 2005, POPUL ECOL, V47, P53, DOI 10.1007/s10144-004-0200-1; KAJI K, 1988, ACTA THERIOL, V33, P187, DOI 10.4098/AT.arch.88-15; Kaji K, 1990, HONYURUI KAGAKU, V30, P183; Kaji K., 2006, CONSERVATION MANAGEM; Kaji K, 1992, REPORT HOKKAIDO I EN, V19, P67; Kaji Koichi, 2009, P421, DOI 10.1007/978-4-431-09429-6_30; Kanagawa Prefecture, 2015, PLAN SIK DEER MAN KA; Laake J, 2016, PROGRAM MARK GENTLE; Largo E, 2008, WILDLIFE BIOL, V14, P489, DOI 10.2981/0909-6396-14.4.489; Legendre P., 2014, LMODEL2 MODEL 2 REGR; Loison A, 2006, WILDLIFE BIOL, V12, P77, DOI 10.2981/0909-6396(2006)12[77:HRATCT]2.0.CO;2; Maillard Daniel, 2010, P441; MARUYAMA N, 1983, Journal of the Mammalogical Society of Japan, V9, P274; McClintock BT, 2012, J ORNITHOL, V152, pS641, DOI 10.1007/s10336-010-0524-x; McClintock BT, 2009, BIOMETRICS, V65, P237, DOI 10.1111/j.1541-0420.2008.01047.x; McClintock BT, 2016, PROGRAM MARK GENTLE; Miyaki M, 2004, ECOL RES, V19, P405, DOI 10.1111/j.1440-1703.2004.00651.x; Morellet N, 2001, WILDLIFE SOC B, V29, P1243; Morellet N, 2007, J APPL ECOL, V44, P634, DOI 10.1111/j.1365-2664.2007.01307.x; Mysterud A, 2007, WILDLIFE BIOL, V13, P285, DOI 10.2981/0909-6396(2007)13[285:MPSORD]2.0.CO;2; R Development Core Team, 2014, R LANG ENV STAT COMP; Ronnegard L, 2008, WILDLIFE BIOL, V14, P358, DOI 10.2981/0909-6396(2008)14[358:EOFMUT]2.0.CO;2; Suzuki M, 1996, J VET MED SCI, V58, P505, DOI 10.1292/jvms.58.505; Takahashi Hiroshi, 2002, Honyurui Kagaku, V42, P45; Takahashi Hiroshi, 2004, Honyurui Kagaku, V44, P189; Tsuruga H, 1999, J WILDLIFE DIS, V35, P774, DOI 10.7589/0090-3558-35.4.774; Ueno M, 2007, ACTA THERIOL, V52, P119, DOI 10.1007/BF03194207; Ueno M, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00083.1; Uno H, 2006, ECOL RES, V21, P624, DOI 10.1007/s11284-006-0158-x; VINCENT JP, 1991, ACTA THERIOL, V36, P315, DOI 10.4098/AT.arch.91-33; White GC, 2008, ENVIRON ECOL STAT, V15, P89, DOI 10.1007/s10651-007-0030-3; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zannese A, 2006, WILDLIFE SOC B, V34, P351, DOI 10.2193/0091-7648(2006)34[351:HFLAIF]2.0.CO;2; [No title captured]	51	8	8	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164345	10.1371/journal.pone.0164345	http://dx.doi.org/10.1371/journal.pone.0164345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711181	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600121
J	Wang, Y; Guan, H; Xie, DF; Xie, Y; Liu, XD; Wang, Q; Sui, L; Song, M; Zhang, H; Zhou, JH; Zhou, PK				Wang, Yu; Guan, Hua; Xie, Da-Fei; Xie, Yi; Liu, Xiao-Dan; Wang, Qi; Sui, Li; Song, Man; Zhang, Hong; Zhou, Jianhua; Zhou, Ping-Kun			Proteomic Analysis Implicates Dominant Alterations of RNA Metabolism and the Proteasome Pathway in the Cellular Response to Carbon-Ion Irradiation	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HUMAN LYMPHOBLASTOID-CELLS; DOSE IONIZING-RADIATION; DNA-DAMAGE RESPONSE; BINDING PROTEIN HUR; IDENTIFICATION; RADIOTHERAPY; REPAIR; GENES; RESISTANCE	Radiotherapy with heavy ions is considered advantageous compared to irradiation with photons due to the characteristics of the Braggs peak and the high linear energy transfer (LET) value. To understand the mechanisms of cellular responses to different LET values and dosages of heavy ion radiation, we analyzed the proteomic profiles of mouse embryo fibroblast MEF cells exposed to two doses from different LET values of heavy ion C-12. Total proteins were extracted from these cells and examined by Q Exactive with Liquid Chromatography (LC)-Electrospray Ionization (ESI) Tandem MS (MS/MS). Using bioinformatics approaches, differentially expressed proteins with 1.5 or 2.0-fold changes between different dosages of exposure were compared. With the higher the dosage and/or LET of ion irradiation, the worse response the cells were in terms of protein expression. For instance, compared to the control (0 Gy), 771 (20.2%) proteins in cells irradiated at 0.2 Gy of carbon-ion radiation with 12.6 keV/mu m, 313 proteins (8.2%) in cells irradiated at 2 Gy of carbon-ion radiation with 12.6 keV/mu m, and 243 proteins (6.4%) in cells irradiated at 2 Gy of carbon-ion radiation with 31.5 keV/mu m exhibited changes of 1.5-fold or greater. Gene ontology (GO) analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, Munich Information Center for Protein Sequences (MIPS) analysis, and BioCarta analysis all indicated that RNA metabolic processes (RNA splicing, destabilization and deadenylation) and proteasome pathways may play key roles in the cellular response to heavy-ion irradiation. Proteasome pathways ranked highest among all biological processes associated with heavy carbon-ion irradiation. In addition, network analysis revealed that cellular pathways involving proteins such as Col1a1 and Fn1 continued to respond to high dosages of heavy-ion irradiation, suggesting that these pathways still protect cells against damage. However, pathways such as those involving Ikbkg1 responded better at lower dosages than at higher dosages, implying that cell damage would occur when the networks involving these proteins stop responding. Our investigation provides valuable proteomic information for elucidating the mechanism of biological effects induced by carbon ions in general.	[Wang, Yu; Guan, Hua; Xie, Da-Fei; Liu, Xiao-Dan; Wang, Qi; Song, Man; Zhou, Ping-Kun] Beijing Inst Radiat Med, Dept Radiat Toxicol & Oncol, Beijing Key Lab Radiat Biol, Beijing, Peoples R China; [Xie, Yi; Zhang, Hong] Chinese Acad Sci, Inst Modern Phys, Dept Heavy Ion Radiat Med, Lanzhou 730000, Peoples R China; [Zhou, Jianhua] iBioinfo Grp, Lexington, MA 02421 USA; [Song, Man; Zhou, Ping-Kun] Soochow Univ, Sch Radiat Med & Protect, Jiangsu Higher Educ Inst, Collaborat Innovat Ctr Radiat Med, Suzhou, Peoples R China; [Sui, Li] China Inst Atom Energy, Beijing 102413, Peoples R China; [Zhou, Jianhua] Nantong Univ, Dept Neuroregenerat, Nantong, Peoples R China	Academy of Military Medical Sciences - China; Chinese Academy of Sciences; Institute of Modern Physics, CAS; Soochow University - China; China Institute of Atomic Energy; Nantong University	Zhou, PK (corresponding author), Beijing Inst Radiat Med, Dept Radiat Toxicol & Oncol, Beijing Key Lab Radiat Biol, Beijing, Peoples R China.; Zhou, JH (corresponding author), iBioinfo Grp, Lexington, MA 02421 USA.; Zhou, PK (corresponding author), Soochow Univ, Sch Radiat Med & Protect, Jiangsu Higher Educ Inst, Collaborat Innovat Ctr Radiat Med, Suzhou, Peoples R China.; Zhou, JH (corresponding author), Nantong Univ, Dept Neuroregenerat, Nantong, Peoples R China.	jianhua55@msn.com; zhoupk@bmi.ac.cn	Zhou, Ping-Kun/GSJ-3972-2022; Zhou, Ping-Kun/AAF-3536-2019	Zhou, Ping-Kun/0000-0001-7666-1209; 	National Natural Science Foundation of China [U1432248]; iBioinfo Groups	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); iBioinfo Groups	This work was supported by the National Natural Science Foundation of China (# U1432248). The author JZ is a professor at Nantong University, Nantong, China. He is also affiliated with iBioinfo Groups. The author played a role in data collection, analysis and discussion, and preparation of the manuscript as a professor at Nantong University. iBioinfo Groups only provided financial support in the form of salary for JZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablikim M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.062001; An J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-18; Ando K, 2006, J RADIAT RES, V47, P167, DOI 10.1269/jrr.47.167; Antonovic L, 2013, J RADIAT RES, V54, P18, DOI 10.1093/jrr/rrs070; Aoki-Nakano M, 2013, J RADIAT RES, V54, P1029, DOI 10.1093/jrr/rrt064; Azimzadeh O, 2014, RADIAT ENVIRON BIOPH, V53, P31, DOI 10.1007/s00411-013-0495-4; Azimzadeh O, 2011, PROTEOMICS, V11, P3299, DOI 10.1002/pmic.201100178; Bakshi MV, 2013, RADIAT ENVIRON BIOPH, V52, P451, DOI 10.1007/s00411-013-0483-8; Bassler N, 2010, ACTA ONCOL, V49, P1170, DOI 10.3109/0284186X.2010.510640; Bing ZT, 2014, RADIOL ONCOL, V48, P142, DOI 10.2478/raon-2013-0087; Blickwedehl J, 2012, MOL CANCER RES, V10, P937, DOI 10.1158/1541-7786.MCR-11-0493-T; Brand M, 2012, EUR J RADIOL, V81, pE357, DOI 10.1016/j.ejrad.2011.11.027; Chatterjee A, 2012, J TOXICOL SCI, V37, P215, DOI 10.2131/jts.37.215; Cheema AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087079; Cheema AK, 2013, RADIAT RES, V179, P674, DOI 10.1667/RR3198.1; Chiu HW, 2015, CANCER LETT, V365, P229, DOI 10.1016/j.canlet.2015.05.025; Choi S, 2012, J PROTEOME RES, V11, P4983, DOI 10.1021/pr3005524; Cron KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073710; Du LQ, 2013, INT J MOL SCI, V14, P24087, DOI 10.3390/ijms141224087; Fakir H, 2006, RADIAT RES, V166, P917, DOI 10.1667/RR0639.1; Firsanov D, 2012, BIOCHIMIE, V94, P2416, DOI 10.1016/j.biochi.2012.06.019; Forrester HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053358; Friedrich T, 2013, J RADIAT RES, V54, P494, DOI 10.1093/jrr/rrs114; Groesser T, 2011, INT J RADIAT BIOL, V87, P696, DOI 10.3109/09553002.2010.549535; Guipaud O, 2013, ADV EXP MED BIOL, V990, P61, DOI 10.1007/978-94-007-5896-4_4; Gurunathan G, 2015, SCI REP-UK, V5, DOI 10.1038/srep10475; Hong ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060208; Hu YY, 2014, RADIAT ENVIRON BIOPH, V53, P73, DOI 10.1007/s00411-013-0499-0; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jensen AD, 2011, BRIT J RADIOL, V84, pS35, DOI 10.1259/bjr/71511359; Jin YW, 2008, ONCOL REP, V19, P135; Kis E, 2006, INT J RADIAT ONCOL, V66, P1506, DOI 10.1016/j.ijrobp.2006.08.004; Lacombe J, 2013, CANCER RADIOTHER, V17, P62, DOI 10.1016/j.canrad.2012.11.003; Lacombe J, 2011, CANCER RADIOTHER, V15, P390, DOI 10.1016/j.canrad.2011.02.006; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Leszczynski D, 2014, PROTEOMICS, V14, P481, DOI 10.1002/pmic.201300390; Li P, 2014, TOXICOL LETT, V230, P36, DOI 10.1016/j.toxlet.2014.08.006; Long XH, 2007, INT J MOL MED, V19, P607; Mosconi M, 2011, RADIAT ENVIRON BIOPH, V50, P345, DOI 10.1007/s00411-011-0366-9; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Polo SE, 2012, MOL CELL, V45, P505, DOI 10.1016/j.molcel.2011.12.035; Ramaekers BLT, 2011, CANCER TREAT REV, V37, P185, DOI 10.1016/j.ctrv.2010.08.004; Ren Y, 2013, MOL CELL PROTEOMICS, V12, P485, DOI 10.1074/mcp.M112.018325; Saager M, 2014, INT J RADIAT ONCOL, V90, P63, DOI 10.1016/j.ijrobp.2014.05.008; Schmid TE, 2010, INT J RADIAT BIOL, V86, P682, DOI 10.3109/09553001003734543; Sedelnikova OA, 2007, CANCER RES, V67, P4295, DOI 10.1158/0008-5472.CAN-06-4442; Smith L, 2009, NEOPLASIA, V11, P1194, DOI 10.1593/neo.09902; Sprung CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025758; Sui L, 2013, CHINESE SCI BULL, V58, P3217, DOI 10.1007/s11434-013-5940-x; Suit H, 2010, RADIOTHER ONCOL, V95, P3, DOI 10.1016/j.radonc.2010.01.015; Tresini M, 2015, NATURE, V523, P53, DOI 10.1038/nature14512; Wang HP, 2006, INT J RADIAT BIOL, V82, P181, DOI 10.1080/09553000600632261; Wilkens JJ, 2008, INT J RADIAT ONCOL, V70, P262, DOI 10.1016/j.ijrobp.2007.08.029; Yentrapalli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070024; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463; Ying WT, 2003, PROTEOMICS, V3, P64, DOI 10.1002/pmic.200390010; Zhang SM, 2015, TOXICOL RES-UK, V4, P613, DOI 10.1039/c5tx00043b; Zhang Y, 2009, CANCER RES, V69, P37, DOI 10.1158/0008-5472.CAN-08-1648; Zhou PK, 2011, CHINESE SCI BULL, V56, P3119, DOI 10.1007/s11434-011-4760-0	59	6	6	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163896	10.1371/journal.pone.0163896	http://dx.doi.org/10.1371/journal.pone.0163896			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711237	gold, Green Submitted, Green Published			2022-12-27	WOS:000385697600047
J	Ibo, M; Srivastava, V; Robinson, DN; Gagnon, ZR				Ibo, Markela; Srivastava, Vasudha; Robinson, Douglas N.; Gagnon, Zachary R.			Cell Blebbing in Confined Microfluidic Environments	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM; QUANTITATIVE-ANALYSIS; GRADIENT GENERATOR; MYOSIN-II; CHEMOTAXIS; MIGRATION; MOTILITY; MODES; INVASION; CHAMBER	Migrating cells can extend their leading edge by forming myosin-driven blebs and F-actin-driven pseudopods. When coerced to migrate in resistive environments, Dictyostelium cells switch from using predominately pseudopods to blebs. Bleb formation has been shown to be chemotactic and can be influenced by the direction of the chemotactic gradient. In this study, we determine the blebbing responses of developed cells of Dictyostelium discoideum to cAMP gradients of varying steepness produced in microfluidic channels with different confining heights, ranging between 1.7 mu m and 3.8 mu m. We show that microfluidic confinement height, gradient steepness, buffer osmolarity and Myosin II activity are important factors in determining whether cells migrate with blebs or with pseudopods. Dictyostelium cells were observed migrating within the confines of microfluidic gradient channels. When the cAMP gradient steepness is increased from 0.7 nM/mu m to 20 nM/mu m, cells switch from moving with a mixture of blebs and pseudopods to moving only using blebs when chemotaxing in channels with confinement heights less than 2.4 mu m. Furthermore, the size of the blebs increases with gradient steepness and correlates with increases in myosin-II localization at the cell cortex. Reduction of intracellular pressure by high osmolarity buffer or inhibition of myosin-II by blebbistatin leads to a decrease in bleb formation and bleb size. Together, our data reveal that the protrusion type formed by migrating cells can be influenced by the channel height and the steepness of the cAMP gradient, and suggests that a combination of confinement-induced myosin-II localization and cAMP-regulated cortical contraction leads to increased intracellular fluid pressure and bleb formation.	[Ibo, Markela; Gagnon, Zachary R.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Srivastava, Vasudha; Robinson, Douglas N.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Gagnon, ZR (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	zgagnon1@jhmi.edu		Robinson, Douglas/0000-0003-1236-4891	National Institutes of Health [GM66817]; National Science Foundation (US) [CBET 1351253, 1605553]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066817] Funding Source: NIH RePORTER; Directorate For Engineering [1605553] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (US)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by DNR: National Institutes of Health (http://www.nih.gov US); GM66817; ZG: National Science Foundation (US); http://www.nsf.gov; CBET 1351253, 1605553. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atencia J, 2012, LAB CHIP, V12, P309, DOI 10.1039/c1lc20829b; Bergert M, 2012, P NATL ACAD SCI USA, V109, P14434, DOI 10.1073/pnas.1207968109; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438; Bozzaro Salvatore, 2013, Methods Mol Biol, V983, P17, DOI 10.1007/978-1-62703-302-2_2; Breckenridge MT, 2010, BIOMED MICRODEVICES, V12, P543, DOI 10.1007/s10544-010-9411-8; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; FISHER PR, 1989, J CELL BIOL, V108, P973, DOI 10.1083/jcb.108.3.973; Friedl P, 2001, J LEUKOCYTE BIOL, V70, P491; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; Heuze ML, 2011, METHODS MOL BIOL, V769, P415, DOI 10.1007/978-1-61779-207-6_28; Huang Y, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3555195; Hung WC, 2016, CELL REP, V15, P1430, DOI 10.1016/j.celrep.2016.04.035; Irimia D, 2006, ANAL CHEM, V78, P3472, DOI 10.1021/ac0518710; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jowhar D, 2010, INTEGR BIOL-UK, V2, P648, DOI 10.1039/c0ib00110d; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Laevsky G, 2003, J CELL SCI, V116, P3761, DOI 10.1242/jcs.00684; Langridye PD, 2006, EXP CELL RES, V312, P2009, DOI 10.1016/j.yexcr.2006.03.007; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Long T, 2009, ENVIRON SCI TECHNOL, V43, P1546, DOI 10.1021/es802558j; Loomis WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042033; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; Maugis B, 2010, J CELL SCI, V123, P3884, DOI 10.1242/jcs.065672; Mavrogiannis N, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4950753; Mills JC, 1998, J CELL BIOL, V140, P627, DOI 10.1083/jcb.140.3.627; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Skoge M, 2010, INTEGR BIOL-UK, V2, P659, DOI 10.1039/c0ib00033g; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; Srivastava V, 2016, SEMIN CELL DEV BIOL, V53, P39, DOI 10.1016/j.semcdb.2015.10.023; Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; TRINKAUS JP, 1973, DEV BIOL, V30, P68, DOI 10.1016/0012-1606(73)90049-3; Tyson RA, 2014, P NATL ACAD SCI USA, V111, P11703, DOI 10.1073/pnas.1322291111; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; vanHaastert PJM, 1997, FEBS LETT, V410, P25, DOI 10.1016/S0014-5793(97)00416-X; Wang P, 2015, ONCOGENE, V34, P4558, DOI 10.1038/onc.2014.397; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zatulovskiy E, 2014, J CELL BIOL, V204, P1027, DOI 10.1083/jcb.201306147	53	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163866	10.1371/journal.pone.0163866	http://dx.doi.org/10.1371/journal.pone.0163866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706201	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697200066
J	Lee, SH; Kwon, AM; Yang, HC; Lee, SK; Kim, Y; Choi, JH; Kim, JH; Shin, C				Lee, Seung Heon; Kwon, Amy M.; Yang, Hae-Chung; Lee, Seung Ku; Kim, Young; Choi, Jong Hyun; Kim, Je Hyeong; Shin, Chol			Longitudinal Lung Function Decrease in Subjects with Spontaneous Healed Pulmonary Tuberculosis	PLOS ONE			English	Article							SMOKING; DISEASE; IMPAIRMENT; DECLINE; VOLUME; COPD	Objective We compared the longitudinal course of post-bronchodilator Forced Expiratory Volume in 1 second (pFEV1) over a 10-year period in subjects with spontaneous healed pulmonary tuberculosis (SHPTB) with that in normal subjects. Methods We prospectively investigated 339 subjects with SHPTB and 3211 normal subjects. pFEV1 values measured biannually over 10 years were analyzed using mixed effects model. Results At baseline, there were no differences in gender, smoking amount, and mean height, except mean age (50.0 +/- 8.1 VS. 48.1 +/- 7.3, P<0.001) between the SHPTB and normal group. 52% of the 339 participants with SHPTB and 56% of the 3211 normal participants participated till the end of study. According to the final model, the SHPTB group showed significantly larger decrease in the average pFEV1 over the time than the normal group (P<0.001) adjusted for gender, age, height, smoking pack years, and time effects. Especially, the interaction effect between time and group was statistically significant (P = 0.036). Conclusion The average lung function in terms of pFEV1 decreases faster in subjects with SHPTB than in normal individuals over time.	[Lee, Seung Heon; Kim, Young; Choi, Jong Hyun; Kim, Je Hyeong; Shin, Chol] Korea Univ, Ansan Hosp, Div Pulm Sleep & Crit Care Med, Dept Internal Med, Ansan, South Korea; [Kwon, Amy M.; Yang, Hae-Chung; Lee, Seung Ku; Shin, Chol] Korea Univ, Ansan Hosp, Inst Human Genom Study, Ansan, South Korea; [Kwon, Amy M.] Korea Univ Sejong, Data Sci & Big Data Anal, Sejong, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Shin, C (corresponding author), Korea Univ, Ansan Hosp, Div Pulm Sleep & Crit Care Med, Dept Internal Med, Ansan, South Korea.; Shin, C (corresponding author), Korea Univ, Ansan Hosp, Inst Human Genom Study, Ansan, South Korea.	chol-shin@korea.ac.kr	Lee, SeungKu/GSN-5012-2022; Lee, Seungheon/F-3246-2019; Kwon, Amy/GWC-4367-2022	Lee, SeungKu/0000-0001-5120-5557; Lee, Seungheon/0000-0002-7180-3877; Kwon, Amy/0000-0003-1632-0677; Kim, Je Hyeong/0000-0002-8995-7460	Korea Centers for Disease Control and Prevention [2012-E71005-00]	Korea Centers for Disease Control and Prevention	This research was supported by grants from the Korea Centers for Disease Control and Prevention (2012-E71005-00).	American Thoracic Society, 2000, American Journal of Respiratory and Critical Care Medicine, V161, pS221; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; *COMM PROF STAND C, 1995, AM J RESP CRIT CARE, V152, P1107, DOI DOI 10.1164/AJRCCM; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Kerstjens HAM, 1997, THORAX, V52, P820, DOI 10.1136/thx.52.9.820; Kim JH, 2015, EMERG INFECT DIS, V21, P1913, DOI 10.3201/eid2111.141894; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Moon WK, 1998, AM J ROENTGENOL, V170, P715, DOI 10.2214/ajr.170.3.9490959; MORRIS JF, 1976, WESTERN J MED, V125, P110; Pasipanodya JG, 2007, CHEST, V131, P1817, DOI 10.1378/chest.06-2949; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Rhee CK, 2013, INT J TUBERC LUNG D, V17, P67, DOI 10.5588/ijtld.12.0351; SNIDER GL, 1971, AM REV RESPIR DIS, V103, P625; Sorheim IC, 2010, THORAX, V65, P480, DOI 10.1136/thx.2009.122002; THOMPSON JR, 1958, AM REV TUBERC PULM, V77, P931; VANPELT W, 1994, AM J RESP CRIT CARE, V149, P1218, DOI 10.1164/ajrccm.149.5.8173762; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; WARE JH, 1990, AM J EPIDEMIOL, V132, P685, DOI 10.1093/oxfordjournals.aje.a115710; WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9; World Health Organization, 2010, GLOB TUB CONTR WHO R	21	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164039	10.1371/journal.pone.0164039	http://dx.doi.org/10.1371/journal.pone.0164039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706203	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200077
J	Kaspersen, KA; Dinh, KM; Erikstrup, LT; Burgdorf, KS; Pedersen, OB; Sorensen, E; Petersen, MS; Hjalgrim, H; Rostgaard, K; Nielsen, KR; Ullum, H; Erikstrup, C				Kaspersen, Kathrine Agergard; Dinh, Khoa Manh; Erikstrup, Lise Tornvig; Burgdorf, Kristoffer Solvsten; Pedersen, Ole Birger; Sorensen, Erik; Petersen, Mikkel Steen; Hjalgrim, Henrik; Rostgaard, Klaus; Nielsen, Kaspar Rene; Ullum, Henrik; Erikstrup, Christian			Low-Grade Inflammation Is Associated with Susceptibility to Infection in Healthy Men: Results from the Danish Blood Donor Study (DBDS)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; INCREASED RISK; WOMEN; LIFE; DISTRIBUTIONS; PREDICTORS; QUALITY; MARKERS; OBESITY	Introduction The aim of this study was to examine whether low-grade inflammation (LGI) is associated with a subsequently increased risk of infection. Methods We included 15,754 healthy participants from the Danish Blood Donor Study, who completed a questionnaire on health-related items. LGI was defined as a C-reactive protein level between 3 and 10 mg/L. Infections were identified by ICD-10 codes in the Danish National Patient Register and ATC-codes in the Danish Prescription Register. Multivariable Cox proportional hazard analysis was used as the statistical model. Results During 53,302 person-years of observation, 571 participants were hospitalized for infection. Similarly, during 26,125 person-years of observation, 7,276 participants filled a prescription of antimicrobials. LGI was associated with increased risk of hospital-based treatment for infection only among men (hazard ratio = 1.60, 95% confidence interval (CI): 1.10-2.34) and specifically infections were abscesses and infections of the skin and subcutaneous tissue. Similarly, LGI was associated with the overall use of antimicrobials among men, and particularly with phenoxymethylpenicillin and broad-spectrum antimicrobials for treatment of urinary tract infections. The difference between men and women was not statistically significant. Conclusions In a large cohort of healthy individuals, LGI was associated with an increased risk of infection among healthy male blood donors.	[Kaspersen, Kathrine Agergard; Dinh, Khoa Manh; Petersen, Mikkel Steen; Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark; [Pedersen, Ole Birger] Naestved Hosp, Dept Clin Immunol, Naestved, Denmark; [Hjalgrim, Henrik; Rostgaard, Klaus] Statens Serum Inst, Dept Epidemiol Res, Copenhagen S, Denmark; [Erikstrup, Lise Tornvig] Aarhus Univ Hosp, Dept Clin Microbiol, Aarhus, Denmark; [Burgdorf, Kristoffer Solvsten; Sorensen, Erik; Ullum, Henrik] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen S, Denmark; [Nielsen, Kaspar Rene] Aalborg Univ Hosp, Dept Clin Immunol, Aalborg, Denmark	Aarhus University; Naestved Hospital; Statens Serum Institut; Aarhus University; Rigshospitalet; University of Copenhagen; Aalborg University; Aalborg University Hospital	Kaspersen, KA (corresponding author), Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark.	kathrinekaspersen@gmail.com	Pedersen, Ole Birger/W-8679-2019; Hjalgrim, Henrik/AAG-4973-2021	Pedersen, Ole Birger/0000-0003-2312-5976; Kaspersen, Kathrine Agergard/0000-0002-7973-3623; Rostgaard, Klaus/0000-0001-6220-9414; Burgdorf, Kristoffer/0000-0001-5814-6844; Erikstrup, Christian/0000-0001-6551-6647; Ullum, Henrik/0000-0001-7306-9058; Dinh, Khoa Manh/0000-0003-1881-5673	Lundbeckfonden; The Danish Council for Independent Research; Danish Administrative Regions; Bloddonorernes Forskningsfond; Fonden til Laegevidenskabens Fremme	Lundbeckfonden(Lundbeckfonden); The Danish Council for Independent Research; Danish Administrative Regions; Bloddonorernes Forskningsfond; Fonden til Laegevidenskabens Fremme	This study is funded by Lundbeckfonden, The Danish Council for Independent Research, The Danish Administrative Regions, Bloddonorernes Forskningsfond, and Fonden til Laegevidenskabens Fremme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Baik I, 2000, ARCH INTERN MED, V160, P3082, DOI 10.1001/archinte.160.20.3082; Cao Y, 2012, TUMOR BIOL, V33, P1039, DOI 10.1007/s13277-012-0337-z; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Ferranti S, 2002, CLIN CHIM ACTA, V317, P1, DOI 10.1016/S0009-8981(01)00797-5; Dinh KM, 2015, ATHEROSCLEROSIS, V242, P222, DOI 10.1016/j.atherosclerosis.2015.07.031; Du Clos TW, 2000, ANN MED, V32, P274, DOI 10.3109/07853890009011772; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Haffner SM, 2006, AM J CARDIOL, V97, p3A, DOI 10.1016/j.amjcard.2005.11.010; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; Imhof A, 2003, CLIN CHEM, V49, P669, DOI 10.1373/49.4.669; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kaspersen KA, 2015, EPIDEMIOLOGY, V26, P580, DOI 10.1097/EDE.0000000000000301; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kornum JB, 2010, EUR RESPIR J, V36, P1330, DOI 10.1183/09031936.00184209; Kotze SR, 2016, VOX SANG, V111, P144, DOI 10.1111/vox.12396; Kotze SR, 2015, TRANSFUSION, V55, P1303, DOI 10.1111/trf.13011; Kuikka LK, 2009, J AM MED DIR ASSOC, V10, P348, DOI 10.1016/j.jamda.2009.02.007; Laaksonen DE, 2004, DIABETOLOGIA, V47, P1403, DOI 10.1007/s00125-004-1472-x; Legouffe E, 1998, LEUKEMIA LYMPHOMA, V31, P351, DOI 10.3109/10428199809059228; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mraz M, 2014, J ENDOCRINOL, V222, pR113, DOI 10.1530/JOE-14-0283; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P2423, DOI 10.1002/art.20431; Ording AG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005082; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pfitzner T, 2008, ORTHOPADE, V37, P1116, DOI 10.1007/s00132-008-1342-1; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rifai N, 2003, CLIN CHEM, V49, P666, DOI 10.1373/49.4.666; Rigas AS, 2015, TRANSFUSION, V55, P1752, DOI 10.1111/trf.13085; Rigas AS, 2014, TRANSFUSION, V54, P789, DOI 10.1111/trf.12518; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Sorensen CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088196; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Tsilidis KK, 2008, INT J CANCER, V123, P1133, DOI 10.1002/ijc.23606; Villegas R, 2012, NUTR METAB CARDIOVAS, V22, P223, DOI 10.1016/j.numecd.2010.07.007; World Health Organization, INT CLASS DIS; Zacho J, 2016, CLIN CHEM, V62, P335, DOI 10.1373/clinchem.2015.249680	40	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164220	10.1371/journal.pone.0164220	http://dx.doi.org/10.1371/journal.pone.0164220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701463	Green Submitted, Green Published, gold			2022-12-27	WOS:000385696900051
J	Bokharaeian, B; Diaz, A; Chitsaz, H				Bokharaeian, Behrouz; Diaz, Alberto; Chitsaz, Hamidreza			Enhancing Extraction of Drug-Drug Interaction from Literature Using Neutral Candidates, Negation, and Clause Dependency	PLOS ONE			English	Article								Motivation Supervised biomedical relation extraction plays an important role in biomedical natural language processing, endeavoring to obtain the relations between biomedical entities. Drug-drug interactions, which are investigated in the present paper, are notably among the critical biomedical relations. Thus far many methods have been developed with the aim of extracting DDI relations. However, unfortunately there has been a scarcity of comprehensive studies on the effects of negation, complex sentences, clause dependency, and neutral candidates in the course of DDI extraction from biomedical articles. Results Our study proposes clause dependency features and a number of features for identifying neutral candidates as well as negation cues and scopes. Furthermore, our experiments indicate that the proposed features significantly improve the performance of the relation extraction task combined with other kernel methods. We characterize the contribution of each category of features and finally conclude that neutral candidate features have the most prominent role among all of the three categories.	[Bokharaeian, Behrouz; Diaz, Alberto] Univ Complutense Madrid, NIL Grp, Ciudad Univ,Calle Prof Jose Garcia Santesmases, E-28040 Madrid, Spain; [Chitsaz, Hamidreza] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA	Complutense University of Madrid; Colorado State University	Bokharaeian, B (corresponding author), Univ Complutense Madrid, NIL Grp, Ciudad Univ,Calle Prof Jose Garcia Santesmases, E-28040 Madrid, Spain.	behroubo@ucm.es	Bokharaeian, Behrouz/AAA-5978-2022	Bokharaeian, Behrouz/0000-0002-3687-5568; DIAZ ESTEBAN, ALBERTO/0000-0003-1966-3421				Airola A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S2; [Anonymous], 2006, EACL; [Anonymous], 2015, PATTERN JAVA PLATFOR; Bokharaeian B., 2015, 4 JOINT IR C FUZZ IN; Bokharaeian B., 2014, P 4 WORKSH BUILD EV; Chowdhury M.F.M., 2013, FBK IRST MULTIPHASE, V351, P53; Faisal M., 2013, HLTNAACL13; Frunza O., 2010, P 2010 WORKSH BIOM N; He LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065814; JOACHIMS T, 1999, MAKING LARGE SCALE S; Kim S, 2015, J BIOMED INFORM, V55, P23, DOI 10.1016/j.jbi.2015.03.002; Konstantinova N., 2012, P 8 INT C LANG RES E; Krallinger M., 2010, NESP NLP 10 P WORKSH; Lappin S., 1994, Computational Linguistics, V20, P535; Loos Eugene E., 2004, GLOSSARY LINGUISTIC; McClosky D., 2011, P BIONLP SHAR TASK 2; McDonald R, 2005, EXTRACTING RELATIONS; Miwa M., 2010, P 23 INT C COMP LING; Mooney Raymond, 2005, ADV NEURAL INFORM PR; Morante R., 2012, SEM 2012 1 JOINT C L; Morante R., 2012, SEM 2012 1 JOINT C L, V2; Peng Y., 2012, BIOINF BIOM BIBM 201; Rowan M, 1989, J BASIC WRITING, P21; Schmid H., 1995, INSTITUT F UR MASCHI, V43, P28; Segura-Bedmar I, 2013, 2 JOINT C LEX COMP S, V2; Segura-Bedmar I., 2011, CHALLENGE TASK DRUG, P1; Segura-Bedmar I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S1; Shepherd G, 2012, ANN PHARMACOTHER, V46, P169, DOI 10.1345/aph.1P592; Siddharthan A., 2014, INT J APPL LINGUISTI, P259, DOI [10.1075/itl.165.2.06sid, DOI 10.1075/ITL.165.2.06SID]; Szarvas Gyorgy, 2008, P WORKSH CURR TRENDS; Thomas P., 2013, 2 JOINT C LEX COMP S; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Velldal E, 2012, COMPUT LINGUIST, V38, P369, DOI 10.1162/COLI_a_00126; Vincze Veronika, 2011, J Biomed Semantics, V2 Suppl 5, pS8, DOI 10.1186/2041-1480-2-S5-S8; VISHWANATHAN SVN, 2003, ADV NEURAL INFORM PR, V15; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163480	10.1371/journal.pone.0163480	http://dx.doi.org/10.1371/journal.pone.0163480			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695078	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100036
J	Feiock, C; Yagi, M; Maidman, A; Rendahl, A; Hui, S; Seelig, D				Feiock, Caitlin; Yagi, Masashi; Maidman, Adam; Rendahl, Aaron; Hui, Susanta; Seelig, Davis			Central Nervous System Injury - A Newly Observed Bystander Effect of Radiation	PLOS ONE			English	Article							BREAST-CANCER SURVIVORS; INFLAMMATORY CYTOKINES; COGNITIVE IMPAIRMENT; SKELETAL-MUSCLE; CHEMOTHERAPY; ACTIVATION; METHOTREXATE; RADIOTHERAPY; ASSOCIATION; DYSFUNCTION	The unintended side effects of cancer treatment are increasing recognized. Among these is a syndrome of long-term neurocognitive dysfunction called cancer/chemotherapy related cognitive impairment. To date, all studies examining the cognitive impact of cancer treatment have emphasized chemotherapy. Radiation-induced bystander effects have been described in cell culture and, to a limited extent, in rodent model systems. The purpose of this study was to examine, for the first time, the impact of non-brain directed radiation therapy on the brain in order to elucidate its potential relationship with cancer/chemotherapy related cognitive impairment. To address this objective, female BALB/c mice received either a single 16 gray fraction of ionizing radiation to the right hind limb or three doses of methotrexate, once per week for three consecutive weeks. Mice were sacrificed either 3 or 30 days post-treatment and brain injury was determined via quantification of activated astrocytes and microglia. To characterize the effects of non-brain directed radiation on brain glucose metabolism, mice were evaluated by fluorodeoxygluocose positron emission tomography. A single fraction of 16 gray radiation resulted in global decreases in brain glucose metabolism, a significant increase in the number of activated astrocytes and microglia, and increased TNF-alpha expression, all of which lasted up to 30 days post-treatment. This inflammatory response following radiation therapy was statistically indistinguishable from the neuroinflammation observed following methotrexate administration. In conclusion, non-brain directed radiation was sufficient to cause significant brain bystander injury as reflected by multifocal hypometabolism and persistent neuroinflammation. These findings suggest that radiation induces significant brain bystander effects distant from the irradiated cells and tissues. These effects may contribute to the development of cognitive dysfunction in treated human cancer patients and warrant further study.	[Feiock, Caitlin; Seelig, Davis] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Yagi, Masashi; Hui, Susanta] Univ Minnesota, Dept Therapeut Radiol, Minneapolis, MN USA; [Maidman, Adam; Rendahl, Aaron] Univ Minnesota, Sch Stat, Minneapolis, MN 55455 USA; [Yagi, Masashi] Osaka Univ, Grad Sch Med, Dept Carbon Ion Radiotherapy, Suita, Osaka, Japan; [Hui, Susanta] City Hope Natl Med Ctr, Dept Radiat Oncol, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Hui, Susanta] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Osaka University; City of Hope; City of Hope; Beckman Research Institute of City of Hope	Seelig, D (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA.	dseelig@umn.edu	Yagi, Masashi/GSN-4424-2022; Yagi, Masashi/GMX-1801-2022	Yagi, Masashi/0000-0002-2827-5407; Rendahl, Aaron/0000-0001-5434-3592	National Institutes of Health [1K12-HD055887-01]; Japan Society for the Promotion of Science Coreto Core Program [23003]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science Coreto Core Program	This work was supported by the National Institutes of Health (https://www.nichd.nih.gov/Pages/index.aspx) 1K12-HD055887-01 to SH and the Japan Society for the Promotion of Science Coreto Core Program (https://www.jsps.go.jp/english/) 23003 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya MM, 2015, CANCER RES, V75, P676, DOI 10.1158/0008-5472.CAN-14-2237; Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Buonanno M, 2011, RADIAT RES, V175, P405, DOI 10.1667/RR2461.1; Calveley VL, 2005, INT J RADIAT BIOL, V81, P887, DOI 10.1080/09553000600568002; Chai Y, 2013, BRIT J CANCER, V108, P91, DOI 10.1038/bjc.2012.498; Christie LA, 2012, CLIN CANCER RES, V18, P1954, DOI 10.1158/1078-0432.CCR-11-2000; Dantzer R, 2000, AUTON NEUROSCI-BASIC, V85, P60, DOI 10.1016/S1566-0702(00)00220-4; De Lisio M, 2011, MUSCLE NERVE, V43, P58, DOI 10.1002/mus.21797; de Ruiter MB, 2012, HUM BRAIN MAPP, V33, P2971, DOI 10.1002/hbm.21422; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dubois M, 2014, NEUROPHARMACOLOGY, V79, P234, DOI 10.1016/j.neuropharm.2013.11.012; Fan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046915; Fardell JE, 2014, PSYCHOPHARMACOLOGY, V231, P841, DOI 10.1007/s00213-013-3301-8; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Hui SK, 2013, CALCIFIED TISSUE INT, V92, P372, DOI 10.1007/s00223-012-9688-0; Israel I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0604-9; Janelsins MC, 2014, INT REV PSYCHIATR, V26, P102, DOI 10.3109/09540261.2013.864260; Jim HSL, 2009, CANCER-AM CANCER SOC, V115, P1776, DOI 10.1002/cncr.24192; Kohli S, 2007, J ONCOL PRACT, V3, P54, DOI 10.1200/JOP.0722001; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Mancuso M, 2008, P NATL ACAD SCI USA, V105, P12445, DOI 10.1073/pnas.0804186105; Marin A, 2015, REP PRACT ONCOL RADI, V20, P12, DOI 10.1016/j.rpor.2014.08.004; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; MEAD JAR, 1963, BIOCHEM PHARMACOL, V12, P371, DOI 10.1016/0006-2952(63)90064-9; Montesinos MC, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1914; Morgan WF, 2015, CANCER LETT, V356, P17, DOI 10.1016/j.canlet.2013.09.009; Mosconi L, 2013, CLIN TRANSL IMAGING, V1, P217, DOI 10.1007/s40336-013-0026-y; Noal S, 2011, INT J RADIAT ONCOL, V81, P795, DOI 10.1016/j.ijrobp.2010.06.037; O'CALLAGHAN J P, 1991, Biomedical and Environmental Sciences, V4, P197; Perez BA, 2015, UROL ONCOL-SEMIN ORI, V33, P226, DOI 10.1016/j.urolonc.2014.09.018; Phillips KM, 2012, CANCER-AM CANCER SOC, V118, P1925, DOI 10.1002/cncr.26432; Pomykala KL, 2013, BRAIN IMAGING BEHAV, V7, P511, DOI 10.1007/s11682-013-9243-2; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rockenbach G, 2011, NUTR HOSP, V26, P737, DOI [10.1590/S0212-16112011000400011, 10.3305/nh.2011.26.4.5067]; Seigers R, 2016, BEHAV BRAIN RES, V299, P19, DOI 10.1016/j.bbr.2015.10.057; Seigers R, 2011, NEUROSCI BIOBEHAV R, V35, P729, DOI 10.1016/j.neubiorev.2010.09.006; Seigers R, 2010, BEHAV BRAIN RES, V207, P265, DOI 10.1016/j.bbr.2009.10.009; Semmler A, 2005, J CHEM NEUROANAT, V30, P144, DOI 10.1016/j.jchemneu.2005.07.003; Shibayama O, 2014, CANCER MED-US, V3, P702, DOI 10.1002/cam4.174; Silverman DHS, 2007, BREAST CANCER RES TR, V103, P303, DOI 10.1007/s10549-006-9380-z; Vardy J, 2008, ANN ONCOL, V19, P623, DOI 10.1093/annonc/mdm500; Wang L, 2016, CANCER-AM CANCER SOC, V122, P258, DOI 10.1002/cncr.29737; Wang XM, 2015, CYTOKINE, V72, P86, DOI 10.1016/j.cyto.2014.12.006; Yagi M, 2014, CALCIFIED TISSUE INT, V94, P544, DOI 10.1007/s00223-014-9839-6; Yang M, 2012, BRAIN RES BULL, V89, P50, DOI 10.1016/j.brainresbull.2012.07.003; Zhang D, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9517; Zuo L, 2015, ACTA PHYSIOL, V214, P329, DOI 10.1111/apha.12515; Zuo L, 2014, AM J PHYSIOL-REG I, V306, pR75, DOI 10.1152/ajpregu.00425.2013	48	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163233	10.1371/journal.pone.0163233	http://dx.doi.org/10.1371/journal.pone.0163233			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690377	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200015
J	Gingras, G; Guertin, MH; Laprise, JF; Drolet, M; Brisson, M				Gingras, Guillaume; Guertin, Marie-Helene; Laprise, Jean-Francois; Drolet, Melanie; Brisson, Marc			Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review	PLOS ONE			English	Review							ANTIMICROBIAL STEWARDSHIP; ASYMPTOMATIC CARRIERS; TASK-FORCE; IMPACT; STRAIN; GUIDELINES; DISEASE; TIME; MANAGEMENT; REDUCTION	Background We conducted a systematic review of mathematical models of transmission dynamic of Clostridium difficile infection (CDI) in healthcare settings, to provide an overview of existing models and their assessment of different CDI control strategies. Methods We searched MEDLINE, EMBASE and Web of Science up to February 3, 2016 for transmission-dynamic models of Clostridium difficile in healthcare settings. The models were compared based on their natural history representation of Clostridium difficile, which could include health states (S-E-A-I-R-D: Susceptible-Exposed-Asymptomatic-Infectious-Resistant-Deceased) and the possibility to include healthcare workers and visitors (vectors of transmission). Effectiveness of interventions was compared using the relative reduction (compared to no intervention or current practice) in outcomes such as incidence of colonization, CDI, CDI recurrence, CDI mortality, and length of stay. Results Nine studies describing six different models met the inclusion criteria. Over time, the models have generally increased in complexity in terms of natural history and transmission dynamics and number/complexity of interventions/bundles of interventions examined. The models were categorized into four groups with respect to their natural history representation: S-A-I-R, S-E-A-I, S-A-I, and S-E-A-I-R-D. Seven studies examined the impact of CDI control strategies. Interventions aimed at controlling the transmission, lowering CDI vulnerability and reducing the risk of recurrence/mortality were predicted to reduce CDI incidence by 3-49%, 5-43% and 5-29%, respectively. Bundles of interventions were predicted to reduce CDI incidence by 14-84%. Conclusions Although CDI is a major public health problem, there are very few published transmission-dynamic models of Clostridium difficile. Published models vary substantially in the interventions examined, the outcome measures used and the representation of the natural history of Clostridium difficile, which make it difficult to synthesize results and provide a clear picture of optimal intervention strategies. Future modeling efforts should pay specific attention to calibration, structural uncertainties, and transparent reporting practices.	[Gingras, Guillaume; Guertin, Marie-Helene; Laprise, Jean-Francois; Drolet, Melanie; Brisson, Marc] Univ Laval, Ctr Rech, SP POS, CHU Quebec, 1050 Chemin St Foy, Quebec City, PQ, Canada; [Gingras, Guillaume; Guertin, Marie-Helene; Brisson, Marc] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Brisson, Marc] Imperial Coll, Dept Infect Dis Epidemiol, London, England	Laval University; Laval University; Imperial College London	Gingras, G; Brisson, M (corresponding author), Univ Laval, Ctr Rech, SP POS, CHU Quebec, 1050 Chemin St Foy, Quebec City, PQ, Canada.; Gingras, G; Brisson, M (corresponding author), Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada.; Brisson, M (corresponding author), Imperial Coll, Dept Infect Dis Epidemiol, London, England.	Guillaume.Gingras@crchudequebec.ulaval.ca; Marc.Brisson@crchudequebec.ulaval.ca			Canada Research Chairs program; Canadian Institutes of Health Research [MOP-136830, FDN-143283]	Canada Research Chairs program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/), (support for MB), an operating grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/), (grant no. MOP-136830), and a foundation scheme grant from the Canadian Institutes of Health Research (grant no. FDN-143283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulac K, 2016, INFECT CONT HOSP EP, V37, P433, DOI 10.1017/ice.2015.319; Best EL, 2014, J HOSP INFECT, V87, P25, DOI 10.1016/j.jhin.2014.02.005; Bishop Jennifer, 2013, Conn Med, V77, P69; Boily MC, 2008, LANCET INFECT DIS, V8, P200, DOI 10.1016/S1473-3099(07)70292-X; Boyce JM, 2008, INFECT CONT HOSP EP, V29, P723, DOI 10.1086/589906; Briggs AH, 2012, VALUE HEALTH, V15, P835, DOI 10.1016/j.jval.2012.04.014; Carling P, 2003, INFECT CONT HOSP EP, V24, P699, DOI 10.1086/502278; Caro JJ, 2014, VALUE HEALTH, V17, P174, DOI 10.1016/j.jval.2014.01.003; Caro JJ, 2012, VALUE HEALTH, V15, P796, DOI 10.1016/j.jval.2012.06.012; Catanzaro M, 2012, AM J INFECT CONTROL, V40, P663, DOI 10.1016/j.ajic.2011.09.005; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; Codella J, 2015, MED DECIS MAKING, V35, P211, DOI 10.1177/0272989X14545788; Committee on Models in the Regulatory Decision Process Board on Environmental Studies and Toxicology Division on Earth and Life Studies National Research Council, 2007, MOD ENV REG DEC MAK; Curry SR, 2013, CLIN INFECT DIS, V57, P1094, DOI 10.1093/cid/cit475; Dancer SJ, 2013, INT J ANTIMICROB AG, V41, P137, DOI 10.1016/j.ijantimicag.2012.10.013; Davey P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003543.pub2, 10.1002/14651858.CD003543.pub3, 10.1002/14651858.CD003543.pub4]; Eddy DM, 2012, MED DECIS MAKING, V32, P733, DOI 10.1177/0272989X12454579; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; FEKETY R, 1981, AM J MED, V70, P906, DOI 10.1016/0002-9343(81)90553-2; Fowler S, 2007, J ANTIMICROB CHEMOTH, V59, P990, DOI 10.1093/jac/dkm014; Ghantoji SS, 2010, J HOSP INFECT, V74, P309, DOI 10.1016/j.jhin.2009.10.016; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Hacek DM, 2010, AM J INFECT CONTROL, V38, P350, DOI 10.1016/j.ajic.2009.11.003; Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339; Henderson DA, 1999, VACCINE, V17, pS53, DOI 10.1016/S0264-410X(99)00293-5; Hughes GJ, 2013, J HOSP INFECT, V84, P227, DOI 10.1016/j.jhin.2012.12.018; Husereau D, 2013, VALUE HEALTH, V16, pE1, DOI 10.1016/j.jval.2013.02.010; Jit M, 2011, PHARMACOECONOMICS, V29, P371, DOI 10.2165/11539960-000000000-00000; Khanafer N, 2015, J HOSP INFECT, V90, P91, DOI 10.1016/j.jhin.2015.02.015; Kiskowski M, 2016, VIRULENCE, V7, P163, DOI 10.1080/21505594.2015.1076613; Kopec JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-710; Kuntz K, 2013, DECISION SIMULATION; Landelle C, 2014, INFECT CONT HOSP EP, V35, P10, DOI 10.1086/674396; Lanzas C, 2011, INFECT CONT HOSP EP, V32, P553, DOI 10.1086/660013; Lanzas C, 2014, INFECT CONT HOSP EP, V35, P1043, DOI 10.1086/677162; Levy AR, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv076; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lofgren ET, 2014, INFECT CONT HOSP EP, V35, P18, DOI 10.1086/674394; Lofgren ET, 2014, FECAL TRANSPLANT SIM; Longtin Y, 2016, JAMA INTERN MED, DOI [10.1001/jamainternmed.2016, DOI 10.1001/JAMAINTERNMED.2016]; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Manian FA, 2013, AM J INFECT CONTROL, V41, P537, DOI 10.1016/j.ajic.2012.06.014; Mayfield JL, 2000, CLIN INFECT DIS, V31, P995, DOI 10.1086/318149; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; Muto CA, 2007, CLIN INFECT DIS, V45, P1266, DOI 10.1086/522654; National Institutes of Health, 2014, STUD CAND CLOSTR DIF; Orenstein R, 2011, INFECT CONT HOSP EP, V32, P1137, DOI 10.1086/662586; Philips Z, 2006, PHARMACOECONOMICS, V24, P355, DOI 10.2165/00019053-200624040-00006; Philips Z, 2004, HEALTH TECHNOL ASSES, V8, P1; Pitman R, 2012, VALUE HEALTH, V15, P828, DOI 10.1016/j.jval.2012.06.011; Price J, 2010, CLIN MICROBIOL INFEC, V16, P1297, DOI 10.1111/j.1469-0691.2009.03077.x; Ramos MCP, 2015, VALUE HEALTH, V18, P512, DOI 10.1016/j.jval.2014.12.014; Rao K, 2015, CLIN INFECT DIS, V61, P233, DOI 10.1093/cid/civ254; Roberts M, 2012, MED DECIS MAKING, V32, P678, DOI [10.1177/0272989X12454941, 10.1016/j.jval.2012.06.016]; Rubin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080671; Salgado CD, 2009, AM J INFECT CONTROL, V37, P458, DOI 10.1016/j.ajic.2008.11.010; Sarma JB, 2015, J HOSP INFECT, V91, P74, DOI 10.1016/j.jhin.2015.05.013; Scott R.D., 2009, DIRECT MED COSTS HEA; See I, 2014, CLIN INFECT DIS, V58, P1394, DOI 10.1093/cid/ciu125; Starr JM, 2009, J HOSP INFECT, V71, P49, DOI 10.1016/j.jhin.2008.09.013; Starr JM, 2001, CLIN MICROBIOL INFEC, V7, P432, DOI 10.1046/j.1198-743x.2001.00291.x; Steen R, 2003, REPROD HEALTH MATTER, V11, P74, DOI 10.1016/S0968-8080(03)02295-X; STRUELENS MJ, 1991, AM J MED, V91, pS138, DOI 10.1016/0002-9343(91)90359-6; Talpaert MJ, 2011, J ANTIMICROB CHEMOTH, V66, P2168, DOI 10.1093/jac/dkr253; Thacker B.H., 2004, CONCEPTS MODEL VERIF; United States Environmental Protection Agency, 2009, GUID DEV EV APPL ENV; US Environmental Protection Agency Science Policy Council, 1999, WHIT PAP NAT SCOP IS; Valiquette L, 2007, CLIN INFECT DIS, V45, pS112, DOI 10.1086/519258; van Kleef E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-294; Vardakas KZ, 2012, INT J INFECT DIS, V16, pE768, DOI 10.1016/j.ijid.2012.07.010; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Watson CH, 2015, VACCINE, V33, pC42, DOI 10.1016/j.vaccine.2015.04.013; Weber DJ, 2011, INFECT CONT HOSP EP, V32, P207, DOI 10.1086/658670; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x; Weinstein MC, 2003, VALUE HEALTH, V6, P9, DOI 10.1046/j.1524-4733.2003.00234.x; Weiss K, 2009, INFECT CONT HOSP EP, V30, P156, DOI 10.1086/593955; Wenisch JM, 2014, ANTIMICROB AGENTS CH, V58, P5079, DOI 10.1128/AAC.03006-14; Yakob L, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.43; Yakob L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-376; You E, 2014, INT J INFECT DIS, V22, P9, DOI [10.1016/j.ijid.2014.01.011, 10.1093/infdis/jit461]; Zacharioudakis IM, 2015, AM J GASTROENTEROL, V110, P381, DOI 10.1038/ajg.2015.22	81	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163880	10.1371/journal.pone.0163880	http://dx.doi.org/10.1371/journal.pone.0163880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690247	Green Published, Green Submitted, gold			2022-12-27	WOS:000384329200030
J	Schiesari, L; Andreatta, G; Kyriacou, CP; O'Connor, MB; Costa, R				Schiesari, Luca; Andreatta, Gabriele; Kyriacou, Charalambos P.; O'Connor, Michael B.; Costa, Rodolfo			The Insulin-Like Proteins dILPs-2/5 Determine Diapause Inducibility in Drosophila	PLOS ONE			English	Article							LIFE-SPAN; NATURAL-SELECTION; MELANOGASTER; GROWTH; GENE; PEPTIDE; CELLS; POLYMORPHISM; EXPRESSION; NEURONS	Diapause is an actively induced dormancy that has evolved in Metazoa to resist environmental stresses. In temperate regions, many diapausing insects overwinter at low temperatures by blocking embryonic, larval or adult development. Despite its Afro-tropical origin, Drosophila melanogaster migrated to temperate regions of Asia and Europe where females overwinter as adults by arresting gonadal development (reproductive diapause) at temperatures < 13 degrees C. Recent work in D. melanogaster has implicated the developmental hormones dILPs-2 and/or dILP3, and dILP5, homologues of vertebrate insulin/insulin-like growth factors (IGFs), in reproductive arrest. However, polymorphisms in timeless (tim) and couch potato (cpo) dramatically affect diapause inducibility and these dILP experiments could not exclude this common genetic variation contributing to the diapause phenotype. Here, we apply an extensive genetic dissection of the insulin signaling pathway which allows us to see both enhancements and reductions in egg development that are independent of tim and cpo variations. We show that a number of manipulations dramatically enhance diapause to similar to 100%. These include ablating, or reducing the excitability of the insulin-producing cells (IPCs) that express dILPs-2,3,5 employing the dilp2,3,5(-/-) triple mutant, desensitizing insulin signaling using a chico mutation, or inhibiting dILP2 and 5 in the hemolymph by over-expressing Imaginal Morphogenesis Protein-Late 2 (Imp-L2). In addition, triple mutant dilp2,3,5(-/-) females maintain high levels of diapause even when temperatures are raised in adulthood to 19 degrees C. However at 22 degrees C, these females all show egg development revealing that the effects are conditional on temperature and not a general female sterility. In contrast, over-expression of dilps-2/5 or enhancing IPC excitability, led to levels of ovarian arrest that approached zero, underscoring dILPs-2 and 5 as key antagonists of diapause.	[Schiesari, Luca; Andreatta, Gabriele; Costa, Rodolfo] Univ Padua, Dept Biol, Padua, Italy; [Schiesari, Luca; O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Kyriacou, Charalambos P.] Univ Leicester, Dept Genet, Leicester, Leics, England	University of Padua; University of Minnesota System; University of Minnesota Twin Cities; University of Leicester	Costa, R (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	rodolfo.costa@unipd.it	Andreatta, Gabriele/AAK-6596-2020; O'Connor, Michael B/C-9977-2014	Andreatta, Gabriele/0000-0001-8857-7282; O'Connor, Michael B/0000-0002-3067-5506	University of Padova (Italy); NIH [GM093301]; European Community (the 6th Framework Project EUCLOCK) [018741]; Fondazione Cariparo (Progetti di Eccellenza); Ministero dell'Universita e delle Ricerca (MIUR); BBSRC [BB/F014082/1]; INsecTIME Marie Curie Initial Training Network [PITN-GA-2012-316790]; Fondazione CaRiPaRo (Italy); NIH grant [RO1GM093301]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118029] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F014082/1] Funding Source: researchfish	University of Padova (Italy); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community (the 6th Framework Project EUCLOCK); Fondazione Cariparo (Progetti di Eccellenza)(Fondazione Cariparo); Ministero dell'Universita e delle Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); INsecTIME Marie Curie Initial Training Network; Fondazione CaRiPaRo (Italy)(Fondazione Cariparo); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	L.S. was supported by a doctoral fellowship from the University of Padova (Italy) and by NIH grant GM093301 (USA); R.C. was supported by grants from the European Community (the 6th Framework Project EUCLOCK no.018741), Fondazione Cariparo (Progetti di Eccellenza 2011-2012), and the Ministero dell'Universita e delle Ricerca (MIUR); C.P.K. by BBSRC grant BB/F014082/1. R.C. and C.P.K. are also supported by the INsecTIME Marie Curie Initial Training Network, grant PITN-GA-2012-316790. G. A. was supported by doctoral fellowships from the Fondazione CaRiPaRo (Italy). L.S. also thanks Fondazione Ing. "A.Gini" of University of Padova (Italy) ; M.B.O. is supported by NIH grant RO1GM093301 (USA).	Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; Anderson AR, 2005, MOL ECOL, V14, P851, DOI 10.1111/j.1365-294X.2005.02445.x; Belgacem YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000187; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Cogni R, 2014, EVOLUTION, V68, P538, DOI 10.1111/evo.12291; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Daimon T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002486; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jones D, 2010, GEN COMP ENDOCR, V165, P244, DOI 10.1016/j.ygcen.2009.07.006; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kubrak OI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113051; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee SF, 2011, MOL ECOL, V20, P2973, DOI 10.1111/j.1365-294X.2011.05155.x; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Okamoto N, 2013, GENE DEV, V27, P87, DOI 10.1101/gad.204479.112; Paaby AB, 2010, MOL ECOL, V19, P760, DOI 10.1111/j.1365-294X.2009.04508.x; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; Schiesari L, 2013, CURR TOP DEV BIOL, V105, P213, DOI 10.1016/B978-0-12-396968-2.00008-7; Schmidt PS, 2008, P NATL ACAD SCI USA, V105, P16207, DOI 10.1073/pnas.0805485105; Schmidt PS, 2008, EVOLUTION, V62, P1204, DOI 10.1111/j.1558-5646.2008.00351.x; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; Seroude L, 2002, AGING CELL, V1, P47, DOI 10.1046/j.1474-9728.2002.00007.x; Sezgin E, 2004, GENETICS, V168, P923, DOI 10.1534/genetics.104.027649; Sim C, 2009, INSECT MOL BIOL, V18, P325, DOI 10.1111/j.1365-2583.2009.00872.x; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Song W, 2010, CELL METAB, V11, P427, DOI 10.1016/j.cmet.2010.04.002; Taghert PH, 2001, J NEUROSCI, V21, P6673, DOI 10.1523/JNEUROSCI.21-17-06673.2001; Tang HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002373; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; WILLIAMS KD, 1993, HEREDITY, V71, P312, DOI 10.1038/hdy.1993.141; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	48	30	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163680	10.1371/journal.pone.0163680	http://dx.doi.org/10.1371/journal.pone.0163680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689881	Green Published, gold, Green Submitted			2022-12-27	WOS:000384329200019
J	Wang, YZ; Yin, XY; Li, L; Deng, SM; He, ZY				Wang, Yanzhe; Yin, Xiaoyu; Li, Lei; Deng, Shumin; He, Zhiyi			Association of Apolipoprotein C3 Genetic Polymorphisms with the Risk of Ischemic Stroke in the Northern Chinese Han Population	PLOS ONE			English	Article							GLOBAL BURDEN; LIPID LEVELS; DISEASE; LIPOPROTEINS; EXPRESSION; SECRETION; VARIANTS; UPDATE; SHESIS; APOC3	The apolipoprotein C3 (APOC3) gene, which is a member of the APOA1/C3/A4/A5 gene cluster, plays a crucial role in lipid metabolism. Dyslipidemia is an important risk factor for ischemic stroke. In the present study, we performed a hospital-based case-control study of 895 ischemic stroke patients and 883 control subjects to examine the effects of four APOC3 single nucleotide polymorphisms (SNPs) (rs2854116, rs2854117, rs4520 and rs5128) on the risk of ischemic stroke in a northern Chinese Han population. The SNaPshot Multiplex sequencing assay was used for SNP genotyping, and the potential association of genotype distributions and allele frequencies with ischemic stroke was analyzed statistically. Compared with the GG genotype, the CC+GC genotype of rs5128 was significantly associated with an increased risk in females (adjusted OR = 3.38, 95% CI = 1.82-6.28, P < 0.01) after all of the risk factors were adjusted for with logistic regression analyses. A similar relationship was found between the rs4520 polymorphism and ischemic stroke risk in Han Chinese women. Under a recessive genetic model, the TT+TC genotypes of this variant increased ischemic stroke risk (adjusted OR = 2.05; 95% CI = 1.28-3.29; P < 0.01). Haplotype analysis revealed that in males, the T-C-T-C haplotype of rs2854116-rs2854117-rs4520-rs5128 was significantly more frequent in the ischemic stroke group than in the control group (OR = 1.49, 95% CI = 1.18-1.87, P < 0.01). The results of our study indicate that the APOC3 polymorphisms contribute to ischemic stroke susceptibility in females in the northern Chinese Han population.	[Wang, Yanzhe; Yin, Xiaoyu; Li, Lei; Deng, Shumin; He, Zhiyi] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Peoples R China	China Medical University	He, ZY (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Peoples R China.	Hezhiyi0301@sina.com			National Natural Science Foundation of China [81070913]; Liaoning Provincial Natural Science Foundation [20102288]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Provincial Natural Science Foundation	This work was supported by the National Natural Science Foundation of China (81070913) (http://www.nsfc.gov.cn/) and the Liaoning Provincial Natural Science Foundation (20102288) (http://kjjh.lninfo.gov.cn/). Zhiyi He is the corresponding author of this article and played a crucial role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have no conflicts of interest or disclosures regarding the results in this manuscript. This work was supported by the National Natural Science Foundation of China (81070913) and the Liaoning Provincial Natural Science Foundation (20102288).	Amouyel P, 2012, LANCET NEUROL, V11, P931, DOI 10.1016/S1474-4422(12)70235-1; Bai Y, 2014, STROKE, V45, P383, DOI 10.1161/STROKEAHA.113.003393; Berkowitz AL, 2015, NEUROLOGY, V84, P2183, DOI 10.1212/WNL.0000000000001618; Cui FH, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-170; Ding Y.C., 2012, MATH PROBL ENG, V2012, P1, DOI DOI 10.1155/2012/509420; Dorfmeister B, 2007, BBA-MOL BASIS DIS, V1772, P355, DOI 10.1016/j.bbadis.2006.11.008; Feigin VL, 2015, STROKE, V46, P1740, DOI 10.1161/STROKEAHA.115.008222; Ginsberg HN, 2011, ARTERIOSCL THROM VAS, V31, P471, DOI 10.1161/ATVBAHA.110.221846; Guardiola M, 2014, ATHEROSCLEROSIS, V237, P528, DOI 10.1016/j.atherosclerosis.2014.10.029; Jiang Y, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0047-9; Kaminsky Z, 2006, ANN MED, V38, P530, DOI 10.1080/07853890600989211; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Lin B, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004156; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Pokharel Y, 2015, ATHEROSCLEROSIS, V241, P641, DOI 10.1016/j.atherosclerosis.2015.06.033; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; Ranta A, 2015, NEUROLOGY, V84, P2204, DOI 10.1212/WNL.0000000000001651; Raz L, 2014, MOL CELL ENDOCRINOL, V389, P22, DOI 10.1016/j.mce.2014.01.015; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Song YY, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0027-0; Tai ES, 2002, ARTERIOSCL THROM VAS, V22, P805, DOI 10.1161/01.ATV.0000012302.11991.42; Tang Liang, 2014, F1000Res, V3, P270, DOI 10.12688/f1000research.5676.2; Vecoli C, 2014, THROMB RES, V133, P804, DOI 10.1016/j.thromres.2014.03.006; Wang XW, 2011, J CLIN ENDOCR METAB, V96, P885, DOI 10.1210/jc.2010-2061; Wei JY, 2012, FEBS J, V279, P91, DOI 10.1111/j.1742-4658.2011.08401.x; Yao Zemin, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P133; Yao ZM, 2012, CURR OPIN LIPIDOL, V23, P206, DOI 10.1097/MOL.0b013e328352dc70	29	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							0163910	10.1371/journal.pone.0163910	http://dx.doi.org/10.1371/journal.pone.0163910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690381	Green Published, gold, Green Submitted			2022-12-27	WOS:000384329200033
J	Brown, SHJ; Eather, SR; Freeman, DJ; Meyer, BJ; Mitchell, TW				Brown, Simon H. J.; Eather, Samuel R.; Freeman, Dilys J.; Meyer, Barbara J.; Mitchell, Todd W.			A Lipidomic Analysis of Placenta in Preeclampsia: Evidence for Lipid Storage	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; MASS-SPECTROMETRY; PREGNANCY; WOMEN; LIPOLYSIS; INSULIN	In preeclampsia, maternal insulin resistance leads to defective expansion of adipocytes, enhanced adipocyte lipolysis, up-regulation of very low density lipoprotein synthesis, maternal hypertriglyceridaemia and the potential for ectopic fat storage. Our aim was to quantitate and compare the total amount and type of lipid in placenta from pregnancies complicated with preeclampsia and healthy pregnancies. Quantitative lipid analysis of lipid extracts from full thickness placental biopsies was carried out by shotgun lipidomics. Placental lipid profiles from pregnancies complicated by preeclampsia (n = 23) were compared to healthy pregnancies (n = 68), and placenta from intrauterine growth restriction pregnancies (n = 10) were used to control for gross differences in placental pathology. Placentae from pregnancies complicated with preeclampsia had higher neutral lipid content than healthy placentae (40% higher triacyglycerol (P = 0.001) and 33% higher cholesteryl ester (P = 0.004)) that was specific to preeclampsia and independent of maternal gestation.	[Brown, Simon H. J.] Univ Wollongong, Sch Biol, Wollongong, NSW, Australia; [Brown, Simon H. J.; Meyer, Barbara J.; Mitchell, Todd W.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Eather, Samuel R.; Meyer, Barbara J.; Mitchell, Todd W.] Univ Wollongong, Sch Med, Wollongong, NSW, Australia; [Freeman, Dilys J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Wollongong; University of Wollongong; University of Wollongong; University of Glasgow	Mitchell, TW (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.; Mitchell, TW (corresponding author), Univ Wollongong, Sch Med, Wollongong, NSW, Australia.	toddm@uow.edu.au	Meyer, Barbara/AAC-6078-2019; Brown, Simon/A-3261-2009; Mitchell, Todd/G-7044-2012	Meyer, Barbara/0000-0001-7962-7890; Brown, Simon/0000-0003-3997-4614; Eather, Samuel/0000-0002-8189-1620; Mitchell, Todd/0000-0002-1372-9963	ARC [FT110100249]; Chief Scientist's Office [CZG/1/74]; British Heart Foundation [PG/03/147/16351, PG/02/167/14801]	ARC(Australian Research Council); Chief Scientist's Office; British Heart Foundation(British Heart Foundation)	TWM holds a Future Fellowship from the ARC (arc.gov.au) FT110100249, DJF received funding from the Chief Scientist's Office (http://www.cso.scot.nhs.uk) CZG/1/74 and DJF received funding from the British Heart Foundation (https://www.bhf.org.uk) PG/03/147/16351 and PG/02/167/14801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baig S, 2013, PLACENTA, V34, P436, DOI 10.1016/j.placenta.2013.02.004; Diderholm B, 2006, BJOG-INT J OBSTET GY, V113, P159, DOI 10.1111/j.1471-0528.2005.00825.x; Ejsing CS, 2006, ANAL CHEM, V78, P6202, DOI 10.1021/ac060545x; Huang X, 2013, INT J MOL SCI, V14, P3487, DOI 10.3390/ijms14023487; Huda SS, 2014, HYPERTENSION, V63, P1094, DOI 10.1161/HYPERTENSIONAHA.113.01824; Huda SS, 2009, CLIN LIPIDOL, V4, P91, DOI 10.2217/17584299.4.1.91; Jarvie E, 2010, CLIN SCI, V119, P123, DOI 10.1042/CS20090640; Kaaja R, 1999, METABOLISM, V48, P892, DOI 10.1016/S0026-0495(99)90225-1; Klingler M, 2003, LIPIDS, V38, P561, DOI 10.1007/s11745-003-1496-8; KNOPP RH, 1982, AM J OBSTET GYNECOL, V143, P626, DOI 10.1016/0002-9378(82)90107-7; Korkes HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110747; Mackay VA, 2012, HYPERTENSION, V60, P1078, DOI 10.1161/HYPERTENSIONAHA.112.197897; MONTELONGO A, 1992, DIABETES, V41, P1651, DOI 10.2337/diabetes.41.12.1651; Murphy RC, 2007, ANAL BIOCHEM, V366, P59, DOI 10.1016/j.ab.2007.03.012; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ramsay JE, 2004, J HYPERTENS, V22, P2177, DOI 10.1097/00004872-200411000-00021; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Roberts JM, 2000, SEMIN PERINATOL, V24, P24, DOI 10.1016/S0146-0005(00)80050-6; Sankar KD, 2013, ANAT CELL BIOL, V46, P285, DOI 10.5115/acb.2013.46.4.285; Sattar N, 1997, OBSTET GYNECOL, V89, P403, DOI 10.1016/S0029-7844(96)00514-5; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Staff AC, 1999, AM J OBSTET GYNECOL, V180, P587, DOI 10.1016/S0002-9378(99)70259-0; Stahlman M, 2009, J CHROMATOGR B, V877, P2664, DOI 10.1016/j.jchromb.2009.02.037; Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083; Sun MN, 2012, CHINESE MED J-PEKING, V125, P3532, DOI 10.3760/cma.j.issn.0366-6999.2012.19.031; Tran PN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5773	27	35	36	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2016	11	9							e0163972	10.1371/journal.pone.0163972	http://dx.doi.org/10.1371/journal.pone.0163972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CV	27685997	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000384328500144
J	Ghaffarzadegan, N; Ebrahimvandi, A; Jalali, MS				Ghaffarzadegan, Navid; Ebrahimvandi, Alireza; Jalali, Mohammad S.			A Dynamic Model of Post-Traumatic Stress Disorder for Military Personnel and Veterans	PLOS ONE			English	Article							SYSTEM DYNAMICS; PRIMARY-CARE; SIMULATION-MODELS; WAR VETERANS; DSM-IV; PTSD; HEALTH; TRAUMA; PREVALENCE; RESILIENCE	Post-traumatic stress disorder (PTSD) stands out as a major mental illness; however, little is known about effective policies for mitigating the problem. The importance and complexity of PTSD raise critical questions: What are the trends in the population of PTSD patients among military personnel and veterans in the postwar era? What policies can help mitigate PTSD? To address these questions, we developed a system dynamics simulation model of the population of military personnel and veterans affected by PTSD. The model includes both military personnel and veterans in a "system of systems." This is a novel aspect of our model, since many policies implemented at the military level will potentially influence (and may have side effects on) veterans and the Department of Veterans Affairs. The model is first validated by replicating the historical data on PTSD prevalence among military personnel and veterans from 2000 to 2014 (datasets from the Department of Defense, the Institute of Medicine, the Department of Veterans Affairs, and other sources). The model is then used for health policy analysis. Our results show that, in an optimistic scenario based on the status quo of deployment to intense/combat zones, estimated PTSD prevalence among veterans will be at least 10% during the next decade. The model postulates that during wars, resiliency-related policies are the most effective for decreasing PTSD. In a postwar period, current health policy interventions (e.g., screening and treatment) have marginal effects on mitigating the problem of PTSD, that is, the current screening and treatment policies must be revolutionized to have any noticeable effect. Furthermore, the simulation results show that it takes a long time, on the order of 40 years, to mitigate the psychiatric consequences of a war. Policy and financial implications of the findings are discussed.	[Ghaffarzadegan, Navid; Ebrahimvandi, Alireza] Virginia Tech, Ind & Syst Engn, Blacksburg, VA USA; [Jalali, Mohammad S.] MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Virginia Polytechnic Institute & State University; Massachusetts Institute of Technology (MIT)	Jalali, MS (corresponding author), MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	Jalali@mit.edu	Ebrahimvandi, Alireza/L-2220-2019; Jalali, Mohammad S./Q-2188-2019; Ebrahimvandi, Alireza/M-8172-2019	Jalali, Mohammad S./0000-0001-6769-2732; Ebrahimvandi, Alireza/0000-0002-6338-2662; Ghaffarzadegan, Navid/0000-0003-3632-8588	Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-12-0016]	Office of the Assistant Secretary of Defense for Health Affairs	This article is based upon MIT Post Traumatic Stress Innovations project supported, in part, by the Office of the Assistant Secretary of Defense for Health Affairs, under award no. W81XWH-12-0016. The US Army Medical Research Acquisition Activity (820 Chandler Street, Fort Detrick, MD 21702-5014) is the awarding and administering acquisition office. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense, MIT, or Virginia Tech.	Abdel-Hamid T, 2014, SYST DYNAM REV, V30, P58, DOI 10.1002/sdr.1517; Adamowicz MW, 2009, CONTROVERSY PTSD 200; Ahmed AS, 2007, ADV PSYCHIAT TREATME, V13, P369, DOI [DOI 10.1192/APT.BP.106.003236, 10.1192/apt.bp.106.003236]; Barlas Y, 1996, SYST DYNAM REV, V12, P183, DOI 10.1002/(SICI)1099-1727(199623)12:3<183::AID-SDR103>3.0.CO;2-4; BARLAS Y, 1989, EUR J OPER RES, V42, P59, DOI 10.1016/0377-2217(89)90059-3; Bohnert KM, 2011, INT J METH PSYCH RES, V20, pE1, DOI 10.1002/mpr.331; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Botella C, 2015, NEUROPSYCH DIS TREAT, V11, P2533, DOI 10.2147/NDT.S89542; Breslau N, 2003, ARCH GEN PSYCHIAT, V60, P289, DOI 10.1001/archpsyc.60.3.289; Campbell DG, 2007, J GEN INTERN MED, V22, P711, DOI 10.1007/s11606-006-0101-4; Davidson JRT, 2005, INT CLIN PSYCHOPHARM, V20, P43, DOI 10.1097/00004850-200501000-00009; Davis SM, 2009, J FAM PRACTICE, V58, P100; de Bont PAJM, 2015, BRIT J PSYCHIAT, V206, P408, DOI 10.1192/bjp.bp.114.148486; Freedy JR, 2010, FAM PRACT, V27, P615, DOI 10.1093/fampra/cmq049; Ghaffarzadegan N, 2015, ARMY MED DE IN PRESS; Ginzburg K, 2010, J AFFECT DISORDERS, V123, P249, DOI 10.1016/j.jad.2009.08.006; Grieger TA, 2007, MIL MED, V172, P451, DOI 10.7205/MILMED.172.5.451; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; HENDIN H, 1991, AM J PSYCHIAT, V148, P586; Henning KR, 1997, J CLIN PSYCHOL, V53, P801, DOI 10.1002/(SICI)1097-4679(199712)53:8<801::AID-JCLP3>3.0.CO;2-I; Highland KB, 2015, NEUROBIOL STRESS, V2, P62, DOI 10.1016/j.ynstr.2015.07.001; Hirsch G, 2014, AM J PUBLIC HEALTH, V104, P1187, DOI 10.2105/AJPH.2013.301816; Homer J.B., 1983, SYST DYNAM REV, V28, P281, DOI DOI 10.1002/SDR.1478; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; Hosseinichimeh N, 2015, MATH BIOSCI, V268, P52, DOI 10.1016/j.mbs.2015.08.004; Hughes V, 2012, NATURE, V490, P165, DOI 10.1038/490165a; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Jalali MS, 2014, 32 INT C SYST DYN SO; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Mabry PL, 2010, AM J PUBLIC HEALTH, V100, P1161, DOI 10.2105/AJPH.2010.198176; Martin M, 2014, PTSD RISK FACTORS; MCFALL ME, 1992, J STUD ALCOHOL, V53, P357, DOI 10.15288/jsa.1992.53.357; McLean CP, 2011, EXPERT REV NEUROTHER, V11, P1151, DOI [10.1586/ERN.11.94, 10.1586/ern.11.94]; Meadows D.H., 2008, THINKING SYSTEMS PRI; Milstein B, 2011, HEALTH AFFAIR, V30, P823, DOI 10.1377/hlthaff.2010.1116; Milstein B, 2010, AM J PUBLIC HEALTH, V100, P811, DOI 10.2105/AJPH.2009.174490; Monahan P, 2013, MSMR, V20, P6; MORECROFT JDW, 1985, MANAGE SCI, V31, P900, DOI 10.1287/mnsc.31.7.900; Murphy D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007051; Peterson AL, 2011, J CLIN PSYCHOL MED S, V18, P164, DOI 10.1007/s10880-011-9238-3; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Purtle J, 2016, SOC SCI MED, V149, P9, DOI 10.1016/j.socscimed.2015.11.039; Purtle J, 2014, J TRAUMA STRESS, V27, P501, DOI 10.1002/jts.21948; Rahmandad H, 2015, SYST DYNAM REV, V31, P149, DOI 10.1002/sdr.1541; Rahmandad H, 2012, SYST DYNAM REV, V28, P396, DOI 10.1002/sdr.1481; SOLOMON Z, 2015, LONG TERM TRAJECTORI, P187, DOI [10.1093/med/9780199378821.003.0011, DOI 10.1093/MED/9780199378821.003.0011]; Steenkamp MM, 2013, CLIN PSYCHOL REV, V33, P45, DOI 10.1016/j.cpr.2012.10.002; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; U.S. Department of Veterans Affairs, 2016, HOW COMM IS PTSD; US Department of Veterans Affairs, 2016, PTSD NAT CTR PTSD 20, DOI [10.1016/j.socscimed.2015.11.039, DOI 10.1016/J.SOCSCIMED.2015.11.039]; Watts BV, 2013, J CLIN PSYCHIAT, V74, pE541, DOI 10.4088/JCP.12r08225; Wisco BE, 2012, MIL MED, V177, P7, DOI 10.7205/MILMED-D-12-00111; Wittenborn AK, 2016, PSYCHOL MED, V46, P551, DOI 10.1017/S0033291715002044; Zalta AK, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0560-6	55	19	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0161405	10.1371/journal.pone.0161405	http://dx.doi.org/10.1371/journal.pone.0161405			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UW	27716776	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100003
J	Xu, X; Greenland, JR; Gotts, JE; Matthay, MA; Caughey, GH				Xu, Xiang; Greenland, John R.; Gotts, Jeffrey E.; Matthay, Michael A.; Caughey, George H.			Cathepsin L Helps to Defend Mice from Infection with Influenza A	PLOS ONE			English	Article							LYSOSOMAL CYSTEINE PROTEASES; ANTIGEN PRESENTATION; VIRUS-INFECTION; CELLS; PATHOGENICITY; HEMAGGLUTININ; REPLICATION; RECOGNITION; CORONAVIRUS; INHIBITORS	Host-derived proteases can augment or help to clear infections. This dichotomy is exemplified by cathepsin L (CTSL), which helps Hendra virus and SARS coronavirus to invade cells, but is essential for survival in mice with mycoplasma pneumonia. The present study tested the hypothesis that CTSL protects mice from serious consequences of infection by the orthomyxovirus influenza A, which is thought to be activated by host-supplied proteases other than CTSL. Ctsl(-/-) mice infected with influenza A/Puerto Rico/8/34(H1N1) had larger lung viral loads and higher mortality than infected Ctsl(+/+) mice. Lung inflammation in surviving infected mice peaked 14 days after initial infection, accompanied marked focal distal airway bronchiolization and epithelial metaplasia followed by desquamation and fibrotic interstitial remodeling, and persisted for at least 6 weeks. Most deaths occurred during the second week of infection in both groups of mice. In contrast to mycoplasma pneumonia, infiltrating cells were predominantly mononuclear rather than polymorphonuclear. The histopathology of lung inflammation and remodeling in survivors was similar in Ctsl(-/-) and Ctsl(+)/(+) mice, although Ctsl(+)/(+) mice cleared immunoreactive virus sooner. Furthermore, Ctsl(-/-) mice had profound deficits in CD4+ lymphocytes before and after infection and weaker production of pathogen-specific IgG. Thus, CTSL appears to support innate as well as adaptive responses, which confer a survival advantage on mice infected with the orthomyxovirus influenza A.	[Xu, Xiang; Greenland, John R.; Gotts, Jeffrey E.; Matthay, Michael A.; Caughey, George H.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Greenland, John R.; Caughey, George H.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Gotts, Jeffrey E.; Matthay, Michael A.; Caughey, George H.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Caughey, GH (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Caughey, GH (corresponding author), Vet Affairs Med Ctr, San Francisco, CA 94121 USA.; Caughey, GH (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	george.caughey@ucsf.edu	Greenland, John R/AAR-6030-2021	Greenland, John R/0000-0003-1422-8367	National Institutes of Health [P01HL024136]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL119997] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX001034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health Grant P01HL024136 (www.nih.gov).	Beck MA, 2001, FASEB J, V15, P1481, DOI 10.1096/fj.00-0721fje; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Blanc F, 2016, AM J PHYSIOL-LUNG C, V310, pL689, DOI 10.1152/ajplung.00314.2015; Brown DM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00093; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; Garten W, 2015, EUR J CELL BIOL, V94, P375, DOI 10.1016/j.ejcb.2015.05.013; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Kitamoto S, 2007, CIRCULATION, V115, P2065, DOI 10.1161/CIRCULATIONAHA.107.688523; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Marzi A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001923; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Pager CT, 2005, J VIROL, V79, P12714, DOI 10.1128/JVI.79.20.12714-12720.2005; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Sun JS, 2011, ARTERIOSCL THROM VAS, V31, P2500, DOI 10.1161/ATVBAHA.111.230201; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; van Kasteren SI, 2014, CURR OPIN CHEM BIOL, V23, P8, DOI 10.1016/j.cbpa.2014.08.011; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Whitmire JK, 2011, VIROLOGY, V411, P216, DOI 10.1016/j.virol.2010.12.015; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Xu X, 2013, AM J RESP CELL MOL, V49, P437, DOI 10.1165/rcmb.2013-0016OC	31	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164501	10.1371/journal.pone.0164501	http://dx.doi.org/10.1371/journal.pone.0164501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716790	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100060
J	AbdelKhalek, A; Ashby, CR; Patel, BA; Talele, TT; Seleem, MN				AbdelKhalek, Ahmed; Ashby, Charles R., Jr.; Patel, Bhargav A.; Talele, Tanaji T.; Seleem, Mohamed N.			In Vitro Antibacterial Activity of Rhodanine Derivatives against Pathogenic Clinical Isolates	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; (Z)-5-ARYLMETHYLIDENE RHODANINES; STAPHYLOCOCCAL INFECTIONS; DAPTOMYCIN; DRUGS	Bacterial infections present a serious challenge to healthcare practitioners due to the emergence of resistance to numerous conventional antibacterial drugs. Therefore, new bacterial targets and new antimicrobials are unmet medical needs. Rhodanine derivatives have been shown to possess potent antimicrobial activity via a novel mechanism. However, their potential use as antibacterials has not been fully examined. In this study, we determined the spectrum of activity of seven rhodanine derivatives (compounds Rh 1-7) against clinical isolates of Gram-positive and Gram-negative bacterial strains and Candida albicans. We also synthesized and tested three additional compounds, ethyl ester and amide of rhodanine 2 (Rh 8 and Rh 10, respectively) and ethyl ester of rhodanine 3 (Rh 9) to determine the significance of the carboxyl group modification towards antibacterial activity and human serum albumin binding. A broth microdilution assay confirmed Rh 1-7 exhibit bactericidal activity against Gram-positive pathogens. Rh 2 had significant activity against various vancomycin-resistant (MIC90 = 4 mu M) and methicillin-resistant (MIC90 = 4 mu M) Staphylococcus aureus (VRSA and MRSA), Staphylococcus epidermidis (MIC = 4 mu M) and vancomycin-resistant Enterococcus (VRE) strains (MIC90 = 8 mu M). The rhodanine compounds exhibited potent activity against Bacillus spp., including Bacillus anthracis, with MIC range of 2-8 mu M. In addition, they had potent activity against Clostridium difficile. The most potent compound, Rh 2, at 4 and 8 times its MIC, significantly decreased S. epidermidis biofilm mass by more than 35% and 45%, respectively. None of the rhodanine compounds showed antimicrobial activity (MIC > 128 mu M) against various 1) Gram-negative pathogens (Acinetobacter baumannii, Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa, and Salmonella Typhimurium) or 2) strains of Candida albicans (MIC > 64 mu M). The MTS assay confirmed that rhodanines were not toxic to mouse murine macrophage (J774.1A) up to 64 mu M, human keratinocytes (HaCat) up to 32 mu M, and human ileocecal colorectal cell (HRT-18) up to 128 mu M. Overall, these data suggest that certain rhodanine compounds may have potential use for the treatment of several multidrug-resistant Gram-positive bacterial infections.	[AbdelKhalek, Ahmed; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathol, 625 Harrison St, W Lafayette, IN 47907 USA; [Ashby, Charles R., Jr.; Patel, Bhargav A.; Talele, Tanaji T.] St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA; [Seleem, Mohamed N.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Saint John's University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathol, 625 Harrison St, W Lafayette, IN 47907 USA.; Talele, TT (corresponding author), St Johns Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA.; Seleem, MN (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.	talelet@stjohns.edu; mseleem@purdue.edu	Patel, Bhargav/H-5563-2018; Seleem, Mohamed/H-2774-2018	Patel, Bhargav/0000-0002-0859-3803; Seleem, Mohamed/0000-0003-0939-0458	National Institute of Allergy And Infectious Diseases of the National Institutes of Health [R56AI114861]; Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program under NIAID/NIH [HHSN272200700055C]	National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program under NIAID/NIH	Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R56AI114861. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Network of Antimicrobial Resistance in Staphylococcus aureus (NARSA) program supported under NIAID/NIH Contract # HHSN272200700055C and BEI resources for providing S. aureus strains used in this study. We thank Dr. Alex O'Neill, University of Leeds, for providing the Escherichia coli SM1411 Delta acrAB strain.	Aldeghi M, 2014, CHEM BIOL DRUG DES, V83, P450, DOI 10.1111/cbdd.12260; [Anonymous], 2011, ADMET MED CHEM PRACT; CHRISTENSEN GD, 1982, ANN INTERN MED, V96, P1, DOI 10.7326/0003-4819-96-1-1; Clinical and Laboratory Standards Institute, 2012, M7A9 NCCLS CLSI; Deresinski S, 2009, CLIN INFECT DIS, V49, P1072, DOI 10.1086/605572; Dolezel J, 2009, MOLECULES, V14, P4197, DOI 10.3390/molecules14104197; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Kamboj M, 2011, CLIN INFECT DIS, V53, P1003, DOI 10.1093/cid/cir643; Mohammad H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130385; Mohammad H, 2015, J ANTIBIOT, V68, P259, DOI 10.1038/ja.2014.142; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Patel BA, 2013, BIOORG MED CHEM LETT, V23, P5523, DOI 10.1016/j.bmcl.2013.08.059; Patel BA, 2013, BIOORGAN MED CHEM, V21, P3262, DOI 10.1016/j.bmc.2013.03.041; Randall CP, 2013, ANTIMICROB AGENTS CH, V57, P637, DOI 10.1128/AAC.02005-12; Singh SR, 2009, ANTIMICROB AGENTS CH, V53, P4495, DOI 10.1128/AAC.00237-09; Thangamani S, 2016, INT J ANTIMICROB AG, V47, P195, DOI 10.1016/j.ijantimicag.2015.12.016; Thangamani S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22571; Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16407; Thangamani S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11596; VILJANEN P, 1984, ANTIMICROB AGENTS CH, V25, P701, DOI 10.1128/AAC.25.6.701; Werner MM, 2015, BIOORGAN MED CHEM, V23, P6125, DOI 10.1016/j.bmc.2015.08.004	21	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164227	10.1371/journal.pone.0164227	http://dx.doi.org/10.1371/journal.pone.0164227			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711156	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600100
J	Figueroa-Bonaparte, S; Segovia, S; Llauger, J; Belmonte, I; Pedrosa, I; Alejaldre, A; Mayos, M; Suarez-Cuartin, G; Gallardo, E; Illa, I; Diaz-Manera, J				Figueroa-Bonaparte, Sebastian; Segovia, Sonia; Llauger, Jaume; Belmonte, Izaskun; Pedrosa, Irene; Alejaldre, Aida; Mayos, Merce; Suarez-Cuartin, Guillermo; Gallardo, Eduard; Illa, Isabel; Diaz-Manera, Jordi		Spanish Pompe Study Grp	Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ENZYME REPLACEMENT THERAPY; ALGLUCOSIDASE ALPHA; INVOLVEMENT; PROGRESSION; MYOPATHIES; GUIDELINES; PATTERNS; DIXON; BOYS	Objectives Enzyme replacement therapy has shown to be effective for childhood/adult onset Pompe disease (AOPD). The discovery of biomarkers useful for monitoring disease progression is one of the priority research topics in Pompe disease. Muscle MRI could be one possible test but the correlation between muscle MRI and muscle strength and function has been only partially addressed so far. Methods We studied 34 AOPD patients using functional scales (Manual Research Council scale, hand held myometry, 6 minutes walking test, timed to up and go test, time to climb up and down 4 steps, time to walk 10 meters and Motor Function Measure 20 Scale), respiratory tests (Forced Vital Capacity seated and lying, Maximun Inspiratory Pressure and Maximum Expiratory Pressure), daily live activities scales (Activlim) and quality of life scales (Short Form-36 and Individualized Neuromuscular Quality of Life questionnaire). We performed a whole body muscle MRI using T1w and 3-point Dixon imaging centered on thighs and lower trunk region. Results T1w whole body muscle MRI showed a homogeneous pattern of muscle involvement that could also be found in pre-symptomatic individuals. We found a strong correlation between muscle strength, muscle functional scales and the degree of muscle fatty replacement in muscle MRI analyzed using T1w and 3-point Dixon imaging studies. Moreover, muscle MRI detected mild degree of fatty replacement in paraspinal muscles in pre-symptomatic patients. Conclusion Based on our findings, we consider that muscle MRI correlates with muscle function in patients with AOPD and could be useful for diagnosis and follow-up in pre-symptomatic and symptomatic patients under treatment. Take home message Muscle MRI correlates with muscle function in patients with AOPD and could be useful to follow-up patients in daily clinic.	[Figueroa-Bonaparte, Sebastian; Segovia, Sonia; Alejaldre, Aida; Gallardo, Eduard; Illa, Isabel; Diaz-Manera, Jordi] Univ Autonoma Barcelona, Neuromuscular Disorders Unit, Dept Neurol, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Figueroa-Bonaparte, Sebastian; Segovia, Sonia; Alejaldre, Aida; Gallardo, Eduard; Illa, Isabel; Diaz-Manera, Jordi] Ctr Invest Red Enfermedades Raras CIBERER, Madrid, Spain; [Llauger, Jaume] Univ Autonoma Barcelona, Dept Radiol, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Belmonte, Izaskun; Pedrosa, Irene] Univ Autonoma Barcelona, Rehabil & Physiotherapy Dept, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain; [Mayos, Merce; Suarez-Cuartin, Guillermo] Univ Autonoma Barcelona, Dept Resp Dis, Hosp Santa Creu & St Pau Barcelona, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona	Diaz-Manera, J (corresponding author), Univ Autonoma Barcelona, Neuromuscular Disorders Unit, Dept Neurol, Hosp Santa Creu & St Pau, E-08193 Barcelona, Spain.; Diaz-Manera, J (corresponding author), Ctr Invest Red Enfermedades Raras CIBERER, Madrid, Spain.	jdiazm@santpau.cat	ILLA, Isabel/AAD-1816-2019; Coll-Canti, Jaume/N-5591-2019; Coll-Canti, Jaume/N-6693-2015; IBIS, NEUROCIENCIAS/C-2262-2016; Moris, German/AAT-8916-2021; Suarez-Cuartin, Guillermo/AAA-8105-2019	Coll-Canti, Jaume/0000-0001-7128-1186; Coll-Canti, Jaume/0000-0001-7128-1186; Moris, German/0000-0001-7608-2194; Suarez-Cuartin, Guillermo/0000-0003-2320-6047; Barcena Llona, Jose Eulalio/0000-0002-7156-5960; Diaz-Manera, Jordi/0000-0003-2941-7988; Gallardo, Eduard/0000-0002-3942-3436	Genzyme; Spanish Ministry of Health [FISS PI15/01822]; Spanish Association of Patients with Glycogenosis	Genzyme(Sanofi-AventisGenzyme Corporation); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Association of Patients with Glycogenosis	This work was supported by a grant from Genzyme to JDM (https://clinicaltrials.gov/ct2/show/NCT914536?term=pompe+disease&rank=13) and a grant from the Spanish Ministry of Health, FISS PI15/01822 to JDM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Spanish Association of Patients with Glycogenosis (www.glucogenosis.org) for their support to our investigation. We thank Carolyn Newey for editorial support and Ignasi Gich for support with statistics. We thank Javier Sanchez Gonzalez and Paula Montesinos Suarez de la Vega from Philips HealthCare Iberia and Dr. Antoni Capdevila for the technical support with the MRI. We thank the MRI whole technician team Esther Alemany, Nieves Campillos, Elisenda Mestres, Eugenia Torres, Ricard Cullell, Alberto Fernandez and Mario Gonzalez for their patience and support with the study. We thank Lidia Gonzalez Quereda, from the Genetic department of Sant Pau Hospital, for reviewing genetic studies of all patients. We also thank Mrs. Concepcion Escold for her assistance during the visits of the study. This study was supported with a grant by GENZYME and a Grant from the Spanish Ministry of Health, FISS PI15/01822 to Dr. Jordi Diaz Manera.	Alejaldre A, 2012, NEUROMUSCULAR DISORD, V22, pS148, DOI 10.1016/j.nmd.2012.05.011; Arpan I, 2014, NEUROLOGY, V83, P974, DOI 10.1212/WNL.0000000000000775; Barba-Romero MA, 2012, REV NEUROLOGIA, V54, P497, DOI 10.33588/rn.5408.2012088; Bembi B, 2008, NEUROLOGY, V71, pS4, DOI 10.1212/WNL.0b013e31818da91e; Bonati U, 2015, NEUROMUSCULAR DISORD, V25, P679, DOI 10.1016/j.nmd.2015.05.006; Carlier PG, 2015, J INHERIT METAB DIS, V38, P565, DOI 10.1007/s10545-015-9825-9; Carlier RY, 2011, NEUROMUSCULAR DISORD, V21, P791, DOI 10.1016/j.nmd.2011.06.748; Cupler EJ, 2012, MUSCLE NERVE, V45, P319, DOI 10.1002/mus.22329; Diaz-Manera Jordi, 2015, Acta Myol, V34, P95; Diaz-Manera J, 2016, NEUROMUSCULAR DISORD, V26, P33, DOI 10.1016/j.nmd.2015.10.001; Fischer D, 2008, NEUROLOGY, V71, P758, DOI 10.1212/01.wnl.0000324927.28817.9b; Gruhn KM, 2015, MOLEC GENET METAB RE, V3, P58, DOI 10.1016/j.ymgmr.2015.03.010; Gungor D, 2016, J INHERIT METAB DIS, V39, P253, DOI 10.1007/s10545-015-9889-6; Gutieerrez-Rivas E, 2015, REV NEUROLOGIA, V60, P321, DOI 10.33588/rn.6007.2015029; Hollingsworth KG, 2014, NEUROLOGY, V83, P956, DOI 10.1212/WNL.0000000000000785; Horvath JJ, 2015, MUSCLE NERVE, V51, P722, DOI 10.1002/mus.24437; Ma JF, 2008, J MAGN RESON IMAGING, V28, P543, DOI 10.1002/jmri.21492; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Morrow JM, 2016, LANCET NEUROL, V15, P65, DOI 10.1016/S1474-4422(15)00242-2; Paradas C, 2010, NEUROLOGY, V75, P316, DOI 10.1212/WNL.0b013e3181ea1564; Pichiecchio A, 2009, MUSCLE NERVE, V40, P122, DOI 10.1002/mus.21304; Ravaglia S, 2010, J INHERIT METAB DIS, V33, P737, DOI 10.1007/s10545-010-9204-5; Straub Volker, 2012, Neuromuscul Disord, V22 Suppl 2, pS42, DOI 10.1016/j.nmd.2012.08.002; Thurberg BL, 2006, LAB INVEST, V86, P1208, DOI 10.1038/labinvest.3700484; Toscano A, 2013, J NEUROL, V260, P951, DOI 10.1007/s00415-012-6636-x; Udd B, 2012, NEUROMUSCULAR DISORD, V22, P5, DOI 10.1016/j.nmd.2011.10.003; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; van der Ploeg AT, 2012, MOL GENET METAB, V107, P456, DOI 10.1016/j.ymgme.2012.09.015; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; Wary C, 2015, NMR BIOMED, V28, P1150, DOI 10.1002/nbm.3352; Wokke BH, 2013, J MAGN RESON IMAGING, V38, P619, DOI 10.1002/jmri.23998; Wyatt K, 2012, HEALTH TECHNOL ASSES, V16, pV	32	37	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163493	10.1371/journal.pone.0163493	http://dx.doi.org/10.1371/journal.pone.0163493			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711114	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600028
J	Nasreen, S; Shokoohi, M; Malvankar-Mehta, MS				Nasreen, Sharifa; Shokoohi, Mostafa; Malvankar-Mehta, Monali S.			Prevalence of Latent Tuberculosis among Health Care Workers in High Burden Countries: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							GAMMA RELEASE ASSAYS; MYCOBACTERIUM-TUBERCULOSIS; MEDICAL-STUDENTS; NURSING PROFESSIONALS; RISK-FACTORS; INFECTION; DISEASE; STATE; CHINA; TESTS	Background Tuberculosis is one of the leading causes of death worldwide. Twenty-two high burden countries contributed to the majority of worldwide tuberculosis cases in 2015. Health care workers are at high risk of acquiring tuberculosis through occupational exposure. Objective To estimate the prevalence of latent tuberculosis infection (LTBI) among health care workers in high burden countries. Methods Databases including MEDLINE (Ovid), EMBASE (Ovid), CINAHL (Ovid) and ISI Web of Science (Thompson-Reuters), and grey literature were searched for English language records on relevant medical subject headings (MeSH) terms of LTBI and health care providers. Literature was systematically reviewed using EPPI-Reviewer4 software. Prevalence and incidence of LTBI and 95% confidence intervals (CI) were reported. Pooled prevalence of LTBI and 95% CI were calculated using random-effects meta-analysis models and heterogeneity was assessed using I 2 statistics. Sub-group analysis was conducted to assess the cause of heterogeneity. Results A total of 990 records were identified. Of those, 18 studies from only 7 high burden countries representing 10,078 subjects were included. Tuberculin skin test results were available for 9,545 participants. The pooled prevalence of LTBI was 47% (95% CI 34% to 60%, I-2 = 99.6%). In subgroup analyses according to the country of the study, the pooled prevalence of LTBI was lowest in Brazil (37%) and highest in South Africa (64%). The pooled prevalence of LTBI among medical and nursing students was 26% (95% CI 6% to 46%, I-2 = 99.3%) while the prevalence among all types of health care workers was 57% (95% CI 44% to 70%, I-2 = 99.1%). Incidence of LTBI was available for health care workers in four countries. The cumulative incidence ranged from 2.8% in Brazilian medical students to 38% among all types of health care workers in South Africa. Conclusion The findings of this study suggest that there is a high burden of LTBI among health care workers in high burden countries. Adequate infection control measures are warranted to prevent and control transmission in health care settings.	[Nasreen, Sharifa; Shokoohi, Mostafa; Malvankar-Mehta, Monali S.] Western Univ, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada; [Shokoohi, Mostafa] Kerman Univ Med Sci, Inst Futures Studies Hlth, HIV STI Surveillance Res Ctr, Kerman, Iran; [Shokoohi, Mostafa] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Malvankar-Mehta, Monali S.] Western Univ, Schulich Sch Med & Dent, Dept Ophthalmol, London, ON, Canada	Western University (University of Western Ontario); Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; Western University (University of Western Ontario)	Nasreen, S (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Epidemiol & Biostat, London, ON, Canada.	snasreen@uwo.ca		Nasreen, Sharifa/0000-0002-9793-113X; Shokoohi, Mostafa/0000-0002-3810-752X				Adams S, 2015, EUR RESPIR J, V45, P1364, DOI 10.1183/09031936.00138414; [Anonymous], 2014, Health and Science Bulletin, V12, P1; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Christopher DJ, 2014, INT J MYCOBACT, V3, P247, DOI 10.1016/j.ijmyco.2014.10.004; Christopher DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010408; Corbett EL, 2007, CLIN INFECT DIS, V44, P317, DOI 10.1086/509926; de Souza FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102773; Ehrlich RI, 2013, OCCUPATIONAL AND ENV, V70, pA57, DOI [10.1136/oemed-2013-101717.169, DOI 10.1136/OEMED-2013-101717.169]; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; dos Reis MCG, 2009, BRAZ J INFECT DIS, V13, P417, DOI 10.1590/S1413-86702009000600006; Teixeira EG, 2011, J HOSP INFECT, V77, P80, DOI 10.1016/j.jhin.2010.07.021; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; He GX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124097; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Hunter JP, 2014, J CLIN EPIDEMIOL, V67, P897, DOI 10.1016/j.jclinepi.2014.03.003; Joshi R, 2011, EUR RESPIR J, V38, P1475, DOI 10.1183/09031936.00014611; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kayanja HK, 2005, INT J TUBERC LUNG D, V9, P686; Lopes LKO, 2008, AM J INFECT CONTROL, V36, P148, DOI 10.1016/j.ajic.2007.01.013; McCarthy KM, 2015, INT J TUBERC LUNG D, V19, P647, DOI 10.5588/ijtld.14.0759; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; Miranda SS, 2012, REV MED CHILENA, V140, P1022, DOI DOI 10.4067/S0034-98872012000800008; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Munn Z, 2014, INT J HEALTH POLICY, V3, P123, DOI 10.15171/ijhpm.2014.71; Nasreen S, 2010, TROP MED INT HEALTH, V15, P762, DOI 10.1111/j.1365-3156.2010.02531.x; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2008, INT J TUBERC LUNG D, V12, P895; Severo KGP, 2011, J OCCUP MED TOXICOL, V6, DOI 10.1186/1745-6673-6-15; Rabahi MF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-148; Rafiza S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-19; Rogerio WP, 2013, CIENC SAUDE COLETIVA, V18, P1331, DOI 10.1590/S1413-81232013000500018; Seidler A, 2005, RESPIRATION, V72, P431, DOI 10.1159/000086261; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun LSL, 2015, PEDIATR PULM, V50, pS75; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Teixeira EG, 2005, INT J TUBERC LUNG D, V9, P841; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461; The World Bank, 2015, COUNTRY AND LENDING; Trajman A, 2013, PULM MED, V2013, DOI 10.1155/2013/601737; van Rie A, 2013, SAMJ S AFR MED J, V103, P853, DOI [10.7196/samj.7092, 10.7196/SAMJ.7092]; Wei Z, 2013, J HOSP INFECT, V84, P323, DOI 10.1016/j.jhin.2013.04.015; World Health Organization, 2013, WHOHTMTB201311; World Health Organization (WHO), 2015, GUIDELINES ON THE MA; Zhang LF, 2013, CHINESE MED J-PEKING, V126, P2039, DOI 10.3760/cma.j.issn.0366-6999.20130355; Zhou F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104673; Zwerling A, 2008, THE BCG WORLD ATLAS; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	49	45	48	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164034	10.1371/journal.pone.0164034	http://dx.doi.org/10.1371/journal.pone.0164034			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711155	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600067
J	Rouxel, RN; Merour, E; Biacchesi, S; Bremont, M				Rouxel, Ronan N.; Merour, Emilie; Biacchesi, Stephane; Bremont, Michel			Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines	PLOS ONE			English	Article							LIVE; GLYCOPROTEIN; STRATEGIES	Novirhabdoviruses like Viral Hemorrhagic Septicemia Virus (VHSV) and Infectious Hematopoietic Necrosis Virus (IHNV) are fish-infecting Rhabdoviruses belonging to the Mononegavirales order. By reverse genetics, we previously showed that a recombinant VHSV expressing the West Nile Virus (WNV) E glycoprotein could serve as a vaccine platform against WNV. In the current study, we aimed to evaluate the potential of the Novirhabdovirus platform as a vaccine against influenza virus. Recombinant Novirhabdoviruses, rVHSV-HA and rIHNV-HA, expressing at the viral surface the hemagglutinin HA ectodomain were generated and used to immunized mice. We showed that mice immunized with either, rVHSV-HA or rIHNV-HA, elicited a strong neutralizing antibody response against influenza virus. A complete protection was conferred to the immunized mice when challenged with a lethal dose of influenza H1N1 A/PR/8/34 virus. Furthermore we showed that although acting as inert antigen in mice, since naturally inactivated over 20 degrees C, mice immunized with rVHSV-HA or rIHNV-HA in the absence of adjuvant were also completely protected from a lethal challenge. Novirhabdoviruses platform are of particular interest as vaccines for mammals since they are cost effective to produce, relatively easy to generate and very effective to protect immunized animals.	[Rouxel, Ronan N.; Merour, Emilie; Biacchesi, Stephane; Bremont, Michel] Univ Paris Saclay, INRA, VIM, F-78350 Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bremont, M (corresponding author), Univ Paris Saclay, INRA, VIM, F-78350 Jouy En Josas, France.	michel.bremont@jouy.inra.fr	Biacchesi, Stephane/A-6924-2010	Biacchesi, Stephane/0000-0002-7020-2391; Rouxel, Ronan/0000-0003-1664-5615	ABIVAX France	ABIVAX France	Dr RN Rouxel has been financially supported by ABIVAX France.	Andrews NJ, 2011, VACCINE, V29, P7913, DOI 10.1016/j.vaccine.2011.08.076; Arkush KD, 2006, DIS AQUAT ORGAN, V69, P145, DOI 10.3354/dao069145; Biacchesi S, 2002, J VIROL, V76, P2881, DOI 10.1128/JVI.76.6.2881-2889.2002; Biacchesi S, 2000, J VIROL, V74, P11247, DOI 10.1128/JVI.74.23.11247-11253.2000; Biacchesi S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-12; Di Pasquale A, 2015, VACCINES-BASEL, V3, P320, DOI 10.3390/vaccines3020320; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fields B. N., 2007, FIELDS VIROLOGY; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Ghedin E., 2006, INFLUENZA A VIRUS A; Halder N, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-266; Jagt HJM, 2010, BIOLOGICALS, V38, P128, DOI 10.1016/j.biologicals.2009.07.006; Kiseleva I, 2012, VACCINE, V30, P7395, DOI 10.1016/j.vaccine.2012.09.076; MURPHY BR, 1988, J CLIN MICROBIOL, V26, P1595, DOI 10.1128/JCM.26.8.1595-1597.1988; Nunnally, 2015, VACCINE ANAL STRATEG, DOI 10.1007/978-3-662-45024-6; Nzonza A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091766; Orenstein V. P., 2012, VACCINES; Pliaka V, 2012, EXPERT REV VACCINES, V11, P609, DOI [10.1586/ERV.12.28, 10.1586/erv.12.28]; Ryder AB, 2016, J VIROL, V90, P2544, DOI 10.1128/JVI.02598-15; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P961, DOI 10.1016/j.jaci.2013.11.043; Sridhar S, 2015, VACCINES, V3, P373, DOI 10.3390/vaccines3020373; Stohr K, 2010, NATURE, V465, P161, DOI 10.1038/465161a; Sturkenboom MCJM, 2015, VACCINE, V33, pB6, DOI 10.1016/j.vaccine.2015.03.026; Tetsutani K, 2012, VACCINE, V30, P7658, DOI 10.1016/j.vaccine.2012.10.007; Treanor JJ, 2015, AM J PREV MED, V49, pS355, DOI 10.1016/j.amepre.2015.09.012; Vo NTK, 2015, J FISH DIS, V38, P121, DOI 10.1111/jfd.12208; Waddington CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2649; World Health Organization, 2013, GUID QUAL SAF EFF BI; Yewdell JW, 2010, MOL IMMUNOL, V47, P1132, DOI 10.1016/j.molimm.2009.10.023	32	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164245	10.1371/journal.pone.0164245	http://dx.doi.org/10.1371/journal.pone.0164245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711176	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600105
J	Roy, TK; Singh, BP				Roy, Tapan Kumar; Singh, Brijesh P.			Correlates of Unwanted Births in Bangladesh: A Study through Path Analysis	PLOS ONE			English	Article								Background Unwanted birth is an important public health concern due to its negative association with adverse outcomes of mothers and children as well as socioeconomic development of a country. Although a number of studies have been investigated the determinants of unwanted births through logistic regression analysis, an extensive assessment using path model is lacking. In the current study, we applied path analysis to know the important covariates for unwanted births in Bangladesh. Methods The study used data extracted from Bangladesh Demographic and Health Survey (BDHS) 2011. It considered sub-sample consisted of 7,972 women who had given most recent births five years preceding the date of interview or who were currently pregnant at survey time. Correlation analysis was used to find out the significant association with unwanted births. This study provided the factors affecting unwanted births in Bangladesh. The path model was used to determine the direct, indirect and total effects of socio-demographic factors on unwanted births. Results The result exhibited that more than one-tenth of the recent births were unwanted in Bangladesh. The differentials of unwanted births were women's age, education, age at marriage, religion, socioeconomic status, exposure of mass-media and use of family planning. In correlation analysis, it showed that unwanted births were positively correlated with women age and place of residence and these relationships were significant. On the contrary, unwanted births were inversely significantly correlated with education and social status. The total effects of endogenous variables such as women age, place of residence and use of family planning methods had favorable effect on unwanted births. Conclusion Policymakers and program planners need to design programs and services carefully to reduce unwanted births in Bangladesh, especially, service should focus on helping those groups of women who were identified in the analysis as being at increased risks of unwanted births-older women, illiterate, low socioeconomic status, early age at marriage and rural poor susceptible women.	[Roy, Tapan Kumar] Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh; [Singh, Brijesh P.] Banaras Hindu Univ, Fac Commerce, Varanasi 221005, Uttar Pradesh, India	University of Rajshahi; Banaras Hindu University (BHU)	Roy, TK (corresponding author), Rajshahi Univ, Dept Populat Sci & Human Resource Dev, Rajshahi 6205, Bangladesh.	roy.tapan@gmail.com						Abdallah IM, 2011, J AM SCI, V7, P497; Adhikari R, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-17; [Anonymous], STAT MODELS CAUSAL A; Bastola K, 2013, THESIS; Bradley SEK, 2011, DHS ANAL STUDIES; Brown S.S., 1995, BEST INTENTIONS UNIN; Chaterjee S., 2006, REGRESSION ANAL EXAM; Geda NR, 2011, GEOGRAPHY REGIONAL P, V4, P417; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Islam M, 2005, J FAM WELFARE, V53, P151; Khan M., 2004, INTRO EMERGENCY CONT; Nalenga G., 2012, CAUSES UNINTENDED PR; Nasab HS, 2010, WORLD APPL SCI J, V9, P199; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; Noor FR, 2012, Q COMMUNITY HLTH ED, V32, P101, DOI [10.2190/IQ.32.2.bPMID: 23000458, DOI 10.2190/IQ.32.2.B]; Omane-Adjepong M, 2012, AM INT J CONT RES, V2, P90; Pathak KB, 1996, BIOSTATISTICS MANNUA, P520; Rashid M, 2007, ANN M POP ASS AM PAA, P29; Sarkar P, 2009, J MOD MATH STAT, V3, P78; Tapan Kumar Roy, 2015, INT J RES EC SOCIAL, V5, P183; Tapan Kumar Roy, 2014, J SCI TECHNOL, V4, P1; World Health Organization (WHO), 2013, AD PREGN; WRIGHT S, 1960, BIOMETRICS, V16, P189, DOI 10.2307/2527551; Zare N., 2012, World Applied Sciences Journal, V20, P1063	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164007	10.1371/journal.pone.0164007	http://dx.doi.org/10.1371/journal.pone.0164007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711211	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600062
J	Scott, A; Noga, MJ; de Graaf, P; Westerlaken, I; Yildirim, E; Danelon, C				Scott, Andrew; Noga, Marek J.; de Graaf, Paul; Westerlaken, Ilja; Yildirim, Esengul; Danelon, Christophe			Cell-Free Phospholipid Biosynthesis by Gene-Encoded Enzymes Reconstituted in Liposomes	PLOS ONE			English	Article							PALMITOYL-COENZYME-A; ESCHERICHIA-COLI; SN-GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; MEMBRANE-PROTEINS; MINIMAL CELL; BACTERIA; ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; PURIFICATION	The goal of bottom-up synthetic biology culminates in the assembly of an entire cell from separate biological building blocks. One major challenge resides in the in vitro production and implementation of complex genetic and metabolic pathways that can support essential cellular functions. Here, we show that phospholipid biosynthesis, a multiple-step process involved in cell membrane homeostasis, can be reconstituted starting from the genes encoding for all necessary proteins. A total of eight E. coli enzymes for acyl transfer and headgroup modifications were produced in a cell-free gene expression system and were co-translationally reconstituted in liposomes. Acyl-coenzyme A and glycerol-3-phosphate were used as canonical precursors to generate a variety of important bacterial lipids. Moreover, this study demonstrates that two-step acyl transfer can occur from enzymes synthesized inside vesicles. Besides clear implications for growth and potentially division of a synthetic cell, we postulate that gene-based lipid biosynthesis can become instrumental for ex vivo and protein purification-free production of natural and non-natural lipids.	[Scott, Andrew; Noga, Marek J.; de Graaf, Paul; Westerlaken, Ilja; Yildirim, Esengul; Danelon, Christophe] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Maasweg 9, NL-2629 HZ Delft, Netherlands	Delft University of Technology	Danelon, C (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, Maasweg 9, NL-2629 HZ Delft, Netherlands.	c.j.a.danelon@tudelft.nl	Noga, Marek/O-4983-2016; Danelon, Christophe/AAW-5303-2021	Noga, Marek/0000-0001-8352-611X; Danelon, Christophe/0000-0002-0961-6640	Netherlands Organization for Scientific Research, VIDI-grant [723.012.007]; Natural Sciences and Engineering Research Council of Canada [PGSD3-404727-2011]	Netherlands Organization for Scientific Research, VIDI-grant; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by Netherlands Organization for Scientific Research (www.nwo.nl), VIDI-grant 723.012.007, to CD; and Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), grant-PGSD3-404727-2011, to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONDEL V, 1993, J BIOL CHEM, V268, P16002; Astarita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096221; Brea RJ, 2014, ANGEW CHEM INT EDIT, V53, P14102, DOI 10.1002/anie.201408538; Caschera F, 2014, CURR OPIN CHEM BIOL, V22, P85, DOI 10.1016/j.cbpa.2014.09.028; COLEMAN J, 1992, MOL GEN GENET, V232, P295, DOI 10.1007/BF00280009; CONSTANTINIDES PP, 1986, ARCH BIOCHEM BIOPHYS, V250, P267, DOI 10.1016/0003-9861(86)90726-5; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; de Souza TP, 2011, CHEMBIOCHEM, V12, P2325, DOI 10.1002/cbic.201100306; DEAMER DW, 1983, ANN NY ACAD SCI, V414, P90, DOI 10.1111/j.1749-6632.1983.tb31677.x; Dowhan W, 2013, BBA-MOL CELL BIOL L, V1831, P471, DOI 10.1016/j.bbalip.2012.08.007; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gonzalez-Covarrubias V, 2013, AGING CELL, V12, P426, DOI 10.1111/acel.12064; GREEN PR, 1981, J BIOL CHEM, V256, P1151; Hardy MD, 2015, P NATL ACAD SCI USA, V112, P8187, DOI 10.1073/pnas.1506704112; Junge F, 2011, NEW BIOTECHNOL, V28, P262, DOI 10.1016/j.nbt.2010.07.002; KESSELS JMM, 1983, BIOCHIM BIOPHYS ACTA, V753, P227, DOI 10.1016/0005-2760(83)90011-5; Kurihara K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9352; Kuruma Y, 2015, NAT PROTOC, V10, P1328, DOI 10.1038/nprot.2015.082; Kuruma Y, 2009, BBA-BIOMEMBRANES, V1788, P567, DOI 10.1016/j.bbamem.2008.10.017; LARSON TJ, 1980, J BIOL CHEM, V255, P9421; Leirer C, 2009, BIOPHYS CHEM, V143, P106, DOI 10.1016/j.bpc.2009.04.002; Luisi PL, 2006, NATURWISSENSCHAFTEN, V93, P1, DOI 10.1007/s00114-005-0056-z; Luisi PL, 2002, ANAT RECORD, V268, P208, DOI 10.1002/ar.10155; Mathiasen S, 2014, NAT METHODS, V11, P931, DOI [10.1038/nmeth.3062, 10.1038/NMETH.3062]; Matsubayashi H, 2014, ANGEW CHEM INT EDIT, V53, P7535, DOI 10.1002/anie.201403929; McFie PJ, 2011, J LIPID RES, V52, P1760, DOI 10.1194/jlr.D016626; Mercier R, 2013, CELL, V152, P997, DOI 10.1016/j.cell.2013.01.043; Noireaux V, 2011, P NATL ACAD SCI USA, V108, P3473, DOI 10.1073/pnas.1017075108; Nourian Zohreh, 2014, Syst Synth Biol, V8, P237, DOI 10.1007/s11693-014-9150-x; Nourian Z, 2013, ACS SYNTH BIOL, V2, P186, DOI 10.1021/sb300125z; Nourian Z, 2012, ANGEW CHEM INT EDIT, V51, P3114, DOI 10.1002/anie.201107123; REQUERO MA, 1995, BIOCHEMISTRY-US, V34, P10400, DOI 10.1021/bi00033a011; Rottig A, 2013, MICROBIOL MOL BIOL R, V77, P277, DOI 10.1128/MMBR.00010-13; Sachse R, 2014, FEBS LETT, V588, P2774, DOI 10.1016/j.febslet.2014.06.007; Sakuma Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.198101; SCHMIDLI PK, 1991, J AM CHEM SOC, V113, P8127, DOI 10.1021/ja00021a043; Schwille P, 2011, SCIENCE, V333, P1252, DOI 10.1126/science.1211701; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Siegel D, 2013, J CHROMATOGR A, V1294, P87, DOI 10.1016/j.chroma.2013.04.029; Sohlenkamp C, 2016, FEMS MICROBIOL REV, V40, P133, DOI 10.1093/femsre/fuv008; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tsumoto K, 2009, COLLOID SURFACE B, V68, P98, DOI 10.1016/j.colsurfb.2008.09.023; VARELA F G, 1974, Biosystems, V5, P187, DOI 10.1016/0303-2647(74)90031-8; Wick R, 1996, CHEM BIOL, V3, P277, DOI 10.1016/S1074-5521(96)90107-6; WILKISON WO, 1986, J BIOL CHEM, V261, P9951; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; Yu XY, 2011, P NATL ACAD SCI USA, V108, P18643, DOI 10.1073/pnas.1110852108; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	50	60	60	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163058	10.1371/journal.pone.0163058	http://dx.doi.org/10.1371/journal.pone.0163058			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711229	Green Published, gold			2022-12-27	WOS:000385697600012
J	Chen, F; Su, WQ; Becker, SH; Payne, M; Sweet, CMC; Peters, AL; Dall, TM				Chen, Fang; Su, Wenqing; Becker, Shawn H.; Payne, Mike; Sweet, Cynthia M. Castro; Peters, Anne L.; Dall, Timothy M.			Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; LIFE-STYLE INTERVENTION; PREVENTION PROGRAM; WEIGHT-LOSS; VALIDATION; PREDICTION; OUTCOMES; ADULTS	Background Type 2 diabetes and cardiovascular disease impose substantial clinical and economic burdens for seniors (age 65 and above) and the Medicare program. Intensive Behavioral Counseling (IBC) interventions like the National Diabetes Prevention Program (NDPP), have demonstrated effectiveness in reducing excess body weight and lowering or delaying morbidity onset. This paper estimated the potential health implications and medical savings of a digital version of IBC modeled after the NDPP. Methods and Findings Participants in this digital IBC intervention, the Omada program, include 1,121 overweight or obese seniors with additional risk factors for diabetes or heart disease. Weight changes were objectively measured via participant use of a networked weight scale. Participants averaged 6.8% reduction in body weight within 26 weeks, and 89% of participants completed 9 or more of the 16 core phase lessons. We used a Markov-based microsimulation model to simulate the impact of weight loss on future health states and medical expenditures over 10 years. Cumulative per capita medical expenditure savings over 3, 5 and 10 years ranged from $1,720 to 1,770 (3 years), $3,840 to $4,240 (5 years) and $11,550 to $14,200 (10 years). The range reflects assumptions of weight re-gain similar to that seen in the DPP clinical trial (lower bound) or minimal weight re-gain aligned with age-adjusted national averages (upper bound). The estimated net economic benefit after IBC costs is $10,250 to $12,840 cumulative over 10 years. Simulation outcomes suggest reduced incidence of diabetes by 27-41% for participants with prediabetes, and stroke by approximately 15% over 5 years. Conclusions A digital, remotely-delivered IBC program can help seniors at risk for diabetes and cardiovascular disease achieve significant weight loss, reduces risk for diabetes and cardiovascular disease, and achieve meaningful medical cost savings. These findings affirm recommendations for IBC coverage by the U.S. Preventive Services Task Force.	[Chen, Fang; Su, Wenqing; Dall, Timothy M.] IHS Life Sci, Washington, DC 98133 USA; [Becker, Shawn H.] Silvercat Advisors LLC, Burlingame, CA USA; [Payne, Mike; Sweet, Cynthia M. Castro] Omada Hlth Inc, San Francisco, CA USA; [Peters, Anne L.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Chen, F (corresponding author), IHS Life Sci, Washington, DC 98133 USA.	frank.chen@ihs.com		Castro Sweet, Cynthia/0000-0001-6860-4095; Peters, Anne/0000-0003-0520-0776	Omada Health, Inc	Omada Health, Inc	Funding for this study was provided by Omada Health, Inc, who provided raw data for analysis and participated in preparation of this manuscript. M.P. and C.M.C.S. are employees of the study sponsor. F.C., W.S., T.M.D., and S.H.B. provide paid consulting services to the study sponsor for this and other research. A.L.P. reports no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article. The study sponsor approved the study design developed by T.M.D., F. C., and W.S. Data provided by study sponsor was analyzed solely by F.C. All authors of this manuscript, with the exception of Dr. Anne L. Peters, contributed to interpretation of study findings and draft of the manuscript. A.L.P. provided critical comments to the intellectual content of manuscript.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Centers for Disease Control, 2020, NATL DIABETES STAT R; Centers for Disease Control and Prevention, 2015, CTR DIS CONTR PREV D; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Congressional Budget Office, 2015, MARCH 2015 MED BAS; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dall TM, 2015, AM J PREV MED, V48, P271, DOI 10.1016/j.amepre.2014.10.003; Faes C, 2011, J ANTIMICROB CHEMOTH, V66, P89, DOI 10.1093/jac/dkr461; Felix HC, 2013, AM J HEALTH PROMOT, V27, P191, DOI 10.4278/ajhp.110617-LIT-259; Gadde KM, 2011, LANCET, V377, P1341, DOI 10.1016/S0140-6736(11)60205-5; Heianza Y, 2012, DIABETES CARE, V35, P1050, DOI 10.2337/dc11-1793; Hippisley-Cox J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-49; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; Kaiser Family Foundation, 2014, MUCH IS EN OUT OF SP; Kannel W.B., 1987, FRAMINGHAM STUDY EPI; KANNEL WB, 1998, AM J CARDIOL, V0082; Kitzman DW, 2016, JAMA-J AM MED ASSOC, V315, P36, DOI 10.1001/jama.2015.17346; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; McGill HC, 1998, AM J CARDIOL, V82, p30T; Moin T, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4332; Nathan DM, 2015, LANCET DIABETES ENDO, V3, P866, DOI 10.1016/S2213-8587(15)00291-0; National Cancer Institute, 2011, ANN MEAN NET COSTS C; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Odden MC, 2011, AM J MED, V124, P827, DOI 10.1016/j.amjmed.2011.04.010; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Semilla AP, 2015, AM J MANAG CARE, V21, pS165; Sepah SC, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4052; Sepah SC, 2014, DIABETES EDUCATOR, V40, P435, DOI 10.1177/0145721714531339; Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345; Su W, 2015, J MED ECON, V18, P886, DOI 10.3111/13696998.2015.1058805; Su WQ, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150357; Sumamo E, 2014, LIFESTYLE INTERVENTI; Thorpe KE, 2013, HEALTH ECON REV, V3, DOI 10.1186/2191-1991-3-7; Wilson PWF, 2008, CIRCULATION, V118, P124, DOI 10.1161/CIRCULATIONAHA.108.772962; WILSON PWF, 1994, J GERONTOL, V49, pM252, DOI 10.1093/geronj/49.6.M252; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334	39	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163627	10.1371/journal.pone.0163627	http://dx.doi.org/10.1371/journal.pone.0163627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706216	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200051
J	Diaz, AH; Kovacs, I; Lindermayr, C				Diaz, Areli Herrera; Kovacs, Izabella; Lindermayr, Christian			Inducible Expression of the De-Novo Designed Antimicrobial Peptide SP1-1 in Tomato Confers Resistance to Xanthomonas campestris pv. vesicatoria	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; PATHOGEN-INDUCED EXPRESSION; DNA-BINDING; STAPHYLOCOCCUS-AUREUS; DISEASE RESISTANCE; CECROPIN-B; GENE; ARABIDOPSIS; PLANTS; SYSTEM	Antimicrobial peptides (AMPs) are small peptides with less than 50 amino acids and are part of the innate immune response in almost all organisms, including bacteria, vertebrates, invertebrates and plants. AMPs are active against a broad-spectrum of pathogens. The inducible expression of AMPs in plants is a promising approach to combat plant pathogens with minimal negative side effects, such as phytotoxicity or infertility. In this study, inducible expression of the de-novo designed AMP SP1-1 in Micro Tom tomato protected tomato fruits against bacterial spot disease caused by Xanthomonas campestris pv. vesicatoria. The peptide SP1-1 was targeted to the apoplast which is the primary infection site for plant pathogens, by fusing SP1-1 peptide to the signal peptide RsAFP1 of radish (Raphanus sativus). The pathogen inducibility of the expression was enabled by using an optimized inducible 4XW2/4XS promoter. As a result, the tomato fruits of independently generated SP1-1 transgenic lines were significantly more resistant to X. campestris pv. vesicatoria than WT tomato fruits. In transgenic lines, bacterial infection was reduced up to 65% in comparison to the infection of WT plants. Our study demonstrates that the combination of the 4XW2/4XS cis-element from parsley with the synthetic antimicrobial peptide SP1-1 is a good alternative to protect tomato fruits against infections with X. campestris pv. vesicatoria.	[Diaz, Areli Herrera; Kovacs, Izabella; Lindermayr, Christian] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biochem Plant Pathol, D-85764 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lindermayr, C (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Biochem Plant Pathol, D-85764 Munich, Germany.	lindermayr@helmholtz-muenchen.de			Bundesministerium fur Bildung and Forschung	Bundesministerium fur Bildung and Forschung(Federal Ministry of Education & Research (BMBF))	This work was funded by Bundesministerium fur Bildung and Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Salazar-Gonzalez JA, 2014, MOL BIOTECHNOL, V56, P1133, DOI 10.1007/s12033-014-9793-6; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Brand LH, 2013, NUCLEIC ACIDS RES, V41, P9764, DOI 10.1093/nar/gkt732; Brouwer CPJM, 2006, PEPTIDES, V27, P2585, DOI 10.1016/j.peptides.2006.05.022; Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; CLARK DP, 1994, J BIOL CHEM, V269, P10849; Company N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109990; Cortina C, 2004, PLANT CELL TISS ORG, V76, P269, DOI 10.1023/B:TICU.0000009249.14051.77; Dan YH, 2006, PLANT CELL REP, V25, P432, DOI 10.1007/s00299-005-0084-3; Dangel A, 2013, FASEB J, V27, P4476, DOI 10.1096/fj.13-234575; Datta A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11951; FILLATTI JJ, 1987, BIO-TECHNOL, V5, P726, DOI 10.1038/nbt0787-726; FLORACK D, 1995, TRANSGENIC RES, V4, P132, DOI 10.1007/BF01969415; Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353; Hahn Matthias, 2014, Journal of Chemical Biology, V7, P133, DOI 10.1007/s12154-014-0113-1; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; HIGHTOWER R, 1994, PLANT CELL REP, V13, P295, DOI 10.1007/BF00233324; Jan PS, 2010, APPL ENVIRON MICROB, V76, P769, DOI 10.1128/AEM.00698-09; Jindal HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128532; Kirsch C, 2000, MOL PLANT PATHOL, V1, P243, DOI 10.1046/j.1364-3703.2000.00029.x; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; Kruszewska D, 2004, J ANTIMICROB CHEMOTH, V54, P648, DOI 10.1093/jac/dkh387; Lacerda ALM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136820; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Lucca P, 2001, MOL BREEDING, V7, P43, DOI 10.1023/A:1009661014167; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Marti E, 2006, J EXP BOT, V57, P2037, DOI 10.1093/jxb/erj154; Nadal A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-159; Nan YH, 2009, FEMS MICROBIOL LETT, V292, P134, DOI 10.1111/j.1574-6968.2008.01484.x; Oard SV, 2006, PLANT CELL REP, V25, P561, DOI 10.1007/s00299-005-0102-5; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Piquerez SJM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00671; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; Rushton PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/tpc.010412; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Shokouhifar F, 2011, IRAN J BIOTECHNOL, V9, P1; Soria-Guerra RE, 2007, PLANT CELL REP, V26, P961, DOI 10.1007/s00299-007-0306-y; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Wang GS, 2015, PHARMACEUTICALS-BASE, V8, P123, DOI 10.3390/ph8010123; Wang GS, 2015, METHODS MOL BIOL, V1268, P43, DOI 10.1007/978-1-4939-2285-7_3; Wu TQ, 2013, GENE, V527, P235, DOI 10.1016/j.gene.2013.06.037; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yang LT, 2005, J AGR FOOD CHEM, V53, P183, DOI 10.1021/jf0493730; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yevtushenko DP, 2007, PLANT BIOTECHNOL J, V5, P720, DOI 10.1111/j.1467-7652.2007.00277.x; Yevtushenko DP, 2005, J EXP BOT, V56, P1685, DOI 10.1093/jxb/eri165; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zeitler B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071687; Zeitler B, 2013, PLANT MOL BIOL, V81, P259, DOI 10.1007/s11103-012-9996-9	54	4	4	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164097	10.1371/journal.pone.0164097	http://dx.doi.org/10.1371/journal.pone.0164097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706237	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697200083
J	Hadjipanayis, A; Efstathiou, E; Alexandrou, M; Panayiotou, L; Zachariadou, C; Petrou, P; Papaevangelou, V				Hadjipanayis, Adamos; Efstathiou, Elisavet; Alexandrou, Maria; Panayiotou, Loukia; Zachariadou, Chrystalla; Petrou, Panayiotis; Papaevangelou, Vasiliki			Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE CARRIAGE; RESPIRATORY-TRACT INFECTIONS; CONJUGATE VACCINE; SEROGROUP 15; DAY-CARE; IMPACT; COLONIZATION; SEROTYPES; DISEASE; 19A	The objective of the study was to describe the incidence of pneumococcal nasopharyngeal carriage, serotype distribution and antibiotic resistance profile of pneumococcal nasopharyngeal isolates in healthy children aged 6 to 36 months following the implementation of conjugate vaccines. A nasopharyngeal swab was collected from 1105 healthy children following a stratified random sampling between September 2013 and April 2014. Demographics, vaccination status and data on possible risk factors were recorded. Isolates were serotyped and tested for antibiotic susceptibility. The nasopharyngeal carriage rate was 25.3%. Among 1105 children enrolled, 393 had received PCV13 and 685 PCV10. The prevailing isolated serotypes were: 23A (14.3%), 15A (8.9%), 6C (8.6%), 23B (7.5%), 19A (5.4%) and 15B (5%). The proportion of non-vaccine serotypes, PCV10 serotypes, PCV13 additional serotypes (3, 6A, 19A) was 76.8%, 2.1% and 10.4% respectively. Although children, who were fully or partially vaccinated with PCV13, were 63% less likely to be colonized with additional PCV13 serotypes compared to those vaccinated with PCV10, the difference is not significant (95%CI = 0.14-1.02, p = 0.053). The highest antibiotic non-susceptible rates were found for erythromycin (28.2%) and penicillin (27.9%). The overall multidrug resistance rate was 13.2%, with serotypes 24F (4/6), 15A (14/25) and 19A (6/15) being the main contributors. Carriage rate was similar between children vaccinated with PCV10 or PCV13. The high incidence of 15A serotype which is also multidrug resistant should be underlined. Ongoing surveillance is needed to monitor the dynamics on nasopharyngeal carriage.	[Hadjipanayis, Adamos; Efstathiou, Elisavet] Larnaca Gen Hosp, Dept Paediat, Larnax, Cyprus; [Hadjipanayis, Adamos] European Univ, Sch Med, 6 Diogenis St, CY-1516 Nicosia, Cyprus; [Alexandrou, Maria; Panayiotou, Loukia; Zachariadou, Chrystalla; Petrou, Panayiotis] Larnaca Gen Hosp, Microbiol Lab, Larnax, Cyprus; [Papaevangelou, Vasiliki] Natl & Kapodistrian Univ Athens, Gen Univ Hosp ATTIKON, Dept Paediat 3, Athens, Greece	Lefke Avrupa University; National & Kapodistrian University of Athens; University Hospital Attikon	Hadjipanayis, A (corresponding author), Larnaca Gen Hosp, Dept Paediat, Larnax, Cyprus.; Hadjipanayis, A (corresponding author), European Univ, Sch Med, 6 Diogenis St, CY-1516 Nicosia, Cyprus.	adamos@paidiatros.com	Hadjipanayis, Adamos/M-6102-2016	Hadjipanayis, Adamos/0000-0003-4337-3176	GSK, Cyprus	GSK, Cyprus	Part of serotype antisera was granted by GSK, Cyprus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abat C, 2015, EUR J CLIN MICROBIOL, V34, P2081, DOI 10.1007/s10096-015-2455-1; Abramson JS, 2000, PEDIATRICS, V106, P362; Ahn JG, 2015, INFECT DIS-NOR, V47, P385, DOI 10.3109/00365548.2014.1001997; Ben-Shimol S, 2015, CLIN INFECT DIS, V60, P1384, DOI 10.1093/cid/civ023; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Camilli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076309; Clinical and Laboratory Standards Institute (CLSI), 2021, M100ED31 CLSI; Cohen R, 2012, ARCH PEDIATRIE, V19, P1132, DOI 10.1016/j.arcped.2012.07.013; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Cyprus Paediatric Society, 2011, VACC SCHED CHILDR; Dunais B, 2011, EUR J CLIN MICROBIOL, V30, P837, DOI 10.1007/s10096-011-1154-9; Dunais B, 2015, PEDIATR INFECT DIS J, V34, P286, DOI 10.1097/INF.0000000000000559; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Frazao N, 2005, PEDIATR INFECT DIS J, V24, P243, DOI 10.1097/01.inf.0000154326.77617.3e; Garcia-Vera C, 2011, MED CLIN-BARCELONA, V137, P1, DOI 10.1016/j.medcli.2010.09.051; Gounder PP, 2014, J INFECT DIS, V209, P1251, DOI 10.1093/infdis/jit642; Grant LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074906; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Ho PL, 2015, DIAGN MICR INFEC DIS, V81, P145, DOI 10.1016/j.diagmicrobio.2014.11.006; Hsieh YC, 2012, PEDIATR INFECT DIS J, V31, pE163, DOI 10.1097/INF.0b013e31825cb9f9; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Jacobs MR, 2008, CLIN INFECT DIS, V47, P1388, DOI 10.1086/592972; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kaltoft MS, 2008, J MICROBIOL METH, V75, P540, DOI 10.1016/j.mimet.2008.08.010; Lee GM, 2014, J PEDIATR INFECT DIS, V3, P23, DOI 10.1093/jpids/pit057; Lehmann D, 1997, PEDIATR INFECT DIS J, V16, P297, DOI 10.1097/00006454-199703000-00009; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Maraki S, 2010, EUR J CLIN MICROBIOL, V29, P1449, DOI 10.1007/s10096-010-1005-0; Martinelli Domenico, 2014, Hum Vaccin Immunother, V10, P33, DOI 10.4161/hv.26650; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Ozawa D, 2015, PEDIATR INFECT DIS J, V34, pE217, DOI 10.1097/INF.0000000000000776; Park SY, 2008, PEDIATR INFECT DIS J, V27, P335, DOI 10.1097/INF.0b013e318161434d; Pavia M, 2009, PEDIATRICS, V123, pE1103, DOI 10.1542/peds.2008-3422; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Reinert RR, 2010, VACCINE, V28, P4249, DOI 10.1016/j.vaccine.2010.04.020; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; Richter SS, 2013, EMERG INFECT DIS, V19, P1074, DOI 10.3201/eid1907.121830; Ricketson LJ, 2014, PEDIATR INFECT DIS J, V33, P724, DOI 10.1097/INF.0000000000000267; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Schutze GE, 2004, PEDIATR INFECT DIS J, V23, P1125, DOI 10.1097/01.inf.0000145478.36236.1e; Torres A, 2015, EUR J CLIN MICROBIOL, V34, P19, DOI 10.1007/s10096-014-2208-6; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Zuccotti G, 2014, VACCINE, V32, P527, DOI 10.1016/j.vaccine.2013.12.003	45	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163269	10.1371/journal.pone.0163269	http://dx.doi.org/10.1371/journal.pone.0163269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706247	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697200036
J	Feng, QM; Liu, SL; Yang, L; Xie, MX; Zhang, Q				Feng, Qingmin; Liu, Shenglin; Yang, Lei; Xie, Mingxing; Zhang, Qiang			The Prevalence of and Risk Factors Associated with Musculoskeletal Disorders among Sonographers in Central China: A Cross-Sectional Study	PLOS ONE			English	Article							CUMULATIVE TRAUMA DISORDERS; REPETITIVE STRAIN INJURIES; CARPAL-TUNNEL-SYNDROME; OFFICE WORKERS; SYMPTOMS; HAND; PAIN; PREVENTION; COMPLAINTS; VALUES	Objective Studies from industrialized countries show that musculoskeletal disorders (MSD) occur commonly in sonographers. However, little is known about sonographers in China, where the awareness of ergonomics and MSD, workload, and available equipment/facilities may differ. We aimed to investigate the prevalence of MSD and associated risk factors in sonographers in central China. Methods A cross-sectional survey was conducted with 381 sonographers from 14 randomly selected tertiary hospitals in Hubei province, central China. Musculoskeletal symptoms (using the Nordic Questionnaire) and risk factors (mostly derived from the Health Benefit Trust survey instrument and the Dutch Musculoskeletal Questionnaire) were recorded. Multivariate logistic regression was used to quantify associations between risk factors and MSD. Results The 12-month period prevalence of MSD was 98.3%, being highest in the neck (93.5%) and shoulder (92.2%), followed by the lower back (83.2%), wrist/hand, upper back, and elbow. Factors contributing to neck pain were psychological fatigue, shoulder abduction and trunk bend-and-twist posture. Height-adjustable tables and chairs were protective factors. Shoulder pain was associated with female sex, health status, mental stress, shoulder abduction, and trunk bend-and-twist posture. Height-adjustable chairs and the awareness of adjusting the workstation before scanning were protective factors. Elbow pain was associated with health status and height-adjustable tables. Wrist/hand pain was associated with female sex, bending the wrist, and working with obese patients. Upper back pain was associated with shoulder abduction, height-adjustable chairs, and device location. Lower back pain was associated with the number of scans performed per day, awkward postures, bending the trunk, twisting or bending the neck forward, and using a footrest. Conclusions This study suggests a high prevalence of MSD in sonographers in central China. Hence, it is necessary to improve the awareness of MSD by training, and the ergonomics of their current work environment by addressing physical workload, and psychological and equipment/facility-related factors.	[Feng, Qingmin; Liu, Shenglin; Zhang, Qiang] Huazhong Univ Sci & Technol, Union Hosp, Dept Med Engn, Tongji Med Coll, 1277 JieFang Ave, Wuhan 430022, Peoples R China; [Feng, Qingmin; Liu, Shenglin; Zhang, Qiang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Healthcare Ergon Lab, 1277 JieFang Ave, Wuhan 430022, Peoples R China; [Yang, Lei] Huazhong Univ Sci & Technol, Dept Occupat & Environm Hlth, Tongji Med Coll, 13 HangKong Rd, Wuhan 430030, Peoples R China; [Xie, Mingxing] Huazhong Univ Sci & Technol, Union Hosp, Dept Med Ultrasound, Tongji Med Coll, 1277 JieFang Ave, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, Q (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Med Engn, Tongji Med Coll, 1277 JieFang Ave, Wuhan 430022, Peoples R China.; Zhang, Q (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Healthcare Ergon Lab, 1277 JieFang Ave, Wuhan 430022, Peoples R China.	whuhcce@163.com		Xie, Mingxing/0000-0003-4984-1567				[Anonymous], 2011, JOINT BONE SPINE, DOI DOI 10.1016/j.jbspin.2011.01.014; ARMSTRONG TJ, 1987, J HAND SURG-AM, V12A, P830, DOI 10.1016/S0363-5023(87)80244-7; ASHBURY FD, 1995, J OCCUP ENVIRON MED, V37, P479, DOI 10.1097/00043764-199504000-00021; Baker JP, 2013, J ULTRAS MED, V32, P1363, DOI 10.7863/ultra.32.8.1363; Bastian EJ, 2009, J DIAGN MED SONOG, V25, P25, DOI 10.1177/8756479308327060; Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8; Bolton GC, 2015, J CLIN ULTRASOUND, V43, P145, DOI 10.1002/jcu.22216; Bureau Of Labour Protection Ministry Of Labour, 1988, 1000088 GB BUR LAB P, P17; Cagnie B, 2007, EUR SPINE J, V16, P679, DOI 10.1007/s00586-006-0269-7; Caillard J, 2000, P HUM FACT ERG SOC A, V44, DOI [10.1177/154193120004403144, DOI 10.1177/154193120004403144]; Carson R, 1994, AAOHN J, V42, P270; Cattell G, 2002, SYNERGY, P7; Cho CY, 2012, J MANIP PHYSIOL THER, V35, P534, DOI 10.1016/j.jmpt.2012.07.004; Claes F, 2015, HUM FACTORS, V57, P238, DOI 10.1177/0018720814547872; Coffin C.T., 2014, REP MED IMAG, V7, P15, DOI [10.2147/rmi.s34724, DOI 10.2147/RMI.S34724, 10.2147/RMI.S34724]; Danuser B, 2014, CONT ERGONOMICS, P69; Du Wei-wei, 2012, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V30, P335; Eatough EM, 2012, APPL ERGON, V43, P554, DOI 10.1016/j.apergo.2011.08.009; European Agency of Safety andHealthatWork., 2008, WORK RELATED MUSCULO; Evans K, 2009, J DIAGN MED SONOG, V25, P287, DOI 10.1177/8756479309351748; Faragher EB, 2005, OCCUP ENVIRON MED, V62, P105, DOI 10.1136/oem.2002.006734; Feather C, 2001, SYNERGY; Feng BB, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006451; Gobba Fabriziomaria, 2010, G Ital Med Lav Ergon, V32, P223; Hallman DM, 2015, INT ARCH OCC ENV HEA, V88, P1031, DOI 10.1007/s00420-015-1031-4; Hildebrandt VH, 2001, ERGONOMICS, V44, P1038, DOI 10.1080/00140130110087437; Hill JJ, 2009, WORK, V33, P181, DOI 10.3233/WOR-2009-0865; Hoe VCW, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008570.pub2; Janga D, 2012, ARCH GYNECOL OBSTET, V286, P353, DOI 10.1007/s00404-012-2306-6; Kim T, 2014, J PHYS THER SCI, V26, P1423, DOI 10.1589/jpts.26.1423; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Li JY, 2012, BIOMED ENVIRON SCI, V25, P421, DOI 10.3967/0895-3988.2012.04.007; Liang BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070423; McDiarmid M, 2000, ENVIRON RES, V83, P23, DOI 10.1006/enrs.2000.4042; McGregor R, 2009, RADIOGRAPHY, V15, P313, DOI 10.1016/j.radi.2009.07.006; Morton B, 2008, RADIOGRAPHY, V14, P195, DOI 10.1016/j.radi.2007.02.004; National Health and Family Commission, 2015, 2014 REP CHIN RES CH; National Health and Family Commission, 2013, CHINA HLTH FAM PLANN; National Health and Family Commission, 2015, CHIN STAT YB 2015; National Institute for Occupational Safety and Health, 2006, PREV WORK REL MUSC O; Oldervoll LM, 2001, J REHABIL MED, V33, P156, DOI 10.1080/165019701750300618; Pike I., 1997, J DIAGN MED SONOGR, V13, P219, DOI DOI 10.1177/875647939701300501; REMPEL DM, 1992, JAMA-J AM MED ASSOC, V267, P838, DOI 10.1001/jama.267.6.838; Roll SC, 2012, ANAL OCCUPATIONAL FA, P355; Rousseau T, 2013, J ULTRAS MED, V32, P157; Russo A, 2002, APPL ERGON, V33, P385, DOI 10.1016/S0003-6870(02)00038-8; Schoenfeld A, 1999, Eur J Ultrasound, V10, P41, DOI 10.1016/S0929-8266(99)00031-2; Seto E, 2008, J DIAGN MED SONOG, V24, P127, DOI 10.1177/8756479308315230; Sikorski J M, 1988, Aust Fam Physician, V17, P81; SILVERSTEIN BA, 1986, BRIT J IND MED, V43, P779; Smith AC, 1997, J AM SOC ECHOCARDIOG, V10, P357, DOI 10.1016/S0894-7317(97)70073-7; Smith DR, 2006, INT J IND ERGONOM, V36, P599, DOI 10.1016/j.ergon.2006.01.014; Smith DR, 2004, OCCUP MED-OXFORD, V54, P579, DOI 10.1093/occmed/kqh117; Smith DR, 2004, J PROF NURS, V20, P390, DOI 10.1016/j.profnurs.2004.08.002; Suzuki H, 2013, J MED ULTRASON, V40, P189, DOI 10.1007/s10396-012-0415-2; Szeto GPY, 2009, J OCCUP REHABIL, V19, P175, DOI 10.1007/s10926-009-9176-1; Tzschatzsch H, 2015, ULTRASOUND MED BIOL, V41, P724, DOI 10.1016/j.ultrasmedbio.2014.11.009; VANDERPOOL HE, 1993, J OCCUP ENVIRON MED, V35, P604, DOI 10.1097/00043764-199306000-00018; Wihlidal LM, 1997, INT J IND ERGONOM, V19, P205, DOI 10.1016/S0169-8141(95)00107-7; Xu Lei, 2011, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V29, P180; Yang L, 2009, IND HLTH OCCUPATIONA, P25; Yu SF, 2012, AM J IND MED, V55, P281, DOI 10.1002/ajim.21037; Yuan Y, 2014, CHINESE MED EQUIPMEN; Yue P, 2014, OCCUP MED-OXFORD, V64, P211, DOI 10.1093/occmed/kqu008; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	65	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163903	10.1371/journal.pone.0163903	http://dx.doi.org/10.1371/journal.pone.0163903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ0TR	27695095	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100063
J	Jernas, L; Wencel, J; Wiak, A; Bieniek, M; Bartosik-Psujek, H				Jernas, Lukasz; Wencel, Jacek; Wiak, Andrzej; Bieniek, Marek; Bartosik-Psujek, Halina			Risk Factors for Poor Adherence to Betaferon (R) Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome	PLOS ONE			English	Article							PLACEBO-CONTROLLED PHASE-3; INTERFERON-BETA THERAPY; BRAIN ATROPHY; ORAL BG-12; GLATIRAMER; EFFICACY; MS; TERIFLUNOMIDE; CONVERSION; DEFINITE	Introduction Adherence to treatment, including early treatment discontinuation, in patients with multiple sclerosis or clinically isolated syndrome can be affected by: treatment tolerability, route of drug administration, patient age, disease duration, comorbidities, medical care, and support from their caregivers. Aim This study aimed to identify the risk factors for poor adherence to Betaferon 1 treatment, including early discontinuation and omitting doses. Materials and Methods 852 adult patients treated with Betaferon participated in this 24-month study. All patients were interviewed using the Risk of Drop-out Questionnaire, the Center for Epidemiologic Studies Depression Scale and the Kurtzke Expanded Disability Status Scale. Results Patients who stopped therapy were younger (p = 0.003) had a higher mean EDSS score (p = 0.022), higher mean number of relapses (p = 0.017), and reported more often fear of injection (p = 0.027) and adverse events (p = 0.007) than those who did not stop treatment. Comparing patients who stopped therapy in the first and the second year, patients who stopped therapy in the first year of treatment more frequently reported flu-like symptoms and fever, and those who stopped therapy in the second year reported-ineffectiveness of treatment and disease progression. Multivariable logistic regression models confirmed that young age, short disease duration, advanced and progressing disease, and poor Betaferon tolerability were related to premature treatment discontinuation. The risk of omitting a dose during therapy was increased in patients who were working or studying, who had more advanced disease or more adverse events, and in patients who received less support from their caregivers. Conclusions Several reasons may lead to problems with adherence to Betaferon treatment. Patients at higher risk of discontinuing treatment need to be identified early to make caregivers' support available to them.	[Jernas, Lukasz] Poznan Univ Med Sci, Dept Neurol, Poznan, Poland; [Wencel, Jacek] L Bierkowski Minist Internal Affairs, Dept Neurolofy, Poznan, Poland; [Wencel, Jacek] Adm Hlth Care Ctr Poznan, Poznan, Poland; [Wiak, Andrzej] 4th Mil Clin Hosp Wroclaw, Dept Neurol, Wroclaw, Poland; [Bieniek, Marek] Bayer Sp Zoo, Pharmaceut, Dept Med, Warsaw, Poland; [Bartosik-Psujek, Halina] Univ Rzeszow, Fac Med, Rzeszow, Poland	Poznan University of Medical Sciences; Bayer AG; University of Rzeszow	Bieniek, M (corresponding author), Bayer Sp Zoo, Pharmaceut, Dept Med, Warsaw, Poland.	marek.bieniek@bayer.com		Bartosik-Psujek, Halina/0000-0002-2860-6456	Bayer sp. z o. o., Warsaw, Poland	Bayer sp. z o. o., Warsaw, Poland	This study was funded by Bayer sp. z o. o., Warsaw, Poland. The funder participated in study design, data analysis, decision to publish and preparation of the manuscript.	Alroughani Raed, 2012, Int J MS Care, V14, P17, DOI 10.7224/1537-2073-14.1.17; Bains SN, 2010, ANN ALLERG ASTHMA IM, V104, P321, DOI 10.1016/j.anai.2009.11.040; Bruce JM, 2010, MULT SCLER, V16, P112, DOI 10.1177/1352458509351897; CLERICO M, 2008, COCHRANE DB SYST REV, V16; Cohen JA, 2011, ANN NEUROL, V69, P759, DOI 10.1002/ana.22426; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Cox Darcy, 2006, J Neurosci Nurs, V38, P167; Cunningham A, 2010, ACTA NEUROL SCAND, V121, P154, DOI 10.1111/j.1600-0404.2009.01285.x; Daugherty KK, 2005, J AM PHARM ASSOC, V45, P371, DOI 10.1331/1544345054003804; Devonshire V, 2011, EUR J NEUROL, V18, P69, DOI 10.1111/j.1468-1331.2010.03110.x; Dhib-Jalbut Suhayl, 2012, Int J MS Care, V14, P198, DOI 10.7224/1537-2073-14.4.198; Dubois BD, 2003, J NEUROL NEUROSUR PS, V74, P946, DOI 10.1136/jnnp.74.7.946; Eaton W. W., 2004, USE PSYCHOL TESTING, V3, P363, DOI DOI 10.1111/J.1083-6101.2007.00367.X; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Fox RJ, 2012, NEW ENGL J MED, V367, P1087, DOI 10.1056/NEJMoa1206328; Francis GS, 2003, DRUG SAFETY, V26, P815, DOI 10.2165/00002018-200326110-00006; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Goodin DS, 2008, NEUROLOGY, V71, P766, DOI 10.1212/01.wnl.0000320512.21919.d2; Haas J, 2005, EUR J NEUROL, V12, P425, DOI 10.1111/j.1468-1331.2005.00936.x; Hansen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133279; Hardmeier M, 2005, NEUROLOGY, V64, P236, DOI 10.1212/01.WNL.0000149516.30155.B8; He DA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009882.pub2; Hutchinson Michael, 2005, Int MS J, V12, P73; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Kappos L, 2007, LANCET, V370, P389, DOI 10.1016/S0140-6736(07)61194-5; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Koch-Henriksen N, 2006, NEUROLOGY, V66, P1056, DOI 10.1212/01.wnl.0000204018.52311.ec; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Milo R, 2014, AUTOIMMUN REV, V13, P518, DOI 10.1016/j.autrev.2014.01.012; Mohr D C, 1996, Mult Scler, V2, P222; Mohr DC, 2001, ANN BEHAV MED, V23, P125, DOI 10.1207/S15324796ABM2302_7; Mohr DC, 1998, MULT SCLER, V4, P487, DOI 10.1191/135245898678845160; Nezu AM, 2002, HANDBOOK OF DEPRESSION, P61; O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656; O'Connor PW, 2006, NEUROLOGY, V66, P894, DOI 10.1212/01.wnl.0000203121.04509.31; O'Rourke KET, 2005, MULT SCLER J, V11, P46, DOI 10.1191/1352458505ms1131oa; Rio J, 2004, NEUROLOGY, V63, P525, DOI 10.1212/01.WNL.0000133206.44931.25; Rio L, 2005, MULT SCLER, V11, P306, DOI 10.1191/1352458505ms1173oa; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Treadaway K, 2009, J NEUROL, V256, P568, DOI 10.1007/s00415-009-0096-y; Tremlett H, 2008, PHARMACOEPIDEM DR S, V17, P565, DOI 10.1002/pds.1593; Tremlett HL, 2003, NEUROLOGY, V61, P551, DOI 10.1212/01.WNL.0000078885.05053.7D	43	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0157950	10.1371/journal.pone.0157950	http://dx.doi.org/10.1371/journal.pone.0157950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695075	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100004
J	Park, Y; Hwang, HB; Kim, HS				Park, Yuli; Hwang, Hyung Bin; Kim, Hyun Seung			Observation of Influence of Cataract Surgery on the Ocular Surface	PLOS ONE			English	Article							MEIBOMIAN GLAND DYSFUNCTION; DRY-EYE DISEASE; LIPID LAYER THICKNESS; SJOGRENS-SYNDROME; TEAR FILM; KERATOCONJUNCTIVITIS SICCA; LOTEPREDNOL ETABONATE; GENE-EXPRESSION; MEIBOGRAPHY; CYTOKINE	Introduction To evaluate meibomian gland function, changes of lacrimal tears and ocular surface parameters and tear inflammatory mediators following cataract surgery. Methods 48 eyes of 34 patients who underwent uncomplicated phacoemulsification were involved and divided into 2 groups with those who had preexisting dry-eye before cataract surgery and those who did not. Ocular symptom score, Schirmer I test, tear film break-up time (TBUT), corneal sensitivity threshold, corneal staining, inflammatory cytokine activities, lid margin abnormalities, meibum expressibility, meibum quality and meibomian gland imaging were evaluated preoperatively, at 1 day, 1 and 2 months postoperatively. Results Ocular symptom scores were worse at 1 and 2 months postoperatively but, TBUT, corneal staining score and corneal sensitivity threshold showed gradual improvements at 1 month and 2 months postoperatively (p<0.05, respectively). Interestingly there were statistically significant improvements in TBUT, corneal staining score and corneal sensitivity threshold at 1 month postoperatively when topical eye drops were used compared to the period without topical therapy which is the months 2 postoperatively. There were statistically significant decreases in IL-1 beta, IL-6, IL-8, MCP-1, TNF-alpha and IFN-gamma concentrations at 1 and 2 months postoperatively. Lid margin abnormalities, meibum quality and expressibility scores increased significantly (p<0.05, respectively) at postoperative period. Compared with the no dry eye group, dry eye group revealed significantly higher ocular symptom scores, lower TBUT, higher lid margin abnormalities, meibum quality and expressibility scores after cataract surgery. There were significant correlations between IL-6 and parameters of dry eye, and between MGD parameters and ocular symptom scores. Conclusions Our study revealed that meibomian gland function is influenced after cataract surgery accompanying structural changes and these were correlated with increased ocular symptom scores. Therefore, it could elucidate the development of dry eye related to cataract surgery.	[Park, Yuli; Kim, Hyun Seung] Catholic Univ Korea, Yeouido St Marys Hosp, Dept Ophthalmol, Coll Med, Seoul, South Korea; [Hwang, Hyung Bin] Incheon St Marys Hosp, Dept Ophthalmol, Seoul, South Korea	Catholic University of Korea	Kim, HS (corresponding author), Catholic Univ Korea, Yeouido St Marys Hosp, Dept Ophthalmol, Coll Med, Seoul, South Korea.	sara514@catholic.ac.kr		Kim, Hyun Seung/0000-0001-6825-8612				Acera A, 2008, OPHTHALMIC RES, V40, P315, DOI 10.1159/000150445; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Arita R, 2009, OPHTHALMOLOGY, V116, P2058, DOI 10.1016/j.ophtha.2009.04.037; Behrens A, 2006, CORNEA, V25, P900, DOI 10.1097/01.ico.0000214802.40313.fa; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; BRON A J, 1991, Eye (London), V5, P395; CHEW CKS, 1993, CURR EYE RES, V12, P247, DOI 10.3109/02713689308999470; De Paiva CS, 2007, INVEST OPHTH VIS SCI, V48, P2553, DOI 10.1167/iovs.07-0069; Goto E, 2003, INVEST OPHTH VIS SCI, V44, P533, DOI 10.1167/iovs.02-0170; Han KE, 2014, AM J OPHTHALMOL, V157, P1144, DOI 10.1016/j.ajo.2014.02.036; Hardten DR, 2008, CORNEA, V27, P855, DOI 10.1097/ICO.0b013e31816f6854; Hwang HB, 2014, CORNEA, V33, P82, DOI 10.1097/ICO.0000000000000001; Jones DT, 1998, ADV EXP MED BIOL, V438, P533; JONES DT, 1994, INVEST OPHTH VIS SCI, V35, P3493; Kang MH, 2011, J KOREAN MED SCI, V26, P938, DOI 10.3346/jkms.2011.26.7.938; Kasetsuwan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078657; Kim JR, 2011, JPN J OPHTHALMOL, V55, P283, DOI 10.1007/s10384-011-0008-4; Kissner A, 2007, KLIN MONATSBL AUGENH, V224, P95, DOI 10.1055/s-2006-927390; KORB DR, 1994, ADV EXP MED BIOL, V350, P293; KORB DR, 1994, CORNEA, V13, P354, DOI 10.1097/00003226-199407000-00012; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lee H, 2014, AM J OPHTHALMOL, V158, P1172, DOI 10.1016/j.ajo.2014.08.015; Lemp Michael A., 1995, CLAO Journal, V21, P221; Li XM, 2007, CORNEA, V26, pS16, DOI 10.1097/ICO.0b013e31812f67ca; Liu Zuguo, 2002, Zhonghua Yan Ke Za Zhi, V38, P274; MATHERS WD, 1994, ARCH OPHTHALMOL-CHIC, V112, P448, DOI 10.1001/archopht.1994.01090160022008; MATHERS WD, 1993, CORNEA, V12, P335, DOI 10.1097/00003226-199307000-00010; Moon H, 2014, CORNEA, V33, P373, DOI 10.1097/ICO.0000000000000072; Nichols JJ, 2005, CORNEA, V24, P382, DOI 10.1097/01.ico.0000148291.38076.59; Oh T, 2012, JPN J OPHTHALMOL, V56, P113, DOI 10.1007/s10384-012-0117-8; Pflugfelder SC, 2004, AM J OPHTHALMOL, V138, P444, DOI 10.1016/j.ajo.2004.04.052; Pflugfelder SC, 2004, AM J OPHTHALMOL, V137, P337, DOI 10.1016/j.ajo.2003.10.036; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Pflugfelder SC, 2007, OCUL SURF, V5, P163; Qiao J, 2013, CLIN OPHTHALMOL, V7, P1797, DOI 10.2147/OPTH.S33182; Ram J, 2002, J CATARACT REFR SURG, V28, P1386, DOI 10.1016/S0886-3350(02)01387-1; ROBIN JB, 1985, OPHTHALMOLOGY, V92, P1423; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Shimazaki J, 1998, OPHTHALMOLOGY, V105, P1485, DOI 10.1016/S0161-6420(98)98033-2; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027; Simone JN, 2001, CURR OPIN OPHTHALMOL, V12, P63, DOI 10.1097/00055735-200102000-00011; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; TAPIE R, 1977, ANN OCUL, V210, P637; Yokoi N, 1999, ARCH OPHTHALMOL-CHIC, V117, P723; Yokoi N, 2007, JPN J OPHTHALMOL, V51, P53, DOI 10.1007/s10384-006-0397-y	45	51	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0152460	10.1371/journal.pone.0152460	http://dx.doi.org/10.1371/journal.pone.0152460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695117	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100002
J	Sendra, L; Miguel, A; Perez-Enguix, D; Herrero, MJ; Montalva, E; Garcia-Gimeno, MA; Noguera, I; Diaz, A; Perez, J; Sanz, P; Lopez-Andujar, R; Marti-Bonmati, L; Alino, SF				Sendra, Luis; Miguel, Antonio; Perez-Enguix, Daniel; Jose Herrero, Maria; Montalva, Eva; Adelaida Garcia-Gimeno, Maria; Noguera, Inmaculada; Diaz, Ana; Perez, Judith; Sanz, Pascual; Lopez-Andujar, Rafael; Marti-Bonmati, Luis; Alino, Salvador F.			Studying Closed Hydrodynamic Models of "In Vivo" DNA Perfusion in Pig Liver for Gene Therapy Translation to Humans	PLOS ONE			English	Article							NAKED PLASMID DNA; VEIN INJECTION; NONVIRAL DNA; SWINE LIVER; RAT-LIVER; DELIVERY; HEPATOCYTES; EXPRESSION; MECHANISM; VOLUME	Introduction Expressing exogenous genes after naked DNA delivery into hepatocytes might achieve sustained and high expression of human proteins. Tail vein DNA injection is an efficient procedure for gene transfer in murine liver. Hydrodynamic procedures in large animals require organ targeting, and improve with liver vascular exclusion. In the present study, two closed liver hydrofection models employing the human alpha-1-antitrypsin (hAAT) gene are compared to reference standards in order to evaluate their potential clinical interest. Material and Methods A solution of naked DNA bearing the hAAT gene was retrogradely injected in 7 pig livers using two different closed perfusion procedures: an endovascular catheterization-mediated procedure (n = 3) with infrahepatic inferior vena cava and portal vein blockage; and a surgery-mediated procedure (n = 4) with completely sealed liver. Gene transfer was performed through the suprahepatic inferior cava vein in the endovascular procedure and through the infrahepatic inferior vena cava in the surgical procedure. The efficiency of the procedures was evaluated 14 days after hydrofection by quantifying the hAAT protein copies per cell in tissue and in plasma. For comparison, samples from mice (n = 7) successfully hydrofected with hAAT and healthy human liver segments (n = 4) were evaluated. Results Gene decoding occurs efficiently using both procedures, with liver vascular arrest improving its efficiency. The surgically closed procedure (sealed organ) reached higher tissue protein levels (4x10<^>5- copies/cell) than the endovascular procedure, though the levels were lower than in human liver (5x10<^>6- copies/cell) and hydrofected mouse liver (10<^>6- copies/cell). However, protein levels in plasma were lower (p<0.001) than the reference standards in all cases. Conclusion Hydrofection of hAAT DNA to "in vivo" isolated pig liver mediates highly efficient gene delivery and protein expression in tissue. Both endovascular and surgically closed models mediate high tissue protein expression. Impairment of protein secretion to plasma is observed and might be species-related. This study reinforces the potential application of closed liver hydrofection for therapeutic purposes, provided protein secretion improves.	[Sendra, Luis; Miguel, Antonio; Jose Herrero, Maria; Alino, Salvador F.] Univ Valencia, Fac Med, Dept Farmacol, Valencia, Spain; [Perez-Enguix, Daniel; Marti-Bonmati, Luis] IIS La Fey, Serv Radiol, Valencia, Spain; [Perez-Enguix, Daniel; Marti-Bonmati, Luis] IIS La Fe, Grp Invest Biorned Imagen GIBI239, Valencia, Spain; [Perez-Enguix, Daniel; Marti-Bonmati, Luis] Hosp Univ & Politecn La Fe, Valencia, Spain; [Jose Herrero, Maria; Alino, Salvador F.] Hosp Univ & Politecn La Fe, IIS La Fe, Unidad Farmacogenet, Valencia, Spain; [Jose Herrero, Maria; Alino, Salvador F.] Hosp Univ & Politecn La Fe, Area Clin Medicamento, Valencia, Spain; [Montalva, Eva; Lopez-Andujar, Rafael] Hosp Univ & Politecn La Fe, Unidad Cirugia Hepatobiliopancreat & Trasplante, Valencia, Spain; [Adelaida Garcia-Gimeno, Maria; Sanz, Pascual] CSIC, GIBER, Valencia, Spain; [Adelaida Garcia-Gimeno, Maria; Sanz, Pascual] CSIC, Inst Biomed Valencia, Valencia, Spain; [Noguera, Inmaculada; Diaz, Ana] Univ Valencia, SCSIE, Valencia, Spain; [Perez, Judith] Hosp Univ & Politecn La Fe, Serv Anat Patol, Valencia, Spain; [Alino, Salvador F.] Hosp Univ & Politecn La Fe, Area Clin Medicamento, Unidad Farmacol Clin, Valencia, Spain	University of Valencia; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); University of Valencia; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Herrero, MJ (corresponding author), Univ Valencia, Fac Med, Dept Farmacol, Valencia, Spain.; Herrero, MJ (corresponding author), Hosp Univ & Politecn La Fe, IIS La Fe, Unidad Farmacogenet, Valencia, Spain.	maria.jose.herrero@uv.es	Montalva, Eva/ABH-7902-2020; Herrero, Maria Jose/M-1649-2014; Marti-Bonmati, Luis/AAF-7107-2020; Lopéz-Andujar, Rafael/ABH-7793-2020; García-Gimeno, María Adelaida/K-9855-2014; Sanz, Pascual/K-2751-2014	Montalva, Eva/0000-0002-8563-1340; Herrero, Maria Jose/0000-0002-6042-4185; Lopéz-Andujar, Rafael/0000-0001-8946-4343; García-Gimeno, María Adelaida/0000-0002-6483-3912; Sanz, Pascual/0000-0002-2399-4103; Diaz Cuevas, Ana/0000-0002-5396-4466; Alino Pellicer, Salvador Francisco/0000-0002-7830-8713; Sendra Gisbert, Luis/0000-0003-3176-9763	Ministerio Espanol de Economia y Competitividad [SAF2011-27002]	Ministerio Espanol de Economia y Competitividad(Spanish Government)	This work has been funded with a Grant from Ministerio Espanol de Economia y Competitividad (ref: SAF2011-27002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 2002, MOL BIOL CELL; Alino SF, 2007, GENE THER, V14, P334, DOI 10.1038/sj.gt.3302873; Alino SF, 2003, GENE THER, V10, P1672, DOI 10.1038/sj.gt.3302065; Brown TA, 2002, GENOMES; Budker V, 1996, GENE THER, V3, P593; Carreno O, 2013, EUR SURG RES, V51, P47, DOI 10.1159/000351339; Crespo A, 2005, GENE THER, V12, P927, DOI 10.1038/sj.gt.3302469; Eastman SJ, 2002, HUM GENE THER, V13, P2065, DOI 10.1089/10430340260395910; Fabre JW, 2008, GENE THER, V15, P452, DOI 10.1038/sj.gt.3303079; Fabre JW, 2011, HUM GENE THER, V22, P879, DOI 10.1089/hum.2010.144; Herrero MJ, 2012, GENE THER, V19, P504, DOI 10.1038/gt.2011.144; Herrero MJ, 2005, GENE THER MOL BIOL, V9, P169; Kamimura K, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.52; Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294; Karimi MH, 2015, INT J TRANSPLANT MED, V6, P45; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; Kimling J, 2006, J PHYS CHEM B, V110, P15700, DOI 10.1021/jp061667w; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lodish H, 2000, MOL CELL BIOL; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Sawyer GJ, 2007, GENE THER, V14, P1208, DOI 10.1038/sj.gt.3302976; Sawyer GJ, 2010, GENE THER, V17, P560, DOI 10.1038/gt.2009.167; Sawyer GJ, 2009, CURR GENE THER, V9, P128, DOI 10.2174/156652309787909535; Sendra L, 2016, EUR RADIOL, V26, P95, DOI 10.1007/s00330-015-3792-2; Sendra L, 2014, J GENE MED, V16, P179, DOI 10.1002/jgm.2777; Suda T, 2007, GENE THER, V14, P129, DOI 10.1038/sj.gt.3302865; Yasuzaki Y, 2013, J CONTROL RELEASE, V172, P805, DOI 10.1016/j.jconrel.2013.09.029; Yoshino H, 2006, GENE THER, V13, P1696, DOI 10.1038/sj.gt.3302833; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhang GF, 1997, HUM GENE THER, V8, P1763, DOI 10.1089/hum.1997.8.15-1763; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang XH, 2001, HUM GENE THER, V12, P2179, DOI 10.1089/10430340152710522; Zhou TA, 2010, AAPS J, V12, P692, DOI 10.1208/s12248-010-9231-z	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163898	10.1371/journal.pone.0163898	http://dx.doi.org/10.1371/journal.pone.0163898			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695064	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100062
J	Puerta-Arias, JD; Pino-Tamayo, PA; Arango, JC; Gonzalez, A				David Puerta-Arias, Juan; Andrea Pino-Tamayo, Paula; Camilo Arango, Julian; Gonzalez, Angel			Depletion of Neutrophils Promotes the Resolution of Pulmonary Inflammation and Fibrosis in Mice Infected with Paracoccidioides brasiliensis	PLOS ONE			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; MATRIX METALLOPROTEINASES; YEAST-CELLS; IMMUNE-RESPONSES; EXTRACELLULAR-MATRIX; ANTIFUNGAL ACTIVITY; FUNGAL-INFECTION; INTERFERON-GAMMA; PROTECTIVE ROLE; BALB/C MICE	Chronic stages of paracoccidioidomycosis (PCM) are characterized by granulomatous lesions which promote the development of pulmonary fibrosis leading to the loss of respiratory function in 50% of patients; in addition, it has been observed that neutrophils predominate during these chronic stages of P. brasiliensis infection. The goal of this study was to evaluate the role of the neutrophil during the chronic stages of experimental pulmonary PCM and during the fibrosis development and tissue repair using a monoclonal specific to this phagocytic cell. Male BALB/c mice were inoculated intranasally with 1.5x10(6) P. brasiliensis yeast cells. A monoclonal antibody specific to neutrophils was administered at 4 weeks post-inoculation followed by doses every 48h during two weeks. Mice were sacrificed at 8 and 12 weeks post-inoculation to assess cellularity, fungal load, cytokine/chemokine levels, histopathological analysis, collagen and expression of genes related to fibrosis development. Depletion of neutrophils was associated with a significant decrease in the number of eosinophils, dendritic cells, B cells, CD4-T cells, MDSCs and Treg cells, fungal load and levels of most of the pro-inflammatory cytokines/chemokines evaluated, including IL-17, TNF-alpha and TGF-beta 1. Recovery of lung architecture was also associated with reduced levels of collagen, high expression of TGF-beta 3, matrix metalloproteinase (MMP)-12 and -14, and decreased expression of tissue inhibitor metalloproteinase (TIMP)-2, and MMP-8. Depletion of neutrophils might attenuate lung fibrosis and inflammation through down-regulating TGF-beta 1, TNF-alpha, IL-17, MMP-8 and TIMP-2. These results suggest that neutrophil could be considered as a therapeutic target in pulmonary fibrosis induced by P. brasiliensis.	[David Puerta-Arias, Juan; Andrea Pino-Tamayo, Paula; Camilo Arango, Julian] CIB, Med & Expt Mycol Unit, Medellin, Colombia; [Camilo Arango, Julian; Gonzalez, Angel] Univ Antioquia, Sch Microbiol, Medellin, Colombia; [Camilo Arango, Julian; Gonzalez, Angel] Univ Antioquia, Basic & Appl Microbiol Res Grp MICROBA, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia	Gonzalez, A (corresponding author), Univ Antioquia, Sch Microbiol, Medellin, Colombia.; Gonzalez, A (corresponding author), Univ Antioquia, Basic & Appl Microbiol Res Grp MICROBA, Medellin, Colombia.	angel.gonzalez@udea.edu.co	Arango, Julián/HCH-3136-2022; Gonzalez, Angel/ABG-7914-2020	Gonzalez, Angel/0000-0002-7052-7938; Puerta, Juan David/0000-0001-6000-2348; Arango Rincon, Julian Camilo/0000-0001-5094-8260	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia [183-2010, 2213-519-28621]; Research Committee (CODI) of Universidad de Antioquia	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia; Research Committee (CODI) of Universidad de Antioquia	This work was supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia, Project 183-2010 (Code number 2213-519-28621), and the Research Committee (CODI) of Universidad de Antioquia through the Sustainability Strategy Program 2014-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Acorci MJ, 2009, SCAND J IMMUNOL, V69, P73, DOI 10.1111/j.1365-3083.2008.02199.x; Amalinei C, 2010, ROM J MORPHOL EMBRYO, V51, P215; Pino-Tamayo PA, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3183285; Balderramas HA, 2014, CYTOKINE, V67, P36, DOI 10.1016/j.cyto.2014.02.004; BEDOYA V, 1986, MYCOPATHOLOGIA, V94, P133, DOI 10.1007/BF00454591; Bode W, 1999, ANN NY ACAD SCI, V878, P73, DOI 10.1111/j.1749-6632.1999.tb07675.x; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; Cano LE, 1998, INFECT IMMUN, V66, P800, DOI 10.1128/IAI.66.2.800-806.1998; Carevic M, 2015, CELL HOST MICROBE, V17, P507, DOI [10.1016/j.chom.2015.02.007, DOI 10.1016/J.CHOM.2015.02.007]; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Chen L, 2000, CLIN EXP IMMUNOL, V120, P125, DOI 10.1046/j.1365-2249.2000.01196.x; Cock Ana M., 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P59, DOI 10.1590/S0036-46652000000200001; Colombo AL, 2011, MED MYCOL, V49, P785, DOI 10.3109/13693786.2011.577821; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Cruz A, 2010, J EXP MED, V207, P1609, DOI 10.1084/jem.20100265; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; de Castro LF, 2013, J INFECTION, V67, P470, DOI 10.1016/j.jinf.2013.07.019; Denkers EY, 2003, CHEM IMMUNOL, V83, P95; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; ECHOLS RM, 1982, REV INFECT DIS, V4, P656; Franco L, 1998, AM J TROP MED HYG, V58, P424, DOI 10.4269/ajtmh.1998.58.424; GOIHMANYAHR M, 1992, MYCOSES, V35, P269, DOI 10.1111/j.1439-0507.1992.tb00873.x; Gonzalez A., 2001, Biomedica, V21, P264; Gonzalez A, 2008, MYCOPATHOLOGIA, V165, P313, DOI 10.1007/s11046-007-9072-1; Gonzalez A, 2011, MICROB PATHOGENESIS, V51, P432, DOI 10.1016/j.micpath.2011.08.003; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; HORWITZ AL, 1977, P NATL ACAD SCI USA, V74, P897, DOI 10.1073/pnas.74.3.897; Huppler AR, 2014, J IMMUNOL, V192, P1745, DOI 10.4049/jimmunol.1302265; Janardhan KS, 2006, FRONT BIOSCI-LANDMRK, V11, P1569, DOI 10.2741/1904; Kallberg E, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-69; KERR IB, 1988, REV I MED TROP, V30, P336, DOI 10.1590/S0036-46651988000500003; Kurita N, 2005, MED MYCOL, V43, P417, DOI 10.1080/13693780400011088; Kurita N, 1999, MED MYCOL, V37, P261, DOI 10.1046/j.1365-280X.1999.00229.x; Kurita N, 2000, MED MYCOL, V38, P177, DOI 10.1080/714030926; Kurita N, 1999, MED MYCOL, V37, P19, DOI 10.1046/j.1365-280X.1999.00194.x; Lewis SM, 2013, INT IMMUNOPHARMACOL, V17, P1226, DOI 10.1016/j.intimp.2013.10.002; Loures FV, 2010, INFECT IMMUN, V78, P1078, DOI 10.1128/IAI.01198-09; Loures FV, 2009, J IMMUNOL, V183, P1279, DOI 10.4049/jimmunol.0801599; Lu KG, 2013, J MOL BIOL, V425, P1815, DOI 10.1016/j.jmb.2013.02.002; Mamoni RL, 2002, MED MYCOL, V40, P153, DOI 10.1080/714031098; Marques SA, 2013, AN BRAS DERMATOL, V88, P700, DOI 10.1590/abd1806-4841.20132463; Mednick AJ, 2003, EUR J IMMUNOL, V33, P1744, DOI 10.1002/eji.200323626; Mircescu MM, 2009, J INFECT DIS, V200, P647, DOI 10.1086/600380; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Muniz VS, 2013, INT ARCH ALLERGY IMM, V162, P276, DOI 10.1159/000354934; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Naranjo TW, 2011, PULM PHARMACOL THER, V24, P81, DOI 10.1016/j.pupt.2010.09.005; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ohbayashi H, 2002, CURR PROTEIN PEPT SC, V3, P409, DOI 10.2174/1389203023380549; Park SJ, 2012, INFECT IMMUN, V80, P1759, DOI 10.1128/IAI.00097-12; Park SJ, 2010, J IMMUNOL, V185, P6190, DOI 10.4049/jimmunol.1002064; Pereira Ricardo Mendes, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P127, DOI 10.1590/S0036-46652004000300002; Pina A, 2006, J LEUKOCYTE BIOL, V79, P1202, DOI 10.1189/jlb.0106052; Pliyev BK, 2008, BIOCHEMISTRY-MOSCOW+, V73, P970, DOI 10.1134/S0006297908090034; Restrepo A, 2011, ESSENTIALS CLIN MYCO, P367, DOI DOI 10.1007/978-1-4419-6640-7_21; Rieber N, 2015, CELL HOST MICROBE, V17, P507, DOI 10.1016/j.chom.2015.02.007; Rodrigues DR, 2014, CYTOKINE, V69, P102, DOI 10.1016/j.cyto.2014.05.009; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; SHIKANAIYASUDA MA, 1992, REV INST MED TROP SP, V34, P85, DOI 10.1590/S0036-46651992000200002; SINGERVERMES LM, 1995, CLIN EXP IMMUNOL, V101, P114; Sousa LMA, 2014, PARASITE IMMUNOL, V36, P13, DOI 10.1111/pim.12078; Souto JT, 2000, AM J PATHOL, V156, P1811, DOI 10.1016/S0002-9440(10)65053-5; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Tobon AM, 2003, CLIN INFECT DIS, V37, P898, DOI 10.1086/377538; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Wagner JM, 1998, AM J TROP MED HYG, V59, P66, DOI 10.4269/ajtmh.1998.59.66; Wang J, 2014, ANN NY ACAD SCI, V1319, P66, DOI 10.1111/nyas.12445; Wozniak KL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-65; Yang Q, 2013, INFECT IMMUN, V81, P1751, DOI 10.1128/IAI.01409-12; Zhang MS, 2016, J LEUKOCYTE BIOL, V99, P467, DOI 10.1189/jlb.4AB0715-281R; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Zuluaga AF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-55	76	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							0163985	10.1371/journal.pone.0163985	http://dx.doi.org/10.1371/journal.pone.0163985			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690127	Green Published, Green Submitted, gold			2022-12-27	WOS:000384329200038
J	Jacobson, AL; Nault, BA; Vargo, EL; Kennedy, GG				Jacobson, Alana L.; Nault, Brian A.; Vargo, Edward L.; Kennedy, George G.			Restricted Gene Flow among Lineages of Thrips tabaci Supports Genetic Divergence Among Cryptic Species Groups	PLOS ONE			English	Article							YELLOW-SPOT-VIRUS; ONION THRIPS; THYSANOPTERA THRIPIDAE; LINDEMAN THYSANOPTERA; POPULATION-STRUCTURE; FIELD CROPS; HYBRIDIZATION; POLYPLOIDIZATION; DIFFERENTIATION; EPIDEMIOLOGY	Knowledge of the relative influence of population-versus species-level genetic variation is important to understand patterns of phenotypic variation and ecological relationships that exist among and within morphologically indistinguishable cryptic species and subspecies. In the case of cryptic species groups that are pests, such knowledge is also essential for devising effective population management strategies. The globally important crop pest Thrips tabaci is a taxonomically difficult group of putatively cryptic species. This study examines population genetic structure of T. tabaci and reproductive isolation among lineages of this species complex using microsatellite markers and mitochondrial COI sequences. Overall, genetic structure supports T. tabaci as a cryptic species complex, although limited interbreeding occurs between different clonal groups from the same lineage as well as between individuals from different lineages. These results also provide evidence that thelytoky and arrhenotoky are not fixed phenotypes among members of different T. tabaci lineages that have been generally associated with either reproductive mode. Possible biological and ecological factors contributing to these observations are discussed.	[Jacobson, Alana L.; Vargo, Edward L.; Kennedy, George G.] North Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Nault, Brian A.] Cornell Univ, Dept Entomol, Geneva, NY USA; [Jacobson, Alana L.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Vargo, Edward L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	University of North Carolina; North Carolina State University; Cornell University; Auburn University System; Auburn University; Texas A&M University System; Texas A&M University College Station	Jacobson, AL (corresponding author), North Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.; Jacobson, AL (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	alj0043@auburn.edu			United States Department of Agriculture National Institute of Food and Agriculture Postdoctoral Fellowship [2012-67012-19757]; Agriculture and Food Research Initiative program	United States Department of Agriculture National Institute of Food and Agriculture Postdoctoral Fellowship; Agriculture and Food Research Initiative program	This project was supported by the 2012 United States Department of Agriculture National Institute of Food and Agriculture Postdoctoral Fellowship Award #2012-67012-19757. This award is now supported by the Agriculture and Food Research Initiative program: https://nifa.usda.gov/funding-opportunity/agriculture-and-food-research-initiative-food-agriculture-natural-resources-and.	Arakaki N, 2001, P ROY SOC B-BIOL SCI, V268, P1011, DOI 10.1098/rspb.2001.1628; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Bachtrog D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001899; Belshaw R, 1999, EVOLUTION, V53, P1189, DOI [10.2307/2640822, 10.1111/j.1558-5646.1999.tb04532.x]; Bournier A., 1983, THRIPS BIOL IMPORTAN; Bournier A., 1956, ARCH ZOOLOGIE EXP RI, V93, P219; Brunner PC, 2004, HEREDITY, V93, P364, DOI 10.1038/sj.hdy.6800512; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Chatzivassiliou EK, 2002, PHYTOPATHOLOGY, V92, P603, DOI 10.1094/PHYTO.2002.92.6.603; Chatzivassiliou EK, 1999, PLANT PATHOL, V48, P700, DOI 10.1046/j.1365-3059.1999.00414.x; Clark LV, 2011, MOL ECOL RESOUR, V11, P562, DOI 10.1111/j.1755-0998.2011.02985.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckel CS, 1996, ENTOMOL EXP APPL, V78, P19, DOI 10.1007/BF00304453; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Jacobson AL, 2013, INSECT MOL BIOL, V22, P12, DOI 10.1111/j.1365-2583.2012.01165.x; Jacobson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054567; Jacobson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054484; Kearney M, 2006, TRENDS ECOL EVOL, V21, P10, DOI 10.1016/j.tree.2005.10.013; Kearney M, 2005, TRENDS ECOL EVOL, V20, P495, DOI 10.1016/j.tree.2005.06.005; Kobayashi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03286; Kumm S, 2010, J APPL ENTOMOL, V134, P491, DOI 10.1111/j.1439-0418.2009.01473.x; Li XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138353; Lundmark M, 2006, TRENDS ECOL EVOL, V21, P9, DOI 10.1016/j.tree.2005.10.007; Mable BK, 2011, J ZOOL, V284, P151, DOI 10.1111/j.1469-7998.2011.00829.x; Monacell JT, 2014, BIOINFORMATICS, V30, P1488, DOI 10.1093/bioinformatics/btu055; Moritz Gerald, 1997, P15; Mound L, 1992, 1991 C THRIPS THYS I, P2; MOUND LA, 1976, B ENTOMOL RES, V66, P179, DOI 10.1017/S0007485300006593; Mound Laurence A., 2009, Zootaxa, V2042, P1; Munro HN, 1964, MAMMALIAN PROTEIN ME; Nault BA, 2006, ENVIRON ENTOMOL, V35, P1264, DOI 10.1603/0046-225X(2006)35[1264:RMIOTT]2.0.CO;2; Nault BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101791; Nguyen DT, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0304-6; NORTH RC, 1986, ENVIRON ENTOMOL, V15, P520, DOI 10.1093/ee/15.3.520; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, GENETICS, V155, P945; Rosa JCCL, 2007, ENTOMOL EXP APPL, V124, P161, DOI 10.1111/j.1570-7458.2007.00564.x; SAKIMURA K, 1946, J ECON ENTOMOL, V39, P398, DOI 10.1093/jee/39.3.398; Sandrock C, 2011, CURR BIOL, V21, P433, DOI 10.1016/j.cub.2011.01.070; Schneider MV, 2003, HEREDITY, V90, P260, DOI 10.1038/sj.hdy.6800245; Shelton AM, 2006, J ECON ENTOMOL, V99, P1798, DOI 10.1603/0022-0493-99.5.1798; Shelton AM, 2003, J ECON ENTOMOL, V96, P1843, DOI 10.1603/0022-0493-96.6.1843; SHELTON AM, 1986, ENVIRON ENTOMOL, V15, P513, DOI 10.1093/ee/15.3.513; Simon JC, 1999, MOL ECOL, V8, P965, DOI 10.1046/j.1365-294x.1999.00648.x; Smith EA, 2015, ENVIRON ENTOMOL, V44, P921, DOI 10.1093/ee/nvv072; Smith EA, 2011, ENVIRON ENTOMOL, V40, P194, DOI 10.1603/EN10246; Sogo K, 2015, APPL ENTOMOL ZOOL, V50, P73, DOI 10.1007/s13355-014-0306-7; Sun DB, 2011, B ENTOMOL RES, V101, P211, DOI 10.1017/S0007485310000416; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toda S, 2007, APPL ENTOMOL ZOOL, V42, P309, DOI 10.1303/aez.2007.309; Toda S, 2009, J ECON ENTOMOL, V102, P2296, DOI 10.1603/029.102.0635; van der Kooi CJ, 2014, EVOLUTION, V68, P1883, DOI 10.1111/evo.12402; Wang P, 2011, INSECT SCI, V18, P67, DOI 10.1111/j.1744-7917.2010.01381.x; Westmore GC, 2013, HEREDITY, V111, P210, DOI 10.1038/hdy.2013.39; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zawirska I., 1976, Archiv fur Phytopathologie und Pflanzenschutz, V12, P411, DOI 10.1080/03235407609431780	56	15	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							0163882	10.1371/journal.pone.0163882	http://dx.doi.org/10.1371/journal.pone.0163882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690317	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200031
J	Li, XN; Duke, NC; Yang, YC; Huang, LS; Zhu, YX; Zhang, Z; Zhou, RC; Zhong, CR; Huang, YL; Shi, SH				Li, Xinnian; Duke, Norman C.; Yang, Yuchen; Huang, Lishi; Zhu, Yuxiang; Zhang, Zhang; Zhou, Renchao; Zhong, Cairong; Huang, Yelin; Shi, Suhua			Re-Evaluation of Phylogenetic Relationships among Species of the Mangrove Genus Avicennia from Indo-West Pacific Based on Multilocus Analyses	PLOS ONE			English	Article							GENETIC DIVERSITY; EVOLUTION; CHLOROPLAST; INTERFERENCE; ACANTHACEAE; HOTSPOTS	Avicennia L. (Avicenniaceae), one of the most diverse mangrove genera, is distributed widely in tropical and subtropical intertidal zones worldwide. Five species of Avicennia in the Indo-West Pacific region have been previously described. However, their phylogenetic relationships were determined based on morphological and allozyme data. To enhance our understanding of evolutionary patterns in the clade, we carried out a molecular phylogenetic study using wide sampling and multiple loci. Our results support two monophyletic clades across all species worldwide in Avicennia: an Atlantic-East Pacific (AEP) lineage and an Indo-West Pacific (IWP) lineage. This split is in line with biogeographic distribution of the clade. Focusing on the IWP branch, we reconstructed a detailed phylogenetic tree based on sequences from 25 nuclear genes. The results identified three distinct subclades, (1) A. rumphiana and A. alba, (2) A. officinalis and A. integra, and (3) the A. marina complex, with high bootstrap support. The results strongly corresponded to two morphological traits in floral structure: stigma position in relation to the anthers and style length. Using Bayesian dating methods we estimated diversification of the IWP lineage was dated to late Miocene (c. 6.0 million years ago) and may have been driven largely by the fluctuating sea levels since that time.	[Li, Xinnian; Yang, Yuchen; Huang, Lishi; Zhu, Yuxiang; Zhang, Zhang; Zhou, Renchao; Huang, Yelin; Shi, Suhua] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China; [Li, Xinnian; Yang, Yuchen; Huang, Lishi; Zhu, Yuxiang; Zhang, Zhang; Zhou, Renchao; Huang, Yelin; Shi, Suhua] Sun Yat Sen Univ, Guangdong Key Lab Plant Resources, Guangzhou, Guangdong, Peoples R China; [Duke, Norman C.] James Cook Univ, Trop WATER, Townsville, Qld, Australia; [Zhong, Cairong] Hainan Dongzhai Harbor Natl Nat Reserve, Haikou, Hainan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; James Cook University	Huang, YL; Shi, SH (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou, Guangdong, Peoples R China.; Huang, YL; Shi, SH (corresponding author), Sun Yat Sen Univ, Guangdong Key Lab Plant Resources, Guangzhou, Guangdong, Peoples R China.	lsshyl@mail.sysu.edu.cn; lssssh@mail.sysu.edu.cn	Yang, Yuchen/GZK-6062-2022; Duke, Norman C/K-5729-2013	Duke, Norman C/0000-0003-2081-9120; Huang, Yelin/0000-0002-2514-0144	National Natural Science Foundation of China [41130208, 91331202, 41276107]; Science Foundation of State Key Laboratory of Biocontrol [SKLBC16A35]; Chang Hungta Science Foundation of Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of State Key Laboratory of Biocontrol; Chang Hungta Science Foundation of Sun Yat-sen University	This study was supported by grants from the National Natural Science Foundation of China (Grant Numbers: 41130208 and 91331202 to SS, 41276107 to YH. http://www.nsfc.gov.cn/), the Science Foundation of State Key Laboratory of Biocontrol (SKLBC16A35 to SS), and the Chang Hungta Science Foundation of Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barber PH, 2005, MOL PHYLOGENET EVOL, V35, P235, DOI 10.1016/j.ympev.2004.10.004; Benzie JAH, 1999, EVOLUTION, V53, P1782, DOI 10.1111/j.1558-5646.1999.tb04562.x; Borg AJ, 2008, TAXON, V57, P811, DOI 10.1002/tax.573012; Brazil M, 2009, NETWORKS, V53, P104, DOI 10.1002/net.20279; Cavagnetto C, 1996, REV PALAEOBOT PALYNO, V92, P281, DOI 10.1016/0034-6667(95)00096-8; Chiang TY, 2001, MOL ECOL, V10, P2697, DOI 10.1046/j.0962-1083.2001.01399.x; CLARKE PJ, 1991, AUST J BOT, V39, P283, DOI 10.1071/BT9910283; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; DUKE N C, 1991, Australian Systematic Botany, V4, P299, DOI 10.1071/SB9910299; DUKE N C, 1990, Australian Systematic Botany, V3, P221, DOI 10.1071/SB9900221; Duke NC, 1998, EVOLUTION, V52, P1612, DOI [10.1111/j.1558-5646.1998.tb02242.x, 10.2307/2411335]; DUKE NC, 1995, HYDROBIOLOGIA, V295, P167, DOI 10.1007/BF00029124; Duke NC, 2002, TREES-STRUCT FUNCT, V16, P65, DOI 10.1007/s00468-001-0141-7; Duke NC, 1988, MANGROVE GENUS AVICE; Duke NC, 2013, WORLD MANGROVE ID; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Giang LH, 2015, INT J PLANT SCI; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo ZX, 2016, J BIOGEOGR, V43, P1856, DOI 10.1111/jbi.12770; Hall R, 2009, BLUMEA, V54, P148, DOI 10.3767/000651909X475941; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Huang YL, 2008, GENETICA, V133, P47, DOI 10.1007/s10709-007-9182-1; Huang YL, 2012, AQUAT BOT, V101, P46, DOI 10.1016/j.aquabot.2012.04.001; LARKIN MA, 2007, BIOINFORMATICS, V23, P2947, DOI DOI 10.1093/BI0INF0RMATICS/BTM404; Li XX, 2013, J EVOLUTION BIOL, V26, P1949, DOI 10.1111/jeb.12193; Liao PC, 2007, CONSERV GENET, V8, P89, DOI 10.1007/s10592-006-9151-8; MADDISON W.P., 2001, MESQUITE MODULAR SYS; McDade LA, 2008, AM J BOT, V95, P1136, DOI 10.3732/ajb.0800096; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Minobe S, 2010, CONSERV GENET, V11, P301, DOI 10.1007/s10592-009-9806-3; Mori GM, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0343-z; Nadia TD, 2013, PLANT SPEC BIOL, V28, P70, DOI 10.1111/j.1442-1984.2011.00361.x; Nettel A, 2008, MOL ECOL, V17, P2680, DOI 10.1111/j.1365-294X.2008.03766.x; Nettel A, 2007, EVOLUTION, V61, P958, DOI 10.1111/j.1558-5646.2007.00070.x; Plaziat Jean-Claude, 2001, Wetlands Ecology and Management, V9, P161, DOI 10.1023/A:1011118204434; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; R Core Team, 2013, R LANG ENV STAT COMP; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; Reid DG, 2013, BIOL J LINN SOC, V110, P564, DOI 10.1111/bij.12151; Renema W, 2008, SCIENCE, V321, P654, DOI 10.1126/science.1155674; Saenger P, 1998, MAR FRESHWATER RES, V49, P277, DOI 10.1071/MF97139; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schwarzbach AE, 2002, SYST BOT, V27, P84; Sorenson L, 2014, MAR BIOL, V161, P2495, DOI 10.1007/s00227-014-2521-8; Tomlinson PB, 1986, THE BOTANY OF MANGRO; Tripp EA, 2014, SYST BIOL, V63, P660, DOI 10.1093/sysbio/syu029; WEBB CJ, 1986, NEW ZEAL J BOT, V24, P163, DOI 10.1080/0028825X.1986.10409726; Yang YC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1813-9; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang HY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-401; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	56	11	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164453	10.1371/journal.pone.0164453	http://dx.doi.org/10.1371/journal.pone.0164453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716800	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000385698100055
J	Torrealba, D; Seras-Franzoso, J; Mamat, U; Wilke, K; Villaverde, A; Roher, N; Garcia-Fruitos, E				Torrealba, Debora; Seras-Franzoso, Joaquin; Mamat, Uwe; Wilke, Kathleen; Villaverde, Antonio; Roher, Nerea; Garcia-Fruitos, Elena			Complex Particulate Biomaterials as Immunostimulant-Delivery Platforms	PLOS ONE			English	Article							BACTERIAL INCLUSION-BODIES; ZEBRAFISH DANIO-RERIO; ESCHERICHIA-COLI; IMMUNE-RESPONSE; VACCINES; FISH; LIPOPOLYSACCHARIDE; ADJUVANTS; ENDOTOXIN; AMYLOIDS	The control of infectious diseases is a major current challenge in intensive aquaculture. Most commercial vaccines are based on live attenuated or inactivated pathogens that are usually combined with adjuvants, oil emulsions being as the most widely used for vaccination in aquaculture. Although effective, the use of these oil emulsions is plagued with important side effects. Thus, the development of alternative safer and cost-effective immunostimulants and adjuvants is highly desirable. Here we have explored the capacity of inclusion bodies produced in bacteria to immunostimulate and protect fish against bacterial infections. Bacterial inclusion bodies are highly stable, non-toxic protein-based biomaterials produced through fully scalable and low-cost bio-production processes. The present study shows that the composition and structured organization of inclusion body components (protein, lipopolysaccharide, peptidoglycan, DNA and RNA) make these protein biomaterials excellent immunomodulators able to generically protect fish against otherwise lethal bacterial challenges. The results obtained in this work provide evidence that their inherent nature makes bacterial inclusion bodies exceptionally attractive as immunostimulants and this opens the door to the future exploration of this biomaterial as an alternative adjuvant for vaccination purposes in veterinary.	[Torrealba, Debora; Seras-Franzoso, Joaquin; Villaverde, Antonio; Roher, Nerea; Garcia-Fruitos, Elena] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Cerdanyola Del Valles, Spain; [Seras-Franzoso, Joaquin; Villaverde, Antonio; Garcia-Fruitos, Elena] Univ Autonoma Barcelona, Dept Genet & Microbiol, Cerdanyola Del Valles, Spain; [Seras-Franzoso, Joaquin; Villaverde, Antonio; Garcia-Fruitos, Elena] CIBER Bioingn Biomat & Nanomed CIBER BBN, Cerdanyola Del Valles, Spain; [Torrealba, Debora; Roher, Nerea] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol Anim & Immunol, Cerdanyola Del Valles, Spain; [Mamat, Uwe; Wilke, Kathleen] ARCN, Prior Area Asthma & Allergy Res Ctr Borstel, Div Struct Biochem, Borstel, Germany; [Mamat, Uwe; Wilke, Kathleen] German Ctr Lung Res DZL, Borstel, Germany; [Seras-Franzoso, Joaquin] Hosp Valle De Hebron, VHIR, Cibbim Nanomed, Barcelona, Spain; [Garcia-Fruitos, Elena] IRTA, Dept Ruminant Prod, Caldes De Montbui, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Autonomous University of Barcelona; Forschungszentrum Borstel; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); IRTA	Roher, N; Garcia-Fruitos, E (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Cerdanyola Del Valles, Spain.; Garcia-Fruitos, E (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Cerdanyola Del Valles, Spain.; Garcia-Fruitos, E (corresponding author), CIBER Bioingn Biomat & Nanomed CIBER BBN, Cerdanyola Del Valles, Spain.; Roher, N (corresponding author), Univ Autonoma Barcelona, Dept Biol Cellular Fisiol Anim & Immunol, Cerdanyola Del Valles, Spain.	nerea.roher@uab.cat; elena.garcia@irta.cat	Villaverde, Antonio/N-3986-2018; Seras-Franzoso, Joaquin/AAF-6539-2020; Garcia-Fruitós, Elena/L-9907-2017; Roher, Nerea/F-3216-2016	Villaverde, Antonio/0000-0002-2615-4521; Seras-Franzoso, Joaquin/0000-0002-7893-4773; Garcia-Fruitós, Elena/0000-0001-7498-4864; Torrealba, Debora/0000-0003-0807-4234; Roher, Nerea/0000-0002-6659-4038	Secretaria de Estado de Investigacion, Desarrollo e Innovacion [AGL2012-33877]; Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria [RTA2012-00028-C02-02]; Agenda de Gestio d'Ajuts Universitaris i de Recerca [2014 SGR-345, 2014 SGR-132]; Centro de Investigacion Biomedica en Red (GIBER) de Bioingenieria, Biomateriales y Nanomedicina by the Institute de Salud Carlos III; CONICYT-Chile; Ramon y Cajal [RYC-2010-06210]	Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria; Agenda de Gestio d'Ajuts Universitaris i de Recerca; Centro de Investigacion Biomedica en Red (GIBER) de Bioingenieria, Biomateriales y Nanomedicina by the Institute de Salud Carlos III; CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Ramon y Cajal(Spanish Government)	This work was supported by grants from the Secretaria de Estado de Investigacion, Desarrollo e Innovacion to NR (AGL2012-33877), from Institute Nacional de Investigacion y Tecnologia Agraria y Alimentaria to EGF (RTA2012-00028-C02-02), and from Agenda de Gestio d'Ajuts Universitaris i de Recerca to NR (2014 SGR-345) and AV (2014 SGR-132). Besides, the authors acknowledge the financial support granted to AV from the Centro de Investigacion Biomedica en Red (GIBER) de Bioingenieria, Biomateriales y Nanomedicina financed by the Institute de Salud Carlos III with assistance from the European Regional Development. DT thanks CONICYT-Chile for a PhD fellowship. NR is supported by Ramon y Cajal (RYC-2010-06210) fellowship. AV has been distinguished with an ICREA ACADEMIA Award.	Brudeseth BE, 2013, FISH SHELLFISH IMMUN, V35, P1759, DOI 10.1016/j.fsi.2013.05.029; Bui TBH, 2013, FISH SHELLFISH IMMUN, V34, P339, DOI 10.1016/j.fsi.2012.11.025; Cano-Garrido O, 2013, ACTA BIOMATER, V9, P6134, DOI 10.1016/j.actbio.2012.11.033; Garcia-Fruitos E, 2010, NANOTECHNOLOGY, V21, DOI [10.1088/0957-4484/21/205101, DOI 10.1088/0957-4484/21/205101]; Garcia-Fruitos E, 2007, J MOL BIOL, V374, P195, DOI 10.1016/j.jmb.2007.09.004; Garcia-Fruitos E, 2012, TRENDS BIOTECHNOL, V30, P65, DOI 10.1016/j.tibtech.2011.09.003; Garcia-Fruitos E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-80; Garcia-Fruitos E, 2009, ADV MATER, V21, P4249, DOI 10.1002/adma.200900283; Georgiou G, 1999, METHOD ENZYMOL, V309, P48; Izard J, 2003, J MICROBIOL METH, V55, P411, DOI 10.1016/S0167-7012(03)00193-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacKenzie SA, 2010, MOL IMMUNOL, V47, P1450, DOI 10.1016/j.molimm.2010.02.009; Magnadottir B, 2010, MAR BIOTECHNOL, V12, P361, DOI 10.1007/s10126-010-9279-x; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Purcell MK, 2006, COMP BIOCHEM PHYS D, V1, P77, DOI 10.1016/j.cbd.2005.07.003; Rodriguez-Carmona E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-71; Roher N, 2011, INNATE IMMUN-LONDON, V17, P16, DOI 10.1177/1753425909348232; Ruyra A, 2014, VACCINE, V32, P3955, DOI 10.1016/j.vaccine.2014.05.010; Selvaraj V, 2006, VET IMMUNOL IMMUNOP, V114, P15, DOI 10.1016/j.vetimm.2006.06.011; Seras-Franzoso J, 2016, SOFT MATTER, V12, P3451, DOI 10.1039/c5sm02930a; Seras-Franzoso J, 2013, NANOMEDICINE-UK, V8, P1587, DOI [10.2217/NNM.12.188, 10.2217/nnm.12.188]; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Spickler AR, 2003, J VET INTERN MED, V17, P273, DOI 10.1892/0891-6640(2003)017&lt;0273:AIVVMO&gt;2.3.CO;2; Tafalla C, 2013, FISH SHELLFISH IMMUN, V35, P1740, DOI 10.1016/j.fsi.2013.02.029; Thomas JG, 1998, J BACTERIOL, V180, P5165, DOI 10.1128/JB.180.19.5165-5172.1998; Vazquez E, 2012, ADV MATER, V24, P1742, DOI 10.1002/adma.201104330; Watzke J, 2007, FISH SHELLFISH IMMUN, V23, P901, DOI 10.1016/j.fsi.2007.03.004; Welch TJ, 2016, FISH SHELLFISH IMMUN, V49, P420, DOI 10.1016/j.fsi.2015.12.037; Wilson-Welder JH, 2009, J PHARM SCI-US, V98, P1278, DOI 10.1002/jps.21523	29	16	17	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164073	10.1371/journal.pone.0164073	http://dx.doi.org/10.1371/journal.pone.0164073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716780	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100019
J	Al-Mohaissen, MA; Carere, RG; Mancini, GBJ; Humphries, KH; Whalen, BA; Lee, T; Scheuermeyer, FX; Ignaszewski, AP				Al-Mohaissen, Maha A.; Carere, Ronald G.; Mancini, G. B. John; Humphries, Karin H.; Whalen, Beth A.; Lee, Terry; Scheuermeyer, Frank X.; Ignaszewski, Andrew P.			A Plaque Disruption Index Identifies Patients with Non-STE-Type 1 Myocardial Infarction within 24 Hours of Troponin Positivity	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; OPTICAL COHERENCE TOMOGRAPHY; PLASMA-PROTEIN; INFLAMMATORY MARKERS; UNSTABLE ANGINA; EARLY-DIAGNOSIS; ARTERY-DISEASE; PREGNANCY; INTERLEUKIN-6; ASSAY	Background Markers of plaque destabilization and disruption may have a role in identifying non-STE-type 1 Myocardial Infarction in patients presenting with troponin elevation. We hypothesized that a plaque disruption index (PDI) derived from multiple biomarkers and measured within 24 hours from the first detectable troponin in patients with acute non-STE-type 1 MI (NSTEMI-A) will confirm the diagnosis and identify these patients with higher specificity when compared to individual markers and coronary angiography. Methods We examined 4 biomarkers of plaque destabilization and disruption: myeloperoxidase (MPO), high-sensitivity interleukin-6, myeloid-related protein 8/14 (MRP8/14) and pregnancy-associated plasma protein-A (PAPP-A) in 83 consecutive patients in 4 groups: stable non-obstructive coronary artery disease (CAD), stable obstructive CAD, NSTEMI-A (enrolled within 24 hours of troponin positivity), and NSTEMI-L (Late presentation NSTEMI, enrolled beyond the 24 hour limit). The PDI was calculated and the patients' coronary angiograms were reviewed for evidence of plaque disruption. The diagnostic performance of the PDI and angiography were compared. Results Compared to other biomarkers, MPO had the highest specificity (83%) for NSTEMI-A diagnosis (P<0.05). The PDI computed from PAPP-A, MRP8/14 and MPO was higher in NSTEMI-A patients compared to the other three groups (p<0.001) and had the highest diagnostic specificity (87%) with 79% sensitivity and 86% accuracy, which were higher compared to those obtained with MPO, but did not reach statistical significance (P>0.05 for all comparisons). The PDI had higher specificity and accuracy for NSTEMI-A diagnosis compared to coronary angiography (P<0.05). Conclusions A PDI measured within 24 hour of troponin positivity has potential to identify subjects with acute Non-ST-elevation type 1 MI. Additional evidence using other marker combinations and investigation in a sufficiently large non-selected cohort is warranted to establish the diagnostic accuracy of the PDI and its potential role in differentiating type 1 and type 2 MI in patients presenting with troponin elevation of uncertain etiology.	[Al-Mohaissen, Maha A.] Princess Nourah Bint Abdul Rahman Univ, Dept Clin Sci, Riyadh, Saudi Arabia; [Carere, Ronald G.; Humphries, Karin H.; Ignaszewski, Andrew P.] St Pauls Hosp, Dept Med, Div Cardiol, Vancouver, BC, Canada; [Carere, Ronald G.; Humphries, Karin H.; Whalen, Beth A.; Lee, Terry; Scheuermeyer, Frank X.; Ignaszewski, Andrew P.] Univ British Columbia, Vancouver, BC, Canada; [Mancini, G. B. John] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Whalen, Beth A.] St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Lee, Terry] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Scheuermeyer, Frank X.] St Pauls Hosp, Dept Emergency Med, Vancouver, BC, Canada	Princess Nourah bint Abdulrahman University; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan	Al-Mohaissen, MA (corresponding author), Princess Nourah Bint Abdul Rahman Univ, Dept Clin Sci, Riyadh, Saudi Arabia.	mahaabdulrahman@hotmail.com	Al-Mohaissen, Maha/GQO-9962-2022					Alcalai R, 2007, ARCH INTERN MED, V167, P276, DOI 10.1001/archinte.167.3.276; Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; Anderson DR, 2013, CYTOKINE, V62, P395, DOI 10.1016/j.cyto.2013.03.020; Apple FS, 2005, CLIN CHEM, V51, P810, DOI 10.1373/clinchem.2004.046292; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Biasucci LM, 1999, CIRCULATION, V99, P2079, DOI 10.1161/01.CIR.99.16.2079; Blich M, 2008, AM J CARDIOL, V101, P1384, DOI 10.1016/j.amjcard.2008.01.011; Chan CPY, 2013, ADV CLIN CHEM, V59, P23, DOI 10.1016/B978-0-12-405211-6.00002-4; de Lemos JA, 2013, JAMA-J AM MED ASSOC, V309, P2262, DOI 10.1001/jama.2013.5809; Ferrante G, 2010, CIRCULATION, V122, P2505, DOI 10.1161/CIRCULATIONAHA.110.955302; Fredericks S, 2006, CLIN CHEM, V52, P1619, DOI 10.1373/clinchem.2006.074138; Hartman J, 2014, CARDIOL REV, V22, P147, DOI 10.1097/CRD.0000000000000021; Hayashida K, 2005, CIRCULATION, V112, P812, DOI 10.1161/CIRCULATIONAHA.104.468397; Ikonomidis I, 2012, BIOFACTORS, V38, P320, DOI 10.1002/biof.1024; Jia HB, 2013, J AM COLL CARDIOL, V62, P1748, DOI 10.1016/j.jacc.2013.05.071; Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082; Lodh M, 2012, CARDIOVASC J AFR, V23, P330, DOI 10.5830/CVJA-2012-008; Maier W, 2005, CIRCULATION, V111, P1355, DOI 10.1161/01.CIR.0000158479.58589.0A; Mancini GBJ, 2009, CIRC-CARDIOVASC QUAL, V2, P320, DOI 10.1161/CIRCOUTCOMES.108.830091; Mueller M, 2012, CLIN CHEM, V58, P209, DOI 10.1373/clinchem.2011.171827; Reichlin T, 2015, CAN MED ASSOC J, V187, pE243, DOI 10.1503/cmaj.141349; Rudolph V, 2012, CIRC-CARDIOVASC GENE, V5, P561, DOI 10.1161/CIRCGENETICS.111.962290; Rudolph V, 2011, INT J CARDIOL, V153, P267, DOI 10.1016/j.ijcard.2010.08.015; Schoos M, 2009, SCAND J CLIN LAB INV, V69, P121, DOI 10.1080/00365510802439080; SU JQ, 1993, J AM STAT ASSOC, V88, P1350; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Twerenbold R, 2015, CIRCULATION, V131, P2041, DOI 10.1161/CIRCULATIONAHA.114.014245; Waxman S, 2003, AM J CARDIOL, V92, P16, DOI 10.1016/S0002-9149(03)00457-0; Wittfooth S, 2011, CLIN CHIM ACTA, V412, P376, DOI 10.1016/j.cca.2010.11.024; Wlazel RN, 2013, ARCH MED SCI, V9, P14, DOI 10.5114/aoms.2013.33343; Wu AHB, 2007, CLIN CHEM, V53, P2086, DOI 10.1373/clinchem.2007.095679; Zhelev Z, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h15	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164315	10.1371/journal.pone.0164315	http://dx.doi.org/10.1371/journal.pone.0164315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711184	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600117
J	Bhatnagar, T; Dutta, T; Stover, J; Godbole, S; Sahu, D; Boopathi, K; Bembalkar, S; Singh, KJ; Goyal, R; Pandey, A; Mehendale, SM				Bhatnagar, Tarun; Dutta, Tapati; Stover, John; Godbole, Sheela; Sahu, Damodar; Boopathi, Kangusamy; Bembalkar, Shilpa; Singh, Kh. Jitenkumar; Goyal, Rajat; Pandey, Arvind; Mehendale, Sanjay M.			Fitting HIV Prevalence 1981 Onwards for Three Indian States Using the Goals Model and the Estimation and Projection Package	PLOS ONE			English	Article							TRANSMITTED-DISEASE CLINICS; FEMALE SEX WORKERS; HIV/AIDS EPIDEMICS; YOUNG MEN; IMPACT; TRANSMISSION; INFECTION; INTERVENTIONS; PREVENTION; AIDS	Models are designed to provide evidence for strategic program planning by examining the impact of different interventions on projected HIV incidence. We employed the Goals Model to fit the HIV epidemic curves in Andhra Pradesh, Maharashtra and Tamil Nadu states of India where HIV epidemic is considered to have matured and in a declining phase. Input data in the Goals Model consisted of demographic, epidemiological, transmission-related and risk group wise behavioral parameters. The HIV prevalence curves generated in the Goals Model for each risk group in the three states were compared with the epidemic curves generated by the Estimation and Projection Package (EPP) that the national program is routinely using. In all the three states, the HIV prevalence trends for high-risk populations simulated by the Goals Model matched well with those derived using state-level HIV surveillance data in the EPP. However, trends for the low-and medium-risk populations differed between the two models. This highlights the need to generate more representative and robust data in these sub-populations and consider some structural changes in the modeling equation and parameters in the Goals Model to effectively use it to assess the impact of future strategies of HIV control in various sub-populations in India at the sub-national level.	[Bhatnagar, Tarun; Boopathi, Kangusamy; Mehendale, Sanjay M.] Indian Council Med Res, Natl Inst Epidemiol, Madras, Tamil Nadu, India; [Dutta, Tapati; Goyal, Rajat] Int AIDS Vaccine Initiat, New Delhi, India; [Stover, John] Avenir Hlth, Glastonbury, CT USA; [Godbole, Sheela; Bembalkar, Shilpa] Indian Council Med Res, Natl AIDS Res Inst, Dept Epidemiol, Pune, Maharashtra, India; [Sahu, Damodar; Singh, Kh. Jitenkumar; Pandey, Arvind] Indian Council Med Res, Natl Inst Med Stat, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); International AIDS Vaccine Initiative; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National Institute of Medical Statistics (NIMS)	Mehendale, SM (corresponding author), Indian Council Med Res, Natl Inst Epidemiol, Madras, Tamil Nadu, India.	sanjaymehendale@icmr.org.in	Godbole, Sheela/ABG-4942-2020; Godbole, Sheela/K-4177-2017	Godbole, Sheela/0000-0001-6537-9064				AIDS Prevention and Control (APAC) Project, 2007, HIV RISK BEHAVIOR SU; Akpa OM, 2010, J INFECT DEV COUNTR, V4, P597, DOI 10.3855/jidc.542; [Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2010, HIV AIDS SITUATION A; Anzala O, 2012, OPEN JOURNAL OF IMMU, V2, p[195, 2572], DOI [10.1097/QAD.0b013e32833e8663, DOI 10.1097/QAD.0B013E32833E8663]; AusAID, 2006, IMPACTS OF HIV AIDS; Auvert B, 2005, PRESENTATION TO THE; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; BLOWER SM, 1991, PHILOS T R SOC B, V331, P171, DOI 10.1098/rstb.1991.0006; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; BONGAARTS J, 1989, STAT MED, V8, P103, DOI 10.1002/sim.4780080111; Brahme R, 2006, JAIDS-J ACQ IMM DEF, V41, P107, DOI 10.1097/01.qai.0000179428.49907.6d; Brahme RG, 2005, AIDS CARE, V17, P377, DOI 10.1080/09540120412331299771; Brown T, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010165; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Directorate of Communicable Disease Control and Environmental Health, 2008, MATHEMATICAL MODEL O; Fonseca MGP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011736; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Ghys PD, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010199; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gribble JN, 1999, J SEX RES, V36, P16, DOI 10.1080/00224499909551963; Hainke K, 2012, BIOMETRICAL J, V54, P617, DOI 10.1002/bimj.201100186; Harmon T, 2015, VACCINES-BASEL, V3, P1, DOI 10.3390/vaccines3010001; HEALY MJR, 1988, J ROY STAT SOC A STA, V151, P50, DOI 10.2307/2982184; Indian Council of Medical Research, 2009, FAMILY HEALTH INTERN; Indian Council of Medical Research Family Health International, 2005, NATIONAL INTERIM SUM; International Institute for Population Sciences (IIPS), 2005, NATIONAL FAMILY HEAL, V3; International Institute for Population sciences (IIPS) and Operations Research Centre (ORC) Macro, 2000, NATIONAL FAMILY HEAL; International Institute for Population Sciences (IIPS) Macro International, 2005, NATIONAL FAMILY HEAL; KAPLAN EH, 1989, REV INFECT DIS, V11, P289; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; Kumar R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-549; Mishra Ram Manohar, 2012, Glob J Health Sci, V4, P100, DOI 10.5539/gjhs.v4n5p100; Mukandavire Z, 2007, J MATH ANAL APPL, V330, P916, DOI 10.1016/j.jmaa.2006.07.102; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; National AIDS Control Organization, 2014, ANNUAL REPORT 2013 1; National Institute of Medical Statistics National AIDS Control Organization, 2012, TECHNICAL REPORT IND; Pandey A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000926; Pretorius C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013646; Prinja S, 2011, SEX TRANSM INFECT, V87, P354, DOI 10.1136/sti.2010.047829; Rao ASRS, 2009, MATH BIOSCI ENG, V6, P779, DOI 10.3934/mbe.2009.6.779; Rao ASRS, 2003, CURR SCI INDIA, V84, P1192; Salomon JA, 2001, B WORLD HEALTH ORGAN, V79, P596; Salomon JA, 1999, METHODS FOR MODELING; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; SIMOES EAF, 1987, INDIAN J MED RES, V85, P335; Stover J, 2000, SEX TRANSM DIS, V27, P572, DOI 10.1097/00007435-200011000-00005; Stover J, 2003, THE FUTURES GROUP IN; Stover J, 2007, HEALTH AFFAIR, V26, P1147, DOI 10.1377/hlthaff.26.4.1147; Stover J, 2014, AIDS, V28, pS225, DOI 10.1097/QAD.0000000000000235; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; Tapadar A, 2011, ADVANCES IN APPLIED, V2, P61; Vickerman P, 2010, AIDS, V24, P2554, DOI 10.1097/QAD.0b013e32833e8663; Walker N, 2003, AIDS, V17, P2215, DOI 10.1097/00002030-200310170-00010	57	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164001	10.1371/journal.pone.0164001	http://dx.doi.org/10.1371/journal.pone.0164001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711212	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600061
J	Blaeser, A; Awano, H; Wu, B; Lu, QL				Blaeser, Anthony; Awano, Hiroyuki; Wu, Bo; Lu, Qi-Long			Progressive Dystrophic Pathology in Diaphragm and Impairment of Cardiac Function in FKRP P448L Mutant Mice	PLOS ONE			English	Article							WALKER-WARBURG-SYNDROME; CONGENITAL MUSCULAR-DYSTROPHY; FUKUTIN-RELATED PROTEIN; LOSS-OF-FUNCTION; ALPHA-DYSTROGLYCAN; GLYCOPROTEIN COMPLEX; MUTATIONS; MUSCLE; 2I; ISPD	Mutations in the gene for fukutin-related protein represent a subset of muscular dystrophies known as dystroglycanopathies characterized by loss of functionally-glycosylated-alpha-dystroglycan and a wide range of dystrophic phenotypes. Mice generated by our lab containing the P448L mutation in the fukutin-related protein gene demonstrate the dystrophic phenotype similar to that of LGMD2I. Here we examined the morphology of the heart and diaphragm, focusing on pathology of diaphragm and cardiac function of the mutant mice for up to 12 months. Both diaphragm and heart lack clear expression of functionally-glycosylated-alpha-dystroglycan throughout the observed period. The diaphragm undergoes progressive deterioration in histology with increasing amount of centranucleation and inflammation. Large areas of mononuclear cell infiltration and fibrosis of up to 60% of tissue area were detected as early as 6 months of age. Despite a less severe morphology with only patches of mononuclear cell infiltration and fibrosis of similar to 5% by 12 months of age in the heart, cardiac function is clearly affected. High frequency ultrasound reveals a smaller heart size up to 10 months of age. There are significant increases in myocardial thickness and decrease in cardiac output through 12 months. Dysfunction in the heart represents a key marker for evaluating experimental therapies aimed at cardiac muscle.	[Blaeser, Anthony; Awano, Hiroyuki; Wu, Bo; Lu, Qi-Long] Carolinas Med Ctr, Cannon Res Ctr, McColl Lockwood Lab Muscular Dystrophy Res, 1000 Blythe Blvd, Charlotte, NC 28203 USA	Carolinas Medical Center	Blaeser, A; Lu, QL (corresponding author), Carolinas Med Ctr, Cannon Res Ctr, McColl Lockwood Lab Muscular Dystrophy Res, 1000 Blythe Blvd, Charlotte, NC 28203 USA.	anthony.blaeser@carolinashealthcare.org; qi.lu@carolinashealthcare.org	lu, qi/HHS-2115-2022		Carolinas Muscular Dystrophy Research Endowment at the Carolinas HealthCare Foundation	Carolinas Muscular Dystrophy Research Endowment at the Carolinas HealthCare Foundation	This work was funded by the Carolinas Muscular Dystrophy Research Endowment at the Carolinas HealthCare Foundation (http://www.givecarolinas.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikov A, 2013, GLYCOBIOLOGY, V23, P303, DOI 10.1093/glycob/cws153; Blaeser A, 2013, HUM GENET, V132, P923, DOI 10.1007/s00439-013-1302-7; Boito CA, 2005, ARCH NEUROL-CHICAGO, V62, P1894, DOI 10.1001/archneur.62.12.1894; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; Buysse K, 2013, HUM MOL GENET, V22, P1746, DOI 10.1093/hmg/ddt021; Chan YM, 2010, HUM MOL GENET, V19, P3995, DOI 10.1093/hmg/ddq314; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fayssoil A, 2013, J ULTRAS MED, V32, P757, DOI 10.7863/ultra.32.5.757; Goddeeris MM, 2013, NATURE, V503, P136, DOI 10.1038/nature12605; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Liang WC, 2013, NEUROMUSCULAR DISORD, V23, P675, DOI 10.1016/j.nmd.2013.05.010; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2003, BIOCHEM BIOPH RES CO, V306, P93, DOI 10.1016/S0006-291X(03)00924-0; Manzini MC, 2012, AM J HUM GENET, V91, P541, DOI 10.1016/j.ajhg.2012.07.009; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Pane M, 2012, NEUROMUSCULAR DISORD, V22, P685, DOI 10.1016/j.nmd.2012.05.006; Poppe M, 2004, ANN NEUROL, V56, P738, DOI 10.1002/ana.20283; Rasmussen M, 2014, ACTA PAEDIATR, V103, P553, DOI 10.1111/apa.12561; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; Stensland E, 2011, NEUROMUSCULAR DISORD, V21, P41, DOI 10.1016/j.nmd.2010.08.008; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Sveen ML, 2006, ANN NEUROL, V59, P808, DOI 10.1002/ana.20824; Toda T, 2000, NEUROMUSCULAR DISORD, V10, P153, DOI 10.1016/S0960-8966(99)00109-1; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Vuillaumier-Barrot S, 2012, AM J HUM GENET, V91, P1135, DOI 10.1016/j.ajhg.2012.10.009; Wahbi K, 2008, NEUROMUSCULAR DISORD, V18, P650, DOI 10.1016/j.nmd.2008.06.365; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276; Zhang P, 2012, GLYCOBIOLOGY, V22, P235, DOI 10.1093/glycob/cwr131	35	9	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164187	10.1371/journal.pone.0164187	http://dx.doi.org/10.1371/journal.pone.0164187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711214	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600094
J	Eun, SJ; Lee, JY; Jung, HM; Lee, JS				Eun, Sang Jun; Lee, Jin Yong; Jung, Hye-Min; Lee, Jin-Seok			Determinants of Attitude toward the Public Health Spending and Its Relationship with Voting Behavior in the 2012 South Korean Presidential Election	PLOS ONE			English	Article							WELFARE; CARE; REDISTRIBUTION; INSURANCE; VOTERS; REFORM	This study aimed to identify the factors influencing South Korean voters' attitudes towards increasing public expenditure on health and to identify whether the issue of healthcare expenditure influenced candidate choice in the 2012 Korean presidential election. The study used the data from a survey conducted by the Institute of Korean Politics at Seoul National University immediately following the 2012 presidential election. The survey was completed by a nationwide sample of 1,200 people aged 19 or over using a face-to-face interview method and proportional quota sampling based on sex, age, and region. About 44.3% of respondents had a positive attitude toward increasing public health expenditure. There was no significant difference by the candidate they supported (conservative Park Geun-hye or liberal Moon Jae-in). In particular, even 44.9% of conservative supporters agreed with more spending. Politically neutral respondents (OR = 1.76, 90% CI 1.22-2.54) and strong conservative party supporters (OR = 1.53, 90% CI 1.05-2.25) were more likely to support public health expenditure increase compared to strong liberal party supporters. Also, respondents who believed that the economic gap in the country was widening were 1.91 times more likely to support an increase in public health expenditures. However, the issue of health expenditure had no influence on voters' choice of presidential candidates, and in particular no negative effect of choice of the ruling (conservative) party's candidate. Our results should be interpreted with care; one possible reason for this lack of effect might be that constituents voted along partisan lines regardless of their attitude to the welfare issue; another possible explanation might be the success of the "left click strategy" of the conservative party. That is, the conservatives did not reject economic democratization or social welfare expansion. Further research should be done to explain why attitudes to health spending did not directly affect choice of candidate.	[Eun, Sang Jun] Chungnam Natl Univ, Sch Med, Dept Prevent Med, Daejeon, South Korea; [Lee, Jin Yong] Seoul Natl Univ, Boramae Med Ctr, Publ Hlth Med Serv, Seoul, South Korea; [Jung, Hye-Min] Chungnam Natl Univ Hosp, Reg Rheumatoid & Degenerat Arthrit Ctr, Daejeon, South Korea; [Jung, Hye-Min; Lee, Jin-Seok] Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea; [Lee, Jin Yong; Lee, Jin-Seok] Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea	Chungnam National University; Seoul National University (SNU); Seoul National University Hospital; Chungnam National University; Chungnam National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Lee, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea.; Lee, JS (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea.	phealth@snu.ac.kr		Eun, Sang Jun/0000-0001-5868-1679; Jung, Hyemin/0000-0001-7339-7983				BARTELS LM, 1993, AM POLIT SCI REV, V87, P267, DOI 10.2307/2939040; Blendon RJ, 2008, NEW ENGL J MED, V359, P2050, DOI 10.1056/NEJMsr0807717; Blendon RJ, 2006, NEW ENGL J MED, V355, P1928, DOI 10.1056/NEJMsr066042; Chen SH, 2013, INT J INFECT DIS, V17, pE1116, DOI 10.1016/j.ijid.2013.06.006; Cho DM, 2001, KOREAN J LABOR STUDI, V7, P157; Choi G, 2000, KOREAN J SOCIAL WELF, V16, P223; Chun CB, 2009, HLTH SYST TRANSIT, V11, P1; Dajdos L, 2012, QUICK POLICY INSIGHT; Derks A., 2005, 3 ESPANET ANN C SEP; Edlund J, 1999, EUR J POLIT RES, V35, P341; HASENFELD Y, 1989, SOC FORCES, V67, P1027, DOI 10.2307/2579713; Houben PHH, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-13; Iversen T, 2001, AM POLIT SCI REV, V95, P875, DOI 10.1017/S0003055400400079; Kang M, 2014, HEALTH POLICY, V115, P9, DOI 10.1016/j.healthpol.2013.09.015; Kim MK, 2008, INT HLTH LAW SOLIDAR; Kim TH, 2012, KOREA TIMES; Konisky DM, 2012, AM POLIT RES, V40, P903, DOI 10.1177/1532673X11434141; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lee HA, 2012, YONHAP NEWS     1107; Lee Hyeon-Woo, 2013, 한국정치연구, V22, P95; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Organisation for Economic Co-operation and Development, 2013, HLTH GLANC 2013 OECD; Organization for Economic Cooperation and Development, 2014, OECD HLTH STAT 2014; Petrocik JR, 1996, AM J POLIT SCI, V40, P825, DOI 10.2307/2111797; Sainsbury D., 1996, GENDER EQUALITY WELF, DOI [10.1017/CBO9780511520921, DOI 10.1017/CBO9780511520921]; Shin GW, 2012, CURR HIST, V111, P223; Slothuus R, 2010, J POLIT, V72, P630, DOI 10.1017/S002238161000006X; Song JinMi, 2014, [Korean Party Studies Review, 한국정당학회보], V13, P5; Svallfors S, 1997, EUR SOCIOL REV, V13, P283, DOI 10.1093/oxfordjournals.esr.a018219; Svallfors S, 2004, SOC POLICY ADMIN, V38, P119, DOI 10.1111/j.1467-9515.2004.00381.x; Svallfors S., 2006, MORAL EC CLASS CLASS; The Economist, 2012, ECONOMIST; 장승진, 2013, [Korean Party Studies Review, 한국정당학회보], V12, P87	33	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163763	10.1371/journal.pone.0163763	http://dx.doi.org/10.1371/journal.pone.0163763			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711213	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600039
J	Heath, JE; Seers, CA; Veith, PD; Butler, CA; Muhammad, NAN; Chen, YY; Slakeski, N; Peng, B; Zhang, LY; Dashper, SG; Cross, KJ; Cleal, SM; Moore, C; Reynolds, EC				Heath, Jacqueline E.; Seers, Christine A.; Veith, Paul D.; Butler, Catherine A.; Muhammad, Nor A. Nor; Chen, Yu-Yen; Slakeski, Nada; Peng, Benjamin; Zhang, Lianyi; Dashper, Stuart G.; Cross, Keith J.; Cleal, Steven M.; Moore, Caroline; Reynolds, Eric C.			PG1058 Is a Novel Multidomain Protein Component of the Bacterial Type IX Secretion System	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS W50; OUTER-MEMBRANE PROTEINS; TERMINAL SIGNAL PEPTIDASE; GRAM-NEGATIVE BACTERIA; PEPTIDOGLYCAN RECOGNITION; SUBGINGIVAL PLAQUE; CRYSTAL-STRUCTURE; GLIDING MOTILITY; GENOME SEQUENCE; PAGE ANALYSIS	Porphyromonas gingivalis utilises the Bacteroidetes-specific type IX secretion system (T9SS) to export proteins across the outer membrane (OM), including virulence factors such as the gingipains. The secreted proteins have a conserved carboxy-terminal domain essential for type IX secretion that is cleaved upon export. In P. gingivalis the T9SS substrates undergo glycosylation with anionic lipopolysaccharide (A-LPS) and are attached to the OM. In this study, comparative analyses of 24 Bacteroidetes genomes identified ten putative novel components of the T9SS in P. gingivalis, one of which was PG1058. Computer modelling of the PG1058 structure predicted a novel N- to C-terminal architecture comprising a tetratricopeptide repeat (TPR) domain, a beta-propeller domain, a carboxypeptidase regulatory domain-like fold (CRD) and an OmpA_C-like putative peptidoglycan binding domain. Inactivation of pg1058 in P. gingivalis resulted in loss of both colonial pigmentation and surface-associated proteolytic activity; a phenotype common to T9SS mutants. Immunoblot and LC-MS/MS analyses of subcellular fractions revealed T9SS substrates accumulated within the pg1058 mutant periplasm whilst whole-cell ELISA showed the Kgp gingipain was absent from the cell surface, confirming perturbed T9SS function. Immunoblot, TEM and whole-cell ELISA analyses indicated A-LPS was produced and present on the pg1058 mutant cell surface although it was not linked to T9SS substrate proteins. This indicated that PG1058 is crucial for export of T9SS substrates but not for the translocation of A-LPS. PG1058 is a predicted lipoprotein and was localised to the periplasmic side of the OM using whole-cell ELISA, immunoblot and LC-MS/MS analyses of subcellular fractions. The structural prediction and localisation of PG1058 suggests that it may have a role as an essential scaffold linking the periplasmic and OM components of the T9SS.	[Heath, Jacqueline E.; Seers, Christine A.; Veith, Paul D.; Butler, Catherine A.; Muhammad, Nor A. Nor; Chen, Yu-Yen; Slakeski, Nada; Peng, Benjamin; Zhang, Lianyi; Dashper, Stuart G.; Cross, Keith J.; Cleal, Steven M.; Moore, Caroline; Reynolds, Eric C.] Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia; [Muhammad, Nor A. Nor] Univ Kebangsaan Malaysia, Inst Syst Biol INBIOSIS, Bangi, Malaysia	University of Melbourne; Universiti Kebangsaan Malaysia	Reynolds, EC (corresponding author), Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia.	e.reynolds@unimelb.au	Zhang, Lianyi/H-7491-2014; Muhammad, Nor Azlan Nor/Y-5368-2018; Cross, Keith J/N-4602-2013	Muhammad, Nor Azlan Nor/0000-0003-4401-0385; Dashper, Stuart/0000-0003-0106-8691; Slakeski, Nada/0000-0001-9776-6018; Butler, Catherine/0000-0001-6371-3954; Veith, Paul/0000-0002-7344-1662	Australian Government, Department of Industry, Innovation and Science [20080108]	Australian Government, Department of Industry, Innovation and Science(Australian GovernmentDepartment of Industry, Innovation and Science)	Australian Government, Department of Industry, Innovation and Science Grant 20080108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Carr S, 2000, STRUCT FOLD DES, V8, P57, DOI 10.1016/S0969-2126(00)00079-4; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curtis MA, 1999, INFECT IMMUN, V67, P3816, DOI 10.1128/IAI.67.8.3816-3823.1999; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Darveau RP, 2012, J DENT RES, V91, P816, DOI 10.1177/0022034512453589; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DEMOT R, 1994, MOL MICROBIOL, V12, P333; DESLAURIERS M, 1990, ORAL MICROBIOL IMMUN, V5, P1, DOI 10.1111/j.1399-302X.1990.tb00217.x; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; Dudley MN, 2013, CLIN INFECT DIS, V56, P1301, DOI 10.1093/cid/cit017; Evans ML, 2014, BBA-MOL CELL RES, V1843, P1551, DOI 10.1016/j.bbamcr.2013.09.010; FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Frazer LT, 2006, VACCINE, V24, P6542, DOI 10.1016/j.vaccine.2006.06.013; Gazda L, 2013, CELL, V152, P183, DOI 10.1016/j.cell.2012.12.025; Geibel S, 2014, BBA-MOL CELL RES, V1843, P1559, DOI 10.1016/j.bbamcr.2013.09.023; Glew MD, 2014, J PROTEOMICS, V110, P72, DOI 10.1016/j.jprot.2014.07.033; Glew MD, 2012, J BIOL CHEM, V287, P24605, DOI 10.1074/jbc.M112.369223; Gomis-Ruth FX, 1999, EMBO J, V18, P5817, DOI 10.1093/emboj/18.21.5817; Gorasia DG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005820; Gorasia DG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005152; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x; Hajishengallis G, 2014, EUR J IMMUNOL, V44, P328, DOI 10.1002/eji.201344202; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hu MJ, 2013, BIOCHEM J, V453, P381, DOI 10.1042/BJ20121829; Huq NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065447; Ishiguro I, 2009, FEMS MICROBIOL LETT, V292, P261, DOI 10.1111/j.1574-6968.2009.01489.x; Iwami J, 2007, ORAL MICROBIOL IMMUN, V22, P356, DOI 10.1111/j.1399-302X.2007.00363.x; Kadowaki T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23288; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kopec KO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077074; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI [10.1902/jop.2013.1340010, 10.1111/jcpe.12064]; McBride MJ, 2013, J BACTERIOL, V195, P270, DOI 10.1128/JB.01962-12; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Murakami Y, 2002, EUR J ORAL SCI, V110, P157, DOI 10.1034/j.1600-0722.2002.11171.x; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Nguyen KA, 2009, MICROBIOL-SGM, V155, P328, DOI 10.1099/mic.0.024323-0; O'Brien-Simpson NM, 2009, INFECT IMMUN, V77, P1246, DOI 10.1128/IAI.01038-08; O'Brien-Simpson NM, 2005, J IMMUNOL, V175, P3980, DOI 10.4049/jimmunol.175.6.3980; O'Brien-Simpson NM, 2003, CURR PROTEIN PEPT SC, V4, P409, DOI 10.2174/1389203033487009; O'Brien-Simpson NM, 2001, INFECT IMMUN, V69, P7527, DOI 10.1128/IAI.69.12.7527-7534.2001; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Paramonov N, 2005, MOL MICROBIOL, V58, P847, DOI 10.1111/j.1365-2958.2005.04871.x; Park JS, 2012, FASEB J, V26, P219, DOI 10.1096/fj.11-188425; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Potempa J, 1997, BIOL CHEM, V378, P223, DOI 10.1515/bchm.1997.378.3-4.223; Rangarajan M, 2008, J BACTERIOL, V190, P2920, DOI 10.1128/JB.01868-07; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; ROGERS MB, 1994, J BACTERIOL, V176, P4376, DOI 10.1128/jb.176.14.4376-4384.1994; Ross BC, 2001, VACCINE, V19, P4135, DOI 10.1016/S0264-410X(01)00173-6; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Saiki K, 2014, MOL ORAL MICROBIOL, V29, P32, DOI 10.1111/omi.12043; Saiki K, 2007, MICROBIOL IMMUNOL, V51, P483, DOI 10.1111/j.1348-0421.2007.tb03936.x; Saiki K, 2010, FEMS MICROBIOL LETT, V310, P168, DOI 10.1111/j.1574-6968.2010.02059.x; Saiki K, 2010, FEMS MICROBIOL LETT, V302, P166, DOI 10.1111/j.1574-6968.2009.01848.x; Sato K, 2005, J BIOL CHEM, V280, P8668, DOI 10.1074/jbc.M413544200; Sato K, 2013, FEMS MICROBIOL LETT, V338, P68, DOI 10.1111/1574-6968.12028; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Shoji M, 2002, MICROBIOL-SGM, V148, P1183, DOI 10.1099/00221287-148-4-1183; Shoji M, 2016, MICROB PATHOGENESIS, V94, P35, DOI 10.1016/j.micpath.2015.09.012; Shoji M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05056; Shoji M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021372; Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10; SLANY RK, 1994, BIOCHIMIE, V76, P1178, DOI 10.1016/0300-9084(94)90047-7; Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681; Smalley JW, 2004, BIOCHEM J, V379, P833, DOI 10.1042/BJ20031221; Smalley JW, 2002, BIOCHEM J, V362, P239, DOI 10.1042/0264-6021:3620239; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tanco S, 2010, J MOL BIOL, V401, P465, DOI 10.1016/j.jmb.2010.06.035; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Veith PD, 2013, J PROTEOME RES, V12, P4449, DOI 10.1021/pr400487b; Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105; Wiebe C B, 2000, J Can Dent Assoc, V66, P594; Yeh YC, 2010, J BACTERIOL, V192, P4847, DOI 10.1128/JB.00607-10; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006	95	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164313	10.1371/journal.pone.0164313	http://dx.doi.org/10.1371/journal.pone.0164313			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711252	Green Published, gold			2022-12-27	WOS:000385697600115
J	Ohashi, A; Saeki, Y; Harada, T; Naito, M; Takahashi, T; Aizawa, S; Hasegawa, H				Ohashi, Akiko; Saeki, Yusuke; Harada, Tomonori; Naito, Masako; Takahashi, Tomihisa; Aizawa, Shin; Hasegawa, Hiroyuki			Tetrahydrobiopterin Supplementation: Elevation of Tissue Biopterin Levels Accompanied by a Relative Increase in Dihydrobiopterin in the Blood and the Role of Probenecid-Sensitive Uptake in Scavenging Dihydrobiopterin in the Liver and Kidney of Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PHENYLALANINE-HYDROXYLASE; TETRAHYDROPTERIN DERIVATIVES; SALVAGE PATHWAY; BIOSYNTHESIS; BRAIN; PHENYLKETONURIA; CELLS; 7,8-DIHYDROBIOPTERIN; TRANSPORTERS	Tetrahydrobiopterin (BH4) is an essential cofactor of nitric oxide synthase (NOS) and aromatic amino acid hydroxylases. BH4 and 7,8-dihydrobiopterin (BH2) are metabolically interchangeable at the expense of NADPH. Exogenously administered BH4 can be metabolized by the body, similar to vitamins. At present, synthetic BH4 is used as an orphan drug for patients with inherited diseases requiring BH4 supplementation. BH4 supplementation has also drawn attention as a means of treating certain cardiovascular symptoms, however, its application in human patients remains limited. Here, we tracked biopterin (BP) distribution in blood, bile, urine, liver, kidney and brain after BH4 administration (5 mg/kg rat, i.v.) with or without prior treatment with probenecid, a potent inhibitor of uptake transporters particularly including organic anion transporter families such as OTA1 and OAT3. The rapid excretion of BP in urine was driven by elevated blood concentrations and its elimination reached about 90% within 120 min. In the very early period, BP was taken up by the liver and kidney and gradually released back to the blood. BH4 administration caused a considerable decrease in the BH4% in blood BP as an inevitable compensatory process. Probenecid treatment slowed down the decrease in blood BP and simultaneously inhibited its initial rapid excretion in the kidney. At the same time, the BH4% was further lowered, suggesting that the probenecid-sensitive BP uptake played a crucial role in BH2 scavenging in vivo. This suggested that the overproduced BH2 was taken up by organs by means of the probenecid-sensitive process, and was then scavenged by counter-conversion to BH4 via the BH4 salvage pathway. Taken together, BH4 administration was effective at raising BP levels in organs over the course of hours but with extremely low efficiency. Since a high BH2 relative to BH4 causes NOS dysfunction, the lowering of the BH4% must be avoided in practice, otherwise the desired effect of the supplementation in ameliorating NOS dysfunction would be spoiled.	[Ohashi, Akiko; Naito, Masako; Takahashi, Tomihisa; Hasegawa, Hiroyuki] Nihon Univ, Sch Dent, Dept Anat, Chiyoda Ku, Tokyo, Japan; [Saeki, Yusuke] Teikyo Univ Sci & TechnologyUenohara, Dept Biosci, Uenohara, Yamanashi, Japan; [Harada, Tomonori; Aizawa, Shin; Hasegawa, Hiroyuki] Nihon Univ, Sch Med, Dept Funct Morphol, Div Anat Sci,Itabashi Ku, Tokyo, Japan	Nihon University; Nihon University	Ohashi, A (corresponding author), Nihon Univ, Sch Dent, Dept Anat, Chiyoda Ku, Tokyo, Japan.	oohashi.akiko@nihon-u.ac.jp	原田, 智紀/AAX-8274-2020		Sato Fund, Nihon University School of Dentistry; Dental Research Center, Nihon University of Dentistry; Uemura Fund, Nihon University School of Dentistry; JSPS KAKENHI [JP16K20429]	Sato Fund, Nihon University School of Dentistry; Dental Research Center, Nihon University of Dentistry; Uemura Fund, Nihon University School of Dentistry; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Sato Fund, Nihon University School of Dentistry to AO; Dental Research Center, Nihon University of Dentistry to AO and MN; Uemura Fund, Nihon University School of Dentistry to TT; and JSPS KAKENHI JP16K20429 to AO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHOLOME K, 1977, PEDIATRICS, V59, P757; Blau N., 2006, PHYS GUIDE TREATMENT, P25, DOI DOI 10.1007/3-540-28962-3_3; Blau N, 2015, EXPERT OPIN PHARMACO, V16, P791, DOI 10.1517/14656566.2015.1013030; Blau N, 2013, EXPERT OPIN DRUG MET, V9, P1207, DOI 10.1517/17425255.2013.804064; Brand MP, 1996, J NEUROCHEM, V66, P1150; COSENTINO F, 1995, CIRCULATION, V91, P139, DOI 10.1161/01.CIR.91.1.139; Crabtree MJ, 2011, FREE RADICAL BIO MED, V50, P1639, DOI 10.1016/j.freeradbiomed.2011.03.010; Crabtree MJ, 2009, J MOL CELL CARDIOL, V47, P749, DOI 10.1016/j.yjmcc.2009.09.011; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hasegawa H, 2005, MOL GENET METAB, V86, pS2, DOI 10.1016/j.ymgme.2005.09.002; Hayashi T.A., 1992, CLIN REPORT, V26, P3471; Heintz C, 2013, HUM MUTAT, V34, P927, DOI 10.1002/humu.22320; HOSHIGA M, 1993, J PHARMACOL EXP THER, V267, P971; Hsu V, 2014, CLIN PHARMACOKINET, V53, P283, DOI 10.1007/s40262-013-0117-y; ICHIYAMA A, 1970, J BIOL CHEM, V245, P1699; INOUE F, 1985, AGENTS ACTIONS, V16, P295, DOI 10.1007/BF01982861; KAUFMAN S, 1963, P NATL ACAD SCI USA, V50, P1085, DOI 10.1073/pnas.50.6.1085; KLATT P, 1994, J BIOL CHEM, V269, P13861; Koshimura K, 2000, PROG NEUROBIOL, V61, P415, DOI 10.1016/S0301-0082(99)00059-3; Kure S, 1999, J PEDIATR-US, V135, P375, DOI 10.1016/S0022-3476(99)70138-1; LEVINE RA, 1987, J PHARMACOL EXP THER, V242, P514; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; MIWA S, 1985, ARCH BIOCHEM BIOPHYS, V239, P234, DOI 10.1016/0003-9861(85)90831-8; Moens AL, 2011, J MOL CELL CARDIOL, V51, P559, DOI 10.1016/j.yjmcc.2011.03.009; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Ohashi A, 2009, J INHERIT METAB DIS, V32, P73, DOI 10.1007/s10545-008-0961-3; Ohashi A, 2013, MOL GENET METAB, V108, P107, DOI 10.1016/j.ymgme.2012.11.007; Ohashi A, 2012, MOL GENET METAB, V105, P575, DOI 10.1016/j.ymgme.2012.01.009; Ohashi A, 2011, MOL GENET METAB, V104, P404, DOI 10.1016/j.ymgme.2011.06.003; Ohashi A, 2011, MOL GENET METAB, V102, P18, DOI 10.1016/j.ymgme.2010.09.005; Sawabe K, 2004, J PHARMACOL SCI, V96, P124, DOI 10.1254/jphs.FP0040280; Sawabe K, 2009, J INHERIT METAB DIS, V32, P79, DOI 10.1007/s10545-008-0964-0; Sawabe K, 2008, MOL GENET METAB, V94, P410, DOI 10.1016/j.ymgme.2008.04.007; SCHAUB J, 1978, ARCH DIS CHILD, V53, P674, DOI 10.1136/adc.53.8.674; Schmidt K, 2014, BIOCHEM PHARMACOL, V90, P246, DOI 10.1016/j.bcp.2014.05.010; SINGHVI SM, 1990, BRIT J CLIN PHARMACO, V29, P239, DOI 10.1111/j.1365-2125.1990.tb03626.x; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Wettstein S, 2015, EUR J HUM GENET, V23, P302, DOI 10.1038/ejhg.2014.114; Whitsett J, 2013, FREE RADICAL BIO MED, V63, P143, DOI 10.1016/j.freeradbiomed.2013.04.035	41	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164305	10.1371/journal.pone.0164305	http://dx.doi.org/10.1371/journal.pone.0164305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711248	gold, Green Submitted, Green Published			2022-12-27	WOS:000385697600112
J	Pawlak, D; Oksztulska-Kolanek, E; Znorko, B; Domaniewski, T; Rogalska, J; Roszczenko, A; Brzoska, MM; Pryczynicz, A; Kemona, A; Pawlak, K				Pawlak, Dariusz; Oksztulska-Kolanek, Ewa; Znorko, Beata; Domaniewski, Tomasz; Rogalska, Joanna; Roszczenko, Alicja; Brzoska, Malgorzata Michalina; Pryczynicz, Anna; Kemona, Andrzej; Pawlak, Krystyna			The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite-5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease	PLOS ONE			English	Article							MINERAL DENSITY; CIRCULATING SEROTONIN; MECHANICAL-PROPERTIES; REUPTAKE INHIBITORS; TURNOVER; MARKERS; MODEL; RISK; ANTIDEPRESSANTS; ADOLESCENTS	Chronic kidney disease (CKD) is associated with disturbances in bone strength and metabolism. The alterations of the serotonergic system are also observed in CKD. We used the 5/6 nephrectomy model of CKD to assess the impact of peripheral serotonin and its metabolite-5-hydroxyindoleacetic acid on bone biomechanical properties and metabolism in growing rats. The animals were sacrificed one and three months after nephrectomy. Biomechanical properties were determined on two different bone types: the cortical bone of the femoral diaphysis using three-point bending test and the mixed cortico-trabecular bone by the bending test of the femoral neck. Biomechanical tests revealed preserved cortical bone strength, whereas work to fracture (W) and yield load (F-y) of mixed cortico-trabecular bone were significantly lower in CKD compared to controls. Serum activity of alkaline phosphatase (ALP), a bone formation marker, and tartrate-resistant acid phosphatase (TRACP 5b) reflecting bone resorption, were similar in CKD and controls. ALP was associated with lower femoral stiffness and strength, and higher displacements and W. TRACP 5b was inversely associated with cortical F-u and W. The elevated peripheral serotonergic system in CKD was: inversely associated with stiffness but positively related to the displacements and W; inversely associated with cortical F-y but positively correlated with this parameter in cortico-trabecular bone; inversely associated with ALP in controls but positively correlated with this biomarker in CKD animals. In conclusion, this study demonstrates the distinct effect of mild degree of CKD on bone strength in rapidly growing rats. The impaired renal function affects the peripheral serotonin metabolism, which in turn may influence the strength and metabolism of bones in these rats. This relationship seems to be beneficial on the biomechanical properties of the cortico-trabecular bone, whereas the cortical bone strength can be potentially reduced.	[Pawlak, Dariusz] Med Univ Bialystok, Dept Pharmacodynam, Bialystok, Poland; [Oksztulska-Kolanek, Ewa; Znorko, Beata; Domaniewski, Tomasz; Pawlak, Krystyna] Med Univ Bialystok, Dept Monitored Pharmacotherapy, Bialystok, Poland; [Rogalska, Joanna; Roszczenko, Alicja; Brzoska, Malgorzata Michalina] Med Univ Bialystok, Dept Toxicol, Bialystok, Poland; [Pryczynicz, Anna; Kemona, Andrzej] Med Univ Bialystok, Dept Gen Pathomorphol, Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok	Pawlak, K (corresponding author), Med Univ Bialystok, Dept Monitored Pharmacotherapy, Bialystok, Poland.	krystynapawlak@poczta.onet.pl	Rogalska, Joanna/T-3253-2018; Pawlak, Dariusz/T-3068-2018; Roszczenko, Alicja/T-4226-2018; Pryczynicz, Anna/S-2713-2018; Znorko-Sieklucka, Beata/S-9932-2018; Pawlak, Krystyna/T-1139-2018	Rogalska, Joanna/0000-0003-2567-2631; Pawlak, Dariusz/0000-0002-3751-0608; Roszczenko, Alicja/0000-0002-0369-1252; Pryczynicz, Anna/0000-0002-2786-7179; Znorko-Sieklucka, Beata/0000-0001-8384-7116; Pawlak, Krystyna/0000-0003-2254-7982; Domaniewski, Tomasz/0000-0002-2126-8423; Brzoska, Malgorzata Michalina/0000-0002-3023-0056	National Science Centre (NCN), Poland [2013/09/B/NZ7/00046]; Medical University of Bialystok, Poland [123-28966 F, 143-28790 F]	National Science Centre (NCN), Poland; Medical University of Bialystok, Poland	This manuscript was financially supported by grant no. 2013/09/B/NZ7/00046 financed by National Science Centre (NCN), Poland; and grants no. 123-28966 F and no. 143-28790 F financed by Medical University of Bialystok, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MR, 2015, OSTEOPOROSIS INT, V26, P977, DOI 10.1007/s00198-014-2978-9; Allen MR, 2013, OSTEOPOROSIS INT, V24, P1471, DOI 10.1007/s00198-012-2103-x; Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; An Ki-Yong, 2013, J Bone Metab, V20, P95, DOI 10.11005/jbm.2013.20.2.95; Brzoska MM, 2005, CALCIFIED TISSUE INT, V76, P287, DOI 10.1007/s00223-004-0089-x; Carsote M, 2014, J Med Life, V7 Spec No. 2, P49; Cejka D, 2011, CLIN J AM SOC NEPHRO, V6, P2264, DOI 10.2215/CJN.09711010; Couturier J, 2013, EAT DISORD, V21, P238, DOI 10.1080/10640266.2013.779183; Dai SQ, 2014, BRAZ J MED BIOL RES, V47, P759, DOI 10.1590/1414-431X20143565; Desbuards N, 2009, NEPHRON EXP NEPHROL, V113, pE35, DOI 10.1159/000228081; Diem SJ, 2007, ARCH INTERN MED, V167, P1240, DOI 10.1001/archinte.167.12.1240; Diem SJ, 2014, J CLIN ENDOCR METAB, V99, pE1732, DOI 10.1210/jc.2014-2288; DIMITRIADIS A, 1990, ADV PERIT D, V6, P220; Eleftheriadis T, 2013, IRAN J KIDNEY DIS, V7, P36; Fang YF, 2014, KIDNEY INT, V85, P142, DOI 10.1038/ki.2013.271; Fekete S, 2015, EUR J PHARMACOL, V761, P65, DOI 10.1016/j.ejphar.2015.04.029; Feuer AJ, 2015, BONE, V78, P28, DOI 10.1016/j.bone.2015.04.042; Fidalgo S, 2013, BIOGERONTOLOGY, V14, P21, DOI 10.1007/s10522-012-9406-3; Groothoff JW, 2003, KIDNEY INT, V63, P266, DOI 10.1046/j.1523-1755.2003.00727.x; Gustafsson BI, 2006, J CELL BIOCHEM, V97, P1283, DOI 10.1002/jcb.20733; HOLMES EW, 1987, EXP MOL PATHOL, V46, P89, DOI 10.1016/0014-4800(87)90033-5; Iwamoto J, 2012, CALCIFIED TISSUE INT, V90, P50, DOI 10.1007/s00223-011-9548-3; Jaiswal P, 2015, NEUROSCI BIOBEHAV R, V55, P413, DOI 10.1016/j.neubiorev.2015.05.013; Jarvinen TLN, 1998, J BONE MINER RES, V13, P1475, DOI 10.1359/jbmr.1998.13.9.1475; Jee W. S. S., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P193; Jokihaara J, 2006, BONE, V39, P353, DOI 10.1016/j.bone.2006.01.157; Kazama JJ, 2013, KIDNEY INT SUPPL, V3, P446, DOI 10.1038/kisup.2013.93; KERR PG, 1992, AM J NEPHROL, V12, P14, DOI 10.1159/000168411; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Krygicz Dariusz, 1996, Polish Journal of Pharmacology, V48, P351; Ksiazek A, 1978, Pol Tyg Lek, V33, P1045; Lambert J, 2005, PEDIATR RES, V57, P227, DOI 10.1203/01.PDR.0000148715.61869.4E; Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Lochmuller EM, 2000, OSTEOPOROSIS INT, V11, P361, DOI 10.1007/s001980070126; Malyszko J, 1996, THROMB RES, V83, P351, DOI 10.1016/0049-3848(96)00145-4; Malyszko JS, 2000, NEPHRON, V84, P305, DOI 10.1159/000045604; Miller MA, 1998, BONE, V23, P257, DOI 10.1016/S8756-3282(98)00098-2; Moe SM, 2015, J BONE MINER RES, V30, P539, DOI 10.1002/jbmr.2372; Moura C, 2014, OSTEOPOROSIS INT, V25, P1473, DOI 10.1007/s00198-014-2649-x; Newman CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099262; Oh CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7794; Pawlak D, 1996, THROMB RES, V83, P189, DOI 10.1016/0049-3848(96)00120-X; Rauma PH, 2015, AUST NZ J PSYCHIAT, V49, P437, DOI 10.1177/0004867414565475; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; RICHMAN IM, 1947, ARCH PATHOL, V44, P92; Schefold JC, 2009, NEPHROL DIAL TRANSPL, V24, P1901, DOI 10.1093/ndt/gfn739; Sebekova K, 2001, Bratisl Lek Listy, V102, P351; STEYN ME, 1992, LIFE SCI, V51, P359, DOI 10.1016/0024-3205(92)90588-G; Sviglerova J, 2010, PHYSIOL RES, V59, pS81, DOI 10.33549/physiolres.932003; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; Tymczyna B, 2012, ANN AGR ENV MED, V19, P535; Urena P, 1999, KIDNEY INT, V55, P2141, DOI 10.1046/j.1523-1755.1999.00461.x; van Dijk SC, 2012, BONE, V50, P1260, DOI 10.1016/j.bone.2012.02.637; Verdel BM, 2010, BONE, V47, P604, DOI 10.1016/j.bone.2010.06.006; Walsh JS, 2013, J CLIN ENDOCR METAB, V98, P2902, DOI 10.1210/jc.2012-4174; Walter S, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-81; Wang Q.B., 2014, ADV MECH ENG, P1; Wei QS, 2014, IRAN J BASIC MED SCI, V17, P62; Yadav VK, 2010, CALCIFIED TISSUE INT, V86, P382, DOI 10.1007/s00223-010-9350-7; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Young Richard L, 2015, Gastroenterology, V149, P253, DOI 10.1053/j.gastro.2015.05.020; Zofkova I, 2014, PHYSIOL RES, V63, P421, DOI 10.33549/physiolres.932668	65	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163526	10.1371/journal.pone.0163526	http://dx.doi.org/10.1371/journal.pone.0163526			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711209	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600029
J	Perera, BPU; Kim, J				Perera, Bambarendage P. U.; Kim, Joomyeong			Sex and Tissue Specificity of Peg3 Promoters	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENES; CANCER-CELL-LINES; IMPRINTED DOMAIN; METHYLATION; EXPRESSION; BEHAVIOR; GROWTH	The expression of mouse Peg3 (Paternally expressed gene 3) is driven by 4 promoters, including its main and three alternative promoters. The sexual, temporal and spatial specificity of these promoters was characterized in the current study. According to the results, the main promoter displays ubiquitous expression patterns throughout different stages and tissues. In contrast, the expression of Peg3 driven by the alternative promoter U2 was detected mainly in muscle and skin, but not in brain, starting from the late embryonic stage, revealing its tissue and stage specificity. The expression levels of both the main and U2 promoters are also sexually biased: the levels in females start higher but become lower than those in males during early postnatal stages. As an imprinted locus, the paternal alleles of these promoters are active whereas the maternal alleles are silent. Interestingly, deletion of the repressed maternal allele of the main promoter has an unusual effect on the opposite paternal allele, causing the up-regulation of both the main and U2 promoters. Overall, the promoters of Peg3 derive sexually biased and tissue-specific expression patterns.	[Perera, Bambarendage P. U.; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Perera, Bambarendage/0000-0002-7774-0985	National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097074, R01GM066225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (JK R01-GM066225, R01-GM097074).	Chen MY, 2011, CANCER-AM CANCER SOC, V117, P4424, DOI 10.1002/cncr.26073; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Faisal M, 2014, GENE, V533, P434, DOI 10.1016/j.gene.2013.10.006; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Frey WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144459; Gore AC, 2014, ENDOCR REV, V35, P961, DOI 10.1210/er.2013-1122; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Huang JM, 2009, GENE, V442, P18, DOI 10.1016/j.gene.2009.04.016; Janssen AB, 2016, PSYCHOL MED, V46, P2999, DOI 10.1017/S0033291716001598; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154216; Kim J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv867; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; Mozhui K, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00063; Perera BPU, 2016, SCI REP-UK, V6, DOI 10.1038/srep24438; Radford EJ, 2012, PLOS GENET, V8, P41, DOI 10.1371/journal.pgen.1002605; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Richardson L, 2014, NUCLEIC ACIDS RES, V42, pD835, DOI 10.1093/nar/gkt1155; Thiaville MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075417; Veselovska L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0769-z; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164158	10.1371/journal.pone.0164158	http://dx.doi.org/10.1371/journal.pone.0164158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711129	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600090
J	Masini, EO; Mansour, O; Speer, CE; Addona, V; Hanson, CL; Sitienei, JK; Kipruto, HK; Githiomi, MM; Mungai, BN				Masini, Enos O.; Mansour, Omar; Speer, Clare E.; Addona, Vittorio; Hanson, Christy L.; Sitienei, Joseph K.; Kipruto, Hillary K.; Githiomi, Martin Muhingo; Mungai, Brenda Nyambura			Using Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in Kenya	PLOS ONE			English	Article							TRIAL; HIV	Despite high tuberculosis (TB) treatment success rate, treatment adherence is one of the major obstacles to tuberculosis control in Kenya. Our objective was to identify patient-related factors that were associated with time to TB treatment interruption and the geographic distribution of the risk of treatment interruption by county. Data of new and retreatment patients registered in TIBU, a Kenyan national case-based electronic data recording system, between 2013 and 2014 was obtained. Kaplan-Meier curves and log rank tests were used to assess the adherence patterns. Mixed-effects Cox proportional hazards modeling was used for multivariate analysis. Records from 90,170 patients were included in the study. The cumulative incidence of treatment interruption was 4.5% for new patients, and 8.5% for retreatment patients. The risk of treatment interruption was highest during the intensive phase of treatment. Having previously been lost to follow-up was the greatest independent risk factor for treatment interruption (HR: 4.79 [3.99, 5.75]), followed by being HIV-positive not on ART (HR: 1.96 [1.70, 2.26]) and TB relapse (HR: 1.70 [1.44, 2.00]). Male and underweight patients had high risks of treatment interruption (HR: 1.46 [1.35, 1.58]; 1.11 [1.03, 1.20], respectively). High rates of treatment interruption were observed in counties in the central part of Kenya while counties in the northeast had the lowest risk of treatment interruption. A better understanding of treatment interruption risk factors is necessary to improve adherence to treatment. Interventions should focus on patients during the intensive phase, patients who have previously been lost to follow-up, and promotion of integrated TB and HIV services among public and private facilities.	[Masini, Enos O.; Sitienei, Joseph K.; Githiomi, Martin Muhingo] Minist Hlth, Nairobi, Kenya; [Mansour, Omar; Speer, Clare E.; Addona, Vittorio; Hanson, Christy L.] Macalester Coll, St Paul, MN 55105 USA; [Kipruto, Hillary K.] World Hlth Org, Nairobi, Kenya; [Mungai, Brenda Nyambura] Ctr Hlth Solut, Nairobi, Kenya	Macalester College; World Health Organization	Mansour, O (corresponding author), Macalester Coll, St Paul, MN 55105 USA.	omar.mansour19@gmail.com	Kipruto, Hillary/ABB-7126-2021; Addona, Vittorio/T-2114-2019		World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2015, SUSTAINABLE DEV GOAL, V19; Atkins S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-275; Beith A, 2007, PERFORMANCE BASED IN; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Finlay A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-56; Garden B, 2013, SCAND J CARING SCI, V27, P117, DOI 10.1111/j.1471-6712.2012.01009.x; Hermans SM, 2012, JAIDS-J ACQ IMM DEF, V60, pE29, DOI 10.1097/QAI.0b013e318251aeb4; Lee ET, 1997, ANNU REV PUBL HEALTH, V18, P105, DOI 10.1146/annurev.publhealth.18.1.105; Martins N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4248; Maruza M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-351; Ministry of Health: Division of Leprosy Tuberculosis and Lung Disease., 2014, NTLD PROGR ANN REP 2; Ministry of Health: Division of Leprosy Tuberculosis and Lung Disease, 2010, NTLD PROGR ANN REP 2; Ministry of Health: Division of Leprosy Tuberculosis and Lung Disease, 2013, GUID MAN TUB LEPR KE; Ministry of Health: Division ofLeprosy Tuberculosis and Lung Disease., 2016, THE TIBU IN; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Piwoz E., 2008, NUTR TUBERCULOSIS RE, P1; R Core Team, 2013, R LANG ENV STAT COMP; Schon T, 2011, TUBERCULOSIS, V91, P370, DOI 10.1016/j.tube.2011.06.002; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Ullah ANZ, 2012, INT J TUBERC LUNG D, V16, P1637, DOI 10.5588/ijtld.12.0378; Vijay S, 2015, INDIAN J TUBERCULOSI, V50, P185; Vuluku G, 2013, ECONOMICS, V2, P7; Wang JM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-354; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2015, TUB COUNTR PROF KEN	29	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164172	10.1371/journal.pone.0164172	http://dx.doi.org/10.1371/journal.pone.0164172			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706230	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200094
J	Nelson, EJ; Helmus, MR; Cavender-Bares, J; Polasky, S; Lasky, JR; Zanne, AE; Pearse, WD; Kraft, NJB; Miteva, DA; Fagan, WF				Nelson, Erik J.; Helmus, Matthew R.; Cavender-Bares, Jeannine; Polasky, Stephen; Lasky, Jesse R.; Zanne, Amy E.; Pearse, William D.; Kraft, Nathan J. B.; Miteva, Daniela A.; Fagan, William F.			Commercial Plant Production and Consumption Still Follow the Latitudinal Gradient in Species Diversity despite Economic Globalization	PLOS ONE			English	Article							CROP PRODUCTION; FOOD; TRADE; PERCEPTIONS; AGRICULTURE; PREFERENCES; INTEGRATION; VARIETY; COSTS	Increasing trade between countries and gains in income have given consumers around the world access to a richer and more diverse set of commercial plant products (i.e., foods and fibers produced by farmers). According to the economic theory of comparative advantage, countries open to trade will be able to consume more-in terms of volume and diversity-if they concentrate production on commodities that they can most cost-effectively produce, while importing goods that are expensive to produce, relative to other countries. Here, we perform a global analysis of traded commercial plant products and find little evidence that increasing globalization has incentivized agricultural specialization. Instead, a country's plant production and consumption patterns are still largely determined by local evolutionary legacies of plant diversification. Because tropical countries harbor a greater diversity of lineages across the tree of life than temperate countries, tropical countries produce and consume a greater diversity of plant products than do temperate countries. In contrast, the richer and more economically advanced temperate countries have the capacity to produce and consume more plant species than the generally poorer tropical countries, yet this collection of plant species is drawn from fewer branches on the tree of life. Why have countries not increasingly specialized in plant production despite the theoretical financial incentive to do so? Potential explanations include the persistence of domestic agricultural subsidies that distort production decisions, cultural preferences for diverse local food production, and that diverse food production protects rural households in developing countries from food price shocks. Less specialized production patterns will make crop systems more resilient to zonal climatic and social perturbations, but this may come at the expense of global crop production efficiency, an important step in making the transition to a hotter and more crowded world.	[Nelson, Erik J.] Bowdoin Coll, Dept Econ, Brunswick, ME 04011 USA; [Helmus, Matthew R.] Temple Univ, Dept Biol, Ctr Biodivers, Philadelphia, PA 19122 USA; [Helmus, Matthew R.] Vrije Univ, Dept Ecol Sci Anim Ecol, Amsterdam, Netherlands; [Cavender-Bares, Jeannine; Polasky, Stephen; Pearse, William D.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Cavender-Bares, Jeannine; Polasky, Stephen] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Lasky, Jesse R.] Columbia Univ, Earth Inst, New York, NY 10025 USA; [Lasky, Jesse R.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10025 USA; [Zanne, Amy E.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Kraft, Nathan J. B.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Miteva, Daniela A.] Ohio State Univ, Dept Agr Environm & Dev Econ, Columbus, OH 43210 USA; [Fagan, William F.] Univ Maryland, Natl Socioenvironm Synth Ctr SESYNC, Annapolis, MD USA; [Lasky, Jesse R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Pearse, William D.] McGill Univ, Dept Biol, Montreal, PQ, Canada; [Pearse, William D.] Univ Quebec Montreal, Dept Sci Biol, Succursale Ctr Ville, Montreal, PQ, Canada; [Kraft, Nathan J. B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Bowdoin College; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Vrije Universiteit Amsterdam; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Columbia University; Columbia University; George Washington University; University System of Maryland; University of Maryland College Park; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; McGill University; University of Quebec; University of Quebec Montreal; University of California System; University of California Los Angeles	Nelson, EJ (corresponding author), Bowdoin Coll, Dept Econ, Brunswick, ME 04011 USA.	enelson2@bowdoin.edu	Helmus, Matthew R./C-4998-2015; Nelson, Erik J./J-4192-2019; Polasky, Stephen/AAC-5341-2019; Cavender-Bares, Jeannine/K-5716-2013; Kraft, Nathan J. B./A-2817-2012	Helmus, Matthew R./0000-0003-3977-0507; Nelson, Erik J./0000-0002-7291-5192; Kraft, Nathan J. B./0000-0001-8867-7806; Cavender-Bares, Jeannine/0000-0003-3375-9630; Pearse, William D/0000-0002-6241-3164; Miteva, Daniela/0000-0002-9123-646X	National Socio-Environmental Synthesis Center (SESYNC) under National Science Foundation [DBI-1052875]; Netherlant Organisation for Scientific Research [858.14.040]; Lund University's Biodiversity and Ecosystem Services in a Changing Climate; Div Of Biological Infrastructure [1639145, 1052875] Funding Source: National Science Foundation	National Socio-Environmental Synthesis Center (SESYNC) under National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Netherlant Organisation for Scientific Research; Lund University's Biodiversity and Ecosystem Services in a Changing Climate; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation DBI-1052875. Matthew R. Helmus was supported by the Netherlant Organisation for Scientific Research (858.14.040). Erik Nelson wishes to acknowledge the salary support he received from Lund University's Biodiversity and Ecosystem Services in a Changing Climate strategic research area during the writing of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alston JM, 2014, J ECON PERSPECT, V28, P121, DOI 10.1257/jep.28.1.121; Anderson K, 2010, PHILOS T R SOC B, V365, P3007, DOI 10.1098/rstb.2010.0131; [Anonymous], 2013, FAOSTAT DAT; Bernhofen DM, 2013, CESIFO WORKING PAPER; Bonilla E D, 2010, FOOD SECURITY PRICE; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Clark G, 2008, W14077 NAT BUR EC RE; Cornwell WK, 2014, J ECOL, V102, P345, DOI 10.1111/1365-2745.12208; Costinot A, 2012, W17969 NAT BUR EC RE; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; FAFCHAMPS M, 1992, AM J AGR ECON, V74, P90, DOI 10.2307/1242993; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Feldmann C, 2015, FOOD QUAL PREFER, V40, P152, DOI 10.1016/j.foodqual.2014.09.014; Gehlhar M, 2001, CHANGING STRUCTURE G, P4; Hamilton S, 2003, LAT AM RES REV, V38, P82, DOI 10.1353/lar.2003.0033; Hausmann R., 2014, ATLAS EC COMPLEXITY, DOI [10.7551/mitpress/9647.001.0001, DOI 10.7551/MITPRESS/9647.001.0001]; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hoekman B.M., 2009, POLITICAL EC WORLD T; Hsiang SM, 2015, AM ECON REV, V105, P257, DOI 10.1257/aer.p20151030; Hummels D, 2007, J ECON PERSPECT, V21, P131, DOI 10.1257/jep.21.3.131; Hunt D, 2011, 201101 AFP BP; IMMINK MDC, 1993, ECON DEV CULT CHANGE, V41, P319, DOI 10.1086/452013; Jacks DS, 2008, AM ECON REV, V98, P529, DOI 10.1257/aer.98.2.529; JACKSON LF, 1984, REV ECON STAT, V66, P8, DOI 10.2307/1924690; Jakab ZM, 2001, J COMP ECON, V29, P276, DOI 10.1006/jcec.2001.1709; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; LANCASTER K, 1990, MARKET SCI, V9, P189, DOI 10.1287/mksc.9.3.189; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; LeSage J, 2009, STAT TEXTB MONOGR, P1; Liu J, 2014, FOOD POLICY, V49, P323, DOI 10.1016/j.foodpol.2014.09.007; Low S.A., 2015, TRENDS US LOCAL REGI; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Martinez S., 2010, 97 USDA ERS; MESSER E, 1984, ANNU REV ANTHROPOL, V13, P205, DOI 10.1146/annurev.an.13.100184.001225; Nygard B, 1998, SOCIOL RURALIS, V38, P35, DOI 10.1111/1467-9523.00062; O'Brien KL, 2000, GLOBAL ENVIRON CHANG, V10, P221, DOI 10.1016/S0959-3780(00)00021-2; Parrott N, 2002, EUR URBAN REG STUD, V9, P241, DOI 10.1177/096977640200900304; Pearse WD, 2015, BIOINFORMATICS, V31, P2888, DOI 10.1093/bioinformatics/btv277; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Pollack S., 2001, CHANGING STRUCTURE G; SACHS JD, 1995, BROOKINGS PAP ECO AC, P1; Schiebinger L., 2004, COLONIAL BOT SCI COM; Umar BB, 2014, RENEW AGR FOOD SYST, V29, P277, DOI 10.1017/S1742170513000148; US Department of Agriculture Agricultural Research Service, 2019, USDA NATL NUTR DATAB; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wierenga B, 1984, INT J RES MARK, V1, P263; World Bank, 2015, WORLD BANK OP DAT; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872	52	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163002	10.1371/journal.pone.0163002	http://dx.doi.org/10.1371/journal.pone.0163002			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706180	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200029
J	Tahara, T; Shibata, T; Horiguchi, N; Kawamura, T; Okubo, M; Ishizuka, T; Nagasaka, M; Nakagawa, Y; Ohmiya, N				Tahara, Tomomitsu; Shibata, Tomoyuki; Horiguchi, Noriyuki; Kawamura, Tomohiko; Okubo, Masaaki; Ishizuka, Takamitsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki			A Possible Link between Gastric Mucosal Atrophy and Gastric Cancer after Helicobacter pylori Eradication	PLOS ONE			English	Article							MONGOLIAN GERBILS; FOLLOW-UP; INFECTION; CARCINOGENESIS; CARCINOMA; ULCER; RISK	Background The effect of H. pylori eradication in gastric cancer prevention can be attributed to the improvement of atrophic gastritis, which is a known risk of gastric cancer. However, gastric cancer has also been diagnosed after long-term H. pylori eradication. This study aimed to clarify the association between gastric atrophy and gastric cancer after H. pylori eradication, including its clinicopathological features. Methods A total of 55 consecutive patients with 64 early gastric cancers (EGCs) diagnosed after H. pylori eradication were enrolled. The degree of endoscopic atrophy and the histological degrees of mononuclear cell infiltration, atrophy, and metaplasia in the corpus and adjacent mucosa of the EGCs were determined and scored. Results The majority of EGCs (63/64) were located within the endoscopically assessed atrophic mucosa or along the atrophic border. The adjacent mucosa of the EGCs presented significantly higher degrees of all histological parameters than in the corpus (mononuclear cell infiltration, 0.86+/-0.09 vs. 0.51+/-0.11, P = 0.016; atrophy, 1.77+/-0.13 vs. 0.65+/-0.14, P<0.0001; metaplasia, 1.68+/-0.13 vs. 0.48+/-0.1, P<0.0001). The degree of endoscopic atrophy improved in the patients with longer post-H. pylori eradication periods; however, this trend was not observed for the histological parameters, and high degrees of atrophy and metaplasia were observed in the adjacent mucosa of the EGCs compared with the corpus during all periods (all P<0.05). The histological degrees of atrophy and metaplasia in the adjacent mucosa were particularly higher in the patients who underwent eradication due to gastric ulcers. Conclusions Severe gastric atrophy remained in the adjacent mucosa of the EGCs after H. pylori eradication, which may be linked to gastric carcinogenesis.	[Tahara, Tomomitsu; Shibata, Tomoyuki; Horiguchi, Noriyuki; Kawamura, Tomohiko; Okubo, Masaaki; Ishizuka, Takamitsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki] Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi, Japan	Fujita Health University	Tahara, T (corresponding author), Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi, Japan.	tomomiccyu@yahoo.co.jp						CORREA P, 1995, AM J SURG PATHOL, V19, pS37; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Hanaoka N, 2010, J GASTROEN HEPATOL, V25, P1844, DOI 10.1111/j.1440-1746.2010.06442.x; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; Ito M, 2005, ALIMENT PHARM THER, V21, P559, DOI 10.1111/j.1365-2036.2005.02360.x; Kamada T, 2005, ALIMENT PHARM THER, V21, P1121, DOI 10.1111/j.1365-2036.2005.02459.x; Kimura K, 1973, ENDOSCOPY, V5, P21, DOI DOI 10.1055/S-0028-1098086; Kobayashi M, 2013, J GASTROENTEROL, V48, P1332, DOI 10.1007/s00535-013-0764-7; LEE S, 1990, SCAND J GASTROENTERO, V25, P1223, DOI 10.3109/00365529008998557; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Saka A, 2015, GASTRIC CANCER, DOI [10.1016/j.gie.2015.03.1860, DOI 10.1016/J.GIE.2015.03.1860]; Shimizu N, 2000, CANCER RES, V60, P1512; Sugano K, 2015, GUT, V64, P1353, DOI 10.1136/gutjnl-2015-309252; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Yamamoto K, 2011, HELICOBACTER, V16, P210, DOI 10.1111/j.1523-5378.2011.00833.x	18	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163700	10.1371/journal.pone.0163700	http://dx.doi.org/10.1371/journal.pone.0163700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706195	gold, Green Submitted, Green Published			2022-12-27	WOS:000385697200055
J	Li, K; Zou, JN; Ye, ZB; Di, JZ; Han, XD; Zhang, HW; Liu, WJ; Ren, QG; Zhang, P				Li, Kun; Zou, Jianan; Ye, Zhibin; Di, Jianzhong; Han, Xiaodong; Zhang, Hongwei; Liu, Weijie; Ren, Qinggui; Zhang, Pin			Effects of Bariatric Surgery on Renal Function in Obese Patients: A Systematic Review and Meta Analysis	PLOS ONE			English	Review							Y GASTRIC BYPASS; CHRONIC KIDNEY-DISEASE; WEIGHT-LOSS; MICROVASCULAR COMPLICATIONS; GLOMERULAR HYPERFILTRATION; DIABETIC-NEPHROPATHY; METABOLIC SYNDROME; MEDICAL THERAPY; ADIPOSE-TISSUE; TYPE-2	Background Obesity is an independent risk factor of development and progression of chronic kidney disease (CKD). Data on the benefits of bariatric surgery in obese patients with impaired kidney function have been conflicting. Objective To explore whether there is improvement in glomerular filtration rate (GFR), proteinuria or albuminuria after bariatric surgery. Methods We comprehensively searched the databases of MEDLINE, Embase, web of science and Cochrane for randomized, controlled trials and observational studies that examined bariatric surgery in obese subjects with impaired kidney function. Outcomes included the pre- and post-bariatric surgery GFR, proteinuria and albuminuria. In obese patients with hyperfiltration, we draw conclusions from studies using measured GFR (inulin or iothalamate clearance) unadjusted for BSA only. Study quality was evaluated using the Newcastle-Ottawa Scale. Results 32 observational studies met our inclusion criteria, and 30 studies were included in the meta-analysis. No matter in dichotomous data or in dichotomous data, there were statistically significant reduction in hyperfiltration, albuminuria and proteinuria after bariatric surgery. Limitations The main limitation of this meta-analysis is the lack of randomized controlled trials (RCTs). Another limitation is the lack of long-term follow-up. Conclusions Bariatric surgery could prevent further decline in renal function by reducing proteinuria, albuminuria and improving glomerular hyperfiltration in obese patients with impaired renal function. However, whether bariatric surgery reverses CKD or delays ESRD progression is still in question, large, randomized prospective studies with a longer follow-up are needed.	[Li, Kun] Fudan Univ, Huadong Hosp, Dept Gen Surg, Shanghai, Peoples R China; [Zou, Jianan; Ye, Zhibin] Fudan Univ, Huadong Hosp, Dept Nephrol, Shanghai, Peoples R China; [Di, Jianzhong; Han, Xiaodong; Zhang, Hongwei; Liu, Weijie; Ren, Qinggui; Zhang, Pin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Gen Surg, Shanghai, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Li, K (corresponding author), Fudan Univ, Huadong Hosp, Dept Gen Surg, Shanghai, Peoples R China.	leeq8110@163.com	han, xiao/HDN-9782-2022					Abouchacra S, 2013, INT UROL NEPHROL, V45, P157, DOI 10.1007/s11255-012-0131-2; Afshinnia F, 2010, NEPHROL DIAL TRANSPL, V25, P1173, DOI 10.1093/ndt/gfp640; Agrawal V, 2008, CLIN NEPHROL, V70, P194; Amor A, 2013, SURG ENDOSC, V27, P2046, DOI 10.1007/s00464-012-2708-3; Aneja A, 2004, RECENT PROG HORM RES, V59, P169, DOI 10.1210/rp.59.1.169; Bolignano D, 2013, NEPHROL DIAL TRANSPL, V28, P82, DOI 10.1093/ndt/gft302; BROCHNERMORTENSEN J, 1980, SCAND J CLIN LAB INV, V40, P695, DOI 10.3109/00365518009095584; Brolin RE, 2002, JAMA-J AM MED ASSOC, V288, P2793, DOI 10.1001/jama.288.22.2793; Celik F, 2013, OBES SURG, V23, P358, DOI 10.1007/s11695-012-0764-3; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chagnac A, 2008, NEPHROL DIAL TRANSPL, V23, P3946, DOI 10.1093/ndt/gfn379; Zeve JLD, 2013, ABCD-ARQ BRAS CIR DI, V26, P47; Decleves AE, 2015, CURR OPIN NEPHROL HY, V24, P28, DOI 10.1097/MNH.0000000000000087; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fenske WK, 2013, SURG OBES RELAT DIS, V9, P559, DOI 10.1016/j.soard.2012.03.009; Friedman AN, 2014, AM J KIDNEY DIS, V63, P598, DOI 10.1053/j.ajkd.2013.11.012; Friedman AN, 2014, AM J NEPHROL, V39, P8, DOI 10.1159/000357231; Gansevoort RT, 2009, J AM SOC NEPHROL, V20, P465, DOI 10.1681/ASN.2008111212; Getty JLZ, 2012, OBES SURG, V22, P1055, DOI 10.1007/s11695-012-0617-0; Gonzalez-Heredia R, 2016, BARIATR SURG PRACT P, V11, P6, DOI 10.1089/bari.2015.0032; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Hallan SI, 2009, J AM SOC NEPHROL, V20, P1069, DOI 10.1681/ASN.2008070730; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Heneghan HM, 2013, SURG OBES RELAT DIS, V9, P7, DOI 10.1016/j.soard.2012.08.016; Hou CC, 2013, SURG OBES RELAT DIS, V9, P202, DOI 10.1016/j.soard.2012.10.005; Iaconelli A, 2011, DIABETES CARE, V34, P561, DOI 10.2337/dc10-1761; Johnson DW, 2012, MED J AUSTRALIA, V197, P224, DOI 10.5694/mja11.11468; Jones DR, 2009, MED CLIN N AM, V93, P1083, DOI 10.1016/j.mcna.2009.05.006; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kim E, 2015, POLYMERS-BASEL, V7, P1, DOI 10.3390/polym7010001; Kota SK, 2011, INT J ENDOCRINOL MET, V9, P374, DOI 10.5812/Kowsar.1726913X.2782; Kumar KVSH, 2009, DIABETES TECHNOL THE, V11, P785, DOI 10.1089/dia.2009.0070; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lieske JC, 2014, AM J KIDNEY DIS, V64, P663, DOI 10.1053/j.ajkd.2014.06.016; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Miras AD, 2015, DIABETOLOGIA, V58, P1443, DOI 10.1007/s00125-015-3595-7; Miras AD, 2012, DIABETES CARE, V35, pE81, DOI 10.2337/dc11-2353; Mohan S, 2012, OBES SURG, V22, P375, DOI 10.1007/s11695-011-0437-7; Navaneethan SD, 2009, SURG OBES RELAT DIS, V5, P662, DOI 10.1016/j.soard.2009.01.006; Navaneethan SD, 2010, OBES SURG, V20, P308, DOI 10.1007/s11695-009-0026-1; Navaneethan SD, 2009, CLIN J AM SOC NEPHRO, V4, P1565, DOI 10.2215/CJN.02250409; Navarro-Diaz M, 2006, J AM SOC NEPHROL, V17, pS213, DOI 10.1681/ASN.2006080917; Neff KJ, 2013, CURR OBES REP, V2, P120, DOI 10.1007/s13679-013-0050-2; Neff KJ, 2015, EXPERT REV ENDOCRINO, V10, P435, DOI 10.1586/17446651.2015.1054808; Ngoh CLY, 2016, SURG OBES RELAT DIS, V12, P600, DOI 10.1016/j.soard.2015.07.003; Palomar R, 2005, OBES SURG, V15, P794, DOI 10.1381/0960892054222687; Reid TJ, 2014, SURG OBES RELAT DIS, V10, P808, DOI 10.1016/j.soard.2014.02.048; Rosenberg DE, 2005, DIABETES OBES METAB, V7, P642, DOI 10.1111/j.1463-1326.2004.00446.x; Ruiz-Tovar J, 2015, OBES SURG, V25, P796, DOI 10.1007/s11695-014-1486-5; Saliba J, 2010, SURGERY, V147, P282, DOI 10.1016/j.surg.2009.09.017; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schwingshackl L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097656; Neto AS, 2009, J NEPHROL, V22, P637; Serra A, 2008, KIDNEY INT, V73, P947, DOI 10.1038/sj.ki.5002796; Stephenson DT, 2013, DIABETES VASC DIS RE, V10, P514, DOI 10.1177/1479164113498083; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tanner RM, 2012, CURR HYPERTENS REP, V14, P152, DOI 10.1007/s11906-012-0254-y; Van Huffel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113667; VERANI RR, 1992, AM J KIDNEY DIS, V20, P629, DOI 10.1016/S0272-6386(12)70230-5; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Wuerzner G, 2010, AM J KIDNEY DIS, V56, P303, DOI 10.1053/j.ajkd.2010.03.017; Zakaria AS, 2016, SURG OBES RELAT DIS, V12, P587, DOI 10.1016/j.soard.2015.10.062; Zalesin KC, 2006, ADV CHRONIC KIDNEY D, V13, P403, DOI 10.1053/j.ackd.2006.07.008; Zhang HW, 2015, OBES SURG, V25, P1263, DOI 10.1007/s11695-015-1666-y	68	66	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163907	10.1371/journal.pone.0163907	http://dx.doi.org/10.1371/journal.pone.0163907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701452	gold, Green Published, Green Submitted			2022-12-27	WOS:000385696900029
J	Flowerika; Alok, A; Kumar, J; Thakur, N; Pandey, A; Pandey, AK; Upadhyay, SK; Tiwari, S				Flowerika; Alok, Anshu; Kumar, Jitesh; Thakur, Neha; Pandey, Ashutosh; Pandey, Ajay Kumar; Upadhyay, Santosh Kumar; Tiwari, Siddharth			Characterization and Expression Analysis of Phytoene Synthase from Bread Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CAROTENOID BIOSYNTHETIC-PATHWAY; LIGHT-DEPENDENT REGULATION; GENE FAMILY; CDNA CLONING; ARABIDOPSIS; LYCOPENE; ENZYMES; CAROTENOGENESIS; PROVITAMIN; EVOLUTION	Phytoene synthase (PSY) regulates the first committed step of the carotenoid biosynthetic pathway in plants. The present work reports identification and characterization of the three PSY genes (TaPSY1, TaPSY2 and TaPSY3) in wheat (Triticum aestivum L.). The TaPSY1, TaPSY2, and TaPSY3 genes consisted of three homoeologs on the long arm of group 7 chromosome (7L), short arm of group 5 chromosome (5S), and long arm of group 5 chromosome (5L), respectively in each subgenomes (A, B, and D) with a similarity range from 89% to 97%. The protein sequence analysis demonstrated that TaPSY1 and TaPSY3 retain most of conserved motifs for enzyme activity. Phylogenetic analysis of all TaPSY revealed an evolutionary relationship among PSY proteins of various monocot species. TaPSY derived from A and D subgenomes shared proximity to the PSY of Triticum urartu and Aegilops tauschii, respectively. The differential expression of TaPSY1, TaPSY2, and TaPSY3 in the various tissues, seed development stages, and stress treatments suggested their role in plant development, and stress condition. TaPSY3 showed higher expression in all tissues, followed by TaPSY1. The presence of multiple stress responsive cis-regulatory elements in promoter region of TaPSY3 correlated with the higher expression during drought and heat stresses has suggested their role in these conditions. The expression pattern of TaPSY3 was correlated with the accumulation of a-carotene in the seed developmental stages. Bacterial complementation assay has validated the functional activity of each TaPSY protein. Hence, TaPSY can be explored in developing genetically improved wheat crop.	[Flowerika; Alok, Anshu; Kumar, Jitesh; Thakur, Neha; Pandey, Ashutosh; Pandey, Ajay Kumar; Tiwari, Siddharth] Govt India, Natl Agri Food Biotechnol Inst NABI, Dept Biotechnol, Minist Sci & Technol, C-127,Ind Area,Phase 8, Mohali 160071, Punjab, India; [Upadhyay, Santosh Kumar] Panjab Univ, Dept Bot, Chandigarh 160014, India; [Flowerika] Panjab Univ, Dept Biotechnol, Chandigarh 160014, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Panjab University; Panjab University	Tiwari, S (corresponding author), Govt India, Natl Agri Food Biotechnol Inst NABI, Dept Biotechnol, Minist Sci & Technol, C-127,Ind Area,Phase 8, Mohali 160071, Punjab, India.; Upadhyay, SK (corresponding author), Panjab Univ, Dept Bot, Chandigarh 160014, India.	santoshpandit16@gmail.com; siddharthdna20@yahoo.com	Upadhyay, Santosh/ABD-2302-2020; Alok, Anshu/AAA-2100-2020; Kumar, Jitesh/ABB-5150-2021; Tiwari, Siddharth/AAC-5135-2020; Tiwari, Siddharth/V-3054-2017	Upadhyay, Santosh/0000-0001-6991-0502; Kumar, Jitesh/0000-0003-1606-3420; Tiwari, Siddharth/0000-0003-3958-8465; Tiwari, Siddharth/0000-0003-3958-8465; Pandey, Ashutosh/0000-0002-5018-9628; Alok, Dr. Anshu/0000-0002-0733-9117; Pandey, Ajay Kumar/0000-0003-1064-139X	NABI CORE Research Grant; SERB, DST (Government of India) for Young Scientist Start up Research Grant [SB/YS/LS-214/2013]; DST (Government of India)	NABI CORE Research Grant; SERB, DST (Government of India) for Young Scientist Start up Research Grant; DST (Government of India)(Department of Science & Technology (India))	This study was funded by NABI CORE Research Grant and partially from SERB, DST (Government of India) for Young Scientist Start up Research Grant (SB/YS/LS-214/2013) to ST. SKU is thankful to DST (Government of India), for DST Inspire faculty fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, P NATL ACAD SCI USA, V100, P4649, DOI 10.1073/pnas.0630618100; Alok A, 2015, PLANT GENE, V4, P10, DOI DOI 10.1016/J.PLGENE.2015.09.004; Ampomah-Dwamena C, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0573-7; Annpomah-Dwamena C, 2012, J EXP BOT, V63, P4497, DOI 10.1093/jxb/ers134; Arango J, 2010, PLANTA, V232, P1251, DOI 10.1007/s00425-010-1250-6; Badakhshan H., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V6, P57; Bai L, 2009, PLANT J, V59, P588, DOI 10.1111/j.1365-313X.2009.03899.x; BARTLEY GE, 1993, J BIOL CHEM, V268, P25718; Crawford AC, 2013, MOL GENET GENOMICS, V288, P483, DOI 10.1007/s00438-013-0767-3; Cunningham FX, 2007, PHOTOSYNTH RES, V92, P245, DOI 10.1007/s11120-007-9210-0; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.2307/3870254; Dibari B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-221; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; Gallagher CE, 2004, PLANT PHYSIOL, V135, P1776, DOI 10.1104/pp.104.039818; GIULIANO G, 1993, PLANT CELL, V5, P379, DOI 10.1105/tpc.5.4.379; Han YJ, 2013, BIOLOGIA, V68, P258, DOI 10.2478/s11756-013-0002-z; Hirschberg J, 2001, CURR OPIN PLANT BIOL, V4, P210, DOI 10.1016/S1369-5266(00)00163-1; Howitt CA, 2006, PLANT CELL ENVIRON, V29, P435, DOI 10.1111/j.1365-3040.2005.01492.x; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Li FQ, 2008, PLANT PHYSIOL, V147, P1334, DOI 10.1104/pp.108.122119; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Li FQ, 2009, PLANT SIGNAL BEHAV, V4, P208, DOI 10.4161/psb.4.3.7798; Lopez-Emparan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114878; Matsumoto H, 2007, J AGR FOOD CHEM, V55, P2356, DOI 10.1021/jf062629c; Mlalazi B, 2012, PLANTA, V236, P1585, DOI 10.1007/s00425-012-1717-8; Pizarro L, 2009, CIENC INVESTIG AGRAR, V36, P143; Salse J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-555; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shumayla, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153925; Simkin AJ, 2003, J PLANT PHYSIOL, V160, P439, DOI 10.1078/0176-1617-00871; Singh P, 2008, COMPR REV FOOD SCI F, V7, P255, DOI 10.1111/j.1541-4337.2008.00044.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wang C, 2014, J EXP BOT, V65, P2545, DOI 10.1093/jxb/eru138; Welsch R, 2000, PLANTA, V211, P846, DOI 10.1007/s004250000352; Welsch R, 2008, PLANT PHYSIOL, V147, P367, DOI 10.1104/pp.108.117028; Young PR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-243; Zeng J, 2015, J AGR FOOD CHEM, V63, P9083, DOI 10.1021/acs.jafc.5b04279; Zhou XJ, 2015, P NATL ACAD SCI USA, V112, P3558, DOI 10.1073/pnas.1420831112	41	19	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162443	10.1371/journal.pone.0162443	http://dx.doi.org/10.1371/journal.pone.0162443			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695116	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100013
J	Chen, R; Schwander, M; Barbe, MF; Chan, MM				Chen, Rensa; Schwander, Martin; Barbe, Mary F.; Chan, Marion M.			Ossicular Bone Damage and Hearing Loss in Rheumatoid Arthritis: A Correlated Functional and High Resolution Morphometric Study in Collagen-Induced Arthritic Mice	PLOS ONE			English	Article							MIDDLE-EAR FUNCTION; INVOLVEMENT; MODEL; CHOLESTEATOMA; DEAFNESS; DISEASE	Globally, a body of comparative case-control studies suggests that rheumatoid arthritis (RA) patients are more prone to developing hearing loss (HL). However, experimental evidence that supports this hypothesis is still lacking because the human auditory organ is not readily accessible. The aim of this study was to determine the association between bone damage to the ossicles of the middle ear and HL, using a widely accepted murine model of collagen-induced arthritis (RA mice). Diarthrodial joints in the middle ear were examined with microcomputer tomography (microCT), and hearing function was assessed by auditory brainstem response (ABR). RA mice exhibited significantly decreased hearing sensitivity compared to age-matched controls. Additionally, a significant narrowing of the incudostapedial joint space and an increase in the porosity of the stapes were observed. The absolute latencies of all ABR waves were prolonged, but mean interpeak latencies were not statistically different. The observed bone defects in the middle ear that were accompanied by changes in ABR responses were consistent with conductive HL. This combination suggests that conductive impairment is at least part of the etiology of RA-induced HL in a murine model. Whether the inner ear sustains bone erosion or other pathology, and whether the cochlear nerve sustains pathology await subsequent studies. Considering the fact that certain anti-inflammatories are ototoxic in high doses, monitoring RA patients' auditory function is advisable as part of the effort to ensure their well-being.	[Chen, Rensa; Chan, Marion M.] Temple Univ, Lewis Katz Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Schwander, Martin] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Barbe, Mary F.] Temple Univ, Lewis Katz Sch Med, Dept Anat, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Chan, MM (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA.	marion.chan@temple.edu		Chan, Marion/0000-0003-1706-2964	National Institutes of Health [R21R21AR051761, 1R03AR063290, R01DC013331, 1S10RR026727]; Aresty Research Center at Rutgers University; Temple University College of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Aresty Research Center at Rutgers University; Temple University College of Science and Technology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	MC was funded by National Institutes of Health grants R21R21AR051761 and 1R03AR063290. MS was funded by National Institutes of Health grant R01DC013331, and MB was funded by National Institutes of Health grant 1S10RR026727.; The authors thank Dr. Kenny H Chan for sharing his clinical knowledge and reading the manuscript, Dr. Dunne Fong and Dr. Pamela Roehm for reading and commenting on the manuscript and Ms. Manta Amin for valuable technical assistance in the microCT study. RC was supported by a research fellowship from the Aresty Research Center at Rutgers University. The authors also thank Temple University College of Science and Technology undergraduate research program for financial and undergraduate student support. We thank Ms. Jessica Walsh for her work on the graphics and refining of the manuscript. Finally, we are grateful to Dr. Rosowski for his inspiring insights and suggestions on the manuscript.	Alonso L, 2011, Hindawi.Com. ISRN Rheumatol, DOI [10.5402/2011/208627, DOI 10.5402/2011/208627]; Bayazit YA, 2007, ORL-J OTO-RHIN-LARYN, V69, P233, DOI 10.1159/000101544; Biasi D, 1996, CLIN EXP RHEUMATOL, V14, P243; Cazals Y, 2000, PROG NEUROBIOL, V62, P583, DOI 10.1016/S0301-0082(00)00027-7; Chan MM, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0565-x; Chan MMY, 2010, J IMMUNOL, V184, P6418, DOI 10.4049/jimmunol.0903816; Colletti V, 1997, AUDIOLOGY, V36, P136; Decraemer WF, 2002, JARO-J ASSOC RES OTO, V4, P250; Dikici O, 2009, EUR ARCH OTO-RHINO-L, V266, P1719, DOI 10.1007/s00405-009-0975-y; ELWANY S, 1986, J RHEUMATOL, V13, P878; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Callejo FJG, 2007, ACTA OTORRINOLAR ESP, V58, P232, DOI 10.1016/S0001-6519(07)74919-1; Halligan CS, 2006, LARYNGOSCOPE, V116, P2044, DOI 10.1097/01.mlg.0000241365.54017.32; HOLMDAHL R, 1989, APMIS, V97, P575, DOI 10.1111/j.1699-0463.1989.tb00446.x; Ikiz AO, 2007, INT J PEDIATR OTORHI, V71, P1079, DOI 10.1016/j.ijporl.2007.03.017; Jahn AF, 2001, PHYSL EAR, P689; JUNG TTK, 1995, ACTA OTO-LARYNGOL, V115, P251, DOI 10.3109/00016489509139302; KAKANI RS, 1990, J OTOLARYNGOL, V19, P100; KASTANIOUDAKIS I, 1995, J LARYNGOL OTOL, V109, P713, DOI 10.1017/S0022215100131135; KITANO H, 1988, AM J OTOL, V9, P465; Lee JH, 2009, ANAT HISTOL EMBRYOL, V38, P311, DOI 10.1111/j.1439-0264.2009.00946.x; Lorenzi MC, 2003, LARYNGOSCOPE, V113, P312, DOI 10.1097/00005537-200302000-00021; MAGARO M, 1990, CLIN EXP RHEUMATOL, V8, P487; MAGARO M, 1984, ANN RHEUM DIS, V43, P658, DOI 10.1136/ard.43.4.658; Massicotte VS, 2015, EXP GERONTOL, V72, P204, DOI 10.1016/j.exger.2015.10.014; Mileshina N. A., 2015, Vestnik Otorinolaringologii, P25, DOI 10.17116/otorino201580125-27; Morita Y, 2014, AURIS NASUS LARYNX, V41, P417, DOI 10.1016/j.anl.2014.05.002; Murdin L, 2008, CLIN RHEUMATOL, V27, P637, DOI 10.1007/s10067-007-0802-z; Muszynski Piotr, 2007, Otolaryngol Pol, V61, P972, DOI 10.1016/S0030-6657(07)70563-2; Nakajima HH, 2005, LARYNGOSCOPE, V115, P147, DOI 10.1097/01.mlg.0000150692.23506.b7; Ozcan M, 2002, RHEUMATOL INT, V22, P16, DOI 10.1007/s00296-002-0185-z; Ozturk A, 2004, AM J OTOLARYNG, V25, P411, DOI 10.1016/j.amjoto.2004.06.001; Qin ZB, 2010, HEARING RES, V263, P93, DOI 10.1016/j.heares.2009.10.002; Raut VV, 2001, J OTOLARYNGOL, V30, P289, DOI 10.2310/7070.2001.19580; ROSENBERG JN, 1978, ANN RHEUM DIS, V37, P522, DOI 10.1136/ard.37.6.522; Rosloniec Edward F, 2001, Curr Protoc Immunol, VChapter 15, DOI [10.1002/0471142735.im1505s89, 10.1002/0471142735.im1505s20]; Salomonsen RL, 2010, OTOL NEUROTOL, V31, P1109, DOI 10.1097/MAO.0b013e3181e9becb; Salvinelli F, 2004, CLIN OTOLARYNGOL, V29, P75, DOI 10.1111/j.1365-2273.2004.00783.x; Schwander M, 2009, P NATL ACAD SCI USA, V106, P5252, DOI 10.1073/pnas.0900691106; Sharma K, 2013, INDIAN J OTOLARYNGOL, V65, pS493, DOI 10.1007/s12070-011-0372-x; SIAMOPOULOUMAVRIDOU A, 1990, ANN RHEUM DIS, V49, P620, DOI 10.1136/ard.49.8.620; Takatsu M, 2005, OTOL NEUROTOL, V26, P755, DOI 10.1097/01.mao.0000178138.19848.bd; Takeda T, 1996, AM J OTOL, V17, P69; Tavernier L, 2011, OTOL NEUROTOL, V32, pE5, DOI 10.1097/MAO.0b013e3181d2f039; WALEK H, 1980, Z RHEUMATOL, V39, P91; Willott James F, 2006, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0821bs34; Yilmaz S, 2007, AURIS NASUS LARYNX, V34, P307, DOI 10.1016/j.anl.2006.11.003; YOO TJ, 1985, AM J OTOLARYNG, V6, P209, DOI 10.1016/S0196-0709(85)80087-9; YOO TJ, 1984, ANN OTO RHINOL LARYN, V93, P3, DOI 10.1177/00034894840930S502; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zhu TY, 2013, J BONE MINER RES, V28, P794, DOI 10.1002/jbmr.1793	51	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							0164078	10.1371/journal.pone.0164078	http://dx.doi.org/10.1371/journal.pone.0164078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690307	Green Published, Green Submitted, gold			2022-12-27	WOS:000384329200040
J	Glajch, KE; Ferraiuolo, L; Mueller, KA; Stopford, MJ; Prabhkar, V; Gravanis, A; Shaw, PJ; Sadri-Vakili, G				Glajch, Kelly E.; Ferraiuolo, Laura; Mueller, Kaly A.; Stopford, Matthew J.; Prabhkar, Varsha; Gravanis, Achille; Shaw, Pamela J.; Sadri-Vakili, Ghazaleh			MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CILIARY NEUROTROPHIC FACTOR; BLOOD-BRAIN-BARRIER; DEHYDROEPIANDROSTERONE DHEA PROTECTS; FACTOR GENE-THERAPY; SPINAL-CORD; FAMILIAL ALS; NEURODEGENERATIVE DISORDERS; INTRATHECAL BDNF; CONTROLLED-TRIAL; FACTOR PREVENTS	Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease caused by loss of motor neurons. ALS patients experience rapid deterioration in muscle function with an average lifespan of 3-5 years after diagnosis. Currently, the most effective therapeutic only extends lifespan by a few months, thus highlighting the need for new and improved therapies. Neurotrophic factors (NTFs) are important for neuronal development, maintenance, and survival. NTF treatment has previously shown efficacy in pre-clinical ALS models. However, clinical trials using NTFs produced no major improvements in ALS patients, due in part to the limited blood brain barrier (BBB) penetration. In this study we assessed the potential neuroprotective effects of a novel class of compounds known as MicroNeurotrophins (MNTs). MNTs are derivatives of Dehydroepiandrosterone (DHEA), an endogenous neurosteroid that can cross the BBB and bind to tyrosine kinase receptors mimicking the pro-survival effects of NTFs. Here we sought to determine whether MNTs were neuroprotective in two different models of ALS. Our results demonstrate that BNN27 (10 mu M) attenuated loss of motor neurons co-cultured with astrocytes derived from human ALS patients with SOD1 mutations via the reduction of oxidative stress. Additionally, in the G93A SOD1 mouse, BNN27 (10 mg/kg) treatment attenuated motor behavioral impairment in the paw grip endurance and rotarod tasks at postnatal day 95 in female but not male mice. In contrast, BNN27 (10 mg/kg and 50 mg/kg) treatment did not alter any other behavioral outcome or neuropathological marker in male or female mice. Lastly, BNN27 was not detected in post-mortem brain or spinal cord tissue of treated mice due to the rapid metabolism of BNN27 by mouse hepatocytes relative to human hepatocytes. Together, these findings demonstrate that BNN27 treatment failed to yield significant neuroprotective effects in the G93A SOD1 model likely due to its rapid rate of metabolism in mice.	[Glajch, Kelly E.; Mueller, Kaly A.; Prabhkar, Varsha; Sadri-Vakili, Ghazaleh] Massachusetts Gen Hosp, MIND, NeuroEpigenet Lab, Boston, MA 02129 USA; [Ferraiuolo, Laura; Stopford, Matthew J.; Shaw, Pamela J.] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, 385A Glossop Rd, Sheffield S10 2HQ, S Yorkshire, England; [Gravanis, Achille] Univ Crete, Sch Med, Inst Mol Biol & Biotechnol FORTH, Dept Pharmacol, Iraklion 71003, Greece	Harvard University; Massachusetts General Hospital; University of Sheffield; University of Crete	Sadri-Vakili, G (corresponding author), Massachusetts Gen Hosp, MIND, NeuroEpigenet Lab, Boston, MA 02129 USA.	gsadrivakili@mgh.harvard.edu	Ferraiuolo, Laura/E-5834-2010	Ferraiuolo, Laura/0000-0001-9118-5714; Mueller, Kaly/0000-0003-2392-8058; Shaw, Pamela/0000-0002-8925-2567	ALS World Wide; National Institute for Health Research [NF-SI-0512-10082] Funding Source: researchfish	ALS World Wide; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by ALS World Wide.	Acsadi G, 2002, HUM GENE THER, V13, P1047, DOI 10.1089/104303402753812458; Alves CJ, 2011, BRAIN RES, V1394, P90, DOI 10.1016/j.brainres.2011.02.060; ANAND P, 1995, NAT MED, V1, P168, DOI 10.1038/nm0295-168; Asaba H, 2000, J NEUROCHEM, V75, P1907, DOI 10.1046/j.1471-4159.2000.0751907.x; Bame M, 2012, GENDER MED, V9, P524, DOI 10.1016/j.genm.2012.10.014; Barneoud P, 1997, NEUROREPORT, V8, P2861, DOI 10.1097/00001756-199709080-00012; Bartus RT, 2017, NEUROBIOL DIS, V97, P169, DOI 10.1016/j.nbd.2016.03.026; Bastianetto S, 1999, MOL BRAIN RES, V66, P35, DOI 10.1016/S0169-328X(99)00002-9; Baulieu EE, 1998, P NATL ACAD SCI USA, V95, P4089, DOI 10.1073/pnas.95.8.4089; Beck M, 2005, AMYOTROPH LATERAL SC, V6, P100, DOI 10.1080/14660820510028412; Bemelmans AP, 2006, J NEUROSCI RES, V83, P50, DOI 10.1002/jnr.20704; Bennett JP, 2016, BIOCHEM PHARMACOL, V117, P68, DOI 10.1016/j.bcp.2016.08.001; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bilican B, 2012, P NATL ACAD SCI USA, V109, P5803, DOI 10.1073/pnas.1202922109; Calogeropoulou T, 2009, J MED CHEM, V52, P6569, DOI 10.1021/jm900468p; Cervetto C, 2013, TOXICOLOGY, V311, P69, DOI 10.1016/j.tox.2013.04.004; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Charalampopoulos I, 2008, TRENDS ENDOCRIN MET, V19, P300, DOI 10.1016/j.tem.2008.07.004; CHIU AY, 1995, MOL CELL NEUROSCI, V6, P349, DOI 10.1006/mcne.1995.1027; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; CORPECHOT C, 1981, P NATL ACAD SCI-BIOL, V78, P4704, DOI 10.1073/pnas.78.8.4704; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052; Eschbach J, 2013, HUM MOL GENET, V22, P3477, DOI 10.1093/hmg/ddt202; Ferrante RJ, 2001, J MOL NEUROSCI, V17, P89, DOI 10.1385/JMN:17:1:89; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Franz CK, 2009, NEUROBIOL DIS, V33, P473, DOI 10.1016/j.nbd.2008.12.003; Glajch KE, 2012, BEHAV BRAIN RES, V230, P309, DOI 10.1016/j.bbr.2011.12.007; Gould TW, 2011, BRAIN RES REV, V67, P1, DOI 10.1016/j.brainresrev.2010.10.003; Gravanis A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003387; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Harlan BA, 2016, J BIOL CHEM, V291, P10836, DOI 10.1074/jbc.M115.698779; Hatzipetros T, 2015, JOVE-J VIS EXP, DOI 10.3791/53257; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayworth CR, 2009, NEUROSCIENCE, V164, P975, DOI 10.1016/j.neuroscience.2009.08.031; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Heiman-Patterson TD, 2005, J NEUROL SCI, V236, P1, DOI 10.1016/j.jns.2005.02.006; Henriques A, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00032; IKEDA K, 1995, ANN NEUROL, V37, P505, DOI 10.1002/ana.410370413; Kalra S, 2003, AMYOTROPH LATERAL SC, V4, P22, DOI 10.1080/14660820301179; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Kastin AJ, 2003, NEUROSCI LETT, V340, P239, DOI 10.1016/S0304-3940(03)00007-7; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kimonides VG, 1998, P NATL ACAD SCI USA, V95, P1852, DOI 10.1073/pnas.95.4.1852; Kirby J, 2005, BRAIN, V128, P1686, DOI 10.1093/brain/awh503; Kirkinezos IG, 2004, J NEUROCHEM, V88, P821, DOI 10.1046/j.1471-4159.2003.02181.x; Kirkinezos IG, 2003, ANN NEUROL, V53, P804, DOI 10.1002/ana.10597; Knippenberg S, 2010, BEHAV BRAIN RES, V213, P82, DOI 10.1016/j.bbr.2010.04.042; Kokona D, 2012, NEUROPHARMACOLOGY, V62, P2106, DOI 10.1016/j.neuropharm.2012.01.006; Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3; Lapchak PA, 2000, STROKE, V31, P1953, DOI 10.1161/01.STR.31.8.1953; Lazaridis I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001051; Lee DA, 1996, J NEUROPATH EXP NEUR, V55, P915, DOI 10.1097/00005072-199608000-00007; Lepore AC, 2007, BRAIN RES, V1185, P256, DOI 10.1016/j.brainres.2007.09.034; Li W, 2007, EXP NEUROL, V203, P457, DOI 10.1016/j.expneurol.2006.08.028; Lim ST, 2010, PHARMACOL RES, V61, P14, DOI 10.1016/j.phrs.2009.10.002; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Lutz C., 2009, WORKING ALS MICE GUI; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Miller RG, 1996, ANN NEUROL, V39, P256, DOI 10.1002/ana.410390215; Mohajeri MH, 1999, HUM GENE THER, V10, P1853, DOI 10.1089/10430349950017536; Naumenko N, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00026; Ono S, 1999, EUR NEUROL, V42, P163, DOI 10.1159/000008092; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; PARDRIDGE WM, 1994, PHARMACEUT RES, V11, P738, DOI 10.1023/A:1018940732550; Park S, 2009, EXP MOL MED, V41, P487, DOI 10.3858/emm.2009.41.7.054; Poduslo JF, 1996, MOL BRAIN RES, V36, P280, DOI 10.1016/0169-328X(95)00250-V; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Ribotta MGY, 1997, J NEUROSCI RES, V48, P281; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; Snow RJ, 2003, NEUROSCIENCE, V119, P661, DOI 10.1016/S0306-4522(03)00212-4; Song S, 2016, NAT MED, V22, P397, DOI 10.1038/nm.4052; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Talbot Kevin, 2009, Pract Neurol, V9, P303, DOI 10.1136/jnnp.2009.188151; Tillerson JL, 2002, EXP NEUROL, V178, P80, DOI 10.1006/exnr.2002.8021; Tuszynski MH, 2002, LANCET NEUROL, V1, P51, DOI 10.1016/S1474-4422(02)00006-6; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; Yu MA, 2011, CELL SIGNAL, V23, P883, DOI 10.1016/j.cellsig.2011.01.014	90	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164103	10.1371/journal.pone.0164103	http://dx.doi.org/10.1371/journal.pone.0164103			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716798	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000385698100023
J	Rivoirard, R; Duplay, V; Oriol, M; Tinquaut, F; Chauvin, F; Magne, N; Bourmaud, A				Rivoirard, Romain; Duplay, Vianney; Oriol, Mathieu; Tinquaut, Fabien; Chauvin, Franck; Magne, Nicolas; Bourmaud, Aurelie			Outcomes Definitions and Statistical Tests in Oncology Studies: A Systematic Review of the Reporting Consistency	PLOS ONE			English	Review							RANDOMIZED-TRIALS; QUALITY; ARTICLES	Background Quality of reporting for Randomized Clinical Trials (RCTs) in oncology was analyzed in several systematic reviews, but, in this setting, there is paucity of data for the outcomes definitions and consistency of reporting for statistical tests in RCTs and Observational Studies (OBS). The objective of this review was to describe those two reporting aspects, for OBS and RCTs in oncology. Methods From a list of 19 medical journals, three were retained for analysis, after a random selection: British Medical Journal (BMJ), Annals of Oncology (AoO) and British Journal of Cancer (BJC). All original articles published between March 2009 and March 2014 were screened. Only studies whose main outcome was accompanied by a corresponding statistical test were included in the analysis. Studies based on censored data were excluded. Primary outcome was to assess quality of reporting for description of primary outcome measure in RCTs and of variables of interest in OBS. A logistic regression was performed to identify covariates of studies potentially associated with concordance of tests between Methods and Results parts. Results 826 studies were included in the review, and 698 were OBS. Variables were described in Methods section for all OBS studies and primary endpoint was clearly detailed in Methods section for 109 RCTs (85.2%). 295 OBS (42.2%) and 43 RCTs (33.6%) had perfect agreement for reported statistical test between Methods and Results parts. In multivariable analysis, variable "number of included patients in study" was associated with test consistency: aOR (adjusted Odds Ratio) for third group compared to first group was equal to: aOR Grp3 = 0.52 [0.31-0.89] (P value = 0.009). Conclusion Variables in OBS and primary endpoint in RCTs are reported and described with a high frequency. However, statistical tests consistency between methods and Results sections of OBS is not always noted. Therefore, we encourage authors and peer reviewers to verify consistency of statistical tests in oncology studies.	[Rivoirard, Romain] Lucien Neuwirth Canc Inst, Dept Med Oncol, St Priest En Jarez, France; [Duplay, Vianney; Oriol, Mathieu; Tinquaut, Fabien; Chauvin, Franck; Bourmaud, Aurelie] Hygee Ctr, Dept Publ Hlth, St Priest En Jarez, France; [Duplay, Vianney; Oriol, Mathieu; Tinquaut, Fabien; Chauvin, Franck; Bourmaud, Aurelie] INSERM, Clin Invest Ctr 1408, F-42055 St Etienne, France; [Magne, Nicolas] Lucien Neuwirth Canc Inst, Dept Radiat Therapy, St Priest En Jarez, France	Institut de Cancerologie de la Loire; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Cancerologie de la Loire	Rivoirard, R (corresponding author), Lucien Neuwirth Canc Inst, Dept Med Oncol, St Priest En Jarez, France.	Romain.RIVOIRARD@icloire.fr		Bourmaud, Aurelie/0000-0002-2228-6471				[Anonymous], 2014, CITEFACTOR ACADEMIC; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Cobo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000332; Hopewell S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4145; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; International Committee of Medical Journal Editors, 2013, INTERNATIONAL COMMIT; Lang TA, 2006, HOW TO REPORT STATIS; McShane LM, 2005, EUR J CANCER, V41, P1690, DOI 10.1016/j.ejca.2005.03.032; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher D, 2012, INT J SURG, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Papathanasiou AA, 2010, ANN EPIDEMIOL, V20, P67, DOI 10.1016/j.annepidem.2009.09.007; Sarter M, 2008, EUR J NEUROSCI, V28, P2363, DOI 10.1111/j.1460-9568.2008.06581.x; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511	15	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164275	10.1371/journal.pone.0164275	http://dx.doi.org/10.1371/journal.pone.0164275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716793	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100039
J	Cadavid, S; Beato, MS				Cadavid, Sara; Soledad Beato, Maria			Memory Distortion and Its Avoidance: An Event-Related Potentials Study on False Recognition and Correct Rejection	PLOS ONE			English	Article							BACKWARD ASSOCIATIVE STRENGTH; 3 CRITICAL WORDS; BRAIN POTENTIALS; ILLUSORY MEMORIES; ELECTROPHYSIOLOGICAL EVIDENCE; PHANTOM RECOLLECTION; ENCODING CONTEXT; DISTINGUISH TRUE; RETRIEVAL; FAMILIARITY	Memory researchers have long been captivated by the nature of memory distortions and have made efforts to identify the neural correlates of true and false memories. However, the underlying mechanisms of avoiding false memories by correctly rejecting related lures remains underexplored. In this study, we employed a variant of the Deese/Roediger-McDermott paradigm to explore neural signatures of committing and avoiding false memories. ERP were obtained for True recognition, False recognition, Correct rejection of new items, and, more importantly, Correct rejection of related lures. With these ERP data, early-frontal, left-parietal, and late right-frontal old/new effects (associated with familiarity, recollection, and monitoring processes, respectively) were analysed. Results indicated that there were similar patterns for True and False recognition in all three old/new effects analysed in our study. Also, False recognition and Correct rejection of related lures activities seemed to share common underlying familiarity-based processes. The ERP similarities between False recognition and Correct rejection of related lures disappeared when recollection processes were examined because only False recognition presented a parietal old/new effect. This finding supported the view that actual false recollections underlie false memories, providing evidence consistent with previous behavioural research and with most ERP and neuroimaging studies. Later, with the onset of monitoring processes, False recognition and Correct rejection of related lures waveforms presented, again, clearly dissociated patterns. Specifically, False recognition and True recognition showed more positive going patterns than Correct rejection of related lures signal and Correct rejection of new items signature. Since False recognition and Correct rejection of related lures triggered familiarity-recognition processes, our results suggest that deciding which items are studied is based more on recollection processes, which are later supported by monitoring processes. Results are discussed in terms of Activation-Monitoring Framework and Fuzzy Trace-Theory, the most prominent explanatory theories of false memory raised with the Deese/Roediger-McDermott paradigm.	[Cadavid, Sara] Univ Minho, Sch Psychol, Dept Basic Psychol, Human Cognit Lab,Res Ctr Psychol CIPsi, Braga, Portugal; [Soledad Beato, Maria] Univ Salamanca, Fac Psychol, Dept Basic Psychol Psychobiol & Methodol Behav Sc, Salamanca, Spain	Universidade do Minho; University of Salamanca	Cadavid, S (corresponding author), Univ Minho, Sch Psychol, Dept Basic Psychol, Human Cognit Lab,Res Ctr Psychol CIPsi, Braga, Portugal.	s.cadavid@psi.uminho.pt	Beato, Maria Soledad/A-5867-2017; Cadavid, Sara/D-8091-2018	Beato, Maria Soledad/0000-0001-6735-8398; Cadavid, Sara/0000-0002-2606-3742	Portuguese Foundation for Science and Technology [UID/PSI/01662/2013]; Portuguese Ministry of Science, Technology and Higher Education; FEDER through COMPETE [POCI-01-0145-FEDER-007653]; Universidade do Minho Portugal [CIPSI-BI-CH-02]; Universidad de Salamanca (Spain) [FPI-USAL-10]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Ministry of Science, Technology and Higher Education; FEDER through COMPETE; Universidade do Minho Portugal; Universidad de Salamanca (Spain)	This research was supported by the Portuguese Foundation for Science and Technology and the Portuguese Ministry of Science, Technology and Higher Education through national funds and co-financed by FEDER through COMPETE2020 under the PT2020 Partnership Agreement (POCI-01-0145-FEDER-007653). Portuguese Foundation for Science and Technology also funded the Psychology Research Centre at Universidade do Minho, Portugal (UID/PSI/01662/2013) (http://www.fct.pt). This study was funded in part by the Portuguese Foundation for Science and Technology and Universidade do Minho Portugal (CIPSI-BI-CH-02 to SC) and in part by the Universidad de Salamanca (Spain) (FPI-USAL-10 to SC) (http://campus.usal.es/similar to agencia/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2008, CEREB CORTEX, V18, P2811, DOI 10.1093/cercor/bhn037; Achim AM, 2005, NEUROIMAGE, V24, P1113, DOI 10.1016/j.neuroimage.2004.10.036; Albuquerque P., 2011, LAB PSICOLOGIA, V9, P23, DOI [https://doi.org/10.14417/lp.634, DOI 10.14417/LP.634]; Allan K, 1998, ACTA PSYCHOL, V98, P231, DOI 10.1016/S0001-6918(97)00044-9; AMDT J, 2012, PSYCHOL LEARN MOTIV, P81, DOI DOI 10.1016/B978-0-12-394393-4.00003-0; Arndt J, 2006, MEMORY, V14, P814, DOI 10.1080/09658210600680749; Arndt J, 2015, MEMORY, V23, P1093, DOI 10.1080/09658211.2014.959527; Arndt J, 2010, J EXP PSYCHOL LEARN, V36, P66, DOI 10.1037/a0017394; Baioui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030416; Boldini A, 2013, NEUROREPORT, V24, P108, DOI 10.1097/WNR.0b013e32835c93e3; Bowman CR, 2015, EXP BRAIN RES, V233, P1963, DOI 10.1007/s00221-015-4268-y; Brainerd CJ, 2005, J EXP PSYCHOL LEARN, V31, P554, DOI 10.1037/0278-7393.31.3.554; Brainerd CJ, 2002, CURR DIR PSYCHOL SCI, V11, P164, DOI 10.1111/1467-8721.00192; Brainerd CJ, 2001, J EXP PSYCHOL LEARN, V27, P307, DOI 10.1037//0278-7393.27.2.307; Brainerd CJ., 2005, SCI FALSE MEMORY, DOI [10.1093/acprof:oso/9780195154054.001.0001, DOI 10.1093/ACPROF:OSO/9780195154054.001.0001]; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; Cadavid S, 2012, PSICOLOGICA, V33, P39; Cheng SK, 2010, INT J PSYCHOPHYSIOL, V77, P95, DOI 10.1016/j.ijpsycho.2010.04.010; Coane JH, 2006, MEM COGNITION, V34, P1026, DOI 10.3758/BF03193249; Cruse D, 2009, NEUROPSYCHOLOGIA, V47, P2779, DOI 10.1016/j.neuropsychologia.2009.06.003; Curran T, 2001, J COGNITIVE NEUROSCI, V13, P201, DOI 10.1162/089892901564261; Curran T, 2003, COGNITIVE BRAIN RES, V15, P191, DOI 10.1016/S0926-6410(02)00192-1; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Curran T., 2006, BINDING HUMAN MEMORY, P467, DOI DOI 10.1093/ACPROF:OSO/9780198529675.003.0018; Danker JF, 2008, PSYCHOPHYSIOLOGY, V45, P784, DOI 10.1111/j.1469-8986.2008.00672.x; DEESE J, 1959, J EXP PSYCHOL, V58, P17, DOI 10.1037/h0046671; Dennis NA, 2014, BRAIN COGNITION, V88, P65, DOI 10.1016/j.bandc.2014.04.009; Dennis NA, 2014, NEUROBIOL AGING, V35, P395, DOI 10.1016/j.neurobiolaging.2013.08.019; Dennis NA, 2012, NEUROIMAGE, V59, P2982, DOI 10.1016/j.neuroimage.2011.09.079; Donaldson DI, 1999, COGNITIVE BRAIN RES, V8, P1, DOI 10.1016/S0926-6410(98)00051-2; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Fernandez A., 2011, MATERIALES NORMATIVO; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Gallo DA, 2004, J EXP PSYCHOL LEARN, V30, P120, DOI 10.1037/0278-7393.30.1.120; Gallo DA, 2002, J MEM LANG, V47, P469, DOI 10.1016/S0749-596X(02)00013-X; Gallo David, 2006, ASSOCIATIVE ILLUSION; Gallo DA, 2010, MEM COGNITION, V38, P833, DOI 10.3758/MC.38.7.833; Garoff-Eaton RJ, 2007, LEARN MEMORY, V14, P684, DOI 10.1101/lm.695707; Garoff-Eaton RJ, 2006, CEREB CORTEX, V16, P1645, DOI 10.1093/cercor/bhj101; Geng HY, 2007, BRAIN RES, V1136, P154, DOI 10.1016/j.brainres.2006.12.027; Giovanello KS, 2010, J COGNITIVE NEUROSCI, V22, P1348, DOI 10.1162/jocn.2009.21274; Goldmann RE, 2003, NEUROREPORT, V14, P1717, DOI 10.1097/00001756-200309150-00012; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Greve A, 2007, NEUROIMAGE, V34, P801, DOI 10.1016/j.neuroimage.2006.07.043; Hayama HR, 2008, NEUROPSYCHOLOGIA, V46, P1211, DOI 10.1016/j.neuropsychologia.2007.11.021; Hicks JL, 2002, PSYCHON B REV, V9, P807, DOI 10.3758/BF03196339; Hoppstadter M, 2015, NEUROIMAGE, V116, P112, DOI 10.1016/j.neuroimage.2015.05.026; Israel L, 1997, PSYCHON B REV, V4, P577, DOI 10.3758/BF03214352; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; Johnson MK, 1997, PSYCHOL SCI, V8, P250, DOI 10.1111/j.1467-9280.1997.tb00421.x; JOHNSON MK, 1981, PSYCHOL REV, V88, P67, DOI 10.1037/0033-295X.88.1.67; Jou J, 2013, PSYCHOL RES-PSYCH FO, V77, P671, DOI 10.1007/s00426-012-0472-6; Kim H, 2007, CEREB CORTEX, V17, P2143, DOI 10.1093/cercor/bhl122; Kim H, 2007, J NEUROSCI, V27, P12190, DOI 10.1523/JNEUROSCI.3408-07.2007; Kubota Y, 2006, NEUROIMAGE, V31, P1783, DOI 10.1016/j.neuroimage.2006.02.003; Kuo TY, 2008, NEUROPSYCHOLOGIA, V46, P2243, DOI 10.1016/j.neuropsychologia.2008.02.018; Kuo TY, 2006, J COGNITIVE NEUROSCI, V18, P1133, DOI 10.1162/jocn.2006.18.7.1133; Luck S, 2005, AN INTRODUCTION TO T; McDermott KB, 2001, J MEM LANG, V45, P160, DOI 10.1006/jmla.2000.2771; McDermott KB, 1998, J MEM LANG, V39, P508, DOI 10.1006/jmla.1998.2582; McDonough IM, 2015, ACTA PSYCHOL, V161, P7, DOI 10.1016/j.actpsy.2015.07.017; Meek SW, 2013, INT J PSYCHOPHYSIOL, V87, P81, DOI 10.1016/j.ijpsycho.2012.11.004; Miller AR, 2001, J EXP PSYCHOL LEARN, V27, P354, DOI 10.1037/0278-7393.27.2.354; Morcom AM, 2015, BRAIN RES, V1624, P336, DOI 10.1016/j.brainres.2015.07.049; Neath I, 2003, HUMAN MEMORY AN INTR; Nessler D, 2003, PSYCHOPHYSIOLOGY, V40, P146, DOI 10.1111/1469-8986.00015; Nessler D, 2001, COGNITIVE BRAIN RES, V10, P283, DOI 10.1016/S0926-6410(00)00049-5; Oates JM, 2015, PSYCHOL PR FESTSCHR, P145; Paller KA, 2007, TRENDS COGN SCI, V11, P243, DOI 10.1016/j.tics.2007.04.002; Paller KA, 2012, TRENDS COGN SCI, V16, P313, DOI 10.1016/j.tics.2012.04.010; Prohaska V, 2016, MEMORY, V24, P865, DOI 10.1080/09658211.2015.1059455; Ranganath C, 2000, COGNITIVE BRAIN RES, V9, P209, DOI 10.1016/S0926-6410(99)00048-8; ROEDIGER HL, 1995, J EXP PSYCHOL LEARN, V21, P803, DOI 10.1037/0278-7393.21.4.803; Roediger HL, 2001, PSYCHON B REV, V8, P385, DOI 10.3758/BF03196177; Roediger HL, THE NATURE OF REMEMB, P95, DOI [10.1037/10394-000, DOI 10.1037/10394-000]; Rugg MD, 1998, J MEM LANG, V39, P47, DOI 10.1006/jmla.1997.2555; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; Schloerscheidt AM, 2004, NEUROPSYCHOLOGIA, V42, P451, DOI 10.1016/j.neuropsychologia.2003.08.010; Schneider W., 2002, E PRIME VERSION 20 C; Senkfor AJ, 1998, J EXP PSYCHOL LEARN, V24, P1005, DOI 10.1037/0278-7393.24.4.1005; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Beato MS, 2014, PSICOTHEMA, V26, P457, DOI 10.7334/psicothema2014.79; Beato MS, 2012, NEUROREPORT, V23, P804, DOI 10.1097/WNR.0b013e32835734de; Beato MS, 2011, BEHAV RES METHODS, V43, P499, DOI 10.3758/s13428-010-0045-9; von Zerssen GC, 2001, EUR J NEUROSCI, V13, P2148, DOI 10.1046/j.0953-816x.2001.01589.x; Warren DE, 2014, J NEUROSCI, V34, P7677, DOI 10.1523/JNEUROSCI.0119-14.2014; Wiese H, 2006, BRAIN RES, V1075, P183, DOI 10.1016/j.brainres.2005.12.117; Wilding E. L., 2012, OXFORD HDB EVENT REL, P373; Wilding E. L., 2003, COGNITIVE ELECTROPHY, P169, DOI DOI 10.1016/B978-012775421-5/50009-1; Wilding EL, 1997, NEUROPSYCHOLOGIA, V35, P119, DOI 10.1016/S0028-3932(96)00076-0; Wilding EL, 1997, NEUROPSYCHOLOGIA, V35, P1185, DOI 10.1016/S0028-3932(97)00048-1; Wilding EL, 1996, BRAIN, V119, P889, DOI 10.1093/brain/119.3.889; Wilding EL, 2000, INT J PSYCHOPHYSIOL, V35, P81, DOI 10.1016/S0167-8760(99)00095-1; Wolk DA, 2009, BRAIN RES, V1250, P218, DOI 10.1016/j.brainres.2008.11.014; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 1999, J EXP PSYCHOL LEARN, V25, P1415, DOI 10.1037/0278-7393.25.6.1415; Yu SS, 2010, BRAIN RES, V1320, P74, DOI 10.1016/j.brainres.2009.12.071	100	12	12	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164024	10.1371/journal.pone.0164024	http://dx.doi.org/10.1371/journal.pone.0164024			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711125	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600065
J	Chen, XL; Song, W; Gao, C; Qin, W; Luo, QL; Liu, J; Liu, LM				Chen, Xiulai; Song, Wei; Gao, Cong; Qin, Wen; Luo, Qiuling; Liu, Jia; Liu, Liming			Fumarate Production by Torulopsis glabrata: Engineering Heterologous Fumarase Expression and Improving Acid Tolerance	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; RHIZOPUS-ORYZAE; ESCHERICHIA-COLI; PYRUVATE PRODUCTION; CANDIDA-GLABRATA; HYPEROSMOTIC STRESS; DIRECTED EVOLUTION; INTRACELLULAR PH; PATHWAY; GLUCOSE	Fumarate is a well-known biomass building block compound. However, the poor catalytic efficiency of fumarase is one of the major factors preventing its widespread production. To address this issue, we selected residues (HPND162)-H-159 of fumarase from Rhizopus oryzae as targets for site-directed mutagenesis based on molecular docking analysis. Twelve mutants were generated and characterized in detail. Kinetic studies showed that the K-m values of the P160A, P160T, P160H, N161E, and D162W mutants were decreased, whereas K-m values of H159Y, H159V, H159S, N161R, N161F, D162K, and D162M mutants were increased. In addition, all mutants displayed decreased catalytic efficiency except for the P160A mutant, whose k(cat)/K-m was increased by 33.2%. Moreover, by overexpressing the P160A mutant, the engineered strain T.G-PMS-P160A was able to produce 5.2 g/L fumarate. To further enhance fumarate production, the acid tolerance of T.G-PMS-P160A was improved by deleting ade12, a component of the purine nucleotide cycle, and the resulting strain T. G(Delta ade12)-PMS-P160A produced 9.2 g/L fumarate. The strategy generated in this study opens up new avenues for pathway optimization and efficient production of natural products.	[Chen, Xiulai; Song, Wei; Gao, Cong; Qin, Wen; Luo, Qiuling; Liu, Jia; Liu, Liming] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Chen, Xiulai; Song, Wei; Gao, Cong; Qin, Wen; Luo, Qiuling; Liu, Jia; Liu, Liming] Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China; [Chen, Xiulai; Song, Wei; Gao, Cong; Qin, Wen; Luo, Qiuling; Liu, Jia; Liu, Liming] Jiangnan Univ, Lab Food Microbial Mfg Engn, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Liu, LM (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Peoples R China.; Liu, LM (corresponding author), Jiangnan Univ, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China.; Liu, LM (corresponding author), Jiangnan Univ, Lab Food Microbial Mfg Engn, Wuxi, Peoples R China.	mingll@jiangnan.edu.cn	Song, Wei/Q-3289-2019; Liu, Liming/B-1972-2009; Gao, Cong/AAB-4849-2022; Gao, Cong/N-2035-2018; song, wei/U-6787-2018; Chen, Xiulai/AAB-8395-2020	Song, Wei/0000-0002-2278-2205; Liu, Liming/0000-0003-3022-936X; Gao, Cong/0000-0001-8505-2026; Gao, Cong/0000-0001-8505-2026; song, wei/0000-0002-2278-2205; Chen, Xiulai/0000-0002-5154-3860	National High Technology Research and Development Program of China [2012AA022108, 2014AA021501, 2014AA021701]; National Natural Science Foundation of China [21422602]; Provincial Natural Science Foundation of Jiangsu Province [BK20160163]; Fundamental Research Funds for the Central Universities [JUSRP51611A, JUSRP116022]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the National High Technology Research and Development Program of China (2012AA022108, 2014AA021501, 2014AA021701); the National Natural Science Foundation of China (21422602); the Provincial Natural Science Foundation of Jiangsu Province (BK20160163); the Fundamental Research Funds for the Central Universities (JUSRP51611A); and the Fundamental Research Funds for the Central Universities (JUSRP116022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Amara AA, 2002, APPL MICROBIOL BIOT, V59, P477, DOI 10.1007/s00253-002-1035-3; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Carta FS, 1999, BIORESOURCE TECHNOL, V68, P23, DOI 10.1016/S0960-8524(98)00074-1; Chen XL, 2015, METAB ENG, V31, P62, DOI 10.1016/j.ymben.2015.02.002; Chen XL, 2015, BIOTECHNOL BIOENG, V112, P156, DOI 10.1002/bit.25334; Chen XL, 2014, TRENDS BIOTECHNOL, V32, P337, DOI 10.1016/j.tibtech.2014.04.003; Chen XL, 2013, METAB ENG, V19, P10, DOI 10.1016/j.ymben.2013.05.002; Duan XG, 2013, APPL ENVIRON MICROB, V79, P4072, DOI 10.1128/AEM.00457-13; Engel CAR, 2008, APPL MICROBIOL BIOT, V78, P379, DOI 10.1007/s00253-007-1341-x; Foo JL, 2012, BIOTECHNOL ADV, V30, P541, DOI 10.1016/j.biotechadv.2011.09.008; FRIEDBERG D, 1995, GENE, V163, P139, DOI 10.1016/0378-1119(95)00367-F; Fu YQ, 2010, KOREAN J CHEM ENG, V27, P183, DOI 10.1007/s11814-009-0323-3; FUHRMANN GF, 1993, BIOCHIM BIOPHYS ACTA, V1145, P180, DOI 10.1016/0005-2736(93)90396-H; Hua Q, 2001, BIOTECHNOL PROGR, V17, P62, DOI 10.1021/bp000138l; Huang D, 2015, BIORESOURCE TECHNOL, V196, P263, DOI 10.1016/j.biortech.2015.07.104; Huang L, 2010, ANN MICROBIOL, V60, P287, DOI 10.1007/s13213-010-0039-y; Jin Congcong, 2016, Weishengwu Xuebao, V56, P1113, DOI 10.13343/j.cnki.wsxb.20150438; Li Y, 2001, APPL MICROBIOL BIOT, V55, P680, DOI 10.1007/s002530100598; Li Y., 2012, ARCH ANIM NUTR, V1, P1, DOI DOI 10.1099/VIR.0.039289-0; Liu LM, 2007, BIOTECHNOL BIOENG, V97, P825, DOI 10.1002/bit.21290; Liu LM, 2007, METAB ENG, V9, P21, DOI 10.1016/j.ymben.2006.07.007; Liu LM, 2004, LETT APPL MICROBIOL, V39, P199, DOI 10.1111/j.1472-765X.2004.01563.x; Liu YF, 2014, METAB ENG, V23, P42, DOI 10.1016/j.ymben.2014.02.005; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Padilla-Lopez S, 2006, J BIOL CHEM, V281, P10273, DOI 10.1074/jbc.M510625200; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P1236, DOI 10.1002/anie.200502746; Reynolds TB, 2008, EUKARYOT CELL, V7, P122, DOI 10.1128/EC.00310-06; Riscaldati E, 2000, BIOTECHNOL LETT, V22, P1043, DOI 10.1023/A:1005621311898; Rose IA, 2004, P NATL ACAD SCI USA, V101, P3393, DOI 10.1073/pnas.0307524101; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Seo SW, 2012, BIOTECHNOL BIOPROC E, V17, P1, DOI 10.1007/s12257-011-0563-z; Song CW, 2013, BIOTECHNOL BIOENG, V110, P2025, DOI 10.1002/bit.24868; Torres LL, 2013, APPL ENVIRON MICROB, V79, P1555, DOI 10.1128/AEM.03215-12; Valli M, 2006, APPL ENVIRON MICROB, V72, P5492, DOI 10.1128/AEM.00683-06; van Maris AJA, 2004, APPL ENVIRON MICROB, V70, P159, DOI 10.1128/AEM.70.1.159-166.2004; Vazquez-Figueroa E, 2007, CHEMBIOCHEM, V8, P2295, DOI 10.1002/cbic.200700500; Wang GY, 2013, BIORESOURCE TECHNOL, V137, P1, DOI 10.1016/j.biortech.2013.03.041; Weaver T, 1996, BIOCHEMISTRY-US, V35, P13955, DOI 10.1021/bi9614702; WEAVER TM, 1995, NAT STRUCT BIOL, V2, P654, DOI 10.1038/nsb0895-654; WEAVER TM, 1993, J MOL BIOL, V231, P141, DOI 10.1006/jmbi.1993.1264; Werpy T., 2004, TOP VALUE ADDED CHEM, DOI DOI 10.2172/15008859; Xiao YT, 2008, INT J BIOCHEM CELL B, V40, P2002, DOI 10.1016/j.biocel.2007.08.006; Xu GQ, 2013, BIORESOURCE TECHNOL, V148, P91, DOI 10.1016/j.biortech.2013.08.115; Xu GQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052086; Xu GQ, 2012, YEAST, V29, P209, DOI 10.1002/yea.2902; Xu GQ, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-24; Xu Q, 2012, BIOTECHNOL ADV, V30, P1685, DOI 10.1016/j.biotechadv.2012.08.007; Xu S, 2010, BIOTECHNOL BIOPROC E, V15, P285, DOI 10.1007/s12257-009-0131-y; Yu SZ, 2012, BIORESOURCE TECHNOL, V114, P610, DOI 10.1016/j.biortech.2012.03.087; Yu XX, 2014, APPL MICROBIOL BIOT, V98, P3099, DOI 10.1007/s00253-014-5589-7; Zelle RM, 2008, APPL ENVIRON MICROB, V74, P2766, DOI 10.1128/AEM.02591-07; Zhang BH, 2012, METAB ENG, V14, P512, DOI 10.1016/j.ymben.2012.07.001; Zhou JW, 2011, J APPL MICROBIOL, V110, P44, DOI 10.1111/j.1365-2672.2010.04865.x; Zhou JW, 2009, J MICROBIOL METH, V76, P70, DOI 10.1016/j.mimet.2008.09.011	59	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164141	10.1371/journal.pone.0164141	http://dx.doi.org/10.1371/journal.pone.0164141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711153	gold, Green Submitted, Green Published			2022-12-27	WOS:000385697600086
J	Nguyen, LT; Gray, E; O'Leary, A; Carr, M; De Gascun, CF				Linh Thuy Nguyen; Gray, Emma; O'Leary, Aisling; Carr, Michael; De Gascun, Cillian F.		Irish Hepatitis C Outcomes Res	The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors	PLOS ONE			English	Article							INTERFERON PLUS RIBAVIRIN; SUSTAINED VIROLOGICAL RESPONSE; VIRAL RESPONSE; HEPATOCELLULAR-CARCINOMA; CLINICAL UTILITY; IL28B GENOTYPE; POLYMORPHISM; PREDICTION; INFECTION; ASSAY	Direct-acting antiviral (DAA) therapies have revolutionised the treatment of hepatitis C virus (HCV). The financial cost of DAAs however is significant, and first generation protease inhibitors (PIs) also require frequent monitoring of viral RNA levels to guide treatment. In this context, we examined the relevance of HCV antigen testing to evaluate the potential role in monitoring virological response to HCV antiviral treatment with the PI-based triple therapies, telaprevir (TVR) and boceprevir (BOC). Chronic HCV-infected individuals (n = 152) enrolled in the Irish Hepatitis C Outcomes Research Network (ICORN) study were prospectively analysed for baseline markers and the early viral kinetics associated with SVR. The sustained virological response (SVR) rates in the cohort receiving TVR and BOC were 87.3% and 73.8%, respectively. Baseline factors associated with successful outcome in TVR therapy were age (P = 0.0098), IFNL3 genotype (P = 0.0330) and viral load (P = 0.0456). RNA level at week 4 (P = 0.0068) and viral antigen negativity at week 2 (P = 0.0359) were predictive of SVR for TVR-based therapy. In BOC therapy, prior interferon treatment (P = 0.0209) and IFNL3 genotype (P = 0.0410) were baseline predictors of SVR. Evidence of viraemia based either on viral RNA or antigen at week 4 predicted SVR in these patients. Our data showed that rapid decline of HCV antigen to negative level at week 2 in TVR treatment and <0.96 log fmol/l in BOC treatment after commencement of PI triple therapy were associated with SVR. HCV antigen measurement should be considered as a potential alternative for monitoring treatment response during DAA-based regimens.	[Linh Thuy Nguyen; Carr, Michael; De Gascun, Cillian F.] Univ Coll Dublin, Natl Virus Reference Lab, Dublin, Ireland; [Linh Thuy Nguyen; De Gascun, Cillian F.] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Linh Thuy Nguyen] Ireland Vietnam Blood Borne Virus Initiat IVVI, Dublin, Ireland; [Linh Thuy Nguyen] Ireland Vietnam Blood Borne Virus Initiat IVVI, Hanoi, Vietnam; [Gray, Emma; O'Leary, Aisling] St James Hosp, Natl Ctr Pharmacoecon Ireland, Dublin, Ireland	University College Dublin; University College Dublin; Trinity College Dublin	Nguyen, LT (corresponding author), Univ Coll Dublin, Natl Virus Reference Lab, Dublin, Ireland.; Nguyen, LT (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland.; Nguyen, LT (corresponding author), Ireland Vietnam Blood Borne Virus Initiat IVVI, Dublin, Ireland.; Nguyen, LT (corresponding author), Ireland Vietnam Blood Borne Virus Initiat IVVI, Hanoi, Vietnam.	linh.nguyen.2@ucdconnect.ie		Carr, Michael/0000-0003-0011-6209	Atlantic Philanthropies; Ireland Vietnam Blood-Borne Virus Initiative (IVVI); Irish Hepatitis C Outcomes Research Network (ICORN)	Atlantic Philanthropies; Ireland Vietnam Blood-Borne Virus Initiative (IVVI); Irish Hepatitis C Outcomes Research Network (ICORN)	This study was funded by the Atlantic Philanthropies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was performed under the auspices of the Ireland Vietnam Blood-Borne Virus Initiative (IVVI) and the Irish Hepatitis C Outcomes Research Network (ICORN). The authors would like to thank the patients and partners in ICORN and to acknowledge the excellent technical assistance from staff at the National Virus Reference Laboratory in University College Dublin and all staff involved in specimen collection.	Asahina Y, 2014, J GASTROENTEROL, V49, P1152, DOI 10.1007/s00535-013-0858-2; Barreiro P, 2011, J INFECT DIS, V203, P1629, DOI 10.1093/infdis/jir113; Cento V, 2015, DIGEST LIVER DIS, V47, P157, DOI 10.1016/j.dld.2014.11.010; Chang KC, 2015, CLIN GASTROENTEROL H, V13, P1017, DOI 10.1016/j.cgh.2014.10.035; Chevaliez S, 2014, J CLIN VIROL, V61, P145, DOI [10.1016/j.jcv.2014.05.014, 10.1016/j.jcv.2014.15.014]; Cohn J, 2015, CURR OPIN HIV AIDS, V10, P369, DOI 10.1097/COH.0000000000000180; Collison M, 2015, J INTERF CYTOK RES, V35, P126, DOI 10.1089/jir.2014.0088; Cresswell FV, 2015, CLIN INFECT DIS, V60, P263, DOI 10.1093/cid/ciu782; D'Ambrosio R, 2014, INT J MOL SCI, V15, P7213, DOI 10.3390/ijms15057213; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Egli A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.51; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Eurich D, 2012, TRANSPLANTATION, V93, P644, DOI 10.1097/TP.0b013e318244f774; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Falleti E, 2011, J CLIN IMMUNOL, V31, P891, DOI 10.1007/s10875-011-9547-1; Fujino T, 2009, J DIGEST DIS, V10, P21, DOI 10.1111/j.1751-2980.2008.00358.x; Garbuglia AR, 2015, J CLIN VIROL, V69, P68, DOI 10.1016/j.jcv.2015.06.002; Heim MH, 2013, NAT REV IMMUNOL, V13, P535, DOI 10.1038/nri3463; Howe JA, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu078; Kadkhoda K, 2014, CLIN LAB, V60, P677, DOI 10.7754/Clin.Lab.2013.130634; Kamal SM, 2015, ALIMENT PHARM THER, V42, P307, DOI 10.1111/apt.13261; Koberle V, 2013, J VIRAL HEPATITIS, V20, P530, DOI 10.1111/jvh.12075; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Larrat S, 2015, J CLIN MICROBIOL, V53, P2195, DOI 10.1128/JCM.03633-14; Nguyen LT, 2015, ANTIVIR THER, V20, P865, DOI 10.3851/IMP2964; Nguyen LT, 2015, J CLIN MICROBIOL, V53, P2697, DOI 10.1128/JCM.01062-15; Loggi E, 2013, J CLIN VIROL, V56, P207, DOI 10.1016/j.jcv.2012.11.012; Matsuura K, 2014, HEPATOL RES, V44, P1208, DOI 10.1111/hepr.12294; Medici MC, 2011, J CLIN VIROL, V51, P260, DOI 10.1016/j.jcv.2011.05.003; Morota K, 2009, J VIROL METHODS, V157, P8, DOI 10.1016/j.jviromet.2008.12.009; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Noureddin M, 2015, GENES IMMUN, V16, P321, DOI 10.1038/gene.2015.11; Noureddin M, 2013, HEPATOLOGY, V58, P1548, DOI 10.1002/hep.26506; Ottiger C, 2013, J CLIN VIROL, V58, P535, DOI 10.1016/j.jcv.2013.08.028; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Payer BA, 2012, EUR J CLIN INVEST, V42, P599, DOI 10.1111/j.1365-2362.2011.02623.x; Pischke S, 2015, TRANSPL INFECT DIS, V18, P141, DOI [10.1111/lid.12475, DOI 10.1111/LID.12475]; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Shimada N, 2014, J GASTROENTEROL, V49, P1485, DOI 10.1007/s00535-013-0918-7; Sterling RK, 2015, ALIMENT PHARM THER, V41, P671, DOI 10.1111/apt.13095; Su TH, 2013, P NATL ACAD SCI USA, V110, P7844, DOI 10.1073/pnas.1306138110; Tamai Hideyuki, 2014, Hepat Res Treat, V2014, P748935, DOI 10.1155/2014/748935; Tamai H, 2011, HEPATOL RES, V41, P1137, DOI 10.1111/j.1872-034X.2011.00879.x; Tedder RS, 2013, J VIRAL HEPATITIS, V20, P65, DOI 10.1111/j.1365-2893.2012.01630.x; Tillmann HL, 2014, WORLD J GASTROENTERO, V20, P6701, DOI 10.3748/wjg.v20.i22.6701; Veillon P, 2003, J CLIN MICROBIOL, V41, P3212, DOI 10.1128/JCM.41.7.3212-3220.2003; Vermehren J, 2012, J CLIN VIROL, V55, P17, DOI 10.1016/j.jcv.2012.05.008; Wada Y, 2014, HEPATOL RES, V44, P179, DOI 10.1111/hepr.12101; Werner CR, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0261-0; Yang CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137852; Zeuzem S, 2013, NEW ENGL J MED, V369, P630, DOI 10.1056/NEJMoa1213557	52	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163900	10.1371/journal.pone.0163900	http://dx.doi.org/10.1371/journal.pone.0163900			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711230	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600048
J	Lu, C; Wang, Y; Ragulskis, M; Cheng, YJ				Lu, Chen; Wang, Yang; Ragulskis, Minvydas; Cheng, Yujie			Fault Diagnosis for Rotating Machinery: A Method based on Image Processing	PLOS ONE			English	Article							EMD ENERGY ENTROPY; BISPECTRUM; DECOMPOSITION; SIGNALS	Rotating machinery is one of the most typical types of mechanical equipment and plays a significant role in industrial applications. Condition monitoring and fault diagnosis of rotating machinery has gained wide attention for its significance in preventing catastrophic accident and guaranteeing sufficient maintenance. With the development of science and technology, fault diagnosis methods based on multi-disciplines are becoming the focus in the field of fault diagnosis of rotating machinery. This paper presents a multi-discipline method based on image-processing for fault diagnosis of rotating machinery. Different from traditional analysis method in one-dimensional space, this study employs computing method in the field of image processing to realize automatic feature extraction and fault diagnosis in a two-dimensional space. The proposed method mainly includes the following steps. First, the vibration signal is transformed into a bi-spectrum contour map utilizing bi-spectrum technology, which provides a basis for the following image-based feature extraction. Then, an emerging approach in the field of image processing for feature extraction, speeded-up robust features, is employed to automatically exact fault features from the transformed bi-spectrum contour map and finally form a high-dimensional feature vector. To reduce the dimensionality of the feature vector, thus highlighting main fault features and reducing subsequent computing resources, t-Distributed Stochastic Neighbor Embedding is adopt to reduce the dimensionality of the feature vector. At last, probabilistic neural network is introduced for fault identification. Two typical rotating machinery, axial piston hydraulic pump and self-priming centrifugal pumps, are selected to demonstrate the effectiveness of the proposed method. Results show that the proposed method based on image-processing achieves a high accuracy, thus providing a highly effective means to fault diagnosis for rotating machinery.	[Lu, Chen; Wang, Yang; Cheng, Yujie] Beihang Univ, Sch Reliabil & Syst Engn, Xueyuan Rd 37, Beijing, Peoples R China; [Lu, Chen; Wang, Yang; Cheng, Yujie] Sci & Technol Reliabil & Environm Engn Lab, Xueyuan Rd 37, Beijing, Peoples R China; [Ragulskis, Minvydas] Kaunas Univ Technol, Res Grp Math & Numer Anal Dynam Syst, Studentu 50-146, LT-51368 Kaunas, Lithuania	Beihang University; Kaunas University of Technology	Cheng, YJ (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Xueyuan Rd 37, Beijing, Peoples R China.; Cheng, YJ (corresponding author), Sci & Technol Reliabil & Environm Engn Lab, Xueyuan Rd 37, Beijing, Peoples R China.	chengyujie@buaa.edu.cn	Lu, Chen/B-6310-2016; Ragulskis, Minvydas/A-1546-2008	Ragulskis, Minvydas/0000-0002-3348-9717	Fundamental Research Funds for the Central Universities [YWF-16-BJ-J-18]; National Natural Science Foundation of China [51575021, 51605014]; Technology Foundation Program of National Defense [Z132013B002]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Foundation Program of National Defense	This study was supported by the Fundamental Research Funds for the Central Universities (Grant No. YWF-16-BJ-J-18) and the National Natural Science Foundation of China (Grant Nos. 51575021 and 51605014), as well as the Technology Foundation Program of National Defense (Grant No. Z13201B002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakim AE, 2006, COMP VIS PATT REC 20; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Bregler C, 1995, COMP VIS 1995 P 5 IN; Carrion MC, 1995, SIGNAL PROCESS, V47, P19, DOI 10.1016/0165-1684(95)00096-8; Cempel C, 2007, MECH SYST SIGNAL PR, V21, P1233, DOI 10.1016/j.ymssp.2006.04.001; Chen JL, 2016, MECH SYST SIGNAL PR, V70-71, P1, DOI 10.1016/j.ymssp.2015.08.023; Collis WB, 1998, MECH SYST SIGNAL PR, V12, P375, DOI 10.1006/mssp.1997.0145; Dong GM, 2015, J SOUND VIB, V339, P396, DOI 10.1016/j.jsv.2014.11.015; Fei SW, 2009, EXPERT SYST APPL, V36, P11352, DOI 10.1016/j.eswa.2009.03.022; Huang JA, 2011, ELECTR POW SYST RES, V81, P400, DOI 10.1016/j.epsr.2010.10.029; Jiang LL, 2011, MEASUREMENT, V44, P1284, DOI 10.1016/j.measurement.2011.03.024; Kumar R., 2013, ISRN CHEM ENG, V2013, P10, DOI DOI 10.1371/JOURNAL.PONE.0078174; Li W, 2015, MECH SYST SIGNAL PR, V50-51, P414, DOI 10.1016/j.ymssp.2014.05.034; Lin JS, 2015, ISA T, V59, P232, DOI 10.1016/j.isatra.2015.10.003; Lindeberg T, 2012, SCHOLARPEDIA, V7, P10491, DOI [DOI 10.4249/SCHOLARPEDIA.10491, 10.4249/scholarpedia.10491]; Liu HH, 2014, MECH MACH THEORY, V75, P67, DOI 10.1016/j.mechmachtheory.2014.01.011; Liu WY, 2013, SHOCK VIB, V20, P213, DOI [10.1155/2013/241937, 10.3233/SAV-2012-00739]; Liu WY, 2012, NEURAL COMPUT APPL, V21, pS385, DOI 10.1007/s00521-012-1050-y; Liu ZW, 2016, ISA T, V61, P211, DOI 10.1016/j.isatra.2015.12.009; Luo SR, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/847802; Mikolajczyk K, 2005, IEEE T PATTERN ANAL, V27, P1615, DOI 10.1109/TPAMI.2005.188; Park H, 2007, POW ENG SOC GEN M 20; Parker BE, 2000, MECH SYST SIGNAL PR, V14, P561; Rublee E., 2011, COMPUTER VISION ICCV; Saidi L, 2013, ISA T, V52, P140, DOI 10.1016/j.isatra.2012.08.003; Saidi L, 2015, ISA T, V54, P193, DOI 10.1016/j.isatra.2014.08.007; Saidi L, 2014, ISA T, V53, P1650, DOI 10.1016/j.isatra.2014.06.002; Samanta B, 2003, MECH SYST SIGNAL PR, V17, P317, DOI 10.1006/mssp.2001.1462; SPECHT DF, 1990, NEURAL NETWORKS, V3, P109, DOI 10.1016/0893-6080(90)90049-Q; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang Y, 2015, OPTIK, V126, P2895, DOI 10.1016/j.ijleo.2015.07.040; Wang ZJ, 2015, ISA T, V55, P208, DOI 10.1016/j.isatra.2014.09.006; Xu XL, 2014, P I MECH ENG C-J MEC, V228, P1958, DOI 10.1177/0954406213511964; Yan Ke, 2004, COMP VIS PATT REC 20; Yang WX, 2009, J SOUND VIB, V321, P1144, DOI 10.1016/j.jsv.2008.10.012; Yu Y, 2006, J SOUND VIB, V294, P269, DOI 10.1016/j.jsv.2005.11.002; Yue SC, 2008, LECT NOTES COMPUT SC, V5226, P329; Zhang XL, 2015, NEUROCOMPUTING, V167, P260, DOI 10.1016/j.neucom.2015.04.069; Zhang Y, 2016, MEASUREMENT, V82, P221, DOI 10.1016/j.measurement.2016.01.001; Zhou Y, 2012, MECH SYST SIGNAL PR, V26, P229, DOI 10.1016/j.ymssp.2011.07.006	41	60	65	8	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164111	10.1371/journal.pone.0164111	http://dx.doi.org/10.1371/journal.pone.0164111			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711246	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600078
J	Raeven, RHM; Brummelman, J; van der Maas, L; Tilstra, W; Pennings, JLA; Han, WGH; van Els, CACM; van Riet, E; Kersten, GFA; Metz, B				Raeven, Rene H. M.; Brummelman, Jolanda; van der Maas, Larissa; Tilstra, Wichard; Pennings, Jeroen L. A.; Han, Wanda G. H.; van Els, Cecile A. C. M.; van Riet, Elly; Kersten, Gideon F. A.; Metz, Bernard			Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune Cells	PLOS ONE			English	Article							ALVEOLAR MACROPHAGE; MEDIATED PROTECTION; LYMPHOID-TISSUE; GOBLET CELLS; VACCINE; MEMORY; LUNG; EXPRESSION; ANTIGENS; TRANSMISSION	Effective immunity against Bordetella pertussis is currently under discussion following the stacking evidence of pertussis resurgence in the vaccinated population. Natural immunity is more effective than vaccine-induced immunity indicating that knowledge on infection-induced responses may contribute to improve vaccination strategies. We applied a systems biology approach comprising microarray, flow cytometry and multiplex immunoassays to unravel the molecular and cellular signatures in unprotected mice and protected mice with infection-induced immunity, around a B. pertussis challenge. Pre-existing systemic memory Th1/Th17 cells, memory B-cells, and mucosal IgA specific for Ptx, Vag8, Fim2/3 were detected in the protected mice 56 days after an experimental infection. In addition, preexisting high activity and reactivation of pulmonary innate cells such as alveolar macrophages, M-cells and goblet cells was detected. The pro-inflammatory responses in the lungs and serum, and neutrophil recruitment in the spleen upon an infectious challenge of unprotected mice were absent in protected mice. Instead, fast pulmonary immune responses in protected mice led to efficient bacterial clearance and harbored potential new gene markers that contribute to immunity against B. pertussis. These responses comprised of innate makers, such as Clca3, Retlna, Glycam1, Gp2, and Umod, next to adaptive markers, such as CCR6(+) B-cells, CCR6(+) Th17 cells and CXCR6(+) T-cells as demonstrated by transcriptome analysis. In conclusion, besides effective Th1/Th17 and mucosal IgA responses, the primary infection-induced immunity benefits from activation of pulmonary resident innate immune cells, achieved by local pathogen-recognition. These molecular signatures of primary infection-induced immunity provided potential markers to improve vaccine-induced immunity against B. pertussis.	[Raeven, Rene H. M.; van der Maas, Larissa; Tilstra, Wichard; van Riet, Elly; Kersten, Gideon F. A.; Metz, Bernard] Intravacc, Bilthoven, Netherlands; [Raeven, Rene H. M.; Kersten, Gideon F. A.] Leiden Acad Ctr Drug Res, Div Drug Delivery Technol, Leiden, Netherlands; [Brummelman, Jolanda; Han, Wanda G. H.; van Els, Cecile A. C. M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Pennings, Jeroen L. A.] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect GZB, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	Raeven, RHM (corresponding author), Intravacc, Bilthoven, Netherlands.; Raeven, RHM (corresponding author), Leiden Acad Ctr Drug Res, Div Drug Delivery Technol, Leiden, Netherlands.	Rene.raeven@intravacc.nl	Brummelman, Jolanda/F-5701-2019; van Riet, Elly/V-2921-2018; Raeven, René/AAV-2461-2020	Brummelman, Jolanda/0000-0003-3581-4816; Raeven, René/0000-0002-1063-271X; Pennings, Jeroen L.A./0000-0002-9188-6358				Bernard NJ, 2015, MUCOSAL IMMUNOL, V8, P982, DOI 10.1038/mi.2014.125; Bertilone C, 2014, COMMUN DIS INTELL, V38, pE195; Campbell PT, 2015, VACCINE, V33, P5794, DOI 10.1016/j.vaccine.2015.09.025; Carbonetti NH, 2003, INFECT IMMUN, V71, P6358, DOI 10.1128/IAI.71.11.6358-6366.2003; CHEN BD, 1988, J IMMUNOL, V141, P139; Chen G, 2014, GUT MICROBES, V5, P363, DOI 10.4161/gmic.29100; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Corr SC, 2008, FEMS IMMUNOL MED MIC, V52, P2, DOI 10.1111/j.1574-695X.2007.00359.x; de Gouw D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105011; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; Dietert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102606; Drake LY, 2016, J IMMUNOL, V197, P1335, DOI 10.4049/jimmunol.1502669; Elgueta R, 2015, J IMMUNOL, V194, P505, DOI 10.4049/jimmunol.1401553; Fedele G, 2011, J IMMUNOL, V186, P5388, DOI 10.4049/jimmunol.1003765; Feunou PF, 2010, VACCINE, V28, P7047, DOI 10.1016/j.vaccine.2010.08.017; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Guo LY, 2015, NAT IMMUNOL, V16, P1051, DOI 10.1038/ni.3244; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hellwig SMM, 2001, INFECT IMMUN, V69, P4846, DOI 10.1128/IAI.69.8.4846-4850.2001; HIROTA K, 2007, THE JOURNAL OF EXPER, V204, P2803, DOI DOI 10.1084/JEM.20071397; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Jackson DW, 2014, EPIDEMIOL INFECT, V142, P672, DOI 10.1017/S0950268812003093; Jongerius I, 2015, J MOL MED, V93, P395, DOI 10.1007/s00109-015-1259-1; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Knolle MD, 2013, J IMMUNOL, V190, P6434, DOI 10.4049/jimmunol.1202329; Kuek LE, 2016, IMMUNOL CELL BIOL, V94, P11, DOI 10.1038/icb.2015.48; Lambrecht BN, 2006, IMMUNITY, V24, P366, DOI 10.1016/j.immuni.2006.03.008; Lee LN, 2011, INFECT IMMUN, V79, P3328, DOI 10.1128/IAI.01133-10; Lo D, 2003, CELL IMMUNOL, V224, P8, DOI 10.1016/S0008-8749(03)00155-2; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Mascart F, 2007, VACCINE, V25, P391, DOI 10.1016/j.vaccine.2006.06.046; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mielcarek N, 2006, PLOS PATHOG, V2, P662, DOI 10.1371/journal.ppat.0020065; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Netea MG, 2013, EUR J CLIN INVEST, V43, P881, DOI 10.1111/eci.12132; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; O'Regan A, 2003, CYTOKINE GROWTH F R, V14, P479, DOI 10.1016/S1359-6101(03)00055-8; Pabst R, 2010, AM J RESP CELL MOL, V43, P137, DOI 10.1165/rcmb.2010-0152RT; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Pennings JLA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018866; Peters A, 2015, J CLIN INVEST, V125, P129, DOI 10.1172/JCI74685; Raeven RHM, 2015, J PROTEOME RES, V14, P2929, DOI 10.1021/acs.jproteome.5b00258; Raeven RHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104548; Rahim MMA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00145; Rantakari P, 2015, NAT IMMUNOL, V16, P386, DOI 10.1038/ni.3101; ROGERS DF, 1994, EUR RESPIR J, V7, P1690; Ross PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003264; Sasawatari S, 2010, IMMUNITY, V32, P200, DOI 10.1016/j.immuni.2010.01.012; Sato S, 2013, MUCOSAL IMMUNOL, V6, P838, DOI 10.1038/mi.2012.122; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Stroncek DF, 1998, TRANSFUSION, V38, P663, DOI 10.1046/j.1537-2995.1998.38798346635.x; Tan TN, 2015, PEDIATR INFECT DIS J, V34, pE222, DOI 10.1097/INF.0000000000000795; von Allmen CE, 2009, P NATL ACAD SCI USA, V106, P11673, DOI 10.1073/pnas.0812569106; von Konig CHW, 2014, EXPERT REV VACCINES, V13, P1167, DOI 10.1586/14760584.2014.950237; Vukman KV, 2013, J LEUKOCYTE BIOL, V94, P439, DOI 10.1189/jlb.0313130; Warfel JM, 2013, MUCOSAL IMMUNOL, V6, P787, DOI 10.1038/mi.2012.117; Warfel JM, 2014, P NATL ACAD SCI USA, V111, P787, DOI 10.1073/pnas.1314688110; Warfel JM, 2012, INFECT IMMUN, V80, P1530, DOI 10.1128/IAI.06310-11; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Wendelboe AM, 2007, PEDIATR INFECT DIS J, V26, P293, DOI 10.1097/01.inf.0000258699.64164.6d; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045	66	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164027	10.1371/journal.pone.0164027	http://dx.doi.org/10.1371/journal.pone.0164027			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711188	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600066
J	Ratliff, EP; Kotzebue, RW; Molina, B; Mauntz, RE; Gonzalez, A; Barekat, A; El-Mecharrafie, N; Garza, S; Gurney, MA; Achal, M; Linton, PJ; Harris, GL; Finley, KD				Ratliff, Eric P.; Kotzebue, Roxanne W.; Molina, Brandon; Mauntz, Ruth E.; Gonzalez, Arysa; Barekat, Ayeh; El-Mecharrafie, Nadja; Garza, Shannon; Gurney, Michael A.; Achal, Madhulika; Linton, Phyllis-Jean; Harris, Greg L.; Finley, Kim D.			Assessing Basal and Acute Autophagic Responses in the Adult Drosophila Nervous System: The Impact of Gender, Genetics and Diet on Endogenous Pathway Profiles	PLOS ONE			English	Article							LIFE-SPAN; MOUSE MODEL; ALZHEIMERS-DISEASE; NEURONAL AUTOPHAGY; BRAIN; RESTRICTION; PROMOTES; HEALTH; EXTENSION; DEFICITS	The autophagy pathway is critical for the long-term homeostasis of cells and adult organisms and is often activated during periods of stress. Reduced pathway efficacy plays a central role in several progressive neurological disorders that are associated with the accumulation of cytotoxic peptides and protein aggregates. Previous studies have shown that genetic and transgenic alterations to the autophagy pathway impacts longevity and neural aggregate profiles of adult Drosophila. In this study, we have identified methods to measure the acute in vivo induction of the autophagy pathway in the adult fly CNS. Our findings indicate that the genotype, age, and gender of adult flies can influence pathway responses. Further, we demonstrate that middle-aged male flies exposed to intermittent fasting (IF) had improved neuronal autophagic profiles. IF-treated flies also had lower neural aggregate profiles, maintained more youthful behaviors and longer lifespans, when compared to ad libitum controls. In summary, we present methodology to detect dynamic in vivo changes that occur to the autophagic profiles in the adult Drosophila CNS and that a novel IF-treatment protocol improves pathway response in the aging nervous system.	[Ratliff, Eric P.; Kotzebue, Roxanne W.; Molina, Brandon; Mauntz, Ruth E.; Gonzalez, Arysa; Barekat, Ayeh; El-Mecharrafie, Nadja; Gurney, Michael A.; Achal, Madhulika; Linton, Phyllis-Jean; Finley, Kim D.] San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA; [Ratliff, Eric P.; Kotzebue, Roxanne W.; Molina, Brandon; Gonzalez, Arysa; Barekat, Ayeh; El-Mecharrafie, Nadja; Garza, Shannon; Gurney, Michael A.; Achal, Madhulika; Harris, Greg L.; Finley, Kim D.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Finley, KD (corresponding author), San Diego State Univ, Donald P Shiley BioSci Ctr, San Diego, CA 92182 USA.; Finley, KD (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	kfinley@mail.sdsu.edu			NIA (National Institute on Aging) division at NIH [R21AG030187, R01AG039628]; NIH/NIA [R21AG030187, R01AG039628]; NATIONAL INSTITUTE ON AGING [R01AG039628, R21AG030187] Funding Source: NIH RePORTER	NIA (National Institute on Aging) division at NIH; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We received the following funding: R21AG030187 and R01AG039628 grants from the NIA (National Institute on Aging) division at NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Mark Kern (SDSU), Dr. William Joiner (UCSD), and Dr. Cynthia Hughes (NSI) for the helpful discussions regarding Drosophila diet, behavior and aging studies. We would also like to thank Dr. Mark Sussman and Dr. Natalie Gude for their confocal microscopy expertise (SDSU). This work was supported by grants from NIH/NIA and include: R21AG030187 and R01AG039628.	Alirezaei M, 2010, AUTOPHAGY, V6, P702, DOI 10.4161/auto.6.6.12376; Au AK, 2015, BBA-MOL BASIS DIS, V1852, P1902, DOI 10.1016/j.bbadis.2015.06.007; Barekat A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25252; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Finley KD, 2003, J NEUROSCI, V23, P1254, DOI 10.1523/JNEUROSCI.23-04-01254.2003; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682; Grandison RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004067; Halagappa VKM, 2007, NEUROBIOL DIS, V26, P212, DOI 10.1016/j.nbd.2006.12.019; HALTER DA, 1995, DEVELOPMENT, V121, P317; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hauw JJ, 2011, J NEUROPATH EXP NEUR, V70, P243, DOI 10.1097/NEN.0b013e318211488e; Hegedus K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470482; Hegedus K, 2013, AUTOPHAGY, V9, P1642, DOI 10.4161/auto.25684; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Herrera VLM, 2008, PHYSIOL GENOMICS, V35, P316, DOI 10.1152/physiolgenomics.00044.2008; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Jain SK, 2015, DRUG DEV IND PH 0602, V2, P1, DOI DOI 10.1063/1.4812323;M.DE; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Juhasz G, 2008, AUTOPHAGY, V4, P357, DOI 10.4161/auto.5572; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Juhasz Gabor, 2008, V445, P125, DOI 10.1007/978-1-59745-157-4_8; Kett LR, 2015, J NEUROSCI, V35, P5724, DOI 10.1523/JNEUROSCI.0632-14.2015; Kim B, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.3; Klionsky DJ, 2007, AUTOPHAGY, V3, P413, DOI 10.4161/auto.4377; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lee S, 2013, EXP GERONTOL, V48, P1085, DOI 10.1016/j.exger.2012.12.008; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Long DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106068; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338; Ma D, 2011, EMBO J, V30, P4642, DOI 10.1038/emboj.2011.322; Maher PA, 2009, EXPERT REV NEUROTHER, V9, P617, DOI 10.1586/ERN.09.18; Marcora MS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-5; Mattson MP, 2015, AGEING RES REV, V20, P37, DOI 10.1016/j.arr.2014.12.011; Mattson MP, 2014, P NATL ACAD SCI USA, V111, P16647, DOI 10.1073/pnas.1413965111; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Moscat J, 2009, EMBO REP, V10, P804, DOI 10.1038/embor.2009.172; Murphy T, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/563160; Naderali EK, 2009, AM J ALZHEIMERS DIS, V24, P445, DOI 10.1177/1533317509348208; Nagy P, 2015, METHODS, V75, P151, DOI 10.1016/j.ymeth.2014.11.016; Nagy P, 2014, AUTOPHAGY, V10, P453, DOI 10.4161/auto.27442; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Ratliff EP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132768; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Reggiori Fulvio, 2012, Int J Cell Biol, V2012, P219625, DOI 10.1155/2012/219625; Rogers I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040569; Rui YN, 2015, NAT CELL BIOL, V17, P262, DOI 10.1038/ncb3101; Sadagurski M, 2011, J CLIN INVEST, V121, P4070, DOI 10.1172/JCI46305; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Simonsen A, 2007, AUTOPHAGY, V3, P499, DOI 10.4161/auto.4604; Simonsen A, 2007, GENETICS, V176, P1283, DOI 10.1534/genetics.106.065011; Stratman NC, 2005, CHEM PHYS LIPIDS, V137, P52, DOI 10.1016/j.chemphyslip.2005.06.005; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Tower J, 2015, ARCH BIOCHEM BIOPHYS, V576, P17, DOI 10.1016/j.abb.2014.10.008; van Praag H, 2014, J NEUROSCI, V34, P15139, DOI 10.1523/JNEUROSCI.2814-14.2014; Walls SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003970; Weis SN, 2014, NEUROSCIENCE, V256, P201, DOI 10.1016/j.neuroscience.2013.10.046; Wesson DW, 2011, J NEUROSCI, V31, P15962, DOI 10.1523/JNEUROSCI.2085-11.2011; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yamamoto R, 2011, AGING CELL, V10, P729, DOI 10.1111/j.1474-9726.2011.00716.x; Yang DS, 2014, BRAIN, V137, P3300, DOI 10.1093/brain/awu278; Yang DS, 2009, METHOD ENZYMOL, V453, P111, DOI 10.1016/S0076-6879(08)04006-8; Yannoni YM, 1997, CHROMOSOMA, V105, P332; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Young JE, 2009, J BIOL CHEM, V284, P2363, DOI 10.1074/jbc.M806088200; Zaninovich OA, 2013, JOVE-J VIS EXP, DOI 10.3791/50801	83	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164239	10.1371/journal.pone.0164239	http://dx.doi.org/10.1371/journal.pone.0164239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711219	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600103
J	Braster, Q; Roig, CS; Hartwig, H; Beckers, L; den Toom, M; Doring, Y; Deemen, MJ; Lutgens, E; Soehnlein, O				Braster, Quinte; Roig, Carlos Silvestre; Hartwig, Helene; Beckers, Linda; den Toom, Myrthe; Doering, Yvonne; Deemen, Mat J.; Lutgens, Esther; Soehnlein, Oliver			Inhibition of NET Release Fails to Reduce Adipose Tissue Inflammation in Mice	PLOS ONE			English	Article							PEPTIDYLARGININE DEIMINASE INHIBITION; NEUTROPHIL EXTRACELLULAR TRAPS; INSULIN-RESISTANCE; IMMUNE CELLS; MYELOPEROXIDASE; NETOSIS; ATHEROSCLEROSIS; ELASTASE; OBESITY	Obesity-associated diseases such as Type 2 diabetes, liver disease and cardiovascular diseases are profoundly mediated by low-grade chronic inflammation of the adipose tissue. Recently, the importance of neutrophils and neutrophil-derived myeloperoxidase and neutrophil elastase on the induction of insulin resistance has been established. Since neutrophil elastase and myeloperoxidase are critically involved in the release of neutrophil extracellular traps (NETs), we here hypothesized that NETs may be relevant to early adipose tissue inflammation. Thus, we tested the effect of the Peptidyl Arginine Deiminase 4 inhibitor Cl-amidine, a compound preventing histone citrullination and subsequent NET release, in a mouse model of adipose tissue inflammation. C57BL6 mice received a 60% high fat diet for 10 weeks and were treated with either Cl-amidine or vehicle. Flow cytometry of adipose tissue and liver, immunohistological analysis and glucose and insulin tolerance tests were performed to determine the effect of the treatment and diet. Although high fat diet feeding induced insulin resistance no significant effect was observed between the treatment groups. In addition no effect was found in leukocyte infiltration and activation in the adipose tissue and liver. Therefore we concluded that inhibition of neutrophil extracellular trap formation may have no clinical relevance for early obesity-mediated pathogenesis of the adipose tissue and liver.	[Braster, Quinte; Roig, Carlos Silvestre; Hartwig, Helene; Deemen, Mat J.; Soehnlein, Oliver] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Beckers, Linda; den Toom, Myrthe; Lutgens, Esther] Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands; [Braster, Quinte; Roig, Carlos Silvestre; Doering, Yvonne; Lutgens, Esther; Soehnlein, Oliver] Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany; [Soehnlein, Oliver] Partner Site Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Soehnlein, O (corresponding author), Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands.; Soehnlein, O (corresponding author), Ludwig Maximilians Univ Munchen, Inst Cardiovasc Prevent IPEK, Munich, Germany.; Soehnlein, O (corresponding author), Partner Site Munich Heart Alliance, DZHK German Ctr Cardiovasc Res, Munich, Germany.	oliver.soehnlein@gmail.com	Silvestre-Roig, Carlos/ABF-9769-2020; Doring, Yvonne/E-1796-2013; Döring, Yvonne/E-9414-2017; Döring, Yvonne/AAA-3018-2022	Silvestre-Roig, Carlos/0000-0003-1169-7475; Döring, Yvonne/0000-0001-9307-3396; Daemen, Mat/0000-0003-1076-199X				Borissoff JI, 2013, ARTERIOSCL THROM VAS, V33, P2032, DOI 10.1161/ATVBAHA.113.301627; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chmelar J, 2013, THROMB HAEMOSTASIS, V109, P399, DOI 10.1160/TH12-09-0703; Chumanevich AA, 2011, AM J PHYSIOL-GASTR L, V300, pG929, DOI 10.1152/ajpgi.00435.2010; Cildir G, 2013, TRENDS MOL MED, V19, P487, DOI 10.1016/j.molmed.2013.05.001; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Knight JS, 2015, ANN RHEUM DIS, V74, P2199, DOI 10.1136/annrheumdis-2014-205365; Knight JS, 2014, CIRC RES, V114, P947, DOI 10.1161/CIRCRESAHA.114.303312; Knight JS, 2013, J CLIN INVEST, V123, P2981, DOI 10.1172/JCI67390; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Menegazzo L, 2015, ACTA DIABETOL, V52, P497, DOI 10.1007/s00592-014-0676-x; Metzler KD, 2014, CELL REP, V8, P883, DOI 10.1016/j.celrep.2014.06.044; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Wang QL, 2014, DIABETES, V63, P4172, DOI 10.2337/db14-0026; Willis V, 2011, J IMMUNOL, V186, P4396, DOI 10.4049/jimmunol.1001620; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	19	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163922	10.1371/journal.pone.0163922	http://dx.doi.org/10.1371/journal.pone.0163922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701440	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900033
J	Morikawa, M; Tsujibe, S; Kiyoshima-Shibata, J; Watanabe, Y; Kato-Nagaoka, N; Shida, K; Matsumoto, S				Morikawa, Masatoshi; Tsujibe, Satoshi; Kiyoshima-Shibata, Junko; Watanabe, Yohei; Kato-Nagaoka, Noriko; Shida, Kan; Matsumoto, Satoshi			Microbiota of the Small Intestine Is Selectively Engulfed by Phagocytes of the Lamina Propria and Peyer's Patches	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; DENDRITIC CELLS; HUMAN FECES; DIVERSITY; SEQUENCES; RESPONSES; SAMPLE; TH17; DIFFERENTIATION; TAXONOMY	Phagocytes such as dendritic cells and macrophages, which are distributed in the small intestinal mucosa, play a crucial role in maintaining mucosal homeostasis by sampling the luminal gut microbiota. However, there is limited information regarding microbial uptake in a steady state. We investigated the composition of murine gut microbiota that is engulfed by phagocytes of specific subsets in the small intestinal lamina propria (SILP) and Peyer's patches (PP). Analysis of bacterial 16S rRNA gene amplicon sequences revealed that: 1) all the phagocyte subsets in the SILP primarily engulfed Lactobacillus (the most abundant microbe in the small intestine), whereas CD11b(hi) and CD11b(hi) CD11c(hi) cell subsets in PP mostly engulfed segmented filamentous bacteria (indigenous bacteria in rodents that are reported to adhere to intestinal epithelial cells); and 2) among the Lactobacillus species engulfed by the SILP cell subsets, L. murinus was engulfed more frequently than L. taiwanensis, although both these Lactobacillus species were abundant in the small intestine under physiological conditions. These results suggest that small intestinal microbiota is selectively engulfed by phagocytes that localize in the adjacent intestinal mucosa in a steady state. These observations may provide insight into the crucial role of phagocytes in immune surveillance of the small intestinal mucosa.	[Morikawa, Masatoshi; Tsujibe, Satoshi; Kiyoshima-Shibata, Junko; Watanabe, Yohei; Kato-Nagaoka, Noriko; Shida, Kan; Matsumoto, Satoshi] Yakult Cent Inst, Tokyo, Japan	Yakult Honsha Company, Limited	Morikawa, M (corresponding author), Yakult Cent Inst, Tokyo, Japan.	masatoshi-morikawa@yakult.co.jp		Watanabe, Yohei/0000-0001-7740-1361				Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chen H, 2015, IEEE-ASME T MECH, V21, P1, DOI DOI 10.1371/J0URNAL.P0NE.0142881; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Hatano S, 2015, INT IMMUNOPHARMACOL, V25, P321, DOI 10.1016/j.intimp.2015.02.011; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwasaki A, 2001, J IMMUNOL, V166, P4884, DOI 10.4049/jimmunol.166.8.4884; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; Persson EK, 2013, EUR J IMMUNOL, V43, P3098, DOI 10.1002/eji.201343740; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sarrabayrouse G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001833; Takada T, 2004, J MICROBIOL METH, V58, P413, DOI 10.1016/j.mimet.2004.05.006; Tang C, 2015, CELL HOST MICROBE, V18, P183, DOI 10.1016/j.chom.2015.07.003; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	35	37	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163607	10.1371/journal.pone.0163607	http://dx.doi.org/10.1371/journal.pone.0163607			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701454	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900014
J	Saito, S; Ohno, K; Okuyama, T; Sakuraba, H				Saito, Seiji; Ohno, Kazuki; Okuyama, Torayuki; Sakuraba, Hitoshi			Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; HUNTER-SYNDROME; DISEASE; IDURONATE-2-SULFATASE; MUTATIONS; IDENTIFICATION; GALACTOSIDASE; PHENOTYPES; ALGORITHMS; EXPRESSION	Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is an X-linked genetic disorder caused by a deficiency of iduronate 2-sulfatase (IDS), and missense mutations comprising about 30% of the mutations responsible for MPS II result in heterogeneous phenotypes ranging from the severe to the attenuated form. To elucidate the basis of MPS II from the structural viewpoint, we built structural models of the wild type and mutant IDS proteins resulting from 131 missense mutations (phenotypes: 67 severe and 64 attenuated), and analyzed the influence of each amino acid substitution on the IDS structure by calculating the accessible surface area, the number of atoms affected and the root-mean-square distance. The results revealed that the amino acid substitutions causing MPS II were widely spread over the enzyme molecule and that the structural changes of the enzyme protein were generally larger in the severe group than in the attenuated one. Coloring of the atoms influenced by different amino acid substitutions at the same residue showed that the structural changes influenced the disease progression. Based on these data, we constructed a database of IDS mutations as to the structures of mutant IDS proteins.	[Saito, Seiji] Hokkaido Informat Univ, Dept Med Management & Informat, 59-2 Nishinopporo, Ebetsu, Hokkaido 0698585, Japan; [Ohno, Kazuki] Catalyst Inc, Chiyoda Ku, 1-5-6 Kudan Minami, Tokyo 1020074, Japan; [Ohno, Kazuki] Tokyo Inst Technol, Educ Acad Computat Life Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan; [Okuyama, Torayuki] Natl Ctr Child Hlth & Dev, Dept Clin Lab Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, 2-522-1 Noshio, Tokyo 2048588, Japan	Tokyo Institute of Technology; National Center for Child Health & Development - Japan; Meiji Pharmaceutical University	Sakuraba, H (corresponding author), Meiji Pharmaceut Univ, Dept Clin Genet, 2-522-1 Noshio, Tokyo 2048588, Japan.	sakuraba@my-pharm.ac.jp			Japan Society for Promotion of Science [15K090]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for Promotion of Science (ID: 15K090, HS).	Chang JH, 2005, HUM GENET, V116, P160, DOI 10.1007/s00439-004-1234-3; Charoenwattanasatien R, 2012, BIOCHEM GENET, V50, P990, DOI 10.1007/s10528-012-9538-9; FLOMEN RH, 1993, HUM MOL GENET, V2, P5, DOI 10.1093/hmg/2.1.5; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Guffon N, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0259-0; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kato T, 2005, J HUM GENET, V50, P395, DOI 10.1007/s10038-005-0266-4; Kim CH, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9128; KUNDROT CE, 1991, J COMPUT CHEM, V12, P402, DOI 10.1002/jcc.540120314; Matsuzawa F, 2005, HUM GENET, V117, P317, DOI 10.1007/s00439-005-1300-5; Millat G, 1998, BBA-MOL BASIS DIS, V1406, P214, DOI 10.1016/S0925-4439(97)00096-3; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Parini R, 2015, MOLEC GENET METAB RE, V3, P65, DOI 10.1016/j.ymgmr.2015.03.011; Parkinson-Lawrence E, 2005, BIOCHEM J, V386, P395, DOI 10.1042/BJ20040739; Saito S, 2011, J HUM GENET, V56, P467, DOI 10.1038/jhg.2011.31; SCHMIDT B, 1995, CELL, V82, P271, DOI 10.1016/0092-8674(95)90314-3; Sohn YB, 2015, MOL GENET METAB, V114, P156, DOI 10.1016/j.ymgme.2014.08.009; SUKEGAWA K, 1995, HUM MUTAT, V6, P136, DOI 10.1002/humu.1380060206; Sukegawa-Hayasaka K, 2006, J INHERIT METAB DIS, V29, P755, DOI 10.1007/s10545-006-0440-7; Tajima G, 2013, MOL GENET METAB, V108, P172, DOI 10.1016/j.ymgme.2012.12.010; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; WILSON PJ, 1993, GENOMICS, V17, P773, DOI 10.1006/geno.1993.1406; WILSON PJ, 1991, HUM GENET, V86, P505; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	25	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163964	10.1371/journal.pone.0163964	http://dx.doi.org/10.1371/journal.pone.0163964			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695081	gold, Green Submitted, Green Published			2022-12-27	WOS:000385553100069
J	Wang, YN; Qiu, XL; Lv, LS; Wang, CX; Ye, ZC; Li, SM; Liu, Q; Lou, TQ; Liu, X				Wang, Yanni; Qiu, Xilian; Lv, Linsheng; Wang, Caixia; Ye, Zengchun; Li, Shaomin; Liu, Qiong; Lou, Tanqi; Liu, Xun			Correlation between Serum Lipid Levels and Measured Glomerular Filtration Rate in Chinese Patients with Chronic Kidney Disease	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN; PREVALENCE; DYSLIPIDEMIA; CHOLESTEROL; METABOLISM; MECHANISMS; ESRD	Introduction Dyslipidemia is often detected in patients with chronic kidney disease (CKD). Previous studies of the relationship between lipid profiles and kidney function have yielded variable results. We aimed to investigate the correlation between serum lipid levels and kidney function evaluated by measured glomerular filtration rate (mGFR) in Chinese patients with CKD. Methods A cross-sectional study was conducted on 2036 Chinese CKD patients who had mGFR. Linear regression analysis was performed to evaluate the correlation between different serum lipid levels and mGFR, while logistic regression analysis was used to investigate the association between CKD stages and the risk of different types of dyslipidemia. Results The mean age was 55 years and the mean mGFR was 63 mL/min/1.73m(2). After adjusting for some confounders (age, gender, body mass index, a history of diabetes, fasting glucose, a history of hypertension, systolic blood pressure, diastolic blood pressure, smoking status, hemoglobin, serum potassium, serum albumin, and serum uric acid), serum triglyceride level showed a negative correlation with mGFR (beta = -0.006, P = 0.006) in linear regression analysis, and CKD stages were positively related to the risk of hypertriglyceridemia (odds ratios were 1.329, 1.868, 2.514 and P were 0.046, < 0.001, < 0.001 for CKD stage 2, 3, 4/5, respectively) in logistic regression anlysis. Conclusions Serum triglyceride level is independently association with mGFR. Patients with reduced kidney function are more likely to have higher serum triglyceride levels. Further longitudinal, multicenter and well-conducted studies are needed to provide more evidence.	[Wang, Yanni; Wang, Caixia; Ye, Zengchun; Li, Shaomin; Lou, Tanqi; Liu, Xun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Wang, Yanni] Hainan Gen Hosp, Dept Nephrol, Haikou, Peoples R China; [Qiu, Xilian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China; [Lv, Linsheng] Sun Yat Sen Univ, Affiliated Hosp 3, Operat Room, Guangzhou, Guangdong, Peoples R China; [Liu, Qiong] South China Univ Tecchonol, Sch Software Engn, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Lou, TQ; Liu, X (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Nephrol, Guangzhou, Guangdong, Peoples R China.	lou.tq@163.com; naturestyle@163.com			National Natural Science Foundation of China [81370866, 81070612]; China Postdoctoral Science Foundation [201104335]; Guangdong Science and Technology Plan [20116031800084, 20136021800190]; Fundamental Research Funds for the Central Universities [11ykpy38]; National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China [201113A1101300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Science and Technology Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Project of Scientific and Technical Supporting Programs - Ministry of Science & Technology of China(Ministry of Science and Technology, China)	This study was funded by 1. the National Natural Science Foundation of China (No. 81370866 and 81070612), http://www.nsfc.gov.cn/, Ministry of Finance of China, XL; 2. the China Postdoctoral Science Foundation (No. 201104335), http://jj.chinapostdoctor.org.cn, Ministry of Finance of China, XL; 3. Guangdong Science and Technology Plan (No. 20116031800084 and 20136021800190), http://pro.gdstc.gov.cn, Finance Department of Guangdong Province, XL; 4. the Fundamental Research Funds for the Central Universities (No. 11ykpy38), Ministry of Finance of China, http://research.sysu.edu.cn/, XL; 5. the National Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (No. 201113A1101300), Ministry of Science & Technology of China, http://www.most.gov.cn, Ministry of Science & Technology of China, XL.	Alaupovic P, 2006, KIDNEY INT, V69, P1865, DOI 10.1038/sj.ki.5000327; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Attman PO, 2009, CURR OPIN LIPIDOL, V20, P293, DOI 10.1097/MOL.0b013e32832dd832; ATTMAN PO, 1993, AM J KIDNEY DIS, V21, P573, DOI 10.1016/S0272-6386(12)80030-8; Baragetti A, 2013, J INTERN MED, V274, P252, DOI 10.1111/joim.12081; Bobik A, 2008, CIRCULATION, V118, P702, DOI 10.1161/CIRCULATIONAHA.108.794081; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; Hou X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106778, 10.1371/journal.pone.0108314]; Ikewaki K, 2005, ARTERIOSCL THROM VAS, V25, P2615, DOI 10.1161/01.ATV.0000188555.60475.c2; Liu X, 2010, ARCH GERONTOL GERIAT, V51, P13, DOI 10.1016/j.archger.2009.06.005; Mesquita Joana, 2010, Endocrinol Nutr, V57, P440, DOI 10.1016/j.endonu.2010.06.003; Odden MC, 2013, ANN EPIDEMIOL, V23, P106, DOI 10.1016/j.annepidem.2012.12.004; Prinsen BHCMT, 2004, KIDNEY INT, V65, P1064, DOI 10.1111/j.1523-1755.2004.00466.x; Scheffer PG, 2008, CLIN CHEM, V54, P1325, DOI 10.1373/clinchem.2008.103234; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Stevens LA, 2008, J NEPHROL, V21, P797; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	25	11	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163767	10.1371/journal.pone.0163767	http://dx.doi.org/10.1371/journal.pone.0163767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695128	Green Submitted, Green Published, gold			2022-12-27	WOS:000385553100051
J	Wu, P; Xiong, XF; Xu, ZZ; Lu, CQ; Cheng, H; Lyu, XL; Zhang, JH; He, W; Deng, W; Lyu, YH; Lou, QS; Hong, YG; Fang, HD				Wu, Peng; Xiong, Xiaofei; Xu, Zhanzhou; Lu, Chuqian; Cheng, Hao; Lyu, Xiangli; Zhang, Jinghuai; He, Wei; Deng, Wei; Lyu, Yihua; Lou, Quansheng; Hong, Yiguo; Fang, Hongda			Bacterial Communities in the Rhizospheres of Three Mangrove Tree Species from Beilun Estuary, China	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; ENVIRONMENTAL VARIABLES; MICROBIAL DIVERSITY; SEDIMENTS; SOIL; SEQUENCES	The bacterial communities played important roles in the high productivity mangrove ecosystem. In this study, we investigated the vertical distributions of rhizosphere bacteria from three mangrove species (Bruguiera gymnorrhiza, Kandelia candel and Aegiceras corniculatum) in Beilun Estuary, China using high throughput DNA pyrosequencing of the 16S rRNA gene. Phylogenetic analysis showed that bacterial communities from mangrove rhizosphere sediments were dominated by Proteobacteria (mostly Deltaproteobacteria and Gammaproteobacteria), followed by Chloroflexi, Bacteroidetes, Planctomycetes and Acid-obacteria. However, the ANOVA analysis on Shannon and Chao1 indices indicated that bacterial communities among sediments of the three mangrove species varied more strongly than the sampling depths. In addition, the PCA result demonstrated that the bacterial communities could be separated into three groups according to the mangrove species. Moreover, the dominated orders Rhodospirillales, GCA004 and envOPS12 were significantly different among sediments of the three mangrove species. The results of this study provided valuable information about the distribution feature of rhizosphere bacteria from Chinese mangrove plants and shed insights into biogeochemical transformations driven by bacteria in rhizosphere sediments.	[Wu, Peng; Xiong, Xiaofei; Xu, Zhanzhou; Lu, Chuqian; Lyu, Xiangli; Zhang, Jinghuai; He, Wei; Deng, Wei; Lyu, Yihua; Lou, Quansheng; Fang, Hongda] State Ocean Adm, South China Sea Environm Monitoring Ctr, Guangzhou, Guangdong, Peoples R China; [Cheng, Hao; Hong, Yiguo] Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China	State Oceanic Administration; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS	Fang, HD (corresponding author), State Ocean Adm, South China Sea Environm Monitoring Ctr, Guangzhou, Guangdong, Peoples R China.; Hong, YG (corresponding author), Chinese Acad Sci, South China Sea Inst Oceanol, State Key Lab Trop Oceanog, Guangzhou, Guangdong, Peoples R China.	yghong@scsio.ac.cn; Fanghongda1@21cn.com	wu, peng/AAI-1749-2021; 张, 敬怀/GXH-6967-2022		Guangdong Natural Science Foundation [2014A030310495, 2014A030313783]; National Natural Science Foundation of China [41406179]; Key Laboratory for Ecological Environment in Coastal Areas, State Oceanic Administration [201508, 201608]; Director Fund of Marine Science and Technology, South China Sea Branch, State Oceanic Administration [1516, 1511]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory for Ecological Environment in Coastal Areas, State Oceanic Administration; Director Fund of Marine Science and Technology, South China Sea Branch, State Oceanic Administration	This work was supported by Guangdong Natural Science Foundation (2014A030310495, 2014A030313783), and National Natural Science Foundation of China (41406179), as well as the Key Laboratory for Ecological Environment in Coastal Areas, State Oceanic Administration (201508, 201608), and sponsored by the Director Fund of Marine Science and Technology, South China Sea Branch, State Oceanic Administration (1516,1511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Alvarenga DO, 2015, BIODIVERS CONSERV, V24, P799, DOI 10.1007/s10531-015-0871-2; Alzubaidy H, 2016, GENE, V576, P626, DOI 10.1016/j.gene.2015.10.032; Andreote FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038600; Basak P, 2015, MICROB ECOL, V69, P500, DOI 10.1007/s00248-014-0498-y; Bashan Y, 2002, TREES-STRUCT FUNCT, V16, P159, DOI 10.1007/s00468-001-0152-4; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Blazejak A, 2010, FEMS MICROBIOL ECOL, V72, P198, DOI 10.1111/j.1574-6941.2010.00838.x; Cabezas A, 2015, ENV MICROBIOL REP, V7, P489, DOI 10.1111/1758-2229.12277; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cleary DFR, 2016, PLANT BIOLOGY, V18, P824, DOI 10.1111/plb.12459; Colares GB, 2013, APPL SOIL ECOL, V64, P171, DOI 10.1016/j.apsoil.2012.12.004; dos Santos HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016943; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Feller IC, 2010, ANNU REV MAR SCI, V2, P395, DOI 10.1146/annurev.marine.010908.163809; Gomes NCM, 2014, ESTUAR COAST SHELF S, V139, P40, DOI 10.1016/j.ecss.2013.12.022; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Holguin G, 2001, BIOL FERT SOILS, V33, P265, DOI 10.1007/s003740000319; Isobe K, 2014, MICROBES ENVIRON, V29, P4, DOI 10.1264/jsme2.ME13159; Jiang XT, 2013, MICROB ECOL, V66, P96, DOI 10.1007/s00248-013-0238-8; Kaster AK, 2014, ISME J, V8, P1831, DOI 10.1038/ismej.2014.24; Kuenen JG, 2008, NAT REV MICROBIOL, V6, P320, DOI 10.1038/nrmicro1857; Lee HJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00639; Loganathachetti DS, 2016, CURR MICROBIOL, V72, P68, DOI 10.1007/s00284-015-0920-9; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Pires ACC, 2012, APPL ENVIRON MICROB, V78, P5520, DOI 10.1128/AEM.00386-12; Rigonato J, 2013, ENVIRON MICROBIOL, V15, P1103, DOI 10.1111/j.1462-2920.2012.02830.x; Sahoo K, 2009, INDIAN J MAR SCI, V38, P249; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sherman RE, 1998, OECOLOGIA, V115, P553, DOI 10.1007/s004420050553; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Taketani RG, 2010, J MICROBIOL, V48, P7, DOI 10.1007/s12275-009-0147-1; Thatoi H, 2013, ANN MICROBIOL, V63, P1, DOI 10.1007/s13213-012-0442-7; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2012, APPL ENVIRON MICROB, V78, P8264, DOI 10.1128/AEM.01821-12; Yamada T, 2005, APPL ENVIRON MICROB, V71, P7493, DOI 10.1128/AEM.71.11.7493-7503.2005; Yu J, 2011, MICROB ECOL, V62, P218, DOI 10.1007/s00248-011-9846-3; Zhang YY, 2009, SCI MAR, V73, P487, DOI 10.3989/scimar.2009.73n3487	42	36	43	8	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164082	10.1371/journal.pone.0164082	http://dx.doi.org/10.1371/journal.pone.0164082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695084	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100086
J	Xing, FQ; Zhan, QQ; He, YD; Cui, JS; He, SL; Wang, GY				Xing, Fuqiang; Zhan, Qiuqiang; He, Yiduo; Cui, Jiesheng; He, Sailing; Wang, Guanyu			1800MHz Microwave Induces p53 and p53-Mediated Caspase-3 Activation Leading to Cell Apoptosis In Vitro	PLOS ONE			English	Article							RADIOFREQUENCY ELECTROMAGNETIC-FIELDS; MOBILE-PHONE RADIATION; OXYGEN SPECIES PRODUCTION; HUMAN NEUROBLASTOMA-CELLS; CYTOCHROME-C RELEASE; OXIDATIVE STRESS; DNA-DAMAGE; HUMAN FIBROBLASTS; HSP70 EXPRESSION; GENE-EXPRESSION	Recent studies have reported that exposure of mammalian cells to microwave radiation may have adverse effects such as induction of cell apoptosis. However, the molecular mechanisms underlying microwave induced mammalian cell apoptosis are not fully understood. Here, we report a novel mechanism: exposure to 1800MHz microwave radiation induces p53-dependent cell apoptosis through cytochrome c-mediated caspase-3 activation pathway. We first measured intensity of microwave radiation from several electronic devices with an irradiation detector. Mouse NIH/3T3 and human U-87 MG cells were then used as receivers of 1800MHz electromagnetic radiation (EMR) at a power density of 1209 mW/m(2). Following EMR exposure, cells were analyzed for viability, intracellular reactive oxygen species (ROS) generation, DNA damage, p53 expression, and caspase-3 activity. Our analysis revealed that EMR exposure significantly decreased viability of NIH/3T3 and U-87 MG cells, and increased caspase-3 activity. ROS burst was observed at 6 h and 48 h in NIH/3T3 cells, while at 3 h in U-87 MG cells. Hoechst 33258 staining and in situ TUNEL assay detected that EMR exposure increased DNA damage, which was significantly restrained in the presence of N-acetyl-L-cysteine (NAC, an antioxidant). Moreover, EMR exposure increased the levels of p53 protein and p53 target gene expression, promoted cytochrome c release from mitochondrion, and increased caspase-3 activity. These events were inhibited by pretreatment with NAC, pifithrin-alpha (a p53 inhibitor) and caspase inhibitor. Collectively, our findings demonstrate, for the first time, that 1800MHz EMR induces apoptosis-related events such as ROS burst and more oxidative DNA damage, which in turn promote p53-dependent caspase-3 activation through release of cytochrome c from mitochondrion. These findings thus provide new insights into physiological mechanisms underlying microwave-induced cell apoptosis.	[Xing, Fuqiang; Zhan, Qiuqiang; He, Sailing] South China Normal Univ, South China Acad Adv Optoelect, SCNU ZJU Joint Res Ctr Photon, Guangzhou 510006, Guangdong, Peoples R China; [Xing, Fuqiang; He, Yiduo; Cui, Jiesheng; Wang, Guanyu] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China; [He, Sailing] Royal Inst Technol KTH, Dept Electromagnet Engn, S-10044 Stockholm, Sweden	South China Normal University; Southern University of Science & Technology; Royal Institute of Technology	He, SL (corresponding author), South China Normal Univ, South China Acad Adv Optoelect, SCNU ZJU Joint Res Ctr Photon, Guangzhou 510006, Guangdong, Peoples R China.; Wang, GY (corresponding author), South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China.; He, SL (corresponding author), Royal Inst Technol KTH, Dept Electromagnet Engn, S-10044 Stockholm, Sweden.	sailing@jorcep.org; wanggy@sustc.edu.cn	He, Sailing/C-2438-2009; Xing, Fuqiang/ABG-4876-2021; ZHAN, Qiuqiang/E-5245-2013	He, Sailing/0000-0002-3401-1125; ZHAN, Qiuqiang/0000-0002-5886-3795	Natural Science Foundation of China [61405062, 91233208, 61471186]; Guangdong Innovative Research Team Program [201001D104799318]; Natural Science Foundation of Guangdong Province [S2013040014211, 2014A030313445]; Fundamental Research Grant of SUSTC [FRG-SUSTC1501A-38]; Postdoctoral Science Foundation of China [2013M530368, 2014T70818]; Discipline and Specialty Construction Foundation of Colleges and Universities of Guangdong Province [2013LYM_0017]; Shenzhen Municipal Research Funds [JCYJ20140417105816347]; Young Faculty Academic Training Foundation of SCNU [2012KJ017]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Innovative Research Team Program; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Fundamental Research Grant of SUSTC; Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation); Discipline and Specialty Construction Foundation of Colleges and Universities of Guangdong Province; Shenzhen Municipal Research Funds; Young Faculty Academic Training Foundation of SCNU	This work was supported by Natural Science Foundation of China (61405062, 91233208 and 61471186), Guangdong Innovative Research Team Program (201001D104799318), Natural Science Foundation of Guangdong Province (S2013040014211, 2014A030313445), Fundamental Research Grant of SUSTC (FRG-SUSTC1501A-38), the Postdoctoral Science Foundation of China (2013M530368, 2014T70818), the Discipline and Specialty Construction Foundation of Colleges and Universities of Guangdong Province (2013LYM_0017), the Shenzhen Municipal Research Funds (JCYJ20140417105816347) and the Young Faculty Academic Training Foundation of SCNU (2012KJ017).	Amaral JD, 2010, DISCOV MED, V9, P145; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; Belyaev IY, 2006, BIOELECTROMAGNETICS, V27, P295, DOI 10.1002/bem.20216; Buttiglione M, 2007, J CELL PHYSIOL, V213, P759, DOI 10.1002/jcp.21146; Caraglia M, 2005, J CELL PHYSIOL, V204, P539, DOI 10.1002/jcp.20327; Chen YC, 1998, J CELL PHYSIOL, V177, P324, DOI 10.1002/(SICI)1097-4652(199811)177:2<324::AID-JCP14>3.0.CO;2-9; De Iuliis GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006446; Derdak Z, 2011, J HEPATOL, V54, P164, DOI 10.1016/j.jhep.2010.08.007; Di Carlo A, 2002, J CELL BIOCHEM, V84, P447, DOI 10.1002/jcb.10036.abs; Diem E, 2005, MUTAT RES-GEN TOX EN, V583, P178, DOI 10.1016/j.mrgentox.2005.03.006; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Hardell L, 2008, INT J ONCOL, V32, P1097; Hong MN, 2012, BIOELECTROMAGNETICS, V33, P604, DOI 10.1002/bem.21731; Hou QX, 2015, ELECTROMAGN BIOL MED, V34, P85, DOI 10.3109/15368378.2014.900507; Huber R, 2002, J SLEEP RES, V11, P289, DOI 10.1046/j.1365-2869.2002.00314.x; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Ivancsits S, 2003, INT ARCH OCC ENV HEA, V76, P431, DOI 10.1007/s00420-003-0446-5; Kesari KK, 2011, ELECTROMAGN BIOL MED, V30, P219, DOI 10.3109/15368378.2011.587930; Krause CM, 2000, NEUROREPORT, V11, P761, DOI 10.1097/00001756-200003200-00021; Lantow M, 2006, RADIAT RES, V165, P88, DOI 10.1667/RR3476.1; Lantow M, 2006, RADIAT ENVIRON BIOPH, V45, P55, DOI 10.1007/s00411-006-0038-3; Leszczynski D, 2002, DIFFERENTIATION, V70, P120, DOI 10.1046/j.1432-0436.2002.700207.x; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lin C-S, 2010, IPEC 2010 C P IEEE; Liu C, 2013, TOXICOL LETT, V218, P2, DOI 10.1016/j.toxlet.2013.01.003; Liu Yun, 2003, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V21, P339; Marchesi N, 2014, J CELL PHYSIOL, V229, P1776, DOI 10.1002/jcp.24631; Markova E, 2005, ENVIRON HEALTH PERSP, V113, P1172, DOI 10.1289/ehp.7561; Mashevich M, 2003, BIOELECTROMAGNETICS, V24, P82, DOI 10.1002/bem.10086; Mazumder Suparna, 2008, V414, P13; Meng CB, 2013, J NEUROSCI, V33, P13505, DOI 10.1523/JNEUROSCI.0918-13.2013; Naziroglu M, 2013, J MEMBRANE BIOL, V246, P869, DOI 10.1007/s00232-013-9597-9; Nikolova T, 2005, FASEB J, V19, P1686, DOI 10.1096/fj.04-3549fje; Schuz J, 2011, AM J EPIDEMIOL, V174, P416, DOI 10.1093/aje/kwr112; Schwarz C, 2008, INT ARCH OCC ENV HEA, V81, P755, DOI 10.1007/s00420-008-0305-5; Sheikh MS, 2000, J CELL PHYSIOL, V182, P171, DOI 10.1002/(SICI)1097-4652(200002)182:2<171::AID-JCP5>3.0.CO;2-3; Shi L, 2010, BRAIN RES, V1352, P255, DOI 10.1016/j.brainres.2010.07.009; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Speidel D, 2015, ARCH TOXICOL, V89, P501, DOI 10.1007/s00204-015-1459-z; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Xu LJ, 2002, J CEREBR BLOOD F MET, V22, P21, DOI 10.1097/00004647-200201000-00003; Xu SC, 2010, BRAIN RES, V1311, P189, DOI 10.1016/j.brainres.2009.10.062; Yang L, 2012, CELL MOL NEUROBIOL, V32, P1039, DOI 10.1007/s10571-012-9821-7; Yang Y, 2010, BIOCHEM BIOPH RES CO, V395, P190, DOI 10.1016/j.bbrc.2010.03.155; Yuan J, 2003, BBA-MOL CELL RES, V1641, P35, DOI 10.1016/S0167-4889(03)00047-8; Zhao TY, 2007, NEUROSCI LETT, V412, P34, DOI 10.1016/j.neulet.2006.09.092; Zmyslony M, 2004, BIOELECTROMAGNETICS, V25, P324, DOI 10.1002/bem.10191; Zuo HY, 2014, INT J MED SCI, V11, P426, DOI 10.7150/ijms.6540	51	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163935	10.1371/journal.pone.0163935	http://dx.doi.org/10.1371/journal.pone.0163935			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689798	Green Submitted, gold, Green Published			2022-12-27	WOS:000384329200036
J	Asperti, M; Stuemler, T; Poli, M; Gryzik, M; Lifshitz, L; Meyron-Holtz, EG; Vlodavsky, I; Arosio, P				Asperti, Michela; Stuemler, Tanja; Poli, Maura; Gryzik, Magdalena; Lifshitz, Lena; Meyron-Holtz, Esther G.; Vlodavsky, Israel; Arosio, Paolo			Heparanase Overexpression Reduces Hepcidin Expression, Affects Iron Homeostasis and Alters the Response to Inflammation	PLOS ONE			English	Article							MAMMALIAN HEPARANASE; MOLECULAR-PROPERTIES; IN-VITRO; SULFATE; PROGRESSION; METASTASIS; ACTIVATION; INHIBITORS; REGULATOR; HEPARINS	Hepcidin is the key regulator of systemic iron availability that acts by controlling the degradation of the iron exporter ferroportin. It is expressed mainly in the liver and regulated by iron, inflammation, erythropoiesis and hypoxia. The various agents that control its expression act mainly via the BMP6/SMAD signaling pathway. Among them are exogenous heparins, which are strong hepcidin repressors with a mechanism of action not fully understood but that may involve the competition with the structurally similar endogenous Heparan Sulfates (HS). To verify this hypothesis, we analyzed how the overexpression of heparanase, the HS degrading enzyme, modified hepcidin expression and iron homeostasis in hepatic cell lines and in transgenic mice. The results showed that transient and stable overexpression of heparanase in HepG2 cells caused a reduction of hepcidin expression and of SMAD5 phosphorylation. Interestingly, the clones showed also altered level of TfR1 and ferritin, indices of a modified iron homeostasis. The heparanase transgenic mice showed a low level of liver hepcidin, an increase of serum and liver iron with a decrease in spleen iron content. The hepcidin expression remained surprisingly low even after treatment with the inflammatory LPS. The finding that modification of HS structure mediated by heparanase overexpression affects hepcidin expression and iron homeostasis supports the hypothesis that HS participate in the mechanisms controlling hepcidin expression.	[Asperti, Michela; Poli, Maura; Gryzik, Magdalena; Arosio, Paolo] Univ Brescia, Dept Mol & Translat Med DMMT, Mol Biol Lab, Viale Europa 11, I-25123 Brescia, Italy; [Stuemler, Tanja; Lifshitz, Lena; Meyron-Holtz, Esther G.] Technion Israel Inst Technol, Fac Biotechnol & Food Engn, Lab Mol Nutr, IL-32000 Haifa, Israel; [Vlodavsky, Israel] Technion Israel Inst Technol, Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel	University of Brescia; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Arosio, P (corresponding author), Univ Brescia, Dept Mol & Translat Med DMMT, Mol Biol Lab, Viale Europa 11, I-25123 Brescia, Italy.	paolo.arosio@unibs.it	arosio, paolo/S-3272-2019	arosio, paolo/0000-0002-5343-8992	Telethon grant [GGP15064]; MIUR-PRIN grant; Grant Fondazione Cariplo; EMBO fellowship	Telethon grant(Fondazione Telethon); MIUR-PRIN grant(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Grant Fondazione Cariplo; EMBO fellowship(European Molecular Biology Organization (EMBO))	The work was partially supported by Telethon grant GGP15064 to PA, by MIUR-PRIN grant 2010-11 to PA, by Grant Fondazione Cariplo to PA and AN. MA was supported by a short term EMBO fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud-Jarrous G, 2008, J BIOL CHEM, V283, P18167, DOI 10.1074/jbc.M801327200; Altamura S, 2016, EUR IR CLUB M INNSBR; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Besson-Fournier C, 2016, EUR IR CLUB M INNSBR; Castagna A, 2010, J PROTEOMICS, V73, P527, DOI 10.1016/j.jprot.2009.08.003; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Ganz T, 2011, HEMATOL-AM SOC HEMAT, P538, DOI 10.1182/asheducation-2011.1.538; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Goldberg R, 2013, MATRIX BIOL, V32, P234, DOI 10.1016/j.matbio.2013.02.008; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Jiao XY, 2007, J BIOL CHEM, V282, P1080, DOI 10.1074/jbc.M513414200; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348; Levy-Adam F, 2005, J BIOL CHEM, V280, P20457, DOI 10.1074/jbc.M414546200; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770; Poli M, 2014, BIOCHEM PHARMACOL, V92, P467, DOI 10.1016/j.bcp.2014.09.007; Poli M, 2014, BLOOD, V123, P1564, DOI 10.1182/blood-2013-07-515221; Poli M, 2011, BLOOD, V117, P997, DOI 10.1182/blood-2010-06-289082; Roetto A, 2010, BLOOD, V115, P3382, DOI 10.1182/blood-2009-09-240960; Silvestri L, 2009, BLOOD, V113, P5605, DOI 10.1182/blood-2008-12-195594; Tatsinkam AJ, 2015, BIOCHEM J, V470, P53, DOI 10.1042/BJ20150228; Tjalsma H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016762; Turnbull J, 2001, TRENDS CELL BIOL, V11, P75, DOI 10.1016/S0962-8924(00)01897-3; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2001, BIOCHIMIE, V83, P831, DOI 10.1016/S0300-9084(01)01318-9; Vlodavsky I, 2012, CANCER MICROENVIRON, V5, P115, DOI 10.1007/s12307-011-0082-7; Zcharia E, 2005, AM J PATHOL, V166, P999, DOI 10.1016/S0002-9440(10)62321-8; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068; Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248	35	16	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164183	10.1371/journal.pone.0164183	http://dx.doi.org/10.1371/journal.pone.0164183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711215	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600093
J	Begum, F; Ruczinski, I; Hokanson, JE; Lutz, SM; Parker, MM; Cho, MH; Hetmanski, JB; Scharpf, RB; Crapo, JD; Silverman, EK; Beaty, TH				Begum, Ferdouse; Ruczinski, Ingo; Hokanson, John E.; Lutz, Sharon M.; Parker, Margaret M.; Cho, Michael H.; Hetmanski, Jacqueline B.; Scharpf, Robert B.; Crapo, James D.; Silverman, Edwin K.; Beaty, Terri H.			Hemizygous Deletion on Chromosome 3p26.1 Is Associated with Heavy Smoking among African American Subjects in the COPDGene Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OBSTRUCTIVE PULMONARY-DISEASE; COPY-NUMBER VARIATION; NICOTINE DEPENDENCE; MOLECULAR-GENETICS; RISK LOCI; EPIDEMIOLOGY; DEPRESSION; BEHAVIORS; LINKAGE	Many well-powered genome-wide association studies have identified genetic determinants of self-reported smoking behaviors and measures of nicotine dependence, but most have not considered the role of structural variants, such as copy number variation (CNVs), influencing these phenotypes. Here, we included 2,889 African American and 6,187 non-Hispanic White subjects from the COPDGene cohort (http://www.copdgene.org) to carefully investigate the role of polymorphic CNVs across the genome on various measures of smoking behavior. We identified a CNV component (a hemizygous deletion) on chromosome 3p26.1 associated with two quantitative phenotypes related to smoking behavior among African Americans. This polymorphic hemizygous deletion is significantly associated with pack-years and cigarettes smoked per day among African American subjects in the COPDGene study. We sought evidence of replication in African Americans from the population based Atherosclerosis Risk in Communities (ARIC) study. While we observed similar CNV counts, the extent of exposure to cigarette smoking among ARIC subjects was quite different and the smaller sample size of heavy smokers in ARIC severely limited statistical power, so we were unable to replicate our findings from the COPDGene cohort. But meta-analyses of COPDGene and ARIC study subjects strengthened our association signal. However, a few linkage studies have reported suggestive linkage to the 3p26.1 region, and a few genome-wide association studies (GWAS) have reported markers in the gene (GRM7) nearest to this 3p26.1 area of polymorphic deletions are associated with measures of nicotine dependence among subjects of European ancestry.	[Begum, Ferdouse; Hetmanski, Jacqueline B.; Beaty, Terri H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Ruczinski, Ingo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Hokanson, John E.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Lutz, Sharon M.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Parker, Margaret M.; Cho, Michael H.; Silverman, Edwin K.] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA; [Parker, Margaret M.; Cho, Michael H.; Silverman, Edwin K.] Harvard Med Sch, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA USA; [Scharpf, Robert B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Crapo, James D.] Natl Jewish Hlth, Dept Med, Denver, CO USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Colorado School of Public Health; Colorado School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Johns Hopkins University; National Jewish Health	Begum, F (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	fbegum1@jhu.edu		Hoffman, Eric/0000-0001-8456-9437	National Heart, Lung, and Blood Institute [R01 HL089856, R01 HL089897, R01 HL113264]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL125858, R01HL089897, R01HL089856, U01HL089897, U01HL089856, R01HL113264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007142] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by Award Number R01 HL089856, R01 HL089897 (EKS and JDC), and R01 HL113264 (MHC) from the National Heart, Lung, and Blood Institute.	Argos M, 2014, J MED GENET, V51, P327, DOI 10.1136/jmedgenet-2013-102151; Begum F, 2016, GENET EPIDEMIOL, V40, P81, DOI 10.1002/gepi.21943; Bierut LJ, 2007, PHARMACOGENOMICS, V8, P881, DOI 10.2217/14622416.8.8.881; Breen G, 2011, AM J PSYCHIAT, V168, P840, DOI 10.1176/appi.ajp.2011.10091342; Cho MH, 2014, LANCET RESP MED, V2, P214, DOI 10.1016/S2213-2600(14)70002-5; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; David SP, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.41; Gelernter J, 2015, BIOL PSYCHIAT, V77, P493, DOI 10.1016/j.biopsych.2014.08.025; General TS, 2014, THE HEALTH CONSEQUEN; Grydeland TB, 2009, EUR RESPIR J, V34, P858, DOI 10.1183/09031936.00167908; Hamidovic A, 2012, NEUROPSYCHOPHARMACOL, V37, P968, DOI 10.1038/npp.2011.280; Hancock DB, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.149; Harari O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050913; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Lee JH, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0097-y; Li MD, 2003, AM J MED SCI, V326, P168, DOI 10.1097/00000441-200310000-00003; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Loukola Anu, 2014, Curr Addict Rep, V1, P75; Maio S, 2012, EUR RESPIR J, V39, P1458, DOI 10.1183/09031936.00111910; Nielsen DA, 2010, PSYCHIAT GENET, V20, P207, DOI 10.1097/YPG.0b013e32833a2106; Olfson E, 2016, MOL PSYCHIATR, V21, P601, DOI 10.1038/mp.2015.105; Parker MM, 2014, GENET EPIDEMIOL, V38, P652, DOI 10.1002/gepi.21847; Pergadia ML, 2011, AM J PSYCHIAT, V168, P848, DOI 10.1176/appi.ajp.2011.10091319; Powell GL, 2015, J NEUROPHYSIOL, V113, P1862, DOI 10.1152/jn.00838.2014; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Scharpf RB, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-81; Sjodin P, 2012, METHODS MOL BIOL, V838, P209, DOI 10.1007/978-1-61779-507-7_10; Tseng TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107268; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Wan ES, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0089-y; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang SL, 2014, MOL NEUROBIOL, V49, P601, DOI 10.1007/s12035-013-8541-4; WHO, 2009, REPORT ON THE GLOBAL; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yoon D, 2012, HUM GENET, V131, P1009, DOI 10.1007/s00439-011-1102-x; Younkin SG, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-24; Zhu G, 2007, AM J RESP CRIT CARE, V176, P167, DOI 10.1164/rccm.200611-1723OC	42	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164134	10.1371/journal.pone.0164134	http://dx.doi.org/10.1371/journal.pone.0164134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711239	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600084
J	Delfiner, MS; Martinez, LR; Pavia, CS				Delfiner, Matthew S.; Martinez, Luis R.; Pavia, Charles S.			A Gram Stain Hands-On Workshop Enhances First Year Medical Students' Technique Competency in Comprehension and Memorization	PLOS ONE			English	Article							LABORATORY MEDICINE; SCHOOLS; PERFORMANCE; EDUCATION; RESIDENCY; PEER	Background Laboratory diagnostic tests have an essential role in patient care, and the increasing number of medical and health professions schools focusing on teaching laboratory medicine to pre-clinical students reflects this importance. However, data validating the pedagogical methods that best influence students' comprehension and interpretation of diagnostic tests have not been well described. The Gram stain is a simple yet significant and frequently used diagnostic test in the clinical setting that helps classify bacteria into two major groups, Gram positive and negative, based on their cell wall structure. Methods and Findings We used this technique to assess which educational strategies may improve students' learning and competency in medical diagnostic techniques. Hence, in this randomized controlled study, we compared the effectiveness of several educational strategies (e.g. workshop, discussion, or lecture) in first year medical students' competency in comprehension and interpretation of the Gram stain procedure. We demonstrated that a hands-on practical workshop significantly enhances students' competency in memorization and overall comprehension of the technique. Interestingly, most students irrespective of their cohort showed difficulty in answering Gram stain-related analytical questions, suggesting that more emphasis should be allocated by the instructors to clearly explain the interpretation of the diagnostic test results to students in medical and health professional schools. Conclusion This proof of principle study highlights the need of practical experiences on laboratory medical techniques during pre-clinical training to facilitate future medical doctors' and healthcare professionals' basic understanding and competency in diagnostic testing for better patient care.	[Delfiner, Matthew S.; Martinez, Luis R.; Pavia, Charles S.] New York Inst Technol, Dept Biomed Sci, NYIT Coll Osteopath Med, Old Westbury, NY 11568 USA	New York Institute Technology	Martinez, LR; Pavia, CS (corresponding author), New York Inst Technol, Dept Biomed Sci, NYIT Coll Osteopath Med, Old Westbury, NY 11568 USA.	lmarti13@nyit.edu; cpavia@nyit.edu			NYITCOM; National Institute of General Medical Sciences of the US NIH [R15GM117501]	NYITCOM; National Institute of General Medical Sciences of the US NIH	M.S.D., L.R.M., and C.S.P. were supported by NYITCOM intramural funds. L.R.M. was supported by the National Institute of General Medical Sciences of the US NIH under award number R15GM117501.	Armbruster P, 2009, CBE-LIFE SCI EDUC, V8, P203, DOI 10.1187/cbe.09-03-0025; Bloom B.S., 1956, TAXONOMY ED OBJECTIV; Crouch CH, 2001, AM J PHYS, V69, P970, DOI 10.1119/1.1374249; Iwashyna TJ, 2011, ACAD MED, V86, P139, DOI 10.1097/ACM.0b013e3181fd85c3; Langdale LA, 2003, ACAD MED, V78, P39, DOI 10.1097/00001888-200301000-00009; LEBOFFE MJ, 2002, MICROBIOLOGY LAB THE; Lyss-Lerman P, 2009, ACAD MED, V84, P823, DOI 10.1097/ACM.0b013e3181a82426; Magid MS, 2012, HUM PATHOL, V43, P567, DOI 10.1016/j.humpath.2011.06.006; Mamede S, 2012, MED EDUC, V46, P464, DOI 10.1111/j.1365-2923.2012.04217.x; Melber DJ, 2016, CLIN INFECT DIS, V63, P164, DOI 10.1093/cid/ciw262; Riskowski JL, 2009, INT J ENG EDUC, V25, P181; Simpson E.J., 1966, ILLINOIS TEACHER HOM, V10, P110; Smith BR, 2016, ACAD MED, V91, P107, DOI 10.1097/ACM.0000000000000817; Smith BR, 2010, AM J CLIN PATHOL, V133, P533, DOI 10.1309/AJCPQCT94SFERLNI; Smith MK, 2009, SCIENCE, V323, P122, DOI 10.1126/science.1165919	15	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163658	10.1371/journal.pone.0163658	http://dx.doi.org/10.1371/journal.pone.0163658			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711118	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600033
J	Habbib, H; Verzeaux, J; Nivelle, E; Roger, D; Lacoux, J; Catterou, M; Hirel, B; Dubois, F; Tetu, T				Habbib, Hazzar; Verzeaux, Julien; Nivelle, Elodie; Roger, David; Lacoux, Jerome; Catterou, Manuella; Hirel, Bertrand; Dubois, Frederic; Tetu, Thierry			Conversion to No-Till Improves Maize Nitrogen Use Efficiency in a Continuous Cover Cropping System	PLOS ONE			English	Article							POSTANTHESIS WATER-DEFICIT; GRAIN-YIELD; WINTER-WHEAT; DRY-MATTER; MEDITERRANEAN CONDITIONS; CARBON SEQUESTRATION; RESIDUE MANAGEMENT; GENETIC-VARIATION; FERTILIZER RATE; ORGANIC-MATTER	A two-year experiment was conducted in the field to measure the combined impact of tilling and N fertilization on various agronomic traits related to nitrogen (N) use efficiency and to grain yield in maize cultivated in the presence of a cover crop. Four years after conversion to no-till, a significant increase in N use efficiency N harvest index, N remobilization and N remobilization efficiency was observed both under no and high N fertilization conditions. Moreover, we observed that grain yield and grain N content were higher under no-till conditions only when N fertilizers were applied. Thus, agronomic practices based on continuous no-till appear to be a promising for increasing N use efficiency in maize.	[Habbib, Hazzar; Verzeaux, Julien; Nivelle, Elodie; Roger, David; Lacoux, Jerome; Catterou, Manuella; Dubois, Frederic; Tetu, Thierry] Univ Picardie Jules Verne, Lab Agroecol Ecophysiol & Biol Integrat, Ecol & Dynam Syst Anthropises EDYSAN, FRE 3498,CNRS, 33 Rue St Leu, F-80039 Amiens, France; [Hirel, Bertrand] Ctr Versailles Grignon, Inst Natl Rech Agron, Adaptat Plantes Environm, Inst Jean Pierre Bourgin,UMR 1318, RD 10, F-78026 Versailles, France	Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Picardie Jules Verne (UPJV); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Habbib, H (corresponding author), Univ Picardie Jules Verne, Lab Agroecol Ecophysiol & Biol Integrat, Ecol & Dynam Syst Anthropises EDYSAN, FRE 3498,CNRS, 33 Rue St Leu, F-80039 Amiens, France.	hazzar.habbib@u-picardie.fr	Dubois, Frederic/AAG-9062-2020; Hirel, Bertrand/AAG-5662-2020	Dubois, Frederic/0000-0001-6972-9869; Hirel, Bertrand/0000-0002-5518-3671	University of Picardy Jules Verne in the context of the collaborative project VEGESOL; Bonduelle; Syngenta	University of Picardy Jules Verne in the context of the collaborative project VEGESOL; Bonduelle; Syngenta(Syngenta)	The study was funded by Bonduelle and Syngenta and the University of Picardy Jules Verne in the context of the collaborative project VEGESOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdin MA, 2005, NITROGEN NUTR PLANT, P1; Al-Kaisi M, 2007, AGRON J, V99, P1548, DOI 10.2134/agronj2007.0012; Alvear M, 2005, SOIL TILL RES, V82, P195, DOI 10.1016/j.still.2004.06.002; Arshad MA, 1999, SOIL TILL RES, V53, P41, DOI 10.1016/S0167-1987(99)00075-6; Auguie B, 2017, GRIDEXTRA MISCELLANE; Aulakh MS, 2012, SOIL TILL RES, V120, P50, DOI 10.1016/j.still.2011.11.001; Awale R, 2013, SOIL TILL RES, V134, P213, DOI 10.1016/j.still.2013.08.006; Bahrani A, 2011, AFR J BIOTECHNOL, V10, P10585; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Beheshti AR, 2010, AUST J CROP SCI, V4, P185; Bertin P, 2000, MAYDICA, V45, P53; Birkas M, 2004, SOIL TILL RES, V78, P185, DOI 10.1016/j.still.2004.02.006; Botta GF, 2006, SOIL TILL RES, V91, P164, DOI 10.1016/j.still.2005.12.011; Brennan J, 2014, EUR J AGRON, V54, P61, DOI 10.1016/j.eja.2013.11.009; Burgess MS, 2002, CAN J SOIL SCI, V82, P127, DOI 10.4141/S01-013; Caviglia OP, 2014, FIELD CROP RES, V168, P27, DOI 10.1016/j.fcr.2014.08.005; Christopher SF, 2009, SOIL SCI SOC AM J, V73, P207, DOI 10.2136/sssaj2007.0336; COX MC, 1985, CROP SCI, V25, P435, DOI 10.2135/cropsci1985.0011183X002500030003x; DAC, 2015, PLIEG PET; Dalal RC, 2011, SOIL SCI SOC AM J, V75, P2251, DOI 10.2136/sssaj2010.0398; Dimassi B, 2013, AGR ECOSYST ENVIRON, V169, P12, DOI 10.1016/j.agee.2013.01.012; Dray S, 2015, ADE4 ANAL ECOLOGICAL; Dumas J. B. A, 1831, ANN CHIM PHYS, V2, P198; Edmonds DE, 2013, J PLANT NUTR, V36, P1013, DOI 10.1080/01904167.2011.585198; Ercoli L, 2008, EUR J AGRON, V28, P138, DOI 10.1016/j.eja.2007.06.002; Erisman JW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0116; Fageria, 2014, NITROGEN MANAGEMENT, P436; Filipovic D, 2006, J TERRAMECHANICS, V43, P177, DOI 10.1016/j.jterra.2005.04.002; Galloway JN, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0120; Giller K.E., 2001, NITROGEN FIXATION TR, P423; Green VS, 2007, SOIL TILL RES, V92, P114, DOI 10.1016/j.still.2006.01.004; Gselman A, 2008, AUST J AGR RES, V59, P1156, DOI 10.1071/AR08015; Gursoy S, 2010, FIELD CROP RES, V119, P260, DOI 10.1016/j.fcr.2010.07.016; Harrell Jr FE, 2015, HMISC HARRELL MISCEL; Hirel B., 2005, Journal of Crop Improvement, V15, P213, DOI 10.1300/J411v15n02_07; Hirel B, 2011, SUSTAINABILITY-BASEL, V3, P1452, DOI 10.3390/su3091452; HUGGINS DR, 1993, AGRON J, V85, P898, DOI 10.2134/agronj1993.00021962008500040022x; International Grains Council, 2013, REP FISC YEAR 2011 1; Josa R, 2010, INT AGROPHYS, V24, P139; Kahlon MS, 2013, SOIL TILL RES, V126, P151, DOI 10.1016/j.still.2012.08.001; Kankanen H, 2011, EUR J AGRON, V34, P35, DOI 10.1016/j.eja.2010.10.002; KARLEN DL, 1991, COMMUN SOIL SCI PLAN, V22, P1985, DOI 10.1080/00103629109368552; Kristensen HL, 2003, SOIL BIOL BIOCHEM, V35, P979, DOI 10.1016/S0038-0717(03)00159-7; Lal R, 2009, EUR J SOIL SCI, V60, P158, DOI 10.1111/j.1365-2389.2008.01114.x; Leveau V, 2011, ADV MAIZE, P509; Lopez-Bellido L, 2005, FIELD CROP RES, V94, P86, DOI 10.1016/j.fcr.2004.11.004; Lopez-Bellido RJ, 2001, FIELD CROP RES, V71, P31, DOI 10.1016/S0378-4290(01)00146-0; Lu P, 2012, PLANT SOIL ENVIRON, V58, P211, DOI 10.17221/531/2011-PSE; Lv Peng, 2011, Plant Nutrition and Fertilizer Science, V17, P852; Machado S, 2007, SOIL TILL RES, V94, P473, DOI 10.1016/j.still.2006.09.007; MACHET JM, 1990, P 1 C EUR SOC AGR PA, P21; Mallarino AP, 1999, AGRON J, V91, P37, DOI 10.2134/agronj1999.00021962009100010007x; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Masoni A, 2007, EUR J AGRON, V26, P179, DOI 10.1016/j.eja.2006.09.006; Meijer AD, 2013, SOIL TILL RES, V126, P1, DOI 10.1016/j.still.2012.07.002; MOLL RH, 1982, AGRON J, V74, P562, DOI 10.2134/agronj1982.00021962007400030037x; Moser SB, 2006, AGR WATER MANAGE, V81, P41, DOI 10.1016/j.agwat.2005.04.005; Njarui DMG, 2010, ANIM PROD SCI, V50, P193, DOI 10.1071/AN09137; Nyakudya IW, 2015, SOIL TILL RES, V145, P184, DOI 10.1016/j.still.2014.09.003; Nyambati EM, 2006, J SUSTAIN AGR, V28, P97, DOI 10.1300/J064v28n01_09; Pampana S, 2007, ITAL J AGRON, V3, P3; Pandey D, 2014, SOIL TILL RES, V136, P51, DOI 10.1016/j.still.2013.09.013; Paponov I, 1996, EUR J AGRON, V5, P115, DOI 10.1016/S1161-0301(96)02015-1; Plaut Z, 2004, FIELD CROP RES, V86, P185, DOI 10.1016/j.fcr.2003.08.005; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Reicosky DC, 2007, SOIL TILL RES, V94, P109, DOI 10.1016/j.still.2006.07.004; Robertson MJ, 2005, FIELD CROP RES, V91, P91, DOI 10.1016/j.fcr.2004.06.009; ROYSTON JP, 1982, J R STAT SOC C-APPL, V31, P115; Saiz-Fernandez I, 2015, J PLANT PHYSIOL, V173, P120, DOI 10.1016/j.jplph.2014.06.018; Salem HM, 2015, GEODERMA, V237, P60, DOI 10.1016/j.geoderma.2014.08.014; Setiyono TD, 2011, AGRON J, V103, P1276, DOI 10.2134/agronj2011.0053; Sinclair TR, 2004, TRENDS PLANT SCI, V9, P70, DOI 10.1016/j.tplants.2003.12.008; Sip V, 2009, FIELD CROP RES, V113, P131, DOI 10.1016/j.fcr.2009.04.013; Soon YK, 2008, NUTR CYCL AGROECOSYS, V82, P149, DOI 10.1007/s10705-008-9176-0; Staggenborg SA, 2003, AGRON J, V95, P253, DOI 10.2134/agronj2003.0253; Tahmasebi Sarvestani Z., 2003, Journal of Agricultural Science and Technology, V5, P21; Thomas GA, 2007, SOIL TILL RES, V94, P295, DOI 10.1016/j.still.2006.08.005; Thorup-Kristensen K, 2001, PLANT SOIL, V230, P185, DOI 10.1023/A:1010306425468; Tonitto C, 2006, AGR ECOSYST ENVIRON, V112, P58, DOI 10.1016/j.agee.2005.07.003; Torbert HA, 2001, AGRON J, V93, P1119, DOI 10.2134/agronj2001.9351119x; Torresen KS, 2003, CROP PROT, V22, P185, DOI 10.1016/S0261-2194(02)00145-X; Verachtert E, 2009, PLANT SOIL, V320, P281, DOI 10.1007/s11104-009-9893-4; Vos J, 2004, NUTR CYCL AGROECOSYS, V70, P23, DOI 10.1023/B:FRES.0000049358.24431.0d; Wang Y, 2015, SOIL TILL RES, V151, P82, DOI 10.1016/j.still.2015.03.003; Zhou JB, 2011, FIELD CROP RES, V122, P157, DOI 10.1016/j.fcr.2011.03.009	86	14	16	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164234	10.1371/journal.pone.0164234	http://dx.doi.org/10.1371/journal.pone.0164234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711154	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600102
J	Stanifer, JW; Cleland, CR; Makuka, GJ; Egger, JR; Maro, V; Maro, H; Karia, F; Patel, UD; Burton, MJ; Philippin, H				Stanifer, John W.; Cleland, Charles R.; Makuka, Gerald Jamberi; Egger, Joseph R.; Maro, Venance; Maro, Honest; Karia, Francis; Patel, Uptal D.; Burton, Matthew J.; Philippin, Heiko			Prevalence, Risk Factors, and Complications of Diabetes in the Kilimanjaro Region: A Population-Based Study from Tanzania	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; INTRACLASS CORRELATION-COEFFICIENT; MELLITUS; PREVENTION; DISEASE; EPIDEMIOLOGY; MANAGEMENT; COMMUNITY; OBESITY; BURDEN	Background In sub-Saharan Africa, diabetes is a growing burden, yet little is known about its prevalence, risk factors, and complications. To address these gaps and help inform public health efforts aimed at prevention and treatment, we conducted a community-based study assessing diabetes epidemiology. Methods and Findings We conducted a stratified, cluster-designed, serial cross-sectional household study from 2014-2015 in the Kilimanjaro Region, Tanzania. We used a three-stage cluster probability sampling method to randomly select individuals. To estimate prevalence, we screened individuals for glucose impairment, including diabetes, using hemoglobin A1C. We also screened for hypertension and obesity, and to assess for potential complications, individuals with diabetes were assessed for retinopathy, neuropathy, and nephropathy. We enrolled 481 adults from 346 urban and rural households. The prevalence of glucose impairment was 21.7% (95% CI 15.2-29.8), which included diabetes (5.7%; 95% CI 3.37 - 9.47) and glucose impairment with increased risk for diabetes (16.0%; 95% CI 10.2-24.0). Overweight or obesity status had an independent prevalence risk ratio for glucose impairment (2.16; 95% CI 1.39-3.36). Diabetes awareness was low (35.6%), and few individuals with diabetes were receiving biomedical treatment (33.3%). Diabetes-associated complications were common (50.2%; 95% CI 33.7-66.7), including renal (12.0%; 95% CI 4.7-27.3), ophthalmic (49.6%; 95% CI 28.6-70.7), and neurological (28.8%; 95% CI8.0-65.1) abnormalities. Conclusions In a northern region of Tanzania, diabetes is an under-recognized health condition, despite the fact that many people either have diabetes or are at increased risk for developing diabetes. Most individuals were undiagnosed or untreated, and the prevalence of diabetes-associated complications was high. Public health efforts in this region will need to focus on reducing modifiable risk factors, which appear to include obesity, as well as early detection that includes increasing awareness. These findings highlight a growing urgency of diabetes prevention in this region as well as the need for treatment, including management of complications.	[Stanifer, John W.; Patel, Uptal D.] Duke Univ, Dept Med, Div Nephrol, Durham, NC 27708 USA; [Stanifer, John W.; Egger, Joseph R.; Patel, Uptal D.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Stanifer, John W.; Patel, Uptal D.] Duke Univ, Duke Clin Res Inst, Durham, NC 27708 USA; [Cleland, Charles R.; Maro, Venance; Philippin, Heiko] Kilimanjaro Christian Med Ctr, Eye Dept, Moshi, Tanzania; [Makuka, Gerald Jamberi; Maro, Venance; Karia, Francis] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Burton, Matthew J.; Philippin, Heiko] London Sch Hyg &Trop Med, Int Ctr Eye Hlth, London, England; [Burton, Matthew J.] Moorfields Eye Hosp, London, England	Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Stanifer, JW (corresponding author), Duke Univ, Dept Med, Div Nephrol, Durham, NC 27708 USA.; Stanifer, JW (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Stanifer, JW (corresponding author), Duke Univ, Duke Clin Res Inst, Durham, NC 27708 USA.	john.stanifer@duke.edu	Philippin, Heiko/AAN-4038-2020	Philippin, Heiko/0000-0002-5380-6994; Burton, Matthew/0000-0003-1872-9169	NIH Research Training Grant - Fogarty International Center [R25 TW009337]; National Institute of Mental Health; International Society of Nephrology Global Outreach Committee; Duke Global Health Institute; AusAID through Christian Blind Mission (CBM); FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER	NIH Research Training Grant - Fogarty International Center; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); International Society of Nephrology Global Outreach Committee; Duke Global Health Institute; AusAID through Christian Blind Mission (CBM); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by an NIH Research Training Grant (#R25 TW009337) funded by the Fogarty International Center and the National Institute of Mental Health; a Research and Prevention Grant funded by the International Society of Nephrology Global Outreach Committee; and a Master's of Science research stipend from the Duke Global Health Institute. Retinopathy screening for individuals with diabetes was done under the Kilimanjaro Diabetic Programme (KDP) supported by AusAID through Christian Blind Mission (CBM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; AHREN B, 1984, DIABETOLOGIA, V26, P333, DOI 10.1007/BF00266032; Alikor C A, 2015, Niger J Med, V24, P114; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 2013, UNITED REPUBLIC OF T; [Anonymous], 2011, UN REP TANZ ED SECT; Aspray TJ, 2000, T ROY SOC TROP MED H, V94, P637, DOI 10.1016/S0035-9203(00)90216-5; Atun R, 2015, LANCET DIABETES ENDO, V3, P675, DOI 10.1016/S2213-8587(15)00236-3; Cleland CR, 2015, TROPICAL MED INT HLT; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; Elmadhoun WM, 2016, J DIABETES, V8, P839, DOI 10.1111/1753-0407.12364; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Harding S, 2003, DIABETIC MED, V20, P965, DOI 10.1111/j.1464-5491.2003.01077.x; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hove M, 2013, STABILITY, V2, DOI 10.5334/sta.ap; Katende D, 2015, TROP MED INT HEALTH, V20, P1385, DOI 10.1111/tmi.12560; Kengne AP, 2013, HEART, V99, P1072, DOI 10.1136/heartjnl-2013-303773; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Levitt NS, 1999, DIABETIC MED, V16, P946, DOI 10.1046/j.1464-5491.1999.00185.x; Mayega RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072554; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; MCLARTY DG, 1989, LANCET, V1, P871; McLarty DG, 1996, DIABETIC MED, V13, P990; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Miller B.A., 2013, THESIS; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Narayan KMV, 2012, HEALTH AFFAIR, V31, P84, DOI 10.1377/hlthaff.2011.1040; nternational Diabetes Federation, 2015, DIABETES ATLAS; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Renzaho AMN, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27600; Ruhembe Carolyne C, 2014, Tanzan J Health Res, V16, P89; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124506; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122638; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; SWAI AB, 1992, BRIT MED J, V305, P1057, DOI 10.1136/bmj.305.6861.1057; Tamayo T, 2014, DIABETES RES CLIN PR, V103, P206, DOI 10.1016/j.diabres.2013.11.007; Werfalli M, 2016, LANCET DIABETES ENDO, V4, P72, DOI 10.1016/S2213-8587(15)00363-0; World Health Organization, 2016, OB OV; Wu S, 2012, CONTEMP CLIN TRIALS, V33, P869, DOI 10.1016/j.cct.2012.05.004; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939; Zou GY, 2004, BIOMETRICS, V60, P807, DOI 10.1111/j.0006-341X.2004.00232.x	44	38	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164428	10.1371/journal.pone.0164428	http://dx.doi.org/10.1371/journal.pone.0164428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711179	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000385697600127
J	Abdelwahab, H; Del Campo, JSM; Dai, YM; Adly, C; El-Sohaimy, S; Sobrado, P				Abdelwahab, Heba; Del Campo, Julia S. Martin; Dai, Yumin; Adly, Camelia; El-Sohaimy, Sohby; Sobrado, Pablo			Mechanism of Rifampicin Inactivation in Nocardia farcinica	PLOS ONE			English	Article							P-HYDROXYBENZOATE HYDROXYLASE; STEADY-STATE; ACTIVE-SITE; RESISTANCE; GENE; OXIDATION; OXYGEN; CONFORMATION; RIBOSYLATION; RHODOCOCCUS	A novel mechanism of rifampicin (Rif) resistance has recently been reported in Nocardia farcinica. This new mechanism involves the activity of rifampicin monooxygenase (RifMO), a flavin-dependent monooxygenase that catalyzes the hydroxylation of Rif, which is the first step in the degradation pathway. Recombinant RifMO was overexpressed and purified for biochemical analysis. Kinetic characterization revealed that Rif binding is necessary for effective FAD reduction. RifMO exhibits only a 3-fold coenzyme preference for NADPH over NADH. RifMO catalyzes the incorporation of a single oxygen atom forming an unstable intermediate that eventually is converted to 2'-N-hydroxy-4-oxo-Rif. Stable C4a-hydroperoxyflavin was not detected by rapid kinetics methods, which is consistent with only 30% of the activated oxygen leading to product formation. These findings represent the first reported detailed biochemical characterization of a flavin-monooxygenase involved in antibiotic resistance.	[Abdelwahab, Heba; Del Campo, Julia S. Martin; Dai, Yumin; Sobrado, Pablo] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Abdelwahab, Heba; Adly, Camelia] Damietta Univ, Dept Chem, Fac Sci, Dumyat 34517, Egypt; [Del Campo, Julia S. Martin; Sobrado, Pablo] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA; [El-Sohaimy, Sohby] City Sci Res & Technol Applicat, Arid Lands Cultivat Res Inst, Dept Food Technol, Alexandria 21934, Egypt; [Sobrado, Pablo] Virginia Tech, Virginia Tech Ctr Drug Discovery, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Egyptian Knowledge Bank (EKB); Damietta University; Virginia Polytechnic Institute & State University; Egyptian Knowledge Bank (EKB); City of Scientific Research & Technological Applications (SRTA-City); Virginia Polytechnic Institute & State University	Sobrado, P (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.; Sobrado, P (corresponding author), Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.; Sobrado, P (corresponding author), Virginia Tech, Virginia Tech Ctr Drug Discovery, Blacksburg, VA 24061 USA.	psobrado@vt.edu	El Sohaimy, Sobhy/Q-3040-2016	El Sohaimy, Sobhy/0000-0002-1657-5162; abdelwahab, heba/0000-0002-4005-464X; S. Martin del Campo, Julia/0000-0001-8914-2504	National Science Foundation [CHE-1506206, MCB 1021384]; Joint Supervision Fellowship - Cultural Affairs and Mission sectors of the Egyptian Ministry of Higher Education; Direct For Biological Sciences [1021384] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Joint Supervision Fellowship - Cultural Affairs and Mission sectors of the Egyptian Ministry of Higher Education; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grants CHE-1506206 and MCB 1021384. This work was also supported by a Joint Supervision Fellowship to H. Abdelwahab funded by the Cultural Affairs and Mission sectors of the Egyptian Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SJ, 1997, ANTIMICROB AGENTS CH, V41, P218, DOI 10.1128/AAC.41.1.218; Aristoff PA, 2010, TUBERCULOSIS, V90, P94, DOI 10.1016/j.tube.2010.02.001; ATLAS E, 1968, AM J MED SCI, V256, P247, DOI 10.1097/00000441-196810000-00006; BEATY NB, 1981, J BIOL CHEM, V256, P4619; Binda C, 2015, J BIOL CHEM, V290, P12676, DOI 10.1074/jbc.M114.629485; Budavari S., 1976, MERCK INDEX ENCY CHE, P12688, DOI [10.1074/jbc.M114.629485, DOI 10.1074/JBC.M114.629485]; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CASEY ML, 1975, J AM CHEM SOC, V97, P6231, DOI 10.1021/ja00854a048; Chocklett SW, 2010, BIOCHEMISTRY-US, V49, P6777, DOI 10.1021/bi100291n; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; DABBS ER, 1995, ANTIMICROB AGENTS CH, V39, P1007, DOI 10.1128/AAC.39.4.1007; DABBS ER, 1987, FEMS MICROBIOL LETT, V44, P395, DOI 10.1016/0378-1097(87)90354-5; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; EZEKIEL DH, 1968, NATURE, V220, P276, DOI 10.1038/220276a0; Fink MJ, 2015, CHEM COMMUN, V51, P2874, DOI 10.1039/c4cc08734h; Forsberg KJ, 2015, CHEM BIOL, V22, P888, DOI 10.1016/j.chembiol.2015.05.017; Fox Brian G, 2009, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0523s56; Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w; Gatti DL, 1996, BIOCHEMISTRY-US, V35, P567, DOI 10.1021/bi951344i; Goldstein BP, 2014, J ANTIBIOT, V67, P625, DOI 10.1038/ja.2014.107; Harris CM, 1997, J BIOL CHEM, V272, P8370, DOI 10.1074/jbc.272.13.8370; HARTMANN G, 1967, BIOCHIM BIOPHYS ACTA, V145, P843, DOI 10.1016/0005-2787(67)90147-5; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hoshino Y, 2011, J BACTERIOL, V193, P441, DOI 10.1128/JB.00897-10; Hoshino Y, 2010, J ANTIBIOT, V63, P23, DOI 10.1038/ja.2009.116; HOWELL LG, 1972, J BIOL CHEM, V247, P4340; Howes BD, 2007, J RAMAN SPECTROSC, V38, P859, DOI 10.1002/jrs.1727; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; Ishikawa J, 2006, ANTIMICROB AGENTS CH, V50, P1342, DOI 10.1128/AAC.50.4.1342-1346.2006; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; Kim TK, 2006, APPL ENVIRON MICROB, V72, P2118, DOI 10.1128/AEM.72.3.2118-2125.2006; Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087; Lerner PI, 1996, CLIN INFECT DIS, V22, P891, DOI 10.1093/clinids/22.6.891; MAGGI N, 1966, CHEMOTHERAPY, V11, P285, DOI 10.1159/000220462; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; McDonald CA, 2013, BIOCHEMISTRY-US, V52, P6076, DOI 10.1021/bi4008462; McMurray DN, 1996, MED MICROBIOLOGY, VFourth; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; MORISAKI N, 1993, J ANTIBIOT, V46, P1605, DOI 10.7164/antibiotics.46.1605; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; PALFEY BA, 1994, BIOCHEMISTRY-US, V33, P1545, DOI 10.1021/bi00172a035; Quan S, 1999, ANTIMICROB AGENTS CH, V43, P181, DOI 10.1128/AAC.43.1.181; SCHNEIDER H, 1972, BRIT J VENER DIS, V48, P500; SENSI P., 1959, ANTIBIOT ANN, V7, P262; SENSI P, 1983, REV INFECT DIS, V5, pS402; Setser JW, 2014, BIOCHEMISTRY-US, V53, P6063, DOI 10.1021/bi500655q; Shimizu M, 2015, DRUG METAB PHARMACOK, V30, P70, DOI 10.1016/j.dmpk.2014.09.008; Shirey C, 2013, J BIOL CHEM, V288, P32440, DOI 10.1074/jbc.M113.487181; Spanogiannopoulos P, 2012, ANTIMICROB AGENTS CH, V56, P5061, DOI 10.1128/AAC.01166-12; SPECTOR T, 1972, J BIOL CHEM, V247, P4679; Staudinger T, 2014, BBA-PROTEINS PROTEOM, V1844, P750, DOI 10.1016/j.bbapap.2014.02.001; Stogios PJ, 2016, NATURE COMMUNICATION, V7; Tanaka Y, 1996, MICROBIOL IMMUNOL, V40, P1, DOI 10.1111/j.1348-0421.1996.tb03303.x; Tao Y, 2004, APPL ENVIRON MICROB, V70, P3814, DOI 10.1128/AEM.70.7.3814-3820.2004; Tupin A, 2010, INT J ANTIMICROB AG, V35, P519, DOI 10.1016/j.ijantimicag.2009.12.017; Ventola C Lee, 2015, P T, V40, P277; Wang P, 2013, J AM CHEM SOC, V135, P7138, DOI 10.1021/ja403516u; Yang WR, 2004, J BIOL CHEM, V279, P52346, DOI 10.1074/jbc.M409573200; YAZAWA K, 1994, J ANTIMICROB CHEMOTH, V33, P1127, DOI 10.1093/jac/33.6.1127; Zucchini D, 2011, ARCH BIOCHEM BIOPHYS, V515, P1, DOI 10.1016/j.abb.2011.08.004	62	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162578	10.1371/journal.pone.0162578	http://dx.doi.org/10.1371/journal.pone.0162578			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706151	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200013
J	Snowden, MC; Cope, KR; Bugbee, B				Snowden, M. Chase; Cope, Kevin R.; Bugbee, Bruce			Sensitivity of Seven Diverse Species to Blue and Green Light: Interactions with Photon Flux	PLOS ONE			English	Article							EMITTING-DIODES LEDS; RED-LIGHT; PLANT-GROWTH; LEAF PHOTOSYNTHESIS; SUPPLEMENTAL BLUE; QUANTUM YIELD; LETTUCE; RADIATION; PHOTOMORPHOGENESIS; SPECTRUM	Despite decades of research, the effects of spectral quality on plant growth, and development are not well understood. Much of our current understanding comes from studies with daily integrated light levels that are less than 10% of summer sunlight thus making it difficult to characterize interactions between light quality and quantity. Several studies have reported that growth is increased under fluorescent lamps compared to mixtures of wavelengths from LEDs. Conclusions regarding the effect of green light fraction range from detrimental to beneficial. Here we report the effects of eight blue and green light fractions at two photosynthetic photon fluxes (PPF; 200 and 500 mu mol m(-2) s(-1); with a daily light integral of 11.5 and 29 mol m(-2) d(-1)) on growth (dry mass), leaf expansion, stem and petiole elongation, and whole-plant net assimilation of seven diverse plant species. The treatments included cool, neutral, and warm white LEDs, and combinations of blue, green and/or red LEDs. At the higher PPF (500), increasing blue light in increments from 11 to 28% reduced growth in tomato, cucumber, and pepper by 22, 26, and 14% respectively, but there was no statistically significant effect on radish, soybean, lettuce or wheat. At the lower PPF (200), increasing blue light reduced growth only in tomato (41%). The effects of blue light on growth were mediated by changes in leaf area and radiation capture, with minimal effects on whole-plant net-assimilation. In contrast to the significant effects of blue light, increasing green light in increments from 0 to 30% had a relatively small effect on growth, leaf area and net assimilation at either low or high PPF. Surprisingly, growth of three of the seven species was not reduced by a treatment with 93% green light compared to the broad spectrum treatments. Collectively, these results are consistent with a shade avoidance response associated with either low blue or high green light fractions.	[Snowden, M. Chase; Cope, Kevin R.; Bugbee, Bruce] Utah State Univ, Dept Plants Soils & Climate, Crop Physiol Lab, 4820 Old Main Hill, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Snowden, MC (corresponding author), Utah State Univ, Dept Plants Soils & Climate, Crop Physiol Lab, 4820 Old Main Hill, Logan, UT 84322 USA.	chase.snowden@gmail.com	Cope, Kevin R./AAB-9174-2020	Cope, Kevin R./0000-0003-0173-2871	Utah Agriculture Experiment Station	Utah Agriculture Experiment Station	This research was supported by the Utah Agriculture Experiment Station. We thank Ty Weaver, Alec Hay, Saundra Rhoades and Boston Swan for conscientious technical support. We also thank the four anonymous reviewers whose comments improved the manuscript. All three authors directly contributed to the design and execution of the experiments and the writing of the manuscript. This work was part of a graduate thesis for M. Chase Snowden and part of an undergraduate research project for Kevin Cope, who is now a PhD candidate at the University of Wisconsin. The work was done in the Crop Physiology Laboratory at USU under the direction of Bruce Bugbee. Mention of trade names is for information only and does not constitute an endorsement by the authors.	[Anonymous], 1957, ENV CONTROL PLANT GR; BROWN CS, 1995, J AM SOC HORTIC SCI, V120, P808, DOI 10.21273/JASHS.120.5.808; BULA RJ, 1991, HORTSCIENCE, V26, P203, DOI 10.21273/HORTSCI.26.2.203; BULLOCK DG, 1988, CROP SCI, V28, P254, DOI 10.2135/cropsci1988.0011183X002800020015x; Chen XL, 2014, SCI HORTIC-AMSTERDAM, V172, P168, DOI 10.1016/j.scienta.2014.04.009; Cope KR, 2014, PHOTOCHEM PHOTOBIOL, V90, P574, DOI 10.1111/php.12233; Cope KR, 2013, HORTSCIENCE, V48, P504, DOI 10.21273/HORTSCI.48.4.504; Dougher TAO, 2004, J AM SOC HORTIC SCI, V129, P467, DOI 10.21273/JASHS.129.4.0467; Dougher TAO, 2001, PHOTOCHEM PHOTOBIOL, V73, P199, DOI 10.1562/0031-8655(2001)073&lt;0199:DITROW&gt;2.0.CO;2; Fan X, 2013, ASIA PACIFIC J TOURI, P1; Folta KM, 2007, J EXP BOT, V58, P3099, DOI 10.1093/jxb/erm130; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Goins G.D, 2001, SAE TECHNICAL PAPER, DOI DOI 10.4271/2001-01-2422; Goins GD, 1997, J EXP BOT, V48, P1407, DOI 10.1093/jxb/48.7.1407; Hernandez R, 2016, ENVIRON EXP BOT, V121, P66, DOI 10.1016/j.envexpbot.2015.04.001; Hernandez R, 2014, SCI HORTIC-AMSTERDAM, V173, P92, DOI 10.1016/j.scienta.2014.04.035; HOENECKE ME, 1992, HORTSCIENCE, V27, P427, DOI 10.21273/HORTSCI.27.5.427; Hogewoning SW, 2010, J EXP BOT, V61, P3107, DOI 10.1093/jxb/erq132; Hogewoning SW, 2010, J EXP BOT, V61, P1267, DOI 10.1093/jxb/erq005; Hoover W.H., 1937, SMITHSONIAN MISC COL, V95, P1; Hunt R, 2002, ANN BOT-LONDON, V90, P485, DOI 10.1093/aob/mcf214; Hunt R., 1982, PLANT GROWTH ANAL, V4; INADA K, 1976, PLANT CELL PHYSIOL, V17, P355; Johkan M, 2012, ENVIRON EXP BOT, V75, P128, DOI 10.1016/j.envexpbot.2011.08.010; Kim HH, 2004, HORTSCIENCE, V39, P1617, DOI 10.21273/HORTSCI.39.7.1617; Kim HH, 2004, ANN BOT-LONDON, V94, P691, DOI 10.1093/aob/mch192; Kim Hyeon-Hye, 2005, Habitation (Elmsford), V10, P71, DOI 10.3727/154296605774791232; Klassen S. P., 2003, Digital imaging and spectral techniques: applications to precision agriculture and crop physiology. Proceedings of a symposium sponsored by Division C-2 of the Crop Science Society of America, the USDA-ARS, and the Rockefeller Foundation in Minneapolis, MN, November 2001, P3; Lambers H., 2008, PLANT PHYSL ECOLOGY, V2nd ed., P321; LEOPOLD AC, 1975, PLANT GROWTH DEV; Li T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00416; Lin KH, 2013, SCI HORTIC, V150; MCCREE KJ, 1972, AGR METEOROL, V9, P191, DOI 10.1016/0002-1571(71)90022-7; Nelson JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138930; Nishio JN, 2000, PLANT CELL ENVIRON, V23, P539, DOI 10.1046/j.1365-3040.2000.00563.x; Ouzounis T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00019; Ouzounis T, 2014, J PLANT PHYSIOL, V171, P1491, DOI 10.1016/j.jplph.2014.06.012; Paradiso R, 2011, SCI HORTIC-AMSTERDAM, V127, P548, DOI 10.1016/j.scienta.2010.11.017; Parry C, 2014, PLANT CELL ENVIRON; POORTER H, 1990, OECOLOGIA, V83, P553, DOI 10.1007/BF00317209; Sepulveda-Ugarte J, 2011, J PHOTOCH PHOTOBIO A, V219, P211, DOI 10.1016/j.jphotochem.2011.02.012; SINCLAIR TR, 1992, CROP SCI, V32, P1281, DOI 10.2135/cropsci1992.0011183X003200050043x; Smith K, 2013, SCI PHOTOBIOLOGY; Son KH, 2013, HORTSCIENCE, V48, P988; Sun JD, 1998, PLANT CELL PHYSIOL, V39, P1020, DOI 10.1093/oxfordjournals.pcp.a029298; Taiz L., 2015, PLANT PHYSL DEV; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; Terfa MT, 2013, PHYSIOL PLANTARUM, V148, P146, DOI 10.1111/j.1399-3054.2012.01698.x; Tubiello F, 1996, LIFE SUPPORT BIOSPH, V4, P77; von Sachs J, 1864, WIRKUNGEN FARBIGEN L; Wang J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00250; Wang X, 2014, COMP MATH MATH PHYS, V2014, P1, DOI DOI 10.1111/CAS.12531; Wang YH, 2013, AM J BOT, V100, P70, DOI 10.3732/ajb.1200354; Wargent JJ, 2009, PHOTOCHEM PHOTOBIOL, V85, P279, DOI 10.1111/j.1751-1097.2008.00433.x; WASSINK EC, 1956, ANNU REV PLANT PHYS, V7, P373, DOI 10.1146/annurev.pp.07.060156.002105; Yorio NC, 2001, HORTSCIENCE, V36, P380, DOI 10.21273/HORTSCI.36.2.380	56	107	108	8	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163121	10.1371/journal.pone.0163121	http://dx.doi.org/10.1371/journal.pone.0163121			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706176	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200034
J	Cheng, N; Li, Q; Xu, XX; Zhang, T				Cheng, Ning; Li, Qun; Xu, Xiaxia; Zhang, Tao			A Precise Annotation of Phase-Amplitude Coupling Intensity	PLOS ONE			English	Article							MULTIITEM WORKING-MEMORY; NEURONAL OSCILLATIONS; PERMUTATION ENTROPY; BRAIN OSCILLATIONS; THETA RHYTHM; FREQUENCY; INFORMATION; EEG; SYNCHRONIZATION; HIPPOCAMPUS	Neuronal information can be coded in different temporal and spatial scales. Cross-frequency coupling of neuronal oscillations, especially phase-amplitude coupling (PAC), plays a critical functional role in neuronal communication and large scale neuronal encoding. Several approaches have been developed to assess PAC intensity. It is generally agreed that the PAC intensity relates to the uneven distribution of the fast oscillation amplitude conditioned on the slow oscillation phase. However, it is still not clear what the PAC intensity exactly means. In the present study, it was found that there were three types of interferential signals taking part in PAC phenomenon. Based on the classification of interferential signals, the conception of PAC intensity is theoretically annotated as the proportion of slow or fast oscillation that is involved in a related PAC phenomenon. In order to make sure that the annotation is proper to some content, simulation data are constructed and then analyzed by three PAC approaches. These approaches are the mean vector length (MVL), the modulation index (MI), and a new permutation mutual information (PMI) method in which the permutation entropy and the information theory are applied. Results show positive correlations between PAC values derived from all three methods and the suggested intensity. Finally, the amplitude distributions, i.e. the phase-amplitude plots, obtained from different PAC intensities show that the annotation proposed in the study is in line with the previous understandings.	[Cheng, Ning; Li, Qun; Xu, Xiaxia; Zhang, Tao] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China; [Cheng, Ning; Li, Qun; Xu, Xiaxia; Zhang, Tao] Nankai Univ, Minist Educ, Key Lab Bioact Mat, Tianjin, Peoples R China; [Li, Qun] Nankai Univ, Coll Math, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Zhang, T (corresponding author), Nankai Univ, Coll Life Sci, Tianjin, Peoples R China.; Zhang, T (corresponding author), Nankai Univ, Minist Educ, Key Lab Bioact Mat, Tianjin, Peoples R China.	zhangtao@nankai.edu.cn						Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2012, IEEE T BIO-MED ENG, V59, P8, DOI 10.1109/TBME.2011.2172439; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cohen MX, 2008, J NEUROSCI METH, V168, P494, DOI 10.1016/j.jneumeth.2007.10.012; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dvorak D, 2014, J NEUROSCI METH, V225, P42, DOI 10.1016/j.jneumeth.2014.01.002; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Ferlazzo E, 2014, CLIN NEUROPHYSIOL, V125, P13, DOI 10.1016/j.clinph.2013.06.023; Handel B, 2009, NEUROIMAGE, V45, P1040, DOI 10.1016/j.neuroimage.2008.12.013; Hasselmo ME, 2014, NEUROIMAGE, V85, P656, DOI 10.1016/j.neuroimage.2013.06.022; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Jackson J, 2014, NAT NEUROSCI, V17, P1362, DOI 10.1038/nn.3803; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; Jensen O, 2007, TRENDS COGN SCI, V11, P267, DOI 10.1016/j.tics.2007.05.003; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Li XL, 2010, NEUROIMAGE, V52, P497, DOI 10.1016/j.neuroimage.2010.05.003; Lisman J, 2005, HIPPOCAMPUS, V15, P913, DOI 10.1002/hipo.20121; Mammone N, 2015, ENTROPY-SWITZ, V17, P4627, DOI 10.3390/e17074627; Mi XC, 2014, J NEUROSCI METH, V227, P57, DOI 10.1016/j.jneumeth.2014.02.006; Morabito FC, 2012, ENTROPY-SWITZ, V14, P1186, DOI 10.3390/e14071186; Olofsen E, 2008, BRIT J ANAESTH, V101, P810, DOI 10.1093/bja/aen290; Palva JM, 2005, J NEUROSCI, V25, P3962, DOI 10.1523/JNEUROSCI.4250-04.2005; Papoulis A., 1991, PROBABILITY RANDOM V; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Schomburg EW, 2014, NEURON, V84, P470, DOI 10.1016/j.neuron.2014.08.051; Schutter DJLG, 2012, MOTIV EMOTION, V36, P46, DOI 10.1007/s11031-011-9237-6; Tort ABL, 2010, J NEUROPHYSIOL, V104, P1195, DOI 10.1152/jn.00106.2010; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Tort ABL, 2008, P NATL ACAD SCI USA, V105, P20517, DOI 10.1073/pnas.0810524105; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Xu XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077796; Xu XX, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00027	40	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163940	10.1371/journal.pone.0163940	http://dx.doi.org/10.1371/journal.pone.0163940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701458	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900036
J	Fava, F; Ponti, M; Abbiati, M				Fava, Federica; Ponti, Massimo; Abbiati, Marco			Role of Recruitment Processes in Structuring Coralligenous Benthic Assemblages in the Northern Adriatic Continental Shelf	PLOS ONE			English	Article							MARINE HARD SUBSTRATA; EPIBENTHIC COLONIZATION; POMATOCEROS-TRIQUETER; ARTIFICIAL SUBSTRATA; EPIFAUNAL COMMUNITY; TEMPORAL VARIATIONS; PERMUTATION TESTS; SPATIAL VARIATION; ROCELLARIA-DUBIA; LIGURIAN SEA	Coralligenous biogenic reefs are among the most diverse marine habitats in the Mediterranean Sea. The northern Adriatic mesophotic coralligenous outcrops host very rich and diverse epibenthic assemblages. Several studies quantified the low temporal variability and high spatial heterogeneity of these habitats, while processes driving structuring and differentiation are still poorly understood. To shed light on these processes, temporal and spatial patterns of colonisation were investigated using travertine tiles deployed on three coralligenous outcrops, corresponding to the main typologies of benthic assemblages described in previous studies. Three years after deployment, assemblages colonising travertine tiles resembled the differentiation among sites revealed by the natural assemblages in terms of major ecological groups. Processes structuring and maintaining species diversity have been explored. Pioneer species with high reproduction rate, long distance larval dispersal and fast growth (e.g. the serpulid polychaete Spirobranchus triqueter and the bivalve Anomia ephippium), were the most abundant in the early stages of recruitment on the two outcrops further away from the coast and with lower sedimentation. Their success may vary according to larval availability and environmental conditions (e.g., sedimentation rates). At these sites early-stage lasted 10-12 months, during which even species from natural substrates began colonising tiles by settlement of planktonic propagules (e.g., encrusting calcareous Rhodophyta) and lateral encroachment (e.g., sponges and ascidians). On coastal outcrop, exposed to a higher sedimentation rates, tiles were colonised by fast-growing algal turfs. Resilience of northern Adriatic coralligenous assemblages, and maintenance of their diversity, appeared largely entrusted to asexual reproduction. Exploring the mechanisms that underlie the formation and maintenance of the species diversity is crucial to improve our understanding of ecological processes and to implement appropriate conservation strategies of the Adriatic coralligenous reefs.	[Fava, Federica; Ponti, Massimo; Abbiati, Marco] Univ Bologna, CoNISMa, Dipartimento Sci Biol Geol & Ambientali BiGeA, Ravenna, Italy; [Fava, Federica; Ponti, Massimo; Abbiati, Marco] Univ Bologna, CoNISMa, CIRSA, Ravenna, Italy; [Abbiati, Marco] CNR, Ist Sci Marine, Bologna, Italy	CoNISMa; University of Bologna; CoNISMa; University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Ponti, M (corresponding author), Univ Bologna, CoNISMa, Dipartimento Sci Biol Geol & Ambientali BiGeA, Ravenna, Italy.; Ponti, M (corresponding author), Univ Bologna, CoNISMa, CIRSA, Ravenna, Italy.	massimo.ponti@unibo.it	Ponti, Massimo/R-3093-2016	Ponti, Massimo/0000-0002-6521-1330; Abbiati, Marco/0000-0002-2426-4524				Abbiati M., 2009, P 1 MED S CONS COR O, P34; Airoldi L, 2003, OCEANOGR MAR BIOL, V41, P161; Airoldi L, 2000, ECOLOGY, V81, P798, DOI 10.2307/177378; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 1997, OECOLOGIA, V109, P442, DOI 10.1007/s004420050104; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Andersson MH, 2009, HELGOLAND MAR RES, V63, P249, DOI 10.1007/s10152-009-0156-9; Antoniadou C, 2010, J EXP MAR BIOL ECOL, V382, P145, DOI 10.1016/j.jembe.2009.11.004; Balata D, 2005, MAR ENVIRON RES, V60, P403, DOI 10.1016/j.marenvres.2004.12.005; Balata D, 2008, BOT MAR, V51, P464, DOI 10.1515/BOT.2008.068; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Bavestrello G, 1997, AQUAT CONSERV, V7, P253, DOI 10.1002/(SICI)1099-0755(199709)7:3<253::AID-AQC243>3.0.CO;2-1; BOURGET E, 1994, J EXP MAR BIOL ECOL, V181, P31, DOI 10.1016/0022-0981(94)90102-3; Bramanti L, 2003, ITAL J ZOOL, V70, P175, DOI 10.1080/11250000309356512; BRUNETTI R, 1994, B ZOOL, V61, P89, DOI 10.1080/11250009409355864; Cabanellas-Reboredo Miguel, 2009, Marine Biodiversity Records, V2, pe126, DOI 10.1017/S1755267209001274; Calcinai B, 2015, MEDITERR MAR SCI, V16, P413, DOI 10.12681/mms.900; Casas-Guell E, 2015, MAR BIOL, V162, P901, DOI 10.1007/s00227-015-2635-7; Casellato S, 2008, MAR ECOL-EVOL PERSP, V29, P321, DOI 10.1111/j.1439-0485.2008.00236.x; Casoli E, 2016, INT BIODETER BIODEGR, V108, P9, DOI 10.1016/j.ibiod.2015.11.026; Casoli E, 2015, MAR ECOL-EVOL PERSP, V36, P1060, DOI 10.1111/maec.12201; Cerrano C, 2007, ITAL J ZOOL, V74, P13, DOI 10.1080/11250000600929370; Chapman MG, 2002, J EXP MAR BIOL ECOL, V275, P95, DOI 10.1016/S0022-0981(02)00134-X; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cocito S, 2002, SCI MAR, V66, P175, DOI 10.3989/scimar.2002.66n2175; Cotter E, 2003, MAR BIOL, V142, P905, DOI 10.1007/s00227-002-0987-2; Curiel D, 2012, BOT MAR, V55, P625, DOI 10.1515/bot-2012-0166; DEGOBBIS D, 1995, SCI TOTAL ENVIRON, V165, P43, DOI 10.1016/0048-9697(95)04542-9; DEGOBBIS D, 1989, MAR POLLUT BULL, V20, P452, DOI 10.1016/0025-326X(89)90066-0; Denitto F, 2007, MAR ECOL-EVOL PERSP, V28, P35, DOI 10.1111/j.1439-0485.2007.00172.x; Di Camillo CG, 2012, HYDROBIOLOGIA, V687, P299, DOI 10.1007/s10750-011-0877-z; Downes BJ, 1998, AUST J ECOL, V23, P8, DOI 10.1111/j.1442-9993.1998.tb00702.x; EDGAR GJ, 1991, HYDROBIOLOGIA, V226, P111, DOI 10.1007/BF00006812; EDYVEAN RGJ, 1984, BIOL J LINN SOC, V23, P353, DOI 10.1111/j.1095-8312.1984.tb00151.x; EDYVEAN RGJ, 1986, BRIT PHYCOL J, V21, P255, DOI 10.1080/00071618600650291; European Commission DG Environment, 2013, EUR28 EUR COMM DG EN; Falace A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140931; Ferdeghini F, 2000, HYDROBIOLOGIA, V440, P27, DOI 10.1023/A:1004124423718; Gabriele M, 1999, CAH BIOL MAR, V40, P65; Glasby TM, 2001, MAR ECOL PROG SER, V214, P127, DOI 10.3354/meps214127; Glasby TM, 1998, MAR FRESHWATER RES, V49, P429, DOI 10.1071/MF98008; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Hunt HL, 1997, MAR ECOL PROG SER, V155, P269, DOI 10.3354/meps155269; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; KEOUGH MJ, 1982, OECOLOGIA, V54, P348, DOI 10.1007/BF00380003; KLOCKNER K, 1976, HELGOLAND WISS MEER, V28, P352, DOI 10.1007/BF01610588; Krohling W, 2008, BRAZ ARCH BIOL TECHN, V51, P213, DOI 10.1590/S1516-89132008000100025; Lambeck K, 2004, QUATERNARY SCI REV, V23, P1567, DOI 10.1016/j.quascirev.2004.02.009; Lopez-Legentil S, 2013, INVERTEBR BIOL, V132, P69, DOI 10.1111/ivb.12013; Maughan BC, 2001, J EXP MAR BIOL ECOL, V256, P59, DOI 10.1016/S0022-0981(00)00304-X; Molin Emiliano, 2003, Bollettino del Museo Civico di Storia Naturale di Venezia, V54, P19; Molin Emiliano, 2011, Bollettino del Museo di Storia Naturale di Venezia, V62, P5; Morton B, 2011, BIOL J LINN SOC, V104, P786, DOI 10.1111/j.1095-8312.2011.01763.x; MYERS AA, 1980, J MAR BIOL ASSOC UK, V60, P963, DOI 10.1017/S0025315400042028; Norderhaug KM, 2002, MAR BIOL, V141, P965, DOI 10.1007/s00227-002-0893-7; Osman RW, 2004, J EXP MAR BIOL ECOL, V311, P117, DOI 10.1016/j.jembe.2004.05.001; Osman RW, 1998, HYDROBIOLOGIA, V375-76, P113, DOI 10.1023/A:1017000820646; Pech D, 2002, ESTUAR COAST SHELF S, V55, P743, DOI 10.1006/ecss.2001.0933; Piazzi L, 2004, BOT MAR, V47, P105, DOI 10.1515/BOT.2004.010; Piazzi L, 2002, BOT MAR, V45, P243, DOI 10.1515/BOT.2002.023; Piazzi L, 2010, J NAT HIST, V44, P1, DOI 10.1080/00222930903377547; Piazzi L, 2011, SCI MAR, V75, P399, DOI 10.3989/scimar.2011.75n2399; Ponti M, 2002, ICES J MAR SCI, V59, pS316, DOI 10.1006/jmsc.2002.1225; Ponti M, 2014, P 2 MED S CONS COR O, P147; Ponti M, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2897-8; Ponti M, 2015, MAR ENVIRON RES, V104, P10, DOI 10.1016/j.marenvres.2014.12.004; Ponti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102782; Ponti M, 2011, MAR BIOL, V158, P1447, DOI 10.1007/s00227-011-1661-3; Ramos Espla AA, 1991, ASCIDIAS LITORALES M; Relini G, 1973, ATT 5 C SOC IT BIOL, P226; RODRIGUEZ SR, 1993, MAR ECOL PROG SER, V97, P193, DOI 10.3354/meps097193; Rule MJ, 2005, MAR ECOL PROG SER, V290, P67, DOI 10.3354/meps290067; Sara M, 1969, MAR ECOL, V37, P124; Schiaparelli S., 2003, ATTI ASS ITALIANA OC, V16, P29; Smith F, 1999, ECOLOGY, V80, P51, DOI 10.2307/176979; Stefanon A, 1980, OXYGEN CRISIS NO ADR, P167; Teixido N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053742; Teixido N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023744; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; TRINCARDI F, 1994, GEO-MAR LETT, V14, P41, DOI 10.1007/BF01204470; TURNER SJ, 1993, J EXP MAR BIOL ECOL, V166, P251, DOI 10.1016/0022-0981(93)90223-B; Tursi A., 1985, Oebalia, V11, P401; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; UNEP-MAP-RAC/SPA, 2008, ACT PLAN CONS COR OT; Virgilio M, 2006, CORAL REEFS, V25, P265, DOI 10.1007/s00338-006-0100-2; Watson DI, 2004, MAR BIOL, V145, P201, DOI 10.1007/s00227-003-1291-5	87	15	15	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163494	10.1371/journal.pone.0163494	http://dx.doi.org/10.1371/journal.pone.0163494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701418	Green Published, gold, Green Submitted			2022-12-27	WOS:000385696900009
J	Park, H; Li, XY; Song, YE; He, KRY; Zhu, XF				Park, Haeil; Li, Xiaoyin; Song, Yeunjoo E.; He, Karen Y.; Zhu, Xiaofeng			Multivariate Analysis of Anthropometric Traits Using Summary Statistics of Genome-Wide Association Studies from GIANT Consortium	PLOS ONE			English	Article							METAANALYSIS; LOCI; INSIGHTS; COHORTS; POWER; TWIN	Meta-analysis of single trait for multiple cohorts has been used for increasing statistical power in genome-wide association studies (GWASs). Although hundreds of variants have been identified by GWAS, these variants only explain a small fraction of phenotypic variation. Cross-phenotype association analysis (CPASSOC) can further improve statistical power by searching for variants that contribute to multiple traits, which is often relevant to pleiotropy. In this study, we performed CPASSOC analysis on the summary statistics from the Genetic Investigation of ANthropometric Traits (GIANT) consortium using a novel method recently developed by our group. Sex-specific meta-analysis data for height, body mass index (BMI), and waist-to-hip ratio adjusted for BMI (WHRadjBMI) from discovery phase of the GIANT consortium study were combined using CPASSOC for each trait as well as 3 traits together. The conventional meta-analysis results from the discovery phase data of GIANT consortium studies were used to compare with that from CPASSOC analysis. The CPASSOC analysis was able to identify 17 loci associated with anthropometric traits that were missed by conventional meta-analysis. Among these loci, 16 have been reported in literature by including additional samples and 1 is novel. We also demonstrated that CPASSOC is able to detect pleiotropic effects when analyzing multiple traits.	[Park, Haeil; Li, Xiaoyin; Song, Yeunjoo E.; He, Karen Y.; Zhu, Xiaofeng] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Park, Haeil] Catholic Univ Korea, Coll Med, Bucheon St Marys Hosp, Dept Lab Med, Seoul, South Korea	Case Western Reserve University; Catholic University of Korea	Zhu, XF (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	Xiaofeng.Zhu@case.edu	Li, Xiaoyin/AAU-3662-2021; Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X; Song, Yeunjoo/0000-0002-7452-3731; Park, Hae-il/0000-0002-1092-0607; He, Karen/0000-0002-8686-7697	NHGRI NIH HHS [R01 HG003054] Funding Source: Medline; NHLBI NIH HHS [T32 HL007567] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007567] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Bolormaa S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004198; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kim J, 2015, GENET EPIDEMIOL, V39, P651, DOI 10.1002/gepi.21931; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Panagiotou OA, 2013, ANNU REV GENOM HUM G, V14, P441, DOI 10.1146/annurev-genom-091212-153520; Province Michael A, 2013, Pac Symp Biocomput, P236; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; Wei FJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11900; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zhu XF, 2015, AM J HUM GENET, V96, P21, DOI 10.1016/j.ajhg.2014.11.011	25	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163912	10.1371/journal.pone.0163912	http://dx.doi.org/10.1371/journal.pone.0163912			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701450	gold, Green Published, Green Submitted			2022-12-27	WOS:000385696900030
J	Al-Wajeeh, NS; Halabi, MF; Hajrezaie, M; Dhiyaaldeen, SM; Bardi, DA; Salama, SM; Rouhollahi, E; Karimian, H; Abdolmalaki, R; Azizan, AHS; Ali, HM; Noor, SM; Abdulla, MA				AL-Wajeeh, Nahla Saeed; Halabi, Mohammed Farouq; Hajrezaie, Maryam; Dhiyaaldeen, Summaya M.; Bardi, Daleya Abdulaziz; Salama, Suzy M.; Rouhollahi, Elham; Karimian, Hamed; Abdolmalaki, Rojin; Azizan, Ainnul Hamidah Syahadah; Ali, Hapipah Mohd; Noor, Suzita Mohd; Abdulla, Mahmood Ameen			The Gastroprotective Effect of Vitex pubescens Leaf Extract against Ethanol-Provoked Gastric Mucosal Damage in Sprague-Dawley Rats	PLOS ONE			English	Article							SULFHYDRYL COMPOUNDS; ANTIOXIDANT ACTIVITY; LIPID-PEROXIDATION; ACUTE TOXICITY; ESSENTIAL OIL; NITRIC-OXIDE; ULCER; INJURY; INVOLVEMENT; MECHANISM	Vitex pubescens is a Malaysian therapeutic plant employed in traditional drug to remedy a variety of disorders. The purpose of this research is to assess the gastroprotective efficiency of V. pubescens leaves against ethanol-induced gastric hemorrhagic laceration in rats. Animals were randomly allocated into seven groups and pre-treated, separately, with 10% Tween 20 (normal and ulcer control groups), 20 mg/kg omeprazole (reference group), and 62.5, 125, 250, and 500 mg/kg of V. pubescens extract (experimental groups). All animals were sacrificed after another hour. Histological evaluation of the ulcer control group revealed significant injury to the gastric mucosa with edema and leucocyte infiltration of the submucosal layer. PAS staining, showed remarkably intense magenta color, remarkable increase of HSP70 and decrease of Bax proteins in rats pre-treated with plant extracts compared to the ulcer control group. Gastric homogenates revealed a remarkable increase in endogenous antioxidant enzyme activities (CAT, SOD, GSH) and a decrease in the lipid peroxidation level (MDA) in animals pre-treated with V. pubescens extract compared with the ulcer control group. The gastroprotective activity of this plant might be related to increased antioxidant enzymes and decrease lipid peroxidation upsurge of HSP70 and reduced expression of Bax proteins	[AL-Wajeeh, Nahla Saeed; Halabi, Mohammed Farouq; Hajrezaie, Maryam; Dhiyaaldeen, Summaya M.; Bardi, Daleya Abdulaziz; Salama, Suzy M.; Rouhollahi, Elham; Karimian, Hamed; Abdolmalaki, Rojin; Noor, Suzita Mohd; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur 50603, Malaysia; [Azizan, Ainnul Hamidah Syahadah; Ali, Hapipah Mohd] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur 50603, Malaysia.	ammeen@um.edu.ny	Salama Fanous, Suzy Munir/AAX-6100-2020; Bardi/ABD-2699-2020; NOOR, SUZITA M/B-9883-2010; Halabi, Mohammed/N-4574-2019	Salama Fanous, Suzy Munir/0000-0003-0430-1436; NOOR, SUZITA M/0000-0001-5344-8165; Halabi, Mohammed/0000-0001-7114-515X				Abdelwahab SI, 2013, J ETHNOPHARMACOL, V148, P277, DOI 10.1016/j.jep.2013.04.027; Abdulla MA, 2009, BIOMED RES-INDIA, V20, P35; Al Batran R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064751; AlRashdi AS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/786426; Batubara I, 2009, J WOOD SCI, V55, P230, DOI 10.1007/s10086-008-1021-1; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen SH, 2005, WORLD J GASTROENTERO, V11, P3746, DOI 10.3748/wjg.v11.i24.3746; Cheng CL, 2000, LIFE SCI, V67, P2647, DOI 10.1016/S0024-3205(00)00848-1; Chung YC, 2012, J ETHNOPHARMACOL, V140, P91, DOI 10.1016/j.jep.2011.12.033; da Silva LM, 2013, FOOD CHEM TOXICOL, V51, P179, DOI 10.1016/j.fct.2012.09.026; Golbabapour S, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/974185; Gorinstein S, 2003, J NUTR BIOCHEM, V14, P154, DOI 10.1016/S0955-2863(02)00278-4; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Gwaram NS, 2012, TROP J PHARM RES, V11, P251, DOI 10.4314/tjpr.v11i2.11; Hajrezaie M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121529; Hajrezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051537; Halabi MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095908; Ham M, 2008, CURR OPIN GASTROEN, V24, P665, DOI 10.1097/MOG.0b013e328311cd93; Hor SY, 2011, J ETHNOPHARMACOL, V137, P1067, DOI 10.1016/j.jep.2011.07.007; Huang SW, 2016, J DERMATOL SCI, V81, P182, DOI 10.1016/j.jdermsci.2015.12.011; Ibrahim MM, 2012, MOLECULES, V17, P12449, DOI 10.3390/molecules171012449; Indran M, 2008, W INDIAN MED J, V57, P323; Ismail IF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/404012; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Ji CX, 2012, EUR J PHARMACOL, V691, P46, DOI 10.1016/j.ejphar.2012.06.041; Ketuly KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059296; Kobayashi T, 2001, PHARMACOL RES, V43, P23, DOI 10.1006/phrs.2000.0748; Kurose I, 1997, HEPATOLOGY, V25, P368; Kwiecien S, 2002, J PHYSIOL PHARMACOL, V53, P39; Diniz LRL, 2013, J ETHNOPHARMACOL, V149, P694, DOI 10.1016/j.jep.2013.07.026; Meena AK, 2011, ASIAN J TRADITIONAL, V6, P54; Moghadamtousi SZ, 2014, DRUG DES DEV THER, V8, P2099, DOI 10.2147/DDDT.S70096; MUTOH H, 1990, GASTROENTEROLOGY, V98, P1452, DOI 10.1016/0016-5085(90)91075-H; Ng WK, 2011, TOXICOL IN VITRO, V25, P1392, DOI 10.1016/j.tiv.2011.04.030; Nordin N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111925; OECD, 2005, ENVIRO MED J, V5; Ong HC, 1999, FITOTERAPIA, V70, P502, DOI 10.1016/S0367-326X(99)00077-5; Oramahi HA, 2013, J WOOD SCI, V59, P344, DOI 10.1007/s10086-013-1340-8; RIABOWOL KT, 1988, SCIENCE, V242, P433, DOI 10.1126/science.3175665; Rouhollahi E, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-378; Rozza AL, 2011, CHEM-BIOL INTERACT, V189, P82, DOI 10.1016/j.cbi.2010.09.031; Salga MS, 2012, CHEM-BIOL INTERACT, V195, P144, DOI 10.1016/j.cbi.2011.11.008; Shaker E, 2010, FOOD CHEM TOXICOL, V48, P2785, DOI 10.1016/j.fct.2010.07.007; Sidahmed HMA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121060; Sidahmed HMA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-183; Tachakittirungrod S, 2007, FOOD CHEM, V103, P381, DOI 10.1016/j.foodchem.2006.07.034; Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030; Tandon R., 2004, IND J PHYSL PHARM, V48, P115; Tuluce Y, 2011, TOXICOL IND HEALTH, V27, P760, DOI 10.1177/0748233710397421; VICTOR BE, 1991, AM J PHYSIOL, V261, pG966, DOI 10.1152/ajpgi.1991.261.6.G966; Wasman SQ, 2011, INDIAN J EXP BIOL, V49, P767; YOSHIKAWA T, 1993, GUT, V34, P732, DOI 10.1136/gut.34.6.732	54	15	15	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0157431	10.1371/journal.pone.0157431	http://dx.doi.org/10.1371/journal.pone.0157431			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689880	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200001
J	Alvarez-Zuzek, LG; La Rocca, CE; Vazquez, F; Braunstein, LA				Alvarez-Zuzek, Lucile G.; La Rocca, Cristian E.; Vazquez, Federico; Braunstein, Lidia A.			Interacting Social Processes on Interconnected Networks	PLOS ONE			English	Article							IMMUNIZATION STRATEGY; MULTIPLEX; DYNAMICS	We propose and study a model for the interplay between two different dynamical processes -one for opinion formation and the other for decision making- on two interconnected networks A and B. The opinion dynamics on network A corresponds to that of the M-model, where the state of each agent can take one of four possible values (S = -2, -1, 1, 2), describing its level of agreement on a given issue. The likelihood to become an extremist (S = +/- 2) or a moderate (S = +/- 1) is controlled by a reinforcement parameter r >= 0. The decision making dynamics on network B is akin to that of the Abrams-Strogatz model, where agents can be either in favor (S = +1) or against (S = -1) the issue. The probability that an agent changes its state is proportional to the fraction of neighbors that hold the opposite state raised to a power beta. Starting from a polarized case scenario in which all agents of network A hold positive orientations while all agents of network B have a negative orientation, we explore the conditions under which one of the dynamics prevails over the other, imposing its initial orientation. We find that, for a given value of beta, the two-network system reaches a consensus in the positive state (initial state of network A) when the reinforcement overcomes a crossover value r*(beta), while a negative consensus happens for r < r*(beta). In the r - beta phase space, the system displays a transition at a critical threshold beta(c), from a coexistence of both orientations for beta < beta(c) to a dominance of one orientation for beta > beta(c). We develop an analytical mean-field approach that gives an insight into these regimes and shows that both dynamics are equivalent along the crossover line (r*, beta*).	[Alvarez-Zuzek, Lucile G.; La Rocca, Cristian E.; Braunstein, Lidia A.] CONICET UNMdP, Inst Invest Fis Mar del Plata, IFIMAR, RA-7600 Mar Del Plata, Buenos Aires, Argentina; [Vazquez, Federico] CONICET UNLP, IFLYSIB, Inst Fis Liquidos & Sistemas Biol, RA-1900 La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Alvarez-Zuzek, LG (corresponding author), CONICET UNMdP, Inst Invest Fis Mar del Plata, IFIMAR, RA-7600 Mar Del Plata, Buenos Aires, Argentina.	lgalvere@mdp.edu.ar		Alvarez Zuzek, Lucila Gisele/0000-0002-5076-8152	CONICET (Argentina); UNMdP; FONCyT; CONICET [Pict 0429/2013, Pict 1407/2014, PIP 0443/2014]	CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UNMdP; FONCyT(FONCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	LGAZ, CEL and LAB wish to thank to UNMdP, FONCyT and CONICET (Pict 0429/2013, Pict 1407/2014 and PIP 0443/2014) for financial support for research. FV also acknowledges financial support from CONICET (Argentina).	Abrams DM, 2003, NATURE, V424, P900, DOI 10.1038/424900a; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Zuzek LGA, 2015, SCI REP-UK, V5, DOI 10.1038/srep12151; Alvarez-Zuzek L. G., 2015, J PHYS C SER, V640; Serrano MA, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/10/P10024; Balenzuela P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139572; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Baxter GJ, 2016, UNDERST COMPLEX SYST, P101, DOI 10.1007/978-3-319-23947-7_6; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Buono C, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/26001; Buono C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092200; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cohen R., 2010, COMPLEX NETWORKS STR, DOI [10.1017/CBO9780511780356, DOI 10.1017/CBO9780511780356]; Cozzo E, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050801; Di Muro MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep22834; Diakonova M, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/2/023010; Diakonova M, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062818; GALAM S, 1987, PHYS LETT A, V122, P271, DOI 10.1016/0375-9601(87)90821-8; GALAM S, 1989, EUROPHYS LETT, V8, P167, DOI 10.1209/0295-5075/8/2/010; Galam S, 1997, PHYSICA A, V238, P66, DOI 10.1016/S0378-4371(96)00456-6; Galam S, 1998, EUR PHYS J B, V4, P529, DOI 10.1007/s100510050410; Gao JX, 2014, NATL SCI REV, V1, P346, DOI 10.1093/nsr/nwu020; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Gozolchiani A, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/28005; Granell C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.128701; Hackett A, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.021002; Halu A, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/16002; Kenett DY, 2015, CHAOS SOLITON FRACT, V80, P1, DOI 10.1016/j.chaos.2015.03.016; La Rocca CE, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/40004; La Rocca CE, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026111; Li DQ, 2015, P NATL ACAD SCI USA, V112, P669, DOI 10.1073/pnas.1419185112; Mas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074516; Mas M, 2013, ORGAN SCI, V24, P716, DOI 10.1287/orsc.1120.0767; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman M, 2010, NETWORKS INTRO, DOI 10.1093/acprof:oso/9780199206650.001.0001; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Piontti ALPY, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046117; Sahneh FD, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062817; Torres MF, 2015, EPL-EUROPHYS LETT, V111, DOI 10.1209/0295-5075/111/46001; Valdez LD, 2013, FRACTALS, V21, DOI 10.1142/S0218348X13500199; Valdez LD, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/38001; Vazquez F, 2016, SCI REP-UK, V6, DOI 10.1038/srep29342; Vazquez F, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/04/P04007; Vazquez F, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063011	48	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163593	10.1371/journal.pone.0163593	http://dx.doi.org/10.1371/journal.pone.0163593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689698	Green Published, gold, Green Submitted			2022-12-27	WOS:000384329200017
J	Lopez-Tejero, MD; Virgilli, N; Targarona, J; Ruiz, J; Garcia, N; Oro, D; Garcia-Villoria, J; Creus, G; Pita, AM				Dolores Lopez-Tejero, M.; Virgilli, Nuria; Targarona, Jordi; Ruiz, Jorge; Garcia, Natalia; Oro, Denise; Garcia-Villoria, Judit; Creus, Gloria; Pita, Ana M.			Apo AIV and Citrulline Plasma Concentrations in Short Bowel Syndrome Patients: The Influence of Short Bowel Anatomy	PLOS ONE			English	Article							APOLIPOPROTEIN-A-IV; ENTEROCYTE MASS; PARENTERAL-NUTRITION; INTESTINAL FAILURE; MARKER; ADAPTATION; CHILDREN; ABSORPTION; ATROPHY	Introduction Parenteral nutrition (PN) dependence in short bowel syndrome (SBS) patients is linked to the functionality of the remnant small bowel (RSB). Patients may wean off PN following a period of intestinal adaptation that restores this functionality. Currently, plasma citrulline is the standard biomarker for monitoring intestinal functionality and adaptation. However, available studies reveal that the relationship the biomarker with the length and function of the RSB is arguable. Thus, having additional biomarkers would improve pointing out PN weaning. Aim By measuring concomitant changes in citrulline and the novel biomarker apolipoprotein AIV (Apo AIV), as well as taking into account the anatomy of the RSB, this exploratory study aims to a better understanding of the intestinal adaptation process and characterization of the SBS patients under PN. Methods Thirty four adult SBS patients were selected and assigned to adapted (aSBS) and non-adapted (nSBS) groups after reconstructive surgeries. Remaining jejunum and ileum lengths were recorded. The aSBS patients were either on an oral diet (ORAL group), those with intestinal insufficiency, or on oral and home parenteral nutrition (HPN group), those with chronic intestinal failure. Apo AIV and citrulline were analyzed in plasma samples after overnight fasting. An exploratory ROC analysis using citrulline as gold standard was performed. Results Biomarkers, Apo AIV and citrulline showed a significant correlation with RSBL in aSBS patients. In jejuno-ileocolic patients, only Apo AIV correlated with RSBL (r(b) = 0.54) and with ileum length (r(b) = 0.84). In patients without ileum neither biomarker showed any correlation with RSBL. ROC analysis indicated the Apo AIV cut-off value to be 4.6 mg/100 mL for differentiating between the aSBS HPN and ORAL groups. Conclusions Therefore, in addition to citrulline, Apo AIV can be set as a biomarker to monitor intestinal adaptation in SBS patients. As short bowel anatomy is shown to influence citrulline and Apo AIV plasma values, both biomarkers complement each other furnishing a new insight to manage PN dependence.	[Dolores Lopez-Tejero, M.; Targarona, Jordi; Garcia, Natalia; Oro, Denise] Univ Barcelona, Fac Biol, Dept Bioquim & Biomed Mol, Barcelona, Spain; [Virgilli, Nuria; Creus, Gloria; Pita, Ana M.] HUB, IDIBELL, Serv Endocrinol & Nutr, Unitat Nutr & Dietet, Barcelona, Spain; [Ruiz, Jorge] MIXeSTAT SL, Barcelona, Spain; [Garcia-Villoria, Judit] Hosp Clin Barcelona, IDIBAPS, CIBERER, Secc Errores Congenitos Metab IBC,Serv Bioquim &, Barcelona, Spain	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Lopez-Tejero, MD (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biomed Mol, Barcelona, Spain.	dolopez@ub.edu	Oró, Denise/H-1391-2015; Garcia, Judit/AAN-1753-2021	Oró, Denise/0000-0001-5255-3692; Garcia Villoria, Judit/0000-0003-2132-4138				Bailly-Botuha C, 2009, PEDIATR RES, V65, P559, DOI 10.1203/PDR.0b013e31819986da; Carbonnel F, 1996, JPEN-PARENTER ENTER, V20, P275, DOI 10.1177/0148607196020004275; CASTILLO L, 1995, AM J PHYSIOL-ENDOC M, V268, pE360, DOI 10.1152/ajpendo.1995.268.2.E360; COHEN SA, 1986, NATURE, V320, P769, DOI 10.1038/320769a0; Crenn P, 2000, GASTROENTEROLOGY, V119, P1496, DOI 10.1053/gast.2000.20227; Crenn P, 2004, GUT, V53, P1279, DOI 10.1136/gut.2003.030601; Crenn P, 2003, GASTROENTEROLOGY, V124, P1210, DOI 10.1016/S0016-5085(03)00170-7; Crenn P, 2008, CLIN NUTR, V27, P328, DOI 10.1016/j.clnu.2008.02.005; Curis E, 2005, AMINO ACIDS, V29, P177, DOI 10.1007/s00726-005-0235-4; Curis E, 2007, CURR OPIN CLIN NUTR, V10, P620, DOI 10.1097/MCO.0b013e32829fb38d; Diamanti A, 2011, LANGENBECK ARCH SURG, V396, P1041, DOI 10.1007/s00423-011-0813-8; Fitzgibbons S, 2009, J PEDIATR SURG, V44, P928, DOI 10.1016/j.jpedsurg.2009.01.034; GHISELLI G, 1986, J LIPID RES, V27, P813; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Jeppesen PB, 2015, CURR OPIN ENDOCRINOL, V22, P14, DOI 10.1097/MED.0000000000000120; Jeppesen PB, 2012, GASTROENTEROLOGY, V143, P1473, DOI 10.1053/j.gastro.2012.09.007; Jie Zhi-gang, 2008, Zhonghua Wei Chang Wai Ke Za Zhi, V11, P558; KOGA S, 1985, DIGESTION, V32, P19, DOI 10.1159/000199211; Luo MH, 2007, JPEN-PARENTER ENTER, V31, P1, DOI 10.1177/014860710703100101; Messing B, 1999, GASTROENTEROLOGY, V117, P1043, DOI 10.1016/S0016-5085(99)70388-4; Papadia C, 2007, AM J GASTROENTEROL, V102, P1474, DOI 10.1111/j.1572-0241.2007.01239.x; Peters JHC, 2008, ALIMENT PHARM THER, V27, P1300, DOI 10.1111/j.1365-2036.2008.03678.x; Peters JHC, 2008, JPEN-PARENTER ENTER, V32, P288, DOI 10.1177/0148607108316186; Peters JHC, 2007, AM J GASTROENTEROL, V102, P2814, DOI 10.1111/j.1572-0241.2007.01513.x; Pironi L, 2015, CLIN NUTR, V34, P171, DOI 10.1016/j.clnu.2014.08.017; Qin XF, 2005, CURR DRUG TARGETS, V6, P145, DOI 10.2174/1389450053174541; Rafat N, 2004, CLIN CHEM, V50, P1270, DOI 10.1373/clinchem.2004.033001; Rhoads JM, 2005, J PEDIATR-US, V146, P542, DOI 10.1016/j.jpeds.2004.12.027; Rubin DC, 1997, REGULATION EPITHELIA, P217; Schneider B, 1999, P 24 ANN SAS US GROU, P250; SEISHIMA M, 1985, Gastroenterologia Japonica, V20, P558; Shaw D, 2012, WORLD J GASTROENTERO, V18, P6357, DOI 10.3748/wjg.v18.i44.6357; SHERMAN JR, 1988, GASTROENTEROLOGY, V95, P394, DOI 10.1016/0016-5085(88)90496-9; Tappenden KA, 2014, JPEN-PARENTER ENTER, V38, p23S, DOI 10.1177/0148607114525210; Tappenden KA, 2013, J CLIN GASTROENTEROL, V47, P602, DOI 10.1097/MCG.0b013e3182828f57; Traves C, 2010, CONCOMITANT APOLIPOP, V5, P219, DOI [10.1016/j.eclnm.2010.07.004, DOI 10.1016/J.ECINM.2010.07.004]; Traves C, 2007, ALCOHOL ALCOHOLISM, V42, P407, DOI 10.1093/alcalc/agm005; Tso P, 2004, AM J PHYSIOL-GASTR L, V286, pG885, DOI 10.1152/ajpgi.00511.2003; van de Poll MCG, 2007, J PHYSIOL-LONDON, V581, P819, DOI 10.1113/jphysiol.2006.126029; Vieyra DS, 2005, STEM CELL REV, V1, P65, DOI 10.1385/SCR:1:1:065; Wakabayashi Y, 1991, ARCH BIOCHEM BIOPHYS, V291, P8; Woods SC, 2006, OBESITY, V14, p171S, DOI 10.1038/oby.2006.301; Yang Q, 2010, J PEDIATR GASTR NUTR, V50, P16, DOI 10.1097/MPG.0b013e3181c2c2af; Ziegler TR, 2006, GASTROENTEROLOGY, V130, pS37, DOI 10.1053/j.gastro.2005.09.063	44	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163762	10.1371/journal.pone.0163762	http://dx.doi.org/10.1371/journal.pone.0163762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689355	Green Published, Green Submitted, gold			2022-12-27	WOS:000384329200025
J	Mallorqui-Bague, N; Fagundo, AB; Jimenez-Murcia, S; de la Torre, R; Banos, RM; Botella, C; Casanueva, FF; Crujeiras, AB; Fernandez-Garcia, JC; Fernandez-Real, JM; Fruhbeck, G; Granero, R; Rodriguez, A; Tolosa-Sola, I; Ortega, FJ; Tinahones, FJ; Alvarez-Moya, E; Ochoa, C; Menchon, JM; Fernandez-Aranda, F				Mallorqui-Bague, Nuria; Fagundo, Ana B.; Jimenez-Murcia, Susana; de la Torre, Rafael; Banos, Rosa M.; Botella, Cristina; Casanueva, Felipe F.; Crujeiras, Ana B.; Fernandez-Garcia, Jose C.; Fernandez-Real, Jose M.; Fruhbeck, Gema; Granero, Roser; Rodriguez, Amaia; Tolosa-Sola, Iris; Ortega, Francisco J.; Tinahones, Francisco J.; Alvarez-Moya, Eva; Ochoa, Cristian; Menchon, Jose M.; Fernandez-Aranda, Fernando			Decision Making Impairment: A Shared Vulnerability in Obesity, Gambling Disorder and Substance Use Disorders?	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; FOOD ADDICTION; DEFICITS; ALCOHOL; ABUSERS; TASK; SEX	Introduction Addictions are associated with decision making impairments. The present study explores decision making in Substance use disorder (SUD), Gambling disorder (GD) and Obesity (OB) when assessed by Iowa Gambling Task (IGT) and compares them with healthy controls (HC). Methods For the aims of this study, 591 participants (194 HC, 178 GD, 113 OB, 106 SUD) were assessed according to DSM criteria, completed a sociodemographic interview and conducted the IGT. Results SUD, GD and OB present impaired decision making when compared to the HC in the overall task and task learning, however no differences are found for the overall performance in the IGT among the clinical groups. Results also reveal some specific learning across the task patterns within the clinical groups: OB maintains negative scores until the third set where learning starts but with a less extend to HC, SUD presents an early learning followed by a progressive although slow improvement and GD presents more random choices with no learning. Conclusions Decision making impairments are present in the studied clinical samples and they display individual differences in the task learning. Results can help understanding the underlying mechanisms of OB and addiction behaviors as well as improve current clinical treatments.	[Mallorqui-Bague, Nuria; Fagundo, Ana B.; Jimenez-Murcia, Susana; Tolosa-Sola, Iris; Alvarez-Moya, Eva; Ochoa, Cristian; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain; [Mallorqui-Bague, Nuria; Fagundo, Ana B.; Jimenez-Murcia, Susana; de la Torre, Rafael; Banos, Rosa M.; Botella, Cristina; Casanueva, Felipe F.; Crujeiras, Ana B.; Fernandez-Garcia, Jose C.; Fernandez-Real, Jose M.; Fruhbeck, Gema; Granero, Roser; Rodriguez, Amaia; Ortega, Francisco J.; Tinahones, Francisco J.; Fernandez-Aranda, Fernando] Inst Salud Carlos III, GIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Jimenez-Murcia, Susana; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [de la Torre, Rafael] Hosp del Mar, Med Res Inst, Integrated Pharmacol & Syst Neurosci Res Grp, Neurosci Res Program,IMIM, Barcelona, Spain; [de la Torre, Rafael] Pompeu Fabra Univ, CEXS UPF, Barcelona, Spain; [Banos, Rosa M.] Univ Valencia, Dept Psychol Personal Evaluat & Treatment, Valencia, Spain; [Botella, Cristina] Univ Jaume 1, Dept Basic Psychol Clin & Psychobiol, Castellon de La Plana, Spain; [Casanueva, Felipe F.; Crujeiras, Ana B.] Univ Santiago de Compostela, Complejo Hosp Univ Santiago, Div Endocrine, Santiago De Compostela, Spain; [Fernandez-Garcia, Jose C.; Tinahones, Francisco J.] Hosp Clin Univ Virgen de Victoria, Dept Endocrinol & Nutr, Malaga, Spain; [Fernandez-Real, Jose M.; Ortega, Francisco J.] Hosp Dr Josep Trueta, Dept Diabet Endocrinol & Nutr, Inst Invest Biomed Girona IdIBGi, Girona, Spain; [Fruhbeck, Gema; Rodriguez, Amaia] Univ Navarra, Univ Navarra Clin, Dept Endocrinol & Nutr, Pamplona, Spain; [Granero, Roser] Univ Autonoma Barcelona, Dept Psicobiol & Metodol, Barcelona, Spain; [Menchon, Jose M.] Inst Salud Carlos III, CIBER Salud Mental CIBERsam, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; University of Valencia; Universitat Jaume I; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); University of Navarra; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III	Fernandez-Aranda, F (corresponding author), Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain.; Fernandez-Aranda, F (corresponding author), Inst Salud Carlos III, GIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain.; Fernandez-Aranda, F (corresponding author), Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain.	ffernandez@bellvitgehospital.cat	Fernandez-Aranda, Fernando/L-9762-2014; Granero, Roser/S-3529-2019; Fernández-Real, Jose Manuel/AGH-3599-2022; de la Torre, Rafael/D-3561-2018; Granero, Roser/F-9492-2016; Ochoa, Cristian/I-8060-2015; Crujeiras, Ana/ABA-8866-2021; BAÑOS, ROSA MARIA/C-6077-2011; Ortega, Francisco José J/F-3883-2016; Tinahones, Francisco José/AAB-2882-2020; JIMENEZ-MURCIA, SUSANA/L-9786-2014; Botella, Cristina/F-9230-2010; Fernandez-Garcia, Jose Carlos/B-5312-2013; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Mallorqui-Bague, Nuria/Q-1721-2015; Rodriguez, Amaia/D-3044-2019; Menchon, Jose/A-5242-2009	Fernandez-Aranda, Fernando/0000-0002-2968-9898; Fernández-Real, Jose Manuel/0000-0002-7442-9323; de la Torre, Rafael/0000-0002-6765-1866; Granero, Roser/0000-0001-6308-3198; Ochoa, Cristian/0000-0002-4508-0951; Crujeiras, Ana/0000-0003-4392-0301; BAÑOS, ROSA MARIA/0000-0003-0626-7665; Ortega, Francisco José J/0000-0003-2111-769X; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; Botella, Cristina/0000-0001-8783-6959; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Mallorqui-Bague, Nuria/0000-0003-1434-3162; Tinahones, Francisco J/0000-0001-6871-4403; Rodriguez, Amaia/0000-0002-2180-461X; Menchon, Jose/0000-0002-6231-6524; Fagundo, Ana Beatriz/0000-0003-1703-9457	Instituto Salud Carlos III (ISCIII) [FIS PI14/00290]; Fondos Europeos de Desarrollo Regional (FEDER) funds; AGAUR [2014 SGR1672]; Ministerio de Economia y Competitividad [PSI2015-68701-R]; Servicio Andaluz de Salud (SAS) [B-0033-2014]	Instituto Salud Carlos III (ISCIII); Fondos Europeos de Desarrollo Regional (FEDER) funds; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Ministerio de Economia y Competitividad(Spanish Government); Servicio Andaluz de Salud (SAS)	This manuscript was supported by grants from Instituto Salud Carlos III (ISCIII; FIS PI14/00290 and CIBERobn) and co-funded by Fondos Europeos de Desarrollo Regional (FEDER) funds - a way to build Europe, and AGAUR (2014 SGR1672). This manuscript was co-funded by Ministerio de Economia y Competitividad (PSI2015-68701-R). CIBERobn and CIBERSAM are both initiatives of ISCIII. Jose C. Fernandez-Garcia is recipient of a research contract from Servicio Andaluz de Salud (SAS) (B-0033-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Brevers D, 2014, ADDICT BEHAV, V39, P1533, DOI 10.1016/j.addbeh.2014.06.004; Brogan A, 2011, J PSYCHOSOM RES, V70, P189, DOI 10.1016/j.jpsychores.2010.07.012; Brogan A, 2010, J INT NEUROPSYCH SOC, V16, P711, DOI 10.1017/S1355617710000354; Fagundo AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043382; Fridberg DJ, 2013, DRUG ALCOHOL DEPEN, V133, P654, DOI 10.1016/j.drugalcdep.2013.08.014; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Gearhardt AN, 2011, CURR PHARM DESIGN, V17, P1140, DOI 10.2174/138161211795656800; Goudriaan AE, 2005, COGNITIVE BRAIN RES, V23, P137, DOI 10.1016/j.cogbrainres.2005.01.017; Grant JE, 2015, ACTA PSYCHIAT SCAND, V131, P379, DOI 10.1111/acps.12353; HOLM S, 1979, SCAND J STAT, V6, P65; Krmpotich T, 2015, J ADDICT MED, V9, P273, DOI 10.1097/ADM.0000000000000129; Michael BF, 2002, STRUCTURED CLIN INTE; Mussolin C, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00663, 10.3389/fpsyt.2013.00179]; Schonberg T, 2011, TRENDS COGN SCI, V15, P11, DOI 10.1016/j.tics.2010.10.002; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Tanabe J, 2015, DRUG ALCOHOL DEPEN, V146, pe115, DOI [10.1016/j.drugalcdep.2014.09.681, DOI 10.1016/J.DRUGALCDEP.2014.09.681]; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V86, P139, DOI 10.1016/j.drugalcdep.2006.05.024; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow ND, 2015, TRENDS NEUROSCI, V38, P345, DOI 10.1016/j.tins.2015.04.002; Wiehler A, 2015, NEUROSCI RES, V90, P3, DOI 10.1016/j.neures.2014.09.008; Wu MD, 2016, NEUROSCI BIOBEHAV R, V61, P177, DOI 10.1016/j.neubiorev.2015.11.017	28	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							0163901	10.1371/journal.pone.0163901	http://dx.doi.org/10.1371/journal.pone.0163901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DX4CZ	27690367	Green Published, gold			2022-12-27	WOS:000384329200032
J	Zhang, QM; Wu, QZ; Zhang, JR; He, L; Huang, JT; Zhang, J; Huang, H; Gong, QY				Zhang, Qiongmin; Wu, Qizhu; Zhang, Junran; He, Ling; Huang, Jiangtao; Zhang, Jiang; Huang, Hua; Gong, Qiyong			Discriminative Analysis of Migraine without Aura: Using Functional and Structural MRI with a Multi-Feature Classification Approach	PLOS ONE			English	Article							RESTING-STATE; ALZHEIMERS-DISEASE; BRAIN; CONNECTIVITY; ABNORMALITIES; DIAGNOSIS; DEPRESSION; SELECTION; SINGLE	Magnetic resonance imaging (MRI) is by nature a multi-modality technique that provides complementary information about different aspects of diseases. So far no attempts have been reported to assess the potential of multi-modal MRI in discriminating individuals with and without migraine, so in this study, we proposed a classification approach to examine whether or not the integration of multiple MRI features could improve the classification performance between migraine patients without aura (MWoA) and healthy controls. Twenty-one MWoA patients and 28 healthy controls participated in this study. Resting-state functional MRI data was acquired to derive three functional measures: the amplitude of low-frequency fluctuations, regional homogeneity and regional functional correlation strength; and structural MRI data was obtained to measure the regional gray matter volume. For each measure, the values of 116 pre-defined regions of interest were extracted as classification features. Features were first selected and combined by a multi-kernel strategy; then a support vector machine classifier was trained to distinguish the subjects at individual level. The performance of the classifier was evaluated using a leave-one-out cross-validation method, and the final classification accuracy obtained was 83.67% (with a sensitivity of 92.86% and a specificity of 71.43%). The anterior cingulate cortex, prefrontal cortex, orbitofrontal cortex and the insula contributed the most discriminative features. In general, our proposed framework shows a promising classification capability for MWoA by integrating information from multiple MRI features.	[Zhang, Qiongmin; Zhang, Junran; He, Ling; Zhang, Jiang; Huang, Hua] Sichuan Univ, Sch Elect Engn & Informat, Dept Med Informat Engn, Chengdu, Sichuan, Peoples R China; [Wu, Qizhu] Monash Univ, Monash Biomed Imaging, Melbourne, Vic, Australia; [Zhang, Junran; Gong, Qiyong] Sichuan Univ, Dept Radiol, West China Hosp, HMRRC, Chengdu, Sichuan, Peoples R China; [Huang, Jiangtao] Guangxi Teachers Educ Univ, Comp & Informat Engn Sch, Nanning, Guangxi, Peoples R China	Sichuan University; Monash University; Sichuan University; Nanning Normal University	Zhang, JR (corresponding author), Sichuan Univ, Sch Elect Engn & Informat, Dept Med Informat Engn, Chengdu, Sichuan, Peoples R China.; Zhang, JR; Gong, QY (corresponding author), Sichuan Univ, Dept Radiol, West China Hosp, HMRRC, Chengdu, Sichuan, Peoples R China.	zhangJunran@126.com; qiyonggong@hmrrc.org.cn	Gong, Qiyong/W-3052-2019	Gong, Qiyong/0000-0002-5912-4871	National Natural Science Foundation of China [81000605, 81371536, 61273361]; Guangdong Natural Science Foundation [S2012020010867]; Sichuan Science and Technology Plan Project [2015HH0036]; Guangxi Natural Science Foundation Key Projects [2014GXNSFDA118037]; Key Lab Science Foundation of Guangxi province [GXSCIIP201411]; Key Technology Research and Development Program of Sichuan Province [2014GZ0003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Sichuan Science and Technology Plan Project; Guangxi Natural Science Foundation Key Projects; Key Lab Science Foundation of Guangxi province; Key Technology Research and Development Program of Sichuan Province	This work was supported by the National Natural Science Foundation of China (JunranZ) Grant No. 81000605 (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#), National Natural Science Foundation of China (QG) Grant No. 81371536 (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#), Guangdong Natural Science Foundation (JunranZ) Grant No. S2012020010867 (http://gonggao.gdstc.gov.cn/itemListAction.do?method=item_List_Data), Sichuan Science and Technology Plan Project (JunranZ) Grant No. 2015HH0036 (http://xmgl.scst.gov.cn/index.html), Guangxi Natural Science Foundation Key Projects (JH) Grant No. 2014GXNSFDA118037 (htt//gxnsf.gxsti.net/stms/login.jsp), Key Lab Science Foundation of Guangxi province (JZ) Grant No. GXSCIIP201411 (http://www.gxtc.edu.cn/Default.aspx), National Natural Science Foundation of China (JiangZ) Grant No. 61273361 (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list#), and Key Technology Research and Development Program of Sichuan Province (JiangZ) Grant No. 2014GZ0003 (httn://xmgl.scst.gov.cn/index.html). The study design, decision to publish, and preparation of the manuscript are sponsored by the funding of Junran Zhang and Jiang Zhang; data collection is sponsored by the funding of Qiyong Gong and Jiangtao Huang.	Abdulkadir A, 2011, NEUROIMAGE, V58, P785, DOI 10.1016/j.neuroimage.2011.06.029; ARMIJO L, 1966, PAC J MATH, V16, P1, DOI 10.2140/pjm.1966.16.1; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Aurora SK, 2000, CURR OPIN NEUROL, V13, P273, DOI 10.1097/00019052-200006000-00007; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Coppola G, 2015, CEPHALALGIA, V35, P783, DOI 10.1177/0333102414559732; Dai ZJ, 2012, NEUROIMAGE, V59, P2187, DOI 10.1016/j.neuroimage.2011.10.003; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; Dixit A, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/697697; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Frick A, 2014, BEHAV BRAIN RES, V259, P330, DOI 10.1016/j.bbr.2013.11.003; Frisoni GB, 2001, J NEUROL NEUROSUR PS, V70, P711, DOI 10.1136/jnnp.70.6.711; Gong QY, 2011, NEUROIMAGE, V55, P1497, DOI 10.1016/j.neuroimage.2010.11.079; Guo WB, 2012, PROG NEURO-PSYCHOPH, V37, P153, DOI 10.1016/j.pnpbp.2012.01.011; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hadjikhani N, 2013, CEPHALALGIA, V33, P1264, DOI 10.1177/0333102413490344; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Haller S, 2014, BRAIN TOPOGR, V27, P329, DOI 10.1007/s10548-014-0360-z; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; Hougaard A, 2014, CURR OPIN NEUROL, V27, P309, DOI 10.1097/WCO.0000000000000086; Hu WT, 2015, INT J CLIN EXP MED, V8, P4311; Hung CI, 2009, J AFFECT DISORDERS, V117, P108, DOI 10.1016/j.jad.2008.12.015; Iwabuchi Sarina J, 2013, Front Psychiatry, V4, P95, DOI 10.3389/fpsyt.2013.00095; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Jin CW, 2013, NMR BIOMED, V26, P58, DOI 10.1002/nbm.2819; Kim J, 2008, CEPHALALGIA, V28, P598, DOI 10.1111/j.1468-2982.2008.01550.x; Liu FY, 2014, IEEE J BIOMED HEALTH, V18, P984, DOI 10.1109/JBHI.2013.2285378; Liu F, 2014, NEUROIMAGE, V84, P466, DOI 10.1016/j.neuroimage.2013.09.015; Long DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040150; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Raggi A, 2011, NEUROL SCI, V32, P387, DOI 10.1007/s10072-010-0466-3; Rana B, 2015, EXPERT SYST APPL, V42, P4506, DOI 10.1016/j.eswa.2015.01.062; Sato JR, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00068; Schwedt TJ, 2015, HEADACHE, V55, P762, DOI 10.1111/head.12584; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Tessitore A, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-89; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ulas A, 2011, LECT NOTES COMPUT SC, V7042, P491, DOI 10.1007/978-3-642-25085-9_58; Velentgas P, 2004, HEADACHE, V44, P642, DOI 10.1111/j.1526-4610.2004.04122.x; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Xue T, 2013, NMR BIOMED, V26, P1051, DOI 10.1002/nbm.2917; Yu DH, 2012, NMR BIOMED, V25, P806, DOI 10.1002/nbm.1796; Yu DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054516; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zhao L, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-85	53	15	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163875	10.1371/journal.pone.0163875	http://dx.doi.org/10.1371/journal.pone.0163875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690138	gold, Green Published, Green Submitted			2022-12-27	WOS:000384329200029
J	Asing; Ali, ME; Abd Hamid, SB; Hossein, MAM; Mustafa, S; Kader, MA; Zaidul, ISM				Asing; Ali, Md. Eaqub; Abd Hamid, Sharifah Bee; Hossein, M. A. Motalib; Mustafa, Shuhaimi; Kader, Md. Abdul; Zaidul, I. S. M.			Lab-on-a-Chip-Based PCR-RFLP Assay for the Detection of Malayan Box Turtle (Cuora amboinensis) in the Food Chain and Traditional Chinese Medicines	PLOS ONE			English	Article							FRAGMENT LENGTH POLYMORPHISM; REAL-TIME PCR; MEAT SPECIES IDENTIFICATION; DEER CAPREOLUS-CAPREOLUS; RIBOSOMAL-RNA GENE; CERVUS-ELAPHUS; DAMA-DAMA; MITOCHONDRIAL; DNA; PRODUCTS	The Malayan box turtle (Cuora amboinensis) (MBT) is a vulnerable and protected turtle species, but it is a lucrative item in the illegal wildlife trade because of its great appeal as an exotic food item and in traditional medicine. Although several polymerase chain reaction (PCR) assays to identify MBT by various routes have been documented, their applicability for forensic authentication remains inconclusive due to the long length of the amplicon targets, which are easily broken down by natural decomposition, environmental stresses or physiochemical treatments during food processing. To address this research gap, we developed, for the first time, a species-specific PCR-restriction fragment length polymorphism (RFLP) assay with a very short target length (120 bp) to detect MBT in the food chain; this authentication ensured better security and reliability through molecular fingerprints. The PCR-amplified product was digested with Bfa1 endonuclease, and distinctive restriction fingerprints (72, 43 and 5 bp) for MBT were found upon separation in a microfluidic chip-based automated electrophoresis system, which enhances the resolution of short oligos. The chances of any false negative identifications were eliminated through the use of a universal endogenous control for eukaryotes, and the limit of detection was 0.0001 ng DNA or 0.01% of the meat under admixed states. Finally, the optimized PCR-RFLP assay was validated for the screening of raw and processed commercial meatballs, burgers and frankfurters, which are very popular in most countries. The optimized PCR-RFLP assay was further used to screen MBT materials in 153 traditional Chinese medicines of 17 different brands and 62 of them were found MBT positive; wherein the ingredients were not declared in product labels. Overall, the novel assay demonstrated sufficient merit for use in any forensic and/or archaeological authentication of MBT, even under a state of decomposition.	[Asing; Ali, Md. Eaqub; Abd Hamid, Sharifah Bee; Hossein, M. A. Motalib] Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, Kuala Lumpur, Malaysia; [Ali, Md. Eaqub] Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia; [Mustafa, Shuhaimi] Univ Putra Malaysia, Inst Halal Prod Res, Upm Serdang, Selangor, Malaysia; [Kader, Md. Abdul] Univ Malaysia Terrenganu, Sch Aquaculture & Fisheries, Kuala Terrenganu, Terrenganu, Malaysia; [Zaidul, I. S. M.] Int Islamic Univ, Dept Pharmaceut Technol, Fac Pharm, Kuantan, Pahang, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Putra Malaysia; International Islamic University Malaysia	Ali, ME (corresponding author), Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, Kuala Lumpur, Malaysia.; Ali, ME (corresponding author), Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia.	eaqubali@gmail.com	HAMID, SHARIFAH BEE ABD/B-9749-2010; Kader, Abdul/V-8475-2017; Sarker, Zaidul Islam/A-3254-2014; Hossain, M. A. Motalib/A-1707-2019; Ali, Eaqub/E-1948-2012	HAMID, SHARIFAH BEE ABD/0000-0002-5104-3938; Kader, Abdul/0000-0002-0119-0630; Sarker, Zaidul Islam/0000-0002-9974-4565; Hossain, M. A. Motalib/0000-0003-2590-5394; Ali, Eaqub/0000-0002-7384-3936	Equitable Society Research Cluster, University of Malaya [GC001A-14SBS]	Equitable Society Research Cluster, University of Malaya	Md. Eaqub Ali declares that he received funding from Equitable Society Research Cluster, University of Malaya (GC001A-14SBS).	Adams DS, 2003, LAB MATH HDB MEASURE; ADEOLA MO, 1992, ENVIRON CONSERV, V19, P125, DOI 10.1017/S0376892900030605; Albers CN, 2013, GEOMICROBIOL J, V30, P675, DOI 10.1080/01490451.2012.758193; Ali M. E., 2015, FOOD ANAL METHOD, P1; Ali ME, 2012, FOOD ANAL METHOD, V5, P613, DOI 10.1007/s12161-011-9290-5; Ali ME, 2015, FOOD ADDIT CONTAM A, V32, P1223, DOI 10.1080/19440049.2015.1058535; Ali ME, 2015, FOOD CHEM, V177, P214, DOI 10.1016/j.foodchem.2014.12.098; Ali ME, 2014, FOOD ANAL METHOD, V7, P1933, DOI 10.1007/s12161-014-9844-4; Alves RNN, 2013, ANIMALS TRADITIONAL, P25, DOI DOI 10.1007/978-3-642-29026-8_3; Alves RRN, 2005, J ETHNOBIOL ETHNOMED, V1, DOI [10.1186/1746-4269-1-10, 10.1186/1746-4269-1-5]; ANGELETTI LR, 1992, LANCET, V340, P223, DOI 10.1016/0140-6736(92)90480-Q; [Anonymous], 2013, 10000 SEA TURTLE EGG; [Anonymous], 2008, TELEGRAPH; ANYINAM C, 1995, SOC SCI MED, V40, P321, DOI 10.1016/0277-9536(94)E0098-D; Arslan A, 2006, MEAT SCI, V72, P326, DOI 10.1016/j.meatsci.2005.08.001; Ayaz Y, 2006, J MUSCLE FOODS, V17, P214, DOI 10.1111/j.1745-4573.2006.00046.x; Ballin NZ, 2009, MEAT SCI, V83, P165, DOI 10.1016/j.meatsci.2009.06.003; Bayazit V, 2005, J CHEM SOC PAKISTAN, V27, P413; Bennett EL, 2002, ORYX, V36, P328, DOI 10.1017/S0030605302000637; Broeders S, 2014, TRENDS FOOD SCI TECH, V37, P115, DOI 10.1016/j.tifs.2014.03.008; Chen SY, 2010, J GENET GENOMICS, V37, P763, DOI 10.1016/S1673-8527(09)60093-X; Chou CC, 2007, J CHROMATOGR B, V846, P230, DOI 10.1016/j.jchromb.2006.09.006; Coghlan ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep17475; Davy CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130965; do Nascimento C, 2010, J CLIN MICROBIOL, V48, P3039, DOI 10.1128/JCM.00390-10; Doosti A, 2014, J FOOD SCI TECH MYS, V51, P148, DOI 10.1007/s13197-011-0456-3; Ellis DI, 2005, ANALYST, V130, P1648, DOI 10.1039/b511484e; Ernst E, 2001, CLIN PHARMACOL THER, V70, P497, DOI 10.1067/mcp.2001.120249; Fairbrother KS, 1998, ANIM BIOTECHNOL, V9, P89, DOI 10.1080/10495399809525897; Fajardo V, 2006, J AGR FOOD CHEM, V54, P1144, DOI 10.1021/jf051766r; Fajardo V, 2008, MEAT SCI, V79, P289, DOI 10.1016/j.meatsci.2007.09.013; Fajardo V, 2010, TRENDS FOOD SCI TECH, V21, P408, DOI 10.1016/j.tifs.2010.06.002; Fajardo V, 2009, J SCI FOOD AGR, V89, P843, DOI 10.1002/jsfa.3522; Fang X, 2016, FOOD CHEM, V192, P485, DOI 10.1016/j.foodchem.2015.07.020; Felbab-Brown V, 2011, DISAPPEARING ACT ILL, V1775, P20036; Fernandez-Tajes J, 2010, FOOD CHEM, V118, P995, DOI 10.1016/j.foodchem.2008.10.043; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Fund TC, 2002, STRATEGY FUNDING PRO, V2007, P30; Gans JD, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks238; Ghovvati S, 2009, FOOD CONTROL, V20, P696, DOI 10.1016/j.foodcont.2008.09.002; Girish PS, 2007, VET RES COMMUN, V31, P447, DOI 10.1007/s11259-006-3390-5; Girish PS, 2005, MEAT SCI, V70, P107, DOI 10.1016/j.meatsci.2004.12.004; Girish PS, 2004, MEAT SCI, V66, P551, DOI 10.1016/S0309-1740(03)00158-X; Graham-Rowe D, 2011, NATURE, V480, pS101, DOI 10.1038/480S101a; Han C, 2003, FASEB J FEDERATION A; Haunshi S, 2009, MEAT SCI, V83, P454, DOI 10.1016/j.meatsci.2009.06.026; Hitam BK, CUSTOMS SEIZE TONNES; Hoffman LC, 2006, MEAT SCI, V74, P197, DOI 10.1016/j.meatsci.2006.04.005; Hsieh H-M, 2008, FORENSIC SCI J, V7, P45; Ilhak OI, 2007, TURK J VET ANIM SCI, V31, P159; IUCN, 2014, IUCN RED LIST THREAT; Karabasanavar NS, 2014, FOOD CHEM, V145, P530, DOI 10.1016/j.foodchem.2013.08.084; Karabasanavar NS, 2011, SMALL RUMINANT RES, V100, P153, DOI 10.1016/j.smallrumres.2011.07.009; Kitpipit T, 2014, FOOD CHEM, V163, P77, DOI 10.1016/j.foodchem.2014.04.062; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; La Neve F, 2008, MEAT SCI, V80, P216, DOI 10.1016/j.meatsci.2007.11.027; Lee TM, 2014, SOUTH AND SOUTHEAST, P15; Liu SYV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079373; Lo CF, 2006, J FOOD DRUG ANAL, V14, P153; Maede D, 2006, EUR FOOD RES TECHNOL, V224, P209, DOI 10.1007/s00217-006-0320-2; Mafra I, 2008, EUR FOOD RES TECHNOL, V227, P649, DOI 10.1007/s00217-007-0782-x; Magnino S, 2009, INT J FOOD MICROBIOL, V134, P163, DOI 10.1016/j.ijfoodmicro.2009.07.001; Mane BG, 2012, FOOD CONTROL, V28, P246, DOI 10.1016/j.foodcont.2012.05.031; Mane BG, 2009, FOOD CHEM, V116, P806, DOI 10.1016/j.foodchem.2009.03.030; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer R, 1995, J AOAC INT, V78, P1542; Montiel-Sosa JF, 2000, J AGR FOOD CHEM, V48, P2829, DOI 10.1021/jf9907438; Montowska M, 2007, ACTA SCI POLON-TECHN, V6, P5; Moore MK, 2003, CONSERV GENET, V4, P95, DOI 10.1023/A:1021881319271; Murugaiah C, 2009, MEAT SCI, V83, P57, DOI 10.1016/j.meatsci.2009.03.015; Mutalib SA, 2012, SAINS MALAYS, V41, P199; Park JK, 2007, KOREAN J FOOD SCI AN, V27, P209, DOI 10.5851/kosfa.2007.27.2.209; Pasqualone A, 1999, EUR FOOD RES TECHNOL, V210, P144, DOI 10.1007/s002170050551; Rahman MM, 2015, FOOD ANAL METHOD, V8, P1598, DOI 10.1007/s12161-015-0090-1; Rahman MM, 2014, MEAT SCI, V97, P404, DOI 10.1016/j.meatsci.2014.03.011; Rashid NRA, 2015, FOOD ADDIT CONTAM A, P1223; Razzak MA, 2015, FOOD ADDIT CONTAM A, V32, P1902, DOI 10.1080/19440049.2015.1087060; Robinson JG, 2002, ORYX, V36, P332, DOI 10.1017/S0030605302000662; Robinson JG, 2000, BIOL RESOURCE MANAGE, P13; Rodriguez MA, 2004, J FOOD PROTECT, V67, P172, DOI 10.4315/0362-028X-67.1.172; Rodriguez MA, 2003, J AGR FOOD CHEM, V51, P1524, DOI 10.1021/jf025784+; Rohman A, 2011, MEAT SCI, V88, P91, DOI 10.1016/j.meatsci.2010.12.007; Saez R, 2004, MEAT SCI, V66, P659, DOI 10.1016/S0309-1740(03)00186-4; Safdar M, 2015, FOOD CHEM, V173, P660, DOI 10.1016/j.foodchem.2014.10.088; Santos A, 2011, APPL BIODIVERSITY PE, V1, P1; Schoppe S., 2011, CHELON RES MONOGR, V5, P1, DOI [DOI 10.3854/CRM.5.053.AMBOINENSIS.V1.2011, 10.3854/crm.5.053.amboinensis.v1.2011]; Schoppe S, 2008, NDF WORKSH CAS STUD; Schoppe S, 2008, CASE STUDY, V2; Shackell GH, 2008, INT J FOOD SCI TECH, V43, P2134, DOI 10.1111/j.1365-2621.2008.01812.x; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sonnante G, 2009, J AGR FOOD CHEM, V57, P10199, DOI 10.1021/jf902624z; Spinks PQ, 2012, MOL PHYLOGENET EVOL, V63, P656, DOI 10.1016/j.ympev.2012.02.014; Still J, 2003, COMPLEMENT THER MED, V11, P118, DOI 10.1016/S0965-2299(03)00055-4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Wolf C, 2000, LEBENSM-WISS TECHNOL, V33, P144, DOI 10.1006/fstl.2000.0630; Wu JH, 2009, J MICROBIOL METH, V77, P267, DOI 10.1016/j.mimet.2009.03.001; WWF, 2015, THE START ONLINE NEW; Xu JH, 2007, FOOD AGR IMMUNOL, V18, P83, DOI 10.1080/09540100701327781; Yang I, 2005, ANAL BIOCHEM, V338, P192, DOI 10.1016/j.ab.2004.09.035	101	15	15	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0163436	10.1371/journal.pone.0163436	http://dx.doi.org/10.1371/journal.pone.0163436			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716792	Green Submitted, gold, Green Published			2022-12-27	WOS:000385698100007
J	Zielinska, E; Tukaj, C; Radomski, MW; Inkielewicz-Stepniak, I				Zielinska, Ewelina; Tukaj, Cecylia; Radomski, Marek Witold; Inkielewicz-Stepniak, Iwona			Molecular Mechanism of Silver Nanoparticles-Induced Human Osteoblast Cell Death: Protective Effect of Inducible Nitric Oxide Synthase Inhibitor	PLOS ONE			English	Article							OXIDATIVE STRESS; FUNCTIONAL-ROLE; APOPTOSIS; TOXICITY; BONE; CYTOTOXICITY; DIFFERENTIATION; EXPRESSION; AUTOPHAGY; ANTIBACTERIAL	Background Silver nanoparticles (AgNPs) show strong antibacterial properties, making them excellent candidates to be used in orthopaedic repair and regeneration. However, there are concerns regarding the cytotoxicity of AgNPs and molecular mechanisms underlying AgNPs-induced bone cells toxicity have not been elucidated. Therefore, the aim of our study was to explore mechanisms of AgNPs-induced osteoblast cell death with particular emphasis on the role of nitric oxide (NO) generated by inducible nitric oxide synthase (iNOS). Methods and Result Silver nanoparticles used in this study were 18.3+/-2.6 nm in size, uncoated, spherical, regular shape and their zeta potential was -29.1+/-2.4 mV as measured by transmission electron microscopy (TEM) and zetasizer. The release of silver (Ag) from AgNPs was measured in cell culture medium by atomic absorption spectroscopy (AAS). The exposure of human osteoblast cells (hFOB 1.19) to AgNPs at concentration of 30 or 60 mu g/mL for 24 or 48 hours, respectively resulted in cellular uptake of AgNPs and changes in cell ultrastructure. These changes were associated with apoptosis and necrosis as shown by flow cytometry and lactate dehydrogenase (LDH) assay as well as increased levels of pro-apoptotic Bax and decreased levels of anti-apoptotic Bcl-2 mRNA and protein. Importantly, we have found that AgNPs elevated the levels of nitric oxide (NO) with concomitant upregulation of inducible nitric oxide synthase (iNOS) mRNA and protein. A significant positive correlation was observed between the concentration of AgNPs and iNOS at protein and mRNA level (r = 0.837, r = 0.721, respectively; p< 0.001). Finally, preincubation of osteoblast cells with N-iminoethyl-L-lysine (L-NIL), a selective iNOS inhibitor, as well as treating cells with iNOS small interfering RNAs (siRNA) significantly attenuated AgNPs-induced apoptosis and necrosis. Moreover, we have found that AgNPs-induced cells death is not related to Ag dissolution is cell culture medium. Conclusion These results unambiguously demonstrate that increased expression of iNOS and generation of NO as well as NO-derived reactive species is involved in AgNPs-induced osteoblast cell death. Our findings may help in development of new strategies to protect bone from AgNPs-induced cytotoxicity and increase the safety of orthopaedic tissue repair.	[Zielinska, Ewelina; Inkielewicz-Stepniak, Iwona] Med Univ Gdansk, Dept Med Chem, Gdansk, Poland; [Tukaj, Cecylia] Med Univ Gdansk, Dept Electron Microscopy, Gdansk, Poland; [Radomski, Marek Witold] Univ Saskatchewan, Coll Med, Saskatoon, SK, Canada; [Radomski, Marek Witold] Kardiomed Silesia, Zabrze, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Saskatchewan	Inkielewicz-Stepniak, I (corresponding author), Med Univ Gdansk, Dept Med Chem, Gdansk, Poland.	iinkiel@gumed.edu.pl		Inkielewicz-Stepniak, Iwona/0000-0003-1676-2723	Medical University of Gdansk, Poland [St-46]	Medical University of Gdansk, Poland(Medical University Gdansk)	This work was supported by the Grant St-46 from the Medical University of Gdansk, Poland.	Ahamed M, 2010, TOXICOL APPL PHARM, V242, P263, DOI 10.1016/j.taap.2009.10.016; Albers CE, 2013, NANOTOXICOLOGY, V7, P30, DOI 10.3109/17435390.2011.626538; Beer C, 2012, TOXICOL LETT, V208, P286, DOI 10.1016/j.toxlet.2011.11.002; Bentz M, 2012, J CELL BIOCHEM, V113, P2256, DOI 10.1002/jcb.24096; Berry CC, 2007, IEEE T NANOBIOSCI, V6, P262, DOI 10.1109/TNB.2007.908973; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brune B, 1999, CELL DEATH DIFFER, V6, P969, DOI 10.1038/sj.cdd.4400582; Chang CC, 2006, J ORTHOP RES, V24, P1917, DOI 10.1002/jor.20244; Chen RM, 2005, J ORTHOP RES, V23, P462, DOI 10.1016/j.orthres.2004.08.011; Chen RM, 2002, J ORTHOP RES, V20, P295, DOI 10.1016/S0736-0266(01)00086-9; Choi JE, 2010, AQUAT TOXICOL, V100, P151, DOI 10.1016/j.aquatox.2009.12.012; CONNOR JR, 1995, EUR J PHARMACOL, V273, P15, DOI 10.1016/0014-2999(94)00672-T; Corbalan JJ, 2011, INT J NANOMED, V6, P2821, DOI 10.2147/IJN.S25071; Da Rocha FAC, 2002, J BONE MINER RES, V17, P434, DOI 10.1359/jbmr.2002.17.3.434; Damoulis PD, 1997, J BONE MINER RES, V12, P412, DOI 10.1359/jbmr.1997.12.3.412; Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006; Fukada SY, 2008, J DENT RES, V87, P1155, DOI 10.1177/154405910808701207; Gao Y, 2007, FLUORIDE, V40, P297; Girase B, 2011, MAT SCI ENG C-MATER, V31, P1759, DOI 10.1016/j.msec.2011.08.007; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gliga AR, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-11; Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001; Halamoda-Kenzaoui B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141593; He W, 2015, RSC ADV, V5, P49809, DOI 10.1039/c5ra06386h; Heinrich TA, 2013, BRIT J PHARMACOL, V169, P1417, DOI 10.1111/bph.12217; Hikiji H, 2000, AM J PHYSIOL-ENDOC M, V278, pE1031, DOI 10.1152/ajpendo.2000.278.6.E1031; Inkielewicz-Stepniak I, 2014, INT J NANOMED, V9, P1677, DOI 10.2147/IJN.S59172; Inkielewicz-Stepniak I, 2012, FOOD CHEM TOXICOL, V50, P583, DOI 10.1016/j.fct.2011.12.015; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Kim SH, 2014, MOL CELL TOXICOL, V10, P173, DOI 10.1007/s13273-014-0019-6; Kim TH, 2012, J BIOMED MATER RES A, V100A, P1033, DOI 10.1002/jbm.a.34053; Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022; Lai JCK, 2008, INT J NANOMED, V3, P533; Laskin DL, 1996, ENVIRON HEALTH PERSP, V104, P1283, DOI 10.2307/3433177; Lee SK, 2009, BIOL PHARM BULL, V32, P1328, DOI 10.1248/bpb.32.1328; Lee YH, 2014, BIOMATERIALS, V35, P4706, DOI 10.1016/j.biomaterials.2014.02.021; Lu WT, 2010, CHEM PHYS LETT, V487, P92, DOI 10.1016/j.cplett.2010.01.027; Ma J, 2015, REGEN BIOMATER, V2, P71, DOI 10.1093/rb/rbu020; MacPherson H, 1999, BONE, V24, P179, DOI 10.1016/S8756-3282(98)00173-2; Mishra AR, 2016, TOXICOL SCI, V150, P473, DOI 10.1093/toxsci/kfw011; Mitchell R, 2010, ROBBINS AND COTRAN P; Mohanty S, 2012, NANOMED-NANOTECHNOL, V8, P916, DOI 10.1016/j.nano.2011.11.007; Nguyen KC, 2013, J PHYS CONF SER, V429, DOI 10.1088/1742-6596/429/1/012025; Niska K, 2015, TOXICOL IN VITRO, V29, P663, DOI 10.1016/j.tiv.2015.02.004; Niska K, 2015, INT J NANOMED, V10, P1095, DOI 10.2147/IJN.S73557; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Park EJ, 2010, ENVIRON TOXICOL PHAR, V30, P162, DOI 10.1016/j.etap.2010.05.004; Pascarelli NA, 2013, J APPL TOXICOL, V33, P1506, DOI 10.1002/jat.2912; Pauksch L, 2014, ACTA BIOMATER, V10, P439, DOI 10.1016/j.actbio.2013.09.037; Peran M, 2013, MATERIALS, V6, P1333, DOI 10.3390/ma6041333; RADOMSKI MW, 1993, THROMB HAEMOSTASIS, V70, P36; Ragaseema VM, 2012, BIOMATERIALS, V33, P3083, DOI 10.1016/j.biomaterials.2012.01.005; Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x; Ramirez-Lee MA, 2014, TOXICOL LETT, V224, P246, DOI 10.1016/j.toxlet.2013.10.027; RIANCHO JA, 1995, J BONE MINER RES, V10, P439; Roy R, 2014, TOXICOL LETT, V227, P29, DOI 10.1016/j.toxlet.2014.02.024; Sabuncuoglu S, 2012, PHARMACOLOGY, V89, P283, DOI 10.1159/000337040; Samberg M, 2012, NANOMEDICINE-UK, V7, P1197, DOI [10.2217/nnm.12.18, 10.2217/NNM.12.18]; Samberg ME, 2010, ENVIRON HEALTH PERSP, V118, P407, DOI 10.1289/ehp.0901398; Satyavani Kaliyamurthi, 2012, Avicenna Journal of Medical Biotechnology, V4, P35; Saura M, 2010, THESCIENTIFICWORLDJO, V10, P624, DOI 10.1100/tsw.2010.58; Sengstock C, 2014, BEILSTEIN J NANOTECH, V5, P2058, DOI 10.3762/bjnano.5.214; Shirwaiker RA, 2013, WIRES NANOMED NANOBI, V5, P191, DOI 10.1002/wnan.1201; Smith CCT, 2011, J CELL MOL MED, V15, P1797, DOI 10.1111/j.1582-4934.2011.01341.x; Stoehr LC, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-36; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Suresh AK, 2012, LANGMUIR, V28, P2727, DOI 10.1021/la2042058; Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13; Tautzenberger A, 2012, INT J NANOMED, V7, P4545, DOI 10.2147/IJN.S34127; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Wu H, 2015, BIOMATERIALS, V62, P47, DOI 10.1016/j.biomaterials.2015.05.033; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Yue Peng-Fei, 2008, PDA J Pharm Sci Technol, V62, P32; Zhang R, 2015, NANOMEDICINE; Zhang XF, 2015, INT J NANOMED, V10, P1335, DOI 10.2147/IJN.S76062	77	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164137	10.1371/journal.pone.0164137	http://dx.doi.org/10.1371/journal.pone.0164137			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716791	Green Submitted, Green Published, gold			2022-12-27	WOS:000385698100026
J	Huebinger, J; Han, HM; Grabenbauer, M				Huebinger, Jan; Han, Hong-Mei; Grabenbauer, Markus			Reversible Cryopreservation of Living Cells Using an Electron Microscopy Cryo-Fixation Method	PLOS ONE			English	Article							RAPID FREEZING SPRF; PULLED STRAW OPS; VITREOUS SECTIONS; HUMAN OOCYTES; VITRIFICATION PROPERTIES; CELLULAR ULTRASTRUCTURE; CRYOELECTRON MICROSCOPY; ETHYLENE-GLYCOL; MOUSE OOCYTES; EMBRYOS	Rapid cooling of aqueous solutions is a useful approach for two important biological applications: (I) cryopreservation of cells and tissues for long-term storage, and (II) cryofixation for ultrastructural investigations by electron and cryo-electron microscopy. Usually, both approaches are very different in methodology. Here we show that a novel, fast and easy to use cryofixation technique called self-pressurized rapid freezing (SPRF) is-after some adaptations-also a useful and versatile technique for cryopreservation. Sealed metal tubes with high thermal diffusivity containing the samples are plunged into liquid cryogen. Internal pressure builds up reducing ice crystal formation and therefore supporting reversible cryopreservation through vitrification of cells. After rapid rewarming of pressurized samples, viability rates of >90% can be reached, comparable to best-performing of the established rapid cooling devices tested. In addition, the small SPRF tubes allow for space-saving sample storage and the sealed containers prevent contamination from or into the cryogen during freezing, storage, or thawing.	[Huebinger, Jan; Han, Hong-Mei; Grabenbauer, Markus] Max Planck Inst Mol Physiol, Dept System Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany; [Grabenbauer, Markus] Heidelberg Univ, Inst Anat & Cell Biol, Neuenheimer Feld 307, D-69120 Heidelberg, Germany	Max Planck Society; Ruprecht Karls University Heidelberg	Grabenbauer, M (corresponding author), Max Planck Inst Mol Physiol, Dept System Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.; Grabenbauer, M (corresponding author), Heidelberg Univ, Inst Anat & Cell Biol, Neuenheimer Feld 307, D-69120 Heidelberg, Germany.	grabenbauer@uni-heidelberg.de		Grabenbauer, Markus/0000-0002-9156-5968	Max-Planck/Fraunhofer interdisciplinary project 'CryoSystems'	Max-Planck/Fraunhofer interdisciplinary project 'CryoSystems'	This study was funded by Max-Planck/Fraunhofer interdisciplinary project 'CryoSystems'.; The excellent technical support of Sabine Dongard, Anette Langerak, Petra Glitz and Bernd Fieber is gratefully acknowledged. This study was funded by Max-Planck/Fraunhofer interdisciplinary project 'CryoSystems'.	Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010; Berthelot F, 2000, CRYOBIOLOGY, V41, P116, DOI 10.1006/cryo.2000.2273; Bielanski A, 2012, THERIOGENOLOGY, V77, P467, DOI 10.1016/j.theriogenology.2011.07.043; Bouchet-Marquis C, 2008, J MICROSC-OXFORD, V230, P308, DOI 10.1111/j.1365-2818.2008.01988.x; Buser C, 2008, J MICROSC-OXFORD, V230, P268, DOI 10.1111/j.1365-2818.2008.01984.x; Cha Soo Kyung, 2011, Clin Exp Reprod Med, V38, P24, DOI 10.5653/cerm.2011.38.1.24; Cobo A, 2012, FERTIL STERIL, V97, P74, DOI 10.1016/j.fertnstert.2011.10.006; Criado E, 2011, FERTIL STERIL, V95, P1777, DOI 10.1016/j.fertnstert.2010.12.044; Dubochet J, 2012, J MICROSC-OXFORD, V245, P221, DOI 10.1111/j.1365-2818.2011.03569.x; Edgar DH, 2012, HUM REPROD UPDATE, V18, P536, DOI 10.1093/humupd/dms016; GILKEY JC, 1986, J ELECTRON MICR TECH, V3, P177, DOI 10.1002/jemt.1060030206; Gomis J, 2013, CRYOBIOLOGY, V66, P144, DOI 10.1016/j.cryobiol.2012.12.009; Grabenbauer M, 2014, METHODS MOL BIOL, V1117, P173, DOI 10.1007/978-1-62703-776-1_9; Gualtieri R, 2011, HUM REPROD, V26, P2452, DOI 10.1093/humrep/der210; Han HM, 2012, J STRUCT BIOL, V178, P84, DOI 10.1016/j.jsb.2012.04.001; He XM, 2008, CRYOBIOLOGY, V56, P223, DOI 10.1016/j.cryobiol.2008.03.005; Huebinger J, 2016, BIOPHYS J, V110, P840, DOI 10.1016/j.bpj.2015.09.029; Iwayama H, 2004, ZYGOTE, V12, P333, DOI 10.1017/S0967199404002928; Kuleshova LL, 1999, CRYOBIOLOGY, V38, P119, DOI 10.1006/cryo.1999.2153; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Leunissen JLM, 2009, J MICROSC-OXFORD, V235, P25, DOI 10.1111/j.1365-2818.2009.03178.x; Liu Y, 2008, CRYOLETTERS, V29, P315; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159; Mikus H, 2016, BIOCHEM BIOPH RES CO, V477, P401, DOI 10.1016/j.bbrc.2016.06.089; Miyata K, 2012, CRYOBIOLOGY, V65, P113, DOI 10.1016/j.cryobiol.2012.05.002; MOOR H, 1971, PHILOS T R SOC B, V261, P121, DOI 10.1098/rstb.1971.0042; MOOR H, 1980, CELL TISSUE RES, V209, P201; Pedro PB, 1997, CRYOBIOLOGY, V35, P150, DOI 10.1006/cryo.1997.2034; Pegg DE, 2015, METHODS MOL BIOL, V1257, P3, DOI 10.1007/978-1-4939-2193-5_1; Pierson J, 2010, J STRUCT BIOL, V169, P219, DOI 10.1016/j.jsb.2009.10.001; POLGE C, 1949, NATURE, V164, P666, DOI 10.1038/164666a0; Preciado JA, 2010, CRYOBIOLOGY, V60, P23, DOI 10.1016/j.cryobiol.2009.06.010; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Rubinsky B, 2005, CRYOBIOLOGY, V50, P121, DOI 10.1016/j.cryobiol.2004.12.002; Schiewe MC, 2015, CRYOBIOLOGY, V71, P264, DOI 10.1016/j.cryobiol.2015.07.009; Seki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036058; Seki S, 2009, CRYOBIOLOGY, V59, P75, DOI 10.1016/j.cryobiol.2009.04.012; Shaw JM, 1997, CRYOBIOLOGY, V35, P219, DOI 10.1006/cryo.1997.2043; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; TEDDER RS, 1995, LANCET, V346, P137, DOI 10.1016/S0140-6736(95)91207-X; Vajta G, 1998, MOL REPROD DEV, V51, P53, DOI 10.1002/(SICI)1098-2795(199809)51:1&lt;53::AID-MRD6&gt;3.0.CO;2-V; Vajta G, 1995, VET REC, V137, P672; Santos MV, 2014, CRYOBIOLOGY, V69, P488, DOI 10.1016/j.cryobiol.2014.10.010; Wowk B, 2010, CRYOBIOLOGY, V60, P11, DOI 10.1016/j.cryobiol.2009.05.007; Wusteman MC, 2003, CRYOBIOLOGY, V46, P135, DOI 10.1016/S0011-2240(03)00019-1; Yakovlev S, 2011, J MICROSC-OXFORD, V244, P235, DOI 10.1111/j.1365-2818.2011.03530.x	47	10	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164270	10.1371/journal.pone.0164270	http://dx.doi.org/10.1371/journal.pone.0164270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711254	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600110
J	Maphisa, DH; Smit-Robinson, H; Underhill, LG; Altwegg, R				Maphisa, David H.; Smit-Robinson, Hanneline; Underhill, Les G.; Altwegg, Res			Drivers of Bird Species Richness within Moist High-Altitude Grasslands in Eastern South Africa	PLOS ONE			English	Article							MPUMALANGA PROVINCE; HABITAT USE; FIRE; CONSERVATION; WILDLIFE; IMPACT; NEST; HETEROGENEITY; VEGETATION; DIVERSITY	Moist high-altitude grasslands in South Africa are renowned for high avifaunal diversity and are priority areas for conservation. Conservation management of these areas conflicts with management for other uses, such as intensive livestock agriculture, which requires annual burning and leads to heavy grazing. Recently the area has become target for water storage schemes and renewable electricity energy projects. There is therefore an urgent need to investigate environmental factors and habitat factors that affect bird species richness in order to optimise management of those areas set aside for conservation. A particularly good opportunity to study these issues arose at Ingula in the eastern South African high-altitude grasslands. An area that had been subject to intense grazing was bought by the national power utility that constructed a pumped storage scheme on part of the land and set aside the rest for bird conservation. Since the new management took over in 2005 the area has been mostly annually burned with relatively little grazing. The new management seeks scientific advice on how to maintain avian species richness of the study area. We collected bird occurrence and vegetation data along random transects between 2006 and 2010 to monitor the impact of the new management, and to study the effect of the habitat changes on bird species richness. To achieve these, we convert bird transect data to presence only data to investigate how bird species richness were related to key transect vegetation attributes under this new grassland management. First we used generalised linear mixed models, to examine changes in vegetation grass height and cover and between burned and unburned habitats. Secondly, we examined how total bird species richness varied across seasons and years. And finally we investigated which habitat vegetation attributes were correlated with species richness of a group of grassland depended bird species only. Transects that were burned showed a larger decrease in vegetation cover compared to transects that were not burned. Grass height increased over time. Bird species richness was highest in summer compared to other seasons and increased over time. Overall bird species richness increased over the three summer surveys but species richness of birds that prefer heavily grazed habitat showed little change over the three years. Changes in bird species richness were best explained by the model with grass height for combined species richness of grassland depended birds but also for birds that prefer heavy grazing when treated alone. On one hand birds that prefer moderate grazing were best explained by a null model. However, overall bird species richness was better positively correlated to grass height than grass cover or dead grass. We conclude that frequent burning alone with relatively reduced grazing led to higher but less dense grass, which benefited some species and disadvantaged others. We suggest that management of this grassland use combination of fire and grazing and leave some areas unburned to accommodates birds of various habitat needs.	[Maphisa, David H.] South African Natl Biodivers Inst, Private Bag X7, ZA-7735 Claremont, South Africa; [Maphisa, David H.; Altwegg, Res] Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7701 Rondebosch, South Africa; [Maphisa, David H.; Underhill, Les G.] Univ Cape Town, Anim Demog Unit, Dept Biol Sci, ZA-7701 Rondebosch, South Africa; [Smit-Robinson, Hanneline] BirdLife South Africa, Private Bag X5000, ZA-2121 Parklands, South Africa; [Smit-Robinson, Hanneline] UNISA, ABEERU, Private Bag X6, ZA-1717 Florida, South Africa; [Altwegg, Res] Univ Cape Town, African Climate & Dev Initiat, ZA-7701 Rondebosch, South Africa	South African National Biodiversity Institute; University of Cape Town; University of Cape Town; University of South Africa; University of Cape Town	Maphisa, DH (corresponding author), South African Natl Biodivers Inst, Private Bag X7, ZA-7735 Claremont, South Africa.; Maphisa, DH (corresponding author), Univ Cape Town, Dept Stat Sci, Stat Ecol Environm & Conservat, ZA-7701 Rondebosch, South Africa.; Maphisa, DH (corresponding author), Univ Cape Town, Anim Demog Unit, Dept Biol Sci, ZA-7701 Rondebosch, South Africa.	Maphisad@gmail.com		Underhill, Les/0000-0002-8758-1527	Eskom through The Ingula Partnership; Mazda Wildlife Fund; South African National Biodiversity Institute; National Research Foundation of South Africa [85802]	Eskom through The Ingula Partnership; Mazda Wildlife Fund; South African National Biodiversity Institute; National Research Foundation of South Africa(National Research Foundation - South Africa)	The first author was supported in the position of BirdLife South Africa Ingula Project Manager with funding by Eskom through The Ingula Partnership. The Mazda Wildlife Fund supported the first author with a vehicle for the duration of the project, while employed by BirdLife South Africa. South African National Biodiversity Institute provided funding during the data analysis and writing up of this paper. RA was supported by the National Research Foundation of South Africa (Grant 85802). The NRF accepts no liability for opinions, findings and conclusions or recommendations expressed in this publication. I confirm that the funders (Ingula Partnership/Mazda Wildlife) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan DG, 1997, BIOL CONSERV, V79, P173, DOI 10.1016/S0006-3207(96)00098-5; Anderson DR, 2001, J WILDLIFE MANAGE, V65, P373, DOI 10.2307/3803088; Asner GP, 2009, P NATL ACAD SCI USA, V106, P4947, DOI 10.1073/pnas.0810637106; Barnes K. N., 1998, IMPORTANT BIRD AREAS; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BELSKY JA, 1992, J VEG SCI, V3, P187, DOI 10.2307/3235679; BERRUTI A, 1994, OSTRICH, V65, P54, DOI 10.1080/00306525.1994.9639666; Blank PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109989; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cao J, 2009, BIOMETRICS, V65, P1052, DOI 10.1111/j.1541-0420.2009.01204.x; Carrascal L, 2009, ANIMAL BIODIVERSITY, V2, P45; Ceballos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008562; Coppedge BR, 2008, BIOL CONSERV, V141, P1196, DOI 10.1016/j.biocon.2008.02.015; Culbert PD, 2012, REMOTE SENS ENVIRON, V118, P140, DOI 10.1016/j.rse.2011.11.004; DAVIES B. R., 1998, VANISHING WATERS; Drewitt AL, 2006, IBIS, V148, P29, DOI 10.1111/j.1474-919X.2006.00516.x; Fairbanks DHK, 2000, S AFR J SCI, V96, P69; Fisher RJ, 2010, J WILDLIFE MANAGE, V74, P265, DOI 10.2193/2009-020; Frankow-Lindberg BE, 2009, ANN BOT-LONDON, V103, P913, DOI 10.1093/aob/mcp008; Fuhlendorf SD, 2006, ECOL APPL, V16, P1706, DOI 10.1890/1051-0761(2006)016[1706:SHBTBF]2.0.CO;2; Fuhlendorf SD, 2009, CONSERV BIOL, V23, P588, DOI 10.1111/j.1523-1739.2008.01139.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Griebel Randall L., 1998, Great Plains Research, V8, P255; Hardman CJ, 2016, J APPL ECOL, V53, P171, DOI 10.1111/1365-2664.12557; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hofmeyr SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096772; Hovick TJ, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00340.1; Howland B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105966; Jansen R, 1999, BIODIVERS CONSERV, V8, P587, DOI 10.1023/A:1008817415103; Jenkins AR, 2010, BIRD CONSERV INT, V20, P263, DOI 10.1017/S0959270910000122; Johnson CJ, 2004, J APPL ECOL, V41, P1032, DOI 10.1111/j.0021-8901.2004.00975.x; Johnson RR, 2010, J FISH WILDL MANAG, V1, P38, DOI 10.3996/JFWM-022; Kery M, 2006, J APPL ECOL, V43, P101, DOI 10.1111/j.1365-2664.2005.01111.x; Kery M, 2009, ECOLOGY, V90, P1279, DOI 10.1890/07-1794.1; Klug PE, 2010, OECOLOGIA, V162, P803, DOI 10.1007/s00442-009-1549-9; Kruger SC, 2014, BIRD CONSERV INT, V24, P162, DOI 10.1017/S0959270913000440; Little IT, 2013, BIOL CONSERV, V158, P258, DOI 10.1016/j.biocon.2012.09.017; Maphisa DH, 2009, OSTRICH, V80, P19, DOI 10.2989/OSTRICH.2009.80.1.3.761; Maphisa DH, 2015, THESIS; Maphisa DH, 1997, VULTURES 21 CENTURY, P90; Marques TA, 2007, AUK, V124, P1229, DOI 10.1642/0004-8038(2007)124[1229:IEOBDU]2.0.CO;2; Martin TG, 2005, J APPL ECOL, V42, P400, DOI 10.1111/j.1365-2664.2005.01012.x; McGrann MC, 2014, AVIAN CONSERV ECOL, V9, DOI 10.5751/ACE-00695-090208; Mentis MT., 2006, BRAAMHOEK PUMPED STO; Muchai M, 2005, J AVIAN BIOL, V36, P110, DOI 10.1111/j.0908-8857.2005.03312.x; Mucina L., 2006, VEGETATION S AFRICA; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nichols JD, 1998, ECOL APPL, V8, P1213, DOI 10.2307/2640974; O'Connor TG, 2009, J ENVIRON MANAGE, V90, P384, DOI 10.1016/j.jenvman.2007.10.012; Parr CL, 2003, AUSTRAL ECOL, V28, P384, DOI 10.1046/j.1442-9993.2003.01296.x; Pearce-Higgins JW, 2009, J APPL ECOL, V46, P1323, DOI 10.1111/j.1365-2664.2009.01715.x; Pillsbury FC, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00154.1; Prince K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117850; R Development Core Team, R LANG ENV STAT COMP; Renner SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112347; Reyers B., 2001, Diversity and Distributions, V7, P79, DOI 10.1046/j.1472-4642.2001.00098.x; Reynolds C, 2013, AFR ZOOL, V48, P228, DOI 10.3377/004.048.0217; Simmons RE, 2005, GABAR, V16, P25; Spurr E.B., 2012, NZ J ECOLOGY, V36, P1; Svensson M, 2013, PLOS ONE, V8, P1; Taylor M. R., 2015, RED DATA BOOK TAJIKI; Thiele J., 2012, CAB Reviews, V7, P1, DOI [10.1079/PAVSNNR20127017, 10.1079/PAVSNNR20127020, 10.1079/PAVSNNR20127016, 10.1079/PAVSNNR20127018, 10.1079/PAVSNNR20127019]; Trollope WSW, 2011, FIRE ECOL, V7, P57, DOI 10.4996/fireecology.0701057; Valko O, 2014, AGR ECOSYST ENVIRON, V182, P80, DOI 10.1016/j.agee.2013.06.012; Valko O, 2014, BASIC APPL ECOL, V15, P26, DOI 10.1016/j.baae.2013.11.002; White CS, 2010, J RANGE MANAGE, V53, P52; Whittingham MJ, 2008, BASIC APPL ECOL, V9, P779, DOI 10.1016/j.baae.2007.08.002	68	7	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162609	10.1371/journal.pone.0162609	http://dx.doi.org/10.1371/journal.pone.0162609			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706186	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200015
J	Spielmann, KA; Peeples, MA; Glowacki, DM; Dugmore, A				Spielmann, Katherine A.; Peeples, Matthew A.; Glowacki, Donna M.; Dugmore, Andrew			Early Warning Signals of Social Transformation: A Case Study from the US Southwest	PLOS ONE			English	Article							MESA VERDE REGION; CRITICAL TRANSITIONS; CLIMATE-CHANGE; SLOWING-DOWN; COLLAPSE; SOCIETIES; VILLAGE; SUSTAINABILITY; ARCHAEOLOGY; RESILIENCE	Recent research in ecology suggests that generic indicators, referred to as early warning signals (EWS), may occur before significant transformations, both critical and non-critical, in complex systems. Up to this point, research on EWS has largely focused on simple models and controlled experiments in ecology and climate science. When humans are considered in these arenas they are invariably seen as external sources of disturbance or management. In this article we explore ways to include societal components of socio-ecological systems directly in EWS analysis. Given the growing archaeological literature on 'collapses,' or transformations, in social systems, we investigate whether any early warning signals are apparent in the archaeological records of the build-up to two contemporaneous cases of social transformation in the prehistoric US Southwest, Mesa Verde and Zuni. The social transformations in these two cases differ in scope and severity, thus allowing us to explore the contexts under which warning signals may (or may not) emerge. In both cases our results show increasing variance in settlement size before the transformation, but increasing variance in social institutions only before the critical transformation in Mesa Verde. In the Zuni case, social institutions appear to have managed the process of significant social change. We conclude that variance is of broad relevance in anticipating social change, and the capacity of social institutions to mitigate transformation is critical to consider in EWS research on socio-ecological systems.	[Spielmann, Katherine A.; Peeples, Matthew A.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Glowacki, Donna M.] Univ Notre Dame, Dept Anthropol, Notre Dame, IN USA; [Dugmore, Andrew] Univ Edinburgh, Sch Geosci, Inst Geog & Lived Environm, Edinburgh, Midlothian, Scotland	Arizona State University; Arizona State University-Tempe; University of Notre Dame; University of Edinburgh	Spielmann, KA (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	kate.spielmann@asu.edu		Peeples, Matthew/0000-0003-4496-623X	National Science Foundation [BCS-9043134, BCS-0119981]; Wenner-Gren Foundation [09094295]; Office of Polar Programs (OPP) [1140106] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funded by National Science Foundation (http://www.nsf.org/) BCS-9043134. MAP is co-PI on this grant with Keith Kintigh. The Zuni settlement data used for the analyses in this paper were acquired in part through this funding. The Wenner-Gren Foundation (http.//www.wennergren.org), 09094295. MAP is the PI on this grant. The Zuni settlement data used for the analyses in this paper were acquired in part through this funding. Research funded by the National Science Foundation (http://www.nsf.org/) BCS-0119981 to Timothy Kohler (lead PI) in part acquired the Mesa Verde settlement data used in the analyses in this manuscript. The specific analyses for and preparation of this manuscript were not supported by external funding.	ADLER MA, 1990, WORLD ARCHAEOL, V22, P133, DOI 10.1080/00438243.1990.9980136; [Anonymous], 2010, LEAVING MESA VERDE P; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Bocinsky RK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501532; Brandt E. A., 1994, ANCIENT SW COMMUNITY, P9; Brandt EA, 1977, FLOWERS WIND PAPERS, P11; Brandt Elizabeth, 1980, SECRECY CROSS CULTUR, P123; Brock WA, 2010, ECOL MONOGR, V80, P353, DOI 10.1890/09-1824.1; Brock W.A., 2008, COMPLEXITY THEORY SU, P180; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Costanza R, 2007, AMBIO, V36, P522, DOI 10.1579/0044-7447(2007)36[522:SOCWCW]2.0.CO;2; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041010, 10.1371/journal.pone.0045586]; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Ditlevsen PD, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044486; Duff Andrew I., 2007, HINTERLANDS REGIONAL, P185; Ferguson T. J., 1985, A ZUNI ATLAS; Folke C, 2002, AMBIO, V31, P437, DOI 10.1639/0044-7447(2002)031[0437:RASDBA]2.0.CO;2; Glowacki D. M., 2015, LIVING LEAVING SOCIA; Glowacki DM, 2012, ORIG HUM BEHAV, V6, P219; GrissinoMayer HD, 1996, TREE RINGS, ENVIRONMENT AND HUMANITY, P191; Kefi S, 2013, OIKOS, V122, P641, DOI 10.1111/j.1600-0706.2012.20838.x; Kintigh K.W., 1996, KIVA, V61, P257; Kintigh Keith W., 1985, SETTLEMENT SUBSISTEN, P1; Kintigh KW, 2004, AM ANTIQUITY, V69, P432, DOI 10.2307/4128401; Kuckelman KA, 2010, AM ANTIQUITY, V75, P497, DOI 10.7183/0002-7316.75.3.497; Lekson S.H., 2007, ARCHITECTURE CHACO C, P7; LEKSON SH, 1995, J ANTHROPOL ARCHAEOL, V14, P184, DOI 10.1006/jaar.1995.1010; Lipe WilliamD., 2002, SEEKING CTR PLACE AR, P203; Lipe WillianD., 1999, COLORADO PREHISTORY; MCANANY Patricia, 2009, QUESTIONING COLLAPSE; Nelson MC, 2016, P NATL ACAD SCI USA, V113, P298, DOI 10.1073/pnas.1506494113; Nelson MC, 2010, ECOL SOC, V15; Ortiz Alfonso, 1969, TEWA WORLD SPACE TIM; Ortman SG, 2007, AM ANTIQUITY, V72, P241, DOI 10.2307/40035813; Peeples M. A, 2011, THESIS; Peeples MA, 2012, J ARCHAEOL SCI, V39, P2818, DOI 10.1016/j.jas.2012.04.040; Peeples Matthew A., 2014, ARIZONA STATE MUSEUM, V209, P93; Schachner Gregson, 2012, POPULATION CIRCULATI; Scheffer M, 2003, ECOSYSTEMS, V6, P493, DOI 10.1007/s10021-002-0146-0; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schwindt DM, 2016, AM ANTIQUITY, V81, P74, DOI 10.7183/0002-7316.81.1.74; Tainter JA, 2006, ANNU REV ANTHROPOL, V35, P59, DOI 10.1146/annurev.anthro.35.081705.123136; Turner BL, 2012, P NATL ACAD SCI USA, V109, P13908, DOI 10.1073/pnas.1210106109; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Van West CarlaR., 2000, KIVA, V66, P19, DOI DOI 10.1080/00231940.2000.11758420; Van West CR, 2005, ENV STUDIES, V3; Van West CR, 1994, PULLMAN DEP ANTHR RE, V67; Varien M., 1999, SEDENTISM MOBILITY S; Varien M. D., 1996, PREHISTORIC PUEBLO W, P86; Varien MD, 2007, AM ANTIQUITY, V72, P273, DOI 10.2307/40035814; Walker B, 2004, ECOL SOC, V9; Ware JA., 2014, PUEBLO SOCIAL HIST K; Watson PJ, 1980, J FIELD ARCHAEOL, V7, P201, DOI DOI 10.1179/009346980791505536; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470; Wright A., 2010, LEAVING MESA VERDE P, P180; Wright AM., 2010, LEAVING MESA VERDE P, P75	59	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163685	10.1371/journal.pone.0163685	http://dx.doi.org/10.1371/journal.pone.0163685			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706200	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200054
J	Ye, CY; Zhang, W; Wu, WG; Xu, MY; Nonso, NS; He, RX				Ye, Chenyi; Zhang, Wei; Wu, Weigang; Xu, Mingyuan; Nonso, Nwofor Samuel; He, Rongxin			Influence of the Infrapatellar Fat Pad Resection during Total Knee Arthroplasty: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							PATELLAR TENDON LENGTH; STATISTICAL-METHODS; HETEROGENEITY; COMPLICATIONS; OSTEOARTHRITIS; PRESERVATION; EXCISION; OUTCOMES	Background To enhance surgical exposure, resection of the infrapatellar fat pad (IPFP) is usually a routine procedure in total knee arthroplasty (TKA). However, there is conflicting evidence regarding whether IPFP resection during TKA impairs clinical outcome. We performed a systematic review and meta-analysis to clarify the influence of IPFP resection on primary TKA. Methods Embase, PubMed, and the Cochrane Library were systematically searched up to August 2016 to identify relevant studies. All clinical studies comparing IPFP resection (IPFP-R) and IPFP preservation (IPFP-P) in patients undergoing primary TKA were obtained. The meta-analysis was performed with Revman 5.3 and STATA 12.0 software. The weighted mean was estimated by using random effects (RE) models with 95% CIs, heterogeneity was assessed using the H statistic and the inconsistency index (I-2). Results Seven studies involving 2,734 patients (3,258 knees) were included. IPFP resection trended to increase the incidence of postoperative anterior knee pain within 2 months post-operatively, compared with patients in whom the IPFP was preserved (odds ratio [OR]s 2.12[0.95, 4.73], p = 0.07). An increased incidence of anterior knee pain was observed in the IPFP resection group >12 months postoperatively, but the difference was not significant (OR, 3.69 [0.81, 16.82], p = 0.07). In addition, a trend towards more shortening of the patellar tendon was also observed in the IPFP-R group. No significant results were found regarding postoperative knee function. Conclusion These results suggest that preserving the IPFP may be superior to IPFP resection in patients undergoing primary TKA, due to the relatively lower rate of anterior knee pain after short-term follow-up.	[Ye, Chenyi; Zhang, Wei; Wu, Weigang; Nonso, Nwofor Samuel; He, Rongxin] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthoped Surg, Hangzhou 310009, Zhejiang, Peoples R China; [Xu, Mingyuan] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Plast Surg, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	He, RX (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthoped Surg, Hangzhou 310009, Zhejiang, Peoples R China.	herongxin666@163.com			National Natural Science Foundation of China [81572124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81572124). The funder has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson GD, 1997, AM J OBSTET GYNECOL, V177, P1413, DOI 10.1016/S0002-9378(97)70084-X; [Anonymous], 2005, NZ J PHYSIOTHER, V33, P19; [Anonymous], 2004, NATL JOINT REGISTRY; Bao JP, 2010, MOL BIOL REP, V37, P3265, DOI 10.1007/s11033-009-9911-x; Bastiaansen-Jenniskens YM, 2012, ANN RHEUM DIS, V71, P288, DOI 10.1136/ard.2011.153858; Bohnsack M, 2005, KNEE SURG SPORT TR A, V13, P135, DOI 10.1007/s00167-004-0561-1; Bohnsack M, 2004, AM J SPORT MED, V32, P1873, DOI 10.1177/0363546504263946; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Clockaerts S, 2012, ANN RHEUM DIS, V71, P642, DOI 10.1136/annrheumdis-2011-200092; Clockaerts S, 2010, OSTEOARTHR CARTILAGE, V18, P876, DOI 10.1016/j.joca.2010.03.014; Colombel M, 1998, SURG RADIOL ANAT, V20, P35, DOI 10.1007/s00276-998-0035-0; DANDY DJ, 1994, J BONE JOINT SURG BR, V76B, P198, DOI 10.1302/0301-620X.76B2.8113275; de Carvalho PP, 2014, J TISSUE ENG REGEN M, V8, P757, DOI 10.1002/term.1565; Dragoo JL, 2012, SPORTS MED, V42, P51, DOI 10.2165/11595680-000000000-00000; Erickson BJ, 2016, ORTHOPEDICS, V39, P32, DOI 10.3928/01477447-20151218-06; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Gallagher J, 2005, KNEE SURG SPORT TR A, V13, P268, DOI 10.1007/s00167-004-0592-7; Gandhi R, 2006, J ARTHROPLASTY, V21, P46, DOI 10.1016/j.arth.2005.06.004; Gwyn R, 2016, Eur J Orthop Surg Traumatol, V26, P545, DOI 10.1007/s00590-016-1775-x; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOZACK WJ, 1988, CLIN ORTHOP RELAT R, P123; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; KAYLER DE, 1988, CLIN ORTHOP RELAT R, P221; Kontopantelis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069930; Kontopantelis E, 2012, STAT METHODS MED RES, V21, P409, DOI 10.1177/0962280210392008; Lemon M, 2007, J ARTHROPLASTY, V22, P574, DOI 10.1016/j.arth.2006.04.026; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Macule Francisco, 2005, Acta Orthop Belg, V71, P714; Mandalia V, 2008, J BONE JOINT SURG BR, V90B, P265, DOI 10.1302/0301-620X.90B3.20140; Meneghini RM, 2007, J ARTHROPLASTY, V22, P47, DOI 10.1016/j.arth.2007.03.031; Mittlbock M, 2006, STAT MED, V25, P4321, DOI 10.1002/sim.2692; MOCHIZUKI RM, 1979, J BONE JOINT SURG AM, V61, P879, DOI 10.2106/00004623-197961060-00012; MORELAND JR, 1988, CLIN ORTHOP RELAT R, P49; Moverley R, 2014, INT ORTHOP, V38, P2483, DOI 10.1007/s00264-014-2427-6; NOYES FR, 1991, CLIN ORTHOP RELAT R, P241; Ohashi K, 2012, BIOCHIMIE, V94, P2137, DOI 10.1016/j.biochi.2012.06.008; Pawar U, 2009, J ARTHROPLASTY, V24, P636, DOI 10.1016/j.arth.2008.02.017; Pinsornsak P, 2014, CLIN ORTHOP RELAT R, V472, P695, DOI 10.1007/s11999-013-3321-z; Saddik D, 2004, SKELETAL RADIOL, V33, P433, DOI 10.1007/s00256-003-0724-z; Seo JG, 2015, ARCH ORTHOP TRAUM SU, V135, P1157, DOI 10.1007/s00402-015-2233-7; Seo SS KC, 2010, J BONE JOINT SURG B, V92; Sivrioglu Ali Kemal, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-008795; Subramanyam Padma, 2012, Avicenna J Med, V2, P54; Tanaka N, 2003, J ARTHROPLASTY, V18, P897, DOI 10.1016/S0883-5403(03)00271-7; Van Beeck A, 2013, KNEE, V20, P226, DOI 10.1016/j.knee.2013.01.005; Walter SD, 2007, J CLIN EPIDEMIOL, V60, P849, DOI 10.1016/j.jclinepi.2006.11.003; Weale AE, 1999, J BONE JOINT SURG BR, V81B, P790, DOI 10.1302/0301-620X.81B5.9590; White L, 2016, ARCH ORTHOP TRAUM SU, V136, P701, DOI 10.1007/s00402-016-2440-x; White L, 2015, ADV ORTHOP SURG, V2015, P1, DOI [10.1155/2015/817906, DOI 10.1155/2015/817906]; Wojtys E M, 1997, Instr Course Lect, V46, P241	51	13	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163515	10.1371/journal.pone.0163515	http://dx.doi.org/10.1371/journal.pone.0163515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706208	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200047
J	Umu, OCO; Bauerl, C; Oostindjer, M; Pope, PB; Hernandez, PE; Perez-Martinez, G; Diep, DB				Umu, Ozgun C. O.; Bauerl, Christine; Oostindjer, Marije; Pope, Phillip B.; Hernandez, Pablo E.; Perez-Martinez, Gaspar; Diep, Dzung B.			The Potential of Class II Bacteriocins to Modify Gut Microbiota to Improve Host Health	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; LACTOCOCCUS-GARVIEAE DCC43; ENTEROCOCCUS-FAECIUM L50; CLOSTRIDIUM-DIFFICILE; DIET; DIVERSITY; SEQUENCES; OBESITY; STRAIN; MECHANISMS	Production of bacteriocins is a potential probiotic feature of many lactic acid bacteria (LAB) as it can help prevent the growth of pathogens in gut environments. However, knowledge on bacteriocin producers in situ and their function in the gut of healthy animals is still limited. In this study, we investigated five bacteriocin-producing strains of LAB and their isogenic non-producing mutants for probiotic values. The LAB bacteriocins, sakacin A (SakA), pediocin PA-1 (PedPA-1), enterocins P, Q and L50 (enterocins), plantaricins EF and JK (plantaricins) and garvicin ML (GarML), are all class II bacteriocins, but they differ greatly from each other in terms of inhibition spectrum and physicochemical properties. The strains were supplemented to mice through drinking water and changes on the gut microbiota composition were interpreted using 16S rRNA gene analysis. In general, we observed that overall structure of the gut microbiota remained largely unaffected by the treatments. However, at lower taxonomic levels, some transient but advantageous changes were observed. Some potentially problematic bacteria were inhibited (e.g., Staphylococcus by enterocins, Enterococcaceae by GarML, and Clostridium by plantaricins) and the proportion of LAB was increased in the presence of SakA-, plantaricins- and GarML-producing bacteria. Moreover, the treatment with GarML-producing bacteria co-occurred with decreased triglyceride levels in the host mice. Taken together, our results indicate that several of these bacteriocin producers have potential probiotic properties at diverse levels as they promote favorable changes in the host without major disturbance in gut microbiota, which is important for normal gut functioning.	[Umu, Ozgun C. O.; Oostindjer, Marije; Pope, Phillip B.; Diep, Dzung B.] Norwegian Univ Life Sci NMBU, Dept Chem Biotechnol & Food Sci, As, Norway; [Bauerl, Christine; Perez-Martinez, Gaspar] CSIC, IATA, Dept Biotecnol, Valencia, Spain; [Hernandez, Pablo E.] Univ Complutense Madrid, Fac Vet, Dept Nutr Bromatol & Tecnol Alimentos, Madrid, Spain	Norwegian University of Life Sciences; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Complutense University of Madrid	Diep, DB (corresponding author), Norwegian Univ Life Sci NMBU, Dept Chem Biotechnol & Food Sci, As, Norway.	dzung.diep@nmbu.no	Martinez, Gaspar Perez/H-4167-2012; Pope, Phillip/AAQ-2251-2021; Diệp, Dzũng/ABG-9262-2020; Bäuerl, Christine/A-4334-2017; Hernandez, Pablo E./P-8701-2014; Diep, Dzung B./AAK-1419-2021	Martinez, Gaspar Perez/0000-0003-3501-1626; Pope, Phillip/0000-0002-2067-4059; Bäuerl, Christine/0000-0002-5226-9920; Hernandez, Pablo E./0000-0001-6259-8456; Diep, Dzung/0000-0001-7661-5501; Onarman Umu, Ozgun Candan/0000-0003-4060-7766	Norwegian University of Life Sciences (NMBU) [1205051025]; Spanish Ministerio de Economia y Competitividad [AGL2013-47420-R]; European Research Council [336355-MicroDE]; EEA Coordinated Mobility of Researchers NILS Science and Sustainability Project [017-CM-01-2013]	Norwegian University of Life Sciences (NMBU); Spanish Ministerio de Economia y Competitividad(Spanish Government); European Research Council(European Research Council (ERC)European Commission); EEA Coordinated Mobility of Researchers NILS Science and Sustainability Project	OCOU was supported by a strategic scholarship program to food science research, from Norwegian University of Life Sciences (NMBU) (project 1205051025). CB and part of this work was supported by a contract financed by the Spanish Ministerio de Economia y Competitividad (AGL2013-47420-R). PBP is supported by a grant from the European Research Council (336355-MicroDE). Travels and stays in Spain and Norway for this study were supported by EEA Coordinated Mobility of Researchers NILS Science and Sustainability Project 017-CM-01-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11; Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bhardwaj A, 2010, INT J FOOD MICROBIOL, V141, P156, DOI 10.1016/j.ijfoodmicro.2010.05.001; Bien J, 2013, THER ADV GASTROENTER, V6, P53, DOI 10.1177/1756283X12454590; Borrero J, 2011, APPL ENVIRON MICROB, V77, P369, DOI 10.1128/AEM.01173-10; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Collado MC, 2010, AM J CLIN NUTR, V92, P1023, DOI 10.3945/ajcn.2010.29877; Chang YH, 2001, ANTON LEEUW INT J G, V80, P193, DOI 10.1023/A:1012213728917; Cintas LM, 1998, J BACTERIOL, V180, P1988, DOI 10.1128/JB.180.8.1988-1994.1998; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clarke SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065790; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Criado R, 2006, APPL ENVIRON MICROB, V72, P6653, DOI 10.1128/AEM.00859-06; Dabour N, 2009, INT J FOOD MICROBIOL, V133, P225, DOI 10.1016/j.ijfoodmicro.2009.05.005; DAESCHEL M A, 1990, Food Microbiology (London), V7, P91, DOI 10.1016/0740-0020(90)90014-9; de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Desbonnet L, 2015, BRAIN BEHAV IMMUN, V48, P165, DOI 10.1016/j.bbi.2015.04.004; Diep DB, 2000, MICROBIOL-SGM, V146, P2155, DOI 10.1099/00221287-146-9-2155; Diep DB, 2009, PEPTIDES, V30, P1562, DOI 10.1016/j.peptides.2009.05.014; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eijsink VGH, 2002, ANTON LEEUW INT J G, V81, P639, DOI 10.1023/A:1020582211262; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Gabrielsen C, 2014, J BACTERIOL, V196, P911, DOI 10.1128/JB.01115-13; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; HOLZAPFEL WH, 1995, INT J FOOD MICROBIOL, V24, P343, DOI 10.1016/0168-1605(94)00036-6; Illumina, 16S MET SEQ LIB PREP, P1; JACK RW, 1995, MICROBIOL REV, V59, P171, DOI 10.1128/MMBR.59.2.171-200.1995; Jeffery IB, 2013, NUTRIENTS, V5, P234, DOI 10.3390/nu5010234; Kjos M, 2011, MICROBIOL-SGM, V157, P3256, DOI 10.1099/mic.0.052571-0; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Kles KA, 2006, GASTROENTEROLOGY, V130, pS100, DOI 10.1053/j.gastro.2005.11.048; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524; Kwok LY, 2015, BENEF MICROBES, V6, P405, DOI 10.3920/BM2014.0063; La Rosa SL, 2013, APPL ENVIRON MICROB, V79, P3986, DOI 10.1128/AEM.00831-13; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Luoto R, 2013, ANN NUTR METAB, V63, P17, DOI 10.1159/000354896; Magnusson J, 2001, APPL ENVIRON MICROB, V67, P1, DOI 10.1128/AEM.67.1.1-5.2001; Malys MK, 2015, MEDICINA-LITHUANIA, V51, P69, DOI 10.1016/j.medici.2015.03.001; MARUGG JD, 1992, APPL ENVIRON MICROB, V58, P2360, DOI 10.1128/AEM.58.8.2360-2367.1992; Millette M, 2008, APPL ENVIRON MICROB, V74, P1997, DOI 10.1128/AEM.02150-07; Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172; Mota-Meira M, 2005, J ANTIMICROB CHEMOTH, V56, P869, DOI 10.1093/jac/dki295; Nes IF, 2007, FOOD SCI BIOTECHNOL, V16, P675; O'Toole Paul W, 2008, Interdiscip Perspect Infect Dis, V2008, P175285, DOI 10.1155/2008/175285; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pessione E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00086; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rea MC, 2013, J MED MICROBIOL, V62, P1369, DOI 10.1099/jmm.0.058933-0; Rea MC, 2011, P NATL ACAD SCI USA, V108, P4639, DOI 10.1073/pnas.1001224107; Riboulet-Bisson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031113; SCHILLINGER U, 1989, APPL ENVIRON MICROB, V55, P1901, DOI 10.1128/AEM.55.8.1901-1906.1989; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Umu OCO, 2013, ANTON LEEUW INT J G, V104, P609, DOI 10.1007/s10482-013-0008-0; Walsh MC, 2008, FEMS MICROBIOL ECOL, V64, P317, DOI 10.1111/j.1574-6941.2008.00454.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112	72	68	71	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164036	10.1371/journal.pone.0164036	http://dx.doi.org/10.1371/journal.pone.0164036			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695121	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000385553100078
J	Baroy, T; Chilamakuri, CSR; Lorenz, S; Sun, JC; Bruland, OS; Myklebost, O; Meza-Zepeda, LA				Baroy, Tale; Chilamakuri, Chandra S. R.; Lorenz, Susanne; Sun, Jinchang; Bruland, Oyvind S.; Myklebost, Ola; Meza-Zepeda, Leonardo A.			Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene	PLOS ONE			English	Article							HIGH-GRADE OSTEOSARCOMA; P-GLYCOPROTEIN EXPRESSION; STUDY-GROUP PROTOCOLS; RAB ESCORT PROTEIN-1; MULTIDRUG-RESISTANCE; NUCLEAR TRANSLOCATION; CISPLATIN RESISTANCE; SOMATIC ALTERATIONS; CLONAL EVOLUTION; PATIENT SURVIVAL	Osteosarcoma (OS) is the most common primary malignant tumor of bone, showing complex chromosomal rearrangements but with few known consistent changes. Deeper biological understanding is crucial to find new therapies to improve patient survival. We have sequenced the whole exome of two primary tumors (before and after chemotherapy), one metastatic tumor and a matched normal sample from two OS patients, to identify mutations involved in cancer biology. The metastatic samples were also RNA sequenced. By RNA sequencing we identified dysregulated expression levels of drug resistance- and apoptosis-related genes. Two fusion transcripts were identified in one patient (OS111); the first resulted in p53 inactivation by fusing the first exon of TP53 to the fifth exon of FAM45A. The second fusion joined the two first exons of FGFR1 to the second exon of ZNF343. Furthermore, FGFR1 was amplified and highly expressed, representing a potential treatment target in this patient. Whole exome sequencing revealed large intertumor heterogeneity, with surprisingly few shared mutations. Careful evaluation and validation of the data sets revealed a number of artefacts, but one recurrent mutation was validated, a nonsense mutation in CHM (patient OS106), which also was the mutation with the highest expression frequency (53%). The second patient (OS111) had wild-type CHM, but a downregulated expression level. In a panel of 71 clinical samples, we confirmed significant low expression of CHM compared to the controls (p = 0.003). Furthermore, by analyzing public datasets, we identified a significant association between low expression and poor survival in two other cancer types. Together, these results suggest CHM as a candidate tumor suppressor gene that warrants further investigation.	[Baroy, Tale; Chilamakuri, Chandra S. R.; Lorenz, Susanne; Sun, Jinchang; Myklebost, Ola; Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, NO-0310 Oslo, Norway; [Baroy, Tale; Bruland, Oyvind S.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Bruland, Oyvind S.] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, NO-0310 Oslo, Norway; [Chilamakuri, Chandra S. R.; Lorenz, Susanne; Sun, Jinchang; Myklebost, Ola; Meza-Zepeda, Leonardo A.] Norwegian Canc Genom Consortium, Oslo, Norway; [Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Genom Core Facil,Dept Core Facil, NO-0310 Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Meza-Zepeda, LA (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Tumor Biol, NO-0310 Oslo, Norway.; Meza-Zepeda, LA (corresponding author), Norwegian Canc Genom Consortium, Oslo, Norway.; Meza-Zepeda, LA (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Genom Core Facil,Dept Core Facil, NO-0310 Oslo, Norway.	leonardo.meza-zepeda@rr-research.no	Meza-Zepeda, Leonardo Andres/CAG-5229-2022	Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X; Bruland, Oyvind Sverre/0000-0003-1631-3733	Oslo University; Oslo University Hospital; Norwegian Research Council [218241]; Norwegian Cancer Society [PR-2007-0163]	Oslo University; Oslo University Hospital; Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	TB, OSB and OM were financed by Oslo University and Oslo University Hospital. SL, JS, CSRC and LAMZ were financed by Oslo University Hospital. The work was further supported by the Norwegian Research Council (grant 218241) and the Norwegian Cancer Society (grant PR-2007-0163). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Amary MF, 2014, CANCER MED-US, V3, P980, DOI 10.1002/cam4.268; Amelio I, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.9; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Assaraf YG, 2007, CANCER METAST REV, V26, P153, DOI 10.1007/s10555-007-9049-z; Bauer JA, 2007, INT J RADIAT ONCOL, V69, pS106, DOI 10.1016/j.ijrobp.2007.05.080; Berner Kjetil, 2015, Sarcoma, V2015, P516843, DOI 10.1155/2015/516843; Berner K, 2015, ACTA ONCOL, V54, P25, DOI 10.3109/0284186X.2014.923934; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Brambilla D, 2012, INT J CANCER, V130, P2824, DOI 10.1002/ijc.26285; Buddingh EP, 2011, CLIN CANCER RES, V17, P2110, DOI 10.1158/1078-0432.CCR-10-2047; Caronia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026091; Chan HSL, 1997, J NATL CANCER I, V89, P1706, DOI 10.1093/jnci/89.22.1706; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chen ZS, 2002, CANCER RES, V62, P3144; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Chioni AM, 2012, J CELL BIOL, V197, P801, DOI 10.1083/jcb.201108077; Chou AJ, 2006, EXPERT REV ANTICANC, V6, P1075, DOI 10.1586/14737140.6.7.1075; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Coleman SJ, 2014, EMBO MOL MED, V6, P467, DOI 10.1002/emmm.201302698; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; de Anta JM, 2006, ANTI-CANCER DRUG, V17, P1171, DOI 10.1097/01.cad.0000236311.73703.d2; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; DORFMAN HD, 1995, CANCER, V75, P203, DOI 10.1002/1097-0142(19950101)75:1+<203::AID-CNCR2820751308>3.0.CO;2-V; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goody RS, 2005, CELL MOL LIFE SCI, V62, P1657, DOI 10.1007/s00018-005-4486-8; Gorlick R, 1996, NEW ENGL J MED, V335, P1041, DOI 10.1056/NEJM199610033351408; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Guo W, 1999, CLIN CANCER RES, V5, P621; Heikkinen T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3076; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Holzmann K, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/950508; Horgan CP, 2011, BIOCHEM SOC T, V39, P1202, DOI 10.1042/BST0391202; Hornicek FJ, 2000, CLIN ORTHOP RELAT R, P11, DOI 10.1097/00003086-200004000-00003; HOU JZ, 1991, SCIENCE, V251, P665, DOI 10.1126/science.1846977; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kruh GD, 2001, J BIOENERG BIOMEMBR, V33, P493, DOI 10.1023/A:1012827221844; Kuijjer ML, 2013, INT J CANCER, V133, P2512, DOI 10.1002/ijc.28124; Kuijjer ML, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-66; Lorenz S, 2016, ONCOTARGET, V7, P5273, DOI 10.18632/oncotarget.6567; Mackall CL, 2002, CANCER CELL, V2, P175, DOI 10.1016/S1535-6108(02)00132-0; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meier B, 2014, GENOME RES, V24, P1624, DOI 10.1101/gr.175547.114; Myers JM, 2003, J CELL BIOCHEM, V88, P1273, DOI 10.1002/jcb.10476; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Nguyen PT, 2013, BRIT J CANCER, V109, P2248, DOI 10.1038/bjc.2013.550; Ohta T, 2001, TERATOGEN CARCIN MUT, V21, P275, DOI 10.1002/tcm.1015; Osmak M, 1998, NEOPLASMA, V45, P223; Pakos EE, 2003, CANCER-AM CANCER SOC, V98, P581, DOI 10.1002/cncr.11546; Pasello M, 2008, CANCER RES, V68, P6661, DOI 10.1158/0008-5472.CAN-07-5840; Pasello M, 2011, ANAL CELL PATHOL, V34, P131, DOI [10.1155/2011/414985, 10.3233/ACP-2011-012]; Posthuma de Boer J, 2013, ONCOL DISCOV, V8, DOI [10.7243/2052-6199-1-4, DOI 10.7243/2052-6199-1-8, DOI 10.7243/2052-6199-1-4]; Ribi S, 2015, ONCOTARGET, V6, P7727, DOI 10.18632/oncotarget.3115; Schwartz CL, 2007, J CLIN ONCOL, V25, P2057, DOI 10.1200/JCO.2006.07.7776; SCOTLANDI K, 1994, INT J CANCER, V58, P95, DOI 10.1002/ijc.2910580116; Serra M, 2003, J CLIN ONCOL, V21, P536, DOI 10.1200/JCO.2003.03.144; Strunnikova NV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008402; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Vignot S, 2013, J CLIN ONCOL, V31, P2167, DOI 10.1200/JCO.2012.47.7737; Weekes D, 2016, ONCOGENE, V35, P2852, DOI 10.1038/onc.2015.344; Whelan JS, 2015, ANN ONCOL, V26, P407, DOI 10.1093/annonc/mdu526; Xie T, 2014, GENOMICS, V104, P234, DOI 10.1016/j.ygeno.2014.07.012; Yang C, 2009, APOPTOSIS, V14, P124, DOI 10.1007/s10495-008-0282-x; Zeng H, 2001, CANCER RES, V61, P7225; Zhang J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-146; Zhou D, 2013, ASIAN PAC J CANCER P, V14, P929, DOI 10.7314/APJCP.2013.14.2.929	73	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2016	11	9							e0163859	10.1371/journal.pone.0163859	http://dx.doi.org/10.1371/journal.pone.0163859			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CV	27685995	Green Submitted, Green Published, gold			2022-12-27	WOS:000384328500130
J	Backenroth, D; Chase, H; Friedman, C; Wei, Y				Backenroth, Daniel; Chase, Herbert; Friedman, Carol; Wei, Ying			Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug Reactions	PLOS ONE			English	Article							SIGNAL-DETECTION	Recent research has suggested that the case-control study design, unlike the self-controlled study design, performs poorly in controlling confounding in the detection of adverse drug reactions (ADRs) from administrative claims and electronic health record (EHR) data, resulting in biased estimates of the causal effects of drugs on health outcomes of interest (HOI) and inaccurate confidence intervals. Here we show that using rich data on comorbidities and automatic variable selection strategies for selecting confounders can better control confounding within a case-control study design and provide a more solid basis for inference regarding the causal effects of drugs on HOIs. Four HOIs are examined: acute kidney injury, acute liver injury, acute myocardial infarction and gastrointestinal ulcer hospitalization. For each of these HOIs we use a previously published reference set of positive and negative control drugs to evaluate the performance of our methods. Our methods have AUCs that are often substantially higher than the AUCs of a baseline method that only uses demographic characteristics for confounding control. Our methods also give confidence intervals for causal effect parameters that cover the expected no effect value substantially more often than this baseline method. The case-control study design, unlike the self- controlled study design, can be used in the fairly typical setting of EHR databases without longitudinal information on patients. With our variable selection method, these databases can be more effectively used for the detection of ADRs.	[Backenroth, Daniel; Wei, Ying] Columbia Univ, Dept Biostat, New York, NY 10027 USA; [Chase, Herbert; Friedman, Carol] Columbia Univ, Dept Biomed Informat, New York, NY USA	Columbia University; Columbia University	Backenroth, D (corresponding author), Columbia Univ, Dept Biostat, New York, NY 10027 USA.	db2175@cumc.columbia.edu			U.S. National Library of Medicine [R01:LM010016]; NATIONAL LIBRARY OF MEDICINE [T15LM007079, R01LM010016] Funding Source: NIH RePORTER	U.S. National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	CF is supported by the U.S. National Library of Medicine (https://www.nlm.nih.gov/) grant number R01:LM010016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Baraldi Olga, 2015, World J Nephrol, V4, P511, DOI 10.5527/wjn.v4.i5.511; Bate A, 2009, PHARMACOEPIDEM DR S, V18, P427, DOI 10.1002/pds.1742; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; Gould L., 2014, STAT METHODS EVALUAT, DOI [10.1002/9781118763070, DOI 10.1002/9781118763070]; JACOBY RM, 1992, J AM COLL CARDIOL, V20, P736, DOI 10.1016/0735-1097(92)90033-J; Li Y, 2015, DRUG SAFETY, V38, P895, DOI 10.1007/s40264-015-0314-8; Li Y, 2014, J AM MED INFORM ASSN, V21, P308, DOI 10.1136/amiajnl-2013-001718; Lin KJ, 2016, CLIN PHARMACOL THER, V100, P147, DOI 10.1002/cpt.359; Madigan D, 2014, ANNU REV STAT APPL, V1, P11, DOI 10.1146/annurev-statistics-022513-115645; Madigan D, 2013, DRUG SAFETY, V36, pS73, DOI 10.1007/s40264-013-0105-z; Meyboom RHB, 1997, DRUG SAFETY, V16, P355, DOI 10.2165/00002018-199716060-00002; Murff HJ, 2011, JAMA-J AM MED ASSOC, V306, P848, DOI 10.1001/jama.2011.1204; Nelson SJ, 2011, J AM MED INFORM ASSN, V18, P441, DOI 10.1136/amiajnl-2011-000116; Petejova N, 2013, BIOMED PAP, V157, P105, DOI 10.5507/bp.2013.048; Reich CG, 2013, DRUG SAFETY, V36, pS181, DOI 10.1007/s40264-013-0111-1; Rosenbaum PR, 2010, SPRINGER SER STAT, P327, DOI 10.1007/978-1-4419-1213-8_19; Ryan PB, 2013, DRUG SAFETY, V36, pS143, DOI 10.1007/s40264-013-0108-9; Ryan PB, 2013, DRUG SAFETY, V36, pS33, DOI 10.1007/s40264-013-0097-8; Schneeweiss S, 2007, MED CARE, V45, pS131, DOI 10.1097/MLR.0b013e318070c08e; Weber FL, 1996, DIGEST DIS, V14, P53; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164304	10.1371/journal.pone.0164304	http://dx.doi.org/10.1371/journal.pone.0164304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716785	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100042
J	Cseplo, P; Vamos, Z; Ivic, I; Torok, O; Toth, A; Koller, A				Cseplo, Peter; Vamos, Zoltan; Ivic, Ivan; Torok, Orsolya; Toth, Attila; Koller, Akos			The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+](i)	PLOS ONE			English	Article							PROPRANOLOL-INDUCED RELAXATION; FLOW-DEPENDENT DILATION; NITRIC-OXIDE; SKELETAL-MUSCLE; BLOOD-FLOW; ENDOTHELIAL DYSFUNCTION; EUROPEAN-SOCIETY; BASILAR ARTERY; MYOGENIC TONE; BETA-BLOCKER	Rationale Nebivolol is known to have beta-1 blocker activity, but it was also suggested that it elicits relaxation of the peripheral arteries in part via release of nitric oxide (NO). However, the effect of nebivolol on the vasomotor tone of cerebral arteries is still unclear. Objective To assess the effects of nebivolol on the diameter of isolated rat basilar arteries (BA) in control, in the presence of inhibitors of vasomotor signaling pathways of know action and hemolysed blood. Methods and Results Vasomotor responses were measured by videomicroscopy and the intracellular Ca 2+ by the Fura-2 AM ratiometric method. Under control conditions, nebivolol elicited a substantial dilation of the BA (from 216+/-22 to 394+/-20 mu m; p< 0.05) in a concentration-dependent manner (10(-7) to 10(-4) M). The dilatation was significantly reduced by endothelium denudation or by L-NAME (inhibitor of NO synthase) or by SQ22536 (adenylyl cyclase blocker). Dilatation of BA was also affected by beta-2 receptor blockade with butoxamine, but not by the guanylate cyclase blocker ODQ. Interestingly, beta-1 blockade by atenolol inhibited nebivololinduced dilation. Also, the BKCa channel blocker iberiotoxin and KCa channel inhibitor TEA significantly reduced nebivolol-induced dilation. Nebivolol significantly reduced smooth muscle Ca 2+ level, which correlated with the increases in diameters and moreover it reversed the hemolysed blood-induced constriction of BA. Conclusions Nebivolol seems to have an important dilator effect in cerebral arteries, which is mediated via several vasomotor mechanisms, converging on the reduction of smooth muscle Ca2+ levels. As such, nebivolol may be effective to improve cerebral circulation in various diseased conditions, such as hemorrhage.	[Cseplo, Peter; Vamos, Zoltan; Ivic, Ivan; Torok, Orsolya; Koller, Akos] Univ Pecs, Sch Med, Inst Translat Med, Pecs, Hungary; [Cseplo, Peter; Vamos, Zoltan; Ivic, Ivan; Torok, Orsolya; Koller, Akos] Univ Pecs, Szentagothai Res Ctr, Sch Med, Pecs, Hungary; [Cseplo, Peter] Petz Aladar Cty Teaching Hosp, Dept Cent Anesthesiol & Intens Therapy, Gyor, Hungary; [Vamos, Zoltan] Univ Pecs, Sch Med, Dept Anaesthesiol & Intens Therapy, Pecs, Hungary; [Ivic, Ivan] Univ Pecs, Sch Med, Dept Anat, Pecs, Hungary; [Toth, Attila] Univ Debrecen, Fac Med, Inst Cardiol, Div Clin Physiol, Debrecen, Hungary; [Koller, Akos] Univ Pecs, Sch Med, Dept Neurosurg, Pecs, Hungary; [Koller, Akos] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Koller, Akos] Univ Phys Educ, Inst Nat Sci, Budapest, Hungary	University of Pecs; University of Pecs; University of Pecs; University of Pecs; University of Debrecen; University of Pecs; New York Medical College; University of Physical Education	Koller, A (corresponding author), Univ Pecs, Sch Med, Inst Translat Med, Pecs, Hungary.; Koller, A (corresponding author), Univ Pecs, Szentagothai Res Ctr, Sch Med, Pecs, Hungary.; Koller, A (corresponding author), Univ Pecs, Sch Med, Dept Neurosurg, Pecs, Hungary.; Koller, A (corresponding author), New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA.; Koller, A (corresponding author), Univ Phys Educ, Inst Nat Sci, Budapest, Hungary.	koller.akos@tf.hu	Ákos, Koller/Q-4672-2019; Tóth, Attila/F-4859-2010	Tóth, Attila/0000-0001-6503-3653; Torok, Orsolya/0000-0001-8317-066X	Hungarian National Research Fund (OTKA) [K108444]; FP7 Marie Curie project Small Artery Remodeling (SmART) ITN; National Excellence Program [SROP-4.2.4.N2-11-1-2012-0001]; Hungarian Hypertension Society (MHT); Hungarian Society of Anaesthesiology and Intensive Therapy - Wittek Award	Hungarian National Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); FP7 Marie Curie project Small Artery Remodeling (SmART) ITN; National Excellence Program; Hungarian Hypertension Society (MHT); Hungarian Society of Anaesthesiology and Intensive Therapy - Wittek Award	This work was supported by the Hungarian National Research Fund (OTKA K108444, A. Koller), FP7 Marie Curie project Small Artery Remodeling (SmART) ITN (I. Ivic, A. Koller), SROP-4.2.4.N2-11-1-2012-0001 "National Excellence Program" (P. Cseplo), Hungarian Hypertension Society (MHT) 2012-2015 (A. Koller), Hungarian Society of Anaesthesiology and Intensive Therapy - Wittek Award 2014-2015 (P. Cseplo).	Andresen J, 2006, J APPL PHYSIOL, V100, P318, DOI 10.1152/japplphysiol.00937.2005; BARER DH, 1988, BRIT MED J, V296, P737, DOI 10.1136/bmj.296.6624.737; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BOWMAN AJ, 1994, BRIT J CLIN PHARMACO, V38, P199, DOI 10.1111/j.1365-2125.1994.tb04342.x; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cekic EG, 2013, VASC PHARMACOL, V58, P307, DOI 10.1016/j.vph.2012.12.004; Cockcroft J, 2007, VASC HEALTH RISK MAN, V3, P909; COCKCROFT JR, 1995, J PHARMACOL EXP THER, V274, P1067; Cosentino F, 2001, J CARDIOVASC PHARM, V38, pS75, DOI 10.1097/00005344-200111002-00018; Cosentino F, 2002, J HYPERTENS, V20, P421, DOI 10.1097/00004872-200203000-00017; Cseplo P, 2017, J NEUROTRAUM, V34, P529, DOI 10.1089/neu.2015.4365; Czikora A, 2012, BRIT J PHARMACOL, V165, P1801, DOI 10.1111/j.1476-5381.2011.01645.x; de Boer RA, 2007, EXPERT OPIN PHARMACO, V8, P1539, DOI 10.1517/14656566.8.10.1539; Dessy C, 2005, CIRCULATION, V112, P1198, DOI 10.1161/CIRCULATIONAHA.104.532960; Evangelista S, 2007, PHARMACOL RES, V55, P303, DOI 10.1016/j.phrs.2006.12.008; FARACI FM, 1990, AM J PHYSIOL, V259, pH1216, DOI 10.1152/ajpheart.1990.259.4.H1216; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; FUJII K, 1991, STROKE, V22, P763, DOI 10.1161/01.STR.22.6.763; GAO YS, 1991, J CARDIOVASC PHARM, V17, P964, DOI 10.1097/00005344-199106000-00016; Georgescu A, 2008, PHARMACOLOGY, V81, P110, DOI 10.1159/000110011; Georgescu A, 2005, EUR J PHARMACOL, V508, P159, DOI 10.1016/j.ejphar.2004.11.043; Grammas P, 2000, ANN NY ACAD SCI, V903, P55, DOI 10.1111/j.1749-6632.2000.tb06350.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hardy P, 1998, CIRC RES, V83, P721, DOI 10.1161/01.RES.83.7.721; Huang A, 2000, AM J PHYSIOL-HEART C, V278, pH762, DOI 10.1152/ajpheart.2000.278.3.H762; Huang A, 2001, AM J PHYSIOL-HEART C, V280, pH2462, DOI 10.1152/ajpheart.2001.280.6.H2462; Ignarro LJ, 2004, BLOOD PRESSURE, V13, P2, DOI 10.1080/08038020410016557; Ignarro LJ, 2002, NITRIC OXIDE-BIOL CH, V7, P75, DOI 10.1016/S1089-8603(02)00112-X; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ignarro LJ, 2008, CARDIOVASC THER, V26, P115, DOI 10.1111/j.1527-3466.2008.00044.x; Illiano S, 1996, BRIT J PHARMACOL, V117, P360, DOI 10.1111/j.1476-5381.1996.tb15199.x; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Jebelovszki E, 2008, AM J PHYSIOL-HEART C, V294, pH2558, DOI 10.1152/ajpheart.01198.2007; Kalinowski L, 2003, CIRCULATION, V107, P2747, DOI 10.1161/01.CIR.0000066912.58385.DE; KATUSIC ZS, 1987, AM J PHYSIOL, V252, pH671, DOI 10.1152/ajpheart.1987.252.3.H671; Kitazawa T, 2009, J PHYSIOL-LONDON, V587, P3587, DOI 10.1113/jphysiol.2009.172189; Knot HJ, 1998, J PHYSIOL-LONDON, V508, P199, DOI 10.1111/j.1469-7793.1998.199br.x; Koller A, 2004, AM J PHYSIOL-HEART C, V287, pH2461, DOI 10.1152/ajpheart.00295.2004; KOLLER A, 1993, CIRC RES, V72, P1276, DOI 10.1161/01.RES.72.6.1276; KOLLER A, 1994, AM J PHYSIOL, V267, pH326, DOI 10.1152/ajpheart.1994.267.1.H326; KOLLER A, 1990, AM J PHYSIOL, V258, pH916, DOI 10.1152/ajpheart.1990.258.3.H916; Koller A, 2012, J VASC RES, V49, P375, DOI 10.1159/000338747; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mistry DK, 1998, BRIT J PHARMACOL, V124, P1131, DOI 10.1038/sj.bjp.0701940; MOHAMED AA, 1985, J CEREBR BLOOD F MET, V5, P26, DOI 10.1038/jcbfm.1985.4; Mollace V, 2005, PHARMACOL REV, V57, P217, DOI 10.1124/pr.57.2.1; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Mulder M, 2013, NEW ENGL J MED, V369, P1274, DOI 10.1056/NEJMc1309586; Nuttall SL, 2003, J CLIN PHARM THER, V28, P179, DOI 10.1046/j.1365-2710.2003.00477.x; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Ogawa N, 2009, AM J PHYSIOL-REG I, V297, pR968, DOI 10.1152/ajpregu.91005.2008; Olah C, 2013, IDEGGYOGY SZEMLE, V66, P273; OSOL G, 1985, AM J PHYSIOL, V249, pH914, DOI 10.1152/ajpheart.1985.249.5.H914; OSOL G, 1991, CIRC RES, V68, P359, DOI 10.1161/01.RES.68.2.359; Paterno R, 1996, STROKE, V27, P1603, DOI 10.1161/01.STR.27.9.1603; Pierre LN, 1999, STROKE, V30, P638, DOI 10.1161/01.STR.30.3.638; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; POOL JL, 1958, JAMA-J AM MED ASSOC, V167, P1599, DOI 10.1001/jama.1958.02990300025005; Prisant LM, 2008, J CLIN PHARMACOL, V48, P225, DOI 10.1177/0091270007310378; Priviero FBM, 2006, CLIN EXP PHARMACOL P, V33, P448, DOI 10.1111/j.1440-1681.2006.04386.x; Quang TT, 2009, BRIT J PHARMACOL, V156, P601, DOI 10.1111/j.1476-5381.2009.00074.x; Ramirez-Rosas MB, 2011, STEROIDS, V76, P409, DOI 10.1016/j.steroids.2010.12.012; SAKANASHI M, 1983, JPN J PHARMACOL, V33, P603, DOI 10.1254/jjp.33.603; Salvemini D, 1996, J CLIN INVEST, V97, P2562, DOI 10.1172/JCI118704; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Salvemini D, 1997, CELL MOL LIFE SCI, V53, P576, DOI 10.1007/s000180050074; Silberstein SD, 2012, NEUROLOGY, V78, P1337, DOI 10.1212/WNL.0b013e3182535d20; Sun D, 2001, MICROVASC RES, V61, P179, DOI 10.1006/mvre.2000.2291; Szekeres M, 2001, J CARDIOVASC PHARM, V38, P584, DOI 10.1097/00005344-200110000-00011; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; Toth P, 2013, AM J PHYSIOL-HEART C, V305, pH1698, DOI 10.1152/ajpheart.00377.2013; Toth P, 2013, BRIT J PHARMACOL, V168, P1878, DOI 10.1111/bph.12079; Toth P, 2011, J CEREBR BLOOD F MET, V31, P2096, DOI 10.1038/jcbfm.2011.74; Tzemos N, 2001, CIRCULATION, V104, P511, DOI 10.1161/hc3001.094207; Ungvari Z, 2000, J CARDIOVASC PHARM, V35, P849, DOI 10.1097/00005344-200006000-00004; Ungvari Z, 1999, STROKE, V30, P1949, DOI 10.1161/01.STR.30.9.1949; Ungvari Z, 2001, MICROCIRCULATION, V8, P265; Veverka A, 2006, ANN PHARMACOTHER, V40, P1353, DOI 10.1345/aph.1G708; Wu BN, 2005, BRIT J PHARMACOL, V146, P862, DOI 10.1038/sj.bjp.0706387; Yarova PL, 2013, BRIT J PHARMACOL, V169, P875, DOI 10.1111/bph.12160; ZIV I, 1992, STROKE, V23, P1014, DOI 10.1161/01.STR.23.7.1014	83	4	4	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164010	10.1371/journal.pone.0164010	http://dx.doi.org/10.1371/journal.pone.0164010			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716772	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100016
J	Kaplan, O; Zarubova, J; Mikulova, B; Filova, E; Bartova, J; Bacakova, L; Brynda, E				Kaplan, Ondrej; Zarubova, Jana; Mikulova, Barbora; Filova, Elena; Bartova, Jirina; Bacakova, Lucie; Brynda, Eduard			Enhanced Mitogenic Activity of Recombinant Human Vascular Endothelial Growth Factor VEGF(121) Expressed in E. coli Origami B (DE3) with Molecular Chaperones	PLOS ONE			English	Article							ANGIOGENIC GENE-THERAPY; ESCHERICHIA-COLI; VEGF-A; FUNCTIONAL EXPRESSION; EXTRACELLULAR-MATRIX; CELL-PROLIFERATION; TYROSINE KINASES; FUSION PROTEINS; PURIFICATION; THIOREDOXIN	We describe the production of a highly-active mutant VEGF variant, alpha(2)-PI1-8-VEGF(121), which contains a substrate sequence for factor XIIIa at the aminoterminus designed for incorporation into a fibrin gel. The alpha(2)-PI1-8-VEGF(121) gene was synthesized, cloned into a pET-32a(+) vector and expressed in Escherichia coli Origami B (DE3) host cells. To increase the protein folding and the solubility, the resulting thioredoxin-alpha(2)-PI1-8-VEGF(121) fusion protein was co-expressed with recombinant molecular chaperones GroES/EL encoded by independent plasmid pGro7. The fusion protein was purified from the soluble fraction of cytoplasmic proteins using affinity chromatography. After cleavage of the thioredoxin fusion part with thrombin, the target protein was purified by a second round of affinity chromatography. The yield of purified alpha(2)-PI1-8-VEGF(121) was 1.4 mg per liter of the cell culture. The alpha(2)-PI1-8-VEGF(121) expressed in this work increased the proliferation of endothelial cells 3.9-8.7 times in comparison with commercially-available recombinant VEGF(121). This very high mitogenic activity may be caused by co-expression of the growth factor with molecular chaperones not previously used in VEGF production. At the same time, alpha(2)-PI1-8-VEGF(121) did not elicit considerable inflammatory activation of human endothelial HUVEC cells and human monocyte-like THP-1 cells.	[Kaplan, Ondrej; Brynda, Eduard] Czech Acad Sci, Inst Macromol Chem, CZ-16206 Prague, Czech Republic; [Kaplan, Ondrej; Zarubova, Jana; Mikulova, Barbora; Filova, Elena; Bacakova, Lucie] Czech Acad Sci, Inst Physiol, CZ-14220 Prague, Czech Republic; [Mikulova, Barbora] Charles Univ Prague, Fac Sci, CZ-12840 Prague, Czech Republic; [Bartova, Jirina] Gen Univ Hosp Prague, Sch Dent Med, CZ-12808 Prague, Czech Republic; [Mikulova, Barbora] Czech Acad Sci, Inst Microbiol, CZ-14220 Prague, Czech Republic	Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; General University Hospital Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Kaplan, O (corresponding author), Czech Acad Sci, Inst Macromol Chem, CZ-16206 Prague, Czech Republic.; Kaplan, O (corresponding author), Czech Acad Sci, Inst Physiol, CZ-14220 Prague, Czech Republic.	ondrej.kaplan@gmail.com	Filova, Elena/C-2209-2012; Kaplan, Ondrej/L-1832-2013; Brynda, Eduard/H-6818-2014; Zárubová, Jana/K-4357-2017; Bacakova, Lucie/C-2664-2012	Zárubová, Jana/0000-0002-9647-9997; Bacakova, Lucie/0000-0002-1818-9484	Ministry of Education, Youth and Sports of the Czech Republic [EE2.30.0029]; Ministry of Education, Youth and Sports of the Czech Republic (National Sustainability Program II Project BIOCEV-FAR) [LQ1604]; BIOCEV project [CZ.1.05/1.1.00/02.0109]; Agency for the Czech Republic Health Research, Ministry of Health of the Czech Republic [15-29153A]; Technology Agency of the Czech Republic [TA04011345]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic (National Sustainability Program II Project BIOCEV-FAR); BIOCEV project; Agency for the Czech Republic Health Research, Ministry of Health of the Czech Republic; Technology Agency of the Czech Republic	This work has been supported by the Ministry of Education, Youth and Sports of the Czech Republic (Grant No. EE2.30.0029 and by National Sustainability Program II Project BIOCEV-FAR LQ1604), by the BIOCEV project (CZ.1.05/1.1.00/02.0109), by the Agency for the Czech Republic Health Research, Ministry of Health of the Czech Republic (Grant No. 15-29153A), and by the Technology Agency of the Czech Republic (grant No. TA04011345).	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; An NF, 2014, ADV CANCER RES, V122, P245, DOI 10.1016/B978-0-12-420117-0.00007-4; Arcondeguy T, 2013, NUCLEIC ACIDS RES, V41, P7997, DOI 10.1093/nar/gkt539; Backer MV, 2001, PROTEIN EXPRES PURIF, V23, P1, DOI 10.1006/prep.2001.1472; Borrelli V, 2001, J SURG RES, V100, P154, DOI 10.1006/jsre.2001.6231; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Costa SJ, 2013, APPL MICROBIOL BIOT, V97, P6779, DOI 10.1007/s00253-012-4559-1; Cui SS, 2011, PROTEIN EXPRES PURIF, V77, P166, DOI 10.1016/j.pep.2011.01.009; Delcombel R, 2013, ANGIOGENESIS, V16, P353, DOI 10.1007/s10456-012-9320-y; Dormond O, 2012, HUM IMMUNOL, V73, P1261, DOI 10.1016/j.humimm.2012.07.334; Dunn LL, 2010, ARTERIOSCL THROM VAS, V30, P2089, DOI 10.1161/ATVBAHA.110.209643; Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; GASDASKA JR, 1995, CELL GROWTH DIFFER, V6, P1643; Gasparian ME, 2009, BIOCHEMISTRY-MOSCOW+, V74, P221, DOI 10.1134/S000629790902014X; Gavilondo JV, 2014, VACCINE, V32, P2241, DOI 10.1016/j.vaccine.2013.11.102; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Heiring C, 2001, PROTEIN ENG, V14, P183, DOI 10.1093/protein/14.3.183; Hendel RC, 2000, CIRCULATION, V101, P118, DOI 10.1161/01.CIR.101.2.118; Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A; Houck K. A., 1991, ENDOCRINOLOGY, V5, P1806, DOI [10.1210/mend-5-12-1806, DOI 10.1210/MEND-5-12-1806]; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Hu Zhi-ming, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P1083; Joukov V, 1996, EMBO J, V15, P290; Kang W, 2013, PROTEIN EXPRES PURIF, V87, P55, DOI 10.1016/j.pep.2012.10.004; Kazemi-Lomedasht F, 2014, ADV PHARM BULL, V4, P323, DOI 10.5681/apb.2014.047; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kim JH, 2013, J BIOMED MATER RES A, V101, P1447, DOI 10.1002/jbm.a.34446; Kim S, 2007, J BIOTECHNOL, V128, P638, DOI 10.1016/j.jbiotec.2006.11.027; LAVALLIE ER, 1995, CURR OPIN BIOTECH, V6, P501, DOI 10.1016/0958-1669(95)80083-2; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Lee IL, 2011, PROTEIN EXPRES PURIF, V76, P54, DOI 10.1016/j.pep.2010.08.014; Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Liu P, 2015, MAT SCI ENG C-MATER, V55, P1, DOI 10.1016/j.msec.2015.05.047; Maeng BH, 2011, WORLD J MICROB BIOT, V27, P1391, DOI 10.1007/s11274-010-0590-5; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; Matsushima S, 2011, J MOL CELL CARDIOL, V51, P570, DOI 10.1016/j.yjmcc.2010.09.020; Mitsuda M, 2006, PROTEIN EXPRES PURIF, V46, P401, DOI 10.1016/j.pep.2005.10.017; Morera Y, 2006, BIOTECHNOL APPL BIOC, V44, P45, DOI 10.1042/BA20050169; Morera Y, 2010, VACCINE, V28, P3453, DOI 10.1016/j.vaccine.2010.02.069; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; Parizek M, 2012, INT J NANOMED, V7, P1931, DOI 10.2147/IJN.S26665; PARK JE, 1993, MOL BIOL CELL, V4, P1317, DOI 10.1091/mbc.4.12.1317; Sanchez LP, 2015, HUM VACC IMMUNOTHER, V11, P2030, DOI 10.1080/21645515.2015.1029213; Petrickova A, 2012, APPL MICROBIOL BIOT, V93, P1553, DOI 10.1007/s00253-011-3525-7; Pfeffer J, 2007, J MOL CATAL B-ENZYM, V45, P62, DOI 10.1016/j.molcatb.2006.11.006; Pizarro SA, 2010, PROTEIN EXPRES PURIF, V72, P184, DOI 10.1016/j.pep.2010.03.007; Rodrigo WWP, 2014, ASIAN PAC J TROP MED, V7, P85, DOI 10.1016/S1995-7645(14)60001-8; Rosengart TK, 1999, ANN SURG, V230, P466, DOI 10.1097/00000658-199910000-00002; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sachdev D, 1998, PROTEIN EXPRES PURIF, V12, P122, DOI 10.1006/prep.1997.0826; Scrofani SDB, 2000, PROTEIN SCI, V9, P2018, DOI 10.1110/ps.9.10.2018; Simon-Yarza T, 2012, THERANOSTICS, V2, P541, DOI 10.7150/thno.3682; Sonoda H, 2010, PROTEIN EXPRES PURIF, V70, P248, DOI 10.1016/j.pep.2009.11.003; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Suresh SC, 2015, INT J CARDIOL, V201, P517, DOI 10.1016/j.ijcard.2015.08.117; Vempati P, 2014, CYTOKINE GROWTH F R, V25, P1, DOI 10.1016/j.cytogfr.2013.11.002; Wang HS, 1997, J SURG RES, V68, P139, DOI 10.1006/jsre.1997.5044; Wang J, 2015, J BIOMED NANOTECHNOL, V11, P1947, DOI 10.1166/jbn.2015.2138; Xiong S, 2005, WORLD J GASTROENTERO, V11, P1077, DOI 10.3748/wjg.v11.i7.1077; Yang F, 2015, APPL MICROBIOL BIOT, V99, P8903, DOI 10.1007/s00253-015-6619-9; Yla-Herttuala S, 2007, J AM COLL CARDIOL, V49, P1015, DOI 10.1016/j.jacc.2006.09.053; Zhou TB, 2011, TRANSPL IMMUNOL, V25, P207, DOI 10.1016/j.trim.2011.08.001; Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8; Zucker S, 1998, INT J CANCER, V75, P780, DOI 10.1002/(SICI)1097-0215(19980302)75:5<780::AID-IJC19>3.0.CO;2-A	69	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0163697	10.1371/journal.pone.0163697	http://dx.doi.org/10.1371/journal.pone.0163697			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716773	Green Submitted, Green Published, gold			2022-12-27	WOS:000385698100010
J	Spector, JT; Bonauto, DK; Sheppard, L; Busch-Isaksen, T; Calkins, M; Adams, D; Lieblich, M; Fenske, RA				Spector, June T.; Bonauto, David K.; Sheppard, Lianne; Busch-Isaksen, Tania; Calkins, Miriam; Adams, Darrin; Lieblich, Max; Fenske, Richard A.			A Case-Crossover Study of Heat Exposure and Injury Risk in Outdoor Agricultural Workers	PLOS ONE			English	Article							WASHINGTON-STATE; PHYSIOLOGICAL-MECHANISMS; HEALTH IMPACTS; PUBLIC-HEALTH; ILLNESS; TEMPERATURES; PERFORMANCE; MORTALITY; EVENTS; MOOD	Background Recent research suggests that heat exposure may increase the risk of traumatic injuries. Published heat-related epidemiological studies have relied upon exposure data from individual weather stations. Objective To evaluate the association between heat exposure and traumatic injuries in outdoor agricultural workers exposed to ambient heat and internal heat generated by physical activity using modeled ambient exposure data. Methods A case-crossover study using time-stratified referent selection among 12,213 outdoor agricultural workers with new Washington State Fund workers' compensation traumatic injury claims between 2000 and 2012 was conducted. Maximum daily Humidex exposures, derived from modeled meteorological data, were assigned to latitudes and longitudes of injury locations on injury and referent dates. Conditional logistic regression was used to estimate odds ratios of injury for a priori daily maximum Humidex categories. Results The mean of within-stratum (injury day and corresponding referent days) standard deviations of daily maximum Humidex was 4.8. The traumatic injury odds ratio was 1.14 (95% confidence interval 1.06, 1.22), 1.15 (95% confidence interval 1.06, 1.25), and 1.10 (95% confidence interval 1.01, 1.20) for daily maximum Humidex of 25-29, 30-33, and >= 34, respectively, compared to < 25, adjusted for self-reported duration of employment. Stronger associations were observed during cherry harvest duties in the June and July time period, compared to all duties over the entire study period. Conclusions Agricultural workers laboring in warm conditions are at risk for heat-related traumatic injuries. Combined heat-related illness and injury prevention efforts should be considered in high-risk populations exposed to warm ambient conditions in the setting of physical exertion.	[Spector, June T.; Sheppard, Lianne; Busch-Isaksen, Tania; Calkins, Miriam; Fenske, Richard A.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Spector, June T.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Bonauto, David K.; Adams, Darrin] Washington State Dept Labor & Ind, Safety & Hlth Assessment & Res Prevent SHARP Prog, Olympia, WA 98504 USA; [Sheppard, Lianne] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Lieblich, Max] Univ Washington, Dept Math, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Spector, JT (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.; Spector, JT (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	spectj@u.washington.edu	Sheppard, Lianne/AAF-6304-2021	Sheppard, Lianne/0000-0003-1622-508X; Calkins, Miriam/0000-0001-5097-053X; Busch Isaksen, Tania/0000-0001-8180-6054	National Institute for Occupational Safety and Health (NIOSH) [5K010H010672-02]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [K01OH010672] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	Support was provided by The National Institute for Occupational Safety and Health (NIOSH) 5K010H010672-02 (to JTS) [http://www.cdc.gov/niosh/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACGIH, HEAT STRESS HEAT STR; Adam-Poupart A, 2015, OCCUP ENVIRON MED, V72, P338, DOI 10.1136/oemed-2014-102428; [Anonymous], 2016, GEOCODER US; Armstrong LE, 2012, J NUTR, V142, P382, DOI 10.3945/jn.111.142000; Bonauto D, 2007, AM J IND MED, V50, P940, DOI 10.1002/ajim.20517; Calkins MM, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0109-0; Citizenship US and Services Immigration, 2016, H 2A TEMP AGR WORK; Distefano LJ, 2013, MED SCI SPORT EXER, V45, P1166, DOI 10.1249/MSS.0b013e3182805b83; Edenhofer O., 2014, CONTRIBUTION WORKING; Ganio MS, 2011, BRIT J NUTR, V106, P1535, DOI 10.1017/S0007114511002005; Gubernot DM, 2015, AM J IND MED, V58, P203, DOI 10.1002/ajim.22381; Hofmann J, 2006, OCCUP MED-OXFORD, V56, P251, DOI 10.1093/occmed/kql018; Isaksen TB, 2015, REV ENVIRON HEALTH, V30, P51, DOI 10.1515/reveh-2014-0050; Isaksen Tania Busch, 2014, Reviews on Environmental Health, V29, P119, DOI 10.1515/reveh-2014-0029; Jackson JE, 2010, CLIMATIC CHANGE, V102, P159, DOI 10.1007/s10584-010-9852-3; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Johansson B, 2010, APPL ERGON, V41, P607, DOI 10.1016/j.apergo.2009.12.020; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kuras ER, 2015, INT J BIOMETEOROL, V59, P1363, DOI 10.1007/s00484-014-0946-x; Lewis K., 2015, MECH ORCHARD PRACTIC; Lumley T, 2000, ENVIRONMETRICS, V11, P689, DOI 10.1002/1099-095X(200011/12)11:6<689::AID-ENV439>3.0.CO;2-N; Masterton J. M., 1979, Report, Environment Canada, ppp; Maurer EP, 2002, J CLIMATE, V15, P3237, DOI [10.1175/1520-0442(2002)015<3237:ALTHBD>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3237:ALTHBD&gt;2.0.CO;2]; Morabito M, 2006, IND HEALTH, V44, P458, DOI 10.2486/indhealth.44.458; OHCOW, 2012, HUM BAS HEAT RESP PL; R Core Team, 2021, R LANGUAGE ENV STAT; Sawka MN, 2011, COMPR PHYSIOL, V1, P1883, DOI 10.1002/cphy.c100082; Smith AM, 1997, EXP BRAIN RES, V114, P578, DOI 10.1007/PL00005666; Spector JT, 2015, J AGROMEDICINE, V20, P349, DOI 10.1080/1059924X.2015.1047107; Spector JT, 2014, AM J IND MED, V57, P881, DOI 10.1002/ajim.22357; US Department of Labor, 2012, INJ ILLN FAT CENS FA; WA ESD, 2013, 2013 AGR WORKF; Washington Administrative Code, 2012, SAF STAND AGR; Western Regional Climate Center, 2014, CLIM WASH; WSDA, 2015, TOP CROPS FOOD PROC; Xiang JJ, 2014, OCCUP ENVIRON MED, V71, P246, DOI 10.1136/oemed-2013-101584; Zemkova E, 2014, SPORTS MED, V44, P437, DOI 10.1007/s40279-013-0129-7	37	59	60	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164498	10.1371/journal.pone.0164498	http://dx.doi.org/10.1371/journal.pone.0164498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716794	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100058
J	Dietl, A; Stark, K; Zimmermann, ME; Meisinger, C; Schunkert, H; Birner, C; Maier, LS; Peters, A; Heid, IM; Luchner, A				Dietl, Alexander; Stark, Klaus; Zimmermann, Martina E.; Meisinger, Christa; Schunkert, Heribert; Birner, Christoph; Maier, Lars S.; Peters, Annette; Heid, Iris M.; Luchner, Andreas			NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; HEART-FAILURE; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; CHAMBER QUANTIFICATION; DYSFUNCTION; MORTALITY; EVENTS; RISK; ECHOCARDIOGRAPHY	Aims B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) predict cardiovascular endpoints in patients and all-cause death in the general population. This was assigned to their association with clinical cardiac remodelling defined as changes in size, shape and function of the heart. The aim of this study was to evaluate whether NT-proBNP and BNP were associated with cardiovascular and overall death independent of clinical cardiac remodelling measured by echocardiography as left ventricular hypertrophy (LVH), diastolic dysfunction and left ventricular ejection fraction (EF). Methods and Results In a general population-based cohort study from Germany (KORA-S3) with subjects' baseline age ranging from 25 to 74 years, cardiac morphology and function were assessed as left ventricular mass (LVM), diastolic dysfunction and EF by echocardiography and circulating NT-proBNP and BNP were measured at baseline. In 1,223 subjects with mortality follow-up information, we examined the association of baseline NT-proBNP and BNP with cardiovascular mortality (number of deaths = 52, median follow-up time = 12.9years) using Cox regression without and with adjustment for cardiovascular risk factors, LVM, diastolic dysfunction and EF. The risk of cardiovascular mortality increased with higher NT-proBNP levels measured at baseline (hazard ratio HR = 1.67 per unit increment in logNT-proBNP, p = 2.78*10(-4), adjusted for age and sex). This increased risk persisted after adjustment for cardiovascular risk factors, LVM, diastolic dysfunction and EF (HR = 1.73; p = 0.047). When excluding subjects with relevant LVH (LVM to body surface area > 149g/m(2) in men / 122g/m(2) in women), the NT-proBNP association with mortality was still significant (n = 1,138; number of deaths = 35; HR = 1.48; p = 0.04). We found similar results for BNP. Conclusion Our data confirms NT-proBNP and BNP as predictor of cardiovascular mortality in a large general population-based study with long-term follow-up. Our study extends previously published population-based studies to younger and potentially healthier individuals without relevant LVH, diastolic dysfunction or LVD.	[Dietl, Alexander; Stark, Klaus; Zimmermann, Martina E.; Heid, Iris M.] Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany; [Dietl, Alexander; Birner, Christoph; Maier, Lars S.; Luchner, Andreas] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany; [Meisinger, Christa; Peters, Annette] Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Schunkert, Heribert] Tech Univ Muenchen, Deutsch Herzzentrum Muenchen, Munich, Germany; [Schunkert, Heribert] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Luchner, Andreas] Klinikum Amberg, Amberg, Germany	University of Regensburg; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Heid, IM (corresponding author), Univ Regensburg, Dept Genet Epidemiol, Regensburg, Germany.	iris.heid@ukr.de	Meisinger, Christine/B-5358-2014; Stark, Klaus/L-7367-2013; Zimmermann, Martina/AAL-2990-2021; Maier, Lars/AAQ-8313-2021; Peters, Annette/A-6117-2011	Stark, Klaus/0000-0002-7832-1942; Zimmermann, Martina/0000-0002-6916-4404; Maier, Lars/0000-0001-9915-4429; Peters, Annette/0000-0001-6645-0985	Helmholtz Zentrum Muenchen; German Research Centre for Environmental Health - German Federal Ministry of Science and Research (Berlin, Germany); State of Bavaria (Germany); Deutsche Forschungsgemeinschaft (Germany) [LU 562/3-1]; Competence Network of Heart Failure (Germany) [BMBF-01GI0205]	Helmholtz Zentrum Muenchen; German Research Centre for Environmental Health - German Federal Ministry of Science and Research (Berlin, Germany); State of Bavaria (Germany); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG)); Competence Network of Heart Failure (Germany)	The KORA research platform and the KORA Augsburg studies are financed by the Helmholtz Zentrum Muenchen, German Research Centre for Environmental Health which is funded by the German Federal Ministry of Science and Research (Berlin, Germany) and by the State of Bavaria (Germany). The study was further supported by the Deutsche Forschungsgemeinschaft (LU 562/3-1, Germany) and the Competence Network of Heart Failure (BMBF-01GI0205, Germany). Roche Diagnostics has provided kits for assessment of NT-proBNP free of charge, but it did not play a role in the study design, in the collection, analysis, and interpretation of data, in the writing of the manuscript or in the decision to submit the manuscript for publication.	Abdullah SM, 2005, AM J CARDIOL, V96, P1284, DOI 10.1016/j.amjcard.2005.06.073; American Diabetes A, 2010, DIABETES CARE S1, V33, pS62, DOI [10.2337/dc10-S062, DOI 10.2337/DC10-S062]; Authors/Task Force M Document R, 2016, EUR J HEART FAIL; Birner C, 2012, J CARD FAIL, V18, P660, DOI 10.1016/j.cardfail.2012.06.418; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bower JK, 2015, AM J HYPERTENS; Burton RF, 2008, ANN HUM BIOL, V35, P170, DOI 10.1080/03014460801908439; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Devereux RB, 2001, AM HEART J, V141, P439, DOI 10.1067/mhj.2001.113223; Dietl A, 2014, EUR J HEART FAIL, V16, P835, DOI 10.1002/ejhf.122; Eckel R. H., 2013, CIRCULATION; Folsom AR, 2015, CIRCULATION; Gjesdal O, 2011, NAT REV CARDIOL, V8, P673, DOI 10.1038/nrcardio.2011.154; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; Kara K, 2015, INT J CARDIOL, V183, P155, DOI 10.1016/j.ijcard.2015.01.082; Kathiresan S, 2006, CIRCULATION, V113, P938, DOI 10.1161/CIRCULATIONAHA.105.580233; Kistorp C, 2005, JAMA-J AM MED ASSOC, V293, P1609, DOI 10.1001/jama.293.13.1609; Kuch B, 2000, CIRCULATION, V102, P405; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Laukkanen JA, 2006, EUR HEART J, V27, P1230, DOI 10.1093/eurheartj/ehi878; Linssen GCM, 2010, EUR HEART J, V31, P120, DOI 10.1093/eurheartj/ehp420; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Luchner A, 2000, J HYPERTENS, V18, P1121, DOI 10.1097/00004872-200018080-00018; Luchner A, 2013, EUR J HEART FAIL, V15, P859, DOI 10.1093/eurjhf/hft048; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Maragiannis D, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-014-0561-9; McKie PM, 2010, J AM COLL CARDIOL, V55, P2140, DOI 10.1016/j.jacc.2010.01.031; McKie PM, 2006, HYPERTENSION, V47, P874, DOI 10.1161/01.HYP.0000216794.24161.8c; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Park S H, 1996, J Am Soc Echocardiogr, V9, P119, DOI 10.1016/S0894-7317(96)90019-X; Pastormerlo LE, 2016, EUR J PREV CARDIOL, V23, P366, DOI 10.1177/2047487315569675; Patterson CC, 2015, INT J CARDIOL, V201, P113, DOI 10.1016/j.ijcard.2015.07.106; Ponikowski P, 2016, EUR J HEART FAIL; Portegies MLP, 2015, EUR J NEUROL, V22, P695, DOI 10.1111/ene.12633; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Schunkert H, 2000, J HYPERTENS, V18, P1483, DOI 10.1097/00004872-200018100-00017; Stritzke J, 2009, J AM COLL CARDIOL, V54, P1982, DOI 10.1016/j.jacc.2009.07.034; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994	44	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164060	10.1371/journal.pone.0164060	http://dx.doi.org/10.1371/journal.pone.0164060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711172	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600072
J	Song, YZ; Zhang, FJ; Zhao, YY; Sun, MS; Tao, J; Liang, YC; Ma, L; Yu, YQ; Wang, JH; Hao, JF				Song, Yanzheng; Zhang, Fengju; Zhao, Yanyan; Sun, Mingshen; Tao, Jun; Liang, Yanchuang; Ma, Ling; Yu, Yanqiu; Wang, Jianhua; Hao, Junfeng			Enlargement of the Axial Length and Altered Ultrastructural Features of the Sclera in a Mutant Lumican Transgenic Mouse Model	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; HIGH MYOPIA MAPS; KERATAN SULFATE PROTEOGLYCAN; REFRACTIVE ERROR; GENE; LOCUS; COLLAGEN; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION	Lumican (LUM) is a candidate gene for myopia in the MYP3 locus. In this study, a mutant lumican (L199P) transgenic mouse model was established to investigate the axial length changes and ultrastructural features of the sclera. The mouse model was established by pronuclear microinjection. Transgenic mice and wild-type B6 mice were killed at eight weeks of age. Gene expression levels of LUM and collagen type I (COL1) in the sclera were analyzed by quantitative real-time polymerase chain reaction (qPCR), and the protein levels were assessed by Western blot analysis. Ocular axial lengths were measured on the enucleated whole eye under a dissecting microscope. Ultrastructural features of collagen fibrils in the sclera were examined with transmission electron microscopy (TEM). Lumican and collagen type I were both elevated at the transcriptional and protein levels. The mean axial length of eyes in the transgenic mice was significantly longer than that in the wild-type mice (3,231.0 +/- 11.2 mu m (transgenic group) vs 3,199.7 +/- 11.1 mu m (controls), p<0.05 =). Some ultrastructural changes were observed in the sclera of the transgenic mice under TEM, such as evident lamellar disorganizations and abnormal inter-fibril spacing. The average collagen fibril diameter was smaller than that in their wild-type counterparts. These results indicate that the ectopic mutant lumican (L199P) may induce enlargement of axial lengths and abnormal structures and distributions of collagen fibrils in mouse sclera. This transgenic mouse model can be used for the mechanistic study of myopia.	[Song, Yanzheng; Zhang, Fengju; Zhao, Yanyan; Sun, Mingshen; Tao, Jun; Liang, Yanchuang] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Ma, Ling; Yu, Yanqiu] China Med Univ, Dept Pathophysiol, Shenyang, Peoples R China; [Wang, Jianhua; Hao, Junfeng] Chinese Acad Sci, Inst Biophys, Beijing, Peoples R China	Capital Medical University; China Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, FJ (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China.	wxw93@hotmail.com	zhao, yan/GWC-9174-2022		National Natural Science Foundation of China [81271041, 81570877]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Grants from the National Natural Science Foundation of China (No. 81271041, and No. 81570877) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin BA, 2002, INVEST OPHTH VIS SCI, V43, P1695; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Chakravarti S, 2003, INVEST OPHTH VIS SCI, V44, P2422, DOI 10.1167/iovs.02-0783; CHAKRAVARTI S, 1995, GENOMICS, V27, P481, DOI 10.1006/geno.1995.1080; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen YP, 2011, INVEST OPHTH VIS SCI, V52, P4003, DOI 10.1167/iovs.10-7044; Chen ZTY, 2009, OPHTHALMOLOGY, V116, P1920, DOI 10.1016/j.ophtha.2009.03.023; Cheng CY, 2013, AM J HUM GENET, V93, P264, DOI 10.1016/j.ajhg.2013.06.016; CURTIN BJ, 1979, ARCH OPHTHALMOL-CHIC, V97, P912, DOI 10.1001/archopht.1979.01020010470017; Dunlevy JR, 2004, INVEST OPHTH VIS SCI, V45, P3849, DOI 10.1167/iovs.04-0496; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Gentle A, 2003, J BIOL CHEM, V278, P16587, DOI 10.1074/jbc.M300970200; Goldschmidt E, 2014, EYE, V28, P126, DOI 10.1038/eye.2013.254; GROVER J, 1995, J BIOL CHEM, V270, P21942, DOI 10.1074/jbc.270.37.21942; Hocking AM, 1998, MATRIX BIOL, V17, P1; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Kiefer AK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003299; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Lin HJ, 2010, EYE, V24, P1093, DOI 10.1038/eye.2009.254; Lin HJ, 2010, INVEST OPHTH VIS SCI, V51, P96, DOI 10.1167/iovs.09-3612; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyhne N, 2001, BRIT J OPHTHALMOL, V85, P1470, DOI 10.1136/bjo.85.12.1470; Majava M, 2007, HUM MUTAT, V28, P336, DOI 10.1002/humu.20444; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; McBrien NA, 2009, OPTOMETRY VISION SCI, V86, P23, DOI 10.1097/OPX.0b013e3181940669; Naiglin L, 2002, J MED GENET, V39, P118, DOI 10.1136/jmg.39.2.118; Nishizaki R, 2009, EYE, V23, P222, DOI 10.1038/eye.2008.152; Paluru PC, 2005, INVEST OPHTH VIS SCI, V46, P2300, DOI 10.1167/iovs.04-1423; RADA JA, 1993, EXP EYE RES, V56, P635, DOI 10.1006/exer.1993.1081; SCHWARTZ M, 1990, CLIN GENET, V38, P281; Shi Y, 2011, AM J HUM GENET, V88, P805, DOI 10.1016/j.ajhg.2011.04.022; Simpson CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107110; Tang WC, 2008, CLIN EXP OPTOM, V91, P4, DOI 10.1111/j.1444-0938.2007.00181.x; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Wang IJ, 2006, MOL VIS, V12, P852; Wojciechowski R, 2011, CLIN GENET, V79, P301, DOI 10.1111/j.1399-0004.2010.01592.x; Yeh LK, 2010, J BIOL CHEM, V285, P28141, DOI 10.1074/jbc.M109.043679; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306; Young TL, 2007, ARCH OPHTHALMOL-CHIC, V125, P38, DOI 10.1001/archopht.125.1.38; Young TL, 1998, AM J HUM GENET, V63, P109, DOI 10.1086/301907; Young TL, 1998, AM J HUM GENET, V63, P1419, DOI 10.1086/302111; Zhang F, 2009, FERROALLOYS, V1, P1, DOI DOI 10.1155/2009/514306; Zhang Q, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037853; Zhang QJ, 2005, MOL VIS, V11, P554	45	7	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163165	10.1371/journal.pone.0163165	http://dx.doi.org/10.1371/journal.pone.0163165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711221	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600016
J	van Santen, DK; de Vos, AS; Matser, A; Willemse, SB; Lindenburg, K; Kretzschmar, MEE; Prins, M; de Wit, GA				van Santen, Daniela K.; de Vos, Anneke S.; Matser, Amy; Willemse, Sophie B.; Lindenburg, Karen; Kretzschmar, Mirjam E. E.; Prins, Maria; de Wit, G. Ardine			Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands	PLOS ONE			English	Article							DACLATASVIR PLUS SOFOSBUVIR; SPONTANEOUS VIRAL CLEARANCE; VIRUS-INFECTION; GENOTYPE 1; UNTREATED PATIENTS; HCV INFECTION; USERS; HIV; RIBAVIRIN; CIRRHOSIS	Background People who inject drugs (PWID) are disproportionally affected by the hepatitis C virus (HCV) infection. The efficacy of HCV treatment has significantly improved in recent years with the introduction of direct-acting antivirals (DAAs). However, DAAs are more costly than pegylated-interferon and ribavirin (PegIFN/RBV). We aimed to assess the cost-effectiveness of four HCV treatment strategies among PWID and treatment scale-up. Methods An individual-based model was used describing HIV and HCV transmission and disease progression among PWID. We considered two epidemiological situations. A declining epidemic, based on the situation in Amsterdam, the Netherlands, and a stable HCV epidemic, as observed in other settings. Data on HCV incidence, prevalence, treatment setting and uptake were derived from observed data among PWID in Amsterdam. We assessed the incremental cost-effectiveness ratio (ICER, costs in (sic)/quality-adjusted life year (QALY)) of four treatment strategies: 1) PegIFN/RBV; 2) sofosbuvir/RBV for genotype 2-3 and dual DAA for genotype 1-4; 3) Dual DAA for all genotypes; 4) Dual DAA with 3x treatment uptake. Results In both types of epidemic, dual DAA therapy was most cost-effective strategy. In the declining epidemic, dual DAA yielded an ICER of 344 (sic)/QALY while in the stable epidemic dual DAA led to cost-savings. Scaling-up treatment was also highly cost-effective. Our results were robust over a range of sensitivity analyses. Conclusion HCV treatment with DAA-containing regimens is a highly cost-effective intervention among PWID. Based on the economic and population benefits of scaling-up treatment, stronger efforts are needed to achieve higher uptake rates among PWID.	[van Santen, Daniela K.; Matser, Amy; Lindenburg, Karen; Prins, Maria] Publ Hlth Serv Amsterdam, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands; [de Vos, Anneke S.; Kretzschmar, Mirjam E. E.; de Wit, G. Ardine] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Willemse, Sophie B.] Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Kretzschmar, Mirjam E. E.; de Wit, G. Ardine] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Prins, Maria] Acad Med Ctr AMC, Dept Infect Dis, Ctr Infect & Immunol Amsterdam CINIMA, Amsterdam, Netherlands	Public Health Service Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam	van Santen, DK (corresponding author), Publ Hlth Serv Amsterdam, Dept Infect Dis Res & Prevent, Amsterdam, Netherlands.	dvsanten@ggd.amsterdam.nl	van Santen, Daniela/AAF-9260-2020	Matser, Amy/0000-0003-4291-1905; de Wit, G. Ardine/0000-0002-1375-7657; Kretzschmar, Mirjam/0000-0002-4394-7697; de Vos, Anneke S./0000-0002-4754-0026	Research and Development Fund of the Public Health Service of Amsterdam; ZonMW, Netherlands Organization for Health Research and Development [125020005]; Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment	Research and Development Fund of the Public Health Service of Amsterdam; ZonMW, Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment	Research and Development Fund of the Public Health Service of Amsterdam and ZonMW, The Netherlands Organization for Health Research and Development, Grant number 125020005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the participants of the ACS for their contribution, research nurses of the ACS Wendy van der Veldt, Laura del Grande and Maja Totte for data collection and cohort management, Rabin E.J Neslo for his help on probabilistic sensitivity analyses, Matty de Wit for supplying non-published data relevant for the model, and Claire Buswell for editing the final manuscript. The Amsterdam Cohort Studies on HIV infection and AIDS, which is a collaboration between the Public Health Service of Amsterdam, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation, Medical Center Jan van Goyen, and the HIV Focus Center of the DC-Clinics, is part of the Netherlands HIV Monitoring Foundation and financially supported by the Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment.	Alavi M, 2013, CLIN INFECT DIS, V57, pS62, DOI 10.1093/cid/cit305; Cure S, 2015, J VIRAL HEPATITIS, V22, P882, DOI 10.1111/jvh.12409; de Vos AS, 2014, AIDS, V28, P911, DOI 10.1097/QAD.0000000000000190; de Vos AS, 2013, ADDICTION, V108, P1070, DOI 10.1111/add.12125; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Ferrante SA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-190; Gissel C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1048-z; Grebely J, 2015, INT J DRUG POLICY, V26, P1028, DOI 10.1016/j.drugpo.2015.07.005; Hagan LM, 2014, HEPATOLOGY, V60, P37, DOI 10.1002/hep.27151; Hakkaart-van Roijen L, 2010, HANDLEIDING KOSTENON; Hellard M, 2015, J GASTROENTEROL HEPA; Helsper CW, 2012, NETH J MED, V70, P145; Hoofnagle JH, 1999, J HEPATOL, V31, P264, DOI 10.1016/S0168-8278(99)80414-0; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Leleu H, 2015, J VIRAL HEPATITIS, V22, P376, DOI 10.1111/jvh.12311; Lindenburg CEA, 2011, EUR J GASTROEN HEPAT, V23, P23, DOI 10.1097/MEG.0b013e328340c451; Litwin AH, 2009, J SUBST ABUSE TREAT, V37, P32, DOI 10.1016/j.jsat.2008.09.009; Maag Darm Lever Stichting, 2016, LEV; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Martin NK, 2015, J VIRAL HEPATITIS, V22, P399, DOI 10.1111/jvh.12338; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Martin NK, 2016, J HEPATOL; Matser A, 2012, ADDICTION, V107, P614, DOI 10.1111/j.1360-0443.2011.03654.x; Memon MI, 2002, J VIRAL HEPATITIS, V9, P84, DOI 10.1046/j.1365-2893.2002.00329.x; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Mira JA, 2012, CLIN INFECT DIS, V55, P1719, DOI 10.1093/cid/cis779; Mohsen AH, 2001, GUT, V48, P707, DOI 10.1136/gut.48.5.707; Molina JM, 2015, LANCET, V385, P1098, DOI 10.1016/S0140-6736(14)62483-1; Nederlandse Vereniging van Maag-Darm-leverartsen, 2008, RICHTL BEH CHRON HEP; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Petta S, 2014, HEPATOLOGY, V59, P1692, DOI 10.1002/hep.27010; Polsky D, 2015, EC EVALUATION CLIN T; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Powis J, 2008, J VIRAL HEPATITIS, V15, P52, DOI 10.1111/j.1365-2893.2007.00889.x; Rosinska M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0828-9; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Schreuder I, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-25; Shepherd J, 2007, HEALTH TECHNOL ASSES, V11, P1; Siebert U, 2003, GUT, V52, P425, DOI 10.1136/gut.52.3.425; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Sulkowski MS, 2014, NEW ENGL J MED, V370, P1560, DOI 10.1056/NEJMc1401726; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Sulkowski MS, 2015, GASTROENTEROLOGY; Termorshuizen F, 2005, AM J EPIDEMIOL, V161, P271, DOI 10.1093/aje/kwi035; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; van de Laar TJW, 2005, J MED VIROL, V77, P509, DOI 10.1002/jmv.20486; van den Berg CHSB, 2007, EUR J EPIDEMIOL, V22, P183, DOI 10.1007/s10654-006-9089-7; van Santen DK, 2014, AIDS, V28, P2589, DOI 10.1097/QAD.0000000000000450; Wiessing L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103345; World Health Organization (WHO), 2016, COST EFF STRAT PLANN; Wyles DL, 2015, NEW ENGL J MED, V373, P714, DOI 10.1056/NEJMoa1503153; Younossi ZM, 2014, HEPATOLOGY, V59, P2161, DOI 10.1002/hep.27161; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145	59	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163488	10.1371/journal.pone.0163488	http://dx.doi.org/10.1371/journal.pone.0163488			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711200	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600027
J	Wu, CM; Gong, YH; Wu, J; Zhang, SC; Yin, XX; Dong, XX; Li, WZ; Cao, SY; Mkandawire, N; Lu, ZX				Wu, Chunmei; Gong, Yanhong; Wu, Jiang; Zhang, Shengchao; Yin, Xiaoxv; Dong, Xiaoxin; Li, Wenzhen; Cao, Shiyi; Mkandawire, Naomie; Lu, Zuxun			Chinese Version of the EQ-5D Preference Weights: Applicability in a Chinese General Population	PLOS ONE			English	Article							QUALITY-OF-LIFE; SF-36 HEALTH SURVEY; UTILITY MEASURES; NORMATIVE DATA; STATES; SAMPLE; US; MULTIATTRIBUTE; QUESTIONNAIRE; VALIDATION	Objectives This study aimed to test the reliability, validity and sensitivity of Chinese version of the EQ-5D preference weights in Chinese general people, examine the differences between the China value set and the UK, Japan and Korea value sets, and provide methods for evaluating and comparing the EQ-5D value sets of different countries. Methods A random sample of 2984 community residents (15 years or older) were interviewed using a questionnaire including the EQ-5D scale. Level of agreement, convergent validity, known-groups validity and sensitivity of the EQ-5D China, United Kingdom (UK), Japan and Korea value sets were determined. Results The mean EQ-5D index scores were significantly (P<0.05) different among the UK (0.964), Japan (0.981), Korea (0.987), and China (0.985) weights. High level of agreement (intraclass correlations coefficients >0.75) and convergent validity (Pearson's correlation coefficients P>0.95) were found between each paired schemes. The EQ-5D index scores discriminated equally well for the four versions between levels of 10 known-groups (P<0.05). The effect size and the relative efficiency statistics showed that the China weights had better sensitivity. Conclusions The China EQ-5D preference weights show equivalent psychometric properties with those from the UK, Japan and Korea weights while slightly more sensitive to known group differences than those from the Japan and Korea weights. Considering both psychometric and sociocultural issues, the China scheme should be a priority as an EQ-5D based measure of the health related quality of life in Chinese general population.	[Wu, Chunmei; Gong, Yanhong; Yin, Xiaoxv; Li, Wenzhen; Cao, Shiyi; Mkandawire, Naomie; Lu, Zuxun] Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan, Hubei Province, Peoples R China; [Wu, Chunmei] Gannan Med Univ, Sch Basic Med, Ganzhou, Jiangxi, Peoples R China; [Wu, Jiang; Zhang, Shengchao] Xixiang Management Ctr Community Hlth Serv, Shenzhen, Guangdong, Peoples R China; [Dong, Xiaoxin] Ningbo Coll Hlth Sci, Ningbo, Zhejiang, Peoples R China	Huazhong University of Science & Technology; Gannan Medical University	Lu, ZX (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, Wuhan, Hubei Province, Peoples R China.	zuxunlu@yahoo.com						Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Busschbach J, 2003, MEASUREMENT AND VALUATION OF HEALTH STATUS USING EQ-5D: A EUROPEAN PERSPECTIVE, P143; Chang TJ, 2007, J FORMOS MED ASSOC, V106, P1023, DOI 10.1016/S0929-6646(08)60078-9; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colton T., 1974, STAT MED, P307; Cruz LN, 2013, CIENC SAUDE COLETIVA, V18, P1911, DOI 10.1590/S1413-81232013000700006; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Feeny D, 2002, MED CARE, V40, P113, DOI 10.1097/00005650-200202000-00006; Fukuhara S., 2004, MANUAL SF 36V2 JAPAN; Greiner W, 2005, Eur J Health Econ, V6, P124, DOI 10.1007/s10198-004-0264-z; Greiner Wolfgang, 2003, Eur J Health Econ, V4, P222, DOI 10.1007/s10198-003-0182-5; HAYS RD, 1993, QUAL LIFE RES, V2, P441, DOI 10.1007/BF00422218; Huang IC, 2007, QUAL LIFE RES, V16, P1065, DOI 10.1007/s11136-007-9206-4; Ikeda S, 1999, IRYO SHAKAI, V9, P83, DOI DOI 10.4091/IKEN1991.9.3_; JENKINSON C, 1993, BRIT MED J, V306, P1437, DOI 10.1136/bmj.306.6890.1437; Jin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041550; Jo MW, 2008, VALUE HEALTH, V11, P1186, DOI 10.1111/j.1524-4733.2008.00348.x; Johnson JA, 1998, QUAL LIFE RES, V7, P155, DOI 10.1023/A:1008809610703; Kim J, 2010, JPN J OPHTHALMOL, V54, P325, DOI 10.1007/s10384-010-0825-x; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Kind P., 2009, REVISED PROTOCOL VAL; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Liu GG, 2014, VALUE HEALTH, V17, P597, DOI 10.1016/j.jval.2014.05.007; Marra CA, 2005, SOC SCI MED, V60, P1571, DOI 10.1016/j.socscimed.2004.08.034; Pickard AS, 2012, VALUE HEALTH, V15, P305, DOI 10.1016/j.jval.2011.11.029; Prieto Luis, 2004, BMC Med Res Methodol, V4, P10, DOI 10.1186/1471-2288-4-10; Rosner B., 2000, FUNDAMENTAL BIOSTATI; Sakthong P, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-71; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Sun S, 2011, QUAL LIFE RES, V20, P309, DOI 10.1007/s11136-010-9762-x; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; TORRANCE GW, 1982, OPER RES, V30, P1043, DOI 10.1287/opre.30.6.1043; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Walters SJ, 2005, QUAL LIFE RES, V14, P1523, DOI 10.1007/s11136-004-7713-0; Wang H, 2005, QUAL LIFE RES, V14, P119, DOI 10.1007/s11136-004-0612-6; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wu J, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0156-6; Wu Yi-qun, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P397; 2002, J HLTH EC, V21, P271, DOI DOI 10.1016/S0167-6296(01)00130-8	42	45	45	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164334	10.1371/journal.pone.0164334	http://dx.doi.org/10.1371/journal.pone.0164334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711169	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697600120
J	Bakrania, K; Yates, T; Rowlands, AV; Esliger, DW; Bunnewell, S; Sanders, J; Davies, M; Khunti, K; Edwardson, CL				Bakrania, Kishan; Yates, Thomas; Rowlands, Alex V.; Esliger, Dale W.; Bunnewell, Sarah; Sanders, James; Davies, Melanie; Khunti, Kamlesh; Edwardson, Charlotte L.			Intensity Thresholds on Raw Acceleration Data: Euclidean Norm Minus One (ENMO) and Mean Amplitude Deviation (MAD) Approaches	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SEDENTARY TIME; TRIAXIAL ACCELEROMETER; WEARABLE MONITORS; HUMAN MOVEMENT; ADULTS; WRIST; CLASSIFICATION; COMPARABILITY; METAANALYSIS	Objectives (1) To develop and internally-validate Euclidean Norm Minus One (ENMO) and Mean Amplitude Deviation (MAD) thresholds for separating sedentary behaviours from common light-intensity physical activities using raw acceleration data collected from both hip-and wrist-worn tri-axial accelerometers; and (2) to compare and evaluate the performances between the ENMO and MAD metrics. Methods Thirty-three adults [mean age (standard deviation (SD)) = 27.4 (5.9) years; mean BMI (SD) = 23.9 (3.7) kg/m(2); 20 females (60.6%)] wore four accelerometers; an ActiGraph GT3X+ and a GENEActiv on the right hip; and an ActiGraph GT3X+ and a GENEActiv on the non-dominant wrist. Under laboratory-conditions, participants performed 16 different activities (11 sedentary behaviours and 5 light-intensity physical activities) for 5 minutes each. ENMO and MAD were computed from the raw acceleration data, and logistic regression and receiver-operating-characteristic (ROC) analyses were implemented to derive thresholds for activity discrimination. Areas under ROC curves (AUROC) were calculated to summarise performances and thresholds were assessed via executing leave-one-out-cross-validations. Results For both hip and wrist monitor placements, in comparison to the ActiGraph GT3X+ monitors, the ENMO and MAD values derived from the GENEActiv devices were observed to be slightly higher, particularly for the lower-intensity activities. Monitor-specific hip and wrist ENMO and MAD thresholds showed excellent ability for separating sedentary behaviours from motion-based light-intensity physical activities (in general, AUROCs >0.95), with validation indicating robustness. However, poor classification was experienced when attempting to isolate standing still from sedentary behaviours (in general, AUROCs <0.65). The ENMO and MAD metrics tended to perform similarly across activities and accelerometer brands. Conclusions Researchers can utilise these robust monitor-specific hip and wrist ENMO and MAD thresholds, in order to accurately separate sedentary behaviours from common motion-based light-intensity physical activities. However, caution should be taken if isolating sedentary behaviours from standing is of particular interest.	[Bakrania, Kishan] Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester, Leics, England; [Bakrania, Kishan; Yates, Thomas; Rowlands, Alex V.; Bunnewell, Sarah; Davies, Melanie; Khunti, Kamlesh; Edwardson, Charlotte L.] Univ Leicester, Leicester Gen Hosp, Diabet Res Ctr, Leicester, Leics, England; [Bakrania, Kishan; Yates, Thomas; Rowlands, Alex V.; Esliger, Dale W.; Sanders, James; Davies, Melanie; Edwardson, Charlotte L.] Leicester Gen Hosp, Diabet Res Ctr, Lifestyle & Phys Act Biomed Res Unit BRU, Natl Inst Hlth Res NIHR Leicester Loughborough Di, Leicester, Leics, England; [Rowlands, Alex V.] Univ South Australia, Div Hlth Sci, Sansom Inst Hlth Res, ARENA, Adelaide, SA, Australia; [Esliger, Dale W.; Sanders, James] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Khunti, Kamlesh] Leicester Gen Hosp, Diabet Res Ctr, CLAHRC EM, NIHR, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of South Australia; Loughborough University; University Hospitals of Leicester NHS Trust; Leicester General Hospital	Bakrania, K (corresponding author), Univ Leicester, Leicester Gen Hosp, Dept Hlth Sci, Leicester, Leics, England.; Bakrania, K (corresponding author), Univ Leicester, Leicester Gen Hosp, Diabet Res Ctr, Leicester, Leics, England.; Bakrania, K (corresponding author), Leicester Gen Hosp, Diabet Res Ctr, Lifestyle & Phys Act Biomed Res Unit BRU, Natl Inst Hlth Res NIHR Leicester Loughborough Di, Leicester, Leics, England.	kb318@le.ac.uk	Rowlands, Alex V/J-8878-2019; /ABC-9527-2021	Rowlands, Alex V/0000-0002-1463-697X; Davies, Melanie/0000-0002-9987-9371; Yates, Thomas/0000-0002-5724-5178; Edwardson, Charlotte/0000-0001-6485-9330; Bunnewell, Sarah/0000-0001-6590-5415	National Institute for Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research Unit (BRU) based at University Hospitals of Leicester and Loughborough University; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC-EM); Leicester Clinical Trials Unit	National Institute for Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research Unit (BRU) based at University Hospitals of Leicester and Loughborough University; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC-EM); Leicester Clinical Trials Unit	The research was supported by the National Institute for Health Research (NIHR) Diet, Lifestyle & Physical Activity Biomedical Research Unit (BRU) based at University Hospitals of Leicester and Loughborough University, the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care - East Midlands (NIHR CLAHRC-EM) and the Leicester Clinical Trials Unit. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Aittasalo M, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0010-0; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Bastian T, 2015, J APPL PHYSIOL, V118, P716, DOI 10.1152/japplphysiol.01189.2013; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Brond JC, 2016, J APPL PHYSIOL, V120, P362, DOI 10.1152/japplphysiol.00628.2015; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Chung WY, 2008, C P IEEE ENG MED BIO; Colley RC, 2011, HLTH REP, V22, P7; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P601, DOI 10.1007/s00421-006-0307-5; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Efron B, 1994, INTRO BOOTSTRAP, P240; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Figo D, 2010, PERS UBIQUIT COMPUT, V14, P645, DOI 10.1007/s00779-010-0293-9; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Godfrey A, 2008, MED ENG PHYS, V30, P1364, DOI 10.1016/j.medengphy.2008.09.005; Grentved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI [10.1001/jama.2011.812, DOI 10.1001/JAMA.2011.812]; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Henson J, 2016, DIABETES CARE, V39, P130, DOI 10.2337/dc15-1240; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Husu P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3591-y; John D, 2013, SENSORS-BASEL, V13, P14754, DOI 10.3390/s131114754; Joint Health Surveys Unit, HLTH SURV ENGL 2008; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; Khusainov R, 2013, SENSORS-BASEL, V13, P12852, DOI 10.3390/s131012852; Loprinzi PD, 2013, J DIABETES COMPLICAT, V27, P134, DOI 10.1016/j.jdiacomp.2012.09.004; Marschollek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063522; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Rowlands AV, 2015, MED SCI SPORT EXER, V47, P201, DOI 10.1249/MSS.0000000000000394; Rowlands AV, 2014, MED SCI SPORT EXER, V46, P1235, DOI 10.1249/MSS.0000000000000224; Straker LM, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-54; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Trost SG, 2014, PHYSIOL MEAS, V35, P2183, DOI 10.1088/0967-3334/35/11/2183; Vaha-Ypya H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134813; Vaha-Ypya H, 2015, CLIN PHYSIOL FUNCT I, V35, P64, DOI 10.1111/cpf.12127; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Zhang SY, 2012, MED SCI SPORT EXER, V44, P742, DOI 10.1249/MSS.0b013e31823bf95c	41	52	52	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164045	10.1371/journal.pone.0164045	http://dx.doi.org/10.1371/journal.pone.0164045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706241	Green Published, gold, Green Accepted			2022-12-27	WOS:000385697200078
J	Cesaretti, R; Lobo, J; Bettencourt, LMA; Ortman, SG; Smith, ME				Cesaretti, Rudolf; Lobo, Jose; Bettencourt, Luis M. A.; Ortman, Scott G.; Smith, Michael E.			Population-Area Relationship for Medieval European Cities	PLOS ONE			English	Article							INSTITUTIONS; MERCHANTS; ENGLAND; ECONOMY; GROWTH	Medieval European urbanization presents a line of continuity between earlier cities and modern European urban systems. Yet, many of the spatial, political and economic features of medieval European cities were particular to the Middle Ages, and subsequently changed over the Early Modern Period and Industrial Revolution. There is a long tradition of demographic studies estimating the population sizes of medieval European cities, and comparative analyses of these data have shed much light on the long-term evolution of urban systems. However, the next step-to systematically relate the population size of these cities to their spatial and socioeconomic characteristics-has seldom been taken. This raises a series of interesting questions, as both modern and ancient cities have been observed to obey area-population relationships predicted by settlement scaling theory. To address these questions, we analyze a new dataset for the settled area and population of 173 European cities from the early fourteenth century to determine the relationship between population and settled area. To interpret this data, we develop two related models that lead to differing predictions regarding the quantitative form of the population-area relationship, depending on the level of social mixing present in these cities. Our empirical estimates of model parameters show a strong densification of cities with city population size, consistent with patterns in contemporary cities. Although social life in medieval Europe was orchestrated by hierarchical institutions (e.g., guilds, church, municipal organizations), our results show no statistically significant influence of these institutions on agglomeration effects. The similarities between the empirical patterns of settlement relating area to population observed here support the hypothesis that cities throughout history share common principles of organization that self-consistently relate their socioeconomic networks to structured urban spaces.	[Cesaretti, Rudolf; Smith, Michael E.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA; [Lobo, Jose] Arizona State Univ, Sch Sustainabil, Tempe, AZ 85281 USA; [Bettencourt, Luis M. A.; Ortman, Scott G.] Santa Fe Inst, 1399 Hyde Pk Rd, Santa Fe, NM 87501 USA; [Ortman, Scott G.] Univ Colorado Boulder, Dept Anthropol, Boulder, CO 80309 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; The Santa Fe Institute; University of Colorado System; University of Colorado Boulder	Cesaretti, R (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA.	Rudolf.Cesaretti@asu.edu	Smith, Michael E/A-2935-2008; Bettencourt, Luis/R-9861-2019	Smith, Michael E/0000-0002-0677-8206; Cesaretti, Rudolf/0000-0002-7003-1211	Arizona State University Santa Fe Institute Center for Biosocial Complex Systems; Scott Ortman's James S. McDonnell Foundation [220020438]; Luis Bettencourt's John Templeton Foundation [15705]	Arizona State University Santa Fe Institute Center for Biosocial Complex Systems; Scott Ortman's James S. McDonnell Foundation; Luis Bettencourt's John Templeton Foundation	The (joint) Arizona State University Santa Fe Institute Center for Biosocial Complex Systems funded Rudolf Cesaretti's data collection and analysis, and preparation of the manuscript, through a Research Assistantship. Scott Ortman's James S. McDonnell Foundation Grant (grant #220020438; www.jsmf.org) assisted in this ongoing research program and paid for publication fees. This research builds off of work undertaken via Luis Bettencourt's John Templeton Foundation Grant (grant #15705; www.templeton.org), and therefore assisted in making this research a reality.	Allen P. M., 1996, CITIES REGIONS SELF; Allen R. C, 2009, BRIT IND REVOLUTION; Alonso W., 1964, LOCATION LAND USE; Ammann H, 1969, STADT MITTELALTERS, P408; [Anonymous], 1989, EUROPEAN HEGEMONYTHE; Bairoch P., 1991, CITIES EC DEV DAWN H, DOI [10.5744/bi.2019.1010, DOI 10.5744/BI.2019.1010]; Bairoch P., 1988, POPULATION VILLES EU; Balchin P. N., 2008, URBAN DEV RENAISSANC; Barley M. W., 1976, PLANS TOPOGRAPHY MED; Batty M., 1994, FRACTAL CITIES; Beloch KJ, 1961, BEVOLKERUNGSGESCHICH; Beresford Maurice., 1967, NEW TOWNS MIDDLE AGE; Bettencourt L. M. A., 2013, 1301004 SANT FE I; Bettencourt LMA, 2013, 201301004 SANT FE I; Bettencourt LMA, 2015, 201506020 SANT FE I; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Blockmans W, 2008, NEW CAMBRIDGE MEDIEV, VV, P405; Braudel F, 1979, WHEELS COMMERCE; Braudel F, 1979, STRUCTURE EVERYDAY L; Braudel Fernand., 1979, PERSPECTIVE WORLD; Bretagnolle A, 1997, EUROPEAN J GEOGRAPHY, V61; Britnell R., 2000, TRADE URBAN HINTERLA; BRITNELL RH, 1991, ECON HIST REV, V44, P21; Britnell RH, 2000, CAMBRIDGE URBAN HIST, VI, P313; Britnell Richard, 2000, CAMBRIDGE URBAN HIST, VI, P105; Britnell Richard H, 1993, COMMERCIALIZATION EN; Caille J, 1998, URBAN RURAL COMMUNIT, P51; Campbell BMS, 2008, ECON HIST REV, V61, P896, DOI 10.1111/j.1468-0289.2007.00407.x; Campbell Bruce M. S., 1993, MEDIEVAL CAPITAL ITS; Carpentier Elisabeth, 1996, FRANCE 11 15 SIECLE; CARTER Harold, 1983, INTRO URBAN HIST GEO; Challier MCT, 2011, REV EUROP STUD, V3, P13; Chandler T, 1987, 4000 YEARS URBAN GRO, DOI [10.5744/bi.2019.1012, DOI 10.5744/BI.2019.1012]; Clark D., 2003, URBAN WORLD GLOBAL C, V2nd ed.; Clark Peter, 2009, EUROPEAN CITIES TOWN; Conzen M.R., 2004, THINKING URBAN FORM; Cox E, 2008, NEW CAMBRIDGE MEDIEV, VV, P358; Creighton Oliver., 2005, MEDIEVAL TOWN WALLS; Cuenca Esteban J., 2004, EXCEPTIONALISM IND B; Davids K, 2014, INNOVATION AND CREATIVITY IN LATE MEDIEVAL AND EARLY MODERN EUROPEAN CITIES, P1; de Vries Jan, 1984, EUROPEAN URBANIZATIO; DELONG JB, 1993, J LAW ECON, V36, P671, DOI 10.1086/467294; Dobson B, 2000, CAMBRIDGE URBAN HIST, VI, P273; Dyer A, 2000, CAMBRIDGE URBAN HIST, VI, P741; Dyer C. C., 2000, CAMBRIDGE URBAN HIST, VI, P505; Edwards J, 2012, EXPLOR ECON HIST, V49, P131, DOI 10.1016/j.eeh.2011.12.002; Engels F, 1952, CONDITION WORKING CL; Epstein S., 1991, WAGE LABOR GUILDS ME; EPSTEIN SR, 1993, ECON HIST REV, V46, P453; Fenwick C., 1998, POLL TAXES 1377 1379; Franceschi F., 2004, ITALY AGE RENAISSANC, P124; Fujita M., 2001, SPATIAL EC CITIES RE; Geremek Bronislaw, 1987, MARGINS SOC LATE MED; Gies Joseph, 1969, LIFE MEDIEVAL CITY; Glaeser EL, 2004, PAP REG SCI, V83, P197, DOI 10.1007/s10110-003-0183-x; Glasscock R.E., 1975, LAY SUBSIDY 1334; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; HADWIN JF, 1983, ECON HIST REV, V36, P200; Haggett P, 1969, NETWORK ANAL GEOGRAP; HAUSER PM, 1965, STUDY URBANIZATION; Heers Jacques, 1990, VILLE MOYEN AGE OCCI; Henrich J, 2016, SECRET OF OUR SUCCESS: HOW CULTURE IS DRIVING HUMAN EVOLUTION, DOMESTICATING OUR SPECIES, AND MAKING US SMARTER, P1; Hilton RH, 1995, ENGLISH FRENCH TOWNS; Jones CI, 2010, AM ECON J-MACROECON, V2, P224, DOI 10.1257/mac.2.1.224; Jordan WC, 2008, NEW CAMBRIDGE MEDIEV, VV, P279; JORDAN William Chester, 1996, GREAT FAMINE NO EURO; Kander A., 2014, POWER PEOPLE ENERGY; Keene Derek, 2000, CAMBRIDGE URBAN HIST, V1, P187; Keene DJ, 1976, PLANS TOPOGRAPHY MED, P71; Kent D., 2004, ITALY AGE RENAISSANC, P165; Kermode J., 2000, CAMBRIDGE URBAN HIST, VI, P441; King D.J.C., 1983, CASTELLARIUM ANGLICA; Klasen S, 2006, J POPUL ECON, V19, P25, DOI 10.1007/s00148-005-0030-2; Kriedte P., 1981, IND IND RURAL IND GE; Lenski G. E., 1966, POWER PRIVILEGE THEO, DOI [10.1007/BF00602744, DOI 10.1007/BF00602744]; Lilley Keith, 2002, URBAN LIFE MIDDLE AG; Lilley Keith D., 2000, TOWNS DECLINE AD 100, P235; Lobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058407; Lopez R. S., 1971, COMMERCIAL REVOLUTIO; Malanima P, 2005, ITALIAN URBAN POPULA, P1300; Malanima P., 2012, AGRARIAN CHANGE CRIS; Malanima P., 2009, JB GESCH LANDLICHEN, V6, P18; Malanima P, 2005, EUR REV ECON HIST, V9, P97, DOI 10.1017/S1361491604001327; Martines Lauro, 1988, POWER IMAGINATION CI; MENDELS FF, 1972, J ECON HIST, V32, P241, DOI 10.1017/S0022050700075495; Michaud F, 1998, URBAN RURAL COMMUNIT, P275; Mokyr Joel, 1992, LEVER RICHES TECHNOL; Mols R., 1954, INTRO DEMOGRAPHIE HI; Mols R, 1955, INTRO DEMOGRAPHIE HI, VII; Munro J. H., 2012, STUDIES MEDIEVAL REN, VIX, P45; Najemy JM, 2004, ITALY AGE RENAISSANC, P184; Nicholas, 1987, METAMORPHOSIS MEDIEV; Nicholas D., 1992, MEDIEVAL FLANDERS, V2nd; Nicholas David, 2003, URBAN EUROPE 1100 17; Nicholas David, 1997, LATER MEDIEVAL CITY; Nicholas David, 1997, GROWTH MEDIEVAL CITY; Nightingale P, 2000, PAST PRESENT, P36; Nightingale P, 2002, WORD IMAGE NUMBER CO; Nightingale P, 2000, TRADE URBAN HINTERLA, P83; Nightingale Pamela., 2002, CREDIT DEBT MEDIEVAL, P89; Nightingale Pamela, 2004, MEDIEVAL MONEY MATTE, P51; Ogilvie S, 1996, PROTOINDUSTRIALIZATI; Ogilvie S, 2014, J ECON PERSPECT, V28, P169, DOI 10.1257/jep.28.4.169; Ortman SG, 2016, J ARCHAEOL SCI, V73, P94, DOI 10.1016/j.jas.2016.07.012; Ortman SG, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400066; Ortman SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087902; OSullivan Arthur., 2011, URBAN EC, V8th; Palliser DM, 2000, CAMBRIDGE URBAN HIST, VI; Pirenne H., 1927, VILLES MOYEN AGE ESS; Pirenne H., 1946, MEDIEVAL CITIES THEI; Pirenne Henri, 1937, EC SOCIAL HIST MEDIE; Postan M.M., 1972, MEDIEVAL EC SOC EC H; Pounds N., 2005, THE MEDIEVAL CITY; Pumain D., 2000, GEOGR ANN B, V82B, P73, DOI [10.1111/1468-0467.00075, DOI 10.1111/J.0435-3684.2000.00075.X, DOI 10.1111/j.0435-3684.2000.00075.x]; Pumain D., 2006, CYBERGEO EUROPEAN J; R Core Team, 2013, R LANG ENV STAT COMP; Reyerson Kathryn, 1998, URBAN RURAL COMMUNIT, P253; Rigby SH, 2000, CAMBRIDGE URBAN HIST, VI; Rollo-Koster J, 1998, URBAN RURAL COMMUNIT, P73; RUSSELL JC, 1972, MEDIEVAL REGIONS THE; Russell JC., 1948, BRIT MEDIEVAL POPULA; Rutledge E, 1988, URBAN HIST YB, V15, P15; Rutledge Elizabeth, 1995, URBAN HIST, V22, P7; Schofield J., 2000, CAMBRIDGE URBAN HIST, V1, P371; Schofield J, 2003, ARCHAELOGY MEDIEVAL, V2nd; Shapiro C., 1999, INFORM RULES STRATEG; Sjoberg G., 1960, PREINDUSTRIAL CITY P; Spufford P., 2003, POWER PROFIT MERCHAN; Strange William C, 2008, NEW PALGRAVE DICT EC; Thisse, 2004, HDB REGIONAL URBAN E, P2063, DOI [10.1016/S1574-0080(04)80005-1, DOI 10.1016/S1574-0080(04)80005-1]; Thunen J.H. von, 1966, ISOLATED STATE; Tonnies F., 1887, GEMEINSCHAFT GESELLS; van Bavel B., 2010, MANORS MARKETS EC SO; Wallerstein I, 1989, 2 ERA GREAT EXPANSIO; Weber M, 1968, CITY; Weber M., 1978, EC SOC OUTLINE INTER; Weber Max, 1964, WIRTSCHAFT GESELLSCH, Vfirst half; White R., 2015, MODELING CITIES REGI, DOI 10.7551/mitpress/9780262029568.001.0001; Williamson O.E., 1991, NATURE FIRM ORIGINS; Wilson Richard, 2004, MEDIEVAL NORWICH, P157; Wolfe M, 2009, WALLED TOWNS AND THE SHAPING OF FRANCE: FROM THE MEDIEVAL TO THE EARLY MODERN ERA, P1, DOI 10.1057/9780230101128; Wrigley E. A., 2010, ENERGY ENGLISH IND R; Wrigley E.A., 2004, POVERTY PROGR POPULA; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; Zorzi Andrea, 2004, ITALY AGE RENAISSANC, P145	146	38	40	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162678	10.1371/journal.pone.0162678	http://dx.doi.org/10.1371/journal.pone.0162678			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706192	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200019
J	Dankai, W; Pongpom, M; Youngchim, S; Cooper, CR; Vanittanakom, N				Dankai, Wiyada; Pongpom, Monsicha; Youngchim, Sirida; Cooper, Chester R., Jr.; Vanittanakom, Nongnuch			The yapA Encodes bZIP Transcription Factor Involved in Stress Tolerance in Pathogenic Fungus Talaromyces marneffei	PLOS ONE			English	Article							PENICILLIUM-MARNEFFEI; OXIDATIVE STRESS; CANDIDA-ALBICANS; GENE; INFECTION; YEAST; HOMOLOG; RESISTANCE; PATHWAYS; PATIENT	Talaromyces marneffei, formerly Penicillium marneffei, is a thermally dimorphic fungus. It causes a fatal disseminated disease in patients infected with the human immunodeficiency virus (HIV). Studies on the stress defense mechanism of T. marneffei can lead to a better understanding of the pathogenicity and the progression of the disease due to this fungus. The basic leucine-zipper (bZip) transcription factor gene in Saccharomyces cerevisiae, named yap1 (yeast activating protein-1), is known as a crucial central regulator of stress responses including those caused by oxidative agents, cadmium, and drugs. An ortholog of yap1, designated yapA, was identified in T. marneffei. We found that the yapA gene was involved in growth and fungal cell development. The yapA deletion mutant exhibited delays in the rate of growth, germination, and conidiation. Surprisingly, the yapA gene was also involved in the pigmentation of T. marneffei. Moreover, the mutant was sensitive to oxidative stressors such as H2O2 and menadione, similar to S. cerevisiae yap1 mutant, as well as the nitrosative stressor NaNO2. In addition, the yapA mutant demonstrated significantly decreased survival in human macrophage THP-1 compared to wild-type and complemented strains. This study reveals the role of yapA in fungal growth, cell development, stress response, and potential virulence in T. marneffei.	[Dankai, Wiyada; Pongpom, Monsicha; Youngchim, Sirida; Vanittanakom, Nongnuch] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai, Thailand; [Cooper, Chester R., Jr.] Youngstown State Univ, Ctr Appl Chem Biol, One Univ Plaza, Youngstown, OH USA; [Cooper, Chester R., Jr.] Youngstown State Univ, Dept Biol Sci, One Univ Plaza, Youngstown, OH USA	Chiang Mai University; University System of Ohio; Youngstown State University; University System of Ohio; Youngstown State University	Vanittanakom, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai, Thailand.	drnongnuch@gmail.com	Pongpom, Monsicha/AAH-9133-2019	Pongpom, Monsicha/0000-0003-4822-5850	"National Research University" Project under Thailand's Office of the Higher Education Commission; Faculty of Medicine, Chiang Mai University	"National Research University" Project under Thailand's Office of the Higher Education Commission; Faculty of Medicine, Chiang Mai University	This work was supported by the "National Research University" Project under Thailand's Office of the Higher Education Commission, and the Faculty of Medicine, Chiang Mai University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Borneman AR, 2001, GENETICS, V157, P1003; Bugeja HE, 2012, FUNGAL GENET BIOL, V49, P772, DOI 10.1016/j.fgb.2012.08.003; Campos EG, 2005, GENET MOL RES, V4, P409; Cao CW, 2009, MYCOPATHOLOGIA, V168, P23, DOI 10.1007/s11046-009-9192-x; Cartwright GM, 2013, EUKARYOT CELL, V12, P1335, DOI 10.1128/EC.00129-13; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; Ikner A, 2005, MUTAT RES-FUND MOL M, V569, P13, DOI 10.1016/j.mrfmmm.2004.09.006; Lee PPW, 2014, J ALLERGY CLIN IMMUN, V133, P894, DOI 10.1016/j.jaci.2013.08.051; Lessing F, 2007, EUKARYOT CELL, V6, P2290, DOI 10.1128/EC.00267-07; Lin CH, 2009, MOL PLANT MICROBE IN, V22, P942, DOI 10.1094/MPMI-22-8-0942; Lo Y, 2000, T ROY SOC TROP MED H, V94, P187, DOI 10.1016/S0035-9203(00)90271-2; Luo DQ, 2011, MYCOPATHOLOGIA, V171, P191, DOI 10.1007/s11046-010-9363-9; Ma Bosco H M, 2009, Can Respir J, V16, pe50; Molina L, 2007, PLANT CELL, V19, P2293, DOI 10.1105/tpc.107.052332; Moye-Rowley WS, 2008, BRIT MYCOL SOC, V27, P275; Nimmanee P, 2015, INT J MED MICROBIOL, V305, P65, DOI 10.1016/j.ijmm.2014.11.003; Nimmanee P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111200; Patassi Akouda Akessiwe, 2013, BMC Res Notes, V6, P506, DOI 10.1186/1756-0500-6-506; Pongpom P, 2005, MED MYCOL, V43, P403, DOI 10.1080/13693780400007144; SCHNELL N, 1992, CURR GENET, V21, P269, DOI 10.1007/BF00351681; Sripa C, 2010, J MED ASS THAI S3, V93, P69; Thirach S, 2007, MED MYCOL, V45, P409, DOI 10.1080/13693780701381271; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Toone WM, 1999, CURR OPIN GENET DEV, V9, P55, DOI 10.1016/S0959-437X(99)80008-2; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Vanittanakom Nongnuch, 1997, Current Topics in Medical Mycology, V8, P35; Wang Y, 2006, FREE RADICAL BIO MED, V40, P1201, DOI 10.1016/j.freeradbiomed.2005.11.019; Woo PCY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06728; WU AL, 1994, MOL CELL BIOL, V14, P5832, DOI 10.1128/MCB.14.9.5832	31	11	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163778	10.1371/journal.pone.0163778	http://dx.doi.org/10.1371/journal.pone.0163778			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706212	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697200058
J	Othman, SA; Majawit, LP; Hassan, WNW; Wey, MC; Razi, RM				Othman, Siti Adibah; Majawit, Lynnora Patrick; Hassan, Wan Nurazreena Wan; Wey, Mang Chek; Razi, Roziana Mohd			Anthropometric Study of Three-Dimensional Facial Morphology in Malay Adults	PLOS ONE			English	Article							SOFT-TISSUE LANDMARKS; WHITE-POPULATIONS; SEXUAL-DIMORPHISM; REPRODUCIBILITY; CHINESE; HEAD; AGE	Objectives To establish the three-dimensional (3D) facial soft tissue morphology of adult Malaysian subjects of the Malay ethnic group; and to determine the morphological differences between the genders, using a non-invasive stereo-photogrammetry 3D camera. Material and Methods One hundred and nine subjects participated in this research, 54 Malay men and 55 Malay women, aged 20-30 years old with healthy BMI and with no adverse skeletal deviation. Twenty-three facial landmarks were identified on 3D facial images captured using a VECTRA M5-360 Head System (Canfield Scientific Inc, USA). Two angular, 3 ratio and 17 linear measurements were identified using Canfield Mirror imaging software. Intra-and inter-examiner reliability tests were carried out using 10 randomly selected images, analyzed using the intra-class correlation coefficient (ICC). Multivariate analysis of variance (MANOVA) was carried out to investigate morphologic differences between genders. Results ICC scores were generally good for both intra-examiner (range 0.827-0.987) and inter-examiner reliability (range 0.700-0.983) tests. Generally, all facial measurements were larger in men than women, except the facial profile angle which was larger in women. Clinically significant gender dimorphisms existed in biocular width, nose height, nasal bridge length, face height and lower face height values (mean difference > 3mm). Clinical significance was set at 3mm. Conclusion Facial soft tissue morphological values can be gathered efficiently and measured effectively from images captured by a non-invasive stereo-photogrammetry 3D camera. Adult men in Malaysia when compared to women had a wider distance between the eyes, a longer and more prominent nose and a longer face.	[Othman, Siti Adibah; Majawit, Lynnora Patrick; Hassan, Wan Nurazreena Wan; Wey, Mang Chek; Razi, Roziana Mohd] Univ Malaya, Dept Paediat Dent & Orthodont, Kuala Lumpur, Malaysia; [Othman, Siti Adibah; Hassan, Wan Nurazreena Wan; Wey, Mang Chek; Razi, Roziana Mohd] Univ Malaya, Clin Craniofacial Dent Res Grp, Fac Dent, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Othman, SA (corresponding author), Univ Malaya, Dept Paediat Dent & Orthodont, Kuala Lumpur, Malaysia.; Othman, SA (corresponding author), Univ Malaya, Clin Craniofacial Dent Res Grp, Fac Dent, Kuala Lumpur, Malaysia.	sitiadibah@um.edu.my	WEY, MANG CHEK/C-1039-2010; Hassan, Wan Wan/R-2690-2019; Hassan, Wan N Wan/F-8889-2010; razi, roziana mohd/G-4994-2011; Othman, Siti Adibah/B-9784-2010	WEY, MANG CHEK/0000-0003-0188-0727; Hassan, Wan Wan/0000-0003-1627-3671; Hassan, Wan N Wan/0000-0003-1627-3671; razi, roziana mohd/0000-0003-3398-2672; Othman, Siti Adibah/0000-0002-3846-7701	University Malaya High Impact Research Grant - SAO [UM.C/625/1/HIR/MOHE/DENT/13]; University Malaya Postgraduate Research Fund [PPPC/C1-2013/DKGC/04]	University Malaya High Impact Research Grant - SAO; University Malaya Postgraduate Research Fund	UM.C/625/1/HIR/MOHE/DENT/13 http://hir.um.edu.my/ University Malaya High Impact Research Grant - SAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PPPC/C1-2013/DKGC/04 http://umresearch.um.edu.my/index.php University Malaya Postgraduate Research Fund - LPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khatib AR, 2012, CLEFT PALATE-CRAN J, V49, P463, DOI 10.1597/11-151; Al-Khatib AR, 2010, ARCH OROFAC SCI, V5, P1; [Anonymous], 2010, MAL DIET GUID, P20; [Anonymous], 2005, EUR J ORTHODONT, V27, P562, DOI [10.1093/ejo/cji052, DOI 10.1093/EJO/CJI052]; Baik Hyoung-Seon, 2006, World J Orthod, V7, P7; Baik HS, 2007, AM J ORTHOD DENTOFAC, V131, P759, DOI 10.1016/j.ajodo.2005.08.038; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bastir M, 2011, AM J PHYS ANTHROPOL, V146, P414, DOI 10.1002/ajpa.21596; Bozic M, 2009, ANGLE ORTHOD, V79, P640, DOI 10.2319/081608-432.1; Brons S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041898; Buretic-Tomljanovic A, 2007, ANN HUM BIOL, V34, P296, DOI 10.1080/03014460701211017; Dong Y, 2011, J ORAL MAXIL SURG, V69, P1195, DOI 10.1016/j.joms.2010.05.023; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Fang JJ, 2011, LECT NOTES COMPUT SC, V6777, P12, DOI 10.1007/978-3-642-21799-9_2; Farkas LG, 2005, J CRANIOFAC SURG, V16, P615, DOI 10.1097/01.scs.0000171847.58031.9e; Farkas LG, 1996, AM J MED GENET, V65, P1, DOI 10.1002/ajmg.1320650102; Gor T, 2010, AM J ORTHOD DENTOFAC, V137, P424, DOI 10.1016/j.ajodo.2008.12.022; Gwilliam JR, 2006, EUR J ORTHODONT, V28, P408, DOI 10.1093/ejo/cjl024; Hajnis Karle, 1994, P201; Holton NE, 2014, AM J PHYS ANTHROPOL, V153, P52, DOI 10.1002/ajpa.22402; Hubbe M, 2009, ANAT REC, V292, P1720, DOI 10.1002/ar.20976; Jayaratne YSN, 2014, CRANIOMAX TRAUM REC, V7, P101, DOI 10.1055/s-0034-1371540; Kau C H, 2006, Orthod Craniofac Res, V9, P10, DOI 10.1111/j.1601-6343.2006.00359.x; Kau CH, 2010, AM J DENTOFACIAL ORT, V137, pe51, DOI DOI 10.1016/J.AJ0D0.2009.04.022; Kau CH, 2010, 3 DIEMENSIONAL IMAGI, DOI [10.1002/9781118786642, DOI 10.1002/9781118786642]; Lin CS, 2013, BANGLADESH J MED SCI, V12, P209, DOI 10.3329/bjms.v12i2.14951; Little BB, 2006, AM J PHYS ANTHROPOL, V131, P127, DOI 10.1002/ajpa.20406; MOORREES CFA, 1958, AM J PHYS ANTHROPOL, V16, P213, DOI 10.1002/ajpa.1330160206; Ngeow WC, 2009, SINGAP MED J, V50, P525; Othman SA, 2014, BRIT J ORAL MAX SURG, V52, P208, DOI 10.1016/j.bjoms.2013.11.008; Othman SA, 2013, AUST ORTHOD J, V29, P58; Ozdemir ST, 2009, AESTHET PLAST SURG, V33, P175, DOI 10.1007/s00266-008-9274-z; Plooij JM, 2011, INT J ORAL MAX SURG, V40, P341, DOI 10.1016/j.ijom.2010.10.013; Reksodiputro MH, 2009, ARCH FACIAL PLAST S, V11, P347, DOI 10.1001/archfacial.2009.59; Rosas A, 2002, AM J PHYS ANTHROPOL, V117, P236, DOI 10.1002/ajpa.10023; Savoye I, 1998, ANGLE ORTHOD, V68, P467; Seager DC, 2009, ANGLE ORTHOD, V79, P991, DOI 10.2319/111408-579.1; Smith R, 2009, ARCH ORAL BIOL, V54, pS118, DOI 10.1016/j.archoralbio.2008.05.018; Torlakovic L, 2011, ANGLE ORTHOD, V81, P50, DOI 10.2319/042110-215.1; Wen YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134525; Wirthlin J, 2013, INT J ORAL MAX SURG, V42, P1100, DOI 10.1016/j.ijom.2013.03.008; Wong JY, 2008, CLEFT PALATE-CRAN J, V45, P232, DOI 10.1597/06-175	43	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164180	10.1371/journal.pone.0164180	http://dx.doi.org/10.1371/journal.pone.0164180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706220	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697200096
J	Payne, L; Heard, PJ; Scott, TB				Payne, Liam; Heard, Peter J.; Scott, Thomas B.			Examination of Surface Deposits on Oldbury Reactor Core Graphite to Determine the Concentration and Distribution of C-14	PLOS ONE			English	Article							RAMAN-SPECTROSCOPIC CHARACTERIZATION; IRRADIATED GRAPHITE; NUCLEAR GRAPHITE	Pile Grade A graphite was used as a moderator and reflector material in the first generation of UK Magnox nuclear power reactors. As all of these reactors are now shut down there is a need to examine the concentration and distribution of long lived radioisotopes, such as C-14, to aid in understanding their behaviour in a geological disposal facility. A selection of irradiated graphite samples from Oldbury reactor one were examined where it was observed that Raman spectroscopy can distinguish between underlying graphite and a surface deposit found on exposed channel wall surfaces. The concentration of C-14 in this deposit was examined by sequentially oxidising the graphite samples in air at low temperatures (450 degrees C and 600 degrees C) to remove the deposit and then the underlying graphite. The gases produced were captured in a series of bubbler solutions that were analysed using liquid scintillation counting. It was observed that the surface deposit was relatively enriched with C-14, with samples originating lower in the reactor exhibiting a higher concentration of C-14. Oxidation at 600 degrees C showed that the remaining graphite material consisted of two fractions of C-14, a surface associated fraction and a graphite lattice associated fraction. The results presented correlate well with previous studies on irradiated graphite that suggest there are up to three fractions of C-14; a readily releasable fraction (corresponding to that removed by oxidation at 450 degrees C in this study), a slowly releasable fraction (removed early at 600 degrees C in this study), and an unreleasable fraction (removed later at 600 degrees C in this study).	[Payne, Liam; Heard, Peter J.; Scott, Thomas B.] Univ Bristol, Interface Anal Ctr, Bristol BS8 1TL, Avon, England	University of Bristol	Payne, L (corresponding author), Univ Bristol, Interface Anal Ctr, Bristol BS8 1TL, Avon, England.	Liam.Payne@bristol.ac.uk	Heard, Peter J/C-2155-2008	Heard, Peter J/0000-0002-8926-4680	Engineering and Physical Sciences Research Council (EPSRC); Radioactive Waste Management (RWM) [EP/I036354/1]; Engineering and Physical Sciences Research Council [EP/I036354/1] Funding Source: researchfish; EPSRC [EP/I036354/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Radioactive Waste Management (RWM); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Engineering and Physical Sciences Research Council (EPSRC) and Radioactive Waste Management (RWM) under the contract GeoWaste (EP/I036354/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baston GMN, 2012, MINERAL MAG, V76, P3293, DOI 10.1180/minmag.2012.076.8.42; Baston GMN, 2014, CARBON 14 RELEASE OL; Black G, 2013, MODELLING MEASURING; Brown T, 2013, WAST MAN S 2013 P PH; Cleaver J, 2012, WAST MAN S 2012 P PH; Cleaver J, 2014, WAST MAN S 2014 P PH; Dunzik-Gougar ML, 2014, J NUCL MATER, V451, P328, DOI 10.1016/j.jnucmat.2014.03.018; Dunzik-Gougar ML, 2013, WAST MAN S 2013 P PH; El-Genk MS, 2011, J NUCL MATER, V411, P193, DOI 10.1016/j.jnucmat.2011.01.129; Fachinger J, 2008, NUCL ENG DES, V238, P3086, DOI 10.1016/j.nucengdes.2008.02.010; Fuller L, 1997, J NUCL MATER, V240, P241, DOI 10.1016/S0022-3115(96)00462-X; GULBRANSEN EA, 1963, J ELECTROCHEM SOC, V110, P476, DOI 10.1149/1.2425797; Handy BJ, 2006, 11996TR001 NNC; Heard PJ, 2014, J NUCL MATER, V445, P91, DOI 10.1016/j.jnucmat.2013.10.058; JAWHARI T, 1995, CARBON, V33, P1561, DOI 10.1016/0008-6223(95)00117-V; Jones AN, 2008, J NUCL MATER, V381, P152, DOI 10.1016/j.jnucmat.2008.07.038; Kim HR, 2011, PROGR NUCL SCI TECHN, V1, P412, DOI [10.15669/pnst.1.412, DOI 10.15669/PNST.1.412]; KNIGHT DS, 1989, J MATER RES, V4, P385, DOI 10.1557/JMR.1989.0385; Krishna R, 2015, RADIAT PHYS CHEM, V107, P121, DOI 10.1016/j.radphyschem.2014.10.005; LaBrier D, 2014, J NUCL MATER, V448, P113, DOI 10.1016/j.jnucmat.2014.01.041; Marshall TA, 2011, LONGER TERM RELEASE; Metcalfe MP, 2015, ANN NUCL ENERGY, V75, P665, DOI 10.1016/j.anucene.2014.08.071; Metcalfe MP, 2016, ANNEX IAEA TECDOC 17; Mironov BE, 2012, J PHYS CONF SER, V371, DOI 10.1088/1742-6596/371/1/012017; Moskovic R, 2013, NUCL ENG DES, V263, P431, DOI 10.1016/j.nucengdes.2013.05.011; NIKIEL L, 1993, CARBON, V31, P1313, DOI 10.1016/0008-6223(93)90091-N; Nuclear Decommissioning Authority, 2013, HIGH ACT WAST LONG T; Nuclear Decommissioning Authority, 2012, GEOL DISP CARB 14 PR; Payne L, 2015, WAST MAN S 2015 P PH; Payne L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143041; Pimenta MA, 2007, PHYS CHEM CHEM PHYS, V9, P1276, DOI 10.1039/b613962k; Sadezky A, 2005, CARBON, V43, P1731, DOI 10.1016/j.carbon.2005.02.018; TUINSTRA F, 1970, J CHEM PHYS, V53, P1126, DOI 10.1063/1.1674108; von Lensa W, 2011, ATW-INT J NUCL POWER, V56, P263; Vulpius D, 2013, NUCL ENG DES, V265, P294, DOI 10.1016/j.nucengdes.2013.09.007; WANG Y, 1990, CHEM MATER, V2, P557, DOI 10.1021/cm00011a018; White I. F, 1984, ASSESSMENT GRAPHITE; Wickham AJ, 2010, GRAPHITE DUST EXPLOS; Wickham AJ, 1998, GRAPHITE CORE STABIL; Yim MS, 2006, PROG NUCL ENERG, V48, P2, DOI 10.1016/j.pnucene.2005.04.002	40	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164159	10.1371/journal.pone.0164159	http://dx.doi.org/10.1371/journal.pone.0164159			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706228	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200091
J	Lin, YS; Wang, HY; Huang, DF; Hsieh, PF; Lin, MY; Chou, CH; Wu, IJ; Huang, GJ; Gau, SSF; Huang, HS				Lin, Yi-Sian; Wang, Han-Ying; Huang, De-Fong; Hsieh, Pei-Fen; Lin, Meng-Ying; Chou, Chih-Hsuan; Wu, I-Ju; Huang, Guo-Jen; Gau, Susan Shur-Fen; Huang, Hsien-Sung			Neuronal Splicing Regulator RBFOX3 (NeuN) Regulates Adult Hippocampal Neurogenesis and Synaptogenesis	PLOS ONE			English	Article							MOUSE CEREBRAL NEOCORTEX; LONG-TERM DEPRESSION; KINASE-C INHIBITOR; POSTNATAL-DEVELOPMENT; GENE-EXPRESSION; CEREBELLAR DEVELOPMENT; MICE; BALANCE; LEARN; MOTOR	Dysfunction of RBFOX3 has been identified in neurodevelopmental disorders such as autism spectrum disorder, cognitive impairments and epilepsy and a causal relationship with these diseases has been previously demonstrated with Rbfox3 homozygous knockout mice. Despite the importance of RBFOX3 during neurodevelopment, the function of RBFOX3 regarding neurogenesis and synaptogenesis remains unclear. To address this critical question, we profiled the developmental expression pattern of Rbfox3 in the brain of wild-type mice and analyzed brain volume, disease-relevant behaviors, neurogenesis, synaptic plasticity, and synaptogenesis in Rbfox3 homozygous knockout mice and their corresponding wild-type counterparts. Here we report that expression of Rbfox3 differs developmentally for distinct brain regions. Moreover, Rbfox3 homozygous knockout mice exhibited cold hyperalgesia and impaired cognitive abilities. Focusing on hippocampal phenotypes, we found Rbfox3 homozygous knockout mice displayed deficits in neurogenesis, which was correlated with cognitive impairments. Furthermore, RBFOX3 regulates the exons of genes with synapse-related function. Synaptic plasticity and density, which are related to cognitive behaviors, were altered in the hippocampal dentate gyrus of Rbfox3 homozygous knockout mice; synaptic plasticity decreased and the density of synapses increased. Taken together, our results demonstrate the important role of RBFOX3 during neural development and maturation. In addition, abnormalities in synaptic structure and function occur in Rbfox3 homozygous knockout mice. Our findings may offer mechanistic explanations for human brain diseases associated with dysfunctional RBFOX3.	[Lin, Yi-Sian; Wang, Han-Ying; Huang, De-Fong; Hsieh, Pei-Fen; Lin, Meng-Ying; Chou, Chih-Hsuan; Wu, I-Ju; Gau, Susan Shur-Fen; Huang, Hsien-Sung] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan; [Huang, Guo-Jen] Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan; [Gau, Susan Shur-Fen] Natl Taiwan Univ, Coll Med, Dept Psychiat, Taipei, Taiwan; [Gau, Susan Shur-Fen; Huang, Hsien-Sung] Natl Taiwan Univ Hosp, Clin Ctr Neurosci & Behav, Taipei, Taiwan; [Gau, Susan Shur-Fen; Huang, Hsien-Sung] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei, Taiwan; [Huang, Hsien-Sung] Natl Taiwan Univ, PhD Program Translat Med, Taipei, Taiwan; [Huang, Hsien-Sung] Acad Sinica, Taipei, Taiwan; [Huang, Hsien-Sung] Neurodev Club Taiwan, Taipei, Taiwan	National Taiwan University; Chang Gung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Huang, HS (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei, Taiwan.; Huang, HS (corresponding author), Natl Taiwan Univ Hosp, Clin Ctr Neurosci & Behav, Taipei, Taiwan.; Huang, HS (corresponding author), Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei, Taiwan.; Huang, HS (corresponding author), Natl Taiwan Univ, PhD Program Translat Med, Taipei, Taiwan.; Huang, HS (corresponding author), Acad Sinica, Taipei, Taiwan.; Huang, HS (corresponding author), Neurodev Club Taiwan, Taipei, Taiwan.	huang.hsiensung@gmail.com	Gau, Susan Shur-Fen/P-4726-2017	Gau, Susan Shur-Fen/0000-0002-2718-8221; Huang, De-Fong/0000-0003-0289-3650; Huang, Guo-Jen/0000-0002-6392-2155; Huang, Hsien-Sung/0000-0003-2657-3635	Ministry of Science and Technology, Taiwan [NSC 102-2320-B-002-001, MOST 103-2320-B-002-057, MOST 104-2314-B-002-078-MY3]; National Taiwan University (AIM for Top University Excellent Research Project) [102C101-42, 103R4000]; National Research Program for Biopharmaceuticals (NRPB) at the Ministry of Science and Technology (MOST) of Taiwan [MOST 104-2325-B-001-011]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University (AIM for Top University Excellent Research Project); National Research Program for Biopharmaceuticals (NRPB) at the Ministry of Science and Technology (MOST) of Taiwan	This work was funded by the Ministry of Science and Technology, Taiwan (NSC 102-2320-B-002-001, MOST 103-2320-B-002-057 and MOST 104-2314-B-002-078-MY3 to H-S.H.), and National Taiwan University (AIM for Top University Excellent Research Project, 102C101-42 and 103R4000 to H-S.H. and S.S.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Welgene Company conducted RNA-Seq and its data analysis. We thank the Behavior Core Lab of the Neurobiology and Cognitive Science Center, National Taiwan University for technical and facility support. We also thank the staff of the imaging core at the First Core Labs, National Taiwan University College of Medicine, for technical assistance. We thank the Taiwan Mouse Clinic (MOST 104-2325-B-001-011) which is funded by the National Research Program for Biopharmaceuticals (NRPB) at the Ministry of Science and Technology (MOST) of Taiwan for technical support in Biospec 4.7T 40-cm bore horizontal MRI system experiment.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; BERGER TW, 1984, SCIENCE, V224, P627, DOI 10.1126/science.6324350; Bosch D, 2015, J PHYSIOL-LONDON, V593, P4387, DOI 10.1113/JP270645; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dehghani N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23176; Dredge BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021585; Drew LJ, 2013, LEARN MEMORY, V20, P710, DOI 10.1101/lm.026542.112; Duan W, 2016, MOL NEUROBIOL, V53, P1637, DOI 10.1007/s12035-015-9122-5; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eto R, 2010, INT J DEV NEUROSCI, V28, P359, DOI 10.1016/j.ijdevneu.2010.04.004; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Garthe A, 2016, HIPPOCAMPUS, V26, P261, DOI 10.1002/hipo.22520; Gehman LT, 2012, GENE DEV, V26, P445, DOI 10.1101/gad.182477.111; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Keays DA, 2010, DEV NEUROSCI-BASEL, V32, P268, DOI 10.1159/000319663; Kelsch W, 2010, ANNU REV NEUROSCI, V33, P131, DOI 10.1146/annurev-neuro-060909-153252; Kim KK, 2013, J CELL BIOL, V200, P443, DOI 10.1083/jcb.201206146; Lal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073323; Lee E, 2017, BIOL PSYCHIAT, V81, P838, DOI 10.1016/j.biopsych.2016.05.011; Leekam SR, 2007, J AUTISM DEV DISORD, V37, P894, DOI 10.1007/s10803-006-0218-7; LEUBA G, 1978, J HIRNFORSCH, V19, P301; LEUBA G, 1977, J HIRNFORSCH, V18, P461; Lim CR, 2004, GENE, V333, P3, DOI 10.1016/j.gene.2004.02.026; Lovci MT, 2013, NAT STRUCT MOL BIOL, V20, P1434, DOI 10.1038/nsmb.2699; Lucas CH, 2014, NEUROSCI LETT, V558, P97, DOI 10.1016/j.neulet.2013.10.037; Mahmmoud RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139739; Matoba R, 2000, PHYSIOL GENOMICS, V4, P155, DOI 10.1152/physiolgenomics.2000.4.2.155; Maxeiner S, 2014, HISTOCHEM CELL BIOL, V141, P43, DOI 10.1007/s00418-013-1159-9; Miller JA, 2013, DEVELOPMENT, V140, P4633, DOI 10.1242/dev.097212; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monteiro BMM, 2014, HIPPOCAMPUS, V24, P239, DOI 10.1002/hipo.22218; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Oomen CA, 2014, WIRES COGN SCI, V5, P573, DOI 10.1002/wcs.1304; Paul A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00037; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Tsai CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9373; Utami KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090852; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Volk LJ, 2006, J NEUROPHYSIOL, V95, P2427, DOI 10.1152/jn.00383.2005; Wang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17383; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yau SY, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/717958; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	48	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164164	10.1371/journal.pone.0164164	http://dx.doi.org/10.1371/journal.pone.0164164			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701470	Green Published, Green Submitted, gold			2022-12-27	WOS:000385696900048
J	Suzuki, Y; Fukushima, M; Sakuraba, K; Sawaki, K; Sekigawa, K				Suzuki, Yoshio; Fukushima, Minoru; Sakuraba, Keishoku; Sawaki, Keisuke; Sekigawa, Kazuaki			Krill Oil Improves Mild Knee Joint Pain: A Randomized Control Trial	PLOS ONE			English	Article							FATTY-ACIDS; SUPPLEMENTATION; OSTEOARTHRITIS; INFLAMMATION; MANAGEMENT; RATS	Background Krill oil is an edible oil extracted from krill, a small red-colored crustacean found in the Antarctic Ocean. The administration of krill oil is reported to mitigate inflammation in patients with cardiac disease, rheumatoid arthritis, or osteoarthritis. However, the effect of krill oil on mild knee pain has not yet been determined. Objective To assess the effect of krill oil on mild knee pain. Design A randomized, double-blind, parallel-group, placebo-controlled trial of fifty adults (38-85 years old) with mild knee pain attending the Fukushima Orthopedic Clinic (Tochigi, Japan) between September 2014 and March 2015. Interventions Participants were randomized to receive 2 g per day of either krill oil or an identical placebo for 30 days. Outcomes The primary outcome was improvement in subjective symptoms of knee pain as assessed by the Japanese Knee Osteoarthritis Measure (JKOM) and Japanese Orthopaedic Association score (JOA). Secondary outcomes included blood and urine biochemical parameters. Results Both the placebo and krill oil groups showed significant improvements in the questions in the JKOM and JOA questionnaires after administration. After the intervention, krill oil group showed more improvements than placebo group in two questions regarding the pain and stiffness in knees in JKOM. Controlling for age, sex, weight, and smoking and drinking habits, krill oil significantly mitigated knee pain in sleeping (P < 0.001), standing (P < 0.001) and the range of motion of both right and left knees (both P = 0.011) compared to placebo. Krill oil administration raised plasma EPA (P = 0.048) and EPA/AA ratio (P = 0.003). Conclusion This study indicates that krill oil administration (2 g/day, 30 days) improved the subjective symptoms of knee pain in adults with mild knee pain.	[Suzuki, Yoshio; Sakuraba, Keishoku; Sawaki, Keisuke] Juntendo Univ, Grad Sch Hlth & Sports Sci, Inzai, Chiba, Japan; [Suzuki, Yoshio; Sakuraba, Keishoku; Sawaki, Keisuke; Sekigawa, Kazuaki] Juntendo Univ, Fac Hlth & Sports Sci, Inzai, Chiba, Japan; [Fukushima, Minoru; Sakuraba, Keishoku] Juntendo Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Fukushima, Minoru] Fukushima Orthoped Clin, Nasushiobara, Tochigi, Japan	Juntendo University; Juntendo University; Juntendo University	Suzuki, Y (corresponding author), Juntendo Univ, Grad Sch Hlth & Sports Sci, Inzai, Chiba, Japan.; Suzuki, Y (corresponding author), Juntendo Univ, Fac Hlth & Sports Sci, Inzai, Chiba, Japan.	yssuzuki@juntendo.ac.jp	Suzuki, Yoshio/U-5586-2019	Suzuki, Yoshio/0000-0003-4982-5591				Akai M, 2005, J RHEUMATOL, V32, P1524; Bastick AN, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0670-x; Batetta B, 2009, J NUTR, V139, P1495, DOI 10.3945/jn.109.104844; Cicero AFG, 2015, CLIN LIPIDOL, V10, P1, DOI 10.2217/CLP.14.67; De Silva V, 2011, RHEUMATOLOGY, V50, P911, DOI 10.1093/rheumatology/keq379; Deutsch L, 2007, J AM COLL NUTR, V26, P39, DOI 10.1080/07315724.2007.10719584; Grimstad T, 2012, SCAND J GASTROENTERO, V47, P49, DOI 10.3109/00365521.2011.634025; GURALNIK JM, 1993, NEW ENGL J MED, V329, P110, DOI 10.1056/NEJM199307083290208; Ierna M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-136; Kirsch I, 2013, COMPLEMENT THER MED, V21, P102, DOI 10.1016/j.ctim.2012.12.003; Lopez HL, 2012, PM&R, V4, pS155, DOI 10.1016/j.pmrj.2012.02.023; Maki KC, 2009, NUTR RES, V29, P609, DOI 10.1016/j.nutres.2009.09.004; Monograph KO, 2010, ALTERN MED REV, V15, P84; Okuda M, 2012, J ORTHOP SCI, V17, P750, DOI 10.1007/s00776-012-0274-0; Sampalis Fotini, 2003, Altern Med Rev, V8, P171; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wendell SG, 2014, J ALLERGY CLIN IMMUN, V133, P1255, DOI 10.1016/j.jaci.2013.12.1087; Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014	18	11	11	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0162769	10.1371/journal.pone.0162769	http://dx.doi.org/10.1371/journal.pone.0162769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701428	gold, Green Published, Green Submitted			2022-12-27	WOS:000385696900003
J	Goertler, PAL; Scheuerell, MD; Simenstad, CA; Bottom, DL				Goertler, Pascale A. L.; Scheuerell, Mark D.; Simenstad, Charles A.; Bottom, Daniel L.			EstimatingCommon Growth Patterns in Juvenile Chinook Salmon (Oncorhynchus tshawytscha) from Diverse Genetic Stocks and a Large Spatial Extent	PLOS ONE			English	Article							RIVER ESTUARY; HABITAT QUALITY; LIFE-HISTORY; COLUMBIA; MICROSTRUCTURE; IDENTIFICATION; POPULATION; SURVIVAL; RATES; FISH	Life history variation in Pacific salmon (Oncorhynchus spp.) supports species resilience to natural disturbances and fishery exploitation. Within salmon species, life-history variation often manifests during freshwater and estuarine rearing, as variation in growth. To date, however, characterizing variability in growth patterns within and among individuals has been difficult via conventional sampling methods because of the inability to obtain repeated size measurements. In this study we related otolith microstructures to growth rates of individual juvenile Chinook salmon (O. tshawytscha) from the Columbia River estuary over a two-year period (2010-2012). We used dynamic factor analysis to determine whether there were common patterns in growth rates within juveniles based on their natal region, capture location habitat type, and whether they were wild or of hatchery origin. We identified up to five large-scale trends in juvenile growth rates depending on month and year of capture. We also found that hatchery fish had a narrower range of trend loadings for some capture groups, suggesting that hatchery fish do not express the same breadth of growth variability as wild fish. However, we were unable to resolve a relationship between specific growth patterns and habitat transitions. Our study exemplifies how a relatively new statistical analysis can be applied to dating or aging techniques to summarize individual variation, and characterize aspects of life history diversity.	[Goertler, Pascale A. L.; Simenstad, Charles A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Scheuerell, Mark D.; Bottom, Daniel L.] NOAA, Fish Ecol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Goertler, PAL (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	pascale.goertler@water.ca.gov	Scheuerell, Mark/N-6683-2016	Scheuerell, Mark/0000-0002-8284-1254	National Oceanic and Atmospheric Administration [EST-O10-1, W66QKZ20272260]; University of Washington School of Aquatic and Fishery Sciences [65-4094]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); University of Washington School of Aquatic and Fishery Sciences(University of Washington)	This study was funded by the National Oceanic and Atmospheric Administration (Administrative Code EST-O10-1, MIPR number W66QKZ20272260) and University of Washington School of Aquatic and Fishery Sciences (fellowship account number 65-4094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KW, 1999, MAR ECOL PROG SER, V187, P227, DOI 10.3354/meps187227; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson G. A., 2006, THESIS; Anderson SC, 2015, ECOL APPL, V25, P559, DOI 10.1890/14-0266.1; [Anonymous], THESIS; Bath GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1705, DOI 10.1016/S0016-7037(99)00419-6; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bottom D, 2012, CONTRIBUTION TIDAL F; Bottom DL, 2005, ESTUAR COAST SHELF S, V64, P79, DOI 10.1016/j.ecss.2005.02.008; Bottom DL, 2005, NMFSNWFSC70 NOAA US; Bradford MJ, 1997, CAN J FISH AQUAT SCI, V54, P1585, DOI 10.1139/cjfas-54-7-1585; Burke JL, 2004, THESIS; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Campbell L. A., 2010, THESIS OREGON STATE; CARL LM, 1984, CAN J FISH AQUAT SCI, V41, P1070, DOI 10.1139/f84-125; Dawley E.M., 1986, MIGRATIONAL CHARACTE; Duffy EJ, 2011, CAN J FISH AQUAT SCI, V68, P232, DOI 10.1139/F10-144; Fraser EDG, 2007, CLIMATIC CHANGE, V83, P495, DOI 10.1007/s10584-007-9240-9; Goertler PAL, 2016, ESTUAR COAST, V39, P542, DOI 10.1007/s12237-015-0002-z; GUNDERSON DR, 1990, ESTUARIES, V13, P59, DOI 10.2307/1351433; Hanson P. C., 1997, WISCUT97001 U WISC S; HEALEY MC, 1983, CAN FIELD NAT, V97, P427; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Holmes E, 2014, MULTIVARIATE AUTOREG; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Johnson GE, 2015, CAN J FISH AQUAT SCI, V72, P684, DOI 10.1139/cjfas-2014-0085; Johnson GE, 2010, ECOLOGY JUVENILE SAL, P312; Kalinowski S.T., 2007, ONCOR COMPUTER PROGR; Kitchell J.F., 1977, J FISH RES BOARD CAN, V34, P1910, DOI [DOI 10.1139/F77-258, 10.1139/f77-258]; Kjelson M, 1981, ESTUARINE COMP, P393; Kukulka T, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001382; LEVINGS CD, 1986, CAN J FISH AQUAT SCI, V43, P1386, DOI 10.1139/f86-172; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Marcoe K, 2013, HABITAT CHANGE LOWER; MARSHALL SL, 1982, CAN J FISH AQUAT SCI, V39, P542, DOI 10.1139/f82-077; McElhany P., 2000, NMFSNWFSC42 NOAA US; Meng L, 2000, MAR ECOL PROG SER, V201, P287, DOI 10.3354/meps201287; Miller JA, 2013, CAN J FISH AQUAT SCI, V70, P617, DOI 10.1139/cjfas-2012-0354; Miller JA, 2010, MAR ECOL PROG SER, V408, P227, DOI 10.3354/meps08613; Naiman RJ, 2012, P NATL ACAD SCI USA, V109, P21201, DOI 10.1073/pnas.1213408109; ( National Research Council) NRC, 1996, UPSTR SALM SOC PAC N; Necaise AMD, 2005, MAR ECOL PROG SER, V285, P157, DOI 10.3354/meps285157; NEILSON JD, 1985, CAN J FISH AQUAT SCI, V42, P899, DOI 10.1139/f85-114; Ohlberger J, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1333; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; REIMERS P E, 1973, Research Reports of the Fish Commission of Oregon, V4, P3; Reimers P.E., 1971, THESIS; Roegner C, 2015, SALMON HABITAT USE T; Roegner GC, 2014, T AM FISH SOC, V143, P1161, DOI 10.1080/00028487.2014.918055; Roegner GC, 2012, MAR COAST FISH, V4, P450, DOI 10.1080/19425120.2012.675982; Ruckelshaus MH, 2002, ANNU REV ECOL SYST, V33, P665, DOI 10.1146/annurev.ecolsys.33.010802.150504; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seeb LW, 2007, FISHERIES, V32, P540, DOI 10.1577/1548-8446(2007)32[540:DOASDD]2.0.CO;2; SHERWOOD CR, 1990, PROG OCEANOGR, V25, P299, DOI 10.1016/0079-6611(90)90011-P; Simenstad C.A., 1982, ESTUARINE COMP, P343; Simenstad CA, 2011, 20111228 US GEOL SUR; Simenstad CA, 1992, WATERSHED MANAGEMENT, P266; SOGARD SM, 1992, MAR ECOL PROG SER, V85, P35, DOI 10.3354/meps085035; Stachura MM, 2014, CAN J FISH AQUAT SCI, V71, P226, DOI 10.1139/cjfas-2013-0367; Sturrock AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122380; Teel DJ, 2014, N AM J FISH MANAGE, V34, P621, DOI 10.1080/02755947.2014.901258; Teel DJ, 2009, T AM FISH SOC, V138, P211, DOI 10.1577/T08-084.1; Thorson JT, 2014, J ANIM ECOL, V83, P157, DOI 10.1111/1365-2656.12117; Titus RG, 2004, AM FISH S S, V39, P181; Volk EC, 2010, T AM FISH SOC, V139, P535, DOI 10.1577/T08-163.1; Weitkamp LA, 2012, FISH B-NOAA, V110, P426; Zuur AF, 2003, ENVIRONMETRICS, V14, P665, DOI 10.1002/env.611	70	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162121	10.1371/journal.pone.0162121	http://dx.doi.org/10.1371/journal.pone.0162121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695094	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100011
J	Peng, YP; Zhu, Y; Yin, LD; Zhang, JJ; Guo, S; Fu, Y; Miao, Y; Wei, JS				Peng, Yun-Peng; Zhu, Yi; Yin, Ling-Di; Zhang, Jing-Jing; Guo, Song; Fu, Yue; Miao, Yi; Wei, Ji-Shu			The Expression and Prognostic Roles of MCMs in Pancreatic Cancer	PLOS ONE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; DOUBLE-HEXAMERIC MCM2-7; CLINICAL-SIGNIFICANCE; DNA-REPLICATION; COMPLEX; INTERACT; CDT1; PROLIFERATION; TRANSCRIPTION; ASSOCIATION	Objectives Minichromosome maintenance (MCM) proteins play important roles in DNA replication by interacting with other factors which participate in the regulation of DNA synthesis. Abnormal over-expression of MCMs was observed in numerous malignancies, such as colorectal cancer. However, the expression of MCMs in pancreatic cancer (PC) was less investigated so far. This study was designed to analyze the expression and prognostic roles of MCM1-10 in PC based on the data provided by The Cancer Genome Atlas (TCGA). Methods Pearson chi(2) test was applied to evaluate the association of MCMs expression with clinicopathologic indicators, and biomarkers for tumor biological behaviors. Kaplan-Meier plots and log-rank tests were used to assess survival analysis, and univariate and multivariate Cox proportional hazard regression models were used to recognize independent prognostic factors. Results MCM1-10 were generally expressed in PC samples. The levels of some molecules were markedly correlated with that of biomarkers for S phase, proliferation, gemcitabine resistance. And part of these molecules over-expression was significantly associated with indicators of disease progression, such as depth of tumor invasion and lymph node metastasis. Furthermore, MCM2, 4, 6, 8, and 10 over-expression was remarkably associated with shorter disease free survival time, and MCM2, 4,8, and 10 over-expression was associated with shorter overall survival time. Further multivariate analysis suggested that MCM8 was an independent prognostic factor for PC. Conclusion MCMs abnormal over-expression was significantly associated with PC progression and prognosis. These molecules could be regarded as prognostic and therapeutic biomarkers for PC. The roles of MCMs may be vitally important and the underlying mechanisms need to be furtherinvestigated.	[Peng, Yun-Peng; Zhu, Yi; Yin, Ling-Di; Zhang, Jing-Jing; Guo, Song; Fu, Yue; Miao, Yi; Wei, Ji-Shu] Nanjing Med Univ, Pancreas Inst, Nanjing 210029, Jiangsu, Peoples R China; [Peng, Yun-Peng; Zhu, Yi; Yin, Ling-Di; Zhang, Jing-Jing; Guo, Song; Fu, Yue; Miao, Yi; Wei, Ji-Shu] Nanjing Med Univ, Affiliated Hosp 1, Pancreas Ctr, Nanjing 210029, Jiangsu, Peoples R China; [Peng, Yun-Peng; Zhu, Yi; Yin, Ling-Di; Zhang, Jing-Jing; Guo, Song; Fu, Yue; Miao, Yi; Wei, Ji-Shu] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Miao, Y; Wei, JS (corresponding author), Nanjing Med Univ, Pancreas Inst, Nanjing 210029, Jiangsu, Peoples R China.; Miao, Y; Wei, JS (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Pancreas Ctr, Nanjing 210029, Jiangsu, Peoples R China.; Miao, Y; Wei, JS (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Jiangsu, Peoples R China.	miaoyi@njmu.edu.cn; weijishu@njmu.edu.cn			National Natural Science Foundation of China [81170336, 81272239]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funded by grant numbers: 81170336 and 81272239, website: http://www.nsfc.gov.cn/, full name of the funding institutions: National Natural Science Foundation of China, authors who received the funding: Yi Miao. Dr. Yi Miao designed this study.	Abraham DS, 2005, EUKARYOT CELL, V4, P1808, DOI 10.1128/EC.4.11.1808-1819.2005; Bryant VL, 2015, MOL CANCER RES, V13, P1296, DOI 10.1158/1541-7786.MCR-14-0464; Das M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069607; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; Giaginis C, 2011, DIGEST DIS SCI, V56, P777, DOI 10.1007/s10620-010-1348-5; Giaginis C, 2009, DIGEST DIS SCI, V54, P282, DOI 10.1007/s10620-008-0305-z; Homesley L, 2000, GENE DEV, V14, P913; Hua C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-526; Hussain SP, 2016, INT J BIOL SCI, V12, P270, DOI 10.7150/ijbs.14950; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Kikuchi J, 2011, LUNG CANCER, V72, P229, DOI 10.1016/j.lungcan.2010.08.020; Kwok HF, 2015, AM J CANCER RES, V5, P52; Lee C, 2004, NATURE, V430, P913, DOI 10.1038/nature02813; Lutzmann M, 2008, MOL CELL, V31, P190, DOI 10.1016/j.molcel.2008.07.001; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Nieduszynski CA, 2005, NUCLEIC ACIDS RES, V33, P2410, DOI 10.1093/nar/gki539; Nishimura K, 2012, MOL CELL, V47, P511, DOI 10.1016/j.molcel.2012.05.047; Padmanabhan V, 2004, J CLIN PATHOL, V57, P1057, DOI 10.1136/jcp.2004.016436; Park J, 2013, MOL CELL BIOL, V33, P1632, DOI 10.1128/MCB.01503-12; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Qin Y, 2014, CANCER LETT, V347, P225, DOI 10.1016/j.canlet.2014.02.013; Quan Y, 2015, CELL REP, V13, P2576, DOI 10.1016/j.celrep.2015.11.018; Ramer MD, 2013, J BIOL CHEM, V288, P14926, DOI 10.1074/jbc.M112.392910; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Snyder M, 2009, J BIOL CHEM, V284, P13466, DOI 10.1074/jbc.M809471200; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; Traver S, 2015, MOL CELL, V59, P831, DOI 10.1016/j.molcel.2015.07.010; Tuveson DA, 2012, CELL, V148, P21, DOI 10.1016/j.cell.2011.12.021; Volkening M, 2005, MOL CELL BIOL, V25, P1560, DOI 10.1128/MCB.25.4.1560-1568.2005; WYNNE J, 1992, NUCLEIC ACIDS RES, V20, P3297, DOI 10.1093/nar/20.13.3297; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Zhu Y, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0309-8; Zienert E, 2015, CANCER LETT, V364, P17, DOI 10.1016/j.canlet.2015.04.019	37	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164150	10.1371/journal.pone.0164150	http://dx.doi.org/10.1371/journal.pone.0164150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695057	gold, Green Submitted, Green Published			2022-12-27	WOS:000385553100093
J	Samy, AM; Elaagip, AH; Kenawy, MA; Ayres, CFJ; Peterson, AT; Soliman, DE				Samy, Abdallah M.; Elaagip, Arwa H.; Kenawy, Mohamed A.; Ayres, Constancia F. J.; Peterson, A. Townsend; Soliman, Doaa E.			Climate Change Influences on the Global Potential Distribution of the Mosquito Culex quinquefasciatus, Vector of West Nile Virus and Lymphatic Filariasis	PLOS ONE			English	Article							PIPIENS COMPLEX; DIPTERA; CULICIDAE; TRANSMISSION; TEMPERATURE; BORNE; IDENTIFICATION; EPIDEMIOLOGY; NIGRIPALPUS; DRIVERS	Rapid emergence of most vector-borne diseases (VBDs) may be associated with range expansion of vector populations. Culex quinquefasciatus Say 1823 is a potential vector of West Nile virus, Saint Louis encephalitis virus, and lymphatic filariasis. We estimated the potential distribution of Cx. quinquefasciatus under both current and future climate conditions. The present potential distribution of Cx. quinquefasciatus showed high suitability across low-latitude parts of the world, reflecting the current distribution of the species. Suitable conditions were identified also in narrow zones of North Africa and Western Europe. Model transfers to future conditions showed a potential distribution similar to that under present-day conditions, although with higher suitability in southern Australia. Highest stability with changing climate was between 30 degrees S and 30 degrees N. The areas present high agreement among diverse climate models as regards distributional potential in the future, but differed in anticipating potential for distribution in North and Central Africa, southern Asia, central USA, and southeastern Europe. Highest disparity in model predictions across representative concentration pathways (RCPs) was in Saudi Arabia and Europe. The model predictions allow anticipation of changing distributional potential of the species in coming decades.	[Samy, Abdallah M.; Kenawy, Mohamed A.; Soliman, Doaa E.] Ain Shams Univ, Dept Entomol, Fac Sci, Cairo 11566, Egypt; [Samy, Abdallah M.; Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Elaagip, Arwa H.] Univ Khartoum, Fac Med Lab Sci, Dept Parasitol & Med Entomol, Khartoum, Sudan; [Ayres, Constancia F. J.] Fundacao Oswaldo Cruz, Dept Entomol, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil	Egyptian Knowledge Bank (EKB); Ain Shams University; University of Kansas; University of Khartoum; Fundacao Oswaldo Cruz	Samy, AM (corresponding author), Ain Shams Univ, Dept Entomol, Fac Sci, Cairo 11566, Egypt.; Samy, AM (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	samy@sci.asu.edu.eg	Ayres, Constancia/AAQ-3448-2020; Samy, Abdallah/B-4375-2010; Soliman, Doaa/GRT-0145-2022; Peterson, A. Townsend/I-5697-2013	Samy, Abdallah/0000-0003-3978-1134; Kenawy, Mohamed/0000-0003-0855-5855; Peterson, A. Townsend/0000-0003-0243-2379; Soliman, Doaa/0000-0002-1646-9140	Graduate Fulbright Egyptian Mission Program (EFMP)	Graduate Fulbright Egyptian Mission Program (EFMP)	AMS was supported by the Graduate Fulbright Egyptian Mission Program (EFMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadis TG, 2012, J AM MOSQUITO CONTR, V28, P137, DOI 10.2987/8756-971X-28.4s.137; [Anonymous], 2011, ECOLOGICAL NICHES GE; Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6; Barve N., 2013, ENMGADGETS TOOLS PRE; Ciota AT, 2014, J MED ENTOMOL, V51, P55, DOI 10.1603/ME13003; Conley AK, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-289; Cornel AJ, 2003, J MED ENTOMOL, V40, P36, DOI 10.1603/0022-2585-40.1.36; Day JF, 2000, J MED ENTOMOL, V37, P626, DOI 10.1603/0022-2585-37.4.626; de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003; Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Fontes G, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-272; Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760; Gunay F, 2015, ACTA TROP, V143, P112, DOI 10.1016/j.actatropica.2014.10.013; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hribar LJ, 2003, J MED ENTOMOL, V40, P361, DOI 10.1603/0022-2585-40.3.361; Huang SM, 2011, AM J TROP MED HYG, V85, P434, DOI 10.4269/ajtmh.2011.10-0679; Humeres SG, 1998, MEM I OSWALDO CRUZ, V93, P57, DOI 10.1590/S0074-02761998000100011; Kading RC, 2012, J AM MOSQUITO CONTR, V28, P100, DOI 10.2987/8756-971X-28.4.100; Khan AM, 2015, J VECTOR DIS, V52, P314; Khasnis AA, 2005, ARCH MED RES, V36, P689, DOI 10.1016/j.arcmed.2005.03.041; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manimegalai K, INT J CURR MICROBIOL, V3, P718; McMichael AJ, 2011, J INTERN MED, V270, P401, DOI 10.1111/j.1365-2796.2011.02415.x; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Morin CW, 2013, P NATL ACAD SCI USA, V110, P15620, DOI 10.1073/pnas.1307135110; Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561; Paz S, 2013, INT J ENV RES PUB HE, V10, P3543, DOI 10.3390/ijerph10083543; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Development Core Team, 2015, LANG ENV STAT COMP; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Roth D, 2010, EMERG INFECT DIS, V16, P1251, DOI 10.3201/eid1608.100483; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Rutledge CR, 2003, J MED ENTOMOL, V40, P253, DOI 10.1603/0022-2585-40.3.253; Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150489; Sang R, 2010, AM J TROP MED HYG, V83, P28, DOI 10.4269/ajtmh.2010.09-0319; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; Sunish IP, 2007, B WORLD HEALTH ORGAN, V85, P138, DOI 10.2471/BLT.06.029389; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Turell MJ, 2012, J AM MOSQUITO CONTR, V28, P123, DOI 10.2987/8756-971X-28.4.123; URBANELLI S, 1995, J MED ENTOMOL, V32, P778, DOI 10.1093/jmedent/32.6.778; Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; World Health Organization, 2016, ZIK VIR MICR GUILL B	50	104	107	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163863	10.1371/journal.pone.0163863	http://dx.doi.org/10.1371/journal.pone.0163863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695107	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100058
J	van Tok, MN; Yeremenko, NG; Teitsma, CA; Kream, BE; Knaup, VL; Lories, RJ; Baeten, DL; van Duivenvoorde, LM				van Tok, Melissa N.; Yeremenko, Nataliya G.; Teitsma, Christine A.; Kream, Barbara E.; Knaup, Veronique L.; Lories, Rik J.; Baeten, Dominique L.; van Duivenvoorde, Leonie M.			Insulin-Like Growth Factor I Does Not Drive New Bone Formation in Experimental Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ANKYLOSING-SPONDYLITIS; IGF-I; DISEASE; CELLS; MICE; SPONDYLOARTHRITIS; SPONDYLARTHRITIS; PROGRESSION	Introduction Insulin like growth factor (IGF)-I can act on a variety of cells involved in cartilage and bone repair, yet IGF-I has not been studied extensively in the context of inflammatory arthritis. The objective of this study was to investigate whether IGF-I overexpression in the osteoblast lineage could lead to increased reparative or pathological bone formation in rheumatoid arthritis and/or spondyloarthritis respectively. Methods Mice overexpressing IGF-I in the osteoblast lineage (Ob-IGF-I+/-) line 324-7 were studied during collagen induced arthritis and in the DBA/1 aging model for ankylosing enthesitis. Mice were scored clinically and peripheral joints were analysed histologically for the presence of hypertrophic chondrocytes and osteocalcin positive osteoblasts. Results 90-100% of the mice developed CIA with no differences between the Ob-IGF-I+/- and non-transgenic littermates. Histological analysis revealed similar levels of hypertrophic chondrocytes and osteocalcin positive osteoblasts in the ankle joints. In the DBA/1 aging model for ankylosing enthesitis 60% of the mice in both groups had a clinical score 1<. Severity was similar between both groups. Histological analysis revealed the presence of hypertrophic chondrocytes and osteocalcin positive osteoblasts in the toes in equal levels. Conclusion Overexpression of IGF-I in the osteoblast lineage does not contribute to an increase in repair of erosions or syndesmophyte formation in mouse models for destructive and remodeling arthritis.	[van Tok, Melissa N.; Yeremenko, Nataliya G.; Teitsma, Christine A.; Knaup, Veronique L.; Baeten, Dominique L.; van Duivenvoorde, Leonie M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands; [van Tok, Melissa N.; Yeremenko, Nataliya G.; Teitsma, Christine A.; Knaup, Veronique L.; Baeten, Dominique L.; van Duivenvoorde, Leonie M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Kream, Barbara E.] Uconn Hlth, Dept Med, Farmington, CT USA; [Lories, Rik J.] Katholieke Univ Leuven, Skeletal Biol & Engn Res Ctr, Lab Tissue Homeostasis & Dis, Leuven, Belgium; [Lories, Rik J.] Univ Hosp Leuven, Div Rheumatol, Leuven, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; KU Leuven; KU Leuven; University Hospital Leuven	van Duivenvoorde, LM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands.; van Duivenvoorde, LM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands.	l.m.vamduivenvoorde@amc.uva.nl	/AAF-6018-2020; Lories, Rik/Q-8328-2019; Lories, Rik/T-2196-2017; Yeremenko, Nataliya/AAR-2962-2020	Lories, Rik/0000-0002-5986-3092; Lories, Rik/0000-0002-5986-3092; 	VICI grant from the Netherlands Scientific Organization (NWO); Consolidator grant from the European Research Council (ERC); Dutch Arthritis Association; ReumaFonds [13-3-305, LLP-2] Funding Source: researchfish	VICI grant from the Netherlands Scientific Organization (NWO); Consolidator grant from the European Research Council (ERC); Dutch Arthritis Association; ReumaFonds	DB is supported by a VICI grant from the Netherlands Scientific Organization (NWO) and a Consolidator grant from the European Research Council (ERC). MT is supported by a grant from the Dutch Arthritis Association.	Braem K, 2012, BIOL PROCED ONLINE, V14, DOI 10.1186/1480-9222-14-10; Corthay A, 2000, ARTHRITIS RHEUM-US, V43, P844, DOI 10.1002/1529-0131(200004)43:4<844::AID-ANR15>3.0.CO;2-B; Dhaunsi GS, 2012, SCAND J RHEUMATOL, V41, P421, DOI 10.3109/03009742.2012.691177; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Fortier LA, 2002, J BONE JOINT SURG BR, V84B, P276, DOI 10.1302/0301-620X.84B2.11167; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Jiang J, 2006, BONE, V39, P494, DOI 10.1016/j.bone.2006.02.068; Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213; Lories RJ, 2009, CLIN EXP RHEUMATOL, V27, pS10; Lories RJU, 2006, ARTHRITIS RHEUM, V54, P1736, DOI 10.1002/art.21897; MCCARTHY TL, 1989, CONNECT TISSUE RES, V20, P277, DOI 10.3109/03008208909023897; Nakasaki M, 2008, BONE, V43, P869, DOI 10.1016/j.bone.2008.07.241; Niemann I, 2013, BONE, V56, P184, DOI 10.1016/j.bone.2013.06.013; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Rudwaleit M, 2009, ARTHRITIS RHEUM-US, V60, P717, DOI 10.1002/art.24483; Schett G, 2008, AUTOIMMUNITY, V41, P224, DOI 10.1080/08916930701694717; Schett G, 2007, ANN RHEUM DIS, V66, P42, DOI 10.1136/ard.2007.078972; Schett G, 2010, BEST PRACT RES CL RH, V24, P363, DOI 10.1016/j.berh.2010.01.005; Turina MC, 2014, ANN RHEUM DIS, V73, P1746, DOI 10.1136/annrheumdis-2014-205506; van Duivenvoorde LM, 2012, ARTHRITIS RHEUM-US, V64, P3210, DOI 10.1002/art.34600; van Duivenvoorde LM, 2004, ARTHRITIS RHEUM-US, V50, P3354, DOI 10.1002/art.20513; Vandooren B, 2009, ANN RHEUM DIS, V68, P1044, DOI 10.1136/ard.2007.085837; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	23	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163632	10.1371/journal.pone.0163632	http://dx.doi.org/10.1371/journal.pone.0163632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695067	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100047
J	Chen, W; Xia, XY; Song, N; Wang, Y; Zhu, H; Deng, W; Kong, Q; Pan, XM; Qin, C				Chen, Wei; Xia, Xiayu; Song, Nan; Wang, Ying; Zhu, Hua; Deng, Wei; Kong, Qi; Pan, Xianmin; Qin, Chuan			Cross-Species Analysis of Gene Expression and Function in Prefrontal Cortex, Hippocampus and Striatum	PLOS ONE			English	Article							INHIBITORY FACTOR-I; CEREBROSPINAL-FLUID PRODUCTION; MITOCHONDRIAL DYSFUNCTION; ALZHEIMERS-DISEASE; PROMOTER METHYLATION; SEMANTIC SIMILARITY; HUMAN BIOLOGY; SUBUNIT VB; MOUSE; EVOLUTION	Background Mouse has been extensively used as a tool for investigating the onset and development of human neurological disorders. As a first step to construct a transgenic mouse model of human brain lesions, it is of fundamental importance to clarify the similarity and divergence of genetic background between non-diseased human and mouse brain tissues. Methods We systematically compared, based on large scale integrated microarray data, the transcriptomes of three anatomically distinct brain regions; prefrontal cortex (PFC), hippocampus (HIP) and striatum (STR), across human and mouse. The widely used DAVID web server was used to decipher the biological functions of the highly expressed genes that were identified using a previously reported approach. Venn analysis was used to depict the overlapping ratios of the notably enriched biological process (BP) terms (one-tailed Fisher's exact test and Benjamini correction; adjusted p < 0.01) between two brain tissues. GOSem-Sim, an R package, was selected to perform GO semantic similarity analysis. Next, we adjusted signal intensities of orthologous genes by the total signals in all samples within species, and used one minus Pearson's correlation coefficient to assess the expression distance. Hierarchical clustering and principal component analysis (PCA) were selected for expression pattern analysis. Lineage specific expressed orthologous genes were identified by comparison of the most extreme sub-datasets across species and further verified using reverse transcription PCR (RT-PCR) and quantitative real-time PCR (qRT-PCR). Results We found that the number of the significantly enriched BP terms of the highly expressed genes in human brain regions is larger than that in mouse corresponding brain regions. The mainly involved BP terms in human brain tissues associated with protein-membrane targeting and selenium metabolism are species-specific. The overlapping ratios of all the significantly enriched BP terms between any two brain tissues across species are lower than that within species, but the pairwise semantic similarities are very high between any two brain tissues from either human or mouse. Hierarchical clustering analysis shows the biological functions of the highly expressed genes in brain tissues are more consistent within species than interspecies; whereas it shows the expression patterns of orthologous genes are evidently conserved between human and mouse equivalent brain tissues. In addition, we identified four orthologous genes (COX5B, WIF1, SLC4A10 and PLA2G7) that are species-specific, which have been widely studied and confirmed to be closely linked with neurophysiological and pathological functions. Conclusion Our study highlights the similarities and divergences in gene function and expression between human and mouse corresponding brain regions, including PFC, HIP and STR.	[Chen, Wei; Xia, Xiayu; Song, Nan; Wang, Ying; Zhu, Hua; Deng, Wei; Kong, Qi; Pan, Xianmin; Qin, Chuan] CAMS, Inst Lab Anim Sci, Beijing, Peoples R China; [Chen, Wei; Xia, Xiayu; Song, Nan; Wang, Ying; Zhu, Hua; Deng, Wei; Kong, Qi; Pan, Xianmin; Qin, Chuan] PUMC, Beijing, Peoples R China; [Pan, Xianmin] Tsinghua Univ, Key Lab Bioinformat, Minist Educ, Sch Life Sci, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University	Qin, C (corresponding author), CAMS, Inst Lab Anim Sci, Beijing, Peoples R China.; Qin, C (corresponding author), PUMC, Beijing, Peoples R China.	qinchuanpumc@sina.com	Deng, Wei/GWC-9207-2022; Kong, Qi/GLR-5166-2022	Kong, Qi/0000-0003-2867-7382	National High Technology Research and Development Program of China [2013AA020106]; PUMC Youth Fund; Fundamental Research Funds for the Central Universities [333210140149]; Basal Research Fund from the Institute of Laboratory Animal Science [DWS201509]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); PUMC Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Basal Research Fund from the Institute of Laboratory Animal Science	This work was supported by National High Technology Research and Development Program of China (2013AA020106), CQ; PUMC Youth Fund and the Fundamental Research Funds for the Central Universities (333210140149), WC; and Basal Research Fund from the Institute of Laboratory Animal Science (DWS201509), WC.	Ahmad-Annuar A, 2003, CURR OPIN NEUROL, V16, P451, DOI 10.1097/01.wco.0000084221.82329.29; Beauchemin AMJ, 2001, BRAIN RES BULL, V56, P285, DOI 10.1016/S0361-9230(01)00583-4; Bemmo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-529; Ben-Hur Asa, 2003, Methods Mol Biol, V224, P159; Benek O, 2015, CURR MED CHEM, V22, P1056, DOI 10.2174/0929867322666150114163051; Bis JC, 2012, NAT GENET, V44, P545, DOI 10.1038/ng.2237; Booij JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-164; Braidy N, 2012, J NEURAL TRANSM, V119, P173, DOI 10.1007/s00702-011-0731-5; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Broadwater L, 2011, BBA-MOL BASIS DIS, V1812, P630, DOI 10.1016/j.bbadis.2011.01.012; Campian JL, 2007, J BIOL CHEM, V282, P12430, DOI 10.1074/jbc.M604547200; CAPALDI RA, 1990, ARCH BIOCHEM BIOPHYS, V280, P252, DOI 10.1016/0003-9861(90)90327-U; Chen RH, 2014, P NATL ACAD SCI USA, V111, P14217, DOI 10.1073/pnas.1409653111; Chen W, 2015, RNA BIOL, V12, P701, DOI 10.1080/15476286.2015.1048954; Del Vescovo V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078870; Devall M, 2014, EPIGENOMICS-UK, V6, P665, DOI [10.2217/epi.14.50, 10.2217/EPI.14.50]; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Eppig JT, 2015, NUCLEIC ACIDS RES, V43, pD726, DOI 10.1093/nar/gku967; Fontanesi F, 2006, AM J PHYSIOL-CELL PH, V291, pC1129, DOI 10.1152/ajpcell.00233.2006; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75; Han ES, 2004, J GERONTOL A-BIOL, V59, P306; Hang LT, 2015, ANN NY ACAD SCI, V1350, P37, DOI 10.1111/nyas.12820; Henningsen K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016428; Hong M, 2015, MAMM GENOME, V26, P191, DOI 10.1007/s00335-015-9559-x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huminiecki L, 2004, GENOME RES, V14, P1870, DOI 10.1101/gr.2705204; Humphries CE, 2015, J ALZHEIMERS DIS, V44, P977, DOI 10.3233/JAD-141989; Jacobs S, 2008, P NATL ACAD SCI USA, V105, P311, DOI 10.1073/pnas.0705487105; Jaksik R, 2014, SENSORS-BASEL, V14, P532, DOI 10.3390/s140100532; Janssen SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083345; Janssen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044973; Jiang DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059752; Kaminsky YG, 2015, FRONT BIOSCI-LANDMRK, V20, P173, DOI 10.2741/4304; Kim SA, 2013, MODERN PATHOL, V26, P626, DOI 10.1038/modpathol.2012.215; Leshkowitz D, 2013, RNA, V19, P527, DOI 10.1261/rna.036475.112; Li CY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000734; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Meng XF, 2010, PSYCHIAT RES, V175, P186, DOI 10.1016/j.psychres.2009.08.025; Morato L, 2014, GLIA, V62, P1878, DOI 10.1002/glia.22670; Ning LF, 2015, GENET MOL RES, V14, P2146, DOI 10.4238/2015.March.27.1; Peters LL, 2007, NAT REV GENET, V8, P58, DOI 10.1038/nrg2025; Ransom BR, 2000, PROG BRAIN RES, V125, P217; Schosser A, 2011, AM J MED GENET B, V156B, P640, DOI 10.1002/ajmg.b.31204; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Strand AD, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030059; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Vassallo I, 2016, ONCOGENE, V35, P12, DOI 10.1038/onc.2015.61; Krepischi AC, 2010, EPILEPSIA, V51, P2457, DOI 10.1111/j.1528-1167.2010.02742.x; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; Witte ME, 2014, TRENDS MOL MED, V20, P179, DOI 10.1016/j.molmed.2013.11.007; Wostyn P, 2011, J NEUROGENET, V25, P195, DOI 10.3109/01677063.2011.620191; Wostyn P, 2011, PERSPECT MED CHEM, V5, P11, DOI 10.4137/PMC.S6509; Wu J, 2012, J CLIN NEUROSCI, V19, P1428, DOI 10.1016/j.jocn.2011.12.023; Yanai I, 2004, OMICS, V8, P15, DOI 10.1089/153623104773547462; Yang J, 2005, MOL BIOL EVOL, V22, P2113, DOI 10.1093/molbev/msi206; Yang ZAY, 2010, ACTA BIOCH BIOPH SIN, V42, P418, DOI 10.1093/abbs/gmq037; Yang ZY, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-26; Yokota H, 2000, CRIT CARE MED, V28, P3275, DOI 10.1097/00003246-200009000-00025; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zaltieri M., 2015, PARKINSONS DIS-US, V2015, DOI [DOI 10.1155/2015/108029, 10.1155/2015/108029]; Zhang J, 2014, CANCER LETT, V348, P12, DOI 10.1016/j.canlet.2014.02.011	70	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164295	10.1371/journal.pone.0164295	http://dx.doi.org/10.1371/journal.pone.0164295			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716781	Green Published, gold, Green Submitted			2022-12-27	WOS:000385698100040
J	Oakley, L; Penn, N; Pipi, M; Oteng-Ntim, E; Doyle, P				Oakley, Laura; Penn, Nicole; Pipi, Maria; Oteng-Ntim, Eugene; Doyle, Pat			Risk of Adverse Obstetric and Neonatal Outcomes by Maternal Age: Quantifying Individual and Population Level Risk Using Routine UK Maternity Data	PLOS ONE			English	Article							PERINATAL OUTCOMES; PREGNANCY OUTCOMES; NULLIPAROUS WOMEN; DELIVERY; METAANALYSIS; PARITY; COHORT; BIRTH	Objective The objective of this study was to investigate whether moderately increased maternal age is associated with obstetric and neonatal outcome in a contemporary population, and to consider the possible role of co-morbidities in explaining any increased risk. Study Design Secondary analysis of routinely collected data from a large maternity unit in London, UK. Data were available on 51,225 singleton deliveries (>= 22 weeks) occurring to women aged >= 20 between 2004 and 2012. Modified Poisson regression was used to estimate risk ratios for the association between maternal age and obstetric and neonatal outcome (delivery type, postpartum haemorrhage, stillbirth, low birthweight, preterm birth, small for gestational age, neonatal unit admission), using the reference group 20-24 years. Population attributable fractions were calculated to quantify the population impact. Results We found an association between increasing maternal age and major postpartum haemorrhage (>= 1000ml blood loss) (RR 1.36 95% CI 1.18-1.57 for age 25-29 rising to 2.41 95% CI 2.02-2.88 for age >= 40). Similar trends were observed for caesarean delivery, most notably for elective caesareans (RR 1.64 95% CI 1.36-1.96 for age 25-29 rising to 4.94 95% CI 4.09-5.96 for age >= 40). There was evidence that parity modified this association, with a higher prevalence of elective caesarean delivery in older nulliparous women. Women aged >= 35 were at increased risk of low birthweight and preterm birth. We found no evidence that the risk of stillbirth, small for gestational age, or neonatal unit admission differed by maternal age. Conclusions Our results suggest a gradual increase in the risk of caesarean delivery and postpartum haemorrhage from age 25, persisting after taking into account maternal BMI, hypertension and diabetes. The risk of low birthweight and preterm birth was elevated in women over 35. Further research is needed to understand the reasons behind the high prevalence of elective caesarean delivery in nulliparous older mothers.	[Oakley, Laura; Doyle, Pat] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Penn, Nicole] Kings Coll London, Sch Med, London, England; [Pipi, Maria; Oteng-Ntim, Eugene] Guys & St Thomas NHS Fdn Trust, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Oakley, L (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England.	laura.oakley@lshtm.ac.uk		/0000-0002-4697-4316				Alves B, 2005, BJOG-INT J OBSTET GY, V112, P994, DOI 10.1111/j.1471-0528.2005.00657.x; Astolfi P, 2002, PAEDIATR PERINAT EP, V16, P67, DOI 10.1046/j.1365-3016.2002.00375.x; Bahtiyar M, 2006, AM J OBSTET GYNECOL, V195, pS209, DOI 10.1016/j.ajog.2006.10.753; Callaway LK, 2005, AUST NZ J OBSTET GYN, V45, P12, DOI 10.1111/j.1479-828X.2005.00333.x; Carolan M, 2013, MIDWIFERY, V29, P479, DOI 10.1016/j.midw.2012.04.001; Carolan M, 2011, MIDWIFERY, V27, P793, DOI 10.1016/j.midw.2010.07.006; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Cleary-Goldman J, 2005, OBSTET GYNECOL, V105, P983, DOI 10.1097/01.AOG.0000158118.75532.51; CNATTINGIUS S, 1993, AM J OBSTET GYNECOL, V168, P16, DOI 10.1016/S0002-9378(12)90878-9; Delbaere I, 2007, EUR J OBSTET GYN R B, V135, P41, DOI 10.1016/j.ejogrb.2006.10.030; Department of Communities and Local Government, 2007, INDEX OF MULTIPLE DE; European Commission, 2014, EUROSTAT FERTILITY S; EZRA Y, 1995, EUR J OBSTET GYN R B, V62, P203, DOI 10.1016/0301-2115(95)02201-H; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Gareen IF, 2003, J CLIN EPIDEMIOL, V56, P1100, DOI 10.1016/S0895-4356(03)00199-9; Greenland S, 1999, AM J EPIDEMIOL, V149, P884; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Herstad L., 2014, BJOG-INT J OBSTET GY, DOI [10.1111/1471-0528.12962, DOI 10.1111/1471-0528.12962]; Herstad L, 2012, ACTA OBSTET GYN SCAN, V91, P816, DOI 10.1111/j.1600-0412.2012.01405.x; Jolly M, 2000, HUM REPROD, V15, P2433, DOI 10.1093/humrep/15.11.2433; Jolly MC, 2000, OBSTET GYNECOL, V96, P962, DOI 10.1016/S0029-7844(00)01075-9; Joseph KS, 2005, OBSTET GYNECOL, V105, P1410, DOI 10.1097/01.AOG.0000163256.83313.36; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Laopaiboon M, 2014, BJOG-INT J OBSTET GY, V121, P49, DOI 10.1111/1471-0528.12659; Li Y., 2014, INT J ANTENN PROPAG, V2014, P1, DOI DOI 10.1101/GR.181990.114; Mills TA., 2011, OBSTET GYNAECOL REPR, V21, P107, DOI [10.1016/j.ogrm.2010.12.003, DOI 10.1016/J.OGRM.2010.12.003]; Mutz-Dehbalaie I, 2014, GYNECOL OBSTET INVES, V77, P50, DOI 10.1159/000357168; Office for National Statistics, 2014, BIRTH SUMMARY TABLES; Oteng-Nim E, 2012, MATERNAL OBESITY; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Rossen J, 2010, ACTA OBSTET GYN SCAN, V89, P1248, DOI 10.3109/00016349.2010.514324; Schempf AH, 2007, PAEDIATR PERINAT EP, V21, P34, DOI 10.1111/j.1365-3016.2007.00785.x; Smith GCS, 2008, PLOS MED, V5, P1123, DOI 10.1371/journal.pmed.0050144; Toledo P, 2007, ANESTH ANALG, V105, P1736, DOI 10.1213/01.ane.0000286233.48111.d8; Vaughan DA, 2014, BJOG-INT J OBSTET GY, V121, P261, DOI 10.1111/1471-0528.12311; Wang Y, 2011, ARCH GYNECOL OBSTET, V284, P31, DOI 10.1007/s00404-010-1587-x; WATERS E G, 1950, J Mich State Med Soc, V49, P435; Yogev Y, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.039	39	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164462	10.1371/journal.pone.0164462	http://dx.doi.org/10.1371/journal.pone.0164462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716789	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000385698100056
J	Chanda-Kapata, P; Kapata, N; Masiye, F; Maboshe, M; Klinkenberg, E; Cobelens, F; Grobusch, MP				Chanda-Kapata, Pascalina; Kapata, Nathan; Masiye, Felix; Maboshe, Mwendaweli; Klinkenberg, Eveline; Cobelens, Frank; Grobusch, Martin P.			Health Seeking Behaviour among Individuals with Presumptive Tuberculosis in Zambia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SOUTH-AFRICA; DIAGNOSTIC DELAY; VIETNAM; GENDER; DETERMINANTS; ETHIOPIA; PATIENT	Background Tuberculosis (TB) prevalence surveys offer a unique opportunity to study health seeking behaviour at the population level because they identify individuals with symptoms that should ideally prompt a health consultation. Objective To assess the health-seeking behaviour among individuals who were presumptive TB cases in a national population based TB prevalence survey. Methods A cross sectional survey was conducted between 2013 and 2014 among 66 survey clusters in Zambia. Clusters were census supervisory areas (CSAs). Participants (presumptive TB cases) were individuals aged 15 years and above; having either cough, fever or chest pain for 2 weeks or more; and/or having an abnormal or inconclusive chest x-ray image. All survey participants were interviewed about symptoms and had a chest X-ray taken. An in-depth interview was conducted to collect information on health seeking behaviour and previous TB treatment. Results Of the 6,708 participants, the majority reported at least a history of chest pain (3,426; 51.1%) followed by cough (2,405; 35.9%), and fever (1,030; 15.4%) for two weeks or more. Only 34.9% (2,340) had sought care for their symptoms, mainly (92%) at government health facilities. Of those who sought care, 13.9% (326) and 12.1% (283) had chest x-ray and sputum examinations, respectively. Those ever treated for TB were 9.6% (644); while 1.7% (114) was currently on treatment. The average time (in weeks) from onset of symptoms to first care-seeking was 3 for the presumptive TB cases. Males, urban dwellers and individuals in the highest wealth quintile were less likely to seek care for their symptoms. The likelihood of having ever been treated for TB was highest among males, urban dwellers; respondents aged 35-64 years, individuals in the highest wealth quintile, or HIV positive. Conclusion Some presumptive TB patients delay care-seeking for their symptoms. The health system misses opportunities to diagnose TB among those who seek care. Improving health-seeking behaviour among males, urban dwellers and those with a higher social economic status; and addressing health care lapses in TB case detection is required if TB is to be effectively controlled in Zambia.	[Chanda-Kapata, Pascalina] Minist Hlth, Dept Dis Surveillance Control & Res, Lusaka, Zambia; [Chanda-Kapata, Pascalina; Kapata, Nathan; Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis, Ctr Trop Med & Travel Med, Amsterdam, Netherlands; [Kapata, Nathan] Minist Hlth, Dept Dis Surveillance Control & Res, Natl TB Leprosy Control Program, Lusaka, Zambia; [Masiye, Felix] Univ Zambia, Dept Econ, Lusaka, Zambia; [Maboshe, Mwendaweli] World Hlth Org Country Off, Lusaka, Zambia; [Klinkenberg, Eveline; Cobelens, Frank] KNCV TB Fdn, Epidemiol, The Hague, Netherlands; [Cobelens, Frank] Acad Med Ctr, Dept Global Hlth & Dev, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Zambia; World Health Organization; KNCV Tuberculosis Foundation; University of Amsterdam; Academic Medical Center Amsterdam	Chanda-Kapata, P (corresponding author), Minist Hlth, Dept Dis Surveillance Control & Res, Lusaka, Zambia.; Chanda-Kapata, P (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Infect Dis, Ctr Trop Med & Travel Med, Amsterdam, Netherlands.	pascykapata@gmail.com	Kapata, Nathan/AAW-2469-2020		Government of The Republic of Zambia through the Ministry of Health; United States Government through USAID/CDC/TBCARE I	Government of The Republic of Zambia through the Ministry of Health; United States Government through USAID/CDC/TBCARE I(United States Agency for International Development (USAID))	This work was funded by the Government of The Republic of Zambia through the Ministry of Health and The United States Government through USAID/CDC/TBCARE I.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuo P O, 2008, East Afr Med J, V85, P263; Cai J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120088; Chang Ching Thon, 2007, Rural Remote Health, V7, P667; Cheng SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067516; Chongwe G, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.692; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Hoa NR, 2004, INT J TUBERC LUNG D, V8, P603; Huong NT, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-110; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; Meintjes G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-72; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; Ministry of Health, NAT TB LEPR REP 2014; Ministry of Health, TECHNICAL REPORT; Mulenga C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-756; Needham DM, 2001, TROP MED INT HEALTH, V6, P256, DOI 10.1046/j.1365-3156.2001.00709.x; Ouedraogo M, 2006, INT J TUBERC LUNG D, V10, P184; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Skordis-Worrall J, 2010, INT J TUBERC LUNG D, V14, P171; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Ukwaja KN, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-25; Waako J, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-349	25	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163975	10.1371/journal.pone.0163975	http://dx.doi.org/10.1371/journal.pone.0163975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711170	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600057
J	Karl, S; White, MT; Milne, GJ; Gurarie, D; Hay, SI; Barry, AE; Felger, I; Mueller, I				Karl, Stephan; White, Michael T.; Milne, George J.; Gurarie, David; Hay, Simon I.; Barry, Alyssa E.; Felger, Ingrid; Mueller, Ivo			Spatial Effects on the Multiplicity of Plasmodium falciparum Infections	PLOS ONE			English	Article							MARK-RELEASE-RECAPTURE; ANOPHELES-GAMBIAE; MALARIA TRANSMISSION; VECTOR CONTROL; HOST-SEEKING; POPULATION; DIPTERA; DISEASE; VIVAX; CULICIDAE	As malaria is being pushed back on many frontiers and global case numbers are declining, accurate measurement and prediction of transmission becomes increasingly difficult. Low transmission settings are characterised by high levels of spatial heterogeneity, which stands in stark contrast to the widely used assumption of spatially homogeneous transmission used in mathematical transmission models for malaria. In the present study an individual-based mathematical malaria transmission model that incorporates multiple parasite clones, variable human exposure and duration of infection, limited mosquito flight distance and most importantly geographically heterogeneous human and mosquito population densities was used to illustrate the differences between homogeneous and heterogeneous transmission assumptions when aiming to predict surrogate indicators of transmission intensity such as population parasite prevalence or multiplicity of infection (MOI). In traditionally highly malaria endemic regions where most of the population harbours malaria parasites, humans are often infected with multiple parasite clones. However, studies have shown also in areas with low overall parasite prevalence, infection with multiple parasite clones is a common occurrence. Mathematical models assuming homogeneous transmission between humans and mosquitoes cannot explain these observations. Heterogeneity of transmission can arise from many factors including acquired immunity, body size and occupational exposure. In this study, we show that spatial heterogeneity has a profound effect on predictions of MOI and parasite prevalence. We illustrate, that models assuming homogeneous transmission underestimate average MOI in low transmission settings when compared to field data and that spatially heterogeneous models predict stable transmission at much lower overall parasite prevalence. Therefore it is very important that models used to guide malaria surveillance and control strategies in low transmission and elimination settings take into account the spatial features of the specific target area, including human and mosquito vector distribution.	[Karl, Stephan; White, Michael T.; Barry, Alyssa E.; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Populat Based Biol Div, Parkville, Vic, Australia; [Karl, Stephan; Barry, Alyssa E.; Mueller, Ivo] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Karl, Stephan] Papua New Guinea Insititute Med Res, Vectorborne Dis Unit, Madang, Madang Province, Papua N Guinea; [White, Michael T.] Imperial Coll, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Milne, George J.] Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA, Australia; [Gurarie, David] Case Western Reserve Univ, Dept Math Appl Math & Stat, Cleveland, OH 44106 USA; [Hay, Simon I.] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Hay, Simon I.] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA; [Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Felger, Ingrid] Univ Basel, Basel, Switzerland; [Mueller, Ivo] Inst Pasteur, Dept Parasites & Insect Vectors, Malaria Parasites & Hosts Unit, Paris, France	Walter & Eliza Hall Institute; University of Melbourne; PNG Institute Of Medical Research; Imperial College London; University of Western Australia; Case Western Reserve University; Institute for Health Metrics & Evaluation; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Karl, S (corresponding author), Walter & Eliza Hall Inst Med Res, Populat Based Biol Div, Parkville, Vic, Australia.; Karl, S (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.; Karl, S (corresponding author), Papua New Guinea Insititute Med Res, Vectorborne Dis Unit, Madang, Madang Province, Papua N Guinea.	karl@wehi.edu.au	Karl, Stephan/A-2365-2012; Hay, Simon Iain/F-8967-2015; Gurarie, David/AAA-2096-2021	Hay, Simon Iain/0000-0002-0611-7272; Barry, Alyssa/0000-0002-1189-2310; Milne, George/0000-0002-9796-0600; White, Michael/0000-0002-7472-4138; Felger, Ingrid/0000-0003-1255-2606; Gurarie, David/0000-0002-5314-7888	Victorian State Government Operational Infrastructure Support; NHMRC (Australia) [GNT 1052760]; MRC (UK); Australian Government NHMRC IRIISS	Victorian State Government Operational Infrastructure Support; NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Government NHMRC IRIISS(National Health and Medical Research Council (NHMRC) of Australia)	SK, AB and IM acknowledge support from the Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. SK was supported by an NHMRC (Australia) Early Career Fellowship (GNT 1052760). MTW was supported by an MRC (UK) Research Fellowship. The authors thank all researchers and study participants involved in the PNG studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMALEK AA, 1966, B WORLD HEALTH ORGAN, V35, P968; Achee NL, 2007, J AM MOSQUITO CONTR, V23, P276, DOI 10.2987/8756-971X(2007)23[276:AMSTDT]2.0.CO;2; Aguas R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001767; ANDERSON R M, 1991; Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085; Arifin SMN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-424; Bailey S F, 1967, Proc Pap Annu Conf Calif Mosq Control Assoc, V35, P55; Barry AE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00359; Barry AE, 2013, AM J TROP MED HYG, V88, P718, DOI 10.4269/ajtmh.12-0056; Bejon P, 2014, ELIFE, V3, DOI 10.7554/eLife.02130; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Betuela I, 2012, J INFECT DIS, V206, P1771, DOI 10.1093/infdis/jis580; Bharti AR, 2006, AM J TROP MED HYG, V75, P610, DOI 10.4269/ajtmh.2006.75.610; Bomblies A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-308; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bretscher MT, 2011, EPIDEMICS-NETH, V3, P109, DOI 10.1016/j.epidem.2011.03.002; Bruce MC, 2000, PARASITOLOGY, V121, P247, DOI 10.1017/S0031182099006344; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; CATTANI JA, 1986, AM J TROP MED HYG, V35, P3, DOI 10.4269/ajtmh.1986.35.3; Chao DL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001876; CHARLWOOD JD, 1987, MED VET ENTOMOL, V1, P319, DOI 10.1111/j.1365-2915.1987.tb00361.x; CHARLWOOD JD, 1988, MED VET ENTOMOL, V2, P101, DOI 10.1111/j.1365-2915.1988.tb00059.x; CHARLWOOD JD, 1985, B ENTOMOL RES, V75, P463, DOI 10.1017/S0007485300014577; Eckhoff PA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-303; EJERCTTO A, 1951, Bull World Health Organ, V3, P663; Felger I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045542; FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Gu WD, 2009, T ROY SOC TROP MED H, V103, P1105, DOI 10.1016/j.trstmh.2009.01.006; Guerra CA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-276; GUPTA S, 1994, P ROY SOC B-BIOL SCI, V256, P231, DOI 10.1098/rspb.1994.0075; Gurarie D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034040; Hetzel MW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-242; Hii JLK, 1997, J MED ENTOMOL, V34, P193, DOI 10.1093/jmedent/34.2.193; Karl S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-447; Karl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020805; Kaufmann C, 2004, J VECTOR ECOL, V29, P140; Keating J, 2005, J MED ENTOMOL, V42, P241, DOI 10.1603/0022-2585(2005)042[0241:AGSAAF]2.0.CO;2; Kim Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101601; Koepfli C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001424; Koepfli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019010; Koinari M, 2013, J HELMINTHOL, V87, P409, DOI 10.1017/S0022149X12000594; Koram KA, 2003, TROP MED INT HEALTH, V8, P793, DOI 10.1046/j.1365-3156.2003.01092.x; Lefevre T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009546; Liebman KA, 2012, PLOS NEGLECT TROP D, V6, pe1472, DOI [10.1371/journal.pntd.0001472, DOI 10.1371/JOURNAL.PNTD.0001472]; Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Maude RJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-191; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2; Milne GJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002518; MUIRHEADTHOMSON RC, 1951, BRIT MED J, V1, P1114, DOI 10.1136/bmj.1.4715.1114; Muller I, 1998, INT J EPIDEMIOL, V27, P878, DOI 10.1093/ije/27.5.878; National Statistical Office of Papua New Guinea, 2013, PREM FIG PAP NEW GUI; Parthasarathy PR, 1997, IMA J MATH APPL MED, V14, P113; Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642; Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; REUBEN R, 1993, SOC SCI MED, V37, P473, DOI 10.1016/0277-9536(93)90282-9; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; Ross A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042496; SMITH D, 2010, NEW RESPONSE YOUTH C, P1, DOI DOI 10.1038/NC0MMS1107; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639; Tanabe K, 2004, SCIENCE, V303, P493, DOI 10.1126/science.1092077; Thomas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068679; Toure YT, 1998, MED VET ENTOMOL, V12, P74, DOI 10.1046/j.1365-2915.1998.00071.x; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; Wernsdorfer Walther H., 1988, MALARIA PRINCIPLES P; Wesolowski A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05678; White MT, 2014, ELIFE, V3, DOI 10.7554/eLife.04692; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153	79	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164054	10.1371/journal.pone.0164054	http://dx.doi.org/10.1371/journal.pone.0164054			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711149	gold, Green Published, Green Accepted			2022-12-27	WOS:000385697600070
J	Lenhard, F; Vigerland, S; Engberg, H; Hallberg, A; Thermaenius, H; Serlachius, E				Lenhard, Fabian; Vigerland, Sarah; Engberg, Hedvig; Hallberg, Anna; Thermaenius, Hanna; Serlachius, Eva			"On My Own, but Not Alone" - Adolescents' Experiences of Internet-DeliveredCognitive Behavior Therapy for Obsessive-Compulsive Disorder	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ANXIETY DISORDERS; QUALITATIVE RESEARCH; CHILDHOOD ANXIETY; METAANALYSIS; DEPRESSION; SEEKING; INTERVENTIONS; FEASIBILITY; CHILDREN	Introduction Childhood Obsessive-Compulsive Disorder (OCD) is a prevalent and impairing condition that can be effectively treated with Cognitive Behavior Therapy (CBT). However, a majority of children and adolescents do not have access to CBT. Internet-delivered CBT (ICBT) has been suggested as a way to increase availability to effective psychological treatments. Yet, the research on ICBT in children and adolescents has been lagging behind significantly both when it comes to quantitative as well as qualitative studies. The aim of the current study was to describe the experience of ICBT in adolescents with OCD. Method Eight adolescents with OCD that had received ICBT were interviewed with qualitative methodology regarding their experiences of the intervention. Data was summarized into thematic categories. Results Two overarching themes were identified, autonomy and support, each consisting of three primary themes (self-efficacy, flexibility, secure self-disclosure and clinician support, parental support, identification/normalization, respectively). Conclusions The experiential hierarchical model that was identified in this study is, in part, transferrable to previous research. In addition, it highlights the need of further study of important process variables of ICBT in young patient populations.	[Lenhard, Fabian; Vigerland, Sarah; Engberg, Hedvig; Serlachius, Eva] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Lenhard, Fabian; Vigerland, Sarah; Thermaenius, Hanna; Serlachius, Eva] Stockholm Cty Council, Stockholm Hlth Care Serv, Stockholm, Sweden; [Hallberg, Anna] Ostersunds Sjukhus, Ostersund Child & Adolescent Mental Hlth Serv, S-83183 Ostersund, Sweden	Karolinska Institutet; Stockholm County Council	Lenhard, F (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden.; Lenhard, F (corresponding author), Stockholm Cty Council, Stockholm Hlth Care Serv, Stockholm, Sweden.	Fabian.lenhard@ki.se	Serlachius, Eva/E-8956-2013; Engberg, Hedvig/AAO-1374-2021	Serlachius, Eva/0000-0001-7115-6422; Engberg, Hedvig/0000-0001-7178-1172; Lenhard, Fabian/0000-0003-0930-6412	Stockholm County Council; Karolinska Institutet [PPG 20120167]	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	Financial support was provided by Stockholm County Council and through the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet (PPG 20120167, https://forskningsstod.vmi.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman CB, 2014, J CLIN PSYCHIAT, V75, pE695, DOI 10.4088/JCP.13r08894; American Psychiatric Association, 2007, PRACTICE GUIDELINE F; American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; Andersson E, 2012, PSYCHOL MED, V42, P2193, DOI 10.1017/S0033291712000244; Andersson E, 2015, JAMA PSYCHIAT, V72, P659, DOI 10.1001/jamapsychiatry.2015.0546; Andersson E, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-125; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; Arnberg FK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098118; Bonnert M., 2014, INTERNET INTERVENTIO, V1, P141, DOI [10.1016/j.invent.2014.07.002, DOI 10.1016/J.INVENT.2014.07.002]; Christensen H, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1194; Findahl O, 2015, SWEDES AND THE INTER; FLAMENT MF, 1988, J AM ACAD CHILD PSY, V27, P764, DOI 10.1097/00004583-198811000-00018; Fullana MA, 2009, AM J PSYCHIAT, V166, P329, DOI 10.1176/appi.ajp.2008.08071006; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Kien Hoa Ly, 2015, Internet Interventions, V2, P60, DOI 10.1016/j.invent.2014.12.002; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; Lenhard F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100773; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Mansson KN, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.3031; McGuire JF, 2015, DEPRESS ANXIETY, V32, P580, DOI 10.1002/da.22389; Merry SN, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2598; Micali N, 2011, PSYCHOL MED, V41, P2507, DOI 10.1017/S003329171100078X; NICE, 2006, OBSESSIVE COMPULSIVE; Olthuis JV, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011565; Piacentini J, 2003, J CHILD ADOL PSYCHOP, V13, pS61, DOI 10.1089/104454603322126359; Reyes-Portillo JA, 2014, J AM ACAD CHILD PSY, V53, P1254, DOI 10.1016/j.jaac.2014.09.005; Rooksby M, 2015, J ANXIETY DISORD, V29, P83, DOI 10.1016/j.janxdis.2014.11.006; Rozental Alexander, 2015, Internet Interventions, V2, P314, DOI 10.1016/j.invent.2015.05.001; Sanchez-Ortiz VC, 2011, EAT WEIGHT DISORD-ST, V16, pE93, DOI 10.1007/BF03325314; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sanders T, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084323, 10.1371/journal.pone.0092040]; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Schilling J, 2006, EUR J PSYCHOL ASSESS, V22, P28, DOI 10.1027/1015-5759.22.1.28; Schwartz C, 2013, J OBSESS-COMPULS REL, V2, P448, DOI 10.1016/j.jocrd.2013.10.006; Seidman I., 2013, INTERVIEWING AS QUAL; Spence SH, 2006, J CONSULT CLIN PSYCH, V74, P614, DOI 10.1037/0022-006X.74.3.614; Spence SH, 2008, BEHAV COGN PSYCHOTH, V36, P411, DOI 10.1017/S135246580800444X; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; VALLENIBASILE LA, 1994, J AM ACAD CHILD PSY, V33, P782, DOI 10.1097/00004583-199407000-00002; Vigerland S, 2016, BEHAV RES THER, V76, P47, DOI 10.1016/j.brat.2015.11.006; Vigerland S, 2013, COGN BEHAV THERAPY, V42, P303, DOI 10.1080/16506073.2013.844201; Wewetzer C, 2001, EUR CHILD ADOLES PSY, V10, P37, DOI 10.1007/s007870170045; Wilhelmsen M, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-296; Wootton BM, 2013, J OBSESS-COMPULS REL, V2, P375, DOI 10.1016/j.jocrd.2013.07.002; Wootton BM, 2011, J ANXIETY DISORD, V25, P1102, DOI 10.1016/j.janxdis.2011.07.009	47	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164311	10.1371/journal.pone.0164311	http://dx.doi.org/10.1371/journal.pone.0164311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711249	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600114
J	Ricceri, F; Sacerdote, C; Giraudo, MT; Fasanelli, F; Lenzo, G; Galli, M; Sieri, S; Pala, V; Masala, G; Bendinelli, B; Tumino, R; Frasca, G; Chiodini, P; Mattiello, A; Panico, S				Ricceri, Fulvio; Sacerdote, Carlotta; Giraudo, Maria Teresa; Fasanelli, Francesca; Lenzo, Giulia; Galli, Matteo; Sieri, Sabina; Pala, Valeria; Masala, Giovanna; Bendinelli, Benedetta; Tumino, Rosario; Frasca, Graziella; Chiodini, Paolo; Mattiello, Amalia; Panico, Salvatore			The Association between Educational Level and Cardiovascular and Cerebrovascular Diseases within the EPICOR Study: New Evidence for an Old Inequality Problem	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ACUTE MYOCARDIAL-INFARCTION; RISK-FACTORS; SOCIOECONOMIC-STATUS; SOCIAL-CLASS; ISCHEMIC-HEART; FOLLOW-UP; HEALTH; MORTALITY; STROKE	Background A consistent association has been reported between low socioeconomic status (SES) and cardiovascular events (CE), whereas the association between SES and cerebrovascular events (CBVD) is less clear. The aim of this study was to investigate the association between SES (measured using education) and CE/CBVD in a cohort study, as well as to investigate lifestyle and clinical risk factors, to help to clarify the mechanisms by which SES influences CE/CBVD. Material and Methods We searched for diagnoses of CE and CBVD in the clinical records of 47,749 members of the EPICOR cohort (average follow-up time: 11 years). SES was determined by the relative index of inequality (RII). Results A total of 1,156 CE and 468 CBVD were found in the clinical records. An increased risk of CE was observed in the crude Cox model for the third tertile of RII compared to the first tertile (hazard ratio [HR] = 1.39; 95% confidence interval [CI] 1.21-1.61). The increased risk persisted after adjustment for lifestyle risk factors (HR = 1.19; 95% CI 1.02-1.38), clinical risk factors (HR = 1.35; 95% CI 1.17-1.56), and after full adjustment (HR = 1.17; 95% CI 1.01-1.37). Structural equation model showed that lifestyle rather than clinical risk factors are involved in the mechanisms by which education influences CE. No significant association was found between education and CBVD. A strong relationship was observed between education and diabetes at baseline. Conclusion The most important burden of inequality in CE incidence in Italy is due to lifestyle risk factors.	[Ricceri, Fulvio] Reg Hlth Serv, Epidemiol Unit, Turin, Italy; [Ricceri, Fulvio; Sacerdote, Carlotta; Fasanelli, Francesca] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Ricceri, Fulvio; Sacerdote, Carlotta; Fasanelli, Francesca] Citta Salute & Sci Hosp, Turin, Italy; [Giraudo, Maria Teresa; Lenzo, Giulia; Galli, Matteo] Univ Turin, Dept Math, Turin, Italy; [Sieri, Sabina; Pala, Valeria] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy; [Masala, Giovanna; Bendinelli, Benedetta] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Tumino, Rosario; Frasca, Graziella] ASP, Dept Prevent, Canc Registry, Ragusa, Italy; [Chiodini, Paolo] Univ Naples 2, Dept Phys & Mental Hlth & Prevent, Naples, Italy; [Mattiello, Amalia; Panico, Salvatore] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; Fondazione IRCCS Istituto Nazionale Tumori Milan; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Universita della Campania Vanvitelli; University of Naples Federico II	Ricceri, F (corresponding author), Reg Hlth Serv, Epidemiol Unit, Turin, Italy.; Ricceri, F (corresponding author), Univ Turin, Canc Epidemiol Unit, Turin, Italy.; Ricceri, F (corresponding author), Citta Salute & Sci Hosp, Turin, Italy.	fulvio.ricceri@unito.it	Masala, Giovanna/AAC-5474-2022; Chiodini, Paolo/E-7290-2014; Ricceri, Fulvio/I-9910-2018; Pala, Valeria/K-4738-2016; Sieri, Sabina/K-4667-2016	Masala, Giovanna/0000-0002-5758-9069; Chiodini, Paolo/0000-0003-0139-2264; Ricceri, Fulvio/0000-0001-8749-9737; Pala, Valeria/0000-0001-5438-970X; Sieri, Sabina/0000-0001-5201-172X; Sacerdote, Carlotta/0000-0002-8008-5096; tumino, rosario/0000-0003-2666-414X; GIRAUDO, Maria Teresa/0000-0002-7152-6902; Bendinelli, Benedetta/0000-0002-4796-1517	Italian Association for Cancer Research (AIRC); Compagnia di San Paolo	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo(Compagnia di San Paolo)	EPICOR is supported by Compagnia di San Paolo. The Italian EPIC collaboration is supported by the Italian Association for Cancer Research (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoli C, 2013, INT J CANCER, V132, P1404, DOI 10.1002/ijc.27740; Albert MA, 2006, CIRCULATION, V114, P2619, DOI 10.1161/CIRCULATIONAHA.106.660043; Avendano M, 2008, STROKE, V39, P1533, DOI 10.1161/STROKEAHA.107.490383; Baldi I, 2013, INT J CARDIOL, V168, P4959, DOI 10.1016/j.ijcard.2013.07.142; Beauchamp A, 2010, J EPIDEMIOL COMMUN H, V64, P542, DOI 10.1136/jech.2009.094516; Bollen K. A, 1989, STRUCTURAL EQUATIONS; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brawley OW, 2008, CANCER-AM CANCER SOC, V113, P1744, DOI 10.1002/cncr.23800; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Cox AM, 2006, LANCET NEUROL, V5, P181, DOI 10.1016/S1474-4422(06)70351-9; Emberson JR, 2004, INT J EPIDEMIOL, V33, P1152, DOI 10.1093/ije/dyh287; Frampton GK, 2009, SOC SCI MED, V69, P1147, DOI 10.1016/j.socscimed.2009.06.012; Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10; Gillum RF, 2003, J CLIN EPIDEMIOL, V56, P188, DOI 10.1016/S0895-4356(02)00535-8; Harald K, 2006, SCAND CARDIOVASC J, V40, P87, DOI 10.1080/14017430500519872; Hart CL, 2000, AM J PUBLIC HEALTH, V90, P1788, DOI 10.2105/AJPH.90.11.1788; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Kivimaki M, 2007, AM J PUBLIC HEALTH, V97, P874, DOI 10.2105/AJPH.2005.078691; Kuper H, 2007, STROKE, V38, P27, DOI 10.1161/01.STR.0000251805.47370.91; Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Mackenbach JP, 2011, J EPIDEMIOL COMMUN H, V65, P568, DOI 10.1136/jech.2010.128280; Manrique-Garcia E, 2011, J EPIDEMIOL COMMUN H, V65, P301, DOI 10.1136/jech.2009.104075; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McFadden E, 2008, EUR J EPIDEMIOL, V23, P449, DOI 10.1007/s10654-008-9262-2; Metcalfe C, 2005, EUR J PUBLIC HEALTH, V15, P238, DOI 10.1093/eurpub/cki063; MUTHEN BO, 1989, PSYCHOMETRIKA, V54, P557, DOI 10.1007/BF02296397; Nordahl H, 2013, EUR J EPIDEMIOL, V28, P149, DOI [10.1007/s10654-012-9745-z, 10.1007/s10]; Palli D, 2003, TUMORI, V89, P586, DOI 10.1177/030089160308900602; Peltonen M, 2000, AM J EPIDEMIOL, V151, P283, DOI 10.1093/oxfordjournals.aje.a010204; Petrelli A, 2006, SOC SCI MED, V63, P446, DOI 10.1016/j.socscimed.2006.01.018; Piccolo RS, 2016, DIABETES CARE, V39, P1208, DOI 10.2337/dc15-2255; POCOCK SJ, 1987, LANCET, V2, P197; Power C, 2008, J EPIDEMIOL COMMUN H, V62, P1030, DOI 10.1136/jech.2007.068817; Rawshani A, 2016, JAMA INTERN MED, V176, P1146, DOI 10.1001/jamainternmed.2016.2940; Robbins JM, 2005, DIABETES RES CLIN PR, V68, P230, DOI 10.1016/j.diabres.2004.09.007; ROSE G, 1981, BRIT HEART J, V45, P13, DOI 10.1136/hrt.45.1.13; Sacerdote C, 2012, INT J EPIDEMIOL, V41, P1162, DOI 10.1093/ije/dys091; Saurel-Cubizolles MJ, 2009, J EPIDEMIOL COMMUN H, V63, P197, DOI 10.1136/jech.2008.078923; Schrijvers CTM, 1999, AM J PUBLIC HEALTH, V89, P535, DOI 10.2105/AJPH.89.4.535; Sieri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062625; Sieri S, 2010, ARCH INTERN MED, V170, P640, DOI 10.1001/archinternmed.2010.15; Steptoe A, 2003, PSYCHOSOM MED, V65, P1029, DOI 10.1097/01.PSY.0000097347.57237.2D; Stringhini S, 2012, AM J EPIDEMIOL, V175, P1275, DOI 10.1093/aje/kwr461; Thurston RC, 2005, AM J EPIDEMIOL, V162, P57, DOI 10.1093/aje/kwi159; Tracey Marsha L, 2015, Prev Med Rep, V2, P699, DOI 10.1016/j.pmedr.2015.08.003; Valkonen T, 1989, HLTH INEQUALITY EURO; Van Lenthe FJ, 2002, ANN EPIDEMIOL, V12, P535, DOI 10.1016/S1047-2797(01)00279-4; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Woodward M, 2003, PREV MED, V36, P561, DOI 10.1016/S0091-7435(03)00010-0; Yarnell J, 2005, INT J EPIDEMIOL, V34, P268, DOI 10.1093/ije/dyh267	53	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164130	10.1371/journal.pone.0164130	http://dx.doi.org/10.1371/journal.pone.0164130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711245	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600083
J	Wang, WY; Liu, SH; Lin, MY; Lin, CC; Wang, IJ				Wang, Wen-Yi; Liu, Sing-Huh; Lin, Meng-Yin; Lin, Che-Chen; Wang, I-Jong			Initial Presentation Sites as Predictors of Herpes Zoster Complications: A Nationwide Cohort Study	PLOS ONE			English	Article							RISK-FACTORS; VARICELLA-ZOSTER; POSTHERPETIC NEURALGIA; NATURAL-HISTORY; PAIN; TAIWAN; VIRUS; EPIDEMIOLOGY; OPHTHALMICUS; RESPONSES	Herpes zoster (HZ) is associated with complications such as postherpetic neuralgia (PHN) and HZ ophthalmicus (HZO). However, few studies have focused on identifying patients having a high risk of PHN and HZO according to the initial presentation sites. The current study investigated these factors in a nationwide population-based cohort derived from Taiwan's Longitudinal Health Insurance Database. The results indicate that the initial presentation sites can predict the complication site of HZ. In this study, elderly patients were found to be more susceptible to HZ and were the first to present with neurological signs (HZN). Furthermore, compared with patients with HZO and other signs (HZT), those with HZN had a higher comorbidity risk. Patients with HZN showed a significantly higher visceral complication risk than did those with HZO (adjusted hazard ratio [HR] = 1.47, 95% confidence interval [CI] = 1.27-1.71). In addition, patients with HZT showed lower risks of ocular and neurological complications than did those with HZN after stratification by age and sex (adjusted HR = 0.46, 95% CI = 0.31-0.68 and HR = 0.73, 95% CI = 0.59-0.91, respectively).	[Wang, Wen-Yi; Liu, Sing-Huh; Wang, I-Jong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Lin, Meng-Yin] Taipei Med Univ, Taipei Med Sch Med, Shuang Ho Hosp, Dept Ophthalmol, Taipei, Taipei County, Taiwan; [Lin, Meng-Yin] Natl Taiwan Univ, Sch Med, Inst Clin Med, Taipei, Taiwan; [Lin, Che-Chen] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Che-Chen] China Med Univ, Sch Med, Taichung, Taiwan; [Wang, I-Jong] China Med Univ, Sch Med, Inst Clin Med, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Shuang Ho Hospital; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Wang, IJ (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.; Wang, IJ (corresponding author), China Med Univ, Sch Med, Inst Clin Med, Taichung, Taiwan.	ijong@ms8.hinet.net		Wang, I-Jong/0000-0002-3045-0614	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105- TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105- TDU-B-212-133019); China Medical University Hospital; Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037); NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005); Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Arvin A, 2005, NEW ENGL J MED, V352, P2266, DOI 10.1056/NEJMp058091; Arvin AM, 1996, CLIN MICROBIOL REV, V9, P361, DOI 10.1128/CMR.9.3.361; Atherton S S, 2001, Herpes, V8, P69; BURKE BL, 1982, ARCH INTERN MED, V142, P291, DOI 10.1001/archinte.142.2.291; Chao DY, 2012, EPIDEMIOL INFECT, V140, P1131, DOI 10.1017/S0950268811001786; Cheng TM, 2010, SIX COUNTRIES SIX RE, P171; Chiu HF, 2013, J EPIDEMIOL, V23, P205, DOI 10.2188/jea.JE20120155; COHEN PR, 1989, CLIN EXP DERMATOL, V14, P273, DOI 10.1111/j.1365-2230.1989.tb01978.x; Decroix J, 2000, J EUR ACAD DERMATOL, V14, P23, DOI 10.1046/j.1468-3083.2000.00020.x; Furuta Y, 2000, J MED VIROL, V62, P42, DOI 10.1002/1096-9071(200009)62:1&lt;42::AID-JMV7&gt;3.0.CO;2-C; Galil K, 1997, ARCH INTERN MED, V157, P1209, DOI 10.1001/archinte.157.11.1209; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Harpaz-Rotem I, 2008, PSYCHIAT SERV, V59, P1184, DOI 10.1176/appi.ps.59.10.1184; HAYWARD AR, 1987, J CLIN IMMUNOL, V7, P174, DOI 10.1007/BF00916011; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Jung BF, 2004, NEUROLOGY, V62, P1545, DOI 10.1212/01.WNL.0000123261.00004.29; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Katz J, 2005, J PAIN, V6, P782, DOI 10.1016/j.jpain.2005.07.006; Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833; 정성규, 2012, [Korean Journal of Dermatology, 대한피부과학회지], V50, P287; Kurokawa I, 2002, J INT MED RES, V30, P56, DOI 10.1177/147323000203000109; Liesegang TJ, 2008, OPHTHALMOLOGY, V115, pS3, DOI 10.1016/j.ophtha.2007.10.009; Lin HC, 2010, NEUROLOGY, V74, P792, DOI 10.1212/WNL.0b013e3181d31e5c; Lin YH, 2010, VACCINE, V28, P1217, DOI 10.1016/j.vaccine.2009.11.029; Margolis T, 1996, OCULAR INFECT IMMUNI, P1155; Nagasako EM, 2002, J AM ACAD DERMATOL, V46, P834, DOI 10.1067/mjd.2002.120924; Parruti G, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-58; SCHMADER K, 1990, J AM GERIATR SOC, V38, P1188, DOI 10.1111/j.1532-5415.1990.tb01497.x; SCHMADER K, 1995, J INFECT DIS, V171, P701, DOI 10.1093/infdis/171.3.701; Scott Fiona T., 2003, Journal of Medical Virology, V70, pS24, DOI 10.1002/jmv.10316; Thomas SL, 2004, BRIT MED J, V328, P439, DOI 10.1136/bmj.37991.511829.F7; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Tran TN, 2014, SCAND J INFECT DIS, V46, P528, DOI 10.3109/00365548.2014.901554; Tsai TF, 2015, INT J DERMATOL, V54, P529, DOI 10.1111/ijd.12484; Vandercam T, 2008, NEUROLOGY, V71, P1268, DOI 10.1212/01.wnl.0000327615.99124.99; Weinberg JM, 2007, J AM ACAD DERMATOL, V57, pS130, DOI 10.1016/j.jaad.2007.08.046; Whitley RJ, 1998, J INFECT DIS, V178, pS71, DOI 10.1086/514274; Wu TY, 2010, LONDON J PRIM CARE, V3, P115, DOI 10.1080/17571472.2010.11493315; Yawn BP, 2013, MAYO CLIN PROC, V88, P562, DOI 10.1016/j.mayocp.2013.03.014; Yawn BP, 2011, MAYO CLIN PROC, V86, P88, DOI 10.4065/mcp.2010.0618	41	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164019	10.1371/journal.pone.0164019	http://dx.doi.org/10.1371/journal.pone.0164019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711168	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600063
J	Carson, MB; Scholtens, DM; Frailey, CN; Gravenor, SJ; Kricke, GE; Soulakis, ND				Carson, Matthew B.; Scholtens, Denise M.; Frailey, Conor N.; Gravenor, Stephanie J.; Kricke, Gayle E.; Soulakis, Nicholas D.			An Outcome-Weighted Network Model for Characterizing Collaboration	PLOS ONE			English	Article							PATIENT-SHARING NETWORKS; COLLEGE-OF-CARDIOLOGY; SOCIAL NETWORK; SCALE-FREE; HEART-FAILURE; PRIMARY-CARE; COMPLEX; HEALTH; QUALITY; PHYSICIANS	Shared patient encounters form the basis of collaborative relationships, which are crucial to the success of complex and interdisciplinary teamwork in healthcare. Quantifying the strength of these relationships using shared risk-adjusted patient outcomes provides insight into interactions that occur between healthcare providers. We developed the Shared Positive Outcome Ratio (SPOR), a novel parameter that quantifies the concentration of positive outcomes between a pair of healthcare providers over a set of shared patient encounters. We constructed a collaboration network using hospital emergency department patient data from electronic health records (EHRs) over a three-year period. Based on an outcome indicating patient satisfaction, we used this network to assess pairwise collaboration and evaluate the SPOR. By comparing this network of 574 providers and 5,615 relationships to a set of networks based on randomized outcomes, we identified 295 (5.2%) pairwise collaborations having significantly higher patient satisfaction rates. Our results show extreme high-and low-scoring relationships over a set of shared patient encounters and quantify high variability in collaboration between providers. We identified 29 top performers in terms of patient satisfaction. Providers in the high-scoring group had both a greater average number of associated encounters and a higher percentage of total encounters with positive outcomes than those in the low-scoring group, implying that more experienced individuals may be able to collaborate more successfully. Our study shows that a healthcare collaboration network can be structurally evaluated to characterize the collaborative interactions that occur between healthcare providers in a hospital setting.	[Carson, Matthew B.; Scholtens, Denise M.; Frailey, Conor N.; Kricke, Gayle E.; Soulakis, Nicholas D.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Gravenor, Stephanie J.] Northwestern Univ, Dept Emergency Med, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Carson, MB (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.	matthew.carson@northwestern.edu		Carson, Matthew/0000-0003-4105-9220	National Library of Medicine [K01LM011973-01]; Clinical and Translational Science Award (CTSA), National Center for Research Resources [UL1TR001422]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K01LM011973] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Clinical and Translational Science Award (CTSA), National Center for Research Resources; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by K01LM011973-01, National Library of Medicine, https://www.hlm.nih.gov: MBC, GEK, NDS; Clinical and Translational Science Award (CTSA) award UL1TR001422, National Center for Research Resources - transitioned to the National Center for Advancing Translational Sciences (NCATS), http://sdminutes.cit.nih.gov/about/almanac/organization/NCRR.htm: MBC and NDS.	Agency for Healthcare Research and Quality (AHRQ), 2015, 2014 NAT HEALTHC QUA; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Anderson C, 2011, NURS RES, V60, P378, DOI 10.1097/NNR.0b013e3182337d97; Barabasi AL, 2003, AIP CONF PROC, V661, P1, DOI 10.1063/1.1571285; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barnett ML, 2012, MED CARE, V50, P152, DOI 10.1097/MLR.0b013e31822dcef7; Barnett ML, 2011, HEALTH SERV RES, V46, P1592, DOI 10.1111/j.1475-6773.2011.01262.x; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Benham-Hutchins MM, 2010, INT J MED INFORM, V79, P252, DOI 10.1016/j.ijmedinf.2009.12.005; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borgatti SP, 2011, SAGE HDB SOCIAL NETW; Centers for Medicare and Medicaid Services, READM RED PROGR; Chambers D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041911; Department of Health and Human Services, 2016, 2015 ANN PROGR REP C; Gao ZK, 2016, CHEM ENG J, V291, P74, DOI 10.1016/j.cej.2016.01.039; Gao ZK, 2015, SCI REP-UK, V5, DOI 10.1038/srep08222; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Gao ZK, 2012, NONLINEAR ANAL-REAL, V13, P947, DOI 10.1016/j.nonrwa.2011.08.029; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gray JE, 2010, PEDIATRICS, V125, pE1460, DOI 10.1542/peds.2009-2621; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Hospital Consumer Assessment of Healthcare Providers and Systems, 2015, HCAHPS FACT SHEET; Hripcsak G, 2011, J AM MED INFORM ASSN, V18, P112, DOI 10.1136/jamia.2010.008441; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; IOM, 2006, IMPR QUAL HLTH CAR M; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jones A, 2013, ARROWS TOOL; Kim J, 2008, PHYSICA A, V387, P2637, DOI 10.1016/j.physa.2008.01.015; Krowinski W, 1996, MEASURING MANAGING P, V73; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Landon BE, 2013, MED CARE, V51, P715, DOI 10.1097/MLR.0b013e3182977991; Landon BE, 2012, JAMA-J AM MED ASSOC, V308, P265, DOI 10.1001/jama.2012.7615; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; Mandl KD, 2014, J GEN INTERN MED, V29, P1499, DOI 10.1007/s11606-014-2964-0; McDonald KM, 2007, AHRQ TECHNICAL REV; Mehta Shivan J, 2015, AMA J Ethics, V17, P616, DOI 10.1001/journalofethics.2015.17.7.ecas3-1507; Meltzer D, 2010, SOC SCI MED, V71, P1119, DOI 10.1016/j.socscimed.2010.05.012; Microsoft, 2012, MICR SQL SERV MAN ST; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Munoz D, 2014, P 2014 IND SYST ENG; Nageswaran S, 2012, ACAD PEDIATR, V12, P189, DOI 10.1016/j.acap.2012.02.007; Neo Technology, 2015, NEO4J MAN V2 2 5; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ong MS, 2016, J GEN INTERN MED, V31, P164, DOI 10.1007/s11606-015-3470-8; Ottino JM, 2004, NATURE, V427, P399, DOI 10.1038/427399a; Padron B, 2011, BASIC APPL ECOL, V12, P713, DOI 10.1016/j.baae.2011.09.004; Pan RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00902; Pham HH, 2009, ANN INTERN MED, V150, P236, DOI 10.7326/0003-4819-150-4-200902170-00004; Pollack CE, 2013, J GEN INTERN MED, V28, P459, DOI 10.1007/s11606-012-2104-7; Pollack CE, 2012, HEALTH SERV RES, V47, P380, DOI 10.1111/j.1475-6773.2011.01331.x; Python Software Foundation, PYTH LANG REF VERS 2; RCoreTeam, 2012, R LANG ENV STAT COMP; Robinson I., 2015, GRAPH DATABASES, V2nd; Saracco F, 2016, SCI REP-UK, V6, DOI 10.1038/srep30286; Soulakis ND, 2015, J AM MED INFORM ASSN, V22, P299, DOI 10.1093/jamia/ocu017; Spertus JA, 2005, CIRCULATION, V111, P1703, DOI 10.1161/01.CIR.0000157096.95223.D7; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Sullivan W, 2010, EMERG PHYS MON; Uddin S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1472-6963-13-234; Vawdrey DK, 2011, APPL CLIN INFORM, V2, P395, DOI 10.4338/ACI-2011-05-RA-0034; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vukotic A., 2015, NEO4J IN ACTION, V22; Wasserman S, 1994, AFFILIATIONS OVERLAP, P291; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weenink JW, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-66; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zusman EE, 2012, NEUROSURGERY, V71, pN21, DOI 10.1227/01.neu.0000417536.07871.ed	75	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163861	10.1371/journal.pone.0163861	http://dx.doi.org/10.1371/journal.pone.0163861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706199	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200065
J	Pageaux, B; Lepers, R; Marcora, SM				Pageaux, Benjamin; Lepers, Romuald; Marcora, Samuele M.			Reliability of a Novel High Intensity One Leg Dynamic Exercise Protocol to Measure Muscle Endurance	PLOS ONE			English	Article							PERIPHERAL FATIGUE; NEUROMUSCULAR FUNCTION; CYCLING EXERCISE; SPORTS-MEDICINE; GROUP-III; HUMANS; PERFORMANCE; FEEDBACK; MASS; AFFERENTS	We recently developed a high intensity one leg dynamic exercise (OLDE) protocol to measure muscle endurance and investigate the central and peripheral mechanisms of muscle fatigue. The aims of the present study were to establish the reliability of this novel protocol and describe the isokinetic muscle fatigue induced by high intensity OLDE and its recovery. Eight subjects performed the OLDE protocol (time to exhaustion test of the right leg at 85% of peak power output) three times over a week period. Isokinetic maximal voluntary contraction torque at 60 (MVC60), 100 (MVC100) and 140 (MVC140) deg/s was measured pre-exercise, shortly after exhaustion (13 +/- 4 s), 20 s (P20) and 40 s (P40) post-exercise. Electromyographic (EMG) signal was analyzed via the root mean square (RMS) for all three superficial knee extensors. Mean time to exhaustion was 5.96 +/- 1.40 min, coefficient of variation was 8.42 +/- 6.24%, typical error of measurement was 0.30 min and intraclass correlation was 0.795. MVC torque decreased shortly after exhaustion for all angular velocities (all P < 0.001). MVC60 and MVC100 recovered between P20 (P < 0.05) and exhaustion and then plateaued. MVC140 recovered only at P40 (P < 0.05). High intensity OLDE did not alter maximal EMG RMS of the three superficial knee extensors during MVC. The results of this study demonstrate that this novel high intensity OLDE protocol could be reliably used to measure muscle endurance, and that muscle fatigue induced by high intensity OLDE should be examined within similar to 30 s following exhaustion.	[Pageaux, Benjamin; Marcora, Samuele M.] Univ Kent Medway, Sch Sport & Exercise Sci, Endurance Res Grp, Chatham, Kent, England; [Pageaux, Benjamin; Lepers, Romuald] Univ Bourgogne Franche Comte, INSERM, CAPS UMR1093, Dijon, France	University of Kent; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Pageaux, B (corresponding author), Univ Kent Medway, Sch Sport & Exercise Sci, Endurance Res Grp, Chatham, Kent, England.; Pageaux, B (corresponding author), Univ Bourgogne Franche Comte, INSERM, CAPS UMR1093, Dijon, France.	benjaminpageaux@gmail.com	Lepers, Romuald/T-8782-2019; Marcora, Samuele/W-4284-2019	Marcora, Samuele/0000-0002-1570-7936; Lepers, Romuald/0000-0002-3870-4017; Pageaux, Benjamin/0000-0001-9302-5183	Region de Bourgogne [9201AA0049S03018]; Fonds Europeen de Developpement Regional (FEDER)	Region de Bourgogne(Region Bourgogne-Franche-Comte); Fonds Europeen de Developpement Regional (FEDER)(European Commission)	The manuscript was written during the postdoctoral position of BP that was funded by the Region de Bourgogne (contract 9201AA0049S03018) and the Fonds Europeen de Developpement Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2013, J APPL PHYSIOL, V115, P355, DOI 10.1152/japplphysiol.00049.2013; Amann M, 2011, MED SCI SPORT EXER, V43, P2039, DOI 10.1249/MSS.0b013e31821f59ab; Amann M, 2011, J PHYSIOL-LONDON, V589, P3855, DOI 10.1113/jphysiol.2011.209353; ANDERSEN P, 1985, J APPL PHYSIOL, V59, P1647, DOI 10.1152/jappl.1985.59.5.1647; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; BANGSBO J, 1993, J PHYSIOL-LONDON, V462, P115, DOI 10.1113/jphysiol.1993.sp019546; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; Dempsey JA, 2014, J PHYSIOL-LONDON, V592, P463, DOI 10.1113/jphysiol.2013.261925; Deschenes M, 2013, ACSMS GUIDELINES EXE, P162; Froyd C, 2013, J PHYSIOL-LONDON, V591, P1339, DOI 10.1113/jphysiol.2012.245316; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Garten RS, 2014, J APPL PHYSIOL, V116, P1204, DOI 10.1152/japplphysiol.00103.2014; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG., 2015, SPORTSCIENCE, V19, P36; Impellizzeri FM, 2008, INT J SPORTS MED, V29, P899, DOI 10.1055/s-2008-1038491; Impellizzeri FM, 2009, INT J SPORT PHYSIOL, V4, P269, DOI 10.1123/ijspp.4.2.269; Marcora SM, 2008, AM J PHYSIOL-REG I, V294, pR874, DOI 10.1152/ajpregu.00678.2007; Marcora SM., ENCY PERCEPTION, V2010, P380, DOI DOI 10.4135/9781412972000.N119; Millet GY, 2004, SPORTS MED, V34, P105, DOI 10.2165/00007256-200434020-00004; MORROW JR, 1993, RES Q EXERCISE SPORT, V64, P352, DOI 10.1080/02701367.1993.10608821; O'Connor PJ, 2001, MED SCI SPORT EXER, V33, P1046, DOI 10.1097/00005768-200106000-00026; Pageaux B, 2016, EUR J SPORT SCI, V16, P885, DOI 10.1080/17461391.2016.1188992; Pageaux B, 2015, AM J PHYSIOL-REG I, V308, pR1008, DOI 10.1152/ajpregu.00280.2014; Pageaux B, 2014, EUR J APPL PHYSIOL, V114, P1095, DOI 10.1007/s00421-014-2838-5; Pageaux B, 2013, MED SCI SPORT EXER, V45, P2254, DOI 10.1249/MSS.0b013e31829b504a; Rossman MJ, 2012, ACTA PHYSIOL, V206, P242, DOI 10.1111/j.1748-1716.2012.02471.x; Rossman MJ, 2014, AM J PHYSIOL-REG I, V306, pR934, DOI 10.1152/ajpregu.00043.2014; Rossman MJ, 2013, AM J PHYSIOL-REG I, V305, pR1163, DOI 10.1152/ajpregu.00360.2013; Rossman MJ, 2013, MED SCI SPORT EXER, V45, P1235, DOI 10.1249/MSS.0b013e3182846d7e; Sidhu SK, 2013, SPORTS MED, V43, P437, DOI 10.1007/s40279-013-0020-6; Strange S, 1999, J PHYSIOL-LONDON, V514, P283, DOI 10.1111/j.1469-7793.1999.283af.x; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163979	10.1371/journal.pone.0163979	http://dx.doi.org/10.1371/journal.pone.0163979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706196	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000385697200072
J	Ssali, T; Anazodo, UC; Bureau, Y; MacIntosh, BJ; Gunther, M; St Lawrence, K				Ssali, Tracy; Anazodo, Udunna C.; Bureau, Yves; MacIntosh, Bradley J.; Guenther, Matthias; St Lawrence, Keith			Mapping Long-Term Functional Changes in Cerebral Blood Flow by Arterial Spin Labeling	PLOS ONE			English	Article							PERFUSION MRI; FMRI DATA; REPRODUCIBILITY; RELIABILITY; BRAIN; ACTIVATION; TASK; TIME; 3T; NORMALIZATION	Although arterial spin labeling (ASL) is appealing for mapping long-term changes in functional activity, inter-sessional variations in basal blood flow, arterial transit times (ATTs), and alignment errors, can result in significant false activation when comparing images from separate sessions. By taking steps to reduce these sources of noise, this study assessed the ability of ASL to detect functional CBF changes between sessions. ASL data were collected in three sessions to image ATT, resting CBF and CBF changes associated with motor activation (7 participants). Activation maps were generated using rest and task images acquired in the same session and from sessions separated by up to a month. Good agreement was found when comparing between-session activation maps to within-session activation maps with only a 16% decrease in precision (within-session: 90 +/- 7%) and a 13% decrease in the Dice similarity (within-session: 0.75 +/- 0.07) coefficient after a month. In addition, voxel-wise reproducibility (within-session: 4.7 +/- 4.5%) and reliability (within-session: 0.89 +/- 0.20) of resting grey-matter CBF decreased by less than 18% for the between-session analysis relative to within-session values. ATT variability between sessions (5.0 +/- 2.7%) was roughly half the between-subject variability, indicating that its effects on longitudinal CBF were minimal. These results demonstrate that conducting voxel-wise analysis on CBF images acquired on different days is feasible with only modest loss in precision, highlighting the potential of ASL for longitudinal studies.	[Ssali, Tracy; Anazodo, Udunna C.; Bureau, Yves; St Lawrence, Keith] Lawson Hlth Res Inst, London, ON, Canada; [Ssali, Tracy; Anazodo, Udunna C.; St Lawrence, Keith] Western Univ, Dept Med Biophys, London, ON, Canada; [MacIntosh, Bradley J.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Guenther, Matthias] Fraunhofer Inst Med Image Comp MEVIS, Bremen, Germany; [Guenther, Matthias] Mediri GmbH, Heidelberg, Germany	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Fraunhofer Gesellschaft	Ssali, T (corresponding author), Lawson Hlth Res Inst, London, ON, Canada.; Ssali, T (corresponding author), Western Univ, Dept Med Biophys, London, ON, Canada.	tssali@uwo.ca		MacIntosh, Bradley/0000-0001-7300-2355; Anazodo, Udunna/0000-0001-8864-035X; St Lawrence, Keith/0000-0001-8022-8205	Canadian Institutes of Health Research [MOP-119453]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from Canadian Institutes of Health Research (MOP-119453). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2009, AM J PHYSIOL-REG I, V296, pR1473, DOI 10.1152/ajpregu.91008.2008; Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Aslan S, 2010, MAGN RESON IMAGING, V28, P928, DOI 10.1016/j.mri.2010.03.037; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Borghammer P, 2008, NEUROIMAGE, V40, P529, DOI 10.1016/j.neuroimage.2007.12.057; Borogovac A, 2010, J CEREBR BLOOD F MET, V30, P1721, DOI 10.1038/jcbfm.2010.89; Chappell MA, 2009, IEEE T SIGNAL PROCES, V57, P223, DOI 10.1109/TSP.2008.2005752; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Dai WY, 2012, MAGN RESON MED, V67, P1252, DOI 10.1002/mrm.23103; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Diamant M, 2002, ACTA PHYSIOL SCAND, V175, P1, DOI 10.1046/j.1365-201X.2002.00953.x; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fernandez-Seara MA, 2008, MAGN RESON MED, V59, P1467, DOI 10.1002/mrm.21633; Fischmeister FPS, 2013, NEUROIMAGE-CLIN, V3, P369, DOI 10.1016/j.nicl.2013.09.007; Fleiss J.L., 2013, STAT METHODS RATES P; Floyd TF, 2003, J MAGN RESON IMAGING, V18, P649, DOI 10.1002/jmri.10416; Fukumoto M, 1999, LANCET, V354, P1790, DOI 10.1016/S0140-6736(99)03746-0; Gevers S, 2011, J CEREBR BLOOD F MET, V31, P1706, DOI 10.1038/jcbfm.2011.10; Gunther M, 2005, MAGN RESON MED, V54, P491, DOI 10.1002/mrm.20580; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Howard MA, 2012, ARTHRITIS RHEUM-US, V64, P3936, DOI 10.1002/art.37685; Howard MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017096; Jahng GH, 2005, RADIOLOGY, V234, P909, DOI 10.1148/radiol.2343031499; Jiang L, 2010, MAGN RESON IMAGING, V28, P1283, DOI 10.1016/j.mri.2010.05.002; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Maclntosh BJ, 2010, AM J NEURORADIOL, V31, P1892, DOI 10.3174/ajnr.A2008; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MATHEW RJ, 1991, AM J PSYCHIAT, V148, P292; Mezue M, 2014, J CEREBR BLOOD F MET, V34, P1919, DOI 10.1038/jcbfm.2014.163; Mutsaerts HJMM, 2015, NEUROIMAGE, V113, P143, DOI 10.1016/j.neuroimage.2015.03.043; Owen DG, 2010, PAIN, V148, P375, DOI 10.1016/j.pain.2009.10.003; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Petersen ET, 2010, NEUROIMAGE, V49, P104, DOI 10.1016/j.neuroimage.2009.07.068; RAMSAY SC, 1993, J PHYSIOL-LONDON, V471, P521, DOI 10.1113/jphysiol.1993.sp019913; Raoult H, 2011, NEUROIMAGE, V58, P157, DOI 10.1016/j.neuroimage.2011.06.011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Skup M, 2010, STAT INTERFACE, V3, P235; Sousa I, 2014, J MAGN RESON IMAGING, V40, P1453, DOI 10.1002/jmri.24493; Tan H, 2011, MAGN RESON MED, V66, P168, DOI 10.1002/mrm.22768; Tjandra T, 2005, NEUROIMAGE, V27, P393, DOI 10.1016/j.neuroimage.2005.04.021; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ushida Takahiro, 2010, Open Neuroimag J, V4, P182, DOI 10.2174/1874440001004010182; Vidorreta M, 2013, NEUROIMAGE, V66, P662, DOI 10.1016/j.neuroimage.2012.10.087; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Wang Y, 2011, NEUROIMAGE, V54, P1188, DOI 10.1016/j.neuroimage.2010.08.043; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Ye FQ, 2000, MAGN RESON MED, V44, P92, DOI 10.1002/1522-2594(200007)44:1<92::AID-MRM14>3.0.CO;2-M	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164112	10.1371/journal.pone.0164112	http://dx.doi.org/10.1371/journal.pone.0164112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706218	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200084
J	Taye, M; Afework, M; Fantaye, W; Diro, E; Worku, A				Taye, Molla; Afework, Mekbeb; Fantaye, Wondwossen; Diro, Ermias; Worku, Alemayehu			Magnitude of Birth Defects in Central and Northwest Ethiopia from 2010-2014: A Descriptive Retrospective Study	PLOS ONE			English	Article							CONGENITAL-ANOMALIES; MALFORMATIONS; PREVALENCE; INFANTS	Background Birth defects are defined as structural and functional defects that develop during the organogenesis period and present at birth or detected later in life. They are one of the leading causes of infant and child mortality, morbidity, and long term disability. The magnitude of birth defects varies from country to country and from race/ethnicity to race/ethnicity, and about 40-60% of their causes are unknown. The known causes of birth defects are genetic and environmental factors which may be prevented. For various reasons, there is lack of data and research on birth defects in Ethiopia. Objective The major objective of this study is to estimate the magnitude of birth defects in Ethiopia. Subject and Methods A hospital based, retrospective, cross sectional, descriptive study was conducted. The subjects were babies/children aged 0-17years who visited selected hospitals between 2010 and 2014. Fourteen hospitals (8 in Addis Ababa, 6 in Amhara Region) were selected purposively based on case load. A data retrieving form was developed to extract relevant information from record books. Results In the hospitals mentioned, 319,776 various medical records of children aged 0-17years were found. Of these, 6,076 (1.9% with 95% CI: 1.85%-1.95%) children were diagnosed as having birth defects. The majority (58.5%) of the children were male and 41.5% female. A slightly more than half (51.1%) of the children were urban dwellers, while 48.9% were from rural areas. Among the participants of the study the proportion of birth defects ranged as follows: orofacial (34.2%), neural tube (30.8%), upper and lower limb (12.8%), cardiovascular system (10.3%), digestive system and abdominal wall (4.8%), unspecified congenital malformations (2.5%), Down syndrome (2%), genitourinary system (2%), head, face, and neck defects (0.4%), and others (0.3%). The trend of birth defects increased linearly over time [Extended Mantel-Haenszel chi square for linear trend = 356.7 (P<0.0001)]. About 275 (4.5%) of the cases had multiple (associated) birth defects and 5,801 (95.5%) isolated (single) birth defects. Out of the total birth defects, 6,018 (99%) were major and 58 (1%) minor. Conclusion The magnitude of birth defects increased from 2010-2014. Orofacial and neural tube defects contributed about two thirds of the birth defects. There is an urgent need for registry and surveillance system strategies for intervention and control of birth defects in Ethiopia.	[Taye, Molla; Afework, Mekbeb] Univ Addis Ababa, Coll Hlth Sci, Dept Anat, Addis Ababa, Ethiopia; [Fantaye, Wondwossen] Univ Addis Ababa, Sch Dent, Coll Hlth Sci, Addis Ababa, Ethiopia; [Diro, Ermias] Univ Gondar, Sch Med, Coll Med & Hlth Sci, Internal Med, Gondar, Ethiopia; [Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University; University of Gondar; Addis Ababa University	Taye, M (corresponding author), Univ Addis Ababa, Coll Hlth Sci, Dept Anat, Addis Ababa, Ethiopia.	mollataye2@gmail.com			Addis Ababa University; University of Gondar	Addis Ababa University; University of Gondar	This study obtained fund from Addis Ababa University and the University of Gondar for data collection only. The authors declare that they have no fund for the publication of this manuscript. The funders have no role in the study design, data analysis and decision to publish for preparation of the manuscript.	Ahmed A. M., 2011, The Journal of American Science, V7, P899; Anyanwu LC, 2015, U J PUBLIC HLTH, V3, P89; Bakare T I B, 2009, Afr J Paediatr Surg, V6, P28, DOI 10.4103/0189-6725.48572; Barisic I, 2009, ZDRAV VESTN S1, V78; Central Statistical Agency, 2013, POP PROJ ETH ALL REG; Central Statistical Agency [Ethiopia], 2008, STAT ABSTR POP PROJ; Christianson A, 2006, HIDDEN TOLL DYING DI; Costa Cláudia Maria da Silva, 2006, Cad. Saúde Pública, V22, P2423, DOI 10.1590/S0102-311X2006001100016; Dastgiri S, 2002, ARCH DIS CHILD, V86, P257, DOI 10.1136/adc.86.4.257; Ekwere OE., 2011, INT J PHARM SCI INVE, V3, P24; Eluwa MA., 2013, INT J PHARM SCI INVE, V2, P27; Fan LC, 2013, BIRTH DEFECTS RES A, V97, P750, DOI 10.1002/bdra.23148; Gonzalez-Andrade F, 2010, APPL CLIN GENET, V3, P29; Kishimba RS, 2015, PAN AFRICAN MED J, V20, DOI 10.11604/pamj.2015.20.153.4492; Kucik JE, 2012, PUBLIC HEALTH REP, V127, P52, DOI 10.1177/003335491212700106; Mashuda Florentina, 2014, BMC Res Notes, V7, P195, DOI 10.1186/1756-0500-7-195; Mazer P, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-102; Muga R, 2009, AFRICAN J FOOD AGR N, V9, DOI [10.4314/ajfand.v9i3.43008, DOI 10.4314/AJFAND.V9I3.43008]; Ndibazza J, 2011, BIRTH DEFECTS RES A, V91, P857, DOI 10.1002/bdra.20838; Nordenskjold A, 2015, EUR UROL SUPPL, V14, P2, DOI 10.1016/j.eursup.2015.01.003; Obu Herbert A, 2012, BMC Res Notes, V5, P177, DOI 10.1186/1756-0500-5-177; Oliveira Camila Ive Ferreira, 2011, BMC Res Notes, V4, P343, DOI 10.1186/1756-0500-4-343; Postoev VA, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-3; Radu R., 2009, Applied Medical Informatics, V25, P37; Riley M, 2005, HIM J, V34, P94; Rizk F., 2014, U J PUBLIC HLTH, V2, P58; Rosano A, 2000, J EPIDEMIOL COMMUN H, V54, P660, DOI 10.1136/jech.54.9.660; Sadler T., 2010, LANGMANS MED EMBRYOL; Serra-Juhe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045530; Shawky RM., 2011, EJMHG, V12, P69, DOI [10.1016/j.ejmhg.2011.02.016, DOI 10.1016/J.EJMHG.2011.02.016]; Tomatir AG, 2009, GENET MOL RES, V8, P19, DOI 10.4238/vol8-1gmr506; van Gelder MMHJ, 2014, HUM REPROD, V29, P161, DOI 10.1093/humrep/det369; World Health Organization, 2014, BIRTH DEF SURV MAN P; Zhang XG, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-125; Zhu MT, 2006, BIRTH DEFECTS RES A, V76, P467, DOI 10.1002/bdra.20270; Zwink N, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-25	36	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0161998	10.1371/journal.pone.0161998	http://dx.doi.org/10.1371/journal.pone.0161998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706169	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697200005
J	Wang, QQ; Zhang, LL; Yuan, XD; Ou, Y; Zhu, XH; Cheng, ZZ; Zhang, PS; Wu, XY; Meng, Y; Zhang, LP				Wang, Quanquan; Zhang, Lili; Yuan, Xiaodong; Ou, Ya; Zhu, Xuhong; Cheng, Zanzan; Zhang, Pingshu; Wu, Xiaoying; Meng, Yan; Zhang, Liping			The Relationship between the Bcl-2/Bax Proteins and the Mitochondria-Mediated Apoptosis Pathway in the Differentiation of Adipose-Derived Stromal Cells into Neurons	PLOS ONE			English	Article							TISSUE; ULTRASTRUCTURE; DEATH	Our objective is to study the relationship between the regulatory proteins Bcl-2/Bax and mitochondria-mediated apoptosis during the differentiation of adipose-derived stromal cells (ADSCs) into neurons. Immunocytochemistry and western blotting showed that the cells weakly expressed neuron-specific enolase (NSE) in the non-induced group and expressed NSE more strongly in the groups induced for 1 h, 3 h, 5 h and 8 h. NSE expression peaked at 5 h (P < 0.05), although there was no significant difference between 5 and 8 h (P > 0.05). Bcl-2 expression gradually decreased over time in the non-induced group (P < 0.05). However, Bax, caspase-9, Cyt-c and caspase-3 expression gradually increased and peaked at 8 h (P < 0.05). Transmission electron microscopy revealed karyopyknosis, chromatin edge setting, mitochondria swelling and cavitation in cells at 5 h, and the mitochondrial membrane potential decreased over time, as demonstrated by laser scanning confocal microscopy. After a 5 h induction, cells differentiated into typical neurons and expressed Bcl-2, which inhibited apoptosis. Bax showed a strong apoptosis-promoting capacity, leading to changes in the mitochondrial membrane potential and structure, and then triggered the caspase-independent apoptotic response through the mitochondrial pathway. At the same time, Cyt-c was directly or indirectly released from the mitochondria to the cytoplasm to trigger the caspase-dependent apoptotic response through the mitochondrial pathway. Therefore, Bcl-2/Bax play an important role in regulating caspase-dependent and caspase-independent apoptosis mediated by the mitochondrial pathway during the differentiation of ADSCs into neurons.	[Wang, Quanquan; Zhang, Lili; Yuan, Xiaodong; Ou, Ya; Zhu, Xuhong; Cheng, Zanzan; Meng, Yan; Zhang, Liping] Univ Sci & Technol, Affiliated Kailuan Gen Hosp North China, Dept Neurol, Tangshan 063000, Hebei Province, Peoples R China; [Zhang, Pingshu] Key Lab Neurol & Biol Funct Hebei Prov, Tangshan 063000, Hebei Province, Peoples R China; [Wu, Xiaoying] Key Lab Neurol Tangshan, Tangshan 063000, Hebei Province, Peoples R China		Yuan, XD (corresponding author), Univ Sci & Technol, Affiliated Kailuan Gen Hosp North China, Dept Neurol, Tangshan 063000, Hebei Province, Peoples R China.	yxd68@sohu.com						Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Cai YN, 2011, NEURAL REGEN RES, V6, P750, DOI 10.3969/j.issn.1673-5374.2011.10.005; Cai YN, 2011, ZHONGHUA XINGWEI YIX, V20, P302; Dhar S, 2007, TISSUE ENG, V13, P2625, DOI 10.1089/ten.2007.0017; Faccenda D, 2013, CELL CYCLE, V12, P2530, DOI 10.4161/cc.25840; He JL, 2000, J PHARMACOL EXP THER, V295, P896; Inayat-Hussain SH, 2010, TOXICOL LETT, V193, P108, DOI 10.1016/j.toxlet.2009.12.010; Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264; Katz AJ, 2005, STEM CELLS, V23, P412, DOI 10.1634/stemcells.2004-0021; Keswani T, 2015, ENVIRON TOXICOL, V30, P411, DOI 10.1002/tox.21916; [刘斌 Liu Bin], 2010, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V14, P15; Lu YH, 2012, NEURAL REGEN RES, V7, P1205, DOI 10.3969/j.issn.1673-5374.2012.16.001; Ou Y, 2011, ZHONGGUO BINGLI SHEN, V27, p[1414, 1212], DOI [10.3969/j.issn.1673-5374.2012.16.001, DOI 10.3969/J.ISSN.1673-5374.2012.16.001]; Ou Y, 2011, CHINESE MED J-PEKING, V124, P2656, DOI 10.3760/cma.j.issn.0366-6999.2011.17.016; Ou Y, 2011, NEURAL REGEN RES, V6, P738, DOI 10.3969/j.issn.1673-5374.2011.10.003; Vitagliano O, 2013, EXPERT REV HEMATOL, V6, P587, DOI 10.1586/17474086.2013.827415; Ye CQ, 2010, NEURAL REGEN RES, V5, P1456, DOI 10.3969/j.issn.1673-5374.2010.19.003; Yuan XD, 2011, NEURAL REGEN RES, V6, P2681, DOI 10.3969/j.issn.1673-5374.2011.34.006; Zhang LL, 2014, NEUROSCI LETT, V575, P19, DOI 10.1016/j.neulet.2014.05.025; Zhang Q., 2007, ENV OCCUP MED, V24, P102; Zhang XL, 2015, MOL MED REP, V11, P3317, DOI 10.3892/mmr.2015.3155; [周向阳 Zhou Xiangyang], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P3024; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	24	68	89	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163327	10.1371/journal.pone.0163327	http://dx.doi.org/10.1371/journal.pone.0163327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706181	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697200038
J	Zemouri, C; Wi, TE; Kiarie, J; Seuc, A; Mogasale, V; Latif, A; Broutet, N				Zemouri, Charifa; Wi, Teodora Elvira; Kiarie, James; Seuc, Armando; Mogasale, Vittal; Latif, Ahmed; Broutet, Nathalie			The Performance of the Vaginal Discharge Syndromic Management in Treating Vaginal and Cervical Infection: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							SEXUALLY-TRANSMITTED INFECTIONS; PRIMARY-HEALTH-CARE; CHLAMYDIAL INFECTIONS; COST-EFFECTIVENESS; RISK-ASSESSMENT; WOMEN; GONORRHEA; PREVALENCE; DIAGNOSIS; DISEASES	Background This review aimed to synthesize and analyze the diagnostic accuracy and the likelihood of providing correct treatment of the syndromic approach Vaginal Discharge Flowchart in managing cervical infections caused by Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT), and vaginal infections caused by Trichomonas vaginalis (TV) and Bacterial vaginosis (BV) and Candida albicans. This review will inform updating the WHO 2003 guidelines on Vaginal Discharge syndromic case management. Methods A systematic review was conducted on published studies from 01-01-2000 to 30-03-2015 in multiple databases. Studies evaluating the diagnostic accuracy and validation of the WHO Vaginal Discharge Flowchart were included. Validation parameters including sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) and the 95% confidence intervals for the different types of the flowchart were taken as outcomes, re-calculated, and analysed using a fixed model meta-analysis for data pooling. The level of agreement between the index and reference test were determined by the Cohen's Kappa co-efficiency test. Each individual study was assessed on quality using the QUADAS-2 tool. Findings The search yielded 2,845 studies of which 16 met the eligibility criteria for final analysis. The diagnostic performance to identify cervical infections was low and resulted in a high proportion of over and missed treatment. The four flowcharts had a sensitivity between 27.37% in history and risk assessment and 90.13% with microscopy, with the inverse in specificity rates. The treatment performances between the flowcharts were inconsistent. The same applies to the use of vaginal discharge flowchart for treating vaginal infections. For vaginal infections the vaginal discharge flowchart had a good performance in flowchart 3 with 91.68% of sensitivity; 99.97% specificity; 99.93% PPV and 0.02% who missed their treatment and 8.32% of women who were over treated by the vaginal discharge flowchart Conclusion The vaginal discharge flowchart should focus on management of vaginal infection. It could be used as an intermediate approach for cervical infections for sex workers until a point of care test is available in resource poor settings.	[Zemouri, Charifa; Wi, Teodora Elvira; Kiarie, James; Seuc, Armando; Broutet, Nathalie] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; [Zemouri, Charifa] Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands; [Zemouri, Charifa] Univ Amsterdam, Amsterdam, Netherlands; [Zemouri, Charifa] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Mogasale, Vittal] Int Vaccine Inst, Polit & Econ Res Ctr, Seoul, South Korea	World Health Organization; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; International Vaccine Institute	Wi, TE (corresponding author), WHO, Dept Reprod Hlth & Res, Geneva, Switzerland.	wit@who.int	Mogasale, Vittal/C-7853-2011; Unemo, Magnus/ABD-6653-2021; Zemouri, Charifa/AEI-1259-2022; Mogasale, Vittal/HCH-7125-2022	Zemouri, Charifa/0000-0002-9211-3744; Mogasale, Vittal/0000-0003-0596-8072; kiarie, james/0000-0003-4180-7858	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Agyarko-Poku T, 2011, SEXUALLY TRANSMITTED, V87, p[305, 64], DOI [10.1097/OLQ.0b013e3181bd1007, DOI 10.1097/OLQ.0B013E3181BD1007]; Becker M, 2010, SEX TRANSM DIS, V37, P159, DOI 10.1097/OLQ.0b013e3181bd1007; Behets FMT, 1998, SEX TRANSM INFECT, V74, pS123; Behets FMTF, 2001, B WORLD HEALTH ORGAN, V79, P1070; Boonstra E, 2003, TROP MED INT HEALTH, V8, P604, DOI 10.1046/j.1365-3156.2003.01076.x; Bourgeois A, 1998, SEX TRANSM INFECT, V74, pS128; Brabin L, 2000, ACTA TROP, V75, P53, DOI 10.1016/S0001-706X(99)00093-5; Cheluget B, 2004, SEX TRANSM DIS, V31, P522, DOI 10.1097/01.olq.0000137896.40790.7d; Chen MY, 2005, AUST NZ J OBSTET GYN, V45, P410, DOI 10.1111/j.1479-828X.2005.00457.x; Christian P, 2005, SEX TRANSM INFECT, V81, P254, DOI 10.1136/sti.2004.011817; Clark JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007201; Colvin M, 2006, SEX TRANSM INFECT, V82, P290, DOI 10.1136/sti.2005.019240; Cornier N, 2010, SEX TRANSM INFECT, V86, P303, DOI 10.1136/sti.2009.040832; Das A, 2011, Infect Dis Obstet Gynecol, V2011, P494769, DOI 10.1155/2011/494769; Desai VK, 2003, SEX TRANSM INFECT, V79, P111, DOI 10.1136/sti.79.2.111; Ekabua JE, 2010, ASIAN PAC J TROP MED, V3, P63, DOI 10.1016/S1995-7645(10)60035-1; Fawzi MCS, 2006, SEX TRANSM INFECT, V82, P175, DOI 10.1136/sti.2005.016733; Francis SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101221; Garcia PJ, 2004, B WORLD HEALTH ORGAN, V82, P483; George R, 2004, INT J STD AIDS, V15, P367, DOI 10.1258/095646204774195191; Granato P. A., 2010, Clinical Microbiology Newsletter, V32, P111, DOI 10.1016/j.clinmicnews.2010.07.001; Johnson LF, 2011, SEX REPROD HEALTHC, V2, P13, DOI 10.1016/j.srhc.2010.08.006; Kisa S, 2009, J CLIN NURS, V18, P1059, DOI 10.1111/j.1365-2702.2008.02702.x; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Lima TM, 2013, REV ESC ENFERM USP, V47, P1265, DOI 10.1590/S0080-623420130000600002; Mabey D, 2010, SEX TRANSM INFECT, V86, P488, DOI 10.1136/sti.2009.041632; Mayaud P, 2004, SEX TRANSM INFECT, V80, P174, DOI 10.1136/sti.2002.004101; Mayaud P, 1995, B WORLD HEALTH ORGAN, V73, P621; Mlisana K, 2012, J INFECT DIS, V206, P6, DOI 10.1093/infdis/jis298; Moges B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-143; Moherdaui F, 1998, SEX TRANSM INFECT, V74, pS38; Moherdaui F, 2005, REV MED HONDUR, V6, P263; Moodley P, 2001, J ANTIMICROB CHEMOTH, V48, P853, DOI 10.1093/jac/48.6.853; Msuya S E, 2009, East Afr J Public Health, V6, P263; Onyekonwu C L, 2011, Niger J Med, V20, P155; Organization WH, 2015, PORGR REP IMPL GLOB; Patel V, 2005, INT J EPIDEMIOL, V34, P853, DOI 10.1093/ije/dyi072; Pepin J, 2004, SEX TRANSM INFECT, V80, P230, DOI 10.1136/sti.2003.007534; Pepin J, 2006, B WORLD HEALTH ORGAN, V84, P729, DOI 10.2471/BLT.06.029819; Pettifor A, 2000, SEX TRANSM DIS, V27, P371, DOI 10.1097/00007435-200008000-00002; Philip Preethi S, 2013, Indian J Sex Transm Dis AIDS, V34, P83, DOI 10.4103/0253-7184.120537; Rassjo EB, 2006, J ADOLESCENT HEALTH, V38, P213, DOI 10.1016/j.jadohealth.2004.10.011; Ray K, 2009, INT J INFECT DIS, V13, pE352, DOI 10.1016/j.ijid.2008.11.021; Romoren M, 2007, B WORLD HEALTH ORGAN, V85, P297, DOI 10.2471/BLT.06.031922; Romoren M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-27; Sahin-Hodoglugil NN, 2003, SEX TRANSM DIS, V30, P455, DOI 10.1097/00007435-200305000-00014; Sloan NL, 2000, STUD FAMILY PLANN, V31, P55, DOI 10.1111/j.1728-4465.2000.00055.x; STIGMA, 2019, GUID MAN SEX TRANSM; Tann CJ, 2006, SEX TRANSM INFECT, V82, P285, DOI 10.1136/sti.2005.014845; Terris-Prestholt F, 2006, SEX TRANSM DIS, V33, pS153, DOI 10.1097/01.olq.0000235177.30718.84; Tolosa JE, 2012, INT J GYNECOL OBSTET, V119, P729; Valsangkar Sameer, 2014, J Reprod Infertil, V15, P87; Wade R, 2013, RES SYNTH METHODS, V4, P280, DOI 10.1002/jrsm.1080; White RG, 2008, SEX TRANSM INFECT, V84, P528, DOI 10.1136/sti.2008.032011; Wilkinson D, 1999, B WORLD HEALTH ORGAN, V77, P22; World Health Organization, 2005, SEX TRANSM OTH REPR; World Health Organization, 2007, GLOB STRAT PREV CONT	57	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163365	10.1371/journal.pone.0163365	http://dx.doi.org/10.1371/journal.pone.0163365			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706174	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200040
J	Berman, R; Jiang, D; Wu, Q; Stevenson, CR; Schaefer, NR; Chu, HW				Berman, Reena; Jiang, Di; Wu, Qun; Stevenson, Connor R.; Schaefer, Niccolette R.; Chu, Hong Wei			MUC18 Regulates Lung Rhinovirus Infection and Inflammation	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; HUMAN-MELANOMA; KINASE M; INTERFERON; RESPONSES	Background MUC18 is upregulated in the lungs of asthma and COPD patients. It has been shown to have pro-inflammatory functions in cultured human airway epithelial cells during viral infections and in mice during lung bacterial infections. However, the in vivo role of MUC18 in the context of viral infections remains poorly understood. The goal of this study is to define the in vivo function of MUC18 during respiratory rhinovirus infection. Methods Muc18 wild-type (WT) and knockout (KO) mice were infected with human rhinovirus 1B (HRV-1B) and sacrificed after 1 day to determine the inflammatory and antiviral responses. To examine the direct effects of Muc18 on viral infection, tracheal epithelial cells isolated from WT and KO mice were grown under air-liquid interface and infected with HRV-1B. Finally, siRNA mediated knockdown of MUC18 was performed in human airway epithelial cells (AECs) to define the impact of MUC18 on human airway response to HRV-1B. Results Both viral load and neutrophilic inflammation were significantly decreased in Muc18 KO mice compared to WT mice. In the in vitro setting, viral load was significantly lower and antiviral gene expression was higher in airway epithelial cells of Muc18 KO mice than the WT mice. Furthermore, in MUC18 knockdown human AECs, viral load was decreased and antiviral gene expression was increased compared to controls. Conclusions Our study is the first to demonstrate MUC18's pro-inflammatory and pro-viral function in an in vivo mouse model of rhinovirus infection.	[Berman, Reena; Jiang, Di; Wu, Qun; Stevenson, Connor R.; Schaefer, Niccolette R.; Chu, Hong Wei] Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA	National Jewish Health	Chu, HW (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	chuhw@njhealth.org			NHLBI NIH HHS [R01 HL125128, R01 HL122321] Funding Source: Medline; NIAID NIH HHS [R01 AI106287] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125128, R01HL122321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106287] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Berman R, 2014, J CLIN CELLULAR IMMU, V5, DOI [10.4172/2155-9899.1000257, DOI 10.4172/2155-9899.1000257]; Berman R, 2016, INT J CHRONIC OBSTR, V11, P1279, DOI 10.2147/COPD.S105717; Bosco A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2405-z; Dauletbaev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143129; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183; Gulraiz F, 2015, FASEB J, V29, P849, DOI 10.1096/fj.14-254359; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Hatchwell L, 2015, THORAX, V70, P854, DOI 10.1136/thoraxjnl-2014-205465; Jean D, 1998, J BIOL CHEM, V273, P16501, DOI 10.1074/jbc.273.26.16501; LEHMANN JM, 1989, P NATL ACAD SCI USA, V86, P9891, DOI 10.1073/pnas.86.24.9891; Simon GC, 2011, AM J RESP CELL MOL, V44, P606, DOI 10.1165/rcmb.2010-0384OC; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Sumino KC, 2010, THORAX, V65, P639, DOI 10.1136/thx.2009.132480; Suzuki T, 2001, AM J PHYSIOL-LUNG C, V280, pL1115, DOI 10.1152/ajplung.2001.280.6.L1115; Thitithanyanont A, 2010, BIOCHEM BIOPH RES CO, V398, P752, DOI 10.1016/j.bbrc.2010.07.017; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wu Q, 2013, VIROLOGY, V446, P199, DOI 10.1016/j.virol.2013.08.005; Wu Q, 2013, AM J PATHOL, V182, P819, DOI 10.1016/j.ajpath.2012.11.005; Wu Q, 2012, J ALLERGY CLIN IMMUN, V129, P825, DOI 10.1016/j.jaci.2011.10.043	23	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163927	10.1371/journal.pone.0163927	http://dx.doi.org/10.1371/journal.pone.0163927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701461	Green Submitted, Green Published, gold			2022-12-27	WOS:000385696900034
J	Bossard, M; Kreuzmann, R; Hochgruber, T; Krisai, P; Zimmermann, AJ; Aeschbacher, S; Pumpol, K; Kessel-Schaefer, A; Stephan, FP; Handschin, N; Sticherling, C; Osswald, S; Kaufmann, BA; Pare, G; Kuhne, M; Conen, D				Bossard, Matthias; Kreuzmann, Rahel; Hochgruber, Thomas; Krisai, Philipp; Zimmermann, Andreas J.; Aeschbacher, Stefanie; Pumpol, Katrin; Kessel-Schaefer, Arnheid; Stephan, Frank-Peter; Handschin, Nadja; Sticherling, Christian; Osswald, Stefan; Kaufmann, Beat A.; Pare, Guillaume; Kuhne, Michael; Conen, David			Determinants of Left Atrial Volume in Patients with Atrial Fibrillation	PLOS ONE			English	Article							TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; CHRONIC KIDNEY-DISEASE; NATRIURETIC PEPTIDE; DIABETES-MELLITUS; RISK; SIZE; STROKE; DEATH; QUANTIFICATION; PREVALENCE	Introduction Left atrial (LA) enlargement is an important risk factor for incident stroke and a key determinant for the success of rhythm control strategies in patients with atrial fibrillation (AF). However, factors associated with LA volume in AF patients remain poorly understood. Methods Patients with paroxysmal or persistent AF were enrolled in this study. Real time 3-D echocardiography was performed in all participants and analyzed offline in a standardized manner. We performed stepwise backward linear regression analyses using a broad set of clinical parameters to determine independent correlates for 3-D LA volume. Results We included 210 patients (70.9% male, mean age 61 +/- 11years). Paroxysmal and persistent AF were present in 95 (45%) and 115 (55%) patients, respectively. Overall, 115 (55%) had hypertension, 11 (5%) had diabetes, and 18 (9%) had ischemic heart disease. Mean indexed LA volume was 36 +/- 12ml/m(2). In multivariable models, significant associations were found for female sex (beta coefficient -10.51 (95% confidence interval (CI) -17.85;-3.16), p = 0.0053), undergoing cardioversion (beta 11.95 (CI 5.15; 18.74), p = 0.0006), diabetes (beta 14.23 (CI 2.36; 26.10), p = 0.019), body surface area (BSA) (beta 34.21 (CI 19.30; 49.12), p< 0.0001), glomerular filtration rate (beta -0.21 (CI -0.36; -0.06), p = 0.0064) and plasma levels of NT-pro brain natriuretic peptide (NT-proBNP) (beta 6.79 (CI 4.05; 9.52), p<0.0001), but not age (p = 0.59) or hypertension (p = 0.42). Our final model explained 52% of the LA volume variability. Conclusions In patients with AF, the most important correlates with LA volume are sex, BSA, diabetes, renal function and NT-proBNP, but not age or hypertension. These results may help to refine rhythm control strategies in AF patients.	[Bossard, Matthias] McMaster Univ, Div Cardiol, Hamilton Gen Hosp, Hamilton Hlth Sci, 237 Barton St East, Hamilton, ON L8L 2X2, Canada; [Bossard, Matthias; Pare, Guillaume] McMaster Univ, Populat Hlth Res Inst, David Braley Cardiac Vasc & Stroke Res Inst, 237 Barton St East, Hamilton, ON L8L 2X2, Canada; [Bossard, Matthias; Kessel-Schaefer, Arnheid; Stephan, Frank-Peter; Sticherling, Christian; Osswald, Stefan; Kaufmann, Beat A.; Kuhne, Michael; Conen, David] Univ Basel Hosp, Div Cardiol, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland; [Bossard, Matthias; Kreuzmann, Rahel; Hochgruber, Thomas; Krisai, Philipp; Zimmermann, Andreas J.; Aeschbacher, Stefanie; Pumpol, Katrin; Kessel-Schaefer, Arnheid; Stephan, Frank-Peter; Handschin, Nadja; Sticherling, Christian; Osswald, Stefan; Kaufmann, Beat A.; Kuhne, Michael; Conen, David] Univ Basel Hosp, Cardiovasc Res Inst Basel, Spitalstr 2, CH-4031 Basel, Switzerland; [Kreuzmann, Rahel; Hochgruber, Thomas; Krisai, Philipp; Zimmermann, Andreas J.; Aeschbacher, Stefanie; Pumpol, Katrin; Conen, David] Univ Basel Hosp, Dept Med, Div Internal Med, Petersgraben 4, CH-4031 Basel, Switzerland; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Michael G DeGroote Sch Med, 1280 Main St West, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University; Population Health Research Institute; University of Basel; University of Basel; University of Basel; McMaster University	Conen, D (corresponding author), Univ Basel Hosp, Div Cardiol, Dept Med, Petersgraben 4, CH-4031 Basel, Switzerland.; Conen, D (corresponding author), Univ Basel Hosp, Cardiovasc Res Inst Basel, Spitalstr 2, CH-4031 Basel, Switzerland.; Conen, D (corresponding author), Univ Basel Hosp, Dept Med, Div Internal Med, Petersgraben 4, CH-4031 Basel, Switzerland.	david.conen@usb.ch	Kaufmann, Beat/AAB-7805-2022; Aeschbacher, Stefanie/E-4935-2017; Osswald, Stefan/A-6904-2018; Sticherling, Christian/AAY-4435-2021; Pare, Guillaume/T-9631-2018; Kühne, Michael/AAB-5202-2022	Osswald, Stefan/0000-0002-9240-6731; Sticherling, Christian/0000-0001-8428-7050; Pare, Guillaume/0000-0002-6795-4760; Kühne, Michael/0000-0002-2937-3711; Kaufmann, Beat/0000-0001-6295-3630	Mach Gaensslen Foundation; University Hospital Basel; Freie Akademische Gesellschaft (FAG) Basel; Swiss National Science Foundation [PP00P3_133681, PP00P3_159322, 3232B0_141603, 310030_149718]	Mach Gaensslen Foundation; University Hospital Basel; Freie Akademische Gesellschaft (FAG) Basel; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by a grant of the Mach Gaensslen Foundation and the University Hospital Basel. Matthias Bossard was supported by a grant of the University of Basel and the Freie Akademische Gesellschaft (FAG) Basel. David Conen and Beat Kaufmann were supported by grants of the Swiss National Science Foundation (PP00P3_133681 and PP00P3_159322 to David Conen, 3232B0_141603 and 310030_149718 to Beat Kaufmann).	Abed HS, 2013, JAMA-J AM MED ASSOC, V310, P2050, DOI 10.1001/jama.2013.280521; Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Asbun J, 2006, J AM COLL CARDIOL, V47, P693, DOI 10.1016/j.jacc.2005.09.050; Bansal N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001303; BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835; Bouzas-Mosquera A, 2011, CAN MED ASSOC J, V183, pE657, DOI 10.1503/cmaj.091688; Buechel RR, 2013, INT J CARDIOVAS IMAG, V29, P601, DOI 10.1007/s10554-012-0127-0; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Cappato R, 2009, J AM COLL CARDIOL, V53, P1798, DOI 10.1016/j.jacc.2009.02.022; Conen D, 2013, INT J CARDIOL, V168, P1894, DOI 10.1016/j.ijcard.2012.12.060; Conen D, 2011, JAMA-J AM MED ASSOC, V305, P2080, DOI 10.1001/jama.2011.659; Conen D, 2010, EUR HEART J, V31, P1730, DOI 10.1093/eurheartj/ehq146; D'Andrea A, 2013, ECHOCARDIOGR-J CARD, V30, P1001, DOI 10.1111/echo.12217; Dzeshka MS, 2015, J AM COLL CARDIOL, V66, P943, DOI 10.1016/j.jacc.2015.06.1313; Gerdts E, 2002, HYPERTENSION, V39, P739, DOI 10.1161/hy0302.105683; Gupta DK, 2014, EUR HEART J, V35, P1457, DOI 10.1093/eurheartj/eht500; Gupta S, 2013, EUR HEART J, V34, P278, DOI 10.1093/eurheartj/ehs188; Heo R, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0032-5; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; Hoit BD, 2014, J AM COLL CARDIOL, V63, P493, DOI 10.1016/j.jacc.2013.10.055; Hwang HJ, 2009, CLIN RES CARDIOL, V98, P213, DOI 10.1007/s00392-009-0744-3; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kadappu KK, 2014, ECHOCARDIOGR-J CARD, V31, P956, DOI 10.1111/echo.12503; Kadappu KK, 2012, EUR HEART J-CARD IMG, V13, P1016, DOI 10.1093/ehjci/jes084; Kou S, 2014, EUR HEART J-CARD IMG, V15, P680, DOI 10.1093/ehjci/jet284; Llombart V, 2015, STROKE, V46, P1187, DOI 10.1161/STROKEAHA.114.008311; Mor-Avi V, 2012, JACC-CARDIOVASC IMAG, V5, P769, DOI 10.1016/j.jcmg.2012.05.011; Nichols GA, 2009, DIABETES CARE, V32, P1851, DOI 10.2337/dc09-0939; Parkash R, 2004, AM HEART J, V148, P649, DOI 10.1016/j.ahj.2004.04.029; Patton KK, 2009, CIRCULATION, V120, P1768, DOI 10.1161/CIRCULATIONAHA.109.873265; Rohner A, 2011, EUR J ECHOCARDIOGR, V12, P497, DOI 10.1093/ejechocard/jer066; Schoen T, 2012, J AM COLL CARDIOL, V60, P1421, DOI 10.1016/j.jacc.2012.06.030; Solheim E, 2012, J INTERV CARD ELECTR, V34, P129, DOI 10.1007/s10840-011-9629-2; Tedrow UB, 2010, J AM COLL CARDIOL, V55, P2319, DOI 10.1016/j.jacc.2010.02.029; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Zimmermann AJ, 2015, CAN J CARDIOL, V31, P36, DOI 10.1016/j.cjca.2014.10.032	38	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0164145	10.1371/journal.pone.0164145	http://dx.doi.org/10.1371/journal.pone.0164145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701468	Green Published, Green Submitted, gold			2022-12-27	WOS:000385696900045
J	Esmail, H; Oni, T; Thienemann, F; Omar-Davies, N; Wilkinson, RJ; Ntsekhe, M				Esmail, Hanif; Oni, Tolu; Thienemann, Friedrich; Omar-Davies, Nashreen; Wilkinson, Robert J.; Ntsekhe, Mpiko			Cardio-Thoracic Ratio Is Stable, Reproducible and Has Potential as a Screening Tool for HIV-1 Related Cardiac Disorders in Resource Poor Settings	PLOS ONE			English	Article							HEART-DISEASE; DILATED CARDIOMYOPATHY; CHEST ROENTGENOGRAM; FAILURE; ADULTS; ECHOCARDIOGRAPHY; ENLARGEMENT; MARKER; SIZE	Background Cardiovascular disorders are common in HIV-1 infected persons in Africa and presentation is often insidious. Development of screening algorithms for cardiovascular disorders appropriate to a resource-constrained setting could facilitate timely referral. Cardiothoracic ratio (CTR) on chest radiograph (CXR) has been suggested as a potential screening tool but little is known about its reproducibility and stability. Our primary aim was to evaluate the stability and the inter-observer variability of CTR in HIV-1 infected outpatients. We further evaluated the prevalence of cardiomegaly (CTR >= 0.5) and its relationship with other risk factors in this population. Methodology HIV-1 infected participants were identified during screening for a tuberculosis vaccine trial in Khayelitsha, South Africa between August 2011 and April 2012. Participants had a digital posterior-anterior CXR performed as well as history, examination and baseline observations. CXRs were viewed using OsiriX software and CTR calculated using digital callipers. Results 450 HIV-1-infected adults were evaluated, median age 34 years (IQR 30-40) with a CD4 count 566/mm(3) (IQR 443-724), 70% on antiretroviral therapy (ART). The prevalence of cardiomegaly was 12.7% (95% C. I. 9.6%-15.8%). CTR was calculated by a 2 nd reader for 113 participants, measurements were highly correlated r = 0.95 (95% C. I. 0.93-0.97) and agreement of cardiomegaly substantial k = 0.78 (95% C. I 0.61-0.95). CXR were repeated in 51 participants at 4-12 weeks, CTR measurements between the 2 time points were highly correlated r = 0.77 (95% C. I 0.68-0.88) and agreement of cardiomegaly excellent. = 0.92 (95% C. I. 0.77-1). Participants with cardiomegaly had a higher median BMI (31.3; IQR 27.4-37.4) versus 26.9; IQR 23.2-32.4); p<0.0001) and median systolic blood pressure (130; IQR 121-141 versus 125; IQR 117-135; p = 0.01). Conclusion CTR is a robust measurement, stable over time with substantial inter-observer agreement. A prospective study evaluating utility of CXR to identify cardiovascular disorder in this population is warranted.	[Esmail, Hanif; Oni, Tolu; Thienemann, Friedrich; Omar-Davies, Nashreen; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, Cape Town, South Africa; [Esmail, Hanif; Wilkinson, Robert J.] Imperial Coll London, Dept Med, London, England; [Esmail, Hanif] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Oni, Tolu] Univ Cape Town, Div Publ Hlth Med, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Thienemann, Friedrich; Wilkinson, Robert J.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Wilkinson, Robert J.] Francis Crick Inst, Mill Hill Lab, London, England; [Ntsekhe, Mpiko] Univ Cape Town, Div Cardiol, Dept Med, Cape Town, South Africa	University of Cape Town; Imperial College London; University of Oxford; University of Cape Town; University of Cape Town; Francis Crick Institute; University of Cape Town	Esmail, H (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, Cape Town, South Africa.; Esmail, H (corresponding author), Imperial Coll London, Dept Med, London, England.; Esmail, H (corresponding author), Univ Oxford, Radcliffe Dept Med, Oxford, England.	hanif.esmail@ndols.ox.ac.uk	ntsekhe, mpiko/AAI-8001-2021; Thienemann, Friedrich/AAX-1197-2020	ntsekhe, mpiko/0000-0002-0851-7675; Thienemann, Friedrich/0000-0002-4801-2030; Esmail, Hanif/0000-0002-4278-9316; Wilkinson, Robert/0000-0002-2753-1800; Oni, Tolu/0000-0003-4499-1910	Wellcome Trust [104803/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10218] Funding Source: researchfish; Wellcome Trust [090170] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute; Wellcome Trust(Wellcome TrustEuropean Commission)		Barbaro G, 2001, Lancet Infect Dis, V1, P115, DOI 10.1016/S1473-3099(01)00067-6; Cantor AB, 1996, PSYCHOL METHODS, V1, P150, DOI 10.1037/1082-989X.1.2.150; Clark AL, 2000, POSTGRAD MED J, V76, P289, DOI 10.1136/pmj.76.895.289; Danzer CS, 1919, AM J MED SCI, V157, P513, DOI 10.1097/00000441-191904000-00007; DAVIS JL, 1986, AM J CARDIOL, V58, P658, DOI 10.1016/0002-9149(86)90300-0; Dimopoulos K, 2013, INT J CARDIOL, V166, P453, DOI 10.1016/j.ijcard.2011.10.125; Fukuta H, 2007, AM J CARDIOL, V99, P62, DOI 10.1016/j.amjcard.2006.07.067; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; General Assembly of the United Nations, 2011, POL DECL HIGH LEV M; Hemingway H, 1998, EUR HEART J, V19, P859, DOI 10.1053/euhj.1997.0862; Herman CR, 2002, AM J ROENTGENOL, V179, P825, DOI 10.2214/ajr.179.4.1790825; KONO T, 1992, JPN CIRC J, V56, P359, DOI 10.1253/jcj.56.359; Loomba RS, 2015, FUTUR CARDIOL, V11, P171, DOI [10.2217/fca.15.5, 10.2217/FCA.15.5]; Morales MA, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.96540; Ndiaye BP, 2015, LANCET RESP MED, V3, P190, DOI 10.1016/S2213-2600(15)00037-5; OBERMAN A, 1967, CIRCULATION, V35, P724, DOI 10.1161/01.CIR.35.4.724; Petrie MC, 2003, EUR J HEART FAIL, V5, P117, DOI 10.1016/S1388-9842(02)00239-8; Remick J, 2014, CIRCULATION, V129, P1781, DOI 10.1161/CIRCULATIONAHA.113.004574; Reuter H, 2005, Cardiovasc J S Afr, V16, P108; Schwartz T, 2012, INT HEALTH, V4, P30, DOI 10.1016/j.inhe.2011.12.003; Sigurdsson E, 1996, AM J CARDIOL, V78, P1355, DOI 10.1016/S0002-9149(96)00650-9; Sliwa K, 2012, EUR HEART J, V33, P866, DOI 10.1093/eurheartj/ehr398; Thienemann F, 2013, EUR HEART J, V34, P3538, DOI 10.1093/eurheartj/eht388; WALKER ARP, 1972, POSTGRAD MED J, V48, P584, DOI 10.1136/pgmj.48.564.584	24	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163490	10.1371/journal.pone.0163490	http://dx.doi.org/10.1371/journal.pone.0163490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701421	Green Submitted, Green Published, gold			2022-12-27	WOS:000385696900008
J	Lee, DW; Hsu, HL; Bacon, KB; Daniel, S				Lee, Donald W.; Hsu, Hung-Lun; Bacon, Kaitlyn B.; Daniel, Susan			Image Restoration and Analysis of Influenza Virions Binding to Membrane Receptors Reveal Adhesion-Strengthening Kinetics	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; SUPPORTED LIPID-BILAYERS; A VIRUS HEMAGGLUTININ; SIALIC-ACID; SUPERRESOLUTION MICROSCOPY; REOVIRUS ATTACHMENT; ELECTRON-MICROSCOPY; MOLECULE TRACKING; FUSION; PLANAR	With the development of single-particle tracking (SPT) microscopy and host membrane mimics called supported lipid bilayers (SLBs), stochastic virus-membrane binding interactions can be studied in depth while maintaining control over host receptor type and concentration. However, several experimental design challenges and quantitative image analysis limitations prevent the widespread use of this approach. One main challenge of SPT studies is the low signal-to-noise ratio of SPT videos, which is sometimes inevitable due to small particle sizes, low quantum yield of fluorescent dyes, and photobleaching. These situations could render current particle tracking software to yield biased binding kinetic data caused by intermittent tracking error. Hence, we developed an effective image restoration algorithm for SPT applications called STAWASP that reveals particles with a signal-to-noise ratio of 2.2 while preserving particle features. We tested our improvements to the SPT binding assay experiment and imaging procedures by monitoring X31 influenza virus binding to alpha 2,3 sialic acid glycolipids. Our interests lie in how slight changes to the peripheral oligosaccharide structures can affect the binding rate and residence times of viruses. We were able to detect viruses binding weakly to a glycolipid called G(M3), which was undetected via assays such as surface plasmon resonance. The binding rate was around 28 folds higher when the virus bound to a different glycolipid called G(D1a), which has a sialic acid group extending further away from the bilayer surface than G(M3). The improved imaging allowed us to obtain binding residence time distributions that reflect an adhesion-strengthening mechanism via multivalent bonds. We empirically fitted these distributions using a time-dependent unbinding rate parameter, k(off), which diverges from standard treatment of k(off) as a constant. We further explain how to convert these models to fit ensemble-averaged binding data obtained by assays such as surface plasmon resonance.	[Lee, Donald W.; Hsu, Hung-Lun; Bacon, Kaitlyn B.; Daniel, Susan] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14850 USA	Cornell University	Lee, DW; Daniel, S (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14850 USA.	dwl57@cornell.edu; sd386@cornell.edu			National Science Foundation (NSF) [DGE-1045513, DGE-0841291]; Engineering Learning Initiative fund; NSF [CBET-1263701, ECCS-0335765]	National Science Foundation (NSF)(National Science Foundation (NSF)); Engineering Learning Initiative fund; NSF(National Science Foundation (NSF))	DWL acknowledges financial support from the National Science Foundation (NSF) GK12 programs, award number DGE-1045513 to Cornell's Grass Roots program and award number DGE-0841291 to Cornell's Learning Initiative for Medicine and Bioengineering (CLIMB) program. KBB acknowledges support from the Engineering Learning Initiative fund, with donations from Genentech and Proctor & Gamble. We thank the NSF (grant CBET-1263701) for financial support for this project. This work was performed in part at the Cornell NanoScale Facility, a member of the National Nanotechnology Infrastructure Network supported by the NSF (grant ECCS-0335765). The funding agencies did not influence the study design, data collection and analysis, or manuscript submission.	Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Balasubramanian S., 2009, INT C CONTR AUT COMM; Bally M, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/2/026011; Bally M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188103; Bally M, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-4; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Bockmann RA, 2003, BIOPHYS J, V85, P1647, DOI 10.1016/S0006-3495(03)74594-9; Bonneau S, 2005, IEEE T IMAGE PROCESS, V14, P1384, DOI 10.1109/TIP.2005.852794; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; Castellana ET, 2006, SURF SCI REP, V61, P429, DOI 10.1016/j.surfrep.2006.06.001; Chao L, 2011, J AM CHEM SOC, V133, P15635, DOI 10.1021/ja205274g; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Costello DA, 2015, J VIROL, V89, P350, DOI 10.1128/JVI.01927-14; Costello DA, 2013, LANGMUIR, V29, P6409, DOI 10.1021/la400861u; Costello DA, 2012, ANAL CHEM, V84, P8480, DOI 10.1021/ac3006473; Cremer PS, 1999, J PHYS CHEM B, V103, P2554, DOI 10.1021/jp983996x; Cureton DK, 2012, J VIROL, V86, P5330, DOI 10.1128/JVI.07194-11; Dupont A, 2013, BIOPHYS J, V104, P2373, DOI 10.1016/j.bpj.2013.04.005; Endesfelder U, 2014, NAT METHODS, V11, P235, DOI 10.1038/nmeth.2852; Enoki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049208; Esakkirajan S, 2011, IEEE SIGNAL PROC LET, V18, P287, DOI 10.1109/LSP.2011.2122333; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Greenwood R, 1999, J EUR CERAM SOC, V19, P479, DOI 10.1016/S0955-2219(98)00208-8; GREIFF D, 1954, J EXP MED, V100, P89, DOI 10.1084/jem.100.1.89; Hayden O, 2003, SENSOR ACTUAT B-CHEM, V91, P316, DOI 10.1016/S0925-4005(03)00093-5; HAYWOOD AM, 1994, J VIROL, V68, P1; Hidari KIPJ, 2007, GLYCOCONJUGATE J, V24, P583, DOI 10.1007/s10719-007-9055-y; Hu JL, 2013, P NATL ACAD SCI USA, V110, P15283, DOI 10.1073/pnas.1305766110; HUERTAS A, 1986, IEEE T PATTERN ANAL, V8, P651, DOI 10.1109/TPAMI.1986.4767838; Ivanovic T, 2013, ELIFE, V2, DOI 10.7554/eLife.00333; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jaqaman Khuloud, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.top65; JERRI AJ, 1977, P IEEE, V65, P1565, DOI 10.1109/PROC.1977.10771; Kanaseki T, 1997, J CELL BIOL, V137, P1041, DOI 10.1083/jcb.137.5.1041; Karatekin E, 2012, NAT PROTOC, V7, P903, DOI 10.1038/nprot.2012.019; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kukura P, 2009, NAT METHODS, V6, P923, DOI 10.1038/nmeth.1395; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee DW, 2016, J VIROL, V90, P4849, DOI 10.1128/JVI.03204-15; Lee DW, 2014, BIOPHYS J, V106, P843, DOI 10.1016/j.bpj.2013.12.048; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Otterstrom J, 2013, BIOCHEMISTRY-US, V52, P1654, DOI 10.1021/bi301573w; Richards MJ, 2016, LANGMUIR, V32, P2963, DOI 10.1021/acs.langmuir.5b03415; Richter RP, 2005, BIOPHYS J, V88, P3422, DOI 10.1529/biophysj.104.053728; Ritter JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011639; ROGERS GN, 1983, VIROLOGY, V131, P394, DOI 10.1016/0042-6822(83)90507-X; Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7; Rowland DJ, 2014, CHEMPHYSCHEM, V15, P712, DOI 10.1002/cphc.201300774; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; RUIGROK RWH, 1984, J GEN VIROL, V65, P799, DOI 10.1099/0022-1317-65-4-799; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Saint-Michel E, 2009, BIOPHYS J, V97, P480, DOI 10.1016/j.bpj.2009.04.044; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Seu KJ, 2007, BIOPHYS J, V92, P2445, DOI 10.1529/biophysj.106.099721; Small A, 2014, NAT METHODS, V11, P267, DOI [10.1038/NMETH.2844, 10.1038/nmeth.2844]; Smith MB, 2011, BIOPHYS J, V101, P1794, DOI 10.1016/j.bpj.2011.09.007; Stettner E, 2015, J VIROL, V89, P6136, DOI 10.1128/JVI.00433-15; SUZUKI Y, 1985, VACCINE, V3, P201, DOI 10.1016/0264-410X(85)90104-5; SUZUKI Y, 1986, J BIOL CHEM, V261, P7057; SUZUKI Y, 1992, VIROLOGY, V189, P121, DOI 10.1016/0042-6822(92)90687-K; Szklarczyk OM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003310; Takahashi T, 2013, GLYCOCONJUGATE J, V30, P709, DOI 10.1007/s10719-013-9477-7; Takemoto DK, 1996, VIROLOGY, V217, P452, DOI 10.1006/viro.1996.0139; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Wessels L, 2007, BIOPHYS J, V93, P526, DOI 10.1529/biophysj.106.097485; Witt H, 2016, BIOPHYS J, V110, P1582, DOI 10.1016/j.bpj.2016.03.006; Woll D, 2013, PHYS CHEM CHEM PHYS, V15, P6196, DOI 10.1039/c3cp44693j; XU YS, 1994, IEEE T IMAGE PROCESS, V3, P747, DOI 10.1109/83.336245	74	21	21	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163437	10.1371/journal.pone.0163437	http://dx.doi.org/10.1371/journal.pone.0163437			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695072	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100033
J	Martin, AJM; Dominguez, C; Contreras-Riquelme, S; Holmes, DS; Perez-Acle, T				Martin, Alberto J. M.; Dominguez, Calixto; Contreras-Riquelme, Sebastian; Holmes, David S.; Perez-Acle, Tomas			Graphlet Based Metrics for the Comparison of Gene Regulatory Networks	PLOS ONE			English	Article							EVOLUTIONARY CONSERVATION; TRANSCRIPTION FACTORS; EXPRESSION; MOTIFS	Understanding the control of gene expression remains one of the main challenges in the post-genomic era. Accordingly, a plethora of methods exists to identify variations in gene expression levels. These variations underlay almost all relevant biological phenomena, including disease and adaptation to environmental conditions. However, computational tools to identify how regulation changes are scarce. Regulation of gene expression is usually depicted in the form of a gene regulatory network (GRN). Structural changes in a GRN over time and conditions represent variations in the regulation of gene expression. Like other biological networks, GRNs are composed of basic building blocks called graphlets. As a consequence, two new metrics based on graphlets are proposed in this work: REConstruction Rate (REC) and REC Graphlet Degree (RGD). REC determines the rate of graphlet similarity between different states of a network and RGD identifies the subset of nodes with the highest topological variation. In other words, RGD discerns how th GRN was rewired. REC and RGD were used to compare the local structure of nodes in condition-specific GRNs obtained from gene expression data of Escherichia coli, forming biofilms and cultured in suspension. According to our results, most of the network local structure remains unaltered in the two compared conditions. Nevertheless, changes reported by RGD necessarily imply that a different cohort of regulators (i.e. transcription factors (TFs)) appear on the scene, shedding light on how the regulation of gene expression occurs when E. coli transits from suspension to biofilm. Consequently, we propose that both metrics REC and RGD should be adopted as a quantitative approach to conduct differential analyses of GRNs. A tool that implements both metrics is available as an on-line web server (http://dlab.cl/loto).	[Martin, Alberto J. M.; Dominguez, Calixto; Contreras-Riquelme, Sebastian; Perez-Acle, Tomas] Fdn Ciencia & Vida, Computat Biol Lab, Santiago, Chile; [Martin, Alberto J. M.; Perez-Acle, Tomas] Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Dominguez, Calixto; Holmes, David S.] Univ Andres Bello, Ctr Bioinformat & Genome Biol, Fdn Ciencia & Vida, Santiago, Chile; [Dominguez, Calixto; Holmes, David S.] Univ Andres Bello, Fac Ciencias Biol, Santiago, Chile	Universidad de Valparaiso; Universidad Andres Bello; Universidad Andres Bello	Martin, AJM; Perez-Acle, T (corresponding author), Fdn Ciencia & Vida, Computat Biol Lab, Santiago, Chile.; Martin, AJM; Perez-Acle, T (corresponding author), Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile.	ajmm@dlab.cl; tomas@dlab.cl	Perez-Acle, Tomas/F-7176-2012	Perez-Acle, Tomas/0000-0002-3769-390X; Holmes, David/0000-0001-9555-138X; Martin, Alberto J/0000-0002-6147-3325	Proyecto Basal from Fundacion Ciencia & Vida (FCV) Cominsion Nacional de Investigacion Cientifica y Tecnologica-Programa de Investigacion Asociativa (CONICYT-PIA) [PFB16]; Iniciativa Cientifica Milenio-Ministerio de Economia, Fomento y Turismo proyect from the Centro Interdisciplinario de Neurociencias de Valparaiso (CINV) [ICM-Economia] [P09-022-F]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [11140342, 1130683, 3140007]; Universidad Andres Bello; Chilean National Laboratory for High Performance Computing (NLHPC) [ECM-02]	Proyecto Basal from Fundacion Ciencia & Vida (FCV) Cominsion Nacional de Investigacion Cientifica y Tecnologica-Programa de Investigacion Asociativa (CONICYT-PIA); Iniciativa Cientifica Milenio-Ministerio de Economia, Fomento y Turismo proyect from the Centro Interdisciplinario de Neurociencias de Valparaiso (CINV) [ICM-Economia]; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Universidad Andres Bello; Chilean National Laboratory for High Performance Computing (NLHPC)	The authors acknowledge partial economical support from Proyecto Basal from Fundacion Ciencia & Vida (FCV) [PFB16] Cominsion Nacional de Investigacion Cientifica y Tecnologica-Programa de Investigacion Asociativa (CONICYT-PIA http://www.conicyt.cl/pia/) and Iniciativa Cientifica Milenio-Ministerio de Economia, Fomento y Turismo proyect from the Centro Interdisciplinario de Neurociencias de Valparaiso (CINV) [ICM-Economia P09-022-F] (http://www.iniciativamilenio.cl/). AJMM and SCR acknowledge economical support from Fondo Nacional de Desarrollo Cientifico y Tecnologico project [11140342] (FONDECYT http://www.conicyt.cl/fondecyt/). SCR acknowledges economical support from Beca asistencia academica from Universidad Andres Bello (http://www.unab.cl/). CD acknowledges economical support from Fondo Nacional de Desarrollo Cientifico y Tecnologico postdoctoral project [3140007] (FONDECYT http//www.concyt.cl/fondecyt/). DSH acknowledges economical support to Fondo Nacional de Desarrollo Cientifico y Tecnologico project [1130683] (FONDECYT http://www.conicyt.cl/fondecyt/). Powered@NLHPC: This research was partially supported by the supercomputing infrastructure of the Chilean National Laboratory for High Performance Computing (NLHPC) [ECM-02] (Cominsion Nacional de Investigacion Cientifica y Tecnologica-Programa de Investigacion Asociativa (CONICYT-PIA http://www.conicyt.cl/pia/).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Artzy-Randrup Yael, 2004, Science, V305, P1107; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Ben Hassen H, 2008, J THEOR BIOL, V253, P717, DOI 10.1016/j.jtbi.2008.04.030; Boyle AP, 2014, NATURE, V512, P453, DOI 10.1038/nature13668; Cheng XR, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0574; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Faisal FE, 2014, BIOINFORMATICS, V30, P1721, DOI 10.1093/bioinformatics/btu089; Gaiteri C, 2014, GENES BRAIN BEHAV, V13, P13, DOI 10.1111/gbb.12106; Guo YC, 2011, EXP BIOL MED, V236, P628, DOI 10.1258/ebm.2011.010324; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hulovatyy Y, 2015, BIOINFORMATICS, V31, P171, DOI 10.1093/bioinformatics/btv227; Jin RM, 2007, IEEE DATA MINING, P541, DOI 10.1109/ICDM.2007.92; Keseler IM, 2011, NUCLEIC ACIDS RES, V39, pD583, DOI 10.1093/nar/gkq1143; Knabe JF, 2008, BIOSYSTEMS, V94, P68, DOI 10.1016/j.biosystems.2008.05.012; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; McDonnell MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114503; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Narang V, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004504; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Palumbo MC, 2005, FEBS LETT, V579, P4642, DOI 10.1016/j.febslet.2005.07.033; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Pescini D, 2012, BIOTECHNOL ADV, V30, P99, DOI 10.1016/j.biotechadv.2011.06.014; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez-Caso C, 2009, MOL BIOSYST, V5, P1617, DOI [10.1039/b904960f, 10.1039/B904960f]; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Ruan D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0735-5; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Silva F, 2015, ARXIV151101964; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wong SWH, 2015, PROTEOMICS, V15, P608, DOI 10.1002/pmic.201400233; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yang TH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-102; Yaveroglu ON, 2015, BIOINFORMATICS, V31, P2697, DOI 10.1093/bioinformatics/btv170; Yaveroglu ON, 2014, SCI REP-UK, V4, DOI 10.1038/srep04547; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zickenrott S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.393	48	12	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163497	10.1371/journal.pone.0163497	http://dx.doi.org/10.1371/journal.pone.0163497			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695050	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100037
J	Sedegah, M; Peters, B; Hollingdale, MR; Ganeshan, HD; Huang, J; Farooq, F; Belmonte, MN; Belmonte, AD; Limbach, KJ; Diggs, C; Soisson, L; Chuang, I; Villasante, ED				Sedegah, Martha; Peters, Bjoern; Hollingdale, Michael R.; Ganeshan, Harini D.; Huang, Jun; Farooq, Fouzia; Belmonte, Maria N.; Belmonte, Arnel D.; Limbach, Keith J.; Diggs, Carter; Soisson, Lorraine; Chuang, Ilin; Villasante, Eileen D.			Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes	PLOS ONE			English	Article							ALTERED PEPTIDE LIGANDS; CLASS-I SUPERTYPES; T-CELL RECEPTOR; MALARIA; BINDING; PROTEIN; IMMUNIZATION; ORIENTATION; PREDICTIONS; AFFINITIES	A DNA prime/adenovirus boost malaria vaccine encoding Plasmodium falciparum strain 3D7 CSP and AMA1 elicited sterile clinical protection associated with CD8+ T cell interferon-gamma (IFN-gamma) cells responses directed to HLA class 1-restricted AMA1 epitopes of the vaccine strain 3D7. Since a highly effective malaria vaccine must be broadly protective against multiple P. falciparum strains, we compared these AMA1 epitopes of two P. falciparum strains (7G8 and 3D7), which differ by single amino acid substitutions, in their ability to recall CD8+ T cell activities using ELISpot and flow cytometry/intracellular staining assays. The 7G8 variant peptides did not recall 3D7 vaccine-induced CD8+ T IFN-gamma cell responses in these assays, suggesting that protection may be limited to the vaccine strain. The predicted MHC binding affinities of the 7G8 variant epitopes were similar to the 3D7 epitopes, suggesting that the amino acid substitutions of the 7G8 variants may have interfered with TCR recognition of the MHC: peptide complex or that the 7G8 variant may have acted as an altered peptide ligand. These results stress the importance of functional assays in defining protective epitopes.	[Sedegah, Martha; Hollingdale, Michael R.; Ganeshan, Harini D.; Huang, Jun; Farooq, Fouzia; Belmonte, Maria N.; Belmonte, Arnel D.; Limbach, Keith J.; Chuang, Ilin; Villasante, Eileen D.] Naval Med Res Ctr, Malaria Dept, Silver Spring, MD 20910 USA; [Peters, Bjoern] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA; [Hollingdale, Michael R.; Ganeshan, Harini D.; Huang, Jun; Farooq, Fouzia; Belmonte, Maria N.; Belmonte, Arnel D.; Limbach, Keith J.] Henry M Jackson Fdn Adv Mil Med, Rockville, MD 20817 USA; [Diggs, Carter; Soisson, Lorraine] USAID, Washington, DC 20523 USA	Naval Medical Research Center (NMRC); La Jolla Institute for Immunology; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Agency for International Development (USAID)	Hollingdale, MR (corresponding author), Naval Med Res Ctr, Malaria Dept, Silver Spring, MD 20910 USA.; Hollingdale, MR (corresponding author), Henry M Jackson Fdn Adv Mil Med, Rockville, MD 20817 USA.	Michael.r.hollingdale.ctr@mail.mil		Farooq, Fouzia/0000-0001-6491-6323	United States Agency for International Development [GHA-P-00-03-00006-01, 936-3118]; Congressionally Directed Medical Research Program [W81XWH-05-2-0041]; Military Infectious Research Program [62787A 870 F 1432]	United States Agency for International Development(United States Agency for International Development (USAID)); Congressionally Directed Medical Research Program(United States Department of Defense); Military Infectious Research Program	This study was supported by the United States Agency for International Development "Development of Adenovirus-Vectored Malaria Vaccines" interagency agreement # GHA-P-00-03-00006-01, project number 936-3118, www.usaid.gov, recipient EV; Congressionally Directed Medical Research Program (https//cdmrp.org) "Development of Recombinant Adenoviral-based Vaccines against Malaria", grant # W81XWH-05-2-0041, recipient EV; Military Infectious Research Program "Phase 1/2a clinical trials assessing the safety, tolerability, immunogenicity & protective efficacy of Ad5-CA, a two-antigen, adenovirus-vectored Plasmodium falciparum malaria vaccine, in healthy, malaria-naive adults", work unit number 62787A 870 F 1432, https://midrp.amedd.army.mil, recipient EV. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barry AE, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00359; Bermudez A, 2014, VACCINE, V32, P2117, DOI 10.1016/j.vaccine.2014.02.003; Bronke C, 2013, AIDS, V27, P899, DOI 10.1097/QAD.0b013e32835e1616; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Coley AM, 2006, INFECT IMMUN, V74, P2628, DOI 10.1128/IAI.74.5.2628-2636.2006; Doolan DL, 2000, J IMMUNOL, V165, P1123, DOI 10.4049/jimmunol.165.2.1123; Drew DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051023; Elias SC, 2013, J IMMUNOL, V190, P1135, DOI 10.4049/jimmunol.1201455; Patarroyo ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123249; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Fadda L, 2010, P NATL ACAD SCI USA, V107, P10160, DOI 10.1073/pnas.0913745107; Flanagan KL, 2016, EXPERT REV VACCINES, V15, P389, DOI 10.1586/14760584.2016.1125785; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gilbert SC, 1998, SCIENCE, V279, P1173, DOI 10.1126/science.279.5354.1173; Hawse WF, 2014, J IMMUNOL, V192, P2885, DOI 10.4049/jimmunol.1302953; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hodgson SH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00686; Kirkman LA, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0022-2014; Lee EAM, 2006, EUR J IMMUNOL, V36, P1168, DOI 10.1002/eji.200526010; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Mantzourani ED, 2007, J MOL GRAPH MODEL, V26, P471, DOI 10.1016/j.jmgm.2007.02.004; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Plebanski M, 1999, NAT MED, V5, P565, DOI 10.1038/8444; Plebanski M, 1997, PARASITOLOGY, V115, pS55, DOI 10.1017/S0031182097002035; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Sedegah M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106241; Sedegah M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-185; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sedegah M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-241; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Tamminga C, 2013, HUM VACC IMMUNOTHER, V9, P2165, DOI 10.4161/hv.24941; Terheggen U, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0183-5; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Valkenburg SA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3663; Valkenburg SA, 2013, P NATL ACAD SCI USA, V110, P5570, DOI 10.1073/pnas.1302935110; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Wilson KL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00303	43	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163026	10.1371/journal.pone.0163026	http://dx.doi.org/10.1371/journal.pone.0163026			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695088	gold, Green Published			2022-12-27	WOS:000385553100020
J	Murone, J; DeMarchi, JA; Venesky, MD				Murone, Julie; DeMarchi, Joseph A.; Venesky, Matthew D.			Exposure to Corticosterone Affects Host Resistance, but Not Tolerance, to an Emerging Fungal Pathogen	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE DEFENSES; AMPHIBIAN IMMUNE-SYSTEM; BATRACHOCHYTRIUM-DENDROBATIDIS; CHYTRID FUNGUS; STRESS RESPONSES; PCR ASSAY; CHYTRIDIOMYCOSIS; DISEASE; FROGS; SKIN	Host responses to pathogens include defenses that reduce infection burden (i.e., resistance) and traits that reduce the fitness consequences of an infection (i.e., tolerance). Resistance and tolerance are affected by an organism's physiological status. Corticosterone ("CORT") is a hormone that is associated with the regulation of many physiological processes, including metabolism and reproduction. Because of its role in the stress response, CORT is also considered the primary vertebrate stress hormone. When secreted at high levels, CORT is generally thought to be immunosuppressive. Despite the known association between stress and disease resistance in domesticated organisms, it is unclear whether these associations are ecologically and evolutionary relevant in wildlife species. We conducted a 3x3 fully crossed experiment in which we exposed American toads (Anaxyrus [Bufo] americanus) to one of three levels of exogenous CORT (no CORT, low CORT, or high CORT) and then to either low or high doses of the pathogenic chytrid fungus Batrachochytrium dendrobatidis ("Bd") or a sham exposure treatment. We assessed Bd infection levels and tested how CORT and Bd affected toad resistance, tolerance, and mortality. Exposure to the high CORT treatment significantly elevated CORT release in toads; however, there was no difference between toads given no CORT or low CORT. Exposure to CORT and Bd each increased toad mortality, but they did not interact to affect mortality. Toads that were exposed to CORT had higher Bd resistance than toads exposed to ethanol controls/low CORT, a pattern opposite that of most studies on domesticated animals. Exposure to CORT did not affect toad tolerance to Bd. Collectively, these results show that physiological stressors can alter a host's response to a pathogen, but that the outcome might not be straightforward. Future studies that inhibit CORT secretion are needed to better our understanding of the relationship between stress physiology and disease resistance and tolerance in wild vertebrates.	[Murone, Julie; DeMarchi, Joseph A.; Venesky, Matthew D.] Allegheny Coll, Dept Biol, Meadville, PA 16335 USA	Allegheny College	Venesky, MD (corresponding author), Allegheny Coll, Dept Biol, Meadville, PA 16335 USA.	mvenesky@gmail.com						Adelman JS, 2013, AM NAT, V181, P674, DOI 10.1086/670024; BARBER AE, 1993, J IMMUNOL, V150, P1999; Belden LK, 2005, COPEIA, P424, DOI 10.1643/CP-04-139R; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Daskin JH, 2012, P ROY SOC B-BIOL SCI, V279, P1457, DOI 10.1098/rspb.2011.2276; Davidson EW, 2003, COPEIA, P601, DOI 10.1643/CP-02-120R1; Davis Andrew K., 2010, International Journal of Zoology, V2010, P1, DOI 10.1155/2010/735937; Dhabhar FS, 2009, INTEGR COMP BIOL, V49, P215, DOI 10.1093/icb/icp045; Dhabhar FS, 1996, J IMMUNOL, V157, P1638; Earl JE, 2015, COPEIA, V103, P297, DOI 10.1643/CH-14-128; Elenkov IJ, 2002, ANN NY ACAD SCI, V966, P290, DOI 10.1111/j.1749-6632.2002.tb04229.x; Ellison AR, 2015, GENOME BIOL EVOL, V7, P286, DOI 10.1093/gbe/evu285; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Gabor CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122685; Gabor CR, 2013, AMPHIBIA-REPTILIA, V34, P151, DOI 10.1163/15685381-00002877; Gabor CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056054; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Gosner K. L., 1960, Herpetologica, V16, P183; GRAYSON J, 1981, J CLIN INVEST, V68, P1539, DOI 10.1172/JCI110408; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jensen LE, 1998, BIOCHEM J, V334, P489, DOI 10.1042/bj3340489; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Johnson PTJ, 2011, FUNCT ECOL, V25, P726, DOI 10.1111/j.1365-2435.2010.01830.x; Kamal SM, 2006, PARASITE IMMUNOL, V28, P483, DOI 10.1111/j.1365-3024.2006.00909.x; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P149, DOI 10.3354/dao071149; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Little TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001006; McMahon TA, 2014, NATURE, V511, P224, DOI 10.1038/nature13491; Norris DO, 1999, GEN COMP ENDOCR, V113, P1, DOI 10.1006/gcen.1998.7177; Owen JC, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-34; Peterson JD, 2011, INTEGR COMP BIOL, V51, pE108; PICKERING AD, 1989, FISH PHYSIOL BIOCHEM, V7, P253, DOI 10.1007/BF00004714; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Rohr JR, 2010, FUNCT ECOL, V24, P1110, DOI 10.1111/j.1365-2435.2010.01709.x; Rollins-Smith LA, 2005, INTEGR COMP BIOL, V45, P137, DOI 10.1093/icb/45.1.137; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P471, DOI 10.1016/S0145-305X(01)00088-X; Rollins-Smith LA, 2015, DIS AQUAT ORGAN, V113, P81, DOI 10.3354/dao02823; RollinsSmith LA, 1997, DEV IMMUNOL, V5, P145, DOI 10.1155/1997/84841; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Roy BA, 2000, EVOLUTION, V54, P51, DOI 10.1111/j.0014-3820.2000.tb00007.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Scholthof KBG, 2007, NAT REV MICROBIOL, V5, P152, DOI 10.1038/nrmicro1596; Scott AP, 2007, GEN COMP ENDOCR, V153, P392, DOI 10.1016/j.ygcen.2006.11.006; Searle CL, 2014, J EXP ZOOL PART A, V321, P243, DOI 10.1002/jez.1855; Sears BF, 2011, TRENDS PARASITOL, V27, P382, DOI 10.1016/j.pt.2011.05.004; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Tatiersky L, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0506-6; Venesky MD, 2014, J ANIM ECOL, V83, P557, DOI 10.1111/1365-2656.12159; Venesky MD, 2012, OECOLOGIA, V169, P23, DOI 10.1007/s00442-011-2171-1; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wack CL, 2012, COMP BIOCHEM PHYS A, V161, P153, DOI 10.1016/j.cbpa.2011.10.017; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x	66	15	15	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163736	10.1371/journal.pone.0163736	http://dx.doi.org/10.1371/journal.pone.0163736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690360	Green Submitted, Green Published, gold			2022-12-27	WOS:000384329200023
J	DuBois, JC; Smulian, AG				DuBois, Juwen C.; Smulian, A. George			Sterol Regulatory Element Binding Protein (Srb1) Is Required for Hypoxic Adaptation and Virulence in the Dimorphic Fungus Histoplasma capsulatum	PLOS ONE			English	Article							LEUCINE ZIPPER PROTEIN; CRYPTOCOCCUS-NEOFORMANS; ASPERGILLUS-FUMIGATUS; INTRACELLULAR GROWTH; TRANSCRIPTION FACTOR; KNOCKOUT MICE; FISSION YEAST; DNA-BINDING; OXYGEN; SREBP	The Histoplasma capsulatum sterol regulatory element binding protein (SREBP), Srb1 is a member of the basic helix-loop-helix (bHLH), leucine zipper DNA binding protein family of transcription factors that possess a unique tyrosine (Y) residue instead of an arginine (R) residue in the bHLH region. We have determined that Srb1 message levels increase in a time dependent manner during growth under oxygen deprivation (hypoxia). To further understand the role of Srb1 during infection and hypoxia, we silenced the gene encoding Srb1 using RNA interference (RNAi); characterized the resulting phenotype, determined its response to hypoxia, and its ability to cause disease within an infected host. Silencing of Srb1 resulted in a strain of H. capsulatum that is incapable of surviving in vitro hypoxia. We found that without complete Srb1 expression, H. capsulatum is killed by murine macrophages and avirulent in mice given a lethal dose of yeasts. Additionally, silencing Srb1 inhibited the hypoxic upregulation of other known H. capsulatum hypoxia-responsive genes (HRG), and genes that encode ergosterol biosynthetic enzymes. Consistent with these regulatory functions, Srb1 silenced H. capsulatum cells were hypersensitive to the antifungal azole drug itraconazole. These data support the theory that the H. capsulatum SREBP is critical for hypoxic adaptation and is required for H. capsulatum virulence.	[DuBois, Juwen C.] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH USA; [DuBois, Juwen C.; Smulian, A. George] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Smulian, A. George] Univ Cincinnati, Dept Internal Med, Cincinnati, OH USA	University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University of Cincinnati	Smulian, AG (corresponding author), Cincinnati VA Med Ctr, Cincinnati, OH USA.; Smulian, AG (corresponding author), Univ Cincinnati, Dept Internal Med, Cincinnati, OH USA.	Alan.Smulian@uc.edu			United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development Program from Office of Research and Development [5I01BX000335]	United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development Program from Office of Research and Development	This work was supported by Merit Review Award # 5I01BX000335 from the United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development Program from the Office of Research and Development (http://www.research.va.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendoerfer R, 1997, INFECT IMMUN, V65, P2564, DOI 10.1128/IAI.65.7.2564-2569.1997; Becerra M, 2002, MOL MICROBIOL, V43, P545, DOI 10.1046/j.1365-2958.2002.02724.x; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Blosser SJ, 2012, ANTIMICROB AGENTS CH, V56, P248, DOI 10.1128/AAC.05027-11; Bohse ML, 2007, INFECT IMMUN, V75, P2811, DOI 10.1128/IAI.00304-07; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bullock WE, ARCH MED RES ELSEVIE, V24, P219; Butler G, 2013, ANNU REV MICROBIOL, V67, P291, DOI 10.1146/annurev-micro-092412-155658; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; Chang YC, 2009, EUKARYOT CELL, V8, P1770, DOI 10.1128/EC.00207-09; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; Daum G, 1999, YEAST, V15, P601, DOI 10.1002/(SICI)1097-0061(199905)15:7<601::AID-YEA390>3.0.CO;2-N; Davies BSJ, 2006, GENETICS, V174, P191, DOI 10.1534/genetics.106.059964; Dean M, 2001, J LIPID RES, V42, P1007; DuBois JC, 2016, MED MYCOL, V54, P40, DOI 10.1093/mmy/myv073; EISSENBERG LG, 1993, J EXP MED, V177, P1605, DOI 10.1084/jem.177.6.1605; EISSENBERG LG, 1987, INFECT IMMUN, V55, P29, DOI 10.1128/IAI.55.1.29-34.1987; Ernst JF, 2009, CELL MICROBIOL, V11, P183, DOI 10.1111/j.1462-5822.2008.01259.x; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Grahl N, 2010, REGULATION HYPOXIA A, V48, P1; Grahl N, 2012, EUKARYOT CELL, V11, P560, DOI 10.1128/EC.00031-12; Guida A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-628; Hon T, 2003, J BIOL CHEM, V278, P50771, DOI 10.1074/jbc.M303677200; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Hwang L, 2003, MOL BIOL CELL, V14, P2314, DOI 10.1091/mbc.E03-01-0027; Hwang LH, 2012, EUKARYOT CELL, V11, P16, DOI 10.1128/EC.05274-11; Ichinose H, 2012, BIOL PHARM BULL, V35, P833; Inglis DO, 2013, EUKARYOT CELL, V12, P828, DOI 10.1128/EC.00069-13; Jacquier N, 2012, J STEROID BIOCHEM, V129, P70, DOI 10.1016/j.jsbmb.2010.11.014; Kauffman CA, 2007, CLIN MICROBIOL REV, V20, P115, DOI 10.1128/CMR.00027-06; Laskowski MC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-49; Lee CYS, 2011, MOL CELL, V44, P225, DOI 10.1016/j.molcel.2011.08.031; Lee CYS, 2009, EMBO J, V28, P135, DOI 10.1038/emboj.2008.271; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Magrini V, 2001, TRENDS MICROBIOL, V9, P541, DOI 10.1016/S0966-842X(01)02204-1; NEWMAN SL, 1991, INFECT IMMUN, V59, P737, DOI 10.1128/IAI.59.2.737-741.1991; NEWMAN SL, 1990, J CLIN INVEST, V85, P223, DOI 10.1172/JCI114416; NEWMAN SL, 1992, INFECT IMMUN, V60, P4593, DOI 10.1128/IAI.60.11.4593-4597.1992; Nittler MP, 2005, MOL BIOL CELL, V16, P4792, DOI 10.1091/mbc.E05-05-0434; Osborne TF, 2011, MOL CELL, V44, P172, DOI 10.1016/j.molcel.2011.10.004; Park HG, 2011, ARCH BIOCHEM BIOPHYS, V509, P9, DOI 10.1016/j.abb.2011.02.002; Piecuch A, 2014, CELL MOL BIOL LETT, V19, P1, DOI 10.2478/s11658-013-0111-2; Porter JR, 2012, MOL BIOL CELL, V23, P3764, DOI 10.1091/mbc.E12-06-0451; Rispal D, 2011, RNA, V17, P1213, DOI 10.1261/rna.2697111; Shimano H, 2002, VITAM HORM, V65, P167, DOI 10.1016/S0083-6729(02)65064-2; Willger SD, 2012, EUKARYOT CELL, V11, P1557, DOI 10.1128/EC.00252-12; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; WORSHAM PL, 1988, J MED VET MYCOL, V26, P137; Yeh TL, 2011, STRUCTURE, V19, P503, DOI 10.1016/j.str.2011.01.017; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Youseff Brian H, 2012, Methods Mol Biol, V845, P151, DOI 10.1007/978-1-61779-539-8_10	54	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163849	10.1371/journal.pone.0163849	http://dx.doi.org/10.1371/journal.pone.0163849			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711233	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697600045
J	Poder, TG; Pruneau, D; Dorval, J; Thibault, L; Fisette, JF; Bedard, SK; Jacques, A; Beauregard, P				Poder, Thomas G.; Pruneau, Denise; Dorval, Josee; Thibault, Louis; Fisette, Jean-Francois; Bedard, Suzanne K.; Jacques, Annie; Beauregard, Patrice			Pressure Infusion Cuff and Blood Warmer during Massive Transfusion: An Experimental Study About Hemolysis and Hypothermia	PLOS ONE			English	Article							MANAGEMENT; TEMPERATURE; HEMORRHAGE	Background Blood warmers were developed to reduce the risk of hypothermia associated with the infusion of cold blood products. During massive transfusion, these devices are used with compression sleeve, which induce a major stress to red blood cells. In this setting, the combination of blood warmer and compression sleeve could generate hemolysis and harm the patient. We conducted this study to compare the impact of different pressure rates on the hemolysis of packed red blood cells and on the outlet temperature when a blood warmer set at 41.5 degrees C is used. Methods Pressure rates tested were 150 and 300 mmHg. Ten packed red blood cells units were provided by He A ma-Que A bec and each unit was sequentially tested. Results We found no increase in hemolysis either at 150 or 300 mmHg. By cons, we found that the blood warmer was not effective at warming the red blood cells at the specified temperature. At 150 mmHg, the outlet temperature reached 37.1 degrees C and at 300 mmHg, the temperature was 33.7 degrees C. Conclusion To use a blood warmer set at 41.5 degrees C in conjunction with a compression sleeve at 150 or 300 mmHg does not generate hemolysis. At 300 mmHg a blood warmer set at 41.5 degrees C does not totally avoid a risk of hypothermia.	[Poder, Thomas G.; Fisette, Jean-Francois; Bedard, Suzanne K.] CIUSSS Estrie CHUS, UETMIS, Sherbrooke, PQ J1G 2E8, Canada; [Poder, Thomas G.] CIUSSS Estrie CHUS, CRCHUS, Sherbrooke, PQ J1H 5N4, Canada; [Pruneau, Denise; Dorval, Josee; Beauregard, Patrice] CIUSSS Estrie CHUS, Blood Bank, Sherbrooke, PQ J1H 5N4, Canada; [Thibault, Louis; Jacques, Annie] Hema Quebec, Div Res & Dev, Quebec City, PQ G1V 5C3, Canada; [Beauregard, Patrice] CIUSSS Estrie CHUS, Div Hematol Oncol, Sherbrooke, PQ J1H 5N4, Canada	Hema-Quebec	Poder, TG (corresponding author), CIUSSS Estrie CHUS, UETMIS, Sherbrooke, PQ J1G 2E8, Canada.; Poder, TG (corresponding author), CIUSSS Estrie CHUS, CRCHUS, Sherbrooke, PQ J1H 5N4, Canada.	tpoder.chus@sss.gouv.qc.ca		Poder, Thomas/0000-0001-7017-096X	operating budgets of the health technology assessment unit of the CHUS; Blood Bank of the CHUS; Hema-Quebec; FRQS	operating budgets of the health technology assessment unit of the CHUS; Blood Bank of the CHUS; Hema-Quebec; FRQS	This project was funded from the operating budgets of the health technology assessment unit of the CHUS, the Blood Bank of the CHUS and Hema-Quebec.; We acknowledge Flavien Nicolas Andrianary, Christian Bellemare, Sylvie Bergeron, Valerie Bertelle, Line Bilodeau, Lise L. Blais, Martine Comtois, Stephanie Dion, Renee Lafreniere, Helene Levesque, Genevieve Paquette, Monique Robillard, Daniel Sale Menard and Sylvie Thibault for their support and advice. We also acknowledge the personnel of the Blood Bank of the CHUS for their cooperation during the study. TGP is a member of the FRQS-funded Centre de recherche du CHUS (CRCHUS).	AABB, 2002, GUID US BLOOD WARM D; AABB, 2014, STANDARDS BLOOD BANK, p[215, 111], DOI [10.1016/s0887-7963(88)70036-x, DOI 10.1016/S0887-7963(88)70036-X]; Aslam AF, 2006, AM J MED, V119, P297, DOI 10.1016/j.amjmed.2005.09.062; BEAUREGARD P, 1994, TRANSFUS MED REV, V8, P184, DOI 10.1016/S0887-7963(94)70110-3; Ciavarella D, 1988, Transfus Med Rev, V2, P95, DOI 10.1016/S0887-7963(88)70036-X; Du Plessis J M, 1966, S Afr Med J, V40, P479; Hardy JF, 2004, CAN J ANAESTH, V51, P293, DOI 10.1007/BF03018233; Hayter MA, 2012, CAN J ANESTH, V59, P1130, DOI 10.1007/s12630-012-9795-4; Hess JR, 2009, TRANSFUSION, V49, P2599, DOI 10.1111/j.1537-2995.2009.02275.x; Kim HJ, 2016, CLIN HEMORHEOL MICRO, V62, P13, DOI 10.3233/CH-151926; Kim P, 2004, CAN J SURG, V47, P295; Lacroix J, 2011, TRANSFUS CLIN BIOL, V18, P97, DOI 10.1016/j.tracli.2011.02.020; LINKO K, 1979, ACTA ANAESTH SCAND, V23, P46, DOI 10.1111/j.1399-6576.1979.tb01420.x; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; MATEER JR, 1985, ANN EMERG MED, V14, P966, DOI 10.1016/S0196-0644(85)80238-9; Miller TE, 2013, PERIOPER MED, V2, DOI 10.1186/2047-0525-2-13; PAPPAS CG, 1995, CRIT CARE MED, V23, P1243, DOI 10.1097/00003246-199507000-00015; Perlman R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1271-z; Pisciotto PT., 2004, HDB PEDIAT TRANSFUSI, pP. 121, DOI [10.1016/B978-012348776-6/50014-5, DOI 10.1016/B978-012348776-6/50014-5]; Poder TG, 2015, TRANSFUS MED REV, V29, P172, DOI 10.1016/j.tmrv.2015.03.002; Ramakrishnan VT, 2014, INDIAN J ANAESTH, V58, P609, DOI 10.4103/0019-5049.144668; Refaai MA, 2013, BEST PRACT RES-CLIN, V27, P17, DOI 10.1016/j.bpa.2012.12.006; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Savage SA, 2015, J TRAUMA ACUTE CARE, V78, P224, DOI 10.1097/TA.0000000000000502; Smith CE, 2008, INT TRAUMACARE, V18, P71; Spinella PC, 2008, CRIT CARE MED, V36, pS340, DOI 10.1097/CCM.0b013e31817e2ef9; Unite d'evaluation des technologies et des modes d'intervention en sante du Centre hospitalier universitaire de Sherbrooke (UETMIS-CHUS), 2013, UN EV TECHN MOD INT, VXIV; VANDERWALT JH, 1978, BRIT J ANAESTH, V50, P815, DOI 10.1093/bja/50.8.815; WILLIAMSON JR, 1975, BLOOD, V46, P611	29	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163429	10.1371/journal.pone.0163429	http://dx.doi.org/10.1371/journal.pone.0163429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711116	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600024
J	Vila, A; Abal, M; Muinelo-Romay, L; Rodriguez-Abreu, C; Rivas, J; Lopez-Lopez, R; Costa, C				Vila, Ana; Abal, Miguel; Muinelo-Romay, Laura; Rodriguez-Abreu, Carlos; Rivas, Jose; Lopez-Lopez, Rafael; Costa, Clotilde			EGFR-Based Immunoisolation as a Recovery Target for Low-EpCAM CTC Subpopulation	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; EXPRESSION; CARCINOMA; LINES; EMT; DIFFERENTIATION; DISSEMINATION; ESTABLISHMENT	Circulating tumour cells (CTCs) play a key role in the metastasis process, as they are responsible for micrometastasis and are a valuable tool for monitoring patients in real-time. Moreover, efforts to develop new strategies for CTCs isolation and characterisation, and the translation of CTCs into clinical practice needs to overcome the limitation associated with the sole use of Epithelial Cell Adhesion Molecule (EpCAM) expression to purify this tumour cell subpopulation. CTCs are rare events in the blood of patients and are believed to represent the epithelial population from a primary tumour of epithelial origin, thus EpCAM immunoisolation is considered an appropriate strategy. The controversy stems from the impact that the more aggressive mesenchymal tumour phenotypes might have on the whole CTC population. In this work, we first characterised a panel of cell lines representative of tumour heterogeneity, confirming the existence of tumour cell subpopulations with restricted epithelial features and supporting the limitations of EpCAM-based technologies. We next developed customised polystyrene magnetic beads coated with antibodies to efficiently isolate the phenotypically different subpopulations of CTCs from the peripheral blood mononuclear cells (PBMCs) of patients with metastatic cancer. Besides EpCAM, we propose Epidermal Growth Factor Receptor (EGFR) as an additional isolation marker for efficient CTCs detection.	[Vila, Ana; Rodriguez-Abreu, Carlos; Rivas, Jose] INL Int Iberian Nanotechnol Lab, AvdaMestre Jose Veiga, P-4715330 Braga, Portugal; [Abal, Miguel; Lopez-Lopez, Rafael; Costa, Clotilde] ComplexoHosp Univ Santiago de Compostela SERGAS, Translat Med Oncol, Hlth Res Inst Santiago IDIS, Trav Choupana S-N, Santiago De Compostela 15706, Spain; [Muinelo-Romay, Laura; Lopez-Lopez, Rafael] ComplexoHosp Univ Santiago de Compostela SERGAS, Liquid Biopsy Anal Unit, Hlth Res Inst Santiago IDIS, Trav Choupana S-N, Santiago De Compostela 15706, Spain; [Rivas, Jose] Univ Santiago de Compostela, Dept Appl Phys, Technol Res Inst, Nanotechnol & Magnetism Lab NANOMAG, Santiago De Compostela 15782, Spain	International Iberian Nanotechnology Laboratory; Universidade de Santiago de Compostela	Vila, A (corresponding author), INL Int Iberian Nanotechnol Lab, AvdaMestre Jose Veiga, P-4715330 Braga, Portugal.; Costa, C (corresponding author), ComplexoHosp Univ Santiago de Compostela SERGAS, Translat Med Oncol, Hlth Res Inst Santiago IDIS, Trav Choupana S-N, Santiago De Compostela 15706, Spain.	ana.vila@inl.int; clotilde.costa.nogueira@sergas.es	Rodriguez-Abreu, Carlos/B-8690-2014	Rodriguez-Abreu, Carlos/0000-0002-5917-6508; Lopez Lopez, Rafael/0000-0003-1315-655X; Abal Posada, Miguel/0000-0003-3533-7781; Costa, Clotilde/0000-0001-7327-2259; Rivas, Jose/0000-0002-5059-3196	Axencia Galega de Innovacion (Xunta de Galicia); InveNNta (Innovation in Nanomedicine); European Union (EU) through Operational Programme for Cross-border Cooperation: Spain-Portugal (POCTEP); European Regional Development Fund (ERDF)	Axencia Galega de Innovacion (Xunta de Galicia)(Xunta de Galicia); InveNNta (Innovation in Nanomedicine); European Union (EU) through Operational Programme for Cross-border Cooperation: Spain-Portugal (POCTEP); European Regional Development Fund (ERDF)(European Commission)	This work was supported by Axencia Galega de Innovacion (Xunta de Galicia) and InveNNta (Innovation in Nanomedicine), co-financed by the European Union (EU) through the Operational Programme for Cross-border Cooperation: Spain-Portugal (POCTEP 2007-2013), and European Regional Development Fund (ERDF).	Alonso-Alconada L, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-223; Barbazan J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040476; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Barriere G, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.10.04; Bedussi F, 2014, EXPERT OPIN THER TAR, V18, P665, DOI 10.1517/14728222.2014.898064; Bitting RL, 2014, CANCER METAST REV, V33, P441, DOI 10.1007/s10555-013-9483-z; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Carnio S, 2014, EXPERT REV ANTICANC, V14, P1495, DOI 10.1586/14737140.2014.949245; Chen CJ, 2015, ONCOL LETT, V9, P1128, DOI 10.3892/ol.2015.2873; Cheng TH, 2013, ADV MATER SCI ENG, V2013, DOI 10.1155/2013/130438; Colas E, 2012, ONCOGENE, V31, P4778, DOI 10.1038/onc.2011.632; Costa C, 2014, SENSORS-BASEL, V14, P4856, DOI 10.3390/s140304856; Curtis C, 2015, CURR OPIN OBSTET GYN, V27, P34, DOI 10.1097/GCO.0000000000000145; Driemel C, 2014, ONCOGENE, V33, P4904, DOI 10.1038/onc.2013.441; Feng SC, 2015, HISTOL HISTOPATHOL, V30, P13, DOI 10.14670/HH-30.13; Fernandez SV, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0445-3; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Fons P, 2015, J CELL PHYSIOL, V230, P43, DOI 10.1002/jcp.24656; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Gazzaniga P, 2014, INT J CANCER, V135, P1978, DOI 10.1002/ijc.28830; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Gires O, 2014, CELL MOL LIFE SCI, V71, P4393, DOI 10.1007/s00018-014-1693-1; Gosens MJEM, 2007, MODERN PATHOL, V20, P221, DOI 10.1038/modpathol.3800733; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harouaka R, 2014, PHARMACOL THERAPEUT, V141, P209, DOI 10.1016/j.pharmthera.2013.10.004; Hewitt RE, 2000, J PATHOL, V192, P446; Igntiadis M, 2008, EUR J CANCER, V44, P2726, DOI 10.1016/j.ejca.2008.09.033; Joosse SA, 2015, EMBO MOL MED, V7, P1, DOI 10.15252/emmm.201303698; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kang YB, 2013, CANCER CELL, V23, P573, DOI 10.1016/j.ccr.2013.04.017; Lianidou ES, 2011, CLIN CHEM LAB MED, V49, P1579, DOI 10.1515/CCLM.2011.628; Lustberg MB, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3622; Martowicz A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-501; Mikolajczyk SD, 2011, J ONCOL, V2011, DOI 10.1155/2011/252361; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Monge M, 2007, CANCER RES, V67, P6753, DOI 10.1158/0008-5472.CAN-06-4487; Muinelo-Romay L, 2014, CANCERS, V6, P153, DOI 10.3390/cancers6010153; Pestrin M, 2015, MOL ONCOL, V9, P749, DOI 10.1016/j.molonc.2014.12.001; Polioudaki H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1386-7; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Raimondi C, 2014, ONCOTARGETS THER, V7, P619, DOI 10.2147/OTT.S46200; Ramirez LP, 2003, MACROMOL CHEM PHYSIC, V204, P22, DOI 10.1002/macp.200290052; Ranieri D, 2015, INT J CANCER, V137, P61, DOI 10.1002/ijc.29373; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Serrano MJ, 2014, ONCOTARGET, V5, P7486, DOI 10.18632/oncotarget.2217; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Terry S, 2015, ONCOTARGET, V6, P11994, DOI 10.18632/oncotarget.2740; Toge M, 2015, INT J ONCOL, V46, P1844, DOI 10.3892/ijo.2015.2861; Tomlinson GE, 1998, CANCER RES, V58, P3237; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vila A, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2014.2324411; Woelfle U, 2004, CLIN CANCER RES, V10, P2670, DOI 10.1158/1078-0432.CCR-03-0114; Yanamoto S, 2007, ORAL ONCOL, V43, P869, DOI 10.1016/j.oraloncology.2006.10.010; Yin KB., 2011, BREAST CANC FOCUSING, P386, DOI [10.3892/ol.2015.2873, DOI 10.3892/OL.2015.2873]; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zhang LX, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005109; Zhu DY, 2014, WORLD J GASTROENTERO, V20, P18306, DOI 10.3748/wjg.v20.i48.18306	59	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163705	10.1371/journal.pone.0163705	http://dx.doi.org/10.1371/journal.pone.0163705			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711186	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600034
J	Yang, YT; Tai, CJ; Chen, CF; Wu, HC; Mikhaylichenko, N; Chiu, HT; Chen, YY; Hsu, YHE				Yang, Ya-Ting; Tai, Cheng-Jeng; Chen, Chiehfeng; Wu, Hong-Cheng; Mikhaylichenko, Natalia; Chiu, Hsien-Tsai; Chen, Yun-Yi; Hsu, Yi-Hsin Elsa			Highly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review	PLOS ONE			English	Review							PHASE-II TRIAL; MATCHED-PAIR ANALYSIS; SINGLE-AGENT; OPEN-LABEL; CHEMOTHERAPY; SURVIVAL; GEMCITABINE	Background The goal of this study was to perform a systematic review to examine the efficacy and safety of various salvage therapy regimens on patients with relapsed/refractory PTCL. Method The electronic searches were performed using PubMed, Cochrane Library, EMBASE, and Web of Science from inception through June 2015, with search terms related to relapsed/refractory PTCL, salvage chemotherapy regimens, and clinical trials. An eligible study met the following inclusion criteria: (1) Patients had refractory or relapsed PTCL; (2) drug regimens were used for salvage therapy; (3) the study was a clinical trial; (4) the study reported on a series of at least 10 patients of PTCL. Results Of 35 records identified, a total of 14 studies were eligible for systematic reviews, and 12 different salvage regimens were investigated. A total of 618 relapsed/refractory PTCL patients were identified. The ORRs ranged from 22% for those treated with lenalidomide to 86% for those with brentuximab vedotin. By the three most frequent subtypes, the ORRs ranged from 14.2% to 71.5% for patients with the PTCL-NOS subtype, 8% to 54% for AITL subtypes, and 24% to 86% for the ALCL subtype. The medians of DOR, PFS, and OS ranged from 2.5 to 16.6 months, 2.6 to 13.3 months, and 3.6 to 14.5 months, respectively. The most frequently reported grade 3 or 4 adverse events (AEs) were hematological AEs, such as neutropenia and thrombocytopenia. Conclusion The efficacy of salvage therapy regimens is highly diverse for patients with relapsed/refractory PTCL; this heterogeneity in therapeutic effects might be due to the diversity in mechanisms, PTCL subtype distribution, and/or numbers/profiles of prior therapy. Comparative studies with matched pair analysis are warranted for more evidence of the salvage treatment effect on relapsed or heavily pretreated patients with PTCL.	[Yang, Ya-Ting; Chen, Yun-Yi] Natl Taiwan Univ, Inst Hlth Policy & Management, 17 Xu Zhou Rd, Taipei 100, Taiwan; [Yang, Ya-Ting; Chiu, Hsien-Tsai; Chen, Yun-Yi; Hsu, Yi-Hsin Elsa] Golden Dream Think Tank & Res Ctr, 17 Songjiang Rd, Taipei 104, Taiwan; [Yang, Ya-Ting; Hsu, Yi-Hsin Elsa] Taipei Med Univ, Sch Hlth Care Adm, 250 Wuxing St, Taipei, Taiwan; [Tai, Cheng-Jeng; Wu, Hong-Cheng] Taipei Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, 252 Wuxing St, Taipei 110, Taiwan; [Tai, Cheng-Jeng] Taipei Med Univ, Sch Med, Dept Internal Med, Coll Med, 250 Wuxing St, Taipei 110, Taiwan; [Chen, Chiehfeng] Taipei Med Univ, Ctr Evidence Based Med, 250 Wuxing St, Taipei 110, Taiwan; [Chen, Chiehfeng] Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, 250 Wuxing St, Taipei 110, Taiwan; [Chen, Chiehfeng] Taipei Med Univ, Wan Fang Hosp, Div Plast Surg, Dept Surg, 111,Sect 3,Hsing Long Rd, Taipei 116, Taiwan; [Chen, Chiehfeng] Taipei Med Univ, Wan Fang Hosp, Evidence Based Med Ctr, 111,Sect 3,Hsing Long Rd, Taipei 116, Taiwan; [Mikhaylichenko, Natalia] Nevron, Int Med Ctr, Vladivostok, Russia; [Chiu, Hsien-Tsai] China Med Univ, Dept Publ Hlth, 91 Hsueh Shih Rd, Taichung 404, Taiwan	National Taiwan University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; China Medical University Taiwan	Hsu, YHE (corresponding author), Golden Dream Think Tank & Res Ctr, 17 Songjiang Rd, Taipei 104, Taiwan.; Hsu, YHE (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, 250 Wuxing St, Taipei, Taiwan.	elsahsu@tmu.edu.tw		Chen, Chiehfeng/0000-0002-1595-6553; Chen, Yun-Yi/0000-0002-5343-4887	"Golden Dream Project" launched by TaiShang Resources International Group in Taiwan	"Golden Dream Project" launched by TaiShang Resources International Group in Taiwan	This study was supported by grants from "Golden Dream Project" launched by TaiShang Resources International Group in Taiwan. The funding body does not play roles in study design, interpretation of data and the manuscript drafting.	Abouyabis AN, 2011, ISRN HEMATOL, V2011, P623924; Bachy E, 2014, BLOOD, V123, P3059, DOI 10.1182/blood-2014-04-565267; Chan WC, 1997, BLOOD, V89, P3909; Cheah Chan Yoon, 2015, Am Soc Clin Oncol Educ Book, pe468, DOI 10.14694/EdBook_AM.2015.35.e468; Coiffier B, 2014, CANCER TREAT REV, V40, P1080, DOI 10.1016/j.ctrv.2014.08.001; Coiffier B, 2012, J CLIN ONCOL, V30, P631, DOI 10.1200/JCO.2011.37.4223; d'Amore F, 2010, BRIT J HAEMATOL, V150, P565, DOI 10.1111/j.1365-2141.2010.08298.x; Damaj G, 2013, J CLIN ONCOL, V31, P104, DOI 10.1200/JCO.2012.43.7285; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Enblad G, 2004, BLOOD, V103, P2920, DOI 10.1182/blood-2003-10-3389; Foerster R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-335; Foss F, 2015, BRIT J HAEMATOL, V168, P811, DOI 10.1111/bjh.13222; Foss F, 2011, NAT REV CLIN ONCOL, V8, P321, DOI 10.1038/nrclinonc.2011.51; Goldberg JD, 2012, LEUKEMIA LYMPHOMA, V53, P1124, DOI 10.3109/10428194.2011.645818; HARRIS NL, 1994, BLOOD, V84, P1361; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horwitz SM, 2014, BLOOD, V123, P3095, DOI 10.1182/blood-2013-12-542142; Huang CL, 2002, LEUKEMIA LYMPHOMA, V43, P1415, DOI 10.1080/1042819022386806; Karlin L, 2014, SEMIN HEMATOL, V51, P25, DOI 10.1053/j.seminhematol.2013.11.001; Kim SJ, 2012, INVEST NEW DRUG, V30, P368, DOI 10.1007/s10637-010-9523-2; Koch E, 2013, LEUKEMIA LYMPHOMA, V54, P2448, DOI 10.3109/10428194.2013.779688; Lunning MA, 2013, CURR TREAT OPTION ON, V14, P212, DOI 10.1007/s11864-013-0232-x; Mak V, 2013, J CLIN ONCOL, V31, P1970, DOI 10.1200/JCO.2012.44.7524; Moga C., 2012, IHE PUBL; Morgensztern D, 2011, LEUKEMIA LYMPHOMA, V52, P194, DOI 10.3109/10428194.2010.542596; Morschhauser F, 2013, EUR J CANCER, V49, P2869, DOI 10.1016/j.ejca.2013.04.029; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; O'Connor OA, 2011, J CLIN ONCOL, V29, P1182, DOI 10.1200/JCO.2010.29.9024; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Rades D, 2010, J CLIN ONCOL, V28, P3597, DOI 10.1200/JCO.2010.28.5635; Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3; Reddy NM, 2014, SEMIN HEMATOL, V51, P17, DOI 10.1053/j.seminhematol.2013.11.006; Sterne JAC., 2014, COCHRANE RISK BIAS A; VELASQUEZ WS, 1994, J CLIN ONCOL, V12, P1169, DOI 10.1200/JCO.1994.12.6.1169; VELASQUEZ WS, 1988, BLOOD, V71, P117; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; Vose JM, 2008, HEMATOL ONCOL CLIN N, V22, P997, DOI 10.1016/j.hoc.2008.07.010; Zelenetz AD, 2003, ANN ONCOL, V14, P5, DOI 10.1093/annonc/mdg702; Zinzani PL, 2010, ANN ONCOL, V21, P860, DOI 10.1093/annonc/mdp508; Zinzani PL, 2000, J CLIN ONCOL, V18, P2603, DOI 10.1200/JCO.2000.18.13.2603	40	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0161811	10.1371/journal.pone.0161811	http://dx.doi.org/10.1371/journal.pone.0161811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711130	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600004
J	Potocar, U; Hudoklin, S; Kreft, ME; Zavrsnik, J; Bozikov, K; Frohlich, M				Potocar, Urska; Hudoklin, Samo; Kreft, Mateja Erdani; Zavrsnik, Janja; Bozikov, Kresimir; Frohlich, Mirjam			Adipose-Derived Stem Cells Respond to Increased Osmolarities	PLOS ONE			English	Article							INTERVERTEBRAL DISC CELLS; INFRAPATELLAR FAT PAD; CHONDROGENIC DIFFERENTIATION; ARTICULAR CHONDROCYTES; GENE-EXPRESSION; CHEMICAL MICROENVIRONMENT; CARTILAGE DEFECTS; NUCLEAR FACTOR; BONE-MARROW; TISSUE	Cell therapies present a feasible option for the treatment of degenerated cartilaginous and intervertebral disc (IVD) tissues. Microenvironments of these tissues are specific and often differ from the microenvironment of cells that, could be potentially used for therapy, e.g. human adipose-derived stem cells (hASC). To ensure safe and efficient implantation of hASC, it is important to evaluate how microenvironmental conditions at the site of implantation affect the implanted cells. This study has demonstrated that cartilaginous tissue-specific osmolarities ranging from 400-600 mOsm/L affected hASC in a dose-and time-dependent fashion in comparison to 300 mOsm/L. Increased osmolarities resulted in transient (nuclear DNA and actin reorganisation) and non-transient, long-term morphological changes (vesicle formation, increase in cell area, and culture morphology), as well as reduced proliferation in monolayer cultures. Increased osmolarities diminished acid proteoglycan production and compactness of chondrogenically induced pellet cultures, indicating decreased chondrogenic potential. Viability of hASC was strongly dependent on the type of culture, with hASC in monolayer culture being more tolerant to increased osmolarity compared to hASC in suspension, alginate-agarose hydrogel, and pellet cultures, thus emphasizing the importance of choosing relevant in vitro conditions according to the specifics of clinical application.	[Potocar, Urska; Frohlich, Mirjam] Educell Ltd, Trzin, Slovenia; [Hudoklin, Samo; Kreft, Mateja Erdani; Frohlich, Mirjam] Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia; [Zavrsnik, Janja; Frohlich, Mirjam] Jozef Stefan Inst, Dept Biochem & Mol Biol, Ljubljana, Slovenia; [Bozikov, Kresimir] Univ Med Ctr Ljubljana, Div Surg, Dept Plast Surg & Burns, Ljubljana, Slovenia	University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University Medical Centre Ljubljana	Frohlich, M (corresponding author), Educell Ltd, Trzin, Slovenia.; Frohlich, M (corresponding author), Univ Ljubljana, Fac Med, Inst Cell Biol, Ljubljana, Slovenia.; Frohlich, M (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol Biol, Ljubljana, Slovenia.	mirjam.frohlich@mf.uni-lj.si		Kreft, Mateja Erdani/0000-0001-6486-165X	European Commission (GENODISC) [HEALTH-F2-2008-201626]; SPIRIT Slovenia Grant [P-MR-10/45]; Slovenian Research Agency [Z4-4063]; Educell Ltd	European Commission (GENODISC); SPIRIT Slovenia Grant; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Educell Ltd	The work was supported in part by European Commission's Seventh Framework Programme FP7 (project GENODISC, Grant Agreement no.: HEALTH-F2-2008-201626; http://www.physiol.ox.ac.uk/genodisc/), SPIRIT Slovenia (Grant to UP: P-MR-10/45; http://www.spiritslovenia.si/), and Slovenian Research Agency (Grant to MF: Z4-4063; https://www.arrs.gov.si/sl/). The funder (Educell Ltd) had a role in study design, data collection and analysis, decision to publish, and preparation of manuscript.	Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb; Bajuk-Studen K., 2009, ZDR VESTN, V78, P129; Barlic A, 2008, J ORTHOP RES, V26, P847, DOI 10.1002/jor.20559; Barone AAL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/383685; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Buckley CT, 2010, OSTEOARTHR CARTILAGE, V18, P1345, DOI 10.1016/j.joca.2010.07.004; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P477; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Bush PG, 2001, J ORTHOP RES, V19, P768, DOI 10.1016/S0736-0266(01)00013-4; Caron MMJ, 2013, BONE, V53, P94, DOI 10.1016/j.bone.2012.11.032; Chan S, 2015, GLOBAL SPINE J, pP008, DOI [10.1055/s-0035-1554503, DOI 10.1055/S-0035-1554503]; Chao PHG, 2006, AM J PHYSIOL-CELL PH, V291, pC718, DOI 10.1152/ajpcell.00127.2005; Cherubino M, 2009, REGEN MED, V4, P109, DOI 10.2217/17460751.4.1.109; DALLASTA V, 1994, J BIOL CHEM, V269, P10485; Dragoo JL, 2003, J BONE JOINT SURG BR, V85B, P740, DOI 10.1302/0301-620X.85B5.13587; Gaetani P, 2008, TISSUE ENG PT A, V14, P1415, DOI 10.1089/ten.tea.2007.0330; Gonzalez-Rey E, 2010, ANN RHEUM DIS, V69, P241, DOI 10.1136/ard.2008.101881; Hopewell B, 2003, BIORHEOLOGY, V40, P73; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Jin XB, 2007, BIOMATERIALS, V28, P2994, DOI 10.1016/j.biomaterials.2007.03.002; Jung Y, 2009, BIOMATERIALS, V30, P4657, DOI 10.1016/j.biomaterials.2009.05.034; Jurgens WJFM, 2012, J TISSUE ENG REGEN M, V6, P570, DOI 10.1002/term.464; Jurgens WJFM, 2009, CYTOTHERAPY, V11, P1052, DOI 10.3109/14653240903219122; Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273; Bui KHT, 2014, BIOMED RES THER, V1, P2, DOI 10.15419/bmrat.v1i01.11; Koga H, 2009, KNEE SURG SPORT TR A, V17, P1289, DOI 10.1007/s00167-009-0782-4; Koh YG, 2015, KNEE SURG SPORT TR A, V23, P1308, DOI 10.1007/s00167-013-2807-2; Koh YG, 2013, ARTHROSCOPY, V29, P748, DOI 10.1016/j.arthro.2012.11.017; LeBaron RG, 2000, BIOMATERIALS, V21, P2575, DOI 10.1016/S0142-9612(00)00125-3; Lee WCC, 2009, INT J CARDIOL, V133, P399, DOI 10.1016/j.ijcard.2007.11.068; Li XD, 2005, CONNECT TISSUE RES, V46, P75, DOI 10.1080/03008200590954104; Liang CZ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-49; Lim MH, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.8; Luh EH, 1996, J SURG RES, V60, P122, DOI 10.1006/jsre.1996.0020; Maidhof R, 2012, DISCOV MED, V14, P401; MAROUDAS A, 1972, Connective Tissue Research, V1, P69, DOI 10.3109/03008207209152058; Martincic D, 2014, KNEE SURG SPORT TR A, V22, P1277, DOI 10.1007/s00167-013-2778-3; Masilamani S, 2000, KIDNEY, P595; Mavrogonatou E, 2012, J CELL PHYSIOL, V227, P1179, DOI 10.1002/jcp.22840; Mavrogonatou E, 2009, DNA REPAIR, V8, P930, DOI 10.1016/j.dnarep.2009.05.005; Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002; Neidlinger-Wilke C, 2012, J ORTHOP RES, V30, P112, DOI 10.1002/jor.21481; Orth P, 2014, STEM CELLS CLONING, V7, P1, DOI 10.2147/SCCAA.S42880; Pak J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/436029; Perdisa F, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/597652; Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]; Racz B, 2007, BONE, V40, P1536, DOI 10.1016/j.bone.2007.02.011; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Saadat E, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2040; Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]; Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132; Sun T, 2006, J BIOTECHNOL, V122, P372, DOI 10.1016/j.jbiotec.2005.12.021; Takeno K, 2007, J NEUROSURG-SPINE, V7, P637, DOI 10.3171/SPI-07/12/637; Tapp H, 2009, EXP BIOL MED, V234, P1, DOI [10.3181/0805-MR-170, 10.3181/0805/MR-170]; Urban JPG, 2002, BIOCHEM SOC T, V30, P858, DOI 10.1042/bst0300858; URBAN JPG, 1993, J CELL PHYSIOL, V154, P262, DOI 10.1002/jcp.1041540208; van der Windt AE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3031; Veranic P, 2004, EUR J CELL BIOL, V83, P27, DOI 10.1078/0171-9335-00351; Vilaboa SD- A, 2013, PLASTIC RECONSTRUCTI, V132, P10; Vrhovec S, 2011, LAB CHIP, V11, P4200, DOI 10.1039/c1lc20531e; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Willerth S.M., 2008, STEMBOOK; Wuertz K, 2007, J ORTHOP RES, V25, P1513, DOI 10.1002/jor.20436; Wuertz K, 2008, SPINE, V33, P1843, DOI 10.1097/BRS.0b013e31817b8f53; Xu X, 2010, OSTEOARTHR CARTILAGE, V18, P433, DOI 10.1016/j.joca.2009.10.003; Yang L, 2008, J BIOL CHEM, V283, P11823, DOI 10.1074/jbc.M800308200; Zhao SY, 2014, FEBS OPEN BIO, V4, P190, DOI 10.1016/j.fob.2014.02.003; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	70	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163870	10.1371/journal.pone.0163870	http://dx.doi.org/10.1371/journal.pone.0163870			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706209	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697200067
J	Xu, LQ; Hiller, S; Simington, S; Nickeleit, V; Maeda, N; James, LR; Yi, XW				Xu, Longquan; Hiller, Sylvia; Simington, Stephen; Nickeleit, Volker; Maeda, Nobuyo; James, Leighton R.; Yi, Xianwen			Influence of Different Levels of Lipoic Acid Synthase Gene Expression on Diabetic Nephropathy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; OXIDATIVE STRESS; MESANGIAL CELLS; NADPH OXIDASES; VITAMIN-C; MICE; PATHOGENESIS; KIDNEY; INFLAMMATION; COMPLICATIONS	Oxidative stress is implicated in the pathogenesis of diabetic nephropathy (DN) but outcomes of many clinical trials are controversial. To define the role of antioxidants in kidney protection during the development of diabetic nephropathy, we have generated a novel genetic antioxidant mouse model with over-or under-expression of lipoic acid synthase gene (Lias). These models have been mated with Ins2(Akita/+) mice, a type I diabetic mouse model. We compare the major pathologic changes and oxidative stress status in two new strains of the mice with controls. Our results show that Ins2(Akita/+) mice with under-expressed Lias gene, exhibit higher oxidative stress and more severe DN features (albuminuria, glomerular basement membrane thickening and mesangial matrix expansion). In contrast, Ins2(Akita/+) mice with highly-expressed Lias gene display lower oxidative stress and less DN pathologic changes. Our study demonstrates that strengthening endogenous antioxidant capacity could be an effective strategy for prevention and treatment of DN.	[Xu, Longquan; Hiller, Sylvia; Simington, Stephen; Nickeleit, Volker; Maeda, Nobuyo; Yi, Xianwen] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [James, Leighton R.] Univ Florida, Dept Med, Div Nephrol & Hypertens, Jacksonville, FL 32611 USA	University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; University of Florida	Yi, XW (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.; James, LR (corresponding author), Univ Florida, Dept Med, Div Nephrol & Hypertens, Jacksonville, FL 32611 USA.	Leighton.James@jax.ufl.edu; xyi2000@med.unc.edu	James, Leighton/AAJ-1455-2021	, Xianwen/0000-0001-9320-2020; James, Leighton/0000-0002-7613-705X	Juvenile Diabetes Research Foundation [5-2011-471]; Diabetic Complications Consortium DCC [3U24DK076169-0452]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042630, U01HL087946] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetic Complications Consortium DCC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study design, data collection and analysis, decision to publish, or preparation of the manuscript are supported by Juvenile Diabetes Research Foundation (5-2011-471) and Diabetic Complications Consortium DCC)3U24DK076169-0452 grants.	Asaba K, 2005, KIDNEY INT, V67, P1890, DOI 10.1111/j.1523-1755.2005.00287.x; BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biewenga GP, 1997, DRUG METAB REV, V29, P1025, DOI 10.3109/03602539709002242; Blum S, 2010, ATHEROSCLEROSIS, V211, P25, DOI 10.1016/j.atherosclerosis.2010.02.018; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Carlson DA, 2007, ALTERN MED REV, V12, P343; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; Darko D, 2002, CLIN SCI, V103, P339, DOI 10.1042/cs1030339; Doherty HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012909; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Gaede P, 2001, DIABETIC MED, V18, P756, DOI 10.1046/j.0742-3071.2001.00574.x; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Ha H, 2008, DIABETES RES CLIN PR, V82, pS42, DOI 10.1016/j.diabres.2008.09.017; Herman-Edelstein M, 2011, DIABETES, V60, P1779, DOI 10.2337/db10-1110; hi Y, 2013, AM J PHYSIOL-RENAL, V304, pF1335, DOI [10.1152/aiprenal.00405.2012PMID:23552883, DOI 10.1152/AIPRENAL.00405.2012]; Kim HS, 2002, P NATL ACAD SCI USA, V99, P4602, DOI 10.1073/pnas.072083799; Kowluru RA, 2003, FREE RADICAL RES, V37, P1169, DOI 10.1080/10715760310001604189; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Mitchell T, 2013, AM J PHYSIOL-ENDOC M, V305, pE585, DOI 10.1152/ajpendo.00093.2013; Morii T, 2003, J DIABETES COMPLICAT, V17, P11, DOI 10.1016/S1056-8727(02)00176-9; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Padmalayam I, 2009, DIABETES, V58, P600, DOI 10.2337/db08-0473; Park IS, 1997, DIABETES, V46, P473, DOI 10.2337/diabetes.46.3.473; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; Raptis AE, 2001, EXP CLIN ENDOCR DIAB, V109, pS424, DOI 10.1055/s-2001-18600; Reed LJ, 1998, PROTEIN SCI, V7, P220, DOI 10.1002/pro.5560070125; ROVIN BH, 1992, J IMMUNOL, V148, P2148; Sancar-Bas S, 2015, GROWTH FACTORS, V33, P419, DOI 10.3109/08977194.2015.1125349; Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026; Shay KP, 2009, BIOGERONTOLOGY, V10, P443, DOI 10.1007/s10522-008-9187-x; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Valero E, 1996, ANAL BIOCHEM, V239, P47, DOI 10.1006/abio.1996.0289; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Yi XW, 2012, J AM SOC NEPHROL, V23, P103, DOI 10.1681/ASN.2011010003; Yi XW, 2005, MOL CELL BIOL, V25, P8387, DOI 10.1128/MCB.25.18.8387-8392.2005; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang Z, 2007, KIDNEY INT, V72, P193, DOI 10.1038/sj.ki.5002296	44	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163208	10.1371/journal.pone.0163208	http://dx.doi.org/10.1371/journal.pone.0163208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706190	gold, Green Published, Green Submitted			2022-12-27	WOS:000385697200035
J	Floryszak-Wieczorek, J; Arasimowicz-Jelonek, M				Floryszak-Wieczorek, Jolanta; Arasimowicz-Jelonek, Magdalena			Contrasting Regulation of NO and ROS in Potato Defense-Associated Metabolism in Response to Pathogens of Different Lifestyles	PLOS ONE			English	Article							NITRIC-OXIDE; CELL-DEATH; BOTRYTIS-CINEREA; OXALATE OXIDASE; SCLEROTINIA-SCLEROTIORUM; HYPERSENSITIVE RESPONSE; NITROSATIVE STRESS; DISEASE RESISTANCE; SALICYLIC-ACID; ARABIDOPSIS-THALIANA	Our research provides new insights into how the low and steady-state levels of nitric oxide (NO) and reactive oxygen species (ROS) in potato leaves are altered after the challenge with the hemibiotroph Phytophthora infestans or the necrotroph Botrytis cinerea, with the subsequent rapid and invader-dependent modification of defense responses with opposite effects. Mainly in the avirulent (avr) P. infestans-potato system, NO well balanced with the superoxide level was tuned with a battery of SA-dependent defense genes, leading to the establishment of the hypersensitive response (HR) successfully arresting the pathogen. Relatively high levels of S-nitrosoglutathione and S-nitrosothiols concentrated in the main vein of potato leaves indicated the mobile function of these compounds as a reservoir of NO bioactivity. In contrast, low-level production of NO and ROS during virulent (vr) P. infestans-potato interactions might be crucial in the delayed up-regulation of PR-1 and PR-3 genes and compromised resistance to the hemibiotrophic pathogen. In turn, B. cinerea triggered huge NO overproduction and governed inhibition of superoxide production by blunting NADPH oxidase. Nevertheless, a relatively high level of H2O2 was found owing to the germin-like activity in cooperation with NO-mediated HR-like cell death in potato genotypes favorable to the necrotrophic pathogen. Moreover, B. cinerea not only provoked cell death, but also modulated the host redox milieu by boosting protein nitration, which attenuated SA production but not SA-dependent defense gene expression. Finally, based on obtained data the organismal cost of having machinery for HR in plant resistance to biotrophs is also discussed, while emphasizing new efforts to identify other components of the NO/ROS cell death pathway and improve plant protection against pathogens of different lifestyles.	[Floryszak-Wieczorek, Jolanta] Poznan Univ Life Sci, Dept Plant Physiol, Wolynska 35, PL-60637 Poznan, Poland; [Arasimowicz-Jelonek, Magdalena] Adam Mickiewicz Univ, Dept Plant Ecophysiol, Fac Biol, Umultowska 89, PL-61614 Poznan, Poland	Poznan University of Life Sciences; Adam Mickiewicz University	Arasimowicz-Jelonek, M (corresponding author), Adam Mickiewicz Univ, Dept Plant Ecophysiol, Fac Biol, Umultowska 89, PL-61614 Poznan, Poland.	arasim@amu.edu.pl	Floryszak-Wieczorek, Jolanta/AAO-9997-2021	Floryszak-Wieczorek, Jolanta/0000-0003-2281-223X; Arasimowicz-Jelonek, Magdalena/0000-0002-3109-5933	National Science Centre [NCN 2011/01/B/NZ9/00243]	National Science Centre(National Science Centre, Poland)	This work was supported by the grant of the National Science Centre - project no. NCN 2011/01/B/NZ9/00243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able AJ, 1998, PLANT PHYSIOL, V117, P491, DOI 10.1104/pp.117.2.491; Abramowski D, 2015, EUR J PLANT PATHOL, V143, P237, DOI 10.1007/s10658-015-0677-9; Arasimowicz-Jelonek M, 2011, PHYTOCHEMISTRY, V72, P681, DOI 10.1016/j.phytochem.2011.02.025; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; Astier J, 2012, BIOCHEM J, V447, P249, DOI 10.1042/BJ20120257; BECANA M, 1986, PLANT PHYSIOL, V82, P1169, DOI 10.1104/pp.82.4.1169; Bolwell GP, 2009, SIGNAL COMMUN PLANTS, P113, DOI 10.1007/978-3-642-00390-5_7; Campos-Soriano L, 2011, PLANT SIGNAL BEHAV, V6, P553, DOI 10.4161/psb.6.4.14914; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Chaki M, 2011, PLANT CELL ENVIRON, V34, P1803, DOI 10.1111/j.1365-3040.2011.02376.x; Chaouch S, 2012, PLANT J, V69, P613, DOI 10.1111/j.1365-313X.2011.04816.x; Chen YC, 2014, INT J PUBLIC ADM DIG, V1, P1, DOI 10.4018/ijpada.2014010101; Christensen AB, 2004, MOL PLANT MICROBE IN, V17, P109, DOI 10.1094/MPMI.2004.17.1.109; Christensen AB, 2004, MOL PLANT MICROBE IN, V17, P109, DOI [10.1094/mpmi.2004.17.1.109, DOI 10.1094/MPMI.2004.17.1.109]; Colmenares AJ, 2002, J CHEM ECOL, V28, P997, DOI 10.1023/A:1015209817830; Corpas FJ, 2008, PLANT CELL PHYSIOL, V49, P1711, DOI 10.1093/pcp/pcn144; De Vleesschauwer D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-9; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Dickman MB, 2001, P NATL ACAD SCI USA, V98, P6957, DOI 10.1073/pnas.091108998; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; Dong XB, 2008, PLANTA, V228, P331, DOI 10.1007/s00425-008-0740-2; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; ELAD Y, 1992, PLANT PATHOL, V41, P417, DOI 10.1111/j.1365-3059.1992.tb02436.x; Floryszak-Wieczorek J, 2007, NEW PHYTOL, V175, P718, DOI 10.1111/j.1469-8137.2007.02142.x; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gebhardt C, 2004, MOL BREEDING, V13, P93, DOI 10.1023/B:MOLB.0000012878.89855.df; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2006, PHYTOPATHOLOGY, V96, P299, DOI 10.1094/PHYTO-96-0299; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Halim VA, 2009, PLANT J, V57, P230, DOI 10.1111/j.1365-313X.2008.03688.x; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Horbach R, 2011, J PLANT PHYSIOL, V168, P51, DOI 10.1016/j.jplph.2010.06.014; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; Huang JC, 2007, TALANTA, V72, P1283, DOI 10.1016/j.talanta.2007.01.033; Huckelhoven R, 1999, PLANT PHYSIOL, V119, P1251, DOI 10.1104/pp.119.4.1251; James W. C, 1971, CAN PLANT DIS SURV, V51, P39; Kim KS, 2008, MOL PLANT MICROBE IN, V21, P605, DOI 10.1094/MPMI-21-5-0605; Kliebenstein DJ, 2008, PLANT SCI, V174, P551, DOI 10.1016/j.plantsci.2008.03.005; Kovacs I, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00137; Kumar R, 2011, INDIAN J BIOCHEM BIO, V48, P42; Livingstone DM, 2005, PLANT PHYSIOL, V137, P1354, DOI 10.1104/pp.104.057232; Lopez-Cruz J, 2017, MOL PLANT PATHOL, V18, P16, DOI 10.1111/mpp.12370; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; McDowell JM, 2000, TRENDS BIOCHEM SCI, V25, P79, DOI 10.1016/S0968-0004(99)01532-7; MEUWLY P, 1993, ANAL BIOCHEM, V214, P500, DOI 10.1006/abio.1993.1529; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Mur LAJ, 2005, PLANT CELL ENVIRON, V28, P548, DOI 10.1111/j.1365-3040.2005.01301.x; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Neill S. J., 2009, Signal crosstalk in plant stress responses, P136, DOI 10.1002/9780813805931.ch7; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plich J, 2015, AM J POTATO RES, V92, P350, DOI 10.1007/s12230-015-9437-9; Rietz S, 2012, J EXP BOT, V63, P5507, DOI 10.1093/jxb/ers203; Romero-Puertas MC, 2008, PROTEOMICS, V8, P1459, DOI 10.1002/pmic.200700536; Schaller A, 2000, PLANTA, V210, P599, DOI 10.1007/s004250050049; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Siegmund U, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055879, 10.1371/annotation/84c258cf-4f98-43d8-a4f0-7032cba36f22]; Sivakumaran A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00709; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Sweat TA, 2007, PLANT CELL, V19, P673, DOI 10.1105/tpc.106.047563; Tada Y, 2004, MOL PLANT MICROBE IN, V17, P245, DOI 10.1094/MPMI.2004.17.3.245; Trapet P, 2015, PHYTOCHEMISTRY, V112, P72, DOI 10.1016/j.phytochem.2014.03.015; Valderrama R, 2007, FEBS LETT, V581, P453, DOI 10.1016/j.febslet.2007.01.006; van Baarlen P, 2007, MOL PLANT PATHOL, V8, P41, DOI 10.1111/j.1364-3703.2006.00367.x; Van Breusegem F, 2006, PLANT PHYSIOL, V141, P384, DOI 10.1104/pp.106.078295; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; VANKAN JAL, 1995, PLANT MOL BIOL, V27, P1205, DOI 10.1007/BF00020894; Veronese P, 2004, PLANT J, V40, P558, DOI 10.1111/j.1365-313X.2004.02232.x; vonTiedemann A, 1997, PHYSIOL MOL PLANT P, V50, P151; Walz A, 2008, PLANT PATHOL, V57, P453, DOI 10.1111/j.1365-3059.2007.01815.x; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Yu MD, 2014, NEW PHYTOL, V202, P1142, DOI 10.1111/nph.12739; Yun BW, 2016, NEW PHYTOL, V211, P516, DOI 10.1111/nph.13903; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Zago E, 2006, PLANT PHYSIOL, V141, P404, DOI 10.1104/pp.106.078444; Zeier J, 2004, PLANT PHYSIOL, V136, P2875, DOI 10.1104/pp.104.042499; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	81	12	12	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163546	10.1371/journal.pone.0163546	http://dx.doi.org/10.1371/journal.pone.0163546			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695047	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100044
J	Sadeghi, K; Wisgrill, L; Wessely, I; Diesner, SC; Schuller, S; Durr, C; Heinle, A; Sachet, M; Pollak, A; Forster-Waldl, E; Spittler, A				Sadeghi, Kambis; Wisgrill, Lukas; Wessely, Isabelle; Diesner, Susanne C.; Schueller, Simone; Duerr, Celia; Heinle, Armando; Sachet, Monika; Pollak, Arnold; Foerster-Waldl, Elisabeth; Spittler, Andreas			GM-CSF Down-Regulates TLR Expression via the Transcription Factor PU.1 in Human Monocytes	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INNATE; PRETERM; SEPSIS; TRIAL	Toll-like receptors (TLR) are crucial sensors of microbial agents such as bacterial or viral compounds. These receptors constitute key players in the induction of inflammation, e.g. in septic or chronic inflammatory diseases. Colony-stimulating factors (CSFs) such as granulocyte-macrophage-CSF (GM-CSF) or granulocyte-CSF (G-CSF) have been extensively investigated in their capacity to promote myelopoiesis in febrile neutropenia or to overcome immunosuppression in patients suffering from sepsis-associated neutropenia or from monocytic immunoincompetence. We report here that GM-CSF, downregulates TLR1, TLR2 and TLR4 in a time-and dose-dependent fashion in human monocytes. Diminished pathogen recognition receptor expression was accompanied by reduced downstream p38 and extracellular-signal-regulated kinase (ERK) signaling upon lipoteichoic acid (LTA) and lipopolysaccharide (LPS) binding D and accordingly led to impaired proinflammatory cytokine production. Knockdown experiments of the transcription factors PU.1 and VentX showed that GM-CSF driven effects on TLR regulation is entirely PU.1 but not VentX dependent. We further analysed monocyte TLR and CD14 expression upon exposure to the IMID (R) immunomodulatory drug Pomalidomide (CC-4047), a Thalidomide analogue known to downregulate PU.1. Indeed, Pomalidomide in part reversed the GM-CSF-mediated effects. Our data indicate a critical role of PU.1 in the regulation of TLR1, 2, 4 and of CD14, thus targeting PU.1 ultimately results in TLR modulation. The PU.1 mediated immunomodulatory properties of GM-CSF should be taken into consideration upon usage of GM-CSF in inflammatory or infection-related conditions.	[Sadeghi, Kambis; Wisgrill, Lukas; Wessely, Isabelle; Diesner, Susanne C.; Schueller, Simone; Duerr, Celia; Pollak, Arnold; Foerster-Waldl, Elisabeth] Med Univ Vienna, Dept Paediat & Adolescent Med, Div Neonatol Paediat Intens Care & Neuropaediatr, Vienna, Austria; [Heinle, Armando; Sachet, Monika] Med Univ Vienna, Dept Surg, Vienna, Austria; [Spittler, Andreas] Med Univ Vienna, Core Facil Flow Cytometry, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Forster-Waldl, E (corresponding author), Med Univ Vienna, Dept Paediat & Adolescent Med, Div Neonatol Paediat Intens Care & Neuropaediatr, Vienna, Austria.	elisabeth.foerster-waldl@meduniwien.ac.at	Wisgrill, Lukas/V-3682-2019; Schüller, Simone/ADA-8472-2022	Schüller, Simone/0000-0003-0344-8786; Spittler, Andreas/0000-0003-2657-6836; Wisgrill, Lukas/0000-0001-9833-9499; Sadeghi, Kambis/0000-0002-1039-3958; Diesner-Treiber, Susanne/0000-0001-8955-4752; Forster-Waldl, Elisabeth/0000-0002-8484-9890	Austrian National Bank "Jubilaumsfond" [13071]; "Hygiene Fonds" of the Medical University of Vienna	Austrian National Bank "Jubilaumsfond"; "Hygiene Fonds" of the Medical University of Vienna	This work was supported in part by the Austrian National Bank "Jubilaumsfond" (grant Number 13071 to KS and EFW) and in part by the "Hygiene Fonds" of the Medical University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to acknowledge Celgene Corporation (www.celgene.com) for kindly providing the substance pomalidomide. The authors have no conflicting financial interests.	Ahmad A, 2002, PEDIATR INFECT DIS J, V21, P1061, DOI 10.1097/00006454-200211000-00017; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Anderson G, 2006, BLOOD, V107, P3098, DOI 10.1182/blood-2005-08-3450; Berclaz PY, 2007, AM J RESP CELL MOL, V36, P114, DOI 10.1165/rcmb.2006-0174OC; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; Bo LL, 2011, CRIT CARE, V15, DOI 10.1186/cc10031; Carr R, 2009, LANCET, V373, P226, DOI 10.1016/S0140-6736(09)60071-4; Cashen Amanda F, 2004, Curr Hematol Rep, V3, P406; CHATTA GS, 1994, BLOOD, V84, P2923; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Erridge C, 2008, TRENDS CARDIOVAS MED, V18, P52, DOI 10.1016/j.tcm.2007.12.003; Fleetwood AJ, 2005, CRIT REV IMMUNOL, V25, P405, DOI 10.1615/CritRevImmunol.v25.i5.50; Galustian C, 2009, CANCER IMMUNOL IMMUN, V58, P1033, DOI 10.1007/s00262-008-0620-4; Hamilton JA, 2013, TRENDS IMMUNOL, V34, P81, DOI 10.1016/j.it.2012.08.006; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kuritzkes DR, 2000, CLIN INFECT DIS, V30, P256, DOI 10.1086/313642; Lederhuber H, 2011, NEONATOLOGY, V99, P51, DOI 10.1159/000301938; Liu PT, 2005, J IMMUNOL, V174, P2467, DOI 10.4049/jimmunol.174.5.2467; Lonial S, 2004, BIOL BLOOD MARROW TR, V10, P848, DOI 10.1016/j.bbmt.2004.07.008; Martinez-Moczygemba M, 2008, J EXP MED, V205, P2711, DOI 10.1084/jem.20080759; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Pal R, 2010, BLOOD, V115, P605, DOI 10.1182/blood-2009-05-221077; Parajuli B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-268; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Perez OD, 2002, NAT BIOTECHNOL, V20, P155, DOI 10.1038/nbt0202-155; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Wu XM, 2011, J CLIN INVEST, V121, P2599, DOI 10.1172/JCI45556	32	13	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0162667	10.1371/journal.pone.0162667	http://dx.doi.org/10.1371/journal.pone.0162667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695085	Green Submitted, gold, Green Published			2022-12-27	WOS:000385553100016
J	Iikuni, S; Ono, M; Watanabe, H; Yoshimura, M; Ishibashi-Ueda, H; Ihara, M; Saji, H				Iikuni, Shimpei; Ono, Masahiro; Watanabe, Hiroyuki; Yoshimura, Masashi; Ishibashi-Ueda, Hatsue; Ihara, Masafumi; Saji, Hideo			Novel Bivalent Tc-99m-Complex with N-Methyl-Substituted Hydroxamamide as Probe for Imaging of Cerebral Amyloid Angiopathy	PLOS ONE			English	Article							ALZHEIMER-DISEASE; BINDING; AGENTS; F-18-FLUTEMETAMOL; VALIDATION; PATHOLOGY; DEPOSITS	Cerebral amyloid angiopathy (CAA) is characterized by the deposition of amyloid aggregates in the walls of the cerebral vasculature. Recently, the development of molecular imaging probes targeting CAA has been attracting much attention. We previously reported the Tc-99m-hydroxamamide (Tc-99m-Ham) complex with a bivalent benzothiazole scaffold as a binding moiety for amyloid aggregates ([Tc-99m]BT2) and its utility for CAA-specific imaging. However, the simultaneous generation of two radiolabeled complexes derived from the geometric isomers was observed in the Tc-99m-labeling reaction. It was recently reported that the complexation reaction of Tc-99 with N-methyl-substituted Ham provided a single Tc-99-Ham complex consisting of two N-methylated Ham ligands with marked stability. In this article, we designed and synthesized a novel N-methylated bivalent Tc-99m-Ham complex ([Tc-99m]MBT2) and evaluated its utility for CAA-specific imaging. N-Methyl substitution of [Tc-99m]BT2 prevented the generation of its isomer in the Tc-99m-labeling reaction. Enhanced in vitro stability of [Tc-99m]MBT2 as compared with [Tc-99m]BT2 was observed. [Tc-99m]MBT2 showed very low brain uptake, which is favorable for CAA-specific imaging. An in vitro inhibition assay using beta-amyloid aggregates and in vitro autoradiographic examination of brain sections from a Tg2576 mouse and a CAA patient showed a decline in the binding affinity for amyloid aggregates due to N-methylation of the Tc-99m-Ham complex. These results suggest that the scaffold of the Tc-99m-Ham complex may play important roles in the in vitro stability and the binding affinity for amyloid aggregates.	[Iikuni, Shimpei; Ono, Masahiro; Watanabe, Hiroyuki; Yoshimura, Masashi; Saji, Hideo] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Kyoto, Japan; [Ishibashi-Ueda, Hatsue] Natl Cerebral & Cardiovasc Ctr, Dept Pathol, Osaka, Japan; [Ihara, Masafumi] Natl Cerebral & Cardiovasc Ctr, Dept Stroke & Cerebrovasc Dis, Osaka, Japan	Kyoto University; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Ono, M (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Pathofunct Bioanal, Kyoto, Japan.	ono@pharm.kyoto-u.ac.jp	Ihara, Masafumi/O-5020-2019; IIKUNI, Shimpei/AAU-7810-2020	Ihara, Masafumi/0000-0002-7102-4048; IIKUNI, Shimpei/0000-0002-7073-9084	Japan Society for the Promotion of Science (JSPS) [LS060]; JSPS KAKENHI Scientific Research (B) [26293274]; JSPS Research Fellowships for Young Scientists [16J05493]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI Scientific Research (B); JSPS Research Fellowships for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (LS060)," initiated by the Council for Science and Technology Policy (CSTP) and JSPS KAKENHI Scientific Research (B) (Grant Number: 26293274), and JSPS Research Fellowships for Young Scientists (16J05493). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (LS060)," initiated by the Council for Science and Technology Policy (CSTP), JSPS KAKENHI Scientific Research (B) (Grant Number: 26293274), and JSPS Research Fellowships for Young Scientists (16J05493).	Becker GA, 2013, J NUCL MED, V54, P723, DOI 10.2967/jnumed.112.107185; Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Choi SR, 2009, J NUCL MED, V50, P1887, DOI 10.2967/jnumed.109.065284; Dierksen GA, 2010, ANN NEUROL, V68, P545, DOI 10.1002/ana.22099; Ellis RJ, 1996, NEUROLOGY, V46, P1592, DOI 10.1212/WNL.46.6.1592; Gahr M, 2013, BRAIN RES, V1519, P19, DOI 10.1016/j.brainres.2013.04.052; Greenberg SA, 2004, STROKE, V35, P2616, DOI 10.1161/01.str.0000143224.36527.44; Holland CM, 2008, STROKE, V39, P1127, DOI 10.1161/STROKEAHA.107.497438; Iikuni S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25990; Iikuni S, 2014, MOL PHARMACEUT, V11, P1132, DOI 10.1021/mp400499y; Jaruszewski KM, 2014, BIOMATERIALS, V35, P1967, DOI 10.1016/j.biomaterials.2013.10.075; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Jia JH, 2015, MOL PHARMACEUT, V12, P2937, DOI 10.1021/acs.molpharmaceut.5b00209; Johnson KA, 2007, ANN NEUROL, V62, P229, DOI 10.1002/ana.21164; Knudsen KA, 2001, NEUROLOGY, V56, P537, DOI 10.1212/WNL.56.4.537; Lundqvist R, 2013, J NUCL MED, V54, P1472, DOI 10.2967/jnumed.112.115006; Ly JV, 2010, NEUROLOGY, V74, P487, DOI 10.1212/WNL.0b013e3181cef7e3; Mehndiratta P, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11370; Nabuurs RJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038284; Nelissen N, 2009, J NUCL MED, V50, P1251, DOI 10.2967/jnumed.109.063305; Smith EE, 2010, STROKE, V41, pS139, DOI 10.1161/STROKEAHA.110.596056; Thipyapong K, 2011, INORG CHEM, V50, P992, DOI 10.1021/ic101714q; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; Viswanathan A, 2011, ANN NEUROL, V70, P871, DOI 10.1002/ana.22516; Walker DA, 2004, AM J ROENTGENOL, V182, P1547, DOI 10.2214/ajr.182.6.1821547; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088; Xu LC, 1999, BIOCONJUGATE CHEM, V10, P9, DOI 10.1021/bc980024j; Zha ZH, 2016, BIOCONJUGATE CHEM, V27, P1314, DOI 10.1021/acs.bioconjchem.6b00127; Zha ZH, 2011, J MED CHEM, V54, P8085, DOI 10.1021/jm2009106; Zhan Ren-ya, 2004, J Zhejiang Univ Sci, V5, P1262, DOI 10.1631/jzus.2004.1262; Zhang W, 2005, NUCL MED BIOL, V32, P799, DOI 10.1016/j.nucmedbio.2005.06.001	31	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							0163969	10.1371/journal.pone.0163969	http://dx.doi.org/10.1371/journal.pone.0163969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689870	Green Published, Green Submitted, gold			2022-12-27	WOS:000384329200037
J	Kimura, M; Wakita, S; Ishikawa, K; Sekine, K; Yoshikawa, S; Sato, A; Okawa, K; Kashimura, A; Sakaguchi, M; Sugahara, Y; Yamanaka, D; Ohno, N; Bauer, PO; Oyama, F				Kimura, Masahiro; Wakita, Satoshi; Ishikawa, Kotarou; Sekine, Kazutaka; Yoshikawa, Satoshi; Sato, Akira; Okawa, Kazuaki; Kashimura, Akinori; Sakaguchi, Masayoshi; Sugahara, Yasusato; Yamanaka, Daisuke; Ohno, Naohito; Bauer, Peter O.; Oyama, Fumitaka			Functional Properties of Mouse Chitotriosidase Expressed in the Periplasmic Space of Escherichia coli	PLOS ONE			English	Article							HUMAN MACROPHAGE CHITOTRIOSIDASE; EXTRACELLULAR EXPRESSION; GLYCOSYL HYDROLASES; CHITINASE; DISEASE; CLONING; GENE; LUNG; ATHEROSCLEROSIS; IDENTIFICATION	Chitotriosidase (Chit1) is an enzyme associated with various diseases, including Gaucher disease, chronic obstructive pulmonary disease, Alzheimer disease and cystic fibrosis. In this study, we first expressed mouse mature Chit1 fused with V5 and (His)(6) tags at the C-terminus (Chit1-V5-His) in the cytoplasm of Escherichia coli and found that most of the expressed protein was insoluble. In contrast, Chit1 tagged with Protein A at the N-terminus and V5-His at the C-terminus, was expressed in the periplasmic space of E. coli as a soluble protein and successfully purified. We evaluated the chitinolytic properties of the recombinant enzyme using 4-nitrophenyl N, N'-diacetyl-beta-D-chitobioside [4NP-chitobioside, 4NP-(GlcNAc)(2)] and found that its activity was comparable to CHO cells-expressed Chit1-V5-His. Optimal conditions for the E. coli-produced Chit1 were pH similar to 5.0 at 50 degrees C. Chit1 was stable after 1 h incubation at pH 5.0 similar to 11.0 on ice and its chitinolytic activity was lost at pH 2.0, although the affinity to chitin remained unchanged. Chit1 efficiently cleaved crystalline and colloidal chitin substrates as well as oligomers of N-acetyl-D- glucosamine (GlcNAc) releasing primarily (GlcNAc)(2) fragments at pH 5.0. On the other hand, (GlcNAc)(3) was relatively resistant to digestion by Chit1. The degradation of 4NP-(GlcNAc)(2) and (GlcNAc)(3) was less evident at pH 7.0 similar to 8.0, while (GlcNAc)(2) production from colloidal chitin and (GlcNAc)(6) at these pH conditions remained strong at the neutral conditions. Our results indicate that Chit1 degrades chitin substrates under physiological conditions and suggest its important pathophysiological roles in vivo.	[Kimura, Masahiro; Wakita, Satoshi; Ishikawa, Kotarou; Sekine, Kazutaka; Yoshikawa, Satoshi; Sato, Akira; Okawa, Kazuaki; Kashimura, Akinori; Sakaguchi, Masayoshi; Sugahara, Yasusato; Oyama, Fumitaka] Kogakuin Univ, Dept Chem & Life Sci, Hachioji, Tokyo 1920015, Japan; [Yamanaka, Daisuke; Ohno, Naohito] Tokyo Univ Pharm & Life Sci, Lab Immunopharmacol Microbial Prod, Hachioji, Tokyo 1920392, Japan; [Bauer, Peter O.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Kogakuin University; Tokyo University of Pharmacy & Life Sciences; Mayo Clinic	Oyama, F (corresponding author), Kogakuin Univ, Dept Chem & Life Sci, Hachioji, Tokyo 1920015, Japan.	f-oyama@cc.kogakuin.ac.jp	Oyama, Fumitaka/Q-4268-2019; Bauer, Peter O./AAD-6502-2022	Oyama, Fumitaka/0000-0002-1095-8306; Bauer, Peter O./0000-0003-2811-1354	JSPS KAKENHI [16K07699]; Research Institute of Science and Technology, Kogakuin University; Science Research Promotion Fund of the Promotion and Mutual Aid Corporation for Private Schools of Japan; Ministry of Education, Culture, Sport, Science and Technology, Japan [S1411005]; ALS Association; Mayo Clinic Center for Regenerative Medicine	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Institute of Science and Technology, Kogakuin University; Science Research Promotion Fund of the Promotion and Mutual Aid Corporation for Private Schools of Japan; Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ALS Association; Mayo Clinic Center for Regenerative Medicine	This work was supported by JSPS KAKENHI Grant Number 16K07699, the Project Research Grant from the Research Institute of Science and Technology, Kogakuin University and Grant from the Science Research Promotion Fund of the Promotion and Mutual Aid Corporation for Private Schools of Japan and in part by a grant of the Strategic Research Foundation Grant-aided Project for Private Universities (S1411005) from the Ministry of Education, Culture, Sport, Science and Technology, Japan. P.O.B. received support from ALS Association and Mayo Clinic Center for Regenerative Medicine.	Artieda M, 2003, ARTERIOSCL THROM VAS, V23, P1645, DOI 10.1161/01.ATV.0000089329.09061.07; Boot RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1283, DOI 10.1369/jhc.4A6547.2005; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bueter CL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003080; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Eide KB, 2012, BIOCHEMISTRY-US, V51, P487, DOI 10.1021/bi2015585; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; Hall AJ, 2008, MICROBES INFECT, V10, P69, DOI 10.1016/j.micinf.2007.10.007; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; JACKSON P, 1990, BIOCHEM J, V270, P705, DOI 10.1042/bj2700705; Kashimura A, 2015, INT J MOL SCI, V16, P4028, DOI 10.3390/ijms16024028; Kashimura A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078669; Kawada Mayumi, 2007, Keio Journal of Medicine, V56, P21, DOI 10.2302/kjm.56.21; Khoushab F, 2010, MAR DRUGS, V8, P1988, DOI 10.3390/md8071988; Kitamoto S, 2013, AM J PATHOL, V183, P313, DOI 10.1016/j.ajpath.2013.04.003; Koch BEV, 2015, GLYCOBIOLOGY, V25, P469, DOI 10.1093/glycob/cwv005; Kumari A, 2012, BIOTECHNOL LETT, V34, P1733, DOI 10.1007/s10529-012-0958-8; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Letuve S, 2010, AM J PATHOL, V176, P638, DOI 10.2353/ajpath.2010.090455; Livnat G, 2014, PEDIATR PULM, V49, P21, DOI 10.1002/ppul.22749; LOWENADLER B, 1987, GENE, V58, P87, DOI 10.1016/0378-1119(87)90032-1; Mack Ines, 2015, Mol Cell Pediatr, V2, P3, DOI 10.1186/s40348-015-0014-6; Ohno M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067399; Ohno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050381; OYAMA F, 1993, J BIOCHEM, V114, P813, DOI 10.1093/oxfordjournals.jbchem.a124261; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; Sakaguchi M, 2014, AMB EXPRESS, V4, DOI 10.1186/2191-0855-4-5; Seibold MA, 2008, J ALLERGY CLIN IMMUN, V122, P944, DOI 10.1016/j.jaci.2008.08.023; Sonmez A, 2010, ENDOCRINE, V37, P455, DOI 10.1007/s12020-010-9334-4; Tiwary E, 2010, J AGR FOOD CHEM, V58, P8380, DOI 10.1021/jf100803g; Vandevenne M, 2011, PROTEIN SCI, V20, P1451, DOI 10.1002/pro.676; Watabe-Rudolph M, 2012, NEUROLOGY, V78, P569, DOI 10.1212/WNL.0b013e318247caa1; Yang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022981; Zheng T, 2005, GENE, V357, P37, DOI 10.1016/j.gene.2005.05.006	40	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2016	11	10							e0164367	10.1371/journal.pone.0164367	http://dx.doi.org/10.1371/journal.pone.0164367			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UW	27716783	Green Published, Green Submitted, gold			2022-12-27	WOS:000385698100048
J	Cai, QQ; Chen, KL; Chen, J; Wu, SX; Geng, QR; Huang, HQ; Lin, TY; Jiang, WQ; Xia, ZJ; Duan, HX; Rao, HL; Yao, MF; Hu, LY				Cai, Qingqing; Chen, Kailin; Chen, Jie; Wu, Shaoxu; Geng, Qirong; Huang, Huiqiang; Lin, Tongyu; Jiang, Wenqi; Xia, Zhongjun; Duan, Huaxin; Rao, Huilan; Yao, Mengfei; Hu, Liyang			The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy	PLOS ONE			English	Article							VIRUS REACTIVATION; CYTOTOXIC CHEMOTHERAPY; CANCER-PATIENTS; RISK-FACTORS; E-ANTIGEN; DIPIVOXIL; RESISTANCE; METAANALYSIS; COMBINATION; ENTECAVIR	Prophylactic antiviral therapy is essential for lymphoma patients with high baseline HBV DNA who undergo cytotoxic chemotherapy. However, there are limited data on the optimal options. The present study was designed to compare the efficacy of prophylactic lamivudine (LAM) with lamivudine plus adefovir dipivoxil (LAM+ADV) in preventing hepatitis B virus (HBV) reactivation in lymphoma with, pre-chemotherapy HBV DNA load >= 2000 IU/ml. We retrospectively analyzed the medical records of 86 lymphoma patients with baseline HBV DNA load >= 2000 IU/ml during chemotherapy and received LAM or LAM+ADV as prophylaxis between January 1, 2008 and November 30, 2014 at Sun Yat-sen University Cancer Center, China. Sixty-five patients received LAM and 21 received LAM+ADV. The rate was significantly lower in the LAM+ADV group compared with the LAM group for HBV reactivation (23.8% vs 55.4%; p = 0.012), while no difference was observed between the two groups in patients for HBV-related hepatitis (21.3% vs 33.3%; p = 0.349), and chemotherapy disruption (10.9% vs 19.0%; p = 0.337). In a multivariate analysis of factors associated with HBV reactivation in these patients, LAM+ADV treatment and HBeAg negative were the independent protective factors. Therefore, LAM+ADV should be considered for antiviral prophylaxis in lymphoma patients with pre-chemotherapy HBV DNA load >= 2000 IU/ml. Further study is warranted to confirm these findings.	[Cai, Qingqing; Chen, Kailin; Huang, Huiqiang; Lin, Tongyu; Jiang, Wenqi; Yao, Mengfei; Hu, Liyang] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Chen, Kailin; Duan, Huaxin] Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Oncol, Changsha, Hunan, Peoples R China; [Chen, Jie] Guangdong Prov Key Lab Arrhythmia & Electrophysio, Guangzhou, Guangdong, Peoples R China; [Chen, Jie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China; [Wu, Shaoxu] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Geng, Qirong; Xia, Zhongjun] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Hematol, Canc Ctr,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Rao, Huilan] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Pathol, Canc Ctr,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Hunan Normal University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Cai, QQ (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	caiqq@sysucc.org.cn	jiang, wen/GYI-9662-2022		National Natural Science Foundation of China [81672686, 81372883, 81001052]; Natural Science Foundation of Guangdong Province, China [2015A030313020]; Science and Technology Planning Project of Guangdong Province, China [2011B031800222]; Young Talents Project of Sun Yat-sen University Cancer Center; Young Talents Key Project of Sun Yat-sen University [2015ykzd13]; Sister Institution Network Fund of MD Anderson Cancer Center	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province, China; Young Talents Project of Sun Yat-sen University Cancer Center; Young Talents Key Project of Sun Yat-sen University; Sister Institution Network Fund of MD Anderson Cancer Center	The work was supported by National Natural Science Foundation of China (NO. 81672686, NO. 81372883, NO. 81001052), Natural Science Foundation of Guangdong Province, China (2015A030313020), Science and Technology Planning Project of Guangdong Province, China (2011B031800222), Young Talents Project of Sun Yat-sen University Cancer Center (to Qingqing Cai), Young Talents Key Project of Sun Yat-sen University (2015ykzd13, to Qingqing Cai), and Sister Institution Network Fund of MD Anderson Cancer Center (to Qingqing Cai; Huilan Rao).	An P, 2012, HEPATO-GASTROENTEROL, V59, P228, DOI 10.5754/hge11247; Cai Q, GLOB AC PROGR GAP 20; CAPPEL R, 1977, J INFECT DIS, V136, P617, DOI 10.1093/infdis/136.5.617; Chen EQ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-163; Chinese Society of Hematology CMA Committee of Malignant Lymphoma Chinese Anti-cancer Association Chinese Society of Hepatology CMA, 2013, Zhonghua Xue Ye Xue Za Zhi, V34, P988, DOI 10.3760/cma.j.issn.0253-2727.2013.11.019; COX DR, 1972, J R STAT SOC B, V34, P187; Dando TM, 2003, DRUGS, V63, P2215, DOI 10.2165/00003495-200363200-00007; Evens AM, 2011, ANN ONCOL, V22, P1170, DOI 10.1093/annonc/mdq583; Ghany MG, 2012, ALIMENT PHARM THER, V35, P1027, DOI 10.1111/j.1365-2036.2012.05059.x; Ghany MG, 2009, HEPATOLOGY, V49, pS174, DOI 10.1002/hep.22900; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Ho EY, 2015, HEPATOL INT, V9, P224, DOI 10.1007/s12072-015-9612-6; Huang H, 2014, JAMA-J AM MED ASSOC, V312, P2521, DOI 10.1001/jama.2014.15704; Ikeda M, 2013, JPN J CLIN ONCOL, V43, P8, DOI 10.1093/jjco/hys191; Kim SJ, 2013, EUR J CANCER, V49, P3486, DOI 10.1016/j.ejca.2013.07.006; Lai CL, 2003, CLIN INFECT DIS, V36, P687, DOI 10.1086/368083; Lampertico PF, 2007, GASTROENTEROLOGY, V133, P1445, DOI 10.1053/j.gastro.2007.08.079; Lau GKK, 2002, BLOOD, V99, P2324, DOI 10.1182/blood.V99.7.2324; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Li HR, 2011, J VIRAL HEPATITIS, V18, P877, DOI 10.1111/j.1365-2893.2010.01386.x; Liu F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-59; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; Lv GC, 2013, WORLD J GASTROENTERO, V19, P3481, DOI 10.3748/wjg.v19.i22.3481; Marcellin P, 2008, HEPATOLOGY, V48, P750, DOI 10.1002/hep.22414; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Pei SN, 2010, ANN HEMATOL, V89, P255, DOI 10.1007/s00277-009-0806-7; Qiu LP, 2014, FUND CLIN PHARMACOL, V28, P364, DOI 10.1111/fcp.12053; Rapti I, 2007, HEPATOLOGY, V45, P307, DOI 10.1002/hep.21534; Sarrecchia Cesare, 2005, Journal of Infection and Chemotherapy, V11, P189, DOI 10.1007/s10156-005-0385-z; SHIH LN, 1990, J MED VIROL, V32, P257, DOI 10.1002/jmv.1890320412; Sorrell MF, 2009, HEPATOLOGY, V49, pS4, DOI 10.1002/hep.22946; Sung JJY, 2008, J HEPATOL, V48, P728, DOI 10.1016/j.jhep.2007.12.026; Tan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032789; Tsutsumi Yutaka, 2005, Expert Opin Drug Saf, V4, P599, DOI 10.1517/14740338.4.3.599; Wang F, 2012, EUR J CANCER PREV, V21, P261, DOI 10.1097/CEJ.0b013e3283498e87; Yatsuji H, 2008, J HEPATOL, V48, P923, DOI 10.1016/j.jhep.2008.02.019; Yeo W, 2004, J CLIN ONCOL, V22, P927, DOI 10.1200/JCO.2004.05.161; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699	39	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164210	10.1371/journal.pone.0164210	http://dx.doi.org/10.1371/journal.pone.0164210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711135	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600097
J	Ferdous, F; Saski, C; Bridges, W; Burns, M; Dunn, H; Elliott, K; Scott, TR				Ferdous, Farzana; Saski, Christopher; Bridges, William; Burns, Matthew; Dunn, Heather; Elliott, Kathryn; Scott, Thomas R.			Transcriptome Profile of the Chicken Thrombocyte: New Implications as an Advanced Immune Effector Cell	PLOS ONE			English	Article							RECEPTOR EXPRESSION; REGULATOR; PLATELETS; LIPOPOLYSACCHARIDE; HEMOSTASIS; MECHANISMS; BACTERIAL; ACCURATE; SEQUENCE; INNATE	Thrombocytes are nucleated platelets involved in immune functions such as pathogen recognition and release of pro-inflammatory bioactive compounds when exposed to bacterial and viral molecules. However, the complete role of these cells in innate and adaptive immune responses is not understood, and little is known about their biology at the molecular-genetic level. Highly sensitive RNA-sequencing technologies were used to analyze the complete transcriptome of thrombocytes for the first time with analytical resolution focused on cell-based components of the immune system/response. Amongst all the genes listed in the current chicken genome assembly, 10,041 gene transcripts were found in the chicken thrombocyte. After 1-hour in vitro stimulation with lipopolysaccharide (LPS, Salmonella minnesota), 490 genes were upregulated and 359 genes were downregulated, respectively, with at least a 1-fold change relative to unexposed thrombocytes. Additionally, by constructing a de novo assembly, we were able to identify a total of 3,030 novel genes in the thrombocyte transcriptome. The information generated here is useful in development of novel solutions to lower the economic burden and zoonotic threat that accompanies infectious diseases for birds and fish. In addition, the resources created here have translational utility as a model system to find orthologous genes and genes related to its enucleated counterpart, the platelet.	[Ferdous, Farzana; Dunn, Heather; Elliott, Kathryn; Scott, Thomas R.] Clemson Univ, Dept Anim & Vet Sci, Clemson, SC 29634 USA; [Saski, Christopher] Clemson Univ, Genom Inst, Clemson, SC USA; [Bridges, William] Clemson Univ, Dept Math Sci, Clemson, SC USA; [Burns, Matthew] Clemson Univ, Clemson Cooperat Extens, Clemson, SC USA	Clemson University; Clemson University; Clemson University; Clemson University	Scott, TR (corresponding author), Clemson Univ, Dept Anim & Vet Sci, Clemson, SC 29634 USA.	trscott@clemson.edu						ArrayExpress, 2013, EMTAB 2996 RNA SEQ C; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202; Biswas A, 2012, J IMMUNOL, V189, P516, DOI 10.4049/jimmunol.1200064; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brownlie R, 2011, CELL TISSUE RES, V343, P121, DOI 10.1007/s00441-010-1026-0; Cognasse F, 2005, IMMUNOL CELL BIOL, V83, P196, DOI 10.1111/j.1440-1711.2005.01314.x; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Duerschmied D, 2014, THROMB HAEMOSTASIS, V112, P678, DOI 10.1160/TH14-02-0146; Elzey BD, 2005, CELL IMMUNOL, V238, P1, DOI 10.1016/j.cellimm.2005.12.005; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Elzey BD, 2008, BLOOD, V111, P3684, DOI 10.1182/blood-2007-05-091728; Elzey BD, 2011, THROMB RES, V127, P180, DOI 10.1016/j.thromres.2010.10.011; Ferdous F, 2008, POULTRY SCI, V87, P61, DOI 10.3382/ps.2007-00356; Ferdous F, 2015, IMMUNOL LETT, V163, P32, DOI 10.1016/j.imlet.2014.11.010; Ferdous F, 2015, DEV COMP IMMUNOL, V49, P225, DOI 10.1016/j.dci.2014.11.019; Ferdous F, 2014, AVIAN THROMBOCYTE IS; Garraud Olivier, 2010, Inflammation & Allergy Drug Targets, V9, P322; George JN, 2000, LANCET, V355, P1531, DOI 10.1016/S0140-6736(00)02175-9; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hirano T, 1998, Int Rev Immunol, V16, P249; Jagadeeswaran P, 1999, METHOD CELL BIOL, V59, P337; Jagadeeswaran P, 1999, BRIT J HAEMATOL, V107, P731, DOI 10.1046/j.1365-2141.1999.01763.x; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lam FW, 2015, PLATELETS THEIR INTE; Levin J, 2007, PLATELETS, 2ND EDITION, P3, DOI 10.1016/B978-012369367-9/50763-1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Motta V, 2015, PHYSIOL REV, V95, P149, DOI 10.1152/physrev.00009.2014; Nagasawa T, 2015, FRONT IMMUNOL, V6, DOI [10.3389/fimmu.2015.00301, 10.3389/fimmu.2014.00445]; Neerincx A, 2010, J BIOL CHEM, V285, P26223, DOI 10.1074/jbc.M110.109736; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; SCHNEIDER W, 1994, EUR J CLIN INVEST, V24, P16, DOI 10.1111/j.1365-2362.1994.tb02420.x; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Scott T, 2008, MOL IMMUNOL, V45, P1001, DOI 10.1016/j.molimm.2007.07.035; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Shiraki R, 2004, THROMB RES, V113, P379, DOI 10.1016/j.thromres.2004.03.023; St Paul M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043381; Tregaskes CA, 2005, DEV COMP IMMUNOL, V29, P361, DOI 10.1016/j.dci.2004.09.001; Vieira-de-Abreu A, 2012, SEMIN IMMUNOPATHOL, V34, P5, DOI 10.1007/s00281-011-0286-4; Ware J, 2013, CURR OPIN HEMATOL, V20, P451, DOI 10.1097/MOH.0b013e32836344d3; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; White GC, 2000, BLOOD COAGUL FIBRIN, V11, pS53, DOI 10.1097/00001721-200004001-00012; Yeaman MR, 2010, FUTURE MICROBIOL, V5, P471, DOI 10.2217/FMB.09.112; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010	54	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163890	10.1371/journal.pone.0163890	http://dx.doi.org/10.1371/journal.pone.0163890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711235	gold, Green Published			2022-12-27	WOS:000385697600046
J	Sousa, LMMD; Mendes, GP; Campos, DB; Baruselli, PS; Papa, PD				Medeiros de Carvalho Sousa, Liza Margareth; Mendes, Gabriela Pacheco; Campos, Danila Barreiro; Baruselli, Pietro Sampaio; Papa, Paula de Carvalho			Equine Chorionic Gonadotropin Modulates the Expression of Genes Related to the Structure and Function of the Bovine Corpus Luteum	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; MESSENGER-RNA EXPRESSION; PLASMINOGEN-ACTIVATOR EXPRESSION; A PAPP-A; NITRIC-OXIDE; FACTOR-I; FOLLICULAR DEVELOPMENT; ESTROUS-CYCLE; MATRIX METALLOPROTEINASES	We hypothesized that stimulatory and superovulatory treatments, using equine chorionic gonadotropin (eCG), modulate the expression of genes related to insulin, cellular modelling and angiogenesis signaling pathways in the bovine corpus luteum (CL). Therefore, we investigated: 1-the effect of these treatments on circulating insulin and somatomedin C concentrations and on gene and protein expression of INSR, IGF1 and IGFR1, as well as other insulin signaling molecules; 2-the effects of eCG on gene and protein expression of INSR, IGF1, GLUT4 and NFKB1A in bovine luteal cells; and 3-the effect of stimulatory and superovulatory treatments on gene and protein expression of ANG, ANGPT1, NOS2, ADM, PRSS2, MMP9 and PLAU. Serum insulin did not differ among groups (P = 0.96). However, serum somatomedin C levels were higher in both stimulated and superovulated groups compared to the control (P = 0.01). In stimulated cows, lower expression of INSR mRNA and higher expression of NFKB1A mRNA and IGF1 protein were observed. In superovulated cows, lower INSR mRNA expression, but higher INSR protein expression and higher IGF1, IGFR1 and NFKB1A gene and protein expression were observed. Expression of angiogenesis and cellular modelling pathway-related factors were as follows: ANGPT1 and PLAU protein expression were higher and MMP9 gene and protein expression were lower in stimulated animals. In superovulated cows, ANGPT1 mRNA expression was higher and ANG mRNA expression was lower. PRSS2 gene and protein expression were lower in both stimulated and superovulated animals related to the control. In vitro, eCG stimulated luteal cells P4 production as well as INSR and GLUT4 protein expression. In summary, our results suggest that superovulatory treatment induced ovarian proliferative changes accompanied by increased expression of genes providing the CL more energy substrate, whereas stimulatory treatment increased lipogenic activity, angiogenesis and plasticity of the extracellular matrix (ECM).	[Medeiros de Carvalho Sousa, Liza Margareth; Mendes, Gabriela Pacheco; Papa, Paula de Carvalho] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo, SP, Brazil; [Campos, Danila Barreiro] Univ Fed Paraiba, Fac Vet Med, Dept Vet Sci, Areia, Paraiba, Brazil; [Baruselli, Pietro Sampaio] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Anim Reprod, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade Federal da Paraiba; Universidade de Sao Paulo	Sousa, LMMD (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo, SP, Brazil.	lizamgth@usp.br	Baruselli, Pietro Sampaio/C-7600-2012; Campos, Danila B/F-6602-2014; Carvalho, Liza/AAS-1880-2021; Barreiro Campos, Danila/V-4179-2017	Baruselli, Pietro Sampaio/0000-0002-6773-4450; Carvalho, Liza/0000-0003-0595-4674; Papa, Paula/0000-0002-3265-3271; Barreiro Campos, Danila/0000-0003-1426-4392	FAPESP [2013/09781-5]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by FAPESP (grant 2013/09781-5).	Abe K, 1998, ENDOCRINOLOGY, V139, P5263, DOI 10.1210/en.139.12.5263; Abe K, 2000, FERTIL STERIL, V74, P141, DOI 10.1016/S0015-0282(00)00585-9; ADASHI EY, 1992, GROWTH REGULAT, V2, P10; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; AZMI TI, 1984, LAB INVEST, V51, P206; Bach LA, 2015, J MOL ENDOCRINOL, V54, pR1, DOI 10.1530/JME-14-0215; BACHARACH E, 1992, P NATL ACAD SCI USA, V89, P10686, DOI 10.1073/pnas.89.22.10686; Baruselli PS, 2012, REPROD DOMEST ANIM, V47, P134, DOI 10.1111/j.1439-0531.2012.02067.x; Baruselli PS, 2004, ANIM REPROD SCI, V82-3, P479, DOI 10.1016/j.anireprosci.2004.04.025; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Bhartiya D, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-32; Bo GA, 2014, ANIMAL, V8, P144, DOI 10.1017/S1751731114000822; Bo GA, 2002, THERIOGENOLOGY, V57, P53, DOI 10.1016/S0093-691X(01)00657-4; Boldt HB, 2007, GROWTH HORM IGF RES, V17, P10, DOI 10.1016/j.ghir.2006.11.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brito AB, 2013, REPROD SCI, V20, P990, DOI 10.1177/1933719112472737; Cao MJ, 2006, MATRIX BIOL, V25, P342, DOI 10.1016/j.matbio.2006.05.005; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chouhan VS, 2014, THERIOGENOLOGY, V82, P1212, DOI 10.1016/j.theriogenology.2014.07.040; Cornish J, 2004, BIOCHEM BIOPH RES CO, V318, P240, DOI 10.1016/j.bbrc.2004.04.020; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Dalle S, 2001, J BIOL CHEM, V276, P15688, DOI 10.1074/jbc.M010884200; Diskin MG, 2003, ANIM REPROD SCI, V78, P345, DOI 10.1016/S0378-4320(03)00099-X; Dupont Joelle, 2003, Birth Defects Research, V69, P257, DOI 10.1002/bdrc.10022; Fatima LA, 2012, ANIMAL REPROD, V9, P7; Fatima LA, 2013, REPROD FERT DEVELOP, V25, P998, DOI [10.1071/RD12155, 10.1071]; Fortune JE, 2000, MOL CELL ENDOCRINOL, V163, P53, DOI 10.1016/S0303-7207(99)00240-3; Fukai N, 2003, ENDOCRINOLOGY, V144, P447, DOI 10.1210/en.2002-220463; Gao XW, 2008, ACTA BIOCH BIOPH SIN, V40, P619, DOI 10.1111/j.1745-7270.2008.00442.x; Gupta PSP, 2002, THERIOGENOLOGY, V57, P1839, DOI 10.1016/S0093-691X(02)00694-5; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hirata Y, 1996, J CLIN ENDOCR METAB, V81, P1449, DOI 10.1210/jc.81.4.1449; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; HORIO T, 1995, CIRC RES, V77, P660, DOI 10.1161/01.RES.77.4.660; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Hurliman AK, 2010, FERTIL STERIL, V93, P1493, DOI 10.1016/j.fertnstert.2009.04.036; ICHIKI Y, 1994, FEBS LETT, V338, P6, DOI 10.1016/0014-5793(94)80106-1; IRELAND JJ, 1980, J DAIRY SCI, V63, P155, DOI 10.3168/jds.S0022-0302(80)82901-8; Iwasaki H, 1998, ENDOCRINOLOGY, V139, P3432, DOI 10.1210/en.139.8.3432; Kato H, 1997, ENDOCRINOLOGY, V138, P2615, DOI 10.1210/en.138.6.2615; Kim W, 2003, FASEB J, V17, P1937, DOI 10.1096/fj.02-1209fje; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Kitamura K, 2001, PEPTIDES, V22, P1713, DOI 10.1016/S0196-9781(01)00529-0; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Kliem H, 2007, REPRODUCTION, V134, P535, DOI 10.1530/REP-06-0172; Kwintkiewicz J, 2009, SEMIN REPROD MED, V27, P43, DOI 10.1055/s-0028-1108009; La Paz MN, 2007, PESQUI VET BRASIL, V27, P6; Lee HS, 1999, BIOCHEM BIOPH RES CO, V257, P182, DOI 10.1006/bbrc.1999.0359; Li YY, 2008, BIOL REPROD, V79, P200, DOI 10.1095/biolreprod.107.064022; Liu K, 1997, MOL CELL ENDOCRINOL, V133, P109, DOI 10.1016/S0303-7207(97)00152-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazerbourg S, 2001, ENDOCRINOLOGY, V142, P5243, DOI 10.1210/en.142.12.5243; Miyabayashi K, 2005, J EXP ZOOL PART A, V303A, P590, DOI 10.1002/jez.a.188; Pinto JME, 2014, REPROD DOMEST ANIM, V49, P453, DOI 10.1111/rda.12307; MONCADA S, 1991, EUR J CLIN INVEST, V21, P361, DOI 10.1111/j.1365-2362.1991.tb01383.x; Moriyama T, 2000, EUR J ENDOCRINOL, V142, P671, DOI 10.1530/eje.0.1420671; Nishimatsu H, 2001, CIRC RES, V89, P63, DOI 10.1161/hh1301.092498; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Nussdorfer GG, 1997, PEPTIDES, V18, P1079, DOI 10.1016/S0196-9781(97)00046-6; Nyegaard M, 2010, BIOL REPROD, V82, P1129, DOI 10.1095/biolreprod.109.079517; Papa PD, 2014, REPRODUCTION, V147, P81, DOI 10.1530/REP-13-0398; Plesner T, 1997, STEM CELLS, V15, P398, DOI 10.1002/stem.150398; Poretsky L, 1999, ENDOCR REV, V20, P535, DOI 10.1210/er.20.4.535; Quirk S M, 2004, J Anim Sci, V82 E-Suppl, pE40; Rekawiecki R, 2005, PROSTAG OTH LIPID M, V78, P169, DOI 10.1016/j.prostaglandins.2005.06.009; Reynolds Lawrence P., 1994, Progress in Growth Factor Research, V5, P159, DOI 10.1016/0955-2235(94)90003-5; REYNOLDS LP, 1992, FASEB J, V6, P886, DOI 10.1096/fasebj.6.3.1371260; Ribeiro LA, 2005, ANGIOGENESIS ANGIORE; RICHARDS RG, 1994, J REPROD FERTIL, V102, P27, DOI 10.1530/jrf.0.1020027; Rigoglio NN, 2013, THERIOGENOLOGY, V79, P673, DOI 10.1016/j.theriogenology.2012.11.023; Sa MF, 2010, THERIOGENOLOGY, V73, P651, DOI 10.1016/j.theriogenology.2009.11.004; Sa MF, 2010, ANIM REPROD SCI, V118, P182, DOI 10.1016/j.anireprosci.2009.10.004; Sales JNS, 2011, ANIM REPROD SCI, V124, P12, DOI 10.1016/j.anireprosci.2011.02.007; Schams D, 2004, REPROD DOMEST ANIM, V39, P241, DOI 10.1111/j.1439-0531.2004.00509.x; SESSA WC, 1994, J VASC RES, V31, P131, DOI 10.1159/000159039; Sheng JH, 2014, J CELL PHYSIOL, V229, P521, DOI 10.1002/jcp.24477; Shichiri M, 1999, MOL ENDOCRINOL, V13, P1353, DOI 10.1210/me.13.8.1353; Shichiri M, 2003, REGUL PEPTIDES, V112, P167, DOI 10.1016/S0167-0115(03)00036-3; SHIMEKAKE Y, 1995, J BIOL CHEM, V270, P4412, DOI 10.1074/jbc.270.9.4412; Skarzynski DJ, 2003, BIOL REPROD, V68, P1674, DOI 10.1095/biolreprod.102.008573; Slomiany MG, 2006, J PHARMACOL EXP THER, V318, P666, DOI 10.1124/jpet.106.104158; Stearns M, 2005, CANCER RES, V65, P2085, DOI 10.1158/0008-5472.CAN-04-4100; SUGO S, 1995, BIOCHEM BIOPH RES CO, V207, P25, DOI 10.1006/bbrc.1995.1148; Tanaka J, 2004, J REPROD DEVELOP, V50, P619, DOI 10.1262/jrd.50.619; TSUKAHARA H, 1994, KIDNEY INT, V45, P598, DOI 10.1038/ki.1994.78; Upton PD, 1997, ENDOCRINOLOGY, V138, P2508, DOI 10.1210/en.138.6.2508; van den Hurk R, 1998, HUM REPROD UPDATE, V4, P833, DOI 10.1093/humupd/4.6.833; VASSALLI JD, 1994, NATURE, V370, P14, DOI 10.1038/370014a0; Wali JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037899; Warren RS, 1996, J BIOL CHEM, V271, P29483, DOI 10.1074/jbc.271.46.29483; Webb R, 2002, DOMEST ANIM ENDOCRIN, V23, P277, DOI 10.1016/S0739-7240(02)00163-7; Wildman E., 1982, J DAIRY SCI, V65, P6, DOI 10.3168/jds.S0022-0302(82)82223-6; Wong BST, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103903; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Young KA, 2004, BIOL REPROD, V70, P244, DOI 10.1095/biolreprod.103.022053; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871	96	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164089	10.1371/journal.pone.0164089	http://dx.doi.org/10.1371/journal.pone.0164089			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711194	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600075
J	Niedrig, DF; Hoppe, L; Machler, S; Russmann, H; Russmann, S				Niedrig, David Franklin; Hoppe, Liesa; Machler, Sarah; Russmann, Heike; Russmann, Stefan			Benzodiazepine Use During Hospitalization: Automated Identification of Potential Medication Errors and Systematic Assessment of Preventable Adverse Events	PLOS ONE			English	Article							DRUG-INTERACTIONS; RISK; PHARMACOKINETICS; PHARMACODYNAMICS; MIDAZOLAM; PRESCRIPTIONS; FLUNITRAZEPAM; ITRACONAZOLE; POPULATION; INHIBITION	Objective Benzodiazepines and "Z-drug" GABA-receptor modulators (BDZ) are among the most frequently used drugs in hospitals. Adverse drug events (ADE) associated with BDZ can be the result of preventable medication errors (ME) related to dosing, drug interactions and comorbidities. The present study evaluated inpatient use of BDZ and related ME and ADE. Methods We conducted an observational study within a pharmacoepidemiological database derived from the clinical information system of a tertiary care hospital. We developed algorithms that identified dosing errors and interacting comedication for all administered BDZ. Associated ADE and risk factors were validated in medical records. Results Among 53,081 patients contributing 495,813 patient-days BDZ were administered to 25,626 patients (48.3%) on 115,150 patient-days (23.2%). We identified 3,372 patient-days (2.9%) with comedication that inhibits BDZ metabolism, and 1,197 (1.0%) with lorazepam administration in severe renal impairment. After validation we classified 134, 56, 12, and 3 cases involving lorazepam, zolpidem, midazolam and triazolam, respectively, as clinically relevant ME. Among those there were 23 cases with associated adverse drug events, including severe CNS-depression, falls with subsequent injuries and severe dyspnea. Causality for BDZ was formally assessed as 'possible' or 'probable' in 20 of those cases. Four cases with ME and associated severe ADE required administration of the BDZ antagonist flumazenil. Conclusions BDZ use was remarkably high in the studied setting, frequently involved potential ME related to dosing, co-medication and comorbidities, and rarely cases with associated ADE. We propose the implementation of automated ME screening and validation for the prevention of BDZ-related ADE.	[Niedrig, David Franklin; Hoppe, Liesa; Russmann, Stefan] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, Zurich Zh, Switzerland; [Niedrig, David Franklin; Russmann, Stefan] ETHZ, Swiss Fed Inst Technol Zurich, Zurich, ZH, Switzerland; [Machler, Sarah; Russmann, Stefan] Drugsafety Ch, Kusnacht Zh, Switzerland; [Russmann, Heike] Neurol See, Kusnacht Zh, Switzerland	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich	Russmann, S (corresponding author), Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, Zurich Zh, Switzerland.; Russmann, S (corresponding author), ETHZ, Swiss Fed Inst Technol Zurich, Zurich, ZH, Switzerland.; Russmann, S (corresponding author), Drugsafety Ch, Kusnacht Zh, Switzerland.	rustefan@ethz.ch			Swiss National Science Foundation [320030_143867]; ID Suisse AG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ID Suisse AG	This work was supported by Swiss National Science Foundation, grant #320030_143867 to Stefan Russmann, and an unrestricted research grant from ID Suisse AG to Stefan Russmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura AC, 2013, EXPERT OPIN DRUG MET, V9, P423, DOI 10.1517/17425255.2013.759209; [Anonymous], 2015, GOOD PRACTICE GUIDE, pPP. 9; Backman JT, 1998, EUR J CLIN PHARMACOL, V54, P53, DOI 10.1007/s002280050420; BAILEY PL, 1990, ANESTHESIOLOGY, V73, P826, DOI 10.1097/00000542-199011000-00005; Bramness JG, 2006, FORENSIC SCI INT, V159, P83, DOI 10.1016/j.forsciint.2005.06.009; Brunero S, 2016, INT PSYCHOGERIATR, V28, P967, DOI 10.1017/S104161021500232X; Carli-Ghabarou D, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13894; Chen SJ, 2015, SLEEP, V38, P1045, DOI 10.5665/sleep.4808; Dionne PA, 2013, PSYCHIAT SERV, V64, P331, DOI 10.1176/appi.ps.201200089; Donoghue J, 2010, INT J PSYCHIAT CLIN, V14, P78, DOI 10.3109/13651500903447810; Ekstrom MP, 2014, BMJ-BRIT MED J, V348, pg445, DOI DOI 10.1136/BMJ.G445; Fritz D, 2012, EUR J CLIN PHARMACOL, V68, P1209, DOI 10.1007/s00228-012-1241-6; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Greenblatt DJ, 2004, CLIN PHARMACOL THER, V76, P467, DOI 10.1016/j.clpt.2004.07.009; Gudin JA, 2013, POSTGRAD MED, V125, P115, DOI 10.3810/pgm.2013.07.2684; Gustavsen I, 2008, SLEEP MED, V9, P818, DOI 10.1016/j.sleep.2007.11.011; Holt S, 2010, DTSCH ARZTEBL INT, V107, P543, DOI 10.3238/arztebl.2010.0543; Huerta C, 2016, PHARMACOEPIDEM DR S, V25, P56, DOI 10.1002/pds.3825; Kamel Amin, 2013, Drug Discov Today Technol, V10, pe177, DOI 10.1016/j.ddtec.2012.09.011; Kawano Daniel Fabio, 2009, J Patient Saf, V5, P69, DOI 10.1097/PTS.0b013e3181a5dafa; Khawaja Muhammad Rizwamillah, 2005, JPMA Journal of the Pakistan Medical Association, V55, P259; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Lader M, 2011, ADDICTION, V106, P2086, DOI 10.1111/j.1360-0443.2011.03563.x; Lagnaoui R, 2001, PHARMACOEPIDEM DR S, V10, P531, DOI 10.1002/pds.621; Lin FY, 2014, SLEEP, V37, P673, DOI 10.5665/sleep.3566; Nakafero G, 2015, PHARMACOEPIDEM DR S, V24, P793, DOI 10.1002/pds.3799; Niedrig DF, 2016, INT CLIN PSYCHOPHARM, V31, P42, DOI 10.1097/YIC.0000000000000103; Onder G, 2012, J GERONTOL A-BIOL, V67, P698, DOI 10.1093/gerona/glr233; Petitjean S, 2007, INT CLIN PSYCHOPHARM, V22, P292, DOI 10.1097/YIC.0b013e328105e0f2; Popovic B, 2014, EUR J CLIN PHARMACOL, V70, P737, DOI 10.1007/s00228-014-1667-0; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Requena G, 2016, PHARMACOEPIDEM DR S, V25, P66, DOI 10.1002/pds.3816; Robin Christian, 2002, Anesth Prog, V49, P128; Saari TI, 2006, CLIN PHARMACOL THER, V79, P362, DOI 10.1016/j.clpt.2005.12.305; SALVA P, 1995, CLIN PHARMACOKINET, V29, P142, DOI 10.2165/00003088-199529030-00002; Starcevic V, 2014, EXPERT REV NEUROTHER, V14, P1275, DOI 10.1586/14737175.2014.963057; Tae CH, 2014, DIGEST LIVER DIS, V46, P710, DOI 10.1016/j.dld.2014.04.007; Taegtmeyer AB, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13615; Tapper EB, 2015, CLIN GASTROENTEROL H, V13, P1670, DOI 10.1016/j.cgh.2015.03.019; Templeton I, 2010, CLIN PHARMACOL THER, V88, P499, DOI 10.1038/clpt.2010.119; VERBEECK RK, 1981, BRIT J CLIN PHARMACO, V12, P749, DOI 10.1111/j.1365-2125.1981.tb01300.x; Vozoris NT, 2014, EUR RESPIR J, V44, P332, DOI 10.1183/09031936.00008014; Webster LR, 2015, POSTGRAD MED, V127, P27, DOI 10.1080/00325481.2015.993276; Zhou SF, 2007, THER DRUG MONIT, V29, P687, DOI 10.1097/FTD.0b013e31815c16f5; Zint K, 2010, PHARMACOEPIDEM DR S, V19, P1248, DOI 10.1002/pds.2031	45	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163224	10.1371/journal.pone.0163224	http://dx.doi.org/10.1371/journal.pone.0163224			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711224	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000385697600017
J	Carchman, EH; Matkowskyj, KA; Meske, L; Lambert, PF				Carchman, Evie H.; Matkowskyj, Kristina A.; Meske, Louise; Lambert, Paul F.			Dysregulation of Autophagy Contributes to Anal Carcinogenesis	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 E6; E7 ONCOGENE; CARCINOMA; CANCER; MICE; ONCOPROTEINS; SENESCENCE; INFECTION; REVEALS; CELLS	Introduction Autophagy is an intracellular catabolic process that removes and recycles unnecessary/dysfunctional cellular components, contributing to cellular health and survival. Autophagy is a highly regulated cellular process that responds to several intracellular signals, many of which are deregulated by human papillomavirus (HPV) infection through the expression of HPV-encoded oncoproteins. This adaptive inhibitory response helps prevent viral clearance. A strong correlation remains between HPV infection and the development of squamous cell carcinoma (SCC) of the anus, particularly in HIV positive and other immunosuppressed patients. We hypothesize that autophagy is inhibited by HPV-encoded oncoproteins thereby promoting anal carcinogenesis (Fig 1). Materials and Methods HPV16 transgenic mice (K14E6/E7) and non-transgenic mice (FVB/N), both of which do not spontaneously develop anal tumors, were treated topically with the chemical carcinogen, 7,12-Dimethylbenz[a]anthracene (DMBA), to induce anal cancer. The anuses at different time points of treatment (5, 10, 15 and 20 weeks) were analyzed using immunofluorescence (IF) for two key autophagy marker proteins (LC3 beta and p62) in addition to histological grading. The anuses from the K14E6/E7 mice were also analyzed for visual evidence of autophagic activity by electron microscopy (EM). To see if there was a correlation to humans, archival anal specimens were assessed histologically for grade of dysplasia and then analyzed for LC3 beta and p62 protein content. To more directly examine the effect of autophagic inhibition on anal carcinogenesis, nontransgenic mice that do not develop anal cancer with DMBA treatment were treated with a known pharmacologic inhibitor of autophagy, chloroquine, and examined for tumor development and analyzed by IF for autophagic proteins. Results Histologically, we observed the progression of normal anoderm to invasive SCC with DMBA treatment in K14E6/E7 mice but not in nontransgenic, syngeneic FVB/N background control mice. With the development of low-grade dysplasia in the K14E6/E7 mice, there was an increase in both punctate LC3 beta and p62 expression while EM revealed increased autophagosomes without evidence of autophagolysosomes. These observations are consistent with autophagy being inhibited at a later stage in the autophagic process. In contrast, in high-grade dysplasia and SCC in the DMBA-treated K14E6/E7 mice, there were decreased levels of p62 with a continued increase in punctate LC3 beta expression by IF, while autophagolysosomes were seen on EM, consistent with the process of autophagy proceeded to completion. Similar findings, including histological grade dependent changes in LC3 beta and p62 expression, were noted with human samples upon analysis of IF. Finally, with pharmacologic inhibition of autophagy in DMBA-treated, nontrangenic FVB/N mice, there was a significant increase in anal cancer development similar to that observed in DMBA-treated K14E6/E7 mice. Conclusion Autophagic dysregulation is noted early on in HPV-associated anal carcinogenesis (low-grade dysplasia), with normalization of the autophagic process arising in late stages of HPV-associated anal carcinogenesis (high-grade dysplasia and invasive carcinoma).	[Carchman, Evie H.; Meske, Louise] Univ Wisconsin, Dept Surg, Madison, WI 53792 USA; [Matkowskyj, Kristina A.] Univ Wisconsin, Dept Pathol & Lab, Madison, WI USA; [Lambert, Paul F.] Univ Wisconsin, Dept Oncol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Carchman, EH (corresponding author), Univ Wisconsin, Dept Surg, Madison, WI 53792 USA.	carchman@surgery.wisc.edu			Society for Surgery of the Alimentary Tract [PRJ96MZ]; Department of General Surgery [PRJ91NA]; Central Surgical Association [AAA1353]; NIH [CM 71873]; NATIONAL CANCER INSTITUTE [R01CA171873] Funding Source: NIH RePORTER	Society for Surgery of the Alimentary Tract; Department of General Surgery; Central Surgical Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Society for Surgery of the Alimentary Tract: PRJ96MZ (EC) Department of General Surgery: PRJ91NA (EC) Central Surgical Association: AAA1353 (EC) NIH CM 71873 (PFL).	[Anonymous], 2015, SEER CANC STAT FACTS; Baricevic I, 2015, EUR J CANCER, V51, P776, DOI 10.1016/j.ejca.2015.01.058; Chung JH, 2016, ANN ONCOL, V27, P1336, DOI 10.1093/annonc/mdw152; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P10978, DOI 10.1073/pnas.97.20.10978; Griffin LM, 2013, VIROLOGY, V437, P12, DOI 10.1016/j.virol.2012.12.004; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; HWANG ES, 1993, J VIROL, V67, P3720, DOI 10.1128/JVI.67.7.3720-3729.1993; Jabbar S, 2010, VIROLOGY, V407, P60, DOI 10.1016/j.virol.2010.08.003; Jabbar SF, 2009, CANCER RES, V69, P4407, DOI 10.1158/0008-5472.CAN-09-0023; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li XL, 2015, INT J CLIN EXP MED, V8, P10304; Lu ZM, 2004, J BIOL CHEM, V279, P35664, DOI 10.1074/jbc.M403385200; Mack Hildegard I D, 2012, Cells, V1, P204, DOI 10.3390/cells1030204; Mileo AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007254; Song S, 2000, VIROLOGY, V267, P141, DOI 10.1006/viro.1999.0106; Spangle JM, 2010, J VIROL, V84, P9398, DOI 10.1128/JVI.00974-10; Stelzer MK, 2010, CANCER PREV RES, V3, P1534, DOI 10.1158/1940-6207.CAPR-10-0086; Subbaramaiah K, 2007, CANCER RES, V67, P3976, DOI 10.1158/0008-5472.CAN-06-4273; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; White E, 2015, CLIN CANCER RES, V21, P5037, DOI 10.1158/1078-0432.CCR-15-0490; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Yan MM, 2015, ONCOL LETT, V10, P1959, DOI 10.3892/ol.2015.3508	23	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0164273	10.1371/journal.pone.0164273	http://dx.doi.org/10.1371/journal.pone.0164273			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706233	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200101
J	Loach, JC; Wang, JZ				Loach, James C.; Wang, Jinzhao			Optimizing the Learning Order of Chinese Characters Using a Novel Topological Sort Algorithm	PLOS ONE			English	Article							RADICALS	We present a novel algorithm for optimizing the order in which Chinese characters are learned, one that incorporates the benefits of learning them in order of usage frequency and in order of their hierarchal structural relationships. We show that our work outperforms previously published orders and algorithms. Our algorithm is applicable to any scheduling task where nodes have intrinsic differences in importance and must be visited in topological order.	[Loach, James C.] Shanghai Jiao Tong Univ, INPAC, Shanghai 200240, Peoples R China; Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200240, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Loach, JC (corresponding author), Shanghai Jiao Tong Univ, INPAC, Shanghai 200240, Peoples R China.	james.loach@sjtu.edu.cn	Loach, James/O-1604-2015	Loach, James/0000-0002-9273-1286	Shanghai Key Lab for Particle Physics and Cosmology (SKLPPC) [15DZ2272100]	Shanghai Key Lab for Particle Physics and Cosmology (SKLPPC)	This work was supported by the Shanghai Key Lab for Particle Physics and Cosmology (SKLPPC), Grant No. 15DZ2272100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JR, 2008, FOREIGN LANG ANN, V41, P237, DOI 10.1111/j.1944-9720.2008.tb03291.x; Burnett FH, 2015, SECRET GARDEN MANDAR; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Chiang T., 2016, NEW YORKER; DeFrancis John., 1989, VISIBLE SPEECH DIVER; Dickens C, 2016, GREAT EXP 1; Feldman LB, 1999, J MEM LANG, V40, P559, DOI 10.1006/jmla.1998.2629; Heisig JW, 2012, REMEMBERING SIMPLIFI; Heisig JW, 2008, REMEMBERING SIMPLIFI; Henson A, 2015, OUTLIER DICT; Ho CY, 2014, APPL ECON, V46, P3828, DOI 10.1080/00036846.2014.943884; Ho CSH, 1999, J CHILD PSYCHOL PSYC, V40, P393; Kane Daniel, 2006, CHINESE LANGUAGE ITS; Ke C., 2001, J CHINESE LANGUAGE T, V36, P25; Lam HC., 2011, ELECT J FOREIGN LANG, V8, P57; Lam HC, 2010, LEARNING CHINESE, P53; Lam HC, 2013, INSTR SCI, V41, P955, DOI 10.1007/s11251-013-9264-7; Li JY, 2007, PHYSICA A, V380, P629, DOI 10.1016/j.physa.2007.02.059; Light T., 1975, J CHINESE LANGUAGE T, V10, P70; Ling LM, 2012, INT J LESSON LEARN S, V1, P7, DOI [10.1108/20468251211179678, 10.1108/ijlls.2012.57901baa.002]; Marton F, 2006, J LEARN SCI, V15, P193, DOI 10.1207/s15327809jls1502_2; Marton F., 1997, LEARNING AWARENESS; Reigeluth CharlesW., 2007, ORDER LEARN SEQUENCE, P19; Richardson TW, 2007, COGNITION LEARNING T; Shen H., 2005, SYSTEM, V33, P49, DOI DOI 10.1016/J.SYSTEM.2004.11.001; *Shen H.H., 2004, LANG EDUC-UK, V18, P167, DOI [DOI 10.1080/, 10.1080/09500780408666873, DOI 10.1080/09500780408666873]; Shen HH, 2007, MOD LANG J, V91, P97, DOI 10.1111/j.1540-4781.2007.00511.x; Shu H, 1997, READ RES QUART, V32, P78, DOI 10.1598/RRQ.32.1.5; Shu H, 2003, CHILD DEV, V74, P27, DOI 10.1111/1467-8624.00519; Taft M, 1999, PSYCHOLOGIA, V42, P243; Tse SK, 2010, LEARNING CHINESE, P75; Tse SK, 2010, LEARNING CHINESE, P1; Walker Galal, 1989, J CHINESE LANGUAGE T, V24, P43; WANG AY, 1992, LANG LEARN, V42, P359, DOI 10.1111/j.1467-1770.1992.tb01340.x; Wang M, 2003, SCI STUD READ, V7, P183, DOI 10.1207/S1532799XSSR0702_4; Xu Y, 2014, MOD LANG J, V98, P773, DOI 10.1111/j.1540-4781.2014.12122.x; Yan XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069745	38	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163623	10.1371/journal.pone.0163623	http://dx.doi.org/10.1371/journal.pone.0163623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UN	27706234	Green Submitted, Green Published, gold			2022-12-27	WOS:000385697200050
J	Stewart, MJ; Wang, TF; Harding, BI; Bose, U; Wyeth, RC; Storey, KB; Cummins, SF				Stewart, Michael J.; Wang, Tianfang; Harding, Bradley I.; Bose, U.; Wyeth, Russell C.; Storey, Kenneth B.; Cummins, Scott F.			Characterisation of Reproduction-Associated Genes and Peptides in the Pest Land Snail, Theba pisana	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; EGG-LAYING HORMONE; GNRH-LIKE PEPTIDE; APGWAMIDE-RELATED PEPTIDES; CENTRAL-NERVOUS-SYSTEM; LOVE-DART; MOLECULAR-CLONING; NEUROPEPTIDES; APLYSIA; LOCALIZATION	Increased understanding of the molecular components involved in reproductionmay assist in understanding the evolutionary adaptations used by animals, including hermaphrodites, to produce offspring and retain a continuation of their lineage. In this study, we focus on the Mediterranean snail, Theba pisana, a hermaphroditic land snail that has become a highly invasive pest species within agricultural areas throughout the world. Our analysis of T. pisana CNS tissue has revealed gene transcripts encoding molluscan reproduction-associated proteins including APGWamide, gonadotropin-releasing hormone (GnRH) and an egg-laying hormone (ELH). ELH isoform 1 (ELH1) is known to be a potent reproductive peptide hormone involved in ovulation and egg-laying in some aquatic molluscs. Two other non-CNS ELH isoforms were also present in T. pisana (Tpi-ELH2 and Tpi-ELH3) within the snail dart sac and mucous glands. Bioactivity of a synthetic ELH1 on sexually mature T. pisana was confirmed through bioassay, with snails showing ELH1-induced egg-laying behaviours, including soil burrowing and oviposition. In summary, this study presents a detailed molecular analysis of reproductive neuropeptide genes in a land snail and provides a foundation for understanding ELH function.	[Stewart, Michael J.; Wang, Tianfang; Harding, Bradley I.; Bose, U.; Cummins, Scott F.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld 4558, Australia; [Wyeth, Russell C.] St Francis Xavier Univ, Antigonish, NS 5000, Canada; [Storey, Kenneth B.] Carleton Univ, Inst Biochem, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada; [Storey, Kenneth B.] Carleton Univ, Dept Biol, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada	University of the Sunshine Coast; Saint Francis Xavier University - Canada; Carleton University; Carleton University	Cummins, SF (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol Res Ctr, Maroochydore, Qld 4558, Australia.	scummins@usc.edu.au	Wang, Tianfang/L-5192-2016; Wyeth, Russell/ABE-1310-2021; Wang, Tianfang/GRO-0844-2022; Bose, Utpal/A-1785-2019; Bose, Utpal/AAU-5241-2020; Wang, Tianfang/AAG-4290-2020; Cummins, Scott/I-6420-2016	Wang, Tianfang/0000-0002-4876-7767; Wang, Tianfang/0000-0002-4876-7767; Bose, Utpal/0000-0003-1156-6504; Bose, Utpal/0000-0003-1156-6504; Wang, Tianfang/0000-0002-4876-7767; Harding, Bradley/0000-0002-4165-2457; Cummins, Scott/0000-0002-1454-2076	Australian Research Council [DP120104360]	Australian Research Council(Australian Research Council)	Funded by Australian Research Council: DP120104360.	ADAMO SA, 1990, J EXP ZOOL, V255, P80, DOI 10.1002/jez.1402550111; ADAMO SA, 1988, CAN J ZOOL, V66, P1446, DOI 10.1139/z88-211; Adamson KJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1510-8; Akalal DBG, 2003, PEPTIDES, V24, P1117, DOI 10.1016/j.peptides.2003.06.001; Amano M, 2008, GEN COMP ENDOCR, V156, P277, DOI 10.1016/j.ygcen.2008.01.008; Amano M, 2010, ZOOL SCI, V27, P656, DOI 10.2108/zsj.27.656; BAKER GH, 1990, J APPL ECOL, V27, P16, DOI 10.2307/2403565; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Bernard A, 1930, CR SOC BIOL, V103, P1119; BRANTON WD, 1978, P NATL ACAD SCI USA, V75, P5732, DOI 10.1073/pnas.75.11.5732; Casadio A, 2004, J NEUROSCI RES, V75, P32, DOI 10.1002/jnr.10841; Chansela P, 2008, AQUACULTURE, V279, P142, DOI 10.1016/j.aquaculture.2008.03.058; Chase R., 2002, BEHAV ITS NEURAL CON; Chase R, 2007, AM MALACOL BULL, V23, P183, DOI 10.4003/0740-2783-23.1.183; Chase R, 2006, P ROY SOC B-BIOL SCI, V273, P1471, DOI 10.1098/rspb.2006.3474; CHIU AY, 1979, P NATL ACAD SCI USA, V76, P6656, DOI 10.1073/pnas.76.12.6656; Cummins SF, 2010, PEPTIDES, V31, P394, DOI 10.1016/j.peptides.2009.10.010; Cummins SF, 2009, INT J DEV BIOL, V53, P1081, DOI 10.1387/ijdb.082791sc; De Boer PACM, 1997, J NEUROPHYSIOL, V78, P2823; de Lange RPJ, 1998, GEN COMP ENDOCR, V109, P166, DOI 10.1006/gcen.1997.7001; DeLange RPJ, 1997, NEUROSCIENCE, V78, P289, DOI 10.1016/S0306-4522(96)00576-3; Di Cristo C, 2009, PEPTIDES, V30, P531, DOI 10.1016/j.peptides.2008.07.008; DUDEK FE, 1978, GEN COMP ENDOCR, V36, P618, DOI 10.1016/0016-6480(78)90103-X; EBBERINK RHM, 1985, P NATL ACAD SCI USA, V82, P7767, DOI 10.1073/pnas.82.22.7767; Favrel P, 1996, NEUROSCI LETT, V205, P210, DOI 10.1016/0304-3940(96)12390-9; Gess F., 2007, VELD FLORA, V93, P216; Ghabooli S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059328; GOLDBERG JI, 1993, J COMP NEUROL, V336, P571, DOI 10.1002/cne.903360409; Gorbman A, 2003, GEN COMP ENDOCR, V131, P62, DOI 10.1016/S0016-6480(02)00647-0; Heifetz Y, 2005, P NATL ACAD SCI USA, V102, P743, DOI 10.1073/pnas.0407692102; HELLER E, 1980, P NATL ACAD SCI-BIOL, V77, P2328, DOI 10.1073/pnas.77.4.2328; Henry J, 1997, PEPTIDES, V18, P1469, DOI 10.1016/S0196-9781(97)00241-6; Henry J, 2000, BRAIN RES, V862, P162, DOI 10.1016/S0006-8993(00)02108-9; Henry J, 2002, PEPTIDES, V23, P1031, DOI 10.1016/S0196-9781(02)00033-5; Hermann PM, 1997, J NEUROPHYSIOL, V78, P2859, DOI 10.1152/jn.1997.78.6.2859; Iwakoshi E, 2002, BIOCHEM BIOPH RES CO, V291, P1187, DOI 10.1006/bbrc.2002.6594; Koene JM, 2001, J COMP PHYSIOL A, V187, P323, DOI 10.1007/s003590100214; Koene JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069968; Koene JM, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00167; Koene JM, 2009, EVOL ECOL, V23, P533, DOI 10.1007/s10682-008-9253-5; KUROKI Y, 1990, BIOCHEM BIOPH RES CO, V167, P273, DOI 10.1016/0006-291X(90)91761-G; Kurosky Alexander, 1997, Invertebrate Neuroscience, V2, P261, DOI 10.1007/BF02211939; Landolfa MA, 2001, BEHAV ECOL, V12, P773, DOI 10.1093/beheco/12.6.773; Leonard E., 2003, BASHEM BURNEM BAITEM; Li LJ, 1999, J EXP BIOL, V202, P2961; Matsumoto T, 2013, ZOOL SCI, V30, P826, DOI 10.2108/zsj.30.826; Morishita F, 2010, CAN J ZOOL, V88, P825, DOI 10.1139/Z10-041; Nakamura S, 2007, MOL REPROD DEV, V74, P108, DOI 10.1002/mrd.20544; NAMBU JR, 1986, J NEUROSCI, V6, P2026; Nuurai P, 2010, ACTA HISTOCHEM, V112, P557, DOI 10.1016/j.acthis.2009.06.002; Osada M, 2013, GEN COMP ENDOCR, V181, P254, DOI 10.1016/j.ygcen.2012.09.002; PAINTER SD, 1991, BIOL BULL, V181, P81, DOI 10.2307/1542491; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Roch GJ, 2011, GEN COMP ENDOCR, V171, P1, DOI 10.1016/j.ygcen.2010.12.014; Rogers DW, 2001, BEHAV ECOL SOCIOBIOL, V50, P122, DOI 10.1007/s002650100345; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salzet M, 1997, MOL BRAIN RES, V49, P211, DOI 10.1016/S0169-328X(97)00145-9; Simmerling C, 2002, J AM CHEM SOC, V124, P11258, DOI 10.1021/ja0273851; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; Stewart MJ, 2016, J BIOL CHEM, V291, P7938, DOI 10.1074/jbc.M115.704395; Stewart MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-840; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsai PS, 2003, GEN COMP ENDOCR, V130, P20, DOI 10.1016/S0016-6480(02)00519-1; VANGOLEN FA, 1995, NEUROSCIENCE, V69, P1275, DOI 10.1016/0306-4522(95)00311-6; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; Veenstra JA, 2010, GEN COMP ENDOCR, V167, P86, DOI 10.1016/j.ygcen.2010.02.010; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watt S., 2012, GROUND COVER, V97, P37; Wicher D, 2006, J NEUROPHYSIOL, V95, P2314, DOI 10.1152/jn.01007.2005; Young KG, 1999, J COMP NEUROL, V404, P427, DOI 10.1002/(SICI)1096-9861(19990222)404:4<427::AID-CNE1>3.0.CO;2-R; Zhang LH, 2008, GEN COMP ENDOCR, V156, P201, DOI 10.1016/j.ygcen.2007.11.015	72	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0162355	10.1371/journal.pone.0162355	http://dx.doi.org/10.1371/journal.pone.0162355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706146	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200010
J	Falgreen, S; Bilgrau, AE; Brondum, RF; Jakobsen, LH; Have, J; Nielsen, KL; El-Galaly, TC; Bodker, JS; Schmitz, A; Young, KH; Johnsen, HE; Dybkaer, K; Bogsted, M				Falgreen, Steffen; Bilgrau, Anders Ellern; Brondum, Rasmus Froberg; Jakobsen, Lasse Hjort; Have, Jonas; Nielsen, Kasper Lindblad; El-Galaly, Tarec Christoffer; Bodker, Julie Stove; Schmitz, Alexander; Young, Ken H.; Johnsen, Hans Erik; Dybkaer, Karen; Bogsted, Martin			hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision Medicine	PLOS ONE			English	Article							AFFYMETRIX-GENECHIP DATA; CELL LYMPHOMA; EXPRESSION; CHEMOTHERAPY; REGULARIZATION; PREDICTION; REGRESSION; SUMMARIES; SELECTION; SURVIVAL	Background Dozens of omics based cancer classification systems have been introduced with prognostic, diagnostic, and predictive capabilities. However, they often employ complex algorithms and are only applicable on whole cohorts of patients, making them difficult to apply in a personalized clinical setting. Results This prompted us to create hemaClass.org, an online web application providing an easy interface to one-by-one RMA normalization of microarrays and subsequent risk classifications of diffuse large B-cell lymphoma (DLBCL) into cell-of-origin and chemotherapeutic sensitivity classes. Classification results for one-by-one array pre-processing with and without a laboratory specific RMA reference dataset were compared to cohort based classifiers in 4 publicly available datasets. Classifications showed high agreement between one-by-one and whole cohort pre-processsed data when a laboratory specific reference set was supplied. The website is essentially the R-package hemaClass accompanied by a Shiny web application. The well-documented package can be used to run the website locally or to use the developed methods programmatically. Conclusions The website and R-package is relevant for biological and clinical lymphoma researchers using affymetrix U-133 Plus 2 arrays, as it provides reliable and swift methods for calculation of disease subclasses. The proposed one-by-one pre-processing method is relevant for all researchers using microarrays.	[Falgreen, Steffen; Bilgrau, Anders Ellern; Brondum, Rasmus Froberg; Jakobsen, Lasse Hjort; Have, Jonas; Nielsen, Kasper Lindblad; El-Galaly, Tarec Christoffer; Bodker, Julie Stove; Schmitz, Alexander; Johnsen, Hans Erik; Dybkaer, Karen; Bogsted, Martin] Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark; [Bilgrau, Anders Ellern; Jakobsen, Lasse Hjort; Have, Jonas; Nielsen, Kasper Lindblad; El-Galaly, Tarec Christoffer; Johnsen, Hans Erik; Dybkaer, Karen; Bogsted, Martin] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Young, Ken H.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	Aalborg University; Aalborg University Hospital; Aalborg University; University of Texas System; UTMD Anderson Cancer Center	Bogsted, M (corresponding author), Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark.; Bogsted, M (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	mbaegsted@dcm.aau.dk		Johnsen, Hans Erik/0000-0001-8253-2913; Dybkaer, Karen/0000-0003-2488-435X; Bogsted, Martin/0000-0001-9192-1814; Brondum, Rasmus/0000-0001-5537-6767; El-Galaly, Tarec Christoffer/0000-0002-4406-380X				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; [Anonymous], 2014, EXPT HEMATOLOGY, V42, P927, DOI [10.1016/j.exphem.2014.07.263, DOI 10.1016/J.EXPHEM.2014.07.263]; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bilgrau AE, 2015, DLBCLDATA AUTOMATED; Boegsted M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019322; Bogsted M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083252; Bolstad B. M., 2004, LOW LEVEL ANAL HIGH; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Care MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055895; Chang W, 2015, SHINY WEB APPL FRAME; CHEN S, 1989, INT J CONTROL, V50, P1873, DOI 10.1080/00207178908953472; Chen XM, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-15; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Coutinho R, 2013, DOVE PRESS, V3, P17, DOI DOI 10.2147/CBF.S29208; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dunleavy K, 2009, BLOOD, V113, P6069, DOI 10.1182/blood-2009-01-199679; Dybkaer K, 2015, J CLIN ONCOL, V33, P1379, DOI 10.1200/JCO.2014.57.7080; Eddelbuettel D, 2014, COMPUT STAT DATA AN, V71, P1054, DOI 10.1016/j.csda.2013.02.005; Eddelbuettel D, 2011, J STAT SOFTW, V40, P1; Falgreen S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1237-6; Friedberg JW, 2011, CLIN CANCER RES, V17, P6112, DOI 10.1158/1078-0432.CCR-11-1073; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Huang LT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-25; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaffe ES, 2009, HEMATOL-AM SOC HEMAT, V2009, P523, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.523; Katz S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-464; Lausen MB, 2015, STUDIES ANTI C UNPUB; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Malumbres R, 2008, BLOOD, V111, P5509, DOI 10.1182/blood-2008-02-136374; McCall MN, 2014, NUCLEIC ACIDS RES, V42, pD938, DOI 10.1093/nar/gkt1204; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Monti S, 2012, CANCER CELL, V22, P359, DOI 10.1016/j.ccr.2012.07.014; Poulsen CB, 2005, EUR J HAEMATOL, V74, P453, DOI 10.1111/j.1600-0609.2005.00429.x; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sanderson C., 2010, ARMADILLO OPEN SOURC; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Sehn LH, 2015, BLOOD, V125, P22, DOI 10.1182/blood-2014-05-577189; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Visco C, 2012, LEUKEMIA, V26, P2103, DOI 10.1038/leu.2012.83; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	52	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163711	10.1371/journal.pone.0163711	http://dx.doi.org/10.1371/journal.pone.0163711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UK	27701436	Green Published, Green Submitted, gold			2022-12-27	WOS:000385696900017
J	Harrison, D; Wilding, J; Bowman, A; Fuller, A; Nicholls, SG; Pound, CM; Reszel, J; Sampson, M				Harrison, Denise; Wilding, Jodi; Bowman, Amanda; Fuller, Ann; Nicholls, Stuart G.; Pound, Catherine M.; Reszel, Jessica; Sampson, Margaret			Using YouTube to Disseminate Effective Vaccination Pain Treatment for Babies	PLOS ONE			English	Article							ROUTINE CHILDHOOD IMMUNIZATIONS; INFORMATION; MANAGEMENT; VIDEOS; HEALTH; ONLINE	Background Infant vaccinations are necessary for public health, but are painful, causing distress to the infant and caregivers. Breastfeeding and sucrose effectively reduce infants' pain during vaccinations, and these strategies are recommended in health care provider (HCP)-targeted education and vaccination pain guidelines. However studies show these strategies are infrequently used. YouTube is a popular medium to publicly share and watch videos, and many consumer posted YouTube videos show distressed infants being vaccinated with no pain treatment. The aims of this study were to evaluate the reach and impact of a consumer-targeted YouTube video demonstrating use of effective pain reduction strategies during infant vaccinations. Methods A brief consumer-targeted video showing two infants being vaccinated was posted onto YouTube on October 2013. One infant was breastfed and another infant received sucrose by mouth before and during the injection. A link to a viewer survey was visible on a banner near the end of the video. An intensive strategically planned knowledge dissemination strategy using the media, social media and messages to professional organizations took place to promote the video. Data analysis of the viewer survey, YouTube analytics of the reach of the video in terms of number of views, country of viewers, and comments relating to the video took place 12 months after the video was posted. Results Twelve months after posting, the video had 65,478views, 68 comments, 245 likes, 17 dislikes, and 90 shares. Average duration of viewer time was 65% of the video. The viewer survey was completed by 156 (0.24%) viewers; 90 (58%) answered as HCPs and 66 (42%) as parents. Survey results showed that the video was persuasive; intent to use or support breastfeeding or sucrose was high in both parents and HCPs after viewing the video. Comments posted were often emotional in nature, and were related to anti-vaccination (n = 26, 38%); effectiveness or positive personal experiences (n = 21, 32%); research team comments or promotion (n = 12, 18%); pro-vaccination (n = 6, 8%) and barriers to using breastfeeding or sucrose during vaccinations (n = 3, 4%). Conclusion The video posted onto YouTube demonstrating effective pain treatment during infant vaccinations was viewed by large numbers of people around the world, however the response rate to the linked survey was extremely low. Using YouTube videos for knowledge dissemination has an extensive reach, however it is difficult to evaluate impact on behaviours and practices.	[Harrison, Denise; Wilding, Jodi; Bowman, Amanda; Fuller, Ann; Nicholls, Stuart G.; Pound, Catherine M.; Reszel, Jessica; Sampson, Margaret] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Harrison, Denise; Wilding, Jodi; Bowman, Amanda; Fuller, Ann; Nicholls, Stuart G.; Pound, Catherine M.; Reszel, Jessica; Sampson, Margaret] CHEO Res Inst, Ottawa, ON, Canada; [Harrison, Denise; Bowman, Amanda] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa	Harrison, D (corresponding author), Childrens Hosp Eastern Ontario, Ottawa, ON, Canada.; Harrison, D (corresponding author), CHEO Res Inst, Ottawa, ON, Canada.; Harrison, D (corresponding author), Univ Ottawa, Sch Nursing, Ottawa, ON, Canada.	dharrison@cheo.on.ca	Nicholls, Stuart G./I-9160-2019; Harrison, Denise/N-6684-2017	Nicholls, Stuart G./0000-0003-0485-9069; Harrison, Denise/0000-0001-7549-7742	Canadian Pain Society Nursing Research and Education Award	Canadian Pain Society Nursing Research and Education Award	This work was partly funded by the Canadian Pain Society (http://www.canadianpainsociety.ca/) Nursing Research and Education Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge The Canadian Pain Society Nursing Research and Education Award 2013 for funding support and Kalina Charnock for her support in data collection.	[Anonymous], 2014, INTERNET IS ZOO IDEA; [Anonymous], 1993, NEONATAL INFANT PAIN, V12, P1993; Brna PM, 2013, EPILEPSY BEHAV, V29, P305, DOI 10.1016/j.yebeh.2013.08.003; Butler DP, 2013, BURNS, V39, P856, DOI 10.1016/j.burns.2012.10.017; Clauser SB, 2011, AM J PREV MED, V40, pS198, DOI 10.1016/j.amepre.2011.01.014; Farkas C, 2015, CLIN J PAIN, V31, P591, DOI [10.1097/AJP.0000000000000263, 10.1097/AJP.0000000000000197]; Gao XL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2290; Giguere A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004398.pub3; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrison D., 2014, INT ASS STUDY D  DEC; Harrison D, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-134; Harrison D, 2013, J PAEDIATR CHILD H, V49, P313, DOI 10.1111/jpc.12161; Harrison D, 2010, ARCH DIS CHILD, V95, P406, DOI 10.1136/adc.2009.174227; Hordern A, 2011, HEALTH INF MANAG J, V40, P6, DOI 10.1177/183335831104000202; Kassab M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008411.pub2; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Keelan J, 2007, JAMA-J AM MED ASSOC, V298, P2482, DOI 10.1001/jama.298.21.2482; Keller B, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2982; Lee GY, 2014, PEDIATRICS, V133, P500, DOI 10.1542/peds.2013-2744; Lisi D, 2013, PAIN, V154, P1245, DOI 10.1016/j.pain.2013.03.036; McMullan M, 2006, PATIENT EDUC COUNS, V63, P24, DOI 10.1016/j.pec.2005.10.006; Nanji A, 2015, TOP 10 ONLINE VIDEO; Nikbakht Nasrabadi Alireza, 2015, Int J Community Based Nurs Midwifery, V3, P105; Public Health Agency of Canada, 2014, PUBL FUND IMM PROGR; Riddell RP, 2013, PAIN, V154, P714, DOI 10.1016/j.pain.2013.01.015; Robichaud P, 2012, VACCINE, V30, P3763, DOI 10.1016/j.vaccine.2012.03.074; Russell Kathryn, 2015, Nurs N Z, V21, P22; Schechter NL, 2007, PEDIATRICS, V119, pE1184, DOI 10.1542/peds.2006-1107; Shah PS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004950.pub3; Shah V, 2009, CLIN THER, V31, pS104, DOI 10.1016/j.clinthera.2009.08.001; Syed-Abdul S, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2237; Taddio A, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-23; Taddio A, 2010, CAN MED ASSOC J, V182, pE843, DOI 10.1503/cmaj.101720; Taddio A, 2009, CLIN THER, V31, pS152, DOI 10.1016/j.clinthera.2009.07.022; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853	35	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0164123	10.1371/journal.pone.0164123	http://dx.doi.org/10.1371/journal.pone.0164123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695054	Green Published, Green Submitted, gold			2022-12-27	WOS:000385553100091
J	Suenaga, G; Ikeda, T; Komohara, Y; Takamatsu, K; Kakuma, T; Tasaki, M; Misumi, Y; Ueda, M; Ito, T; Senju, S; Ando, Y				Suenaga, Genki; Ikeda, Tokunori; Komohara, Yoshihiro; Takamatsu, Koutaro; Kakuma, Tatsuyuki; Tasaki, Masayoshi; Misumi, Yohei; Ueda, Mitsuharu; Ito, Takaaki; Senju, Satoru; Ando, Yukio			Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment	PLOS ONE			English	Article							HEREDITARY TRANSTHYRETIN AMYLOIDOSIS; RETINOL-BINDING-PROTEIN; LIVER-TRANSPLANTATION; SCAVENGER RECEPTOR; PIGMENT-EPITHELIUM; DENDRITIC CELLS; HUMAN PLASMA; MONOCYTES; CD163; REGENERATION	We hypothesized that tissue-resident macrophages in familial amyloid polyneuropathy (FAP) patients will exhibit qualitative or quantitative abnormalities, that may accelerate transthyretin (TTR)-derived amyloid deposition. To evaluate this, we examined the number and subset of tissue-resident macrophages in heart tissue from amyloid-deposited FAP and control patients. In both FAP and control patients, tissue-resident macrophages in heart tissue were all Iba(+)/CD163(+)/CD206(+) macrophages. However, the number of macrophages was significantly decreased in FAP patients compared with control patients. Furthermore, the proportion of intracellular TTR in CD14(+) monocytes was reduced in peripheral blood compared with healthy donors. Based on these results, we next examined degradation and endocytosis of TTR in human induced pluripotent stem (iPS) cell-derived myeloid lineage cells (MLs), which function like macrophages. iPS-MLs express CD163 and CD206, and belong to the inhibitory macrophage category. In addition, iPS-MLs degrade both native and aggregated TTR in a cell-dependent manner in vitro. Further, iPS-MLs endocytose aggregated, and especially polymerized, TTR. These results suggest that decreased tissue-localized macrophages disrupt clearance of TTR-derived amyloid deposits, leading to progression of a pathological condition in FAP patients. To improve this situation, clinical application of pluripotent stem cell-derived MLs may be useful as an approach for FAP therapy.	[Suenaga, Genki; Ikeda, Tokunori; Takamatsu, Koutaro; Tasaki, Masayoshi; Misumi, Yohei; Ueda, Mitsuharu; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan; [Ikeda, Tokunori] Kumamoto Univ, Grad Sch Med Sci, Dept Clin Res Support Ctr, Kumamoto, Japan; [Komohara, Yoshihiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Japan; [Kakuma, Tatsuyuki] Kurume Univ, Sch Med, Dept Biostat Ctr, Kurume, Fukuoka, Japan; [Ito, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto, Japan; [Senju, Satoru] Kumamoto Univ, Grad Sch Med Sci, Dept Immunogenet, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Kurume University; Kumamoto University; Kumamoto University	Ikeda, T; Ando, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto, Japan.; Ikeda, T (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Clin Res Support Ctr, Kumamoto, Japan.	ryousei@kumamoto-u.ac.jp; andoy709@kumamoto-u.ac.jp	Ueda, Mitsuharu/Q-8595-2019; Ikeda, Tokunori/S-6043-2019	Ando, Yukio/0000-0001-7115-9105	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [15K19493, 26860673, 24249036, 15H04841]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was all supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (URL; http://www.mext.go.jp/english/), grant numbers 15K19493 (to T. Ikeda), 26860673 (to K. Takamatsu), 24249036 and 15H04841 (to Y. Ando). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaki Y, 2015, ARTHRITIS RHEUMATOL, V67, P2097, DOI 10.1002/art.39178; Ando Y, 2012, CURR MED CHEM, V19, P2312, DOI 10.2174/092986712800269317; Araki S, 2010, P JPN ACAD B-PHYS, V86, P694, DOI 10.2183/pjab.86.694; Batra AS, 2001, CURR OPIN PEDIATR, V13, P234, DOI 10.1097/00008480-200106000-00004; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; Benson MD, 2013, MUSCLE NERVE, V47, P157, DOI 10.1002/mus.23521; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; COELHO T, 1994, J MED GENET, V31, P293, DOI 10.1136/jmg.31.4.293; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cruz MW, 2015, NEUROL THER, V4, P61, DOI 10.1007/s40120-015-0031-3; Das A, 2015, AM J PATHOL, V185, P2596, DOI 10.1016/j.ajpath.2015.06.001; Dey A, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00683; DICKSON PW, 1986, NEUROSCI LETT, V66, P311, DOI 10.1016/0304-3940(86)90037-6; Ericzon BG, 2015, TRANSPLANTATION, V99, P1847, DOI 10.1097/TP.0000000000000574; Goncalves NP, 2014, AMYLOID, V21, P175, DOI 10.3109/13506129.2014.927759; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gray EE, 2012, J INNATE IMMUN, V4, P424, DOI 10.1159/000337007; Hawkins PN, 2015, ANN MED, V47, P625, DOI 10.3109/07853890.2015.1068949; Hemming AW, 1998, LIVER TRANSPLANT SUR, V4, P236, DOI 10.1002/lt.500040303; HOLMGREN G, 1994, J MED GENET, V31, P351, DOI 10.1136/jmg.31.5.351; HOLNESS CL, 1993, BLOOD, V81, P1607; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; INGBAR SH, 1958, ENDOCRINOLOGY, V63, P256; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; KANAI M, 1968, J CLIN INVEST, V47, P2025, DOI 10.1172/JCI105889; Kawaji T, 2005, EXP EYE RES, V81, P306, DOI 10.1016/j.exer.2005.02.003; Koba C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067567; Komohara Y, 2012, CANCER SCI, V103, P2165, DOI 10.1111/cas.12015; Kowal K, 2011, FOLIA HISTOCHEM CYTO, V49, P365, DOI 10.5603/FHC.2011.0052; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Mills CD, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00620; Misumi Y, 2013, LAB INVEST, V93, P911, DOI 10.1038/labinvest.2013.83; MITA S, 1986, J BIOCHEM-TOKYO, V100, P1215, DOI 10.1093/oxfordjournals.jbchem.a121826; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; Obayashi Konen, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-006593; Okumura K, 2016, AMYLOID, V13, P1; ONG DE, 1994, BIOCHEMISTRY-US, V33, P1835, DOI 10.1021/bi00173a029; Ono K, 2006, J IMMUNOL, V177, P5517, DOI 10.4049/jimmunol.177.8.5517; Oshima T, 2014, J NEUROL NEUROSUR PS, V85, P740, DOI 10.1136/jnnp-2013-305973; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Schneider F, 2001, PROTEIN SCI, V10, P1606, DOI 10.1110/ps.8901; Senju S, 2011, GENE THER, V18, P874, DOI 10.1038/gt.2011.22; Su Y, 2012, PANCREAS, V41, P971, DOI 10.1097/MPA.0b013e318249926a; Suhr OB, 2003, J INTERN MED, V254, P225, DOI 10.1046/j.1365-2796.2003.01173.x; TAKAHASHI K, 1991, HUM PATHOL, V22, P519, DOI 10.1016/0046-8177(91)90227-G; Takamatsu K, 2014, STEM CELL RES, V13, P442, DOI 10.1016/j.scr.2014.10.001; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tsuchiya A, 2008, LIVER TRANSPLANT, V14, P563, DOI 10.1002/lt.21395; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	52	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163944	10.1371/journal.pone.0163944	http://dx.doi.org/10.1371/journal.pone.0163944			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695122	gold, Green Published, Green Submitted			2022-12-27	WOS:000385553100067
J	Zhang, X; Zhao, X; Dong, H; Zhu, YN; Shi, HY; Chen, JF; Shi, D; Feng, L				Zhang, Xin; Zhao, Xin; Dong, Hui; Zhu, Yunnuan; Shi, Hongyan; Chen, Jianfei; Shi, Da; Feng, Li			Characterization of Two Monoclonal Antibodies That Recognize Linker Region and Carboxyl Terminal Domain of Coronavirus Nucleocapsid Protein	PLOS ONE			English	Article							TRANSMISSIBLE GASTROENTERITIS CORONAVIRUS; RESPIRATORY SYNDROME CORONAVIRUS; INFECTIOUS-BRONCHITIS VIRUS; MOUSE HEPATITIS-VIRUS; RNA-BINDING DOMAIN; SARS CORONAVIRUS; DIMERIZATION DOMAIN; N-PROTEIN; CRYSTAL-STRUCTURE; RICH MOTIF	The transmissible gastroenteritis virus (TGEV) nucleocapsid (N) protein plays important roles in the replication and translation of viral RNA. The present study provides the first description of two monoclonal antibodies (mAbs) (5E8 and 3D7) directed against the TGEV N protein linker region (LKR) and carboxyl terminal domain (CTD). The mAbs 5E8 and 3D7 reacted with native N protein in western blotting and immunofluorescence assay (IFA). Two linear epitopes, (189)SVEQAVLAALKKLG(202) and (246)VTRFYGARSSSA(257), located in the LKR and CTD of TGEV N protein, respectively, were identified after truncating the protein and applying a peptide scanning technique. Using mAb 5E8, we observed that the N protein was expressed in the cytoplasm during TGEV replication and that the protein could be immunoprecipitated from TGEV-infected PK-15 cells. The mAb 5E8 can be applied for different approaches to diagnosis of TGEV infection. In addition, the antibodies represent useful tools for investigating the antigenic properties of the N protein.	[Zhang, Xin; Zhao, Xin; Dong, Hui; Zhu, Yunnuan; Shi, Hongyan; Chen, Jianfei; Shi, Da; Feng, Li] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Heilongjiang, Peoples R China; [Dong, Hui] Univ Liege, Gembloux Agrobio Tech, Mol Biol, Liege, Belgium	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University of Liege	Feng, L (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Heilongjiang, Peoples R China.	fl@hvri.ac.cn	Feng, Li/GQQ-3764-2022		National Key Technology Support Program [2015BAD12B02]; National Natural Science Foundation of China [31572541, 31502092]; National Key Laboratory of the Veterinary Biotechnology Support Program [SKLVBP2015005]	National Key Technology Support Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Laboratory of the Veterinary Biotechnology Support Program	This work was financially supported by grants from the National Key Technology Support Program (2015BAD12B02) and the National Natural Science Foundation of China (grant Nos. 31572541, and 31502092), and the National Key Laboratory of the Veterinary Biotechnology Support Program (SKLVBP2015005).; This work was financially supported by grants from the National Key Technology Support Program (2015BAD12B02) and the National Natural Science Foundation of China (grant Nos. 31572541, and 31502092), and the National Key Laboratory of the Veterinary Biotechnology Support Program (SKLVBP2015005). We thank Mr. He Xijun (Harbin Veterinary Research Institute of the CAAS) for help with IHC.	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; ANTON IM, 1995, VIROLOGY, V212, P746, DOI 10.1006/viro.1995.1535; BARIC RS, 1988, J VIROL, V62, P4280, DOI 10.1128/JVI.62.11.4280-4287.1988; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Chang CK, 2014, ANTIVIR RES, V103, P39, DOI 10.1016/j.antiviral.2013.12.009; Chang CK, 2009, J VIROL, V83, P2255, DOI 10.1128/JVI.02001-08; Chang CK, 2006, J BIOMED SCI, V13, P59, DOI 10.1007/s11373-005-9035-9; Chang CK, 2005, FEBS LETT, V579, P5663, DOI 10.1016/j.febslet.2005.09.038; Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069; Chen Q, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-206; de Groot R.J., 2011, VIRUS TAXONOMY, P774; de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7; Eleouet JF, 2000, J VIROL, V74, P3975, DOI 10.1128/JVI.74.9.3975-3983.2000; Fan H, 2005, STRUCTURE, V13, P1859, DOI 10.1016/j.str.2005.08.021; He RT, 2004, BIOCHEM BIOPH RES CO, V316, P476, DOI 10.1016/j.bbrc.2004.02.074; Hiscox JA, 2001, J VIROL, V75, P506, DOI 10.1128/JVI.75.1.506-512.2001; Huang QL, 2004, BIOCHEMISTRY-US, V43, P6059, DOI 10.1021/bi036155b; Hurst KR, 2009, J VIROL, V83, P7221, DOI 10.1128/JVI.00440-09; Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06; Jenwitheesuk E, 2003, BIOORG MED CHEM LETT, V13, P3989, DOI 10.1016/j.bmcl.2003.08.066; Jungmann A, 2001, J GEN VIROL, V82, P1107, DOI 10.1099/0022-1317-82-5-1107; Keane SC, 2012, J BIOL CHEM, V287, P7063, DOI 10.1074/jbc.M111.287763; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuo SM, 2013, VET MICROBIOL, V162, P408, DOI 10.1016/j.vetmic.2012.10.020; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Li PC, 2011, CURR MICROBIOL, V62, P1074, DOI 10.1007/s00284-010-9825-9; Lo YS, 2013, FEBS LETT, V587, P120, DOI 10.1016/j.febslet.2012.11.016; Luo HB, 2005, FEBS LETT, V579, P2623, DOI 10.1016/j.febslet.2005.03.080; Luo HB, 2005, BIOCHEMISTRY-US, V44, P15351, DOI 10.1021/bi051122c; MASTERS PS, 1992, ARCH VIROL, V125, P141, DOI 10.1007/BF01309634; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; NIGG EA, 1991, CELL, V66, P15, DOI 10.1016/0092-8674(91)90135-L; PARKER MM, 1990, VIROLOGY, V179, P463, DOI 10.1016/0042-6822(90)90316-J; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Reguera J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002859; ROBBINS SG, 1986, VIROLOGY, V150, P402, DOI 10.1016/0042-6822(86)90305-3; Rodak L, 2005, J VET MED B, V52, P105, DOI 10.1111/j.1439-0450.2005.00829.x; Saikatendu KS, 2007, J VIROL, V81, P3913, DOI 10.1128/JVI.02236-06; Sheval EV, 2005, EUR J HISTOCHEM, V49, P117; Spencer KA, 2006, FEBS LETT, V580, P5993, DOI 10.1016/j.febslet.2006.09.052; Stewart M, 1996, CURR OPIN STRUC BIOL, V6, P162, DOI 10.1016/S0959-440X(96)80070-4; Surjit M, 2005, J VIROL, V79, P11476, DOI 10.1128/JVI.79.17.11476-11486.2005; Takeda M, 2008, J MOL BIOL, V380, P608, DOI 10.1016/j.jmb.2007.11.093; Wang XF, 2015, VET IMMUNOL IMMUNOP, V166, P88, DOI 10.1016/j.vetimm.2015.06.002; Wong RW, 2015, CHEM BIOL, V22, P1285, DOI 10.1016/j.chembiol.2015.10.001; Wu CH, 2009, J BIOL CHEM, V284, P5229, DOI 10.1074/jbc.M805747200; Wurm T, 2001, J VIROL, V75, P9345, DOI 10.1128/JVI.75.19.9345-9356.2001; You JW, 2005, J GEN VIROL, V86, P3303, DOI 10.1099/vir.0.81076-0; Yount B, 2000, J VIROL, V74, P10600, DOI 10.1128/JVI.74.22.10600-10611.2000; Yu IM, 2006, J BIOL CHEM, V281, P17134, DOI 10.1074/jbc.M602107200; Yu IM, 2005, J BIOL CHEM, V280, P23280, DOI 10.1074/jbc.M501015200; Zhang X, 2014, VET MICROBIOL, V172, P443, DOI 10.1016/j.vetmic.2014.05.034; Zuniga S, 2007, VIROLOGY, V357, P215, DOI 10.1016/j.virol.2006.07.046; Zuniga S, 2010, J VIROL, V84, P2169, DOI 10.1128/JVI.02011-09	55	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							0163920	10.1371/journal.pone.0163920	http://dx.doi.org/10.1371/journal.pone.0163920			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27689694	Green Published, Green Submitted, gold			2022-12-27	WOS:000384329200035
J	Baek, MK; Kim, YS; Kim, EY; Kim, AJ; Choi, WJ				Baek, Min Kwan; Kim, Young Saing; Kim, Eun Young; Kim, Ae Jin; Choi, Won-Jun			Health-Related Quality of Life in Korean Adults with Hearing Impairment: The Korea National Health and Nutrition Examination Survey 2010 to 2012	PLOS ONE			English	Article							OLDER-ADULTS; HANDICAP INVENTORY; RISK-FACTORS; AID USE; PREVALENCE; RELIABILITY; VALIDITY; IMPACT	Background As the global population ages, disabling hearing impairment (HI) have been increased rapidly. The impact of HI on health-related quality of life (HRQoL) is of great importance to aid the development of strategic plans and to guide therapeutic interventions. Purpose To evaluate HRQoL in Korean adults with different degrees of HI using EuroQol five-dimensional (EQ-5D) and EQ-visual analogue scale (VAS), the preference-based generic measures of HRQoL. Methods Using a representative dataset from the Korea National Health and Nutrition Examination Survey (KNHANES) from January 2010 to December 2012, EQ-5D questionnaire and EQ-VAS scores of subjects with HI were compared with those of subjects without HI. Logistic regression analysis, with adjustment for covariates, was used to evaluate the impact of HI on HRQoL scales. HI was defined according to the hearing thresholds of pure-tone averages at 0.5, 1, 2, and 3 kHz of the better hearing ear as follows; mild HI (26 to < 40 dB) and moderate to severe HI (>= 40 dB). Results Of the 16,449 Korean adults in KNHANES (age, 45.0 +/- 0.2 years; male, 49.7%), 1757 (weighted prevalence, 7.6%) had mild HI and 890 (3.6%) had moderate to severe HI. Subjects with HI had impaired HRQoL as compared with subjects without HI (EQ-5D, 0.96 +/- 0.00 vs. 0.88 +/- 0.00 vs. 0.86 +/- 0.01 for control vs. mild HI vs. moderate to severe HI, p < 0.001; EQ-VAS, 75.10 +/- 0.18 vs. 67.48 +/- 0.63 vs. 66.24 +/- 0.92 for control vs. mild HI vs. moderate to severe HI, p < 0.001). After adjusting for socio-demographic factors (age, gender, household income, education level, presence of spouse) and health-related behaviors (smoking status, alcohol intake, regular exercise), psychological stress, and the presence of comorbidities (diabetes, hypercholesterolemia, hypertension, decreased eGFR, and tinnitus), EQ-VAS remained impaired in the moderate to severe HI group (61.72 +/- 1.69) as compared with the control group (65.68 +/- 1.26, p = 0.004), but EQ-5D impairment disappeared (0.86 +/- 0.02 vs. 0.88 +/- 0.01 for moderate to severe HI vs. control, p = 0.058). Conclusion After adjusting for socio-demographic and psychosocial factors and comorbidities, Korean adults with moderate to severe HI rated their health statuses lower than subjects without HI.	[Baek, Min Kwan] Gachon Univ, Gil Med Ctr, Dept Otolaryngol Head & Neck Surg, Incheon, South Korea; [Kim, Young Saing; Kim, Ae Jin] Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea; [Kim, Eun Young] Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea; [Choi, Won-Jun] Gachon Univ, Gil Med Ctr, Dept Occupat & Environm Med, Incheon, South Korea	Gachon University; Gachon University; Gachon University; Gachon University	Kim, EY (corresponding author), Gachon Univ, Gil Med Ctr, Dept Radiol, Incheon, South Korea.	oneshot0229@gmail.com		Kim, Young Saing/0000-0003-0207-2617				[Anonymous], 2001, Indian J Med Sci, V55, P511; [Anonymous], 1995, Otolaryngol Head Neck Surg, V113, P186; [Anonymous], 2016, PREVENTION OF BLINDN; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Campbell V A, 1999, MMWR CDC Surveill Summ, V48, P131; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; Ciorba A, 2012, CLIN INTERV AGING, V7, P159, DOI 10.2147/CIA.S26059; Dallan I, 2014, J LARYNGOL OTOL, V128, P669, DOI 10.1017/S0022215114001595; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; FELCE D, 1995, RES DEV DISABIL, V16, P51, DOI 10.1016/0891-4222(94)00028-8; Fischer N, 2016, LARYNGO RHINO OTOL, V95, P497, DOI 10.1055/s-0042-106918; Fransen E, 2003, EXP GERONTOL, V38, P353, DOI 10.1016/S0531-5565(03)00032-9; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Heine C, 2002, DISABIL REHABIL, V24, P763, DOI 10.1080/09638280210129162; Hogan A, 2009, J AGING HEALTH, V21, P1098, DOI 10.1177/0898264309347821; Hong JW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000611; Hong S, 2015, ANN OCCUP ENVIRON ME, V27, DOI 10.1186/s40557-015-0077-9; Jo Min-Woo, 2007, J Prev Med Public Health, V40, P169; Joo YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131247; Kim JS, 2015, IRAN J PUBLIC HEALTH, V44, P308; Lee YK, 2009, VALUE HEALTH, V12, P1187, DOI 10.1111/j.1524-4733.2009.00579.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Longworth L, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18090; Mahomed F, 2013, EAR HEARING, V34, P745, DOI 10.1097/01.aud.0000436255.53747.a4; Monzani D, 2008, ACTA OTORHINOLARYNGO, V28, P61; Moon IJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001580; Nam HS., 2007, EQ 5D KOREAN VALUATI; NEWMAN CW, 1990, EAR HEARING, V11, P430, DOI 10.1097/00003446-199012000-00004; Osaki Y, 2014, ASIAN PAC J CANCER P, V15, P6571, DOI 10.7314/APJCP.2014.15.16.6571; Park Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132779; Popelka MM, 1998, J AM GERIATR SOC, V46, P1075, DOI 10.1111/j.1532-5415.1998.tb06643.x; Saxena S, 2001, QUAL LIFE RES, V10, P711, DOI 10.1023/A:1013867826835; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Shin KR, 2008, J KOREAN ACAD NURS, V38, P437, DOI 10.4040/jkan.2008.38.3.437; vandenBrink RHS, 1996, BRIT J AUDIOL, V30, P313, DOI 10.3109/03005369609076779; WEINSTEIN BE, 1986, EAR HEARING, V7, P295, DOI 10.1097/00003446-198610000-00002	37	11	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163999	10.1371/journal.pone.0163999	http://dx.doi.org/10.1371/journal.pone.0163999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UR	27711203	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600059
J	He, XX; Wu, XL; Chen, RP; Chen, C; Liu, XG; Wu, BJ; Huang, ZM				He, Xi-Xi; Wu, Xiao-Li; Chen, Ren-Pin; Chen, Chao; Liu, Xiao-Gang; Wu, Bin-Jiao; Huang, Zhi-Ming			Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DOCOSAHEXAENOIC ACID; NONDIABETIC SUBJECTS; INSULIN SENSITIVITY; OMEGA-3-FATTY-ACIDS; STEATOHEPATITIS; ASSOCIATION; RISK; SUPPLEMENTATION; PIOGLITAZONE	Background Non-alcoholic fatty liver disease (NAFLD) is a clinical syndrome with the main characteristic of diffuse liver cells with fatty changes. The clinical evolution of NAFLD includes simple non-alcoholic fatty liver, non-alcoholic steatohepatitis (NASH), liver fibrosis and cirrhosis, and even hepatocellular carcinoma. Methods and Findings We conducted this review to identify the effectiveness of omega-3 polyunsaturated fatty acids (omega-3 PUFA) in NAFLD. We searched PubMed, Cochrane Library and Embase. All randomized controlled trials (RCTs) of omega-3 PUFA treatment for NAFLD were considered. Two reviewers assessed the quality of each study and collected data independently. Disagreements were resolved by discussion among the reviewers and any of the other authors of the paper. We performed a meta-analysis and reported summary estimates of outcomes as inverse variance (IV), fixed or random, with 95% confidence intervals (CIs). We included seven RCTs involving 442 patients (227 for the experimental group and 215 for the control group). All the patients were divided into two groups: one treated with omega-3 PUFA and the other was the control group (generally placebo). The demographics of the omega-3 PUFA and control groups were comparable. Beneficial changes in alanine aminotransferase (ALT) (IV 95% CI: -7.61 [-12.83 to -2.39], p = 0.004), total cholesterol (TC) (IV 95% CI: -13.41 [-21.44 to -5.38], p = 0.001), triglyceride (TG) (IV 95% CI: -43.96 [-51.21 to -36.71], p<0.00001) and high-density lipoprotein cholesterol (HDL-C) (IV 95% CI: 6.97 [2.05 to 11.90], p = 0.006) favored omega-3 PUFA treatment. Omega-3 PUFA tended towards a beneficial effect on aspartate aminotransferase (AST) (IV 95% CI: -6.89 [-17.71 to 3.92], p =0.21),Upsilon-glutamyl transferase (GGT) (IV 95% CI: -8.28 [-18.38 to 1.83], p = 0.11) and lowdensity lipoprotein cholesterol (LDL-C) (IV 95% CI: -7.13 [-14.26 to 0.0], p = 0.05). Conclusions Supplementation with omega-3 PUFA is a practical and effective treatment for NAFLD to decrease ALT, TC and increase HDL-C, especially to decrease TG. Omega-3 PUFA also has a tendency toward a beneficial effect on AST, GGT and LDL-C. More high-quality, large RCTs are needed to validate our findings.	[He, Xi-Xi; Wu, Xiao-Li; Chen, Ren-Pin; Chen, Chao; Huang, Zhi-Ming] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China; [Liu, Xiao-Gang] Ningxia Peoples Hosp, Dept Gastroenterol, Ningxia, Peoples R China; [Wu, Bin-Jiao] Peoples Hosp Yueqing, Dept Acupuncture & Moxibust, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University	Huang, ZM (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Wenzhou, Zhejiang, Peoples R China.	wyyyhzhiming@126.com						Aithal GP, 2008, GASTROENTEROLOGY, V135, P1176, DOI 10.1053/j.gastro.2008.06.047; Angeli P, 2013, LIVER INT, V33, P16, DOI 10.1111/j.1478-3231.2012.02807.x; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Argo CK, 2015, J HEPATOL, V62, P190, DOI 10.1016/j.jhep.2014.08.036; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Capanni M, 2006, ALIMENT PHARM THER, V23, P1143, DOI 10.1111/j.1365-2036.2006.02885.x; Carvalhana S, 2012, CURR OPIN CLIN NUTR, V15, P468, DOI 10.1097/MCO.0b013e3283566614; Chen R, 2008, WORLD CHIN J DIGESTO, V16, P2002, DOI DOI 10.11569/WCJD.V16.I18.2002; Cormier H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030375; Dasarathy S, 2015, J CLIN GASTROENTEROL, V49, P137, DOI 10.1097/MCG.0000000000000099; Eckard C, 2013, THER ADV GASTROENTER, V6, P249, DOI 10.1177/1756283X13484078; Foroughi Mehdi, 2016, Iran J Nurs Midwifery Res, V21, P100, DOI 10.4103/1735-9066.174759; Fracanzani AL, 2016, ATHEROSCLEROSIS, V246, P208, DOI 10.1016/j.atherosclerosis.2016.01.016; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2485, DOI 10.1111/j.1572-0241.2003.08699.x; Hatzitolios Apostolos, 2004, Indian J Gastroenterol, V23, P131; Janczyk W, 2015, J PEDIATR-US, V166, P1358, DOI 10.1016/j.jpeds.2015.01.056; Janczyk W, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-85; Jump DB, 2015, ADV NUTR, V6, P694, DOI 10.3945/an.115.009423; Karnikowski M, 2007, SAO PAULO MED J, V125, P333, DOI 10.1590/S1516-31802007000600006; Kawanaka M, 2013, HEPATIC MED-EVID RES, V5, P11, DOI 10.2147/HMER.S41258; Kumar R, 2012, INDIAN J MED RES, V136, P229; Lalia AZ, 2015, DIABETES CARE, V38, P1228, DOI 10.2337/dc14-3101; Li L, 2016, OBES REV, V17, P510, DOI 10.1111/obr.12407; Li YH, 2015, WORLD J GASTROENTERO, V21, P7008, DOI 10.3748/wjg.v21.i22.7008; Lonardo A, 2015, METABOLISM; Marchesini G, 2001, LANCET, V358, P893, DOI 10.1016/S0140-6736(01)06042-1; Marchioli R, 2003, Minerva Cardioangiol, V51, P561; Moher David, 2009, Open Med, V3, pe123; Musso G, 2010, HEPATOLOGY, V52, P79, DOI 10.1002/hep.23623; Nobili V, 2013, NUTR METAB CARDIOVAS, V23, P1066, DOI 10.1016/j.numecd.2012.10.010; Nobili V, 2013, J MED FOOD, V16, P957, DOI 10.1089/jmf.2013.0043; Nobili V, 2011, ARCH DIS CHILD, V96, P350, DOI 10.1136/adc.2010.192401; Nogueira MA, 2013, J HEPATOL, V58, pS544, DOI 10.1016/S0168-8278(13)61352-5; Nogueira MA, 2016, CLIN NUTR, V35, P578, DOI 10.1016/j.clnu.2015.05.001; Parker HM, 2012, J HEPATOL, V56, P944, DOI 10.1016/j.jhep.2011.08.018; Patel SA, 2012, ENDOCRINOLOGY, V153, P5231, DOI 10.1210/en.2012-1368; Provenzano A, 2014, LIVER INT, V34, P918, DOI 10.1111/liv.12500; Razny U, 2015, BBA CLIN, V4, P7, DOI 10.1016/j.bbacli.2015.05.001; Ristic Vanja, 2003, Med Pregl, V56, P50, DOI 10.2298/MPNS0302050R; Sanyal AJ, 2014, GASTROENTEROLOGY, V147, P377, DOI 10.1053/j.gastro.2014.04.046; Saryusz-Wolska M, 2011, POL ARCH MED WEWN, V121, P61, DOI 10.20452/pamw.1023; Scorletti E, 2014, CONTEMP CLIN TRIALS, V37, P301, DOI 10.1016/j.cct.2014.02.002; Scorletti E, 2014, HEPATOLOGY, V60, P1211, DOI 10.1002/hep.27289; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Simopoulos AP, 2011, WORLD REV NUTR DIET, V102, P10, DOI 10.1159/000327785; Sofi F, 2010, INT J FOOD SCI NUTR, V61, P792, DOI 10.3109/09637486.2010.487480; Spadaro L, 2008, DIGEST LIVER DIS, V40, P194, DOI 10.1016/j.dld.2007.10.003; Suzuki-Kemuriyama N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157580; Tanaka N, 2008, J CLIN GASTROENTEROL, V42, P413, DOI 10.1097/MCG.0b013e31815591aa; Valenti L, 2003, DIGEST LIVER DIS, V35, P172, DOI 10.1016/S1590-8658(03)00025-2; Wang XC, 2015, ENDOCRINE, V48, P143, DOI 10.1007/s12020-014-0247-5; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123; Zhu FS, 2008, WORLD J GASTROENTERO, V14, P6395, DOI 10.3748/wjg.14.6395	55	61	65	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0162368	10.1371/journal.pone.0162368	http://dx.doi.org/10.1371/journal.pone.0162368			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711128	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600006
J	Hicks, MJ; Chiuchiolo, MJ; Ballon, D; Dyke, JP; Aronowitz, E; Funato, K; Tabar, V; Havlicek, D; Fan, F; Sondhi, D; Kaminsky, SM; Crystal, RG				Hicks, Martin J.; Chiuchiolo, Maria J.; Ballon, Douglas; Dyke, Jonathan P.; Aronowitz, Eric; Funato, Kosuke; Tabar, Viviane; Havlicek, David; Fan, Fan; Sondhi, Dolan; Kaminsky, Stephen M.; Crystal, Ronald G.			Anti-Epidermal Growth Factor Receptor Gene Therapy for Glioblastoma	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ADENOASSOCIATED VIRAL VECTORS; BLOOD-BRAIN-BARRIER; HIGH-GRADE GLIOMA; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMA; IMMUNE-RESPONSE; IN-VIVO; VIRUS; RADIOTHERAPY	Glioblastoma multiforme (GBM) is the most common and aggressive primary intracranial brain tumor in adults with a mean survival of 14 to 15 months. Aberrant activation of the epidermal growth factor receptor (EGFR) plays a significant role in GBM progression, with amplification or overexpression of EGFR in 60% of GBM tumors. To target EGFR expressed by GBM, we have developed a strategy to deliver the coding sequence for cetuximab, an anti-EGFR antibody, directly to the CNS using an adeno-associated virus serotype rh.10 gene transfer vector. The data demonstrates that single, local delivery of an anti-EGFR antibody by an AAVrh.10 vector coding for cetuximab (AAVrh. 10Cetmab) reduces GBM tumor growth and increases survival in xenograft mouse models of a human GBM EGFR-expressing cell line and patient-derived GBM. AAVrh10.CetMab-treated mice displayed a reduction in cachexia, a significant decrease in tumor volume and a prolonged survival following therapy. Adeno-associated-directed delivery of a gene encoding a therapeutic anti-EGFR monoclonal antibody may be an effective strategy to treat GBM.	[Hicks, Martin J.; Chiuchiolo, Maria J.; Havlicek, David; Fan, Fan; Sondhi, Dolan; Kaminsky, Stephen M.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Ballon, Douglas; Dyke, Jonathan P.; Aronowitz, Eric] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Funato, Kosuke; Tabar, Viviane] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY USA; [Hicks, Martin J.] Monmouth Univ, Dept Biol Sci, West Long Branch, NJ USA	Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Monmouth University	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu	Dyke, Jonathan/AAX-4362-2020; Kaminsky, Stephen/J-5141-2016	Dyke, Jonathan/0000-0001-7170-488X; Funato, Kosuke/0000-0003-2437-1116; Kaminsky, Stephen/0000-0003-1869-834X; Hicks, Martin J/0000-0001-8787-981X	Starr Cancer Consortium [I5-A537]; National Foundation for Cancer Research; Malcolm Hewitt Wiener Foundation; NIH [T32HL094284]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094284] Funding Source: NIH RePORTER	Starr Cancer Consortium; National Foundation for Cancer Research; Malcolm Hewitt Wiener Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by the Starr Cancer Consortium I5-A537, the National Foundation for Cancer Research and the Malcolm Hewitt Wiener Foundation. MJH was supported, in part, by NIH T32HL094284. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, DRUG METAB DISPOS, V41, P33, DOI 10.1124/dmd.112.048322; Aghi M, 2005, CURR OPIN MOL THER, V7, P419; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Aldape K, 2015, ACTA NEUROPATHOL, V129, P829, DOI 10.1007/s00401-015-1432-1; Allen C, 2013, GENE THER, V20, P444, DOI 10.1038/gt.2012.62; Amano S, 2011, CANCER GENOM PROTEOM, V8, P245; Ayoub D, 2013, MABS-AUSTIN, V5, P699, DOI 10.4161/mabs.25423; Azuaje F, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0098-6; Bourdenx M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00050; Bowers WJ, 2011, HUM MOL GENET, V20, pR28, DOI 10.1093/hmg/ddr110; Bronisz A, 2016, CELL MOL NEUROBIOL, V36, P361, DOI 10.1007/s10571-015-0293-4; Brown MC, 2015, CURR OPIN VIROL, V13, P81, DOI 10.1016/j.coviro.2015.05.007; Buning H, 2015, CURR OPIN PHARMACOL, V24, P94, DOI 10.1016/j.coph.2015.08.002; Calcedo R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00341; Castle MJ, 2016, METHODS MOL BIOL, V1382, P133, DOI 10.1007/978-1-4939-3271-9_10; Castro MG, 2014, EXPERT OPIN BIOL TH, V14, P1241, DOI 10.1517/14712598.2014.915307; Clement N, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.2; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Fine HA, 2015, CLIN CANCER RES, V21, P1984, DOI 10.1158/1078-0432.CCR-14-1328; Freskgard PO, 2017, NEUROPHARMACOLOGY, V120, P38, DOI 10.1016/j.neuropharm.2016.03.014; Fu P, 2016, MOL CLIN ONCOL, V4, P833, DOI 10.3892/mco.2016.816; Furnari FB, 2015, NAT REV CANCER, V15, P302, DOI 10.1038/nrc3918; Goffin JR, 2013, CLIN THER, V35, P1282, DOI 10.1016/j.clinthera.2013.08.007; Graham J, 2004, NAT REV DRUG DISCOV, V3, P549, DOI 10.1038/nrd1445; Hernandez-Pedro NY, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/716813; Hicks MJ, 2015, CANCER GENE THER, V22, P1, DOI 10.1038/cgt.2014.58; Jacobs Andreas, 1999, Neoplasia (New York), V1, P402, DOI 10.1038/sj.neo.7900056; Jordan JT, 2015, CANCER TREAT RES, V163, P117, DOI 10.1007/978-3-319-12048-5_8; Kane JR, 2015, NEURO-ONCOLOGY, V17, pII24, DOI 10.1093/neuonc/nou355; Khasraw M, 2014, EXPERT OPIN BIOL TH, V14, P729, DOI 10.1517/14712598.2014.898060; Kober C, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0586-x; Kwiatkowska Aneta, 2013, Cancers (Basel), V5, P1271, DOI 10.3390/cancers5041271; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Maguire CA, 2010, J NEURO-ONCOL, V96, P337, DOI 10.1007/s11060-009-9972-7; Murlidharan G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00076; Murphy AM, 2013, TRANSL RES, V161, P339, DOI 10.1016/j.trsl.2012.11.003; Natsume A, 2008, CELL ADHES MIGR, V2, P186, DOI 10.4161/cam.2.3.6278; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Niyazi M, 2016, ONCOTARGET, V7, P2313, DOI 10.18632/oncotarget.6320; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; Okura Hidehiro, 2014, Mol Cell Ther, V2, P21, DOI 10.1186/2052-8426-2-21; Omuro A, 2014, CLIN CANCER RES, V20, P5023, DOI 10.1158/1078-0432.CCR-14-0822; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Penas-Prado M, 2012, HAND CLINIC, V105, P485, DOI 10.1016/B978-0-444-53502-3.00004-5; Pulkkanen KJ, 2005, MOL THER, V12, P585, DOI 10.1016/j.ymthe.2005.07.357; Rainov NG, 2000, GENE THER, V7, P1853, DOI 10.1038/sj.gt.3301311; Rashnonejad A, 2016, MOL BIOTECHNOL, V58, P30, DOI 10.1007/s12033-015-9899-5; Rosen S T, 2015, CURRENT UNDERSTANDIN; Rosenberg JB, 2014, HUM GENE THER CL DEV, V25, P164, DOI 10.1089/humc.2013.239; Rosso L, 2009, CANCER RES, V69, P120, DOI 10.1158/0008-5472.CAN-08-2356; Santiago-Ortiz JL, 2016, J CONTROL RELEASE, V240, P287, DOI 10.1016/j.jconrel.2016.01.001; Shah K, 2011, METHODS MOL BIOL, V680, P153, DOI 10.1007/978-1-60761-901-7_11; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sondhi D, 2007, MOL THER, V15, P481, DOI 10.1038/sj.mt.6300049; St-Amour I, 2013, J CEREBR BLOOD F MET, V33, P1983, DOI 10.1038/jcbfm.2013.160; Staedtke V, 2016, EXPERT OPIN INV DRUG, V25, P937, DOI 10.1080/13543784.2016.1182497; Stockhausen MT, 2011, EXP CELL RES, V317, P1513, DOI 10.1016/j.yexcr.2011.04.001; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tobias A, 2013, J NEUROL NEUROSUR PS, V84, P213, DOI 10.1136/jnnp-2012-302946; Van den Eynde M, 2011, ACTA CLIN BELG, V66, P10, DOI 10.1179/ACB.66.1.2062508; Vandenberghe LH, 2009, GENE THER, V16, P311, DOI 10.1038/gt.2008.170; Watanabe M, 2010, GENE THER, V17, P1042, DOI 10.1038/gt.2010.87; Wehrenberg-Klee E, 2015, AM J NUCL MED MOLEC, V5, P379; Weidle UH, 2015, CANCER GENOM PROTEOM, V12, P167; Worgall S, 2008, HUM GENE THER, V19, P463, DOI 10.1089/hum.2008.022; Zerah M, 2015, HUM GENE THER CL DEV, V26, P113, DOI 10.1089/humc.2014.139; Zinn KR, 2015, MOL IMAGING BIOL, V17, P49, DOI 10.1007/s11307-014-0773-9	69	15	17	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0162978	10.1371/journal.pone.0162978	http://dx.doi.org/10.1371/journal.pone.0162978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711187	Green Submitted, gold, Green Published			2022-12-27	WOS:000385697600011
J	Olafsdottir, AS; Hornell, A; Hedelin, M; Waling, M; Gunnarsdottir, I; Olsson, C				Olafsdottir, Anna S.; Hornell, Agneta; Hedelin, Marlene; Waling, Maria; Gunnarsdottir, Ingibjorg; Olsson, Cecilia			Development and Validation of a Photographic Method to Use for Dietary Assessment in School Settings	PLOS ONE			English	Article							DIGITAL PHOTOGRAPHY; ENERGY-INTAKE; VALIDITY; CHILDREN; INDIVIDUALS	Objective To develop and validate a photographic method aimed at making assessment of dietary intake in school canteens non-obstrusive, practical and feasible. Methods The study was conducted in two elementary schools representing two different school canteen systems; main dish being served by canteen staff (Iceland), and complete self-serving (Sweden). Food items in serving and leftovers were weighed and photographed. Trained researchers estimated weights of food items by viewing the photographs and comparing them with pictures of half and full reference portions with known weights. Plates of servings and leftovers from 48 children during five school days (n = 448 plates) and a total of 5967 food items were estimated. The researchers' estimates were then compared with the true weight of the foods and the energy content calculated. Results Weighed and estimated amounts correlated across meals both in grams and as total energy (0.853-0.977, p<0.001). The agreement between estimated energy content in school meals was close to the true measurement from weighed records; on average 4-19 kcal below true values. Organisation of meal service impacted the efficacy of the method as seen in the difference between countries; with Iceland (served by canteen staff) having higher rate of acceptable estimates than Sweden (self-serving), being 95% vs 73% for total amount (g) in serving. Iceland more often had serving size between or above the half and full reference plates compared with Sweden. Conclusions The photographic method provides acceptable estimates of food and energy intake in school canteens. However, greater accuracy can be expected when foods are served by canteen staff compared with self-serving.	[Olafsdottir, Anna S.] Univ Iceland, Sch Educ, Reykjavik, Iceland; [Hornell, Agneta; Hedelin, Marlene; Waling, Maria; Olsson, Cecilia] Umea Univ, Dept Food & Nutr, Umea, Sweden; [Gunnarsdottir, Ingibjorg] Natl Univ Hosp Iceland, Unit Nutr Res, Landspitali, Reykjavik, Iceland; [Gunnarsdottir, Ingibjorg] Univ Iceland, Sch Hlth Sci, Fac Food Sci & Nutr, Reykjavik, Iceland	University of Iceland; Umea University; University of Iceland	Olafsdottir, AS (corresponding author), Univ Iceland, Sch Educ, Reykjavik, Iceland.	annaso@hi.is	Hörnell, Agneta/AAZ-2206-2021; Hörnell, Agneta/H-9058-2016; Olafsdottir, Anna S/A-8804-2013	Hörnell, Agneta/0000-0002-5464-5686; Hörnell, Agneta/0000-0002-5464-5686; Olafsdottir, Anna S/0000-0002-7258-1727; Gunnarsdottir, Ingibjorg/0000-0001-9447-8627	Nord Forsk [54761]	Nord Forsk	This work was funded by Nord Forsk (grant number 54761). Nord Forsk had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amcoff E, 2008, REVIDERING MATMALLEN, DOI 10.11613/bm.2015.015; Burrows TL, 2010, J AM DIET ASSOC, V110, P1501, DOI 10.1016/j.jada.2010.07.008; Gemming L, 2015, J ACAD NUTR DIET, V115, P64, DOI 10.1016/j.jand.2014.09.015; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Higgins JA, 2009, EUR J CLIN NUTR, V63, P1025, DOI 10.1038/ejcn.2009.12; Japur CC, 2010, J HUM NUTR DIET, V23, P272, DOI 10.1111/j.1365-277X.2010.01042.x; Jia WY, 2014, PUBLIC HEALTH NUTR, V17, P1671, DOI 10.1017/S1368980013003236; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Livingstone MBE, 2003, J NUTR, V133, p895S, DOI 10.1093/jn/133.3.895S; Lu AS, 2014, J HUM NUTR DIET, V27, P5, DOI 10.1111/j.1365-277X.2012.01258.x; Martin Corby K, 2007, Eat Behav, V8, P148, DOI 10.1016/j.eatbeh.2006.03.003; Martin CK, 2009, BRIT J NUTR, V101, P446, DOI 10.1017/S0007114508027438; Masson LF, 2003, PUBLIC HEALTH NUTR, V6, P313, DOI 10.1079/PHN2002429; McPherson RS, 2000, PREV MED, V31, pS11, DOI 10.1006/pmed.2000.0631; Nicklas TA, 2012, J NUTR EDUC BEHAV, V44, P618, DOI 10.1016/j.jneb.2011.12.001; Ptomey LT, 2015, J ACAD NUTR DIET, V115, P1392, DOI 10.1016/j.jand.2015.05.006; Rangan A, 2014, J HUM NUTR DIET, V27, P450, DOI 10.1111/jhn.12182; Sabinsky MS, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.20243; Serra-Majem L, 2009, BRIT J NUTR, V102, pS3, DOI 10.1017/S0007114509993114; Swanson M, 2008, J SCHOOL HEALTH, V78, P432, DOI 10.1111/j.1746-1561.2008.00326.x; van Stralen KJ, 2012, NEPHRON CLIN PRACT, V120, pC162, DOI 10.1159/000337798; Waling M, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.30468; Wang DH, 2006, J AM DIET ASSOC, V106, P1588, DOI 10.1016/j.jada.2006.07.004; Williamson D A, 2004, Eat Weight Disord, V9, P24; Williamson DA, 2003, J AM DIET ASSOC, V103, P1139, DOI 10.1016/S0002-8223(03)00974-X	26	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0163970	10.1371/journal.pone.0163970	http://dx.doi.org/10.1371/journal.pone.0163970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711120	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697600055
J	Zhang, JG; Xu, XW; Li, SY; Zhao, Y; Zhang, AF; Zhang, TB; Jiang, R				Zhang, Jianguo; Xu, Xinwen; Li, Shengyu; Zhao, Ying; Zhang, Afeng; Zhang, Tibin; Jiang, Rui			Is the Taklimakan Desert Highway Shelterbelt Sustainable to Long-Term Drip Irrigation with High Saline Groundwater?	PLOS ONE			English	Article							SOIL EVAPORATION; MANAGEMENT STRATEGIES; WATER IRRIGATION; PLANT-GROWTH; FOREST; HINTERLAND; CHINA; CLASSIFICATION; AGRICULTURE; PROJECT	Freshwater resources are scarce in desert regions. Highly saline groundwater of different salinity is being used to drip irrigate the Taklimakan Desert Highway Shelterbelt with a double- branch-pipe system controlling the irrigation cycles. In this study, to evaluate the dynamics of soil moisture and salinity under the current irrigation system, soil samples were collected to a 2-m depth in the shelterbelt planted for different years and irrigated with different groundwater salinities, and soil moisture and salinity were analyzed. The results showed that both depletion of soil moisture and increase of topsoil salinity occurred simultaneously during one irrigation cycle. Soil moisture decreased from 27.4% to 2.4% for a 15-day irrigation cycle and from 26.4% to 2.7% for a 10-day-cycle, respectively. Topsoil electrical conductivity (EC) increased from 0.64 to 3.32 dS/m and 0.70 to 3.99 dS/m for these two irrigation cycles. With increased shelterbelt age, profiled average soil moisture (0-200 cm) reduced from 12.8% (1-year) to 7.1% (10-year); however, soil moisture in 0-20-cm increased, while topsoil salinity decreased. In addition, irrigation salinity mainly affected soil salinity in the 0-20-cm range. We conclude that water supply with the double-branch-pipe is a feasible irrigation method for the Taklimakan Desert Highway Shelterbelt, and our findings provide a model for shelterbelt construction and sustainable management when using highly saline water for irrigation in analogous habitats.	[Zhang, Jianguo; Zhao, Ying; Zhang, Afeng; Jiang, Rui] Northwest A&F Univ, Minist Agr, Key Lab Plant Nutr & Agri Environm Northwest Chin, Yangling, Shaanxi, Peoples R China; [Xu, Xinwen; Li, Shengyu; Zhao, Ying] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China; [Zhang, Tibin] Northwest A&F Univ, Inst Soil & Water Conversat, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China	Zhao, Y (corresponding author), Northwest A&F Univ, Minist Agr, Key Lab Plant Nutr & Agri Environm Northwest Chin, Yangling, Shaanxi, Peoples R China.; Li, SY; Zhao, Y (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China.	oasis@ms.xjb.ac.cn; yzhaosoils@gmail.com			National Natural Science Foundation of China [41471222, 41301038]; Thousand Youth Talents Plan Project [Y472241001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Thousand Youth Talents Plan Project	The study was supported by the financial support by the National Natural Science Foundation of China (41471222, 41301038) and Thousand Youth Talents Plan Project (Y472241001).	Beltran JM, 1999, AGR WATER MANAGE, V40, P183, DOI 10.1016/S0378-3774(98)00120-6; Brown L R, 1998, World Watch, V11, P10; Chen M, 2009, AGR WATER MANAGE, V96, P1766, DOI 10.1016/j.agwat.2009.07.007; Cheng DH, 2013, J HYDROL, V490, P106, DOI 10.1016/j.jhydrol.2013.03.027; D'Odorico P, 2013, ADV WATER RESOUR, V51, P326, DOI 10.1016/j.advwatres.2012.01.013; Fan JL, 2008, CHINESE SCI BULL, V53, P53, DOI 10.1007/s11434-008-6005-4; Han W, 2012, ECOL ENG, V40, P108, DOI 10.1016/j.ecoleng.2011.12.009; Jin ZZ, 2008, CHINESE SCI BULL, V53, P125, DOI 10.1007/s11434-008-6015-2; Kang Y.H., 1998, T CHIN SOC AGR ENG, V14, P251; Lei JQ, 2008, CHINESE SCI BULL, V53, P1, DOI 10.1007/s11434-008-6023-2; Lei JQ, 2008, CHINESE SCI BULL, V53, P190, DOI 10.1007/s11434-008-6022-3; Li BW, 2008, CHINESE SCI BULL, V53, P31, DOI 10.1007/s11434-008-6003-6; Li CJ, 2015, SOIL TILL RES, V146, P99, DOI 10.1016/j.still.2014.03.013; Li XB, 2015, SOIL TILL RES, V146, P159, DOI 10.1016/j.still.2014.10.005; Liu XY, 2012, SCI CHINA EARTH SCI, V55, P446, DOI 10.1007/s11430-011-4251-9; Malash N, 2005, AGR WATER MANAGE, V78, P25, DOI 10.1016/j.agwat.2005.04.016; Mamitimin Y, 2015, ENVIRON EARTH SCI, V73, P559, DOI 10.1007/s12665-014-3245-2; Middleton N., 1997, WORLD ATLAS DESERTIF; MODAIHSH AS, 1985, SOIL SCI, V139, P357, DOI 10.1097/00010694-198504000-00010; Murtaza G, 2006, AGR WATER MANAGE, V81, P98, DOI 10.1016/j.agwat.2005.03.003; Qadir M, 2004, SCI TOTAL ENVIRON, V323, P1, DOI 10.1016/j.scitotenv.2003.10.012; Raz-Yaseef N, 2010, AGR FOREST METEOROL, V150, P454, DOI 10.1016/j.agrformet.2010.01.010; Riediger Jan, 2014, Environmental Sciences Europe, V26, DOI 10.1186/s12302-014-0018-1; Seckler D., 1999, International Journal of Water Resources Development, V15, P29, DOI 10.1080/07900629948916; Setia R, 2013, SCI TOTAL ENVIRON, V465, P267, DOI 10.1016/j.scitotenv.2012.08.028; Skaggs TH, 2014, WATER RESOUR RES, V50, P9656, DOI 10.1002/2014WR016058; Sperling O, 2014, ENVIRON EXP BOT, V99, P100, DOI 10.1016/j.envexpbot.2013.10.014; Valdez-Aguilar LA, 2013, J PLANT NUTR, V36, P1605, DOI 10.1080/01904167.2013.799188; Wang XJ, 2008, CHINESE SCI BULL, V53, P79, DOI 10.1007/s11434-008-6008-1; Wang YD, 2008, CHINESE SCI BULL, V53, P102, DOI 10.1007/s11434-008-6011-6; Xu H, 2008, CHINESE SCI BULL, V53, P146, DOI 10.1007/s11434-008-6017-0; Xu XW, 2006, CHINESE SCI BULL, V51, P161, DOI 10.1007/s11434-006-8221-0; Zhang JG, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1285; Zhang JG, 2013, J SOIL SCI PLANT NUT, V13, P1019, DOI 10.4067/S0718-95162013005000080; Zhang Jian-guo, 2014, Yingyong Shengtai Xuebao, V25, P1415; [张建国 ZHANG Jian-guo], 2009, [自然资源学报, Journal of Natural Resources], V24, P849; [张建国 Zhang Jianguo], 2013, [灌溉排水学报, Journal of Irrigation and Drainage], V32, P55; [张建国 Zhang Jianguo], 2011, [水土保持通报, Bulletin of Soil and Water Conservation], V31, P145; Zhang JG, 2008, CHINESE SCI BULL, V53, P63, DOI 10.1007/s11434-008-6006-3; Zhang JianGuo, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P34; Zhou HW, 2008, CHINESE SCI BULL, V53, P137, DOI 10.1007/s11434-008-6016-1	41	4	7	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2016	11	10							e0164106	10.1371/journal.pone.0164106	http://dx.doi.org/10.1371/journal.pone.0164106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UR	27711244	Green Published, Green Submitted, gold			2022-12-27	WOS:000385697600077
J	Rinne, P; Mace, M; Nakornchai, T; Zimmerman, K; Fayer, S; Sharma, P; Liardon, JL; Burdet, E; Bentley, P				Rinne, Paul; Mace, Michael; Nakornchai, Tagore; Zimmerman, Karl; Fayer, Susannah; Sharma, Pankaj; Liardon, Jean-Luc; Burdet, Etienne; Bentley, Paul			Democratizing Neurorehabilitation: How Accessible are Low-Cost Mobile-Gaming Technologies for Self-Rehabilitation of Arm Disability in Stroke?	PLOS ONE			English	Article							ROBOT-ASSISTED THERAPY; PROOF-OF-CONCEPT; FORCE CONTROL	Motor-training software on tablets or smartphones (Apps) offer a low-cost, widely-available solution to supplement arm physiotherapy after stroke. We assessed the proportions of hemiplegic stroke patients who, with their plegic hand, could meaningfully engage with mobile-gaming devices using a range of standard control-methods, as well as by using a novel wireless grip-controller, adapted for neurodisability. We screened all newly-diagnosed hemiplegic stroke patients presenting to a stroke centre over 6 months. Subjects were compared on their ability to control a tablet or smartphone cursor using: finger-swipe, tap, joystick, screen-tilt, and an adapted handgrip. Cursor control was graded as: no movement (0); less than full-range movement (1); full-range movement (2); directed movement (3). In total, we screened 345 patients, of which 87 satisfied recruitment criteria and completed testing. The commonest reason for exclusion was cognitive impairment. Using conventional controls, the proportion of patients able to direct cursor movement was 38-48%; and to move it full-range was 55-67% (controller comparison: p>0.1). By comparison, handgrip enabled directed control in 75%, and full-range movement in 93% (controller comparison: p<0.001). This difference between controllers was most apparent amongst severely-disabled subjects, with 0% achieving directed or full-range control with conventional controls, compared to 58% and 83% achieving these two levels of movement, respectively, with handgrip. In conclusion, hand, or arm, training Apps played on conventional mobile devices are likely to be accessible only to mildly-disabled stroke patients. Technological adaptations such as grip-control can enable more severely affected subjects to engage with self-training software.	[Rinne, Paul; Nakornchai, Tagore; Zimmerman, Karl; Fayer, Susannah; Liardon, Jean-Luc; Bentley, Paul] Imperial Coll, Div Brain Sci, London, England; [Mace, Michael; Burdet, Etienne] Imperial Coll, Dept Bioengn, Human Robot Grp, London, England; [Sharma, Pankaj] Royal Holloway Univ London, Inst Cardiovasc Res, London, England	Imperial College London; Imperial College London; University of London; Royal Holloway University London	Bentley, P (corresponding author), Imperial Coll, Div Brain Sci, London, England.	p.bentley@ic.ac.uk	Zimmerman, Karl/AAL-4988-2020; sharma, pankaj/HGE-4423-2022; Zimmerman, Karl/S-3406-2016	Zimmerman, Karl/0000-0003-1239-3414; Zimmerman, Karl/0000-0003-1239-3414; Bentley, Paul/0000-0001-8036-7010; Burdet, Etienne/0000-0002-2123-0185; Nakornchai, Tagore/0000-0003-1573-9812	Imperial College Confidence in Concept Award; NHS England Innovation Challenge; EU [PEOPLE-ITN-317488-CONTEST, ICT-601003 BALANCE, ICT-2013-10 SYMBITRON, EU-H2020 ICT-644727 COGIMON]; MRC [MC_PC_14100] Funding Source: UKRI; Medical Research Council [MC_PC_14100] Funding Source: researchfish	Imperial College Confidence in Concept Award; NHS England Innovation Challenge; EU(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by an Imperial College Confidence in Concept Award, NHS England Innovation Challenge Prize, and in part by EU-FP7 grants PEOPLE-ITN-317488-CONTEST, ICT-601003 BALANCE, ICT-2013-10 SYMBITRON, and EU-H2020 ICT-644727 COGIMON.	Balasubramanian S, 2010, CURR OPIN NEUROL, V23, P661, DOI 10.1097/WCO.0b013e32833e99a4; Beebe JA, 2009, STROKE, V40, P1772, DOI 10.1161/STROKEAHA.108.536763; Bernhardt J, 2007, J REHABIL MED, V39, P43, DOI 10.2340/16501977-0013; Dipietro L, 2012, IEEE T NEUR SYS REH, V20, P48, DOI 10.1109/TNSRE.2011.2175008; Friedman N, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-76; Jarrasse Nathanael, 2013, IEEE Int Conf Rehabil Robot, V2013, P6650379, DOI 10.1109/ICORR.2013.6650379; Kizony R, 2016, J NEUROL PHYS THER, V40, P31, DOI 10.1097/NPT.0000000000000110; Krebs HI, 2007, IEEE T NEUR SYS REH, V15, P327, DOI 10.1109/TNSRE.2007.903899; Lambercy O, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-63; Lindberg PG, 2012, BRAIN RES, V1452, P96, DOI 10.1016/j.brainres.2012.03.007; Lohse KR, 2014, STROKE, V45, P2053, DOI 10.1161/STROKEAHA.114.004695; Mace M, 2015, REH ROB ICORR 2015 I; Naik SK, 2011, EXP BRAIN RES, V211, P1, DOI 10.1007/s00221-011-2637-8; NICE, 2013, NAT I CLIN EXC CG 16; Norouzi-Gheidari N, 2012, J REHABIL RES DEV, V49, P479, DOI 10.1682/JRRD.2010.10.0210; Noskin O, 2008, J NEUROL NEUROSUR PS, V79, P401, DOI 10.1136/jnnp.2007.118463; Raghavan Preeti, 2007, Curr Treat Options Cardiovasc Med, V9, P221; Rand D, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0796-9; Rinne P, 2013, NEUROLOGY, V81, P812, DOI 10.1212/WNL.0b013e3182a2ca34; Saposnik G, 2014, INT J STROKE, V9, P956, DOI 10.1111/ijs.12328; Susanto EA, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0033-5; Thomson K, 2016, DISABIL REHABIL-ASSI, V11, P454, DOI 10.3109/17483107.2015.1005031; Thomson K, 2014, INT J STROKE, V9, P479, DOI 10.1111/ijs.12263; Wagner TH, 2011, STROKE, V42, P2630, DOI 10.1161/STROKEAHA.110.606442	24	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2016	11	10							e0163413	10.1371/journal.pone.0163413	http://dx.doi.org/10.1371/journal.pone.0163413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ2UN	27706248	Green Published, gold, Green Submitted			2022-12-27	WOS:000385697200044
J	Hilbe, C; Hagel, K; Milinski, M				Hilbe, Christian; Hagel, Kristin; Milinski, Manfred			Asymmetric Power Boosts Extortion in an Economic Experiment	PLOS ONE			English	Article							ITERATED PRISONERS-DILEMMA; ZERO-DETERMINANT STRATEGIES; DIRECT RECIPROCITY; HUMAN COOPERATION; EVOLUTION; GENEROSITY; COEVOLUTION; CHOOSINESS; PLAYERS; GAMES	Direct reciprocity is a major mechanism for the evolution of cooperation. Several classical studies have suggested that humans should quickly learn to adopt reciprocal strategies to establish mutual cooperation in repeated interactions. On the other hand, the recently discovered theory of ZD strategies has found that subjects who use extortionate strategies are able to exploit and subdue cooperators. Although such extortioners have been predicted to succeed in any population of adaptive opponents, theoretical follow-up studies questioned whether extortion can evolve in reality. However, most of these studies presumed that individuals have similar strategic possibilities and comparable outside options, whereas asymmetries are ubiquitous in real world applications. Here we show with a model and an economic experiment that extortionate strategies readily emerge once subjects differ in their strategic power. Our experiment combines a repeated social dilemma with asymmetric partner choice. In our main treatment there is one randomly chosen group member who is unilaterally allowed to exchange one of the other group members after every ten rounds of the social dilemma. We find that this asymmetric replacement opportunity generally promotes cooperation, but often the resulting payoff distribution reflects the underlying power structure. Almost half of the subjects in a better strategic position turn into extortioners, who quickly proceed to exploit their peers. By adapting their cooperation probabilities consistent with ZD theory, extortioners force their co-players to cooperate without being similarly cooperative themselves. Comparison to non-extortionate players under the same conditions indicates a substantial net gain to extortion. Our results thus highlight how power asymmetries can endanger mutually beneficial interactions, and transform them into exploitative relationships. In particular, our results indicate that the extortionate strategies predicted from ZD theory could play a more prominent role in our daily interactions than previously thought.	[Hilbe, Christian] Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Hilbe, Christian] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Hilbe, Christian] IST Austria, Klosterneuburg, Austria; [Hagel, Kristin; Milinski, Manfred] Max Planck Inst Evolut Biol, Dept Evolutionary Ecol, Plon, Germany	Harvard University; Harvard University; Institute of Science & Technology - Austria; Max Planck Society	Hilbe, C (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA.; Hilbe, C (corresponding author), Harvard Univ, Dept Math, Cambridge, MA 02138 USA.; Hilbe, C (corresponding author), IST Austria, Klosterneuburg, Austria.; Milinski, M (corresponding author), Max Planck Inst Evolut Biol, Dept Evolutionary Ecol, Plon, Germany.	christian.hilbe@ist.ac.at; milinski@evolbio.mpg.de	Hilbe, Christian/K-9412-2013	Hilbe, Christian/0000-0001-5116-955X				Akin E, 2013, STABLE COOPERATIVE S; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Ball P, 2012, NATURE, DOI [10.1038/nature.2012.11254, DOI 10.1038/NATURE.2012.11254]; Chen J, 2014, J THEOR BIOL, V357, P46, DOI 10.1016/j.jtbi.2014.05.004; Dal Bo P, 2005, AM ECON REV, V95, P1591; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dong YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137435; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; Gachter S, 2010, PHILOS T R SOC B, V365, P2651, DOI 10.1098/rstb.2010.0135; Grujic J, 2014, SCI REP-UK, V4, DOI 10.1038/srep04615; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hao D, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.052803; Hauert C, 1997, P ROY SOC B-BIOL SCI, V264, P513, DOI 10.1098/rspb.1997.0073; Hilbe C, 2015, J THEOR BIOL, V374, P115, DOI 10.1016/j.jtbi.2015.03.032; Hilbe C, 2014, P NATL ACAD SCI USA, V111, P16425, DOI 10.1073/pnas.1407887111; Hilbe C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4976; Hilbe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077886; Hilbe C, 2013, P NATL ACAD SCI USA, V110, P6913, DOI 10.1073/pnas.1214834110; Hoffman M, 2015, P NATL ACAD SCI USA, V112, P1727, DOI 10.1073/pnas.1417904112; Imhof LA, 2005, P NATL ACAD SCI USA, V102, P10797, DOI 10.1073/pnas.0502589102; Imhof LA, 2010, P ROY SOC B-BIOL SCI, V277, P463, DOI 10.1098/rspb.2009.1171; Martinez-Vaquero LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035135; McAvoy A, 2016, AUTOCRATIC STRATEGIE; McAvoy A, 2016, P NATL ACAD SCI USA, V113, P3573, DOI 10.1073/pnas.1520163113; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; Melis AP, 2010, PHILOS T R SOC B, V365, P2663, DOI 10.1098/rstb.2010.0157; Milinski M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10915; MOLANDER P, 1985, J CONFLICT RESOLUT, V29, P611, DOI 10.1177/0022002785029004004; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ostrom Elinor, 1990, GOVERNING COMMONS EV; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Sasaki T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2498; Sherratt TN, 1998, J THEOR BIOL, V193, P167, DOI 10.1006/jtbi.1998.0703; Smith JE, 2016, TRENDS ECOL EVOL, V31, P54, DOI 10.1016/j.tree.2015.09.013; Stewart AJ, 2013, P NATL ACAD SCI USA, V110, P15348, DOI 10.1073/pnas.1306246110; Stewart AJ, 2012, P NATL ACAD SCI USA, V109, P10134, DOI 10.1073/pnas.1208087109; Szolnoki A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05496; Szolnoki A, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022804; Tomasello M, 2009, WHY WE COOPERATE, P1; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Lange P. A. M., 2015, SOCIAL DILEMMAS PSYC; van Veelen M, 2012, P NATL ACAD SCI USA, V109, P9929, DOI 10.1073/pnas.1206694109; Wardil L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147850; Wedekind C, 1996, P NATL ACAD SCI USA, V93, P2686, DOI 10.1073/pnas.93.7.2686; Wu ZX, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062102; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V50, P67, DOI 10.1037/0022-3514.50.1.67; Zhong WB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12702	52	16	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2016	11	10							e0163867	10.1371/journal.pone.0163867	http://dx.doi.org/10.1371/journal.pone.0163867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DZ2UK	27701427	Green Submitted, Green Published, gold			2022-12-27	WOS:000385696900024
J	Adler, PH; Takaoka, H; Sofian-Azirun, M; Low, V; Ya'cob, Z; Chen, CD; Lau, KW; Pham, XD				Adler, Peter H.; Takaoka, Hiroyuki; Sofian-Azirun, Mohd; Low, Van Lun; Ya'cob, Zubaidah; Chen, Chee Dhang; Lau, Koon Weng; Xuan Da Pham			Vietnam, a Hotspot for Chromosomal Diversity and Cryptic Species in Black Flies (Diptera: Simuliidae)	PLOS ONE			English	Article							SALIVARY-GLAND CHROMOSOME; COMPLEX DIPTERA; CYTOLOGICAL DESCRIPTION; POPULATION-GENETICS; TUBEROSUM; THAILAND; SPECIATION; CYTOGENETICS; POLYMORPHISM; DROSOPHILA	The increasing attention on Vietnam as a biodiversity hotspot prompted an investigation of the potential for cryptic diversity in black flies, a group well known elsewhere for its high frequency of isomorphic species. We analyzed the banding structure of the larval polytene chromosomes in the Simulium tuberosum species group to probe for diversity beyond the morphological level. Among 272 larvae, 88 different chromosomal rearrangements, primarily paracentric inversions, were discovered in addition to 25 already known in the basic sequences of the group in Asia. Chromosomal diversity in Vietnam far exceeds that known for the group in Thailand, with only about 5% of the rearrangements shared between the two countries. Fifteen cytoforms and nine morphoforms were revealed among six nominal species in Vietnam. Chromosomal evidence, combined with available molecular and morphological evidence, conservatively suggests that at least five of the cytoforms are valid species, two of which require formal names. The total chromosomal rearrangements and species (15) now known from the group in Vietnam far exceed those of any other area of comparable size in the world, supporting the country's status as a biodiversity hotspot. Phylogenetic inference based on uniquely shared, derived chromosomal rearrangements supports the clustering of cytoforms into two primary lineages, the Simulium tani complex and the Southeast Asian Simulium tuberosum subgroup. Some of these taxa could be threatened by habitat destruction, given their restricted geographical distributions and the expanding human population of Vietnam.	[Adler, Peter H.] Clemson Univ, Dept Agr & Environm Sci, Clemson, SC 29634 USA; [Takaoka, Hiroyuki; Sofian-Azirun, Mohd; Ya'cob, Zubaidah; Chen, Chee Dhang; Lau, Koon Weng] Univ Malaya, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Low, Van Lun] Univ Malaya, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia; [Xuan Da Pham] Natl Agcy Southern Reg, Minist Sci & Technol, Ho Chi Minh City 700000, Vietnam	Clemson University; Universiti Malaya; Universiti Malaya	Adler, PH (corresponding author), Clemson Univ, Dept Agr & Environm Sci, Clemson, SC 29634 USA.	padler@clemson.edu	AZIRUN, MOHD SOFIAN/B-9127-2010; Lau, Koon Weng/ABD-9347-2021; Ya'cob, Zubaidah/R-4012-2019; Low, Van Lun/C-8045-2013; Chen, Chee Dhang/ABD-9353-2021; Chen, Chee Dhang/C-6482-2011; Ya'cob, Zubaidah/L-7021-2017	Low, Van Lun/0000-0002-4299-5339; Ya'cob, Zubaidah/0000-0002-7178-6122	National Institute of Food and Agriculture of the US Department of Agriculture; University of Malaya [RP021A-16SUS]	National Institute of Food and Agriculture of the US Department of Agriculture; University of Malaya(Universiti Malaya)	National Institute of Food and Agriculture of the US Department of Agriculture (https://nifa.usda.gov) partly supported the work of PHA. University of Malaya (http://www.um.edu.my/) research grant RP021A-16SUS to HT supported the research of HT, MSA, VLL, ZY, CDC, and KWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PH, 2015, MED VET ENTOMOL, V29, P276, DOI 10.1111/mve.12115; Adler P. H., 2016, WORLD BLACKFLIES DIP; Adler PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158272; Adler PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147673; Adler PH, 2015, ZOOTAXA, V3975, P1, DOI 10.11646/zootaxa.3975.1.1; Adler PH, 2015, BIOL J LINN SOC, V114, P163, DOI 10.1111/bij.12403; Adler PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070765; Adler PH, 2011, CAN ENTOMOL, V143, P612, DOI 10.4039/n11-035; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; ADLER PH, 1994, ENTOMOL SCAND, V25, P439; Adler PH, 2001, CAN J ZOOL, V79, P1972, DOI 10.1139/cjz-79-11-1972; Adler PH, 2004, BLACK FLIES SIMULIID; Bain RH, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)417<0001:CSOACF>2.0.CO;2; BEDO DG, 1979, EVOLUTION, V33, P296, DOI [10.2307/2407620, 10.1111/j.1558-5646.1979.tb04683.x]; Besansky NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P97; CARSON HL, 1967, P NATL ACAD SCI USA, V57, P1280, DOI 10.1073/pnas.57.5.1280; Chubareva L.A., 2008, TSITOLOGICHESKIE KAR; Conflitti IM, 2014, MOL PHYLOGENET EVOL, V78, P43, DOI 10.1016/j.ympev.2014.05.001; CONN J, 1989, CAN J ZOOL, V67, P1217, DOI 10.1139/z89-176; Gaffigan TV, 2016, SYSTEMATIC CATALOG C; Giao PM, 1998, ANIM CONSERV, V1, P61, DOI 10.1111/j.1469-1795.1998.tb00227.x; HENDERSON CAP, 1986, CAN J ZOOL, V64, P859, DOI 10.1139/z86-129; Huang Yao-Te, 2011, Medical Entomology and Zoology, V62, P23; LANDAU R, 1962, CAN J ZOOLOG, V40, P921, DOI 10.1139/z62-082; MASON GF, 1984, CAN J ZOOL, V62, P647, DOI 10.1139/z84-096; MAURAND J, 1975, Annales de Parasitologie Humaine et Comparee, V50, P371; Monastyrskii A.L., 2013, CURRENT PROGR BIOL R, P95, DOI [10.5772/55490, DOI 10.5772/55490]; NEWMAN LJ, 1983, CAN J ZOOL, V61, P2816, DOI 10.1139/z83-369; O'Grady PM, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-6; PASTERNAK J, 1964, CAN J ZOOLOG, V42, P135, DOI 10.1139/z64-013; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Post RJ, 2007, TROP MED INT HEALTH, V12, P1342, DOI 10.1111/j.1365-3156.2007.01921.x; Pramual P, 2005, MOL ECOL, V14, P3989, DOI 10.1111/j.1365-294X.2005.02639.x; Pramual P, 2015, J ASIA-PAC ENTOMOL, V18, P33, DOI 10.1016/j.aspen.2014.11.002; Pramual P, 2014, MOL ECOL RESOUR, V14, P262, DOI 10.1111/1755-0998.12174; Pramual P, 2013, ENTOMOL SCI, V16, P298, DOI 10.1111/ens.12008; Pramual P, 2012, GENOME, V55, P447, DOI [10.1139/G2012-031, 10.1139/g2012-031]; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; ROTHFELS K, 1989, GENOME, V32, P500, DOI 10.1139/g89-475; ROTHFELS K, 1978, CAN J ZOOL, V56, P1110, DOI 10.1139/z78-155; ROTHFELS K, 1983, CAN J ZOOL, V61, P1220, DOI 10.1139/z83-166; Rowley JJL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128382; SHIELDS GF, 1982, POLAR BIOL, V1, P181, DOI 10.1007/BF00287005; Sriphirom P, 2014, GENOME, V57, P45, DOI 10.1139/gen-2013-0145; Sterling E. J., 2007, VIETNAM NATURAL HIST; Sterling Eleanor J., 2005, Proceedings of the California Academy of Sciences, V56, P98; Takano KT, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-41; Takaoka H, 2014, TROP BIOMED, V31, P742; Takaoka H., 1984, Japanese Journal of Sanitary Zoology, V35, P7; Takaoka H, 2016, BLACK FLIES; Takaoka H, 2015, ZOOTAXA, V3961, P1, DOI 10.11646/zootaxa.3961.1.1; Takaoka H, 2014, ZOOTAXA, V3866, P555, DOI 10.11646/zootaxa.3866.4.6; Takaoka H, 2014, ZOOTAXA, V3838, P347, DOI 10.11646/zootaxa.3838.3.6; Tangkawanit U, 2009, ZOOTAXA, P31, DOI 10.11646/zootaxa.2048.1.2; Tangkawanit U, 2009, ZOOL J LINN SOC-LOND, V155, P289, DOI 10.1111/j.1096-3642.2008.00433.x; Low VL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20346; Wikramanayake E., 2002, TERRESTRIAL ECOREGIO	57	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163881	10.1371/journal.pone.0163881	http://dx.doi.org/10.1371/journal.pone.0163881			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695048	Green Published, gold			2022-12-27	WOS:000385553100061
J	Ganguly, S; Kumar, GT; Mantha, S; Panda, K				Ganguly, Souradipta; Kumar, Taposh G.; Mantha, Sudarshan; Panda, Koustubh			Simultaneous Determination of Black Tea-Derived Catechins and Theaflavins in Tissues of Tea Consuming Animals Using Ultra-Performance Liquid-Chromatography Tandem Mass Spectrometry	PLOS ONE			English	Article							GREEN TEA; HEART-DISEASE; POLYPHENOLS; PLASMA; CANCER; RAT; GLUCURONIDATION; PHARMACOKINETICS; METHYLATION; METABOLITES	The bioavailability, tissue distribution and metabolic fate of the major tea polyphenols, catechins and theaflavins as well as their gallated derivatives are yet to be precisely elucidated on a single identification platform for assessment of their relative bioefficacy in vivo. This is primarily due to the lack of suitable analytical tools for their simultaneous determination especially in an in vivo setting, which continues to constrain the evaluation of their relative health beneficiary potential and therefore prospective therapeutic application. Herein, we report a rapid and sensitive Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry (UPLC-MS/MS) based method for the simultaneous determination of the major catechins and theaflavins in black tea infusions as well as in different vital tissues and body fluids of tea-consuming guinea pigs. This method allowed efficient separation of all polyphenols within seven minutes of chromatographic run and had a lower limit of quantification (LLOQ) of similar to 5 ng/ml. Using this method, almost all bioactive catechins and theaflavins could be simultaneously detected in the plasma of guinea pigs orally administered 5% black tea for 14 days. Our method could further detect the majority of these polyphenols in the lung and kidney as well as identify the major catechin metabolites in the urine of the tea-consuming animals. Overall, our study presents a novel tool for simultaneous detection and quantitation of both catechins and theaflavins in a single detection platform that could potentially enable precise elucidation of their relative bioavailability and bioefficacy as well as true health beneficiary potential in vivo. Such information would ultimately facilitate the accurate designing of therapeutic strategies utilizing high efficacy formulations of tea polyphenols for effective mitigation of oxidative damage and inflammation in humans as well as prevention of associated diseases.	[Ganguly, Souradipta; Panda, Koustubh] Univ Calcutta, Dept Biotechnol, Kolkata, India; [Ganguly, Souradipta; Panda, Koustubh] Univ Calcutta, Guha Ctr Genet Engn & Biotechnol, Kolkata, India; [Kumar, Taposh G.; Mantha, Sudarshan] Waters India Private Ltd, Waters Applicat Lab, Bangalore, Karnataka, India	University of Calcutta; University of Calcutta	Panda, K (corresponding author), Univ Calcutta, Dept Biotechnol, Kolkata, India.; Panda, K (corresponding author), Univ Calcutta, Guha Ctr Genet Engn & Biotechnol, Kolkata, India.	kpbcg@caluniv.ac.in	Panda, Koustubh/E-5273-2017	Panda, Koustubh/0000-0002-4783-2221	Tea Board of India, Govt. of India [RL 21 (20) /2007/Part-I/4103]	Tea Board of India, Govt. of India	Financial support for this work was received from Tea Board of India, Govt. of India to KP (Sanction No. RL 21 (20) /2007/Part-I/4103). The funder (Tea Board of India, Govt. of India) provided support in the form of salary (research fellowship) for SG (first author) and funds for procurement of chemicals, equipment and other research materials to KP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of SG and KP in the study are clearly described in the 'author contributions' section. Neither Waters India Pvt. Ltd. nor its Application Scientists TG and SM, serving as co-authors in this manuscript, were involved in any form in the funding or designing of the study but providing assistance in operating of the instruments, acquisition and processing of data (TG & SM) as well as preparation of manuscript (SM).	AITIO A, 1973, XENOBIOTICA, V3, P13, DOI 10.3109/00498257309151496; Banerjee Shuvojit, 2007, J Inflamm (Lond), V4, P3, DOI 10.1186/1476-9255-4-3; BORGHOFF SJ, 1985, DRUG METAB DISPOS, V13, P62; Chen LS, 1997, DRUG METAB DISPOS, V25, P1045; Chhabra SK, 2001, EPIDEMIOL REV, V23, P106, DOI 10.1093/oxfordjournals.epirev.a000774; Chu KO, 2004, J CHROMATOGR B, V810, P187, DOI 10.1016/j.jchromb.2004.07.031; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; Fu T, 2008, J CHROMATOGR B, V875, P363, DOI 10.1016/j.jchromb.2008.09.027; Henning SM, 2004, AM J CLIN NUTR, V80, P1558; Henning SM, 2003, NUTR CANCER, V45, P226, DOI 10.1207/S15327914NC4502_13; Henning SM, 2006, J NUTR, V136, P1839, DOI 10.1093/jn/136.7.1839; Hertog MGL, 1997, AM J CLIN NUTR, V65, P1489, DOI 10.1093/ajcn/65.5.1489; HJELLE JT, 1986, J PHARMACOL EXP THER, V236, P150; Kadian N, 2016, J PHARMACEUT BIOMED, V126, P83, DOI 10.1016/j.jpba.2016.03.052; Kida K, 2000, J AGR FOOD CHEM, V48, P4151, DOI 10.1021/jf000386x; Kim SB, 2000, NUTR CANCER, V37, P41, DOI 10.1207/S15327914NC3701_5; Kohri T, 2001, J AGR FOOD CHEM, V49, P1042, DOI 10.1021/jf0011236; Lambert JD, 2003, J NUTR, V133, p3262S, DOI 10.1093/jn/133.10.3262S; Lee BL, 2000, J CHROMATOGR A, V881, P439, DOI 10.1016/S0021-9673(00)00215-6; LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393; Lee MJ, 2000, ANAL BIOCHEM, V279, P164, DOI 10.1006/abio.2000.4487; Lin LC, 2007, J AGR FOOD CHEM, V55, P1517, DOI 10.1021/jf062816a; Lu H, 2003, DRUG METAB DISPOS, V31, P572, DOI 10.1124/dmd.31.5.572; Masukawa Y, 2006, J CHROMATOGR B, V834, P26, DOI 10.1016/j.jchromb.2006.02.008; Mata-Bilbao MDL, 2007, J AGR FOOD CHEM, V55, P8857, DOI [10.1021/jf0713962, 10.1021/if0713962]; Misaka S, 2013, BIOMED CHROMATOGR, V27, P1, DOI 10.1002/bmc.2740; Misra A, 2003, J NUTR, V133, P2622, DOI 10.1093/jn/133.8.2622; Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7; MUNROE DG, 1987, AM J HUM GENET, V40, P102; Nakagawa K, 1997, ANAL BIOCHEM, V248, P41, DOI 10.1006/abio.1997.2098; Peterson J, 2004, J FOOD COMPOS ANAL, V17, P397, DOI 10.1016/j.jfca.2004.03.022; Pry, 2008, CLIN BIOCHEM REV, V29, pS49; Rietveld A, 2003, J NUTR, V133, p3285S, DOI 10.1093/jn/133.10.3285S; Rimm EB, 1996, ANN INTERN MED, V125, P384, DOI 10.7326/0003-4819-125-5-199609010-00005; Stalmach A, 2010, MOL NUTR FOOD RES, V54, P323, DOI 10.1002/mnfr.200900194; Stangl V, 2006, MOL NUTR FOOD RES, V50, P218, DOI 10.1002/mnfr.200500118; Suzuki Y, 2005, J EPIDEMIOL, V15, P118, DOI 10.2188/jea.15.118; Vaidyanathan JB, 2002, DRUG METAB DISPOS, V30, P897, DOI 10.1124/dmd.30.8.897; Viswanathan CT, 2007, PHARM RES, V24, P1962, DOI 10.1007/s11095-007-9291-7; Wang PW, 2012, FOOD FUNCT, V3, P635, DOI 10.1039/c2fo10254d; Warden BA, 2001, J NUTR, V131, P1731, DOI 10.1093/jn/131.6.1731; Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641; Yang CS, 2006, MOL CARCINOGEN, V45, P431, DOI 10.1002/mc.20228; Yang CS, 1999, CANCER EPIDEM BIOMAR, V8, P83; Yang CS, 1998, CANCER EPIDEM BIOMAR, V7, P351; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhu BT, 2000, DRUG METAB DISPOS, V28, P1024; Zhu M, 2001, XENOBIOTICA, V31, P51, DOI 10.1080/00498250010024988; Zimmermann BF, 2013, TEA IN HEALTH AND DISEASE PREVENTION, P387, DOI 10.1016/B978-0-12-384937-3.00032-X	49	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2016	11	10							e0163498	10.1371/journal.pone.0163498	http://dx.doi.org/10.1371/journal.pone.0163498			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DZ0TR	27695123	Green Published, gold, Green Submitted			2022-12-27	WOS:000385553100038
J	Attia, SM; Ahmed, SF; Ansaria, MA; Nadeem, A; Al-Shabanah, OA; Al-Harbi, MM; Bakheet, SA				Attia, Sabry M.; Ahmed, Sheikh F.; Ansaria, Mushtaq A.; Nadeem, Ahmed; Al-Shabanah, Othman A.; Al-Harbi, Mohammed M.; Bakheet, Saleh A.			Utility of Dexrazoxane for the Attenuation of Epirubicin-Induced Genetic Alterations in Mouse Germ Cells	PLOS ONE			English	Article							BONE-MARROW; BREAST-CANCER; DNA-DAMAGE; SPERM; ANEUPLOIDY; DOXORUBICIN; LEUKEMIA; MICE; ANTHRACYCLINES; MECHANISMS	Dexrazoxane has been approved to treat anthracycline-induced cardiomyopathy and extravasation. However, the effect of dexrazoxane on epirubicin-induced genetic alterations in germ cells has not yet been reported. Thus, the aim of this study was to determine whether dexrazoxane modulates epirubicin-induced genetic damage in the germ cells of male mice. Our results show that dexrazoxane was not genotoxic at the tested doses. Furthermore, it protected mouse germ cells against epirubicin-induced genetic alterations as detected by the reduction in disomic and diploid sperm, spermatogonial chromosomal aberrations, and abnormal sperm heads. The attenuating effect of dexrazoxane was greater at higher dose, indicating a dose-dependent effect. Moreover, sperm motility and count were ameliorated by dexrazoxane pretreatment. Epirubicin induced marked biochemical changes characteristic of oxidative DNA damage including elevated 8-hydroxy-2'-deoxyguanosine levels and reduction in reduced glutathione. Pretreatment of mice with dexrazoxane before epirubicin challenge restored these altered endpoints. We conclude that dexrazoxane may efficiently mitigate the epirubicin insult in male germ cells, and prevent the enhanced risk of abnormal reproductive outcomes and associated health risks. Thus, pretreating patients with dexrazoxane prior to epirubicin may efficiently preserve not only sperm quality but also prevent the transmission of genetic damage to future generations.	[Attia, Sabry M.; Ahmed, Sheikh F.; Ansaria, Mushtaq A.; Nadeem, Ahmed; Al-Shabanah, Othman A.; Al-Harbi, Mohammed M.; Bakheet, Saleh A.] King Saud Univ, Dept Pharmacol & Toxicol, Fac Pharm, Riyadh 11451, Saudi Arabia; [Attia, Sabry M.] Al Azhar Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Al Azhar University	Attia, SM (corresponding author), King Saud Univ, Dept Pharmacol & Toxicol, Fac Pharm, Riyadh 11451, Saudi Arabia.; Attia, SM (corresponding author), Al Azhar Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt.	attiasm@yahoo.com	attia, Sabry M./GRO-6742-2022; Nadeem, Ahmed/ABA-1974-2020; abdullah, othman/AAX-5119-2021; NADEEM, AHMED/AFO-7618-2022; Ahmad, Sheikh Fayaz/R-5853-2017; Bakheet, Saleh A/AEC-8869-2022; Ansari, Mushtaq Ahmad/GQH-7773-2022	Nadeem, Ahmed/0000-0003-2038-8367; NADEEM, AHMED/0000-0003-2038-8367; Ahmad, Sheikh Fayaz/0000-0002-8282-3726; Bakheet, Saleh A/0000-0003-2008-6377; Ansari, Mushtaq Ahmad/0000-0002-3556-5939; Attia, Sabry/0000-0001-8560-8944	Deanship of Scientific Research at King Saud University [RGP-120]	Deanship of Scientific Research at King Saud University(King Saud University)	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project No. RGP-120.	Adler I.-D., 1984, MUTAGENICITY TESTING, P275; Attia S.M., 2008, SAUDI PHARM J, V16, P1; Attia SM, 2016, MUTAGENESIS, V31, P137, DOI 10.1093/mutage/gev065; Attia SM, 2012, MUTAT RES-GEN TOX EN, V741, P22, DOI 10.1016/j.mrgentox.2011.10.008; Attia SM, 2010, OXID MED CELL LONGEV, V3, P238, DOI 10.4161/oxim.3.4.13246; Attia SM, 2009, CANCER CHEMOTH PHARM, V64, P837, DOI 10.1007/s00280-009-0934-8; Attia SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109942; Attia SM, 2002, MUTAT RES-GEN TOX EN, V520, P1, DOI 10.1016/S1383-5718(02)00079-7; Bakheet SA, 2011, MUTAGENESIS, V26, P533, DOI 10.1093/mutage/ger013; BENDER MA, 1973, MUTAT RES, V20, P403, DOI 10.1016/0027-5107(73)90061-4; Bishop JB, 1996, ENVIRON MOL MUTAGEN, V28, P159; Cavallini G, 2006, ASIAN J ANDROL, V8, P143, DOI 10.1111/j.1745-7262.2006.00123.x; Collodel G, 2007, HUM REPROD, V22, P1893, DOI 10.1093/humrep/dem099; Diop NK, 2000, J INORG BIOCHEM, V78, P209, DOI 10.1016/S0162-0134(00)00013-1; El-Mahdy O, 2000, MUTAT RES-GEN TOX EN, V468, P109, DOI 10.1016/S1383-5718(00)00047-4; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fritz B, 2001, EUR J HUM GENET, V9, P910, DOI 10.1038/sj.ejhg.5200741; Galetta F, 2010, BIOMED PHARMACOTHER, V64, P259, DOI 10.1016/j.biopha.2009.06.018; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; GRANKVIST K, 1987, BIOSCIENCE REP, V7, P653, DOI 10.1007/BF01127678; HACKERKLOM UB, 1986, MUTAT RES, V160, P39, DOI 10.1016/S0027-5107(96)90007-X; Hasinoff Brian B, 2002, Cardiovasc Toxicol, V2, P111, DOI 10.1385/CT:2:2:111; Hofland KF, 2005, CLIN CANCER RES, V11, P3915, DOI 10.1158/1078-0432.CCR-04-2343; Hortobagyi GN, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700544-00003; Lipshultz SE, 2004, NEW ENGL J MED, V351, P145, DOI 10.1056/NEJMoa035153; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marint Rh, 1999, ZYGOTE, V7, P131, DOI [10.1017/S0967199499000489, DOI 10.1017/S0967199499000489]; Martin RH, 1999, ZYGOTE, V7, P131, DOI 10.1017/S0967199499000489; Marty M, 2006, ANN ONCOL, V17, P614, DOI 10.1093/annonc/mdj134; Organization WH, 1992, WORLD HLTH ORG LAB M, P23; Palo AK, 2009, MUTAT RES-GEN TOX EN, V673, P29, DOI 10.1016/j.mrgentox.2008.11.007; Pearlman M, 2003, LEUKEMIA RES, V27, P617, DOI 10.1016/S0145-2126(02)00273-4; PEDERSENBJERGAARD J, 1992, J CLIN ONCOL, V10, P1444, DOI 10.1200/JCO.1992.10.9.1444; Praga C, 2005, J CLIN ONCOL, V23, P4179, DOI 10.1200/JCO.2005.05.029; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Schmid TE, 2001, MUTAGENESIS, V16, P339, DOI 10.1093/mutage/16.4.339; Sen AK, 2010, Z NATURFORSCH C, V65, P211; Shen HM, 2000, FREE RADICAL BIO MED, V28, P529, DOI 10.1016/S0891-5849(99)00234-8; Silva LM, 2002, TERATOGEN CARCIN MUT, V22, P257, DOI 10.1002/tcm.10019; Simon B, 2005, CA-CANCER J CLIN, V55, P211, DOI 10.3322/canjclin.55.4.211; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; Tempest HG, 2004, CYTOGENET GENOME RES, V107, P83, DOI 10.1159/000079575; van der Kooi EL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003907.pub2; WYROBEK AJ, 1975, P NATL ACAD SCI USA, V72, P4425, DOI 10.1073/pnas.72.11.4425; Yan TD, 2009, MOL CANCER THER, V8, P1075, DOI 10.1158/1535-7163.MCT-09-0139; Zhang JJ, 2010, J CLIN BIOCHEM NUTR, V47, P238, DOI 10.3164/jcbn.10-64	47	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0163703	10.1371/journal.pone.0163703	http://dx.doi.org/10.1371/journal.pone.0163703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690233	Green Published, gold, Green Submitted			2022-12-27	WOS:000384329200021
J	Jia, YZ; Chang, HC; Schipma, MJ; Liu, J; Shete, V; Liu, N; Sato, T; Thorp, EB; Barger, PM; Zhu, YJ; Viswakarma, N; Kanwar, YS; Ardehali, H; Thimmapaya, B; Reddy, JK				Jia, Yuzhi; Chang, Hsiang-Chun; Schipma, Matthew J.; Liu, Jing; Shete, Varsha; Liu, Ning; Sato, Tatsuya; Thorp, Edward B.; Barger, Philip M.; Zhu, Yi-Jun; Viswakarma, Navin; Kanwar, Yashpal S.; Ardehali, Hossein; Thimmapaya, Bayar; Reddy, Janardan K.			Cardiomyocyte-Specific Ablation of Med1 Subunit of the Mediator Complex Causes Lethal Dilated Cardiomyopathy in Mice (vol 11, e0160755, 2016)	PLOS ONE			English	Correction														Thorp, Edward/0000-0003-1387-7058	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097249] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK097249] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Jia YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160755	1	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2016	11	9							e0164316	10.1371/journal.pone.0164316	http://dx.doi.org/10.1371/journal.pone.0164316			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4CZ	27690354	Green Published, Green Submitted, gold			2022-12-27	WOS:000384329200041
J	Extremera, N; Rey, L				Extremera, Natalio; Rey, Lourdes			Attenuating the Negative Impact of Unemployment: The Interactive Effects of Perceived Emotional Intelligence and Well-Being on Suicide Risk	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUBJECTIVE HAPPINESS; SATISFACTION; HEALTH; DISSATISFACTION; COMPETENCE; SYMPTOMS; DISORDER; IDEATION; DURATION	A growing body of research has demonstrated that deficits in well-being may be related to increased suicide risk, but there is only a limited number of studies that have focused on specific protective factors that can serve as a buffer against suicidal ideation and behaviours. Given that unemployment may be a factor leading to increased risk for suicide, this study assessed whether perceived EI might be a potential moderator in the relationship between life satisfaction/happiness and suicidal behaviours in a relatively large sample of unemployed individuals. Participants were 1125 unemployed (506 men and 619 women) who completed satisfaction with life and happiness questionnaires, the Suicidal Behaviours Questionnaire and the Wong and Law Emotional Intelligence Test. Consistent with the interaction hypothesis, lower scores in life satisfaction and happiness were associated with higher levels of current suicidal behaviours, and perceived EI scores moderated these relationships. Interventions targeting well-being via the promotion of emotional abilities may be useful in the prevention of suicidal ideation in the unemployed. The implications for these findings for research and practice are discussed.	[Extremera, Natalio] Univ Malaga, Dept Social Psychol, Malaga, Spain; [Rey, Lourdes] Univ Malaga, Dept Personal Evaluat & Psychol Treatment, Malaga, Spain	Universidad de Malaga; Universidad de Malaga	Extremera, N (corresponding author), Univ Malaga, Dept Social Psychol, Malaga, Spain.	nextremera@uma.es	Extremera, Natalio/AAA-3716-2021; Extremera, Natalio/K-5882-2015; Rey Peña, Lourdes/Y-2020-2019; Pacheco, Natalio Extremera/AAA-7123-2021	Extremera, Natalio/0000-0002-8874-7912; Rey Peña, Lourdes/0000-0003-1394-1646; Pacheco, Natalio Extremera/0000-0002-8874-7912	Spanish Ministry of Economy and Competitiveness [PSI2012-38813]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This research was supported by the Spanish Ministry of Economy and Competitiveness (Grant PSI2012-38813): NE and LR.	Atienza FL, 2003, PERS INDIV DIFFER, V35, P1255, DOI 10.1016/S0191-8869(02)00332-X; Bray I, 2006, SOC PSYCH PSYCH EPID, V41, P333, DOI 10.1007/s00127-006-0049-z; Catanzaro SJ, 2000, SUICIDE SCI EXPANDIN, P81; Cha CB, 2009, J AM ACAD CHILD PSY, V48, P422, DOI 10.1097/CHI.0b013e3181984f44; Ciarrochi J, 2002, PERS INDIV DIFFER, V32, P197, DOI 10.1016/S0191-8869(01)00012-5; Crum A. J., 2013, OXFORD HDB HAPPINESS, P73, DOI [10.1093 /oxfordhb /9780199557257.013.0006, DOI 10.1093/OXFORDHB/9780199557257.013.0006]; Daly MC, 2009, J EUR ECON ASSOC, V7, P539, DOI 10.1162/JEEA.2009.7.2-3.539; Delfabbro PH, 2013, J AFFECT DISORDERS, V151, P514, DOI 10.1016/j.jad.2013.06.036; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eng W, 2005, J ANXIETY DISORD, V19, P143, DOI 10.1016/j.janxdis.2004.01.007; Extremera N, 2014, SOC INDIC RES, V119, P473, DOI 10.1007/s11205-013-0497-2; Frisch MB, 2000, SOC INDIC RES SER, V4, P207; Gili M, 2013, EUR J PUBLIC HEALTH, V23, P103, DOI DOI 10.1093/EURPUBECKS035; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hirsch JK, 2009, CRISIS, V30, P48, DOI 10.1027/0227-5910.30.1.48; Hodzic S, 2015, APPL PSYCHOL-HLTH WE, V7, P275, DOI 10.1111/aphw.12048; Hodzic S, 2015, J VOCAT BEHAV, V88, P28, DOI 10.1016/j.jvb.2015.02.007; Jahoda M., 1982, EMPLOYMENT UNEMPLOYM; Karim J, 2014, APPL RES QUAL LIFE, V9, P733, DOI 10.1007/s11482-013-9267-1; Kassenboehmer SC, 2009, ECON J, V119, P448, DOI 10.1111/j.1468-0297.2008.02246.x; Keefer KV, 2009, SPRINGER SER HUM EXC, P191, DOI 10.1007/978-0-387-88370-0_11; Kleiman EM, 2013, PERS INDIV DIFFER, V55, P595, DOI 10.1016/j.paid.2013.05.002; Koivumaa-Honkanen H, 2002, ACTA PSYCHIAT SCAND, V105, P444, DOI 10.1034/j.1600-0447.2002.01287.x; Koivumaa-Honkanen H, 2001, AM J PSYCHIAT, V158, P433, DOI 10.1176/appi.ajp.158.3.433; Koivumaa-Honkanen H, 2000, AM J EPIDEMIOL, V152, P983, DOI 10.1093/aje/152.10.983; Kotsou I, 2011, J APPL PSYCHOL, V96, P827, DOI 10.1037/a0023047; Lazarus R.S., 1999, STRESS EMOTION NEW S; LINEHAN MM, 1983, J CONSULT CLIN PSYCH, V51, P276, DOI 10.1037/0022-006X.51.2.276; Lucas RE, 2004, PSYCHOL SCI, V15, P8, DOI 10.1111/j.0963-7214.2004.01501002.x; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Martins A, 2010, PERS INDIV DIFFER, V49, P554, DOI 10.1016/j.paid.2010.05.029; Mayer J. D., 1997, EMOTIONAL DEV EMOTIO, P3, DOI DOI 10.1177/1066480710387486; Mayer JD, 2004, PSYCHOL INQ, V15, P197, DOI 10.1207/s15327965pli1503_02; Mayer JD, 2008, ANNU REV PSYCHOL, V59, P507, DOI 10.1146/annurev.psych.59.103006.093646; McKee-Ryan FM, 2005, J APPL PSYCHOL, V90, P53, DOI 10.1037/0021-9010.90.1.53; Milner A, 2014, PSYCHOL MED, V44, P909, DOI 10.1017/S0033291713001621; Milner A, LONG TERM UNEMPLOYME, DOI [10.1371/journal.pone.0051333, DOI 10.1371/JOURNAL.PONE.0051333]; Nelis D, 2011, EMOTION, V11, P354, DOI 10.1037/a0021554; Nelis D, 2009, PERS INDIV DIFFER, V47, P36, DOI 10.1016/j.paid.2009.01.046; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Paradiso S, 2016, J CLIN EXP NEUROPSYC, V38, P887, DOI 10.1080/13803395.2016.1172558; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Pena M, 2012, REV PSICODIDACT, V17, P341, DOI 10.1387/RevPsicodidact.1220; Ponizovsky AM, 2003, COMPR PSYCHIAT, V44, P442, DOI 10.1016/S0010-440X(03)00146-9; Rajappa K, 2012, COGNITIVE THER RES, V36, P833, DOI 10.1007/s10608-011-9419-2; Rissanen T, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-140; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Salovey P., 1999, COPING PSYCHOL WHAT, P141, DOI DOI 10.1093/MED:PSYCH/9780195119343.003.0007; SALOVEY P, 2001, EMOTIONAL INTELLIGEN, P168; Sanchez-Alvarez N, 2016, J POSIT PSYCHOL, V11, P276, DOI 10.1080/17439760.2015.1058968; Schutte NS, 2007, PERS INDIV DIFFER, V42, P921, DOI 10.1016/j.paid.2006.09.003; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Stankunas M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-174; TIGGEMANN M, 1984, J OCCUP PSYCHOL, V57, P33, DOI 10.1111/j.2044-8325.1984.tb00145.x; Tucker RP, 2013, PERS INDIV DIFFER, V54, P610, DOI 10.1016/j.paid.2012.11.023; Urbanos-Garrido RM, 2015, EUR J HEALTH ECON, V16, P175, DOI 10.1007/s10198-014-0563-y; van Heck G. L., 2008, EMOTION REGULATION C, P97; Wanberg CR, 2012, ANNU REV PSYCHOL, V63, P369, DOI 10.1146/annurev-psych-120710-100500; WINEFIELD AH, 1992, J OCCUP ORGAN PSYCH, V65, P213, DOI 10.1111/j.2044-8325.1992.tb00499.x; WINEFIELD AH, 1989, J OCCUP PSYCHOL, V62, P327, DOI 10.1111/j.2044-8325.1989.tb00503.x; WINEFIELD AH, 1992, J OCCUP ORGAN PSYCH, V65, P307, DOI 10.1111/j.2044-8325.1992.tb00507.x; Winkelmann L, 1998, ECONOMICA, V65, P1, DOI 10.1111/1468-0335.00111; Wong CS, 2002, LEADERSHIP QUART, V13, P243, DOI 10.1016/S1048-9843(02)00099-1; Woolery A., 2004, EMOTIONAL EXPRESSION, P154	64	22	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2016	11	9							e0163656	10.1371/journal.pone.0163656	http://dx.doi.org/10.1371/journal.pone.0163656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DX4CV	27685996	Green Submitted, gold, Green Published			2022-12-27	WOS:000384328500088
